<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
<url><loc>https://ascopost.com/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/topics/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/topics/ai-in-oncology/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/bladder-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/breast-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/cardio-oncology/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/cns-cancers/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/colorectal-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/cost-of-care/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/infectious-diseases/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/gastrointestinal-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/genomicsgenetics/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/geriatric-oncology/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/global-cancer-care/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/gynecologic-cancers/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/head-and-neck-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/health-care-policy/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/hepatobiliary-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/immunotherapy/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/integrative-oncology/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/kidney-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/leukemia/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/lung-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/lymphoma/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/multiple-myeloma/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/myelodysplastic-syndromes/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/neuroendocrine-tumors/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/pain-management/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/palliative-care/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/pancreatic-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/prostate-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/sarcoma/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/skin-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/survivorship/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/symptom-management/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/thyroid-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/solid-tumors/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/hematologic-malignancies/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/issues-in-oncology/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/genitourinary-cancer/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/topics/myeloproliferative-neoplasms/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/meetings/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/2019-san-antonio-breast-cancer-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-asco-quality-care-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-asco-sitc-clinical-immuno-oncology-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-ash-annual-meeting-and-exposition/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-astro-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-gastrointestinal-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-genitourinary-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-multidisciplinary-head-and-neck-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2020-san-antonio-breast-cancer-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-asco-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-asco-quality-care-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-ash-annual-meeting-and-exposition/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-astro-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-gastrointestinal-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-genitourinary-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-multidisciplinary-thoracic-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-pan-pacific-lymphoma-conference/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2021-san-antonio-breast-cancer-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-asco-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-asco-gastrointestinal-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-asco-genitourinary-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-asco-quality-care-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-ash-annual-meeting-and-exposition/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-astro-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-multidisciplinary-head-and-neck-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2022-san-antonio-breast-cancer-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-asco-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-asco-breakthrough-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-asco-gastrointestinal-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-asco-genitourinary-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-ash/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-sabcs/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/meetings/2023-sso-international-conference-on-surgical-cancer-care/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-asco-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-asco-gi-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-asco-gu-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-ash-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-jadpro-live/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-multidisciplinary-head-and-neck-cancers-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-nccn-annual-conference/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-sabcs/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2024-society-of-surgical-oncology-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2025-asco-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2025-asco-gi/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2025-asco-gu/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2025-tandem-meetings/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2026-asco-gi/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/2026-asco-gu/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/24th-suo-annual-meeting/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/42nd-annual-chemotherapy-foundation-symposium/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-annual-meeting-2026/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-annual-meeting-2021/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-annual-meeting-2022/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-annual-meeting-2023/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-annual-meeting-2024/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-virtual-annual-meeting-2020-i/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-virtual-annual-meeting-2020-ii/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-virtual-meeting-covid-19-and-cancer-2020/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-virtual-meeting-covid-19-and-cancer-2021/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/asco-2026/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/asco20-virtual-education-program/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/asco20-virtual-scientific-program/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/ash-2025/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/covid-19-and-cancer-care/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/eha-2021-virtual-congress/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/eha-hybrid-congress-2023/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/eha-2022-congress/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/eha25-virtual/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-congress-2021/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-congress-2022/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-congress-2023/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-congress-2024/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-congress-2025/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-virtual-congress-2020/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/first-international-summit-on-interventional-pharmacoeconomics/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/iaslc-2020-wclc-singapore/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/iaslc-2021-wclc/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/iaslc-2023-wclc/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/meetings/iaslc-2025-wclc/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/iaslc-2024-wclc/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/ibc-east-2024/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/ibc-west-2024/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/jadpro-live-2025/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/lynn-sage-breast-cancer-symposium-2024/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/nccn-2020-virtual-annual-conference/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/nccn-2021-virtual-annual-conference/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/nccn-2021-virtual-congress-hematologic-malignancies/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/nccn-2022-annual-conference/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/nccn-2023-annual-conference/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/quantitative-imaging-workshop-xvii/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/2025-sabcs/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/meetings/sgo-2021-virtual-annual-meeting-on-womens-cancer/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/sgo-2022-annual-meeting-on-womens-cancer/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/sgo-2023-annual-meeting-on-womens-cancer/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/sgo-2024-annual-meeting-on-womens-cancer/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/sitc-2021/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/sitc-2022/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/soho-2021/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/soho-2025/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/coverage/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/meetings/iaslc-wclc-2026/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-congress-2026/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/meetings/cleveland-clinic-ai-summit/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/asco-breakthrough-2026/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-ai-digital-oncology/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/38th-ena-symposium-on-molecular-targets-and-cancer-therapeutics/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/her2plus-targeted-therapy-cardiovascular-risk-epidemiology-and-monitoring/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/hpb-gi-oncology-conference-2026/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/27th-annual-meeting-of-the-suo/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/aci-a-focus-on-intratumoral-therapies-vaccines-and-cytokines/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/3rd-annual-world-conference-on-genitourinary-cancers/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/nccn-2026-lung-cancer-congress/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/aacr-special-conference-in-cancer-research-advances-in-the-pathogenesis-and-immune-therapies-of-liver-cancer/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/2026-san-antonio-breast-cancer-symposium/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/8th-international-prostate-cancer-symposium-and-world-urologic-oncology/</loc><lastmod>2026-11-16</lastmod></url>
<url><loc>https://ascopost.com/meetings/2026-ash-annual-meeting-and-exposition/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/meetings/esmo-immuno-oncology-and-advanced-therapies-congress-2026/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/meetings/2027-asco-gi-cancers-symposium/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/meetings/24th-annual-miami-lung-cancer-conference/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/sections/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/news/</loc><lastmod>2026-08-07</lastmod></url>
<url><loc>https://ascopost.com/sections/news/announcements/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/news/from-the-journals/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/news/fda-update/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/news/direct-from-asco/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/insights/</loc><lastmod>2026-08-07</lastmod></url>
<url><loc>https://ascopost.com/sections/insights/features/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/insights/opinions/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/sections/insights/profiles/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/study-finds-patients-with-colon-cancer-and-obesity-receiving-glp-1-ras-had-significantly-reduced-risk-of-mortality/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/a-battle-with-my-blood/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/novel-endocrine-therapy-giredestrant-improves-invasive-disease-free-survival-in-estrogen-receptor-positive-her2-negative-early-breast-cancer/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/in-head-to-head-comparison-fixed-duration-treatment-noninferior-to-continuous-for-previously-untreated-cll/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/survey-finds-most-people-trust-ai-less-than-physicians-but-see-its-potential-for-cancer-diagnosis/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/using-ai-to-ensure-that-all-patients-with-cancer-have-access-to-precision-oncology-care/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/acs-guidelines-for-cervical-cancer-self-collected-hpv-testing-now-included/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/majestec-3-unprecedented-benefit-in-previously-treated-multiple-myeloma/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/evolving-treatment-landscape-spurs-living-guideline-update-on-multiple-myeloma/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/new-asco-guideline-addresses-management-of-cancer-during-pregnancy-from-diagnosis-through-survivorship/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/deb-schrag-md-mph-fasco-elected-2027-2028-asco-president/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/novel-her2-targeted-bispecific-improves-outcomes-in-patients-with-gastroesophageal-cancer/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/high-neighborhood-fast-food-expenditure-and-early-onset-colorectal-cancer/</loc><lastmod>2025-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/ai-based-imaging-model-predicts-extranodal-extension-burden-and-improves-risk-stratification-in-oropharyngeal-cancer/</loc><lastmod>2026-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/braf-v600e-mutant-colorectal-cancer-first-line-encorafenib-cetuximab-and-folfiri/</loc><lastmod>2026-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/triplet-therapy-demonstrates-superior-progression-free-survival-in-first-line-dmmr-msi-h-metastatic-colorectal-cancer/</loc><lastmod>2026-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/do-glp-1-ras-reduce-the-risk-of-developing-colorectal-cancer-more-than-aspirin/</loc><lastmod>2026-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/physical-activity-and-fatigue-qol-in-nonmetastatic-crc/</loc><lastmod>2026-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/atezolizumab-vs-placebo-with-bevacizumab-and-nonplatinum-chemotherapy-for-recurrent-ovarian-cancer/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/her2-positive-gastroesophageal-cancer-zanidatamab-plus-chemotherapy-prolongs-progression-free-survival/</loc><lastmod>2026-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/adjuvant-epirubicin-plus-cyclophosphamide-followed-by-taxane-with-or-without-carboplatin-in-early-stage-triple-negative-breast-cancer/</loc><lastmod>2026-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/addition-of-epcoritamab-to-lenalidomide-plus-rituximab-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2026-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/cancer-mortality-according-to-occupation-in-the-united-states/</loc><lastmod>2026-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/molecular-profile-based-adjuvant-treatment-in-high-intermediate-risk-endometrial-cancer/</loc><lastmod>2026-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/anaplastic-glioma-concurrent-vs-adjuvant-temozolomide/</loc><lastmod>2026-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/fda-increases-flexibility-on-requirements-for-cell-and-gene-therapies/</loc><lastmod>2026-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/addition-of-postoperative-nivolumab-to-cisplatin-and-radiotherapy-in-high-risk-locally-advanced-hnscc/</loc><lastmod>2026-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/addition-of-nivolumab-to-docetaxel-in-arpi-pretreated-chemotherapy-naive-mcrpc/</loc><lastmod>2026-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/pirtobrutinib-vs-ibrutinib-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/</loc><lastmod>2026-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/multiple-myeloma-sex-differences-in-etiology-and-clinical-presentation/</loc><lastmod>2026-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/can-dna-testing-of-colorectal-polyps-improve-insight-into-genetic-risks/</loc><lastmod>2026-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/a-novel-paradigm-in-acute-kidney-injury-congestive-nephropathy-in-rcc-with-ivc-thrombus/</loc><lastmod>2026-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/county-level-obesity-prevalence-may-predict-obesity-related-cancer-rates-in-young-adults/</loc><lastmod>2026-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/addition-of-tafasitamab-to-lenalidomide-plus-rituximab-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2026-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/determining-the-optimal-duration-of-androgen-deprivation-therapy-added-to-definitive-radiotherapy-in-localized-prostate-cancer/</loc><lastmod>2026-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/astro-relaunches-research-foundation-under-a-single-focused-identity/</loc><lastmod>2026-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/hcc-real-world-patterns-of-systemic-therapy-sequencing-and-survival/</loc><lastmod>2025-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/early-results-show-pirtobrutinib-matches-ibrutinib-in-btk-inhibitor-naive-cll/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/prostate-cancer-novel-psma-targeted-radioligand-shows-reduced-salivary-gland-uptake-in-preclinical-studies/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/are-food-preservatives-linked-to-increased-cancer-risk/</loc><lastmod>2026-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/small-study-examines-potential-of-artificial-saliva-in-patients-with-head-and-neck-cancer/</loc><lastmod>2026-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/researchers-create-immune-cell-atlas-of-bone-marrow-in-patients-with-multiple-myeloma/</loc><lastmod>2026-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/wgs-based-classifier-better-predicts-hrd-across-cancer-types/</loc><lastmod>2026-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/nivolumab-plus-avd-reduces-disease-progression-risk-in-advanced-classical-hodgkin-lymphoma/</loc><lastmod>2026-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/machine-learning-approach-accelerates-discovery-of-novel-cdk9-inhibitors/</loc><lastmod>2026-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/machine-learning-guided-optical-biopsy-accurately-identifies-malignant-lung-nodules-intraoperatively/</loc><lastmod>2026-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/improved-contralateral-breast-cancer-risk-knowledge-with-personalized-counseling-tool/</loc><lastmod>2026-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/genetic-predisposition-to-higher-body-mass-index-linked-to-mortality-after-breast-cancer/</loc><lastmod>2026-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/sclc-small-study-tests-efficacy-of-ctcs-in-predicting-response-to-tarlatamab/</loc><lastmod>2026-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/can-a-genetic-variant-affect-the-efficacy-of-abiraterone/</loc><lastmod>2026-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/global-cancer-survival-gaps-assessed-using-a-country-level-machine-learning-framework/</loc><lastmod>2026-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/ctdna-positivity-after-neoadjuvant-t-dm1-may-predict-her2-positive-breast-cancer-recurrence/</loc><lastmod>2026-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/breast-cancer-risk-may-be-linked-to-physical-activity-levels-in-adolescence/</loc><lastmod>2026-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/hcc-llm-advice-and-treatment-concordance/</loc><lastmod>2026-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/axillary-recurrence-with-or-without-alnd-in-patients-with-residual-micrometastases-after-neoadjuvant-chemotherapy-for-breast-cancer/</loc><lastmod>2026-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/impt-vs-imrt-in-oropharyngeal-cancer/</loc><lastmod>2026-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/regulatory-agencies-establish-principles-of-good-ai-use-in-drug-development/</loc><lastmod>2026-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/investigational-vaccine-intercepts-cancer-cells-in-lynch-syndrome-carriers/</loc><lastmod>2026-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/popular-supplement-may-interfere-with-cancer-treatment/</loc><lastmod>2026-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/meningiomas-phase-ii-trial-shows-activity-of-targeted-therapy/</loc><lastmod>2026-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/fda-releases-draft-guidance-for-use-of-mrd-and-cr-as-primary-endpoints-in-multiple-myeloma-trials/</loc><lastmod>2026-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/limited-or-no-state-regulation-of-stld-health-plans-linked-to-decreases-in-timely-cancer-treatment-initiation/</loc><lastmod>2026-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/past-nci-director-and-asco-president-elected-president-of-the-national-academy-of-medicine/</loc><lastmod>2026-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/phased-variant-ctdna-as-biomarker-after-first-line-treatment-in-lbcl/</loc><lastmod>2026-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/dual-antigen-targeting-of-drug-resistant-extramedullary-myeloma/</loc><lastmod>2026-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/most-patients-support-use-of-ai-in-mammogram-readings-survey-reveals/</loc><lastmod>2026-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/medical-societies-caution-misinformation-may-drive-underuse-of-lung-cancer-screening/</loc><lastmod>2026-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/new-report-shows-colorectal-cancer-is-now-leading-cancer-death-among-those-under-50/</loc><lastmod>2026-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/nutrition-muscle-loss-compromises-survival-in-patients-with-cervical-cancer-undergoing-chemoradiotherapy/</loc><lastmod>2026-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/leader-in-global-cancer-care-paul-e-goss-md-phd-dies-at-70/</loc><lastmod>2026-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/pembrolizumab-plus-lenvatinib-in-recurrent-gynecologic-clear-cell-carcinoma/</loc><lastmod>2026-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/cabozantinib-and-temozolomide-in-unresectable-or-metastatic-leiomyosarcoma/</loc><lastmod>2026-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/colorectal-cancer-how-does-lifetime-alcohol-consumption-affect-risk/</loc><lastmod>2026-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/cancer-workforce-challenges-undermine-patient-care-and-jeopardize-momentum-in-research-report-finds/</loc><lastmod>2026-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/cri-launches-open-database-for-immunotherapy-cancer-research/</loc><lastmod>2026-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/outcomes-with-colorectal-cancer-screening-among-childhood-cancer-survivors-who-received-abdominopelvic-radiation/</loc><lastmod>2026-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/addition-of-cetrelimab-to-erdafitinib-in-metastatic-urothelial-carcinoma-with-fgfr-alterations/</loc><lastmod>2026-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/associations-found-between-air-pollutants-and-lung-cancer-subtypes/</loc><lastmod>2026-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/multiple-myeloma-fda-approves-daratumumab-and-hyaluronidase-fihj-in-combination-with-vrd/</loc><lastmod>2026-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/is-long-term-ppi-use-associated-with-increased-gastric-cancer-risk/</loc><lastmod>2026-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/chemoradiation-plus-atezolizumab-in-limited-stage-small-cell-lung-cancer/</loc><lastmod>2026-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/organ-sparing-pelvic-radiotherapy-may-reduce-female-sexual-toxicity/</loc><lastmod>2026-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/can-color-vision-deficiency-impact-survival-in-bladder-or-colorectal-cancer/</loc><lastmod>2026-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/savolitinib-plus-osimertinib-in-advanced-egfr-mutant-met-amplified-nsclc/</loc><lastmod>2026-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/updated-analysis-of-cartitude-4-cilta-cel-in-lenalidomide-refractory-multiple-myeloma/</loc><lastmod>2026-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/advanced-nsclc-dual-vs-single-checkpoint-blockade/</loc><lastmod>2026-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/american-college-of-surgeons-publishes-annual-ncdb-report/</loc><lastmod>2026-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/machine-learning-enhanced-prognostic-scoring-predicts-survival-and-classifies-risk-from-spinal-metastases/</loc><lastmod>2026-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/consensus-recommendations-developed-for-use-of-liquid-nitrogen-spray-cryotherapy-in-barrett-esophagus-esophageal-cancer/</loc><lastmod>2026-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/extended-endocrine-therapy-in-premenopausal-patients-with-node-positive-hormone-receptor-positive-breast-cancer/</loc><lastmod>2026-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/adjuvant-durvalumab-in-resected-early-stage-nsclc/</loc><lastmod>2026-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/ultrasound-guided-dot-may-reduce-unnecessary-breast-biopsies-by-nearly-25/</loc><lastmod>2026-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/aacr-announces-fellows-of-the-aacr-academy-class-of-2026/</loc><lastmod>2026-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/can-kdm6a-mutations-help-guide-treatment-selection-in-bladder-cancer/</loc><lastmod>2026-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/01-january/refractory-lbcl-cd19-targeting-car-t-cell-therapy-plus-rituximab/</loc><lastmod>2026-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/acs-report-shows-5-year-survival-rate-for-all-cancers-combined-has-reached-70/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ash-2025-highlights-in-relapsedrefractory-multiple-myeloma/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/a-paradigm-shift-in-treating-adult-aml/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/colorectal-cancer-liver-metastases-transplant-or-resect/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/breast-cancer-recurrence-risk-determined-by-deep-learning-model-trained-on-histopathologic-slides/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/what-is-causing-a-rise-in-early-onset-gastrointestinal-cancers-including-pancreatic-cancer/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/asco-s-first-living-guideline-in-gu-cancers-reflects-recent-practice-changing-trials-on-systemic-treatment-of-mcrpc/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ai-selected-biomarker-guides-first-line-treatment-selection-in-advanced-pancreatic-cancer/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/adding-encorafenib-and-cetuximab-to-folfiri-shows-benefit-in-braf-mutant-colorectal-cancer/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/first-results-of-phase-iii-olympia-3-odronextamab-plus-chop-in-untreated-dlbcl/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ultra-low-dose-immunotherapy-in-relapsed-or-refractory-solid-tumors/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/fda-approves-pembrolizumab-with-paclitaxel-for-platinum-resistant-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-carcinoma/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/commit-first-line-atezolizumab-plus-folfox-and-bevacizumab-regimen-in-metastatic-colorectal-cancer/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/introducing-asco-ai-in-oncology/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/leader-in-global-cancer-care-paul-e-goss-md-phd-frcpc-frcp-dies-at-70/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/i-used-ai-to-supplement-my-oncology-care-it-reshaped-my-treatment-plan/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/highlights-from-the-2025-ash-annual-meeting-exposition/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/gimema-all2820-chemotherapy-free-regimen-studied-in-front-line-setting/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/epcoritamab-plus-r2-in-follicular-lymphoma-a-potential-new-treatment-standard/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/early-results-demonstrate-safety-and-efficacy-of-mutant-calreticulin-specific-monoclonal-antibody-in-myelofibrosis/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ash-2025-myelofibrosis-roundup/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/early-findings-from-first-human-study-of-in-vivo-car-t-in-myeloma/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/in-head-to-head-comparison-fixed-duration-treatment-noninferior-to-continuous-for-previously-untreated-cll/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/majestec-3-unprecedented-benefit-in-previously-treated-multiple-myeloma/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/pirtobrutinib-improves-progression-free-survival-vs-bendamustinerituximab-in-front-line-cllsll/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/benefit-of-azacitidine-plus-venetoclax-confirmed-in-aml/</loc><lastmod>2026-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/randomized-trial-shows-ai-supported-mammography-improves-sensitivity-and-lowers-interval-cancer-rate/</loc><lastmod>2026-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/head-and-neck-cancer-how-does-genetic-ancestry-impact-tumor-genomics/</loc><lastmod>2026-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/deep-learning-ct-biomarker-predicts-survival-better-than-traditional-measures-in-immunotherapy-treated-advanced-nsclc/</loc><lastmod>2026-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/novel-her2-targeted-bispecific-benefits-outcomes-in-gastroesophageal-cancer/</loc><lastmod>2026-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/adjuvant-aumolertinib-in-egfr-mutated-nsclc/</loc><lastmod>2026-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/overall-survival-with-3-vs-6-months-of-adjuvant-oxaliplatin-plus-fluoropyrimidine-for-colorectal-cancer/</loc><lastmod>2026-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ai-tool-predicts-cardiac-events-in-patients-with-cancer-and-acute-coronary-syndrome/</loc><lastmod>2026-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/new-four-biomarker-blood-panel-may-improve-early-detection-of-pancreatic-cancer/</loc><lastmod>2026-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/studies-move-away-from-whole-brain-radiotherapy-standard-of-care-for-sclc/</loc><lastmod>2026-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/oxybutynin-may-improve-adt-induced-hot-flashes-in-patients-with-prostate-cancer/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/addition-of-palbociclib-to-standard-therapy-in-hormone-receptor-positive-her2-positive-metastatic-breast-cancer/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/world-cancer-day-2026-uiccs-campaign-united-by-unique/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/who-analysis-finds-many-global-cancer-cases-attributable-to-modifiable-risk-factors/</loc><lastmod>2026-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/metastasis-directed-therapy-for-oligometastatic-prostate-cancer/</loc><lastmod>2026-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/first-line-mfolfoxiri-plus-panitumumab-for-rasbraf-wild-type-mcrc/</loc><lastmod>2026-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/new-european-project-cluster-earlyscan-launched-to-advance-early-detection-of-heritable-cancers/</loc><lastmod>2026-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/agent-orange-exposure-linked-with-risk-for-acral-melanoma-in-veterans/</loc><lastmod>2026-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/vte-during-perioperative-therapy-in-resectable-and-borderline-resectable-pancreatic-cancer/</loc><lastmod>2026-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/fda-provides-safety-labeling-update-for-capecitabine-and-fluorouracil-on-risks-associated-with-dpd-deficiency/</loc><lastmod>2026-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/lymph-node-examination-should-be-expanded-to-accurately-assess-metastasis-in-nsclc-research-says/</loc><lastmod>2026-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/self-acupressure-may-ease-fatigue-in-ovarian-cancer-survivors/</loc><lastmod>2026-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ultraprocessed-food-associated-with-increased-mortality-risk-in-cancer-survivors/</loc><lastmod>2026-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/tissue-free-ctdna-and-outcomes-in-patients-with-colorectal-cancer-receiving-folfox-based-adjuvant-therapy/</loc><lastmod>2026-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/guidelines-harmonize-pan-tumor-pathologic-response-to-neoadjuvant-therapy/</loc><lastmod>2026-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/hpv-testing-during-cervical-cancer-screening-potential-convenient-and-noninvasive-method/</loc><lastmod>2026-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/a-new-risk-model-for-esophagectomy-draws-on-the-sts-national-database/</loc><lastmod>2026-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/olaparib-in-metastatic-breast-cancer-with-germline-mutations-in-palb2-or-somatic-mutations-in-brca/</loc><lastmod>2026-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/asco-and-conexiant-launch-asco-ai-in-oncology/</loc><lastmod>2026-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/psma-petct-guided-radiotherapy-after-prostatectomy/</loc><lastmod>2026-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/rural-populations-face-greater-barriers-as-nonmedical-costs-hinder-cancer-clinical-trial-access/</loc><lastmod>2026-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/coa-survey-shows-insurer-utilization-management-interferes-with-cancer-treatment-decisions/</loc><lastmod>2026-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/interval-cancer-rate-with-ai-supported-mammography-screening/</loc><lastmod>2026-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/fda-approves-ttfields-device-for-pancreatic-cancer/</loc><lastmod>2026-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/young-onset-pancreatic-cancer-can-alcohol-consumption-raise-risk/</loc><lastmod>2026-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ash-publishes-clinical-guidelines-on-al-amyloidosis-diagnosis/</loc><lastmod>2026-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/demographic-and-clinicopathologic-factors-in-colorectal-adenoma-recurrence-risk/</loc><lastmod>2026-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/fda-approves-labeling-changes-to-menopausal-hormone-therapy-products/</loc><lastmod>2026-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/oncolytic-virus-triggers-immune-system-against-glioblastoma-cells/</loc><lastmod>2026-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/neoadjuvant-taxane-plus-trastuzumab-and-pertuzumab-with-or-without-carboplatin-in-her2-positive-breast-cancer/</loc><lastmod>2026-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/induction-nivolumab-before-crt-in-high-risk-hpv-driven-opc/</loc><lastmod>2026-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/nonmetastatic-breast-cancer-treatment-strategies-after-denosumab-discontinuation-in-patients-treated-with-aromatase-inhibitors/</loc><lastmod>2026-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ash-guidelines-on-management-of-newly-diagnosed-and-relapsedrefractory-all-in-aya-patients/</loc><lastmod>2026-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/computational-histology-artificial-intelligence-powered-biomarker-for-selection-of-chemotherapy-in-advanced-pancreatic-cancer/</loc><lastmod>2026-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/fda-approves-once-monthly-dosing-schedule-for-amivantamab-and-hyaluronidase-lpuj/</loc><lastmod>2026-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/genetics-pioneer-zsofia-stadler-to-lead-jco-precision-oncology/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/does-diabetes-increase-pancreatic-cystic-neoplasm-risk/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/multidisciplinary-radiopharmaceutical-therapy-symposium-highlights-from-the-inaugural-new-meeting-from-astro/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/high-response-rates-with-front-line-pivekimab-sunirine-in-bpdcn/</loc><lastmod>2026-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/long-term-survival-results-with-addition-of-adjuvant-mfolfox6-to-hepatectomy-in-patients-with-liver-metastases-from-colorectal-cancer/</loc><lastmod>2026-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/stage-ii-melanoma-adjuvant-pembrolizumab-and-risk-of-new-skin-cancers/</loc><lastmod>2026-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ai-tool-classifies-pediatric-brain-tumors-via-liquid-biopsy/</loc><lastmod>2026-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/survival-outcomes-with-or-without-bilateral-risk-reducing-mastectomy-in-brca1brca2-pathogenic-variant-carriers/</loc><lastmod>2026-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/metastasis-directed-therapy-in-oligometastatic-prostate-cancer/</loc><lastmod>2026-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/cllsll-fda-approves-combination-of-acalabrutinib-and-venetoclax/</loc><lastmod>2026-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/inequalities-in-use-of-minimally-invasive-surgical-resection-in-colon-cancer/</loc><lastmod>2026-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/acral-melanoma-ancestry-and-genetics-impact-outcomes/</loc><lastmod>2026-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/can-a-game-based-intervention-reduce-cardiovascular-risk-in-minority-cancer-survivors/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/topline-pfs-results-from-breakwater-in-mcrc-newly-announced/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/ultra-hypofractionated-vs-conventionally-fractionated-rt-for-localized-prostate-cancer-10-year-outcomes/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/pleurectomy-decortication-safe-in-select-patients-with-pleural-mesothelioma/</loc><lastmod>2026-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/new-biomarker-may-predict-chemotherapy-response-in-patients-with-triple-negative-breast-cancer/</loc><lastmod>2026-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/can-a-new-testing-method-allow-more-patients-with-bladder-cancer-to-avoid-radical-cystectomy/</loc><lastmod>2026-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/proximity-to-nuclear-power-plants-and-cancer-risk/</loc><lastmod>2026-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/microplastics-found-in-90-percent-of-prostate-cancer-samples/</loc><lastmod>2026-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/cancer-surgery-outcomes-similar-between-rural-and-urban-facilities/</loc><lastmod>2026-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/adjuvant-coformulated-vibostolimab-plus-pembrolizumab-in-high-risk-stage-iib-to-iv-melanoma/</loc><lastmod>2026-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/mri-based-neoadjuvant-chemotherapy-duration-in-her2-positive-breast-cancer/</loc><lastmod>2026-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/long-term-health-risks-for-testicular-cancer-survivors-differ-by-chemotherapy-regimen/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/cancer-diagnoses-during-covid-19-pandemic-impact-on-1-year-cause-specific-survival/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/effect-of-medicaid-expansion-on-diagnosis-treatment-and-outcomes-in-nsclc/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/variability-of-open-source-ai-models-in-egfr-mutation-prediction-in-lung-cancer/</loc><lastmod>2026-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/nomogram-for-metastasis-directed-sbrt-in-psma-pet-staged-oligorecurrent-prostate-cancer/</loc><lastmod>2026-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/fda-approves-encorafenib-for-metastatic-braf-v600e-mutated-colorectal-cancer/</loc><lastmod>2026-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/sabcs-2025-top-picks-from-a-breast-cancer-specialist/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/advanced-nonsquamous-nsclc-fda-grants-accelerated-approval-to-zongertinib/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/medical-societies-and-more-respond-to-hhs-rfi-on-ai-use-in-clinical-care/</loc><lastmod>2026-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/02-february/perioperative-enfortumab-vedotin-plus-pembrolizumab-may-reduce-risk-of-recurrence-in-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2026-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/new-first-line-targeted-therapy-recommendations-among-updated-asco-guidance-on-gastroesophageal-cancer-management/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/a-decade-of-research-leads-to-new-guidance-on-using-colony-stimulating-factors-in-anticancer-treatment/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/siog-2025-celebrating-25-years-of-leadership-in-geriatric-oncology/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/how-ai-is-already-having-a-significant-impact-on-cancer-care/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/poems-syndrome-diagnostic-clues-from-neuropathy-to-bone-marrow-findings/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/in-celebration-of-a-decades-long-journey-of-discovery-and-innovation/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/integrative-oncology-scholars-program/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ash-2025-myelofibrosis-roundup/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/three-ai-enabled-analyses-highlight-context-dependent-biomarkers-in-early-onset-colorectal-cancer/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/for-most-men-with-prostate-cancer-hormone-therapy-with-postprostatectomy-radiotherapy-confers-no-survival-benefit/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/neoadjuvantadjuvant-doublet-significantly-improved-survival-in-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/forgotten-lessons-from-south-africa/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/adjuvant-pembrolizumab-plus-belzutifan-may-provide-a-new-standard-of-care-for-patients-with-renal-cell-carcinoma-at-increased-risk-of-recurrence/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/no-recurrence-free-survival-benefit-with-adjuvant-pembrolizumab-in-hepatocellular-carcinoma/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/female-reproductive-cancers-linked-to-reduced-survival-advantage-over-males/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/2026-pezcoller-foundation-aacr-international-award-for-extraordinary-achievement-in-cancer-research/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/peter-wt-pisters-honored-with-top-award-from-society-of-surgical-oncology/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/stanford-names-leader-for-drug-development-and-precision-oncology/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/activity-observed-with-novel-kras-inhibitor-in-pancreatic-cancer/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/fda-approves-teclistamab-and-daratumumab-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/intravesical-immunotherapy-shows-recurrence-control-in-bcg-unresponsive-papillary-only-non-muscle-invasive-bladder-cancer/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/how-the-outlook-on-fertility-preservation-for-patients-with-cancer-is-improving/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/responses-to-initial-pembrolizumab-support-treatment-de-escalation-in-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/imvigor011-subgroup-analysis-role-of-ctdna-in-guiding-adjuvant-treatment-for-muscle-invasive-bladder-cancer/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/gemcitabine-intravesical-system-shows-high-disease-free-survival-rates-in-bcg-unresponsive-papillary-only-nmibc/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/adding-tucatinib-to-first-line-maintenance-therapy-delays-disease-progression-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/skin-fluorescent-imaging-shows-high-sensitivity-specificity-for-discriminating-melanoma-lesions/</loc><lastmod>2026-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/stereotactic-vs-whole-brain-radiation-for-patients-with-brain-metastases/</loc><lastmod>2026-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/advanced-rcc-after-immunotherapy-belzutifan-plus-lenvatinib-or-cabozantinib/</loc><lastmod>2026-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/adjuvant-pembrolizumab-plus-belzutifan-in-patients-with-rcc-at-increased-risk-of-recurrence/</loc><lastmod>2026-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/can-ctdna-negativity-predict-metastasis-free-survival-in-muscle-invasive-bladder-cancer/</loc><lastmod>2026-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ai-model-may-predict-cancer-risk-in-patients-with-colitis-associated-low-grade-dysplasia/</loc><lastmod>2026-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/is-advanced-stage-follicular-lymphoma-curable/</loc><lastmod>2026-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/addition-of-hormone-therapy-to-postoperative-radiotherapy-in-prostate-cancer/</loc><lastmod>2026-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/combined-tests-could-avoid-unnecessary-cystectomy-study-finds/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/perioperative-enfortumab-vedotin-plus-pembrolizumab-in-cisplatin-ineligible-bladder-cancer/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/lisocabtagene-maraleucel-in-relapsed-or-refractory-mzl/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/research-suggests-ai-pathology-models-may-take-unreliable-shortcuts-to-identify-cancer-biomarkers/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/colorectal-cancer-acs-report-shows-increasing-incidence-mortality-rates-in-younger-adults/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/social-cue-prompts-reduce-sharing-of-cancer-treatment-misinformation/</loc><lastmod>2026-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ablation-vs-surgery-for-small-kidney-tumors/</loc><lastmod>2026-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/accuracy-of-molecular-inference-based-ai-model-for-cns-tumor-diagnosis/</loc><lastmod>2026-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/short-term-vaginal-estrogen-therapy-does-not-increase-risks-of-endometrial-cancer-recurrence/</loc><lastmod>2026-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/five-year-outcomes-with-first-line-nivolumab-plus-ipilimumab-in-unresectable-pleural-mesothelioma/</loc><lastmod>2026-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/hpv-vaccination-protection-from-cervical-cancer-sustained-long-term/</loc><lastmod>2026-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/cumulative-incidence-of-advanced-breast-cancer-in-japanese-women-aged-40-to-49-years-with-addition-of-ultrasonography-to-mammography-screening/</loc><lastmod>2026-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/prostate-cancer-does-taking-arpis-and-anticoagulants-together-raise-risks/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/addition-of-axitinib-to-long-acting-octreotide-in-advanced-extrapancreatic-neuroendocrine-tumors/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/sabcs-2025-high-level-review-of-select-data/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/neoadjuvant-sacituzumab-govitecan-plus-perioperative-pembrolizumab-in-muscle-invasive-bladder-cancer/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/fda-releases-updated-guidance-on-biosimilar-development/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/tace-with-camrelizumab-and-rivoceranib-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2026-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ai-backed-liquid-biopsies-identify-liver-diseases/</loc><lastmod>2026-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/prostate-cancer-low-testosterone-levels-may-be-associated-with-increased-risk-of-progression-during-surveillance/</loc><lastmod>2026-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ai-integration-in-breast-cancer-screening-increases-detection-rate-reduces-work-burden/</loc><lastmod>2026-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/metastatic-uveal-melanoma-nivoluma-and-ipilimumab-plus-percutaneous-hepatic-perfusion/</loc><lastmod>2026-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/risk-of-breast-cancer-after-ovarian-cancer-in-women-with-brca12-variants/</loc><lastmod>2026-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/structured-exercise-plan-for-patients-with-cancer-may-reduce-cognitive-effects-of-chemotherapy/</loc><lastmod>2026-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/early-study-evaluates-two-vaccine-strategy-in-t-cell-lymphoma/</loc><lastmod>2026-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/can-viral-respiratory-infections-increase-lung-cancer-risk/</loc><lastmod>2026-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/disease-stage-at-breast-cancer-diagnosis-impacted-by-region-race-and-insurance/</loc><lastmod>2026-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/bcma-car-t-cell-therapy-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2026-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/p53-reactivator-rezatapopt-in-tp53-y220c-mutated-solid-tumors/</loc><lastmod>2026-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/fda-consolidates-systems-into-one-cohesive-adverse-event-monitoring-tool/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/optical-genome-mapping-detects-additional-genetic-variants-in-nearly-20-of-individuals-with-acute-leukemia/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/benmelstobart-plus-anlotinib-in-first-line-treatment-for-pd-l1-positive-advanced-nsclc/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/new-prostate-cancer-risk-classification-with-psma-pet/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/romiplostim-may-improve-chemotherapy-induced-thrombocytopenia-in-patients-with-gi-cancers/</loc><lastmod>2026-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/women-more-likely-to-survive-cancer-but-suffer-more-severe-side-effects/</loc><lastmod>2026-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/addition-of-tislelizumab-to-chemotherapy-in-recurrent-or-metastatic-nasopharyngeal-cancer/</loc><lastmod>2026-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/psma-pet-ct-scan-reduces-need-for-prostate-cancer-biopsies/</loc><lastmod>2026-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/activity-observed-with-novel-kras-inhibitor-in-pancreatic-cancer-1/</loc><lastmod>2026-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/new-aacr-president-elect-and-board-members-announced/</loc><lastmod>2026-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/timely-scans-may-reduce-mortality-in-patients-who-present-to-the-er-with-hematuria/</loc><lastmod>2026-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/studies-suggest-prostate-cancer-screening-may-be-equivalent-to-breast-cancer-screening-in-key-outcomes/</loc><lastmod>2026-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/smfm-issues-new-clinical-guidance-for-cancer-diagnosis-and-treatment-during-pregnancy/</loc><lastmod>2026-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/high-cancer-burden-shifted-from-urban-to-rural-areas/</loc><lastmod>2026-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/study-finds-no-overall-increase-in-cancer-risk-after-medically-assisted-reproduction/</loc><lastmod>2026-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ama-survey-finds-rapid-growth-in-physician-ai-adoption/</loc><lastmod>2026-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/breast-cancer-ultrasensitive-ctdna-assay-findings-and-outcomes-after-neoadjuvant-therapy/</loc><lastmod>2026-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/hypofractionated-locoregional-rt-in-early-breast-cancer/</loc><lastmod>2026-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/melanoma-specific-survival-with-sentinel-lymph-node-biopsy/</loc><lastmod>2026-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/fda-approves-chemoimmunotherapy-regimen-for-hodgkin-lymphoma/</loc><lastmod>2026-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/does-metformin-use-reduce-the-risk-of-esophageal-cancer/</loc><lastmod>2026-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/small-phase-ii-study-examines-triplet-regimen-for-patients-with-her2-positive-breast-cancer-and-leptomeningeal-metastasis/</loc><lastmod>2026-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/the-thymus-plays-a-part-in-adult-cancer-risk-and-treatment-response/</loc><lastmod>2026-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/study-finds-inferior-survival-among-black-patients-with-aml-independent-of-cytogenetic-risk/</loc><lastmod>2026-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/awareness-of-alcohol-cancer-link-holds-steady-despite-omission-in-new-us-dietary-guidelines/</loc><lastmod>2026-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/myelofibrosis-treatment-landscape-is-poised-for-change/</loc><lastmod>2026-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ai-model-classifies-challenging-thymic-epithelial-tumors/</loc><lastmod>2026-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/fda-approves-relacorilant-with-nab-paclitaxel-for-several-platinum-resistant-gynecologic-cancers/</loc><lastmod>2026-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/hyperplasia-and-the-link-between-obesity-and-cancer/</loc><lastmod>2026-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/gedatolisib-based-regimens-in-hr-positive-her2-negative-pik3ca-wild-type-advanced-breast-cancer/</loc><lastmod>2026-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/using-ai-to-differentiate-primary-lung-squamous-cell-carcinomas-from-metastases/</loc><lastmod>2026-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/neoadjuvant-golp-in-high-risk-intrahepatic-cholangiocarcinoma/</loc><lastmod>2026-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/breast-reconstruction-using-polyurethane-coated-implants-may-reduce-the-risk-of-capsular-contracture-additional-surgery/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/breast-cancer-recurrence-remains-low-even-after-10-years-with-radiotherapy-tailored-to-patient-s-individual-risk/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ai-use-in-cancer-diagnosis-prognosis-and-treatment-are-we-there-yet/</loc><lastmod>2026-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/ai-model-for-predicting-oncotype-dx-21-gene-recurrence-score/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/dynamic-accessible-risk-stratification-tool-created-for-smoldering-multiple-myeloma/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/pembrolizumab-with-or-without-lenvatinib-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/early-results-demonstrate-safety-and-efficacy-of-mutant-calreticulin-specific-monoclonal-antibody-in-myelofibrosis/</loc><lastmod>2026-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/two-major-cancer-centers-announce-appointments-of-new-directors/</loc><lastmod>2026-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/radiotherapy-may-reduce-risk-of-lymphedema-in-patients-with-breast-cancer-more-effectively-than-surgery/</loc><lastmod>2026-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/adjuvant-atezolizumab-and-mfolfox6-in-stage-iii-mismatch-repair-deficient-colon-cancer/</loc><lastmod>2026-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/metabolic-subtypes-of-nasopharyngeal-carcinoma-and-response-to-treatment/</loc><lastmod>2026-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/molecular-test-doubles-detection-of-bile-duct-cancer/</loc><lastmod>2026-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/transdermal-estradiol-patches-vs-lhrh-agonists-in-locally-advanced-prostate-cancer/</loc><lastmod>2026-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/risk-of-subsequent-cancer-in-solid-organ-transplant-recipients-with-pretransplant-cancer-history/</loc><lastmod>2026-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/03-march/elinzanetant-may-reduce-side-effects-of-endocrine-therapy-among-patients-with-breast-cancer/</loc><lastmod>2026-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/positive-trial-update-oncologic-outcomes-maintained-after-pausing-endocrine-therapy-for-pregnancy/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/study-finds-glp-1ras-were-associated-with-a-reduced-risk-of-developing-colorectal-cancer-vs-aspirin/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/what-is-the-optimal-setting-for-t-dxd-in-early-breast-cancer/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/abiraterone-plus-olaparib-shows-remarkable-survival-in-brcaatm-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/glp-1-ras-may-reduce-mortality-in-some-patients-with-colorectal-cancer-and-comorbid-obesity-real-world-outcomes/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/update-to-patient-clinician-communication-guideline-provides-recommendations-on-telehealth-boundary-setting/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/cancer-researcher-awarded-sjoeberg-prize-for-describing-tumors-evolution/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/novel-therapies-improve-outcomes-across-hematologic-malignancies/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/long-time-asco-member-philip-a-salem-md-honored-for-medical-excellence-leadership-and-compassion/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ulrich-steidl-md-phd-named-director-of-montefiore-einstein-comprehensive-cancer-center/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ai-driven-multiagent-system-for-guiding-first-line-immunotherapy-for-nsclc/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ai-as-collaborator-in-cancer-research-and-in-clinical-care/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/dietary-influence-on-leukemia-and-lymphoma-progression/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/clinical-trials-may-misrepresent-true-thromboembolic-risks-from-cancer-drugs/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/prostate-screening-saved-my-life-is-that-really-true-in-most-cases/</loc><lastmod>2026-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/early-onset-lung-cancer-may-be-connected-to-pesticide-contaminants/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/mibc-pembrolizumab-with-trimodal-therapy-for-bladder-preservation/</loc><lastmod>2026-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/metabolic-tumor-volume-predicts-car-t-cell-therapy-response-in-lbcl/</loc><lastmod>2026-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/can-pesticide-exposure-increase-early-onset-colorectal-cancer-risk/</loc><lastmod>2026-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/study-finds-prostate-cancer-overdiagnosis-rises-substantially-with-age/</loc><lastmod>2026-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/amivantamab-in-chemorefractory-rasbraf-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2026-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/long-term-outcomes-with-taletrectinib-in-ros1-positive-nsclc/</loc><lastmod>2026-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/breast-cancer-clonal-hematopoiesis-and-risk-of-trastuzumab-related-cardiotoxicity/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/acp-issues-controversial-new-breast-cancer-screening-guidelines/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/educational-disparities-in-young-onset-colorectal-cancer-mortality/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/analysis-of-constitutional-cancer-predisposition-gene-variants-in-nearly-15-000-patients/</loc><lastmod>2026-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/james-p-allison-phd-honored-with-the-2026-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2026-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/neoadjuvant-durvalumab-and-chemotherapy-in-triple-negative-breast-cancer-long-term-follow-up-of-geparnuevo-trial/</loc><lastmod>2026-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/do-political-beliefs-shape-views-on-clinical-trials-in-cancer/</loc><lastmod>2026-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/global-review-shows-impact-of-exposure-to-air-pollution-on-cancer-risk-and-mortality/</loc><lastmod>2026-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/tracking-biological-age-changes-gives-insights-into-cancer-prognosis/</loc><lastmod>2026-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/cll-linked-to-increased-skin-cancer-risk-and-mortality/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/advanced-prostate-cancer-radiographic-progression-and-psa-increase-in-patients-treated-with-enzalutamide/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/american-cancer-society-announces-new-pediatric-adolescent-and-young-adult-cancer-journal/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/colorectal-cancer-duloxetine-not-effective-in-preventing-oxaliplatin-induced-peripheral-neuropathy/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/antoni-ribas-md-phd-honored-with-the-2026-aacr-margaret-foti-award-for-leadership-and-extraordinary-achievements-in-cancer-research/</loc><lastmod>2026-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/electroacupuncture-relieves-cognitive-psychological-symptoms-in-breast-cancer-survivors-in-pilot-study/</loc><lastmod>2026-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ctdna-at-the-end-of-neoadjuvant-therapy-may-predict-breast-cancer-recurrence/</loc><lastmod>2026-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ai-shows-dermatologist-level-accuracy-in-melanoma-diagnosis-but-needs-validation/</loc><lastmod>2026-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/patients-with-lung-cancer-may-safely-receive-adequate-sbrt-dosage-in-one-treatment/</loc><lastmod>2026-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/fda-grants-traditional-approval-to-brexucabtagene-autoleucel-for-relapsed-or-refractory-mcl/</loc><lastmod>2026-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/prompting-strategies-improve-symptom-monitoring-in-childhood-cancer-survivors/</loc><lastmod>2026-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/researchers-identify-blood-based-biomarker-for-cancer-risk-in-people-with-lynch-syndrome/</loc><lastmod>2026-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ama-data-show-nearly-50-percent-of-surveyed-oncologists-reported-burnout-in-2025/</loc><lastmod>2026-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/machine-learning-model-for-hcc-risk-prediction-may-outperform-current-methods/</loc><lastmod>2026-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/one-time-low-dose-ct-screening-may-reduce-lung-cancer-mortality-among-neversmokers-in-asia/</loc><lastmod>2026-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/agent-orange-exposure-linked-to-mds-risk-and-progression/</loc><lastmod>2026-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/financial-hardship-and-late-stage-cancer-diagnosis/</loc><lastmod>2026-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/low-risk-endometrial-cancer-does-a-lack-of-adjuvant-therapy-affect-survival/</loc><lastmod>2026-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/early-onset-ici-related-myocarditis-linked-to-increased-mortality/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/unique-phase-i-nsclc-trial-sites-decreasing-in-united-states/</loc><lastmod>2026-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/perioperative-pembrolizumab-in-localized-colorectal-cancer-with-dmmrmsi/</loc><lastmod>2026-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/tislelizumab-with-induction-chemotherapy-and-concurrent-chemoradiotherapy-in-locally-advanced-esophageal-cancer/</loc><lastmod>2026-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/overall-survival-with-addition-of-relacorilant-to-nab-paclitaxel-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2026-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/long-term-immunotherapy-for-alveolar-soft-part-sarcoma/</loc><lastmod>2026-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/metastatic-nsclc-deep-learning-pathomics-platform-may-help-predict-response-to-immunotherapy/</loc><lastmod>2026-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/methylation-based-ai-model-classifies-tumors-of-unknown-origin/</loc><lastmod>2026-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/intralesional-nivolumab-may-be-effective-against-precancerous-oral-lesions/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/exposure-to-wildfire-smoke-may-be-linked-to-increased-risk-of-developing-several-types-of-cancer/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/pretreatment-mri-prognostic-information-after-radical-prostatectomy/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/first-line-zongertinib-in-advanced-her2-mutant-nsclc/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/asco-expands-tapur-trial-with-two-new-precision-drug-arms/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/treatment-modifications-and-outcomes-for-older-adults-with-advanced-cancer-who-prefer-preserving-qol-vs-prolonging-survival/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/zoldonrasib-in-patients-with-kras-g12d-nsclc-previously-treated-with-chemoimmunotherapy/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/elisrasib-demonstrates-high-dcr-in-kras-g12c-nsclc/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/high-risk-smoldering-multiple-myeloma-bcma-directed-car-t-cell-therapy-shows-activity/</loc><lastmod>2026-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/initial-data-shows-safety-for-wee1-pkmyt1-inhibitor-combination-in-advanced-solid-tumors/</loc><lastmod>2026-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/sequential-or-concurrent-radiotherapy-and-immunotherapy-in-advanced-newly-diagnosed-or-refractory-nsclc/</loc><lastmod>2026-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/bispecific-antibody-shows-deep-remission-in-patients-with-relapsedrefractory-follicular-lymphoma/</loc><lastmod>2026-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/drup-trial-investigates-use-of-off-label-drugs-for-patients-with-advanced-solid-tumors/</loc><lastmod>2026-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ai-tool-shows-early-ability-in-pinpointing-cells-driving-aggressive-cancers/</loc><lastmod>2026-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/melanoma-can-ai-enable-diagnosis-prediction/</loc><lastmod>2026-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/advanced-platinum-resistant-ovarian-cancer-investigational-adc-shows-activity/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/is-standard-of-care-optimal-for-the-individual-patient/</loc><lastmod>2026-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/lupsma-617-and-pembrolizumab-in-mcrpc/</loc><lastmod>2026-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/asbestos-free-talc-not-associated-with-increased-risk-for-respiratory-cancers/</loc><lastmod>2026-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ash-isth-create-guidelines-for-pediatric-vte-prophylaxis/</loc><lastmod>2026-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/aya-cancer-survivors-and-risk-for-earlier-subsequent-primary-neoplasms/</loc><lastmod>2026-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/romiplostim-for-chemotherapy-induced-thrombocytopenia/</loc><lastmod>2026-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/how-cannabis-use-may-be-accelerating-breast-and-testicular-cancer-rates-in-ayas/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/can-saying-i-do-reduce-cancer-risk/</loc><lastmod>2026-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/global-survival-index-for-childhood-cancer-concord-4/</loc><lastmod>2026-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/nccn-names-new-chief-scientific-officer/</loc><lastmod>2026-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/large-language-models-may-generate-concise-coherent-pathology-summaries-reducing-physician-burden/</loc><lastmod>2026-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/new-molecular-based-model-for-classification-and-risk-in-chronic-myelomonocytic-leukemia/</loc><lastmod>2026-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/impt-vs-imrt-in-oropharyngeal-cancer/</loc><lastmod>2026-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/japanese-study-looks-at-rates-of-cancer-therapy-related-aml/</loc><lastmod>2026-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/damaging-missense-variants-in-innate-immunity-genes-linked-to-earlier-breast-cancer-onset-in-brca1-carriers/</loc><lastmod>2026-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/long-term-outcomes-with-pralsetinib-in-ret-fusion-positive-nsclc/</loc><lastmod>2026-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/new-ash-hematomics-program-offers-blood-cancer-data-integration-tool-to-accelerate-research/</loc><lastmod>2026-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/final-report-on-pralsetinib-in-advanced-ret-fusion-positive-nsclc/</loc><lastmod>2026-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/analysis-shows-nearly-7-percent-of-global-clinical-trials-are-impacted-by-middle-east-conflict/</loc><lastmod>2026-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/ablative-radiotherapy-may-improve-outcomes-for-patients-with-large-intrahepatic-cholangiocarcinoma/</loc><lastmod>2026-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/setidegrasib-in-advanced-nsclc-and-pancreatic-cancer-harboring-the-kras-pg12d-variant/</loc><lastmod>2026-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/low-food-access-may-lead-to-more-complications-after-breast-reconstruction/</loc><lastmod>2026-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/adebrelimab-and-bevacizumab-plus-platinum-chemotherapy-in-triple-negative-breast-cancer-with-brain-metastases/</loc><lastmod>2026-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/metastatic-papillary-renal-cancer-final-results-with-savolitinib-and-durvalumab/</loc><lastmod>2026-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/early-results-from-a-trial-of-active-surveillance-for-low-risk-dcis-are-reassuring-say-researchers/</loc><lastmod>2026-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/nivolumab-with-or-without-ipilimumab-in-platinum-refractory-advanced-neuroendocrine-carcinoma/</loc><lastmod>2026-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/surgery-still-safe-beneficial-for-many-octogenarian-patients-with-nsclc/</loc><lastmod>2026-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/christian-capitini-md-named-director-of-the-uw-carbone-cancer-center/</loc><lastmod>2026-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/fullerene-cream-vs-trolamine-cream-in-reducing-acute-radiation-dermatitis-from-radiation-therapy-for-head-and-neck-cancer/</loc><lastmod>2026-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/04-april/nccn-2026-annual-conference-prepares-cancer-care-providers-worldwide-for-healing-the-whole-patient/</loc><lastmod>2026-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-zenocutuzumab-zbco-for-advanced-unresectable-or-metastatic-cholangiocarcinoma/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/first-virtual-cancer-clinic-to-receive-asco-certified-status/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/guideline-concordant-care-is-associated-with-improved-survival-so-why-aren-t-more-aya-patients-receiving-this-care/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ascende-rt-15-year-update-shows-no-overall-survival-benefit-with-borderline-signal-for-fewer-deaths/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/adding-capivasertib-to-abiraterone-in-pten-deficient-metastatic-hormone-sensitive-prostate-cancer-the-patient-experience/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/how-conquering-cancer-is-a-team-effort/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/using-artificial-intelligence-to-prescribe-cancer-drugs-and-perform-other-tasks/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/a-timely-compendium-for-the-era-of-precision-oncology/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/i-have-advanced-stage-lung-cancer-i-refuse-to-be-a-victim-of-the-disease/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/better-together-the-case-for-true-physician-ap-partnership-in-oncology/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/beyond-nodule-detection-ai-chest-ct-and-a-vision-for-population-health/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/four-ways-ai-is-transforming-patient-care-and-what-lies-ahead/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/asco-congratulates-2026-special-award-recipients/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/asco-expands-landmark-tapur-trial/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/facing-a-year-ahead-of-unprecedented-opportunities-and-challenges/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/survival-among-patients-treated-in-community-oncology-settings-compared-with-national-benchmarks-from-seer-database/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/relacorilant-plus-nab-paclitaxel-improves-overall-survival-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/combination-enzalutamide-and-radium-223-extends-overall-survival-in-bone-dominant-mcrpc/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/uniting-science-practice-and-purpose-for-better-cancer-care/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/early-myocarditis-after-immune-checkpoint-inhibitors-signals-elevated-mortality-risk/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/preclinical-study-in-mice-addresses-a-question-should-ras-inhibitors-be-given-preemptively/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/2026-nccn-clinical-practice-guidelines-in-oncology-key-updates-across-tumor-types/</loc><lastmod>2026-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/curing-most-leukemias-on-the-horizon-a-5-decade-md-anderson-perspective-on-leukemia-research/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/de-escalation-recovery-and-robotic-surgery-in-breast-cancer-care/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/llm-tool-significantly-reduces-participant-screening-burdens-improves-enrollment-for-phase-iii-trial-in-polycythemia-vera/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/llm-based-preoperative-patient-communications-alleviate-anxiety-physician-workload/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/can-physical-activity-reduce-cancer-related-fatigue/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/lack-of-research-in-understanding-the-global-population-of-childhood-cancer-survivors-leads-to-gaps-in-care-and-cures/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/belzutifan-lenvatinib-outperforms-cabozantinib-after-checkpoint-inhibitors-in-advanced-renal-cell-carcinoma/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ras-inhibitor-daraxonrasib-in-metastatic-pancreatic-cancer/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ai-powered-next-generation-sequencing-blood-based-assay-evaluated-for-detection-of-post-hct-relapse-in-aml-and-mds/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/cardiovascular-effects-and-risk-factors-identified-with-braf-and-mek-inhibition-in-melanoma/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/keynote-905-perioperative-immunotherapy-regimen-active-in-cisplatin-ineligible-mibc/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/gerald-hsu-md-phd-named-editor-in-chief-of-the-asco-educational-book/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/patient-care-is-not-what-we-do-but-what-patients-perceive/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/i-m-young-and-have-advanced-neuroendocrine-carcinoma-of-the-rectum/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/promising-signal-only-ctdna-in-early-breast-cancer-not-yet-ready-for-clinical-use/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/plasma-mir-371a-3p-predicts-recurrence-in-stage-i-testicular-cancer-interim-results-from-the-climate-study/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/acupuncture-for-nocturia-in-survivors-of-prostate-cancer/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/long-term-risks-revealed-for-older-survivors-of-childhood-cancers/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/could-ai-be-licensed-to-practice-oncology/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/from-hawaii-to-health-ai-a-career-at-the-intersection-of-oncology-data-science-and-clinical-knowledge/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ars-honors-thomas-buchholz-md-with-2026-gold-medal-award/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/national-academy-of-medicine-recognizes-100-newly-elected-members/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/new-asco-guideline-fills-gap-in-guidance-on-rapidly-evolving-treatment-options-in-thyroid-cancer/</loc><lastmod>2026-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/atezolizumab-in-alveolar-soft-part-sarcoma-long-term-follow-up/</loc><lastmod>2026-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/5-year-follow-up-from-augment-lenalidomide-plus-rituximab-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/</loc><lastmod>2026-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/melanoma-gut-microbiome-may-help-predict-recurrence-after-immunotherapy/</loc><lastmod>2026-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/can-pfas-exposure-raise-all-risk/</loc><lastmod>2026-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/association-of-body-size-and-bladder-cancer-risk/</loc><lastmod>2026-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-vepdegestrant-for-er-her2-esr1-advanced-breast-cancer/</loc><lastmod>2026-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/on-treatment-psa-and-overall-survival-in-prostate-cancer/</loc><lastmod>2026-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/four-drug-regimen-induces-high-complete-response-rate-in-early-stage-classical-hodgkin-lymphoma/</loc><lastmod>2026-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-permits-expanded-access-for-investigational-pancreatic-cancer-drug/</loc><lastmod>2026-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/coa-and-flatiron-health-study-finds-patients-may-experience-longer-survival-in-community-oncology-settings/</loc><lastmod>2026-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/targeted-therapies-drive-long-term-decline-in-multiple-myeloma-mortality-in-the-united-states/</loc><lastmod>2026-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/adjuvant-hepatic-arterial-infusion-after-surgery-for-four-or-more-colorectal-liver-metastases/</loc><lastmod>2026-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/integrated-molecular-analysis-identifies-determinants-of-outcomes-in-tp53-mutated-dlbcl/</loc><lastmod>2026-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/advanced-ckm-syndrome-associated-with-greater-cancer-risk/</loc><lastmod>2026-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ai-model-enables-earlier-detection-of-pancreatic-cancer-on-routine-ct-scans/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/breast-density-reduction-endoxifen-vs-tamoxifen/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/appendiceal-cancer-serum-tumor-marker-levels-may-guide-treatment-in-patients-undergoing-crs/</loc><lastmod>2026-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/long-term-outcomes-with-maintenance-rucaparib-in-advanced-pancreatic-cancer-with-brca-or-palb2-pathogenic-variants/</loc><lastmod>2026-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/tiragolumab-plus-atezolizumab-and-chemotherapy-in-advanced-nonsquamous-nsclc/</loc><lastmod>2026-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/meta-analysis-explores-impact-of-ovarian-function-suppression-on-breast-cancer-recurrence-and-survival/</loc><lastmod>2026-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/b-cell-depletion-for-prevention-of-corticosteroid-requiring-chronic-gvhd/</loc><lastmod>2026-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/recent-rates-of-systemic-treatment-for-metastatic-nsclc-in-older-adults/</loc><lastmod>2026-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/noninvasive-urine-test-may-provide-grade-group-information-in-patients-with-prostate-cancer/</loc><lastmod>2026-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/whole-genome-sequencing-test-enables-genomically-informed-treatment-decision-making-in-multiple-myeloma/</loc><lastmod>2026-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/inflammatory-breast-cancer-blood-based-biomarkers-identified/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/neoadjuvant-single-cycle-pembrolizumab-for-stage-i-to-iii-dmmr-colon-cancer/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/addition-of-toripalimab-to-perioperative-chemotherapy-in-locally-advanced-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/inherited-long-telomeres-may-increase-the-risk-of-lymphoid-cancers/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/study-examines-genetic-testing-to-inform-follow-up-care-for-cancer-survivors/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-combination-regimen-for-newly-diagnosed-aml/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/sonrotoclax-receives-accelerated-approval-in-relapsed-or-refractory-mcl/</loc><lastmod>2026-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/does-the-timing-of-immunotherapy-administration-affect-outcomes-in-advanced-cancers/</loc><lastmod>2026-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/local-salvage-therapy-for-post-radiotherapy-local-recurrence-of-prostate-cancer/</loc><lastmod>2026-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/early-ovarian-cancer-minimally-invasive-surgery-intraoperative-capsule-rupture-and-survival/</loc><lastmod>2026-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/study-finds-dlbcl-subtype-may-have-higher-mortality-risk-in-female-patients/</loc><lastmod>2026-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/sigmoidoscopy-reduces-crc-incidence-rates-in-men-in-norwegian-screening-study/</loc><lastmod>2026-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-atezolizumab-for-adjuvant-treatment-of-mrd-positive-mibc/</loc><lastmod>2026-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-fam-trastuzumab-deruxtecan-nxki-indications-in-her2-positive-early-breast-cancer/</loc><lastmod>2026-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/study-finds-stage-iv-breast-cancer-increasing-in-incidence-and-proportion-over-the-last-decade/</loc><lastmod>2026-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/study-finds-methylphenidate-type-psychostimulants-may-reduce-cancer-related-fatigue/</loc><lastmod>2026-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/daraxonrasib-for-previously-treated-ras-mutated-pancreatic-cancer/</loc><lastmod>2026-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ficerafusp-alfa-plus-pembrolizumab-2-year-outcomes-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2026-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/patients-with-ibd-may-be-at-risk-for-vte-after-colorectal-cancer-surgery/</loc><lastmod>2026-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/recurrence-with-concurrent-or-sequential-radiation-dose-escalation-to-the-surgical-cavity-in-high-risk-early-breast-cancer/</loc><lastmod>2026-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/study-shows-potential-missing-patient-information-in-seer-database/</loc><lastmod>2026-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/novel-gene-fusion-detector-for-pediatric-b-all-shows-high-sensitivity/</loc><lastmod>2026-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ai-avatar-based-education-leads-to-improved-patient-understanding-of-radiation-treatment-plans/</loc><lastmod>2026-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/early-stage-breast-cancer-losing-weight-gaining-quality-of-life/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/short-term-fasting-around-chemotherapy-may-improve-treatment-response-in-ovarian-cancer/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/yoga-intervention-may-reduce-mood-disturbance-anxiety-fatigue-and-insomnia-in-cancer-survivors/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/glp-1-ras-may-reduce-metastatic-progression-in-certain-obesity-related-cancers/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/cognitive-effects-of-darolutamide-vs-enzalutamide-in-advanced-prostate-cancer/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/preclinical-studies-evaluate-mezigdomide-for-t-cell-dysfunction-in-multiple-myeloma/</loc><lastmod>2026-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/metastatic-castration-resistant-prostate-cancer-addition-of-olaparib-to-radium-223/</loc><lastmod>2026-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/long-term-eortc-trial-challenges-assumptions-about-lymph-node-radiation-therapy-in-breast-cancer/</loc><lastmod>2026-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/outcomes-in-patients-with-breast-cancer-and-obesity-or-t2d-receiving-glp-1-ras/</loc><lastmod>2026-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/early-breast-cancer-is-surgery-omission-possible-following-estrogen-and-ablative-radiation-therapy/</loc><lastmod>2026-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/radiotherapy-for-prostate-cancer-hermes-trial-compares-two-and-five-fractions/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/off-the-shelf-car-t-cell-therapy-produces-deep-durable-responses-in-heavily-pretreated-multiple-myeloma/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/after-the-founder-what-a-cervical-cancer-program-in-haiti-teaches-about-sustaining-prevention/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/tailorx-and-rxponder-trials-shift-to-a-discovery-platform/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/bpdcn-fda-approves-pivekimab-sunirine-pvzy/</loc><lastmod>2026-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/local-radiotherapy-may-help-control-oligometastatic-breast-cancer/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-durvalumab-plus-bcg-for-high-risk-nmibc/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/behind-the-scenes-of-the-2026-asco-annual-meeting/</loc><lastmod>2026-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/first-line-sunvozertinib-in-advanced-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2026-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/asco-collaborates-with-ryght-ai-to-accelerate-site-selection-for-metastatic-breast-cancer-trial/</loc><lastmod>2026-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/lymph-node-surgery-and-cdk46-inhibitor-treatment-in-early-breast-cancer/</loc><lastmod>2026-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/pain-and-health-related-qol-with-darolutamide-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2026-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/ai-pathology-framework-for-biological-understanding-of-tumors/</loc><lastmod>2026-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/high-yap1-expression-leads-to-chemotherapy-resistance-relapse-in-treated-sclc/</loc><lastmod>2026-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/fda-approves-antibody-drug-conjugate-for-triple-negative-breast-cancer/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/patient-reported-outcomes-support-niraparib-maintenance-in-advanced-ovarian-cancer-regardless-of-homologous-recombination-deficiency-status/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/05-may/weight-trajectories-associated-with-obesity-related-cancer-risk/</loc><lastmod>2026-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/proteus-trial-suggests-perioperative-apalutamide-may-improve-outcomes-in-high-risk-localized-prostate-cancer/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/daraxonrasib-nearly-doubles-survival-in-previously-treated-metastatic-pancreatic-cancer/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/overall-survival-benefit-with-ivonescimab-plus-chemotherapy-in-advanced-squamous-nsclc/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/adjuvant-selpercatinib-improves-event-free-survival-in-ret-positive-early-stage-nsclc/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/many-patients-with-limited-sentinel-node-positive-breast-cancer-can-safely-avoid-axillary-dissection-study-shows/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/implanted-cesium-131-tiles-improve-local-control-and-survival-in-patients-with-resected-brain-metastases/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/does-tissue-tmb-outperform-blood-based-testing-for-predicting-immunotherapy-response/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/long-term-follow-up-of-three-first-line-treatment-regimens-in-mantle-cell-lymphoma/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/american-cancer-society-updates-colorectal-cancer-screening-guideline/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/addition-of-pembrolizumab-to-chemotherapy-continues-to-demonstrate-overall-survival-benefit-in-advanced-or-recurrent-endometrial-cancer/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/cochrane-review-finds-current-breast-cancer-risk-models-have-limited-accuracy-in-women-with-a-family-history-of-disease/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/friends-of-cancer-research-names-richard-pazdur-md-to-board-of-directors/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/phase-iii-trial-shows-noninferiority-for-test-guided-chemotherapy-decisions-in-early-breast-cancer/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/vaccine-plus-pembrolizumab-reduces-risk-of-recurrence-in-high-risk-resected-melanoma/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/online-patient-resources-about-ai-and-cancer-found-lacking/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/combining-targeted-immunotherapies-with-standard-r-chop-delays-progression-of-aggressive-b-cell-lymphomas/</loc><lastmod>2026-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/symptom-monitoring-app-helps-patients-with-advanced-cancer-maintain-quality-of-life/</loc><lastmod>2026-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/hcc-tace-plus-stride-with-or-without-lenvatinib/</loc><lastmod>2026-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/oral-metronomic-chemotherapy-plus-ultra-low-dose-immunotherapy-improves-survival-in-advanced-head-and-neck-cancer/</loc><lastmod>2026-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/sacituzumab-govitecan-with-pembrolizumab-extends-pfs2-in-pd-l1-positive-metastatic-triple-negative-breast-cancer/</loc><lastmod>2026-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/annual-galleri-screening-reduced-stage-iv-cancer-diagnoses-but-missed-primary-endpoint-in-first-randomized-mced-trial/</loc><lastmod>2026-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/update-to-asco-guideline-on-advanced-nsclc-without-driver-alterations-adds-retifanlimab-to-treatment-options/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/asco-collaborates-with-ryght-ai-to-accelerate-site-selection-for-metastatic-breast-cancer-trial/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/fda-approves-capivasertib-plus-abiraterone-with-adtprednisone-in-patients-with-mhspc/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/fda-approval-in-renal-cell-carcinoma-adjuvant-belzutifan-with-pembrolizumab/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/senomac-trial-omission-of-completion-axillary-dissection-is-oncologically-safe-in-expanded-breast-cancer-population/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/abemaciclib-reduces-disease-progression-death-in-rare-aggressive-soft-tissue-sarcoma/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/tapur-marks-a-decade-of-innovation/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/next-generation-kras-inhibitors-show-promising-activity-in-advanced-non-small-cell-lung-cancer/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/i-d-like-to-agree-with-you-but-then-we-would-both-be-wrong/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/i-ve-beaten-the-odds-for-stage-iv-lung-cancer/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/coming-out-in-the-exam-room/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/asco-welcomes-proposal-to-implement-electronic-prior-authorization-requirements-for-covered-drugs-in-federal-health-plans/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/2026-asco-breakthrough-meeting-to-highlight-new-advances-in-liquid-biopsy-metabolic-risks-and-tailored-therapies-for-asian-populations/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/physician-scientist-albert-b-deisseroth-md-phd-dies-at-84/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/how-new-york-city-and-the-nation-got-its-first-cancer-hospitals/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/advancing-clinical-trials-and-decision-making-with-synthetic-real-world-data/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/prostate-cancer-screening-controversies/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/daraxonrasib-in-kras-mutant-pancreatic-cancer-a-first-step-in-shifting-the-paradigm-of-treatment/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/can-psychostimulants-treat-cancer-related-fatigue/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/the-science-and-practice-of-translation-improving-cancer-outcomes-worldwide/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/another-point-of-view-reefer-madness/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/expanded-living-guidelines-program-ushers-in-a-new-era-for-asco-guidelines/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/asco-updates-policy-statement-on-340b-drug-pricing-program/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/society-of-gynecological-oncology-names-2026-president-matthew-a-powell-md/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/early-study-finds-intralesional-pd-1-blockade-promising-for-oral-cancer-prevention/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/geriatric-assessment-is-the-future-retiring-karnofsky-and-ecog-performance-status-in-modern-cancer-care/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/a-burning-question-can-wildfire-smoke-drive-cancer-risk/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/weighing-the-evidence-supporting-aspirin-vs-glp-1-ras-in-colorectal-cancer-prevention/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/review-of-breast-cancer-news-and-studies/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/tafasitamablenalidomide-combination-vs-r-chop-in-high-risk-dlbcl-phase-iii-frontmind-trial/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/four-year-ruby-data-support-curative-intent-with-dostarlimab-in-dmmrmsi-h-endometrial-cancer/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/music-therapy-noninferior-to-cognitive-behavioral-therapy-for-anxiety-among-cancer-survivors-in-large-telehealth-trial/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/new-section-chief-of-medical-oncology-and-hematology-and-deputy-director-for-clinical-affairs-for-yale-cancer-center-and-smilow-cancer-hospital-named/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/wearable-devices-may-help-detect-crs-earlier-in-patients-with-myeloma-receiving-car-t-cell-therapy/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/advanced-breast-cancer-novel-cdk46-inhibitor-plus-an-aromatase-inhibitor/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/talquetamab-combinations-in-relapsed-or-refractory-myeloma/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/existing-cardioprotective-agents-provide-limited-benefits-for-patients-with-cancer/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/sunvozertinib-in-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/pooled-analysis-of-5-year-outcomes-with-ultra-hypofractionated-sabr-in-primary-renal-cell-carcinoma/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/addition-of-talazoparib-to-enzalutamide-in-metastatic-androgen-pathway-modulation-sensitive-prostate-cancer/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/sclc-with-brain-only-progression-original-or-substitute-systemic-therapy-with-or-without-brain-radiotherapy/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/study-identifies-serious-infection-risks-linked-to-antibody-drug-conjugates/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/overall-survival-with-ebrt-in-hepatocellular-carcinoma/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/aml-all-oral-regimen-safe-and-eases-treatment-administration-burden/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/which-genes-contribute-to-early-onset-breast-cancer-in-black-women/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/teclistamab-in-previously-treated-multiple-myeloma/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/glp-1-ras-associated-with-lower-breast-cancer-incidence/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/five-year-survival-analysis-neoadjuvant-trastuzumab-pertuzumab-plus-endocrine-therapy-or-chemotherapy-in-hr-positiveher2-positive-breast-cancer/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/adverse-events-with-cd3-based-t-cell-engaging-bispecific-antibody-treatment-in-cancer/</loc><lastmod>2026-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/survey-results-show-patients-prefer-learning-of-a-diagnosis-from-their-doctor-rather-than-a-health-portal/</loc><lastmod>2026-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/i-miss-my-life/</loc><lastmod>2026-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/educational-gaps-found-in-cardio-oncology-training/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/breast-cancer-palbociclib-based-regimen-approved-for-hr-positive-her2-positive-metastatic-disease/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/digital-tool-may-improve-patient-engagement-in-oncology-clinical-trials/</loc><lastmod>2026-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/asco-remembers-karnofsky-award-recipient-maura-gillison-pioneer-in-hpv-associated-cancers/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/mri-guided-radiotherapy-in-high-grade-glioma/</loc><lastmod>2026-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/long-term-outcomes-with-sabr-in-primary-kidney-cancer/</loc><lastmod>2026-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/novel-risk-score-stratifies-major-bleeding-risks-in-patients-with-vte-on-doacs/</loc><lastmod>2026-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/fertility-preservation-access-remains-limited-and-unequal-for-many-girls-and-young-women-with-cancer/</loc><lastmod>2026-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/novel-gene-therapy-radiotherapy-combination-in-localized-prostate-cancer/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/long-term-outcomes-of-adjuvant-hypofractionated-radiotherapy-for-breast-cancer/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/machine-learning-model-may-improve-accuracy-of-liquid-biopsy-results/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/tp53-mutation-acquisition-timing-influences-prognosis-in-mpns/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/glp-1-ras-may-reduce-risk-of-obesity-related-cancers/</loc><lastmod>2026-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/new-research-links-low-alcohol-consumption-to-elevated-health-risks/</loc><lastmod>2026-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/glp-1-receptor-agonists-linked-to-lower-colorectal-cancer-risk-in-patients-with-ibd/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/chinese-study-of-her2-targeted-combination-therapy-for-locally-advanced-breast-cancer/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/can-ai-provide-an-early-alert-for-breast-cancer-before-diagnosis/</loc><lastmod>2026-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/perioperative-serplulimab-in-pd-l1-positive-gastric-cancer/</loc><lastmod>2026-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/urologic-surgeon-sworn-in-as-ama-president/</loc><lastmod>2026-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/head-and-neck-cancer-hpv-deepseek-may-identify-earlier-signs-of-postoperative-recurrence/</loc><lastmod>2026-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/ai-assisted-tumor-volume-response-criteria-outperform-physician-assessments-and-recist-criteria-in-pleural-mesothelioma/</loc><lastmod>2026-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/aumolertinib-plus-chemotherapy-in-egfr-mutated-advanced-nsclc/</loc><lastmod>2026-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/ga-68-psma-11-petct-in-diagnosis-of-prostate-cancer/</loc><lastmod>2026-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/addition-of-mezigdomide-to-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2026-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/multi-cancer-early-detection-test-performs-well-in-real-world-asian-cohort/</loc><lastmod>2026-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/subgroup-analysis-demonstrates-efficacy-of-inavolisib-regimen-in-asian-patients-with-advanced-breast-cancer/</loc><lastmod>2026-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/relapsed-or-refractory-multiple-myeloma-talquetamab-daratumumab/</loc><lastmod>2026-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/low-dose-tamoxifen-in-noninvasive-breast-neoplasia/</loc><lastmod>2026-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/preclinical-research-shows-interferon-may-attenuate-neutrophil-response-to-cancer-immunotherapy/</loc><lastmod>2026-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/st-jude-redesignation-marks-collaboration-with-who-toward-improved-pediatric-cancer-outcomes-globally/</loc><lastmod>2026-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/fda-warns-of-ongoing-breast-biopsy-needle-shortage/</loc><lastmod>2026-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/aga-recommends-colonoscopy-over-alternative-colorectal-cancer-screening-methods/</loc><lastmod>2026-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/metastatic-colorectal-cancer-gucy2c-targeted-car-t-cell-therapy/</loc><lastmod>2026-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/neoadjuvant-sacituzumab-govitecan-in-mibc/</loc><lastmod>2026-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/mibc-intravesical-recombinant-bcg-and-chemoimmunotherapy/</loc><lastmod>2026-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/two-pronged-nudges-result-in-timely-conversations-around-priorities-of-cancer-care/</loc><lastmod>2026-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/thyroid-cancer-reproductive-lifespan-hormone-therapy-potentially-linked-to-incidence/</loc><lastmod>2026-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/new-acsm-expert-consensus-statement-exercise-in-children-and-adolescents-with-cancer/</loc><lastmod>2026-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/fda-approves-sacituzumab-govitecan-hziy-as-monotherapy-and-in-combination-with-pembrolizumab-for-first-line-treatment-of-tnbc/</loc><lastmod>2026-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/changes-in-ai-mammogram-risk-scores-over-time-may-help-to-predict-future-breast-cancer/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/cns-prophylaxis-with-high-dose-methotrexate-in-ultra-high-risk-large-b-cell-lymphoma/</loc><lastmod>2026-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/first-line-avelumab-plus-methotrexate-in-low-risk-gestational-trophoblastic-tumors/</loc><lastmod>2026-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/fda-approves-capivasertib-plus-abiraterone-and-prednisone-for-metastatic-prostate-cancer/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/06-june/lu-177-dotatate-in-metastatic-pancreatic-neuroendocrine-tumors/</loc><lastmod>2026-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/access-denied-insurance-barriers-to-biomarker-testing-in-lung-cancer/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/asco-publishes-first-guideline-on-ctdna-testing-in-solid-tumors-and-lymphoma/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/electronic-prior-authorization-requirements-for-drugs/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/the-fear-of-having-cancer-never-goes-away/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/discovery-is-an-act-of-hope-remembering-dr-maura-gillison-s-pursuit-of-truth/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/neoadjuvant-inetetamab-plus-pyrotinib-evaluated-in-her2-positive-locally-advanced-breast-cancer-in-china/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/multiple-myeloma-studies-highlight-advances-across-the-field/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/integrating-environmental-health-into-pediatric-cancer-care-may-improve-outcomes/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/emerald-3-shows-benefit-with-stride-plus-tace-in-hepatocellular-carcinoma/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/paving-new-roads-in-the-treatment-of-brain-metastases-with-implanted-tile-based-radiation-therapy/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/aacr-cancer-disparities-progress-report-mortality-rates-improve-but-care-inequities-persist/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/early-palliative-care-improves-quality-of-life-for-patients-with-breast-cancer-in-india/</loc><lastmod>2026-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/proposed-rule-changing-federal-grantmaking-will-have-devastating-impact-on-cancer-research-patients/</loc><lastmod>2026-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/relapsed-or-refractory-multiple-myeloma-early-phase-trial-investigates-novel-bispecific-antibody/</loc><lastmod>2026-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/dabrafenib-plus-trametinib-improves-progression-free-survival-in-braf-v600e-positive-differentiated-thyroid-cancer/</loc><lastmod>2026-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/avatrombopag-manages-persistent-chemotherapy-induced-thrombocytopenia-in-gi-cancer/</loc><lastmod>2026-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/proton-pump-inhibitor-antibiotic-exposure-linked-to-inferior-durvalumab-outcomes-in-unresectable-stage-iii-nsclc/</loc><lastmod>2026-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/elevate-trial-shows-disease-free-survival-benefit-with-adjuvant-ensartinib-in-alk-positive-nsclc/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/long-term-overall-survival-with-addition-of-sbrt-to-abiraterone-acetate-and-adt-in-oligometastatic-castration-resistant-prostate-cancer/</loc><lastmod>2026-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-approves-isatuximab-irfc-for-subcutaneous-injection-for-multiple-myeloma-indications/</loc><lastmod>2026-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-approves-pembrolizumab-or-pembrolizumab-and-berahyaluronidase-alfa-pmph-each-with-enfortumab-vedotin-ejfv-for-muscle-invasive-bladder-cancer/</loc><lastmod>2026-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/shared-risk-factors-between-breast-cancer-and-atrial-fibrillationflutter/</loc><lastmod>2026-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/breast-cancer-tailoring-radiotherapy-based-on-nodal-response-to-primary-chemotherapy/</loc><lastmod>2026-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/no-survival-benefit-from-chemoradiotherapy-after-d2-gastrectomy-in-gastric-cancer/</loc><lastmod>2026-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/targeting-bcl2-may-overcome-acquired-resistance-in-braf-mutant-melanoma/</loc><lastmod>2026-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/in-the-united-states-men-may-be-more-likely-than-women-to-receive-later-stage-diagnoses-for-many-cancer-types/</loc><lastmod>2026-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/oral-cancer-novel-diagnostic-test-demonstrates-high-accuracy/</loc><lastmod>2026-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/advanced-gastric-or-gej-cancer-first-line-disitamab-vedotin-tislelizumab-and-s-1/</loc><lastmod>2026-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/long-term-follow-up-of-postoperative-chemoradiotherapy-with-weekly-vs-every-3-week-cisplatin-in-head-and-neck-cancer/</loc><lastmod>2026-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/zenocutuzumab-shows-durable-antitumor-activity-in-nrg1-positive-cholangiocarcinoma/</loc><lastmod>2026-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/disparities-in-cancer-screening-persist-among-sexual-orientation-and-gender-identity-minority-populations/</loc><lastmod>2026-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/inotuzumab-ozogamicin-induces-long-term-survival-in-b-cell-all/</loc><lastmod>2026-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/investigators-identify-resistance-mechanism-to-tagraxofusp-among-patients-with-bpdcn/</loc><lastmod>2026-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/all-oral-combination-of-revumenib-decitabinecedazuridine-and-venetoclax-for-relapsed-or-refractory-aml/</loc><lastmod>2026-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/intraoperative-margin-assessment-with-specimen-petct-imaging-in-early-breast-cancer/</loc><lastmod>2026-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/performance-of-lung-cancer-risk-prediction-models-across-racial-and-ethnic-groups-in-the-united-states/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/study-clarifies-hpv-related-cancer-risk-in-immunosuppressed-populations/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/ai-powered-tumor-microenvironment-analysis-may-predict-immunotherapy-response-in-patients-with-rare-cancers/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/ten-year-follow-up-shows-durable-remissions-after-car-t-cell-therapy-for-b-cell-lymphoma/</loc><lastmod>2026-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/impact-of-treatment-delays-in-early-onset-colorectal-cancer/</loc><lastmod>2026-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/early-research-explores-how-fatty-liver-disease-may-affect-liver-metastasis-among-patients-with-colorectal-cancer/</loc><lastmod>2026-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/aacr-statement-and-call-to-action-concerning-omb-proposal/</loc><lastmod>2026-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/break-through-cancer-and-the-lustgarten-foundation-launch-new-pancreatic-cancer-initiative/</loc><lastmod>2026-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/real-world-heart-and-lung-radiation-doses-from-nhs-breast-radiotherapy-plans/</loc><lastmod>2026-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/previously-untreated-advanced-nsclc-with-high-pd-l1-expressionb-pd-1-l1-inhibitor-monotherapy-or-chemoimmunotherapy/</loc><lastmod>2026-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/second-primary-malignancies-after-t-cell-engaging-bispecific-antibody-therapy/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/study-uncovers-how-obesity-influences-molecular-pathways-in-breast-cancer-progression/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/polargo-trial-shows-survival-benefit-with-polatuzumab-vedotin-based-regimen-in-relapsed-or-refractory-dlbcl/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-approves-zidesamtinib-for-second-line-treatment-of-ros1-positive-nsclc/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/paraneoplastic-neurological-syndromes-associated-with-improved-survival-in-sclc/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/cancer-survivors-and-providers-differ-on-cannabis-risk-awareness-and-communication/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/single-fraction-sbrt-in-localized-prostate-cancer/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-approves-immunotherapy-to-reduce-chronic-gvhd-in-patients-undergoing-stem-cell-transplant/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/amp-recognizes-nci-pathologist-with-award-for-excellence-in-molecular-diagnostics/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/emergency-department-cancer-diagnosis-associated-with-higher-mortality-across-16-cancer-types/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/early-research-examines-daraxonrasib-in-nras-mutant-melanoma/</loc><lastmod>2026-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/treatment-delays-may-increase-metastasis-risk-in-nonmetastatic-colorectal-cancer/</loc><lastmod>2026-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/can-consolidative-thoracic-radiotherapy-improve-outcomes-during-immunotherapy-maintenance-in-extensive-stage-sclc/</loc><lastmod>2026-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/ai-derived-bone-marrow-architecture-score-improves-disease-assessment-in-myelodysplastic-neoplasms/</loc><lastmod>2026-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/meta-analysis-highlights-cardiovascular-safety-advantage-of-second-generation-btk-inhibitors/</loc><lastmod>2026-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/study-finds-rising-breast-cancer-incidence-across-asian-american-native-hawaiian-and-pacific-islander-groups/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/oral-nicotinamide-may-offer-cost-effective-prevention-of-keratinocyte-carcinoma/</loc><lastmod>2026-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/national-survey-links-civic-engagement-to-higher-breast-cancer-screening-rates/</loc><lastmod>2026-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/early-trial-supports-kras-vaccine-strategy-for-pancreatic-cancer-interception/</loc><lastmod>2026-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/defining-functional-high-risk-multiple-myeloma-in-the-era-of-quadruplet-therapy-and-autologous-stem-cell-transplant/</loc><lastmod>2026-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/virtual-sustained-counseling-and-tobacco-treatment-improve-quit-rates-for-patients-with-cancer-in-community-settings/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/how-do-surgical-ovarian-cancer-prevention-strategies-compare-for-sexual-function/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/node-negative-breast-cancer-20-year-outcomes-with-im-ms-lymph-node-irradiation/</loc><lastmod>2026-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/expert-dermatologists-outperform-ai-foundation-models-in-real-world-skin-cancer-diagnosis/</loc><lastmod>2026-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/tumor-microenvironment-ecotypes-may-explain-differences-in-multiple-myeloma-outcomes/</loc><lastmod>2026-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/ctdna-status-may-predict-benefit-from-adjuvant-chemotherapy-after-resection-of-colorectal-liver-metastases/</loc><lastmod>2026-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/over-50-million-americans-live-in-counties-without-a-radiation-oncology-clinic/</loc><lastmod>2026-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/kras-g12d-mutated-metastatic-pancreatic-cancer-zoldonrasib-plus-chemotherapy/</loc><lastmod>2026-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/addition-of-sacituzumab-tirumotecan-to-pembrolizumab-in-pd-l1-positive-advanced-nsclc/</loc><lastmod>2026-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/endurance-trial-in-newly-diagnosed-myeloma-no-survival-benefit-with-indefinite-vs-2-years-of-maintenance-treatment/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/overall-survival-with-ivonescimab-or-tislelizumab-plus-chemotherapy-in-advanced-squamous-nsclc/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/digital-check-ins-may-improve-outcomes-in-patients-undergoing-treatment-for-advanced-cancer/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/american-cancer-society-reports-latest-global-cancer-statistics/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/stage-iii-her2-negative-breast-cancer-with-hrd-standard-chemotherapy-plus-olaparib/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/radiotherapy-dose-escalation-with-intraoperative-radiotherapy-vs-surgery-alone-in-glioblastoma/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/setmelanotide-in-patients-with-acquired-hypothalamic-obesity/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-grants-traditional-approval-to-selpercatinib-for-locally-advanced-or-metastatic-ret-fusion-positive-solid-tumors/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/gedatolisib-combinations-approved-by-fda-for-hr-positiveher2-negative-breast-cancer/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/nci-names-new-ccr-director/</loc><lastmod>2026-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/pirtobrutinib-triplet-improves-progression-free-survival-in-previously-treated-cll/</loc><lastmod>2026-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/transplant-consolidation-improves-survival-in-primary-cns-lymphoma/</loc><lastmod>2026-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/acs-study-quantifies-financial-burden-of-cancer-in-older-patients/</loc><lastmod>2026-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/perioperative-systemic-therapy-vs-surgery-alone-in-colorectal-peritoneal-only-metastases/</loc><lastmod>2026-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/emergency-hospital-admission-accounts-for-40-of-ovarian-cancer-diagnoses-in-england/</loc><lastmod>2026-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/germline-genetic-variants-associated-with-car-t-cell-therapy-safety-and-efficacy-in-hematologic-malignancies/</loc><lastmod>2026-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/monica-baskin-named-director-of-vcu-massey-comprehensive-cancer-center/</loc><lastmod>2026-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/beth-erickson-md-fastro-named-astro-president-elect/</loc><lastmod>2026-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/mri-based-t-staging-matches-traditional-clinical-staging-in-localized-prostate-cancer/</loc><lastmod>2026-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/case-series-supports-high-dose-oral-vitamin-d-for-cancer-therapy-related-skin-toxicities/</loc><lastmod>2026-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/rectal-cancer-ai-identifies-patients-most-likely-to-benefit-from-irinotecan-intensified-neoadjuvant-chemoradiotherapy/</loc><lastmod>2026-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-releases-final-guidances-to-expand-participation-in-cancer-clinical-trials/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/phase-iii-trial-finds-no-benefit-for-magrolimab-combination-in-higher-risk-mds/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/concurrent-palliative-care-remains-underused-among-young-adults-with-advanced-cancer/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/global-breast-cancer-survival-estimates-who-analysis/</loc><lastmod>2026-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/mmud-vs-mrd-transplantation-in-the-posttransplant-cyclophosphamide-era/</loc><lastmod>2026-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/07-july/fda-approves-simplescreen-crc-blood-based-screening-test-for-colorectal-cancer/</loc><lastmod>2026-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-radionuclide-therapy-plus-arpi-for-mapmns-prostate-cancer/</loc><lastmod>2026-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/researchers-identify-donor-nk-cell-subset-that-impairs-car-nk-cell-therapy-and-demonstrate-a-manufacturing-solution/</loc><lastmod>2026-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/safety-and-efficacy-of-il-10-expressing-car-t-cell-therapy-in-relapsed-or-refractory-dlbcl/</loc><lastmod>2026-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/quantum-machine-learning-framework-improves-prediction-of-antigen-presentation-and-immunotherapy-response/</loc><lastmod>2026-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/enfortumab-vedotin-plus-pembrolizumab-improves-outcomes-in-cisplatin-eligible-muscle-invasive-bladder-cancer/</loc><lastmod>2026-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/next-generation-sequencing-uptake-remains-low-among-medicare-beneficiaries-study-finds/</loc><lastmod>2026-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/topaz-1-post-hoc-analysis-supports-durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer/</loc><lastmod>2026-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/us-news-world-report-announces-2026-2027-best-cancer-hospitals/</loc><lastmod>2026-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/ai-based-cfdna-fragmentome-classifier-may-improve-detection-of-hcc/</loc><lastmod>2026-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/population-based-mgus-screening-enables-earlier-detection-of-multiple-myeloma-without-increasing-psychological-distress/</loc><lastmod>2026-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/when-diagnosis-waits-lung-cancer-pet-access-and-global-oncology/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/phase-i-trial-evaluates-allogeneic-cd70-targeted-car-t-cell-therapy-in-advanced-renal-cell-carcinoma/</loc><lastmod>2026-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/ckm-syndrome-associated-with-increased-stage-specific-cancer-risk-study-finds/</loc><lastmod>2026-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/combination-regimen-prolongs-pfs-in-dmmr-msi-h-metastatic-colorectal-cancer/</loc><lastmod>2026-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/her2-targeted-regimen-yields-high-pathologic-complete-response-rate-in-locally-advanced-breast-cancer/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/hrr-altered-metastatic-prostate-cancer-talazoparib-plus-enzalutamide-improves-progression-free-survival/</loc><lastmod>2026-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/durvalumab-plus-radiation-therapy-in-frail-patients-with-locally-advanced-nsclc/</loc><lastmod>2026-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/new-data-on-14-vs-28-day-venetoclaxazacitidine-in-aml/</loc><lastmod>2026-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fusobacterium-positivity-predicts-relapse-risk-and-limited-benefit-from-adjuvant-chemotherapy-in-colorectal-cancer/</loc><lastmod>2026-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/trastuzumab-rezetecan-improves-progression-free-survival-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2026-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-oncolytic-viral-therapy-with-immunotherapy-for-advanced-melanoma/</loc><lastmod>2026-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/who-calls-for-action-in-new-status-report-on-cancer/</loc><lastmod>2026-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/amh-levels-may-predict-adjuvant-chemotherapy-benefit-in-premenopausal-women-with-breast-cancer/</loc><lastmod>2026-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/durvalumab-plus-bcg-improves-outcomes-in-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/teclistamab-improves-progression-free-and-overall-survival-in-previously-treated-multiple-myeloma/</loc><lastmod>2026-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/outreach-to-hct-recipients-primary-care-doctors-may-reduce-skin-cancer-risk/</loc><lastmod>2026-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/phase-iii-trial-supports-intensified-total-neoadjuvant-therapy-in-high-risk-rectal-cancer/</loc><lastmod>2026-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/american-college-of-surgeons-commission-on-cancer-introduces-rural-cancer-program-accreditation/</loc><lastmod>2026-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/stanford-appoints-new-leader-to-expand-impact-in-early-drug-development/</loc><lastmod>2026-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/nih-funded-international-research-yields-patient-derived-tumor-compendium/</loc><lastmod>2026-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/ai-biomarker-may-guide-adjuvant-chemotherapy-in-resected-pancreatic-cancer/</loc><lastmod>2026-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/first-in-class-bispecific-adc-shows-activity-in-relapsed-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/global-survey-identifies-barriers-to-integrative-oncology-use-in-cancer-care/</loc><lastmod>2026-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/residential-social-vulnerability-associated-with-worse-survival-among-black-women-with-epithelial-ovarian-cancer/</loc><lastmod>2026-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/astro-updates-guideline-on-radiation-therapy-for-pancreatic-cancer/</loc><lastmod>2026-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/immune-cell-dysfunction-not-absence-defines-nonmelanoma-skin-cancer-in-immunosuppressed-patients/</loc><lastmod>2026-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/does-ctdna-guided-surveillance-after-curative-intent-surgery-benefit-outcomes-in-cases-of-recurrent-colorectal-cancer/</loc><lastmod>2026-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/darolutamide-plus-goserelin-in-ar-positive-salivary-gland-carcinoma/</loc><lastmod>2026-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-celmod-combination-regimen-for-pretreated-multiple-myeloma/</loc><lastmod>2026-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/what-is-the-optimal-psa-to-determine-prostate-cancer-treatment-efficacy/</loc><lastmod>2026-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/qol-impact-of-postmastectomy-chest-wall-radiotherapy-5-year-follow-up/</loc><lastmod>2026-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/cretostimogene-grenadenorepvec-in-bcg-unresponsive-non-muscle-invasive-bladder-cancer/</loc><lastmod>2026-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/can-newborn-genetic-testing-identify-cancer-predisposition-genes/</loc><lastmod>2026-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/darovasertib-plus-crizotinib-may-set-new-first-line-standard-in-hla-a2-negative-metastatic-uveal-melanoma/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/ai-model-predicts-tp53-status-tumor-type-and-survival-from-routine-he-slides/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/early-intravesical-pirarubicin-improves-relapse-free-survival-in-upper-tract-urothelial-carcinoma/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/adding-irinotecan-to-preoperative-chemoradiotherapy-does-not-improve-outcomes-in-locally-advanced-rectal-cancer/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/lori-j-pierce-md-fasco-named-distinguished-university-professor-university-of-michigan/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/living-guideline-adds-repotrectinib-and-zongertinib-as-treatment-options-for-advanced-nsclc-with-driver-alterations/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/cancer-epidemiologist-joseph-f-fraumeni-jr-md-dies-at-93/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/phase-iii-optima-trial-many-patients-with-er-positive-her2-negative-breast-cancer-may-be-able-to-avoid-chemotherapy/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/chemotherapy-immunotherapy-and-targeted-therapy-in-advanced-refractory-malignancies/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/digital-integrative-medicine-program-improves-overall-survival-in-patients-undergoing-systemic-cancer-treatment/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/rezatapopt-shows-activity-in-tp53-y220c-mutated-advanced-ovarian-cancer/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/navigating-early-relapse-in-multiple-myeloma-new-evidence-from-the-2026-asco-and-eha-congresses/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/metabolic-syndrome-frequently-documented-during-first-year-of-adt-arpi-therapy-in-prostate-cancer/</loc><lastmod>2026-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/preoperative-weight-loss-program-shows-feasibility-before-endometrial-cancer-surgery/</loc><lastmod>2026-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/long-term-survivors-of-hodgkin-lymphoma-may-face-elevated-health-risks-study-finds/</loc><lastmod>2026-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/the-mid-career-oncologist-in-lmic-regions-navigating-disparities-avoiding-burnout-and-delivering-optimal-care/</loc><lastmod>2026-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-zanidatamab-combination-regimens-for-her2-gastric-gej-or-esophageal-cancer/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/asco-remembers-supportive-care-and-symptom-management-pioneer-gary-r-morrow-phd-ms/</loc><lastmod>2026-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/research-finds-supercentenarians-have-an-abundance-of-cd4-ctls/</loc><lastmod>2026-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/dr-gary-r-morrow-a-pioneer-in-cancer-research-dies-at-82/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/colorectal-cancer-may-cause-peripheral-neuropathy-before-treatment-preclinical-study-finds/</loc><lastmod>2026-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-daraxonrasib-for-metastatic-pancreatic-adenocarcinoma/</loc><lastmod>2026-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/cleveland-clinic-president-discusses-ai-summit-for-health-care-professionals/</loc><lastmod>2026-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/expanded-ehr-data-may-improve-prediction-of-early-adverse-events-after-aml-induction-chemotherapy/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/washu-medicine-appoints-new-chief-of-head-and-neck-surgery/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/prostate-cancer-nrg-gu005-defines-trade-offs-between-sbrt-and-moderately-hypofractionated-imrt/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/asco-remembers-dr-harold-p-freeman-preeminent-health-equity-expert-and-pioneer-of-patient-navigation/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/study-evaluates-chemotherapy-free-quadruplet-in-hr-positive-her2-positive-metastatic-breast-cancer/</loc><lastmod>2026-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/in-cancer-trials-federal-and-industry-sponsors-play-complementary-roles/</loc><lastmod>2026-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/cfdna-fragmentomics-plus-methylation-analysis-may-improve-detection-of-precancerous-colorectal-lesions/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/tissue-free-ctdna-assay-may-help-identify-recurrence-risk-in-early-triple-negative-breast-cancer/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/large-multicenter-study-evaluates-litt-for-primary-and-metastatic-brain-tumors/</loc><lastmod>2026-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-rusfertide-for-erythrocytosis-in-adults-with-polycythemia-vera/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/biomarker-guides-treatment-sequencing-predicts-outcomes-in-braf-mutated-metastatic-melanoma/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-approves-ropeginterferon-alfa-2b-njft-for-essential-thrombocythemia/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/high-dose-vitamin-d3-does-not-improve-pfs-in-metastatic-colorectal-cancer/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/additional-safety-analysis-of-destiny-breast05-what-did-it-show/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/aasld-publishes-landmark-north-american-framework-to-advance-treatment-decisions-for-hcc/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/tace-plus-thermal-ablation-improves-survival-in-unresectable-hcc/</loc><lastmod>2026-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/high-risk-erbb2-negative-breast-cancer-adding-dual-checkpoint-blockade-to-neoadjuvant-chemotherapy/</loc><lastmod>2026-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/sugar-vs-artificially-sweetened-beverages-and-gastric-cancer-risk/</loc><lastmod>2026-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/genomic-profiles-and-adjuvant-chemotherapy-outcomes-in-resected-pancreatic-cancer/</loc><lastmod>2026-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/is-excess-adiposity-linked-to-vertebral-fracture-progression-in-aromatase-inhibitor-treated-early-breast-cancer/</loc><lastmod>2026-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/charles-wm-roberts-named-president-and-chief-executive-officer-of-st-jude-children-s-research-hospital/</loc><lastmod>2026-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/adding-a-radiopharmaceutical-to-standard-therapy-in-mrcc-does-not-improve-skeletal-events/</loc><lastmod>2026-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/cleveland-clinic-to-host-second-annual-ai-summit-for-health-care-professionals/</loc><lastmod>2026-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/mosunetuzumab-with-response-adapted-therapy-in-previously-untreated-nhl/</loc><lastmod>2026-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/county-level-medical-debt-linked-to-advanced-stage-cancers-worse-survival-among-newly-diagnosed-us-adults/</loc><lastmod>2026-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/study-supports-personalized-weight-loss-intervention-for-breast-cancer-survivors/</loc><lastmod>2026-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/pilots-and-flight-attendants-show-elevated-radiation-related-cancer-mortality/</loc><lastmod>2026-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/interpath-001-trial-of-mrna-based-individualized-neoantigen-therapy-meets-primary-and-key-secondary-endpoints-in-patients-with-high-risk-resected-melanoma/</loc><lastmod>2026-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/early-histotripsy-use-for-liver-tumors-raises-questions-about-patient-selection/</loc><lastmod>2026-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/08-august/fda-seeks-public-input-relating-to-regulatory-considerations-for-generative-ai-enabled-medical-devices/</loc><lastmod>2026-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/two-studies-build-evidence-supporting-the-use-of-ctdna-as-an-early-endpoint/</loc><lastmod>2026-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/the-2026-asco-annual-meeting-geriatric-oncology-update-the-next-challenge-is-implementation/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/radiation-to-the-thymus-in-nsclc-treatment-may-increase-risk-of-metastasis/</loc><lastmod>2026-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/osimertinib-plus-chemotherapy-significantly-extends-progression-free-survival-in-egfrtp53-mutated-nsclc/</loc><lastmod>2026-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-camizestrant-combination-regimen-for-locally-advanced-or-metastatic-breast-cancer/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/guideline-update-recommends-tailoring-breast-cancer-surveillance-based-on-recurrence-risk/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/i-wasn-t-expecting-cancer-at-22/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/building-momentum-asco-s-geriatric-oncology-cop/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/as-ai-advances-how-will-the-clinician-s-role-change/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/how-one-nonprofit-is-providing-access-to-a-discontinued-investigational-drug-for-children-with-a-rare-form-of-aml/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/trastuzumab-rezetecan-improves-progression-free-survival-in-chemotherapy-refractory-her2-positive-advanced-colorectal-cancer/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/asco-breakthrough-studies-target-supportive-care-problems-that-can-derail-treatment/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/plant-based-diet-linked-to-lower-risk-of-prostate-cancer-progression-on-active-surveillance/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/old-habits-die-hard-project-optimus-and-the-next-generation-of-kras-g12c-inhibitors/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/20th-annual-award-for-leadership-in-personalized-medicine/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/surviving-cancer-put-me-on-a-career-path-in-cancer-research/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/ascent-04-exploratory-analysis-sacituzumab-govitecan-plus-pembrolizumab-improves-pfs2-delays-next-treatment/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/long-term-trial-supports-selective-use-of-extended-pelvic-lymph-node-dissection-in-high-grade-prostate-cancer/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/structured-exercise-after-adjuvant-chemotherapy-for-colon-cancer-improves-survival-and-saves-costs/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-first-in-class-targeted-therapy-for-metastatic-pancreatic-cancer/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/save-research-campaign-champions-federal-funding/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/envafolimab-regimen-improves-pathologic-complete-response-in-mss-locally-advanced-rectal-cancer/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/acs-publishes-report-on-cancers-in-asian-american-native-hawaiian-and-pacific-islander-people/</loc><lastmod>2026-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/adcimmunotherapy-combination-shows-activity-in-treatment-resistant-nasopharyngeal-carcinoma/</loc><lastmod>2026-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/hypofractionated-salvage-radiotherapy-evaluated-after-prostatectomy-for-biochemical-recurrence/</loc><lastmod>2026-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/researchers-define-molecular-prognostic-subgroups-in-therapy-related-myeloid-neoplasms/</loc><lastmod>2026-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/dual-oral-regimen-shows-encouraging-activity-in-kras-g12c-mutated-metastatic-colorectal-cancer/</loc><lastmod>2026-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/predictors-of-pcr-to-neoadjuvant-thp-explored-in-her2-positive-breast-cancer/</loc><lastmod>2026-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/cervical-cancer-nonscreening-increased-over-nearly-2-decades/</loc><lastmod>2026-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/investment-in-blood-cancer-research-has-saved-nearly-26-million-years-of-life-but-major-gaps-in-survival-remain/</loc><lastmod>2026-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/prostate-cancer-cardiovascular-risk-factors-may-help-identify-patients-who-would-benefit-from-additional-cardiac-care/</loc><lastmod>2026-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/ai-applied-to-mammograms-may-help-identify-common-cardiovascular-conditions/</loc><lastmod>2026-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/duane-mitchell-named-director-of-the-uf-health-cancer-institute/</loc><lastmod>2026-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/long-course-chemoradiotherapy-shows-early-organ-preservation-advantage-in-rectal-cancer/</loc><lastmod>2026-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/prostate-cancer-higher-saturated-fat-intake-may-be-linked-to-worse-outcomes/</loc><lastmod>2026-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/robert-kyle-myeloma-expert-dies-at-98/</loc><lastmod>2026-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/refined-risk-index-improves-outcome-prediction-after-limited-duration-cll-therapy/</loc><lastmod>2026-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/suoaua-updates-guidelines-for-non-muscle-invasive-bladder-cancer/</loc><lastmod>2026-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/early-ctdna-molecular-response-may-predict-outcomes-with-azenosertib-in-ovarian-cancer/</loc><lastmod>2026-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/esmo-announces-2026-society-award-recipients/</loc><lastmod>2026-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/nsclc-fda-grants-accelerated-approval-to-sevabertinib-for-locally-advanced-or-metastatic-nonsquamous-disease/</loc><lastmod>2026-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/perioperative-atezolizumab-plus-chemotherapy-improves-outcomes-in-resectable-stage-ii-iiib-nsclc/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-topical-photodynamic-therapy-for-superficial-bcc/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/genomic-profiles-compared-in-early-and-average-onset-metastatic-colorectal-cancer/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/favorable-safety-profile-found-for-subcutaneous-tarlatamab-in-es-sclc/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/extended-interval-dosing-of-tarlatamab-found-safe-effective-in-sclc/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/adjuvant-alectinib-maintains-quality-of-life-during-2-years-of-treatment-in-resected-alk-positive-nsclc/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/new-executive-director-of-the-duke-cancer-institute-named/</loc><lastmod>2026-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/darol-examines-darolutamide-with-lipid-modifying-agents-in-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2026-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/maverick-trial-supports-brain-mri-surveillance-alone-as-standard-of-care-for-sclc/</loc><lastmod>2026-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/ivonescimab-significantly-improves-overall-survival-vs-pembrolizumab-in-pd-l1-positive-advanced-nsclc/</loc><lastmod>2026-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/izalontamab-brenitecan-active-in-previously-treated-egfr-nsclc/</loc><lastmod>2026-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/long-term-benefit-seen-with-adjuvant-osimertinib-in-egfr-mutated-nsclc/</loc><lastmod>2026-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/two-phase-iii-trials-explore-b7-h3-directed-adcs-in-relapsed-sclc/</loc><lastmod>2026-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/pd-l1-high-metastatic-nsclc-first-line-sacituzumab-govitecan-plus-pembrolizumab-does-not-meet-pfs-endpoint/</loc><lastmod>2026-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/american-cancer-society-urges-men-to-understand-their-risk-for-prostate-cancer/</loc><lastmod>2026-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/independent-validation-supports-prognostic-value-of-computational-tils-in-triple-negative-breast-cancer/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/zidesamtinib-demonstrates-94-percent-response-rate-in-tki-naive-patients-with-advanced-ros1-positive-nsclc/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/high-risk-prostate-cancer-getug-afu-18-suggests-a-role-for-dose-escalated-radiotherapy-with-long-term-adt/</loc><lastmod>2026-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/md-anderson-president-announces-retirement-shares-leadership-transition-plans/</loc><lastmod>2026-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/sociological-study-explores-the-concept-of-temporal-misalignment-among-patients-with-terminal-cancer/</loc><lastmod>2026-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/spartalizumab-based-triplet-improves-long-term-overall-survival-in-braf-v600-mutant-melanoma/</loc><lastmod>2026-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/what-constitutes-clinical-expertise-in-an-ai-enabled-era/</loc><lastmod>2026-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/optimum-trial-reports-5-year-outcomes-with-extended-therapy-in-high-risk-multiple-myeloma/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/zipalertinib-added-to-chemotherapy-improves-pfs-in-first-line-egfr-exon-20-nsclc/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/first-line-trastuzumab-deruxtecan-prolongs-pfs-in-her2-mutant-nsclc/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-new-labeling-of-ros1-inhibitor-for-nsclc/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/ai-s-evolving-role-in-clinical-care-enterprise-wide/</loc><lastmod>2026-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/tumor-budding-grading-system-can-identify-high-risk-patients-with-lung-squamous-cell-carcinoma/</loc><lastmod>2026-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/azacitidinevenetoclax-improves-event-free-survival-in-fit-patients-with-aml/</loc><lastmod>2026-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/alcohol-attributable-cancer-deaths-more-than-double-in-the-united-states/</loc><lastmod>2026-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/first-line-amivantamabchemotherapy-in-egfr-exon-20-insertion-positive-advanced-nsclc/</loc><lastmod>2026-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-imlunestrant-in-combination-with-abemaciclib-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer/</loc><lastmod>2026-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/astro-issues-its-first-clinical-guideline-on-radiation-therapy-for-bladder-cancer/</loc><lastmod>2026-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/mobile-ct-lung-cancer-screening-may-expand-access-for-underserved-populations/</loc><lastmod>2026-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/keynote-826-long-term-outcomes-with-pembrolizumab-plus-chemotherapy-in-advanced-cervical-cancer/</loc><lastmod>2026-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/aacr-releases-annual-cancer-progress-report/</loc><lastmod>2026-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/braf-class-alterations-in-nsclc-have-different-characteristics-outcomes-and-co-mutations-research-shows/</loc><lastmod>2026-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/second-line-investigational-monoclonal-antibody-in-metastatic-squamous-nsclc/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/germline-egfr-t790m-associated-with-significant-lung-cancer-risk/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/neoadjuvant-anbenitamabchemotherapy-combination-improves-response-in-erbb2-positive-breast-cancer/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/excess-mortality-halts-trial-of-venetoclax-added-to-da-epoch-r-in-double-hit-lymphoma/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-lirafugratinib-for-previously-treated-unresectable-locally-advanced-or-metastatic-cholangiocarcinoma/</loc><lastmod>2026-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/tambotatug-pelitecan-may-improve-survival-outcomes-in-relapsed-sclc/</loc><lastmod>2026-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/daraxonrasib-shows-antitumor-activity-in-previously-treated-ras-mutant-nsclc/</loc><lastmod>2026-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/cap-updates-cancer-protocols-for-breast-cancer-biomarker-reporting-and-gist-molecular-testing/</loc><lastmod>2026-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-advisory-committee-votes-in-favor-of-approval-of-multi-cancer-early-detection-test/</loc><lastmod>2026-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fda-approves-belzutifan-in-combination-with-lenvatinib-for-advanced-ccrcc/</loc><lastmod>2026-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/phase-iii-trial-compares-her2-directed-antibody-drug-conjugates-in-advanced-breast-cancer/</loc><lastmod>2026-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/fractionated-srs-approach-improves-outcomes-for-patients-with-resected-large-brain-metastases/</loc><lastmod>2026-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/srs-is-a-reasonable-option-for-patients-with-sclc-and-brain-metastases/</loc><lastmod>2026-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/adding-targeted-immunotherapy-to-pembrolizumab-in-recurrent-or-metastatic-hpv16-positive-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2026-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/bivalent-car-t-cell-therapy-shows-no-delayed-toxicity-and-promising-survival-in-recurrent-glioblastoma/</loc><lastmod>2026-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/new-prognostic-model-may-improve-risk-classification-in-metastatic-clear-cell-rcc/</loc><lastmod>2026-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/short-course-sbrt-better-preserves-physical-function-before-pancreatic-cancer-surgery/</loc><lastmod>2026-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/ultra-low-dose-radiation-therapy-may-relieve-bone-pain-from-multiple-myeloma/</loc><lastmod>2026-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/long-term-disease-control-from-sbrt-equal-to-surgery-in-localized-prostate-cancer/</loc><lastmod>2026-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/real-world-data-indicate-lower-adherence-rates-for-breast-cancer-endocrine-therapy-when-radiation-therapy-is-omitted/</loc><lastmod>2026-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/mindfulness-and-tai-chi-may-improve-symptoms-after-cancer-treatment/</loc><lastmod>2026-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/depression-increases-cancer-specific-mortality-risks-in-common-cancers/</loc><lastmod>2026-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/sympro-lung-could-weekly-pro-symptom-monitoring-improve-survival-outcomes-in-any-stage-lung-cancer/</loc><lastmod>2026-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/09-september/new-ai-model-outperforms-oncotype-dx-for-predicting-recurrence-risk-in-breast-cancer/</loc><lastmod>2026-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/glp-1-receptor-agonist-use-linked-to-lower-colorectal-cancer-risk-in-patients-with-inflammatory-bowel-disease/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/lung-cancer-specialist-apar-kishor-ganti-md-shares-his-insights/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/new-nccn-survey-highlights-persistent-cancer-medication-shortages-across-united-states/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/tmc-i-regimen-may-expand-treatment-access-in-advanced-head-and-neck-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/losing-weight-and-breast-cancer-risk-the-glp-1-question/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/nccn-releases-new-guideline-for-patients-and-caregivers-older-adults-with-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/implementing-massage-and-acupuncture-to-achieve-better-pain-management-in-oncology-care-an-overview-of-the-imagine-project/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/can-long-distance-running-be-a-risk-factor-for-early-onset-colorectal-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/amyloidosis-novel-treatments-could-improve-poor-outcomes/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/the-molecular-watchman-why-measurable-residual-disease-testing-is-redefining-treatment-and-surveillance-in-colorectal-and-bladder-cancers/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/evolving-strategies-in-relapsedrefractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/mocertatug-rezetecan-mo-rez-shows-early-activity-in-platinum-resistant-ovarian-and-endometrial-cancers/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/three-decades-of-aya-cancer-survivorship/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/of-note-in-the-oncology-community-septemberoctober-2026/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/asco-issues-its-first-living-guideline-on-systemic-treatment-of-recurrent-ovarian-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/patient-friendly-research-summaries-spotlight-advances-in-pancreatic-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/data-from-pivotal-trials-lead-to-recent-drug-approvals-in-colorectal-breast-rcc-and-cllsll-malignancies/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/bivalent-car-t-cell-therapy-shows-durable-activity-and-manageable-safety-in-recurrent-glioblastoma/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/real-world-data-are-not-necessarily-real-world-evidence/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/presidential-symposium-highlights-in-small-cell-lung-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/mammography-screening-for-recurrence-after-a-diagnosis-of-breast-cancer/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/robert-a-kyle-md-renowned-expert-in-myeloma-dies-at-98/</loc><lastmod>2026-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/two-studies-show-breast-cancer-survival-and-mortality-gaps-are-widening-between-rural-and-urban-areas/</loc><lastmod>2026-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/replacing-intensive-chemotherapy-with-blinatumomab-improves-outcomes-in-high-risk-pediatric-acute-lymphoblastic-leukemia/</loc><lastmod>2026-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/residual-ovarian-cancer-risk-in-brca-carriers-may-inform-timing-of-preventive-surgery/</loc><lastmod>2026-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/2026-albany-prize-awardees-announced/</loc><lastmod>2026-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/pediatric-bone-sarcoma-gets-first-nccn-guidelines/</loc><lastmod>2026-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/iberdomide-triplet-improves-mrd-negative-complete-response-in-relapsedrefractory-multiple-myeloma/</loc><lastmod>2026-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/even-highly-curable-childhood-leukemias-take-a-substantial-toll-on-families/</loc><lastmod>2026-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/phase-iii-verify-trial-demonstrates-benefits-of-rusfertide-in-polycythemia-vera/</loc><lastmod>2026-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/novel-androgen-receptor-degrader-demonstrates-promising-antitumor-activity-in-advanced-prostate-cancer/</loc><lastmod>2026-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/immunotherapy-based-downstaging-linked-to-improved-outcomes-after-liver-transplantation-in-hepatocellular-carcinoma/</loc><lastmod>2026-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/ash-issues-new-recommendations-for-the-management-of-myelofibrosis/</loc><lastmod>2026-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/fda-approves-dostarlimab-for-msi-hdmmr-locally-advanced-rectal-cancer/</loc><lastmod>2026-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/national-academy-of-medicine-elects-100-new-members-for-2026/</loc><lastmod>2026-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/community-oncology-practices-bring-advances-in-cancer-testing-and-treatment-closer-to-patients/</loc><lastmod>2026-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/iarc-panel-provides-international-determination-on-lung-cancer-screening-benefits-and-harms/</loc><lastmod>2026-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/are-narrower-negative-margins-linked-to-higher-risk-of-dcis-recurrence/</loc><lastmod>2026-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/annual-report-to-the-nation-progress-against-lung-cancer-drives-down-cancer-mortality/</loc><lastmod>2026-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/pembrolizumabolaparib-strategy-in-brca-nonmutated-advanced-ovarian-cancer/</loc><lastmod>2026-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/lung-cancer-ai-model-may-predict-pneumonitis-risk-from-immunotherapy/</loc><lastmod>2026-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/fda-approves-first-line-pirtobrutinib-for-cll-sll/</loc><lastmod>2026-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/er-positive-her2-negative-advanced-breast-cancer-giredestrant-plus-everolimus/</loc><lastmod>2026-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/autonomous-ai-triaged-urgent-suspected-skin-cancer-referrals-in-real-world-implementation-study/</loc><lastmod>2026-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/verifying-the-seen-and-unseen-by-ai-in-cancer-imaging/</loc><lastmod>2026-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/global-gaps-in-cancer-control-expenditure-data-identified/</loc><lastmod>2026-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/wildfire-related-fine-particulate-matter-linked-to-higher-mortality-in-older-patients-with-lung-cancer/</loc><lastmod>2026-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/ai-extracted-chart-data-for-expanding-surgical-oncology-learnings/</loc><lastmod>2026-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/tile-based-radiation-outperforms-postoperative-stereotactic-radiation-therapy-in-resected-brain-metastases/</loc><lastmod>2026-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/pediatric-and-adolescent-colorectal-carcinoma-a-retrospective-analysis/</loc><lastmod>2026-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/automated-vs-handheld-ultrasound-for-breast-cancer-screening/</loc><lastmod>2026-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/sitagliptin-added-to-standard-prophylaxis-reduces-risk-of-acute-gvhd-following-alternative-donor-transplantation/</loc><lastmod>2026-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/facilitated-cascade-genetic-testing-improves-uptake-among-relatives-of-brca12-variant-carriers/</loc><lastmod>2026-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/fda-approves-expanded-indication-for-nogapendekin-alfa-inbakicept-in-bcg-unresponsive-nmibc/</loc><lastmod>2026-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/study-supports-universal-germline-genetic-testing-regardless-of-age-at-cancer-diagnosis/</loc><lastmod>2026-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/asco-and-who-formalize-partnership/</loc><lastmod>2026-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/chronic-immune-related-adverse-events-common-after-adjuvant-anti-pd-1-therapy-for-melanoma/</loc><lastmod>2026-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/nccn-models-how-to-tailor-cancer-care-for-different-regions-during-2026-world-cancer-congress/</loc><lastmod>2026-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/cleveland-clinic-london-appoints-oncology-vice-chief/</loc><lastmod>2026-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/multicancer-early-detection-screening-does-not-reduce-overall-late-stage-cancer-diagnosis/</loc><lastmod>2026-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/fda-launches-effort-to-expand-scientific-expertise-consumer-voice-to-advisory-committees/</loc><lastmod>2026-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/her2-positive-breast-cancer-fda-approves-triplet-for-maintenance-therapy/</loc><lastmod>2026-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/charles-perou-2026-william-l-mcguire-memorial-lecture-award/</loc><lastmod>2026-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/study-supports-sentinel-lymph-node-biopsy-after-chemotherapy-in-locally-advanced-breast-cancer/</loc><lastmod>2026-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/acs-report-highlights-cancer-burden-and-screening-disparities-in-us-hispanic-population/</loc><lastmod>2026-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/starting-surveillance-colonoscopy-after-high-risk-adenoma-removal-when-is-the-right-time/</loc><lastmod>2026-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/robotic-esophagectomy-improves-lymph-node-yield-in-esophageal-cancer/</loc><lastmod>2026-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/fda-approves-atezolizumab-in-combination-with-chemotherapy-for-stage-iii-dmmr-colon-cancer/</loc><lastmod>2026-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/insurance-and-cost-barriers-to-oral-therapies-for-blood-cancers/</loc><lastmod>2026-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/her2-negative-advanced-gastric-cancers-first-line-retlirafusp-alfa-combination-demonstrates-survival-benefit/</loc><lastmod>2026-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/early-research-links-abdominal-obesity-to-increased-lung-cancer-risk/</loc><lastmod>2026-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/the-wistar-institute-names-new-president-and-chief-executive-officer/</loc><lastmod>2026-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/financial-navigation-support-may-help-reduce-financial-toxicity-for-some-people-with-advanced-cancer/</loc><lastmod>2026-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/remote-exercise-program-reduces-cancer-related-fatigue-improves-quality-of-life-for-patients-undergoing-immunotherapy/</loc><lastmod>2026-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/anitocabtagene-autoleucel-shows-high-response-rate-in-heavily-pretreated-relapsedrefractory-multiple-myeloma/</loc><lastmod>2026-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/experts-call-for-better-quality-of-life-reporting-in-adjuvant-cancer-trials/</loc><lastmod>2026-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/phase-iii-rt-charm-trial-supports-shorter-postmastectomy-radiation-therapy-after-breast-reconstruction/</loc><lastmod>2026-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/remote-expert-case-reviews-identify-opportunities-to-improve-cancer-care-and-reduce-costs/</loc><lastmod>2026-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/metastasis-directed-ablation-does-not-improve-survival-outcomes-in-oligometastatic-breast-cancer/</loc><lastmod>2026-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/ai-model-based-on-facial-image-analysis-estimates-biological-age-and-mortality-risk-in-patients-with-cancer/</loc><lastmod>2026-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/geographic-distribution-of-triple-negative-breast-cancer-clinical-trials/</loc><lastmod>2026-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/final-mint-study-results-strengthen-real-world-evidence-for-mogamulizumab-in-mycosis-fungoides-and-sezary-syndrome/</loc><lastmod>2026-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/financial-incentives-increase-smoking-abstinence-among-those-referred-for-lung-cancer-screening/</loc><lastmod>2026-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/fda-grants-traditional-approval-to-pembrolizumab-for-tmb-h-solid-tumors/</loc><lastmod>2026-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/divarasib-in-previously-treated-advanced-kras-g12c-mutated-nsclc/</loc><lastmod>2026-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/radiation-added-to-systemic-therapy-improves-pfs-but-not-os-for-oligometastatic-nsclc/</loc><lastmod>2026-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/immunotherapyparp-inhibitor-combination-prolongs-survival-in-advanced-endometrial-cancer/</loc><lastmod>2026-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/impact-of-digital-breast-tomosynthesis-on-invasive-interval-breast-cancer-rate/</loc><lastmod>2026-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/is-enucleation-a-safe-alternative-to-pancreatoduodenectomy-for-benign-or-low-grade-pancreatic-head-tumors/</loc><lastmod>2026-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/expert-histopathology-and-molecular-testing-improve-diagnosis-of-ambiguous-cutaneous-melanocytic-tumors/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/sacituzumab-tirumotecan-extends-pfs-os-in-advanced-recurrent-endometrial-cancer/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/machine-learning-models-outperform-traditional-approaches-to-multicancer-risk-prediction/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/til-therapy-plus-pembrolizumab-for-advanced-melanoma/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/f-sharp-trial-evaluates-focal-salvage-brachytherapy-and-genomic-risk-stratification-in-recurrent-prostate-cancer/</loc><lastmod>2026-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/tarlatamab-plus-durvalumab-as-first-line-maintenance-in-extensive-stage-sclc/</loc><lastmod>2026-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/substudy-validates-perioperative-approach-of-systemic-therapy-with-radical-prostatectomy/</loc><lastmod>2026-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/talent-neoadjuvant-t-dxd-in-her2-low-early-breast-cancer/</loc><lastmod>2026-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/adding-a-chatbot-to-cancer-predisposition-visits-improves-risk-knowledge-in-ayas/</loc><lastmod>2026-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/disitamab-vedotin-plus-tislelizumab-shows-activity-in-very-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2026-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/financial-navigation-program-may-help-reduce-cancer-related-financial-hardship/</loc><lastmod>2026-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/selpercatinib-sacituzumab-govitecan-show-activity-in-thyroid-cancer-subtypes/</loc><lastmod>2026-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/astro-updates-guideline-on-shorter-course-radiation-therapy-for-localized-prostate-cancer/</loc><lastmod>2026-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/optitrop-lung06-a-potential-alternative-to-chemotherapy-in-advanced-pd-l1-negative-nsclc/</loc><lastmod>2026-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/high-risk-melanoma-personalized-mrna-vaccine-plus-immunotherapy-reduces-risk-of-recurrence-after-surgery/</loc><lastmod>2026-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/triplet-therapy-with-abiraterone-improves-os-long-term-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2026-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/omega-3-epa-linked-to-longer-survival-after-surgery-for-colorectal-cancer-liver-metastases/</loc><lastmod>2026-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/10-october/glp-1-ra-use-lower-among-adults-with-both-diabetes-and-a-history-of-cancer/</loc><lastmod>2026-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/optimizing-treatment-for-relapsedrefractory-follicular-lymphoma/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/how-medicare-advantage-and-traditional-medicare-influence-palliative-and-hospice-care-implementation/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/claudia-henschke-phd-md-finding-lung-cancer-in-time/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/cancer-statistics-2026-incidence-mortality-survival-and-disparities-in-us-oncology/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/asco-remembers-rachna-shroff-expert-in-gastrointestinal-cancers/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/asco-and-esmo-issue-joint-consensus-calling-for-streamlined-clinical-research-under-updated-international-standards/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/jco-announces-new-editor-in-chief/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/rosella-subgroup-analysis-supports-relacorilant-use-in-patients-previously-treated-with-taxanes/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/keeping-pace-with-surgery-sbrt-for-localized-prostate-cancer/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/a-fraction-of-the-fractions-sbrt-before-pancreatic-cancer-surgery/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/fda-approves-talazoparib-with-enzalutamide-for-certain-metastatic-hrr-mutated-prostate-cancers/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/ai-diagnostics-and-what-clinicians-can-verify-in-oncology/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/us-food-and-drug-administration-expanded-indications-and-approvals-in-bladder-and-colorectal-cancers/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/nobel-prize-in-physiology-or-medicine-2026-awarded-for-optogenetics/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/first-line-t-dxd-a-change-of-destiny-for-her2-mutant-nsclc/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/preventing-africa-s-coming-cancer-crisis-the-harm-reduction-imperative/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/beyond-chemotherapy-overall-survival-nearly-doubled-with-investigational-immunotherapy-in-advanced-squamous-nsclc/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/of-note-in-the-oncology-community/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/fda-approves-pimicotinib-for-symptomatic-tgct/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/study-reveals-distinct-cellular-and-genetic-differences-in-early-onset-colorectal-cancer/</loc><lastmod>2026-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/phase-iii-volga-trial-explores-outcomes-in-muscle-invasive-bladder-cancer/</loc><lastmod>2026-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/current-public-knowledge-rates-on-alcohol-and-cancer-risks/</loc><lastmod>2026-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/researchers-explore-potential-strategy-for-overcoming-resistance-to-ras-inhibitors/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/neoadjuvant-niraparib-shows-activity-in-hrd-positive-advanced-ovarian-cancer/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/hypofractionated-postmastectomy-radiotherapy-with-internal-mammary-node-irradiation-demonstrates-noninferior-locoregional-control/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/her2-positive-targeted-therapy-cardiovascular-risk-acc-upcoming-journal-club/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/upcoming-asco-ai-in-oncology-webinar-turns-chatbot-printouts-into-better-patient-conversations/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/perlmutter-cancer-center-names-director-of-early-phase-drug-development-and-rare-cancer-programs/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/wake-forest-university-school-of-medicine-names-inaugural-chair-of-the-department-of-cancer-medicine/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/first-line-pembrolizumab-improves-progression-free-survival-in-dmmr-advanced-endometrial-cancer/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/iof-issues-position-statement-on-bone-fragility-management-for-patients-with-mgus/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/bispecific-adc-may-offer-new-treatment-option-for-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/basser-center-for-brca-awards-2026-global-prize/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/osimertinib-plus-savolitinib-in-egfr-mutated-nsclc-after-disease-progression/</loc><lastmod>2026-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/heron-lung01-her3-directed-adc-prolongs-pfs-in-egfr-mutated-advanced-nsclc/</loc><lastmod>2026-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/anthony-el-khoueiry-named-director-of-the-usc-norris-comprehensive-cancer-center/</loc><lastmod>2026-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/pediatric-brain-tumors-prognostic-ai-model-guides-precision-therapy-choices/</loc><lastmod>2026-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/fda-grants-accelerated-approval-to-amivantamab-and-hyaluronidase-for-previously-treated-hnscc/</loc><lastmod>2026-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/izalontamab-brengitecan-improves-progression-free-survival-in-egfr-mutated-advanced-nonsquamous-nsclc/</loc><lastmod>2026-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/american-lung-association-and-prevent-cancer-foundation-host-virtual-qiw-workshop-advancing-routine-clinical-use-of-health-information-from-chest-ct-screening-for-public-health/</loc><lastmod>2026-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/ponatinibblinatumomab-improves-event-free-survival-in-ph-positive-all/</loc><lastmod>2026-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/extended-follow-up-of-nivolumab-ipilimumab-for-localized-dmmr-msi-h-gastric-gej-cancer/</loc><lastmod>2026-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/methylphenidate-may-reduce-cancer-related-fatigue-in-patients-with-hematologic-malignancies/</loc><lastmod>2026-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/two-forever-chemicals-associated-higher-risk-of-er-negative-breast-cancer/</loc><lastmod>2026-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/i-spy22-rt-dxd-may-reduce-chemotherapy-exposure-in-immune-positive-early-breast-cancer/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/adding-sbrt-to-chemotherapy-reduces-locoregional-recurrence-in-high-risk-pancreatic-cancer/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/anbenitamabhb1801-vs-thp-in-her2-positive-advanced-breast-cancer/</loc><lastmod>2026-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/keynote-867-immunotherapy-should-not-be-combined-with-sbrt-in-unresected-early-stage-nsclc/</loc><lastmod>2026-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/researchers-pinpoint-hundreds-of-genetic-variants-that-may-offer-new-insights-into-inherited-breast-cancer-risk/</loc><lastmod>2026-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/ctcl-denileukin-diftitox-may-improve-hrqol/</loc><lastmod>2026-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/metastatic-uveal-melanoma-darovasertibcrizotinib-evaluated-as-first-line-targeted-therapy/</loc><lastmod>2026-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/immunochemotherapy-improves-event-free-survival-in-borderline-resectable-or-locally-advanced-pancreatic-cancer/</loc><lastmod>2026-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/childhood-cancers-survival-gains-reveal-progress-and-persistent-disparities/</loc><lastmod>2026-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/american-cancer-society-updates-prostate-cancer-screening-guideline/</loc><lastmod>2026-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/clinical-trial-participation-among-patients-with-advanced-cancer-driven-by-structural-factors-at-physician-and-practice-levels/</loc><lastmod>2026-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/surgical-resection-associated-with-lower-mortality-than-sabr-in-early-stage-nsclc/</loc><lastmod>2026-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/broad-based-genomic-sequencing-associated-with-survival-benefit-over-focused-testing-for-advanced-nsclc/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/fda-approves-durvalumab-with-enfortumab-vedotin-ejfv-for-muscle-invasive-bladder-cancer/</loc><lastmod>2026-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/fda-approves-giredestrant-plus-everolimus-for-esr1-mutant-advanced-breast-cancer/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/chemotherapy-for-breast-cancer-linked-to-accelerated-biological-aging/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/fda-grants-accelerated-approval-to-neladalkib-for-alk-positive-nsclc/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/germline-testing-remains-low-among-patients-with-upper-tract-urothelial-carcinoma/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/risovalisib-yields-highest-reported-monotherapy-response-rate-in-ovarian-clear-cell-carcinoma/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/a-split-decision-fractionated-vs-single-fraction-radiosurgery-after-brain-metastasis-resection/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/report-outlines-evolutionary-dynamics-in-the-years-before-aml-diagnosis/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/asco-international-affairs-committee-leaders-discuss-global-oncology-priorities/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2026/11-november/2026-sio-annual-international-conference-cultivating-community-and-belonging-in-integrative-oncology/</loc><lastmod>2026-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/european-society-for-medical-oncology-congress-2025-meeting-highlights/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ivonescimab-a-dual-targeting-bispecific-antibody-improves-progression-free-survival-in-squamous-nsclc/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/final-analysis-supports-use-of-durvalumab-plus-bcg-infusions-in-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/primary-analysis-shows-survival-benefit-with-bemarituzumab-plus-chemotherapy-in-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/lupsma-617-plus-hormone-therapy-improves-radiographic-progression-free-survival-in-metastatic-hormone-naive-prostate-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/perioperative-immunotherapy-regimen-improves-outcomes-in-cisplatin-ineligible-muscle-invasive-bladder-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/her2-positive-early-breast-cancer-trastuzumab-deruxtecan-moves-into-earlier-clinical-settings/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/sacituzumab-tirumotecan-improves-survival-in-egfr-mutated-nsclc-after-tyrosine-kinase-inhibitor-failure/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/christine-m-lovly-md-phd-fasco-named-head-thoracic-oncology-at-city-of-hope/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ross-levine-md-named-chief-scientific-officer-of-memorial-sloan-kettering-cancer-center/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/how-ai-is-ushering-in-a-new-era-in-cancer-care/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/american-cancer-society-launches-nationwide-program-to-increase-equity-in-clinical-trials/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/research-supports-fda-approval-of-sevabertinib-for-her2-mutant-lung-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/final-analysis-supports-use-of-durvalumab-plus-bcg-infusions-in-high-risk-non-muscle-invasive-bladder-cancer-1/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/lupsma-617-plus-hormone-therapy-improves-radiographic-progression-free-survival-in-metastatic-hormone-naive-prostate-cancer-1/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/sacituzumab-tirumotecan-improves-survival-in-egfr-mutated-nsclc-after-tyrosine-kinase-inhibitor-failure-1/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/final-overall-survival-confirms-benefit-of-durvalumab-plus-flot-in-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas-1/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/primary-analysis-shows-survival-benefit-with-bemarituzumab-plus-chemotherapy-in-gastric-or-gastroesophageal-junction-cancer-1/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/sio-2025-the-future-of-integrative-oncology/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/gemcitabinenab-paclitaxel-vs-modified-folfirinox-in-metastatic-pancreatic-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/lifileucel-demonstrates-feasibility-and-disease-stability-in-advanced-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/neoadjuvant-dual-ici-blockade-vs-perioperative-flot-in-dmmrmsi-h-gastroesophageal-adenocarcinoma/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/hear-hear-to-advancing-geriatric-oncology-where-we-have-been-and-where-we-are-going/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ironically-smoking-may-have-saved-my-life/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ai-tops-density-in-predicting-breast-cancer-risk/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/montefiore-einstein-comprehensive-cancer-center-director-physician-scientist-edward-chu-md-mms-dies-at-66/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/aaci-issues-statement-on-death-of-dr-ed-chu/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/rainer-storb-md-receives-distinguished-wallace-h-coulter-award-at-ash-annual-congress/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ash-recognizes-leaders-for-support-of-patient-care-and-research/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/eliminating-barriers-to-care-for-patients-with-intellectual-andor-developmental-disabilities/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/mount-sinai-tisch-cancer-center-receives-comprehensive-cancer-center-designation-and-funding-from-national-cancer-institute/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/the-diagnosis-i-couldn-t-deliver-an-oncologist-s-journey-between-roles/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/high-risk-of-metastatic-recurrence-among-young-patients-with-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/asco-and-ai-in-oncology-rooted-in-human-centered-care/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/asco-statement-hhs-revision-of-black-box-warning-for-hormone-replacement-therapy-and-its-implications-for-cancer-care/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/uicc-s-world-cancer-declaration-2025-2035/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/integrating-mental-health-into-cancer-care-a-community-oncology-imperative/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/soho-2025-keynote-speakers-highlight-progress-in-hematologic-oncology/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/validation-of-pathology-ai-integration-tool-for-risk-stratification-in-locally-advanced-colon-cancer-without-chemotherapy/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/building-the-cancer-care-africa-deserves/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/new-fda-approved-oncology-drugs-and-label-updates-between-december-1-2024-and-november-19-2025/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/astro-marks-former-president-biden-s-prostate-cancer-treatment-milestone/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/benefits-mount-for-trop2-directed-antibody-drug-conjugates-in-triple-negative-breast-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/toxicity-concerns-for-parp-inhibition-given-concurrently-with-adjuvant-radiotherapy-for-breast-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/no-overall-survival-benefit-for-lenvatinib-in-leap-014-trial-of-esophageal-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/external-validation-confirms-ability-of-ai-model-to-stratify-recurrence-risk-in-early-stage-lung-cancer/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/basser-center-for-brca-announces-two-award-winners/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/reducing-the-barriers-to-receiving-car-t-cell-therapy-for-patients-with-hematologic-malignancies/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/geriatric-assessment-guided-approach-to-treatment-intensity-in-older-adults-with-acute-myeloid-leukemia/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/my-50-years-in-lymphoma-lessons-learned/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/armando-giuliano-honored-with-2025-william-l-mcguire-memorial-lecture-award/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/advancing-geriatric-oncology-a-personal-and-professional-journey/</loc><lastmod>2025-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/intravesical-cretostimogene-grenadenorepvec-shows-strong-high-grade-recurrence-free-survival-in-bcg-unresponsive-papillary-only-non-muscle-invasive-bladder-cancer/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/noninferiority-shown-for-pirtobrutinib-vs-ibrutinib-in-cllsll/</loc><lastmod>2025-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/abbreviated-azacitidine-regimen-improves-outcomes-in-lower-risk-mds/</loc><lastmod>2025-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/p-rad-trial-shows-increased-t-cell-infiltration-with-preoperative-radiation-added-to-anti-pd-1-therapy-in-early-breast-cancer/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/doublet-therapy-yields-higher-response-rates-and-fewer-complications-than-standard-induction-in-aml/</loc><lastmod>2025-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/epcoritamab-added-to-second-line-lenalidomiderituximab-improves-responses-in-follicular-lymphoma/</loc><lastmod>2025-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/intravesical-oncolytic-adenovirus-delivers-high-complete-response-rates-in-bcg-naive-high-risk-nmibc-with-carcinoma-in-situ/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/molecular-analysis-reveals-underlying-sex-linked-multiple-myeloma-progression-patterns/</loc><lastmod>2025-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/deb-schrag-elected-2027-2028-asco-president/</loc><lastmod>2025-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/study-explores-association-of-glp-1-ras-with-risk-of-obesity-related-cancers/</loc><lastmod>2025-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/cyclophosphamide-based-strategy-enables-safe-transplant-from-broadly-mismatched-donors/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/non-total-body-irradiation-conditioning-regimen-for-young-patients-with-mrd-negative-b-all/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/chemotherapy-free-regimen-improves-outcomes-in-newly-diagnosed-patients-with-ph-positive-all/</loc><lastmod>2025-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/cd123-targeting-adc-shows-activity-in-aml-and-bpdcn/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fda-approves-amivantamab-and-hyaluronidase-lpuj-for-subcutaneous-injection/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/data-published-on-incidence-of-immune-checkpoint-inhibitor-associated-itp/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/lymphocyte-kinetics-after-car-t-infusion-predict-survival-outcomes-in-non-hodgkin-lymphoma/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/neoadjuvant-sabr-improves-outcomes-in-patients-with-rcc-and-ivc-tumor-thrombus/</loc><lastmod>2025-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/nsaids-may-improve-survival-in-postoperative-ctdna-positive-patients-with-colon-cancer/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/amivantamab-plus-lazertinib-in-atypical-egfr-mutated-advanced-nsclc/</loc><lastmod>2025-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/addition-of-eflornithine-to-lomustine-in-patients-with-recurrent-grade-3-astrocytoma/</loc><lastmod>2025-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/distant-disease-free-survival-as-a-surrogate-for-overall-survival-in-trials-of-neoadjuvant-therapy-in-early-breast-cancer/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/10-year-outcomes-with-adjuvant-metronomic-capecitabine-in-early-triple-negative-breast-cancer/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/community-oncology-report-showcases-barriers-to-therapy-access-staffing-and-clinical-trial-participation/</loc><lastmod>2025-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fda-grants-regular-approval-to-rucaparib-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2025-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ai-models-advance-individualized-breast-cancer-recurrence-risk-assessments/</loc><lastmod>2025-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/her2-positive-breast-cancer-fda-approves-t-dxd-plus-pertuzumab/</loc><lastmod>2025-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/flipi24-new-prognostic-model-for-newly-diagnosed-follicular-lymphoma/</loc><lastmod>2025-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/tanning-bed-exposure-and-melanoma-risks/</loc><lastmod>2025-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/flipped-nivolumabipilimumab-dosing-improves-outcomes-in-advanced-melanoma/</loc><lastmod>2025-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/preoperative-paxg-vs-mfolfirinox-in-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2025-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/acupuncture-may-improve-perceived-cognitive-difficulties-in-breast-cancer-survivors/</loc><lastmod>2025-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/ianalumab-plus-eltrombopag-extends-time-to-treatment-failure-in-itp/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/can-multimodal-ai-models-predict-distant-recurrence-risk-in-patients-with-early-breast-cancer/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/mobile-health-intervention-offers-tailored-support-for-adolescent-and-young-adult-breast-cancer-survivors/</loc><lastmod>2025-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/menopausal-hormone-therapy-not-associated-with-increased-breast-cancer-risk/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fda-approves-regimen-for-brca2-mutated-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2025-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/phase-iii-trial-shows-no-oncologic-benefit-from-routine-preoperative-mri-for-some-early-breast-cancers/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/oral-serd-improves-disease-free-survival-over-standard-of-care-for-patients-with-early-stage-breast-cancer/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/sacituzumab-govitecan-vs-standard-of-care-for-certain-endocrine-therapy-refractory-advanced-breast-cancers/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/regional-control-unchanged-by-avoiding-sentinel-lymph-node-biopsy-in-early-node-negative-breast-cancer/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/cd40-overexpression-emerges-as-a-potential-biomarker-for-angioimmunoblastic-t-cell-lymphoma/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/follicular-lymphoma-durable-remissions-and-sustained-safety-with-third-line-lisocabtagene-maraleucel/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/renuka-iyer-md-named-new-chief-medical-officer-for-nccn/</loc><lastmod>2025-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fuzuloparib-in-her2-negative-metastatic-breast-cancer-with-germline-brca12-mutations/</loc><lastmod>2025-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/total-neoadjuvant-therapy-and-nonoperative-management-in-pmmrmss-stage-ii-to-iii-rectal-cancer/</loc><lastmod>2025-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/camrelizumab-plus-rivoceranib-vs-sorafenib-for-the-first-line-treatment-of-unresectable-hepatocellular-carcinoma/</loc><lastmod>2025-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/aacr-pediatric-cancer-progress-report-2025/</loc><lastmod>2025-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fda-approves-car-t-cell-therapy-for-relapsedrefractory-marginal-zone-lymphoma/</loc><lastmod>2025-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fda-grants-traditional-approval-to-pirtobrutinib-for-cllsll/</loc><lastmod>2025-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/pancreatic-cancer-detection-ai-vs-radiologists/</loc><lastmod>2025-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/upfront-reduced-dose-enfortumab-vedotin-with-pembrolizumab-in-first-line-treatment-of-advanced-urothelial-cancer/</loc><lastmod>2025-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/are-glycemic-index-and-load-associated-with-lung-cancer-risk/</loc><lastmod>2025-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/mammography-based-outreach-increases-lung-cancer-screening-enrollment-in-eligible-women/</loc><lastmod>2025-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/asco-statement-on-departure-of-richard-pazdur-from-fda/</loc><lastmod>2025-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/retrospective-review-shows-persistent-breast-cancer-burden-in-younger-women/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/aya-cancers-survival-for-metastatic-recurrence-worse-than-de-novo-metastatic-disease/</loc><lastmod>2025-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/survey-finds-global-embrace-of-integrative-cancer-care/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/nivolumab-and-ipilimumab-in-advanced-dmmrmsi-h-noncolorectal-cancers/</loc><lastmod>2025-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/lung-cancer-deaths-prevented-and-life-years-gained-from-lung-cancer-screening/</loc><lastmod>2025-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/second-line-pembrolizumab-plus-lenvatinib-in-pleural-mesothelioma/</loc><lastmod>2025-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/adcs-vs-standard-chemotherapy-cardiotoxicity-in-her2-positive-advanced-breast-cancer/</loc><lastmod>2025-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/exploratory-flaura2-analysis-confirms-overall-survival-benefit-for-osimertinib-in-nsclc-subgroups/</loc><lastmod>2025-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/image-only-ai-model-outperforms-breast-density-for-5-year-breast-cancer-risk-stratification/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/is-chronic-hepatitis-c-infection-associated-with-pancreatic-cancer/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/tisagenlecleucel-in-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/addition-of-neoadjuvant-lupsma-pnt2002-to-sbrt-in-oligorecurrent-prostate-cancer/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/new-pooled-analysis-strengthens-case-for-mrd-as-surrogate-endpoint-in-aml/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/one-in-three-families-of-children-with-all-face-financial-hardship-during-treatment/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/experimental-car-t-cell-therapy-shows-high-efficacy-and-a-favorable-safety-profile-in-multiple-myeloma/</loc><lastmod>2025-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/lung-cancer-screening-criteria-nelson-vs-plcom2012/</loc><lastmod>2025-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/addition-of-pirfenidone-to-glucocorticoids-in-grade-2-or-3-radiation-induced-lung-injury/</loc><lastmod>2025-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/outcomes-associated-with-consensus-molecular-subtypes-in-first-line-treatment-in-ras-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2025-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/fixed-duration-doublet-noninferior-to-continuous-ibrutinib-in-cll/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/12-december/black-patients-with-aml-face-younger-onset-and-significantly-worse-survival-outcomes/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/postsurgical-ctdna-testing-in-stage-iii-colon-cancer-for-treatment-de-escalation/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/how-the-proliferation-of-fraudulent-scientific-papers-is-threatening-the-integrity-of-cancer-research/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/preneoplastic-and-neoplastic-small-lymphocytic-proliferations/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/cognitive-function-preserved-with-statin-administration-during-chemotherapy/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/pembrolizumab-plus-weekly-paclitaxel-improves-survival-outcomes-in-platinum-resistant-recurrent-ovarian-cancer/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/reflections-of-a-medical-oncologist-empathy-matters-in-caring-for-patients-with-cancer/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-daratumumab-and-hyaluronidase-fihj-for-high-risk-smoldering-multiple-myeloma/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/treatment-advances-in-malignant-hematology-2025-updates/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/long-term-survival-with-stereotactic-ablative-radiotherapy-vs-surgery-for-early-stage-nsclc/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/proton-vs-photon-radiation-therapy-for-nonmetastatic-breast-cancer/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/ivonescimab-a-dual-targeting-bispecific-antibody-improves-progression-free-survival-in-squamous-nsclc/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/icahn-school-of-medicine-family-center-for-caregiving-launches-website-to-further-reach-and-broaden-mission/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/zanzalintinib-plus-immune-checkpoint-inhibitor-in-metastatic-colorectal-cancer/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/project-disarm-new-cancer-mission-emphasizes-risk-assessment-and-early-detection-of-ovarian-cancer/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/significant-medicare-physician-reimbursement-methodology-changes-finalized-for-2026/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/asco-election-for-open-leadership-positions/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/memorial-sloan-kettering-names-recipients-of-2025-paul-marks-prize-for-cancer-research/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/how-an-endowed-chair-in-cord-blood-research-is-providing-new-hope-for-patients-with-high-risk-leukemia/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/astro-recognizes-2025-award-recipients-for-excellence-in-radiation-oncology/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/new-approvals-in-hematologic-malignancies-skin-cancer-and-small-cell-lung-cancer/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/how-to-adapt-to-the-era-of-ai-and-the-changing-interactions-with-patients-lessons-from-a-low-resource-setting/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/as-a-cancer-survivor-my-main-worry-now-is-affording-health-insurance/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/intensity-modulated-radiation-therapy-vs-proton-therapy-for-oropharyngeal-cancer/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/safety-and-benefit-of-radiation-therapy-for-high-risk-muscle-invasive-bladder-cancer/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/astro-announces-new-president-elect-officers-to-board-of-directors/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/immunotherapy-combination-active-in-patients-with-large-b-cell-lymphoma-who-are-not-eligible-for-autologous-stem-cell-transplant/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/multidrug-resistant-ulcerative-colitis-response-to-cd19-car-t-cell-therapy-in-a-single-case/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/reducing-the-impact-of-climate-induced-events-on-patients-and-oncology-staff/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/diminishing-the-national-cancer-institute-threatens-americans/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/perioperative-immunotherapy-regimen-improves-outcomes-in-cisplatin-ineligible-muscle-invasive-bladder-cancer/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/alcohol-and-cancer-risk-is-a-drop-too-much/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/variation-in-psa-levels-in-annual-testing-among-individuals-without-prostate-cancer-diagnosis/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/cutaneous-t-cell-lymphoma-use-of-durvalumab-alone-or-with-lenalidomide-under-study-in-phase-ii-trial/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/creatine/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/the-consequences-of-climate-change-on-cancer-development-and-patient-care/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/making-clinical-trials-more-accessible-new-report-highlights-barriers-and-solutions/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/asco-and-ons-issue-first-collaborative-guideline-on-extravasation/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/armando-e-giuliano-md-to-be-honored-with-2025-william-l-mcguire-memorial-lecture-award-at-sabcs/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/her2-positive-early-breast-cancer-trastuzumab-deruxtecan-moves-into-earlier-clinical-settings/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/a-serendipitous-fall-may-have-saved-my-life/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/deep-learning-and-mammography-for-identifying-interval-breast-cancers/</loc><lastmod>2025-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/addition-of-abemaciclib-to-abiraterone-in-mcrpc/</loc><lastmod>2025-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/malignant-melanoma-addition-of-whole-body-imaging-in-postsurgery-follow-up/</loc><lastmod>2025-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/experts-outline-roadmap-for-clinical-implementation-of-ai-in-pediatric-cns-tumor-management/</loc><lastmod>2025-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/axicabtagene-ciloleucel-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/</loc><lastmod>2025-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/zanzalintinib-plus-atezolizumab-vs-regorafenib-in-previously-treated-metastatic-colorectal-cancer-without-msi-h-or-dmmr-tumors/</loc><lastmod>2025-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-pembrolizumab-with-enfortumab-vedotin-ejfv-for-muscle-invasive-bladder-cancer/</loc><lastmod>2025-11-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/astro-publishes-first-clinical-guideline-on-radiation-therapy-for-gastric-cancer/</loc><lastmod>2025-11-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/ai-simplifies-patients-comprehension-of-ct-reports-but-are-errors-possible/</loc><lastmod>2025-11-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/pancreatic-cancer-mild-duct-dilation-may-serve-as-early-indicator-in-high-risk-patients/</loc><lastmod>2025-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/md-anderson-launches-25-billion-philanthropic-campaign/</loc><lastmod>2025-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/more-patients-with-cancer-are-using-crowdfunding-to-pay-for-care-and-coming-up-short/</loc><lastmod>2025-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/could-a-liquid-biopsy-lead-to-earlier-diagnoses-for-numerous-cancer-types/</loc><lastmod>2025-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/does-regular-opioid-use-increase-risks-for-certain-cancers/</loc><lastmod>2025-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-durvalumab-with-flot-for-resectable-gastric-gej-adenocarcinoma/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/transfusion-access-prioritized-over-routine-hospice-services-among-patients-with-blood-cancers/</loc><lastmod>2025-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/ezabenlimab-induction-chemotherapy-and-adaptive-chemoradiotherapy-in-stage-iii-squamous-cell-anal-carcinoma/</loc><lastmod>2025-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-ziftomenib-for-npm1-positive-aml/</loc><lastmod>2025-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/preliminary-activity-of-lupsma-it-plus-ra-223-in-metastatic-castration-resistant-prostate-cancer-with-bone-metastasis/</loc><lastmod>2025-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/long-term-continuous-nirogacestat-in-adults-with-desmoid-tumors/</loc><lastmod>2025-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-new-interchangeable-biosimilar-to-pertuzumab/</loc><lastmod>2025-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/t-dxd-plus-pertuzumab-in-her2-positive-advanced-or-metastatic-breast-cancer/</loc><lastmod>2025-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/addition-of-eryaspase-to-chemotherapy-in-advanced-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2025-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/longtime-fda-innovator-appointed-as-director-of-cder/</loc><lastmod>2025-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/supportive-care-most-clinic-staff-prefer-people-focused-vs-digital-solutions/</loc><lastmod>2025-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/exercise-training-improves-strength-and-quality-of-life-for-patients-with-metastatic-breast-cancer/</loc><lastmod>2025-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/advanced-epithelial-ovarian-cancer-first-line-parp-inhibitor-maintenance-therapy-and-survival/</loc><lastmod>2025-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/impact-of-concomitant-noncancer-medications-on-outcomes-in-breast-cancer/</loc><lastmod>2025-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/study-finds-gaps-exist-in-quality-of-cancer-care-for-incarcerated-people/</loc><lastmod>2025-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/her3-dxd-in-patients-with-active-brain-metastases-from-nsclc-and-breast-cancer/</loc><lastmod>2025-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/model-for-predicting-risk-of-heart-failure-or-cardiomyopathy-after-breast-cancer-treatment/</loc><lastmod>2025-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/global-report-highlights-decade-of-uneven-progress-in-advanced-breast-cancer-care/</loc><lastmod>2025-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/survey-highlights-unmet-needs-among-young-women-with-advanced-breast-cancer/</loc><lastmod>2025-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/extended-erspc-analysis-demonstrates-long-term-mortality-benefit-of-psa-screening-for-prostate-cancer/</loc><lastmod>2025-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/study-finds-breast-cancer-risk-varies-between-different-hormonal-contraceptives/</loc><lastmod>2025-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/oropharyngeal-cancer-in-the-us-recent-estimates-and-future-trends/</loc><lastmod>2025-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/lung-cancer-advancements-are-saving-more-lives-than-ever-but-funding-cuts-may-hinder-progress/</loc><lastmod>2025-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/adding-an-investigational-monoclonal-antibody-to-ibrutinib-may-allow-patients-with-cll-to-discontinue-daily-treatment/</loc><lastmod>2025-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/nccn-guidelines-to-be-integrated-into-openevidence-medical-ai-platform/</loc><lastmod>2025-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/melanoma-cancer-cluster-found-in-parts-of-pennsylvania/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-grants-accelerated-approval-to-sevabertinib-for-nonsquamous-nsclc/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/traditional-approval-granted-to-tarlatamab-dlle-for-extensive-stage-sclc/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/could-opportunistic-salpingectomy-prevent-ovarian-cancer-in-postreproductive-women/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/astro-experts-comment-on-the-results-of-the-supremo-trial/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/extensive-la-area-fires-altered-blood-proteins-in-firefighters/</loc><lastmod>2025-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-selumetinib-for-adults-with-nf1-with-symptomatic-inoperable-plexiform-neurofibromas/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/curative-treatment-after-first-line-immunotherapy-improves-survival-in-hcc/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/new-computational-tool-shows-strong-accuracy-in-predicting-cancer-drug-targets/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/newly-diagnosed-al-amyloidosis-fda-grants-traditional-approval-to-regimen/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/vorasidenib-in-idh12-mutant-low-grade-glioma/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/patient-immune-system-characteristics-and-long-term-remission-from-car-t-cell-therapy-in-multiple-myeloma/</loc><lastmod>2025-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/quality-improvement-program-cuts-missed-radiation-appointments-by-40-percent/</loc><lastmod>2025-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/active-surveillance-with-metformin-vs-placebo-in-low-risk-prostate-cancer/</loc><lastmod>2025-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/dexrazoxane-use-and-cardiovascular-health-care-utilization-in-children-with-acute-myeloid-leukemia/</loc><lastmod>2025-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/fda-approves-epcoritamab-for-two-follicular-lymphoma-indications/</loc><lastmod>2025-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/long-term-survival-with-vs-without-postmastectomy-chest-wall-irradiation-in-breast-cancer/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/new-study-explores-why-male-patients-with-aml-may-have-worse-outcomes/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/first-line-ivonescimab-or-tislelizumab-plus-chemotherapy-in-advanced-squamous-nsclc/</loc><lastmod>2025-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/hepatic-arterial-infusion-pump-chemotherapy-in-unresectable-intrahepatic-cholangiocarcinoma/</loc><lastmod>2025-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/addition-of-durvalumab-to-bcg-after-turbt-for-bcg-naive-high-risk-nmibc/</loc><lastmod>2025-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/large-ai-breast-cancer-screening-trial-increases-detection-rate/</loc><lastmod>2025-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/does-kidney-stone-history-impact-survival-outcomes-in-upper-tract-urothelial-carcinoma/</loc><lastmod>2025-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/11-november/izalontamab-brengitecan-in-recurrent-or-metastatic-nasopharyngeal-carcinoma/</loc><lastmod>2025-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/how-a-2-billion-gift-to-the-knight-cancer-institute-may-accelerate-cancer-advances-and-streamline-care-for-patients/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/medicine-is-in-the-genes-of-neelima-denduluri-md-fasco-a-third-generation-clinician/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/biomarker-driven-apalutamide-therapy-for-patients-with-recurrent-prostate-cancer/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/defying-the-odds/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/new-approvals-in-breast-and-bladder-cancers/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/how-embedding-an-algorithm-based-referral-system-into-electronic-health-records-is-increasing-access-to-palliative-care/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/new-guideline-reflects-the-latest-evidence-in-support-of-postmastectomy-radiation-therapy-for-patients-with-breast-cancer/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/should-lung-cancer-screening-guidelines-be-expanded-to-include-female-asian-nonsmokers/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/considerations-on-cancer-drug-development/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/improved-outcomes-reported-with-second-line-regimen-of-ivonescimab-plus-chemotherapy-in-nsclc/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/federally-funded-clinical-trials-play-a-vital-role-in-cancer-research-especially-for-rare-and-pediatric-cancers/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/prior-authorization-is-burdensome-for-patients-resulting-in-treatment-delays-financial-strain-and-stress/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/use-of-obecabtagene-autoleucel-car-t-cell-therapy-for-b-cell-acute-lymphocytic-leukemia/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/in-extensive-stage-small-cell-lung-cancer-novel-maintenance-regimen-boosts-overall-survival/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/aacr-cancer-progress-report-highlights-breakthroughs-in-blood-cancers-and-how-nih-funding-uncertainty-threatens-advances/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/zidesamtinib-shows-activity-in-pretreated-and-tyrosine-kinase-inhibitor-naive-patients-with-ros1-positive-nsclc/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/anthony-letai-sworn-in-as-new-nci-director/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/clonal-hematopoiesis/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/early-study-results-with-novel-bruton-s-tyrosine-kinase-degrader-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/contemporary-management-of-chronic-myeloid-leukemia-according-to-hagop-m-kantarjian-md-fasco/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/how-a-novel-coaching-intervention-is-building-resilience-and-hope-in-adolescents-and-young-adults-with-advanced-cancer/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/a-year-of-global-progress-against-cancer-and-persistent-challenges/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/advancing-geriatric-oncology-where-we-have-been-and-where-we-are-going/</loc><lastmod>2025-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/jobs-commonly-held-by-immigrant-women-may-put-them-at-increased-risk-for-breast-cancer/</loc><lastmod>2025-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/carboplatin-plus-taxane-anthracycline-neoadjuvant-chemotherapy-for-triple-negative-breast-cancer/</loc><lastmod>2025-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/perioperative-camrelizumab-plus-rivoceranib-vs-surgery-alone-in-hepatocellular-carcinoma/</loc><lastmod>2025-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/sacituzumab-tirumotecan-in-egfr-mutated-advanced-nsclc/</loc><lastmod>2025-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/physician-complementing-artificial-intelligence-in-oncology/</loc><lastmod>2026-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/testing-for-melanoma-sentinel-lymph-node-status/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/glofitamab-plus-polatuzumab-vedotin-in-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/cancer-data-scientist-joins-translational-research-institute-at-cedars-sinai/</loc><lastmod>2025-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/global-analysis-uncovers-wide-inequalities-in-care-for-breast-cervical-and-ovarian-cancers/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/advanced-urothelial-carcinoma-pparg-inhibitor-shows-preliminary-efficacy/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/investigational-antibody-drug-conjugate-in-previously-treated-sclc/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/nivolumab-vs-ipilimumab-in-resected-stage-iii-or-iv-melanoma-9-year-follow-up-of-checkmate-238/</loc><lastmod>2025-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/neoadjuvant-dual-ici-blockade-vs-perioperative-flot-in-dmmrmsi-h-gastroesophageal-adenocarcinoma/</loc><lastmod>2025-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/pembrolizumab-plus-chemotherapy-without-radiotherapy-in-unresectable-locally-advanced-nsclc-with-high-pd-l1-expression/</loc><lastmod>2025-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/ruxolitinib-in-steroid-refractory-acute-gvhd-final-analysis-from-the-reach2-trial/</loc><lastmod>2025-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/elironrasib-active-in-kras-g12c-resistant-nsclc/</loc><lastmod>2025-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/zenocutuzumab-potential-explored-in-nrg1-cholangiocarcinoma/</loc><lastmod>2025-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/president-biden-completes-radiation-therapy-course/</loc><lastmod>2025-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/unresectable-stage-iii-nsclc-addition-of-simultaneous-durvalumab-to-chemoradiotherapy/</loc><lastmod>2025-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/fda-approves-belantamab-mafodotin-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2025-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/revumenib-approved-by-fda-for-npm1-aml/</loc><lastmod>2025-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/disitamab-vedotin-plus-toripalimab-vs-chemotherapy-in-her2-expressing-advanced-urothelial-cancer/</loc><lastmod>2025-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/astro-announces-2025-awards-and-research-grants/</loc><lastmod>2025-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/aga-issues-new-guideline-urging-risk-based-surveillance-in-barrett-s-esophagus/</loc><lastmod>2025-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/fertility-sparing-surgery-vs-hysterectomy-for-early-stage-cervical-cancer-comparable-survival-rates-but-higher-recurrence-risk/</loc><lastmod>2025-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/local-consolidative-therapy-enhances-outcomes-with-osimertinib-in-egfr-mutant-nsclc/</loc><lastmod>2025-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/slnb-alone-vs-lymphadenectomy-in-cervical-cancer/</loc><lastmod>2025-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/pd-l1-plus-ctla-4-inhibition-for-renal-cell-carcinoma-following-resection-rampart/</loc><lastmod>2025-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/risk-factors-for-valvular-heart-disease-among-childhood-cancer-survivors/</loc><lastmod>2025-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/first-line-ribociclib-at-400-vs-600-mg-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2025-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/study-confirms-it-is-never-too-late-to-see-survival-benefits-from-quitting-smoking-even-with-late-stage-cancer/</loc><lastmod>2025-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/eha-publishes-guidelines-for-lbcl-and-multiple-myeloma/</loc><lastmod>2025-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/state-of-the-hematology-and-medical-oncologist-workforce-in-the-united-states/</loc><lastmod>2025-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/obesity-related-cancers-are-rising-among-both-younger-and-older-adults-worldwide/</loc><lastmod>2025-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/clinical-usefulness-of-linking-whole-genome-data-to-mortality-statistics-in-uk-patients-with-breast-cancer/</loc><lastmod>2025-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/muscle-invasive-bladder-cancer-imvigor011-trial-investigates-ctdna-guided-adjuvant-pd-l1-inhibition/</loc><lastmod>2025-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/final-flaura2-analysis-confirms-first-line-benefit-of-osimertinib-chemotherapy-in-egfr-positive-nsclc/</loc><lastmod>2025-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/adjuvant-pembrolizumab-in-merkel-cell-carcinoma/</loc><lastmod>2025-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/reversible-tki-in-her2-mutant-nsclc/</loc><lastmod>2025-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/significant-os-benefit-with-enzalutamide-plus-leuprolide-for-biochemically-recurrent-prostate-cancer/</loc><lastmod>2025-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/esmo-publishes-guidance-on-large-language-model-use-for-oncology-practice/</loc><lastmod>2025-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/vt3989-demonstrates-antitumor-activity-and-tolerability-in-refractory-mesothelioma/</loc><lastmod>2025-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/mrna-based-covid-vaccines-may-generate-improved-responses-to-immunotherapy/</loc><lastmod>2025-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/rcc-lenvatinibeverolimus-extends-pfs-after-pd-1-inhibition/</loc><lastmod>2025-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/metastatic-er-positive-her2-negative-breast-cancer-novel-treatment-combination-improves-progression-free-survival/</loc><lastmod>2025-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/belzutifan-achieves-durable-responses-without-surgery-in-advanced-pheochromocytoma-paraganglioma/</loc><lastmod>2025-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/adc-improves-outcomes-for-patients-with-advanced-tnbc-ineligible-for-immunotherapy/</loc><lastmod>2025-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/risk-of-colorectal-subsequent-malignant-neoplasms-in-childhood-cancer-survivors/</loc><lastmod>2025-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/lisaftoclax-regimens-effective-in-plasma-cell-disorders/</loc><lastmod>2025-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/new-leadership-elected-to-the-american-society-of-hematology/</loc><lastmod>2025-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/first-line-pd-1pd-l1-inhibitors-vs-braf-plus-mek-inhibitors-in-braf-v600e-mutated-metastatic-nsclc/</loc><lastmod>2025-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/thymic-health-associated-with-ici-response/</loc><lastmod>2025-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/multidisciplinary-program-doubles-lung-cancer-screening-rates/</loc><lastmod>2025-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/chemotherapy-free-regimen-vs-standard-immunochemotherapy-in-mantle-cell-lymphoma-in-older-patients/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/individuals-with-rare-cancers-present-distinct-diagnosis-patterns-many-experience-treatment-delays/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/new-aaci-president-elect-selected-two-cancer-center-leaders-join-board/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/palliative-care-remains-underused-among-young-adults-with-advanced-cancer/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/aml-alliance-global-study-challenges-age-based-treatment-decisions/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/survival-with-dual-ctla-4-and-pd-l1pd-1-blockade-in-advanced-nsclc/</loc><lastmod>2025-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/advanced-biliary-tract-cancer-adding-a-polymeric-micellar-paclitaxel-to-gemcitabine-plus-cisplatin/</loc><lastmod>2025-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/ziftomenib-in-relapsed-or-refractory-npm1-mutant-aml/</loc><lastmod>2025-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/gaps-persist-in-follow-up-care-among-young-survivors-of-breast-cancer/</loc><lastmod>2025-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/incidence-of-invasive-lobular-carcinoma-rising-faster-than-other-breast-cancers/</loc><lastmod>2025-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/10-year-incidence-of-second-cancers-in-hpv-oropharyngeal-cancer/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/combination-therapies-for-diffuse-large-b-cell-lymphoma-5-year-outcomes-of-polarix-trial/</loc><lastmod>2025-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/patients-value-communication-skills-from-cancer-surgeons-across-six-key-areas/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/mastectomy-linked-to-worsened-sexual-health-and-body-image-after-surgery-study-finds/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/john-l-cameron-receives-wangensteen-scientific-forum-award/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/antidepressants-may-improve-surgical-outcomes-in-patients-with-gi-cancer-and-depression/</loc><lastmod>2025-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/financial-toxicity-tied-to-increased-risk-of-mortality-among-patients-with-cancer/</loc><lastmod>2025-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/study-identifies-rectal-bleeding-as-key-predictor-of-early-onset-colorectal-cancer/</loc><lastmod>2025-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/predicting-future-breast-cancer-outcomes-efficacy-of-a-polygenic-risk-score/</loc><lastmod>2025-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/pulsed-low-dose-rate-chemoradiation-reduces-severe-esophagitis-in-esophageal-cancer-and-nsclc/</loc><lastmod>2025-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/inflammatory-activity-and-cancer-related-fatigue-in-early-breast-cancer/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/inotuzumab-ozogamicin-followed-by-blinatumomab-in-older-patients-with-newly-diagnosed-b-cell-all/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/systemic-anticancer-therapy-at-end-of-life-and-health-care-use-among-older-patients/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/pd-1-inhibitor-approved-for-adjuvant-treatment-of-cscc/</loc><lastmod>2025-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/immunotherapy-addition-yields-qol-benefits-in-limited-stage-small-cell-lung-cancer/</loc><lastmod>2025-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/dexamethasone-sparing-regimen-for-frail-patients-with-newly-diagnosed-multiple-myeloma/</loc><lastmod>2025-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/genetic-modification-of-the-ajcc-classification-for-papillary-thyroid-cancer/</loc><lastmod>2025-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/breast-volume-preservation-comparable-after-five-fraction-whole-or-partial-breast-radiotherapy/</loc><lastmod>2025-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/network-of-cancer-drug-repositories-improves-access-to-treatment-reduces-waste/</loc><lastmod>2025-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/immunogenicity-of-rsv-vaccines-in-immunocompromised-allogeneic-hsct-recipients/</loc><lastmod>2025-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/impact-of-proton-and-photon-therapy-on-hrqol-in-breast-cancer/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/kidney-cancer-cases-expected-to-double-by-2050/</loc><lastmod>2025-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/911-first-responder-study-shows-how-toxic-exposures-may-lead-to-blood-cancers/</loc><lastmod>2025-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/dose-intensified-proton-therapy-for-newly-diagnosed-glioblastoma/</loc><lastmod>2025-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/patient-reported-outcomes-and-overall-survival-in-cancer/</loc><lastmod>2025-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/association-of-survival-with-treatment-recommendation-and-receipt-in-older-patients-with-early-stage-cervical-cancer/</loc><lastmod>2025-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/cytogenetic-remission-linked-to-improved-survival-in-patients-with-aml/</loc><lastmod>2025-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/nci-issues-request-for-2027-budget/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/impact-of-her2-receptor-status-in-mcrc-treated-with-chemotherapy-plus-bevacizumab-or-anti-egfrs/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/sabr-may-be-comparable-to-surgery-for-early-stage-nsclc/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/oropharyngeal-cancer-quality-of-life-outcomes-imrt-vs-proton-beam-therapy/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/intermediate-risk-prostate-cancer-shorter-radiation-improves-patient-experience-but-not-disease-control/</loc><lastmod>2025-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/sunvozertinib-in-platinum-pretreated-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2025-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/ct-adapative-sbrt-for-recurrent-retroperitoneal-sarcomas/</loc><lastmod>2025-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/cd19-car-t-cell-therapy-may-be-effective-in-treating-resistant-ulcerative-colitis/</loc><lastmod>2025-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/pembrolizumab-plus-platinum-based-chemotherapy-in-advanced-penile-cancer/</loc><lastmod>2025-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/fda-approves-combination-regimen-for-extensive-stage-sclc/</loc><lastmod>2025-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/10-october/medicare-telehealth-flexibilities-and-cms-operations-during-government-shutdown/</loc><lastmod>2025-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/adding-the-hepcidin-mimetic-rusfertide-to-the-standard-of-care-yields-benefits-in-polycythemia-vera/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/ayurveda-in-cancer-care/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/investigating-the-mechanisms-of-cardiovascular-adverse-events-linked-to-certain-cancer-treatments/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/perioperative-pembrolizumab-plus-surgery-and-risk-adapted-standard-adjuvant-therapy-shows-benefit-in-locally-advanced-head-and-neck-cancer/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/acute-myeloid-leukemia-with-runx1runx1t1-fusion/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/what-we-wish-we-knew-during-fellowship/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/how-the-ai-powered-asco-guidelines-assistant-is-improving-clinical-decision-making/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/addition-of-sintilimab-to-total-neoadjuvant-treatment-in-locally-advanced-rectal-cancer/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/understanding-accelerated-aging-in-survivors-of-childhood-cancers/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/neoadjuvant-osimertinib-in-the-perioperative-setting-for-resectable-egfr-mutated-nsclc/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/conversion-of-unresectable-into-resectable-pancreatic-cancer-chemoradiotherapy-vs-chemotherapy/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/nivolumab-maintains-quality-of-life-and-reduces-symptom-deterioration-in-resectable-nsclc/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/cardiotoxicity-from-the-use-of-anthracyclines-in-cancer-survivors-preventive-strategies/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/jco-authorship-guidelines-are-of-benefit-to-those-caring-for-older-patients/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/asco-approves-first-guideline-on-cancer-specific-geriatric-assessment-of-older-patients-in-resource-limited-settings/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/osimertinib-plus-chemotherapy-significantly-prolongs-overall-survival-in-egfr-mutated-advanced-nsclc/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/overall-survival-benefit-shown-for-neoadjuvant-nivolumab-plus-chemotherapy-in-non-small-cell-lung-cancer/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/new-approvals-for-thrombocytopenia-lung-cancer-brain-cancer-and-multiple-myeloma/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/city-of-hope-awarded-237-million-to-map-biomarkers-in-nsclc/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/asco-remembers-past-president-harvey-m-golomb-md-fasco/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/asco-thanks-richard-l-schilsky-md-facp-fsct-fasco-for-his-vision-and-leadership-of-tapur/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/new-nih-funded-study-identifies-urine-based-assay-for-prostate-cancer/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/james-r-doty-md-pioneer-in-neurosurgical-innovation-and-the-scientific-study-of-compassion-dies-at-69/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/jeffrey-a-drebin-md-phd-named-chief-physician-executive-of-memorial-sloan-kettering-cancer-center/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/overcoming-the-challenges-of-safely-using-opioids-to-treat-patients-with-chronic-cancer-related-pain/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/bridging-the-gap-in-geriatric-oncology-education-a-global-imperative/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/a-playbook-for-best-practices-asco-and-coa-release-updated-oncology-medical-home-standards/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/do-the-results-from-cartitude-1-represent-a-cure-for-patients-with-multiple-myeloma-we-need-longer-follow-up-to-know-for-sure/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/the-implications-of-the-results-from-cartitude-1-for-future-research-and-care-in-multiple-myeloma/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/update-to-asco-living-guideline-for-nsclc-without-driver-alterations-includes-first-comparison-of-immunotherapy-options/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/parp-inhibition-plus-abiraterone-shows-benefit-in-hrr-altered-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/living-with-the-real-world-consequences-of-federal-budget-cuts-on-cancer-research/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/experts-share-their-perspectives-on-navigating-opioid-induced-constipation-in-oncology/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/radiation-oncology-leaders-name-2025-fellows-of-the-american-society-for-radiation-oncology/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/is-cure-finally-achievable-in-multiple-myeloma/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/treatment-rechallenge-after-interstitial-lung-disease-related-to-t-dxd/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/realizing-the-full-potential-of-patient-engagement-in-clinical-research/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/use-of-cemiplimab-as-adjuvant-therapy-for-high-risk-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/personalizing-first-line-therapy-in-nsclc-plasma-guided-adaptive-treatment-approach/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/john-byrd-named-upmc-hillman-cancer-center-director/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/ohsu-knight-cancer-institute-receives-2-billion-commitment-from-phil-and-penny-knight/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/optimizing-the-car-to-the-disease-in-b-cell-malignancies/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/smoldering-multiple-myeloma-how-the-guidance-is-changing/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/study-finds-insufficient-evidence-demonstrating-clinical-benefit-of-multicancer-detection-tests/</loc><lastmod>2025-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/addition-of-metastasis-directed-sbrt-to-standard-therapy-in-oligometastatic-castration-resistant-prostate-cancer/</loc><lastmod>2025-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/chronic-toxicity-rates-with-de-escalated-vs-standard-adjuvant-radiotherapy-in-hpv-associated-oropharyngeal-squamous-cell-carcinoma/</loc><lastmod>2025-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/policy-review-hrqol-data-in-clinical-trials-for-advanced-cancer/</loc><lastmod>2025-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/leading-societies-update-clinical-guideline-on-postmastectomy-radiation-therapy/</loc><lastmod>2025-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/oral-microbiota-and-risk-for-pancreatic-cancer/</loc><lastmod>2025-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/adjuvant-chemoradiotherapy-vs-radiotherapy-for-high-risk-endometrial-cancer-10-year-portec-3-outcomes/</loc><lastmod>2025-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/overall-survival-after-hormonal-therapy-vs-hysterectomy-in-early-endometrial-cancer/</loc><lastmod>2025-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/proton-craniospinal-irradiation-for-leptomeningeal-metastasis-in-lung-or-breast-cancer/</loc><lastmod>2025-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/metastasis-directed-radiotherapy-for-oligometastatic-clear-cell-renal-cell-carcinoma/</loc><lastmod>2025-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/use-of-pazopanib-in-advanced-extrapancreatic-neuroendocrine-tumors/</loc><lastmod>2025-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/acute-cystitis-may-signal-urogenital-cancer/</loc><lastmod>2025-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/does-early-pesticide-exposure-lead-to-higher-mortality-risk-in-pediatric-all/</loc><lastmod>2025-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/perioperative-use-of-nivolumab-with-or-without-ipilimumab-for-resectable-diffuse-pleural-mesothelioma/</loc><lastmod>2025-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/surgery-for-early-stage-cancer-and-opioid-use/</loc><lastmod>2025-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/amivantamab-plus-lazertinib-vs-osimertinib-in-egfr-mutated-advanced-nsclc/</loc><lastmod>2025-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/hpv-self-sampling-collection-test-improved-cervical-cancer-screening-rates-among-asian-american-women/</loc><lastmod>2025-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/aya-cancer-survivors-face-increased-social-risks/</loc><lastmod>2025-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/more-tattoos-lessened-risk-of-melanoma-new-study-investigates/</loc><lastmod>2025-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/medical-imaging-and-risk-of-pediatric-and-adolescent-hematologic-cancer/</loc><lastmod>2025-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/can-nicotinamide-lessen-the-risk-of-skin-cancer-development/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/advanced-or-metastatic-breast-cancer-fda-approves-imlunestrant-for-er-positive-her2-negative-esr1-mutated-disease/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/cutaneous-squamous-cell-carcinoma-ai-model-rivals-dermatologists-in-differentiation-assessment/</loc><lastmod>2025-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/neoadjuvant-folfirinox-vs-gemcitabine-based-chemoradiotherapy-in-pdac/</loc><lastmod>2025-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/localized-pi3k-altered-colorectal-cancer-does-low-dose-aspirin-reduce-the-risk-of-recurrence/</loc><lastmod>2025-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/fda-removes-vandetanib-rems-program/</loc><lastmod>2025-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/16-million-prism-trial-will-explore-ai-in-breast-cancer-screening/</loc><lastmod>2025-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/addition-of-xevinapant-to-platinum-based-chemoradiotherapy-in-unresected-locally-advanced-squamous-cell-carcinoma-of-the-head-and-neck/</loc><lastmod>2025-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/modified-folfirinox-vs-gemcitabinenab-paclitaxel-in-metastatic-pancreatic-cancer/</loc><lastmod>2025-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/cancer-deaths-expected-to-rise-to-over-18-million-in-2050/</loc><lastmod>2025-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/impact-of-novel-donor-search-strategy-on-outcomes-for-potential-hct-recipients/</loc><lastmod>2025-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/association-of-tert-expression-with-outcomes-in-meningioma/</loc><lastmod>2025-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/prostate-cancer-radiopharmaceutical-plus-sbrt-delays-progression-in-patients-with-limited-metastatic-disease/</loc><lastmod>2025-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/pam50-subtyping-identifies-patients-with-prostate-cancer-most-likely-to-benefit-from-apalutamide/</loc><lastmod>2025-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/adjuvant-radiation-therapy-safe-and-beneficial-in-locally-advanced-mibc/</loc><lastmod>2025-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/fda-approves-pembrolizumab-and-berahyaluronidase-alfa-pmph-for-subcutaneous-injection/</loc><lastmod>2025-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/government-housing-assistance-linked-to-reduced-medical-financial-hardship-among-cancer-survivors/</loc><lastmod>2025-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/gastrointestinal-tumor-microbes-may-predict-prognosis-and-therapeutic-response/</loc><lastmod>2025-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/geriatric-assessment-guided-approach-to-treatment-intensity-in-older-adults-with-aml/</loc><lastmod>2025-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/do-breast-and-gynecologic-cancers-contribute-to-job-resignation-in-working-women/</loc><lastmod>2025-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/fda-approves-btk-inhibitor-for-itp/</loc><lastmod>2025-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/ido1-inhibition-mitigates-diet-induced-risk-of-cancer-associated-vte-in-preclinical-models/</loc><lastmod>2025-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/public-awareness-of-hpv-hpv-vaccine-and-the-association-of-hpv-with-cancer/</loc><lastmod>2025-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/study-shows-that-after-early-breast-cancer-diagnosis-risk-of-a-second-cancer-is-low/</loc><lastmod>2025-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/lifileucel-demonstrates-feasibility-and-disease-stability-in-advanced-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2025-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/ai-shear-wave-elastography-model-for-diagnosing-breast-cancer-in-bi-rads-3-or-4-masses/</loc><lastmod>2025-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/model-to-identify-patients-with-clinical-high-risk-early-breast-cancer-who-may-avoid-escalated-adjuvant-therapy/</loc><lastmod>2025-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/new-report-on-breast-reconstruction-preferences-among-african-american-women/</loc><lastmod>2025-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/could-a-nasal-spray-help-protect-patients-with-cancer-against-covid-19-infection/</loc><lastmod>2025-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/study-finds-personalized-risk-messages-had-no-effect-in-raising-colorectal-cancer-screening-participation/</loc><lastmod>2025-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/can-a-common-anti-inflammatory-drug-help-to-control-progression-of-clonal-hematopoiesis/</loc><lastmod>2025-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/inherited-variants-in-16-genes-may-double-the-risk-of-multiple-primary-cancers/</loc><lastmod>2025-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/egfr-mutated-nsclc-continuing-osimertinib-plus-chemotherapy-through-disease-progression-improves-pfs/</loc><lastmod>2025-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/urine-based-biomarker-panel-for-the-detection-of-prostate-cancer/</loc><lastmod>2025-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/observation-outperforms-adjuvant-crizotinib-for-resected-alk-nsclc/</loc><lastmod>2025-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/fdas-oce-invites-external-research-questions-to-advance-science-benefit-patients/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/novel-adc-under-study-in-previously-treated-egfr-mutated-nsclc/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/izalontamab-brengitecan-plus-osimertinib-shows-activity-in-first-line-egfr-mutant-nsclc/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/zidesamtinib-demonstrates-responses-in-ros1-positive-nsclc-after-prior-tki-treatment/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/aumolertinib-plus-chemotherapy-improves-pfs-in-nsclc-with-egfr-and-concomitant-tumor-suppressor-genes/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/glp-1-ras-and-cancer-risk-in-adults-with-overweightobesity/</loc><lastmod>2025-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/all-trans-retinoic-acid-and-arsenic-trioxide-in-high-risk-acute-promyelocytic-leukemia/</loc><lastmod>2025-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/previously-treated-es-sclc-i-dxd-demonstrates-high-response-rate/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/fda-approves-gemcitabine-intravesical-system-for-non-muscle-invasive-bladder-cancer/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/fda-approves-kinase-inhibitor-for-pediatric-patients-with-nf1/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/adjuvant-chemoimmunotherapy-for-resected-stage-ib-iiia-nsclc/</loc><lastmod>2025-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/no-os-benefit-for-concurrent-and-consolidative-durvalumab-vs-consolidation-alone-in-unresectable-stage-iii-nsclc/</loc><lastmod>2025-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/lung-cancer-screening-may-benefit-adults-up-to-age-80-who-are-fit-for-surgery/</loc><lastmod>2025-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/overall-survival-risk-for-vats-vs-open-lobectomy-for-early-lung-cancer/</loc><lastmod>2025-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/novel-targeted-agent-under-study-in-mtap-deleted-nsclc/</loc><lastmod>2025-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/new-subcutaneous-amivantamab-combo-dosing-schedule-shows-safety-and-efficacy-in-egfr-positive-nsclc/</loc><lastmod>2025-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/tarlatamab-and-anti-pd-1-therapy-as-first-line-maintenance-for-es-sclc/</loc><lastmod>2025-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/hypofractionated-vs-conventional-radiotherapy-in-phase-iii-trial-for-ls-sclc/</loc><lastmod>2025-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/stas-predicts-prognosis-in-early-nsclc-regardless-of-surgical-approach/</loc><lastmod>2025-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/is-ifitm3-a-driver-of-immunotherapy-response-in-sclc/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/ctdna-may-guide-immunotherapy-in-limited-stage-sclc/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/surgical-resection-with-egfr-tki-demonstrates-promising-pfs-in-egfr-mutant-nsclc/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/viral-immunotherapy-may-extend-survival-in-advanced-nsclc-after-progression-on-immune-checkpoint-inhibition/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/dll3-targeted-antibody-drug-conjugate-in-relapsed-sclc/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/new-acs-prostate-cancer-report-late-stage-incidence-rates-continue-to-increase-rapidly-as-mortality-declines-slow/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/addition-of-neoadjuvant-tar-200-to-cetrelimab-in-cisplatin-ineligible-muscle-invasive-bladder-cancer/</loc><lastmod>2025-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/tislelizumab-based-triplet-therapy-for-conversion-of-unresectable-to-resectable-locally-advanced-biliary-tract-cancer/</loc><lastmod>2025-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/noncancer-related-mortality-in-rcts-with-targeted-screening/</loc><lastmod>2025-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/study-finds-high-risk-prescriptions-drive-frailty-hospitalization-and-mortality-in-older-adults-with-cancer/</loc><lastmod>2025-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/benmelstobart-plus-anlotinib-vs-sunitinib-as-first-line-treatment-of-advanced-renal-cell-carcinoma/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/new-liquid-biopsy-test-for-early-detection-of-head-and-neck-cancers/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/is-tbi-associated-with-malignant-brain-tumors/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/clear-margin-diagnostic-excisional-biopsy-may-adequately-treat-melanoma-in-situ-study-finds/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/incorporating-family-caregivers-into-shared-decision-making-for-patients-with-cancer/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/09-september/study-finds-postapproval-cancer-trials-fell-after-inflation-reduction-act/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/emerging-pd-1-inhibitor-plus-chemotherapy-shows-efficacy-in-second-line-classical-hodgkin-lymphoma/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/studies-on-egfr-mutations-and-nrg1-fusions-included-in-asco-nsclc-living-guideline-update/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/new-report-supports-overhaul-of-cancer-drug-dosing/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/asco-names-2025-q1-q2-fasco-recipients/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/ash-announces-2025-hematologists-to-be-honored-with-top-awards-and-distinguished-lectures/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/a-diagnosis-of-stage-iv-lung-cancer-at-18-has-tested-my-faith-and-made-it-stronger/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/tafasitamab-combined-with-lenalidomide-and-rituximab-improved-outcomes-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/best-of-asco-20th-anniversary-advancing-medicine-and-patient-care-asco-style/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/potential-new-second-line-standard-of-care-emerges-in-small-cell-lung-cancer/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/immune-checkpoint-inhibitors-cardiovascular-health-and-a-potentially-protective-biomarker/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/the-inflation-reduction-act-and-ibrutinib/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/similar-efficacy-improved-safety-achieved-without-concurrent-cisplatin-for-locoregionally-advanced-nasopharyngeal-cancer/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/experimental-approach-to-gvhd-prophylaxis-offers-alternative-to-standard-regimen/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/upfront-radical-cytoreductive-surgery-extends-progression-free-survival-in-advanced-ovarian-cancer/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/alcohol-associated-cancer-death-rates-are-climbing/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/studies-explore-cardiac-risks-and-clinical-characteristics-associated-with-immune-checkpoint-inhibitor-related-myocarditis/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/a-young-hematologist-s-take-on-icml-2025/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/is-this-the-end-of-cancer-research-as-we-know-it/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/adding-nivolumab-to-adjuvant-chemoradiotherapy-reduces-risk-of-recurrence-in-patients-with-head-and-neck-cancer/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/lls-unveils-name-change/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/updated-chest-guidelines-emphasize-minimally-invasive-surgery-for-early-stage-nsclc/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/avutometinib-plus-defactinib-in-recurrent-low-grade-serous-ovarian-cancer/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/does-preexisting-depression-impact-prostate-cancer-survival/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/pediatric-cns-tumors-long-term-survival-and-cure-fraction-estimates/</loc><lastmod>2025-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/prostate-cancer-one-in-six-grade-group-1-cases-linked-to-higher-risk-disease/</loc><lastmod>2025-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/outcomes-associated-with-covid-19-infection-in-patients-with-cancer/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/ultraprocessed-food-consumption-linked-to-increased-lung-cancer-risk/</loc><lastmod>2025-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/nivolumab-plus-ipilimumab-in-mcrpc-with-an-immunogenic-signature/</loc><lastmod>2025-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/pediatric-gliomas-early-research-on-targeted-therapies/</loc><lastmod>2025-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/perceived-dermatologic-side-effects-of-cancer-treatment/</loc><lastmod>2025-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/immunoglobulin-replacement-therapy-and-infection-risks-in-cll/</loc><lastmod>2025-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/asco-edge-launches-for-all-members/</loc><lastmod>2025-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/alpelisib-plus-olaparib-vs-single-agent-chemotherapy-in-platinum-resistant-or-refractory-hgsoc-without-brca-mutation/</loc><lastmod>2025-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/mfolfirinox-and-s-irox-vs-nab-paclitaxel-plus-gemcitabine-in-metastatic-or-recurrent-pancreatic-cancer/</loc><lastmod>2025-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/real-world-study-highlights-gaps-in-hypomethylating-agent-treatment-for-mds/</loc><lastmod>2025-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/novel-single-cell-sequencing-blood-test-for-multiple-myeloma/</loc><lastmod>2025-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/mortality-in-advanced-stage-ovarian-cancer-effect-of-neoadjuvant-chemotherapy-and-cytoreductive-surgery-case-volume/</loc><lastmod>2025-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/genetic-testing-may-reduce-chemotherapy-side-effects-for-patients-with-gi-cancers/</loc><lastmod>2025-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/smoking-cessation-in-cancer-care-challenges-and-opportunities/</loc><lastmod>2025-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/glp-1-receptor-agonists-vs-other-glucose-lowering-drugs-survival-in-older-patients-with-cancer-and-diabetes/</loc><lastmod>2025-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/kinase-inhibitor-approved-for-nonsquamous-nsclc-with-her2-tkd-activating-mutations/</loc><lastmod>2025-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/web-tool-seeks-to-reduce-state-lung-cancer-mortality-rates/</loc><lastmod>2025-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/genomics-guided-tool-to-inform-treatment-of-advanced-kidney-cancers/</loc><lastmod>2025-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/two-acs-studies-show-colorectal-cancer-screening-and-early-diagnosis-have-soared-in-adults-aged-45-to-49-years/</loc><lastmod>2025-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/nivolumab-plus-ipilimumab-in-advanced-ovarian-and-endometrial-clear-cell-cancers/</loc><lastmod>2025-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/rcc-genetic-testing-key-to-avoiding-misdiagnosis-of-rare-subtypes/</loc><lastmod>2025-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/protease-activator-approved-by-the-fda-for-diffuse-midline-glioma/</loc><lastmod>2025-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/childhood-cancer-survivors-and-long-term-risks-for-health-conditions-new-data/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/subspecialization-in-oncology-is-increasing-but-unevenly-distributed-across-the-country/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/older-women-with-high-risk-breast-cancer-addition-of-adjuvant-chemotherapy-to-hormone-therapy/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/can-baseline-psma-pet-help-to-predict-response-to-lupsma-and-enzalutamide-in-mcrpc/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/age-threshold-for-survival-benefit-of-adding-oxaliplatin-to-adjuvant-chemotherapy-in-stage-ii-and-iii-colorectal-cancer/</loc><lastmod>2025-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/breast-cancer-surveillance-in-pre-vs-post-covid-19-periods/</loc><lastmod>2025-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/rsna-challenge-ai-models-enhance-mammography-detection-of-invasive-breast-cancer/</loc><lastmod>2025-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/routine-ai-assistance-may-lead-to-loss-of-skills-in-endoscopists-study-shows/</loc><lastmod>2025-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/clinically-significant-fatigue-and-inflammation-in-breast-cancer-survivors/</loc><lastmod>2025-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/ebrt-with-focal-boost-to-intraprostatic-tumor-in-localized-prostate-cancer/</loc><lastmod>2025-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/new-drug-releasing-system-eliminates-bladder-cancer-in-over-80-of-patients-in-a-phase-ii-trial/</loc><lastmod>2025-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/stronger-primary-care-ties-may-improve-cancer-survivorship/</loc><lastmod>2025-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/glioblastoma-dual-immunotherapy-plus-radiotherapy-in-newly-diagnosed-mgmt-unmethylated-disease/</loc><lastmod>2025-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/mifamurtide-plus-chemotherapy-for-nonmetastatic-high-grade-osteosarcoma/</loc><lastmod>2025-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/real-world-incidence-and-management-of-infusion-related-reactions-to-monoclonal-antibody-therapy/</loc><lastmod>2025-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/pembrolizumab-plus-chemotherapy-vs-chemotherapy-in-advanced-gastric-cancers-final-survival-analysis-from-keynote-585/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/association-of-germline-pathogeniclikely-pathogenic-mutations-and-subsequent-neoplasms-in-childhood-cancer-survivors/</loc><lastmod>2025-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/analysis-shows-no-major-racial-differences-in-somatic-mutations-of-triple-negative-breast-cancer/</loc><lastmod>2025-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/disparities-in-us-county-level-cervical-cancer-screening-coverage-lead-to-differences-in-outcomes/</loc><lastmod>2025-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/survey-finds-discordance-between-treatment-preferences-and-clinical-care-for-advanced-cancer/</loc><lastmod>2025-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/lu-177-dotatate-in-progressive-metastatic-pheochromocytomas-and-paragangliomas/</loc><lastmod>2025-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/identifying-cns-tumors-with-multianalyte-cerebrospinal-fluid-test/</loc><lastmod>2025-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/adding-dendritic-cell-vaccination-to-hepatocellular-carcinoma-therapy/</loc><lastmod>2025-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/dendrimer-based-sn38-nanoparticle-shows-favorable-safety-and-activity-in-advanced-solid-tumors/</loc><lastmod>2025-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/are-postmastectomy-implant-based-breast-reconstructions-associated-with-lymphomas-of-the-breast/</loc><lastmod>2025-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/can-autoimmune-diseases-increase-the-risk-of-digestive-system-cancer/</loc><lastmod>2025-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/locoregionally-advanced-nasopharyngeal-carcinoma-comparison-of-regimens-following-induction-chemotherapy/</loc><lastmod>2025-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/metastatic-colorectal-cancer-pros-with-sotorasib-and-panitumumab-vs-standard-of-care/</loc><lastmod>2025-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/new-recommendations-released-for-managing-aromatase-inhibitor-induced-bone-loss/</loc><lastmod>2025-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/patient-and-health-care-professional-groups-express-support-for-bipartisan-clinical-trial-bill/</loc><lastmod>2025-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/friends-of-cancer-research-advances-work-to-improve-interpretation-of-interim-os-data-in-oncology-trials/</loc><lastmod>2025-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/hybrid-ai-approach-with-uncertainty-quantification-for-mammography-reading-supports-safe-workload-reduction/</loc><lastmod>2025-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/rural-and-urban-differences-in-prostate-cancer-recurrence/</loc><lastmod>2025-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/patient-awareness-of-pharmacogenomic-testing-remains-low-acs-can-survey-reports/</loc><lastmod>2025-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/psma-petct-and-salvage-radiotherapy-in-recurrent-prostate-cancer/</loc><lastmod>2025-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/endocrine-therapy-with-aromatase-inhibitor-for-postmenopausal-women-with-breast-cancer/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/can-a-mitochondrial-antioxidant-drive-metastasis/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/treatment-resistant-melanoma-novel-checkpoint-inhibitor-combination/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/effect-of-hippocampal-avoidance-in-prophylactic-cranial-irradiation-in-sclc/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/underlying-mechanisms-of-chemoresistance-in-aml/</loc><lastmod>2025-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/adagrasib-vs-docetaxel-in-previously-treated-advanced-or-metastatic-krasg12c-mutated-nsclc/</loc><lastmod>2025-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/identification-of-fap-expressing-tumors-with-radiotracer/</loc><lastmod>2025-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/nivolumab-plus-rp1-shows-durable-responses-in-advanced-melanoma-after-pd-1-inhibitor-resistance/</loc><lastmod>2025-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/cancer-induced-nerve-injury-identified-as-driver-of-pd-1-resistance-across-tumor-types/</loc><lastmod>2025-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/can-beta-blockers-help-halt-the-progression-of-triple-negative-breast-cancer/</loc><lastmod>2025-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/study-finds-weather-disasters-increase-risk-for-us-drug-supply-chain-disruption/</loc><lastmod>2025-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/bacterial-decolonization-to-manage-radiation-induced-oral-mucositis-in-nasopharyngeal-carcinoma/</loc><lastmod>2025-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/racial-and-ethnic-disparities-in-guideline-concordant-pancreatic-cancer-care-among-older-adults/</loc><lastmod>2025-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/rare-secondary-cancer-after-car-t-cell-therapy-successfully-treated-case-report-shows/</loc><lastmod>2025-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/basal-cell-carcinoma-early-research-on-a-novel-topical-fluorescent-imaging-technique/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/unmet-social-needs-distort-trust-in-cancer-information-study-shows/</loc><lastmod>2025-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/added-everolimus-reduces-risk-for-advanced-tnbc/</loc><lastmod>2025-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/factors-influencing-symptom-burden-in-pediatric-patients-with-cancer-insights-from-routine-screening/</loc><lastmod>2025-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/which-first-line-systemic-therapy-balances-survival-and-quality-of-life-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2025-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/bwel-weight-loss-trial-reports-success-for-patients-with-breast-cancer-at-1-year-mark/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/can-baseline-kidney-function-predict-chronic-kidney-disease-after-cisplatin-treatment/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/08-august/asco-thanks-richard-schilsky-for-his-vision-and-leadership-of-tapur/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/does-menopausal-hormone-therapy-increase-the-risk-of-death-in-women-with-brca-mutated-breast-cancer/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/surviving-pancreatic-cancer/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/nearly-50-percent-of-all-cancer-deaths-worldwide-attributable-to-modifiable-risk-factors/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/does-exposure-to-wildfire-dominated-inhalable-fine-particulate-matter-impact-survival-in-nsclc/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/evidence-of-potential-cure-with-single-car-t-cell-infusion-for-some-patients-with-multiple-myeloma/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/a-potential-new-standard-of-care-in-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/plenary-highlights-across-tumor-types-reflect-advances-in-research-improvements-in-care-and-changes-in-practice/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/updates-in-systemic-light-chain-amyloidosis/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/medicare-advantage-audits-are-expanding/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/immunotherapy-combination-a-potential-new-standard-in-triple-negative-breast-cancer/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/how-i-discuss-the-current-political-chaos-when-patients-ask-health-related-questions-about-it/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/phase-iii-polargo-addition-of-polatuzumab-vedotin-improves-overall-survival-in-refractory-dlbcl/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/genitourinary-oncology-highlights-treatment-advances-in-renal-cell-bladder-urothelial-and-prostate-cancers/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/corticosteroids-may-limit-efficacy-of-immunotherapy-in-patients-with-nsclc/</loc><lastmod>2025-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/women-aged-65-plus-still-at-heightened-risk-of-hpv-related-cervical-cancer/</loc><lastmod>2025-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/ruxolitinib-for-steroid-refractory-or-dependent-chronic-graft-vs-host-disease/</loc><lastmod>2025-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/ajcc-guideline-reassessment-aims-to-improve-hpv-positive-throat-cancer-staging/</loc><lastmod>2025-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/sharp-rise-in-obesity-linked-cancer-mortality-highlights-geographic-and-demographic-gaps/</loc><lastmod>2025-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/outcomes-with-perioperative-immunotherapy-in-resectable-nsclc/</loc><lastmod>2025-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/metformin-in-metastatic-prostate-cancer/</loc><lastmod>2025-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/phase-ii-trial-supports-srt-as-alternative-to-wbrt-in-sclc/</loc><lastmod>2025-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/teclistamab-for-high-risk-heavily-pretreated-multiple-myeloma-real-world-data/</loc><lastmod>2025-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/new-guidelines-on-comprehensive-biomarker-testing-of-bronchoscopic-biopsies/</loc><lastmod>2025-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/people-with-acromegaly-face-elevated-cancer-risk-study-finds/</loc><lastmod>2025-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/online-ai-tool-offers-rapid-accurate-diagnosis-for-endocrine-cancers/</loc><lastmod>2025-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/lisocabtagene-maraleucel-as-second-line-therapy-in-relapsedrefractory-large-b-cell-lymphoma-3-year-follow-up/</loc><lastmod>2025-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/can-use-of-aprepitant-during-chemotherapy-improve-triple-negative-breast-cancer-outcomes/</loc><lastmod>2025-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/risk-of-liver-cancer-with-oral-contraceptive-use/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/survey-highlights-top-anxiety-points-for-caregivers-after-a-cancer-diagnosis/</loc><lastmod>2025-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/survey-shows-inaccuracies-in-us-perceptions-of-testicular-cancer/</loc><lastmod>2025-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/her3-dxd-in-nsclc-without-egfr-activating-mutations/</loc><lastmod>2025-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/metastatic-castration-resistant-prostate-cancer-comparison-of-second-line-regimens/</loc><lastmod>2025-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/utdna-may-help-to-personalize-bladder-cancer-treatment/</loc><lastmod>2025-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/ai-enhanced-pact-as-a-noninvasive-breast-imaging-alternative/</loc><lastmod>2025-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/uterine-cancer-incidence-and-mortality-rates-projected-to-rise-substantially-by-2050/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/can-hormone-therapy-affect-breast-cancer-risk-in-younger-women/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/lean-body-mass-based-oxaliplatin-dosing-and-risk-of-neurotoxicity-in-adjuvant-treatment-of-stage-iii-colon-cancer/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/study-reveals-long-term-consequences-of-chemotherapy-on-healthy-blood-cells/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/fda-grants-accelerated-approval-to-linvoseltamab-gcpt-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/ppp2r1a-mutations-linked-to-improved-immunotherapy-outcomes-in-ovarian-clear-cell-carcinoma/</loc><lastmod>2025-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/bevacizumab-plus-erlotinib-in-hereditary-and-sporadic-papillary-kidney-cancer/</loc><lastmod>2025-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/addition-of-glofitamab-to-r-chop-or-pola-r-chp-in-younger-patients-with-high-risk-lbcl/</loc><lastmod>2025-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/fda-grants-accelerated-approval-to-sunvozertinib-for-metastatic-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2025-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/air-pollution-linked-to-distinct-genomic-signatures-in-lung-cancers-among-never-smokers/</loc><lastmod>2025-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/preclinical-leukemia-chip-platform-improves-evaluation-of-car-t-cell-therapies/</loc><lastmod>2025-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/survival-disparities-rise-in-patients-with-advanced-cancer-depending-on-whether-they-have-insurance-to-cover-immune-checkpoint-inhibitors/</loc><lastmod>2025-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/intratumoral-bo-112-with-pembrolizumab-in-anti-pd-1-resistant-melanoma/</loc><lastmod>2025-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/y-90-resin-microspheres-receive-fda-approval-for-the-treatment-of-unresectable-hcc/</loc><lastmod>2025-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/survey-finds-confusion-over-mammogram-guidelines/</loc><lastmod>2025-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/zanidatamab-plus-chemotherapy-in-advanced-her2-positive-gastroesophageal-adenocarcinoma/</loc><lastmod>2025-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/bmi-and-cardiovascular-disease-associated-with-increased-breast-cancer-risk/</loc><lastmod>2025-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/can-planned-c-sections-increase-the-risk-of-childhood-all/</loc><lastmod>2025-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/adult-survivors-of-childhood-cancer-may-be-at-increased-risk-of-severe-covid-19-infection/</loc><lastmod>2025-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/nivolumab-or-brentuximab-vedotin-with-avd-in-older-patients-with-advanced-classical-hodgkin-lymphoma/</loc><lastmod>2025-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/subsequent-neoplasm-risk-among-childhood-cancer-survivors-effect-of-bmi-and-physical-activity/</loc><lastmod>2025-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/study-supports-multi-contaminant-water-treatment-to-reduce-cancer-risk/</loc><lastmod>2025-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/breastfeeding-patterns-after-treatment-of-early-hormone-receptor-positive-breast-cancer/</loc><lastmod>2025-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/biomarker-testing-in-advanced-cancer-suboptimal-rates-despite-guideline-recommendations-and-growing-insurance-coverage/</loc><lastmod>2025-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/cbo-report-finds-federal-cuts-to-nih-would-threaten-new-drug-development-and-innovation/</loc><lastmod>2025-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/final-overall-survival-analysis-of-flaura2-osimertinib-plus-chemotherapy-in-egfr-mutant-nsclc/</loc><lastmod>2025-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/evaluation-of-racial-classification-standards-in-us-cancer-surveillance-systems/</loc><lastmod>2025-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/short-term-hormonal-treatment-offers-early-insight-into-tumor-behavior-and-resistance-for-er-her2-breast-cancer/</loc><lastmod>2025-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/her2dx-assay-and-survival-outcomes-in-her2-positive-breast-cancer/</loc><lastmod>2025-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/association-of-type-2-diabetes-with-colorectal-cancer-risk-and-survival-by-tumor-immunity-status/</loc><lastmod>2025-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/american-cancer-society-names-new-ceo/</loc><lastmod>2025-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/nsclc-trial-shows-radiation-may-overcome-primary-resistance-to-pembrolizumab/</loc><lastmod>2025-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/study-links-childhood-proximity-to-radiation-contaminated-coldwater-creek-with-elevated-cancer-odds/</loc><lastmod>2025-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/classifying-pancreatic-cysts-using-ai-models/</loc><lastmod>2025-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/early-ctdna-change-and-outcomes-with-ici-treatment-in-metastatic-colorectal-cancer/</loc><lastmod>2025-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/thyroidectomy-without-postoperative-radioiodine-ablation-in-low-risk-differentiated-thyroid-cancer/</loc><lastmod>2025-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/urothelial-cancer-survival-in-the-eras-before-and-after-immune-checkpoint-inhibitors-and-antibody-drug-conjugates/</loc><lastmod>2025-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/outcomes-support-car-t-cell-therapy-use-in-elderly-patients-with-b-cell-lymphomas/</loc><lastmod>2025-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/covid-19-boosters-offer-protection-for-patients-with-cancer/</loc><lastmod>2025-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/extended-follow-up-for-neoadjuvant-and-adjuvant-relatlimab-plus-nivolumab-in-resectable-melanoma/</loc><lastmod>2025-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/dreamm-7-analysis-compares-survival-outcomes-between-triplet-regimens-for-rr-multiple-myeloma/</loc><lastmod>2025-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/study-finds-no-difference-in-dietary-habits-between-cancer-survivors-and-general-population/</loc><lastmod>2025-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/camrelizumab-plus-famitinib-vs-camrelizumab-alone-in-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2025-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/literature-review-highlights-rising-incidence-and-disparities-in-many-early-onset-gi-cancers/</loc><lastmod>2025-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/rp1-plus-nivolumab-in-anti-pd-1-resistant-advanced-melanoma/</loc><lastmod>2025-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/chemoimmunotherapy-for-advanced-btc-3-year-overall-survival-update-from-the-topaz-trial/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/new-research-offers-reassurance-about-localized-prostate-cancer-prognosis/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/surgery-vs-ablation-in-small-hepatocellular-carcinoma/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/four-year-outcomes-highlight-efficacy-of-neoadjuvant-nivolumab-and-relatlimab-in-advanced-resectable-melanoma/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/astro-announces-new-president-elect-officers/</loc><lastmod>2025-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/intense-resistance-training-for-breast-cancer-survivors-with-lymphedema-risk/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/fertility-outcomes-in-patients-of-childbearing-potential-receiving-first-line-therapy-for-advanced-lymphoma/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/patritumab-deruxtecan-shows-efficacy-in-leptomeningeal-metastases-from-solid-tumors/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/patients-with-interstitial-lung-disease-face-elevated-lung-cancer-risk-study-finds/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/studies-on-egfr-mutations-and-nrg1-fusions-included-in-asco-nsclc-living-guideline-update/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/update-to-asco-living-guideline-for-nsclc-without-driver-alterations-includes-first-comparison-of-immunotherapy-options/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/standard-dna-testing-may-miss-majority-of-nut-carcinomas-study-finds/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/reevaluating-pathologic-complete-response-as-a-surrogate-for-survival-in-rectal-cancer/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/stride-in-unresectable-hcc-5-year-overall-survival-results-from-himalaya/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/study-finds-racial-and-economic-segregation-may-impact-advanced-stage-breast-and-cervical-cancer-diagnoses/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/acs-study-finds-firefighters-face-increased-cancer-risk-and-mortality-especially-for-skin-and-kidney-cancers/</loc><lastmod>2025-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/extended-outcomes-with-addition-of-sugemalimab-to-first-line-chemotherapy-in-metastatic-nsclc/</loc><lastmod>2025-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/esophageal-adenocarcinoma-recurrence-patterns-with-perioperative-chemotherapy-vs-preoperative-chemoradiotherapy/</loc><lastmod>2025-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/addition-of-talazoparib-to-enzalutamide-in-metastatic-crpc-in-genetically-unselected-cohort/</loc><lastmod>2025-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/final-overall-survival-analysis-in-hrr-deficient-cohort-in-talapro-2-addition-of-talazoparib-to-enzalutamide-in-metastatic-crpc/</loc><lastmod>2025-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/three-in-five-liver-cancer-cases-may-be-due-to-preventable-risk-factors/</loc><lastmod>2025-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/ai-enhances-detection-of-missed-breast-cancers-on-screening-tomosynthesis/</loc><lastmod>2025-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/llm-trained-on-somatic-mutations-shows-prognostic-and-predictive-utility/</loc><lastmod>2025-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/pembrolizumab-and-de-escalation-of-treatment-in-resectable-cutaneous-squamous-cell-cancer/</loc><lastmod>2025-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/study-shows-increased-prescribing-after-accelerated-vs-regular-approval-of-cancer-drugs/</loc><lastmod>2025-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/figo-releases-best-practice-advice-on-cancer-during-pregnancy/</loc><lastmod>2025-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/07-july/cannabis-use-disorder-and-risk-of-oral-cancer/</loc><lastmod>2025-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/menopause-medication-may-help-to-prevent-invasive-breast-cancer-study-finds/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/impact-of-dietary-patterns-on-survival-in-stage-iii-colon-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/i-was-expecting-to-hear-i-have-heart-disease-not-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/the-ohio-state-appoints-christian-rolfo-md-phd-mba-to-lead-division-of-medical-oncology/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/mailed-self-collection-hpv-tests-improve-cervical-cancer-screening-rates-study-finds/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/establishing-novel-models-of-interdisciplinary-care-to-improve-survival-outcomes-in-patients-with-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/how-a-commonly-inherited-genetic-alteration-is-driving-breast-cancer-metastasis-and-predicting-survival/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/use-of-adjuvant-aspirin-reduces-the-risk-of-recurrence-in-pi3k-mutated-colorectal-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/chinese-herbal-medicine-for-improving-adjuvant-chemotherapy-completion-in-patients-with-colon-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/number-of-cancer-survivors-in-the-united-states-reaches-186-million-and-projected-to-exceed-22-million-by-2035/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/minnesota-society-of-clinical-oncology-recognized-for-advocacy-at-2025-asco-annual-meeting/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/malignant-hematology-expert-and-medicare-reimbursement-advocate-samuel-m-silver-md-phd-frcp-fasco-macp-dies-at-74/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/william-c-wood-md-fasco-renowned-surgeon-esteemed-mentor-global-academic-dean-dies-at-84/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/w-kimryn-rathmell-md-phd-fasco-selected-for-women-who-conquer-cancer-mentorship-award/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/early-esr1-mutation-detection-and-therapy-switch-in-advanced-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/asco-and-medicaid-advocacy-in-action/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/vepdegestrant-vs-fulvestrant-in-estrogen-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/asco-honors-karen-eubanks-jackson-of-sisters-network-inc-with-2025-patient-advocate-award/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/hla-matching-considerations-for-hematopoietic-cell-transplantation-in-hematologic-malignancies/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/preoperative-endocrine-therapy-for-older-women-with-estrogen-receptor-positive-breast-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/acs-study-focuses-on-effects-of-medicaid-expansion-in-low-income-older-adults-with-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/in-second-line-setting-t-dxd-improves-survival-outcomes-in-her2-positive-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/asco-guideline-update-calls-for-omission-of-slnb-in-select-patients-with-early-stage-breast-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/phase-iii-trial-results-suggest-a-new-standard-of-care-in-metastatic-her2-positive-breast-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/adjuvant-use-of-atezolizumab-plus-chemotherapy-in-dna-mismatch-repair-deficient-colon-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/silence-is-complicity/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-darolutamide-for-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/molecular-assay-identifies-patients-with-early-nsclc-likely-to-benefit-from-adjuvant-chemotherapy/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/chronicling-the-extraordinary-career-of-stephen-r-grobmyer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/hypofractionation-vs-conventional-fractionation-in-patients-with-breast-cancer-planning-breast-reconstruction/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/trends-in-breast-cancer-incidence-for-women-between-the-ages-of-20-and-49/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/updated-results-confirm-benefit-of-combination-regimen-in-braf-v600e-mutated-metastatic-colorectal-cancer/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/how-family-adventures-precision-oncology-and-living-purposefully-bring-balance-to-the-life-of-charu-aggarwal-md-mph-fasco/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/mark-cuban-does-it-again-reshuffling-the-deck-of-front-line-cml-therapy/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/cellular-therapies-show-sustained-promise-in-hematologic-malignancies-but-access-remains-uneven/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-oce-announces-project-interface-outreach-initiative/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-first-oral-therapy-for-pheochromocytoma-and-paraganglioma/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-therapy-for-nsclc-with-high-c-met-protein-overexpression/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/circulating-tumor-dna-guided-risk-stratification-in-colorectal-cancer-evolving-evidence-and-future-utility/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/recent-advances-in-treating-diffuse-large-b-cell-lymphoma/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/revisiting-margin-width-guidelines-for-dcis-and-the-role-of-routine-reexcision/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/castor-oil/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/overall-survival-benefit-achieved-with-inavolisib-plus-palbociclib-and-fulvestrant-in-advanced-breast-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/maintenance-therapy-with-lurbinectedin-plus-atezolizumab-improves-survival-outcomes-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-finds-glp-1ras-may-lower-risk-of-obesity-related-cancers-vs-dpp-4-inhibitors-in-adults-with-diabetes-and-obesity/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/structured-exercise-program-improves-survival-outcomes-in-patients-with-stage-iii-or-high-risk-stage-ii-colon-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-shows-potential-benefits-of-ai-assisted-classification-in-her2-low-and-her2-ultralow-breast-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/pathology-machine-learning-models-and-diagnosis-of-nonmelanoma-skin-cancers-in-resource-limited-settings/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/digital-histopathology-and-automated-classification-of-pediatric-sarcomas/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/improving-the-alliance-between-oncologists-and-primary-care-providers-a-call-for-collaborative-action/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/how-the-elimination-of-federal-gender-related-grants-and-dei-programs-is-impacting-lgbtqplus-health-research/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/expanded-treatment-options-for-metastatic-crpc-asco-guideline-addresses-somatic-genetic-testing-radiopharmaceuticals/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/retifanlimab-dlwr-approved-for-anal-cancer-in-combination-with-carboplatin-plus-paclitaxel-and-as-a-single-agent/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/astro-survey-data-illustrate-impact-of-continued-medicare-cuts-on-cancer-care/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/why-black-women-have-a-higher-risk-of-dying-of-all-types-of-breast-cancer-than-white-women/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/estro-2025-major-advances-in-radiotherapy-for-anal-and-rectal-cancers/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/crispr-cas9-edited-tumor-infiltrating-lymphocytes-in-metastatic-colorectal-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/use-of-bispecific-antibody-in-older-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/md-anderson-names-jeffrey-e-lee-md-chief-medical-executive/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/i-was-an-n-of-1-in-a-car-t-cell-therapy-trial-for-ovarian-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/aacr-statement-on-former-president-joseph-biden-s-cancer-diagnosis/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/cutting-cancer-research-funding-is-a-costly-gamble-with-millions-of-lives/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/early-onset-breast-colorectal-melanoma-thyroid-testicular-and-other-cancers-are-on-the-rise-in-the-united-states/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/everolimus-plus-lanreotide-vs-everolimus-alone-in-aggressive-gastroenteropancreatic-neuroendocrine-tumors/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/conundrums-in-treating-her2-positive-early-breast-cancer/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/kindness-mercy-empathy-compassion-are-they-relevant-in-the-era-of-robotics-and-ai/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/asco-and-google-cloud-ai-powered-tool/</loc><lastmod>2025-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/cancercare-survey-reveals-how-insurance-red-tape-impacts-cancer-treatment-delays/</loc><lastmod>2025-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-mitomycin-intravesical-solution-for-recurrent-low-grade-intermediate-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2025-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/relacorilant-and-nab-paclitaxel-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2025-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/reduced-dose-chemoradiotherapy-in-early-stage-anal-cancer/</loc><lastmod>2025-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/ramucirumab-beyond-progression-plus-irinotecan-in-ramucirumab-refractory-advanced-gastric-cancer/</loc><lastmod>2025-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/could-a-telehealth-program-enhance-geriatric-cancer-care/</loc><lastmod>2025-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-neoadjuvant-and-adjuvant-pembrolizumab-for-resectable-locally-advanced-head-and-neck-cancer/</loc><lastmod>2025-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/colorectal-cancer-screening-ct-colonography-vs-stool-testing/</loc><lastmod>2025-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/concurrent-vs-sequential-pembrolizumab-with-chemoradiation-in-locally-advanced-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/do-the-benefits-of-fluoropyrimidine-for-gi-cancers-outweigh-cardiovascular-risk/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/neoadjuvant-pd-1pd-l1-inhibition-plus-chemotherapy-in-borderline-resectable-or-unresectable-stage-iii-nsclc/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/patient-reported-outcomes-and-symptomatic-skeletal-events-with-lu-psma-in-progressive-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/early-results-for-car-t-cell-therapy-for-relapsed-or-refractory-al-amyloidosis/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/revumenib-in-triplet-regimen-under-study-in-newly-diagnosed-aml-with-npm1-kmt2a-alterations/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-defines-divergent-molecular-pathways-in-hpv-associated-vs-hpv-independent-sinonasal-cancers/</loc><lastmod>2025-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/brca-mutations-could-increase-risk-of-rare-lymphoma-among-women-who-received-textured-breast-implants-during-breast-cancer-treatment/</loc><lastmod>2025-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/avelumab-plus-cetuximab-in-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2025-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/proposed-budget-cuts-to-medicaid-may-result-in-more-than-16-500-medically-preventable-deaths-annually/</loc><lastmod>2025-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/adding-atezolizumab-to-adjuvant-chemotherapy-improves-disease-free-survival-in-dmmr-colon-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/meta-analysis-reveals-how-icis-may-impact-solid-organ-transplant-responses/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/new-application-may-help-caregivers-of-patients-undergoing-bone-marrow-transplant/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/scholastic-performance-among-adolescents-and-young-adults-with-cancer/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/potential-new-standard-of-care-emerges-in-multiple-myeloma/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/biomarkers-may-shed-light-on-treatment-options-for-high-risk-prostate-cancer/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/dual-immunotherapy-may-improve-progression-free-survival-in-advanced-squamous-cell-carcinoma/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/presurgical-combination-therapy-boosts-survival-in-rare-thyroid-cancer-study-finds/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/niraparib-plus-abiraterone-in-hrr-mutant-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/investigational-menin-inhibitor-under-study-in-npm1-mutant-aml/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/married-people-may-have-better-colorectal-cancer-outcomes-study-shows/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/neoadjuvant-nivolumab-and-chemotherapy-shows-significant-os-benefit-at-5-years-in-resectable-nsclc/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-explores-the-impact-of-prediagnosis-adverse-financial-events-on-risk-of-cancer-mortality/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/emr-integrated-messaging-drastically-increases-cancer-related-fertility-preservation-referrals/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/novel-dual-target-car-t-cell-therapy-may-slow-growth-of-recurrent-glioblastoma/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/anti-inflammatory-diet-could-influence-survival-following-stage-iii-colorectal-cancer/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/ciltacabtagene-autoleucel-delivers-lasting-remissions-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/preoperative-thp-leads-to-pcr-in-two-thirds-of-patients-with-early-stage-her2-positive-er-negative-breast-cancer/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/early-driver-of-lineage-plasticity-in-prostate-cancer-cells/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/swog-s2302-pragmatica-lung-study-design-still-significant-even-with-negative-results-in-advanced-nsclc/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/structured-exercise-program-improves-survival-in-some-patients-with-colon-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/perioperative-durvalumab-boosts-flot-chemotherapy-benefit-for-some-gastric-cancers/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/switching-to-camizestrant-after-detection-of-an-esr1-mutation-improves-progression-free-survival-for-some-patients-with-advanced-breast-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/trastuzumab-deruxtecan-pertuzumab-leads-to-improved-pfs-for-her2-positive-breast-cancer/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/her3-targeted-antibody-drug-conjugate-for-treatment-resistant-solid-tumors/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/novel-antibody-drug-conjugate-for-newly-diagnosed-bpdcn/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/first-line-nivolumab-plus-low-dose-ipilimumab-in-msi-h-advanced-gastricgej-cancer/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/are-most-americans-aware-of-the-link-between-alcohol-and-cancer-risk/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/treatment-for-intractable-cancer-pain-pioneered/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/diagnostic-accuracy-of-navigational-bronchoscopy-vs-transthoracic-needle-biopsy-in-lung-nodules/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/acs-can-statement-on-federal-cuts-to-cancer-research/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/breast-cancer-radiotherapy-leads-to-moderate-cardiac-function-decline-over-years/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/prophylactic-radiation-therapy-of-the-contralateral-breast-in-brca-carriers-with-early-stage-breast-cancer/</loc><lastmod>2025-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/localized-prostate-cancer-long-term-follow-up-of-hypofractionated-dose-escalated-vs-conventionally-fractionated-rt/</loc><lastmod>2025-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/cancer-may-be-detectable-in-bloodstream-3-years-prior-to-diagnosis/</loc><lastmod>2025-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/four-drug-induction-regimen-under-study-in-advanced-melanoma-with-braf-mutation/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/order-of-crc-diagnosis-may-influence-survival-in-patients-with-multiple-malignancies/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/noncovalent-btk-inhibitor-in-chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/psilocybin-may-benefit-patients-with-cancer-major-depressive-disorder/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/regional-nodal-irradiation-in-node-negative-breast-cancer-after-neoadjuvant-chemotherapy/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/elevated-cardiac-biomarkers-associated-with-increased-cancer-risk/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/key-lbcl-traits-tied-to-greatest-benefit-from-cd19-car-t-cell-therapy/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-cd19-directed-antibody-based-regimen-for-follicular-lymphoma/</loc><lastmod>2025-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/addition-of-tumor-treating-fields-to-gemcitabinenab-paclitaxel-in-locally-advanced-pancreatic-adenocarcinoma/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/contributors-to-risk-of-subsequent-neoplasms-in-long-term-survivors-of-childhood-cancer/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/ropeginterferon-alfa-2b-outperforms-anagrelide-as-second-line-therapy-for-et/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/novel-tri-specific-antibody-shows-efficacy-and-safety-in-refractory-myeloma/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/outcomes-of-oncologic-extended-resection-for-gallbladder-cancer-results-of-a-global-analysis/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/tafasitamab-plus-lenalidomide-and-rituximab-significantly-improves-outcomes-in-relapsedrefractory-follicular-lymphoma/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/national-comprehensive-cancer-network-launches-nccn-guidelines-navigator/</loc><lastmod>2025-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/ash-2025-awardees-hematologists-to-be-honored-with-highest-distinctions/</loc><lastmod>2025-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/symptom-detected-breast-cancers-may-be-linked-to-higher-mortality-and-advanced-disease-risk/</loc><lastmod>2025-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/gut-microbiome-may-hold-key-to-avoiding-chemotherapy-related-cardiotoxicity-in-patients-with-breast-cancer/</loc><lastmod>2025-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/new-model-predicts-risk-of-progression-in-early-stage-classical-hodgkin-lymphoma/</loc><lastmod>2025-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/mrd-guided-therapy-with-ibrutinib-venetoclax-or-ibrutinib-alone-in-chronic-lymphocytic-leukemia/</loc><lastmod>2025-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/mindfulness-and-tai-chi-interventions-for-mood-improvement-in-cancer-survivors-with-distress/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/cohort-study-finds-genetics-of-cardiomyopathy-risk-in-cancer-survivors-differ-by-age-of-onset/</loc><lastmod>2025-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-grants-accelerated-approval-to-datopotamab-deruxtecan-dlnk-for-egfr-mutated-nsclc/</loc><lastmod>2025-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/adding-olanzapine-to-triplet-antiemetics-post-anthracyclinecyclophosphamide-chemotherapy/</loc><lastmod>2025-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/addition-of-lenvatinib-pembrolizumab-to-chemotherapy-in-advancedmetastatic-gastroesophageal-adenocarcinoma/</loc><lastmod>2025-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/role-of-mitochondrial-pathways-in-melanoma-progression-treatment-resistance/</loc><lastmod>2025-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-finds-ai-chatbots-are-vulnerable-to-spreading-malicious-false-health-information/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/dual-menin-and-kat6a-7-inhibition-improves-outcomes-in-nup98-rearranged-pediatric-aml-models/</loc><lastmod>2025-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/breast-cancer-new-study-finds-survivors-may-face-lower-risk-of-alzheimer-dementia/</loc><lastmod>2025-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/perioperative-pembrolizumab-in-locally-advanced-head-and-neck-cancer/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/early-toxicity-with-intensity-modulated-moderately-hypofractionated-radiotherapy-vs-stereotactic-body-radiotherapy-in-intermediate-and-high-risk-prostate-cancer/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/best-practice-recommendations-for-clinical-homologous-recombination-deficiency-testing/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/predictive-biomarker-under-study-in-colorectal-cancer/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/botulinum-toxin-and-scopolamine-for-radiation-induced-salivary-gland-toxicity-in-metastatic-prostate-cancer/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/addition-of-retifanlimab-to-first-line-chemotherapy-in-advanced-squamous-cell-carcinoma-of-the-anal-canal/</loc><lastmod>2025-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/astro-updates-guideline-on-radiation-therapy-for-high-grade-diffuse-glioma/</loc><lastmod>2025-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-finds-about-one-in-six-chemotherapy-drugs-in-sub-saharan-africa-fails-quality-tests/</loc><lastmod>2025-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/partial-breast-radiotherapy-after-breast-conserving-surgery-10-year-outcomes/</loc><lastmod>2025-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/frontline-triplet-regimens-for-intensive-chemotherapy-ineligible-idh-mutant-aml/</loc><lastmod>2025-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-label-expansion-for-agent-used-in-patient-selection-for-pre-taxane-radioligand-therapy/</loc><lastmod>2025-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/gpc3-targeted-immunopet-helps-detect-earlier-stage-hepatocellular-carcinoma/</loc><lastmod>2025-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/inherited-genetic-differences-may-predict-resistance-to-immunotherapy-in-metastatic-melanoma/</loc><lastmod>2025-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/low-value-cancer-screenings-may-continue-for-years-following-guideline-change-to-limit-unnecessary-tests/</loc><lastmod>2025-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/self-collection-kit-mailings-may-increase-cervical-cancer-screening-rates-in-underserved-settings/</loc><lastmod>2025-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/adjuvant-cemiplimab-in-high-risk-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2025-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/mrd-guided-treatment-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2025-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/study-reports-increasing-incidence-rates-of-appendiceal-adenocarcinoma-in-those-born-after-1945/</loc><lastmod>2025-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/fda-approves-taletrectinib-for-ros1-positive-non-small-cell-lung-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/nomogram-model-may-predict-dvt-risk-in-patients-with-ovarian-cancer/</loc><lastmod>2025-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/elinzanetant-for-vasomotor-symptoms-from-endocrine-therapy-for-breast-cancer/</loc><lastmod>2025-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/resectable-nsclc-overall-survival-with-neoadjuvant-nivolumab-plus-chemotherapy/</loc><lastmod>2025-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/06-june/cell-free-dna-fragmentomics-based-model-for-early-detection-of-pancreatic-cancer/</loc><lastmod>2025-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/two-vs-8-week-course-of-radiotherapy-for-prostate-cancer-10-year-follow-up/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/asco-proposed-changes-to-federal-health-agencies-threaten-future-cancer-research-advancements/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/fda-approves-doublet-for-kras-mutated-recurrent-low-grade-serous-ovarian-cancer/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/nccn-clinical-practice-guidelines-in-oncology-2025-updates/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/early-phase-trial-shows-activity-and-safety-of-zongertinib-in-previously-treated-her2-mutant-nsclc/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/the-power-of-translational-science-to-transform-the-lives-of-patients-worldwide/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/together-we-re-building-a-better-future-for-people-with-cancer-and-for-our-profession/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/early-stage-nonrectal-mismatch-repair-deficient-tumors-respond-to-neoadjuvant-pd-1-blockade-facilitating-nonoperative-management/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/additional-abstracts-of-interest-in-cancer-research/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/fellows-of-the-aacr-academy-class-of-2025/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/w-kimryn-rathmell-md-phd-fasco-named-ceo-of-osuccc-james/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/asco-congratulates-2025-special-awards-recipients/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/what-is-the-value-in-cost-and-lives-saved-of-cancer-screening-and-prevention/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/strategy-for-managing-immunotherapy-induced-parkinsonism-in-patients-with-multiple-myeloma/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/the-legal-impacts-on-oncology-care-of-prohibiting-diversity-equity-and-inclusion-efforts/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/bringing-evidence-based-integrative-medicine-into-everyday-oncology-practice/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/i-have-stage-iv-lung-cancer-and-still-consider-myself-the-luckiest-man-in-the-world/</loc><lastmod>2025-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/how-could-so-many-physicians-have-failed-me/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/addition-of-perioperative-pembrolizumab-to-standard-of-care-in-newly-diagnosed-locally-advanced-head-and-neck-cancer/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/applications-are-now-open-for-the-2025-integrative-oncology-scholars-program-and-integrative-oncology-fellows-program/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/quick-takes-on-research-findings-on-novel-therapies-for-gynecologic-cancers/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/study-shows-disparities-in-diagnosing-endometrial-cancer-in-women-with-postmenopausal-bleeding/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/evolving-role-of-surgical-de-escalation-for-endometrial-ovarian-cervical-and-vulvar-cancers/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/off-the-shelf-natural-killer-car-t-cell-therapy-shows-efficacy-in-small-study-of-relapsed-or-refractory-blood-cancers/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/amivantamab-vmjw-plus-lazertinib-vs-osimertinib-in-egfr-mutated-non-small-cell-lung-cancer/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/2024-annual-report-to-the-nation-on-the-status-of-cancer-finds-mortality-rates-continue-to-decline/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/joint-clinical-practice-guideline-addresses-opioid-conversion-for-patients-with-cancer/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/ash-studies-bolster-support-for-menin-inhibitor-in-acute-leukemia/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/rakesh-k-jain-phd-faacr-honored-with-2025-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/keith-t-flaherty-md-faacr-elected-as-aacr-president-elect-for-2025-2026/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/remembering-roswell-park-leader-thomas-b-tomasi-jr-md-phd/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/venetoclax-based-therapy-for-patients-with-newly-diagnosed-acute-myeloid-leukemia/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/fda-approves-anti-pd-1-antibody-for-nasopharyngeal-cancer/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/richard-pazdur-md-honored-with-2025-aacr-enduring-impact-award-for-transformative-service-to-cancer-science-and-medicine/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/therapy-with-a-tki-for-egfr-variant-lung-adenocarcinoma-lessons-from-cml/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/renowned-breast-cancer-physician-scientist-to-lead-womens-cancers-program-at-city-of-hope/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/building-and-sharing-dietary-evidence-in-cancer-care/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/is-active-monitoring-a-safe-option-for-patients-with-ductal-carcinoma-in-situ/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/how-the-cancer-moonshot-is-making-a-difference-for-patients-here-and-across-the-world/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/is-clonal-cytopenia-of-undetermined-significance-distinct-from-lower-risk-myelodysplastic-syndrome/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/cancer-aging-and-meaning-navigating-psychosocial-challenges/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/novel-btk-and-bcl2-inhibitors-redefine-cll-treatment-across-front-line-and-relapsed-settings/</loc><lastmod>2025-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/genetic-mutations-linked-to-worse-stomach-cancer-outcomes/</loc><lastmod>2025-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/20-year-screening-program-drives-down-colorectal-cancer-cases-deaths/</loc><lastmod>2025-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/novel-car-t-cell-therapy-induces-response-in-patients-with-advanced-thyroid-cancers/</loc><lastmod>2025-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/influence-of-aca-on-breast-reconstruction-disparities/</loc><lastmod>2025-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/hiv-related-structural-barriers-in-cancer-care/</loc><lastmod>2025-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/symptoms-preceding-unplanned-acute-care-in-patients-with-cancer/</loc><lastmod>2025-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/outcomes-with-hsct-in-pediatric-high-risk-aml/</loc><lastmod>2025-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/survival-trends-in-melanoma-brain-metastases-update-of-melanoma-graded-prognostic-assessment/</loc><lastmod>2025-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/2025-acs-cancer-prevention-early-detection-report-cancer-screening-rates-modifiable-risk-factors/</loc><lastmod>2025-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/cannabis-use-disorder-significantly-increases-mortality-risk-in-colorectal-cancer/</loc><lastmod>2025-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/use-of-ruxolitinib-to-resolve-ciltacabtagene-autoleucel-induced-parkinsonism-in-patients-with-multiple-myeloma/</loc><lastmod>2025-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/malaria-subtype-may-be-linked-to-development-of-burkitt-lymphoma/</loc><lastmod>2025-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/adavosertib-in-recurrent-or-persistent-uterine-serous-carcinoma/</loc><lastmod>2025-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/use-of-cad-cam-may-improve-jaw-reconstruction-outcomes-among-patients-with-head-and-neck-cancer/</loc><lastmod>2025-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/dose-escalation-of-fluorodeoxyglucose-pet-guided-radiotherapy-for-locally-advanced-nsclc/</loc><lastmod>2025-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/financial-toxicity-tumor-board-can-it-reduce-treatment-costs/</loc><lastmod>2025-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/anal-cancer-rates-rising-most-among-older-white-and-hispanic-women/</loc><lastmod>2025-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/early-stage-stomach-cancer-diagnoses-on-the-rise/</loc><lastmod>2025-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/cancer-briefs-from-digestive-disease-week-2025/</loc><lastmod>2025-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/new-treatment-approach-could-enhance-care-for-aggressive-relapsed-refractory-t-and-nk-cell-lymphomas/</loc><lastmod>2025-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/smoking-cessation-may-be-critical-to-mitigate-burden-of-second-primary-cancers/</loc><lastmod>2025-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/five-major-advances-in-radiotherapy-for-anal-and-rectal-cancer-presented-at-estro-2025/</loc><lastmod>2025-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/molecular-profiling-may-optimize-treatment-for-endometrial-cancer/</loc><lastmod>2025-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/aml-mrd-testing-led-to-survival-benefits-in-subset-of-patients/</loc><lastmod>2025-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/ablative-radiation-therapy-for-resectable-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2025-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/breast-cancer-radiotherapy-1-vs-3-week-course/</loc><lastmod>2025-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/collaborative-strategy-involving-ai-human-task-sharing-could-help-minimize-mammogram-costs/</loc><lastmod>2025-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/patterns-in-oncology-drug-use-after-accelerated-approval-is-withdrawn/</loc><lastmod>2025-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/early-onset-breast-colorectal-endometrial-pancreatic-and-kidney-cancers-on-the-rise/</loc><lastmod>2025-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/effects-of-tumor-infiltrating-clonal-hematopoiesis/</loc><lastmod>2025-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/fda-approves-at-home-self-collection-device-for-cervical-cancer-screening/</loc><lastmod>2025-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/icymi-additional-abstracts-of-interest-from-aacr/</loc><lastmod>2025-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/annual-or-biennial-multicancer-early-detection-screening-improves-patient-outcomes/</loc><lastmod>2025-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/crispr-cas9-edited-tils-targeting-intracellular-immune-checkpoint-cish-in-metastatic-colorectal-cancer/</loc><lastmod>2025-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/combination-of-weight-gain-late-age-at-pregnancy-could-increase-risk-of-breast-cancer/</loc><lastmod>2025-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/glp-1-receptor-agonists-could-show-anticancer-benefits-beyond-weight-loss/</loc><lastmod>2025-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/cohort-study-shows-benefits-of-bilateral-salpingo-oophorectomy-without-increased-health-risks/</loc><lastmod>2025-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/overall-survival-analysis-in-codebreak-300-sotorasib-plus-panitumumab-vs-investigator-s-choice-in-chemorefractory-kras-g12c-colorectal-cancer/</loc><lastmod>2025-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/ai-model-estimates-biological-age-and-predicts-survival-in-patients-with-cancer/</loc><lastmod>2025-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/afatinib-vs-chemotherapy-in-nsclc-with-uncommon-activating-egfr-mutations/</loc><lastmod>2025-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/first-line-tfox-vs-folfox-in-advanced-her2-negative-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2025-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/elective-nodal-radiotherapy-for-oligorecurrent-nodal-prostate-cancer-metastases/</loc><lastmod>2025-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/patient-advocacy-groups-health-care-programs-are-lifelines-not-line-items/</loc><lastmod>2025-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/breast-parenchymal-phenotypes-and-risk-of-breast-cancer/</loc><lastmod>2025-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/chemotherapy-free-triplet-in-previously-treated-hr-positive-her2-positive-advanced-breast-cancer/</loc><lastmod>2025-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/retifanlimab-dlwr-approved-for-anal-cancer/</loc><lastmod>2025-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/second-line-endocrine-therapy-with-or-without-palbociclib-rechallenge-in-hr-positiveher2-negative-advanced-breast-cancer/</loc><lastmod>2025-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/neoadjuvant-therapy-for-ibd-related-rectal-cancer/</loc><lastmod>2025-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/novel-prediction-model-for-hearing-loss-from-chemotherapy-in-pediatric-patients-with-cancer/</loc><lastmod>2025-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/risk-of-gynecologic-cancers-after-5-years-of-testosterone-use/</loc><lastmod>2025-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/reduced-dose-chemoradiotherapy-for-early-stage-anal-cancer/</loc><lastmod>2025-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/antimicrobial-resistance-in-outpatients-with-cancer/</loc><lastmod>2025-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/use-of-ai-assistance-to-improve-her2-breast-cancer-classifications/</loc><lastmod>2025-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/extensive-stage-sclc-lurbinectedin-and-atezolizumab/</loc><lastmod>2025-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/glp-1-ras-may-lower-risk-of-obesity-related-cancers/</loc><lastmod>2025-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/inavolisib-based-regimen-in-pik3ca-mutated-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2025-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/chemotherapy-free-neoadjuvant-therapy-for-her2-enriched-early-breast-cancer/</loc><lastmod>2025-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/former-president-biden-diagnosed-with-metastatic-prostate-cancer/</loc><lastmod>2025-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/stromal-disruption-associated-with-higher-risk-of-developing-aggressive-breast-cancer/</loc><lastmod>2025-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/gabapentin-may-extend-survival-in-patients-with-glioblastoma/</loc><lastmod>2025-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/a-high-proportion-of-us-adults-are-behind-on-cancer-screenings/</loc><lastmod>2025-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/breast-cancer-genome-wide-study-identifies-two-new-risk-genes-in-black-south-african-women/</loc><lastmod>2025-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/anlotinib-plus-penpulimab-in-first-line-treatment-of-unresectable-hepatocellular-carcinoma/</loc><lastmod>2025-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/p53-dysfunction-in-myelodysplastic-syndromes/</loc><lastmod>2025-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/association-between-risk-reducing-surgeries-and-survival-in-young-brca-carriers-with-breast-cancer/</loc><lastmod>2025-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/addition-of-tocilizumab-to-nab-paclitaxel-and-gemcitabine-in-first-line-treatment-of-advanced-pancreatic-cancer/</loc><lastmod>2025-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/revealing-critical-insights-for-precision-medicine-in-patients-with-metastatic-prostate-cancer/</loc><lastmod>2025-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/abbreviated-mri-scans-in-detecting-breast-cancer-for-women-with-dense-breasts/</loc><lastmod>2025-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/use-of-niraparib-in-patients-with-advanced-melanoma/</loc><lastmod>2025-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/mortality-associated-with-risk-adapted-adjuvant-therapy-in-postmenopausal-women-with-early-breast-cancer/</loc><lastmod>2025-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/dose-escalated-stereotactic-body-radiotherapy-vs-conventional-radiotherapy-for-painful-bone-metastases/</loc><lastmod>2025-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/doj-finds-federal-bureau-of-prisons-colorectal-cancer-screening-practices-lacking/</loc><lastmod>2025-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/esmo-releases-version-20-of-the-magnitude-of-clinical-benefit-scale/</loc><lastmod>2025-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/enhanced-car-t-cell-therapy-for-lymphoma-after-previous-failure-on-car-t-cell-therapy/</loc><lastmod>2025-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/first-line-nivolumab-ipilimumab-vs-lenvatinib-or-sorafenib-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2025-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/alcohol-may-be-linked-to-higher-risk-of-pancreatic-cancer/</loc><lastmod>2025-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/physical-function-acts-as-predictor-of-survival-for-daratumumab-based-therapy-in-multiple-myeloma/</loc><lastmod>2025-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/genomic-score-may-predict-progression-from-precursor-condition-to-active-multiple-myeloma/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/online-genetic-testing-platform-demonstrates-engagement-among-patients-with-young-onset-colorectal-cancer/</loc><lastmod>2025-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/car-t-cell-therapy-continues-to-demonstrate-activity-in-advanced-clear-cell-renal-cell-carcinoma/</loc><lastmod>2025-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/study-finds-novel-triplet-regimen-safe-and-effective-for-patients-with-higher-risk-mds-and-cmml/</loc><lastmod>2025-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/spatial-transcriptomics-identifies-novel-subtypes-associated-with-disease-prognosis-in-leiomyosarcoma/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/subset-of-men-with-rare-prostate-cancer-may-benefit-from-immunotherapy-added-to-chemotherapy-and-targeted-maintenance-therapy/</loc><lastmod>2025-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/impact-of-wildfire-related-pollution-on-survival-in-nsclc/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/alcohol-related-cancer-deaths-are-on-the-rise-in-the-united-states/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/encorafenib-cetuximab-plus-chemotherapy-improves-survival-in-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2025-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/vepdegestrant-improves-pfs-in-select-patients-with-esr1-mutant-advanced-breast-cancer/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/climate-change-and-risk-for-breast-and-gynecologic-cancers/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/harm-benefit-balance-of-immune-checkpoint-inhibitor-treatment-in-non-small-cell-lung-cancer/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/folfirinox-vs-gemcitabine-in-nonresectable-locally-advanced-pancreatic-carcinoma/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/addition-of-radium-223-to-stereotactic-ablative-radiotherapy-in-oligometastatic-prostate-cancer/</loc><lastmod>2025-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/trastuzumab-deruxtecan-improves-survival-outcomes-in-patients-with-her2-positive-gastric-gej-cancer/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/sacituzumab-govitecan-and-pembrolizumab-improve-disease-control-in-advanced-pd-l1-positive-tnbc/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/05-may/wgs-liquid-biopsies-for-hpv-associated-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2025-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/ai-integration-in-global-programs-of-ct-screening-for-lung-cancer-and-other-tobacco-related-illnesses/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/several-trials-show-clinical-activity-with-osimertinib-in-advanced-egfr-mutant-non-small-cell-lung-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/hyperefficient-and-super-digitized-health-care/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/sgo-s-president-elect-brings-professional-experience-and-passion-to-her-new-role/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/managing-dermatologic-reactions-to-combination-therapy-for-patients-with-egfr-mutated-nsclc/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/use-of-investigational-tool-to-detect-advanced-stage-invasive-cervical-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/karen-e-knudsen-mba-phd-appointed-chief-executive-officer-of-the-parker-institute-for-cancer-immunotherapy/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/asco-updates-guideline-for-fertility-preservation-in-people-with-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/executive-orders-and-cancer-care/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/cabozantinib-approved-for-treatment-of-neuroendocrine-tumors/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/combination-immunotherapy-approved-for-unresectable-or-metastatic-hepatocellular-carcinoma/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/raising-awareness-of-inflammatory-breast-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/fda-approves-nivolumab-with-ipilimumab-for-unresectable-or-metastatic-msi-hdmmr-colorectal-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/combination-therapy-for-newly-diagnosed-brca-nonmutated-advanced-epithelial-ovarian-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/proton-therapy-and-intensity-modulated-radiation-therapy-for-localized-prostate-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/study-finds-standard-chemoradiation-therapy-superior-to-deintensification-approaches-for-hpv-related-oropharyngeal-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/fda-expands-indication-for-lu-177-vipivotide-tetraxetan-in-mcrpc/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/fda-approves-perioperative-durvalumab-for-muscle-invasive-bladder-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/final-results-of-libretto-001-selpercatinib-in-ret-fusion-positive-nsclc/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/pembrolizumab-plus-chemotherapy-new-standard-of-care-in-locally-advanced-cervical-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/active-surveillance-vs-standard-surgery-after-complete-response-to-neoadjuvant-chemoradiotherapy-in-esophageal-cancer/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/presymptomatic-awareness-of-brca1brca2-status-and-outcomes-in-ovarian-cancer/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/could-brain-imaging-plus-vr-minimize-cancer-related-pain/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/daily-physical-activity-even-at-light-intensities-may-reduce-cancer-risk/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/patterns-in-adherence-to-uspstf-lung-cancer-screening-guidelines/</loc><lastmod>2025-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/machine-learning-program-may-enhance-transplantation-risk-assessment-in-patients-with-myelofibrosis/</loc><lastmod>2025-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/exploring-impact-of-covid-19-pandemic-on-colorectal-cancer-screening-diagnosis/</loc><lastmod>2025-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/smoking-status-of-the-us-cancer-population/</loc><lastmod>2025-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/local-excision-may-be-feasible-in-patients-with-low-rectal-adenocarcinoma/</loc><lastmod>2025-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/awareness-of-alcohol-related-cancer-risks-may-be-growing/</loc><lastmod>2025-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/is-surgery-necessary-to-treat-invasive-breast-cancer/</loc><lastmod>2025-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/low-dose-ct-screening-for-lung-cancer-in-a-high-risk-population/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/accelerated-onset-of-aging-related-diseases-in-childhood-cancer-survivors/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/breast-shrinkage-following-breast-conserving-therapy/</loc><lastmod>2025-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/treatment-discontinuation-in-patients-with-cml-role-of-digital-pcr/</loc><lastmod>2025-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/grocery-store-choice-could-impact-obesity-related-cancer-mortality/</loc><lastmod>2025-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/characteristics-of-nasopharyngeal-carcinoma-in-the-united-states/</loc><lastmod>2025-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/comparing-biopsy-techniques-for-prostate-cancer-detection/</loc><lastmod>2025-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/crossing-state-borders-addressing-residential-barriers-to-cancer-care/</loc><lastmod>2025-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/prostate-cancer-biomarker-test-may-predict-gu-toxicity-from-sbrt/</loc><lastmod>2025-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/frailty-following-chemotherapy-may-be-linked-to-poorer-survival-in-older-women-with-breast-cancer/</loc><lastmod>2025-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/american-cancer-society-launches-ceo-search/</loc><lastmod>2025-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/study-illuminates-disparities-in-treatment-survival-in-metastatic-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2025-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/invitation-to-colonoscopy-vs-fecal-immunochemical-test-screening-for-colorectal-cancer/</loc><lastmod>2025-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/pausing-vs-continuing-btk-inhibitors-at-time-of-covid-19-vaccination-in-patients-with-cll/</loc><lastmod>2025-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/low-dose-vs-regular-dose-apixaban-for-prevention-of-vte-recurrence-in-patients-with-cancer/</loc><lastmod>2025-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/fda-approves-nivolumab-plus-ipilimumab-for-unresectable-or-metastatic-hcc/</loc><lastmod>2025-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/neoantigen-selected-tils-boost-response-to-immunotherapy-in-heavily-pretreated-gi-cancers/</loc><lastmod>2025-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/novel-strategy-may-enhance-sensitivity-of-monitoring-cancer-in-blood-samples/</loc><lastmod>2025-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/metastatic-castration-resistant-prostate-cancer-immune-modulating-adc-targeting-cd46/</loc><lastmod>2025-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/ideal-apixaban-dose-for-cancer-associated-vte/</loc><lastmod>2025-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/fda-approves-bevacizumab-biosimilar/</loc><lastmod>2025-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/most-pediatric-cancer-deaths-occur-in-regions-of-conflict/</loc><lastmod>2025-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/immunotherapy-radiosurgery-combination-and-risk-of-radiation-necrosis-in-patients-with-cancer-who-have-brain-metastases/</loc><lastmod>2025-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/link-between-ct-scans-and-future-cancer-incidence/</loc><lastmod>2025-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/incidence-rates-of-colorectal-and-pancreatic-cancers-are-rising-most-among-young-adults/</loc><lastmod>2025-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/pediatric-all-or-lymphoblastic-lymphoma-reduced-induction-dexamethasone-and-high-dose-methotrexate/</loc><lastmod>2025-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/adar1-gene-and-response-to-lenalidomide-in-patients-with-multiple-myeloma/</loc><lastmod>2025-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/novel-drug-device-combination-may-improve-outcomes-in-metastatic-uveal-melanoma/</loc><lastmod>2025-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/parasitic-infection-and-its-treatment-linked-to-cancer-related-gene-activity-in-the-cervix/</loc><lastmod>2025-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/neoadjuvant-chemotherapy-for-resectable-pancreatic-cancer/</loc><lastmod>2025-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/can-ctdna-monitoring-help-to-predict-melanoma-recurrence/</loc><lastmod>2025-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/germline-variants-may-impact-unique-nature-of-patients-cancer/</loc><lastmod>2025-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/dual-use-of-cigarettes-and-e-cigarettes-on-par-with-sole-cigarette-use-in-terms-of-toxic-exposure/</loc><lastmod>2025-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/poor-agreement-reported-among-diagnostic-tests-for-breast-cancer-related-lymphedema/</loc><lastmod>2025-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/advanced-esophageal-cancer-notch1-mutation-and-efficacy-of-immunotherapy/</loc><lastmod>2025-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/how-does-medicaid-expansion-affect-access-to-care-in-patients-with-nsclc/</loc><lastmod>2025-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/rates-of-breast-crc-screenings-almost-four-times-higher-than-lung-cancer-screenings/</loc><lastmod>2025-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/study-identifies-biologic-reasons-for-selective-benefit-of-parp-inhibitors/</loc><lastmod>2025-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/nk-cells-complexed-with-bispecific-antibody-may-be-of-benefit-to-patients-with-lymphoma/</loc><lastmod>2025-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/patterns-of-ici-use-and-survival-outcomes-in-metastatic-colorectal-cancer/</loc><lastmod>2025-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/patient-reported-outcomes-with-mirvetuximab-soravtansine-vs-chemotherapy-in-ovarian-cancer/</loc><lastmod>2025-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/preclinical-study-finds-fgfr2-inhibition-may-prevent-some-kras-expressing-pancreatic-cancers/</loc><lastmod>2025-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/talazoparib-plus-enzalutamide-in-advanced-prostate-cancer-patient-reported-outcomes/</loc><lastmod>2025-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/rescue-therapy-for-newly-diagnosed-high-grade-osteosarcoma/</loc><lastmod>2025-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/metabolic-syndrome-may-increase-risk-of-cancer-recurrence-subsequent-mortality-among-breast-cancer-survivors/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/early-life-exposure-to-environmental-carcinogens-may-increase-risk-of-pediatric-papillary-thyroid-cancer/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/activity-of-ros1-tki-in-nsclc/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/cap-issues-new-and-updated-cancer-protocols/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/some-patients-with-advanced-nsclc-experience-durable-disease-control-after-immunotherapy-discontinuation/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/patient-support-found-for-ai-use-as-second-reader-of-mammograms/</loc><lastmod>2025-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/updated-cap-guideline-aims-to-address-rising-rates-of-hpv-associated-squamous-cell-carcinomas/</loc><lastmod>2025-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/adaptive-manufactured-lentiviral-anti-cd20-anti-cd19-car-t-cells-in-relapsed-refractory-mantle-cell-lymphoma/</loc><lastmod>2025-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/2024-annual-report-to-the-nation-on-the-status-of-cancer-released/</loc><lastmod>2025-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/detecting-invasive-nodules-could-be-key-to-preventing-unnecessary-pancreatic-cancer-surgery/</loc><lastmod>2025-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/claim-denials-for-medicare-cancer-related-ngs-testing-show-uncertainty-of-coverage/</loc><lastmod>2025-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/role-of-pathologists-in-improving-access-to-safer-more-effective-allogeneic-cell-therapies/</loc><lastmod>2025-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/extended-follow-up-of-belzutifan-treatment-for-von-hippel-lindau-disease-associated-rcc/</loc><lastmod>2025-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/radiotherapy-dosing-for-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2025-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/response-to-immune-checkpoint-inhibitors-not-affected-by-age/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/addition-of-daratumumab-to-treatment-regimen-in-transplant-ineligible-newly-diagnosed-multiple-myeloma/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/benefits-of-walnut-consumption-curbing-inflammation-colorectal-cancer-risk/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/polygenic-risk-score-for-prostate-cancer-screening/</loc><lastmod>2025-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/w-kimryn-rathmell-named-ceo-of-the-ohio-state-james-cancer-hospital-and-solove-research-institute/</loc><lastmod>2025-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/use-of-statins-in-cllsll/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/childhood-exposure-to-bacterial-toxin-may-trigger-early-onset-colorectal-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/omission-of-endocrine-therapy-in-estrogen-receptor-low-early-stage-breast-cancer/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/addition-of-neoadjuvant-adjuvant-pembrolizumab-significantly-improves-outcomes-in-locally-advanced-hnscc/</loc><lastmod>2025-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/nonoperative-management-of-mismatch-repair-deficient-tumors/</loc><lastmod>2025-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/use-of-ctdna-based-liquid-biopsy-assay-in-resectable-colorectal-cancer/</loc><lastmod>2025-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/zoldonrasib-may-elicit-objective-responses-in-patients-with-kras-g12d-mutated-nsclc/</loc><lastmod>2025-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/off-the-shelf-natural-killer-car-therapy-active-in-hematologic-malignancies/</loc><lastmod>2025-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/aacr-2025-oral-her2-targeted-therapy-for-advanced-her2-mutated-lung-cancer/</loc><lastmod>2025-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/novel-targeted-therapy-under-study-in-selected-patients-with-advanced-solid-tumors/</loc><lastmod>2025-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/survival-outcomes-may-improve-when-treatment-is-guided-by-using-both-tissue-and-liquid-biopsies/</loc><lastmod>2025-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/neoadjuvant-durvalumab-plus-chemotherapy-for-high-risk-upper-tract-urothelial-carcinoma/</loc><lastmod>2025-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/whi-funding-future-unclear/</loc><lastmod>2025-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/pretrained-ai-models-could-help-accurately-diagnose-nonmelanoma-skin-cancers-in-resource-limited-settings/</loc><lastmod>2025-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/ai-driven-model-for-identifying-cancer-cachexia/</loc><lastmod>2025-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/sex-disparities-identified-in-fatigue-and-depression-for-cancer-survivors/</loc><lastmod>2025-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/ai-driven-analysis-of-digital-pathology-images-may-improve-sarcoma-subtyping-among-pediatric-patients/</loc><lastmod>2025-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/topical-braf-inhibitor-under-study-for-managing-acneiform-rash/</loc><lastmod>2025-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/molecularly-selected-tumor-agnostic-phase-ii-trial-focuses-on-combination-therapy/</loc><lastmod>2025-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/04-april/using-single-cell-rna-sequencing-to-evaluate-cell-states-in-aml/</loc><lastmod>2025-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/stem-cell-transplant-may-not-be-necessary-in-first-remission-for-patients-with-mantle-cell-lymphoma-and-undetectable-mrd/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/enfortumab-vedotin-plus-pembrolizumab-continues-to-show-benefit-in-metastatic-urothelial-carcinoma/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/study-finds-no-clear-evidence-that-red-wine-mitigates-cancer-risk/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/tafasitamab-plus-lenalidomide-and-rituximab-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/early-research-evaluates-association-between-diet-and-lung-cancer-risk/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/new-asco-guideline-addresses-germline-and-somatic-genomic-testing-in-metastatic-prostate-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/new-guideline-supports-transoral-robotic-surgery-in-the-multidisciplinary-management-of-patients-with-oropharyngeal-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/confronting-the-growing-global-threat-of-antimicrobial-resistance-in-cancer-care/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/conexiant-signs-partnership-deal-with-elsevier-to-enhance-society-marketing-and-member-engagement-solutions/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/benefit-suggested-for-early-treatment-of-advanced-stage-very-low-tumor-burden-follicular-lymphoma/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/bringing-palliative-care-to-every-patient-with-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/cms-expects-between-750-000-to-2-million-to-lose-coverage-if-aca-proposal-is-implemented/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/screening-was-key-to-the-early-detection-of-my-prostate-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/results-announced-from-phase-ii-veritac-2-clinical-trial-in-breast-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/new-reports-assess-oncology-workforce-well-being-propose-solutions-to-address-burnout/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/exploratory-post-hoc-analysis-of-duo-e-reveals-olaparib-s-benefit-in-endometrial-cancer-subsets/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/intraperitoneal-paclitaxel-combination-regimen-improves-overall-survival-in-advanced-gastric-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/advancing-clinical-decisions-with-circulting-tumor-dna-insights-from-recent-clinical-trials/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/recent-fda-approvals-in-lymphoma-and-in-rarer-tumors/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/monica-m-bertagnolli-md-facs-fasco-joins-friends-of-cancer-research-board-of-directors/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/douglas-hanahan-phd-faacr-to-be-honored-at-2025-aacr-annual-meeting/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/neoadjuvant-chemoradiotherapy-plus-immunotherapy-in-esophageal-squamous-cell-carcinoma/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/benefit-of-regular-physical-activity-prior-to-cancer-diagnosis/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/icymi-abstracts-on-novel-therapies-in-gastrointestinal-cancers/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/nivolumab-plus-cabozantinib-continues-to-show-superior-long-term-outcomes-in-advanced-renal-cell-carcinoma/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/partial-gland-removal-may-be-an-option-for-many-men-with-prostate-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/two-decades-of-collaboration-the-accelerating-anticancer-agent-development-and-validation-aaadv-workshop/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/digital-integrative-medicine-intervention-for-patients-undergoing-active-cancer-treatment/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/discussing-breast-density-with-patients-following-the-fda-mammography-quality-standards-act-mandate/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/the-importance-of-diversity-in-clinical-research/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/influencing-geriatric-oncology-practice-worldwide-2024-international-society-of-geriatric-oncology-conference/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/testosterone-recovery-after-androgen-deprivation-therapy-linked-to-improved-survival-in-high-risk-prostate-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/ageism-and-its-role-in-the-treatment-of-cancer/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/top-picks-from-sabcs-2024/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/in-case-you-missed-it-additional-studies-of-interest-from-ash-2024/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/palbociclib-plus-endocrine-therapy-vs-capecitabine-in-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2025-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/breast-cancer-mortality-rates-may-have-stopped-declining/</loc><lastmod>2025-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/greater-plant-based-oil-lower-butter-intake-could-improve-risk-of-cancer-related-mortality/</loc><lastmod>2025-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/acs-awards-dr-w-kimryn-rathmell-the-2025-medal-of-honor/</loc><lastmod>2025-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/clonal-and-subclonal-pathogenic-alterations-at-diagnosis-in-high-risk-neuroblastoma/</loc><lastmod>2025-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/chemoimmunotherapy-approach-for-advanced-hpv-negative-head-and-neck-cancer/</loc><lastmod>2025-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/health-related-qol-with-belzutifan-vs-everolimus-in-advanced-renal-cell-carcinoma/</loc><lastmod>2025-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/neoadjuvant-nivolumab-plus-chemotherapy-and-response-stratified-crt-in-hpv-negative-head-and-neck-cancer/</loc><lastmod>2025-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/virtual-reality-therapy-may-improve-chemotherapy-associated-side-effects/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/tobacco-control-may-have-prevented-millions-of-premature-lung-cancer-deaths-in-united-states/</loc><lastmod>2025-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/parker-institute-for-cancer-immunotherapy-names-new-ceo/</loc><lastmod>2025-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/adjuvant-chemoradiotherapy-vs-radiotherapy-alone-in-intermediate-risk-cervical-cancer/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/interventions-to-improve-uptake-of-fit-colorectal-cancer-screening-in-scotland/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/age-et-persistence-and-disease-free-survival-in-hr-positive-early-breast-cancer/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/early-stage-nsclc-geographic-access-to-cancer-care-and-outcomes/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/prevalence-of-genetic-testing-in-women-with-ovarian-cancer/</loc><lastmod>2025-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/novel-limonene-lipid-formulation-may-help-alleviate-xerostomia-in-patients-with-cancer/</loc><lastmod>2025-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/hypofractionated-radiotherapy-in-prostate-cancer/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/are-new-onset-type-2-diabetes-and-obesity-related-cancers-linked/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/fda-approves-cabozantinib-for-pnet-and-epnet/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/delays-in-breast-cancer-surgery-could-raise-mortality-risk-for-certain-subtypes/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/lifetime-body-weight-patterns-could-affect-risk-of-developing-renal-cell-carcinoma/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/enfortumab-vedotin-based-approaches-to-metastatic-urothelial-carcinoma/</loc><lastmod>2025-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/novel-strategy-could-help-recover-erectile-function-following-prostate-cancer-surgery/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/can-a-urine-test-minimize-postoperative-scans-for-rcc-recurrence/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/tb-vaccination-could-enhance-bcg-response-in-patients-with-non-muscle-invasive-bladder-cancer-study-finds/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/microultrasound-vs-mri-guided-biopsy-for-prostate-cancer-diagnosis/</loc><lastmod>2025-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/her2-selective-tki-in-advanced-solid-tumors-with-her2-alterations/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/sex-differences-in-waist-circumference-vs-bmi-as-risk-factors-for-obesity-related-cancers/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/breakthrough-combination-therapy-could-help-avoid-drug-resistance-in-patients-with-kras-mutated-nsclc/</loc><lastmod>2025-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/cervical-precancer-incidence-decreases-as-hpv-vaccination-rates-rise/</loc><lastmod>2025-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/genomic-study-reveals-similarities-differences-in-ovarian-cancer-mutations-among-black-white-patients/</loc><lastmod>2025-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/neoadjuvant-combination-immunotherapy-for-head-and-neck-cancer/</loc><lastmod>2025-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/race-associated-molecular-differences-and-treatment-response-in-pancreatic-cancer/</loc><lastmod>2025-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/exercise-intervention-may-improve-sexual-dysfunction-in-men-with-prostate-cancer/</loc><lastmod>2025-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/advanced-refractory-melanoma-addition-of-tilsotolimod-to-ipilimumab/</loc><lastmod>2025-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/can-adding-antihistamines-to-second-line-therapy-improve-outcomes-in-advanced-urothelial-carcinoma/</loc><lastmod>2025-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/colorectal-cancer-may-be-linked-to-heightened-risk-of-cardiovascular-mortality/</loc><lastmod>2025-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/high-levels-of-ptsd-may-exist-among-caregivers-of-adult-patients-with-cancer/</loc><lastmod>2025-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/impact-of-duration-of-neoadjuvant-immunotherapy-in-mmrd-colorectal-cancer/</loc><lastmod>2025-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/association-of-pathogenic-variants-in-atm-chek2-or-palb2-with-cancer-mortality/</loc><lastmod>2025-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/definitive-radiation-therapy-effectively-treats-locally-advanced-bcc/</loc><lastmod>2025-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/techniques-for-preventing-taxane-induced-neuropathy-in-breast-cancer/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/fda-approves-pembrolizumab-for-her2-positive-gastric-or-gej-cancer-expressing-pd-l1/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/advanced-pd-l1-positive-nsclc-ivonescimab-vs-pembrolizumab/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/ai-tool-may-help-to-predict-which-patients-with-prostate-cancer-may-benefit-from-focal-therapy/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/misconceptions-regarding-skin-cancer-risk-in-the-united-states/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/cervical-cancer-outcomes-according-to-urban-vs-rural-residence/</loc><lastmod>2025-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/high-risk-rhabdomyosarcoma-long-term-outcomes-with-maintenance-chemotherapy/</loc><lastmod>2025-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/receipt-of-guideline-concordant-care-in-patients-with-inflammatory-breast-cancer/</loc><lastmod>2025-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/the-real-cost-campaign-may-have-prevented-thousands-of-youths-from-initiating-e-cigarette-use/</loc><lastmod>2025-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/triple-negative-breast-cancer-neoadjuvant-nivolumab-initiation/</loc><lastmod>2025-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/checking-psa-levels-too-soon-after-prostatectomy-may-lead-to-overtreatment/</loc><lastmod>2025-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/atezolizumab-plus-carboplatin-paclitaxel-in-advanced-thymic-carcinoma/</loc><lastmod>2025-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/advances-in-endometrial-cancer-detection-treatment/</loc><lastmod>2025-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/bvac-c-plus-durvalumab-may-show-potential-in-patients-with-recurrent-cervical-cancer/</loc><lastmod>2025-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/mrd-and-adjuvant-osimertinib-in-resected-egfr-mutated-stage-ib-iiia-nsclc/</loc><lastmod>2025-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/do-congenital-heart-defects-affect-cancer-risk-in-newborns-and-their-mothers/</loc><lastmod>2025-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/radiotherapy-alone-following-radical-hysterectomy-for-cervical-cancer/</loc><lastmod>2025-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/addition-of-pembrolizumab-to-chemotherapy-for-previously-treated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2025-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/genomic-differences-and-treatment-inequities-in-black-and-white-patients-with-metastatic-breast-cancer/</loc><lastmod>2025-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/study-finds-wildfires-pose-health-threat-for-patients-recovering-from-lung-cancer-surgery/</loc><lastmod>2025-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/moderate-to-vigorous-physical-activity-may-lower-risk-of-cardiovascular-disease-related-mortality-in-women-with-cancer-history/</loc><lastmod>2025-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/firefighters-may-face-higher-risk-of-gliomas-associated-with-gene-mutations-caused-by-haloalkanes/</loc><lastmod>2025-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/pembrolizumab-and-bevacizumab-in-untreated-melanoma-brain-metastases/</loc><lastmod>2025-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/outcomes-after-complete-response-to-immunotherapy-in-patients-with-advanced-hepatocellular-carcinoma/</loc><lastmod>2025-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/genetic-factors-could-illuminate-which-patients-with-prostate-cancer-could-benefit-from-combination-of-ipatasertib-abiraterone/</loc><lastmod>2025-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/sglt2-inhibitors-could-help-protect-against-heart-failure-in-patients-with-cancer/</loc><lastmod>2025-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/addition-of-adt-to-sbrt-in-hormone-sensitive-oligorecurrent-prostate-cancer/</loc><lastmod>2025-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/liquid-biopsies-could-help-guide-colorectal-cancer-treatment/</loc><lastmod>2025-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/two-initiatives-could-help-increase-oncogene-testing-in-primary-care-settings/</loc><lastmod>2025-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/trastuzumab-rezetecan-in-advanced-her2-positive-nsclc/</loc><lastmod>2025-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/mrd-based-endpoint-to-support-accelerated-approval-of-treatment-for-multiple-myeloma/</loc><lastmod>2025-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/consumer-survey-reveals-common-misconceptions-about-hpv-and-hpv-related-cancer/</loc><lastmod>2025-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/novel-biomarkers-may-improve-diagnosis-of-gallbladder-cancer/</loc><lastmod>2025-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/combination-of-immunotherapies-for-advanced-hpv-associated-cancers/</loc><lastmod>2025-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/can-plasma-ctdna-kinetics-predict-response-to-systemic-therapy-in-advanced-nsclc/</loc><lastmod>2025-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/clinical-characteristics-of-breast-cancer-in-young-brca-carriers/</loc><lastmod>2025-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/prophylactic-strategy-for-preventing-infusion-related-reactions-with-iv-amivantamab-in-egfr-mutated-nsclc/</loc><lastmod>2025-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/tattoos-may-be-linked-to-increased-cancer-risk/</loc><lastmod>2025-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/postradiotherapy-survival-in-patients-with-glioblastoma-multiforme-and-low-grade-gliomas/</loc><lastmod>2025-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/mstfcrc-updates-recommendations-for-colonoscopy-preparation/</loc><lastmod>2025-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/overcoming-resistance-to-kras-g12c-inhibitors-in-pancreatic-and-colorectal-cancers/</loc><lastmod>2025-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/novel-nanoliposome-radiotherapeutic-may-enhance-survival-in-patients-with-glioblastoma/</loc><lastmod>2025-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/cancer-incidence-and-mortality-in-southeast-asia-for-2022/</loc><lastmod>2025-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/idecabtagene-vicleucel-vs-ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2025-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/chemotherapy-endocrine-therapy-may-have-different-long-term-physical-health-effects-in-breast-cancer-survivors/</loc><lastmod>2025-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/novel-prediction-score-may-estimate-risk-of-early-onset-colorectal-cancer-precancerous-polyps/</loc><lastmod>2025-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/03-march/francis-collins-retires-from-the-national-institutes-of-health/</loc><lastmod>2025-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/cancer-mortality-rates-continue-to-decline-incidence-rates-in-women-rise-and-racial-disparities-persist/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/felix-feng-md-leader-in-genitourinary-cancer-dies-at-age-48/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/former-unmc-cancer-center-director-kenneth-h-cowan-md-phd-dies-at-77/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/i-m-a-20-version-of-myself-after-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/bruton-tyrosine-kinase-inhibitor-naive-relapsed-or-refractory-mantle-cell-lymphoma/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/car-t-cell-therapy-for-relapsed-or-refractory-mantle-cell-lymphoma-zuma-2/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/how-telehealth-is-broadening-access-to-early-palliative-care-and-improving-outcomes-for-patients-with-advanced-lung-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/early-stage-classic-hodgkin-lymphoma/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/t-dxd-approved-by-the-fda-for-pretreated-patients-with-her2-low-or-ultralow-metastatic-breast-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/imlunestrant-alone-or-with-abemaciclib-an-all-oral-targeted-therapy-for-er-positive-advanced-breast-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/chatgpt-has-limitations-in-clinical-utility-for-colorectal-cancer-but-may-be-useful-for-patient-education/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/fda-approves-acalabrutinib-with-bendamustine-and-rituximab-for-previously-untreated-mantle-cell-lymphoma/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/exercise-therapy-as-candidate-anticancer-strategy/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/can-r-chop-like-therapy-effectively-treat-late-relapse-dlbcl/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/fda-approves-first-companion-diagnostic-to-identify-patients-with-metastatic-breast-cancer-eligible-for-t-dxd/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/bicistronic-car-t-cell-therapy-demonstrates-clinical-activity-in-relapsed-or-refractory-b-cell-all/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/novel-menin-inhibitors-show-safety-and-activity-in-several-clinical-trials/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/fda-approves-preparative-regimen-for-allogeneic-hsct-in-patients-with-aml-or-mds/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/boreas-trial-navtemadlin-demonstrates-clinical-benefit-in-jak-inhibitor-refractory-myelofibrosis/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/jennifer-a-woyach-named-the-ohio-state-s-director-of-hematology/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/asco-updates-guidelines-on-neoadjuvant-chemotherapy-in-advanced-ovarian-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/lung-map-30-simplifying-the-process-to-meet-patients-needs/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/new-blood-based-screening-test-accurately-detects-colorectal-cancer-risk-in-adults-aged-45-and-older/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/dual-immunotherapy-extended-progression-free-survival-in-metastatic-colorectal-cancer-subgroup/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/experimental-regimen-demonstrates-benefit-in-braf-v600e-mutant-metastatic-colorectal-ca/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/only-half-of-young-adults-with-cancer-are-told-of-fertility-preservation-options-by-their-providers/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/fda-approves-mirdametinib-for-nf1/</loc><lastmod>2025-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/anticancer-drug-pharmacokinetics-may-differ-by-sex/</loc><lastmod>2025-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/pain-may-influence-use-of-nonopioid-substances-among-cancer-survivors/</loc><lastmod>2025-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/survey-finds-more-than-half-of-oncologists-are-experiencing-professional-burnout/</loc><lastmod>2025-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/weight-change-and-heart-failure-risk-after-breast-cancer-diagnosis/</loc><lastmod>2025-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/mobile-prostate-cancer-screening-clinic-was-effective-in-detecting-prostate-cancer-in-underserved-men/</loc><lastmod>2025-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/triplet-regimen-demonstrates-benefit-in-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/talazoparib-plus-enzalutamide-significantly-improves-overall-survival-in-prostate-cancer-regardless-of-hrr-gene-status/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/ipilimumab-nivolumab-vs-nivolumab-alone-in-melanoma-brain-metastases/</loc><lastmod>2025-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/decoding-varying-risk-of-colorectal-cancer-among-different-steatotic-liver-disease-subgroups/</loc><lastmod>2025-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/combination-of-mcl-1-and-src-inhibitors-may-increase-cell-death-in-aml/</loc><lastmod>2025-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/text-message-platform-may-help-to-address-time-toxicity-in-patients-with-cancer/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/tumor-infiltrating-lymphocytes-and-survival-outcomes-in-early-her2-positive-breast-cancer/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/overall-survival-and-hrqol-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/astro-issues-its-first-clinical-guideline-on-radiation-therapy-for-anal-cancer/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/bacterial-leakage-across-gastric-lining-could-signify-cancer-risk/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/breast-conserving-surgery-may-improve-sexual-well-being-compared-with-postmastectomy-breast-reconstruction/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/brca1-gene-mutations-may-not-be-key-to-prostate-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/participation-in-early-trials-may-provide-some-patients-with-access-to-cancer-drugs-later-fda-approved/</loc><lastmod>2025-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/cabozantinibatezolizumab-in-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2025-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/cryotherapy-with-taxane-infusion-strategy-for-preventing-peripheral-neuropathy-in-breast-cancer/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/darolutamide-in-triple-negative-ar-positive-advanced-breast-cancer/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/effect-of-high-risk-cytogenetic-abnormalities-in-multiple-myeloma/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/asco-engages-in-judicial-and-legislative-advocacy-to-protect-nih-funding/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/activity-of-ipilimumab-nivolumab-in-melanoma-brain-metastases-after-progression-on-anti-pd-1-therapy/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/evaluation-of-surrogate-endpoints-for-overall-survival-in-neoadjuvant-randomized-trials-in-early-breast-cancer/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/physical-activity-may-help-colorectal-cancer-survivors-live-as-long-as-those-in-general-population/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/new-study-uncovers-low-uptake-of-supportive-care-at-end-of-life-in-patients-with-advanced-cancer/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/novel-antibody-toxin-conjugate-evaluated-in-early-study/</loc><lastmod>2025-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/novel-cd19-1xx-car-with-calibrated-signaling-in-lbcl/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/locally-advanced-gastric-cancer-adjuvant-or-perioperative-therapy-with-d2-resection/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/adding-tumor-deposit-status-to-cancer-staging-may-improve-prognostication-in-colorectal-cancer/</loc><lastmod>2025-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/genetic-testing-may-identify-high-risk-cytogenetic-abnormalities-in-patients-with-multiple-myeloma/</loc><lastmod>2025-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/the-death-of-alexei-navalny-and-the-discovery-of-cancer-chemotherapy/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/cancer-mortality-rates-among-black-patients-vs-other-racial-ethnic-groups/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/untreated-cll-acalabrutinib-combinations-vs-chemoimmunotherapy/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/safety-of-ceasing-combination-therapy-after-2-years-in-patients-with-renal-cell-carcinoma/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/racial-ethnic-disparities-in-same-day-care-may-exist-following-abnormal-mammograms/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/pembrolizumab-in-previously-treated-advanced-clear-cell-gynecological-cancers/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/combination-immunotherapy-plus-radiotherapy-in-muscle-invasive-bladder-cancer/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/chronic-lymphocytic-leukemiasmall-lymphocytic-lymphoma/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/car-t-cell-therapy-not-linked-to-secondary-cancers/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/salpingectomy-during-other-abdominal-surgeries-may-lower-ovarian-cancer-risk/</loc><lastmod>2025-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/cancer-symptoms-mistaken-for-pregnancy-symptoms-could-lead-to-delays-in-cancer-diagnosis/</loc><lastmod>2025-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/chemotherapy-linked-to-chronic-neuropathy-for-4-in-every-10-patients/</loc><lastmod>2025-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/who-st-jude-launch-new-global-platform-to-deliver-cancer-drugs-to-pediatric-patients-in-low-middle-income-countries/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/ariel4-rucaparib-vs-chemotherapy-for-relapsed-ovarian-cancer-with-deleterious-brca1-or-brca2-mutations/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/neoadjuvant-radiotherapy-may-hamper-immunotherapy-response-in-patients-with-breast-cancer/</loc><lastmod>2025-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/ai-may-boost-efficacy-of-cancer-care-but-physicians-remain-critical-to-decision-making/</loc><lastmod>2025-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/results-from-fire-4-show-liquid-biopsy-can-detect-ras-braf-mutated-metastatic-colorectal-cancer/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/discontinuation-and-resumption-of-larotrectinib-in-pediatric-patients-with-trk-fusion-sarcomas-and-related-mesenchymal-tumors/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/botensilimab-plus-balstilimab-in-relapsed-or-refractory-metastatic-sarcomas/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/potential-link-between-early-side-effects-from-radiation-therapy-and-long-term-side-effects-in-patients-with-prostate-cancer/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/thermal-ablation-vs-surgical-resection-of-small-resectable-colorectal-liver-metastases/</loc><lastmod>2025-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/trastuzumab-pertuzumab-plus-eribulin-or-taxane-in-locally-advanced-or-metastatic-breast-cancer/</loc><lastmod>2025-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/rising-advanced-prostate-cancer-rates-in-california-follow-changes-to-recommendations/</loc><lastmod>2025-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/predicting-response-to-kras-g12c-inhibitors-in-nsclc/</loc><lastmod>2025-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/adjuvant-chemotherapy-after-preoperative-mfolfirinox-and-resection-of-localized-pancreatic-adenocarcinoma/</loc><lastmod>2025-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/gastroenteropancreatic-neuroendocrine-tumor-incidence-in-the-united-states/</loc><lastmod>2025-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/novel-personalized-cancer-vaccine-may-be-effective-in-patients-with-stage-iii-and-iv-clear-cell-renal-cell-carcinoma/</loc><lastmod>2025-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/using-ai-to-identify-treatment-options-for-castleman-disease/</loc><lastmod>2025-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/trends-in-cancer-incidence-and-mortality-in-appalachia/</loc><lastmod>2025-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/pertuzumab-retreatment-in-her2-positive-locally-advancedmetastatic-breast-cancer/</loc><lastmod>2025-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/adjuvant-t-dm1-vs-trastuzumab-for-residual-her2-positive-breast-cancer-overall-survival-in-katherine/</loc><lastmod>2025-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/addition-of-bevacizumab-to-pembrolizumab-in-platinum-resistant-recurrent-or-metastatic-nasopharyngeal-carcinoma/</loc><lastmod>2025-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/mantle-cell-lymphoma-addition-of-venetoclax-to-ibrutinib/</loc><lastmod>2025-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/vimseltinib-approved-by-the-fda-for-symptomatic-tgct/</loc><lastmod>2025-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/triplet-for-untreated-tp53-mutated-mantle-cell-lymphoma/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/survival-outcomes-in-patients-with-erbb2-positive-metastatic-breast-cancer-with-cns-involvement/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/is-thyroid-cancer-overdiagnosed/</loc><lastmod>2025-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/new-study-identifies-potential-genes-implicated-in-treatment-resistant-melanoma/</loc><lastmod>2025-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/ctdna-and-immunoscore-in-resected-stage-iii-colon-cancer/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/colorectal-cancer-treatment-resistance-oncofetal-reprogramming/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/flagellin-and-immune-checkpoint-inhibition-in-patients-with-ovarian-cancer/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/effectiveness-of-immune-checkpoint-inhibitors-in-hospitalized-patients-with-cancer/</loc><lastmod>2025-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/comprehensive-ct-scans-may-help-to-identify-atherosclerosis-among-patients-with-lung-cancer/</loc><lastmod>2025-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/merkel-cell-carcinoma-nivolumab-with-or-without-ipilimumab-in-recurrent-or-metastatic-disease/</loc><lastmod>2025-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/final-overall-survival-results-from-talapro-2-in-unselected-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/baseline-liquid-biopsy-vs-tissue-based-findings-in-metastatic-colorectal-cancer/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/association-of-acute-and-late-toxicity-in-radiotherapy-for-prostate-cancer/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/annual-vs-less-frequent-mammographic-surveillance-in-breast-cancer-patients-aged-50-years-or-older/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/novel-blood-test-may-help-to-identify-pancreatic-ductal-adenocarcinoma-at-an-earlier-stage/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/potential-benefit-of-consuming-yogurt-in-decreasing-the-risk-of-certain-types-of-colorectal-cancers/</loc><lastmod>2025-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/short-vs-standard-course-radiation-therapy-for-endometrial-cancer/</loc><lastmod>2025-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/does-epstein-barr-virus-increase-cancer-risk-among-kidney-transplant-recipients/</loc><lastmod>2025-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/fda-approves-brentuximab-vedotin-with-lenalidomide-and-rituximab-for-relapsed-or-refractory-lbcl/</loc><lastmod>2025-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/mobocertinib-vs-platinum-based-chemotherapy-in-first-line-treatment-of-egfr-exon-20-insertion-positive-metastatic-nsclc/</loc><lastmod>2025-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/intratumoral-injection-of-mrna-2752-and-pembrolizumab-in-high-risk-dcis/</loc><lastmod>2025-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/02-february/enrgy-trial-zenocutuzumab-for-nrg1-gene-fusion-positive-solid-tumors/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/aall1731-trial-adding-blinatumomab-to-standard-chemotherapy-improves-outcomes-in-pediatric-b-cell-all/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/aquila-trial-daratumumab-proves-beneficial-in-smoldering-multiple-myeloma/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/medicare-physician-reimbursement-cut-finalized-for-2025/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/getting-a-lung-cancer-diagnosis-was-shocking/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/some-patients-with-low-risk-ductal-carcinoma-in-situ-may-be-able-to-avoid-surgery/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/adjuvant-tamoxifen-reduces-15-year-risk-of-recurrence-in-good-risk-dcis-without-radiation-therapy/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/my-cancer-diagnosis-and-renewed-commitment-to-fight-for-patients/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/age-is-just-a-number-treatment-considerations-for-endometrial-cancer-in-older-women/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/managing-comorbidities-in-oncology-practical-strategies-for-optimized-patient-care/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/olympia-trial-long-term-benefits-of-olaparib-confirmed-in-high-risk-subgroup-of-breast-cancer/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/addition-of-palbociclib-to-standard-therapy-in-metastatic-hormone-receptor-positive-her2-positive-breast-cancer/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/risk-reducing-surgeries-improve-survival-for-younger-patients-with-breast-cancer-who-are-brca-carriers-study-finds/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/studies-point-to-the-role-of-diet-in-hematologic-malignancies/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/balancing-pain-management-and-addiction-risks-in-oncology/</loc><lastmod>2025-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fda-approves-nivolumab-and-hyaluronidase-nvhy-for-subcutaneous-injection/</loc><lastmod>2025-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/ai-may-improve-ovarian-cancer-diagnoses/</loc><lastmod>2025-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/nuclear-speckle-signatures-in-clear-cell-rcc/</loc><lastmod>2025-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/npm1-genotypes-and-outcomes-in-aml/</loc><lastmod>2025-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/maintenance-therapy-after-induction-with-rvd-with-or-without-isatuximab-in-transplant-eligible-newly-diagnosed-multiple-myeloma/</loc><lastmod>2025-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/tool-for-prognosis-in-hormone-receptor-positive-her2-negative-node-positive-breast-cancer/</loc><lastmod>2025-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/addition-of-nab-paclitaxel-to-gemcitabine-cisplatin-in-advanced-biliary-tract-cancers/</loc><lastmod>2025-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/novel-topical-combination-may-prevent-squamous-cell-carcinoma/</loc><lastmod>2025-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/new-research-approaches-to-metastatic-breast-cancer/</loc><lastmod>2025-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/surgeon-general-s-report-calls-for-cancer-warning-labels-on-alcoholic-beverages/</loc><lastmod>2025-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/trends-in-early-onset-colorectal-cancer/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/advanced-imaging-may-uncover-hidden-metastases-in-high-risk-prostate-cancer-cases/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/psilocybin-based-therapy-may-address-mental-health-issues-in-patients-with-cancer-addiction/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/relativity-047-extended-analysis-of-overall-survival-with-nivolumab-relatlimab-vs-nivolumab-in-previously-untreated-advanced-melanoma/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/hrqol-with-endocrine-therapy-vs-radiotherapy-after-breast-conserving-surgery-in-older-women-with-luminal-a-like-early-breast-cancer/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/glucarpidase-may-improve-recovery-following-methotrexate-induced-kidney-toxicity/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/role-of-cancer-gene-in-esophageal-adenocarcinoma-may-support-paradigm-shift-in-predicting-disease/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/risk-adapted-active-surveillance-after-neoadjuvant-chemotherapy-for-muscle-invasive-bladder-cancer/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/effect-on-ki67-index-of-high-omega-3-low-omega-6-diet-with-fish-oil-in-prostate-cancer-during-active-surveillance/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/oncology-society-urges-americans-to-heed-surgeon-general-s-advisory-on-alcohol-and-cancer/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/nivolumab-plus-avd-as-front-line-therapy-in-older-adults-with-classical-hodgkin-lymphoma/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/final-overall-survival-results-from-solo3-trial-olaparib-vs-nonplatinum-chemotherapy-in-platinum-sensitive-brca-mutated-relapsed-ovarian-cancer/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/study-identifies-potential-new-target-to-overcome-breast-cancer-resistance/</loc><lastmod>2025-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/benefit-of-regular-physical-activity-prior-to-cancer-diagnosis/</loc><lastmod>2025-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/belinda-avalos-begins-term-as-2025-ash-president/</loc><lastmod>2025-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/uiccs-new-world-cancer-day-campaign-calls-for-fundamental-shift-in-cancer-care-delivery/</loc><lastmod>2025-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fda-highlights-importance-of-dpd-deficiency-discussions-with-patients-prior-to-capecitabine-or-fluorouracil-treatment/</loc><lastmod>2025-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/pilot-study-of-letetresgene-autoleucel-in-myxoid-round-cell-liposarcoma/</loc><lastmod>2025-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/perioperative-chemotherapy-vs-preoperative-chemoradiotherapy-in-resectable-locally-advanced-esophageal-carcinoma/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/long-term-follow-up-of-nrg258-trial-adjuvant-chemoradiation-vs-chemotherapy-in-locally-advanced-endometrial-carcinoma/</loc><lastmod>2025-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/oracle-test-may-predict-survival-in-early-stages-of-lung-cancer/</loc><lastmod>2025-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/novel-ai-platform-may-help-identify-patients-likely-to-benefit-most-from-clinical-trials/</loc><lastmod>2025-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/former-unmc-cancer-center-director-kenneth-h-cowan-md-phd-dies-at-77/</loc><lastmod>2025-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/datopotamab-deruxtecan-in-advanced-or-metastatic-nsclc-with-actionable-genomic-alterations/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/medicare-advantage-vs-traditional-medicare-cost-differences-in-cancer-drugs/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/nccn-joins-international-meeting-to-improve-cancer-care-in-the-middle-east-north-africa-region/</loc><lastmod>2025-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/investigators-have-uncovered-global-trends-in-risk-factors-linked-to-lung-cancer-mortality/</loc><lastmod>2025-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/therapeutic-de-escalation-in-breast-cancer-can-omitting-axillary-surgery-match-survival-while-improving-patient-outcomes/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/ai-may-enhance-cervical-cancer-detection/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/effects-of-obesity-on-survival-outcomes-following-cancer-diagnosis-in-pediatric-patients/</loc><lastmod>2025-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/potential-of-rad51-testing-in-tailoring-treatment-strategies-in-early-breast-cancer/</loc><lastmod>2025-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/addition-of-brentuximab-vedotin-to-lenalidomide-rituximab-in-relapsed-or-refractory-dlbcl/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/study-finds-travel-distance-to-lung-cancer-screening-facilities-differs-by-race-and-ethnicity/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fda-grants-orphan-drug-designation-to-new-agent-for-pancreatic-neuroendocrine-tumors/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/even-low-levels-of-ctdna-may-be-linked-to-recurrence-risk-in-early-lung-cancer-study-finds/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/novel-antibody-drug-conjugate-in-advanced-gastricgastroesophageal-junction-cancer/</loc><lastmod>2025-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/transplant-free-treatment-approach-in-relapsed-classical-hodgkin-lymphoma-in-children-and-adolescents-and-young-adults/</loc><lastmod>2025-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/ecog-acrin-breast-cancer-screening-trial-compares-standard-vs-three-dimensional-mammography/</loc><lastmod>2025-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/pfas-contamination-in-drinking-water-may-be-linked-to-several-rare-cancers/</loc><lastmod>2025-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fda-proposes-significant-step-to-reduce-nicotine-levels-in-cigarettes-tobacco-products/</loc><lastmod>2025-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/dr-monica-bertagnolli-steps-down-as-nih-director/</loc><lastmod>2025-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/belzutifan-plus-cabozantinib-as-first-line-treatment-in-advanced-clear-cell-renal-cell-carcinoma/</loc><lastmod>2025-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/use-of-denileukin-diftitox-cxdl-in-relapsed-or-refractory-ctcl/</loc><lastmod>2025-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/novel-tool-for-predicting-response-to-immunotherapy-in-melanoma-under-study/</loc><lastmod>2025-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/new-study-identifies-genes-that-could-be-implicated-in-glioblastoma-in-adulthood/</loc><lastmod>2025-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/improvements-in-brca2-testing-could-enhance-cancer-risk-assessment-patient-care/</loc><lastmod>2025-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/mobility-patterns-and-survival-disparities-in-patients-with-cancer/</loc><lastmod>2025-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/adjuvant-dose-dense-vs-conventional-chemotherapy-in-node-positive-breast-cancer/</loc><lastmod>2025-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/primary-lung-tumor-sbrt-followed-by-mediastinal-chemoradiotherapy-in-locally-advanced-nsclc/</loc><lastmod>2025-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/adjuvant-t-dm1-in-patients-with-her2-positive-breast-cancer-long-term-results-of-the-katherine-trial/</loc><lastmod>2025-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/mri-and-biopsy-may-reduce-treatment-delays-for-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2025-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/extent-and-impact-of-primary-mmrd-in-gliomas-among-children-adolescents-and-young-adults/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/trastuzumabpertuzumab-vs-cetuximabirinotecan-in-rasbraf-wild-type-her2-positive-metastatic-colorectal-cancer/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/acs-annual-report-cancer-mortality-rates-decline-but-challenges-remain/</loc><lastmod>2025-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/risks-of-preterm-birth-low-birth-weight-birth-defects-among-children-born-to-young-men-with-cancer/</loc><lastmod>2025-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/aacr-expresses-sincere-appreciation-after-nih-director-monica-m-bertagnolli-md-steps-down/</loc><lastmod>2025-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fda-approves-sotorasib-with-panitumumab-for-kras-g12c-mutated-colorectal-cancer/</loc><lastmod>2025-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fulvestrant-vs-anastrozole-in-endocrine-therapy-naive-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2025-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fda-approves-datopotamab-deruxtecan-dlnk-for-advanced-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2024-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/asco-thanks-drs-bertagnolli-rathmell-for-their-service-leading-nih-nci/</loc><lastmod>2025-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/new-study-identifies-potential-dose-dependent-relationship-among-alcohol-consumption-hbv-associated-cirrhosis-hepatocellular-carcinoma/</loc><lastmod>2025-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/does-a-new-blood-based-screening-test-accurately-detect-colorectal-cancer-risk/</loc><lastmod>2025-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/everolimuslanreotide-vs-everolimus-in-gastroenteropancreatic-neuroendocrine-tumors/</loc><lastmod>2025-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/telephone-based-therapy-may-reduce-fatigue-interference-with-functioning-in-metastatic-breast-cancer-survivors/</loc><lastmod>2025-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/genomic-classifier-tests-may-influence-treatment-decisions-in-prostate-cancer-despite-lack-of-evidence-for-long-term-outcomes/</loc><lastmod>2025-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/muscular-strength-cardiorespiratory-fitness-may-be-linked-to-lower-risk-of-mortality-in-patients-with-cancer/</loc><lastmod>2025-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/new-study-highlights-financial-burden-of-medical-equipment-on-cancer-survivors/</loc><lastmod>2025-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/addition-of-lenvatinibpembrolizumab-to-tace-in-unresectable-nonmetastatic-hcc/</loc><lastmod>2025-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/advanced-nsclc-with-brain-metastases-potential-novel-therapeutic-option/</loc><lastmod>2025-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/addition-of-cyclophosphamide-to-posttransplantation-gvhd-prophylaxis/</loc><lastmod>2025-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/eular-balancing-treatment-risks-for-inflammatory-arthritis-and-cancer/</loc><lastmod>2025-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/new-research-explores-blood-test-to-determine-prognosis-benefit-of-celecoxib-in-stage-iii-colon-cancer/</loc><lastmod>2025-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/new-findings-on-aspirin-and-risk-of-colorectal-cancer-recurrence/</loc><lastmod>2025-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/melanoma-among-adult-survivors-of-childhood-cancer/</loc><lastmod>2024-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/novel-combination-targeted-therapies-chemotherapy-in-braf-mutated-metastatic-colorectal-cancer/</loc><lastmod>2025-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/anatomic-lung-resection-may-be-linked-to-improved-survival-in-early-stage-nsclc/</loc><lastmod>2025-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/pinpointing-contributing-factors-in-response-to-posttransplant-donor-lymphocyte-infusion-in-patients-with-aml/</loc><lastmod>2025-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/clearance-of-driver-mutations-after-allogeneic-hematopoietic-stem-cell-transplantation-for-myelofibrosis/</loc><lastmod>2025-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/talquetamab-plus-teclistamab-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2025-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/effect-of-kras-mutation-status-on-treatment-outcomes-in-metastatic-pancreatic-adenocarcinoma/</loc><lastmod>2025-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/study-finds-therapeutic-vaccine-targeting-hpv16-is-safe-and-effective-in-eradicating-precancerous-cervical-lesions/</loc><lastmod>2025-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/addition-of-cetuximab-to-postoperative-radiotherapy-in-intermediate-risk-head-and-neck-cancer/</loc><lastmod>2025-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/neoadjuvant-nivolumab-ipilimumab-vs-chemotherapy-in-resectable-nsclc/</loc><lastmod>2025-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/young-patients-with-cancer-living-in-historic-redlined-neighborhoods-are-dying-at-higher-rates-than-those-in-nonredlined-areas/</loc><lastmod>2025-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/fecal-microbiota-transplantation-following-asct/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/talimogene-laherparepvec-may-effectively-reduce-basal-cell-carcinoma-size-prior-to-surgical-resection/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/expediting-cancer-diagnoses-with-acoustofluidics/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/tiragolumab-plus-atezolizumab-bevacizumab-in-unresectable-locally-advanced-or-metastatic-hepatocellular-carcinoma/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/checkmate-7fl-neoadjuvant-immunochemotherapy-in-er-positive-her2-negative-breast-cancer/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/tace-and-durvalumabbevacizumab-in-unresectable-hcc/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/does-brain-mri-surveillance-benefit-asymptomatic-patients-with-stage-iv-breast-cancer/</loc><lastmod>2025-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2025/01-january/hereditary-ovarian-cancer-risk-unlocking-new-insights/</loc><lastmod>2025-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/adriatic-trial-durvalumab-consolidation-extends-survival-in-limited-stage-small-cell-lung-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/peace-3-enzalutamide-plus-radium-223-significantly-improves-survival-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/trial-updates-in-stage-iii-melanoma-solidify-the-neoadjuvant-use-of-immunotherapy-as-the-current-standard-of-care/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/keynote-811-pembrolizumab-combination-in-first-line-setting-improves-overall-survival-in-gastric-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/highlights-from-the-esmo-congress-2024/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/i-spy22-dato-dxd-plus-durvalumab-yields-high-pathologic-response-rate-in-breast-cancer-subset/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/hypog-01-trial-reducing-the-treatment-time-for-breast-cancer-nodal-irradiation/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/overall-survival-analysis-confirms-pembrolizumab-regimen-as-standard-of-care-for-triple-negative-breast-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/t-dxd-of-benefit-in-patients-with-breast-cancer-and-brain-metastases/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/leap-012-combination-of-therapies-extends-progression-free-survival-in-intermediate-stage-hepatocellular-carcinoma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/himalaya-5-year-analysis-confirms-survival-benefit-of-stride-regimen-in-hepatocellular-carcinoma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/understanding-how-stigma-and-incorrect-physician-assumptions-about-lgbtq-patients-needs-contribute-to-medical-mistrust/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-cameroon/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/2024-sio-annual-international-conference-a-rich-program-of-cutting-edge-science-and-learning/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/roswell-park-announces-centers-first-physician-in-chief/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/nccn-joins-international-cancer-organizations-during-oncology-event-in-china/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/metformin-may-impact-immunotherapy-in-nsclc/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/the-lindy-effect-and-open-cancer-surgery/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/will-car-t-cell-therapy-be-the-magic-bullet-for-my-multiple-myeloma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/award-recipients-announced-for-the-2024-san-antonio-breast-cancer-symposium/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/in-treatment-of-transplant-ineligible-myeloma-addition-of-isatuximab-improves-outcomes/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/adding-chemoradiation-in-perioperative-gastric-cancer-treatment-improves-pathologic-response-rates-without-survival-benefit/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/understanding-the-link-between-obesity-and-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/study-evaluating-lung-cancer-screening-program-receives-margulis-award-for-scientific-excellence/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/ai-and-the-future-of-lung-cancer-screening-still-room-for-improvement/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/study-highlights-from-md-anderson-researchers/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/novel-combination-studied-in-hpv16-positive-relapsed-or-metastatic-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/temozolomide-plus-radiotherapy-for-low-grade-gliomas/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/daratumumab-induction-regimen-in-transplant-ineligible-patients-newly-diagnosed-with-multiple-myeloma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/could-sars-cov-2-be-an-oncogenic-agent-and-cancer-initiator/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/the-future-of-cancer-care-part-2/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/pediatric-cancer-clinical-trial-research-should-include-social-determinants-of-health/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/deciphering-the-impact-of-the-2024-election-on-cancer-care/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/cetuximab-vs-durvalumab-in-treatment-of-head-and-neck-cancers/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/oral-liquid-imatinib-approved-by-the-fda-in-leukemia/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/accelerated-approval-granted-to-zanidatamab-hrii-for-her2-positive-biliary-tract-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/ash-announces-recipients-of-2024-ash-advocacy-awards/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/updated-findings-in-preventive-breast-cancer-vaccine-study/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/imf-welcomes-newly-elected-board-of-directors-members/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/understanding-the-assessment-and-treatment-of-high-risk-myelofibrosis/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/nodal-burden-and-recurrence-in-patients-with-breast-cancer-with-residual-isolated-tumor-cells-after-neoadjuvant-chemotherapy/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/novel-egfr-inhibitor-firmonertinib-shows-activity-in-rare-subtype-of-nsclc/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/addition-of-hyperthermic-intraperitoneal-chemotherapy-to-surgery-for-recurrent-ovarian-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/impact-of-ash-minority-recruitment-initiative-on-retaining-engaging-underrepresented-hematologists/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/perioperative-toripalimab-in-locoregionally-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/pooled-analysis-of-long-term-outcomes-with-nivolumab-with-or-without-ipilimumab-in-advanced-melanoma/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/outcomes-of-immune-checkpoint-inhibitor-treatment-for-cancer-in-black-vs-white-patients-in-the-us-vha-system/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/overall-survival-not-improved-with-maintenance-niraparib-in-advanced-ovarian-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/genitourinary-cancer-expert-yuksel-urun-md-shares-his-career-journey-and-the-importance-of-achieving-a-worklife-balance/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/is-there-a-role-for-neoadjuvant-chemotherapy-in-hr-positive-her2-negative-early-breast-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/4-year-asian-subpopulation-data-from-the-checkmate-816-trial-of-neoadjuvant-nivolumab-plus-chemotherapy-in-resectable-nsclc/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/increase-in-young-onset-pancreatic-cancer-may-be-due-to-overdiagnosis-of-early-stage-endocrine-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/neoadjuvant-chemoradiation-followed-by-immunochemotherapy-and-surgery-may-improve-outcomes-in-esophageal-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/addition-of-inavolisib-to-palbociclib-fulvestrant-in-pik3ca-mutated-advanced-breast-cancer/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/fda-approves-novel-companion-diagnostic-assay/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/rwanda-s-progress-in-eradicating-hepatitis-c-virus-a-feasible-approach-to-reducing-liver-cancer-incidence-in-sub-saharan-africa/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/prophylactic-surgical-menopause-for-women-with-familial-risk-of-ovarian-cancer-impact-on-coronary-artery-calcium-development/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/prior-authorization-delays-may-lead-to-severe-consequences-for-patients-with-cancer/</loc><lastmod>2024-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/potential-cancer-vaccine-target-uncovered-in-e-coli-bacteria/</loc><lastmod>2024-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/fda-grants-approval-to-new-bispecific-antibody-for-nsclc-and-pancreatic-adenocarcinoma/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/de-escalated-neoadjuvant-combination-therapy-for-her2-positive-early-breast-cancer/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/alkylating-agent-based-treatment-in-neuroendocrine-tumors-according-to-mgmt-status/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/fda-approves-durvalumab-for-limited-stage-small-cell-lung-cancer/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/radiotherapy-with-durvalumab-or-cetuximab-in-locoregionally-advanced-head-and-neck-cancer-with-contraindication-for-cisplatin/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/study-may-illuminate-cause-of-common-checkpoint-inhibitor-adverse-effect/</loc><lastmod>2024-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/pharmacokinetic-comparison-of-aumolertinib-osimertinib-gefitinib-and-their-major-metabolites-in-nsclc/</loc><lastmod>2024-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/mrd-guided-chemotherapy-intensification-after-induction-in-fit-older-patients-with-aml/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/evidence-based-recommendations-and-knowledge-gaps-regarding-cardio-oncology/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/ramucirumab-paclitaxel-as-switch-maintenance-in-advanced-her2-negative-gastric-gastroesophageal-junction-cancer/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/lung-cancer-ct-screening-may-help-to-detect-coronary-artery-disease/</loc><lastmod>2024-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/poor-diets-may-increase-risk-of-gastrointestinal-cancer/</loc><lastmod>2024-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/obecabtagene-autoleucel-in-adults-with-b-cell-all/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/lenvatinib-pembrolizumab-vs-chemotherapy-in-advanced-endometrial-cancer/</loc><lastmod>2024-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/toripalimab-plus-chemotherapy-in-first-line-therapy-for-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2024-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/challenges-and-potential-of-mesenchymal-stem-cells-in-cancer-immunotherapy/</loc><lastmod>2024-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/regional-racial-economic-disparities-in-air-pollution-related-cancer-risk-may-be-improving-but-still-persist/</loc><lastmod>2024-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/impact-of-menopausal-status-on-long-term-benefit-from-antihormonal-treatment-in-women-with-breast-cancer/</loc><lastmod>2024-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/preclinical-findings-show-ketogenic-diet-enhances-car-t-cell-function-improves-tumor-control/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/lower-socioeconomic-status-impacts-aml-patients-ability-to-receive-hematopoietic-cell-transplantation/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/study-finds-daratumumab-monotherapy-prevented-or-delayed-progression-from-smoldering-to-active-multiple-myeloma/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/rilzabrutinib-found-safe-and-effective-for-refractory-immune-thrombocytopenia/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/loncastuximab-tesirine-may-improve-outcomes-in-high-risk-follicular-lymphoma-marginal-zone-lymphoma/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/common-bacterial-toxin-may-speed-up-colorectal-cancer-metastasis/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/imlunestrant-alone-and-combined-with-abemaciclib-effective-in-esr1-mutated-breast-cancer/</loc><lastmod>2024-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/high-fiber-diet-may-slow-disease-progression-to-multiple-myeloma/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/combination-of-two-oral-agents-may-improve-progression-free-survival-in-patients-with-previously-untreated-cll/</loc><lastmod>2024-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/pirtobrutinib-may-improve-survival-outcomes-in-pretreated-patients-with-cll-or-sll/</loc><lastmod>2024-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/fiber-rich-diet-may-help-prevent-complications-after-stem-cell-transplant/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/brca-mutation-carriers-with-prior-diagnosis-of-early-onset-breast-cancer-may-benefit-from-risk-reducing-surgery/</loc><lastmod>2024-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/nivolumabipilimumab-vs-chemotherapy-with-or-without-targeted-agents-in-msi-h-or-dmmr-metastatic-colorectal-cancer/</loc><lastmod>2024-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/bicistronic-car-t-cell-therapy-achieved-durable-remissions-in-children-with-relapsed-refractory-b-cell-all/</loc><lastmod>2024-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/active-monitoring-may-be-a-viable-option-for-some-patients-with-low-risk-dcis/</loc><lastmod>2024-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/quality-of-life-similar-among-patients-with-low-risk-dcis-whether-they-received-active-monitoring-or-surgery/</loc><lastmod>2024-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/blinatumomab-in-combination-with-chemotherapy-may-improve-survival-in-pediatric-patients-newly-diagnosed-with-b-cell-precursor-all/</loc><lastmod>2024-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/autologous-stem-cell-transplantation-may-not-improve-survival-in-patients-with-mcl-undetectable-measurable-residual-disease/</loc><lastmod>2024-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/intermittent-or-continuous-panitumumab-plus-folfiri-in-first-line-treatment-of-ras-and-braf-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/most-patients-with-intermediate-risk-breast-cancer-may-safely-avoid-chest-wall-irradiation-after-mastectomy/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/adjuvant-tamoxifen-may-reduce-recurrence-risk-for-patients-with-good-risk-dcis-who-forgo-radiation/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/trastuzumab-deruxtecan-vs-chemotherapy-in-advanced-breast-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/geriatric-surgery-verification-program-may-improve-outcomes-in-older-patients-with-cancer-in-community-hospitals/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/novel-oncolytic-immunotherapy-yields-durable-responses-in-high-risk-bladder-cancer/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/cancer-risk-associated-with-use-of-disease-modifying-antirheumatic-drugs/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/self-pay-ai-based-program-may-help-boost-mammogram-findings/</loc><lastmod>2024-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/novel-immunotherapy-may-offer-benefit-in-early-clinical-trial-for-breast-cancer/</loc><lastmod>2024-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/impact-of-prevention-and-screening-on-mortality-from-five-common-cancers/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/negative-colonoscopy-screening-results-and-risk-for-colorectal-cancer-and-mortality/</loc><lastmod>2024-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/cosibelimab-ipdl-approved-by-fda-for-treatment-of-metastatic-or-locally-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2024-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/learning-from-the-zest-trial-in-using-ctdna-to-predict-breast-cancer-recurrence/</loc><lastmod>2024-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/low-omega-6-high-omega-3-diet-and-fish-oil-supplementation-may-help-slow-prostate-cancer-growth/</loc><lastmod>2024-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/improving-hepatocellular-carcinoma-outcomes-through-enhanced-immunotherapy/</loc><lastmod>2024-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/effectiveness-of-multimodal-machine-learning-model-in-predicting-response-to-treatment-in-breast-cancer-subtype/</loc><lastmod>2024-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/anthracyclines-plus-taxane-based-chemotherapy-for-certain-patients-at-high-risk-for-breast-cancer-recurrence/</loc><lastmod>2024-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/generic-platinum-chemotherapy-shortages-may-not-have-increased-mortality/</loc><lastmod>2024-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/cbd-may-not-reduce-scan-related-anxiety-in-patients-with-advanced-breast-cancer/</loc><lastmod>2024-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/primary-lung-tumor-sbrt-followed-by-concurrent-mediastinal-chemoradiotherapy-and-immunotherapy-consolidation-in-locally-advanced-nsclc/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/mixed-formulation-fosrolapitant-and-palonosetron-in-preventing-cisplatin-based-highly-emetogenic-chemotherapy-induced-nausea-and-vomiting/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/larotrectinib-in-newly-diagnosed-infantile-fibrosarcoma-and-other-pediatric-ntrk-fusion-positive-solid-tumors/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/uicc-iccp-landmark-review-of-national-cancer-strategies-illuminates-progress-persistent-challenges/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/researchers-may-have-uncovered-protein-that-helps-cancer-cells-dodge-car-t-cell-therapy/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/primary-analysis-of-zuma-2-treatment-of-btk-inhibitor-naive-relapsedrefractory-mantle-cell-lymphoma/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/car-t-cell-therapy-for-relapsedrefractory-mantle-cell-lymphoma-zuma-2/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/fda-approves-ensartinib-for-alk-positive-locally-advanced-or-metastatic-nsclc/</loc><lastmod>2024-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/alpelisib-plus-fulvestrant-in-pik3ca-mutated-hormone-receptor-positive-her2-negative-advanced-breast-cancer-after-previous-therapy/</loc><lastmod>2024-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/detection-of-occult-maternal-cancer-through-prenatal-cell-free-dna-sequencing/</loc><lastmod>2024-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/asco-elects-2026-2027-president-six-new-members-of-board-of-directors-nominating-committee/</loc><lastmod>2024-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/mesenchymal-cell-therapy-approved-for-steroid-refractory-acute-gvhd/</loc><lastmod>2024-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/influence-of-social-networks-among-older-patients-with-cancer/</loc><lastmod>2024-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/use-of-ibrutinib-in-early-stage-chronic-lymphocytic-leukemia/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/epcoritamab-monotherapy-for-pretreated-relapsed-or-refractory-cll/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/addition-of-sbrt-to-systemic-therapy-may-improve-outcomes-in-select-patients-with-locally-advanced-hepatocellular-carcinoma/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/mri-first-strategy-may-be-safe-for-prostate-cancer-detection/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/study-finds-genetic-changes-elevated-leukemia-risk-in-ground-zero-first-responders/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/long-term-overall-survival-with-adjuvant-gemcitabine-capecitabine-vs-gemcitabine-in-pancreatic-adenocarcinoma/</loc><lastmod>2024-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/ctx130-car-t-cell-therapy-for-relapsed-or-refractory-t-cell-lymphoma/</loc><lastmod>2024-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/sequoia-5-year-follow-up-zanubrutinib-vs-bendamustinerituximab-in-treatment-naive-cllsll/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/fda-grants-accelerated-approval-to-encorafenib-combination-for-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/primary-analysis-of-zuma-2-treatment-of-btk-inhibitor-naive-relapsed-refractory-mantle-cell-lymphoma/</loc><lastmod>2024-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/12-december/hipec-in-platinum-sensitive-recurrent-ovarian-cancer/</loc><lastmod>2024-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/high-burden-of-chronic-health-conditions-disability-and-cognitive-and-physical-limitations-reported-in-lgbtqplus-cancer-survivors/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/nccn-guidelines-expanded-to-meet-growing-understanding-of-hereditary-risk/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/shared-reflections-on-the-2024-asco-annual-meeting-from-networking-to-mentorship-and-more/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/cancer-has-plagued-my-family/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/trastuzumab-duocarmazine-in-previously-treated-her2-positive-metastatic-breast-cancer/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/novel-p53-mdm2-inhibitor-plus-ribociclib-demonstrates-anticancer-activity-in-liposarcoma-subset/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/katherine-van-loon-named-editor-in-chief-of-jco-global-oncology/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/information-blocking-proposal-helps-protect-reproductive-health-information-patient-preferences/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/carmen-lc03-tusamitamab-ravtansine-vs-docetaxel-in-previously-treated-advanced-nonsquamous-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/how-functional-and-genomic-precision-medicine-are-getting-closer-to-matching-each-patient-to-the-right-therapy/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/impact-of-food-insecurity-on-the-incidence-of-hepatocellular-carcinoma/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/determining-the-optimal-first-line-management-of-advanced-classical-hodgkin-lymphoma/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/medical-legal-partnerships-a-promising-innovation-in-oncology/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/participation-in-virtual-prehabilitation-and-outcomes-following-thoracic-cancer-surgery/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/tropion-lung01-update-dato-dxd-shows-activity-in-previously-treated-advanced-nonsquamous-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/i-spy22-dato-dxd-plus-durvalumab-yields-high-pathologic-response-rate-in-breast-cancer-subset/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/use-of-aumolertinib-extends-progression-free-survival-in-stage-iii-egfr-mutated-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/exploring-issues-in-oncofertility/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/in-case-you-missed-it-roundup-from-esmo-congress-2024/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/project-facilitate-5-years-of-progress-outreach-and-service/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/ash-to-present-2024-honorific-awards-at-annual-meeting/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/patient-level-data-support-perioperative-use-of-nivolumab-in-resectable-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/encouraging-pathologic-responses-achieved-with-novel-combination-regimen-in-early-stage-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/harmoni-2-ivonescimab-outperforms-pembrolizumab-as-first-line-treatment-in-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/amivantamab-vmjw-plus-lazertinib-improves-long-term-outcomes-in-first-line-setting-of-egfr-mutant-advanced-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/osimertinib-plus-savolitinib-responses-reported-in-first-line-treatment-of-met-aberrant-egfr-mutant-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/novel-egfr-inhibitor-firmonertinib-shows-activity-in-rare-subtype-of-nsclc/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/new-hope-for-patients-with-her2-mutant-nsclc-durable-responses-to-two-novel-targeted-therapies/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/carmen-lc03-tusamitamab-ravtansine-vs-docetaxel-in-previously-treated-advanced-nonsquamous-nsclc-1/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/tropion-lung01-update-dato-dxd-shows-activity-in-previously-treated-advanced-nonsquamous-nsclc-1/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/ifinatamab-deruxtecan-shows-activity-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/highlights-from-the-2024-world-conference-on-lung-cancer/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/breast-cancer-in-2024-looking-back-and-moving-forward/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/nci-grant-may-facilitate-development-of-breast-ct-screening-technology/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/neoadjuvant-therapy-yields-notable-outcomes-in-triple-negative-breast-cancer/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/from-gaps-to-bridges-cancer-care-rooted-in-equity-quality-and-value/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/a-diagnosis-of-lymphoma-has-changed-my-life/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/study-finds-cisplatin-shortage-led-to-treatment-alternatives-for-head-and-neck-cancer-significantly-increasing-cost/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/tarlatamab-dlle-for-previously-treated-extensive-stage-sclc/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/physician-wellness-and-professional-burnout/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/18-researchers-and-mentors-selected-for-asco-s-inaugural-international-clinical-research-scholars-program-in-latin-america/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/unexpected-results-in-solid-tumors-what-we-learned-from-negative-findings/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/evolving-role-of-mrd-status-in-multiple-myeloma/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/eyeing-the-future-of-oncology-highlights-from-the-presidential-symposium-at-esmo-congress-2024/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/when-cancer-and-cardiovascular-disease-intersect/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/durvalumab-plus-chemotherapy-improves-overall-survival-in-localized-muscle-invasive-bladder-cancer/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/how-end-of-life-dreams-and-visions-are-bringing-comfort-to-dying-patients/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/ensuring-an-inclusive-environment-for-female-minority-oncologists/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/tumor-treating-fields-therapy-receives-fda-approval-in-metastatic-nsclc/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/advancing-diversity-equity-and-inclusion-through-a-challenging-policy-landscape/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/fda-approves-novel-combination-regimen-for-gi-cancers/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/patient-level-data-support-perioperative-use-of-nivolumab-in-resectable-nsclc-1/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/hypog-01-trial-reducing-the-treatment-time-for-breast-cancer-nodal-irradiation/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/ashp-offers-new-guidance-for-managing-iv-fluid-shortages/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/adding-durvalumab-to-neoadjuvant-regimen-improves-pathologic-complete-response-rate-in-high-risk-breast-cancer/</loc><lastmod>2024-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/dkn-01-with-tislelizumab-and-chemotherapy-in-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/inotuzumab-ozogamicin-with-low-intensity-chemotherapy-in-older-patients-with-cd22-positive-philadelphia-chromosome-negative-b-cell-precursor-all/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/nccn-harmonized-guidelines-for-sub-saharan-africa-experts-convene-in-ghana-to-update-cancer-treatment-guidelines/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/quantifying-the-benefit-of-smoking-cessation-within-6-months-of-a-cancer-diagnosis/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/valemetostat-in-relapsed-or-refractory-peripheral-t-cell-lymphoma/</loc><lastmod>2024-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/prediction-of-fracture-risk-in-patients-with-cancer/</loc><lastmod>2024-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/novel-method-for-liquid-biopsies-may-streamline-cancer-detection/</loc><lastmod>2024-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/immunotherapy-combination-may-demonstrate-benefit-in-patients-with-cutaneous-melanoma/</loc><lastmod>2024-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/jennifer-bickel-md-named-md-anderson-vice-president-and-chief-wellness-officer/</loc><lastmod>2024-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/international-cancer-organizations-present-collaborative-work-during-oncology-event-in-china/</loc><lastmod>2024-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/suicide-related-mortality-in-male-aya-cancer-survivors/</loc><lastmod>2024-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/study-identifies-new-approach-to-overcome-docetaxel-resistance-in-patients-with-advanced-prostate-cancer/</loc><lastmod>2024-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/onvansertib-with-chemotherapy-and-bevacizumab-in-second-line-treatment-of-kras-mutant-metastatic-colorectal-cancer/</loc><lastmod>2024-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/addition-of-pembrolizumab-to-radiation-therapy-and-surgery-in-stage-iii-soft-tissue-sarcoma-of-the-extremity/</loc><lastmod>2024-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/cancer-specific-mortality-trends-among-us-asian-and-pacific-islander-populations/</loc><lastmod>2024-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/ai-tool-may-detect-cancer-gene-signatures-in-biopsy-images/</loc><lastmod>2024-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/new-technique-may-allow-for-visualization-of-car-t-cells-postinjection/</loc><lastmod>2024-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/performance-of-first-line-chemotherapy-regimens-in-unresectable-advanced-or-metastatic-pancreatic-cancer/</loc><lastmod>2024-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/nivolumab-plus-ipilimumab-in-aggressive-thyroid-carcinoma/</loc><lastmod>2024-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/fda-approves-novel-t-cell-immunotherapy-for-adults-with-relapsed-or-refractory-b-cell-precursor-acute-lymphoblastic-leukemia/</loc><lastmod>2024-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/new-insights-into-innate-resistance-for-immunotherapies-in-colorectal-cancer/</loc><lastmod>2024-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/breast-cancer-vaccine-could-be-preventive-well-tolerated-in-high-risk-patients/</loc><lastmod>2024-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/study-finds-in-situ-vaccination-using-tumor-treating-fields-plus-immune-checkpoint-inhibitors-extended-survival-in-patients-with-glioblastoma/</loc><lastmod>2024-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/study-finds-long-term-risks-associated-with-prostate-cancer-treatment-and-highlights-the-importance-of-counseling-prior-to-screening-and-treatment/</loc><lastmod>2024-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/effect-of-smoking-cessation-intervention-on-survival-after-a-cancer-diagnosis/</loc><lastmod>2024-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/pembrolizumab-plus-standard-chemotherapy-may-benefit-patients-with-rare-aggressive-cancers/</loc><lastmod>2024-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/valemetostat-in-relapsed-or-refractory-non-hodgkin-lymphoma/</loc><lastmod>2024-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/addition-of-adjuvant-epirubicin-to-docetaxel-cyclophosphamide-in-early-top2a-normal-breast-cancer/</loc><lastmod>2024-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/prostatectomy-with-or-without-postprostatectomy-radiotherapy-and-long-term-hrqol-in-localized-prostate-cancer/</loc><lastmod>2024-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/are-young-patients-with-cancer-discussing-fertility-preservation-with-physicians/</loc><lastmod>2024-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/treatment-advances-predictive-biomarkers-may-improve-urothelial-carcinoma-care/</loc><lastmod>2024-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/addition-of-veliparib-to-temozolomide-in-newly-diagnosed-mgmt-methylated-glioblastoma/</loc><lastmod>2024-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/enfortumab-vedotin-in-previously-treated-advanced-head-and-neck-cancer/</loc><lastmod>2024-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/novel-liquid-biopsies-and-cancer-detection/</loc><lastmod>2024-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/immunotherapy-combination-for-cutaneous-melanoma/</loc><lastmod>2024-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/trends-in-use-of-primary-cytoreductive-surgery-and-neoadjuvant-chemotherapy-in-advanced-stage-ovarian-cancer/</loc><lastmod>2024-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/case-study-shows-striking-improvements-in-patient-with-metastatic-prostate-cancer/</loc><lastmod>2024-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/grant-of-over-2-million-dollars-may-help-increase-lung-cancer-screenings-in-underserved-communities/</loc><lastmod>2024-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/risk-of-second-primary-cancers-after-breast-cancer-in-brca1-and-brca2-pathogenic-variant-carriers/</loc><lastmod>2024-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/resection-of-stage-i-to-iii-thymic-tumors-in-high-volume-us-centers/</loc><lastmod>2024-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/next-generation-oral-serd-in-postmenopausal-women-with-er-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/addition-of-atezolizumab-plus-bevacizumab-to-chemotherapy-in-advanced-biliary-tract-cancer/</loc><lastmod>2024-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/how-hypoxia-may-help-cancer-metastasize/</loc><lastmod>2024-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/researchers-may-have-uncovered-why-some-aml-cells-resist-treatment/</loc><lastmod>2024-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/risk-of-ischemic-cardiotoxicity-with-aromatase-inhibitors-in-postmenopausal-patients-with-early-breast-cancer/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/sitc-study-finds-io102-io103-vaccine-plus-pembrolizumab-active-in-patients-with-non-small-cell-lung-cancer/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/detecting-evidence-of-lung-cancer-in-exhaled-breath/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/study-explores-underpinnings-of-immunotherapy-releated-myocarditis-in-patients-with-cancer/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/tanning-bed-access-usage-may-be-driving-higher-rates-of-melanoma-in-new-england/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/nccn-guidelines-have-expanded-to-meet-growing-understanding-of-hereditary-risk/</loc><lastmod>2024-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/trastuzumab-duocarmazine-in-previously-treated-her2-positive-metastatic-breast-cancer-1/</loc><lastmod>2024-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/study-finds-long-term-risks-associated-with-prostate-cancer-treatment/</loc><lastmod>2024-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/healthy-women-may-have-aneuploid-epithelial-cells-resembling-breast-cancer/</loc><lastmod>2024-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/global-adaptive-platform-trial-for-glioblastoma-to-evaluate-novel-atm-kinase-inhibitor/</loc><lastmod>2024-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/penpulimab-combination-therapy-for-first-line-treatment-of-hepatocellular-carcinoma/</loc><lastmod>2024-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/firefighters-may-be-exposed-to-chemicals-associated-with-breast-cancer/</loc><lastmod>2024-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/neuro-oncology-guidelines-reveal-how-ai-could-improve-brain-cancer-diagnosis-monitoring-and-treatment/</loc><lastmod>2024-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/adding-temozolomide-to-radiation-therapy-may-improve-survival-in-adults-with-low-grade-gliomas/</loc><lastmod>2024-11-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/effect-of-myeloma-therapy-in-a-patient-with-monoclonal-gammopathy-of-thrombotic-significance/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/glofitamab-or-rituximab-plus-gemcitabineoxaliplatin-in-relapsedrefractory-dlbcl/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/mirdametinib-in-adults-and-children-with-symptomatic-neurofibromatosis-type-1-associated-plexiform-neurofibroma/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/prognostic-factors-in-limited-stage-sclc-treated-with-escalated-radiotherapy-doses/</loc><lastmod>2024-11-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/fda-approves-oral-liquid-imatinib-to-treat-patients-with-leukemia-and-other-cancer-types/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/peer-support-intervention-may-help-improve-psychological-outcomes-among-patients-with-cancer-in-low-resource-settings/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/at-home-testing-kits-coordinated-outreach-may-improve-colorectal-cancer-screening-rates/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/fda-grants-accelerated-approval-to-zanidatamab-hrii-for-previously-treated-unresectable-or-metastatic-her2-positive-biliary-tract-cancer/</loc><lastmod>2024-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/11-november/novel-hypofractionated-proton-beam-therapy-for-older-patients-with-newly-diagnosed-glioblastoma/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cancer-deaths-of-55-million-men-worldwide-have-led-to-141-million-new-paternal-orphans/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/aacr-cancer-progress-report-features-breakthroughs-in-cancer-science-and-persistent-inequities-in-care/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cabinet-trial-supports-multitargeted-tyrosine-kinase-inhibitor-for-advanced-neuroendocrine-tumors/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/acs-report-despite-overall-decreases-in-breast-cancer-mortality-incidence-rising-in-key-groups/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/no-cut-trial-nonoperative-management-of-benefit-for-many-patients-with-rectal-cancer/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/fda-approves-perioperative-nivolumab-for-resectable-nsclc/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/raising-awareness-of-the-health-consequences-of-alcohol-consumption-during-and-after-a-cancer-diagnosis/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/shared-reflections-on-the-2024-asco-annual-meeting-from-networking-to-mentorship-and-more-part-2/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/meeting-the-long-term-challenge-of-achieving-equity-in-global-cancer-care/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/conversations-on-cancer-exploring-religious-literacy-and-spirituality-in-cancer-care/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/three-days-was-enough/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/adriatic-trial-durvalumab-consolidation-extends-survival-in-limited-stage-small-cell-lung-cancer/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/whole-person-cancer-care-a-transformative-vision-for-oncology/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/my-melanoma-could-have-been-prevented/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/osimertinib-plus-savolitinib-responses-reported-in-first-line-treatment-of-met-aberrant-egfr-mutant-nsclc/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/new-hope-for-patients-with-her2-mutant-nsclc-durable-responses-to-two-novel-targeted-therapies/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cancer-clinical-trials-continue-to-be-out-of-reach-for-many-patients/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/ama-house-of-delegates-adopts-asco-sponsored-resolutions-on-interpretation-of-stark-law-and-prior-authorization-costs/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/leap-012-combination-of-therapies-extends-progression-free-survival-in-intermediate-stage-hepatocellular-carcinoma/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/peace-3-enzalutamide-plus-radium-223-significantly-improves-survival-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/new-directions-in-all-cml-and-cll-treatment/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/trial-updates-in-stage-iii-melanoma-solidify-the-neoadjuvant-use-of-immunotherapy-as-the-current-standard-of-care/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/keynote-811-pembrolizumab-combination-in-first-line-setting-improves-overall-survival-in-gastric-cancer/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/overall-survival-analysis-confirms-pembrolizumab-regimen-as-standard-of-care-for-triple-negative-breast-cancer/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cancer-provider-groups-across-the-country-urge-congress-to-pass-prior-authorization-reform/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/asco-updates-stage-iii-nsclc-guideline-to-include-osimertinib-in-wake-of-laura-trial-data/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/ann-partridge-md-mph-receives-esmo-award-for-significant-contributions-to-breast-cancer-research-and-patient-care/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/coping-with-the-risk-of-hereditary-cancer/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/shared-reflections-on-the-2024-asco-annual-meeting-from-networking-to-mentorship-and-more/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/himalaya-5-year-analysis-confirms-survival-benefit-of-stride-regimen-in-hepatocellular-carcinoma/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/navigating-uncharted-waters-in-the-post-chevron-sea-change/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/distinguished-service-awards-presented-at-the-iaslc-world-conference-on-lung-cancer/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/encouraging-pathologic-responses-achieved-with-novel-combination-regimen-in-early-stage-nsclc/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/destiny-breast12-t-dxd-of-benefit-in-patients-with-breast-cancer-and-brain-metastases/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/amivantamab-vmjw-plus-lazertinib-improves-long-term-outcomes-in-first-line-setting-of-egfr-mutant-advanced-nsclc/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/creating-a-culture-of-diversity-equity-and-inclusion-why-it-matters-clinically-and-ethically/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/study-finds-nearly-70-billion-in-socioeconomic-losses-across-11-countries-attributable-to-ovarian-cancer/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/fda-approves-amivantamab-vmjw-with-carboplatin-and-pemetrexed-for-non-small-cell-lung-cancer-with-egfr-exon-19-deletions-or-l858r-mutations/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/isatuximab-plus-vrd-approved-by-fda-for-newly-diagnosed-transplant-ineligible-multiple-myeloma/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/the-formative-years-of-medical-oncology-in-the-united-states-a-rough-and-tumble-road-part-2/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/keynote-a18-overall-survival-in-cervical-cancer-improved-by-pembrolizumab-plus-chemoradiotherapy/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/fda-approves-osimertinib-in-stage-iii-nsclc-after-chemoradiotherapy/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/ayas-enrolled-in-a-cancer-program-were-more-likely-to-receive-guideline-recommended-care/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/more-than-half-of-aya-cancer-survivors-experience-financial-toxicity-and-are-unable-to-afford-food-and-housing/</loc><lastmod>2024-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/new-data-from-swog-s1826-trial-may-confirm-benefit-of-nivolumab-plus-avd-in-patients-with-hodgkin-lymphoma/</loc><lastmod>2024-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/large-proportion-of-childhood-cancer-survivors-may-experience-significant-fear-of-cancer-recurrence/</loc><lastmod>2024-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/large-proportion-of-postmenopausal-hormone-receptor-positive-breast-cancers-may-be-linked-to-excess-body-fat/</loc><lastmod>2024-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/sts-launches-two-new-thoracic-surgery-risk-calculators/</loc><lastmod>2024-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/what-is-the-impact-of-a-colon-or-colorectal-cancer-diagnosis-on-younger-adults/</loc><lastmod>2024-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/skin-cancer-risk-after-radioactive-iodine-treatment-for-thyroid-cancer/</loc><lastmod>2024-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/do-social-support-measures-improve-uptake-of-cancer-screening/</loc><lastmod>2024-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/head-and-neck-cancer-clinical-trials-may-be-becoming-less-diverse-despite-national-efforts/</loc><lastmod>2024-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/standard-vs-extended-lymphadenectomy-in-radical-cystectomy-for-muscle-invasive-bladder-cancer/</loc><lastmod>2024-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/addition-of-ramucirumab-to-osimertinib-in-tki-naive-egfr-mutant-metastatic-nsclc/</loc><lastmod>2024-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/patients-with-multiple-sclerosis-may-have-an-increased-risk-of-certain-types-of-cancer/</loc><lastmod>2024-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cancer-clinical-trials-may-continue-to-be-inaccessible-for-many-patients/</loc><lastmod>2024-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/accelerated-approval-for-bladder-cancer-drug-to-be-withdrawn-after-negative-trial/</loc><lastmod>2024-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/listening-to-music-may-accelerate-postsurgical-recovery/</loc><lastmod>2024-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/heart-failure-and-cancer-new-insights-into-reciprocal-relationship/</loc><lastmod>2024-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/carmen-lc03-tusamitamab-ravtansine-vs-docetaxel-in-previously-treated-advanced-nonsquamous-nsclc/</loc><lastmod>2024-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cosmetic-outcomes-with-two-schedules-of-partial-breast-irradiation-in-early-breast-cancer/</loc><lastmod>2024-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/outcomes-with-adjuvant-ici-treatment-in-resected-stage-iiiiv-melanoma/</loc><lastmod>2024-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/regorafenib-in-refractory-advanced-gastric-cancer/</loc><lastmod>2024-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cancer-diagnoses-may-be-linked-to-lasting-financial-challenges/</loc><lastmod>2024-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/acs-program-may-reduce-postsurgical-mortality-improve-care-among-older-patients/</loc><lastmod>2024-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/rogaratinibatezolizumab-in-cisplatin-ineligible-fgfr-mrna-overexpressing-urothelial-cancer/</loc><lastmod>2024-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/mri-may-help-prevent-unnecessary-surgery-in-patients-with-rectal-cancer/</loc><lastmod>2024-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/new-33-million-dollar-nci-grant-may-facilitate-development-of-more-accurate-comfortable-breast-cancer-screening-technology/</loc><lastmod>2024-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/preoperative-chemotherapy-and-perioperative-nivolumab-in-nsclc/</loc><lastmod>2024-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/impact-of-hormonal-contraception-on-breast-cancer-risk-in-brca12-germline-mutation-carriers/</loc><lastmod>2024-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/sbrt-vs-conventional-radiotherapy-for-localized-prostate-cancer/</loc><lastmod>2024-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/national-academy-of-medicine-elects-100-new-members/</loc><lastmod>2024-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/mutations-and-dna-structures-may-drive-urothelial-carcinoma/</loc><lastmod>2024-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/ecog-acrin-cancer-research-group-caris-life-sciences-partner-to-learn-more-from-tailorx-trial/</loc><lastmod>2024-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/addition-of-induction-chemotherapy-to-standard-chemoradiotherapy-in-locally-advanced-cervical-cancer/</loc><lastmod>2024-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/immunotherapy-plus-targeted-therapy-for-anaplastic-thyroid-carcinoma/</loc><lastmod>2024-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/early-results-show-novel-agent-has-clinical-activity-in-fgfr3-driven-advanced-bladder-cancer/</loc><lastmod>2024-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/scientists-develop-a-digital-twin-model-to-predict-cancer-treatment-responses/</loc><lastmod>2024-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/new-marker-for-immunotherapy-response-in-hepatocellular-carcinoma/</loc><lastmod>2024-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/medicaid-expansion-may-improve-cancer-care-survival-among-patients-with-hormone-receptor-negative-her2-positive-breast-cancer/</loc><lastmod>2024-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/association-between-pathologic-response-and-relapse-free-survival-with-neoadjuvant-immune-checkpoint-inhibitor-therapy-for-hepatocellular-carcinoma/</loc><lastmod>2024-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/distant-recurrence-risk-among-women-with-early-breast-cancer-enrolled-in-clinical-trials-between-1990-and-2009-ebctcg-analysis/</loc><lastmod>2024-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/risk-of-subsequent-neoplasms-in-survivors-of-childhood-neuroblastoma/</loc><lastmod>2024-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/fda-grants-accelerated-approval-to-asciminib-for-newly-diagnosed-chronic-myeloid-leukemia/</loc><lastmod>2024-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/chinese-phase-iii-trial-explores-novel-treatment-options-in-cervical-cancer/</loc><lastmod>2024-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/novel-treatment-options-for-children-and-young-adults-with-relapsed-osteosarcoma/</loc><lastmod>2024-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/using-ai-to-measure-prostate-cancer-lesions-could-aid-diagnosis-and-treatment/</loc><lastmod>2024-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/weighing-blood-based-vs-standard-colorectal-cancer-screening-options/</loc><lastmod>2024-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2024-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/outcomes-with-brexucabtagene-autoleucel-as-standard-therapy-for-adults-with-relapsedrefractory-b-cell-acute-lymphoblastic-leukemia/</loc><lastmod>2024-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cdk46-inhibition-in-peritoneal-mucinous-carcinomatosis-with-gnas-mutation/</loc><lastmod>2024-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/new-computational-tool-may-predict-immunotherapy-outcomes-in-patients-with-metastatic-breast-cancer/</loc><lastmod>2024-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/lung-cancer-screening-model-may-remove-barriers-for-vulnerable-patients-residing-in-central-texas/</loc><lastmod>2024-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/keynote-671-overall-survival-with-perioperative-pembrolizumab-in-resectable-nsclc/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/immunotherapychemoradiotherapy-in-limited-stage-small-cell-lung-cancer/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/intensity-modulated-radiation-therapy-and-proton-beam-therapy-may-offer-equally-high-quality-of-life-and-tumor-control-in-patients-with-localized-prostate-cancer/</loc><lastmod>2024-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/standard-chemoradiation-may-be-superior-to-deintensification-approaches-in-patients-with-hpv-associated-oropharyngeal-cancer/</loc><lastmod>2024-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/addition-of-nivolumab-to-tivozanib-following-immune-checkpoint-inhibitor-treatment-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2024-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/lupsma-vs-change-of-androgen-receptor-pathway-inhibitor-in-taxane-naive-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2024-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/radiotherapy-vs-transoral-robotic-surgery-for-oropharyngeal-squamous-cell-carcinoma/</loc><lastmod>2024-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/pharmaceutical-industry-sponsors-and-clinical-cancer-research-in-the-united-states/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/cancer-and-cancer-related-therapy-may-increase-cardiovascular-disease-risk-in-older-cancer-survivors/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/ember-imlunestrant-in-estrogen-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/adjuvant-nivolumab-vs-placebo-in-localized-renal-cell-carcinoma-at-high-risk-of-recurrence-after-nephrectomy/</loc><lastmod>2024-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/duration-of-postmastectomy-radiation-therapy-in-patients-planning-breast-reconstruction/</loc><lastmod>2024-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/conversations-on-cancer-exploring-religious-literacy-and-spirituality-in-cancer-care-1/</loc><lastmod>2024-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/strategies-for-recovering-neurocognitive-function-after-cranial-radiation-therapy/</loc><lastmod>2024-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/autologous-vs-allogeneic-stem-cell-transplantation-in-younger-patients-with-peripheral-t-cell-lymphoma-7-year-follow-up/</loc><lastmod>2024-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/variations-in-kras-gene-mutations-linked-to-prognosis-in-pancreatic-cancer/</loc><lastmod>2024-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/radiopharmaceutical-therapy-may-offer-benefit-in-patients-with-refractory-meningioma/</loc><lastmod>2024-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/spiritual-themes-distrust-may-factor-into-black-patients-reluctance-to-participate-in-cancer-clinical-trials/</loc><lastmod>2024-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/atezolizumab-plus-platinum-doublet-and-maintenance-niraparib-for-late-relapsing-recurrent-ovarian-cancer/</loc><lastmod>2024-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/novel-radioconjugate-or-conventional-care-prior-to-allogeneic-hematopoietic-cell-transplantation-in-relapsedrefractory-aml/</loc><lastmod>2024-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/addition-of-liver-transplantation-to-chemotherapy-for-permanently-unresectable-colorectal-cancer-liver-metastases/</loc><lastmod>2024-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/acas-dependent-coverage-expansion-may-have-benefited-young-adult-patients-diagnosed-with-cancer/</loc><lastmod>2024-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/common-breast-cancer-treatments-may-speed-aging-process/</loc><lastmod>2024-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/sexual-health-and-quality-of-life-with-simple-vs-radical-hysterectomy-in-low-risk-early-stage-cervical-cancer/</loc><lastmod>2024-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/transperineal-vs-transrectal-prostate-biopsy-for-suspicion-of-prostate-cancer/</loc><lastmod>2024-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/exercise-linked-to-fewer-falls-in-older-adults-with-cancer/</loc><lastmod>2024-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/stereotactic-vs-hypofractionated-radiotherapy-for-inoperable-stage-i-nsclc/</loc><lastmod>2024-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/novel-cell-therapy-may-offer-benefit-in-patients-with-relapsed-or-refractory-t-cell-all/</loc><lastmod>2024-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/one-dose-hpv-vaccination-approach-may-help-to-eliminate-cervical-cancer/</loc><lastmod>2024-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/can-blood-test-predict-survival-in-metastatic-prostate-cancer/</loc><lastmod>2024-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/bridging-the-gap-in-cancer-clinical-trial-funding/</loc><lastmod>2024-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/two-universities-to-develop-incisionless-prostate-cancer-surgery-using-mri-and-robotics/</loc><lastmod>2024-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/global-disparities-may-exist-in-availability-timeliness-of-new-cancer-drugs/</loc><lastmod>2024-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/fda-approves-inavolisib-combination-in-pik3ca-mutated-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/sintilimabbevacizumab-in-relapsed-or-persistent-ovarian-clear-cell-carcinoma/</loc><lastmod>2024-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/chatgpt-may-demonstrate-human-level-assessment-of-brain-tumor-mri-reports/</loc><lastmod>2024-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/ai-language-models-may-generate-effective-physicians-letters/</loc><lastmod>2024-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/two-us-scientists-receive-2024-nobel-prize-in-physiology-or-medicine/</loc><lastmod>2024-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/higher-dosage-of-radioembolization-with-y-90-therapy-may-improve-survival-rates-and-facilitate-curative-treatment-in-patients-with-hepatocellular-carcinoma/</loc><lastmod>2024-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/african-men-may-have-higher-risk-of-developing-prostate-cancer-earlier/</loc><lastmod>2024-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/radiation-associated-secondary-cancers-in-breast-cancer-harboring-tp53-germline-pathogenic-variants/</loc><lastmod>2024-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/updated-findings-in-prostate-cancer-screening-with-systemic-biopsy-vs-mri-targeted-biopsy/</loc><lastmod>2024-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/association-of-excess-body-weight-and-risk-of-second-primary-cancers-among-survivors-of-first-primary-cancers/</loc><lastmod>2024-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/capmatinib-in-met-exon-14-mutated-nsclc/</loc><lastmod>2024-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/addition-of-thoracic-radiotherapy-to-first-line-treatment-of-egfr-mutated-metastatic-nsclc/</loc><lastmod>2024-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/10-october/association-of-tert-expression-and-survival-in-pulmonary-carcinoids/</loc><lastmod>2024-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/adjuvant-dabrafenib-plus-trametinib-for-stage-iii-braf-v600-mutated-melanoma-final-results-of-the-combi-ad-trial/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/prescription-for-progress-lancet-oncology-commissions-practical-strategies-for-global-cancer-surgery/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/phase-iii-alexandraimpassion030-any-survival-benefit-for-adjuvant-atezolizumab-in-triple-negative-breast-cancer/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/the-formative-years-of-medical-oncology-in-the-united-states-a-rough-and-tumble-road-part-1/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/asco-presents-ethan-basch-md-msc-fasco-with-the-joseph-simone-quality-care-award/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/combination-targeted-therapy-produces-durable-remissions-in-some-patients-with-relapsed-diffuse-large-b-cell-lymphoma/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/iaslc-ivonescimab-vs-pembrolizumab-as-first-line-treatment-in-nsclc/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/a-clinical-trial-has-halted-progression-of-merkel-cell-carcinoma-and-allowed-me-to-pursue-my-love-of-music/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/use-of-immune-checkpoint-inhibitors-under-study-in-high-risk-hormone-receptor-positive-early-stage-breast-cancer/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/optimizing-the-use-of-multicancer-early-detection-tests/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/asco-issues-first-guideline-specific-to-locally-advanced-rectal-cancer/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/iaslc-ifinatamab-deruxtecan-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2024-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/disparities-in-exposure-to-tobacco-content-on-streaming-platforms/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/idea-awardees-reflections-on-the-2024-asco-annual-meeting/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/new-studies-explore-relationships-between-heart-failure-and-lymphoma-arterial-thromboembolism-and-cancer/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/a-diagnosis-of-triple-negative-breast-cancer-was-not-on-my-radar/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/optimizing-cancer-care-for-older-adults/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/chinese-study-finds-radiation-alone-may-be-as-effective-as-chemoradiation-in-patients-with-low-risk-nasopharyngeal-cancer/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/nivolumab-plus-chemotherapy-extends-survival-in-lymph-node-only-metastatic-urothelial-cancer/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/new-collaborative-guideline-highlights-the-importance-of-multidisciplinary-care-for-patients-with-osteoradionecrosis/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/nivolumab-in-combination-with-cisplatin-plus-gemcitabine-in-treatment-of-unresectable-or-metastatic-urothelial-carcinoma/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fam-trastuzumab-deruxtecan-nxki-in-unresectable-or-metastatic-her2-positive-solid-tumors/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/t-dxd-effective-for-breast-tumors-with-her2-low-and-her2-ultralow-expression-in-earlier-line-of-therapy/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/what-is-the-better-target-for-bispecific-antibodies-in-multiple-myeloma-bcma-or-gprc5d/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/inoperable-stage-iii-nsclc-adaptive-radiotherapy-based-on-fdg-pet-tumor-residual-uptake/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/remembering-a-pioneer-in-melanoma-and-immunotherapy-jeffrey-weber/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/extranodal-marginal-zone-lymphoma-is-overtreatment-common/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/discontinuation-of-cml-therapy-which-patients-are-ideal-candidates/</loc><lastmod>2024-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/menopausal-hormone-therapy-and-risk-of-ovarian-and-endometrial-cancers/</loc><lastmod>2024-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/chronic-conditions-could-delay-lung-cancer-diagnoses/</loc><lastmod>2024-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/effect-of-false-positives-on-adherence-to-subsequent-breast-cancer-screening/</loc><lastmod>2024-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/recurrent-or-metastatic-hnscc-overall-survival-with-immunotherapy/</loc><lastmod>2024-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/use-of-immune-checkpoint-inhibitors-under-study-in-high-risk-hormone-receptor-positive-early-stage-breast-cancer-1/</loc><lastmod>2024-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/delays-in-oral-antimyeloma-treatment-initiation-role-of-social-determinants-of-health/</loc><lastmod>2024-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/belzutifan-vs-everolimus-in-previously-treated-advanced-renal-cell-carcinoma/</loc><lastmod>2024-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/new-study-illuminates-variations-in-performance-characteristics-between-fit-tests/</loc><lastmod>2024-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/mobile-phones-may-not-be-linked-to-brain-cancer-who-backed-study-finds/</loc><lastmod>2024-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/ici-related-cardiotoxicity-in-patients-with-cancer/</loc><lastmod>2024-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/can-ai-tool-improve-detection-of-immune-related-adverse-events-in-patients-with-cancer/</loc><lastmod>2024-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/liquid-biopsy-may-predict-risk-of-venous-thromboembolism-in-patients-with-cancer/</loc><lastmod>2024-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/sacituzumab-govitecan-in-advanced-urothelial-cancer-after-ici-therapy/</loc><lastmod>2024-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/addition-of-oxaliplatin-to-fluoropyrimidinebevacizumab-in-initial-therapy-for-metastatic-colorectal-cancer-in-older-patients/</loc><lastmod>2024-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/detecting-clear-cell-renal-cell-carcinoma-use-of-zr-89-girentuximab-pet-ct-imaging/</loc><lastmod>2024-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/addition-of-lu-177-psma-617-to-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2024-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/aca-may-increase-access-to-colorectal-cancer-care-among-underserved-groups/</loc><lastmod>2024-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/sexual-health-symptoms-may-be-linked-to-poor-adherence-to-adjuvant-endocrine-therapy-in-black-women-with-breast-cancer/</loc><lastmod>2024-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/survival-outcomes-with-addition-of-trabectedin-to-docetaxel-in-leiomyosarcoma/</loc><lastmod>2024-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/world-cancer-research-day-2024/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/black-patients-with-triple-negative-breast-cancer-may-be-less-likely-to-receive-immunotherapy-compared-with-white-patients/</loc><lastmod>2024-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/adjuvant-pembrolizumab-following-surgery-may-improve-cancer-free-survival-in-patients-with-high-risk-urothelial-carcinoma/</loc><lastmod>2024-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/cisplatin-shortage-led-to-treatment-alternatives-for-head-and-neck-cancer-significantly-increasing-cost/</loc><lastmod>2024-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/overall-survival-with-cabozantinib-vs-sunitinib-in-advanced-papillary-renal-cell-carcinoma/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/impact-of-adjuvant-chemotherapy-on-resected-intraductal-papillary-mucinous-neoplasm-derived-pancreatic-cancer/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/risk-of-immune-checkpoint-inhibitor-induced-diabetes/</loc><lastmod>2024-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/breast-and-ovarian-cancers-may-be-newly-linked-to-thousands-of-rad51c-gene-variants/</loc><lastmod>2024-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/black-women-may-have-a-higher-risk-of-mortality-from-all-breast-cancer-subtypes/</loc><lastmod>2024-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/atezolizumab-venetoclax-and-obinutuzumab-in-richter-transformation-diffuse-large-b-cell-lymphoma/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/tarlatamab-in-previously-treated-small-cell-lung-cancer/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/immunotherapy-combination-may-improve-long-term-survival-in-patients-with-metastatic-melanoma/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/phase-iii-cabinet-trial-cabozantinib-in-advanced-neuroendocrine-tumors/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/long-term-outcomes-with-adjuvant-trastuzumab-for-9-weeks-or-1-year-in-her2-positive-breast-cancer-analysis-from-sold-trial/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/hrqol-in-advanced-breast-cancer-capitello-291-trial/</loc><lastmod>2024-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/neoadjuvant-chemotherapy-for-early-breast-cancer/</loc><lastmod>2024-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/pathway-to-developing-predictive-biomarkers-for-immune-checkpoint-inhibitors-in-nsclc/</loc><lastmod>2024-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/iaslc-global-survey-on-biomarker-testing-reveals-progress-and-persistent-barriers-in-lung-cancer-biomarker-testing/</loc><lastmod>2024-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/perioperative-nivolumab-may-improve-event-free-survival-compared-with-neoadjuvant-nivolumab-plus-chemotherapy-alone-in-patients-with-resectable-nsclc/</loc><lastmod>2024-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/right-sided-colon-cancer-complete-mesocolic-excision-vs-d2-dissection/</loc><lastmod>2024-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/study-compares-lung-cancer-screening-triage-protocols/</loc><lastmod>2024-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/poor-prognosis-germ-cell-tumors/</loc><lastmod>2024-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/recurrent-high-grade-t1-bladder-cancer/</loc><lastmod>2024-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/bmi-impact-on-crc-risk-mortality-in-asia/</loc><lastmod>2024-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/using-trop2-expression-to-predict-outcomes-in-advanced-nsclc/</loc><lastmod>2024-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/neocoast-2-trial-durvalumab-plus-novel-agents-may-increase-pathologic-responses-in-resectable-nsclc/</loc><lastmod>2024-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/iaslc-taletrectinib-in-ros1-positive-nsclc/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/secondary-cancers-after-car-t-cell-therapy/</loc><lastmod>2024-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-approves-atezolizumab-and-hyaluronidase-tqjs-for-subcutaneous-injection/</loc><lastmod>2024-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-seeks-consumer-representatives-for-odac/</loc><lastmod>2024-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/leap-012-pembrolizumab-plus-lenvatinib-added-to-tace-improved-progression-free-survival-in-hcc/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/two-recent-studies-provide-evidence-that-breastfeeding-after-breast-cancer-may-be-safe/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/nasal-and-paranasal-sinus-cancer-neoadjuvant-chemotherapy-and-organ-preservation/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/5-year-analysis-of-phase-iii-himalaya-confirms-survival-benefit-of-stride-in-hepatocellular-carcinoma/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/studies-show-immunotherapy-improves-long-term-survival-in-growing-number-of-cancers/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/immunotherapy-and-novel-targeted-drug-appear-beneficial-in-women-with-early-stage-gynecologic-disease/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/perioperative-durvalumab-reduced-risk-of-recurrence-or-death-vs-neoadjuvant-chemotherapy-alone-in-muscle-invasive-bladder-cancer/</loc><lastmod>2024-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/novel-antibody-drug-conjugate-puxitatug-samrotecan-may-demonstrate-manageable-safety-profile-and-preliminary-efficacy-in-first-in-human-trial/</loc><lastmod>2024-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/high-dose-vitamin-d3-does-not-provide-benefit-for-metastatic-colorectal-cancer/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/retifanlimab-plus-chemotherapy-may-extend-progression-free-survival-in-patients-with-squamous-cell-anal-carcinoma/</loc><lastmod>2024-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/prostate-cancer-mortality-and-5-ari-use/</loc><lastmod>2024-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/study-supports-universal-genetic-testing-of-newly-diagnosed-patients-with-invasive-breast-cancer/</loc><lastmod>2024-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/omitting-5-fu-bolus-may-reduce-side-effects-in-patients-with-gastrointestinal-cancers/</loc><lastmod>2024-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/how-accurate-is-staging-in-early-pancreatic-cancer/</loc><lastmod>2024-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-approves-ready-to-use-version-of-bortezomib-for-subcutaneous-administration/</loc><lastmod>2024-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/iaslc-ai-method-transforms-gene-mutation-prediction-in-lung-cancer/</loc><lastmod>2024-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/high-proportion-of-us-men-older-than-45-years-may-have-misconceptions-about-prostate-cancer-screening-as-rates-of-late-stage-diagnoses-continue-to-rise/</loc><lastmod>2024-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/treating-tki-resistant-egfr-mutant-metastatic-nonsquamous-nsclc/</loc><lastmod>2024-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/youth-e-cigarette-use-may-have-declined-to-lowest-level-in-a-decade/</loc><lastmod>2024-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-approves-ribociclib-with-an-aromatase-inhibitor-and-ribociclibletrozole-co-pack-for-early-high-risk-breast-cancer/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/nure-combo-first-results-for-a-perioperative-chemoimmunotherapy-approach-in-muscle-invasive-bladder-cancer/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/novel-triplet-combination-may-yield-positive-response-in-patients-with-advanced-phase-cml/</loc><lastmod>2024-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-draft-guidance-on-conducting-multiregional-oncology-clinical-trials/</loc><lastmod>2024-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-approves-pembrolizumab-with-chemotherapy-for-unresectable-advanced-or-metastatic-malignant-pleural-mesothelioma/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/addition-of-palliative-radiotherapy-to-best-supportive-care-in-painful-hepatic-cancer/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/aegean-update-confirms-benefit-of-perioperative-durvalumab-in-resectable-nsclc/</loc><lastmod>2024-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/neighborhood-environment-may-be-linked-to-prostate-cancer-risk-in-men-with-west-african-genetic-ancestry/</loc><lastmod>2024-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/quality-of-life-outcomes-with-whole-breast-irradiation-vs-accelerated-partial-breast-irradiation-following-breast-conserving-surgery/</loc><lastmod>2024-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/overall-survival-results-with-pembrolizumab-and-chemoradiotherapy-in-newly-diagnosed-high-risk-locally-advanced-cervical-cancer/</loc><lastmod>2024-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/datopotamab-deruxtecan-vs-docetaxel-in-previously-treated-advanced-or-metastatic-nsclc/</loc><lastmod>2024-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/olanzapine-may-reduce-chemotherapy-induced-nausea-and-improve-quality-of-life-among-patients-with-cancer/</loc><lastmod>2024-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/community-academic-partnership-may-successfully-reduce-radon-related-lung-cancer-risk-in-native-population/</loc><lastmod>2024-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/fda-approves-selpercatinib-for-ret-fusion-positive-medullary-thyroid-cancer/</loc><lastmod>2024-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/conversations-between-physicians-and-older-patients-about-physical-activity-may-reduce-falls-during-cancer-treatment/</loc><lastmod>2024-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/quality-improvements-in-lung-cancer-surgery-and-tumor-pathology-may-extend-survival-postsurgery/</loc><lastmod>2024-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/impact-of-whole-lung-irradiation-in-newly-diagnosed-rhabdomyosarcoma-with-lung-metastases/</loc><lastmod>2024-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/09-september/updated-findings-with-belzutifan-in-von-hippel-lindau-disease-associated-cns-hemangioblastomas/</loc><lastmod>2024-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/cancer-has-robbed-me-of-my-fertility-and-my-olympic-dreams/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/car-t-cell-therapy-in-refractory-follicular-lymphoma/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/inotuzumab-ozogamicin-for-pediatric-acute-lymphoblastic-leukemia/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/ponatinib-with-chemotherapy-for-newly-diagnosed-philadelphia-chromosome-positive-all/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/btk-degraders-and-celmods-novel-mechanisms-overcoming-resistance-in-hematologic-malignancies/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/asco-guideline-update-highlights-the-importance-of-early-integration-of-palliative-care-for-patients-with-cancer/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/update-on-leaner-trial-in-patients-with-breast-cancer/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/gynecologic-oncologist-lynette-ann-denny-dies-at-age-66/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/in-remembrance-of-my-friend-lyn-denny/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/gift-of-truth-reflections-on-a-father-s-cancer-journey/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/what-is-the-optimal-first-line-therapy-for-chronic-lymphocytic-leukemia/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-approves-immunotherapy-for-relapsed-or-refractory-ctcl/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/lorlatinib-vs-crizotinib-in-advanced-alk-positive-nsclc-5-year-outcomes-from-phase-iii-crown-trial/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-approves-idh12-inhibitor-for-certain-patients-with-astrocytoma-or-oligodendroglioma/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/glofitamab-combination-therapy-shows-survival-benefit-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/scotus-ruling-upends-country-s-regulatory-framework-threatens-to-complicate-and-delay-health-care-delivery/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/acalabrutinib-plus-chemoimmunotherapy-improves-progression-free-survival-in-older-patients-with-mantle-cell-lymphoma/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/detecting-residual-disease-after-neoadjuvant-chemoradiation-in-esophageal-squamous-cell-carcinoma/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/libretto-431-trial-shows-selpercatinib-is-effective-in-east-asian-patients-with-ret-fusion-positive-non-small-cell-lung-cancer/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/an-integrated-approach-to-treating-cancer-and-cardiovascular-disease-when-oncologists-and-cardiologists-collaborate/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/cancer-screening-estimated-to-cost-43-billion-dollars-annually-in-united-states/</loc><lastmod>2024-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/oral-cannabis-extract-for-refractory-chemotherapy-induced-nausea-and-vomiting/</loc><lastmod>2024-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/adjuvant-pembrolizumab-vs-placebo-in-stage-iii-melanoma-long-term-health-related-quality-of-life/</loc><lastmod>2024-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/the-evolving-epidemiology-of-gastrointestinal-stromal-tumors-in-major-organ-sites/</loc><lastmod>2024-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/early-interventions-may-improve-long-term-academic-achievement-in-pediatric-brain-tumor-survivors/</loc><lastmod>2024-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/hpv-vaccination-rate-among-young-female-patients-with-psychiatric-diagnoses/</loc><lastmod>2024-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/ruxolitinib-for-corticosteroid-refractory-sclerotic-chronic-gvhd/</loc><lastmod>2024-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/genomic-determinants-of-relapse-in-childhood-all/</loc><lastmod>2024-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/impact-of-breast-cancer-screening-interval-on-stage-at-diagnosis-and-overall-survival/</loc><lastmod>2024-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/structural-racism-and-cancer-risk-from-traffic-related-air-pollution/</loc><lastmod>2024-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/early-onset-colorectal-cancer-rurality-and-poverty-may-be-linked-to-lower-survival/</loc><lastmod>2024-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/many-women-unaware-of-preventive-benefits-of-diet-for-breast-cancer-risk/</loc><lastmod>2024-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/can-a-blood-test-predict-obesity-related-cancer-risk-in-patients-with-type-2-diabetes/</loc><lastmod>2024-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/previously-untreated-cancer-of-unknown-primary-site-specific-therapy-guided-by-a-90-gene-expression-assay/</loc><lastmod>2024-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/ici-based-strategies-in-advanced-progressing-egfr-mutated-nsclc/</loc><lastmod>2024-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-approves-cancer-biomarker-test-companion-diagnostic-indications/</loc><lastmod>2024-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/preclinical-study-examines-novel-pancreatic-cancer-treatment/</loc><lastmod>2024-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/novel-insights-into-multiple-myeloma-progression/</loc><lastmod>2024-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/hypofractionated-vs-conventionally-fractionated-radiation-after-implant-based-breast-reconstruction/</loc><lastmod>2024-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/pregnancy-associated-cancer-incidence-and-risks-of-adverse-obstetric-perinatal-outcomes/</loc><lastmod>2024-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/olaparib-may-be-effective-without-hormone-therapy-in-some-men-with-biochemically-recurrent-prostate-cancer/</loc><lastmod>2024-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/medication-related-osteonecrosis-of-the-jaw-in-patients-with-breast-cancer/</loc><lastmod>2024-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/adjuvant-everolimus-in-localized-papillary-and-chromophobe-non-clear-cell-renal-cell-carcinoma/</loc><lastmod>2024-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/can-mindful-breathing-reduce-the-intensity-of-cancer-related-pain/</loc><lastmod>2024-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/first-line-nivolumabrelatlimab-vs-nivolumabipilimumab-in-advanced-melanoma/</loc><lastmod>2024-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/advanced-biliary-tract-cancers-bevacizumaberlotinib-maintenance-vs-active-surveillance/</loc><lastmod>2024-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/menin-inhibitor-in-kmt2a-rearranged-relapsed-or-refractory-acute-leukemia/</loc><lastmod>2024-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/the-power-of-patient-reported-outcome-measures-in-assessing-chemotherapy-induced-peripheral-neuropathy/</loc><lastmod>2024-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/targetable-variant-found-in-chinese-patients-with-ovarian-cancer/</loc><lastmod>2024-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/can-alternative-criteria-help-identify-patients-who-may-benefit-from-lung-cancer-screening/</loc><lastmod>2024-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-approves-lazertinib-with-amivantamab-vmjw-for-egfr-mutated-nsclc/</loc><lastmod>2024-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/breast-conserving-surgery-with-or-without-postoperative-radiotherapy-in-early-stage-breast-cancer-30-year-update/</loc><lastmod>2024-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/metastatic-pancreatic-adenocarcinoma-addition-of-devimistat-to-mffx/</loc><lastmod>2024-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/exploring-targeted-therapies-in-multiple-myeloma/</loc><lastmod>2024-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/ai-may-help-uncover-relationship-between-radiation-therapy-for-nsclc-and-cardiac-arrhythmias/</loc><lastmod>2024-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/causal-attribution-of-hpv-genotypes-to-invasive-cervical-cancer/</loc><lastmod>2024-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/long-term-look-at-selpercatinib-in-ret-activated-thyroid-cancer/</loc><lastmod>2024-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/patients-with-rare-cancers-may-face-increased-risk-of-anxiety-and-depression/</loc><lastmod>2024-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/breast-cancer-index-confirmed-as-prognostic-in-a-soft-trial-derived-population/</loc><lastmod>2024-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/new-modeling-data-show-effective-detection-and-health-care-savings-associated-with-the-multitarget-stool-dna-test/</loc><lastmod>2024-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/exercise-program-may-improve-symptoms-quality-of-life-in-patients-with-metastatic-breast-cancer/</loc><lastmod>2024-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-approves-neoadjuvantadjuvant-durvalumab-for-resectable-nsclc/</loc><lastmod>2024-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/cancer-mortality-among-adults-with-learning-disabilities/</loc><lastmod>2024-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/risk-of-suicidal-behavior-among-spouses-of-patients-with-cancer/</loc><lastmod>2024-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/high-risk-localized-hcc-efficacy-of-neoadjuvant-immunotherapy-vs-upfront-surgery/</loc><lastmod>2024-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-oce-invites-pediatric-cancer-advocates-to-meet-on-october-15/</loc><lastmod>2024-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/metastatic-nsclc-survival-rates-in-the-immunotherapy-era/</loc><lastmod>2024-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/corticosteroids-for-immune-related-adverse-events-and-clinical-outcomes-with-icis-for-solid-tumors/</loc><lastmod>2024-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/novel-insights-may-transform-diagnosis-and-treatment-of-pediatric-patients-with-t-lineage-all/</loc><lastmod>2024-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/dietary-risk-factors-for-early-onset-colorectal-cancer/</loc><lastmod>2024-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/recurrent-or-advanced-endometrial-cancer-atezolizumab-plus-chemotherapy/</loc><lastmod>2024-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/are-some-uterine-tumors-more-aggressive-in-black-patients/</loc><lastmod>2024-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/mouthwash-based-test-may-help-predict-head-and-neck-cancer-recurrence/</loc><lastmod>2024-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/arpa-h-awards-to-develop-novel-technologies-in-cancer-surgery/</loc><lastmod>2024-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/new-study-may-unveil-prognostic-genetic-insights-into-colorectal-cancer/</loc><lastmod>2024-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/combination-immunotherapies-may-boost-t-cell-responses-in-patients-with-melanoma/</loc><lastmod>2024-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/efficacy-of-symptom-triggered-testing-for-detection-of-ovarian-cancer/</loc><lastmod>2024-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/completion-axillary-lymph-node-dissection-to-select-adjuvant-treatment-in-breast-cancer-and-associated-impairment-of-arm-function/</loc><lastmod>2024-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-approves-axatilimab-csfr-for-chronic-gvhd/</loc><lastmod>2024-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/sacituzumab-govitecan-may-be-effective-at-treating-breast-cancer-related-brain-tumors/</loc><lastmod>2024-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/advanced-gist-long-term-outcomes-with-discontinuation-vs-continuation-of-imatinib/</loc><lastmod>2024-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/cancer-cases-and-mortality-among-men-predicted-to-increase-globally/</loc><lastmod>2024-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/salpingectomy-vs-tubal-occlusion/</loc><lastmod>2024-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/resected-melanoma-subsequent-systemic-therapy-after-recurrence-on-adjuvant-nivolumab/</loc><lastmod>2024-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/t-dxd-in-her2-positive-advanced-colorectal-cancer/</loc><lastmod>2024-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/can-neoadjuvant-atezolizumab-set-a-new-standard-for-unresectable-stage-iii-nsclc/</loc><lastmod>2024-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/metastasis-directed-radiation-therapy-plus-chemotherapy-in-oligometastatic-pancreatic-cancer/</loc><lastmod>2024-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/gestational-diabetes-and-risk-for-breast-cancer/</loc><lastmod>2024-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/cannabis-use-and-risk-of-head-and-neck-cancer/</loc><lastmod>2024-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/association-of-regular-aspirin-use-with-colorectal-cancer-risk-according-to-lifestyle-factors/</loc><lastmod>2024-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/pattern-in-protein-production-may-be-predictive-of-side-effects-from-immunotherapy-in-patients-with-melanoma/</loc><lastmod>2024-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/primary-ovarian-insufficiency-early-menopause-may-be-linked-to-increased-risk-of-breast-cancer/</loc><lastmod>2024-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/efficacy-of-a-jak2mtor-inhibitor-combination-in-controlling-acute-graft-vs-host-disease/</loc><lastmod>2024-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/cancer-of-unknown-primary-molecularly-guided-therapy-after-disease-control-on-platinum-based-chemotherapy/</loc><lastmod>2024-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/egfr-and-alk-altered-nsclc-tkis-with-and-stereotactic-radiosurgery-for-brain-metastases/</loc><lastmod>2024-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/merkel-cell-carcinoma-association-of-ctdna-with-recurrence-risk/</loc><lastmod>2024-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/visceral-pleural-invasion-and-recurrence-risk-in-patients-undergoing-surgery-for-nsclc/</loc><lastmod>2024-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/daily-e-cigarette-use-may-be-linked-to-higher-combustible-cigarette-cessation/</loc><lastmod>2024-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/should-low-dose-ct-screening-be-recommended-for-those-at-low-risk-for-lung-cancer/</loc><lastmod>2024-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/selpercatinib-in-east-asian-patients-with-ret-fusion-positive-nsclc-libretto-431/</loc><lastmod>2024-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/active-surveillance-may-enable-patients-with-esophageal-cancer-to-delay-or-avoid-surgery/</loc><lastmod>2024-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/radiation-alone-may-be-as-effective-as-chemoradiation-in-patients-with-low-risk-nasopharyngeal-cancer/</loc><lastmod>2024-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/physician-community-comes-together-to-urge-congress-to-act-on-medicare-payment-reform/</loc><lastmod>2024-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-grants-accelerated-approval-to-t-cell-therapy-for-unresectable-or-metastatic-synovial-sarcoma/</loc><lastmod>2024-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/common-blood-tests-may-improve-early-cancer-diagnosis/</loc><lastmod>2024-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/investigating-fungal-bloodstream-infections-in-bone-marrow-transplant-recipients/</loc><lastmod>2024-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/sacituzumab-govitecan-in-advanced-endometrial-cancer/</loc><lastmod>2024-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/egfr-mutated-nsclc-tepotinibosimertinib-in-patients-with-met-amplification/</loc><lastmod>2024-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/births-and-adverse-obstetric-outcomes-among-female-survivors-of-adolescent-and-young-adult-cancers/</loc><lastmod>2024-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/liver-transplantation-vs-standard-therapies-in-patients-with-colorectal-cancer-liver-metastasis/</loc><lastmod>2024-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/heart-sparing-radiation-therapy-technique-in-left-sided-breast-cancer-benefits-and-costs/</loc><lastmod>2024-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/estrogen-plus-progestin-and-risk-of-colorectal-cancer/</loc><lastmod>2024-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/ponatinib-and-blinatumomab-in-newly-diagnosed-ph-positive-all/</loc><lastmod>2024-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/fda-expands-endometrial-cancer-indication-for-dostarlimab-gxly-with-chemotherapy/</loc><lastmod>2024-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/novel-ai-tool-may-predict-risk-of-chronic-pain-in-patients-with-breast-cancer/</loc><lastmod>2024-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/new-report-shows-vaping-and-smoking-together-increases-lung-cancer-risk-fourfold/</loc><lastmod>2024-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/generation-x-and-millennials-have-higher-risk-for-many-cancers-compared-to-older-generations/</loc><lastmod>2024-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/08-august/education-level-social-media-awareness-may-be-linked-to-cancer-fatalism/</loc><lastmod>2024-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/overcoming-the-disparity-in-cancer-incidence-and-mortality-rates-among-alaska-native-individuals/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/new-genetic-test-may-predict-response-to-immunotherapy-in-triple-negative-breast-cancer/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/a-role-for-avelumab-in-triple-negative-breast-cancer/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/long-term-survival-possible-after-liver-transplant-for-colorectal-liver-metastases/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/two-phase-iii-trials-report-benefit-with-isatuximab-based-regimens-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/lavern-s-law-and-its-implications-for-oncology/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/addition-of-ibrutinib-to-immunochemotherapy-and-asct-improves-survival-in-mantle-cell-lymphoma/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/cancer-and-fatherhood-a-story-of-personal-power-in-the-face-of-a-mortal-disease/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/introducing-conexiant/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/preserving-reproductive-health-for-patients-with-cancer-insights-from-an-oncofertility-patient-navigator/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/alliance-for-global-implementation-of-lung-and-cardiac-early-disease-detection-and-treatment-meeting-highlights/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/esopec-trial-flot-protocol-proves-superior-to-cross-regimen-in-locally-advanced-esophageal-cancer/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/triplet-combination-improves-survival-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma-in-third-line-setting/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/amivantamab-vmjw-in-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/updated-asco-guidance-on-cancer-related-fatigue-expands-patient-options-for-interventions/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/phase-ii-study-shows-activity-for-novel-targeted-agent-in-kras-g12c-mutated-nsclc/</loc><lastmod>2024-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/in-gastroesophageal-cancer-switch-maintenance-improves-outcomes-over-chemotherapy-continuation/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/asco-issues-new-guidance-on-vaccinations-for-adults-with-cancer/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/ama-house-of-delegates-adopts-record-six-asco-led-resolutions/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/novel-antibody-drug-conjugate-extends-survival-vs-chemotherapy-in-triple-negative-breast-cancer/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/breaking-the-silence-addressing-sexual-and-reproductive-health-in-cancer-care/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/chronic-graft-vs-host-disease-clinical-trial-updates/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/having-acute-lymphoblastic-leukemia-took-away-my-fear-of-death/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/capivasertib-with-fulvestrant-for-previously-treated-advanced-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/relativity-048-triplet-immunotherapy-shows-activity-in-untreated-advanced-melanoma/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/mast-trial-metformin-does-not-slow-disease-progression-of-low-risk-prostate-cancer/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/second-line-therapy-with-adagrasib-in-kras-g12c-mutated-non-small-cell-lung-cancer/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/astro-names-new-chief-executive-officer/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/switching-to-abemaciclib-may-improve-outcomes-after-disease-progression/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/v-craig-jordan-a-founding-father-of-targeted-therapy-in-cancer-dies-at-age-76/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/breast-implant-related-cancers-should-our-patients-be-concerned/</loc><lastmod>2024-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/uncovering-the-genetic-risk-of-hereditary-breast-and-ovarian-cancer-syndrome-lynch-syndrome/</loc><lastmod>2024-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/are-eligible-breast-cancer-survivors-receiving-genetic-testing/</loc><lastmod>2024-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/can-living-in-a-disadvantaged-area-increase-the-risk-of-aggressive-prostate-cancer/</loc><lastmod>2024-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/cancer-risk-from-exposure-to-pesticides-may-be-comparable-to-risk-from-smoking-study-finds/</loc><lastmod>2024-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/new-study-highlights-improvements-in-treating-pediatric-patients-with-retinoblastoma/</loc><lastmod>2024-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/triplet-as-initial-salvage-treatment-for-advanced-germ-cell-tumors-long-term-outcomes/</loc><lastmod>2024-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/recurrentmetastatic-hnscc-pembrolizumab-plus-carboplatin-and-paclitaxel/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/new-study-demonstrates-similar-outcomes-between-patients-with-protocol-exceptions-to-participate-in-targeted-therapy-trial-and-eligible-participants/</loc><lastmod>2024-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/tai-chi-vs-cognitive-behavioral-therapy-measuring-inflammatory-biomarkers-in-breast-cancer-survivors-with-insomnia/</loc><lastmod>2024-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/perioperative-nivolumab-in-renal-cell-carcinoma/</loc><lastmod>2024-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/impact-of-cisplatin-based-chemotherapy-on-hearing-in-cancer-survivors/</loc><lastmod>2024-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/psa-may-insufficiently-detect-early-prostate-cancer-in-transgender-women/</loc><lastmod>2024-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/relapsed-or-refractory-multiple-myeloma-activity-of-bcma-x-cd3-bispecific-antibody/</loc><lastmod>2024-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/previously-untreated-egfr-mutated-advanced-nsclc-amivantamablazertinib-vs-osimertinib/</loc><lastmod>2024-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/nonplatinum-chemotherapy-regimen-for-advanced-cholangiocarcinoma/</loc><lastmod>2024-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/risk-of-adverse-obstetric-outcomes-in-adolescent-and-young-adult-cancer-survivors/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/previously-untreated-intermediate-risk-rhabdomyosarcoma-addition-of-temsirolimus-to-chemotherapy-in-young-patients/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/exercise-may-prevent-nerve-damage-during-chemotherapy/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/american-indian-and-alaskan-native-women-may-be-less-likely-to-undergo-breast-reconstruction/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/exploring-health-care-provider-attitudes-toward-hpv-self-collection-testing/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/novel-algorithm-may-help-to-identify-aggressive-basal-cell-carcinoma/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/endometrial-thickness-in-triage-for-endometrial-cancer-among-black-women/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/advanced-melanoma-efficacy-of-monoclonal-antibody-doublet/</loc><lastmod>2024-07-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/can-adhering-to-a-mediterranean-diet-reduce-mortality-in-cancer-survivors/</loc><lastmod>2024-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/survivorship-standards-at-commission-on-cancer-accredited-cancer-care-facilities-may-help-address-needs-of-adult-cancer-survivors/</loc><lastmod>2024-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/tumor-surveillance-in-pediatric-patients-with-cancer-predisposition-syndromes/</loc><lastmod>2024-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/germline-risk-of-taxane-induced-peripheral-neuropathy-in-black-women-with-early-stage-breast-cancer/</loc><lastmod>2024-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/advancedmetastatic-genitourinary-tumors-cabozantinibnivolumab-with-or-without-ipilimumab/</loc><lastmod>2024-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/nasopharyngeal-carcinoma-adding-sintilimab-to-standard-chemoradiotherapy-for-locoregionally-advanced-disease/</loc><lastmod>2024-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/infection-risk-in-patients-with-mantle-cell-lymphoma/</loc><lastmod>2024-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/stiripentol-could-prolong-efficacy-of-chemotherapy-in-patients-with-gastric-cancer/</loc><lastmod>2024-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/relapsed-or-refractory-neuroblastoma-addition-of-dasatinibrapamycin-to-irinotecantemozolomide/</loc><lastmod>2024-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/factors-impacting-adherence-to-adjuvant-endocrine-therapy-in-premenopausal-women-with-breast-cancer/</loc><lastmod>2024-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/response-adapted-radiation-therapy-for-orbital-indolent-b-cell-lymphoma/</loc><lastmod>2024-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/immunotherapy-induced-multiorgan-immune-related-adverse-events-co-occurrence-patterns-and-prognostic-implications/</loc><lastmod>2024-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/asco-to-present-ethan-basch-with-the-joseph-simone-quality-care-award/</loc><lastmod>2024-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/asco-friends-of-cancer-research-applaud-fda-draft-guidance/</loc><lastmod>2024-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/asco-scotus-ruling-upends-country-s-regulatory-framework-threatens-to-complicate-and-delay-health-care-delivery/</loc><lastmod>2024-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/lbcl-cd22-directed-car-t-cell-therapy-after-disease-progression-on-cd19-directed-car-t-cell-therapy/</loc><lastmod>2024-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/electronic-health-record-based-prompt-may-help-reduce-breast-cancer-overtreatment/</loc><lastmod>2024-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/new-imaging-guidelines-for-head-and-neck-cancers-published/</loc><lastmod>2024-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/neha-vapiwala-voted-president-elect-of-astro/</loc><lastmod>2024-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/egfr-her3-bispecific-antibody-drug-conjugate-in-locally-advanced-or-metastatic-solid-tumors/</loc><lastmod>2024-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/how-does-endometriosis-typology-influence-ovarian-cancer-risk/</loc><lastmod>2024-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/donor-socioeconomic-status-may-influence-outcomes-in-hematopoietic-cell-transplantation/</loc><lastmod>2024-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/testosterone-therapy-may-protect-against-breast-cancer-in-transmasculine-patients/</loc><lastmod>2024-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/new-study-may-provide-insights-into-common-immune-system-mechanism-between-pregnancy-and-cancer/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/certain-patients-diagnosed-with-benign-classification-of-prostate-cancer-may-actually-have-high-risk-disease/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/predictive-models-for-disease-recurrence-after-breast-conserving-surgery-for-dcis/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/association-of-genetic-risk-for-prostate-cancer-with-early-prostate-cancer-death/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/resected-pancreatic-cancer-autologous-dendritic-cell-vaccination/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/can-glp-1-receptor-agonists-prevent-obesity-associated-cancers-in-patients-with-type-2-diabetes/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/predicting-taxane-induced-peripheral-neuropathy-after-breast-cancer-therapy/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/rnas-may-help-to-identify-patients-with-stage-ii-colorectal-cancer-who-may-benefit-from-adjuvant-chemotherapy/</loc><lastmod>2024-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/40-percent-of-cancer-cases-and-almost-half-of-all-cancer-deaths-in-the-united-states-linked-to-modifiable-risk-factors/</loc><lastmod>2024-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/surveillance-for-pancreatic-cancer-in-high-risk-individuals/</loc><lastmod>2024-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/adjuvant-therapeutic-regimens-for-gallbladder-cancer/</loc><lastmod>2024-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/stage-i-her2-positive-breast-cancer-long-term-follow-up-of-adjuvant-t-dm1/</loc><lastmod>2024-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/outcomes-for-brca-pathogenic-variant-carriers-undergoing-breast-conserving-therapy/</loc><lastmod>2024-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/prostate-cancer-detection-with-ai-vs-radiologist-readings-of-mri/</loc><lastmod>2024-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/novel-immunotherapy-approach-in-metastatic-solid-tumors/</loc><lastmod>2024-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/high-risk-melanoma-inhibiting-mek-and-pd-l1-in-tandem/</loc><lastmod>2024-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/uk-based-survey-finds-cancer-is-the-leading-health-concern-among-the-public/</loc><lastmod>2024-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/advanced-classical-hodgkin-lymphoma-pet-guided-brecadd-vs-ebeacopp/</loc><lastmod>2024-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/out-of-pocket-costs-from-diagnostic-testing-after-prostate-cancer-screening/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/premenopausal-women-with-breast-cancer-receiving-estradiol-suppression-therapy-effect-of-denosumab-on-bone-loss/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/hormone-modulating-therapy-may-be-linked-to-lower-dementia-risk-in-patients-with-breast-cancer/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/new-study-demonstrates-safe-successful-pregnancy-may-be-possible-following-allo-hct/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/recurrent-cervical-cancer-tisotumab-vedotin-in-second-or-third-line-therapy/</loc><lastmod>2024-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/early-breast-cancer-genetic-testing-and-communication-of-results-with-family-after-diagnosis/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/pmmrmss-locally-advanced-rectal-cancer-immunotherapy-based-total-neoadjuvant-therapy/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/panel-issues-first-guidelines-to-prevent-anal-cancer-in-patients-with-hiv/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/liquid-biopsy-may-enable-monitoring-of-disease-evolution-in-patients-with-metastatic-prostate-cancer/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/tailored-dose-dense-adjuvant-chemotherapy-in-high-risk-early-breast-cancer/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/aacr-asa-fda-outline-considerations-for-overall-survival-analyses-in-clinical-trials/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/novel-target-identified-for-treating-htlv-1-associated-diseases/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/does-neighborhood-walkability-impact-the-burden-of-cardiovascular-risk-factors-in-patients-with-cancer/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/immunotherapy-in-unresectable-hcc-with-child-pugh-class-b-dysfunction/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/pancreatic-cancer-celiac-plexus-radiosurgery-for-retroperitoneal-pain-syndrome/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/eliminating-racial-disparities-in-colorectal-cancer-screening/</loc><lastmod>2024-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/shortening-fda-mandated-car-t-cell-therapy-monitoring-periods-could-improve-access-to-treatment-in-patients-with-dlbcl/</loc><lastmod>2024-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/multiple-myeloma-using-absolute-lymphocyte-count-to-predict-outcomes-after-car-t-cell-therapy/</loc><lastmod>2024-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/neoadjuvant-camrelizumab-plus-apatinib-in-locally-advanced-colorectal-cancer/</loc><lastmod>2024-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/rsclin-tool-and-risk-for-late-distant-recurrence-in-breast-cancer/</loc><lastmod>2024-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/patients-with-prostate-cancer-social-factors-may-be-tied-to-racial-disparities-in-cardiovascular-outcomes/</loc><lastmod>2024-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/does-bilateral-mastectomy-for-unilateral-breast-cancer-impact-mortality/</loc><lastmod>2024-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/risk-of-breast-cancer-may-be-lower-within-first-years-following-ovarian-cancer-diagnosis/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/is-lower-dose-radiopharmaceutical-therapy-effective-in-advanced-prostate-cancer/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/guardant-health-s-shield-blood-test-approved-by-the-fda-as-a-primary-screening-option-for-colorectal-cancer/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/baseline-bone-pain-and-survival-in-newly-diagnosed-prostate-cancer/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/mrd-negative-all-addition-of-blinatumomab-to-consolidation-chemotherapy/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/effect-of-posttransplantation-cyclophosphamide-based-gvhd-prophylaxis-on-patients-with-hematologic-malignancies/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/fecal-microbiota-transplant-may-help-patients-with-gastrointestinal-cancers-overcome-immunotherapy-resistance/</loc><lastmod>2024-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/key-immune-cells-for-combating-aggressive-merkel-cell-carcinoma-uncovered/</loc><lastmod>2024-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/cancer-research-and-care-beyond-borders-for-global-oncologist-dario-trapani/</loc><lastmod>2024-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/making-a-difference-in-global-oncology/</loc><lastmod>2024-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/advanced-nsclc-association-of-intratumoral-escherichia-with-overall-survival/</loc><lastmod>2024-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/do-nonstatin-cholesterol-lowering-drugs-influence-the-risk-of-hepatic-cancer/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/fda-approves-daratumumab-and-hyaluronidase-fihj-with-vrd-for-multiple-myeloma/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/can-mutations-in-dna-damage-repair-genes-predict-cisplatin-response-in-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/07-july/early-stage-breast-cancer-mammaprint-prediction-of-extended-letrozole-benefit/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/pembrolizumabchemotherapy-in-first-line-treatment-of-her2-negative-advanced-gastric-or-gej-adenocarcinoma/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/mirvetuximab-soravtansine-gynx-for-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/retroperitoneal-lymphadenectomy-can-it-be-safely-omitted-for-some-patients-with-advanced-ovarian-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/long-term-study-finds-most-breast-cancer-survivors-were-able-to-preserve-fertility-and-achieve-pregnancy-after-diagnosis/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/asco-issues-new-guidance-on-cannabis-and-cannabinoid-use-in-adults-with-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/asco-sets-six-guiding-principles-for-ai-in-oncology/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/estrogen-alone-increased-ovarian-cancer-incidence-and-mortality-combination-hormone-therapy-did-not/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/cshl-and-northwell-health-extend-strategic-affiliation/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/durvalumab-consolidation-therapy-extends-survival-in-limited-stage-small-cell-lung-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/accelerating-progress-in-melanoma-and-cancer-research/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/advanced-lung-cancer-studies-explore-palliative-care-delivered-by-telehealth-and-in-a-stepped-care-approach/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/dreamm-8-belantamab-mafodotin-blmf-shows-robust-benefit-in-early-relapse-of-myeloma/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/tovorafenib-in-relapsed-or-refractory-braf-altered-pediatric-low-grade-glioma/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-grants-accelerated-approval-to-repotrectinib-for-ntrk-fusion-positive-solid-tumors/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/adjuvant-use-of-alectinib-in-alk-positive-nsclc/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/eflornithine-for-adult-and-pediatric-patients-with-high-risk-neuroblastoma/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-finds-fewer-than-half-of-accelerated-approval-drugs-show-benefit-in-overall-survival-or-quality-of-life-within-5-years/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/addition-of-adjuvant-ribociclib-to-nonsteroidal-aromatase-inhibitor-therapy-improves-survival-in-early-breast-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/lu-177-dotatate-for-pediatric-patients-with-gastroenteropancreatic-neuroendocrine-tumors/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/be-prepared-a-patient-perspective/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-approves-selpercatinib-for-ret-fusion-positive-thyroid-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/oral-serds-poised-to-impact-treatment-of-hormone-receptor-positive-breast-cancer/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/phase-i-study-in-nhl-use-of-armored-car-t-cells-may-be-feasible-after-standard-car-t-cell-failure/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/aacr-cancer-disparities-progress-report-2024-highlights-ongoing-health-inequities-experienced-by-racial-and-ethnic-minorities/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-documents-decline-in-reimbursements-for-breast-cancer-surgery-from-2003-to-2023/</loc><lastmod>2024-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/osimertinib-therapy-poised-to-become-new-standard-of-care-for-unresectable-stage-iii-egfr-mutated-nsclc/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/optimizing-the-management-of-dcis/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/cardiotoxicity-how-far-have-we-come/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/pancreatic-surgeon-named-new-director-of-moores-cancer-center-at-uc-san-diego-health/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/nadina-trial-shows-robust-benefit-for-neoadjuvant-nivolumab-plus-ipilimumab-in-stage-iii-melanoma/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/tepotinib-for-metastatic-nsclc-with-met-exon-14-skipping-alterations/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-misses-endpoints-but-still-shows-benefit-for-lenvatinibpembrolizumab-in-endometrial-cancer-subsets/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/nogapendekin-alfa-inbakicept-pmln-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/how-the-museum-of-medicine-and-biomedical-discovery-aims-to-bring-scientific-achievements-of-the-past-present-and-future-to-life/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/multiple-myeloma-survivor-and-advocate-shares-12-step-program-how-not-to-die-of-cancer/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/in-celebration-of-a-remarkable-life-and-career-in-oncology/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/i-am-living-with-recurring-stage-iv-colorectal-cancer/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-s-oncology-center-of-excellence-launches-project-5-in-5/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/guideline-update-seeks-to-aid-clinicians-in-the-selection-of-systemic-treatments-for-advanced-hepatocellular-carcinoma/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-grants-accelerated-approval-to-lisocabtagene-maraleucel-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/innovative-staging-system-for-de-novo-metastatic-breast-cancer-validated-internationally/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-approves-lisocabtagene-maraleucel-for-relapsed-or-refractory-mantle-cell-lymphoma/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/a-new-international-initiative-for-faculty-collaboration-and-patient-advocacy-in-immune-related-adverse-events/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/hpv-vaccine-shows-prevention-efficacy-for-several-types-of-hpv-related-cancers-in-both-males-and-females/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/aua-asco-and-suo-publish-2024-amendment-to-nonmetastatic-muscle-invasive-bladder-cancer-guidelines/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/first-line-venetoclax-combinations-in-fit-patients-with-cll/</loc><lastmod>2024-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/methylphenidate-for-treating-fatigue-in-patients-with-advanced-cancer/</loc><lastmod>2024-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/low-risk-prostate-cancer-disease-free-survival-with-hypofractionated-vs-conventionally-fractionated-radiotherapy/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/more-on-using-ai-to-enhance-cancer-care/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/integrating-palliative-care-education-into-hematology-oncology-fellowships/</loc><lastmod>2024-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/novel-gamma-delta-t-cell-based-therapy-plus-temozolomide-maintenance-in-glioblastoma-multiforme/</loc><lastmod>2024-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/neoadjuvant-combination-of-pd-1-and-angiogenesis-inhibitors-in-genomically-unstable-colorectal-cancer-neocap/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/novel-spatial-gene-signature-approach-may-help-to-predict-immunotherapy-outcomes-in-patients-with-melanoma/</loc><lastmod>2024-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/strategies-for-reducing-the-risk-of-cancers-in-patients-with-alcohol-dependence/</loc><lastmod>2024-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/transplant-eligible-newly-diagnosed-multiple-myeloma-long-term-follow-up-of-the-cassiopeia-trial/</loc><lastmod>2024-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/primary-breast-cancer-pretreatment-exercise-level-and-distant-recurrence-free-interval/</loc><lastmod>2024-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/mobile-monitoring-system-may-improve-detection-of-ethylene-oxide-in-louisianas-cancer-alley/</loc><lastmod>2024-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/er-positive-advanced-breast-cancer-oral-serd-plus-palbociclib-in-first-line-setting/</loc><lastmod>2024-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/recurrent-or-metastatic-hnscc-first-line-vegfr2-plus-pd-1-inhibition/</loc><lastmod>2024-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/novel-biomarker-may-be-predictive-of-clear-cell-renal-cell-carcinoma-recurrence/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/can-chemotherapy-impact-the-gut-microbiome-in-patients-with-breast-cancer/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-grants-accelerated-approval-to-epcoritamab-bysp-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/adding-cox-2-inhibition-to-chemotherapy-in-pik3ca-activated-stage-iii-colon-cancer/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/previously-treated-metastatic-nsclc-sacituzumab-govitecan-vs-docetaxel/</loc><lastmod>2024-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/dendritic-cell-therapy-in-pleural-mesothelioma/</loc><lastmod>2024-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/relapsed-or-refractory-jmml-study-evaluates-trametinib/</loc><lastmod>2024-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/early-surveillance-in-pediatric-patients-genetically-predisposed-to-cancer/</loc><lastmod>2024-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/can-acupuncture-improve-hormonal-side-effects-in-women-undergoing-breast-cancer-therapy/</loc><lastmod>2024-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/new-survey-finds-cancer-drug-shortage-management-remains-a-moving-target/</loc><lastmod>2024-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/air-pollution-may-increase-cardiovascular-risk-in-patients-with-cancer/</loc><lastmod>2024-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/lgbtq-cancer-survivors-have-a-higher-burden-of-chronic-health-conditions-disabilities-than-cisgender-cancer-survivors/</loc><lastmod>2024-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/socioeconomic-disparities-in-quality-of-life-after-early-stage-breast-cancer-diagnosis/</loc><lastmod>2024-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-grants-accelerated-approval-to-adagrasib-with-cetuximab-for-kras-g12c-mutated-colorectal-cancer/</loc><lastmod>2024-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/modified-perioperative-chemotherapy-regimen-may-benefit-patients-with-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2024-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/immunoglobulin-g-testing-may-reduce-infections-increase-receipt-of-immunoglobulin-replacement-therapy-in-patients-with-cll-and-nhl/</loc><lastmod>2024-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-approves-imetelstat-for-patients-with-low-to-intermediate-1-risk-mds-and-transfusion-dependent-anemia/</loc><lastmod>2024-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/new-risk-stratification-model-for-waldenstrom-s-macroglobulinemia/</loc><lastmod>2024-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/combination-targeted-therapy-produces-durable-responses-in-patients-with-relapsed-dlbcl/</loc><lastmod>2024-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/adjuvant-dabrafenib-plus-trametinib-for-stage-iii-braf-v600-mutated-melanoma/</loc><lastmod>2024-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/clinical-trial-testing-brenetafusp-plus-nivolumab-in-advanced-or-metastatic-cutaneous-melanoma-kicks-off/</loc><lastmod>2024-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/repurposing-brigatinib-to-treat-nf2-related-schwannomatosis/</loc><lastmod>2024-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/patient-reported-outcomes-from-the-himalaya-trial-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/childhood-cancer-survivors-burden-of-cardiovascular-disease-and-risk-of-major-cardiovascular-events/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/prostate-cancer-adjuvant-radiotherapy-with-6-months-of-adt-vs-no-adt/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-identifies-subset-of-patients-with-lung-adenocarcinoma-who-have-her2-alterations/</loc><lastmod>2024-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/addition-of-chemoradiation-to-adjuvant-systemic-therapy-differences-in-node-negative-vs-node-positive-pancreatic-cancer/</loc><lastmod>2024-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/can-pembrolizumab-improve-outcomes-in-soft-tissue-sarcoma/</loc><lastmod>2024-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/dennis-slamon-awarded-2024-szent-gyorgyi-prize-for-progress-in-cancer-research/</loc><lastmod>2024-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/aspirin-as-adjuvant-therapy-for-breast-cancer/</loc><lastmod>2024-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/chemotherapy-administration-and-survival-in-patients-with-very-advanced-solid-tumors/</loc><lastmod>2024-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/neoadjuvant-pembrolizumab-may-improve-outcomes-in-some-patients-with-colorectal-cancer-surgery/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-finds-early-menopause-may-be-linked-to-greater-risk-of-breast-and-ovarian-cancers/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/proton-therapy-vs-traditional-radiation-therapy-in-patients-with-oropharyngeal-cancer/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/many-breast-cancer-survivors-may-experience-excess-weight-gain/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/adjuvant-radiotherapy-with-24-vs-6-months-of-adt-in-prostate-cancer/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/imrt-reirradiation-plus-nivolumab-in-recurrent-or-second-primary-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/stress-related-to-residing-in-violent-neighborhoods-may-be-tied-to-aggressive-lung-cancer-in-black-men/</loc><lastmod>2024-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/impact-of-high-blood-insulin-levels-on-triple-negative-breast-cancer-survival-in-black-women/</loc><lastmod>2024-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/new-study-highlights-benefits-of-stepped-palliative-care-in-advanced-lung-cancer/</loc><lastmod>2024-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/usp1-inhibitor-in-metastatic-solid-tumors/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-including-only-black-patients-with-breast-cancer-compares-rates-of-taxane-induced-peripheral-neuropathy/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/telehealth-may-reduce-greenhouse-gas-emissions-associated-with-cancer-care/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/risk-factors-and-outcomes-among-women-with-interval-vs-screen-detected-breast-cancer/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/novel-car-t-cell-therapy-under-study-in-relapsed-or-refractory-non-hodgkin-lymphoma/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/novel-ctdna-liquid-biopsy-may-help-predict-breast-cancer-recurrence-years-before-relapse/</loc><lastmod>2024-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/t-dxd-improves-progression-free-survival-in-patients-with-breast-cancer-previously-treated-with-endocrine-therapy/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/consolidation-therapy-with-durvalumab-for-limited-stage-sclc/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/osimertinib-for-patients-with-locally-advanced-egfr-mutated-nsclc-a-new-standard-of-care/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/advanced-ovarian-cancer-can-lymphadenectomy-be-avoided-for-some-patients/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/neoadjuvant-immunotherapy-combination-improves-outcomes-in-patients-with-melanoma/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/novel-antibody-drug-conjugate-may-improve-response-in-advanced-colorectal-cancer/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/combination-brecadd-is-significantly-more-effective-than-beacopp-for-classical-hodgkin-lymphoma-study-finds/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/antibody-drug-conjugate-plus-checkpoint-inhibitor-for-pd-l1-positive-hr-positiveher2-negative-breast-cancer/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/car-t-cell-therapy-in-patients-with-central-nervous-system-lymphoma/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/adding-belantamab-mafodotin-to-doublet-may-slow-disease-progression-or-death-in-relapsed-or-refractory-myeloma/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/perioperative-chemotherapy-vs-neoadjuvant-chemoradiation-in-esophageal-cancer/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/telehealth-shown-to-be-effective-for-palliative-care-delivery-in-patients-with-advanced-lung-cancer/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/lorlatinib-vs-crizotinib-in-previously-untreated-advanced-alk-positive-nsclc/</loc><lastmod>2024-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/esophageal-cancer-neoadjuvant-triplet-or-doublet-chemotherapy-with-or-without-radiotherapy/</loc><lastmod>2024-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/risk-of-secondary-cancer-after-car-t-cell-therapy/</loc><lastmod>2024-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/american-cancer-society-and-asco-announce-expanded-patient-centered-online-collaboration/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/relapsed-or-refractory-b-cell-all-novel-car-t-cell-therapy-yields-strong-remission-rates/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/shorter-durations-of-venetoclax-yield-similar-response-rates-in-aml/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/efficacy-of-adjuvant-everolimus-plus-endocrine-therapy-in-high-risk-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fapi-petct-may-improve-staging-in-newly-diagnosed-breast-cancer/</loc><lastmod>2024-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/can-fap-targeted-radioligand-therapy-benefit-patients-with-advanced-sarcomas/</loc><lastmod>2024-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/radioligand-therapy-may-improve-radiographic-progression-free-survival-in-taxane-naive-patients-with-advanced-prostate-cancer/</loc><lastmod>2024-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/carboplatin-induced-nausea-and-vomiting-addition-of-olanzapine-to-triple-antiemetic-therapy/</loc><lastmod>2024-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/previously-untreated-metastatic-pancreatic-cancer-cd40-agonist-plus-mfolfirinox/</loc><lastmod>2024-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/previously-treated-metastatic-colorectal-cancer-lenvatinibpembrolizumab-vs-standard-of-care/</loc><lastmod>2024-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/using-a-novel-ai-tool-for-cancer-detection-on-whole-body-petct-scans/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/pretargeted-dual-isotope-radionuclide-therapy-in-colorectal-cancer/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/chelating-agent-may-reduce-toxicity-associated-with-psma-radiopharmaceutical-therapy/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-approves-two-immunochemotherapy-combinations-for-endometrial-cancer/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/fda-approves-blinatumomab-as-consolidation-for-cd19-positive-ph-negative-b-cell-precursor-all/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/previously-untreated-advanced-clear-cell-rcc-bempegaldesleukinnivolumab-vs-tki-therapy/</loc><lastmod>2024-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/updated-astro-clinical-guidelines-on-radiation-therapy-in-hpv-positive-oropharyngeal-cancer/</loc><lastmod>2024-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/celecoxib-may-benefit-a-subset-of-patients-with-empik3caem-mutations/</loc><lastmod>2024-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/metastatic-colorectal-cancer-addition-of-atezolizumab-to-first-line-folfoxiribevacizumab/</loc><lastmod>2024-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/advanced-neuroendocrine-tumors-adding-lu-177-dotatate-to-standard-first-line-therapy/</loc><lastmod>2024-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/lenalidomide-exposed-relapsed-or-refractory-multiple-myeloma-bpd-vs-pvd/</loc><lastmod>2024-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/drug-resistance-in-melanoma-related-leptomeningeal-disease/</loc><lastmod>2024-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/can-positive-psychology-influence-outcomes-in-hematopoietic-stem-cell-transplantation-recipients/</loc><lastmod>2024-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/machine-learning-model-may-aid-in-early-diagnosis-of-hepatocellular-carcinoma/</loc><lastmod>2024-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/study-evaluates-cancer-screening-behaviors-among-a-population-of-muslim-individuals/</loc><lastmod>2024-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/robert-ferris-appointed-executive-director-of-unc-lineberger-comprehensive-cancer-center/</loc><lastmod>2024-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/do-patients-with-cancer-require-additional-covid-19-vaccine-doses/</loc><lastmod>2024-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/lung-cancer-screening-prevalence-among-eligible-us-individuals/</loc><lastmod>2024-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/ribociclib-plus-endocrine-therapy-vs-combination-chemotherapy-in-premenopausal-women-with-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/cardiac-dysfunction-among-breast-cancer-survivors/</loc><lastmod>2024-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/newly-diagnosed-patients-with-multiple-myeloma-ineligible-for-transplant-addition-of-isatuximab-to-vrd/</loc><lastmod>2024-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/lung-cancer-screening-may-improve-early-detection-survival-in-u-s-veterans/</loc><lastmod>2024-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/06-june/how-often-do-patients-with-cancer-face-barriers-when-attempting-to-access-care/</loc><lastmod>2024-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/a-fathers-advice-plus-a-desire-to-help-spur-a-career-in-oncology-and-a-leadership-role-in-african-cancer-care/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/for-an-international-expert-in-gynecologic-cancer-being-reared-by-educators-who-stressed-knowledge-and-service-was-key/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/motivated-by-his-mother-s-brain-cancer-and-his-own-life-threatening-disease-a-young-physician-works-to-pay-back-the-universe/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/immigrant-reared-during-the-lebanese-civil-war-by-parents-who-valued-education-becomes-a-leader-in-genitourinary-oncology/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/born-in-a-small-village-in-india-a-breast-cancer-expert-assumes-a-leadership-role-in-oncology-in-cleveland-and-beyond/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/the-national-cancer-act-of-1971-inspired-a-career-in-service-to-and-advocacy-for-patients-with-cancer/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/a-mother-s-encouragement-and-a-husband-wife-doctor-team-set-the-stage-for-a-career-in-hematologic-oncology/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/a-daughter-of-first-generation-immigrants-follows-their-can-do-philosophy-in-her-research-efforts-in-hematologic-oncology/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/fda-s-crowdsourcing-initiative-to-benefit-patient-centric-clinical-trial-innovation/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/multicultural-asco-president-elect-was-raised-in-mexico-by-parents-who-instilled-a-sense-of-duty-to-make-a-difference/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/narratives-in-oncology-through-the-years/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/study-reveals-potential-overtreatment-of-dcis-in-older-women-with-limited-life-expectancy/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/breast-conserving-therapy-in-brca-mutation-carriers-study-looks-at-long-term-outcomes/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/nccn-clinical-practice-guidelines-in-oncology-2024-updates/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/noninferiority-of-simple-vs-radical-hysterectomy-for-pelvic-recurrence-in-low-risk-cervical-cancer/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/adjuvant-alectinib-improves-survival-vs-platinum-based-chemotherapy-in-alk-positive-nsclc/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/study-explores-how-partner-relationships-impact-the-well-being-of-breast-cancer-survivors/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/study-finds-the-financial-hardship-caused-by-cancer-is-long-lasting-for-many-working-age-adults/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/crispr-edited-off-the-shelf-car-t-cell-therapy-shows-proof-of-concept-in-renal-cell-carcinoma/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/use-of-topical-diclofenac-gel-to-prevent-capecitabine-associated-hand-foot-syndrome/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/asco-issues-updated-guidelines-for-stage-iv-nsclc-with-and-without-driver-alterations/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/linvoseltamab-achieves-high-response-rates-in-relapsed-or-refractory-myeloma/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/novel-approaches-show-early-activity-in-endocrine-resistant-breast-cancer/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/uspstf-issues-final-recommendation-statement-on-screening-for-breast-cancer/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/atezolizumabcabozantinib-vs-docetaxel-in-previously-treated-metastatic-nsclc/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/understanding-the-legal-and-ethical-challenges-ai-poses-in-oncology/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/applying-the-power-of-knowledge-to-drive-positive-change-in-oncology-care/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/a-look-back-on-an-impactful-and-inspiring-presidential-year/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/is-a-test-for-early-detection-of-pancreatic-cancer-on-the-horizon/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/the-future-of-cancer-care/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/nccn-appoints-chair-vice-chair-of-board-of-directors/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/rosai-dorfman-disease-sinus-histiocytosis-with-massive-lymphadenopathy/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/apply-through-july-31-2024-for-survivorship-champion-s-prize/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/derek-raghavan-joins-perthera-as-chief-medical-officer/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/dancemovement-therapy-for-pediatric-oncology-patients-and-their-caregivers/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/partnering-with-patients-is-integral-for-a-good-outcome/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/we-have-an-idea-united-in-the-fight-against-cancer/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/keynote-564-adjuvant-pembrolizumab-improves-overall-survival-vs-placebo-in-renal-cell-carcinoma/</loc><lastmod>2024-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/new-policy-statement-addresses-social-economic-and-environmental-factors-influencing-cancer-care-outcomes/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/selective-targeting-of-parp1-in-early-phase-study-shows-activity-in-breast-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/for-detection-of-measurable-residual-disease-in-ovarian-cancer-are-two-methods-better-than-one/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/model-for-predicting-outcomes-after-sentinel-lymph-node-biopsy-in-melanoma/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/alectinib-approved-as-adjuvant-treatment-for-alk-positive-non-small-cell-lung-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/breast-cancer-with-sentinel-node-metastases-axillary-dissection-vs-sentinel-node-biopsy-alone/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/ai-in-cancer-care-embrace-the-change/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/bispecific-antibody-plus-chemotherapy-improves-survival-in-patients-with-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/duo-e-trial-results-support-new-treatment-options-in-endometrial-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/keynote-756-additional-findings-pembrolizumab-shown-to-be-beneficial-regardless-of-age-menopausal-status/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/bishoy-faltas-md-named-chief-research-officer-of-the-englander-institute-for-precision-medicine-at-weill-cornell-medicine/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/america-s-cancer-doctors-demand-action-from-congress-address-drug-shortages/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/pembrolizumab-and-chemotherapy-for-advanced-biliary-tract-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/pirtobrutinib-in-patients-with-previously-treated-cll-sll/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/nihs-new-cancer-screening-research-network-and-cancer-screening-technologies/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/a-delay-in-diagnosis-led-to-advanced-prostate-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/two-studies-support-deintensification-of-treatment-for-hpv-associated-oropharyngeal-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/asco-survey-finds-oncologists-well-being-worsened-over-the-past-decade-but-steps-can-be-taken-to-mitigate-burnout/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/fda-grants-accelerated-approval-to-lifileucel-for-unresectable-or-metastatic-melanoma/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/cell-free-dna-blood-based-test-and-next-generation-multitarget-stool-dna-test-in-colorectal-cancer-screening/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/enfortumab-vedotin-ejfv-plus-pembrolizumab-improves-survival-vs-platinum-based-chemotherapy-in-advanced-urothelial-cancer/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/belzutifan-in-previously-treated-advanced-renal-cell-carcinoma/</loc><lastmod>2024-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/aspirin-use-among-breast-cancer-survivors-navigating-negative-results-age-and-health-equity/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/cancer-screening-rates-may-be-significantly-lower-in-us-federally-qualified-health-centers/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/older-patients-with-newly-diagnosed-hodgkin-lymphoma-preexisting-heart-failure-and-survival-outcomes/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/pediatric-aml-comparison-of-induction-regimens/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/metastatic-castration-resistant-prostate-cancer-addition-of-lupsma-to-enzalutamide/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/glecirasib-shows-efficacy-and-safety-in-kras-g12c-mutated-nsclc/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/mortality-trends-among-asian-american-native-hawaiian-and-other-pacific-islander-patients-with-preventable-cancers/</loc><lastmod>2024-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/effect-of-mindfulness-audio-recordings-on-physical-emotional-side-effects-during-radiation-therapy-for-prostate-cancer/</loc><lastmod>2024-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/salvage-reirradiation-for-locally-recurrent-prostate-cancer-7-year-follow-up/</loc><lastmod>2024-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/metastatic-urothelial-cancer-nectin4-amplification-and-response-to-enfortumab-vedotin/</loc><lastmod>2024-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/risk-of-arterial-thromboembolism-in-japanese-patients-with-cancer/</loc><lastmod>2024-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/preferred-sites-of-cancer-care-community-oncology-practices-vs-hospitals-and-academic-centers/</loc><lastmod>2024-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/smoking-cessation-regimens-does-dose-of-therapy-matter/</loc><lastmod>2024-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/liposomal-irinotecan-vs-topotecan-in-relapsed-small-cell-lung-cancer/</loc><lastmod>2024-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/premastectomy-radiotherapy-surgery-and-immediate-breast-reconstruction/</loc><lastmod>2024-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/relapsed-or-refractory-cd7-positive-leukemia-or-lymphoma-car-t-cell-therapy-plus-hsct-without-gvhd-prophylaxis/</loc><lastmod>2024-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/ai-model-may-accurately-predict-mental-health-outcomes-in-patients-with-cancer/</loc><lastmod>2024-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/improving-aml-outcomes-testing-for-mrd-prior-to-bone-marrow-transplant/</loc><lastmod>2024-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/united-kingdoms-first-cardio-oncology-service-10-year-experience/</loc><lastmod>2024-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/durvalumab-after-chemoradiotherapy-in-unresectable-nsclc-real-world-use-and-outcomes/</loc><lastmod>2024-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/dato-dxd-in-advanced-or-metastatic-hr-positive-her2-negative-or-triple-negative-breast-cancer/</loc><lastmod>2024-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/bavituximab-plus-pembrolizumab-for-patients-with-hepatocellular-carcinoma/</loc><lastmod>2024-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/effects-of-radiation-therapy-timing-on-lifespan-of-artificial-urinary-sphincters-in-prostate-cancer-survivors/</loc><lastmod>2024-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/t-dxd-vs-physicians-choice-of-therapy-in-her2-positive-metastatic-breast-cancer-pros-in-destiny-breast02/</loc><lastmod>2024-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/hemihepatectomy-outcomes-with-laparoscopic-vs-open-surgery/</loc><lastmod>2024-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/newly-identified-biomarkers-may-improve-diagnosis-and-treatment-of-rcc-subtypes/</loc><lastmod>2024-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/historical-community-outreach-and-engagement-efforts-at-nci-designated-cancer-centers/</loc><lastmod>2024-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/local-recurrence-of-endometrial-cancer-radiotherapy-with-or-without-cisplatin/</loc><lastmod>2024-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/omission-of-axillary-dissection-after-nodal-downstaging-with-neoadjuvant-chemotherapy-in-breast-cancer/</loc><lastmod>2024-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/addition-of-durvalumab-to-gemcitabinecisplatin-in-advanced-biliary-tract-cancer-pros-in-topaz-1/</loc><lastmod>2024-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/chemical-related-epigenetic-modifications-may-increase-risk-of-prostate-cancer-among-firefighters/</loc><lastmod>2024-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/novel-pet-agent-may-accelerate-imaging-in-patients-with-clear-cell-renal-cell-carcinoma/</loc><lastmod>2024-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/impact-of-age-on-outcomes-in-endometrial-cancer/</loc><lastmod>2024-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/head-and-neck-cancer-osteoradionecrosis-of-the-jaw-classification-system/</loc><lastmod>2024-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/whole-pelvic-radiation-therapy-for-unfavorable-risk-prostate-cancer/</loc><lastmod>2024-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/venetoclax-plus-hypomethylating-agents-analyzing-standard-of-care-outcomes-in-older-patients-with-aml/</loc><lastmod>2024-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/oral-rinse-could-provide-early-screening-for-gastric-cancer/</loc><lastmod>2024-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/colorectal-cancer-incidence-is-rising-among-teenagers-and-young-adults/</loc><lastmod>2024-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/survey-finds-majority-of-patients-with-cancer-and-survivors-have-or-expect-to-incur-medical-debt-even-those-with-insurance/</loc><lastmod>2024-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/doublet-for-previously-treated-patients-with-advanced-leiomyosarcoma/</loc><lastmod>2024-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/lymphoid-neoplasms-european-national-health-expenditure-and-long-term-survival/</loc><lastmod>2024-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/appendectomy-may-lower-risk-of-colorectal-cancer-subtype/</loc><lastmod>2024-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/childrens-cancer-cause-opens-applications-for-the-2024-survivorship-champions-prize/</loc><lastmod>2024-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/childhood-cancer-survivors-genetic-risk-factors-for-treatment-related-type-2-diabetes-mellitus/</loc><lastmod>2024-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/t-dxd-for-advanced-solid-tumors-with-activating-her2-mutations/</loc><lastmod>2024-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/plant-based-diet-may-offer-benefit-in-patients-with-prostate-cancer/</loc><lastmod>2024-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/newly-identified-genetic-variants-linked-to-breast-cancer-risk-in-women-of-african-ancestry/</loc><lastmod>2024-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/chemotherapy-may-accelerate-physical-decline-in-older-patients-with-early-stage-breast-cancer/</loc><lastmod>2024-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/disparities-in-melanoma-outcomes-among-black-patients/</loc><lastmod>2024-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/fda-approves-hpv-self-collection-solution/</loc><lastmod>2024-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/marker-for-distinguishing-renal-cell-carcinoma-from-benign-renal-masses/</loc><lastmod>2024-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/previously-untreated-mantle-cell-lymphoma-ibrutinib-immunochemotherapy-and-asct/</loc><lastmod>2024-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/daniel-geynisman-named-new-jnccn-editor-in-chief/</loc><lastmod>2024-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/providing-culturally-sensitive-palliative-care-to-children-with-cancer/</loc><lastmod>2024-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/donepezil-for-the-treatment-of-cognitive-impairment-in-breast-cancer-survivors-after-adjuvant-chemotherapy/</loc><lastmod>2024-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/childhood-adiposity-and-risk-for-breast-cancer/</loc><lastmod>2024-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/half-matched-family-donors-may-improve-asct-outcomes-in-hispanic-patients-with-all/</loc><lastmod>2024-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/fda-grants-accelerated-approval-to-tarlatamab-dlle-for-extensive-stage-sclc/</loc><lastmod>2024-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/definitive-concurrent-chemoradiotherapy-for-unresectable-locally-advanced-esophageal-cancer-comparison-of-agents/</loc><lastmod>2024-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/multiple-myeloma-is-mrd-status-at-1-year-after-treatment-predictive-of-survival/</loc><lastmod>2024-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/bariatric-surgery-may-help-reduce-the-risk-of-breast-cancer-in-female-patients-with-obesity-hyperinsulinemia/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/end-of-life-systemic-therapy-may-not-improve-survival-in-patients-with-advanced-solid-tumors/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/advanced-gastric-or-gastroesophageal-junction-cancer-addition-of-relatlimab-to-immunochemotherapy/</loc><lastmod>2024-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/metformin-may-help-reduce-the-risk-of-developing-myeloproliferative-neoplasms/</loc><lastmod>2024-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/onychopapilloma-may-be-linked-to-bap1-tumor-predisposition-syndrome/</loc><lastmod>2024-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/outcomes-for-cancer-drugs-initially-fda-approved-with-immature-overall-survival-data/</loc><lastmod>2024-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/gallbladder-cancer-rates-among-black-patients-in-the-united-states/</loc><lastmod>2024-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/sexual-well-being-in-the-female-partners-of-patients-with-prostate-cancer/</loc><lastmod>2024-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/survival-outcomes-following-adjuvant-therapy-in-patients-with-clinical-t2n0-rectal-adenocarcinoma/</loc><lastmod>2024-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/fda-withdraws-approval-of-cholangiocarcinoma-drug-indication-for-fgfr-inhibitor/</loc><lastmod>2024-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/hpv-screening-intervals-for-cervical-cancer-may-be-safely-extended-beyond-the-current-5-year-recommendation-study-finds/</loc><lastmod>2024-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/pembrolizumab-in-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2024-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/pertuzumab-plus-trastuzumab-for-advanced-biliary-tract-cancer-with-her23-alterations/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/nivolumabipilimumab-boost-in-metastatic-urothelial-carcinoma/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/adding-perioperative-nivolumab-to-neoadjuvant-chemotherapy-in-resectable-nsclc-checkmate-77t/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/ai-based-virtual-patient-navigator-boosts-colonoscopy-adherence/</loc><lastmod>2024-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/most-breast-cancer-survivors-able-to-achieve-pregnancy-after-diagnosis-study-finds/</loc><lastmod>2024-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/influence-of-menopausal-hormone-therapy-on-gynecologic-cancer-incidence-and-mortality/</loc><lastmod>2024-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/can-exercise-boost-the-efficacy-of-rituximab-in-treatment-of-cll/</loc><lastmod>2024-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/pancreatic-cancer-sociodemographic-disparities-and-fragmented-care/</loc><lastmod>2024-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/interval-between-first-colonoscopy-with-negative-findings-and-repeat-colonoscopy/</loc><lastmod>2024-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/early-breast-cancer-alnd-or-slnb-for-ypn-positive-disease-after-neoadjuvant-chemotherapy/</loc><lastmod>2024-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/astro-releases-updated-clinical-guidelines-on-radiation-therapy-for-patients-with-bone-metastases/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/are-tattoos-linked-to-a-heightened-risk-of-lymphoma/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/fda-grants-accelerated-approval-to-selpercatinib-for-pediatric-patients-with-ret-altered-metastatic-thyroid-cancer-or-solid-tumors/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/advanced-ovarian-cancer-adding-ruxolitinib-to-front-line-neoadjuvant-chemotherapy-plus-interval-debulking-surgery/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/cancer-incidence-curative-treatment-and-overall-survival-in-the-english-prison-population/</loc><lastmod>2024-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/cyclophosphamide-may-enable-more-patients-with-high-risk-hematologic-malignancies-to-receive-stem-cell-transplantation/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/differences-in-prostate-cancer-genomics-among-us-veterans/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/can-a-novel-combination-therapy-improve-metastatic-colorectal-cancer-outcomes/</loc><lastmod>2024-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/asciminib-shows-superior-efficacy-vs-standard-of-care-frontline-tkis-in-cml/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/lorlatinib-vs-crizotinib-for-advanced-alk-positive-nsclc-extended-crown-follow-up/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/05-may/patient-characteristics-may-impact-results-of-ai-algorithm-interpreted-screening-mammograms/</loc><lastmod>2024-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/comparative-effectiveness-of-acupuncture-vs-massage-for-relieving-pain-in-patients-with-advanced-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/a-pioneering-female-oncologist-in-morocco-helps-advance-the-global-shift-toward-gender-equity-in-academia/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/breast-cancer-stalked-my-family-for-generations-and-finally-came-for-me/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/adagrasib-plus-cetuximab-potential-option-for-kras-g12c-mutated-colorectal-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/survival-benefit-emerges-with-use-of-dostarlimab-gxly-plus-chemotherapy-in-advanced-or-recurrent-endometrial-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/epov-gini-fleming/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/ai-analysis-of-cell-free-dna-fragments-and-protein-biomarkers-for-noninvasive-detection-of-ovarian-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/can-hpv-circulating-tumor-dna-guide-adjuvant-treatment-of-oropharyngeal-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/epov-glenn-hanna/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/activity-shown-for-antibody-drug-conjugates-in-gynecologic-cancers/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/rapid-guideline-update-supports-capivasertib-for-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/pamela-kunz-named-editor-in-chief-of-new-jco-oncology-advances/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/advanced-stage-classical-hodgkin-lymphoma/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/zanubrutinib-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/novel-mdm2-inhibitor-shows-activity-in-salivary-gland-cancers/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/progression-free-survival-benefit-confirmed-with-triplet-combination-in-brca-wild-type-hrd-positive-ovarian-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/insights-from-the-2023-international-society-of-geriatric-oncology-conference/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/treating-dcis-to-escalate-or-de-escalate/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/can-artificial-intelligence-predict-treatment-response-and-outcomes-in-breast-cancer/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/asco-congratulates-2024-special-awards-recipients/</loc><lastmod>2024-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/t-dxd-in-her2-overexpressing-unresectable-or-metastatic-nsclc/</loc><lastmod>2024-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/pazopanib-in-patients-with-metastatic-renal-cell-carcinoma-and-no-evidence-of-disease-after-metastasectomy/</loc><lastmod>2024-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/giredestrant-in-previously-treated-patients-with-er-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/tuberculosis-may-be-linked-to-increased-risk-of-various-cancer-types/</loc><lastmod>2024-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/benefit-of-prostate-mri-plus-psa-density-test-in-patients-suspected-of-having-prostate-cancer/</loc><lastmod>2024-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/microwave-ablation-vs-surgical-resection-in-multifocal-papillary-thyroid-carcinoma/</loc><lastmod>2024-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/can-tils-help-to-determine-outcomes-in-triple-negative-breast-cancer/</loc><lastmod>2024-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/one-in-five-people-with-cancer-participate-in-clinical-research-new-study-finds/</loc><lastmod>2024-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/gedatolisib-plus-palbociclib-and-endocrine-therapy-in-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/hr-positive-her2-negative-metastatic-breast-cancer-treatment-after-progression-on-cdk46-and-aromatase-inhibitors/</loc><lastmod>2024-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/asking-chatgpt-about-radiation-oncology-treatment/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/study-examines-shared-decision-making-policies-and-practices-around-lung-cancer-screening/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/naprc-accredited-hospitals-vs-nonaccredited-hospitals-proctectomy-outcomes/</loc><lastmod>2024-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/surveyed-oncologists-attitudes-toward-ethical-implications-of-ai-in-cancer-care/</loc><lastmod>2024-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/advanced-pancreatic-cancer-oncolytic-virus-based-immunostimulatory-gene-therapy-plus-chemotherapy/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/danicopan-approved-as-add-on-therapy-to-ravulizumab-or-eculizumab-for-extravascular-hemolysis-in-adults-with-paroxysmal-nocturnal-hemoglobinuria/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/american-cancer-society-releases-latest-global-cancer-statistics-cancer-cases-expected-to-rise-to-35-million-worldwide-by-2050/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/distinct-microbial-signature-uncovered-in-kras-mutated-colorectal-cancer/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/improving-adjuvant-treatment-in-patients-with-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fewer-than-half-of-accelerated-approval-drugs-demonstrated-benefit-within-5-years/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/accelerated-aging-may-be-a-risk-factor-for-early-onset-cancers-in-younger-generations/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fda-grants-accelerated-approval-to-fam-trastuzumab-deruxtecan-nxki-for-unresectable-or-metastatic-her2-positive-solid-tumors/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/can-a-personalized-antitumor-vaccine-plus-pembrolizumab-improve-outcomes-in-hepatocellular-carcinoma/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/mirvetuximab-soravtansine-plus-pembrolizumab-in-patients-with-endometrial-cancer-subtype/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/ciltacabtagene-autoleucel-and-idecabtagene-vicleucel-approved-by-the-fda-for-pretreated-patients-with-multiple-myeloma/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/novel-car-t-cell-therapy-may-show-benefit-in-patients-with-advanced-clear-cell-renal-cell-carcinoma/</loc><lastmod>2024-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/rp1-immunotherapy-in-solid-organ-transplant-recipients-with-skin-cancer/</loc><lastmod>2024-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/bispecific-immune-checkpoint-inhibitor-improves-survival-in-patients-with-gastric-cancer-regardless-of-pd-l1-status/</loc><lastmod>2024-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/immune-response-to-investigational-rna-vaccine-for-pancreatic-cancer-continues-to-correlate-with-clinical-benefit/</loc><lastmod>2024-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/biologic-drug-device-combination-immunotherapy-in-metastatic-prostate-cancer/</loc><lastmod>2024-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/adagrasib-plus-cetuximab-in-kras-g12c-mutated-colorectal-cancer/</loc><lastmod>2024-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/atm-kinase-inhibitor-plus-radiotherapy-for-patients-with-glioblastoma/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/investigational-personalized-vaccine-in-resected-head-and-neck-cancers/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/parp1-selective-inhibitor-in-hrr-deficient-breast-cancer/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/aacr-inaugurates-new-leadership/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/proteogenomic-signatures-may-help-identify-risk-of-prostate-cancer-progression-in-certain-populations/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/an-exosome-based-liquid-biopsy-for-early-detection-of-pancreatic-cancer/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/bap1-mutations-may-increase-susceptibility-to-asbestos-induced-malignant-mesothelioma/</loc><lastmod>2024-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/educational-videos-may-encourage-prostate-cancer-screening-in-black-patients/</loc><lastmod>2024-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/anti-cd19-car-t-cell-therapy-for-richter-transformation/</loc><lastmod>2024-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/effect-of-virtually-delivered-cbt-for-insomnia-on-cancer-related-cognitive-impairment/</loc><lastmod>2024-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/blood-based-machine-learning-assay-may-noninvasively-detect-early-ovarian-cancer/</loc><lastmod>2024-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/the-lancet-commission-on-prostate-cancer-strategies-to-prepare-for-predicted-increases-in-disease-burden-by-2040/</loc><lastmod>2024-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/longer-interval-may-be-safe-for-prostate-cancer-screening-in-low-risk-patients/</loc><lastmod>2024-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/novel-urine-biomarker-test-may-reduce-unnecessary-cystoscopies-in-patients-with-bladder-cancer/</loc><lastmod>2024-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/lung-cancer-screening-eligibility-effect-of-using-history-vs-pack-year-history-of-smoking/</loc><lastmod>2024-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/b-cell-non-hodgkin-lymphoma-extended-follow-up-with-mosunetuzumab/</loc><lastmod>2024-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/radon-gas-exposure-may-be-linked-to-increased-incidence-of-lung-cancer-in-nonsmokers/</loc><lastmod>2024-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/illuminating-a-potential-culprit-in-melanoma-treatment-resistance/</loc><lastmod>2024-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/advanced-anal-cancer-addition-of-atezolizumab-to-first-line-modified-docetaxel-cisplatin-and-fluorouracil/</loc><lastmod>2024-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/t-cell-therapy-in-advanced-synovial-sarcoma-and-myxoid-round-cell-liposarcoma/</loc><lastmod>2024-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/feasibility-of-ending-specialist-follow-up-in-patients-with-low-risk-cll/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/oxaliplatin-based-adjuvant-therapy-in-older-patients-with-stage-iii-colon-cancer/</loc><lastmod>2024-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/newly-diagnosed-locally-advanced-hnscc-adding-pembrolizumab-to-concurrent-chemoradiotherapy/</loc><lastmod>2024-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/genetic-variants-potentially-linked-to-prevalent-or-persistent-hpv-infections-identified/</loc><lastmod>2024-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/new-findings-suggest-no-correlation-between-glp-1-receptor-agonists-and-thyroid-cancer-risk/</loc><lastmod>2024-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/risk-of-second-primary-breast-cancer-in-young-breast-cancer-survivors/</loc><lastmod>2024-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/survival-rates-in-patients-with-cancer-and-intellectual-and-developmental-disabilities/</loc><lastmod>2024-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/improving-early-detection-of-pancreatic-cancer-in-high-risk-patients/</loc><lastmod>2024-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/professional-societies-introduce-new-evidence-based-guidelines-on-testing-immunotherapy-biomarkers-in-nsclc/</loc><lastmod>2024-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/novel-spectct-imaging-technique-under-study-in-prostate-cancer/</loc><lastmod>2024-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/functional-disability-among-us-cancer-survivors-2017-2022/</loc><lastmod>2024-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/observing-a-healthy-diet-may-reduce-risk-of-cardiovascular-disease-in-breast-cancer-survivors/</loc><lastmod>2024-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/propofol-based-anesthesia-may-offer-improved-detection-of-serrated-polyps-during-colonoscopy/</loc><lastmod>2024-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/nivolumab-with-or-without-ipilimumab-in-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2024-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/cabozantinib-in-metastatic-pheochromocytomas-or-paragangliomas/</loc><lastmod>2024-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/chemohormonal-therapy-for-locally-advanced-prostate-cancer/</loc><lastmod>2024-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/predicting-ovarian-cancer-relapse-with-spatial-tissue-analysis/</loc><lastmod>2024-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fda-approves-nogapendekin-alfa-inbakicept-pmln-for-bcg-unresponsive-non-muscle-invasive-bladder-cancer/</loc><lastmod>2024-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/induction-and-concurrent-vismodegib-with-radiation-therapy-for-locally-advanced-unresectable-basal-cell-carcinoma/</loc><lastmod>2024-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fda-grants-accelerated-approval-to-tovorafenib-for-patients-with-relapsed-or-refractory-braf-altered-pediatric-low-grade-glioma/</loc><lastmod>2024-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/potential-protective-effects-of-aspirin-against-colorectal-cancer/</loc><lastmod>2024-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fda-approves-lu-177-dotatate-for-pediatric-patients-with-gep-nets/</loc><lastmod>2024-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/imaging-drug-to-assist-in-detection-of-cancerous-tissue-following-lumpectomy-approved/</loc><lastmod>2024-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/in-hospital-mortality-among-patients-with-covid-19-infection-with-or-without-cancer/</loc><lastmod>2024-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/ai-model-may-help-predict-treatment-responses-select-most-effective-cancer-therapies-in-patients-with-cancer/</loc><lastmod>2024-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/atezolizumabcabozantinib-vs-docetaxel-in-previously-treated-metastatic-nsclc/</loc><lastmod>2024-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/alk-positive-nsclc-adjuvant-alectinib-vs-platinum-based-chemotherapy/</loc><lastmod>2024-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/cabozantinib-in-advanced-adrenocortical-carcinoma/</loc><lastmod>2024-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/her2-positive-early-breast-cancer-pet-based-pcr-adapted-strategy/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/cisplatin-gemcitabine-and-imrt-in-locally-advanced-vulvar-cancer/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/breast-cancer-survivors-relationship-satisfaction-and-emotional-and-physical-well-being/</loc><lastmod>2024-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/lack-of-research-focused-on-older-adults-with-cancer-may-be-contributing-to-disparities-in-care/</loc><lastmod>2024-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/risk-of-t-cell-and-second-primary-malignant-neoplasms-after-car-t-cell-therapy/</loc><lastmod>2024-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/combined-ici-and-vegf-inhibitor-trials-in-cancer-cardiovascular-eligibility-criteria-and-adverse-event-reporting/</loc><lastmod>2024-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/adjuvant-pembrolizumab-in-renal-cell-carcinoma-overall-survival-in-keynote-564/</loc><lastmod>2024-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/barriers-to-autologous-hematopoietic-cell-transplantation-in-multiple-myeloma/</loc><lastmod>2024-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/immunotherapy-plus-folfiri-for-advanced-gastricgastroesophageal-junction-adenocarcinoma/</loc><lastmod>2024-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/mri-guided-duration-of-neoadjuvant-chemotherapy-in-her2-positive-breast-cancer/</loc><lastmod>2024-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/financial-hardships-caused-by-cancer-are-long-lasting-for-many-working-age-adults/</loc><lastmod>2024-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/trends-in-hematopoietic-cell-transplantation-survival-rates-across-racial-and-ethnic-groups/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/combination-of-preketone-supplements-and-immunotherapy-may-be-effective-in-patients-with-prostate-cancer/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fda-approves-tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/fda-approves-trastuzumab-biosimilar-trastuzumab-strf/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/neoadjuvant-chemoimmunotherapy-in-patients-with-early-stage-nsclc/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/propofol-exposure-and-neurocognitive-outcomes-in-children-with-high-risk-all/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/uspstf-issues-final-recommendation-statement-on-screening-for-breast-cancer/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/the-lancet-commission-on-breast-cancer-reducing-overlooked-inequities-in-breast-cancer/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/04-april/immunotherapy-resistance-and-response-to-adoptive-therapy-in-patients-with-metastatic-uveal-melanoma/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-amivantamab-vmjw-for-egfr-exon-20-insertion-mutated-nsclc/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/liposomal-irinotecan-in-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/w-kimryn-rathmell-md-phd-selected-as-17th-director-of-the-nci/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/asco-releases-resource-stratified-guideline-for-the-treatment-of-metastatic-breast-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fruquintinib-plus-paclitaxel-under-study-as-second-line-treatment-of-gastroesophageal-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/esophageal-squamous-cell-cancer-overall-survival-improved-with-tiragolumab-and-atezolizumab-plus-chemotherapy/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/lenvatinib-plus-pembrolizumab-fails-to-improve-overall-survival-in-advanced-head-and-neck-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/promoting-cardiovascular-health-in-adult-survivors-of-childhood-cancers/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/lifileucel-for-unresectable-or-metastatic-melanoma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/adjuvant-nivolumab-in-stage-iibc-melanoma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/integrative-approaches-to-managing-symptoms-of-anxiety-and-depression-in-adults-with-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/a-clinical-trial-for-bladder-cancer-gave-me-back-my-life/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/brachytherapy-boost-may-decrease-the-duration-of-androgen-deprivation-therapy-for-high-risk-prostate-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/in-resectable-non-small-cell-lung-cancer-perioperative-use-of-tislelizumab-alone-or-with-chemotherapy-improved-outcomes/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-luis-paz-ares/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/from-fatal-to-fearless-how-patients-can-take-control-of-their-disease-and-fear-cancer-less/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/kathy-giusti-s-experience-with-stem-cell-transplant-for-multiple-myeloma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/erdafitinib-for-previously-treated-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/enfortumab-vedotin-ejfv-plus-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/strategies-for-cardiovascular-risk-mitigation-and-monitoring-in-patients-with-cll/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/mantle-cell-lymphoma-front-line-therapy/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/use-of-combination-immunotherapy-before-lung-cancer-surgery/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/adjuvant-pembrolizumab-a-new-option-for-high-risk-muscle-invasive-urothelial-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/cancer-care-providers-urge-president-biden-to-make-health-care-a-state-of-the-union-priority/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/enfortumab-vedotin-plus-pembrolizumab-yields-benefit-in-key-subgroups-with-advanced-urothelial-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-nivolumab-in-combination-with-cisplatin-and-gemcitabine-for-unresectable-or-metastatic-urothelial-carcinoma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-grants-accelerated-approval-to-zanubrutinib-plus-obinutuzumab-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/risks-of-cardiovascular-disease-in-patients-receiving-therapies-for-lung-cancer/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/osimertinib-with-chemotherapy-for-egfr-mutated-nsclc/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/repotrectinib-for-ros1-fusion-positive-advanced-nsclc/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/cabozantinib-plus-atezolizumab-improves-progression-free-survival/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/cardio-oncology-is-a-growing-subspecialty-but-where-are-the-oncologists/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/multitarget-fecal-immunochemical-test-in-stool-based-colorectal-cancer-screening/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/president-s-cancer-panel-report-highlights-opportunities-to-accelerate-progress-toward-the-national-cancer-plan/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/romidepsin-plus-chop-in-previously-untreated-peripheral-t-cell-lymphoma-final-analysis-of-ro-chop-trial/</loc><lastmod>2024-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/from-a-small-town-in-lebanon-a-young-doctor-follows-his-passion-to-an-international-career-in-cancer-research/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/asco-chief-medical-officer-testifies-to-congress-about-ongoing-cancer-drug-shortage-crisis/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/i-am-young-and-fit-and-have-stage-iv-alveolar-soft-part-sarcoma/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/geriatric-oncology-educational-opportunity-at-memorial-sloan-kettering-cancer-center/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/accc-changes-name-to-association-of-cancer-care-centers/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-rachid-baz/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/patricia-lorusso-named-the-amy-and-joseph-perella-professor-of-medicine-at-yale-school-of-medicine/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/asco-and-sso-publish-new-guideline-on-germline-testing-in-breast-cancer/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/relationship-between-second-malignant-neoplasm-and-heart-disease-studied-in-childhood-cancer-survivors/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/olaparib-plus-abiraterone-and-prednisone-improves-outcomes-over-single-agents-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-kim-chi/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/how-the-max-foundation-is-accelerating-equitable-cancer-care-globally/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fruquintinib-in-refractory-metastatic-colorectal-cancer/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/benefit-of-belantamab-mafodotin-based-regimen-supported-in-multiple-myeloma/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/studies-show-progress-in-using-ctdna-to-guide-colorectal-cancer-treatment/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-aparna-parikh/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/should-you-reconsider-transplant-for-relapsed-large-b-cell-lymphoma-in-complete-remission/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-michael-crump/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/long-term-follow-up-affirms-benefit-of-pembrolizumab-plus-chemotherapy-in-advanced-esophageal-cancer/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/newly-diagnosed-multiple-myeloma/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-irinotecan-liposome-for-the-first-line-treatment-of-metastatic-pancreatic-adenocarcinoma/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/reframing-dcis-as-an-opportunity-for-cancer-prevention/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/two-adjuvant-therapy-studies-show-divergent-outcomes-with-pd-1-inhibitors-in-renal-cell-carcinoma/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-pedro-barata/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/nivolumab-plus-ipilimumab-improves-progression-free-survival-in-first-line-setting-of-metastatic-colorectal-cancer/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/epov-alan-venook/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/celebrating-advances-in-cancer-care-and-a-look-at-how-ai-is-revolutionizing-oncology/</loc><lastmod>2024-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/online-genetic-education-programs-may-spur-testing-for-patients-at-risk-for-cancer/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/aua-astro-suo-release-clinical-practice-guidelines-on-salvage-therapy-for-prostate-cancer/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/nasopharyngeal-carcinoma-radiotherapy-vs-chemoradiotherapy-after-induction-chemotherapy/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/advanced-multiple-myeloma-prediction-model-for-outcomes-after-bcma-directed-car-t-cell-therapy/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/circulating-leukocyte-subsets-after-breast-cancer-diagnosis-and-treatment/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/nccn-updates-treatment-recommendations-for-breast-colorectal-lung-and-other-cancers/</loc><lastmod>2024-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/social-determinants-of-health-potentially-responsible-for-low-breast-cancer-screening-rates/</loc><lastmod>2024-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/can-dual-her2-blockade-treat-more-than-just-breast-or-gastric-cancer/</loc><lastmod>2024-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/hpv-vaccination-among-young-adults-prior-to-and-during-the-covid-19-pandemic/</loc><lastmod>2024-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/variations-in-use-of-chemotherapy-in-patients-with-newly-diagnosed-common-cancers/</loc><lastmod>2024-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/hpv-associated-oropharyngeal-cancer-adjuvant-treatment-deintensification/</loc><lastmod>2024-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/could-smoking-related-dna-changes-reflect-differential-lung-cancer-risks-by-race-and-ethnicity/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/medical-debt-may-be-associated-with-poorer-health-status-and-survival-outcomes-at-us-county-level/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-denosumab-biosimilars/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/low-risk-cervical-cancer-pelvic-recurrence-with-simple-vs-radical-hysterectomy/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/novel-cd123-targeting-antibody-drug-conjugate-in-relapsed-or-refractory-aml/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/factors-associated-with-myeloid-neoplasms-following-car-t-cell-therapy/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-inotuzumab-ozogamicin-for-pediatric-patients-with-all/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/finding-new-therapeutic-targets-for-male-breast-cancer/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/physician-attitudes-toward-2020-acs-cervical-cancer-screening-guidelines/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/patients-with-early-stage-hr-positive-breast-cancer-may-be-over-or-undertreated-without-breast-cancer-index-genomic-testing/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/topical-diclofenac-to-prevent-capecitabine-associated-hand-foot-syndrome/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/higher-bmi-may-be-linked-to-complications-following-autologous-breast-reconstruction/</loc><lastmod>2024-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/worsening-metabolic-syndrome-may-increase-cancer-risk/</loc><lastmod>2024-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/zanubrutinib-vs-acalabrutinib-in-relapsed-or-refractory-cll-new-efficacy-analysis/</loc><lastmod>2024-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/variations-in-use-of-radiotherapy-in-patients-with-newly-diagnosed-common-cancers/</loc><lastmod>2024-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/patients-with-biochemical-recurrence-of-prostate-cancer-ga-68-rm2-pet-mri-vs-mri-alone-for-lesion-detection/</loc><lastmod>2024-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/hpv-associated-oropharyngeal-cancer-intratreatment-fdg-pet-response-as-a-biomarker-for-de-escalation-of-radiotherapy/</loc><lastmod>2024-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/collaborative-care-intervention-may-benefit-patients-with-cancer-health-care-systems/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/risk-score-to-assess-cardiovascular-complications-in-hematopoietic-stem-cell-transplant-recipients/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/immunotherapy-trials-for-metastatic-nsclc-fda-pooled-analysis/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/sunitinib-in-metastatic-progressive-pheochromocytomas-and-paragangliomas/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/metastatic-triple-negative-breast-cancer-sacituzumab-govitecan-vs-single-agent-chemotherapy-in-previously-treated-patients/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/cancer-prevalence-in-europe-as-of-2020/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/germ-cell-tumors-survival-rates-in-female-vs-male-patients/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/novel-dual-target-car-t-cell-therapy-for-recurrent-glioblastoma/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/acs-and-flatiron-health-announce-recipients-of-fourth-annual-real-world-data-impact-awards/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/nab-sirolimus-in-advanced-malignant-perivascular-epithelioid-cell-tumors-ampect-trial-final-analysis/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-tislelizumab-for-previously-treated-patients-with-advanced-esophageal-cancer/</loc><lastmod>2024-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/accelerated-approval-granted-to-first-car-t-cell-therapy-for-relapsed-or-refractory-cllsll/</loc><lastmod>2024-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/h-pylori-infection-risk-of-colorectal-cancer-and-colorectal-cancer-related-mortality/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/sabr-for-patients-with-primary-kidney-cancer-not-undergoing-resection/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/exploring-the-genetic-link-between-colorectal-cancer-and-meat-consumption/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/chatgpt-may-accurately-answer-common-patient-questions-regarding-gynecologic-cancer/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/localized-or-advanced-prostate-cancer-short-or-longer-term-relugolix-plus-radiotherapy/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/durvalumab-based-regimens-improve-response-over-chemotherapy-alone-in-pmmr-advanced-endometrial-cancer/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/performance-of-cfdna-blood-based-test-for-colorectal-cancer-screening/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/hormonal-therapy-plus-sbrt-for-advanced-prostate-cancer/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/lillian-siu-named-2024-2025-aacr-president-elect/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/adjuvant-pembrolizumab-in-resected-stage-iib-or-iic-melanoma/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/next-generation-multitarget-stool-dna-test-for-colorectal-cancer-screening/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-grants-accelerated-approval-to-ponatinib-with-chemotherapy-for-newly-diagnosed-philadelphia-chromosome-positive-all/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/liquid-biopsy-may-help-predict-outcomes-in-patients-with-gastroesophageal-cancers-following-immunotherapy/</loc><lastmod>2024-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/avelumab-plus-axitinib-in-mismatch-repair-proficient-recurrent-or-persistent-endometrial-cancer/</loc><lastmod>2024-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/impact-of-behavioral-health-disorders-on-cancer-surgery-outcomes/</loc><lastmod>2024-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/disparities-in-treatment-outcomes-among-non-hispanic-black-patients-with-locally-advanced-rectal-cancer/</loc><lastmod>2024-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/racialethnic-differences-in-treatment-outcomes-among-patients-with-triple-negative-breast-cancer/</loc><lastmod>2024-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/can-hpv-ctdna-guide-the-adjuvant-treatment-of-oropharyngeal-cancer/</loc><lastmod>2024-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/inherited-genetic-factors-may-influence-risk-of-subsequent-cancer-diagnoses-in-childhood-cancer-survivors/</loc><lastmod>2024-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/five-new-cancer-grand-challenges-teams-named-in-global-effort-to-resolve-hurdles-in-cancer-research/</loc><lastmod>2024-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/primary-tumor-resection-before-chemotherapy-in-patients-with-colon-cancer-and-unresectable-metastases/</loc><lastmod>2024-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/novel-mdm2-inhibitor-for-salivary-gland-cancers/</loc><lastmod>2024-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/localized-prostate-cancer-association-of-psa-nadir-within-6-months-of-radiotherapy-with-outcomes/</loc><lastmod>2024-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/effect-of-her2-gene-expression-levels-on-outcomes-in-metastatic-colorectal-cancer/</loc><lastmod>2024-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/car-t-cell-therapy-complications-comparison-of-three-testing-modalities/</loc><lastmod>2024-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/venetoclax-in-relapsed-or-refractory-chronic-lymphocytic-leukemia/</loc><lastmod>2024-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/racialethnic-differences-in-care-intensity-at-the-end-of-life-for-patients-with-lung-cancer/</loc><lastmod>2024-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/pembrolizumab-may-improve-breast-cancer-outcomes-regardless-of-age-or-menopausal-status/</loc><lastmod>2024-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/updated-immune-classifier-imprinttn-may-accurately-identify-patients-with-triple-negative-breast-cancer-who-are-unlikely-to-respond-to-immunotherapy/</loc><lastmod>2024-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/incidence-of-secondary-t-cell-malignancies-following-car-t-cell-therapy/</loc><lastmod>2024-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/effect-of-exercise-on-symptom-burden-and-quality-of-life-in-patients-with-metastatic-breast-cancer/</loc><lastmod>2024-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/addition-of-atezolizumab-to-adjuvant-chemotherapy-in-triple-negative-breast-cancer/</loc><lastmod>2024-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-safety-labeling-changes-regarding-dpd-deficiency-for-fluorouracil-injection-products/</loc><lastmod>2024-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/flt3-itd-mutated-aml-gilteritinib-in-posttransplantation-maintenance/</loc><lastmod>2024-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/is-hypofractionated-radiotherapy-emerging-as-the-new-standard-of-care-after-prostatectomy/</loc><lastmod>2024-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/combined-pet-mri-scan-could-benefit-patients-with-early-stage-breast-cancer/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/response-to-primary-systemic-therapy-could-dictate-whether-extensive-lymph-node-removal-is-needed-in-patients-with-breast-cancer/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/low-dose-radiotherapy-boost-in-young-patients-with-breast-cancer/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/fda-approves-mirvetuximab-soravtansine-gynx-for-epithelial-ovarian-fallopian-tube-or-primary-peritoneal-cancer/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/early-breast-cancer-adding-adjuvant-ribociclib-to-nonsteroidal-aromatase-inhibitor-therapy/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/dostarlimab-based-combinations-in-advanced-endometrial-cancer/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/subtype-of-fusobacterium-nucleatum-may-be-linked-to-colorectal-cancer-progression-and-poor-outcomes/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/gut-microbiome-signatures-may-help-unravel-disparities-in-early-onset-colorectal-cancer/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/integrated-screening-and-stepped-collaborative-care-intervention-effect-on-health-related-quality-of-life-in-patients-with-cancer/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/stopping-tki-treatment-in-chronic-myeloid-leukemia/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/endoscopic-screening-and-esophageal-cancer-incidence-and-mortality/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/stage-iii-colorectal-cancer-association-of-immunoscore-with-disease-free-survival/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/novel-drug-combination-in-multiple-myeloma/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/ikzf1-genetic-variant-may-contribute-to-disparities-in-risk-of-all-in-pediatric-hispanic-and-latino-patients/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/pembrolizumab-with-chemoradiotherapy-for-figo-2014-stage-iii-iva-cervical-cancer/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/belzutifan-in-previously-treated-advanced-renal-cell-carcinoma/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/early-breast-cancer-nurse-led-follow-up-intervention-and-quality-of-life-after-treatment/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/eflornithine-for-adult-and-pediatric-patients-with-high-risk-neuroblastoma/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/amivantamab-vmjw-in-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/inotuzumab-ozogamicin-for-relapsed-or-refractory-pediatric-acute-lymphoblastic-leukemia/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/eligibility-for-and-prevalence-of-lung-cancer-screening-in-the-united-states-in-2022/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/chemoradiotherapy-with-or-without-pembrolizumab-for-newly-diagnosed-high-risk-locally-advanced-cervical-cancer/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/older-patients-with-aml-does-stem-cell-transplant-improve-long-term-outcomes/</loc><lastmod>2024-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/malpractice-risk-with-active-surveillance-for-patients-with-low-risk-cancer/</loc><lastmod>2024-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/prolonged-use-of-progestogens-may-be-linked-to-increased-risk-of-brain-cancer/</loc><lastmod>2024-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/nsclc-neoadjuvant-chemoimmunotherapy-vs-neoadjuvant-chemotherapy/</loc><lastmod>2024-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/gu-and-gi-symptoms-with-postprostatectomy-radiotherapy-for-prostate-cancer/</loc><lastmod>2024-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/sabr-in-patients-with-early-nsclc-and-interstitial-lung-disease/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/previously-untreated-advanced-urothelial-cancer-antibody-drug-conjugate-plus-pd-1-inhibitor/</loc><lastmod>2024-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/trends-in-breast-cancer-diagnoses-during-the-covid-19-pandemic/</loc><lastmod>2024-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/03-march/p16-positive-oropharyngeal-cancer-surrogate-endpoints-for-overall-survival-in-clinical-trials/</loc><lastmod>2024-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/highlights-from-the-2023-san-antonio-breast-cancer-symposium/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/idea-trial-might-radiation-one-day-be-safely-omitted-for-younger-favorable-risk-postmenopausal-patients-with-breast-cancer/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-laura-huppert/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/neoadjuvant-chemoimmunotherapy-improves-pathologic-complete-response-rates-in-subgroup-analysis-of-keynote-756/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-heather-han/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/natalee-trial-long-term-results-on-ribociclib-combination-therapy-in-early-stage-breast-cancer/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-valentina-guarneri/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/tucatinib-plus-t-dm1-extends-progression-free-survival-vs-t-dm1-alone-in-advanced-her2-positive-breast-cancer/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/first-line-radioligand-based-therapy-demonstrates-benefit-in-some-neuroendocrine-tumors/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/understanding-risk-stratification-in-monoclonal-gammopathy-of-undetermined-significance/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/for-unresectable-liver-cancer-the-addition-of-durvalumab-and-bevacizumab-boosts-efficacy-of-transarterial-chemoembolization/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/evaluating-the-use-of-perioperative-chemoimmunotherapy-in-resectable-gastric-and-gastroesophageal-junction-cancers/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/idea-trial-might-radiation-one-day-be-safely-omitted-for-younger-favorable-risk-postmenopausal-patients-with-breast-cancer-1/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/belzutifan-new-standard-in-previously-treated-renal-cell-carcinoma/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-lisa-pickering/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/preventing-cancer-should-not-mean-sacrificing-quality-of-life/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/asco-remembers-humanitarian-and-health-equity-champion-edith-mitchell/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/exploring-the-role-of-intravenous-mistletoe-extract-in-treating-metastatic-solid-tumors/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/aacr-cancer-centers-alliance-formed/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/all-oral-regimen-feasible-and-effective-in-acute-promyelocytic-leukemia-study-finds/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-aaron-t-gerds/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/annual-report-to-the-nation-part-2-new-cancer-diagnoses-fell-abruptly-early-in-the-covid-19-pandemic/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/asco-welcomes-new-rule-establishing-electronic-prior-authorization-in-federal-health-plans/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/rapid-guideline-update-on-radiotracers-for-determining-radioligand-treatment-eligibility-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/american-cancer-society-annual-report-shows-cancer-mortality-still-declining-but-cancer-incidence-is-projected-to-top-2-million/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/sotorasib-the-poster-child-for-project-optimus-truths-and-fantasies/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/high-risk-localized-prostate-cancer-survival-benefit-with-long-term-adt-and-dose-escalated-radiation-therapy/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/how-asco-s-regional-councils-are-having-an-international-impact-on-patients-with-cancer/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/reflections-on-cancer-s-toll-on-my-family/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/understanding-the-discordance-about-prognosis-between-clinicians-and-terminally-ill-patients-and-their-surrogates/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/some-patients-with-breast-cancer-may-safely-avoid-locoregional-irradiation-after-neoadjuvant-chemotherapy/</loc><lastmod>2024-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-david-sallman-and-mikkael-sekeres/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/venetoclax-plus-azacitidine-evaluated-in-high-risk-myelodysplastic-syndromes/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-prithviraj-bose/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/first-line-ruxolitinib-combinations-boost-benefit-over-single-agent-in-myelofibrosis/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-dipenkumar-modi/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/study-finds-four-drug-targeted-treatment-reduces-chemotherapy-requirement-for-some-in-large-b-cell-lymphoma/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-carla-casulo/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/ultra-low-dose-of-radiotherapy-may-be-enough-in-gastric-malt-lymphoma/</loc><lastmod>2024-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-cynthia-dunbar/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/real-world-experience-mirrors-perseus-findings/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-ajay-nooka-and-dan-vogl/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/highlights-from-the-2023-ash-annual-meeting-exposition/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-michael-crump/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/should-you-reconsider-transplant-for-relapsed-large-b-cell-lymphoma-in-complete-remission/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-peter-voorhees/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/addition-of-isatuximab-to-carfilzomib-based-regimen-doubles-mrd-negativity-rates-in-multiple-myeloma/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-william-g-blum-and-mikkael-sekeres/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/in-npm1-mutated-aml-benefit-of-transplant-limited-to-patients-with-residual-disease/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/canadian-study-shows-myeloma-outcomes-in-the-real-world-may-be-worse-than-clinical-trials-suggest/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/perseus-daratumumab-regimen-significantly-improves-progression-free-survival-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/epov-aaron-t-gerds-1/</loc><lastmod>2024-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/all-oral-regimen-feasible-and-effective-in-acute-promyelocytic-leukemia-study-finds-1/</loc><lastmod>2024-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/osimertinib-vs-sequential-gefitinibosimertinib-in-advanced-egfr-mutant-nsclc/</loc><lastmod>2024-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/low-dose-pem-may-help-transform-breast-cancer-detection/</loc><lastmod>2024-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/can-physical-activity-lessen-pain-intensity-in-cancer-survivors/</loc><lastmod>2024-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/breast-cancer-incidence-by-race-stage-and-hormone-receptor-status-in-us-women/</loc><lastmod>2024-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/crenolanib-and-intensive-chemotherapy-in-newly-diagnosed-flt3-mutated-aml/</loc><lastmod>2024-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/trabectedin-vs-chemotherapy-in-recurrent-ovarian-cancer-with-brca-mutation-or-brcaness-phenotype/</loc><lastmod>2024-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/sleep-apnea-may-be-prevalent-among-patients-with-cancer-at-high-risk-of-congestive-heart-failure/</loc><lastmod>2024-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/plant-based-diet-may-be-linked-to-improved-sexual-health-in-men-treated-for-prostate-cancer/</loc><lastmod>2024-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/postmenopausal-patients-with-er-richher2-negative-breast-cancer-neoadjuvant-therapies/</loc><lastmod>2024-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/mia-calculator-for-predicting-recurrence-free-and-overall-survival-in-stage-ii-melanoma/</loc><lastmod>2024-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/are-major-adverse-financial-events-linked-to-a-later-stage-cancer-diagnosis/</loc><lastmod>2024-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/shedding-light-on-mechanisms-behind-fulvestrant-resistance-in-advanced-er-positive-breast-cancer/</loc><lastmod>2024-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/novel-biomarker-in-cancer-survivors-may-be-linked-to-higher-risk-of-mortality/</loc><lastmod>2024-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/molecular-subtype-based-therapy-in-the-first-line-treatment-of-metastatic-or-recurrent-triple-negative-breast-cancer/</loc><lastmod>2024-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/neoadjuvant-immunotherapy-may-improve-long-term-survival-in-patients-with-soft-tissue-sarcoma/</loc><lastmod>2024-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/durvalumab-plus-ceralasertib-in-patients-with-immunotherapy-resistant-nsclc/</loc><lastmod>2024-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/system-to-improve-clinical-staging-in-localized-pancreatic-cancer/</loc><lastmod>2024-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/triplet-for-advanced-her2-negative-breast-cancer/</loc><lastmod>2024-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/representation-may-be-essential-for-black-men-seeking-prostate-cancer-information-online/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/stab-t-cell-based-immunotherapy-in-multiple-myeloma/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/steven-rosenberg-honored-with-2024-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/novel-monotherapy-in-recurrent-h3-k27m-mutant-diffuse-midline-glioma/</loc><lastmod>2024-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/fda-approves-osimertinib-with-chemotherapy-for-egfr-mutated-nsclc/</loc><lastmod>2024-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/analysis-of-cancer-diagnoses-after-recent-weight-loss/</loc><lastmod>2024-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/modified-chemotherapy-regimens-may-improve-quality-of-life-in-older-patients-with-advanced-cancer/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/does-risk-reducing-mastectomy-reduce-breast-cancer-mortality/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/tbi-and-risk-of-brain-cancer-in-veterans-of-the-iraq-and-afghanistan-wars/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/genetic-alterations-associated-with-interval-breast-cancer-diagnosis/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/final-results-of-the-pout-trial-adjuvant-chemotherapy-vs-surveillance-after-nephroureterectomy-for-upper-tract-urothelial-cancer/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/perioperative-tislelizumab-plus-chemotherapy-in-resectable-nsclc/</loc><lastmod>2024-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/does-annual-breast-cancer-screening-starting-at-age-40-offer-benefit/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/strategies-to-reduce-burden-of-colorectal-cancer-in-latin-america/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/postdiagnosis-mental-disorders-among-ayas-with-cancer/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/hyperbaric-oxygen-therapy-for-late-local-toxic-effects-in-patients-receiving-adjuvant-radiotherapy-for-breast-cancer/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/long-term-follow-up-of-the-anthracyclines-in-early-breast-cancer-abc-trials/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/fda-approves-biweekly-teclistamab-dosing-regimen-for-patients-with-multiple-myeloma/</loc><lastmod>2024-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/prophylactic-oral-vancomycin-may-prevent-c-difficile-infections-raise-risk-of-gram-negative-bacteremia-in-stem-cell-transplant-recipients/</loc><lastmod>2024-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/nihs-new-cancer-screening-research-network-could-help-determine-effective-cancer-screening-technologies/</loc><lastmod>2024-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/high-risk-non-muscle-invasive-bladder-cancer-reduced-induction-courses-of-bcg/</loc><lastmod>2024-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/enobosarm-in-previously-treated-patients-with-ar-positive-er-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2024-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/metastatic-castration-resistant-prostate-cancer-tumor-mutational-burden-and-response-to-checkpoint-inhibition/</loc><lastmod>2024-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/sbrt-vs-conventional-external-beam-radiotherapy-for-painful-bone-metastases/</loc><lastmod>2024-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/adjuvant-olaparib-for-germline-brca12-mutant-high-risk-her2-negative-early-breast-cancer-pros-from-the-olympia-trial/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/fda-approves-tepotinib-for-metastatic-nsclc/</loc><lastmod>2024-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/ablative-stereotactic-mr-guided-adaptive-radiation-therapy-in-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2024-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/neoadjuvant-chemotherapy-may-benefit-patients-with-penile-squamous-cell-carcinoma/</loc><lastmod>2024-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/families-of-men-with-subfertility-may-have-increased-risk-of-several-types-of-cancers/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/8-year-follow-up-of-mindact-trial-locoregional-breast-cancer-recurrence-in-patients-undergoing-breast-conserving-surgery/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/covid-19-risk-in-pediatric-patients-receiving-treatment-for-leukemia-or-lymphoma/</loc><lastmod>2024-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/pegasparaginase-dosing-and-risk-of-hypersensitivity-reactions-in-pediatric-all/</loc><lastmod>2024-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/gene-signature-may-predict-response-to-combination-therapy-in-patients-with-nsclc/</loc><lastmod>2024-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/psychological-distress-may-contribute-to-cancer-treatment-delays/</loc><lastmod>2024-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/doxorubicin-exposure-and-risk-of-breast-cancer-in-survivors-of-hodgkin-lymphoma/</loc><lastmod>2024-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/rusfertide-for-erythrocytosis-in-polycythemia-vera/</loc><lastmod>2024-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/adding-first-line-nivolumab-to-chemotherapy-in-advanced-gastric-gastroesophageal-junction-and-esophageal-adenocarcinoma/</loc><lastmod>2024-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/us-individuals-with-incarceration-history-may-have-lower-likelihood-of-undergoing-cancer-screenings/</loc><lastmod>2024-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/exposure-to-secondhand-smoke-during-chemotherapy-may-decrease-treatment-efficacy-in-patients-with-head-and-neck-cancer/</loc><lastmod>2024-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/risk-of-stroke-in-survivors-of-head-and-neck-cancer/</loc><lastmod>2024-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/mtor-inhibitor-prednisone-and-cemiplimab-for-kidney-transplant-recipients-with-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2024-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/annual-increases-in-cardiorespiratory-fitness-may-help-reduce-risk-of-prostate-cancer/</loc><lastmod>2024-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/blood-tests-could-help-predict-which-patients-with-lymphoma-may-respond-poorly-to-car-t-cell-therapy/</loc><lastmod>2024-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/addition-of-palbociclib-to-letrozole-in-er-positive-her2-negative-advanced-breast-cancer-overall-survival-in-paloma-2/</loc><lastmod>2024-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/addition-of-nivolumab-to-chemotherapy-in-egfr-mutant-metastatic-nsclc-after-disease-progression-on-prior-therapy/</loc><lastmod>2024-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/effects-of-switch-to-high-deductible-health-plans-for-patients-with-cancer/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/report-sheds-light-on-critical-pathway-responsible-for-treatment-resistance-in-melanoma/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/survivors-of-childhood-cancer-with-high-anthracycline-exposure-can-a-beta-blocker-improve-cardiac-function/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/actinium-225-psma-radioligand-therapy-for-prostate-cancer/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/osimertinib-may-offer-survival-benefit-over-immunotherapy-in-some-patients-with-unresectable-nsclc/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/global-cancer-burden-may-be-growing-amidst-mounting-need-for-cancer-services/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/hpv-related-oropharyngeal-carcinoma-tumor-hypoxia-directed-treatment/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/golidocitinib-in-relapsed-or-refractory-peripheral-t-cell-lymphoma/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/intensification-of-adt-in-patients-with-high-risk-biochemically-relapsed-castration-sensitive-prostate-cancer-after-radical-prostatectomy/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/btk-degrader-may-target-treatment-resistance-in-patients-with-cll/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/antihypertensive-drug-combinations-may-help-reduce-blood-pressure-in-patients-receiving-ibrutinib/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/triplet-without-or-with-ipilimumab-in-kidney-transplant-recipients-with-advanced-cutaneous-cancers/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/azacitidine-venetoclax-and-gilteritinib-in-newly-diagnosed-and-relapsed-or-refractory-flt3-mutated-aml/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/metastatic-castration-resistant-prostate-cancer-lupsma-vs-cabazitaxel/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/high-reoperation-rates-following-breast-conserving-surgery-may-increase-cost-of-care-and-risk-of-complications/</loc><lastmod>2024-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/insufficiencies-discovered-in-patient-reported-outcomes-data-from-genitourinary-cancer-clinical-trials/</loc><lastmod>2024-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/localized-prostate-cancer-functional-outcomes-after-specific-treatments/</loc><lastmod>2024-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/skin-microbiome-and-severe-radiodermatitis-in-patients-with-breast-cancer/</loc><lastmod>2024-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/fruquintinib-plus-paclitaxel-as-second-line-treatment-for-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2024-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/dreamm-7-confirms-benefit-of-triplet-regimen-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2024-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/ephrin-b2-identified-as-potential-therapeutic-target-to-inhibit-multiple-myeloma-growth/</loc><lastmod>2024-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/machine-learning-model-may-predict-oxaliplatin-benefit-in-colon-cancer/</loc><lastmod>2024-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/mrd-markers-and-outcomes-in-patients-with-mds-after-stem-cell-transplant/</loc><lastmod>2024-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/ebv-positive-posttransplantation-lymphoproliferative-disease-t-cell-immunotherapy-efficacy/</loc><lastmod>2024-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/02-february/multiplex-analysis-of-intratumoral-immune-infiltrate-and-prognosis-in-colorectal-cancer/</loc><lastmod>2024-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-harry-p-erba/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/study-examines-real-world-outcomes-with-ivosidenib-vs-venetoclax-in-acute-myeloid-leukemia/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-paul-hampel/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/personalized-ibrutinib-plus-venetoclax-therapy-new-treatment-standard-for-chronic-lymphocytic-leukemia/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/the-high-cost-of-oral-agents-for-relapsed-and-refractory-multiple-myeloma/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/use-of-enzalutamide-in-nonmetastatic-castration-sensitive-prostate-cancer-with-biochemical-recurrence/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/my-breast-cancer-experience-has-led-me-to-leverage-my-expertise-in-human-centered-design-to-transform-patient-care/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/george-d-demetri-md-fasco-earns-lifetime-achievement-award-in-medicine-from-stanford-medicine-alumni-association/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/perseus-daratumumab-regimen-significantly-improves-progression-free-survival-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/real-world-experience-mirrors-perseus-findings/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-ajay-nooka-and-dan-vogl/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/sympatico-trial-ibrutinib-plus-venetoclax-improves-progression-free-survival-in-relapsed-mantle-cell-lymphoma/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-andrew-zelenetz/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/canadian-study-shows-myeloma-outcomes-in-the-real-world-may-be-worse-than-clinical-trials-suggest/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-cynthia-dunbar/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/natalee-trial-long-term-results-on-ribociclib-combination-therapy-in-early-stage-breast-cancer/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-heather-han/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/neoadjuvant-chemoimmunotherapy-improves-pathologic-complete-response-rates-in-subgroup-analysis-of-keynote-756/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-laura-huppert/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/integrated-medicine-and-collaborative-care-innovations-in-cancer-treatment-and-mental-health-care/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-daniel-curtis-mcfarland/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/international-collaborative-research-efforts-in-cardio-oncology/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/ovhipec-1-trial-hyperthermic-intraperitoneal-chemotherapy-plus-interval-cytoreductive-surgery-improves-survival-in-advanced-ovarian-cancer/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/2023-asco-advocacy-highlights/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/generic-drug-shortages-and-essential-cancer-medicines/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/new-director-of-the-university-of-hawaii-cancer-center-naoto-t-ueno-md-phd-facp-is-also-a-two-time-cancer-survivor/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/matthijs-oudkerk-phd-md-msc-honored-for-contributions-to-cancer-prevention-and-research/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/long-term-follow-up-supports-postneoadjuvant-t-dm1-over-trastuzumab-in-early-high-risk-her2-positive-breast-cancer/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/all-in-adults-trial-updates-and-clinical-considerations-for-selecting-consolidation-therapy/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/medical-cannabis-patterns-of-use-among-patients-with-cancer/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/tackling-the-challenges-of-oncology-workforce-shortages-increased-patient-demand-and-rising-costs-of-care/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/beyond-lung-cancer-leveraging-machine-learning-techniques-to-understand-other-diseases/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/how-being-a-member-of-the-president-s-national-cancer-advisory-board-is-contributing-to-high-quality-oncology-care/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/2023-members-appointed-to-the-national-cancer-advisory-board/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/undocumented-cost-of-care-discussions-a-missed-opportunity-in-cancer-treatment/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/patients-with-advanced-breast-cancer-may-gain-multiple-benefits-from-exercise-as-part-of-palliative-care/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-carlos-arteaga/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/eric-small-elected-asco-president-for-2025-2026-term/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/novel-pi3k-inhibitor-as-part-of-triplet-improves-outcomes-in-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2024-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-rory-m-shallis/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/menin-inhibitor-revumenib-shows-activity-in-kmt2a-rearranged-acute-leukemia/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/novel-pi3k-inhibitor-as-part-of-triplet-improves-outcomes-in-hormone-receptor-positive-her2-negative-breast-cancer-1/</loc><lastmod>2024-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-carlos-arteaga-1/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/patients-with-advanced-breast-cancer-may-gain-multiple-benefits-from-exercise-as-part-of-palliative-care-1/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/some-patients-with-breast-cancer-may-safely-avoid-locoregional-irradiation-after-neoadjuvant-chemotherapy/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/acro-acr-astro-and-asco-unite-to-ensure-patient-access-to-quality-cancer-care/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/novel-risk-model-may-personalize-prognosis-prediction-in-patients-with-multiple-myeloma/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/a-new-approach-to-identifying-consumer-products-that-contain-cancer-causing-chemicals/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/novel-blood-test-may-help-distinguish-neuroendocrine-prostate-cancer-from-other-subtypes/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/rituximab-maintenance-in-younger-patients-with-mantle-cell-lymphoma-long-term-follow-up/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/addition-of-avasopasem-to-sbrt-in-localized-pancreatic-cancer/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/unintentional-weight-loss-may-be-a-warning-sign-of-cancer-study-finds/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/study-finds-plant-rich-foods-nutsseeds-may-benefit-childhood-cancer-survivors/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/cabozantinib-and-atezolizumab-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/uchl1-protein-potential-biomarker-and-therapeutic-target-in-neuroendocrine-carcinomas-and-neuroblastoma/</loc><lastmod>2024-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/accelerated-hypofractionated-chemoradiation-with-adaptive-sabr-boost-in-locally-advanced-unresectable-nsclc/</loc><lastmod>2024-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/sacituzumab-govitecan-plus-pembrolizumab-in-metastatic-urothelial-cancer-progressing-after-platinum-based-chemotherapy/</loc><lastmod>2024-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/adjuvant-treatment-of-resected-melanoma-mrna-based-personalized-therapy-plus-immunotherapy/</loc><lastmod>2024-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/first-line-nivolumab-plus-ipilimumab-shows-benefit-in-metastatic-colorectal-cancer-subset/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/long-term-follow-up-of-keynote-590-benefit-of-pembrolizumab-plus-chemotherapy-affirmed-in-advanced-esophageal-cancer/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/uicc-offers-recommendations-in-preparation-for-world-cancer-day-2024/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/immunotherapy-outcomes-in-patients-with-primary-cardiac-soft-tissue-sarcomas/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/is-hrr-testing-underused-in-patients-with-prostate-cancer/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/subcutaneous-vs-intravenous-nivolumab-in-advanced-clear-cell-rcc/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/potential-risk-factors-for-postoperative-venous-thromboembolism-in-lung-cancer-identified/</loc><lastmod>2024-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/colon-cancer-mortality-rates-predictions-across-the-european-union-and-united-kingdom/</loc><lastmod>2024-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/ambassador-pembrolizumab-in-muscle-invasive-and-locally-advanced-urothelial-carcinoma/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/survival-benefit-with-adjuvant-immunotherapy-in-patients-with-clear-cell-rcc/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/fdg-petct-imaging-performed-after-1-week-of-immunotherapy-may-predict-treatment-response-in-patients-with-advanced-melanoma/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/more-intensified-salvage-regimen-for-prostate-cancer-does-not-impair-health-related-quality-of-life/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/immune-checkpoint-inhibitor-based-therapy-may-have-comparative-efficacy-in-black-and-white-patients-with-metastatic-renal-cell-carcinoma/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/use-of-adjuvant-nivolumab-in-patients-with-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/use-of-direct-oral-anticoagulant-agents-in-active-cancer-meta-analysis/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/additional-analysis-of-matterhorn-confirms-global-benefit-of-durvalumab-plus-flot-in-gastricgastroesophageal-cancer/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/rate-of-second-primary-lung-cancers-with-lobar-vs-sublobar-resection-of-t1an0-nsclc/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/intensified-vs-standard-induction-in-younger-patients-with-newly-diagnosed-aml/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/secondary-cancers-may-be-rare-in-patients-treated-with-car-t-cell-therapy/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/cervical-cancer-rates-may-be-rising-in-low-income-us-counties/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/novel-molecular-twin-tool-may-improve-precision-medicine-care-in-patients-with-pancreatic-cancer/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/antiemetic-strategies-for-patients-receiving-highly-emetogenic-chemotherapy/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/study-finds-most-patients-with-lynch-syndrome-are-not-using-aspirin-to-reduce-risk-of-colon-cancer/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/melanoma-overdiagnoses-may-be-rising-among-white-us-patients/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/fda-issues-safety-labeling-change-notification-to-car-t-cell-therapy-manufacturers/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/gemcitabinepaclitaxel-vs-gemcitabine-alone-after-folfirinox-in-metastatic-pancreatic-cancer/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/call-to-action-issued-to-expand-access-to-clinical-trials/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/addition-of-mri-to-ct-in-patients-scheduled-for-colorectal-liver-metastases-local-therapy/</loc><lastmod>2023-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/immunotherapy-initiation-at-the-end-of-life-for-patients-with-metastatic-cancers/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/locally-advanced-cervical-cancer-addition-of-camrelizumab-to-neoadjuvant-chemotherapy/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/normal-risk-ovarian-screening-study-long-term-update/</loc><lastmod>2024-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/factors-influencing-selection-of-active-surveillance-for-low-risk-prostate-cancer/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/netter-2-lu-177-dotatate-for-advanced-gastroenteropancreatic-neuroendocrine-tumors/</loc><lastmod>2024-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/real-world-data-show-impact-of-immunotherapy-in-populations-underrepresented-in-lung-cancer-clinical-trials/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/atezolizumab-plus-carboplatin-in-metastatic-triple-negative-breast-cancer/</loc><lastmod>2024-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/attitudes-toward-climate-change-may-impact-cancer-screening-behavior/</loc><lastmod>2024-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/novel-vaccine-may-delay-relapse-in-kras-mutated-pancreatic-and-colorectal-cancers/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/use-of-carvedilol-to-help-prevent-heart-failure-in-childhood-cancer-survivors/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/do-patients-with-molecular-mrd-detected-after-colorectal-cancer-surgery-benefit-from-adjuvant-chemotherapy/</loc><lastmod>2024-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/car-nk-cell-therapy-may-offer-benefit-in-patients-with-b-cell-malignancies/</loc><lastmod>2024-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/fda-approves-erdafitinib-for-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2024-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/standard-vs-histology-tailored-neoadjuvant-chemotherapy-in-high-grade-myxoid-liposarcoma/</loc><lastmod>2024-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/final-overall-survival-analysis-of-clearkeynote-581-lenvatinibpembrolizumab-vs-sunitinib-in-first-line-treatment-of-advanced-rcc/</loc><lastmod>2024-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/adding-immunotherapy-based-combination-to-tace-improves-progression-free-survival-in-hcc/</loc><lastmod>2024-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/addition-of-cetuximab-maintenance-to-first-line-folfiricetuximab-in-emrasbrafem-wild-type-colorectal-cancer/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/overall-survival-and-long-term-outcomes-in-the-monarche-trial/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/use-of-antiviral-therapy-and-10-year-outcomes-in-resected-hepatitis-related-hepatocellular-carcinoma/</loc><lastmod>2024-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/prevalence-of-substance-use-disorders-among-us-adult-cancer-survivors/</loc><lastmod>2024-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/combining-pd-l1-and-tigit-inhibitors-plus-chemotherapy-in-esophageal-cancer/</loc><lastmod>2024-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/role-of-postoperative-ctdna-in-patients-with-low-risk-stage-iia-colon-cancer/</loc><lastmod>2024-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/patient-choice-of-location-for-breast-cancer-surgery/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/new-study-uncovers-potential-factors-contributing-to-development-of-colitis-in-patients-undergoing-cancer-immunotherapy/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/triple-negative-breast-cancer-several-treatment-response-trajectories-identified/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/investigators-highlight-characteristics-potentially-linked-to-improved-car-t-cell-therapy-outcomes-in-large-b-cell-lymphoma/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/combating-racial-and-ethnic-disparities-in-precision-medicine-for-colorectal-cancer/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/follicular-lymphoma-long-term-follow-up-of-rituximab-dosing-strategies-among-patients-with-low-tumor-burden/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/minimizing-the-severe-side-effects-of-immunotherapy-in-patients-with-multiple-myeloma/</loc><lastmod>2024-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/comparing-outcomes-of-robotic-and-laparoscopic-surgeries-for-colorectal-cancer/</loc><lastmod>2024-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/lapatinib-increases-overall-survival-in-patients-with-metastatic-breast-cancer-and-her2-positive-ctcs/</loc><lastmod>2024-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/long-term-results-with-front-line-dasatinibblinatumomab-for-philadelphia-chromosome-positive-all/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/non-locally-advanced-rectal-cancer-impact-of-reduced-use-of-neoadjuvant-radiotherapy/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/leisure-time-physical-activity-and-breast-cancer-risk-in-premenopausal-women/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/rare-t-cells-may-help-predict-immunotherapy-response-in-patients-with-skin-cancer/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/treatment-at-community-cancer-centers-may-be-linked-to-poorer-outcomes-in-patients-with-hpv-related-oropharyngeal-squamous-cell-carcinoma/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/baseline-estradiol-and-prevention-of-breast-cancer-in-high-risk-postmenopausal-women/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/perioperative-pembrolizumab-plus-chemotherapy-in-locally-advanced-gastricgastroesophageal-cancer/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/addition-of-sbrt-to-standard-of-care-systemic-therapy-in-oligoprogressive-disease/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/muscle-invasive-bladder-cancer-5-year-survival-with-dd-mvac/</loc><lastmod>2024-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/second-line-lisocabtagene-maraleucel-may-be-more-cost-effective-than-standard-care-dlbcl-therapy/</loc><lastmod>2024-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/next-generation-sequencing-may-help-improve-access-to-immunotherapy-among-patients-with-cancer-and-mismatch-repair-deficiency/</loc><lastmod>2024-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/mrd-guided-ibrutinibvenetoclax-for-previously-untreated-patients-with-cll/</loc><lastmod>2024-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/overall-survival-with-atezolizumabchemotherapy-vs-chemotherapy-in-untreated-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2024-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/ovhipec1-trial-hyperthermic-intraperitoneal-chemotherapy-plus-interval-cytoreductive-surgery-improves-survival-in-advanced-ovarian-cancer/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/antibody-drug-conjugate-ifinatamab-deruxtecan-shows-robust-activity-in-refractory-small-cell-lung-cancer/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/imvigor130-atezolizumab-vs-chemotherapy-in-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/incidence-of-second-primary-cancers-in-adult-cancer-survivors/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/addition-of-atezolizumab-to-bevacizumab-and-chemotherapy-in-metastatic-persistent-or-recurrent-cervical-cancer/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/can-immunotherapy-induce-sustained-disease-control-among-patients-with-colorectal-cancer/</loc><lastmod>2023-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/phase-iii-trial-shows-novel-four-drug-regimen-improves-survival-outcomes-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/epov-noemi-reguart/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/use-of-lower-than-recommended-doses-of-immune-checkpoint-inhibitors-in-various-tumor-types-indian-study/</loc><lastmod>2024-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/repotrectinib-in-ros1-fusion-positive-nsclc/</loc><lastmod>2024-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/medicaid-expansion-may-improve-postsurgical-survival-outcomes-in-patients-with-nsclc/</loc><lastmod>2024-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/dxh9-depletion-may-expose-small-cell-lung-cancer-tumors-to-immune-system-attack/</loc><lastmod>2024-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/cannabis-use-during-pregnancy-may-be-linked-to-cns-cancers-in-children/</loc><lastmod>2024-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/immune-checkpoint-inhibitor-induced-myocarditis-contemporary-retrospective-analysis/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/genetic-identification-of-women-at-lower-risk-of-breast-cancer/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/young-women-with-breast-cancer-discussing-vs-pursuing-fertility-preservation/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/study-identifies-potential-variations-in-us-health-insurance-coverage-at-cancer-diagnosis-by-state/</loc><lastmod>2024-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/obesity-and-a-precursor-of-multiple-myeloma/</loc><lastmod>2024-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/fda-approves-pembrolizumab-plus-chemoradiotherapy-for-figo-2014-stage-iii-iva-cervical-cancer/</loc><lastmod>2024-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2024/01-january/mrd-status-and-outcomes-with-obinutuzumab-and-rituximab-based-treatment-in-follicular-lymphoma/</loc><lastmod>2024-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/i-don-t-want-cancer-to-define-me/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/neoadjuvantadjuvant-pembrolizumab-in-resectable-nsclc/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/steven-rosenberg-awarded-honor-for-technology-and-innovation/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/another-treatment-option-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/improving-cancer-control-in-a-changing-world/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-christopher-j-sweeney/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-bonny-morris-1/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/cardiovascular-health-of-women-treated-for-cancer-understanding-the-long-term-risks/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-susan-faye-dent/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/all-adult-oncologists-are-geriatric-oncologists/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/tucatinib-plus-t-dm1-extends-progression-free-survival-vs-t-dm1-alone-in-advanced-her2-positive-breast-cancer/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-valentina-guarneri/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/asco-and-ontario-health-publish-new-recommendations-for-systemic-therapy-in-sclc/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/novel-antibody-drug-conjugate-under-study-in-treatment-of-gastric-or-gastroesophageal-junction-cancers/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-elizabeth-smyth-md/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/the-power-of-patient-advocacy-10-year-study-reveals-increased-survival-rates-with-enhanced-advance-care-planning/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-bonny-morris/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/community-program-cuts-treatment-delays-in-half-for-minority-and-low-income-patients/</loc><lastmod>2023-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/alina-trial-anticancer-activity-of-alectinib-reported-in-earlier-stage-alk-positive-nsclc/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/understanding-the-treatment-options-for-pd-1-refractory-melanoma/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/sustained-mrd-negativity-achieved-with-isa-krd-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-s-vincent-rajkumar/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/antibody-drug-conjugate-makes-progress-as-second-line-therapy-for-advanced-nsclc/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-sarat-chandarlapaty/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/increase-trial-immunotherapy-plus-chemoradiotherapy-doubles-complete-pathologic-response-rate-in-nsclc/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/early-data-show-novel-immunotherapy-regimen-may-improve-outcomes-in-advanced-gastric-cancer/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-elizabeth-smyth/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/on-mark-cuban-and-the-chemotherapy-crisis/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/beatcc-trial-atezolizumab-based-regimen-improves-outcomes-in-first-line-setting-for-advanced-cervical-cancer/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-bradley-monk/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/oncology-care-model-studies-find-significant-savings-but-minor-quality-improvement/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-kerin-adelson/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/chemotherapy-induction-before-chemoradiotherapy-improves-survival-in-locally-advanced-cervical-cancer/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-krishnansu-tewari/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/syed-ali-abutalib-moves-to-advocate-aurora-health-to-lead-hematology-transplant-programs/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/encorafenib-plus-binimetinib-in-metastatic-nsclc-with-braf-v600e-mutation/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/new-guideline-offers-much-needed-support-in-the-treatment-of-neuroendocrine-tumors/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-marina-c-garassino/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-upal-basu-roy/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/american-cancer-society-releases-updated-lung-cancer-screening-guideline/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/remembering-cancer-prevention-and-health-equity-champion-worta-j-mccaskill-stevens-md-ms/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/supportive-parents-and-early-love-of-science-lead-to-a-career-in-hematology-oncology-for-nina-shah-md/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/papillon-adding-amivantamab-to-first-line-chemotherapy-prolongs-progression-free-survival-in-nsclc-subset/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-benjamin-besse/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/codebreak-300-sotorasib-plus-panitumumab-of-benefit-in-kras-mutated-metastatic-colorectal-cancer/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/epov-miriam-koopman/</loc><lastmod>2023-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/understanding-racial-and-ethnic-disparities-in-modern-aml-care-after-the-approval-of-venetoclax/</loc><lastmod>2023-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/fda-approves-belzutifan-for-advanced-renal-cell-carcinoma/</loc><lastmod>2023-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/concertai-to-acquire-cancerlinq/</loc><lastmod>2023-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/combining-ribociclib-with-hormone-therapy-improves-patient-outcomes-in-early-stage-breast-cancer-natalee/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/advanced-nsclc-adding-canakinumab-to-first-line-chemoimmunotherapy/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/5-year-outcomes-of-the-idea-trial-omission-of-radiotherapy-after-breast-conserving-surgery-for-low-risk-patients/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/is-prediabetes-linked-to-cardiovascular-and-kidney-diseases-in-adult-survivors-of-childhood-cancer/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/age-race-and-sex-found-to-impact-survival-rates-in-patients-with-bpdcn/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/overcoming-bpdcn-tagraxofusp-sets-new-landmark-in-patient-survival/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/allogeneic-hematopoietic-stem-cell-transplantation-for-dendritic-cell-neoplasm-subtype/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/international-collaborative-research-efforts-in-cardio-oncology-focus-on-basic-and-translational-science/</loc><lastmod>2023-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/imetelstat-for-rbc-transfusion-independence-in-lower-risk-myelodysplastic-syndromes/</loc><lastmod>2023-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/new-findings-challenge-widely-accepted-beliefs-about-the-relative-efficacy-of-opioids-in-treating-cancer-pain/</loc><lastmod>2023-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/implementation-of-updated-who-screening-guidelines-could-cut-cervical-cancer-mortality-rates-in-half-in-lower-income-countries/</loc><lastmod>2023-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/egfr-mutated-advanced-nsclc-cns-efficacy-with-combination-of-osimertinib-and-chemotherapy/</loc><lastmod>2023-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/overall-survival-with-lupsma-vs-cabazitaxel-in-previously-treated-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/risk-of-subsequent-colorectal-cancer-after-abdominopelvic-radiotherapy-among-childhood-cancer-survivors/</loc><lastmod>2023-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/toxicities-potentially-linked-to-combination-immunotherapy-for-mesothelioma/</loc><lastmod>2023-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/risk-adapted-radioimmunotherapy-for-locally-advanced-pd-l1-positive-nsclc/</loc><lastmod>2023-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/regular-screening-mammograms-may-significantly-reduce-breast-cancer-mortality-swedish-study-shows/</loc><lastmod>2023-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/colorectal-cancer-incidence-and-time-to-recurrence/</loc><lastmod>2023-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/consuming-navy-beans-may-improve-gut-health-regulate-immune-and-inflammatory-processes-in-colorectal-cancer-survivors/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/black-men-with-advanced-prostate-cancer-may-be-less-likely-to-receive-treatment/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/fda-grants-accelerated-approval-to-pirtobrutinib-for-cllsll/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/predicting-primary-ovarian-insufficiency-in-childhood-cancer-survivors/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/adding-tiragolumab-to-atezolizumab-and-chemotherapy-in-previously-untreated-extensive-stage-sclc/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/disitamab-vedotin-in-previously-treated-patients-with-advanced-her2-positive-urothelial-carcinoma/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/lung-map-trial-demonstrates-potential-of-public-private-partnerships-in-advancement-of-cancer-therapy/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/chronic-health-conditions-may-be-prevalent-among-lgb-adolescent-and-young-adult-cancer-survivors/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/everolimus-for-pediatric-recurrentprogressive-low-grade-glioma/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/first-line-treatment-of-advanced-hcc-addition-of-pembrolizumab-to-lenvatinib/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/adding-durvalumab-to-chemoradiotherapy-in-locally-advanced-cervical-cancer/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/neoadjuvant-chemotherapy-may-help-some-patients-with-breast-cancer-skip-regional-nodal-irradiation/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/tucatinib-plus-t-dm1-may-benefit-patients-with-advanced-or-metastatic-her2-positive-breast-cancer/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/car-t-cell-therapy-may-be-effective-but-unaffordable-as-second-line-therapy-for-patients-with-dlbcl/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/erdafitinib-vs-chemotherapy-in-previously-treated-fgfr-mutated-advanced-urothelial-carcinoma/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/mantle-cell-lymphoma-predictive-value-of-measurable-residual-disease-with-rituximab-maintenance/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/study-finds-link-between-t-cell-diversity-in-peripheral-blood-patient-age-and-stage-of-breast-cancer-development/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/novel-selective-biomarker-tool-may-help-select-effective-targeted-therapies-in-patients-with-metastatic-breast-cancer/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/risk-model-may-accurately-predict-aromatase-inhibitor-nonadherence/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/novel-targeted-therapies-may-benefit-patients-with-metastatic-hr-positiveher2-negative-breast-cancer/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/exercise-may-boost-quality-of-life-for-patients-with-metastatic-breast-cancer/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/patients-with-hr-positive-breast-cancer-may-use-fertility-preservation-and-assisted-reproductive-technologies-without-increased-risk-of-recurrence/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/younger-postmenopausal-patients-with-early-stage-breast-cancer-may-be-able-to-safely-omit-adjuvant-radiotherapy/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/abemaciclib-plus-ai-in-postmenopausal-patients-with-advanced-breast-cancer-final-overall-survival-analysis-from-monarch-3/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/using-estrogen-levels-to-predict-who-may-benefit-from-preventive-treatment-with-anastrozole/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/genetic-characteristics-of-her2-low-advanced-breast-cancers-may-guide-treatment-selection/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/recipients-of-2023-susan-g-komen-breast-cancer-awards-honored/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/potentially-targetable-fusion-rnas-may-be-more-common-in-metastatic-breast-cancer-than-previously-realized/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/skipping-adjuvant-radiotherapy-may-not-impact-risk-of-recurrence-or-progression-in-patients-with-low-risk-dcis/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/some-breast-cancer-survivors-may-safely-de-escalate-mammography-3-years-after-surgery/</loc><lastmod>2023-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/fda-approves-enfortumab-vedotin-ejfv-with-pembrolizumab-for-locally-advanced-or-metastatic-urothelial-cancer/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/first-line-treatment-for-older-patients-with-mantle-cell-lymphoma-venetoclax-plus-standard-chemoimmunotherapy/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/combination-treatment-that-skips-chemotherapy-may-be-effective-for-older-patients-with-philadelphia-chromosome-positive-all/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/glp-1-receptor-agonists-may-reduce-risk-of-colorectal-cancer-in-patients-with-high-bmi-and-diabetes/</loc><lastmod>2023-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/w-kimryn-rathmell-begins-work-as-17th-director-of-the-nci/</loc><lastmod>2023-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/adding-immune-checkpoint-inhibitors-to-perioperative-treatment-for-solid-tumors-associated-toxicity/</loc><lastmod>2023-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/hpv-ctdna-detection-after-chemoradiation-in-patients-with-cervical-cancer/</loc><lastmod>2023-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/dna-mutational-profiling-in-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2023-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/childhood-cancer-survivors-risk-of-second-cancer-and-heart-disease/</loc><lastmod>2023-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/lung-nodule-program-may-help-detect-lung-cancer-in-patients-age-ineligible-for-lung-cancer-screening/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/psilocybin-assisted-therapy-may-reduce-depressive-symptoms-in-patients-with-cancer/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/targeted-therapy-for-fr-alpha-positive-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/acs10-score-may-help-inform-treatment-reduce-racial-disparities-in-black-pediatric-patients-with-aml/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/male-researchers-lead-majority-of-nihs-active-r01-grants-in-classical-hematology-research/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/patients-with-multiple-myeloma-may-experience-poorer-outcomes-in-the-real-world-compared-with-reported-outcomes-from-clinical-trials/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/psychiatric-and-substance-use-disorders-may-be-linked-to-poorer-outcomes-in-aml-following-venetoclax-combination-therapies/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/ibrutinib-plus-venetoclax-with-duration-of-treatment-determined-by-mrd-in-newly-diagnosed-cll/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/autologous-stem-cell-transplant-vs-car-t-cell-therapy-in-patients-with-lbcl-in-complete-remission/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/oral-regimen-with-minimal-chemotherapy-found-to-be-safe-effective-for-patients-with-apl/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/car-t-cell-therapy-for-lymphoma-in-remission/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/ai-model-may-help-distinguish-between-two-rare-hematologic-malignancies/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/novel-car-t-cell-therapy-may-show-early-efficacy-in-patients-with-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/ibrutinibvenetoclax-in-relapsedrefractory-mantle-cell-lymphoma/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/potential-underlying-genetic-mutations-identified-in-patients-with-myelodysplastic-syndromes/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/daratumumab-plus-vrd-outperforms-vrd-alone-for-multiple-myeloma/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/fda-approves-eflornithine-for-adult-and-pediatric-patients-with-high-risk-neuroblastoma/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/presence-of-mrd-after-chemotherapy-may-predict-benefit-from-donor-transplant-in-npm1-mutated-aml/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/menin-inhibitors-in-patients-with-advanced-aml-and-gene-mutations/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/novel-bet-inhibitor-for-advanced-myelofibrosis/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/ruxolitinib-plus-navitoclax-may-reduce-spleen-volume-in-patients-with-myelofibrosis/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/revumenib-in-high-risk-kmt2ar-acute-leukemia/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/use-of-elranatamab-for-black-patients-with-multiple-myeloma/</loc><lastmod>2023-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/12-december/bezuclastinib-may-reduce-symptoms-in-patients-with-nonadvanced-systemic-mastocytosis/</loc><lastmod>2023-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/highlights-from-the-esmo-congress-2023/</loc><lastmod>2023-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-elizabeth-smyth/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adding-checkpoint-inhibition-to-perioperative-chemotherapy-boosts-pathologic-complete-response-rates-in-gastric-cancers/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-laura-locati/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/first-line-selpercatinib-new-standard-of-care-for-ret-positive-medullary-thyroid-cancer/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-sarat-chandarlapaty/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/antibody-drug-conjugate-makes-progress-as-second-line-therapy-for-advanced-nsclc/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-zofia-piotrowska/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/amivantamab-based-regimens-show-anticancer-activity-in-egfr-mutated-advanced-nsclc/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-noemi-reguart/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/phase-iii-trial-shows-novel-four-drug-immunotherapy-regimen-improves-survival-outcomes-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-upal-basu-roy/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/increase-trial-immunotherapy-plus-chemoradiotherapy-doubles-complete-pathologic-response-rate-in-nsclc/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-helena-linardou-1/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/antibody-drug-conjugate-ifinatamab-deruxtecan-shows-robust-activity-in-refractory-small-cell-lung-cancer/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-hiroaki-akamatsu/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/iruplinalkib-demonstrates-improved-efficacy-and-tolerance-vs-crizotinib-in-alk-inhibitor-naive-advanced-alk-positive-nsclc/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-roy-herbst/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/flaura2-trial-osimertinib-plus-chemotherapy-improves-outcomes-in-advanced-egfr-positive-nsclc/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-gerard-a-silvestri/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/taiwan-national-lung-cancer-early-detection-screening-program-targets-smokers-and-nonsmokers-with-family-history/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-paula-antonia-ugalde/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/extended-pleurectomy-decortication-plus-chemotherapy-for-mesothelioma-linked-to-increased-risk-of-death-in-mars-2-trial/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/highlights-from-the-2023-world-conference-on-lung-cancer/</loc><lastmod>2023-11-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/small-breast-cancer-omission-of-axillary-surgery-vs-sentinel-lymph-node-biopsy/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/combination-of-ceralasertib-and-durvalumab-shows-activity-in-phase-ii-trial-of-advanced-nsclc/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/first-line-selpercatinib-vs-chemotherapy-with-or-without-pembrolizumab-in-ret-fusion-positive-nsclc/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/addition-of-first-line-pembrolizumab-to-chemotherapy-in-her2-negative-advanced-gastric-cancer/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/tropion-breast01-and-destiny-breast04-antibody-drug-conjugates-of-benefit-in-patients-with-metastatic-breast-cancer/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-sarat-chandarlapaty-1/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/first-line-dabrafenib-plus-trametinib-vs-standard-chemotherapy-for-pediatric-low-grade-glioma-with-braf-v600-mutations/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/astrum-004-serplulimab-plus-chemotherapy-as-first-line-treatment-of-advanced-squamous-non-small-cell-lung-cancer/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-justin-gainor/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/small-study-identifies-safe-effective-radiation-dose-to-add-to-neoadjuvant-chemotherapy-and-durvalumab/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/optimizing-treatment-selection-for-newly-diagnosed-and-secondary-aml-focus-on-cytogenetic-and-molecular-data/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/updates-in-lower-risk-myelodysplastic-syndromesneoplasms/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/cardiac-imaging-and-biomarkers-for-patients-receiving-cancer-treatment-what-oncologists-need-to-know/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/from-a-small-town-in-the-rust-belt-dennis-slamon-plays-a-big-role-in-changing-the-face-of-breast-cancer-treatment/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/a-cancer-diagnosis-at-19-taught-me-that-it-takes-constant-vigilance-to-stay-mentally-healthy/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/society-for-integrative-oncology-celebrates-20-years-of-excellence/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/bosutinib-in-pediatric-chronic-myeloid-leukemia/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/national-academy-of-medicine-elects-new-members/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adjuvant-everolimus-improves-recurrence-free-survival-in-very-high-risk-renal-cell-carcinoma/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/perioperative-durvalumab-improves-surgical-outcomes-in-resectable-nsclc/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-solange-peters-and-upal-basu-roy/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/short-course-radiotherapy-may-reduce-resource-burden-of-head-and-neck-cancer-treatment-in-low-and-middle-income-countries/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-beth-beadle/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/survivors-of-childhood-cancer-study-shows-heart-related-ailments-linked-to-radiotherapy-dose/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-bonnie-ky/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/hypofractionation-shows-comparable-results-to-conventional-postmastectomy-radiation-therapy-with-added-benefits/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-lori-j-pierce/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/studies-explore-efficacy-of-venetoclax-in-t-1114-positive-myeloma/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-faith-e-davies/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/olaparib-plus-abiraterone-in-metastatic-castration-resistant-prostate-cancer-unselected-for-hrr-mutation-status/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/asco-rapid-recommendation-update-cautions-against-triplet-therapy-for-metastatic-clear-cell-rcc/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/the-progress-of-delivering-high-quality-cancer-care-takes-center-stage-at-workshop/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/in-recurrent-cervical-cancer-tisotumab-vedotin-tftv-improves-overall-survival-in-phase-iii-trial/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-krishnansu-tewari/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/two-studies-show-improved-survival-with-novel-front-line-combinations-in-advanced-urothelial-carcinoma/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-andrea-apolo/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/durvalumab-based-treatment-with-or-without-olaparib-boosts-progression-free-survival-in-endometrial-cancer/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-domenica-lorusso/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/aacr-annual-cancer-progress-report-highlights-scientific-advances-against-cancer-challenges-and-opportunities-ahead/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/value-of-some-established-treatment-practices-in-chronic-myeloid-leukemia/</loc><lastmod>2023-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-andrea-apolo-1/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/two-studies-show-improved-survival-with-novel-front-line-combinations-in-advanced-urothelial-carcinoma-1/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-sarat-chandarlapaty-2/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/tropion-breast01-and-destiny-breast04-antibody-drug-conjugates-of-benefit-in-patients-with-metastatic-breast-cancer-1/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/results-of-pacific-trial-being-replicated-in-real-world-settings/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/how-asco-is-tackling-the-need-to-improve-workforce-diversity-and-the-looming-oncology-workforce-shortage/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/screening-for-lung-cancer-much-work-remains-to-be-done/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/british-pharmacological-society-names-v-craig-jordan-dsc-phd-recipient-of-the-sir-henry-wellcome-gold-medal/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/understanding-patient-engagement-in-virtual-mind-body-therapies/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/having-colorectal-cancer-at-32-changed-the-trajectory-of-my-life/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/asco-launches-asco-certified-to-ensure-the-delivery-of-high-quality-patient-centered-cancer-care-to-every-patient/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/association-urges-congress-to-prioritize-childhood-cancer-funding-research/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/addition-of-tumor-treating-fields-therapy-to-standard-systemic-therapy-improves-survival-in-metastatic-nsclc-after-progression-on-platinum-based-therapy/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/pace-trials-support-stereotactic-body-radiotherapy-for-some-patients-with-localized-prostate-cancer/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-neha-vapiwala/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/stereotactic-body-radiation-therapy-demonstrates-exceptional-control-in-primary-renal-cell-carcinoma/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/epov-rohann-correa/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/cardiovascular-disease-and-cancer-a-reciprocal-relationship/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/personalized-care-may-prevent-overscreening-for-colorectal-cancer-in-older-patients/</loc><lastmod>2023-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/secondary-pik3ca-mutations-drug-resistance-and-novel-pi3k-alpha-inhibitors-in-breast-cancer/</loc><lastmod>2023-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-strategy-may-improve-outcomes-in-patients-with-treatment-resistant-dlbcl/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-machine-learning-model-may-accurately-calculate-chemotherapy-success-in-patients-with-osteosarcoma/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/addition-of-first-line-pembrolizumab-to-chemotherapy-with-or-without-bevacizumab-in-advanced-cervical-cancer-final-overall-survival-results-from-keynote-826/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adding-hipec-to-cytoreductive-surgery-in-gastric-cancer-with-synchronous-peritoneal-metastases/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adjuvant-atezolizumabbevacizumab-vs-active-surveillance-in-resected-or-ablated-high-risk-hepatocellular-carcinoma/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/can-high-bmi-in-youth-affect-cancer-risk-later-on/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/race-psa-level-and-risk-of-prostate-cancer/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/lung-cancer-screenings-may-increase-long-term-survival-rates/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/nemtabrutinib-may-provide-benefit-in-patients-with-relapsed-hematologic-malignancies/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/patient-facing-ai-in-cancer-care/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adding-pembrolizumab-to-trastuzumab-and-chemotherapy-in-her2-positive-gastricgastroesophageal-junction-adenocarcinoma-keynote-811/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/asco-applauds-confirmation-of-monica-bertagnolli-as-nih-director/</loc><lastmod>2023-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/computer-models-may-help-reduce-cancer-disparities/</loc><lastmod>2023-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/metastatic-castration-resistant-prostate-cancer-single-dose-lupsma-plus-maintenance-pembrolizumab/</loc><lastmod>2023-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/genetics-of-nearby-healthy-tissue-may-help-predict-lung-cancer-recurrence/</loc><lastmod>2023-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/subsequent-cancer-diagnosis-after-no-diagnosis-with-urgent-suspected-cancer-referral/</loc><lastmod>2023-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-antibody-drug-conjugate-shows-potential-in-treating-cldn182-positive-gastric-and-gej-cancers/</loc><lastmod>2023-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/immune-checkpoint-inhibition-with-single-fraction-stereotactic-radiosurgery-may-not-increase-risk-of-radiation-necrosis-in-patients-with-nsclc-brain-metastases/</loc><lastmod>2023-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-blood-test-may-offer-early-cancer-detection/</loc><lastmod>2023-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/perioperative-durvalumab-in-resectable-nsclc-aegean-trial/</loc><lastmod>2023-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/2023-national-youth-tobacco-survey-shows-drop-in-e-cigarette-use-among-high-school-students/</loc><lastmod>2023-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/bispecific-t-cell-engager-tarlatamab-in-previously-treated-patients-with-small-cell-lung-cancer/</loc><lastmod>2023-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/soy-expansion-in-brazil-may-be-linked-to-increased-mortality-among-pediatric-patients-with-all/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/insurance-coverage-disruptions-may-reduce-rate-of-cancer-screenings/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-pembrolizumab-plus-chemotherapy-for-biliary-tract-cancer/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/three-year-overall-survival-with-tebentafusp-in-previously-untreated-advanced-uveal-melanoma/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/advanced-ret-mutant-medullary-thyroid-cancer-first-line-selpercatinib/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/acs-releases-updated-lung-cancer-screening-guideline/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/international-group-of-surgical-oncologists-presents-new-commission-outlining-pragmatic-solutions-to-improve-cancer-surgery-outcomes-worldwide/</loc><lastmod>2023-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-fruquintinib-for-refractory-metastatic-colorectal-cancer/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-amends-pembrolizumab-s-gastric-cancer-indication/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/advancing-clinical-research-on-ovarian-cancer-and-overcoming-gender-inequity-in-low-and-middle-income-countries/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-first-treatment-for-patients-with-rare-congenital-blood-disorder/</loc><lastmod>2023-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/vitamin-d-supplements-may-help-reduce-chemotherapy-induced-peripheral-neuropathy/</loc><lastmod>2023-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/patients-with-lower-extremity-lymphedema-may-face-increased-risk-of-skin-cancer/</loc><lastmod>2023-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/investigational-dual-pd-1-and-tigit-blockade-in-advanced-gastroesophageal-cancer/</loc><lastmod>2023-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/effect-of-bendamustine-prior-to-apheresis-on-outcomes-in-large-b-cell-lymphoma-treated-with-car-t-cell-therapy/</loc><lastmod>2023-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/osimertinib-with-or-without-chemotherapy-in-egfr-mutant-advanced-nsclc/</loc><lastmod>2023-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/cancer-care-disparities-among-patients-with-early-onset-colorectal-cancer/</loc><lastmod>2023-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/comparing-the-accuracy-of-initial-staging-methods-in-prostate-cancer/</loc><lastmod>2023-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/exposure-to-ct-radiation-and-risk-of-blood-cancers-in-young-patients/</loc><lastmod>2023-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/long-term-organ-preservation-with-total-neoadjuvant-therapy-in-rectal-adenocarcinoma/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/researchers-identify-novel-genetic-variants-predictive-of-prostate-cancer-risk-and-severity/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-assay-may-help-detect-and-treat-patients-with-aml/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/asco-applauds-appointment-of-w-kimryn-rathmell-as-next-nci-director/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adding-pembrolizumab-to-chemotherapy-for-previously-untreated-advanced-pleural-mesothelioma/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/blinatumomab-as-an-alternative-to-first-line-intensive-chemotherapy-in-pediatric-b-all/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/axillary-soft-tissue-involvement-in-lymph-node-positive-breast-cancer/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/early-stage-cervical-cancer-defining-follow-up-after-fertility-sparing-surgery/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/metastatic-castration-resistant-prostate-cancer-efficacy-of-anti-psma-antibody-with-alpha-emitter/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/ibrutinibvenetoclax-vs-chlorambucilobinutuzumab-in-previously-untreated-chronic-lymphocytic-leukemia-glow-trial-4-year-follow-up/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/modified-vs-standard-ipilimumab-plus-nivolumab-in-advanced-renal-cell-carcinoma/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-next-generation-tyrosine-kinase-inhibitor-repotrectinib-for-ros1-positive-nsclc/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-capivasertib-with-fulvestrant-for-breast-cancer/</loc><lastmod>2023-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/updated-findings-on-increased-cancer-occurrence-in-sweden-after-1986-chernobyl-accident/</loc><lastmod>2023-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/partial-breast-irradiation-in-patients-with-early-stage-invasive-breast-cancer-or-dcis/</loc><lastmod>2023-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/ai-based-pathology-for-sensitivity-to-atezolizumabbevacizumab-in-hcc/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/ofranergene-obadenovec-with-weekly-paclitaxel-for-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/racial-disparities-in-guideline-concordant-care-in-early-onset-colorectal-cancer-in-the-united-states/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/number-of-cancer-treatments-performed-during-early-covid-19-pandemic/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/occupational-exposure-to-solar-uv-radiation-and-nonmelanoma-skin-cancer/</loc><lastmod>2023-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/overall-survival-with-ctc-count-driven-treatment-in-advanced-breast-cancer/</loc><lastmod>2023-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/early-breast-cancer-effect-of-radiotherapy-to-regional-nodes/</loc><lastmod>2023-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/prevalence-of-unsatisfactory-samples-from-fit-tests-for-colorectal-cancer-screening/</loc><lastmod>2023-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-nirogacestat-for-desmoid-tumors/</loc><lastmod>2023-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/outcomes-with-olaparib-in-metastatic-castration-resistant-prostate-cancer-and-brca-alterations-in-the-profound-trial/</loc><lastmod>2023-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/lack-of-basic-care-in-patients-with-colorectal-cancer-in-sub-saharan-africa/</loc><lastmod>2023-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-uterine-cancer-detection-method-for-women-with-abnormal-uterine-bleeding/</loc><lastmod>2023-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/durvalumab-may-offer-survival-benefit-in-patients-with-nsclc-and-borderline-performance-status/</loc><lastmod>2023-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/urban-environmental-exposures-and-incidence-of-breast-cancer-in-north-carolina/</loc><lastmod>2023-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/adding-atezolizumab-to-perioperative-chemotherapy-in-resectable-esophagogastric-cancer/</loc><lastmod>2023-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-approves-enzalutamide-for-nonmetastatic-castration-sensitive-prostate-cancer-with-biochemical-recurrence/</loc><lastmod>2023-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/addition-of-adjuvant-hipec-to-standard-chemotherapy-in-locally-advanced-colon-cancer/</loc><lastmod>2023-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/fda-investigating-risk-of-t-cell-malignancy-following-bcma-or-cd19-directed-autologous-car-t-cell-immunotherapies/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/ultraprocessed-food-may-heighten-risk-of-head-and-neck-cancer-and-esophageal-adenocarcinoma/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/trastuzumab-plus-gemcitabinecisplatin-in-advanced-her2-positive-biliary-tract-adenocarcinoma/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/novel-ai-model-may-predict-nonsmokers-at-high-risk-for-lung-cancer/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/inotuzumab-ozogamicin-based-induction-in-older-patients-with-philadelphia-chromosome-negative-b-cell-precursor-all/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/11-november/incidence-of-breast-cancer-after-false-positive-mammography/</loc><lastmod>2023-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-marina-garassino/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/perioperative-nivolumab-plus-chemotherapy-improves-event-free-survival-in-resectable-non-small-cell-lung-cancer/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-matthew-hatton-and-charles-simone/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/comparing-two-radiation-therapy-techniques-for-locally-advanced-nsclc-focus-on-toxicity/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-helena-linardou-1-1/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/role-of-trop-2-directed-antibody-drug-conjugates-with-immune-checkpoint-inhibitors-in-advanced-nsclc/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-approves-new-updated-indications-for-temozolomide/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/the-new-era-of-perioperative-therapy-in-non-small-cell-lung-cancer/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/neoadjuvant-folfox-vs-chemoradiotherapy-in-locally-advanced-rectal-cancer/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/getting-a-cancer-diagnosis-at-age-16-has-taught-me-to-live-in-the-present/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/university-of-arizona-welcomes-thoracic-surgeon-praveen-sridhar/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/gender-equity-in-academic-hematology-where-there-s-a-wil-there-s-a-way/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/encorafenib-and-binimetinib-in-braf-v600e-mutant-metastatic-nsclc/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/pembrolizumabolaparib-vs-next-generation-hormonal-agents-in-previously-treated-patients-with-biomarker-unselected-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/trop-2-directed-antibody-drug-conjugate-datopotamab-deruxtecan-in-advanced-nsclc/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/annual-report-to-the-nation-on-covid-19-s-impact-on-cancer-diagnosis-finds-sharp-declines-in-new-diagnoses-of-six-major-cancers/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/overcoming-the-challenges-of-treating-adolescents-and-young-adults-with-cancer-living-in-rural-communities/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/asco-response-to-drug-shortages-request-for-information/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/cms-congress-must-work-together-to-support-access-to-cancer-care-and-physician-practice-health/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/from-humble-beginnings-elisabete-weiderpass-distinguishes-herself-as-first-woman-to-head-the-iarc/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/breakthrough-prize-oscars-of-science-celebrates-2024-laureates-in-life-sciences/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/quality-of-life-maintained-for-many-patients-treated-with-ribociclib-for-early-stage-breast-cancer/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-michail-ignatiadis-and-stephen-rd-johnston/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/diagnosis-of-cardiovascular-disease-and-risk-of-subsequent-incident-cancer-diagnosis/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-helena-linardou/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/antitumor-activity-shown-with-her3-dxd-in-egfr-mutated-nsclc/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/breast-cancer-2022-2023-almanac/</loc><lastmod>2023-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/recent-fda-approvals-in-breast-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-meritxell-bellet-ezquerra-and/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/overall-survival-in-two-monarch-trials-of-abemaciclib-in-advanced-breast-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-virginia-kaklamani-md/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/can-younger-women-with-hormone-receptor-positive-breast-cancer-safely-pause-endocrine-therapy-to-pursue-pregnancy/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-polly-niravath-and-virginia-kaklamani/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/soft-analysis-breast-cancer-index-may-identify-which-patients-need-ovarian-suppression/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-virginia-kaklamani/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/capivasertib-plus-fulvestrant-doubles-progression-free-survival-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-debu-tripathy/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/palbociclibfulvestrant-does-not-improve-progression-free-survival-after-progression-on-a-cdk46-inhibitor-in-metastatic-breast-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-neelima-vidula/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/t-dxd-confirmed-as-preferred-second-line-therapy-for-metastatic-her2-positive-breast-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-nancy-chan/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/update-from-monarche-benefit-of-abemaciclib-increases-over-time-in-early-stage-breast-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/national-inventors-hall-of-fame-recognizes-jennifer-doudna-phd-emmanuelle-charpentier-phd-and-angela-hartley-brodie-phd/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/from-a-sleepy-town-in-pakistan-seema-a-khan-md-mph-emerges-as-a-leader-in-surgical-oncology/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/psilocybin/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/a-diagnosis-of-ewing-sarcoma-altered-the-trajectory-of-my-life/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/flaura2-trial-osimertinib-plus-chemotherapy-improves-outcomes-in-advanced-egfr-positive-nsclc/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-roy-herbst/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/tracking-the-progress-being-made-in-the-treatment-of-breast-cancer-and-the-challenges-ahead/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/checkpoint-inhibitors-offer-limited-benefit-in-egfr-mutated-lung-cancer-after-disease-progression/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-justin-gainor/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/nuc-1031cisplatin-fails-to-improve-outcomes-in-advanced-biliary-tract-cancer/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/epov-gentry-king/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/accelerated-approval-granted-for-use-of-elranatamab-bcmm-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/melphalan-based-liver-directed-therapy-for-metastatic-uveal-melanoma/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/patterns-in-early-onset-cancer-in-the-united-states-from-2010-to-2019/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/asco-and-state-affiliates-wrap-up-successful-state-sessions/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/guideline-update-reflects-recent-surge-of-new-data-in-systemic-therapy-for-melanoma/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/circulating-tumor-dna-identified-in-breast-milk-from-women-with-breast-cancer-first-results-published/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/decentralized-care-models-empower-equitable-pediatric-cancer-treatment/</loc><lastmod>2023-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/kras-g12c-inhibitors-durability-of-response-efficacy-in-combination-in-nsclc/</loc><lastmod>2023-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/racial-and-ethnic-minority-patients-with-breast-cancer-may-be-less-likely-to-receive-palliative-care-than-white-patients/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/liquid-biopsy-may-help-identify-patients-with-nsclc-that-could-benefit-from-radiation-therapy/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/diabetes-may-be-linked-to-lower-survival-among-patients-with-multiple-myeloma-survival-outcomes-may-be-race-dependent/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/new-poll-weighs-necessity-of-life-expectancy-in-cancer-screening-guidelines/</loc><lastmod>2023-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/addition-of-sbrt-to-abiraterone-acetate-in-oligometastatic-castrate-resistant-prostate-cancer/</loc><lastmod>2023-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/shorther-update-10-year-survival-outcomes-with-9-weeks-vs-1-year-of-adjuvant-trastuzumab-in-her2-positive-breast-cancer/</loc><lastmod>2023-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/addition-of-lapatinib-to-chemoradiotherapy-in-non-hpv-related-head-and-neck-cancer/</loc><lastmod>2023-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/adjuvant-pembrolizumab-may-offer-survival-benefit-over-observation-in-patients-with-muscle-invasive-or-locally-advanced-urothelial-carcinoma/</loc><lastmod>2023-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/do-patients-with-advanced-cancer-value-quality-over-quantity-of-life/</loc><lastmod>2023-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/individualized-sabr-for-lung-tumors/</loc><lastmod>2023-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/pertuzumabtrastuzumab-for-nonindicated-her2-altered-advanced-solid-tumors-mypathway-update/</loc><lastmod>2023-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/her3-expressing-metastatic-breast-cancer-patritumab-deruxtecan-in-previously-treated-patients/</loc><lastmod>2023-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/children-of-young-female-patients-with-a-history-of-cancer-may-be-at-risk-of-birth-defects/</loc><lastmod>2023-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/investigators-compare-health-information-exchange-data-with-patient-self-reported-data-to-measure-cancer-screening-uptake/</loc><lastmod>2023-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/adjuvant-canakinumab-in-completely-resected-nsclc/</loc><lastmod>2023-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/ivig-may-reduce-infection-risk-among-patients-with-multiple-myeloma-receiving-anti-bcma-therapy/</loc><lastmod>2023-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-grants-marketing-authorization-to-edison-histotripsy-system-for-treatment-of-liver-tumors/</loc><lastmod>2023-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/cadonilimab-an-anti-pd-1ctla-4-bispecific-antibody-for-advanced-solid-tumors/</loc><lastmod>2023-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-approves-encorafenib-with-binimetinib-for-metastatic-braf-v600e-mutated-nsclc/</loc><lastmod>2023-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/germline-variants-and-risk-of-aggressive-prostate-cancer/</loc><lastmod>2023-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/nonmelanoma-skin-cancers-may-have-higher-mortality-rate-than-melanoma/</loc><lastmod>2023-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/chemical-hair-relaxers-may-increase-risk-of-uterine-cancer-among-black-women/</loc><lastmod>2023-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/rectal-cancer-managed-by-watch-and-wait-strategy-validation-of-immunoscore-biopsy/</loc><lastmod>2023-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/ai-software-demonstrates-potential-to-accurately-detect-skin-cancer/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/prophylactic-salpingo-oophorectomy-and-survival-after-resection-of-germline-brca12-mutant-breast-cancer/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/patients-with-cancer-may-be-interested-in-complementary-therapies-survey-says/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/how-war-has-disrupted-the-management-of-patients-with-breast-cancer-in-sudan/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/can-ai-help-identify-kidney-tumors-that-may-respond-to-immunotherapy/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/lung-art-trial-end-of-the-road-for-postoperative-radiotherapy/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/asco-launches-new-webinar-making-palliative-care-a-part-of-your-oncology-practice/</loc><lastmod>2023-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-approves-adjuvant-nivolumab-for-stage-ii-bc-melanoma/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/tumor-debulking-plus-palliative-chemotherapy-may-not-impact-quality-of-life-in-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/pet-imaging-may-validate-use-of-antibody-drug-conjugates-plus-lovastatin-to-enhance-her2-targeted-cancer-therapy/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/rates-of-vte-chemoprophylaxis-prescriptions-and-vte-diagnosis-after-major-cancer-surgery/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/many-survivors-of-childhood-cancer-experience-lifelong-chronic-health-problems-and-shorter-lifespans-than-their-healthier-peers/</loc><lastmod>2023-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/structural-racism-s-effect-on-cancer-mortality-rates/</loc><lastmod>2023-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/isa-krd-for-transplant-eligible-and-ineligible-high-risk-newly-diagnosed-multiple-myeloma/</loc><lastmod>2023-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/neighborhood-walkability-and-risk-of-obesity-related-cancers/</loc><lastmod>2023-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/chemotherapy-shortages-ongoing-according-to-new-survey/</loc><lastmod>2023-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-approves-neoadjuvantadjuvant-pembrolizumab-for-resectable-nsclc/</loc><lastmod>2023-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/addition-of-berzosertib-to-topotecan-in-relapsed-sclc/</loc><lastmod>2023-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/do-low-and-moderate-grade-adverse-events-affect-rates-of-treatment-discontinuation-in-cll/</loc><lastmod>2023-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/the-future-of-ai-in-cancer-care/</loc><lastmod>2023-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/gut-microbiome-variations-and-colorectal-cancer-risk/</loc><lastmod>2023-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/air-pollution-and-breast-cancer-risk-residential-and-workplace-exposure/</loc><lastmod>2023-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/cns-prophylaxis-with-high-dose-methotrexate-in-high-risk-aggressive-b-cell-lymphoma/</loc><lastmod>2023-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/mri-scans-could-predict-postradiation-urinary-side-effects-in-patients-with-prostate-cancer/</loc><lastmod>2023-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/almost-half-of-oncology-drugs-approved-since-1998-have-been-precision-therapies-new-study-finds/</loc><lastmod>2023-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/blood-based-testing-for-multicancer-early-detection/</loc><lastmod>2023-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/efficacy-of-radiotherapy-in-rhabdomyosarcoma/</loc><lastmod>2023-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/tislelizumab-vs-sorafenib-in-first-line-treatment-of-unresectable-hepatocellular-carcinoma/</loc><lastmod>2023-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/patients-and-survivors-of-cancer-may-be-impacted-by-us-drug-shortages/</loc><lastmod>2023-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/is-idecabtagene-vicleucel-effective-in-patients-with-multiple-myeloma-regardless-of-race/</loc><lastmod>2023-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/pre-and-postsurgical-immunotherapy-improves-outcomes-for-patients-with-resectable-early-stage-nsclc/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/everest-trial-adjuvant-everolimus-for-high-risk-clear-cell-renal-cell-carcinoma/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-expands-pediatric-indication-for-entrectinib-and-approves-new-pellet-formulation/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/belzutifan-improves-outcomes-for-pretreated-patients-with-clear-cell-renal-cell-carcinoma-compared-to-everolimus/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/parp-inhibitor-plus-immunotherapy-added-to-chemotherapy-lowers-risk-of-disease-progression-in-patients-with-advanced-endometrial-cancer/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/esmo-2023-new-data-in-skin-cancers/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/erdafitinib-demonstrates-improved-responses-in-fgfr-altered-advanced-urothelial-carcinoma/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/cabozantinib-for-pretreated-patients-with-advanced-neuroendocrine-tumors-cabinet-trial/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/nivolumab-plus-gemcitabine-and-cisplatin-may-improve-survival-in-patients-with-metastatic-urothelial-carcinoma/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/induction-chemotherapy-and-subsequent-chemoradiation-may-improve-survival-and-recurrence-rates-in-patients-with-cervical-cancer/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/trends-in-lung-cancer-incidence-among-women-and-men-in-the-united-states/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/germline-cancer-predisposing-variants-and-increased-risk-of-late-mortality-from-subsequent-malignant-neoplasms-in-long-term-childhood-cancer-survivors/</loc><lastmod>2023-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/major-pathologic-response-to-neoadjuvant-pembrolizumab-in-advanced-melanoma-trial-exceeds-50-percent/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/psmafore-lutetium-lu-177-vipivotide-tetraxetan-in-metastatic-prostate-cancer/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/adults-living-alone-are-at-higher-risk-of-cancer-mortality-compared-to-adults-living-with-others/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/novel-strategies-for-eliminating-dormant-tumor-cells-in-breast-cancer-survivors/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/ai-based-calculator-may-accurately-predict-long-term-cancer-survival/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/patient-education-materials-on-breast-cancer-may-be-difficult-to-access/</loc><lastmod>2023-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-approves-ivosidenib-for-myelodysplastic-syndromes/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/primary-care-intervention-to-improve-follow-up-of-overdue-abnormal-cancer-screening-test-results/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/perioperative-chemotherapy-and-pembrolizumab-in-locally-advanced-resectable-gastric-and-gastroesophageal-junction-adenocarcinomas/</loc><lastmod>2023-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/mind-body-fitness-classes-may-reduce-unplanned-hospitalizations-urgent-care-visits-during-cancer-care/</loc><lastmod>2023-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/yoga-based-supportive-care-may-prevent-treatment-related-complications-in-patients-with-head-and-neck-cancer/</loc><lastmod>2023-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/text-message-based-prescreening-could-benefit-patients-receiving-immunotherapy/</loc><lastmod>2023-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/pfas-exposure-may-increase-risk-of-thyroid-cancer/</loc><lastmod>2023-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/asco-launches-asco-certified-to-ensure-the-delivery-of-high-quality-patient-centered-cancer-care-to-every-patient/</loc><lastmod>2023-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/pembrolizumab-plus-lenvatinib-as-second-and-third-line-treatments-of-pleural-mesothelioma/</loc><lastmod>2023-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/enzalutamide-with-or-without-leuprolide-and-leuprolide-alone-in-biochemically-recurrent-prostate-cancer/</loc><lastmod>2023-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/sequential-cd19-and-cd22-directed-car-t-cell-therapy-in-pediatric-b-cell-all/</loc><lastmod>2023-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/datopotamab-deruxtecan-may-improve-progression-free-survival-in-patients-with-metastatic-nsclc/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/two-new-studies-using-cancerlinq-data/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-approves-toripalimab-tpzi-for-nasopharyngeal-carcinoma/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/intraductal-papillary-mucinous-neoplasms-risk-of-pancreatic-cancer/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/sotorasib-plus-panitumumab-in-kras-g12c-mutated-advanced-colorectal-cancer-codebreak-300/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/role-of-crowdfunding-campaigns-in-covering-medical-expenses-for-cancer-survivors/</loc><lastmod>2023-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/nivolumab-with-or-without-nivolumabipilimumab-boost-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2023-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/patients-with-newly-diagnosed-nsclc-or-melanoma-may-receive-limited-documentation-of-treatment-cost-discussions/</loc><lastmod>2023-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/association-of-germline-egfr-mutations-with-familial-lung-cancer/</loc><lastmod>2023-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/addition-of-amivantamab-to-chemotherapy-in-first-line-treatment-of-advanced-nsclc-with-egfr-exon-20-insertions/</loc><lastmod>2023-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/dendritic-cell-vaccine-plus-stem-cell-transplant-for-multiple-myeloma/</loc><lastmod>2023-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/neoadjuvant-immune-checkpoint-blockade-may-be-effective-across-multiple-cancer-types/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/long-term-low-grade-intestinal-inflammation-may-be-prevalent-among-patients-who-have-undergone-radiotherapy/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/fda-grants-first-marketing-authorization-for-a-dna-test-to-assess-predisposition-for-dozens-of-cancer-types/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/postdiagnosis-exercise-and-mortality-risk-among-patients-with-cancer/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/prophylactic-radiation-for-high-risk-asymptomatic-bone-metastases/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/tucatinibtrastuzumab-for-previously-treated-patients-with-her2-positive-metastatic-biliary-tract-cancer/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/sbrt-vs-standard-radiotherapy-for-localized-prostate-cancer-5-year-analysis-of-pace-b/</loc><lastmod>2023-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/stereotactic-radiotherapy-for-patients-with-primary-rcc-unsuitable-for-surgery-fastrack-ii/</loc><lastmod>2023-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/hypofractionated-vs-conventionally-fractionated-postmastectomy-radiation-fabrec-trial/</loc><lastmod>2023-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/precision-medicine-navigators-may-increase-genomic-testing-rates-among-black-patients-with-prostate-cancer/</loc><lastmod>2023-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/liquid-biopsies-may-be-predictive-of-cancer-recurrence-following-chemoradiation-in-patients-with-cervical-cancer/</loc><lastmod>2023-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/hypofractionated-radiotherapy-may-reduce-burden-of-head-and-neck-cancer-in-low-and-middle-income-countries/</loc><lastmod>2023-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/sexual-activity-and-vaginal-dilation-associated-with-fewer-side-effects-after-chemoradiation-for-cervical-cancer/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/10-october/using-recent-diagnostic-scans-may-cut-time-to-treatment-for-patients-needing-urgent-palliative-radiotherapy/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/ibrutinib-included-among-the-10-drugs-slated-for-medicare-price-negotiations/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/from-texas-to-sweden-medical-oncologist-gil-morgan-enjoys-connecting-the-cancer-community/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/acs-funds-uams-study-to-understand-treatment-resistance-in-pancreatic-cancer/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/surgical-oncologist-heber-salvador-offers-an-inside-look-at-cancer-care-in-brazil-complete-with-its-diversity-and-inequities/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/finding-a-new-life-purpose-after-cancer/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/catalyzing-change-young-moroccan-oncologists-spearhead-the-fight-against-sarcoma/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/27th-cancer-leadership-awards-recipients-announced-by-friends-of-cancer-research/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/city-of-hope-receives-323-million-from-cirm-to-advance-innovative-therapies/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/md-anderson-and-ochsner-health-partner-to-create-first-fully-integrated-cancer-program-in-louisiana/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/highlights-in-cancer-and-aging-from-the-2023-asco-annual-meeting/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/focus-on-atezolizumab-plus-cabozantinib-vs-cabozantinib-alone/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/more-on-biliary-tract-cancer-from-asco-2023-focus-on-zanidatamab/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/ipilimumab-plus-nivolumab-may-improve-outcomes-in-refractory-metastatic-melanoma-study-suggests/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/new-assistant-program-director-for-complex-general-surgical-oncology-fellowship-at-fox-chase-cancer-center/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/fixed-dose-niraparib-and-abiraterone-plus-prednisone-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/accelerated-approval-granted-for-talquetamab-tgvs-in-treatment-of-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/astro-names-fastro-recipients-for-2023/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/asco-releases-rapid-recommendation-update-on-use-of-olanzapine-to-treat-cancer-related-cachexia/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/asco-participates-in-president-s-cancer-panel/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/sio-and-asco-partner-to-develop-integrative-oncology-care-recommendations-for-anxiety-and-depression-in-patients-with-cancer/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/distributing-scarce-cancer-drugs-legally-and-ethically/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/understanding-the-treatment-of-waldenstroem-s-macroglobulinemia/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/accelerating-progress-against-cancer-and-other-life-threatening-diseases/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/retrospective-study-reports-tyrosine-kinase-inhibitor-used-in-cml-associated-with-nephrotoxicity/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/first-line-pembrolizumab-plus-lenvatinib-active-in-advanced-non-clear-cell-renal-cell-carcinoma/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/fda-approves-melphalan-hepatic-delivery-system-for-adult-patients-with-unresectable-hepatic-dominant-metastatic-uveal-melanoma/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/vorasidenib-in-idh1-or-idh2-mutant-grade-2-glioma/</loc><lastmod>2023-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/head-and-neck-cancers-2022-2023-almanac/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/first-in-class-agent-given-with-chemoradiotherapy-improves-survival-in-locally-advanced-head-and-neck-cancer-study-finds/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/first-in-class-bifunctional-antibody-plus-pembrolizumab-shows-activity-in-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/could-fluorouracil-free-first-line-regimen-challenge-the-standard-of-care-in-advanced-head-and-neck-cancer/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/epov-renata-ferrarotto/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/cabozantinib-plus-atezolizumab-warrants-further-study-in-treatment-of-advanced-head-and-neck-cancer/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/epov-glenn-j-hanna-and-sherene-loi/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/pembrolizumab-plus-chemoradiation-therapy-falls-short-in-locally-advanced-head-and-neck-cancer/</loc><lastmod>2023-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/phase-iii-trial-reports-chemoimmunotherapy-is-superior-to-chemotherapy-alone-in-malignant-pleural-mesothelioma/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/updates-on-cancer-therapies-under-study-from-2023-asco-breakthrough/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/selinexor-shows-activity-as-maintenance-therapy-for-tp53-wild-type-endometrial-cancer-in-phase-iii-trial/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/epov-martina-c-murphy/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/dostarlimab-gxly-with-chemotherapy-for-endometrial-cancer/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/no-significant-benefit-for-lenvatinib-plus-pembrolizumab-in-non-msi-hdmmr-metastatic-colorectal-cancer/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/perspectives-on-cancer-therapy-development/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/data-analysis-of-young-onset-lung-cancer-reveals-key-differences-compared-with-the-disease-in-older-adults/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/asco-updates-guideline-on-assessment-management-of-vulnerabilities-in-older-patients-receiving-systemic-cancer-therapy/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/fda-grants-accelerated-approval-to-elranatamab-bcmm-for-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/more-on-treatments-under-study-in-non-small-cell-lung-cancer-from-asco-2023/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/first-in-class-bifunctional-antibody-plus-pembrolizumab-shows-activity-in-head-and-neck-squamous-cell-carcinoma-1/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/incremental-gains-toward-better-outcomes-in-small-cell-lung-cancer/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/quizartinib-in-newly-diagnosed-flt3-itd-positive-acute-myeloid-leukemia/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/ishwaria-subbiah-joins-scri-as-executive-director-cancer-care-equity-and-professional-wellness/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/atrium-health-levine-children-s-expands-to-include-new-outpatient-center-for-cancer-and-blood-disorders/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/gut-microbiome-differs-in-responders-and-nonresponders-to-immune-checkpoint-inhibitors-in-patients-with-hcc/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/epov-peter-paul-yu-1/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/ai-based-tool-aids-in-diagnosis-of-cervical-cancers-and-precancers/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/study-shows-benefit-with-addition-of-tumor-treating-fields-therapy-in-metastatic-non-small-cell-lung-cancer/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/more-on-multiple-myeloma-from-asco-2023-focus-on-bispecific-antibodies/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/more-on-melanoma-from-asco-2023-focus-on-two-different-treatment-strategies/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/rising-after-struggle-surviving-my-first-asco-breakthrough-in-japan/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/asco-remembers-chemotherapy-pioneer-and-karnofsky-award-recipient-irwin-h-krakoff-md/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/crystal-s-denlinger-md-facp-named-new-chief-executive-officer-of-nccn/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/study-shows-exercise-may-improve-sexual-function-in-men-with-prostate-cancer/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/predicting-recurrence-in-colorectal-cancer-using-postoperative-circulating-tumor-dna-dynamics/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/epov-peter-paul-yu/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/instinct-and-perseverance-helped-save-me-from-two-cancers/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/there-s-an-app-for-that-digital-health-solutions-for-treating-insomnia-in-cancer-survivors/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/benjamin-besse-md-phd-chooses-a-career-in-medicine-over-music/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/new-updated-edition-of-a-classic-in-hematology-literature/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/thomas-j-herzog-md-takes-office-as-president-of-the-gog-foundation-inc/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/a-near-future-look-at-medicine-when-ai-has-a-mind-of-its-own/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/epov-cathy-eng/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/addition-of-nivolumab-to-stereotactic-ablative-radiotherapy-in-early-stage-or-isolated-lung-parenchymal-recurrent-nsclc/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/trifluridinetipiracil-plus-bevacizumab-in-previously-treated-metastatic-colorectal-cancer/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/nicholas-petrelli-md-facs-receives-lifetime-achievement-award-from-tulane-university-medical-school/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/vivek-subbiah-md-joins-scri-to-advance-early-phase-clinical-research/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/jesse-m-ehrenfeld-md-mph-inaugurated-as-president-of-the-ama/</loc><lastmod>2023-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/allogeneic-hct-outcomes-in-patients-with-mds-and-high-risk-genetics/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/germline-predisposition-and-homologous-recombination-deficiency-in-pancreatic-acinar-cell-carcinoma/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/is-cardiovascular-disease-linked-to-increased-risk-of-cancer/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/snmmi-provides-new-consensus-statement-on-lupsma-therapy/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/enhanced-recovery-program-may-be-effective-at-reducing-opioid-use-after-pancreatic-cancer-surgery/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/high-grade-serous-ovarian-cancer-impact-of-multimodal-screening-on-survival/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/kras-wild-type-advanced-pancreatic-cancer-addition-of-monoclonal-antibody-to-chemotherapy/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/modified-classification-of-pulmonary-adenocarcinomas-may-be-more-accurate-than-who-classification-system/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/taiwanese-program-shows-potential-for-detecting-early-stage-lung-cancer/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/aegean-trial-demonstrates-positive-surgical-outcomes-with-the-addition-of-perioperative-durvalumab-to-neoadjuvant-chemotherapy/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/relapsed-or-refractory-multiple-myeloma-mezigdomide-plus-dexamethasone/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/selinexor-maintenance-therapy-in-advanced-or-recurrent-endometrial-cancer/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/nsclc-osimertinib-plus-chemo-vs-osimertinib-alone/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/study-questions-role-of-extended-pleurectomy-decortication-in-patients-with-mesothelioma/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/fda-approves-new-multiple-myeloma-combination-therapy/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/patients-with-cancer-and-dpyd-variant-alleles-outcomes-with-reduced-dose-fluoropyrimidine-therapy/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/can-an-anti-ebv-antibody-assist-in-screening-for-nasopharyngeal-cancer/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/montefiore-einstein-comprehensive-cancer-center-awarded-comprehensive-designation-from-the-nci/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/comparing-radiation-therapies-for-nsclc/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/accuracy-of-iaslcs-2009-database-for-pleural-mesothelioma-staging/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/localized-ewing-sarcoma-interval-compressed-vs-standard-timing-chemotherapy/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/relapsed-pediatric-t-cell-all-base-edited-car7-t-cells/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/cancer-moonshot-initiative-receives-240-million-boost/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/egfr-tyrosine-kinase-inhibitors-vs-durvalumab-in-egfr-mutated-nsclc-impact-on-survival/</loc><lastmod>2023-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/pd-l1-inhibition-for-advanced-alveolar-soft-part-sarcoma/</loc><lastmod>2023-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/immunotherapy-combination-vs-standard-chemotherapy-for-metastatic-nsclc/</loc><lastmod>2023-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/is-adagrasib-active-in-kras-g12c-mutated-nsclc/</loc><lastmod>2023-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/impact-of-stigmatization-on-patients-with-lung-cancer/</loc><lastmod>2023-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/aacr-issues-annual-cancer-progress-report/</loc><lastmod>2023-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/extensive-stage-small-cell-lung-cancer-triplet-combination-vs-chemotherapy-alone/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/23andme-granted-fda-510k-clearance-to-report-additional-brca-variants/</loc><lastmod>2023-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/platinum-sensitive-ovarian-cancer-addition-of-atezolizumab-to-bevacizumab-and-platinum-based-therapy/</loc><lastmod>2023-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/receptor-status-among-patients-with-invasive-breast-cancer-what-s-missing/</loc><lastmod>2023-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/addition-of-tumor-treating-fields-therapy-to-standard-systemic-therapy-in-metastatic-nsclc-after-disease-progression/</loc><lastmod>2023-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/examining-disparities-in-endometrial-cancer-outcomes-among-black-patients/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/can-ai-assessment-of-screening-mammograms-offer-similar-accuracy-to-human-readers/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/risk-factors-for-melanoma-among-individuals-living-in-atlantic-canada/</loc><lastmod>2023-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/improving-nutrition-guidance-may-optimize-fertility-treatments-for-female-cancer-survivors/</loc><lastmod>2023-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/dlbcl-benefit-from-polatuzumab-vedotin-containing-regimens-based-on-cell-of-origin-subtype/</loc><lastmod>2023-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/newly-published-data-on-a-response-biomarker-for-dovitinib-in-patients-with-rcc/</loc><lastmod>2023-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/strategies-to-predict-immunotherapy-benefit-among-patients-with-advanced-colorectal-cancer/</loc><lastmod>2023-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/statins-may-be-linked-to-lower-risk-of-colorectal-cancer-in-patients-with-ulcerative-colitis/</loc><lastmod>2023-09-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/testicular-cancer-surveillance-vs-chemotherapy-after-postchemotherapy-rplnd-shows-viable-residual-cancer/</loc><lastmod>2023-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/magrolimab-plus-azacitidine-in-previously-untreated-patients-with-aml-ineligible-for-intensive-chemotherapy/</loc><lastmod>2023-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/adjuvant-pemetrexedcisplatin-vs-vinorelbinecisplatin-in-stage-ii-iiia-nonsquamous-nsclc/</loc><lastmod>2023-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/neoadjuvant-chemotherapy-followed-by-surgery-vs-standard-chemoradiation-for-cervical-cancer/</loc><lastmod>2023-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/lung-map-study-may-improve-access-to-clinical-trials-for-underrepresented-patients/</loc><lastmod>2023-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/particulate-matter-concentrations-and-incidence-of-breast-cancer/</loc><lastmod>2023-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/fda-approves-momelotinib-for-patients-with-myelofibrosis-and-anemia/</loc><lastmod>2023-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/study-examines-disparities-in-access-to-cancer-care-among-non-english-speaking-patients-in-the-united-states/</loc><lastmod>2023-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/ctdna-identified-in-breast-milk-from-women-with-breast-cancer/</loc><lastmod>2023-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/the-immune-system-may-play-vital-role-in-remission-duration-among-patients-with-multiple-myeloma/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/neocoast-durvalumab-monotherapy-vs-combined-with-other-immunotherapies-for-early-stage-nsclc/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/herthena-lung01-patritumab-deruxtecan-for-advanced-egfr-mutant-nsclc/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/psa-screening-for-him-act-introduced-in-senate-aims-to-reduce-costs-for-prostate-cancer-screening/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/effect-of-adjuvant-metformin-on-risk-of-new-primary-cancers-in-patients-with-early-breast-cancer/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/addition-of-olaparib-to-abiraterone-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/colorectal-cancer-screening-major-communication-gap-in-the-clinical-setting/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/effect-of-diet-and-exercise-intervention-on-chemotherapy-dose-intensity-response-rate-among-patients-with-breast-cancer/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/first-line-nalirifox-vs-nab-paclitaxelgemcitabine-in-metastatic-pancreatic-cancer-napoli-3/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/ambulatory-thromboprophylaxis-in-patients-with-lung-and-gastrointestinal-cancers/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/addition-of-first-line-regorafenib-to-nivolumab-and-chemotherapy-in-metastatic-esophageal-cancer/</loc><lastmod>2023-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/previously-untreated-advanced-melanoma-addition-of-bempegaldesleukin-to-nivolumab/</loc><lastmod>2023-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/tisotumab-vedotin-based-combinations-in-advanced-cervical-cancer/</loc><lastmod>2023-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/lungcan-advocacy-program-nets-25-percent-increase-in-lcrp-funding/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/reproductive-factors-may-be-associated-with-higher-risk-of-lung-cancer-in-women/</loc><lastmod>2023-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/quality-of-life-with-nivolumab-plus-chemotherapy-in-advanced-gastricgej-cancer-or-esophageal-adenocarcinoma/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/effect-of-travel-time-and-distance-to-cancer-center-on-participation-of-patients-in-genotype-matched-trials/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/does-colon-tumor-location-play-a-role-in-metastasis-and-survival/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/hyperglycemia-among-patients-with-breast-cancer-receiving-alpelisib/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/using-whole-body-imaging-agent-to-predict-response-to-treatment-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/feminist-approach-to-address-gender-inequalities-may-improve-women-s-access-to-cancer-prevention-detection-and-care/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/destiny-lung02-t-dxd-for-her2-mutant-metastatic-nsclc/</loc><lastmod>2023-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/annual-report-to-the-nation-on-the-status-of-cancer-part-2-focuses-on-covid-19-s-impact-on-cancer-diagnoses/</loc><lastmod>2023-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/carfilzomib-and-lenalidomide-based-therapy-in-primary-plasma-cell-leukemia/</loc><lastmod>2023-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/bariatric-surgery-may-reduce-the-risk-of-hematologic-malignancies-particularly-among-female-patients/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/mutations-in-11-genes-may-be-associated-with-aggressive-prostate-cancer/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/first-line-dabrafenibtrametinib-in-pediatric-braf-v600-mutated-low-grade-glioma/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/hypofractionated-vs-conventional-fractionated-proton-radiotherapy-after-mastectomy-for-breast-cancer/</loc><lastmod>2023-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/addition-of-hyperthermic-intraperitoneal-chemotherapy-to-interval-cytoreductive-surgery-in-advanced-ovarian-cancer/</loc><lastmod>2023-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/do-checkpoint-inhibitors-show-benefit-in-egfr-mutated-nsclc-after-progression/</loc><lastmod>2023-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/oral-health-may-be-linked-to-survival-in-patients-with-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2023-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/gynecologic-cancer-misinformation-may-be-widespread-on-tiktok/</loc><lastmod>2023-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/fda-approves-bosutinib-for-pediatric-patients-with-chronic-myelogenous-leukemia/</loc><lastmod>2023-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/risk-factors-for-incident-heart-failure-among-cancer-survivors-aged-18-to-39/</loc><lastmod>2023-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/cytotoxic-and-immune-stimulatory-gene-therapy-for-adults-with-primary-high-grade-glioma/</loc><lastmod>2023-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/neoadjuvant-palbociclib-plus-giredestrant-or-anastrozole-in-er-positive-her2-negative-breast-cancer/</loc><lastmod>2023-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/exposure-to-pfas-and-phenols-may-be-linked-to-cancer-risk/</loc><lastmod>2023-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/high-intensity-training-may-reduce-the-risk-of-colorectal-cancer-in-patients-with-lynch-syndrome/</loc><lastmod>2023-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/personalized-biomarker-based-umbrella-trial-in-recurrent-or-metastatic-hnscc/</loc><lastmod>2023-09-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/immune-checkpoint-inhibitors-for-patients-with-child-pugh-class-b-vs-a-advanced-hepatocellular-carcinoma/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/efficacy-of-the-9-valent-hpv-vaccine-10-year-follow-up/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/asco-participates-in-president-s-cancer-panel-event/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/vitamin-c-and-d-supplements-for-patients-with-aml-undergoing-intensive-chemotherapy/</loc><lastmod>2023-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/radiation-exposure-from-medical-imaging-in-pediatric-patients-with-down-syndrome/</loc><lastmod>2023-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/09-september/dabrafenib-plus-trametinib-in-relapsed-or-refractory-braf-v600-mutant-pediatric-high-grade-glioma/</loc><lastmod>2023-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/phergain-adapted-response-trial-guides-treatment-with-dual-her2-blockade-alone/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-kevin-kalinsky/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/early-phase-study-reports-activity-of-cabozantinib-and-cetuximab-combination-in-refractory-head-and-neck-cancer/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/study-finds-durvalumab-plus-carboplatin-and-paclitaxel-effective-tolerable-in-frail-patients-with-head-and-neck-cancer/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fda-approves-trifluridine-and-tipiracil-with-bevacizumab-for-previously-treated-metastatic-colorectal-cancer/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/gilteritinib-maintenance-therapy-after-transplantation-in-patients-with-flt3-itd-aml-who-have-measurable-residual-disease/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/artistry-7-and-rosella-phase-iii-trials-to-evaluate-novel-agents-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/liquid-biopsy-assay-demonstrated-effectiveness-in-early-cancer-detection-in-asymptomatic-individuals-in-vietnam/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/developing-solutions-for-cancer-care-disparities-across-geography/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-barbara-burtness/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/new-challenge-in-triple-negative-breast-cancer-optimizing-the-sequencing-of-treatments/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/chemotherapy-shortage-impacts-patients-physicians-costs-and-clinical-trials/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/is-chemotherapy-shortage-setting-back-clinical-trials/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/md-anderson-names-christopher-flowers-md-msc-fasco-division-head-of-cancer-medicine/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-joshua-zeidner/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/the-future-priorities-of-the-national-cancer-institute/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/noninvasive-multitarget-stool-dna-methylation-assay-under-study-in-early-detection-of-multiple-gastrointestinal-cancers/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/rapid-guideline-update-offers-key-evidence-based-recommendations-for-stage-iii-nsclc-management/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/how-the-cancer-moonshot-aims-to-improve-the-quality-of-life-for-adolescent-and-young-adult-cancer-survivors/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/more-on-the-complexity-of-prior-authorization/</loc><lastmod>2023-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-xin-gao/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/sacituzumab-govitecan-hziy-achieves-response-after-disease-progression-on-immune-checkpoint-inhibitor-in-metastatic-urothelial-cancer/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-daniel-petrylak/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/thor-trial-erdafitinib-improves-outcomes-vs-chemotherapy-in-fgfr-altered-advanced-urothelial-carcinoma/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/rucaparib-vs-physicians-choice-of-single-agent-therapy-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-oliver-sartor/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/improvement-in-progression-free-survival-with-first-line-olaparib-plus-abiraterone-in-metastatic-prostate-cancer/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-sumanta-k-pal/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/extended-follow-up-supports-first-line-use-of-nivolumab-plus-cabozantinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-david-a-braun/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/continued-survival-benefit-with-first-line-lenvatinib-plus-pembrolizumab-in-advanced-kidney-cancer/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/genitourinary-oncology-2023-almanac/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/recent-fda-approvals-in-hematologic-oncology/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-ajay-k-nooka/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/study-shows-activity-of-talquetamab-in-highly-refractory-multiple-myeloma/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-urvi-shah/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/elranatamab-induces-responses-in-many-patients-with-resistant-multiple-myeloma-in-phase-ii-trial/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-ciara-l-freeman-and-asher-chanan-khan/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/ciltacabtagene-autoleucel-beneficial-in-early-myeloma-relapse/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-mrinal-s-patnaik-mbbs/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-alexey-danilov/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/is-zanubrutinib-poised-to-become-a-new-standard-of-care-in-relapsed-or-refractory-cll-and-sll/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-catherine-s-diefenbach-md/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/car-t-cell-therapy-vs-chemoimmunotherapy-in-second-line-treatment-of-resistant-large-b-cell-lymphoma/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-julio-chavez/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/magnolia-trial-zanubrutinib-yields-high-response-rates-with-low-rate-of-cardiac-events-in-marginal-zone-lymphoma/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-ann-s-lacasce/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/nivolumab-plus-avd-surpasses-standard-of-care-combination-regimen-in-patients-with-advanced-hodgkin-lymphoma/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-caron-jacobson/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/primary-overall-survival-analysis-supports-axicabtagene-ciloleucel-as-second-line-therapy-in-advanced-lymphoma/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/hematologic-oncology-2023-almanac/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/car-t-cell-therapies-trends-and-indications/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/susan-love-breast-cancer-surgeon-researcher-and-advocate/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/overcoming-financial-toxicity-from-cancer/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/american-society-for-radiation-oncology-names-newly-elected-officers-to-board-of-directors/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/potential-of-quizartinib-for-improving-outcomes-in-acute-myeloid-leukemia/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/talazoparib-with-enzalutamide-in-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/novel-hpv-targeted-agents-boost-efficacy-of-pembrolizumab-in-head-and-neck-cancer-two-studies-show/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-erminia-massarelli/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-ines-vaz-luis/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/cll14-long-term-results-of-fixed-duration-venetoclax-plus-obinutuzumab-in-elderly-patients-with-cll/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/incorporation-of-gilteritinib-into-induction-and-consolidation-chemotherapy-and-as-maintenance-therapy-in-newly-diagnosed-patients-with-aml/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/first-line-atezolizumab-vs-single-agent-chemotherapy-in-patients-with-advanced-nsclc-ineligible-for-platinum-based-chemotherapy/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/first-line-pembrolizumablenvatinib-in-advanced-non-clear-cell-renal-cell-carcinoma/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/adjuvant-nivolumab-vs-observation-for-patients-with-completely-resected-merkel-cell-carcinoma/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/on-the-art-of-organizing-best-of-asco-meetings/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/three-studies-from-asco-2023-focus-on-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/for-advanced-nasopharyngeal-cancer-adjuvant-gemcitabine-plus-cisplatin-favored-over-fluorouracil-plus-cisplatin-study-reports/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/imerge-trial-use-of-imetelstat-reduces-transfusion-dependence-in-lower-risk-mds/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-anand-ashwin-patel/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/ebctcg-meta-analysis-confirms-benefit-of-ovarian-ablation-or-suppression-in-preventing-breast-cancer-recurrence/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/asco-awarded-11-million-to-study-oral-drug-dosing-strategies-in-older-adults-with-metastatic-breast-cancer-receiving-cdk46-inhibitors/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/cancer-care-providers-applaud-new-federal-rule-regulating-short-term-limited-duration-plans/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/new-world-economic-forum-research-identifies-top-ai-applications-that-could-revolutionize-global-health-care/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/her2-low-status-is-dynamic-for-patients-with-triple-negative-breast-cancer/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-barbara-pistilli/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/how-multidisciplinary-specialties-are-coming-together-to-improve-the-quality-of-life-of-cancer-survivors/</loc><lastmod>2023-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/epov-daniel-g-stover/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/should-cdk46-inhibitors-be-a-first-line-option-for-advanced-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/for-advanced-nasopharyngeal-cancer-adjuvant-gemcitabine-plus-cisplatin-favored-over-fluorouracil-plus-cisplatin-study-reports-1/</loc><lastmod>2023-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/three-studies-from-asco-2023-focus-on-metastatic-castration-resistant-prostate-cancer-1/</loc><lastmod>2023-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fda-approves-dostarlimab-gxly-plus-chemotherapy-for-dmmr-or-msi-h-endometrial-cancer/</loc><lastmod>2023-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/molecular-classification-and-response-to-radiotherapy-in-early-stage-endometrioid-endometrial-cancer/</loc><lastmod>2023-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/exercise-may-reduce-sexual-dysfunction-caused-by-prostate-cancer-treatment/</loc><lastmod>2023-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/can-an-ai-based-tool-accurately-detect-precancerous-cervical-lesions/</loc><lastmod>2023-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/researchers-may-have-uncovered-two-new-subtypes-of-hpv-positive-head-and-neck-squamous-cell-carcinomas/</loc><lastmod>2023-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/addition-of-talazoparib-to-enzalutamide-in-the-first-line-treatment-of-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/neoadjuvant-pembrolizumabchemotherapy-and-adjuvant-pembrolizumab-in-early-stage-nsclc/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/how-is-administrative-payment-burden-associated-with-cost-related-delays-in-cancer-care/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/new-clinical-trial-seeks-to-reduce-cardiovascular-damage-in-patients-undergoing-anticancer-therapy-for-breast-cancer/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/edoxaban-taken-for-12-months-may-improve-outcomes-in-patients-with-cancer-and-isolated-distal-deep-vein-thrombosis/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/time-gaps-may-be-critical-parameters-when-sparing-skin-during-flash-radiation-therapy/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/immunochemotherapy-triplet-in-patients-with-advanced-nonsquamous-nsclc-and-untreated-brain-metastases/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fda-approves-luspatercept-aamt-as-first-line-treatment-for-adult-patients-with-lower-risk-mds-and-anemia-who-may-require-transfusions/</loc><lastmod>2023-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/optimizing-tobacco-cessation-treatment-with-lung-cancer-screenings/</loc><lastmod>2023-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/are-cannabinoids-safe-and-effective-for-reducing-symptoms-in-pediatric-patients-with-cancer/</loc><lastmod>2023-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/er-positive-breast-cancer-addition-of-adjuvant-ovarian-function-suppression-to-tamoxifen-in-premenopausal-patients/</loc><lastmod>2023-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/addition-of-perioperative-pd-l1-inhibition-to-neoadjuvant-chemotherapy-in-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2023-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/divarasib-in-patients-with-advanced-solid-tumors-and-a-kras-g12c-mutation/</loc><lastmod>2023-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/rural-patients-with-cancer-receipt-of-surgical-care-at-high-vs-low-volume-hospitals/</loc><lastmod>2023-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/high-temporalhigh-spatial-resolution-breast-mri-for-patients-with-high-background-parenchymal-enhancement/</loc><lastmod>2023-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/follow-up-of-chronic-immune-related-adverse-events-after-adjuvant-immunotherapy-for-high-risk-resected-melanoma/</loc><lastmod>2023-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/study-shows-potential-of-cabozantinib-to-treat-patients-with-advanced-neuroendocrine-tumors/</loc><lastmod>2023-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/how-guideline-concordant-are-cancer-treatment-recommendations-from-chatgpt/</loc><lastmod>2023-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/cllsll-efficacy-of-cd19-directed-car-t-cell-therapy-in-relapsed-or-refractory-disease/</loc><lastmod>2023-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/novel-targeted-therapy-combination-may-be-an-effective-first-line-option-for-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2023-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/modified-citrus-pectin-treatment-for-nonmetastatic-biochemically-relapsed-prostate-cancer/</loc><lastmod>2023-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/patterns-in-early-onset-cancer-incidence-in-the-united-states-from-2010-to-2019/</loc><lastmod>2023-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/cardiorespiratory-fitness-in-youth-may-be-associated-with-a-lower-risk-of-nine-cancer-types/</loc><lastmod>2023-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/short-term-use-of-immunosuppressants-may-not-be-linked-to-increased-cancer-risk-in-patients-with-ocular-inflammatory-diseases/</loc><lastmod>2023-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/adherence-to-mediterranean-lifestyle-may-be-associated-with-lower-risk-of-all-cause-and-cancer-mortality/</loc><lastmod>2023-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/bariatric-surgery-and-cancer-incidence-and-mortality-for-patients-with-severe-obesity/</loc><lastmod>2023-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/crystal-s-denlinger-md-facp-named-new-chief-executive-officer-of-nccn/</loc><lastmod>2023-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/addition-of-neoadjuvant-monoclonal-antibody-to-platinum-based-chemotherapy-in-resectable-nsclc/</loc><lastmod>2023-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/alcohol-consumption-behaviors-among-patients-diagnosed-with-cancer/</loc><lastmod>2023-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/pertuzumabtrastuzumab-with-or-without-chemotherapy-followed-by-t-dm1-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2023-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/sacituzumab-continues-to-show-benefit-in-patients-with-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2023-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/breast-cancer-screening-and-10-year-net-survival-in-canadian-women-aged-40-to-49/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/unraveling-the-mechanisms-behind-the-antichemotherapy-effects-of-abcg2-proteins/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/use-of-abiraterone-acetate-with-or-without-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/addition-of-zanubrutinib-to-obinutuzumab-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2023-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/targeted-axillary-dissection-after-neoadjuvant-therapy-in-node-positive-breast-cancer/</loc><lastmod>2023-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/personalized-calculator-may-be-predictive-of-benefits-from-adjuvant-tace-in-patients-with-hepatocellular-carcinoma-undergoing-hepatectomy/</loc><lastmod>2023-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/t-cell-tolerant-fraction-may-predict-immune-related-adverse-events-among-patients-receiving-immunotherapy/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/association-of-pathologic-lymph-node-regression-after-neoadjuvant-chemotherapy-with-outcomes-in-esophageal-adenocarcinoma/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/first-line-cemiplimab-vs-chemotherapy-in-advanced-nsclc-35-month-follow-up-of-empower-lung-1/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/addition-of-neoadjuvant-talimogene-laherparepvec-to-surgery-in-advanced-melanoma-5-year-follow-up/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/researchers-may-have-identified-several-new-breast-cancer-susceptibility-genes/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/understanding-how-tet2-gene-deficiency-may-fuel-development-of-aml/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/ai-driven-muscle-mass-assessment-may-aid-in-detecting-sarcopenia-in-patients-with-head-and-neck-cancer/</loc><lastmod>2023-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fda-approves-niraparib-and-abiraterone-acetate-plus-prednisone-for-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/are-immune-checkpoint-inhibitors-efficacious-among-patients-with-penile-squamous-cell-carcinoma/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/ai-supported-screen-reading-vs-standard-double-reading-in-mammography-screening-for-breast-cancer/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/homoharringtonine-based-induction-in-pediatric-aml/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/vigorous-intermittent-lifestyle-physical-activity-and-cancer-incidence-among-nonexercising-adults/</loc><lastmod>2023-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/ipilimumab-plus-nivolumab-may-improve-outcomes-in-patients-with-refractory-metastatic-melanoma-study-suggests/</loc><lastmod>2023-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fda-grants-accelerated-approval-to-talquetamab-tgvs-for-treatment-of-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fda-approves-pralsetinib-for-ret-fusion-positive-nsclc/</loc><lastmod>2023-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/impact-of-interventions-to-promote-adjuvant-endocrine-therapy-adherence-among-breast-cancer-survivors/</loc><lastmod>2023-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/risk-of-death-cancer-and-autoimmune-disease-among-patients-undergoing-thymectomy/</loc><lastmod>2023-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/avelumab-vs-standard-second-line-chemotherapy-in-dmmrmsi-metastatic-colorectal-cancer/</loc><lastmod>2023-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/breast-cancer-overdiagnosis-may-be-common-among-older-female-patients/</loc><lastmod>2023-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/use-of-lorazepam-and-survival-outcomes-for-patients-with-pancreatic-cancer/</loc><lastmod>2023-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/locoregional-recurrence-patterns-among-molecular-subtypes-of-breast-cancer/</loc><lastmod>2023-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/radiation-facility-volume-and-survival-in-very-high-risk-prostate-cancer-treated-with-curative-radiation-and-androgen-deprivation-therapy/</loc><lastmod>2023-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/medicaid-expansion-and-participation-in-cancer-clinical-trials-among-patients-insured-by-medicaid/</loc><lastmod>2023-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/therapeutic-implications-of-dna-repair-discoveries-in-patients-with-homologous-recombination-deficiencies/</loc><lastmod>2023-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/novel-mepenk-test-may-be-effective-at-diagnosing-early-stage-bladder-cancer-in-patients-with-hematuria/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/effects-of-bmi-in-patients-with-hormone-receptor-positive-breast-cancer-receiving-adjuvant-palbociclib-and-endocrine-therapy/</loc><lastmod>2023-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/time-to-treatment-and-survival-among-adults-aged-50-years-with-colorectal-cancer/</loc><lastmod>2023-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/effect-of-atorvastatin-on-cardiac-dysfunction-in-patients-receiving-anthracyclines-for-lymphoma/</loc><lastmod>2023-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/four-novel-biomarkers-may-help-detect-black-patients-at-risk-of-advanced-prostate-cancer/</loc><lastmod>2023-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/do-mds-diagnoses-require-second-opinions/</loc><lastmod>2023-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/erdafitinib-for-patients-with-fgfr-altered-advanced-solid-tumors/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/adjuvant-everolimus-in-patients-with-renal-cell-carcinoma-at-high-risk-of-recurrence/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/elevated-mri-enhancement-may-indicate-increased-risk-of-cancer-in-patients-with-very-dense-breasts/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/does-daily-consumption-of-sugar-sweetened-beverages-increase-the-risk-of-liver-disease-among-postmenopausal-women/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/alcohol-consumption-and-risk-of-breast-cancer-recurrence/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/psma-petct-imaging-may-eliminate-the-need-for-preimaging-biopsy-in-older-patients-undergoing-screening-for-prostate-cancer/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/treatment-related-mortality-among-children-with-cancer-in-low-and-middle-income-countries/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/preoperative-chemoradiation-with-or-without-pazopanib-in-nonrhabdomyosarcoma-soft-tissue-sarcoma/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/study-shows-substantial-racial-and-ethnic-disparities-among-survivors-of-second-primary-cancers-in-the-united-states/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/report-highlights-rapid-adoption-of-clinical-research-results-into-colon-cancer-chemotherapy-prescribing-patterns/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/fine-particulate-matter-exposure-may-increase-risk-of-primary-cancers-other-than-lung-cancer/</loc><lastmod>2023-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/panda-trial-first-line-treatment-regimens-for-elderly-patients-with-rasbraf-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/outcomes-in-children-and-young-adults-with-t-cell-all-and-induction-failure-in-contemporary-treatment-trials/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/ebv-based-screening-methods-for-identifying-nasopharyngeal-carcinoma/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/outcomes-with-cancer-associated-isolated-distal-deep-vein-thrombosis/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/how-does-bmi-affect-cardiac-health-for-patients-with-breast-cancer-receiving-chemotherapy/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/analysis-challenges-theory-that-depression-and-anxiety-may-increase-cancer-risk/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/translating-consent-documents-potential-barrier-for-including-underrepresented-groups-in-clinical-trials/</loc><lastmod>2023-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/bladder-sparing-trimodal-therapy-vs-radical-cystectomy-in-patients-with-clinically-node-positive-nonmetastatic-bladder-cancer/</loc><lastmod>2023-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/long-term-outcomes-with-zanubrutinib-vs-ibrutinib-in-symptomatic-waldenstroms-macroglobulinemia/</loc><lastmod>2023-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/camrelizumab-plus-rivoceranib-vs-sorafenib-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2023-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/comparison-of-outcomes-of-surgical-vs-nonsurgical-approaches-in-patients-with-malignant-bowel-obstructions/</loc><lastmod>2023-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/wildfire-exposure-and-survival-outcomes-after-surgery-for-nsclc/</loc><lastmod>2023-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/contribution-of-mek-inhibition-to-combined-brafmek-inhibitor-treatment-in-advanced-braf-mutant-melanoma/</loc><lastmod>2023-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/liquid-biopsy-assay-demonstrates-effective-early-cancer-detection-in-asymptomatic-individuals-in-vietnam/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/noninvasive-multitarget-stool-dna-methylation-assay-in-the-early-detection-of-multiple-gastrointestinal-cancers/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/researchers-characterize-adverse-immune-events-in-patients-with-cancer-who-experience-immune-checkpoint-inhibitor-associated-arthritis/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/gastrointestinal-symptoms-may-be-prevalent-in-geriatric-female-colorectal-cancer-survivors/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/acp-issues-updated-clinical-guidelines-for-screening-asymptomatic-average-risk-adults-for-colorectal-cancer/</loc><lastmod>2023-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/08-august/early-stage-cancer-diagnoses-in-the-united-states-may-have-decreased-during-the-first-year-of-the-covid-19-pandemic/</loc><lastmod>2023-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/study-finds-durvalumab-plus-carboplatin-and-paclitaxel-effective-tolerable-in-frail-patients-with-head-and-neck-cancer/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-barbara-burtness-1/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/addition-of-relacorilant-to-nab-paclitaxel-in-recurrent-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/addition-of-neoadjuvant-nivolumab-to-platinum-based-chemotherapy-in-stage-iii-nsclc/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/congress-sends-asco-astro-supported-letter-on-cancer-drug-shortages-to-the-hhs-and-the-fda/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/glofitamab-gxbm-for-select-relapsed-or-refractory-large-b-cell-lymphomas/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/asco-cap-guideline-update-confirms-previous-recommendations-for-her2-testing-in-breast-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/implementation-of-clinical-treatment-act-advances-increasing-access-to-cancer-clinical-trials/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/asco-blueprint-report-captures-steady-progress-toward-equity-diversity-and-inclusion/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/asco-issues-statements-on-recent-us-supreme-court-rulings-on-affirmative-action-lgbtq-rights/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/i-want-to-kill-you/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/keeping-staff-and-patients-safe-from-workplace-violence/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/association-of-alcohol-intake-with-risk-of-early-onset-colorectal-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/omitting-mediastinal-radiotherapy-in-some-patients-with-primary-mediastinal-b-cell-lymphoma-after-immunochemotherapy/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-corey-speers-and-julie-gralow/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/thor-trial-erdafitinib-improves-outcomes-vs-chemotherapy-in-fgfr-altered-advanced-urothelial-carcinoma/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-daniel-petrylak/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/roundup-of-abstracts-on-new-therapies-for-gastrointestinal-cancers-from-asco-2023/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/investigators-evaluate-the-effect-of-body-mass-index-on-outcomes-in-patients-with-head-and-neck-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/current-management-of-and-future-possibilities-for-triple-negative-breast-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/quarterback-trial-de-escalation-of-chemoradiotherapy-for-subset-of-patients-with-hpv-positive-oropharyngeal-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-priyanka-bhateja/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-saba-and-choe/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/in-ovarian-cancer-neoadjuvant-olaparib-feasible-appears-effective-in-pilot-study-among-patients-with-brca-mutation/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-kathleen-moore/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/two-studies-highlight-benefits-in-quality-of-life-and-symptom-management-with-novel-treatments-of-advanced-breast-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-gustavo-werutsky-and-lisa-a-carey/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/allison-institute-announces-appointment-of-inaugural-members/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/alfredo-quinones-hinojosa-md-from-migrant-farm-worker-to-neurosurgeon-in-search-of-a-cure-for-brain-cancer/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/berberine/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/damon-runyon-names-physician-scientist-awardees/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/study-of-cancer-metastasis-receives-35-million-boost-at-johns-hopkins-medicine/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/asco-remembers-former-board-of-directors-member-and-radiation-oncologist-a-william-blackstock-jr-md-fasco/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/sso-names-chandrakanth-are-mbbs-mba-chief-executive-officer-of-global-forum-of-cancer-surgeons/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/turning-fear-into-hope/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/continuum-in-locally-advanced-nasopharyngeal-cancer-addition-of-sintilimab-to-chemoradiotherapy-offers-benefit/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-barbara-burtness/</loc><lastmod>2023-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-barbara-pistilli/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/extended-follow-up-of-tropics-02-trial-sacituzumab-govitecan-in-metastatic-breast-cancer/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-ines-vaz-luis/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/ebctcg-meta-analysis-confirms-benefit-of-ovarian-ablation-or-suppression-in-preventing-breast-cancer-recurrence/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-saba-and-choe-1/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/jupiter-02-toripalimab-plus-chemotherapy-improved-survival-outcomes-for-some-patients-with-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/dysphagia-optimized-vs-standard-imrt-in-newly-diagnosed-patients-with-head-and-neck-cancer/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-priyanka-bhateja-1/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/quarterback-trial-de-escalation-of-chemoradiotherapy-for-subset-of-patients-with-hpv-positive-oropharyngeal-cancer-1/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-barbara-burtness-2/</loc><lastmod>2023-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/continuum-in-locally-advanced-nasopharyngeal-cancer-addition-of-sintilimab-to-chemoradiotherapy-offers-benefit-1/</loc><lastmod>2023-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/addition-of-atezolizumab-to-cabozantinib-in-renal-cell-carcinoma-progressing-during-or-after-prior-immune-checkpoint-inhibition/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-erminia-massarelli/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/novel-hpv-targeted-agents-boost-efficacy-of-pembrolizumab-in-head-and-neck-cancer-two-studies-show/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/adaura-trial-adjuvant-osimertinib-improves-overall-survival-in-resectable-egfr-mutated-nsclc/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-benjamin-j-solomon/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/pelvic-radiation-therapy-avoided-for-most-patients-with-intermediate-risk-locally-advanced-rectal-cancer/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-pamela-l-kunz-md-and-corrie-marijnen-md-phd/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/a-call-for-tailored-medical-services-in-oncology-care-for-older-deaf-patients/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/ciltacabtagene-autoleucel-beneficial-in-early-myeloma-relapse/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-ciara-l-freeman-and-asher-chanan-khan/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/perioperative-pembrolizumab-plus-chemotherapy-improves-outcomes-in-stage-ii-and-iii-nsclc/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-mark-awad/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/nivolumab-plus-avd-surpasses-standard-of-care-combination-regimen-in-patients-with-advanced-hodgkin-lymphoma/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-ann-s-lacasce/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/is-t-dxd-heading-for-tumor-agnostic-status/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-kohei-shitara-and-bradley-alexander-mcgregor/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/pathology-assessment-during-mastectomy-and-overtreatment-of-the-axilla-in-clinically-node-negative-breast-cancer/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/continued-survival-benefit-with-first-line-lenvatinib-plus-pembrolizumab-in-advanced-kidney-cancer/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/lobular-vs-ductal-breast-cancer-distinctions-in-management/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/addition-of-tislelizumab-to-chemotherapy-improves-survival-in-treatment-of-metastatic-esophageal-squamous-cell-carcinoma/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-david-a-braun/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/a-european-leader-in-surgical-oncology-isabel-rubio-shares-her-story-and-sheds-light-on-the-challenges-ahead/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/primary-overall-survival-analysis-supports-axicabtagene-ciloleucel-as-second-line-therapy-in-advanced-lymphoma/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/second-annual-conference-at-the-nixon-presidential-library-and-museum-emphasizes-patients-concerns/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epov-caron-jacobson/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/health-systems-strengthening-approach-in-the-united-states-mexico-border-region-improved-5-year-survival-for-children-with-all/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/a-telephone-based-weight-loss-intervention-induced-clinically-meaningful-weight-loss-in-patients-with-breast-cancer-and-overweight-or-obesity/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/how-asco-s-2023-breakthrough-meeting-is-putting-a-spotlight-on-cutting-edge-advances-in-cancer-care-technology-and-innovation/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/asco-updates-guideline-on-venous-thromboembolism-prophylaxis-and-treatment-in-patients-with-cancer/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/epcoritamab-bysp-in-treatment-of-relapsed-or-refractory-b-cell-lymphomas/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/olaparib-with-abiraterone-and-prednisone-or-prednisolone-for-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/sara-hurvitz-joins-fred-hutch-university-of-washington-seattle/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/assessing-geriatric-oncology-practice-in-portugal/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/retrospective-view-of-medical-dissection-from-may-1896/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/targeting-depressive-symptoms-in-younger-breast-cancer-survivors/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/i-didn-t-want-my-past-to-become-my-future/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/study-finds-preoperative-mri-does-not-significantly-impact-margin-status-in-patients-with-breast-cancer/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/trends-in-receipt-of-end-of-life-systemic-treatment-for-patients-with-cancer/</loc><lastmod>2023-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/diversity-may-play-a-key-role-in-black-patients-trust-of-videos-about-prostate-cancer/</loc><lastmod>2023-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/investigators-offer-guidance-for-improving-access-to-oncology-drugs-in-sub-saharan-africa/</loc><lastmod>2023-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/adjuvant-osimertinib-in-resected-egfr-mutant-nsclc-overall-survival-analysis-of-the-adaura-trial/</loc><lastmod>2023-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/activity-and-toxicity-of-pembrolizumab-in-rare-sarcomas/</loc><lastmod>2023-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/neoadjuvant-and-adjuvant-gvax-plus-nivolumab-and-urelemab-may-increase-immune-response-in-patients-with-resectable-pancreatic-cancer/</loc><lastmod>2023-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/study-examines-impact-of-modified-treatment-protocols-on-survival-in-pediatric-patients-with-all/</loc><lastmod>2023-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/biological-aging-and-radiation-therapy-for-breast-cancer/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/psilocybin-and-other-psychedelics-may-help-patients-with-late-stage-gynecologic-cancer-tackle-mental-health-symptoms/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/dysphagia-optimized-vs-standard-imrt-in-newly-diagnosed-patients-with-head-and-neck-cancer-1/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/pediatric-early-warning-systems-implementation-in-resource-limited-latin-american-hospitals/</loc><lastmod>2023-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/addition-of-sbrt-to-immunotherapy-in-advanced-solid-tumors/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/olaparib-and-temozolomide-in-advanced-uterine-leiomyosarcoma/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/intervention-to-increase-uptake-of-tobacco-use-treatment-for-patients-with-cancer-who-smoke/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/stereotactic-radiosurgery-before-resection-of-brain-metastases-from-solid-tumors/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/improving-screening-and-surveillance-practices-for-early-cancer-detection-in-patients-with-barretts-esophagus/</loc><lastmod>2023-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/novel-imaging-guided-radiotherapy-technique-may-reduce-short-term-side-effects-for-patients-with-prostate-cancer/</loc><lastmod>2023-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/prediction-of-lung-cancer-mortality-with-blood-based-biomarker-panel-and-plco-risk-model/</loc><lastmod>2023-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/intraoperative-mri-guided-vs-aminolevulinic-acid-guided-resection-in-newly-diagnosed-patients-with-glioblastoma/</loc><lastmod>2023-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/pirtobrutinib-after-covalent-btk-inhibitor-treatment-in-relapsed-or-refractory-cllsll/</loc><lastmod>2023-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/zanidatamab-in-her2-positive-advanced-biliary-tract-cancer/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/functional-recovery-and-quality-of-life-in-older-patients-undergoing-colorectal-cancer-surgery/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/academically-developed-bcma-directed-car-t-cell-therapy-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/new-tool-may-help-physicians-pinpoint-gaps-in-hematologic-malignancy-awareness/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/incidence-and-outcomes-of-severe-hepatopathy-in-national-wilms-tumor-study-protocols/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/mlh1-methylation-status-and-screenings-for-colorectal-or-endometrial-cancer/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/decimation-of-gut-bacteria-and-chemotherapy-induced-weight-gain-in-patients-with-breast-cancer/</loc><lastmod>2023-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/pembrolizumab-based-combination-therapies-may-improve-outcomes-in-advanced-nsclc/</loc><lastmod>2023-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/use-of-zipalertinib-in-previously-treated-patients-with-advanced-nsclc-and-egfr-exon-20-insertions/</loc><lastmod>2023-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/meta-analysis-of-the-addition-of-docetaxel-to-adt-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2023-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/crenigacestat-plus-bcma-car-t-cell-therapy-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/aspartame-hazard-and-risk-assessment-results-released-by-iarc-and-jecfa/</loc><lastmod>2023-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/apobec3a-protein-may-be-linked-to-drug-resistance-in-patients-with-nsclc/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/cetuximab-plus-radiotherapy-shows-activity-in-patients-with-locally-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/lazertinib-vs-gefitinib-in-the-first-line-treatment-of-egfr-mutated-advanced-nsclc/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/second-line-trastuzumab-ramucirumab-and-paclitaxel-in-previously-treated-patients-with-her2-positive-advanced-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/prevalence-of-prior-cancer-among-patients-with-newly-diagnosed-cancer/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/germline-variants-in-colorectal-cancer-susceptibility-genes-by-raceethnicity-in-patients-with-early-onset-colorectal-cancer/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/patients-with-prostate-cancer-may-face-high-rates-of-financial-toxicity/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/fecal-microbiota-transplants-show-potential-in-improving-melanoma-treatment/</loc><lastmod>2023-07-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/changing-how-immune-checkpoint-inhibitors-are-delivered-could-reduce-costs-by-14-study-finds/</loc><lastmod>2023-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/overweight-and-obese-bmi-may-be-linked-to-adverse-treatment-outcomes-in-aya-patients-with-all/</loc><lastmod>2023-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/first-line-folfoxiri-plus-cetuximab-or-bevacizumab-in-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2023-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/medicaid-expansion-may-be-linked-to-increase-in-palliative-care-for-patients-with-advanced-cancers/</loc><lastmod>2023-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/robotic-assisted-resection-of-challenging-gastric-gists-may-be-safe-and-effective/</loc><lastmod>2023-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/investigators-evaluate-the-role-of-bmi-in-outcomes-in-patients-with-head-and-neck-cancer/</loc><lastmod>2023-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/vemurafenib-plus-cobimetinib-in-newly-diagnosed-patients-with-papillary-craniopharyngiomas/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/regional-nodal-irradiation-and-locoregional-recurrence-in-patients-with-favorable-risk-node-positive-breast-cancer/</loc><lastmod>2023-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/addition-of-nivolumab-to-sabr-in-early-stage-or-isolated-lung-parenchymal-recurrent-nsclc/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/atezolizumab-vemurafenib-and-cobimetinib-in-patients-with-braf-v600-mutated-melanoma-and-cns-metastases/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/integrated-clinical-molecular-classification-of-colorectal-liver-metastases/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/polygenic-risk-score-and-chemotherapy-related-subsequent-malignant-neoplasms-in-childhood-cancer-survivors/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/study-explores-incidence-and-mortality-rates-of-cardiovascular-disease-among-black-vs-white-cancer-survivors/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/volume-of-liver-resected-during-gallbladder-surgery-may-not-significantly-affect-overall-survival-in-patients-with-gallbladder-cancer/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/vaccine-rollout-may-reduce-covid-19-related-mortality-by-84-among-patients-with-cancer-study-predicts/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/forced-displacement-and-diagnosis-of-cancer-in-syrian-refugees/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/acupuncture-may-improve-sleep-among-patients-with-multiple-myeloma-undergoing-hsct/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/niraparib-maintenance-in-newly-diagnosed-advanced-ovarian-cancer/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/primary-cancer-and-noncancer-mortality-among-long-term-survivors-of-solid-tumors/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/selinexor-as-maintenance-therapy-for-p53-wild-type-endometrial-cancer/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/can-an-ai-model-improve-mortality-risk-prediction-linked-to-lung-cancer-or-cardiovascular-disease/</loc><lastmod>2023-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/the-role-of-us-cancer-centers-in-preparing-patients-with-cancer-for-climate-change-emergencies/</loc><lastmod>2023-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/modeled-effects-of-reducing-the-recommended-screening-age-for-colorectal-cancer-in-canada/</loc><lastmod>2023-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/outcomes-in-pediatric-all-with-prolonged-therapy-for-ikzf1-deletion-and-reduced-therapy-for-other-risk-groups/</loc><lastmod>2023-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/skin-cancer-screenings-and-melanoma-outcomes-among-racial-and-ethnic-minority-patients/</loc><lastmod>2023-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/fda-approves-quizartinib-for-newly-diagnosed-flt3-itd-positive-acute-myeloid-leukemia/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/individual-patient-meta-analysis-of-neoadjuvant-chemotherapy-and-chemoradiotherapy-for-esophageal-or-gej-carcinoma/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/overall-survival-with-axicabtagene-ciloleucel-in-large-b-cell-lymphoma-results-from-zuma-7/</loc><lastmod>2023-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/atezolizumab-with-or-without-radiotherapy-in-advanced-penile-cancer/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/ciltacabtagene-autoleucel-vs-standard-care-in-lenalidomide-refractory-patients-with-multiple-myeloma/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/patients-in-lower-income-communities-may-be-less-likely-to-receive-ct-colonography-than-those-in-higher-income-communities/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/short-bursts-of-vigorous-daily-activity-may-be-linked-to-reduced-cancer-incidence/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/comparison-of-conditioning-treatments-in-patients-with-aml-undergoing-hla-haploidentical-hematopoietic-stem-cell-transplant/</loc><lastmod>2023-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/multicancer-early-detection-test-in-symptomatic-patients-referred-from-primary-care/</loc><lastmod>2023-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/first-line-enfortumab-vedotin-plus-pembrolizumab-in-cisplatin-ineligible-patients-with-locally-advanced-or-metastatic-urothelial-cancer/</loc><lastmod>2023-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/first-line-systemic-treatment-strategies-for-initially-unresectable-colorectal-cancer-liver-metastases/</loc><lastmod>2023-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/personalized-dosing-may-improve-outcomes-in-patients-with-prostate-cancer/</loc><lastmod>2023-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/investigators-identify-requirements-to-potentially-optimize-cancer-survivorship-care-for-patients-in-rural-areas/</loc><lastmod>2023-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/patients-whose-pancreatic-cysts-remain-stable-for-5-years-may-have-decreased-risk-of-pancreatic-cancer/</loc><lastmod>2023-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/staging-laparoscopy-may-help-identify-early-metastases-in-patients-with-pancreatic-cancer/</loc><lastmod>2023-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/covid-19-booster-doses-may-strengthen-immunity-in-patients-with-lymphoma/</loc><lastmod>2023-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/cancer-mortality-trends-among-us-hispanic-populations-from-1999-to-2020/</loc><lastmod>2023-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/intracranial-activity-of-adagrasib-in-patients-with-kras-g12c-mutated-nsclc-and-untreated-cns-metastases/</loc><lastmod>2023-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/07-july/reasons-for-nonparticipation-in-a-colorectal-cancer-screening-trial-comparing-outcomes-with-colonoscopy-vs-fit/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fda-approves-olaparib-plus-abiraterone-and-prednisone-or-prednisolone-for-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/de-escalation-of-surgery-feasible-for-selected-patients-with-low-risk-early-stage-cervical-cancer/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/prostate-cancer-disparities-and-the-last-mile-problem/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/first-targeted-therapy-for-platinum-resistant-ovarian-cancer-to-improve-survival-outcomes/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-roisin-e-o-cearbhaill/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/minimally-invasive-distal-pancreatectomy-noninferior-to-open-surgery-for-early-stage-pancreatic-cancer/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/medicaid-expansion-associated-with-a-reduction-in-mortality-for-black-patients-with-gastrointestinal-malignancies/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/building-a-more-equitable-oncology-practice-the-path-to-better-patient-outcomes/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/thinking-outside-the-box-embracing-innovation-and-collaboration-in-oncology/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/in-case-you-missed-it-brief-highlights-from-studies-presented-during-aacr-2023/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/asco-issues-clinical-guidance-for-treating-gastrointestinal-cancers-amid-acute-drug-shortages/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/guideline-update-provides-new-testing-and-treatment-recommendations-for-patients-with-er-positive-her2-negative-metastatic-breast-cancer-with-esr1-mutations/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/retrospective-study-finds-black-patients-with-colorectal-cancer-had-fewer-actionable-genomic-mutations-than-white-patients/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-lisa-newman/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/swog-s1512-trial-pembrolizumab-achieves-high-response-rates-in-rare-type-of-melanoma/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-zeynep-eroglu/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/immune-checkpoint-inhibitors-show-promise-for-people-living-with-hiv/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/certain-cancers-will-likely-rise-exponentially-because-of-covid-19-screening-delays-study-predicts/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/rwandas-vision-for-increasing-cervical-cancer-prevention-one-village-at-a-time/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/traditional-chinese-medicine-herbal-formula-suan-zao-ren-tang-for-insomnia/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/ivy-brain-tumor-center-appoints-new-chief-medical-officer/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/idh-inhibitor-improves-progression-free-survival-in-grade-2-idh12-mutated-gliomas/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-rimas-vincas-lukas/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-jose-alejandro-rauh-hain/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/benefit-shown-for-durvalumab-plus-olaparib-in-advanced-ovarian-cancer/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-christina-fotopoulou/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-chandrakanth-are/</loc><lastmod>2023-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-rita-nanda/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adjuvant-treatment-with-ribociclib-reduces-risk-of-recurrence-in-hormone-receptor-positive-her2-negative-early-stage-breast-cancer/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/addressing-racial-disparities-in-cancer-pain-management-a-potential-role-for-music-therapy/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/polatuzumab-vedotin-piiq-for-previously-untreated-dlbcl-not-otherwise-specified-and-high-grade-b-cell-lymphoma/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/tak-w-mak-phd-faacr-selected-for-2023-pezcoller-foundation-aacr-international-award-for-achievement-in-cancer-research/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/early-detection-of-pancreatic-cancer-saved-my-life/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/her3-targeting-antibody-drug-conjugates-show-encouraging-results-in-breast-cancer-subtypes/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-rebecca-dent/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-devraj-basu/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/asco-updates-guideline-for-management-of-anxiety-and-depression-in-adult-cancer-survivors/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/asco-member-testifies-before-congress-to-urge-significant-increase-in-federal-cancer-research-funding/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/can-bariatric-surgery-decrease-the-risk-of-obesity-related-cancers/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-loren-laine-md/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/interruption-of-endocrine-therapy-to-attempt-pregnancy-in-women-with-hormone-receptor-positive-early-breast-cancer/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/pembrolizumab-added-to-chemotherapy-improves-survival-in-advanced-cervical-cancer-regardless-of-pd-l1-expression/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/neotorch-trial-toripalimab-plus-chemotherapy-improves-event-free-survival-in-resectable-stage-iii-nsclc/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-tina-cascone/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/two-studies-of-atezolizumab-based-regimens-in-early-stage-triple-negative-and-her2-positive-breast-cancers/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-matteo-lambertini/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/better-awareness-of-hpv-associated-cancers-is-still-needed-in-the-united-states-study-finds/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/involving-all-of-society-to-end-cancer-as-we-know-it/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/first-line-luspatercept-boosts-chance-of-transfusion-independence-in-lower-risk-mds/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/epov-mikkael-sekeres/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/rethinking-prior-authorization/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/nccn-addresses-ongoing-chemotherapy-shortages-as-new-survey-suggests-more-than-90-percent-of-cancer-centers-may-be-impacted/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/cancer-survivors-who-quit-smoking-may-have-36-percent-lower-cardiovascular-risk-than-those-who-continue-smoking/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/reducing-air-pollution-may-contribute-to-healthier-lifestyles-and-lower-cancer-risks-globally/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/5a-reductase-inhibitor-use-and-progression-of-bladder-cancer-in-south-korean-males/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/endocrine-therapy-switch-with-or-without-ribociclib-after-disease-progression-on-endocrine-therapy-and-cdk46-inhibition-for-metastatic-breast-cancer/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/atom-coalition-seeks-to-ensure-equitable-cancer-care-in-low-and-middle-income-countries/</loc><lastmod>2023-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/study-finds-wide-variations-in-intratumoral-microbiome-of-patients-with-early-vs-late-onset-colorectal-cancer/</loc><lastmod>2023-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/extended-lymphadenectomy-may-not-benefit-patients-with-clinically-localized-muscle-invasive-bladder-cancer/</loc><lastmod>2023-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/simple-hysterectomy-may-be-a-safe-option-for-patients-with-early-stage-low-risk-cervical-cancer/</loc><lastmod>2023-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adding-ribociclib-to-endocrine-therapy-may-reduce-recurrence-risk-in-patients-with-hr-positive-her2-negative-early-stage-breast-cancer/</loc><lastmod>2023-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/addition-of-olaparib-and-durvalumab-to-standard-of-care-may-prolong-progression-free-survival-in-patients-with-advanced-ovarian-cancer/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/zanidatamab-shows-activity-in-refractory-her2-amplified-biliary-tract-cancer/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/early-cessation-of-neoadjuvant-chemotherapy-may-lead-to-worse-outcomes-in-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/impact-of-changing-opioid-prescription-landscape-for-patients-with-cancer/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/veterans-exposed-to-agent-orange-may-be-at-increased-risk-of-developing-myeloproliferative-neoplasms/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/is-pembrolizumab-effective-in-patients-with-brain-metastases/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/changes-in-recist-tumor-measures-correlate-linearly-with-survival-in-patients-treated-with-checkpoint-inhibitors/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/patients-with-slfn11-expressing-sclc-may-benefit-from-immune-checkpoint-inhibitor-plus-parp-inhibitor/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/nivolumab-may-reduce-risk-of-disease-progression-or-death-in-previously-untreated-patients-with-hodgkin-lymphoma-compared-to-brentuximab-vedotin/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/mirvetuximab-soravtansine-improves-survival-in-patients-with-recurrent-ovarian-cancer/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adjuvant-osimertinib-improves-survival-in-patients-with-resected-egfr-mutated-nsclc/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/vorasidenib-delays-disease-progression-or-death-in-patients-with-grade-2-idh-mutated-glioma/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/radiation-may-be-safely-omitted-in-select-patients-with-locally-advanced-rectal-cancer/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/black-patients-with-metastatic-prostate-cancer-may-benefit-from-apalutamide-and-abiraterone-acetate-plus-prednisone/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/chemotherapy-induced-peripheral-neuropathy-may-be-more-severe-with-paclitaxel-than-with-docetaxel/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/transcriptional-profiling-may-provide-clues-to-treating-colorectal-cancer-more-effectively-in-younger-patients/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/study-finds-t-dxd-effectively-treats-her2-expressing-cancers-regardless-of-tumor-location/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/ciltacabtagene-autoleucel-reduces-risk-of-disease-progression-in-patients-with-lenalidomide-refractory-multiple-myeloma/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/erdafitinib-achieves-responses-across-multiple-cancer-types-with-fgfr-alterations/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/axicabtagene-ciloleucel-improves-overall-survival-in-patients-with-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/exercise-may-strengthen-immune-system-in-patients-with-multiple-myeloma/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/race-and-ethnicity-may-affect-21-gene-recurrence-score-in-patients-with-estrogen-receptor-positive-breast-cancer/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/stopping-immunotherapy-after-2-years-vs-continuing-treatment-may-yield-similar-survival-outcomes-in-patients-with-advanced-nsclc/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/radiation-treatment-may-not-be-necessary-after-chemoimmunotherapy-for-primary-mediastinal-b-cell-lymphoma/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/asco-issues-clinical-guidance-for-treating-gastrointestinal-cancers-amid-acute-drug-shortages-1/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/cancer-survivors-with-transportation-barriers-to-care-may-also-experience-financial-hardship-food-insecurity-and-delays-in-timely-care/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/black-and-hispanic-cancer-survivors-may-have-highest-risk-of-death-from-subsequent-primary-cancers-and-cardiovascular-disease/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/microdoses-of-incisional-antibiotics-and-surgical-site-infections-in-surgery-for-skin-cancer/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/allostatic-load-and-mortality-in-patients-with-breast-cancer/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/anthracycline-related-cardiomyopathy-and-hp-gene-expression-in-childhood-cancer-survivors/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/second-generation-antiandrogens-and-cognitive-and-functional-toxicity-in-patients-with-prostate-cancer/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/risk-of-dementia-and-mortality-with-bcg-vaccine-in-non-muscle-invasive-bladder-cancer/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/olvimulogene-nanivacirepvec-primed-immunochemotherapy-in-platinum-resistant-or-refractory-ovarian-cancer/</loc><lastmod>2023-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/ncis-combomatch-initiative-will-evaluate-new-drug-combinations-guided-by-tumor-biology/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/patients-with-lymphoma-who-have-depression-or-anxiety-may-experience-worse-survival-outcomes/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/new-data-may-inform-treatment-of-pregnant-patients-with-relapsed-or-refractory-lymphoma/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/effect-of-upregulated-kdm5d-gene-on-y-chromosome-in-male-patients-with-kras-mutated-colorectal-cancer/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/dose-escalated-simultaneous-integrated-boost-radiotherapy-for-early-stage-breast-cancer/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/ibrutinibvenetoclax-vs-chlorambucilobinutuzumab-in-previously-untreated-patients-with-cll-association-of-mrd-with-progression-free-survival/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fda-grants-full-approval-to-blinatumomab-for-mrd-positive-b-cell-precursor-all/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/accumulation-of-chronic-comorbidities-among-survivors-of-childhood-cancer/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fecal-microbiota-transplantation-its-role-for-patients-undergoing-allogeneic-hct-and-receiving-induction-therapy-for-aml/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/factors-associated-with-nonadherence-to-lung-cancer-screening-recommendations/</loc><lastmod>2023-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/exposure-to-ultraviolet-radiation-may-propel-transformation-of-bpdcn-cells-to-leukemia-in-the-skin/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/personalized-mrna-vaccines-may-transform-the-treatment-of-melanoma/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/study-illuminates-potential-marked-disparities-in-federal-cancer-research-funding/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/noncovalent-btk-inhibitor-pirtobrutinib-in-patients-with-mantle-cell-lymphoma-previously-treated-with-covalent-btk-inhibitors/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/effect-of-cancer-history-on-disability-unemployment-and-medical-expenditures/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/risk-factors-for-primary-bone-cancer-in-childhood-cancer-survivors-bone-tissue-radiation-exposure-and-alkylating-agent-dose/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/preoperative-stereotactic-radiosurgery-may-help-patients-with-metastatic-brain-tumors-reduce-the-risk-of-disease-progression-and-adverse-effects/</loc><lastmod>2023-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/impact-of-mccpdc-prices-of-generic-oncology-drugs-on-medicare-beneficiaries/</loc><lastmod>2023-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/mortality-rates-from-second-cancers-in-hispanic-and-non-hispanic-black-breast-cancer-survivors/</loc><lastmod>2023-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/trauma-and-long-term-risk-of-death-or-immune-mediated-disease-or-cancer-in-twin-pairs/</loc><lastmod>2023-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/perioperative-palliative-care-and-health-related-quality-of-life-in-patients-undergoing-curative-intent-surgery-for-upper-gastrointestinal-cancers/</loc><lastmod>2023-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adagrasib-in-treatment-of-kras-g12c-mutated-advanced-solid-tumors/</loc><lastmod>2023-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/s-1-chemoradiotherapy-for-older-patients-with-inoperable-esophageal-squamous-cell-carcinoma/</loc><lastmod>2023-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/alectinib-may-be-more-effective-when-taken-with-larger-meals-in-some-patients-with-nsclc/</loc><lastmod>2023-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/research-sheds-light-on-the-evolution-of-precursor-conditions-to-multiple-myeloma/</loc><lastmod>2023-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/study-evaluates-clinical-utility-of-novel-liquid-biopsy-breast-cancer-methylation-prototype-assay/</loc><lastmod>2023-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/impact-of-historic-redlining-practices-on-cancer-screening-rates/</loc><lastmod>2023-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/food-deserts-food-swamps-and-obesity-related-cancer-mortality-in-the-united-states/</loc><lastmod>2023-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adherence-to-cancer-prevention-lifestyle-recommendations-before-during-and-after-treatment-for-high-risk-breast-cancer-association-with-recurrence-and-mortality/</loc><lastmod>2023-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fda-grants-accelerated-approval-to-glofitamab-gxbm-for-relapsed-or-refractory-dlbcl/</loc><lastmod>2023-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/longitudinal-ctdna-methylation-status-and-risk-of-recurrence-after-surgery-in-patients-with-stage-i-to-iii-colorectal-cancer/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/patient-reported-outcomes-from-the-prospect-trial-neoadjuvant-folfox-vs-chemoradiation-for-locally-advanced-rectal-cancer/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/global-funding-for-cancer-research-2016-2020/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/vision-trial-hrqol-with-the-addition-of-lu-177-vipivotide-tetraxetan-to-standard-of-care-in-patients-with-advanced-prostate-cancer/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/older-breast-cancer-survivors-may-experience-accelerated-aging-worse-functional-outcomes-following-chemotherapy/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/aromatase-inhibitors-may-limit-effectiveness-of-weight-loss-medications-in-breast-cancer-survivors/</loc><lastmod>2023-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/patients-with-refractory-metastatic-colorectal-cancer-may-experience-survival-benefits-with-fruquintinib/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/retrospective-analysis-of-survival-with-surgery-in-the-treatment-of-small-cell-carcinoma-of-the-cervix/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adagrasib-shows-activity-in-patients-with-kras-g12c-mutated-nsclc-and-untreated-brain-metastases/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/adjuvant-cisplatingemcitabine-vs-cisplatinfluorouracil-after-chemoradiotherapy-for-nasopharyngeal-carcinoma/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/late-onset-memory-impairment-in-adult-survivors-of-childhood-cancer/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/petct-fdg-vs-conventional-staging-in-locally-advanced-breast-cancer/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fda-launches-pilot-program-to-help-reduce-risks-associated-with-using-laboratory-developed-tests-to-identify-cancer-biomarkers/</loc><lastmod>2023-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/cancer-disparities-potentially-responsible-for-higher-incidence-and-mortality-rates-in-appalachian-kentucky/</loc><lastmod>2023-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fda-approves-talazoparib-with-enzalutamide-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/first-line-nivolumabipilimumab-followed-by-nivolumab-in-a-clinically-diverse-population-with-unresectable-stage-iii-or-iv-melanoma/</loc><lastmod>2023-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/addition-of-blinatumomab-to-standard-chemotherapy-in-b-cell-all-in-low-risk-first-relapse/</loc><lastmod>2023-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/surgeon-quality-metrics-and-survival-after-curative-intent-surgery-for-nsclc/</loc><lastmod>2023-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/children-of-parents-with-a-history-of-cancer-may-experience-housing-food-and-financial-hardship-as-well-as-delays-in-medical-care/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/endometrial-cancer-risks-and-trends-among-different-populations-of-african-descent/</loc><lastmod>2023-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/potential-role-of-chatgpt-4-in-selecting-appropriate-imaging-tests-for-breast-cancer-screenings-and-breast-pain/</loc><lastmod>2023-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/outcomes-with-an-anthracycline-free-treatment-protocol-in-favorable-risk-childhood-all/</loc><lastmod>2023-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/use-of-eltrombopag-in-low-risk-myelodysplastic-syndrome-with-thrombocytopenia/</loc><lastmod>2023-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/t-dxd-in-her2-positive-advanced-gastric-or-gastroesophageal-junction-cancer-destiny-gastric02/</loc><lastmod>2023-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fda-approves-iopromide-injection-for-contrast-enhanced-mammography/</loc><lastmod>2023-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/biden-harris-administration-launches-initiative-to-improve-cancer-outcomes-in-low-income-areas/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/curettage-and-cryosurgery-may-be-effective-for-patients-with-basal-cell-carcinoma/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/lgbtq-patients-and-survivors-of-cancer-expressed-concern-over-discrimination-in-health-care-settings-according-to-new-survey/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/risk-adapted-neoadjuvant-chemoradiotherapy-in-rectal-cancer/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/direct-oral-anticoagulants-vs-low-molecular-weight-heparin-in-preventing-recurrent-vte-in-patients-with-cancer/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/amcenestrant-vs-standard-endocrine-therapy-in-er-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2023-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/use-of-fruquintinib-in-treating-refractory-metastatic-colorectal-cancer/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/daratumumab-plus-chemotherapy-as-induction-and-extended-consolidation-therapy-for-ultra-high-risk-multiple-myeloma/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/long-term-survival-outcomes-with-pembrolizumab-vs-ipilimumab-in-advanced-melanoma-7-year-follow-up-of-keynote-006/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/study-identifies-potential-risk-factors-for-early-onset-colorectal-cancer-in-male-patients/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/fertility-in-female-survivors-treated-for-hodgkin-lymphoma-as-children/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/risk-of-ovarian-cancer-in-postmenopausal-patients-with-polycystic-ovary-syndrome/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/addition-of-external-beam-radiation-therapy-to-brachytherapy-in-intermediate-risk-prostate-cancer/</loc><lastmod>2023-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/largest-human-breast-cell-atlas-to-date-may-offer-insights-into-mammary-biology/</loc><lastmod>2023-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/cdcp1-may-be-an-effective-therapeutic-target-for-patients-with-metastatic-bladder-cancer/</loc><lastmod>2023-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/novel-radiotracer-may-accurately-detect-and-differentiate-renal-cell-carcinomas/</loc><lastmod>2023-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/risk-of-intracranial-hemorrhage-with-direct-oral-anticoagulants-vs-low-molecular-weight-heparin-in-patients-with-glioblastoma-and-vte/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/egfr-and-erbb2-mutations-may-be-associated-with-lenvatinib-resistant-hepatocellular-carcinoma/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/pretherapy-imaging-and-dosimetry-may-inform-personalized-treatment-strategies-for-patients-with-refractory-differentiated-thyroid-cancer/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/role-of-chemotherapy-in-patients-with-nonmetastatic-nasopharyngeal-carcinoma-treated-with-radiotherapy/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/association-of-cardiac-substructure-radiation-dose-and-risk-of-late-cardiac-disease-in-survivors-of-childhood-cancer/</loc><lastmod>2022-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/posttransplantation-cyclophosphamide-based-gvhd-prophylaxis-in-patients-with-hematologic-cancers-undergoing-allogeneic-hsct/</loc><lastmod>2023-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/asco-chief-executive-officer-issues-statement-on-affirmative-action-ruling/</loc><lastmod>2023-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/06-june/loss-of-y-chromosome-in-men-and-bladder-cancer-progression/</loc><lastmod>2023-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/new-fellows-of-the-american-society-of-clinical-oncology/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/finding-early-female-role-models-helped-shape-a-notable-career-in-oncology/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/daughter-of-immigrants-who-fled-the-pogroms-she-followed-a-love-of-science-into-a-noted-career-in-cancer-pathology/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/asco-congratulates-2023-special-awards-recipients/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/an-oncology-leader-whose-immigrant-parents-taught-him-by-example-about-life-and-service-to-humanity/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/involvement-in-swog-and-jco-leads-to-a-fulfilling-career-as-a-leader-in-oncology/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/an-oncologist-from-guam-devotes-his-career-to-the-care-of-pelvic-cancers-and-the-sexual-health-of-all-cancer-survivors/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/the-second-generation-son-of-greek-immigrants-the-first-to-go-to-college-becomes-a-leader-in-sarcoma-research-and-treatment/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/mourned-and-missed/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/narratives-in-oncology-through-the-years/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/a-leader-in-oncology-from-humble-beginnings-never-forgets-life-lessons-learned-along-the-way/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/a-love-of-immunology-leads-to-a-notable-career-in-dermatology-with-a-focus-on-melanoma-research-and-treatment/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/inspired-by-an-uncle-who-was-a-compassionate-family-doctor-this-nonagenarian-continues-a-renowned-career-in-hematology/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/from-a-small-town-in-north-carolina-a-young-girl-finds-her-calling-in-battling-inequity-in-cancer-care/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/a-free-spirited-childhood-on-a-dairy-farm-where-books-and-science-experiments-were-encouraged/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/exercise-wellness-interventions-in-early-breast-cancer-demonstrate-measurable-benefits-even-economic-ones/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-sarah-blair/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/immunotherapychemotherapy-combination-prolongs-survival-in-advanced-biliary-tract-cancers/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-rachna-t-shroff/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/krystal-1-update-adagrasib-yields-benefit-in-variety-of-kras-g12c-mutated-tumors/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-elena-garralda/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/israeli-surgical-oncology-leader-dov-zippel-considers-the-evolving-landscape-of-cancer-care-in-a-small-nation/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-kenneth-c-anderson/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/adjuvant-regimen-of-atezolizumab-plus-bevacizumab-in-resectable-hepatocellular-carcinoma/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-stephen-lam-chan/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/playing-a-doctor-in-a-school-play-sparked-an-early-desire-to-become-a-real-doctor-for-sibylle-loibl/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/circulating-tumor-dna-identified-prior-to-and-during-treatment-is-associated-with-poorer-outcomes-in-primary-cns-lymphoma/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/radiation-oncology-workforce-expected-to-remain-stable-through-2030/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/new-roles-at-st-louis-siteman-cancer-center/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/highlighting-progress-in-myeloma-treatment-pollux-trial-final-overall-survival-results-with-daratumumab-based-therapy/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/american-college-of-surgeons-evaluates-the-impact-of-covid-19-pandemic-on-national-cancer-database-reporting/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/surviving-but-not-always-thriving-after-cancer-part-1/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/survival-in-patients-with-neuroblastoma-on-reduced-therapy-as-a-result-of-change-in-cog-risk-stratification/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/researchamerica-announces-new-board-members/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/asco-ceo-clifford-hudis-discusses-how-the-cancer-care-community-will-meet-the-daunting-challenges-ahead/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/surviving-but-not-always-thriving-after-cancer-part-2/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/northwell-launches-cancer-care-direct-pairing-nurse-navigators-with-patients-through-spectrum-of-care/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/mount-sinai-achieves-highest-rating-from-society-of-thoracic-surgeons-for-esophagectomy-program/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/tumor-genomic-profile-and-risk-for-arterial-thromboembolism-in-patients-with-solid-cancer/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/disparities-in-cancer-care-a-bangladeshi-perspective/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/new-fellows-of-the-american-society-of-clinical-oncology-fasco/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/i-was-unprepared-for-a-diagnosis-of-mantle-cell-lymphoma/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/making-the-art-of-oncology-and-cancer-care-central-to-her-presidential-term/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/nccn-clinical-practice-guidelines-in-oncology-2023-updates/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/asco-congratulates-2023-special-awards-recipients-1/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/genetic-sequencing-may-identify-cancers-often-missed-by-traditional-screening-guidelines/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/gog-258-final-results-no-improvement-in-survival-by-adding-radiotherapy-to-chemotherapy-in-advanced-endometrial-cancer/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-kathleen-moore/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/gog-3026-durable-responses-with-ribociclib-plus-letrozole-in-low-grade-serous-ovarian-cancer/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-amanda-nickles-fader/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/poor-tolerability-appears-to-hinder-benefit-of-adavosertib-in-uterine-serous-carcinoma/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-joshua-cohen/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/sgo-presentations-explore-inequitable-access-to-clinical-trials-and-its-impact-on-survival/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/nova-final-analysis-confirms-no-significant-overall-survival-benefit-for-maintenance-niraparib-in-recurrent-ovarian-cancer/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-carol-aghajanian/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/omidubicel-onlv-to-reduce-time-to-neutrophil-recovery-and-incidence-of-infection-in-hematologic-malignancies/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/retifanlimab-dlwr-for-metastatic-or-recurrent-locally-advanced-merkel-cell-carcinoma/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/e-john-wherry-phd-recognized-with-the-2023-aacr-cancer-research-institute-lloyd-j-old-award-in-cancer-immunology/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/surveillance-mammography-rates-after-breast-cancer-treatment-remain-high-irrespective-of-life-expectancy/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-elizabeth-a-morris/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/novel-bispecific-antibody-for-multiple-myeloma-shows-high-response-rates-in-early-trial/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/uspstf-issues-draft-recommendation-statement-on-screening-for-breast-cancer/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/organizations-team-up-to-improve-cancer-care-in-rural-appalachia/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/partnering-with-patients-the-cornerstone-of-cancer-care-and-research/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/cancer-susceptibility-germline-pathogenic-variants-among-older-patients/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-bortezomib-to-first-line-dexamethasone-rituximab-and-cyclophosphamide-for-waldenstroem-s-macroglobulinemia/</loc><lastmod>2023-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/prognostic-factors-associated-with-survival-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/novel-immunotherapy-combination-explored-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/artistry-7-and-rosella-phase-iii-trials-to-evaluate-novel-agents-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-carol-aghajanian-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/nova-final-analysis-confirms-no-significant-overall-survival-benefit-for-maintenance-niraparib-in-recurrent-ovarian-cancer-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-amanda-nickles-fader-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/gog-3026-durable-responses-with-ribociclib-plus-letrozole-in-low-grade-serous-ovarian-cancer-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-debra-l-richardson-and-joyce-f-liu/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/final-soraya-analysis-supports-mirvetuximab-soravtansine-in-ovarian-cancer/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/sgo-presentations-explore-inequitable-access-to-clinical-trials-and-its-impact-on-survival-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-joshua-cohen-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/poor-tolerability-appears-to-hinder-benefit-of-adavosertib-in-uterine-serous-carcinoma-1/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-rebecca-arend-and-ilaria-colombo/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/checkpoint-inhibitors-poised-to-change-standard-of-care-in-advanced-endometrial-cancer/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/highlights-of-the-sgo-2023-annual-meeting-on-women-s-cancer/</loc><lastmod>2023-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/study-shows-mrna-based-personalized-vaccine-plus-pembrolizumab-active-in-melanoma-for-the-first-time/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-margaret-k-callahan/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/study-reveals-link-between-obesity-and-gastric-cancer-aggressiveness/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-jaffer-a-ajani/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/final-soraya-analysis-supports-mirvetuximab-soravtansine-in-ovarian-cancer-1/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-debra-l-richardson-and-joyce-f-liu-1/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/olivier-delattre-md-phd-honored-with-2023-aacr-st-baldrick-s-foundation-award/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/codebreak-200-sotorasib-offers-improved-quality-of-life-for-patients-with-previously-treated-nsclc/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-jarushka-naidoo-mbbch-mhs/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/checkmate-816-3-year-update-shows-improved-event-free-survival-with-neoadjuvant-nivolumab-and-chemotherapy-for-resectable-nsclc/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-antonio-passaro-md-phd/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/front-line-vs-sequential-use-of-osimertinib-in-egfr-mutant-nsclc-potential-impact-of-liquid-biopsies/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-daniel-sw-tan/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/amivantamab-shows-efficacy-in-advanced-nsclc-with-egfr-exon-20-insertions/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-jarushka-naidoo/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/aacr-announces-fellows-of-the-aacr-academy-class-of-2023/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/novel-hormone-receptor-driven-therapies-tackling-endocrine-resistance-in-breast-cancer/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/asco-releases-guideline-updates-for-stage-iv-nsclc-with-and-without-driver-alterations/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/detection-of-early-emphysema-during-lung-cancer-screening-opportunities-to-optimize-health/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/enfortumab-vedotin-ejfv-with-pembrolizumab-in-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/cancer-immunology-and-immunotherapy-principles-and-practice/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/study-finds-cancer-related-emergency-department-visits-increased-mainly-because-of-uncontrolled-pain/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/ed-visits-among-patients-with-cancer-three-main-messages/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/personalized-mind-body-medicine-in-integrative-oncology/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/city-of-hope-appoints-new-director-and-chief-scientific-officer/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/an-incidental-finding-of-cancer-likely-saved-my-life/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/aegean-trial-shows-benefit-with-immunotherapy-based-combination-for-nsclc/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/epov-roy-s-herbst/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/lung-cancer-screening-and-possible-unappreciated-benefits/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/the-role-of-salpingectomy-in-ovarian-cancer-standard-of-care-or-targeted-therapy/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/fda-approves-polatuzumab-vedotin-piiq-plus-r-chp-for-previously-untreated-dlbcl-not-otherwise-specified-and-high-grade-b-cell-lymphoma/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/fda-approves-omidubicel-onlv-to-reduce-time-to-neutrophil-recovery-and-infection-in-patients-with-hematologic-malignancies/</loc><lastmod>2023-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/birth-by-cesarean-delivery-and-development-of-early-onset-colorectal-cancer/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/sotorasib-in-pretreated-patients-with-kras-g12c-mutated-nsclc-2-year-analysis-of-codebreak100/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/induction-failure-in-pediatric-and-young-adult-patients-with-t-cell-all/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/antibacterial-treatment-may-resolve-acute-radiation-dermatitis-in-patients-with-breast-cancer-undergoing-radiation-therapy/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/enrollment-criteria-for-multiple-myeloma-clinical-trials-may-exclude-patients-from-racial-and-ethnic-minorities/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/response-assessment-in-neuro-oncology-criteria-in-determining-correlation-of-survival-outcomes-in-glioblastoma/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/patients-who-practice-qigong-may-be-able-to-improve-their-cancer-related-fatigue/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/uicc-urges-action-on-world-no-tobacco-day-to-prevent-tobacco-related-cancer-deaths/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/crispr-approach-may-help-identify-therapeutic-targets-in-patients-with-multiple-myeloma/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/tumor-mutational-burden-and-outcomes-in-patients-with-advanced-cancers-treated-with-immune-checkpoint-inhibitors/</loc><lastmod>2023-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/diffusing-alpha-emitter-radiation-therapy-for-recurrent-or-unresectable-skin-cancers/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/sglt2-inhibitors-and-cardiovascular-outcomes-in-older-anthracycline-treated-patients-with-cancer/</loc><lastmod>2023-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/mgmt-promoter-methylation-and-survival-outcomes-in-low-grade-and-anaplastic-gliomas-after-alkylating-chemotherapy/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/long-term-outcomes-with-single-fraction-vs-multifraction-sabr-for-pulmonary-oligometastases/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-first-line-dalpiciclib-to-letrozole-or-anastrozole-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/new-bladder-cancer-classification-may-predict-response-to-bcg-immunotherapy-in-patients-with-non-muscle-invasive-bladder-cancer/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/incidence-of-colorectal-lung-and-breast-cancers-may-be-rising-due-to-covid-19-related-screening-delays/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/fda-approves-flotufolastat-fluorine-18-injection-first-radiohybrid-psma-targeted-pet-imaging-agent-for-prostate-cancer/</loc><lastmod>2023-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/adding-pembrolizumab-to-chemotherapy-may-improve-survival-in-patients-with-advanced-cervical-cancer/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/luspatercept-improves-reliance-on-blood-transfusions-for-patients-with-lower-risk-mds/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/medicaid-expansion-associated-with-a-reduction-in-mortality-for-black-patients-with-gastrointestinal-cancers/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/telephone-based-weight-loss-intervention-for-patients-with-breast-cancer-and-overweightobesity/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/using-a-health-systems-strengthening-approach-in-the-united-states-mexico-border-region-improved-survival-rates-for-children-with-all/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/minimally-invasive-distal-pancreatectomy-in-patients-with-resectable-pancreatic-cancer/</loc><lastmod>2023-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/fda-approves-avapritinib-for-indolent-systemic-mastocytosis/</loc><lastmod>2023-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/prevalence-of-functional-limitations-in-us-cancer-survivors/</loc><lastmod>2023-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/interleukin-21-identified-as-potential-new-therapeutic-target-to-prevent-endocrine-autoimmune-adverse-effects-from-cancer-immunotherapy/</loc><lastmod>2023-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/computer-aided-diagnosis-may-improve-breast-ultrasound-performance/</loc><lastmod>2023-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/anti-pd-l1-combination-vs-sunitinib-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2023-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/effect-of-her2-expression-levels-on-survival-outcomes-in-patients-with-metastatic-breast-cancer-receiving-targeted-therapy-plus-endocrine-therapy/</loc><lastmod>2023-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/bariatric-surgery-may-reduce-risk-of-obesity-related-cancers-by-more-than-half/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/pain-control-for-localized-spine-metastases-stereotactic-radiosurgery-vs-conventional-radiotherapy/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/tucatinib-plus-trastuzumab-in-her2-positive-refractory-ras-wild-type-unresectable-or-metastatic-colorectal-cancer/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/radical-cystectomy-vs-trimodality-therapy-for-muscle-invasive-bladder-cancer/</loc><lastmod>2023-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-panitumumab-to-trifluridinetipiracil-in-anti-egfr-treatment-rechallenge-in-refractory-ras-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2023-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/bcg-vaccines-may-provide-protective-effect-against-alzheimers-disease/</loc><lastmod>2023-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/study-analyzes-relationship-between-cancer-survivors-tobacco-use-symptom-burden-and-motivation-to-quit-smoking/</loc><lastmod>2023-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/multisystem-inflammatory-syndrome-in-children-with-cancer-and-covid-19/</loc><lastmod>2023-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/assay-prediction-of-pcr-in-patients-with-her2-positive-breast-cancer-treated-with-neoadjuvant-paclitaxel-trastuzumab-and-pertuzumab/</loc><lastmod>2023-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/does-stem-cell-transplantation-extend-survival-in-patients-with-advanced-cutaneous-t-cell-lymphomas/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/extension-of-adjuvant-anastrozole-after-initial-therapeutic-regimen-in-postmenopausal-patients-with-hr-positive-breast-cancer/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/three-new-studies-unveil-recent-developments-in-the-screening-and-treatment-of-biliary-tract-cancer-and-colorectal-cancer/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/augmented-early-intensification-and-higher-consolidation-methotrexate-dosing-show-no-benefit-in-childhood-all/</loc><lastmod>2023-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/association-between-overweightobesity-and-risk-of-gastrointestinal-cancer/</loc><lastmod>2023-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/specialist-palliative-care-for-patients-undergoing-major-abdominal-surgery-for-cancer/</loc><lastmod>2023-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/nccn-clinical-practice-guidelines-in-oncology-2023-updates-1/</loc><lastmod>2023-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/fda-grants-accelerated-approval-to-epcoritamab-bysp-for-relapsed-or-refractory-b-cell-lymphoma/</loc><lastmod>2023-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/late-major-surgical-intervention-in-survivors-of-childhood-cancer/</loc><lastmod>2023-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/cancer-specific-mortality-rates-vary-widely-across-the-globe-study-finds/</loc><lastmod>2023-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/does-prediagnosis-smoking-cessation-improve-overall-survival-in-patients-with-nsclc/</loc><lastmod>2023-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/implantable-ultrasound-device-to-open-blood-brain-barrier-for-peritumoral-delivery-of-albumin-bound-paclitaxel-in-recurrent-glioblastoma/</loc><lastmod>2023-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/trastuzumabpertuzumab-plus-neoadjuvant-paclitaxel-or-endocrine-therapy-in-hr-positive-her2-positive-early-breast-cancer/</loc><lastmod>2023-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/first-line-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/</loc><lastmod>2023-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/use-of-5-aris-and-prostate-cancer-mortality/</loc><lastmod>2023-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-bevacizumab-to-trifluridinetipiracil-in-refractory-metastatic-colorectal-cancer/</loc><lastmod>2023-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/immune-checkpoint-inhibitors-show-promise-for-people-living-with-hiv/</loc><lastmod>2023-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/phase-ii-trial-of-guadecitabine-plus-atezolizumab-in-patients-with-metastatic-bladder-cancer/</loc><lastmod>2023-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/combined-delivery-of-dnx-2401-plus-pembrolizumab-may-be-safe-and-effective-in-patients-with-recurrent-glioblastoma/</loc><lastmod>2023-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/hpv-self-collection-kits-may-increase-cervical-cancer-screenings-among-underscreened-underserved-patients/</loc><lastmod>2023-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/patients-with-cervical-cancer-may-be-at-higher-risk-for-urinary-tract-infections-after-radical-hysterectomies/</loc><lastmod>2023-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/patient-reported-outcomes-from-the-nrg-oncologyrtog-0815-in-intermediate-risk-prostate-cancer/</loc><lastmod>2023-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/familial-clonal-hematopoiesis-in-individuals-with-a-mutation-in-telomere-related-gene-pot1/</loc><lastmod>2023-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/long-term-risk-prediction-for-invasive-breast-cancer-ai-system-plus-volumetric-density-on-screening-mammography/</loc><lastmod>2023-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/immigrant-adults-with-hepatocellular-carcinoma-may-have-higher-survival-rates-than-those-born-in-the-united-states/</loc><lastmod>2023-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/patients-with-cancer-may-prefer-telemedicine-appointments-over-in-person-visits-when-both-are-available/</loc><lastmod>2023-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/potential-utility-of-polygenic-risk-scores-in-cancer-screening-in-the-united-kingdom/</loc><lastmod>2023-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/ibrutinib-and-rituximab-vs-fludarabine-cyclophosphamide-and-rituximab-in-previously-untreated-patients-with-cll/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/adding-azacitidine-to-standard-chemotherapy-may-be-effective-for-patients-with-ptcl-tfh/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/cabozantinib-in-combination-with-nivolumab-and-ipilimumab-may-slow-progression-of-advanced-renal-cell-carcinoma/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/young-native-hawaiians-and-pacific-islanders-may-face-highest-rates-of-cancer-mortality/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/president-biden-announces-intent-to-nominate-monica-m-bertagnolli-md-as-director-of-the-nih/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-short-term-adt-to-dose-escalated-radiotherapy-in-intermediate-risk-prostate-cancer/</loc><lastmod>2023-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/racial-disparities-in-the-risk-of-ovarian-cancer-for-patients-with-fibroids-and-endometriosis/</loc><lastmod>2023-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/abiraterone-acetate-plus-prednisolone-with-or-without-enzalutamide-in-patients-with-metastatic-prostate-cancer-initiating-adt/</loc><lastmod>2023-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/longitudinal-change-in-mammographic-breast-density-and-risk-of-breast-cancer/</loc><lastmod>2023-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/lenalidomide-in-previously-treated-children-with-low-grade-gliomas/</loc><lastmod>2023-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/ruxolitinib-for-patients-with-polycythemia-vera-intolerant-or-resistant-to-hydroxycarbamide/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/interruption-of-adjuvant-endocrine-therapy-to-attempt-pregnancy-in-women-with-breast-cancer/</loc><lastmod>2023-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/newly-identified-risk-factors-may-point-to-a-heightened-risk-for-early-onset-colorectal-cancer-among-younger-adult-patients/</loc><lastmod>2023-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/limited-surgery-plus-proton-therapy-in-pediatric-and-adolescent-patients-with-craniopharyngioma/</loc><lastmod>2023-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/risk-of-early-onset-digestive-tract-cancers-among-young-adults-with-nonalcoholic-fatty-liver-disease/</loc><lastmod>2023-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/first-in-patient-study-of-psma-targeted-fluorescent-tracer-for-intraoperative-imaging-of-psma-positive-prostate-cancer/</loc><lastmod>2023-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/new-breast-cancer-screening-guidelines-call-for-earlier-more-intensive-screenings-for-women-at-high-risk/</loc><lastmod>2023-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/novel-calculator-may-identify-patients-with-favorable-prognosis-hematologic-cancers/</loc><lastmod>2023-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-blinatumomab-to-chemotherapy-in-infant-patients-with-kmt2a-rearranged-all/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/economic-hardship-may-be-predictive-of-neurocognitive-outcomes-in-pediatric-patients-undergoing-radiation-therapy/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/novel-imaging-agent-may-help-surgeons-detect-residual-tumor-tissue-following-breast-conserving-surgery/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/pcr-and-individual-patient-prognosis-after-neoadjuvant-chemotherapy-and-anti-her2-therapy-in-her2-positive-early-breast-cancer/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-tislelizumab-to-chemotherapy-in-first-line-treatment-of-advanced-or-metastatic-esophageal-squamous-cell-carcinoma/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/novel-ai-model-offers-potential-for-earlier-lung-cancer-diagnoses/</loc><lastmod>2023-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/ai-based-decision-support-systems-for-mammography/</loc><lastmod>2023-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/lifestyle-habits-risk-factors-and-cancer-screening-during-covid-19-pandemic/</loc><lastmod>2023-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/lenvatinib-plus-pembrolizumab-in-previously-treated-patients-with-advanced-endometrial-cancer/</loc><lastmod>2023-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/first-line-zolbetuximab-plus-mfolfox6-in-cldn182-positive-her2-negative-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2023-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/clonal-hematopoiesis-risk-score-for-myeloid-neoplasms-in-patients-with-myeloid-precursor-conditions/</loc><lastmod>2023-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/survival-in-patients-with-neuroblastoma-on-reduced-therapy-as-a-result-of-change-in-cog-risk-stratification-1/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/addition-of-quizartinib-to-chemotherapy-in-newly-diagnosed-flt3-itd-positive-acute-myeloid-leukemia/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/cardiovascular-disease-in-survivors-of-testicular-cancer/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/preoperative-mri-scans-may-not-reduce-positive-margins-and-reoperations-in-patients-with-breast-cancer-undergoing-lumpectomy/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/researchers-identify-lethal-molecular-alterations-in-patients-with-metastatic-melanoma-who-failed-to-respond-to-previous-therapies/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/remote-outreach-may-boost-cancer-screenings-in-rural-female-patients-by-sixfold/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/despite-gender-affirming-surgery-transgender-women-may-still-be-at-risk-of-developing-prostate-cancer/</loc><lastmod>2023-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/adjuvant-chemotherapy-after-standard-chemoradiotherapy-in-locally-advanced-cervical-cancer/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/subcutaneous-vs-intravenous-rituximab-in-first-line-treatment-of-low-tumor-burden-follicular-lymphoma/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/does-surveillance-mammography-benefit-geriatric-patients-with-breast-cancer/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/exercise-and-wellness-programs-may-enhance-well-being-and-reduce-health-care-costs-in-patients-with-breast-cancer/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/intraoperative-vs-postoperative-lymph-node-pathology-evaluation-in-patients-with-breast-cancer-undergoing-mastectomy/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/05-may/meta-analysis-of-outcomes-with-anthracycline-containing-and-taxane-containing-chemotherapy-in-early-stage-breast-cancer/</loc><lastmod>2023-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-kathleen-moore-1/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/in-pilot-study-neoadjuvant-olaparib-appears-feasible-effective-in-patients-with-ovarian-cancer-and-brca-mutation/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-kathleen-moore/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/gog-258-final-results-no-improvement-in-survival-by-adding-radiotherapy-to-chemotherapy-in-advanced-endometrial-cancer/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/how-effectively-are-you-helping-patients-with-cancer-at-the-end-of-life/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/neoadjuvant-pembrolizumab-in-desmoplastic-melanoma/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-callisia-n-clarke/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/early-stage-triple-negative-breast-cancer-optimizing-therapy/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/summing-it-up-neoadjuvant-therapy-in-triple-negative-disease/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/checkpoint-inhibitors-poised-to-change-standard-of-care-in-advanced-endometrial-cancer/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-rebecca-arend-and-ilaria-colombo/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/glow-trial-zolbetuximab-plus-chemotherapy-sets-new-treatment-standard-in-gastric-cancer-subset/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-yelena-y-janjigian/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/social-drivers-of-health-grabbing-the-steering-wheel/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/using-circulating-tumor-dna-to-predict-early-recurrence-of-soft-tissue-sarcomas/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-callisia-n-clarke-1/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/emerging-success-with-novel-targeted-therapies-in-endocrine-resistant-metastatic-breast-cancer/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/asco-member-testifies-before-congress-urging-significant-increase-in-federal-cancer-research-funding/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/i-m-brca-positive-and-survived-both-breast-and-pancreatic-cancers/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/patricia-m-lorusso-do-phd-hc-chosen-as-aacr-president-elect-for-2023-2024/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/dabrafenib-with-trametinib-for-pediatric-low-grade-glioma-with-braf-v600e-mutation/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/homage-to-a-giant-in-hematology-the-fascinating-story-of-the-quest-to-cure-leukemia/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/which-patients-with-breast-cancer-can-omit-radiotherapy/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/lymphoma-research-foundation-establishes-kanti-r-rai-md-clinical-scholar-program-for-the-ongoing-study-of-cll/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/president-biden-prioritizes-cancer-research-access-to-care-in-fy-2024-budget-proposal/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/heavy-toll-from-prior-authorization-exceeds-alleged-benefits-according-to-ama-survey/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/abemaciclib-expanded-indication-for-adjuvant-use-in-hr-positive-her2-negative-node-positive-early-breast-cancer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/genetics-likely-caused-my-small-cell-lung-cancer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/poorer-survival-in-stage-iii-colon-cancer-with-greater-inflammation-after-surgery-and-prior-to-adjuvant-therapy/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/darolutamide-plus-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-monica-chatwal/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/understanding-fertility-issues-in-young-patients-with-breast-cancer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/kerin-adelson-md-named-md-anderson-chief-quality-and-value-officer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/eau-and-asco-release-collaborative-guidelines-on-penile-cancer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/highlights-of-novel-therapies-under-study-in-genitourinary-cancers/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/two-cancer-experts-to-head-new-tisch-cancer-hospital-at-mount-sinai-hospital/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/improvement-in-progression-free-survival-with-first-line-olaparib-plus-abiraterone-in-metastatic-prostate-cancer/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-oliver-sartor/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addressing-health-disparities-in-oncology-care-legally-and-ethically/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/nuances-in-breast-cancer-imaging-for-screening-and-surveillance/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/yes-you-should-attend-the-2023-asco-annual-meeting/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/nobel-laureate-carolyn-r-bertozzi-phd-to-receive-2023-aacr-award-for-outstanding-achievement-cancer-research/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/elizabeth-m-jaffee-md-faacr-to-receive-2023-aacr-margaret-foti-award-for-leadership-and-extraordinary-achievements-in-cancer-research/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/surgeon-and-cancer-researcher-kelly-m-mcmasters-md-phd-celebrates-the-miracle-of-translational-science/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/city-of-hope-to-rebrand-cancer-treatment-centers-of-america-locations-to-reflect-transition-to-national-system/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/uspstf-announces-new-leadership/</loc><lastmod>2023-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/ficlatuzumab-with-or-without-cetuximab-in-pan-refractory-recurrentmetastatic-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/prognostic-performance-of-a-molecular-international-prognostic-scoring-system-for-mds/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addition-of-bortezomib-to-r-chop-in-patients-with-dlbcl-according-to-molecular-subgroups/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addition-of-niraparib-to-abiraterone-acetate-and-prednisone-for-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-assesses-prevalence-severity-and-co-occurrence-of-common-symptoms-that-may-be-undertreated-in-patients-with-cancer/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/car-t-cell-therapy-may-improve-quality-of-life-of-patients-with-hematologic-malignancies/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/new-data-on-amivantamab-vmjw-in-patients-with-advanced-nsclc-and-egfr-exon-20-insertion-mutations/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/initiative-for-managing-adverse-events-of-immunotherapy-leads-to-clinical-practice-changes-at-md-anderson/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/menin-inhibitors-under-study-in-kmt2a-rearranged-or-npm1-mutant-acute-myeloid-leukemia/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/epov-mikkael-sekeres/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/chatgpt-may-have-potential-to-help-educate-patients-with-cirrhosis-and-hepatic-cancer-in-basic-knowledge-lifestyle-and-treatment-domains/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/more-us-patients-with-prostate-cancer-may-be-electing-for-active-surveillance/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/pathologic-complete-responses-may-be-prognostic-of-outcomes-for-patients-with-soft-tissue-sarcoma/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/fda-grants-accelerated-approval-to-enfortumab-vedotin-ejfvpembrolizumab-for-locally-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/hhs-releases-national-cancer-plan-to-advance-the-goals-of-the-cancer-moonshot-and-improve-outcomes-for-all-patients/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/risk-of-local-recurrence-after-breast-conserving-therapy-in-patients-with-multiple-ipsilateral-breast-cancer/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addition-of-toripalimab-to-definitive-chemoradiotherapy-in-locally-advanced-esophageal-squamous-cell-carcinoma/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/deductibles-copays-may-discourage-patients-from-receiving-follow-up-breast-cancer-screenings/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/nccn-names-uchicago-medicine-comprehensive-cancer-center-as-33rd-member-institution/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/primary-overall-survival-analysis-of-the-enzamet-trial-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/training-oncology-nurses-on-primary-palliative-care-may-improve-end-of-life-care-and-spur-creation-of-advance-directives-for-patients-with-cancer/</loc><lastmod>2023-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/interferon-alfa-2b-may-substantially-increase-survival-in-patients-with-lymphomatoid-granulomatosis/</loc><lastmod>2023-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-examines-utility-accuracy-of-chatgpt-in-offering-breast-cancer-screening-recommendations/</loc><lastmod>2023-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/effect-of-smoking-cessation-after-diagnosis-of-renal-cell-carcinoma-on-disease-progression-and-survival-outcomes/</loc><lastmod>2023-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/researchers-identify-potential-biomarkers-of-response-to-immunotherapy-in-patients-with-renal-cell-carcinoma/</loc><lastmod>2023-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/healthy-lifestyles-may-be-associated-with-reduced-mortality-risk-in-pediatric-cancer-survivors/</loc><lastmod>2023-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/azacitidine-in-combination-with-trametinib-may-be-effective-for-pediatric-patients-with-jmml/</loc><lastmod>2023-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/interaction-of-h-pylori-infection-and-germline-pathogenic-variants-in-risk-for-gastric-cancer/</loc><lastmod>2023-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/t-dxd-in-her2-expressing-advanced-or-recurrent-uterine-carcinosarcoma/</loc><lastmod>2023-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/olanzapine-to-prevent-chemotherapy-related-anorexia-in-newly-diagnosed-patients-with-advanced-cancers/</loc><lastmod>2023-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/endoscopic-surveillance-in-patients-at-risk-for-hereditary-diffuse-gastric-cancer/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/mortality-after-colonoscopy-detected-vs-postcolonoscopy-diagnosed-colorectal-cancer-in-the-va-health-care-system/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/pathologic-complete-response-as-surrogate-for-event-free-and-overall-survival-in-neoadjuvant-trials-in-her2-positive-early-breast-cancer/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-finds-precursor-pancreatic-lesions-occur-frequently-in-healthy-human-pancreases/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/combination-therapy-may-help-patients-with-kmt2a-mutated-all-or-aml-overcome-bet-inhibitor-resistance/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/prior-ctla-4-inhibition-may-influence-response-to-pd-1-inhibitors-in-patients-with-advanced-melanoma/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/financial-toxicity-of-cancer-may-impact-partners-quality-of-life/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/novel-device-may-be-safe-effective-chemotherapy-delivery-system-for-patients-with-muscle-invasive-bladder-cancer-who-are-unfit-for-standard-therapy/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/gd2-car-t-cells-for-relapsed-or-refractory-high-risk-neuroblastoma/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/consensus-molecular-subtypes-as-markers-for-maintenance-therapy-regimens-for-ras-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addition-of-ipilimumab-to-nivolumab-in-recurrent-or-metastatic-head-and-neck-cancer/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/statewide-survey-may-provide-insight-into-cancer-related-knowledge-beliefs-and-behaviors-of-hispanic-individuals-in-indiana/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/digital-breast-tomosynthesis-may-improve-breast-cancer-screening-performance-in-community-settings/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/new-study-examines-cancer-related-mortality-rates-during-first-year-of-covid-19-pandemic/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/pragmatica-lung-trial-begins-enrolling-patients-with-nsclc-who-did-not-respond-to-previous-therapy/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/update-on-withdrawal-of-ibrutinib-accelerated-approvals-for-mcl-and-mzl-in-the-united-states/</loc><lastmod>2023-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/confirmatory-mediastinoscopy-vs-immediate-resection-after-endosonography-for-resectable-nsclc/</loc><lastmod>2023-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/belzutifan-plus-cabozantinib-in-advanced-clear-cell-renal-cell-carcinoma-previously-treated-with-pd-1-or-pd-l1-inhibitors/</loc><lastmod>2023-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/pathologic-complete-response-and-outcomes-in-localized-soft-tissue-sarcoma-treated-with-neoadjuvant-chemoradiotherapy-or-radiotherapy/</loc><lastmod>2023-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addition-of-abiraterone-acetate-and-prednisone-to-enzalutamide-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/mrd-and-kmt2a-fusion-partners-in-predicting-outcomes-of-childhood-kmt2a-rearranged-acute-myeloid-leukemia/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addition-of-metastasis-directed-therapy-to-intermittent-hormone-therapy-for-oligometastatic-prostate-cancer/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/addressing-racial-disparities-in-cancer-pain-management-a-potential-role-for-music-therapy/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/neoadjuvant-durvalumab-plus-chemotherapy-followed-by-adjuvant-durvalumab-in-patients-with-resectable-nsclc-aegean/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/first-line-pembrolizumab-plus-gemcitabinecisplatin-may-improve-overall-survival-in-advanced-biliary-tract-cancer/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/personalized-mrna-based-cancer-vaccine-plus-pembrolizumab-for-high-risk-melanoma/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/single-agent-pembrolizumab-may-benefit-patients-with-advanced-desmoplastic-melanoma/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/nih-study-outlines-opportunities-to-achieve-president-biden-s-cancer-moonshot-goal-of-reducing-cancer-mortality-in-the-united-states/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/imbrave050-recurrence-free-survival-with-adjuvant-atezolizumab-plus-bevacizumab-for-hcc/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/aua-and-suo-release-new-guidelines-for-the-diagnosis-and-treatment-of-patients-with-nonmetastatic-upper-tract-urothelial-carcinoma/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/cancer-survivors-with-transportation-challenges-may-face-higher-risk-of-emergency-room-use-and-mortality/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/extended-antibiotic-prophylaxis-may-not-prevent-infections-improve-outcomes-in-patients-with-breast-cancer-undergoing-postmastectomy-breast-reconstruction/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/tumor-genomic-profile-and-risk-for-arterial-thromboembolism-in-patients-with-solid-cancers/</loc><lastmod>2023-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/vt3989-may-be-safe-effective-in-patients-with-advanced-mesothelioma-and-nf2-mutant-solid-tumors/</loc><lastmod>2023-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/novel-car-t-cell-therapy-demonstrated-promising-early-results-in-patients-with-metastatic-clear-cell-renal-cell-carcinoma/</loc><lastmod>2023-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-identifies-mutations-that-may-be-associated-with-poor-outcomes-in-patients-with-nsclc-treated-with-kras-g12c-inhibitors/</loc><lastmod>2023-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/validation-of-a-prognostic-model-for-overall-survival-in-chemotherapy-naive-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/sugemalimab-in-relapsed-or-refractory-extranodal-natural-killert-cell-lymphoma/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/association-of-delayed-or-foregone-care-among-patients-with-cancer-and-patient-clinician-identity-discordance/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/covid-19-pandemic-may-have-disrupted-cancer-reporting-in-2020-and-beyond/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/patients-with-brain-metastases-from-renal-cell-carcinoma-may-have-distinct-immunosuppressive-tumor-microenvironment/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/early-trial-results-show-potential-benefits-of-fgfr-inhibitors-and-parpatr-inhibitor-combinations-in-multiple-tumor-types/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/racialethnic-disparities-in-locoregional-recurrence-among-patients-with-breast-cancer-treated-in-the-tailorx-trial/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/toripalimab-plus-chemotherapy-may-improve-event-free-survival-in-resectable-stage-iii-nsclc/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/neoadjuvant-trabectedin-and-radiotherapy-in-myxoid-liposarcoma/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/extreme-poverty-may-be-a-key-driver-for-relapse-in-pediatric-patients-with-all/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/black-patients-with-cancer-may-be-more-likely-to-experience-cardiotoxicity-following-chemotherapy/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/vitamin-d-deficiencies-may-lead-to-health-disparities-in-black-patients-with-prostate-cancer/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/awareness-of-the-link-between-hpv-and-cervical-cancer-has-declined-between-2014-and-2020/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-finds-lung-cancer-incidence-rates-vary-significantly-among-florida-s-black-and-hispanic-ethnic-subgroups/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-explores-genomic-basis-of-racial-disparities-among-patients-with-colorectal-cancer/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/liquid-biopsy-based-multicancer-early-detection-test-may-find-early-stage-and-low-dna-shedding-cancers/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/bispecific-antibody-regn5459-shows-activity-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/preoperative-peritumoral-infiltration-of-local-anesthetic-in-patients-with-early-breast-cancer-effect-on-survival/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/psilocybin-therapy-for-patients-with-cancer-and-major-depression-disorder/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/immune-checkpoint-inhibition-and-long-term-survival-in-patients-with-metastatic-urothelial-cancer/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/olaparib-plus-ceralasertib-may-benefit-patients-with-pediatric-cancer-who-have-dna-replication-or-repair-deficient-tumors/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/investigational-deep-learning-model-may-help-stratify-risk-of-distant-recurrence-in-patients-with-endometrial-cancer/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/whole-exome-sequencing-may-help-identify-individuals-with-cancer-predisposition-syndromes-missed-by-current-screening-guidelines/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/long-term-survival-in-patients-diagnosed-with-cancer-during-pregnancy-or-postpartum/</loc><lastmod>2023-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-investigates-prevalence-of-low-value-psa-screening-for-prostate-cancer-in-older-patients/</loc><lastmod>2023-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/financial-impact-on-caregivers-of-spouses-with-cancer/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/second-line-liposomal-irinotecan-plus-fluorouracilleucovorin-in-metastatic-biliary-tract-cancer/</loc><lastmod>2023-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/krystal-1-update-adagrasib-yields-benefit-in-variety-of-kras-g12c-mutated-tumors/</loc><lastmod>2023-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/trastuzumab-deruxtecan-vs-physician-s-choice-in-her2-positive-metastatic-breast-cancer-previously-treated-with-trastuzumab-emtansine/</loc><lastmod>2023-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/advance-care-planning-may-lead-to-less-aggressive-more-comfort-focused-care-for-patients-with-cancer/</loc><lastmod>2023-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/are-patients-with-inflammatory-bowel-disease-at-increased-risk-for-developing-lymphoma/</loc><lastmod>2023-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/tonsl-gene-may-be-potential-new-target-for-breast-cancer-therapy/</loc><lastmod>2023-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/long-term-cardiac-safety-and-efficacy-of-sb3-trastuzumab-biosimilar-vs-reference-trastuzumab-in-her2-positive-early-breast-cancer/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/updated-findings-from-javelin-bladder-100-trial-of-avelumab-first-line-maintenance-in-advanced-urothelial-carcinoma/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/e-cigarette-use-increased-significantly-among-younger-us-adults-between-2019-and-2021/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/astro-and-estro-issue-new-clinical-guidelines-on-local-therapy-for-patients-with-oligometastatic-nsclc/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/04-april/study-explores-impact-of-radiation-therapy-on-immune-cells-and-tumor-cells-in-renal-cell-carcinoma/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/early-exposure-to-health-care-inequities-sets-the-stage-for-a-leadership-role-in-global-oncology-for-satish-gopal-md-mph/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/accc-releases-advocacy-agenda-at-49th-annual-meeting-cancer-center-business-summit/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/adjuvant-accelerated-partial-breast-irradiation-vs-whole-breast-irradiation-in-early-breast-cancer-10-year-outcomes-of-phase-iii-study/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/the-will-to-go-on/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/carl-h-june-md-faacr-to-be-honored-with-2023-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/use-of-low-dose-naltrexone/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/i-haven-t-known-a-life-without-von-hippel-lindau-disease/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/michael-taylor-md-phd-appointed-director-at-texas-children-s-hospital-and-baylor-college-of-medicine/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/talapro-2-talazoparib-plus-enzalutamide-extends-radiographic-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-elena-castro/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/colorectal-cancer-rates-are-rising-in-younger-adults-shifting-to-more-advanced-disease-across-all-ages/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/formula-509-intensified-postoperative-regimen-may-be-of-benefit-in-subset-of-high-risk-prostate-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-tyler-seibert/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/sacituzumab-govitecan-hziy-achieves-response-after-disease-progression-on-immune-checkpoint-inhibitor-in-metastatic-urothelial-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-xin-gao/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/rucaparib-vs-physicians-choice-of-single-agent-therapy-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/racialethnic-disparities-in-all-cause-and-cardiovascular-mortality-among-us-patients-with-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/association-of-baseline-and-subsequent-cardiovascular-health-metrics-to-risk-for-incident-cancers/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/regular-approval-for-dostarlimab-gxly-in-dmmr-recurrent-or-advanced-endometrial-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/studies-of-novel-therapeutic-approaches-highlighted-during-colorectal-cancer-awareness-month-at-dana-farber/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/10-facts-about-colorectal-cancer-from-the-colorectal-cancer-alliance/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/pirtobrutinib-for-relapsed-or-refractory-mantle-cell-lymphoma/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/idecabtagene-vicleucel-vs-standard-regimens-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/sotorasib-improves-progression-free-survival-vs-docetaxel-in-previously-treated-advanced-nsclc-with-kras-g12c-mutation/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/destiny-breast03-t-dxd-improves-overall-survival-vs-t-dm1-in-previously-treated-her2-positive-metastatic-breast-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/asco-updates-guideline-on-sacituzumab-govitecan-hziy-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/three-models-testing-ways-to-lower-drug-costs-outlined-in-health-and-human-services-report/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/2024-aca-proposal-aims-to-reduce-health-care-coverage-gaps/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/eight-oncology-health-systems-participating-in-efforts-to-improve-vaccination-rates-among-high-risk-adults/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/asco-celebrates-the-cancer-moonshot-on-its-relaunch-anniversary/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/it-is-time-to-close-the-gap-in-cancer-care/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/first-line-pembrolizumab-in-older-patients-with-dmmr-metastatic-colorectal-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/axicabtagene-ciloleucel-in-refractory-large-b-cell-lymphoma-5-year-results-of-the-zuma-1-trial/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/neoadjuvant-plus-adjuvant-vs-adjuvant-pembrolizumab-in-advanced-melanoma/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/dinutuximab-beta-and-interleukin-2-after-haploidentical-stem-cell-transplantation-in-patients-with-relapsed-neuroblastoma/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/savolitinib-and-durvalumab-in-metastatic-papillary-renal-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/continued-disease-free-survival-benefits-with-adjuvant-nivolumab-in-high-risk-urothelial-carcinoma/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-michiel-s-van-der-heijden/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/when-can-you-stop-lenalidomide-maintenance-in-myeloma/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-dan-vogl/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/keynote-859-interim-analysis-overall-survival-benefit-for-first-line-pembrolizumab-in-advanced-gastric-cancer/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-elizabeth-smyth/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/walks-on-a-beach-with-an-inspiring-grandfather-led-to-a-career-in-cancer-research-and-drug-development-for-vivek-subbiah-md/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/zanubrutinib-improves-progression-free-survival-vs-ibrutinib-in-relapsed-or-refractory-cll-or-sll/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/a-pioneering-oncologist-a-pilot-and-a-choral-singer-among-other-things/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/cleveland-clinic-opens-new-cancer-center-in-abu-dhabi/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/rangaswamy-govindarajan-md-named-chief-of-uams-hematology-and-oncology-division/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/three-md-anderson-researchers-elected-aaas-fellows/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/northwell-health-names-richard-d-carvajal-md-to-lead-medical-oncology-programs/</loc><lastmod>2023-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-monica-chatwal/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/darolutamide-plus-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2023-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/oncologists-applaud-state-of-the-union-s-focus-on-ending-cancer-as-we-know-it/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/first-asco-guideline-for-immunotherapy-and-targeted-therapy-in-advanced-gastroesophageal-cancer-now-available/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/phallcon-study-ponatinib-superior-to-imatinib-in-combination-with-chemotherapy-in-newly-diagnosed-ph-positive-all/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-anjali-advani/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/four-leading-upmcpitt-scientists-receive-funding-for-research-in-breast-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/unique-challenges-of-cancer-care-in-india/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/tucatinib-with-trastuzumab-in-previously-treated-ras-wild-type-her2-positive-advanced-colorectal-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/mirvetuximab-soravtansine-active-in-platinum-resistant-ovarian-cancer-with-high-fra-expression/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/vanessa-sheppard-named-american-cancer-society-researcher-of-the-year/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/novel-herbal-oncology-program-for-management-of-cancer-symptoms-at-an-nci-designated-cancer-center/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/cancer-mortality-decreased-in-newest-data-reported-by-the-american-cancer-society/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/dont-blame-the-test/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/i-m-doing-my-part-to-erase-the-stigma-surrounding-lung-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/miguel-angel-perales-named-2023-2024-president-of-astct/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/best-of-sabcs-top-7-picks-from-the-2022-meeting-by-jame-abraham-md-facp/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/sacituzumab-govitecan-hziy-in-hr-positive-her2-negative-advanced-or-metastatic-breast-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/highlights-of-the-2022-annual-conference-of-the-international-society-of-geriatric-oncology/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/pilot-program-shows-diversity-focused-clinical-trial-tools-are-useful-at-cancer-research-sites/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/studies-focusing-on-age-and-race-related-disparities-in-multiple-myeloma-and-sickle-cell-disease/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/rucaparib-extends-progression-free-survival-in-selected-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-elena-castro-1/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/understanding-the-link-between-prognostic-perception-and-patient-oncologist-prognostic-discordance-in-the-advanced-cancer-setting/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/improving-physician-patient-communication/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/working-together-to-close-the-global-care-gap/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/extended-follow-up-supports-first-line-use-of-nivolumab-plus-cabozantinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/phase-iii-trials-confirm-benefit-of-first-line-anti-pd-1-plus-chemotherapy-in-gastric-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-david-wang/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/novel-immunotherapy-combination-shows-activity-in-microsatellite-stable-metastatic-colorectal-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-aparna-r-parikh/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/elacestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/how-patient-navigation-programs-are-helping-drive-equitable-care-for-patients-with-cancer-and-improve-outcomes/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/neighborhood-social-vulnerability-and-its-influence-on-the-availability-of-clinical-trials-in-multiple-myeloma/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/encorafenib-binimetinib-and-cetuximab-in-previously-untreated-patients-with-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/abstracts-of-interest-on-novel-therapies-for-gastrointestinal-cancers/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/addition-of-avelumab-to-carboplatinpaclitaxel-in-first-line-treatment-of-advanced-or-recurrent-endometrial-cancer/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/triplet-and-quadruplet-regimens-in-smoldering-multiple-myeloma/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-robert-rifkin/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/ponatinib-and-blinatumomab-combination-safe-and-effective-in-patients-with-newly-diagnosed-ph-positive-all/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-emily-k-curran/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/camrelizumabapatinib-in-recurrent-or-metastatic-nasopharyngeal-carcinoma/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/brexucabtagene-autoleucel-in-relapsed-or-refractory-mantle-cell-lymphoma-in-standard-of-care-practice/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/continued-disease-free-survival-benefits-with-adjuvant-nivolumab-in-high-risk-urothelial-carcinoma-1/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/epov-michiel-s-van-der-heijden-1/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/hormone-therapy-may-reduce-risk-of-lung-cancer-in-female-patients-despite-former-misperceptions/</loc><lastmod>2023-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/access-to-paid-sick-leave-may-result-in-more-cancer-screenings/</loc><lastmod>2023-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-expands-early-breast-cancer-indication-for-abemaciclib-plus-endocrine-therapy/</loc><lastmod>2023-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/can-long-noncoding-rna-expression-help-predict-outcomes-in-pediatric-patients-with-aml/</loc><lastmod>2023-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/prognosis-of-her2-low-vs-her2-negative-breast-cancer/</loc><lastmod>2023-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/racialethnic-disparities-in-all-cause-and-cardiovascular-mortality-among-patients-with-cancer/</loc><lastmod>2023-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/extended-performance-of-an-image-based-short-term-risk-model-for-predicting-breast-cancer/</loc><lastmod>2023-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/effect-of-insurance-status-on-racial-and-ethnic-inequities-in-the-diagnosis-of-advanced-stage-cervical-cancer/</loc><lastmod>2023-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/hypercalcemia-in-patients-with-cholangiocarcinoma/</loc><lastmod>2023-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/long-term-results-of-european-pediatric-soft-tissue-sarcoma-study-in-nonmetastatic-rhabdomyosarcoma/</loc><lastmod>2023-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/addition-of-immunotherapy-to-chemotherapy-regimen-may-increase-progression-free-survival-in-patients-with-advanced-or-recurrent-endometrial-cancer/</loc><lastmod>2023-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/time-related-and-financial-burdens-may-impact-quality-of-life-for-patients-with-gynecologic-cancer/</loc><lastmod>2023-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/how-do-novel-genetic-subtypes-of-urothelial-carcinoma-respond-to-immune-checkpoint-blockade/</loc><lastmod>2023-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/clinical-trial-participation-may-be-associated-with-improved-overall-survival-in-patients-with-ovarian-cancer/</loc><lastmod>2023-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/researchers-uncover-how-incurable-skin-cancer-may-resist-treatment-at-the-end-of-life/</loc><lastmod>2023-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/nivolumab-injected-directly-into-spinal-fluid-may-be-safe-and-effective-for-some-patients-with-melanoma-who-have-leptomeningeal-disease/</loc><lastmod>2023-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/atezolizumab-may-be-an-effective-primer-for-chemoradiation-in-patients-with-locally-advanced-cervical-cancer/</loc><lastmod>2023-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/positive-outcomes-demonstrated-in-patients-with-ovarian-cancer-treated-with-olaparib-prior-to-surgical-intervention-and-subsequent-chemotherapy/</loc><lastmod>2023-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/researchers-find-no-significant-differences-in-overall-survival-among-patients-with-platinum-sensitive-recurrent-ovarian-cancer-who-received-niraparib-maintenance-therapy-vs-placebo/</loc><lastmod>2023-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-grants-full-approval-to-pembrolizumab-for-certain-adult-and-pediatric-patients-with-advanced-msi-h-or-dmmr-solid-tumors/</loc><lastmod>2023-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/subcutaneous-vs-iv-administration-of-medications-and-fluids-in-patients-with-cancer/</loc><lastmod>2023-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/addition-of-gemcitabine-to-cisplatin-and-intensity-modulated-radiation-therapy-may-improve-outcomes-for-patients-with-locally-advanced-vulvar-cancer/</loc><lastmod>2023-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/new-prognostic-staging-system-for-de-novo-metastatic-breast-cancer/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/risk-of-cervical-cancer-may-be-twice-as-high-in-patients-with-mental-illnesses/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/brown-adipose-tissue-may-not-be-associated-with-cancer-cachexia-may-not-worsen-cancer-mortality/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/lower-dose-regimens-of-exemestane-in-postmenopausal-patients-with-stage-0-to-ii-er-positive-breast-cancer/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/antibiotic-use-and-survival-among-patients-with-metastatic-pancreatic-cancer-receiving-specific-chemotherapy-regimens/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/ruby-trial-dostarlimab-plus-carboplatin-and-paclitaxel-in-advanced-endometrial-cancer/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/lower-income-patients-with-early-stage-esophageal-adenocarcinoma-may-face-disparities-in-cancer-care-and-higher-mortality-rates/</loc><lastmod>2023-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/obesity-may-contribute-to-breast-cancer-risk-in-high-risk-patients-with-brca-mutations/</loc><lastmod>2023-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/smoking-cessation-intervention-in-patients-with-a-history-of-cervical-intraepithelial-neoplasia-or-cervical-cancer/</loc><lastmod>2023-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/significance-of-the-mgus-like-phenotype-in-patients-with-multiple-myeloma-and-light-chain-amyloidosis/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/naporafenib-plus-trametinib-in-advanced-nras-mutant-melanoma/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/change-in-frailty-status-among-older-patients-undergoing-locoregional-therapy-for-early-stage-breast-cancer/</loc><lastmod>2023-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-grants-accelerated-approval-to-retifanlimab-dlwr-for-metastatic-or-recurrent-locally-advanced-merkel-cell-carcinoma/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/patricia-m-lorusso-do-phd-hc-elected-2023-2024-aacr-president-elect/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/study-examines-effect-of-physical-activity-on-recurrence-in-patients-previously-treated-for-colorectal-cancer/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/addition-of-vistusertib-to-paclitaxel-in-platinum-resistant-ovarian-high-grade-serous-carcinoma/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-issues-draft-guidance-aimed-at-improving-oncology-clinical-trials-for-accelerated-approval/</loc><lastmod>2023-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/first-line-systemic-treatments-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2023-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/ai-based-model-for-nodal-metastasis-detection-using-whole-slide-images-in-bladder-cancer/</loc><lastmod>2023-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/accc-releases-2022-impact-report/</loc><lastmod>2023-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/cancer-diagnostic-services-offered-at-a-community-health-center-may-speed-diagnoses-for-underserved-patients/</loc><lastmod>2023-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/retroperitoneal-lymph-node-dissection-for-early-metastatic-testicular-seminoma/</loc><lastmod>2023-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/prevalence-of-hpv-dna-and-p16ink4a-positivity-in-vulvar-cancer-and-vulvar-intraepithelial-neoplasia/</loc><lastmod>2023-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/report-examines-accuracy-of-chatgpt-in-providing-information-on-common-cancer-myths-and-misconceptions/</loc><lastmod>2023-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/laparoscopy-assisted-vs-open-distal-gastrectomy-for-locally-advanced-gastric-cancer-relapse-free-survival-at-5-years/</loc><lastmod>2023-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/active-monitoring-surgery-or-radiotherapy-for-localized-prostate-cancer-15-year-outcomes-in-the-uk-protect-trial/</loc><lastmod>2023-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/isolated-hepatic-perfusion-may-improve-response-and-survival-among-patients-with-metastatic-uveal-melanoma/</loc><lastmod>2023-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/glow-trial-zolbetuximab-plus-capox-extends-survival-in-gastric-cancer-subtype/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/magrolimab-plus-azacitidine-in-higher-risk-myelodysplastic-syndromes/</loc><lastmod>2023-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/costs-of-cancer-in-adolescents-and-young-adults-in-the-united-states/</loc><lastmod>2023-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/axitinib-and-avelumab-in-recurrentmetastatic-adenoid-cystic-carcinoma/</loc><lastmod>2023-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/low-dose-tamoxifen-to-prevent-recurrence-in-patients-with-breast-noninvasive-neoplasia-10-year-follow-up-of-tam-01-trial/</loc><lastmod>2023-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/study-reveals-potential-cause-of-resistance-to-revumenib-in-patients-with-acute-leukemia/</loc><lastmod>2023-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/trust-in-cancer-information-may-have-declined-among-black-individuals-during-covid-19-pandemic/</loc><lastmod>2023-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/does-discrimination-accelerate-aging-in-black-cancer-survivors/</loc><lastmod>2023-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/pembrolizumab-plus-ifosfamide-carboplatin-and-etoposide-in-relapsed-or-refractory-classical-hodgkin-lymphoma/</loc><lastmod>2023-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/vitamin-a-and-risk-for-pancreatitis-during-chemotherapy-for-all/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/addition-of-fulvestrant-to-alisertib-in-endocrine-resistant-metastatic-breast-cancer/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/activity-of-novel-car-t-cells-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-approves-dabrafenibtrametinib-for-pediatric-patients-with-braf-v600e-mutated-low-grade-glioma/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/detection-of-emphysema-during-lung-cancer-screening/</loc><lastmod>2023-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/neoadjuvant-dual-immunotherapy-plus-chemotherapy-improves-patient-outcomes-in-operable-lung-cancer/</loc><lastmod>2023-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/delaying-treatment-for-patients-with-localized-prostate-cancer-may-not-increase-mortality-risk-protect-trial-shows/</loc><lastmod>2023-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/involving-hospitalists-in-inpatient-cancer-care-may-reduce-patient-stays-oncologist-stress/</loc><lastmod>2023-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/new-research-highlights-the-negative-impact-of-continued-exclusion-of-patients-with-african-ancestry-from-research-on-cancer-genomics/</loc><lastmod>2023-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/covid-19-vaccination-rates-may-be-lower-in-patients-with-cancer-who-have-comorbidities-certain-types-of-cancer-and-specific-sociodemographic-factors/</loc><lastmod>2023-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/racial-inequalities-in-prostate-cancer-care-may-be-associated-with-facility-level-disparities/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/gut-microbiome-may-influence-how-patients-with-non-hodgkin-lymphoma-respond-to-car-t-cell-therapy/</loc><lastmod>2023-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/hyperfractionated-vs-standard-fractionation-imrt-in-locally-advanced-recurrent-nasopharyngeal-carcinoma/</loc><lastmod>2023-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/new-technique-may-reduce-postoperative-complications-in-prostate-cancer-surgery/</loc><lastmod>2023-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/novel-urine-test-may-play-a-role-in-bladder-cancer-prediction/</loc><lastmod>2023-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/regorafenib-ipilimumab-and-nivolumab-in-microsatellite-stable-metastatic-colorectal-cancer/</loc><lastmod>2023-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/health-related-quality-of-life-in-the-keynote-826-trial-in-patients-with-cervical-cancer/</loc><lastmod>2023-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/large-study-finds-dbt-may-be-superior-to-digital-mammography-for-breast-cancer-detection/</loc><lastmod>2023-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/impact-of-tai-ji-quan-or-strength-training-vs-stretching-in-preventing-falls-in-postmenopausal-women-who-received-chemotherapy-for-cancer/</loc><lastmod>2023-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/psma-petct-may-help-improve-clinical-treatment-of-prostate-cancer/</loc><lastmod>2022-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/digital-rectal-examination-fails-to-detect-early-prostate-cancer-study-shows/</loc><lastmod>2023-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/european-oncovid-registry-analysis-of-covid-19-sequelae-during-omicron-phase-vs-earlier-phases-in-patients-with-cancer/</loc><lastmod>2023-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/pelabresib-plus-ruxolitinib-in-patients-with-myelofibrosis-and-no-prior-jak-inhibitor-treatment/</loc><lastmod>2023-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-issues-safety-communication-on-reports-of-squamous-cell-carcinoma-in-the-capsule-around-breast-implants/</loc><lastmod>2023-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/nicotinamide-for-chemoprevention-of-skin-cancer-in-solid-organ-transplant-recipients/</loc><lastmod>2023-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/omission-of-radiotherapy-in-children-and-adolescents-with-early-stage-classical-hodgkin-lymphoma-with-adequate-response-to-oepa-chemotherapy/</loc><lastmod>2023-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fda-updates-mammography-regulations-to-require-reporting-of-breast-density-information-and-enhance-facility-oversight/</loc><lastmod>2023-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/nirogacestat-may-benefit-patients-with-desmoid-tumors/</loc><lastmod>2023-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/study-reveals-new-understanding-of-how-androgen-therapy-affects-breast-tissue/</loc><lastmod>2022-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/trends-in-active-surveillance-for-management-of-low-risk-prostate-cancer-in-the-united-states/</loc><lastmod>2023-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/study-finds-cancer-screening-in-the-united-states-lagged-during-the-second-year-of-the-covid-19-pandemic/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/researchers-find-new-genetic-risk-factors-in-large-study-of-prostate-cancer-in-black-patients/</loc><lastmod>2023-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/regardless-of-income-american-indiannative-american-women-may-be-less-likely-to-undergo-mammography-than-white-women/</loc><lastmod>2023-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/antibiotic-exposure-before-immune-checkpoint-inhibitor-treatment-and-overall-survival-in-older-patients-with-cancer/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/blood-test-may-identify-patients-with-aml-at-greater-risk-of-relapse-after-bone-marrow-transplant/</loc><lastmod>2023-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/radiation-oncology-workforce-expected-to-remain-stable-through-2030-according-to-astro-report/</loc><lastmod>2023-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/first-line-lenvatinibpembrolizumab-vs-sunitinib-in-advanced-renal-cell-carcinoma-extended-follow-up-of-the-clear-trial/</loc><lastmod>2023-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/psa-level-at-time-of-salvage-radiation-therapy-after-radical-prostatectomy-and-risk-of-all-cause-mortality/</loc><lastmod>2023-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/adjuvant-paclitaxel-and-trastuzumab-in-node-negative-her2-positive-breast-cancer-long-term-follow-up/</loc><lastmod>2023-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/fewer-cases-of-melanoma-and-extracutaneous-malignancies-detected-among-patients-with-atopic-diseases/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/cancer-stage-and-receptor-status-may-indicate-risk-of-disease-recurrence-in-breast-cancer-survivors/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/nivolumab-followed-by-nivolumabipilimumab-boosting-in-nonresponders-among-previously-treated-patients-with-advanced-urothelial-carcinoma/</loc><lastmod>2023-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/combination-chemotherapy-may-be-safe-and-effective-alternative-for-the-treatment-of-patients-with-non-muscle-invasive-bladder-cancer-amid-bcg-shortage/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/addition-of-pembrolizumab-to-pemetrexedplatinum-in-the-first-line-treatment-of-metastatic-nonsquamous-nsclc-5-year-outcomes-in-the-keynote-189-study/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/association-of-baseline-and-subsequent-cardiovascular-health-metrics-with-risk-for-incident-cancers/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/american-cancer-society-data-show-colorectal-cancer-rates-are-rising-in-younger-adults-and-shifting-to-more-advanced-disease-in-people-of-all-ages/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/chemotherapy-may-alter-immune-cell-landscape-in-patients-with-pancreatic-cancer/</loc><lastmod>2023-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/depression-may-be-linked-to-higher-levels-of-inflammation-poorer-outcomes-in-patients-with-lung-cancer/</loc><lastmod>2023-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/vitamin-b5-may-help-improve-red-blood-cell-production-in-patients-with-myelodysplastic-syndromes/</loc><lastmod>2023-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/black-women-at-high-risk-of-breast-cancer-may-face-obstacles-in-receiving-preventive-care/</loc><lastmod>2023-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/cancer-organizations-respond-to-turkey-and-syria-earthquakes/</loc><lastmod>2023-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/surgeon-anesthesiologist-familiarity-and-short-term-outcomes-in-complex-gastrointestinal-cancer-surgery/</loc><lastmod>2023-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/survival-in-patients-with-brain-metastases-limited-or-stable-extracranial-disease/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/03-march/prediction-models-for-kidney-failure-in-long-term-survivors-of-childhood-cancer/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/yale-study-indicates-older-patients-are-excluded-from-progress-against-lung-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/updated-results-from-the-adaura-trial-continued-disease-free-survival-benefit-with-adjuvant-osimertinib-vs-placebo-in-egfr-mutated-stage-ib-iiia-nsclc/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/grateful-to-be-alive/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/president-biden-announces-key-appointments-to-national-cancer-advisory-board/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/challenges-of-accurately-identifying-her2-low-breast-cancers/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/fda-approves-sacituzumab-govitecan-hziy-for-pretreated-patients-with-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/zanubrutinib-for-chronic-lymphocytic-leukemia-or-small-lymphocytic-lymphoma/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/fda-approves-elacestrant-for-er-positive-her2-negative-esr1-mutated-advanced-or-metastatic-breast-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/fda-grants-accelerated-approval-to-pirtobrutinib-for-relapsed-or-refractory-mantle-cell-lymphoma/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-breelyn-wilky/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/neoadjuvant-chemotherapy-in-triple-negative-breast-cancer-carboplatin-adds-benefit-new-study-shows/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-adam-brufsky/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/asco-endorses-cap-guideline-to-better-define-who-benefits-from-immune-checkpoint-inhibitor-therapy/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/asco-updates-living-guidelines-on-stage-iv-nsclc-based-on-destiny-lung01-codebreak100-other-trials/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/urologic-oncologist-hyung-kim-named-chair-of-cedars-sinai-department-of-urology/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/have-we-reached-the-limits-of-chemotherapy-for-burkitt-lymphoma/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/first-line-nalirifox-improves-survival-in-metastatic-pancreatic-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-laura-goff/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/neo-aegis-trial-finds-two-approaches-comparable-in-treating-advanced-esophageal-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-pretesh-patel/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/intrigue-study-circulating-tumor-dna-analysis-may-predict-optimal-treatment-of-patients-with-gist/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/what-can-be-learned-from-negative-findings-of-two-trials-in-biliary-tract-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-imane-el-dika/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/addition-of-bevacizumab-to-trifluridinetipiracil-new-standard-of-care-in-refractory-colorectal-cancer/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-dustin-deming/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/understanding-the-health-disparities-that-sexual-and-gender-minorities-face-in-oncology-care/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/recommendations-for-promoting-sexual-and-gender-minority-inclusion-in-oncology-care/</loc><lastmod>2023-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/robert-brodsky-begins-term-as-2023-ash-president/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-ajay-k-nooka/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/study-shows-activity-of-talquetamab-in-highly-refractory-multiple-myeloma/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-urvi-shah/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/complete-response-to-glofitamab-at-end-of-treatment-heralds-prolonged-remission-in-lymphoma/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-bita-fakhri/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/cll2-give-trial-regimen-of-obinutuzumab-ibrutinib-and-venetoclax-effective-in-high-risk-cll/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-emily-k-curran/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/ponatinib-and-blinatumomab-combination-safe-and-effective-in-patients-with-newly-diagnosed-ph-positive-all/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-jane-n-winter-and-catherine-bollard/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/many-survivors-of-childhood-hodgkin-lymphoma-show-signs-of-neurocognitive-impairment/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-amir-t-fathi/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-catherine-s-diefenbach-md/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/car-t-cell-therapy-vs-chemoimmunotherapy-in-second-line-treatment-of-resistant-large-b-cell-lymphoma/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/addition-of-venetoclax-to-intensive-chemotherapy-yields-durable-responses-in-younger-patients-with-high-risk-aml/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-julio-chavez/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/magnolia-trial-zanubrutinib-yields-high-response-rates-with-low-rate-of-cardiac-events-in-marginal-zone-lymphoma/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-alexey-danilov/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/is-zanubrutinib-poised-to-become-a-new-standard-of-care-in-relapsed-or-refractory-cll-and-sll/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-mrinal-s-patnaik-mbbs/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-mikkael-sekeres/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/studies-explore-novel-triplet-combinations-in-acute-myeloid-leukemia/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/highlights-from-the-2022-ash-annual-meeting-and-exposition/</loc><lastmod>2023-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-julio-c-chavez/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/new-leaders-named-for-the-university-of-arkansas-for-medical-sciences/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/quick-takes-on-important-cancer-research-from-ash-2022/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/mosunetuzumab-axgb-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/asco-formalizes-free-membership-for-physicians-in-lower-middle-income-countries/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/asco-publishes-new-guideline-on-immunotherapy-biomarker-testing-in-advanced-head-and-neck-cancer/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/new-jco-oncology-practice-special-series-highlights-current-state-of-team-based-care-innovations-and-future-direction/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/adagrasib-with-or-without-cetuximab-in-previously-treated-patients-with-metastatic-colorectal-cancer-and-a-kras-g12c-mutation/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/krystal-1-confirms-activity-of-adagrasib-in-kras-g12c-mutated-metastatic-colorectal-cancer-and-highlights-need-for-randomized-controlled-trials/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/terry-hyslop-joins-skcc-as-cancer-risk-and-control-program-co-leader-and-center-for-health-equity-director/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/common-immune-related-adverse-events-spotlight-on-gastrointestinal-and-hepatic-toxicities/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/guillermina-lozano-receives-aamc-award-for-distinguished-research-in-the-biomedical-sciences/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/traveling-the-world-at-an-early-age-gave-perspective-and-balance-to-future-oncology-leader-derek-raghavan/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/raised-in-africa-surgeon-kristin-flowers-continues-the-tradition-of-service-in-a-rural-hospital-in-alaska/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/the-beauty-and-the-beast-of-cancer/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/acupuncture-for-chemotherapy-induced-peripheral-neuropathy-health-related-quality-of-life-outcomes-from-a-randomized-clinical-trial/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/continued-declines-in-cancer-mortality-and-reductions-in-cervical-cancer-incidence-but-increases-in-advanced-prostate-cancer-and-persistent-racial-disparities/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/car-t-cell-therapy-vs-chemoimmunotherapy-in-second-line-treatment-of-resistant-large-b-cell-lymphoma-1/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-catherine-s-diefenbach-md-1/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/influence-of-the-mark-cuban-effect-on-cancer-drug-prices-in-the-united-states-focus-on-cml/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/soft-analysis-breast-cancer-index-may-identify-which-patients-need-ovarian-suppression/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-polly-niravath-and-virginia-kaklamani/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/despite-similar-recurrence-scores-breast-cancer-outcomes-differ-by-race/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-virginia-kaklamani-lori-j-pierce-and-eric-winer/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/is-efficacy-of-sacituzumab-govitecan-hziy-in-the-tropics-02-trial-dependent-on-trop-2-expression/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-maryam-b-lustberg/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/complete-response-to-glofitamab-at-end-of-treatment-heralds-prolonged-remission-in-lymphoma-1/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/subset-of-patients-with-advanced-gastric-cancer-may-benefit-from-claudin182-targeted-agent-zolbetuximab/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/epov-david-wang/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/lenvatinib-and-pembrolizumab-in-previously-treated-patients-with-advanced-endometrial-carcinoma/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/ibrutinib-in-the-first-line-treatment-of-chronic-gvhd/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/fda-oncology-center-of-excellence-seeks-applications-for-new-research-funding-opportunities/</loc><lastmod>2023-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/mdm2-inhibitor-milademetan-in-advanced-liposarcoma-solid-tumors-or-lymphomas/</loc><lastmod>2023-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/gap-discovered-in-breast-cancer-radiotherapy-recommendations-for-patients-aged-70-vs-69-years/</loc><lastmod>2023-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/study-finds-breast-mri-superior-vs-other-supplementary-screening-tests-for-detecting-breast-cancer-in-patients-with-dense-breasts/</loc><lastmod>2023-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/levels-of-inflammatory-biomarkers-and-survival-in-patients-receiving-adjuvant-therapy-for-stage-iii-colon-cancer/</loc><lastmod>2023-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/canadian-trial-highlights-adverse-outcomes-in-survivors-of-childhood-medulloblastoma/</loc><lastmod>2023-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/dexrazoxane-and-long-term-heart-function-in-survivors-of-childhood-cancer-treated-with-doxorubicin/</loc><lastmod>2023-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/addition-of-anti-igf-1r-antibody-ganitumab-to-interval-compressed-chemotherapy-in-newly-diagnosed-patients-with-metastatic-ewing-sarcoma/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/adjuvant-osimertinib-significantly-improves-disease-free-survival-for-patients-with-resected-egfr-mutant-nsclc/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/consuming-ultraprocessed-foods-may-be-linked-to-increased-cancer-risk-and-mortality/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/surgical-quality-metric-scoring-and-survival-among-us-veterans-with-early-stage-nsclc/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/neoadjuvant-plus-adjuvant-chemotherapy-vs-adjuvant-chemotherapy-alone-for-locally-advanced-colon-cancer/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/review-provides-recommendations-on-cancer-treatment-in-the-context-of-preexisting-dementia/</loc><lastmod>2023-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/10-year-outcomes-with-adjuvant-apbi-using-multicatheter-brachytherapy-vs-wbi-after-breast-conserving-surgery-for-early-breast-cancer/</loc><lastmod>2023-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/axatilimab-for-refractory-chronic-graft-vs-host-disease/</loc><lastmod>2023-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/oncologists-look-for-strong-health-care-priorities-in-the-state-of-the-union-address/</loc><lastmod>2023-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/covid-19-outcomes-across-pandemic-phases-in-european-patients-with-breast-cancer/</loc><lastmod>2023-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/lung-cancer-screening-may-be-more-cost-effective-when-using-risk-model-based-strategies/</loc><lastmod>2023-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/methotrexate-may-be-associated-with-an-increased-risk-for-some-skin-cancers/</loc><lastmod>2023-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/carl-june-honored-with-2023-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2023-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/long-term-outcomes-among-survivors-of-wilms-tumor/</loc><lastmod>2023-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/higher-rate-of-clonal-hematopoiesis-in-pediatric-cancer-survivors-may-be-linked-with-treatment-induced-stat3-gene-mutations-and-risk-of-adverse-long-term-outcomes/</loc><lastmod>2023-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/half-of-patients-with-cancer-may-develop-long-covid-with-risk-higher-in-female-patients/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/new-study-highlights-impact-of-covid-19-pandemic-on-cancer-screening-delays/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/findings-on-cardiovascular-imaging-in-patients-receiving-ibrutinib-association-with-cardiotoxicity/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/oncologists-applaud-state-of-the-union-s-focus-on-ending-cancer-as-we-know-it/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/proton-therapy-reirradiation-in-recurrent-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/who-launches-new-roadmap-on-breast-cancer/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/mirvetuximab-soravtansine-in-patients-with-platinum-resistant-ovarian-cancer-and-high-fra-expression/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/association-of-radiation-and-procarbazine-dose-with-risk-of-colorectal-cancer-in-survivors-of-hodgkin-lymphoma/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/ctdna-as-a-prognostic-marker-in-intermediate-risk-rhabdomyosarcoma/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/preclinical-study-shows-losartan-may-prevent-immune-checkpoint-inhibitor-induced-cerebral-edema-in-glioblastoma/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/researchers-uncover-racial-and-ethnic-disparities-in-widely-used-precision-oncology-data-registry/</loc><lastmod>2023-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/defensive-beliefs-may-prevent-individuals-from-partaking-in-screening-for-colorectal-cancer/</loc><lastmod>2023-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/sbrt-for-patients-with-primary-lung-neuroendocrine-tumors/</loc><lastmod>2023-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/docetaxel-as-a-radiosensitizer-in-cisplatin-ineligible-patients-with-locally-advanced-head-and-neck-cancer/</loc><lastmod>2023-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/fda-grants-regular-approval-to-dostarlimab-gxly-for-dmmr-endometrial-cancer/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/diagnosis-treatment-and-outcomes-of-breast-cancer-in-patients-from-sex-and-gender-minority-groups/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/focal-vs-extended-irreversible-electroporation-in-ablation-of-localized-low-or-intermediate-risk-prostate-cancer/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/addition-of-pembrolizumab-to-chemotherapy-in-first-line-treatment-of-metastatic-squamous-nsclc/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/dietary-intervention-may-help-reduce-chronic-fatigue-improve-quality-of-life-for-cancer-survivors/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/lack-of-resources-may-be-associated-with-increased-mortality-rates-among-pediatric-cancer-survivors/</loc><lastmod>2023-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/sublobar-vs-lobar-resection-for-peripheral-stage-ia-nsclc/</loc><lastmod>2023-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/darolutamide-maintenance-in-patients-with-metastatic-castration-resistant-prostate-cancer-without-disease-progression-on-taxane-treatment/</loc><lastmod>2023-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/second-line-bevacizumab-plus-folfiri-for-advanced-gastroenteropancreatic-neuroendocrine-carcinoma/</loc><lastmod>2023-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/pancreatic-cancer-rates-may-be-rising-faster-among-younger-women-patients-than-younger-men/</loc><lastmod>2023-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/new-predictive-epidemiologic-model-may-identify-individuals-at-high-risk-for-endometrial-cancer/</loc><lastmod>2023-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/decline-in-psa-level-after-treatment-with-enzalutamide-effect-on-metastasis-and-survival/</loc><lastmod>2023-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/codebreak-200-trial-sotorasib-vs-docetaxel-in-previously-treated-patients-with-advanced-kras-g12c-mutated-nsclc/</loc><lastmod>2023-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/new-study-calls-for-lgbtqia-community-inclusion-in-stem-cell-donor-recruitment/</loc><lastmod>2023-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/hyaluronic-acid-rectal-spacer-in-hypofractionated-radiation-therapy-for-prostate-cancer/</loc><lastmod>2023-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/is-a-diet-higher-in-plant-based-foods-associated-with-a-lower-risk-of-prostate-cancer-progression-and-recurrence/</loc><lastmod>2023-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/outcomes-after-minimally-invasive-vs-open-surgery-for-pancreatic-adenocarcinoma/</loc><lastmod>2023-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/ponatinib-may-be-more-effective-than-imatinib-for-newly-diagnosed-patients-with-ph-positive-all/</loc><lastmod>2023-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/ocra-issues-consensus-statement-calling-for-consideration-of-fallopian-tube-removal-to-prevent-ovarian-cancer/</loc><lastmod>2023-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/researchers-develop-ai-algorithm-to-gain-new-insights-into-glioblastoma/</loc><lastmod>2023-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/world-cancer-day-commercial-interests-may-drive-millions-of-avoidable-cancer-deaths/</loc><lastmod>2023-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/massage-therapy-may-improve-symptom-burden-for-pediatric-patients-with-hematologic-andor-oncologic-conditions/</loc><lastmod>2023-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/talapro-2-talazoparib-plus-enzalutamide-improves-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/association-of-anthracycline-use-with-risk-of-congestive-heart-failure-among-patients-treated-for-breast-cancer-or-lymphoma/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/cancer-symptom-algorithm-may-aid-oncologists-in-predicting-which-patients-are-at-risk-for-unplanned-ed-visits/</loc><lastmod>2023-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/allogeneic-hct-vs-consolidation-chemotherapy-in-patients-aged-60-years-or-younger-with-intermediate-risk-aml/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/intensified-drug-regimen-added-to-standard-of-care-improves-outcomes-in-subset-of-patients-with-high-risk-prostate-cancer/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/single-arm-phase-ii-noninferiority-trial-evaluates-active-surveillance-vs-cystectomy-following-neoadjuvant-chemotherapy-for-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/nivolumab-after-surgical-resection-improves-disease-free-survival-in-patients-with-high-risk-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/adding-talazoparib-to-enzalutamide-extends-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/study-finds-neoadjuvant-nivolumab-led-to-improved-5-year-survival-outcomes-in-patients-with-resectable-nsclc/</loc><lastmod>2023-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/triton3-rucaparib-vs-physician-s-choice-of-single-agent-therapy-in-metastatic-castration-resistant-prostate-cancer-with-brca-or-atm-alterations/</loc><lastmod>2023-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/nivolumab-and-relatlimab-in-patients-with-advanced-melanoma-progressing-on-anti-pd-1pd-l1-therapy/</loc><lastmod>2023-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/keynote-859-interim-analysis-overall-survival-benefit-for-first-line-pembrolizumab-in-advanced-gastric-cancer/</loc><lastmod>2023-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/pediatric-patients-with-all-living-along-the-texas-mexico-border-may-experience-lower-rates-of-survival/</loc><lastmod>2023-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/first-line-tyrosine-kinase-inhibitor-therapy-for-advanced-clear-cell-renal-cell-carcinoma-temporary-treatment-cessation-vs-continuation/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/low-income-linked-to-high-recurrence-risk-poorer-survival-in-patients-with-er-positive-breast-cancer/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/study-examines-stress-and-social-support-for-lgbtqi-patients-with-cancer-and-their-caregivers/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/discordance-of-p16-and-hpv-dnarna-status-prognostic-implication-in-squamous-cell-oropharyngeal-carcinoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/adjuvant-nivolumabipilimumab-vs-placebo-in-localized-renal-cell-carcinoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/karmma-3-idecabtagene-vicleucel-vs-standard-regimens-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/whole-genome-sequencing-may-illuminate-the-genetic-evolution-of-classical-hodgkin-lymphoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/estimating-the-environmental-impact-of-prostate-biopsies-and-mris-may-help-reduce-health-care-pollution/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/residual-nonretroperitoneal-disease-after-chemotherapy-for-nonseminomatous-germ-cell-tumors/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/new-study-demonstrates-inferior-vena-cava-filters-may-be-safe-and-effective-way-to-prevent-venous-thromboembolism/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/millions-of-us-individuals-may-have-missed-cancer-screenings-during-second-year-of-covid-19-pandemic/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/remote-interventions-to-improve-uptake-of-cancer-genetic-risk-assessment-in-patients-with-ovarian-cancer-or-high-risk-breast-cancer/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/association-of-immune-related-adverse-events-with-overall-survival-in-patients-receiving-atezolizumab-containing-therapy-for-metastatic-nonsquamous-nsclc/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/mediterranean-diet-and-immune-checkpoint-blockade-outcomes-in-advanced-melanoma/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/darolutamide-plus-adt-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer-outcomes-by-disease-volume-and-risk-status-in-the-arasens-trial/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/prevalence-of-high-grade-serous-carcinoma-at-risk-reducing-salpingo-oophorectomy-in-asymptomatic-patients-with-brca12-pathogenic-variants/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/combination-abatacept-ruxolitinib-andor-mechanical-ventilation-may-decrease-mortality-in-patients-with-immune-checkpoint-inhibitor-associated-cardiotoxicity/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/immunotherapy-costs-may-drive-increase-in-medicare-spending-for-outpatient-end-of-life-cancer-care/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/de-escalated-neoadjuvant-t-dm1-with-or-without-et-vs-trastuzumab-with-et-in-hr-positiveher2-positive-early-breast-cancer/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/hospital-surgical-volume-may-impact-survival-in-patients-with-pancreatic-cancer-whose-minimally-invasive-surgery-is-converted-to-an-open-procedure/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/02-february/prime-ii-trial-breast-conserving-surgery-with-or-without-radiotherapy-in-early-breast-cancer/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/genomic-screening-may-help-detect-medullary-thyroid-cancer-study-finds/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/addition-of-pazopanib-to-concurrent-radiotherapy-and-paclitaxel-in-anaplastic-thyroid-cancer/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/elranatamab-induces-responses-in-many-patients-with-resistant-multiple-myeloma-in-phase-ii-trial/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-explores-the-addition-of-first-line-atezolizumab-in-braf-v600-mutant-advanced-melanoma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risks-of-cardiovascular-and-immune-related-adverse-events-in-immune-checkpoint-inhibitor-therapy/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/cardiovascular-events-before-and-after-initiation-of-immune-checkpoint-inhibitor-therapy-for-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/significant-benefit-with-addition-of-daratumumab-to-bortezomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/first-adenoviral-vector-based-gene-therapy-for-high-risk-bcg-unresponsive-non-muscle-invasive-bladder-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/maureen-murphy-named-deputy-director-of-the-wistar-institute-ellen-and-ronald-caplan-cancer-center/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-alexey-danilov/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/cll2-give-trial-regimen-of-obinutuzumab-ibrutinib-and-venetoclax-effective-in-high-risk-cll/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-bita-fakhri/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/is-zanubrutinib-poised-to-become-a-new-standard-of-care-in-relapsed-or-refractory-cll-and-sll/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-urvi-shah/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/a-serendipitous-opportunity-steers-a-theater-major-into-oncology/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/being-on-the-other-side-an-oncologist-s-perspective-on-grieving/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/phase-iii-nora-trial-niraparib-maintenance-shows-overall-survival-trend-in-platinum-sensitive-recurrent-ovarian-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-antonio-gonzalez-martin/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/nrg-oncology-announces-leadership-of-new-dei-committee-and-new-vice-chair-for-ancillary-projects-committee/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/determining-the-role-of-muscadine-grape-skin-extract-in-treating-prostate-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/how-experts-treat-mantle-cell-lymphoma-in-first-complete-response/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/northwell-receives-gift-from-trustee-roy-zuckerberg-to-create-first-cancer-hospital-and-cancer-campus-on-long-island/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/the-influence-of-structural-racism-and-poverty-on-outcomes-in-leukemia/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ku-medical-center-researchers-receive-r01-grant-from-nci-to-improve-access-to-targeted-cancer-treatments-for-rural-patients/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/andrea-schietinger-to-present-2023-aacr-irving-weinstein-foundation-distinguished-lecture/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/intensive-remission-induction-chemotherapy-vs-less-intensive-approach-prior-to-transplant-for-relapsedrefractory-aml/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-jaime-suarez-londono/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/update-from-monarche-benefit-of-abemaciclib-increases-over-time-in-early-stage-breast-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-nancy-chan/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/remembering-breast-cancer-pioneer-isaac-craig-henderson/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/inaugural-recipients-of-the-lubin-family-foundation-scholar-award-named/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/communicating-prognosis-a-core-competency-of-patient-centered-oncology-care/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/atrium-health-and-wake-forest-university-school-of-medicine-cancer-program-appoint-new-director/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/undaunted/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/magnolia-trial-zanubrutinib-yields-high-response-rates-with-low-rate-of-cardiac-events-in-marginal-zone-lymphoma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-julio-chavez/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/many-survivors-of-childhood-hodgkin-lymphoma-show-signs-of-neurocognitive-impairment/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-jane-n-winter-and-catherine-bollard/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/olutasidenib-for-relapsed-or-refractory-acute-myeloid-leukemia-with-a-susceptible-idh1-mutation/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/yale-cancer-center-presents-2022-research-awards/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/anti-tigit-antibody-may-boost-the-benefit-of-immunotherapy-in-stage-iv-lung-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-solange-peters/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/northwell-cancer-institute-welcomes-new-chief-of-hematologic-malignancies/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/asco-guideline-offers-recommendations-on-prescribing-opioids-to-patients-with-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/former-asco-president-monica-bertagnolli-welcomed-as-nci-director-in-capitol-hill-reception/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/robin-zon-elected-asco-president-for-2024-2025-term-other-leadership-positions-filled/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ensuring-a-more-diverse-equitable-and-inclusive-workforce-within-the-swog-cancer-research-network/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-shows-activity-of-talquetamab-in-highly-refractory-multiple-myeloma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-reports-activity-with-oncolytic-vaccine-plus-pembrolizumab-in-bcg-unresponsive-bladder-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/addressing-the-continued-existence-of-racial-inequities-in-cancer-care/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/capivasertib-plus-fulvestrant-doubles-progression-free-survival-in-hormone-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-virginia-kaklamani/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/neoadjuvant-t-dxd-demonstrates-activity-in-phase-ii-study-of-patients-with-her2-low-breast-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-jason-aboudi-mouabbi/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/camizestrant-improves-progression-free-survival-in-advanced-breast-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-carlos-l-arteaga-and-william-sikov/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/can-younger-women-with-hormone-receptor-positive-breast-cancer-safely-pause-endocrine-therapy-to-pursue-pregnancy/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-virginia-kaklamani-md/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/palbociclibfulvestrant-does-not-improve-progression-free-survival-after-progression-on-a-cdk46-inhibitor-in-metastatic-breast-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-debu-tripathy/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ash-2022-multiple-myeloma-highlights/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-ajay-k-nooka/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/cabozantinib-plus-atezolizumab-warrants-further-study-in-treatment-of-advanced-head-and-neck-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-renata-ferrarotto/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-finds-immune-checkpoint-inhibitors-safe-and-effective-for-patients-living-with-hiv-who-have-nsclc/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-neil-j-shah/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/studies-explore-novel-triplet-combinations-in-acute-myeloid-leukemia/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-mikkael-sekeres/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/tremelimumab-actl-in-combination-with-durvalumab-for-unresectable-hepatocellular-carcinoma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-mrinal-s-patnaik-mbbs/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-suggests-ibrutinib-may-obviate-need-for-autologous-stem-cell-transplantation-in-some-younger-patients-with-mantle-cell-lymphoma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-jeremy-s-abramson/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/can-women-with-two-or-three-ipsilateral-breast-cancer-sites-safely-undergo-breast-conserving-therapy/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ruxolitinib-demonstrates-clinical-activity-in-a-phase-ii-trial-of-chronic-myelomonocytic-leukemia/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-factors-for-local-failure-after-chemoradiation-and-mri-guided-brachytherapy-for-locally-advanced-cervical-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/blinatumomab-improves-survival-in-mrd-negative-b-cell-acute-lymphoblastic-leukemia/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-joseph-c-alvarnas/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/emerald-trial-elacestrant-vs-standard-endocrine-monotherapy-for-advanced-breast-cancer-after-cdk46-inhibition/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-seth-wander/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/pollux-trial-final-overall-survival-analysis-addition-of-daratumumab-to-lenalidomidedexamethasone-in-previously-treated-patients-with-multiple-myeloma/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/sotorasib-in-previously-treated-patients-with-kras-g12c-mutated-advanced-pancreatic-cancer/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/outcomes-in-infants-and-young-children-with-relapsed-medulloblastoma-after-initial-craniospinal-irradiation-sparing-curative-intent-treatment/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-jeremy-s-abramson-1/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-suggests-ibrutinib-may-obviate-need-for-autologous-stem-cell-transplantation-in-some-younger-patients-with-mantle-cell-lymphoma-1/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/blinatumomab-improves-survival-in-mrd-negative-b-cell-acute-lymphoblastic-leukemia-1/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-joseph-c-alvarnas-1/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/blinatumomab-improves-survival-in-mrd-negative-b-cell-acute-lymphoblastic-leukemia-2/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-joseph-c-alvarnas-2/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ruxolitinib-demonstrates-clinical-activity-in-a-phase-ii-trial-of-chronic-myelomonocytic-leukemia-1/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ruxolitinib-demonstrates-clinical-activity-in-a-phase-ii-trial-of-chronic-myelomonocytic-leukemia-2/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/long-term-follow-up-supports-postneoadjuvant-t-dm1-over-trastuzumab-in-early-high-risk-her2-positive-breast-cancer/</loc><lastmod>2023-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/emerald-trial-elacestrant-vs-standard-endocrine-monotherapy-for-advanced-breast-cancer-after-cdk46-inhibition-1/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-seth-wander-1/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/addition-of-apalutamide-may-slow-progression-of-early-stage-prostate-cancer-during-active-surveillance/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/novel-therapy-afamitresgene-autoleucel-shows-early-potential-for-antitumor-activity/</loc><lastmod>2023-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-investigates-burden-of-cervical-cancer-among-patients-aged-65-and-older/</loc><lastmod>2023-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/mitomycin-gel-for-upper-tract-urothelial-cancers-postmarket-analysis/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/addition-of-adjuvant-nab-paclitaxel-to-gemcitabine-in-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2023-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/pembrolizumab-as-second-line-therapy-in-asian-patients-with-advanced-hcc/</loc><lastmod>2023-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/association-of-prs313-polygenic-risk-score-with-tumor-characteristics-and-survival-in-patients-with-invasive-breast-cancer/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-of-subsequent-gastrointestinal-tract-malignancies-after-blood-or-marrow-transplantation/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/two-methods-studied-in-defining-prognosis-for-patients-with-er-positive-node-positive-breast-cancer/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/immunotherapy-combined-with-targeted-therapy-in-patients-with-braf-v600e-mutated-colorectal-cancer/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/association-of-immune-related-gene-expression-signatures-and-tils-with-outcomes-in-early-stage-her2-positive-breast-cancer/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/momelotinib-may-effectively-reduce-anemia-and-other-symptoms-for-patients-with-myelofibrosis/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/sex-disparities-in-childhood-cancer-diagnoses-in-india/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/uptake-of-immune-checkpoint-inhibitors-and-survival-among-younger-and-older-patients-with-advanced-nsclc/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/fda-approves-pembrolizumab-as-adjuvant-treatment-for-nsclc/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/trends-in-use-of-next-generation-sequencing-in-us-patients-according-to-genetic-ancestry/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/new-study-shows-increased-cancer-mortality-among-patients-with-type-2-diabetes-in-england/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/new-analysis-sheds-light-on-potential-link-between-ovulation-and-ovarian-cancer/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/adjuvant-folfox-hepatic-arterial-infusion-in-hepatocellular-carcinoma-with-microvascular-invasion/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/adjuvant-s-1-vs-observation-for-resected-biliary-tract-cancer/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/new-study-evaluates-online-colorectal-cancer-risk-calculators/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/receiving-chemotherapy-in-the-afternoon-may-improve-treatment-outcomes-in-some-patients-with-dlbcl/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-of-major-psychiatric-disorders-among-survivors-of-childhood-and-adolescent-cancers/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/updated-results-of-destiny-breast03-t-dxd-vs-t-dm1-for-previously-treated-patients-with-her2-positive-metastatic-breast-cancer/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/analysis-of-mutations-associated-with-high-tumor-mutation-burden-in-microsatellite-stable-gastrointestinal-cancers/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ctdna-analysis-may-predict-optimal-treatment-for-patients-with-gist/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/combination-of-botensilimab-and-balstilimab-shows-activity-in-patients-with-metastatic-mss-colorectal-cancer/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/first-line-nalirifox-regimen-improves-overall-survival-in-metastatic-pancreatic-cancer/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/addition-of-ultrasound-to-dbt-for-breast-cancer-screening-in-patients-with-dense-breasts/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/trends-in-stage-treatment-and-outcomes-in-rectal-adenocarcinoma-in-the-united-states-2004-to-2019/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/interventions-to-improve-skin-cancer-surveillance-in-childhood-cancer-survivors-who-received-radiotherapy/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/real-world-use-of-idecabtagene-vicleucel-for-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/is-the-risk-of-suicide-higher-among-individuals-with-cancer/</loc><lastmod>2023-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/subset-of-patients-with-advanced-gastricgej-cancer-may-benefit-from-cldn182-targeted-drug-zolbetuximab/</loc><lastmod>2023-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/fda-grants-accelerated-approval-to-tucatinib-plus-trastuzumab-for-advanced-her2-positive-colorectal-cancer/</loc><lastmod>2023-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/fda-approves-zanubrutinib-for-cll-or-sll/</loc><lastmod>2023-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/accelerated-partial-breast-irradiation-vs-whole-breast-irradiation-long-term-cosmetic-results-and-toxicity/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/addition-of-veliparib-to-cisplatin-in-advanced-triple-negative-breast-cancer-with-brca-like-and-non-brca-like-phenotype/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/new-study-shows-impact-of-low-adherence-to-guideline-based-imaging-before-radiotherapy-on-outcomes-in-medicare-patients-with-nsclc/</loc><lastmod>2023-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/uterine-cancer-now-covered-by-wtc-health-program/</loc><lastmod>2023-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/appendectomy-with-or-without-hemicolectomy-for-1-to-2-cm-appendiceal-neuroendocrine-tumors/</loc><lastmod>2023-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-of-contralateral-breast-cancer-among-patients-with-invasive-breast-cancer-and-various-germline-pathogenic-variants/</loc><lastmod>2023-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/futibatinib-in-previously-treated-patients-with-advanced-fgfr2-rearranged-intrahepatic-cholangiocarcinoma/</loc><lastmod>2023-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/first-line-zanidatamab-plus-chemotherapy-for-her2-expressing-metastatic-gastroesophageal-adenocarcinoma/</loc><lastmod>2023-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/mri-guided-vs-ct-guided-sbrt-for-localized-prostate-cancer/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-suggests-ibrutinib-may-obviate-need-for-asct-in-some-younger-patients-with-mantle-cell-lymphoma/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/epov-jeremy-abramson/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/acupuncture-and-acupressure-may-help-alleviate-pain-and-anxiety-for-patients-undergoing-surgery-for-gynecologic-cancer/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/ovarian-cancer-may-be-linked-to-pathogenic-microbe-colonization-in-reproductive-tract/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/neoadjuvant-gemcitabinecisplatin-in-high-risk-upper-tract-urothelial-carcinoma/</loc><lastmod>2023-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/long-term-follow-up-of-combined-text-and-soft-trials/</loc><lastmod>2023-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/robo2-as-a-novel-susceptibility-gene-for-risk-of-anthracycline-related-cardiomyopathy-in-childhood-cancer-survivors/</loc><lastmod>2023-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/molecular-tumor-board-offers-assistance-that-may-boost-effectiveness-of-precision-oncology/</loc><lastmod>2023-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/reminders-based-on-machine-learning-algorithms-may-improve-end-of-life-care-for-patients-with-cancer/</loc><lastmod>2023-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/frequency-and-dosage-of-radiotherapy-in-chemoradiotherapy-for-limited-stage-sclc/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/carfilzomib-lenalidomide-and-dexamethasone-vs-lenalidomide-in-maintenance-therapy-after-asct-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2023-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/subcutaneous-epcoritamab-for-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/circulating-tumor-dna-profiling-and-outcomes-in-cns-lymphoma/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/nonablative-fractional-laser-therapy-may-help-prevent-nonmelanoma-skin-cancers/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/novel-artificial-intelligence-tool-may-predict-risk-of-lung-cancer-using-low-dose-ct-scan-data/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/american-cancer-society-cancer-statistics-2023-report-released/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/neoadjuvant-pembrolizumab-in-localized-msi-hdmmr-solid-tumors/</loc><lastmod>2023-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-finds-posoleucel-demonstrated-antiviral-efficacy-and-safety-against-viral-infections-following-allogeneic-stem-cell-transplantation/</loc><lastmod>2023-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/older-minority-patients-with-cancer-face-inequities-in-opioid-access-near-the-end-of-life/</loc><lastmod>2023-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/new-scoring-system-measures-inflammation-levels-may-improve-risk-stratification-in-aml/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/neoadjuvant-immunotherapy-in-patients-with-localized-dmmr-colorectal-cancer/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/experts-publish-consensus-statement-on-classification-system-for-pathology-and-diagnosis-of-melanocytic-lesions/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/trends-in-us-e-cigarette-sales-price-and-nicotine-strength/</loc><lastmod>2023-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/crizotinib-combined-with-chemotherapy-in-pediatric-alk-positive-anaplastic-large-cell-lymphoma/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/phase-iii-imerge-trial-of-imetelstat-in-lower-risk-mds/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/effect-of-medicaid-expansion-on-survival-for-young-adults-with-cancer/</loc><lastmod>2023-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-identifies-potential-molecular-differences-between-primary-breast-cancer-and-its-metastases/</loc><lastmod>2023-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/fewer-cases-of-melanoma-found-among-individuals-taking-vitamin-d-supplements/</loc><lastmod>2023-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/cancer-survival-in-africa-central-and-south-america-and-asia-survcan-3-study/</loc><lastmod>2023-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-compares-the-cost-and-efficacy-of-anticoagulant-therapies/</loc><lastmod>2023-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/triple-immunotherapy-combination-studied-preclinically-for-pancreatic-cancer/</loc><lastmod>2023-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/updated-data-from-a-phase-ii-trial-of-triplet-therapy-in-hpv-positive-cancers/</loc><lastmod>2023-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/world-cancer-day-2023-february-4/</loc><lastmod>2023-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/late-mortality-subsequent-malignant-neoplasms-and-chronic-health-conditions-among-survivors-of-neuroblastoma-diagnosed-during-infancy/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/endoscopic-surveillance-with-systematic-random-biopsy-vs-targeted-biopsy-for-early-diagnosis-of-hereditary-diffuse-gastric-cancer/</loc><lastmod>2023-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/hypofractionated-3-week-course-of-preoperative-radiotherapy-for-soft-tissue-sarcomas/</loc><lastmod>2023-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-of-incident-lung-cancer-in-individuals-with-clonal-hematopoiesis/</loc><lastmod>2023-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/study-examines-reconstructive-burnout-phenomenon-patients-who-start-breast-reconstruction-after-mastectomy-but-dont-complete-it/</loc><lastmod>2023-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/one-in-seven-diagnosed-cancers-is-found-by-recommended-screening-tests/</loc><lastmod>2023-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-prediction-model-for-contralateral-breast-cancer-in-brca-carriers-with-breast-cancer/</loc><lastmod>2023-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/adjuvant-endocrine-therapy-and-ovarian-suppression-for-premenopausal-patients-with-hr-positive-breast-cancer/</loc><lastmod>2023-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/adagrasib-with-or-without-cetuximab-in-previously-treated-patients-with-metastatic-colorectal-cancer-and-a-kras-g12c-mutation/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/effect-of-adjuvant-chemotherapy-on-survival-in-patients-with-resected-pancreatic-adenocarcinoma-after-multiagent-neoadjuvant-chemotherapy/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/genomic-profile-to-identify-candidates-for-omission-of-local-adjuvant-radiation-among-patients-with-breast-cancer/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/delaying-antibiotics-may-not-affect-overall-survival-among-inpatients-with-cancer-who-have-neutropenic-fever/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/silicone-film-to-prevent-acute-radiation-dermatitis-in-patients-with-breast-cancer/</loc><lastmod>2023-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/racial-ethnic-disparities-in-recommendations-for-surgical-resection-of-newly-diagnosed-brain-tumors/</loc><lastmod>2023-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/risk-reducing-medication-in-patients-with-high-risk-er-positive-breast-cancer-benefits-and-harms/</loc><lastmod>2023-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/foundationone-liquid-cdx-receives-fda-approval-as-a-companion-diagnostic-for-entrectinib/</loc><lastmod>2023-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/prostate-cancer-screening-among-primary-care-providers/</loc><lastmod>2023-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/new-ai-based-biomarker-may-help-predict-immunotherapy-response-for-patients-with-nsclc/</loc><lastmod>2023-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/first-line-atezolizumab-plus-bevacizumab-in-metastatic-nonsquamous-nsclc-with-high-tumor-mutation-burden/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2023/01-january/immune-system-b-cells-may-help-to-predict-treatment-response-among-patients-with-her2-positive-breast-cancer/</loc><lastmod>2023-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/brentuximab-vedotin-combined-with-chemotherapy-in-pediatric-classical-hodgkin-lymphoma/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/indiana-university-names-music-therapy-researcher-sheri-robb-phd-as-new-walther-professor-of-supportive-oncology/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/understanding-the-health-provisions-in-the-inflation-reduction-act-and-their-implications-for-oncology-care/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/alex-herrera-md-finds-a-path-from-the-baseball-fields-of-miami-to-a-leadership-role-at-city-of-hope/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/tremelimumab-combined-with-durvalumab-and-platinum-based-chemotherapy-in-metastatic-nsclc/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/from-immigrant-roots-to-a-budding-career-in-oncology-gladys-magaly-rodriguez-md-aims-to-advance-health-equity-in-vulnerable-populations/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/new-approaches-still-needed-to-treat-patients-with-cancer-who-have-serious-mental-illness/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fox-chase-receives-6-million-grant-as-founding-member-of-new-nci-prevention-initiative/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/how-do-you-move-forward-with-a-life-you-didn-t-choose-after-a-cancer-diagnosis/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/cedars-sinai-cancer-leaders-assume-new-roles/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/ivosidenibazacitidine-for-newly-diagnosed-idh1-mutant-acute-myeloid-leukemia-in-patients-aged-75-or-older-or-with-comorbidities/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/aacr-and-asco-release-joint-policy-statement-on-electronic-nicotine-delivery-systems/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/uniting-on-shared-priorities-to-improve-cancer-care-asco-and-eco-formalize-collaboration-with-a-memorandum-of-understanding/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/nearly-all-oncology-providers-report-prior-authorization-causing-delayed-care-other-patient-harms/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/updated-position-statement-on-drug-repository-programs-aims-to-increase-access-to-treatment/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/md-anderson-and-who-establish-a-new-international-collaboration-to-reduce-the-global-burden-of-women-s-cancers/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/sodium-thiosulfate-to-reduce-the-risk-of-cisplatin-related-ototoxicity-in-pediatric-patients-with-localized-solid-tumors/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/2021-jadpro-article-of-the-year-award-spotlights-management-of-adverse-events-in-immunotherapy/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/traditional-chinese-medicine-herbal-formula-shen-ling-bai-zhu-san-for-chronic-diarrhea/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/sidney-kimmel-cancer-center-establishes-geriatric-oncology-center-of-excellence-at-jefferson-health/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/a-serendipitous-ride-along-a-highway-may-have-saved-my-life/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/ribociclib-plus-endocrine-therapy-vs-combination-chemotherapy-for-patients-with-breast-cancer-focus-on-those-in-visceral-crisis/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-aditya-bardia/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/how-the-american-cancer-society-aims-to-improve-outcomes-in-breast-and-cervical-cancers-and-reduce-health-disparities/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/how-telemedicine-can-transform-clinical-research-and-practice/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/t-dxd-confirmed-as-preferred-second-line-therapy-for-metastatic-her2-positive-breast-cancer/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-neelima-vidula/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/research-exposes-inequities-in-health-care-access-and-delivery-for-blood-disorders/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-lifileucel-active-in-advanced-melanoma-after-disease-progression-on-immune-checkpoint-inhibitors/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-ryan-sullivan/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/from-the-clinic-to-the-lab-overcoming-resistance-to-immune-checkpoint-therapy/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-microbiome-derived-vaccine-plus-nivolumab-and-bevacizumab-may-improve-outcomes-in-recurrent-glioblastoma/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-rimas-lukas/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/risk-reducing-bilateral-mastectomy-may-help-women-with-high-penetrance-genetic-mutations-to-avoid-cancer/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/changing-landscape-in-the-management-of-high-risk-lesions-for-breast-cancer/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/world-cancer-research-fund-international-launches-new-flagship-research-program/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/how-asco-and-the-oncology-community-came-together-to-discuss-progress-in-global-cancer-control-and-the-challenges-ahead/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/managing-severe-diarrhea-in-patients-with-cancer/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/lung-cancer-screening-perceptions-of-patients-and-clinicians-the-power-of-shared-decision-making/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-joelle-fathi/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/chronic-myelomonocytic-leukemia-treatment-and-prognosis-part-2/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/a-lifelong-love-of-science-leads-to-a-leadership-role-in-oncology-for-laurie-glimcher/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/2022-san-antonio-breast-cancer-symposium-award-recipients-announced/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/eyal-gottlieb-to-join-md-anderson-as-vice-president-for-research/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/barbara-burtness-named-chief-translational-research-officer-for-yale-cancer-center-and-smilow-cancer-hospital/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/mirvetuximab-soravtansine-for-fr%C9%91-positive-platinum-resistant-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer/</loc><lastmod>2022-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/dabrafenib-in-combination-with-trametinib-for-unresectable-or-metastatic-solid-tumors-with-braf-v600e-mutation/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/michael-a-caligiuri-md-traveled-from-humble-beginnings-to-a-notable-career-as-an-oncology-leader/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/silicone-film-dressing-may-reduce-acute-radiation-dermatitis-in-some-patients-with-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-jean-lundberg-wright-md/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/the-effect-of-the-reversal-of-roe-v-wade-on-care-of-pregnant-women-with-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/teclistamab-in-the-treatment-of-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/phase-ii-trial-reports-high-response-rates-with-neoadjuvant-cemiplimab-in-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-christian-blank/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/radiotherapy-added-to-sorafenib-improves-survival-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-grants-accelerated-approval-to-mirvetuximab-soravtansine-gynx-for-fr-positive-platinum-resistant-epithelial-ovarian-fallopian-tube-or-peritoneal-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/randomized-phase-ii-trial-shows-benefits-of-prophylactic-radiation-therapy-for-asymptomatic-bone-metastases/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-benjamin-movsas-md/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-cemiplimab-rwlc-in-combination-with-platinum-based-chemotherapy-for-nsclc/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-oral-mek-inhibitor-cobimetinib-for-histiocytic-neoplasms/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/futibatinib-for-cholangiocarcinoma-with-fgfr2-gene-fusion-or-other-rearrangements/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/5-weeks-of-radiation-therapy-may-be-equivalent-to-8-weeks-in-high-risk-prostate-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-sophia-c-kamran/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/how-the-pancreatic-cancer-early-detection-consortium-aims-to-advance-survival-rates-in-this-deadly-disease/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/cancer-drugs-and-price-controls-is-it-time/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/addition-of-neoadjuvant-nivolumab-to-chemotherapy-improves-complete-pathologic-response-rate-and-event-free-survival-in-resectable-nsclc/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-patritumab-deruxtecan-active-in-her3-expressing-metastatic-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-veronique-dieras-md/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/pembrolizumab-plus-chemotherapy-for-triple-negative-breast-cancer-clinical-implications-of-residual-cancer-burden/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-erica-michelle-stringer-reasor/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/how-low-dose-oral-minoxidil-is-providing-hope-for-patients-with-later-stage-alopecia/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-iris-c-gibbs-and-sophia-c-kamran/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-use-of-remote-interventions-improved-adherence-to-cancer-screenings-among-women-living-in-rural-areas/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/patient-reported-outcomes-study-finds-severe-symptoms-in-meaningful-minority-of-patients-with-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epov-therese-m-mulvey/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/capturing-tumor-evolution-with-serial-biopsies-may-guide-treatment-changes-to-benefit-patients-with-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/selpercatinib-approved-for-advanced-ret-fusion-positive-solid-tumors-and-advanced-ret-fusion-positive-nsclc/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/putting-the-patient-at-the-center-the-career-of-jeffery-ward-md-fasco/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/asco-guideline-highlights-newest-breakthroughs-in-the-treatment-of-metastatic-colorectal-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/ama-house-of-delegates-approves-asco-backed-resolutions-on-fertility-preservation-american-manufactured-personal-protective-equipment-and-third-party-pharmacy-benefit-administrators/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/legal-and-ethical-use-of-complementary-and-alternative-medicine-interventions-in-oncology/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/astro-celebrates-contributions-to-radiation-oncology-with-2022-gold-medals-and-other-awards/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/sexual-side-effects-of-radiotherapy-for-genitourinary-cancers-is-physician-assessment-equitable-for-women-and-men/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/pregnancy-confers-dual-effect-on-breast-cancer-risk/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/education-and-diligence-required-to-confront-the-challenges-of-pregnancy-associated-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/liquid-biopsies-may-identify-patients-with-cancer-at-higher-risk-of-developing-additional-blood-cancers/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/akt-inhibitor-shows-signs-of-activity-in-a-trial-matching-drugs-to-tumor-gene-mutations/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/experimental-drug-under-study-in-liver-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/i-have-the-brca2-gene-mutation-here-s-what-i-m-doing-to-prevent-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/cemiplimabchemotherapy-combination-in-advanced-nsclc-with-no-egfr-alk-or-ros1-aberrations/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/national-academy-of-medicine-elects-100-new-members/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-bolivia/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/2022-society-for-integrative-oncology-annual-international-conference/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/world-travel-helped-brittany-l-bychkovsky-md-msc-shape-her-global-commitment-to-breast-cancer-care/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/heartbreak-and-a-second-chance-at-love-and-life/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/epigenetic-imprinted-biomarker-test-to-identify-malignant-thyroid-nodules/</loc><lastmod>2022-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/incidence-of-cervical-cancer-in-women-in-the-united-states-2001-to-2019/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/autologous-tumor-lysate-loaded-dendritic-cell-vaccine-for-glioblastoma/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/does-cbd-oil-improve-symptom-distress-in-patients-with-advanced-cancer-receiving-palliative-care/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-americans-have-a-low-awareness-of-the-link-between-alcohol-use-and-increased-cancer-risk/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/lung-cancer-screening-may-increase-long-term-survival-rate/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/high-deductibles-may-discourage-patients-from-receiving-additional-testing-after-an-abnormal-mammogram/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/are-patients-older-than-65-years-being-overscreened-for-cervical-cancer/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/risk-of-cancer-may-double-for-patients-with-skewed-blood-cells/</loc><lastmod>2022-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-olutasidenib-for-relapsed-or-refractory-aml-with-a-susceptible-idh1-mutation/</loc><lastmod>2022-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/breast-cervical-and-colorectal-cancer-screening-rates-before-vs-after-the-covid-19-pandemic/</loc><lastmod>2022-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/residential-racial-and-economic-segregation-and-cancer-mortality-in-the-united-states/</loc><lastmod>2022-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/physical-activity-and-all-cause-mortality-among-postmenopausal-breast-cancer-survivors/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/eliana-trial-3-year-update-tisagenlecleucel-in-pediatric-and-young-adult-patients-with-relapsed-or-refractory-b-cell-all/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/dna-repair-protein-mre11-expression-and-disease-specific-mortality-among-patients-with-muscle-invasive-bladder-cancer-receiving-trimodality-therapy/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/avelumab-plus-talazoparib-in-patients-with-advanced-solid-tumors/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/lu-177-vipivotide-tetraxetan-shows-benefit-in-patients-with-psma-positive-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/adjuvant-pembrolizumab-may-improve-quality-of-life-in-patients-with-high-risk-resected-melanoma/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/black-patients-with-breast-cancer-may-have-worse-outcomes-than-other-patients-despite-similar-genetic-recurrence-scores/</loc><lastmod>2022-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/genomic-assay-may-predict-long-term-prognosis-in-premenopausal-patients-with-hormone-receptor-positive-early-stage-breast-cancer/</loc><lastmod>2022-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-racial-disparity-in-prometastatic-tumor-microenvironment-among-patients-with-residual-breast-cancer-after-neoadjuvant-chemotherapy/</loc><lastmod>2022-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/machine-learning-based-scoring-of-tils-and-outcomes-with-immunotherapy-in-patients-with-nsclc/</loc><lastmod>2022-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/breast-implants-after-mastectomy-associated-with-very-low-risk-of-alcl/</loc><lastmod>2022-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/first-line-ribociclib-plus-endocrine-therapy-may-be-more-effective-than-combination-chemotherapy-in-patients-with-aggressive-breast-cancer/</loc><lastmod>2022-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/addition-of-daratumumab-to-bortezomib-plus-dexamethasone-in-relapsed-or-refractory-multiple-myeloma-castor-trial-final-overall-survival-analysis/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/addition-of-first-line-atezolizumab-to-vemurafenibcobimetinib-in-braf-v600-mutant-advanced-melanoma/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/neoadjuvant-t-dxd-shows-clinical-activity-in-patients-with-her2-low-breast-cancer/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/t-dxd-yields-longer-overall-survival-than-t-dm1-as-second-line-treatment-in-patients-with-her2-positive-metastatic-breast-cancer/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/astro-issues-updated-guideline-on-radiation-therapy-for-patients-with-endometrial-cancer/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/adding-capivasertib-to-fulvestrant-may-improve-progression-free-survival-in-patients-with-advanced-hr-positive-breast-cancer/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/patients-with-breast-cancer-who-interrupted-endocrine-therapy-to-pursue-pregnancy-did-not-experience-worse-short-term-recurrence-rates/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/camizestrant-may-be-superior-to-fulvestrant-in-patients-with-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/circulating-tumor-cell-count-driven-treatment-decisions-may-improve-long-term-outcomes-for-patients-with-metastatic-breast-cancer/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-grants-approval-to-atezolizumab-in-treatment-of-alveolar-soft-part-sarcoma/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/breast-conserving-therapy-may-be-a-treatment-option-for-some-patients-with-multiple-ipsilateral-breast-lesions/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/genetic-profiling-may-identify-patients-with-breast-cancer-who-can-safely-omit-radiation-therapy-after-breast-conserving-surgery/</loc><lastmod>2022-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/impact-on-cognitive-function-of-adding-chemotherapy-to-endocrine-therapy-for-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/will-ibrutinib-replace-stem-cell-transplantation-as-first-line-treatment-for-mantle-cell-lymphoma/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-explores-when-to-proceed-to-stem-cell-transplantation-for-patients-with-resistant-aml/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/elacestrant-vs-endocrine-monotherapy-in-advanced-breast-cancer-phase-iii-emerald-trial/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/talquetamab-generates-high-response-rate-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/high-dose-methotrexate-may-make-posttreatment-steroids-unnecessary-for-some-pediatric-patients-with-all-or-lbl/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/commonly-prescribed-restrictive-diet-may-be-unnecessary-before-autologous-stem-cell-transplantation/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/survey-finds-sexuality-and-fertility-discussions-remain-sidelined-among-young-patients-diagnosed-with-breast-cancer/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/monarche-update-benefit-of-abemaciclib-increases-over-time/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/efficacy-of-sacituzumab-govitecan-in-tropics-02-trial-not-dependent-on-trop-2-expression/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/targeting-menin-may-induce-responses-in-patients-with-acute-leukemias-and-kmt2a-rearrangements-or-npm1-mutations/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/report-outlines-advance-in-retreatment-with-car-t-cell-therapy-in-patients-with-relapsed-or-refractory-non-hodgkin-lymphoma-or-cll/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/clinical-trial-lab-based-eligibility-criteria-disproportionately-excluded-non-white-patients-with-dlbcl-from-study-participation/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-adult-survivors-of-pediatric-hodgkin-lymphoma-experience-significant-epigenetic-age-acceleration-associated-with-neurocognitive-deficits/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/identifying-which-patients-receive-the-most-specialized-types-of-stem-cell-transplant-requiring-the-highest-level-of-care/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/global-study-uncovers-regional-differences-in-the-use-of-curative-transplants-for-patients-with-acute-myeloid-leukemia/</loc><lastmod>2022-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-grants-accelerated-approval-to-adagrasib-for-kras-g12c-mutated-nsclc/</loc><lastmod>2022-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/tailorx-update-12-year-recurrence-and-survival-outcomes-for-patients-with-early-stage-breast-cancer/</loc><lastmod>2022-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/three-drug-combination-therapy-may-be-effective-in-patients-with-high-risk-cll/</loc><lastmod>2022-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/new-clinical-tool-for-clonal-hematopoiesis-may-identify-patients-at-high-risk-for-hematologic-cancer/</loc><lastmod>2022-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/pilot-study-investigates-axicabtagene-ciloleucel-in-primary-and-secondary-cns-lymphoma/</loc><lastmod>2022-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/simplified-treatment-regimen-reduces-early-deaths-in-patients-with-apl/</loc><lastmod>2022-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/blinatumomab-further-improves-survival-among-patients-with-b-lineage-all-and-a-good-prognosis/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/older-or-high-risk-patients-with-newly-diagnosed-acute-myeloid-leukemia-may-respond-to-triplet-therapy/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/chemotherapy-free-regimen-of-ponatinib-and-blinatumomab-may-be-effective-for-patients-with-newly-diagnosed-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/venetoclax-with-intensive-chemotherapy-regimen-may-be-effective-in-younger-patients-with-newly-diagnosed-acute-myeloid-leukemia-high-risk-myelodysplastic-syndrome/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/zanubrutinib-found-superior-to-ibrutinib-for-cll-and-sll/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/scientists-map-genetic-evolution-of-cll-to-richter-syndrome/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/nci-director-monica-bertagnolli-announces-breast-cancer-diagnosis/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/genome-sequencing-of-circulating-tumor-cells-in-detection-of-myeloma-and-precursor-conditions/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/modakafusp-alfa-may-be-effective-at-treating-patients-with-multiple-myeloma/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/new-study-shows-travel-time-for-breast-cancer-screening-may-remain-long-for-many-patients/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/bipartisan-comprehensive-cancer-survivorship-act-introduced/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/updated-subgroup-analyses-from-the-her2climb-trial-in-previously-treated-patients-with-her2-positive-breast-cancer/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/impact-of-adjuvant-therapy-on-outcomes-in-patients-with-node-negative-disease-after-neoadjuvant-therapy-and-resection-of-pancreatic-carcinoma/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-updated-drug-labeling-for-capecitabine-tablets-under-project-renewal/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-that-patients-with-neuroendocrine-cancer-and-doctors-may-agree-on-treatment-goals-only-half-of-the-time/</loc><lastmod>2022-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/impact-of-geriatric-assessment-and-management-on-quality-of-life-and-other-outcomes-in-older-patients-with-cancer/</loc><lastmod>2022-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/brain-cancer-after-ct-scans-in-children-and-young-adults/</loc><lastmod>2022-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/til-therapy-vs-ipilimumab-in-advanced-melanoma/</loc><lastmod>2022-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/adavosertib-in-refractory-solid-tumors-with-ccne1-amplification/</loc><lastmod>2022-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-reports-activity-with-oncolytic-vaccine-plus-pembrolizumab-in-bcg-unresponsive-bladder-cancer/</loc><lastmod>2022-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-first-gene-therapy-for-the-treatment-of-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/first-line-nivolumabipilimumab-vs-extreme-regimen-in-recurrent-or-metastatic-head-and-neck-cancer/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/potential-impact-of-the-covid-19-pandemic-on-place-of-death-among-medicaid-insured-and-commercially-insured-patients-with-cancer-in-washington-state/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/t-dxd-yields-superior-outcomes-over-chemotherapy-based-regimens-in-patients-previously-treated-with-t-dm1-destiny-breast02/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/trends-in-squamous-cell-carcinoma-of-the-anus-incidence-and-mortality-in-the-united-states/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/prostate-cancer-screening-with-mri-targeted-vs-mri-targeted-and-systemic-biopsy/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/financial-burden-for-blood-or-marrow-transplantation-survivors-during-the-covid-19-pandemic/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/chemotherapy-dose-intensity-and-survival-in-older-women-with-early-stage-breast-cancer/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-pafolacianine-to-aid-lung-cancer-surgery/</loc><lastmod>2022-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/risk-model-for-predicting-the-development-of-prostate-cancer/</loc><lastmod>2022-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/interim-analysis-of-overall-survival-in-the-monarche-trial/</loc><lastmod>2022-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-foundationone-liquid-cdx-as-a-companion-diagnostic-for-a-certain-group-of-tyrosine-kinase-inhibitors/</loc><lastmod>2022-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/nivolumab-plus-cabozantinib-with-or-without-ipilimumab-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2022-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/cardiovascular-events-before-and-after-initiation-of-immune-checkpoint-inhibitor-therapy-for-cancer-agreement-between-icd-coded-and-adjudicated-events/</loc><lastmod>2022-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/quantifying-the-population-clinical-and-scientific-impact-of-nctn-research/</loc><lastmod>2022-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-finds-medicaid-expansion-may-improve-survival-outcomes-for-young-adult-patients-with-cancer/</loc><lastmod>2022-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/in-stage-iv-nsclc-anti-tigit-antibody-boosts-immunotherapy-benefit/</loc><lastmod>2022-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/risk-of-adverse-side-effects-from-cancer-immunotherapy-may-be-higher-in-patients-with-certain-inherited-genetic-variations/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/robin-zon-md-facp-fasco-elected-asco-president-for-2024-2025-term/</loc><lastmod>2022-12-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/long-term-follow-up-of-high-dose-cytarabine-and-autologous-stem-cell-transplantation-in-mantle-cell-lymphoma/</loc><lastmod>2022-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/associations-between-cdh1-germline-variants-and-hereditary-diffuse-gastric-cancer-syndrome-cancer-phenotypes/</loc><lastmod>2022-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/preexisting-autoimmune-disease-and-risk-for-cardiovascular-events-in-patients-receiving-immune-checkpoint-inhibitor-therapy-for-cancer/</loc><lastmod>2022-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/study-examines-genitourinary-cancer-trends-disparities-in-the-united-states/</loc><lastmod>2022-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/sotorasib-shows-clinically-meaningful-activity-among-patients-with-kras-g12c-mutated-advanced-pancreatic-cancer/</loc><lastmod>2022-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/forte-trial-of-carfilzomib-containing-induction-consolidation-and-maintenance-in-newly-diagnosed-multiple-myeloma-subgroup-analysis-by-cytogenetic-risk/</loc><lastmod>2022-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/fda-approves-mosunetuzumab-axgb-a-first-in-class-bispecific-antibody-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/concomitant-and-sequential-nivolumab-doxorubicin-vinblastine-and-dacarbazine-in-early-stage-unfavorable-hodgkin-lymphoma/</loc><lastmod>2022-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/cervical-cancer-incidence-and-survival-by-histologic-subtype-among-racialethnic-groups/</loc><lastmod>2022-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/12-december/phase-iii-nora-study-niraparib-maintenance-shows-favorable-overall-survival-trend-in-platinum-sensitive-recurrent-ovarian-cancer/</loc><lastmod>2022-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/new-leadership-elected-to-the-american-society-of-hematology/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/building-a-new-normal-symptom-self-management-intervention-may-benefit-cancer-survivors/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-manali-i-patel-md-mph-ms/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/chronic-myelomonocytic-leukemia-treatment-and-prognosis-part-1/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/longer-term-follow-up-from-adaura-supports-adjuvant-osimertinib-as-standard-of-care-for-egfr-mutated-stage-ib-to-iiia-nsclc/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-sanjay-popat/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/asco-publishes-rapid-guideline-update-on-parp-inhibitors-in-ovarian-cancer/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-grants-accelerated-approval-to-teclistamab-cqyv-for-resistant-myeloma/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/before-becoming-a-leader-in-multiple-myeloma-research-sarah-a-holstein-md-phd-considered-a-career-in-music/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cs-pramesh-seeks-to-bring-equity-to-india-s-sprawling-cancer-care-system/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/annual-report-to-the-nation-cancer-deaths-continue-downward-trend/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/pharmacology-researcher-james-turkson-to-become-director-for-diversity-inclusion-and-strategy-at-cedars-sinai/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/report-on-brain-cancer-crisis-in-the-childhood-and-adolescent-cancer-community/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/a-laryngectomy-altered-how-i-see-myself-in-the-world/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/breast-cancer-advocate-and-chief-of-surgical-oncology-at-howard-university-lori-wilson-dies/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/trastuzumab-deruxtecan-for-advanced-her2-low-breast-cancer/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/pallas-trial-no-benefit-reported-for-adjuvant-palbociclib-in-stage-iia-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-fabrice-andre/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/how-asco-is-helping-members-navigate-the-cancer-care-terrain-for-pregnant-patients-since-the-reversal-of-roe-v-wade/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/the-nordicc-trial-the-devil-is-in-the-details/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/short-course-of-radiotherapy-with-concurrent-radiation-boost-for-high-risk-early-stage-breast-cancer/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/first-line-maintenance-therapy-with-olaparib-improved-outcomes-in-brca-mutated-hrd-positive-advanced-ovarian-cancer/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-jonathan-ledermann/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/effect-of-invitation-to-colonoscopy-screening-on-risk-of-colorectal-cancer-and-risk-of-mortality-the-nordicc-trial/</loc><lastmod>2022-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/increased-mortality-from-comorbid-cancer-and-cardiovascular-disease-associated-with-increased-social-vulnerability/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-approves-selpercatinib-for-locally-advanced-or-metastatic-ret-fusion-positive-nsclc/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/national-lung-screening-trial-results-highlight-importance-of-lifelong-follow-up/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-grants-accelerated-approval-to-futibatinib-for-previously-treated-patients-with-fgfr2-mutated-cholangiocarcinoma/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/international-career-joins-cancer-research-and-clinical-care-of-patients-with-lung-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-approves-pemigatinib-for-patients-with-myeloidlymphoid-neoplasms-and-fgfr1-rearrangement/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/transforming-our-thinking-about-second-line-therapy-for-high-risk-large-b-cell-lymphoma-bring-in-the-cars/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/newly-diagnosed-aml-induction-to-maintenance/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/how-to-advance-antiracist-approaches-to-patient-engagement-in-aya-oncology-and-research/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/study-finds-nearly-half-of-black-women-with-metastatic-breast-cancer-never-receive-information-about-clinical-trial-participation/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/sotorasib-a-new-standard-of-care-for-second-or-third-line-treatment-of-kras-g12c-mutated-nsclc/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-natasha-leighl/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/integrative-approaches-to-managing-pain-in-patients-with-cancer-sio-asco-guideline/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/new-directions-for-cancer-care-major-trends-in-us-health-policy/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/pediatric-surgeon-henri-r-ford-md-chosen-new-president-elect-of-american-college-of-surgeons/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/high-dose-chemotherapy-and-stem-cell-transplant-vs-car-t-cell-therapy-for-resistant-dlbcl/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/lutetium-lu-177-vipivotide-tetraxetan-for-psma-positive-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/with-newer-therapies-aml-diagnosis-and-prognosis-evolve/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/nci-honors-augusto-ochoa-md-for-contributions-to-community-based-cancer-clinical-trials/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/the-evolving-role-of-pi3k-inhibitors-in-double-refractory-cll/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/global-effort-to-eliminate-cervical-cancer-hpv-vaccinations-are-steadily-increasing-in-the-united-states-but-barriers-still-exist/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/echelon-1-shows-benefit-for-first-line-brentuximab-vedotin-plus-avd-in-advanced-hodgkin-lymphoma/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/hpv-vaccine-works-astonishingly-well/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/multilayered-approach-to-financial-toxicity-solutions-for-patients-with-cancer-and-their-families/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/i-ve-had-two-primary-lung-cancers-and-they-haven-t-defeated-me/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/erica-huelsmann-md-wins-a-conquer-cancer-annual-meeting-merit-award/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/overall-survival-in-two-monarch-trials-of-abemaciclib-in-advanced-breast-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-anand-devaraj-1/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-meritxell-bellet-ezquerra-and/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/uchicago-medicine-names-new-associate-director-of-cancer-prevention-and-population-sciences/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/prolonging-remission-in-anti-pd-1-refractory-melanoma-with-tumor-infiltrating-lymphocyte-therapy/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-ignacio-melero/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/lisocabtagene-maraleucel-improves-event-free-survival-in-second-line-treatment-of-relapsed-or-refractory-lbcl/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/asco-treatment-guidance-for-metastatic-castration-resistant-prostate-cancer-updated-to-include-lupsma/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/poseidon-follow-up-suggests-chemoimmunotherapy-triplet-extends-survival-in-difficult-to-treat-nsclc-mutational-subtypes/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/study-sheds-light-on-need-for-optimal-dosing-standards-for-patients-with-metastatic-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/tropics-02-efficacy-of-sacituzumab-govitecan-within-her2-negative-subsets-of-breast-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/asco-releases-updated-resource-stratified-guideline-for-the-secondary-prevention-of-cervical-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-shom-goel/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/phase-iii-fresco-2-trial-of-fruquintinib-meets-primary-endpoint-in-metastatic-colorectal-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/swog-names-don-s-dizon-md-vice-chair-for-diversity-equity-inclusion-and-professional-integrity/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/eytan-stein-appointed-chief-of-the-leukemia-service-at-msk/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/yuan-yuan-joins-cedars-sinai-cancer-medical-center-as-director-of-breast-oncology/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/keynote-412-pembrolizumab-plus-chemoradiation-falls-short-in-locally-advanced-head-and-neck-cancer/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-glenn-hanna-and-sherene-loi/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/lenvatinib-plus-pembrolizumab-in-hepatocellular-carcinoma-leap-002-fails-to-meet-co-primary-endpoints/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-robin-kate-kelley/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/my-white-coat-doesn-t-fit/</loc><lastmod>2022-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-glenn-j-hanna-and-sherene-loi/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/pembrolizumab-plus-chemoradiation-therapy-falls-short-in-locally-advanced-head-and-neck-cancer/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-alexander-eggermont-omid-hamid-james-larkin/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/swog-s1801-addition-of-neoadjuvant-pembrolizumab-to-adjuvant-pembrolizumab-yields-benefits-in-high-risk-resectable-melanoma/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-robin-kate-kelley-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/lenvatinib-plus-pembrolizumab-in-hepatocellular-carcinoma-leap-002-fails-to-meet-co-primary-endpoints-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-bernard-escudier-and-brian-i-rini/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/negative-phase-iii-trials-may-dampen-enthusiasm-for-immunotherapy-in-the-adjuvant-setting-in-kidney-cancer/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-sumanta-k-pal/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-mary-o-brien/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/poseidon-follow-up-suggests-chemoimmunotherapy-triplet-extends-survival-in-difficult-to-treat-nsclc-mutational-subtypes-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-natasha-leighl-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/platinum-ineligible-patients-with-nsclc-may-gain-survival-benefit-from-atezolizumab-therapy/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-natasha-leighl-2/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/sotorasib-a-new-standard-of-care-for-second-or-third-line-treatment-of-kras-g12c-mutated-nsclc-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/epov-sanjay-popat-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/longer-term-follow-up-from-adaura-supports-adjuvant-osimertinib-as-standard-of-care-for-egfr-mutated-stage-ib-to-iiia-nsclc-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/highlights-from-the-esmo-congress-2022/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/chemotherapy-outcomes-in-noninfant-childhood-all-with-11q23kmt2a-rearrangements/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/andrea-and-brady-mckee-honored-with-the-james-mulshine-national-leadership-award/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/genomic-microsatellite-signature-assay-to-identify-germline-mmrd-in-patients-with-cmmrd/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/addition-of-capecitabine-to-temozolomide-in-advanced-pancreatic-neuroendocrine-tumors/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/psa-screening-rates-and-incidence-of-metastatic-prostate-cancer-at-vha-facilities/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/researchers-discover-differences-in-response-to-pembrolizumab-among-patients-with-endometrial-cancer/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/novel-research-suggests-new-way-to-target-mantle-cell-lymphoma-using-foxo1-inhibitors/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/novel-delfi-ai-blood-test-may-aid-in-detecting-hepatocellular-carcinoma/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/avelumab-plus-talazoparib-in-patients-with-brca12-or-atm-altered-advanced-solid-tumors/</loc><lastmod>2022-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/t-dxd-in-pretreated-patients-with-her2-low-advanced-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2022-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/potential-factors-in-oxaliplatin-induced-peripheral-neuropathy-in-patients-with-stage-iii-colon-cancer/</loc><lastmod>2022-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/novel-bispecific-antibody-zanidatamab-in-advanced-her2-expressing-or-her2-amplified-cancers/</loc><lastmod>2022-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/medicare-advantage-vs-traditional-medicare-for-elective-inpatient-cancer-surgery-access-postoperative-outcomes-and-estimated-cost/</loc><lastmod>2022-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/ethnic-diversity-and-disparities-in-access-to-genetic-testing-may-impact-prostate-cancer-development-and-treatment-research-shows/</loc><lastmod>2022-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/intraoperative-ultrasound-vs-wire-localization-in-surgery-for-ductal-carcinoma-in-situ/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/presence-of-tumor-infiltrating-lymphocytes-following-neoadjuvant-treatment-may-contribute-to-worse-survival-in-patients-with-her2-positive-breast-cancer/</loc><lastmod>2022-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/patients-who-are-hiv-positive-and-have-cancer-may-have-accelerated-epigenetic-aging/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/high-sugar-consumption-may-be-linked-to-increased-risk-of-premature-aging-in-pediatric-cancer-survivors/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/study-examines-coping-strategies-used-by-caregivers-of-patients-undergoing-stem-cell-transplants/</loc><lastmod>2022-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/zanubrutinib-vs-ibrutinib-in-relapsed-or-refractory-cll/</loc><lastmod>2022-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/personalized-breast-cancer-screening-model-may-improve-outcomes-and-reduce-overdiagnosis/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/more-cancers-are-diagnosed-at-an-advanced-stage-if-patients-already-have-type-2-diabetes/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/alnd-vs-axillary-radiotherapy-in-sentinel-node-positive-breast-cancer/</loc><lastmod>2022-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/5-year-survival-and-cure-fraction-estimates-for-childhood-cancer-in-europe-from-2000-to-2014-eurocare-6/</loc><lastmod>2022-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/5-year-outcomes-with-stereotactic-ablative-body-radiotherapy-for-primary-renal-cell-carcinoma/</loc><lastmod>2022-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/effect-of-geriatric-assessment-intervention-on-patient-reported-symptomatic-toxicity-in-patients-aged-70-and-older-receiving-treatment-for-advanced-cancer/</loc><lastmod>2022-11-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/management-of-severe-immune-related-adverse-events-with-ipilimumabnivolumab-and-survival-in-advanced-melanoma/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cost-effectiveness-of-cog-breast-cancer-screening-guidelines-for-hodgkin-lymphoma-survivors-who-received-chest-irradiation/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/new-phase-iii-data-on-the-cd40-antibody-sotigalimab-in-combination-with-pembrolizumab-in-patients-with-metastatic-melanoma/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/early-discontinuation-of-full-treatment-regimen-or-oxaliplatin-alone-in-patients-receiving-adjuvant-oxaliplatinfluoropyrimidine-therapy-for-stage-iii-colon-cancer/</loc><lastmod>2022-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/trametinib-with-or-without-dabrafenib-in-pediatric-braf-v600-mutant-low-grade-glioma/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/uicc-outlines-antimicrobial-resistance-in-cancer-treatment/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/hormone-therapy-may-lower-risk-of-immune-checkpoint-inhibitor-associated-myocarditis-in-female-patients/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/potential-treatment-options-for-patients-with-relapsed-multiple-myeloma-following-car-t-cell-therapy/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/immune-checkpoint-inhibitors-for-patients-living-with-hiv-safe-and-effective-in-metastatic-nsclc/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/first-line-pembrolizumab-vs-chemotherapy-in-advanced-pd-l1-positive-nsclc-without-egfralk-alterations/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/rare-germline-atm-variants-in-chronic-lymphocytic-leukemia/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/prevalence-of-mismatch-repair-deficiency-in-rectal-adenocarcinoma-in-a-prospective-screening-program/</loc><lastmod>2022-11-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/long-term-quality-of-life-and-cognition-outcomes-in-patients-receiving-srs-vs-wbrt-for-resected-brain-metastasis/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/addition-of-enzalutamide-to-salvage-radiotherapy-in-patients-with-biochemically-recurrent-prostate-cancer-after-radical-prostatectomy/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-approves-brentuximab-vedotin-in-combination-with-chemotherapy-for-pediatric-patients-with-classical-hodgkin-lymphoma/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-approves-tremelimumab-in-combination-with-durvalumab-and-platinum-based-chemotherapy-for-metastatic-nsclc/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/comparison-of-two-chemotherapy-regimens-for-newly-diagnosed-ewing-sarcoma/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cns-directed-therapy-and-neurocognitive-outcomes-in-survivors-of-childhood-all-receiving-no-cranial-irradiation/</loc><lastmod>2022-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fda-approves-new-dosing-regimen-for-asparaginase-erwinia-chrysanthemi-recombinant-rywn/</loc><lastmod>2022-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cost-effectiveness-of-polatuzumab-vedotin-piiq-plus-r-chp-and-car-t-cell-therapy-vs-standard-of-care-in-dlbcl/</loc><lastmod>2022-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/effect-of-baseline-immunosuppression-on-covid-19-severity-and-risk-of-cytokine-storm-in-patients-receiving-immunotherapy-for-cancer/</loc><lastmod>2022-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/intraindividual-comparison-of-f-18-naf-pet-ct-vs-tc-99m-mdp-spect-in-detecting-bone-metastasis-in-high-risk-prostate-and-breast-cancers/</loc><lastmod>2022-11-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/gradual-increase-in-daily-activity-with-psychological-therapies-may-improve-mental-and-physical-health-for-patients-and-survivors-of-breast-cancer/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/researchers-find-changes-in-blood-proteins-up-to-2-years-before-breast-cancer-diagnosis/</loc><lastmod>2022-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/evaluation-of-plasmid-dna-vaccine-encoding-her2-intracellular-domain-in-patients-with-advanced-her2-positive-breast-cancer/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/presence-of-small-subclonal-populations-of-high-risk-genetic-events-at-diagnosis-in-multiple-myeloma/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/car-t-cell-therapy-outcomes-similar-across-different-socioeconomic-levels-among-patients-with-pediatric-all/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/study-examines-potential-factors-leading-to-recurrence-of-cancers-caused-by-brca-mutations/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/comparison-of-bevacizumab-durations-in-front-line-therapy-for-advanced-ovarian-cancer/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/coadministration-of-cd19-cd22-directed-car-t-cell-therapy-in-pediatric-b-cell-all/</loc><lastmod>2022-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/moderate-exercise-may-help-reduce-inflammation-increase-survival-in-patients-with-colorectal-cancer-by-improving-gut-microbiota/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/teclistamab-cqyv-in-the-treatment-of-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cemiplimab-rwlc-in-combination-with-platinum-based-chemotherapy-in-advanced-nsclc-with-no-egfr-alk-or-ros1-aberrations/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/margetuximab-cmkb-vs-trastuzumab-with-chemotherapy-in-previously-treated-advanced-her2-positive-breast-cancer/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/dabrafenib-in-combination-with-trametinib-for-unresectable-or-metastatic-solid-tumors-with-braf-v600e-mutation/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/poseidon-trial-first-line-durvalumab-with-or-without-tremelimumab-plus-chemotherapy-in-metastatic-nsclc/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/2022-state-of-lung-cancer-report-critically-low-lung-cancer-screening-rates-reveal-opportunity-to-save-more-lives/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/selpercatinib-approved-for-advanced-ret-fusion-positive-solid-tumors-and-advanced-ret-fusion-positive-nsclc/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/sodium-thiosulfate-to-reduce-the-risk-of-cisplatin-related-ototoxicity-in-pediatric-patients-with-localized-solid-tumors/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/futibatinib-for-cholangiocarcinoma-with-fgfr2-gene-fusion-or-other-rearrangements/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/prophylactic-bilateral-mastectomy-among-women-with-breast-cancer-and-pathogenic-variants-in-high-penetrance-and-moderate-penetrance-genes/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/study-shows-that-immune-cells-may-help-identify-patients-with-high-risk-smoldering-myeloma-most-likely-to-benefit-from-treatment/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/proposed-threshold-for-circulating-tumor-plasma-cells-to-define-plasma-cell-leukemia-like-multiple-myeloma/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/fracture-risk-among-older-cancer-survivors/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/addition-of-fluorouracil-to-adjuvant-chemotherapy-and-comparison-of-standard-vs-dose-dense-treatment-in-node-positive-early-breast-cancer/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/prevalence-of-tumor-thrombus-at-rcc-diagnosis-and-risk-of-venous-thromboembolism/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/durvalumab-plus-chemotherapy-in-advanced-biliary-tract-cancer/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/used-as-a-biomarker-microrna-may-help-predict-which-patients-with-breast-cancer-are-more-likely-to-have-cancer-recurrence/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/phase-i-trial-shows-experimental-mini-protein-may-be-able-to-inhibit-the-cancer-driving-myc-gene/</loc><lastmod>2022-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/nci-match-trial-ipatasertib-shows-signs-of-effectiveness-in-patients-with-akt1-e17k-mutant-solid-tumors/</loc><lastmod>2022-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cancer-clinical-trial-participation-among-medicare-fee-for-service-beneficiaries-with-cancer/</loc><lastmod>2022-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/researchers-identify-subset-of-patients-with-stage-i-melanoma-who-have-low-risk-of-melanoma-mortality/</loc><lastmod>2022-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/nationwide-study-finds-higher-rates-of-cancer-mortality-increasing-cases-of-early-onset-colorectal-cancer-among-american-indian-and-alaska-native-individuals/</loc><lastmod>2022-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/new-research-highlights-disparities-in-receipt-of-guideline-concordant-treatment-among-patients-with-ovarian-cancer/</loc><lastmod>2022-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/preliminary-results-from-arros-1-phase-i-clinical-trial-suggest-that-nvl-520-may-be-well-tolerated-and-active-in-nsclc/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/repotrectinib-for-ros1-positive-nsclc-examined-in-phase-i-and-ii-trident-1-trial/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/avoidance-of-surgery-in-patients-with-invasive-breast-cancer-and-exceptional-response-to-neoadjuvant-systemic-therapy/</loc><lastmod>2022-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/pet-adapted-therapy-for-bulky-stage-iii-classical-hodgkin-lymphoma/</loc><lastmod>2022-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/sequencing-of-short-duration-adt-with-radiotherapy-in-nonmetastatic-prostate-cancer/</loc><lastmod>2022-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/indian-trial-explores-addition-of-low-dose-nivolumab-to-chemotherapy-in-advanced-head-and-neck-cancer/</loc><lastmod>2022-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/sequential-dosing-of-olaparib-and-adavosertib-in-patients-with-advanced-tumors/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/cell-free-dna-profiling-in-patients-with-advanced-cancers-may-lead-to-early-detection-of-myeloid-malignancies/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/concurrent-olaparib-and-radiotherapy-for-triple-negative-breast-cancer/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/mosaic-chromosomal-alterations-and-risk-of-lung-cancer/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/small-study-of-experimental-drug-to-treat-liver-cancer-shows-evidence-of-activity-with-manageable-side-effects/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/some-head-and-neck-cancer-survivors-may-be-at-greater-risk-for-long-term-gastrostomy-tube-use/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/shorter-course-of-hypofractionated-radiation-therapy-yields-comparable-results-to-conventional-radiotherapy-for-patients-with-nonmetastatic-soft-tissue-sarcoma/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/biomarker-assessment-for-benefit-of-lupsma-vs-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/telisotuzumab-vedotin-plus-erlotinib-in-c-met-protein-expressing-nsclc/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/keynote-716-distant-metastasis-free-survival-with-adjuvant-pembrolizumab-in-resected-stage-iib-or-iic-melanoma/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/researchers-identify-specific-mutations-in-the-braf-gene-that-may-affect-response-to-treatment-and-survival-in-adult-brain-cancers/</loc><lastmod>2022-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/the-nordicc-trial-the-devil-is-in-the-details-1/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/focal-adhesion-kinase-inhibitor-in-patients-with-meningioma-and-somatic-nf2-mutations/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/managing-primary-prophylactic-colony-stimulating-factor-use-in-patients-receiving-regimens-associated-with-intermediate-risk-for-febrile-neutropenia/</loc><lastmod>2022-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/effect-of-smartphone-psychotherapy-apps-on-fear-of-recurrence-among-young-breast-cancer-survivors/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/association-of-flt3-itd-mrd-with-outcomes-in-newly-diagnosed-acute-myeloid-leukemia/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/11-november/addition-of-brentuximab-vedotin-to-chemotherapy-in-pediatric-high-risk-hodgkin-lymphoma/</loc><lastmod>2022-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/unprecedented-waterfall-plot-achieved-with-neoadjuvant-immunotherapy-in-dmmr-colon-cancer/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-james-larkin-and-andrea-cercek/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/duration-of-androgen-deprivation-therapy-with-radiotherapy-after-radical-prostatectomy/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/fda-approves-sodium-thiosulfate-to-reduce-the-risk-of-ototoxicity-associated-with-cisplatin/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/platinum-ineligible-patients-with-nsclc-may-gain-survival-benefit-from-atezolizumab-therapy/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-natasha-leighl/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/why-are-young-adult-women-developing-later-stage-more-aggressive-breast-cancer-than-older-women/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/a-call-for-creativity-the-shades-of-gray-in-delivery-of-goal-concordant-care/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/negative-phase-iii-trials-may-dampen-enthusiasm-for-immunotherapy-in-the-adjuvant-setting-in-kidney-cancer/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-bernard-escudier-and-brian-i-rini/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/incarceration-may-be-associated-with-higher-cancer-mortality-yale-study-shows/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/richter-transformation-remains-challenging-but-better-treatments-are-on-the-horizon/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/for-william-l-dahut-md-a-career-of-service-in-oncology/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/sio-asco-guideline-proposes-evidence-based-approaches-to-pain-management-incorporating-integrative-medicine-interventions/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/future-leaders-selected-to-advance-gender-equality-through-the-leadership-programme-for-women-in-oncology/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/asco-applauds-president-biden-s-leadership-in-relaunching-the-cancer-moonshot/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-sumanta-k-pal/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/elacestrant-improves-progression-free-survival-vs-standard-endocrine-therapy-in-previously-treated-estrogen-receptor-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/novel-selective-estrogen-receptor-degraders-in-advanced-breast-cancer-use-of-elacestrant-in-the-phase-iii-emerald-trial/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/providing-a-tailored-approach-to-prostate-cancer-care-for-gay-and-bisexual-men/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/yes-oklahoma-project-created-to-improve-representation-of-native-americans-in-cancer-research/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/clinical-and-translational-researcher-rossana-berardi-works-to-overcome-the-gender-gap-in-oncology-in-italy/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/a-urologic-surgeon-shares-his-insights-on-robotic-radical-prostatectomy/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/incidence-and-cancer-related-mortality-in-austria/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/leader-in-genitourinary-oncology-nicholas-vogelzang-dies-at-72/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/cosmic-313-triplet-therapy-is-active-in-renal-cell-carcinoma-but-toxicities-pose-a-challenge/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/novel-gamma-secretase-inhibitor-halts-progression-of-desmoid-tumors/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-jean-yves-blay/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/real-world-experience-with-durvalumab-at-the-mayo-clinic-mirrors-pacific-findings/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/high-intensity-intervention-helps-one-third-of-participants-in-lung-cancer-screening-program-quit-smoking/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-jacek-jassem/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/selpercatinib-approved-for-locally-advanced-or-metastatic-ret-fusion-positive-solid-tumors/</loc><lastmod>2022-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-mafalda-oliveira/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/monaleesa-3-ribociclib-plus-fulvestrant-improves-overall-survival-over-fulvestrant-alone-in-the-first-line-setting/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-debu-tripathy/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/tropics-02-sacituzumab-govitecan-effective-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/breast-cancer-2021-2022-almanac/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/t-dxd-improves-progression-free-survival-vs-t-dm1-in-metastatic-her2-positive-breast-cancer/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-mafalda-oliveira-2/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/t-dxd-shows-efficacy-against-active-brain-metastases-in-her2-positive-breast-cancer/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-patricia-lorusso/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/destiny-breast04-trial-t-dxd-significantly-improves-survival-in-patients-with-her2-low-metastatic-breast-cancer/</loc><lastmod>2022-10-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-debu-tripathy-and-hope-rugo/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/datopotamab-deruxtecan-shows-activity-in-advanced-triple-negative-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/addition-of-pembrolizumab-to-chemotherapy-improves-event-free-survival-in-triple-negative-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-mafalda-oliveira-1/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/begonia-trial-reports-activity-with-datopotamab-deruxtecan-plus-durvalumab-in-triple-negative-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-amy-tiersten-and-carlos-l-arteaga/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/pada-1-trial-with-early-identification-of-esr1-mutation-switch-to-fulvestrant-in-metastatic-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-angela-demichele/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/dual-checkpoint-inhibitor-therapy-elicits-responses-in-highly-mutated-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-mark-robson/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/olympia-trial-adjuvant-olaparib-significantly-improves-overall-survival-in-germline-brca-mutated-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/recent-fda-approvals-in-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/enfortumab-vedotin-plus-pembrolizumab-in-cisplatin-ineligible-patients-with-advanced-urothelial-cancer/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-james-larkin-and-andrea-cercek-1/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/unprecedented-waterfall-plot-achieved-with-neoadjuvant-immunotherapy-in-dmmr-colon-cancer-1/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/duration-of-androgen-deprivation-therapy-with-radiotherapy-after-radical-prostatectomy-1/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/sublobar-resection-for-small-early-stage-nsclc-establishing-a-new-standard-of-care/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-hisashi-saji/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/cristina-r-ferrone-md-named-chair-of-cedars-sinai-department-of-surgery/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/reshma-jagsi-md-dphil-fasco-named-new-chair-of-emory-radiation-oncology/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/shaji-k-kumar-md-named-editor-in-chief-of-the-hematologist/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/scott-m-welford-phd-named-sylvester-s-tumor-biology-research-program-co-leader/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/massey-cancer-center-and-vcu-health-appoint-paula-m-fracasso-md-phd-facp-to-leadership-roles/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/stephen-a-strickland-jr-md-msci-joins-the-sarah-cannon-transplant-cellular-therapy-network/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/update-on-the-impact-of-the-russian-invasion-of-ukraine-on-patients-with-cancer/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/darolutamide-combined-with-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/the-development-of-geriatric-oncology-in-france-an-outside-view/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/the-development-of-geriatric-oncology-in-france-timeline/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/living-with-metastatic-breast-cancer/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/saul-a-rosenberg-md-fasco-a-pioneer-in-the-field-of-lymphoma-dies-at-95/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/swog-s1801-addition-of-neoadjuvant-pembrolizumab-to-adjuvant-pembrolizumab-yields-benefits-in-high-risk-resectable-melanoma/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-alexander-eggermont-omid-hamid-james-larkin/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/cancer-and-fertility-preservation-will-new-laws-leave-patients-without-options/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/what-is-the-best-induction-regimen-for-newly-diagnosed-pcnsl/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/mechanism-linking-air-pollution-to-lung-cancer-identified/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-suzette-delaloge/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/5-year-follow-up-supports-survival-benefit-of-pembrolizumab-plus-chemotherapy-in-squamous-and-nonsquamous-nsclc/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-mary-obrien/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/tropics-02-sacituzumab-govitecan-improves-overall-survival-in-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-meritxell-bellet-ezquerra/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/first-line-maintenance-with-olaparib-improved-overall-survival-in-subsets-of-patients-with-advanced-ovarian-cancer-in-two-phase-iii-trials/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-jonathan-ledermann/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/vanderbilt-university-medical-center-selects-new-director-of-the-division-of-infectious-diseases/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/managing-lymphomas-in-the-future-some-bright-spots-are-emerging/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/ibrutinib-for-pediatric-patients-with-chronic-graft-vs-host-disease/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/asco-and-the-african-organisation-for-research-and-training-in-cancer-announce-innovative-collaboration-to-advance-cancer-research-in-africa/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/cancer-care-and-reproductive-health-resources-for-the-oncology-community/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/asco-treatment-guidelines-for-her2-negative-metastatic-breast-cancer-updated-to-reflect-new-trastuzumab-deruxtecan-data/</loc><lastmod>2022-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/cosmic-313-triplet-therapy-is-active-in-renal-cell-carcinoma-but-toxicities-pose-a-challenge-1/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/cosmic-313-triplet-therapy-is-active-in-renal-cell-carcinoma-but-toxicities-pose-a-challenge-2/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/iaslc-names-co-chairs-of-the-2023-world-conference-on-lung-cancer/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/real-world-experience-with-durvalumab-at-the-mayo-clinic-mirrors-pacific-trial-findings/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/real-world-evidence-confirms-survival-benefit-of-durvalumab-in-locally-advanced-non-small-cell-lung-cancer/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-jacek-jassem-1/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-benjamin-besse/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-finds-high-intensity-intervention-helped-one-third-of-participants-in-lung-cancer-screening-program-to-quit-smoking/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/impower010-early-survival-data-favor-atezolizumab-over-best-supportive-care-in-resected-nsclc-with-pd-l1-expression-50/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/highlights-from-the-iaslc-2022-world-conference-on-lung-cancer/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-anand-devaraj-1/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/national-lung-screening-trial-results-highlight-importance-of-lifelong-follow-up/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-anand-devaraj/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/nelson-vs-nlst-nodule-management-based-on-volumetry-shows-increased-benefits/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/dart-trial-concurrent-radiotherapy-plus-durvalumab-active-in-older-patients-with-locally-advanced-lung-cancer/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-corinne-faivre-finn-and-masahiro-tsuboi/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/nadim-ii-trial-neoadjuvant-chemoimmunotherapy-improved-survival-in-resectable-stage-iiia-nsclc/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-chia-puey-ling/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/exploratory-analysis-of-poseidon-chemoimmunotherapy-regimen-may-offer-survival-benefit-in-subgroups-of-patients-with-metastatic-nsclc/</loc><lastmod>2022-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/novel-gamma-secretase-inhibitor-halts-progression-of-desmoid-tumors-1/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/epov-jean-yves-blay-1/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/extended-interval-vs-standard-interval-dosing-of-single-agent-pembrolizumab/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/risks-associated-with-sinoatrial-node-radiation-dose-in-patients-with-lung-cancer-receiving-definitive-chemoradiotherapy/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/selpercatinib-in-ret-fusion-positive-advanced-nsclc/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/researchers-identify-potential-biomarker-to-distinguish-group-3-and-group-4-medulloblastomas/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-focuses-on-molecular-details-of-precancerous-clonal-outgrowth-in-blood-cells/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/active-surveillance-for-low-risk-papillary-thyroid-carcinoma/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/oncologist-use-of-reduced-doses-of-new-systemic-treatments-in-patients-with-metastatic-cancer/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/minimally-invasive-vs-open-nephrectomy-for-kidney-cancer-1-year-health-care-expenditure-and-utilization/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/gprc5d-targeted-car-t-cell-therapy-in-heavily-pretreated-patients-with-multiple-myeloma/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/research-examines-a-new-tool-for-discovering-cancer-driving-structural-variations/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-investigates-potential-embryonic-origin-of-medulloblastomas/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/single-vs-multiple-doses-of-prophylactic-iv-antibiotics-to-prevent-surgical-site-infection-in-implant-based-breast-reconstruction/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/symptom-clusters-in-adult-survivors-of-childhood-cancer/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/adjuvant-nivolumabipilimumab-vs-nivolumab-in-resected-stage-iiib-d-or-iv-melanoma/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/is-mortgage-discrimination-adversely-associated-with-receipt-of-guideline-concordant-nsclc-care/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/transportation-barriers-among-cancer-survivors-effect-on-er-use-and-mortality/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/new-study-highlights-sexual-problems-among-young-women-who-have-had-cancer/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/addition-of-pd-1-inhibitor-serplulimab-to-chemotherapy-in-the-first-line-treatment-of-extensive-stage-sclc/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/chemotherapy-for-children-with-type-ii-or-iii-pleuropulmonary-blastoma/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/toxicity-outcomes-with-stereotactic-ablative-radiotherapy-for-patients-with-up-to-five-oligometastases/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/association-of-social-vulnerability-with-mortality-from-comorbid-cancer-and-cardiovascular-disease/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/historical-housing-discrimination-may-adversely-affect-contemporary-colon-cancer-care-and-outcomes/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/medicaid-expansion-and-palliative-care-use-among-patients-newly-diagnosed-with-advanced-cancer/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/health-related-quality-of-life-for-survivors-of-metastatic-prostate-cancer/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/c-reactive-protein-level-and-cognitive-function-in-breast-cancer-survivors-aged-60-and-older/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/treatments-and-outcomes-for-locally-advanced-rectal-cancer-in-patients-aged-80-and-older/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/impact-of-cdc-opioid-prescribing-guideline-on-prescriptions-and-potential-misusesubstance-use-disorder-among-childhood-cancer-survivors/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/nivolumabipilimumab-vs-dabrafenibtrametinib-with-switch-at-disease-progression-for-metastatic-braf-mutant-melanoma/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/financial-hardship-and-risk-factors-in-patients-with-cancer-receiving-routine-clinical-care/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/oncologist-participation-in-medicare-ocm-and-patient-receipt-of-novel-therapies/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/eligibility-for-lung-cancer-screening-among-women-with-a-smoking-history-undergoing-breast-cancer-screening/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/letrozoleabemaciclib-for-estrogen-receptor-positive-recurrent-endometrial-cancer/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-analyzes-postimaging-diagnoses-of-pancreatic-cancer/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/mediterranean-diet-may-improve-immunotherapy-response-rates-and-progression-free-survival-in-advanced-melanoma/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/effect-of-social-factors-on-cancer-screening-rates-across-us-counties/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/risk-of-meningioma-in-childhood-cancer-survivors/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/neoadjuvant-intensity-modulated-radiotherapy-in-centrally-located-hepatocellular-carcinoma/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/polycystic-ovary-syndrome-and-risk-of-pancreatic-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/decrease-in-breast-cancer-mortality-rate-continues-but-gap-persists-for-black-women-from-american-cancer-society-report/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-finds-cost-of-cancer-care-may-impact-health-of-low-income-survivors/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/real-world-cost-of-care-for-pediatric-all-among-commercially-insured-patients/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/asco-launches-webinar-series-to-close-the-global-divide-between-survivorship-and-palliative-care-in-breast-cancer/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/financial-hardship-among-adult-survivors-of-childhood-cancer-after-implementation-of-the-affordable-care-act/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/prevalence-of-and-risks-for-thoracic-soft-tissue-sarcomas-in-breast-cancer-survivors/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/first-line-nivolumab-ipilimumab-vs-chemotherapy-in-metastatic-nsclc-without-egfr-or-alk-alterations/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/researchers-find-possible-link-between-immune-cells-closest-neighbors-and-survival-time-in-patients-with-pancreatic-cancer/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-identifies-how-cancer-causing-gene-might-regulate-genetic-variation-in-prostate-cancer/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/pembrolizumab-with-or-without-chemotherapy-vs-cetuximabchemotherapy-in-recurrent-or-metastatic-head-and-neck-cancer/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/single-dose-carboplatin-plus-involved-node-radiotherapy-in-stage-iiaiib-seminoma/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/timely-surveillance-with-chest-imaging-may-benefit-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/study-examines-efficacy-cost-of-fit-vs-multitarget-stool-dna-testing-for-colorectal-cancer-screening/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/no-benefit-for-adjuvant-palbociclib-in-stage-iia-breast-cancer-analysis-from-the-pallas-trial/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/silicone-based-polyurethane-film-may-reduce-acute-radiation-dermatitis-in-patients-with-breast-cancer/</loc><lastmod>2022-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/responses-to-irinotecan-temozolomide-dinutuximab-and-gm-csf-regimen-in-patients-with-relapsed-high-risk-neuroblastoma/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/intensive-chemoresection-with-mitomycin-to-reduce-need-for-surgical-procedures-in-patients-with-recurrent-non-muscle-invasive-bladder-cancer/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/maternal-deaths-from-cancer-worldwide-have-led-to-approximately-1-million-new-maternal-orphans/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/use-of-remote-interventions-increased-adherence-to-cancer-screenings-among-women-in-rural-areas/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/acs-can-survey-female-patients-with-cancer-report-less-satisfaction-more-challenges-with-cancer-care/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/hair-straightening-chemicals-may-be-associated-with-higher-uterine-cancer-risk/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/effect-of-goals-of-care-program-for-inpatients-at-a-comprehensive-cancer-center-during-the-covid-19-pandemic/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/incidence-of-cutaneous-adverse-events-with-adjuvant-pi3k-inhibitor-therapy/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/incidence-of-neurologic-side-effects-from-car-t-cell-therapy-is-higher-in-patients-with-hypophosphatemia-study-finds/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/exercise-may-improve-cardiorespiratory-fitness-during-and-after-chemotherapy/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/multicenter-study-sheds-light-on-features-of-invasive-lobular-carcinoma/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/can-patients-with-cancer-treated-with-immunotherapy-safely-receive-mrna-covid-19-vaccines/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/nci-honors-augusto-ochoa-for-his-contributions-to-community-based-cancer-clinical-trials/</loc><lastmod>2022-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/ai-model-using-daily-step-counts-may-help-predict-unplanned-hospitalizations-during-cancer-therapy/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/adding-sbrt-to-sorafenib-may-improve-survival-and-time-to-disease-progression-in-patients-with-advanced-hcc/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/small-first-in-human-trial-investigates-flash-proton-radiotherapy-for-patients-with-bone-metastases/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/pcs5-trial-long-term-outcomes-of-moderately-shortened-radiation-course-for-high-risk-prostate-cancer/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/prophylactic-radiation-for-asymptomatic-bone-metastases-may-reduce-pain-and-extend-survival/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/fda-approves-tremelimumab-plus-durvalumab-for-adult-patients-with-unresectable-hcc/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/computer-platform-may-help-match-patients-with-cancer-to-targeted-therapy-trials/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/long-term-outcomes-with-minimal-access-vs-conventional-breast-surgery-in-stage-0-to-iii-breast-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/researchers-discover-predictive-biomarker-of-response-to-therapy-in-patients-with-microsatellite-stable-metastatic-colorectal-cancer/</loc><lastmod>2022-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/fda-approves-teclistamab-cqyv-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/medical-physicist-consults-may-help-reduce-patient-anxiety-and-increase-satisfaction-with-radiation-care/</loc><lastmod>2022-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/sexual-side-effects-of-cancer-treatment-often-unaddressed-with-female-patients/</loc><lastmod>2022-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/response-adapted-ultra-low-dose-radiation-achieves-complete-response-in-majority-of-patients-with-orbital-indolent-b-cell-lymphomas/</loc><lastmod>2022-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/metastasis-directed-radiation-therapy-plus-hormone-therapy-may-improve-progression-free-survival-in-patients-with-advanced-prostate-cancer/</loc><lastmod>2022-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/3-week-course-of-radiotherapy-with-concurrent-radiation-boost-found-to-be-safe-and-effective-for-patients-with-early-stage-breast-cancer-and-elevated-risk-of-recurrence/</loc><lastmod>2022-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/aacr-and-asco-release-joint-policy-statement-on-electronic-nicotine-delivery-systems/</loc><lastmod>2022-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/small-study-examines-repeated-convection-enhanced-delivery-of-topotecan-for-recurrent-glioblastoma/</loc><lastmod>2022-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/have-changes-in-cancer-therapy-over-time-affected-the-risk-of-breast-cancer-among-female-childhood-cancer-survivors/</loc><lastmod>2022-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/2022-annual-report-to-the-nation-on-the-status-of-cancer-released/</loc><lastmod>2022-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/multimodal-artificial-intelligence-models-may-offer-an-accurate-prognostication-method-for-intermediate-to-high-risk-localized-prostate-cancer/</loc><lastmod>2022-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/analysis-of-radiotherapy-and-breast-cancer-recurrence-in-the-rxponder-trial/</loc><lastmod>2022-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/new-cervical-screening-test-could-predict-cell-changes-years-before-they-occur/</loc><lastmod>2022-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/minority-patients-face-longer-waits-for-non-small-cell-lung-cancer-treatment/</loc><lastmod>2022-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/can-genetic-mutations-impact-radiation-sensitivity/</loc><lastmod>2022-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/continuous-enzalutamide-plus-docetaxel-for-patients-with-metastatic-castration-resistant-prostate-cancer-with-disease-progression-on-enzalutamide/</loc><lastmod>2022-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/concurrent-bevacizumab-and-reirradiation-vs-bevacizumab-alone-in-recurrent-glioblastoma/</loc><lastmod>2022-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/first-line-toripalimab-plus-chemotherapy-in-advanced-nsclc-choice-01/</loc><lastmod>2022-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/addition-of-cediranib-to-olaparib-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/rogaratinib-vs-chemotherapy-in-previously-treated-patients-with-advanced-urothelial-carcinoma-and-fgfr13-mrna-overexpression/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/addition-of-bemarituzumab-to-mfolfox-in-fgfr2b-selected-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/identifying-patients-with-ovarian-cancer-with-greatest-potential-benefit-from-first-line-bevacizumab/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/neoadjuvant-immunotherapy-with-relatlimab-and-nivolumab-in-stage-iii-melanoma/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/legal-and-ethical-use-of-complementary-and-alternative-medicine-interventions-in-oncology/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/deaths-attributed-to-both-cancer-and-covid-19-in-the-united-states/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/10-october/switch-to-fulvestrantpalbociclib-with-rising-esr1-mutation-level-in-blood-during-aipalbociclib-therapy-in-patients-with-advanced-breast-cancer/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-ibrutinib-for-pediatric-patients-with-chronic-graft-vs-host-disease/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-durvalumab-based-combination-for-locally-advanced-or-metastatic-biliary-tract-cancer/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/nadim-trial-neoadjuvant-chemoimmunotherapy-improved-survival-in-resectable-stage-iiia-nsclc/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-corinne-faivre-finn-and-masahiro-tsuboi/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/is-germline-testing-warranted-for-all-patients-with-lung-cancer/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-kara-n-maxwell/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/what-the-supreme-court-s-abortion-decision-means-for-patients-with-cancer-and-their-clinicians/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/impower010-early-survival-data-favor-atezolizumab-over-best-supportive-care-in-resected-nsclc-with-pd-l1-expression-50/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-benjamin-besse/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/nelson-vs-nlst-nodule-management-based-on-volumetry-shows-increased-benefits/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-anand-devaraj/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/practice-changing-studies-important-new-data-and-more-clinical-oncology-news-from-esmo-2022-paris/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/capmatinib-for-metastatic-nsclc-with-met-exon-14-skipping-mutation/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/loic-le-marchand-awarded-2022-aacr-lectureship-on-science-of-cancer-health-disparities/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/trastuzumab-deruxtecan-for-advanced-her2-mutant-nsclc/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/patients-with-multiple-myeloma-may-face-car-t-cell-shortages/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/geriatric-oncology-and-hematology-in-singapore/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/chemoimmunotherapy-regimen-may-offer-survival-benefit-in-subgroups-of-metastatic-nsclc/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/axicabtagene-ciloleucel-improves-event-free-survival-vs-standard-care-in-second-line-treatment-for-large-b-cell-lymphoma/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-chia-puey-ling/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/determining-prognosis-in-aggressive-lymphomas-integrating-liquid-biopsy-into-imaging-assessment/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/diversify-cancer-clinical-trials-with-new-recruitment-and-retention-resources/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/changing-the-algorithm-for-relapsed-or-refractory-large-b-cell-lymphomas/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/exercise-therapy-across-the-cancer-care-continuum/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/a-physicist-father-inspired-a-love-of-science-in-oncology-researcher-stanton-gerson/</loc><lastmod>2022-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/adjuvant-atezolizumab-does-not-improve-disease-free-survival-in-patients-with-rcc/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-crizotinib-for-alk-positive-inflammatory-myofibroblastic-tumors/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/sylvester-researchers-receive-95-million-grant-to-study-esophageal-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/companion-diagnostic-to-identify-patients-with-endometrial-cancer-eligible-for-pembrolizumab-therapy-approved-by-the-fda/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/thomas-j-herzog-md-to-serve-as-board-president-elect-of-the-gog-foundation-inc-for-gynecologic-malignancies/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/pebbles-fagan-phd-mph-joins-leadership-team-at-uams-winthrop-p-rockefeller-cancer-institute/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/asco-updated-guideline-of-biomarkers-in-metastatic-breast-cancer-supports-pik3ca-brca12-pd-l1-testing/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/reconciliation-bill-focuses-on-health-care-provisions/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/neurosurgeon-ashish-shah-md-returns-to-sylvester-to-head-clinical-trials-and-translational-research-on-brain-tumors/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/iaslc-names-co-chairs-of-the-2023-world-conference-on-lung-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/association-of-community-cancer-centers-announces-2022-innovator-award-winner-ochsner-cancer-institute/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/allison-institute-announces-creation-of-scientific-advisory-board/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-shows-2-million-life-years-lost-and-21-billion-in-lost-earnings-annually-from-smoking-associated-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/how-eqrx-aims-to-reengineer-the-health-care-system-to-produce-more-effective-less-costly-cancer-drugs/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/eqrx-pricing-strategy-not-a-win-for-everyone-but-a-key-first-step-to-expand-access-to-cancer-care/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/bispecific-antibodies-and-the-dawn-of-a-new-era-in-treatment-of-multiple-myeloma/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/an-aggressive-type-of-non-hodgkin-lymphoma-threatened-my-life/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/brca-gene-testing-for-men-msk-launches-cancer-screening-clinic/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/concurrent-chemoradiation-therapy-with-weekly-cisplatin-for-locally-advanced-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/v-craig-jordan-cmg-obe-phd-dsc-fmedsci-the-father-of-tamoxifen-recounts-a-life-of-adventure-and-science/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/wall-street-doesn-t-believe-in-this-target/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/dart-trial-concurrent-radiotherapy-plus-durvalumab-active-in-older-patients-with-locally-advanced-lung-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/activity-shown-for-novel-immunotherapy-combination-in-microsatellite-stable-colorectal-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-ryan-corcoran/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/can-patients-with-low-risk-nasopharyngeal-cancer-be-treated-safely-with-radiotherapy-alone/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/real-world-evidence-confirms-survival-benefit-of-durvalumab-in-locally-advanced-non-small-cell-lung-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/rationale-306-survival-benefit-attained-with-tislelizumab-in-advanced-esophageal-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/epov-michael-cecchini/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-capmatinib-for-metastatic-nsclc-with-met-exon-14-skipping-mutations/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-grants-accelerated-approval-to-trastuzumab-deruxtecan-for-her2-mutant-nsclc/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-darolutamide-for-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-first-targeted-therapy-for-her2-low-breast-cancer/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/acquired-egfr-inhibitor-resistance-alterations-identified-in-ctdna-analysis-in-patients-with-refractory-metastatic-colorectal-cancer/</loc><lastmod>2022-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/5-year-outcomes-with-adjuvant-mfolfirinox-vs-gemcitabine-in-pancreatic-cancer/</loc><lastmod>2022-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/outcomes-of-lung-cancer-screening-in-individuals-with-or-without-lung-related-comorbidities/</loc><lastmod>2022-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/patient-reported-outcomes-with-the-addition-of-olaparib-to-abiraterone-in-castration-resistant-prostate-cancer/</loc><lastmod>2022-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-explores-link-between-use-of-antipsychotic-agents-and-increased-breast-cancer-risk/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/lung-cancer-screening-increases-percentage-of-stage-i-cases-detected-while-reducing-percentage-of-stage-iv-cases-detected/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/association-of-neurofilament-light-chain-levels-with-icans-risk-after-car-t-cell-therapy/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/trends-in-incidence-of-cutaneous-t-cell-lymphoma-in-the-united-states/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/sequencing-of-ipilimumabnivolumab-with-encorafenibbinimetinib-in-braf-mutant-metastatic-melanoma/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/rezvilutamide-vs-bicalutamide-combined-with-adt-in-high-volume-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/use-of-trimodality-therapy-in-stage-iiiii-rectal-cancer-in-the-united-states-10-year-period/</loc><lastmod>2022-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/cost-effectiveness-of-chemotherapy-sequences-in-metastatic-breast-cancer-according-to-prior-therapy-exposure/</loc><lastmod>2022-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-study-shows-patients-paying-more-out-of-pocket-costs-for-cancer-care/</loc><lastmod>2022-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-research-from-cohort-k-of-the-ev-103-trial-of-enfortumab-vedotin-for-patients-with-urothelial-cancer/</loc><lastmod>2022-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/reporting-of-hispanic-ethnicity-and-race-in-breast-cancer-studies/</loc><lastmod>2022-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/compliance-of-nci-designated-cancer-centers-with-january-2021-cms-price-transparency-requirements/</loc><lastmod>2022-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/recurrence-free-survival-as-surrogate-for-overall-survival-in-patients-undergoing-resection-of-colorectal-liver-metastases/</loc><lastmod>2022-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/novel-photon-counting-ct-may-improve-myeloma-bone-disease-detection/</loc><lastmod>2022-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-study-shows-sugar-sweetened-drinks-may-increase-risk-of-cancer-mortality/</loc><lastmod>2022-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/total-cost-of-cancer-care-may-be-reduced-with-lower-cost-alternate-drugs-without-compromising-quality-of-care/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/can-a-navigation-program-lower-care-costs-for-patients-with-cancer/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/research-finds-medicaid-expansion-led-to-decreases-in-cancer-incidence-and-mortality-rates/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/effectiveness-of-dexamethasone-for-dyspnea-in-patients-with-cancer/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/risk-factors-for-heart-failure-among-survivors-of-childhood-cancer/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/overall-survival-with-maintenance-olaparib-in-newly-diagnosed-patients-with-advanced-brca-mutated-ovarian-cancer/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/genomic-testing-may-aid-in-identifying-patients-of-african-descent-with-high-risk-prostate-cancer/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/unhealthy-gut-may-set-the-stage-for-breast-cancer-to-spread-preclinical-research-reveals/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/uams-winthrop-p-rockefeller-cancer-institute-welcomes-pebbles-fagan-phd-mph-to-leadership-team/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/blood-pressure-and-risk-of-heart-failure-in-patients-with-cancer/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/therapeutic-universal-cancer-peptide-based-vaccine-in-refractory-advanced-nsclc/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/avelumab-plus-axitinib-in-advanced-type-b3-thymomas-and-thymic-carcinomas/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/financial-burden-of-high-cost-targeted-oral-anticancer-drugs-among-medicare-patients/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/cancer-phenotypes-associated-with-germline-chek2-variants/</loc><lastmod>2022-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/constitutional-brca1-methylation-and-risk-of-triple-negative-breast-cancer-and-ovarian-cancer/</loc><lastmod>2022-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/lasker-foundation-announces-2022-lasker-award-winners/</loc><lastmod>2022-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/report-emphasizes-continued-access-to-fertility-preservation-is-critical-for-ayas-with-cancer-following-scotus-decision/</loc><lastmod>2022-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-examines-potential-benefits-of-a-fourth-covid-19-vaccination-for-patients-with-cancer/</loc><lastmod>2022-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/genetic-variation-may-explain-racial-disparity-in-esophageal-cancer-cases/</loc><lastmod>2022-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-biosimilar-bevacizumab-adcd-for-the-treatment-of-six-types-of-cancer/</loc><lastmod>2022-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/outcomes-after-nonresponse-and-relapse-in-childrenyoung-adults-receiving-tisagenlecleucel-for-b-cell-all/</loc><lastmod>2022-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/association-of-breast-cancer-recurrence-in-patients-achieving-pcr-with-vs-without-residual-dcis-after-neoadjuvant-chemotherapy/</loc><lastmod>2022-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/2-year-toxicity-with-conventional-imrt-vs-hypofractionated-sbrt-for-localized-prostate-cancer/</loc><lastmod>2022-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/inflammatory-markers-and-clinical-decline-after-adjuvant-chemotherapy-in-older-women-with-breast-cancer/</loc><lastmod>2022-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/tissue-vs-ctdna-ngs-for-detecting-actionable-alterations-in-patients-with-advanced-cancer/</loc><lastmod>2022-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/asco-announces-election-candidates-voting-opens-on-november-2/</loc><lastmod>2022-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-finds-cancer-mortality-rates-correlate-with-geography-as-well-as-known-behavioral-risk-factors/</loc><lastmod>2022-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/preclinical-study-finds-new-synthetic-lethal-agent-could-be-potential-treatment-for-pancreatic-cancer/</loc><lastmod>2022-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/ctdna-analysis-of-acquired-egfr-resistance-alterations-with-first-line-cetuximab-plus-chemotherapy-in-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2022-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/association-of-distance-to-treatment-facility-region-and-insurance-status-with-diagnosis-of-advanced-colon-cancer/</loc><lastmod>2022-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/adjuvant-nivolumab-with-or-without-ipilimumab-in-patients-with-resected-stage-iv-melanoma-with-no-evidence-of-disease/</loc><lastmod>2022-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/neoadjuvant-atezolizumab-may-be-safe-effective-option-for-localized-non-small-cell-lung-cancer/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/housing-instability-and-risk-of-mortality-in-patients-with-cancer/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-imaging-technique-may-improve-accuracy-of-basal-cell-carcinoma-diagnosis/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/many-families-of-children-with-leukemia-may-experience-food-insecurity-that-is-not-alleviated-by-federal-assistance-program/</loc><lastmod>2022-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/neoadjuvant-endocrine-therapy-may-elicit-differential-responses-in-black-vs-white-women-with-breast-cancer/</loc><lastmod>2022-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/antibody-response-to-three-dose-covid-19-mrna-1273-vaccination-schedule-in-immunocompromised-patients-with-hematologic-cancers/</loc><lastmod>2022-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/most-lgbtqi-patients-with-cancer-do-not-receive-information-tailored-to-their-needs/</loc><lastmod>2022-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/prostate-tumor-biology-may-be-influenced-by-genetic-ancestry/</loc><lastmod>2022-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/individuals-of-mexican-descent-may-have-higher-risk-of-liver-cancer-with-each-successive-generation/</loc><lastmod>2022-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/bcma-cd3-bispecific-t-cell-redirecting-antibody-abbv-383-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/adjuvant-pembrolizumab-in-patients-with-clear-cell-renal-cell-carcinoma-and-increased-risk-of-recurrence/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/astro-issues-clinical-guideline-on-radiation-therapy-for-idh-mutant-glioma/</loc><lastmod>2022-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/neoadjuvant-chemotherapy-and-organ-preserving-surgery-in-early-rectal-cancer/</loc><lastmod>2022-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/addition-of-t-vec-to-pembrolizumab-in-advanced-melanoma/</loc><lastmod>2022-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-cervicovaginal-epigenetic-test-for-screening-of-suspected-endometrial-cancer/</loc><lastmod>2022-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/durability-of-responses-to-bcma-car-t-cell-therapy-in-patients-with-multiple-myeloma-may-depend-on-specific-components-of-the-tumor-microenvironment/</loc><lastmod>2022-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-risk-stratification-system-for-completely-resected-stage-ii-or-iii-colorectal-cancer/</loc><lastmod>2022-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/combination-of-sephb4-hsa-plus-pembrolizumab-in-metastatic-urothelial-carcinoma/</loc><lastmod>2022-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/luspatercept-for-anemia-in-patients-with-lower-risk-myelodysplastic-syndromes-long-term-follow-up/</loc><lastmod>2022-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-examines-how-genetic-mutations-may-contribute-to-the-development-of-cholangiocarcinoma/</loc><lastmod>2022-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/two-new-studies-find-aggressive-prostate-cancer-may-be-linked-to-ancestral-heritage/</loc><lastmod>2022-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/long-term-findings-of-metastasis-directed-therapy-in-oligometastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2022-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fertility-preservation-procedures-at-breast-cancer-diagnosis-risk-of-relapse-and-disease-specific-mortality/</loc><lastmod>2022-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/is-pd-l1-expression-a-good-predictor-of-survival-benefit-in-patients-with-advanced-gastroesophageal-cancer-treated-with-immunotherapy/</loc><lastmod>2022-09-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/addition-of-sintilimab-and-bevacizumab-biosimilar-to-chemotherapy-for-patients-with-advanced-egfr-mutated-nsclc-and-disease-progression-on-egfr-inhibitors/</loc><lastmod>2022-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/addition-of-telaglenastat-to-cabozantinib-in-previously-treated-patients-with-metastatic-renal-cell-carcinoma/</loc><lastmod>2022-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/report-finds-batwing-mastopexy-may-enable-more-women-to-undergo-nipple-sparing-mastectomy/</loc><lastmod>2022-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/final-analysis-of-griffin-study-presented-for-daratumumab-based-investigational-quadruplet-regimen-in-newly-diagnosed-transplant-eligible-patients-with-multiple-myeloma/</loc><lastmod>2022-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/asco-remembers-saul-a-rosenberg-asco-past-president-and-pioneer-of-hodgkin-lymphoma-treatment/</loc><lastmod>2022-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/postmarketing-colitis-cases-may-be-associated-with-alpelisib-use/</loc><lastmod>2022-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/sacituzumab-govitecan-in-pretreated-patients-with-hr-positive-her2-negative-endocrine-resistant-advanced-breast-cancer/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-examines-efficacy-of-t-cell-redirection-therapies-for-patients-with-relapsed-multiple-myeloma/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/report-finds-cancers-in-adults-younger-than-age-50-are-on-the-rise-globally/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/researchers-find-dopa-may-protect-against-melanoma-and-identify-potential-new-therapeutic-targets-to-treat-melanoma/</loc><lastmod>2022-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/esmo-and-eons-announce-launch-of-prevcan/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/researchers-examine-how-air-pollution-may-drive-lung-cancer-in-neversmokers/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fda-approves-eflapegrastim-xnst-injection-for-chemotherapy-induced-neutropenia/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/prosper-rcc-neoadjuvant-nivolumab-prior-to-nephrectomy-followed-by-additional-nivolumab-in-patients-with-renal-cell-carcinoma/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/cosmic-313-cabozantinib-nivolumab-and-ipilimumab-in-previously-untreated-patients-with-advanced-renal-cell-carcinoma/</loc><lastmod>2022-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/nirogacestat-for-progressive-desmoid-tumors-defi-trial/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/m14til-tumor-infiltrating-lymphocytes-for-patients-with-advanced-melanoma/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/t-dxd-for-patients-with-her2-low-metastatic-breast-cancer-patient-reported-outcomes/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/tropics-02-update-sacituzumab-govitecan-improves-overall-survival-in-previously-treated-patients-with-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/presto-treatment-beyond-androgen-deprivation-therapy-for-relapsed-patients-with-high-risk-prostate-cancer/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/swog-s1801-neoadjuvant-and-adjuvant-pembrolizumab-for-patients-with-stage-iiib-to-iv-melanoma/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/research-explores-multicancer-early-detection-blood-testing/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/updated-results-from-the-krystal-1-study-of-adagrasib-in-advanced-kras-g12c-mutated-colorectal-cancer/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/neoadjuvant-cemiplimab-in-patients-with-stage-ii-to-iv-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/fresco-2-fruquintinib-for-patients-with-refractory-metastatic-colorectal-cancer/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/asco-applauds-president-biden-s-leadership-in-relaunching-the-cancer-moonshot/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/early-research-identifies-effective-combination-immunotherapy-for-subgroup-of-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/dual-checkpoint-inhibitor-blockade-as-first-line-and-salvage-therapy-for-patients-with-advanced-merkel-cell-carcinoma/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/updated-results-from-the-adaura-trial-of-adjuvant-osimertinib-in-egfr-mutated-nsclc/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/adjuvant-pembrolizumab-in-patients-with-completely-resected-stage-ib-to-iiia-nsclc/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/pafolacianine-for-intraoperative-imaging-of-folate-receptor-positive-ovarian-cancer/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/new-long-term-opioid-use-after-lung-cancer-surgery-linked-to-reduced-2-year-survival/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/precision-physical-activity-prescriptions-may-improve-survival-in-patients-with-stage-iii-colon-cancer/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/study-shows-many-patients-prefer-stool-test-to-colonoscopy-for-colorectal-cancer-screening/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/conditioning-with-busulfan-cyclophosphamide-vs-total-body-irradiation-cyclophosphamide-for-b-cell-all/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/september-24-is-world-cancer-research-day/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/selpercatinib-in-ret-fusion-positive-solid-tumors-other-than-lung-or-thyroid-malignancies/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/aacr-cancer-progress-report-2022-shows-cancer-mortality-rates-continue-to-decline-but-challenges-remain/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/09-september/updated-overall-survival-findings-with-adjuvant-erlotinib-vs-vinorelbinecisplatin-in-egfr-mutant-stage-iiia-nsclc/</loc><lastmod>2022-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cabozantinib-prolongs-progression-free-survival-in-previously-treated-radioiodine-refractory-differentiated-thyroid-cancer/</loc><lastmod>2022-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-quynh-thu-le/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/midtreatment-imaging-de-escalates-therapy-for-half-of-study-patients-with-oropharyngeal-cancer/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-quynh-thu-le-1/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/blood-test-predicts-recurrence-of-hpv-driven-oropharyngeal-cancer-after-treatment/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/head-and-neck-cancer-2021-2022-almanac/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-investigates-ruralurban-disparities-in-hospice-care-among-patients-with-hematologic-malignancies/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/asco-endorses-president-biden-s-pick-of-asco-past-president-monica-bertagnolli-as-incoming-head-of-nci/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/an-early-encounter-with-cancer-sets-a-path-to-a-career-in-oncology-research/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/mountaineer-tucatinib-plus-trastuzumab-active-in-metastatic-colorectal-cancer/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-cathy-eng/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/a-surgical-oncologist-from-afghanistan-discusses-the-challenges-of-delivering-cancer-care-in-a-war-torn-nation/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/sequencing-therapies-may-improve-overall-survival-in-metastatic-pancreatic-cancer/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epcoritamab-under-study-in-difficult-to-treat-large-b-cell-lymphoma/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-alexey-danilov/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/is-science-getting-closer-to-preventing-multiple-myeloma/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/impact-of-the-dobbs-v-jackson-women-s-health-organization-ruling-on-patients-with-cancer/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/snapshots-of-studies-of-interest-presented-at-asco-2022/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/is-advance-care-planning-of-any-value/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/lisocabtagene-maraleucel-in-second-line-treatment-of-large-b-cell-lymphoma/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cardiovascular-mortality-and-cancer-mortality-over-time-among-cancer-survivors/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/biden-administration-announces-new-model-to-improve-cancer-care-for-medicare-patients/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/new-guideline-updates-address-stage-iv-non-small-cell-lung-cancer-with-and-without-driver-alterations/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/2023-hospital-outpatient-payment-proposal-does-not-reflect-scotus-ruling-on-340b-reimbursement/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/nine-oncology-practices-certified-through-asco-patient-centered-cancer-care-certification-pilot/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/crizotinib-in-adult-and-pediatric-alk-positive-inflammatory-myofibroblastic-tumors/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/aphinity-trial-in-patients-with-her2-positive-early-breast-cancer-update-at-8-years/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-katrina-s-pedersen-md-ms/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/azacitidine-for-newly-diagnosed-juvenile-myelomonocytic-leukemia/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/tisagenlecleucel-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/an-oncologist-and-his-patient-with-cancer-look-at-the-intimate-experience-of-life-and-death/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/the-sandra-and-edward-meyer-cancer-center-at-weill-cornell-medicine-appoints-new-directors/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/dong-quai/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/surviving-advanced-prostate-cancer-has-made-me-a-more-empathetic-physician/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/varenicline-increases-smoking-cessation-rates-for-african-american-smokers/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/mri-guided-ultrasound-focal-therapy-may-delay-or-avoid-prostatectomy-or-radiotherapy-in-patients-with-intermediate-risk-prostate-cancer/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/success-story-in-prostate-cancer-for-many-men/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-javier-cortes-md-phd/</loc><lastmod>2022-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/intermittent-folfiri-plus-panitumumab-proves-more-effective-less-toxic-than-continuous-treatment-in-metastatic-colorectal-cancer/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-christina-wu/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/are-virtual-frailty-assessments-for-older-patients-with-hematologic-malignancies-effective/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/age-at-initiation-of-colorectal-cancer-screening-and-risk-of-colorectal-cancer-among-us-women/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/kimberly-hoggatt-krumwiede-phd-named-dean-of-md-anderson-s-school-of-health-professions/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/asco-endorses-new-astro-guideline-on-the-use-of-radiation-treatment-of-metastatic-brain-cancer/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/asco-releases-first-comprehensive-evidence-based-guidelines-for-metastatic-clear-cell-rcc/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/asco-and-who-to-collaborate-on-quality-indicators-for-cancer-facilities/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cancerlinq-and-owkin-collaborate-to-use-federated-learning-on-real-world-oncology-data-to-better-understand-lung-cancer-treatment/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/initiatives-by-professional-oncology-organizations-focus-on-improving-equitable-cancer-care/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/selwyn-m-vickers-md-facs-named-president-and-ceo-of-memorial-sloan-kettering-cancer-center/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/howard-sandler-md-fastro-voted-president-elect-of-astro-along-with-other-new-officers/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/donna-hansel-md-phd-to-join-md-anderson-as-division-head-of-pathology-and-laboratory-medicine/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/how-asco-and-accc-aim-to-increase-diversity-in-clinical-trials-and-close-the-equity-gap-in-cancer-care/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/asco-accc-recommendations-to-reduce-barriers-to-clinical-trial-enrollment/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/his-grandmother-s-death-inspires-a-career-in-oncology-for-manmeet-s-ahluwalia-md-mba/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/an-oncology-nurse-becomes-a-cancer-survivor/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/pat-morin-phd-appointed-deputy-scientific-director-of-the-ludwig-institute-for-cancer-research/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/radiologist-claudia-henschke-phd-md-of-icahn-school-of-medicine-receives-the-37th-annual-alton-ochsner-award/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/jaye-gardiner-phd-receives-the-2022-eddie-mendez-award-honoring-underrepresented-scientists/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/dana-farber-s-irene-ghobrial-md-selected-as-william-dameshek-prize-winner/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/thriving-after-a-diagnosis-of-stage-ii-anal-cancer/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/aya-leukemia-survivors-have-higher-mortality-rates-than-the-general-population/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/how-smoking-cessation-after-a-lung-cancer-diagnosis-improves-overall-survival/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/nivolumab-plus-t-dxd-under-study-in-her2-expressing-metastatic-breast-cancer/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-rebecca-dent/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cancer-knows-no-borders/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/immunotherapy-for-gastrointestinal-malignancies-is-it-ready-for-prime-time/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/noted-oncology-surgeon-kevin-billingsley-uses-life-experiences-to-mold-his-leadership-philosophy/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/atlas-trial-risk-adapted-triplet-maintenance-therapy-may-benefit-some-patients-with-multiple-myeloma/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-peter-voorhees/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cairo5-determines-optimal-approach-to-colorectal-liver-metastases/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-cathy-eng-1/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/hematology-highlights-from-asco-2022/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/no-overall-survival-benefit-reported-with-palbociclibletrozole-in-advanced-breast-cancer/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-claudine-isaacs/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/brentuximab-vedotin-with-chemotherapy-offers-survival-benefit-in-stage-iii-or-iv-hodgkin-lymphoma/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/epov-alison-moskowitz/</loc><lastmod>2022-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/brentuximab-vedotin-plus-avd-vs-abvd-for-the-first-line-treatment-of-early-stage-unfavorable-risk-hodgkin-lymphoma/</loc><lastmod>2022-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/long-term-risk-of-hospitalization-for-infection-in-childhood-cancer-survivors/</loc><lastmod>2022-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/adhering-to-a-healthy-diet-after-a-head-and-neck-cancer-diagnosis-may-boost-survival/</loc><lastmod>2022-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-evaluates-availability-of-imatinib-in-online-pharmacies/</loc><lastmod>2022-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/oral-paclitaxel-plus-p-glycoprotein-pump-inhibitor-encequidar-vs-intravenous-paclitaxel-in-metastatic-breast-cancer/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/frequent-aspirin-use-and-risk-of-ovarian-cancer/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/survey-reveals-that-most-americans-are-not-concerned-about-getting-lung-cancer/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/gaps-in-representation-of-women-and-younger-scholars-among-medical-educators/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/duration-of-adjuvant-oxaliplatin-with-6-months-of-fluoropyrimidine-treatment-in-high-risk-stage-ii-or-iii-colorectal-cancer/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/new-study-shows-options-for-older-patients-with-liver-cancer/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/patients-with-triple-negative-breast-cancer-benefited-from-presurgical-immunotherapy-regardless-of-race/</loc><lastmod>2022-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/lenvatinib-plus-pembrolizumab-for-advanced-melanoma-progressing-on-pd-1pd-l1-inhibitor-therapy/</loc><lastmod>2022-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/is-there-a-link-between-high-insulin-dosage-and-cancer/</loc><lastmod>2022-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/fewer-people-tried-to-quit-smoking-during-covid-19-pandemic-study-shows/</loc><lastmod>2022-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/outcomes-with-postconsolidation-dinutuximab-based-immunotherapy-for-neuroblastoma/</loc><lastmod>2022-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-could-lead-to-better-education-and-treatment-of-sexual-health-for-patients-with-breast-cancer/</loc><lastmod>2022-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/enzalutamide-in-advanced-androgen-receptor-positive-salivary-gland-cancer/</loc><lastmod>2022-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/talazoparib-plus-avelumab-in-recurrent-mismatch-repair-proficient-endometrial-cancer/</loc><lastmod>2022-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-suggests-hpv-vaccination-alongside-local-excision-of-cervical-lesions-may-reduce-risk-of-recurrence/</loc><lastmod>2022-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/older-age-and-smoking-are-the-most-important-risk-factors-for-developing-any-cancer-study-shows/</loc><lastmod>2022-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/media-emphasis-on-urinary-symptoms-may-delay-diagnosis-of-early-prostate-cancer/</loc><lastmod>2022-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/mrd-adapted-study-of-elotuzumab-plus-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma-without-transplantation-intent/</loc><lastmod>2022-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/columbus-trial-5-year-update-encorafenibbinimetinib-vs-vemurafenib-or-encorafenib-in-advanced-braf-v600-mutant-melanoma/</loc><lastmod>2022-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/research-shows-poor-patient-comprehension-of-terms-commonly-found-in-electronic-health-information/</loc><lastmod>2022-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/genetics-may-predict-bladder-cancer-immunotherapy-response/</loc><lastmod>2022-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/global-phase-iii-fresco-2-study-has-met-its-primary-endpoint-in-evaluation-of-fruquintinib-for-metastatic-colorectal-cancer/</loc><lastmod>2022-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/second-primary-cancer-risk-after-primary-radiotherapy-vs-surgery-or-other-treatment-in-veterans-with-localized-prostate-cancer/</loc><lastmod>2022-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/5-year-outcomes-with-laparoscopic-vs-open-distal-gastrectomy-in-locally-advanced-gastric-cancer/</loc><lastmod>2022-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/long-term-outcomes-with-adjuvant-goserelin-and-tamoxifen-in-premenopausal-er-positive-breast-cancer/</loc><lastmod>2022-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/why-do-men-face-a-higher-risk-of-most-types-of-cancer-than-women/</loc><lastmod>2022-08-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/long-term-regional-disease-control-with-sentinel-lymph-node-biopsy-in-patients-with-melanoma/</loc><lastmod>2022-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-finds-adding-tremelimumab-and-durvalumab-to-chemotherapy-improves-overall-survival-in-metastatic-nsclc-regardless-of-krasstk11keap1-mutations/</loc><lastmod>2022-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/increased-utilization-of-sbrt-has-decreased-treatment-disparities-for-early-stage-nsclc/</loc><lastmod>2022-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/time-to-initiation-of-adjuvant-endocrine-therapy-and-likelihood-of-adherence-in-medicaid-insured-women-with-breast-cancer/</loc><lastmod>2022-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/models-to-assess-impact-of-centralization-of-specialist-cancer-services-in-england/</loc><lastmod>2022-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/does-daily-insulin-dose-affect-cancer-risk-in-patients-with-type-1-diabetes/</loc><lastmod>2022-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/durvalumab-plus-concurrent-radiotherapy-in-unresectable-locally-advanced-nsclc-dolphin-study/</loc><lastmod>2022-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/informed-consent-forms-for-lung-cancer-clinical-trials-may-be-a-barrier-to-informed-participation/</loc><lastmod>2022-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/intrigue-trial-second-line-ripretinib-vs-sunitinib-in-advanced-gist/</loc><lastmod>2022-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/locoregional-recurrence-with-predefined-risk-based-de-escalation-of-radiotherapy-after-primary-chemotherapy-in-ct1-2n1-breast-cancer/</loc><lastmod>2022-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/perspective-article-explores-implications-of-supreme-court-abortion-ruling-on-pregnant-women-with-cancer/</loc><lastmod>2022-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/nelson-trial-protocol-may-be-more-sensitive-than-nlst-may-increase-benefits-of-lung-cancer-screening/</loc><lastmod>2022-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-investigates-incidence-timing-and-survival-of-patients-with-second-primary-lung-cancer/</loc><lastmod>2022-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/sexual-dysfunction-is-prevalent-among-women-with-lung-cancer/</loc><lastmod>2022-08-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/breast-induration-risk-with-partial-vs-whole-breast-irradiation-after-breast-conserving-surgery-for-node-negative-early-disease/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/higher-doses-of-car-t-cell-therapy-may-improve-survival-for-young-patients-with-b-cell-all/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/sugemalimab-found-to-be-a-safe-and-effective-consolidation-therapy-for-patients-with-unresectable-stage-iii-nsclc/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/molecular-map-reveals-insights-into-the-genetic-drivers-of-cll/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/relationship-between-polypharmacy-and-frailty-among-older-adults-with-blood-cancers/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/gnrh-agonist-therapy-for-prostate-cancer-and-cardiovascular-disease-risk-in-men-with-type-2-diabetes/</loc><lastmod>2022-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/characteristics-of-data-supporting-fda-initial-approval-and-subsequent-indications-for-new-cancer-drugs/</loc><lastmod>2022-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/evaluating-strategies-for-treating-pediatric-metastatic-rhabdomyosarcoma/</loc><lastmod>2022-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/psa-screening-and-prostate-cancer-mortality-among-black-and-white-veterans/</loc><lastmod>2022-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/fda-approves-ventana-mmr-rxdx-panel-to-identify-patients-with-dmmr-solid-tumors-and-pmmr-endometrial-cancer-eligible-for-treatment-with-pembrolizumab/</loc><lastmod>2022-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/disparities-in-the-diagnosis-of-lung-cancer-among-younger-vs-older-adults/</loc><lastmod>2022-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/research-suggests-air-pollution-be-included-as-risk-factor-for-nonsmoking-patients-with-lung-cancer/</loc><lastmod>2022-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/us-cancer-care-facility-acceptance-of-medicaid-for-simulated-patients-with-newly-diagnosed-common-cancers/</loc><lastmod>2022-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/wbi-with-boost-after-breast-conserving-surgery-in-non-low-risk-dcis/</loc><lastmod>2022-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-reveals-potential-genomic-contributors-to-the-development-of-dlbcl/</loc><lastmod>2022-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/pralsetinib-achieves-tissue-agnostic-benefits-for-patients-with-ret-fusion-positive-cancers/</loc><lastmod>2022-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/fda-approves-first-cell-based-gene-therapy-to-treat-adult-and-pediatric-patients-with-beta-thalassemia-who-require-regular-blood-transfusions/</loc><lastmod>2022-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-shows-germline-testing-may-be-warranted-for-all-patients-with-lung-cancer/</loc><lastmod>2022-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/first-line-lenalidomiderituximab-vs-rituximabchemotherapy-with-rituximab-maintenance-for-advanced-follicular-lymphoma/</loc><lastmod>2022-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/low-dose-decitabine-and-azacitidine-in-lower-risk-mds/</loc><lastmod>2022-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/t-dxd-shows-high-intracranial-response-rate-in-patients-with-active-brain-metastases-from-her2-positive-breast-cancer/</loc><lastmod>2022-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/does-exposure-to-pfos-elevate-risk-of-developing-hepatocellular-carcinoma/</loc><lastmod>2022-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/risk-prediction-models-for-coronary-heart-disease-and-heart-failure-after-treatment-for-hodgkin-lymphoma/</loc><lastmod>2022-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-tests-strategy-for-reducing-colorectal-cancer-risk-among-patients-with-familial-adenomatous-polyposis/</loc><lastmod>2022-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/premmplus-tool-may-assist-in-identifying-people-likely-to-benefit-from-multigene-hereditary-cancer-risk-assessment/</loc><lastmod>2022-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/atezolizumab-plus-vemurafenibcobimetinib-for-patients-with-braf-v600-mutated-melanoma-and-cns-metastases/</loc><lastmod>2022-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/addition-of-transarterial-chemoembolization-to-lenvatinib-in-first-line-treatment-of-advanced-hepatocellular-carcinoma/</loc><lastmod>2022-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/effect-of-physical-activity-on-disease-free-survival-in-patients-receiving-adjuvant-therapy-for-stage-iii-colon-cancer/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/rucaparib-maintenance-after-platinum-based-chemotherapy-for-metastatic-urothelial-carcinoma/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/anthony-fauci-md-to-step-down-from-current-roles-in-december/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/durvalumabtremelimumab-for-previously-treated-patients-with-advanced-soft-tissue-and-bone-sarcomas/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/global-burden-of-cancer-attributable-to-modifiable-risk-factors-in-2019/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/rituximab-lenalidomide-and-ibrutinib-with-sequential-addition-of-chemotherapy-in-newly-diagnosed-dlbcl/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cancer-related-fatigue-linked-to-balance-problems-after-chemotherapy-for-breast-cancer/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/proximity-to-fracking-sites-may-be-associated-with-risk-of-pediatric-leukemia/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-examines-effects-of-advance-care-planning-for-adolescents-with-cancer/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/adding-ct-to-x-ray-for-follow-up-of-completely-resected-nsclc/</loc><lastmod>2022-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/elotuzumab-plus-pomalidomidedexamethasone-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/neoadjuvant-nivolumab-plus-ipilimumab-in-localized-dmmrmsi-h-gastric-cancer/</loc><lastmod>2022-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/how-did-the-first-year-of-the-covid-19-pandemic-affect-cancer-survivors/</loc><lastmod>2022-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/long-term-benefit-of-radiotherapy-confirmed-in-advanced-prostate-cancer-stampede-trial-follow-up/</loc><lastmod>2022-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/stem-cell-boost-as-salvage-therapy-for-severe-hematologic-toxicity-after-cd19-car-t-cell-therapy/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-evaluates-uv-protective-behaviors-in-american-indian-and-alaskan-native-populations/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/clinical-and-translational-researcher-rossana-berardi-works-to-overcome-the-gender-gap-in-oncology-in-italy/</loc><lastmod>2022-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/racialethnic-representation-in-pivotal-clinical-trials-for-drugs-approved-for-leukemias-and-multiple-myeloma/</loc><lastmod>2022-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/etoposidecisplatin-vs-irinotecancisplatin-in-advanced-digestive-system-neuroendocrine-carcinoma/</loc><lastmod>2022-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/researchers-identify-markers-of-chemotherapy-resistance-and-outcome-in-patients-with-triple-negative-breast-cancer/</loc><lastmod>2022-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/deep-learning-algorithm-may-streamline-lung-cancer-radiotherapy-treatment/</loc><lastmod>2022-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/addition-of-galunisertib-to-neoadjuvant-chemoradiotherapy-in-locally-advanced-rectal-cancer/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/prevalence-of-mgus-among-rescue-and-recovery-workers-exposed-to-the-world-trade-center-disaster/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/fertility-preservation-measures-do-not-appear-to-increase-the-risk-of-breast-cancer-recurrence/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/addition-of-chemotherapy-to-gefitinib-in-first-line-treatment-of-advanced-nsclc-with-egfr-mutations/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/radiotherapy-alone-vs-concurrent-chemoradiotherapy-in-low-risk-nasopharyngeal-cancer/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/analysis-of-outcomes-in-nci-sponsored-phase-i-trials-in-solid-tumors-2000-2019/</loc><lastmod>2022-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/chronic-toxicity-with-adjuvant-intensity-modulated-vs-conventional-radiation-therapy-for-cervical-or-endometrial-cancer/</loc><lastmod>2022-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/cabazitaxel-in-advanced-dedifferentiated-liposarcoma/</loc><lastmod>2022-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/researchers-outline-a-path-to-representation-in-cancer-clinical-trials/</loc><lastmod>2022-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/study-shows-ai-may-improve-prediction-of-colorectal-cancer-recurrence/</loc><lastmod>2022-08-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/do-perioperative-beta-blockers-improve-survival-in-patients-with-cardiovascular-conditions-undergoing-surgery-for-ovarian-cancer/</loc><lastmod>2022-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/08-august/racial-trends-in-advanced-cervical-cancer-in-the-united-states/</loc><lastmod>2022-08-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/no-overall-survival-benefit-reported-with-palbociclibletrozole-in-advanced-breast-cancer/</loc><lastmod>2022-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/two-early-career-cancer-researchers-from-africa-aim-to-make-a-difference-and-never-give-up/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/living-with-hereditary-cancer-oncologist-mark-a-lewis-shares-his-experiences-on-social-media-to-assist-others/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/affirming-health-equity-a-model-for-integrative-health-care/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/asco-statement-on-supreme-court-decision-in-dobbs-v-jackson-women-s-health-organization/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/asco-guideline-update-supports-new-second-and-third-line-treatments-for-her2-positive-breast-cancer/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/ama-house-of-delegates-approves-asco-backed-resolutions-on-ancillary-clinical-trial-costs-and-arpa-h-funding/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/adjuvant-everolimus-narrowly-misses-statistical-significance-in-rcc-except-for-very-high-risk-patients/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-ribociclib-to-letrozole-improves-survival-in-women-with-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/time-restricted-eating-intervention-reduces-cardiovascular-risk-in-older-breast-cancer-survivors/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/cln-081-shows-selective-activity-in-nsclc-with-egfr-exon-20-insertions/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-reports-time-limited-venetoclax-based-regimens-of-benefit-in-front-line-treatment-of-cll/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/changing-the-natural-history-of-er-positive-her2-negative-breast-cancer-with-the-introduction-of-cdk46-inhibition/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/medical-costs-and-clinical-value-playing-the-long-game/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-finds-radiation-therapy-may-be-safely-omitted-for-some-older-patients-with-luminal-a-breast-cancer/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/car-t-cell-reimbursement-measuring-health-disparities-digital-quality-in-focus-in-comments-on-2023-hospital-inpatient-payment-proposal/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/phase-iii-trial-reports-quizartinib-doubles-overall-survival-in-flt3-itd-positive-aml/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-amir-fathi/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/responses-to-teclistamab-reported-in-early-phase-trial-of-highly-refractory-multiple-myeloma/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-madhav-v-dhodapkar/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/deciphering-the-elusive-origin-and-pathways-of-brain-metastases/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/lupsma-improves-progression-free-survival-vs-cabazitaxel-in-psma-positive-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-points-to-expanded-genomic-testing-to-benefit-children-and-young-adults-with-cancer/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/postmarketing-ocular-toxicity-in-us-adults-treated-with-daratumumab/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/fda-approves-lisocabtagene-maraleucel-for-the-second-line-treatment-of-large-b-cell-lymphoma/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/radiation-segmentectomy-for-very-early-and-early-stage-hepatocellular-carcinoma/</loc><lastmod>2022-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/first-randomized-chemotherapy-study-in-relapsed-or-refractory-ewing-sarcoma-reports-modest-gains-in-survival-with-high-dose-ifosfamide/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-katherine-janeway/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/death-and-clinical-trials-in-the-plague-years/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/cleveland-clinic-appoints-alex-a-adjei-md-phd-as-chair-of-taussig-cancer-institute/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/ash-statement-on-diversity-equity-and-inclusion-toolkit/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/francesca-m-gany-md-ms-receives-excellence-in-health-care-award-from-united-hospital-fund/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/jeffrey-m-rosen-phd-honored-with-2022-william-l-mcguire-memorial-lecture-award/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/dana-farber-cancer-institute-and-l-institut-servier-of-gustave-roussy-sign-an-oncology-cooperation-agreement/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/thomas-stricker-md-joins-oneoncology-as-medical-director-for-precision-medicine/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/circulating-tumor-dna-guided-approach-to-treating-stage-ii-colon-cancer/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/fda-launches-campaign-aimed-at-preventing-e-cigarette-use-among-american-indianalaska-native-youth/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/astro-welcomes-new-vice-president-of-education-and-director-of-diversity-equity-and-inclusion/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-ben-ho-park/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-hematology-chief-and-director-of-the-wesley-center-for-immunotherapy-named-for-uh-seidman-cancer-center/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/shaping-the-future-of-cancer-care-the-value-of-managing-aggregated-data-from-patients-online-communities/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/cautious-optimism-about-mining-for-patient-centric-data/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-marianne-pavel/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/moffitt-mourns-the-loss-of-research-giant-robert-gillies/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/car-t-cell-therapy-gave-me-back-a-high-quality-life/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/mount-sinai-researcher-receives-award-from-the-american-association-of-indian-scientists-in-cancer-research/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/asco-guideline-update-aims-to-improve-patient-outcomes-for-her2-positive-breast-cancer-with-brain-metastases/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/asco-guideline-update-for-systemic-melanoma-therapy-addresses-new-treatment-option-for-uveal-melanoma/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/asco-s-cancerlinq-and-healthverity-collaborate-to-accelerate-cancer-research/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/history-of-radiation-oncology-in-the-united-states/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/former-nci-director-takes-stock-of-his-accomplishments-and-looks-ahead-to-the-next-challenge/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/inspired-by-the-tv-show-mash-lori-wilson-achieves-many-firsts-as-a-leader-in-oncology/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/dual-targeted-therapy-improves-outcomes-vs-chemotherapy-for-some-pediatric-patients-with-low-grade-glioma/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-joseph-mikhael/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/early-transplant-with-triplet-therapy-may-delay-progression-of-myeloma-but-individualized-approach-recommended/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/strides-are-being-made-in-the-treatment-of-brain-metastases-from-breast-cancer/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/rucaparib-maintenance-improves-pfs-in-patients-with-newly-diagnosed-advanced-ovarian-cancer-who-responded-to-platinum-based-therapy/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-ernst-lengyel/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/in-metastatic-ras-wild-type-left-sided-colorectal-cancer-panitumumab-proves-superior-to-bevacizumab/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-chiara-cremolini/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/chipping-away-at-targetable-mutations-in-nsclc-amivantamab-in-nsclc-with-met-exon-14-skipping-mutations/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-ben-creelan/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/dabrafenib-plus-trametinib-receives-fda-approval-for-braf-v600e-mutated-solid-tumors/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/raising-the-bar-rethinking-the-accelerated-drug-approval-process/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/overall-survival-in-metastatic-colorectal-cancer-in-phase-iii-trials-and-seer-database-over-a-30-year-period/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/germline-variants-in-types-of-cancer-without-hereditary-testing-guidelines/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/capecitabine-plus-temozolomide-for-advanced-pancreatic-neuroendocrine-tumors/</loc><lastmod>2022-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/strides-are-being-made-in-the-treatment-of-brain-metastases-from-breast-cancer-1/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/association-of-ctc-levels-with-outcomes-in-transplant-eligible-patients-with-newly-diagnosed-multiple-myeloma/</loc><lastmod>2022-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/fda-warns-about-possible-increased-risk-of-death-and-serious-side-effects-with-duvelisib/</loc><lastmod>2022-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/screening-study-to-identify-risk-factors-for-breast-cancer-related-lymphedema/</loc><lastmod>2022-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/food-interventions-and-cancer-treatment-completion-rates-among-food-insecure-patients-in-new-york-city/</loc><lastmod>2022-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/first-line-radiotherapy-with-or-without-procarbazine-lomustine-and-vincristine-chemotherapy-for-anaplastic-oligodendroglial-tumors/</loc><lastmod>2022-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/real-world-treatment-outcomes-with-transplantation-and-maintenance-rituximab-in-previously-untreated-patients-with-mantle-cell-lymphoma/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-olaparib-to-durvalumab-in-previously-untreated-platinum-ineligible-patients-with-metastatic-urothelial-carcinoma/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/taxane-maintenance-vs-surveillance-in-advanced-ovarian-cancer/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/aacr-statement-on-the-us-supreme-court-decision-in-the-dobbs-v-jackson-women-s-health-organization-case/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-enzalutamide-to-active-surveillance-in-low-or-intermediate-risk-localized-prostate-cancer/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-examines-high-early-death-rates-treatment-resistance-and-short-survival-among-black-aya-patients-with-aml/</loc><lastmod>2022-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/phase-iii-trial-of-cabozantinib-and-atezolizumab-vs-sorafenib-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/initial-risk-factors-and-time-to-cure-in-childhood-and-young-adult-acute-lymphoblastic-leukemia/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/antibody-response-to-sars-cov-2-wild-type-virus-and-variants-after-mrna-vaccination-in-patients-with-nsclc/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-gene-profiling-technology-reveals-potential-melanoma-biomarkers/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/poziotinib-shows-activity-in-egfr-exon-20-mutant-nsclc-with-efficacy-dependent-on-insertion-location/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/geriatrics-experts-explore-relationship-between-heart-disease-and-cancer/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/bispecific-antibody-mosunetuzumab-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/rates-of-major-adverse-cardiovascular-events-in-patients-receiving-immune-checkpoint-inhibitors/</loc><lastmod>2022-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/risk-of-oropharyngeal-cancer-after-a-positive-hpv16-e6-serology-test/</loc><lastmod>2022-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/eau22-ctdna-may-help-to-predict-response-to-atezolizumab-in-patients-with-bladder-cancer/</loc><lastmod>2022-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/eau22-trial-shows-new-imaging-technology-may-be-less-accurate-than-mri-in-detecting-prostate-cancer/</loc><lastmod>2022-07-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/immune-checkpoint-inhibitors-for-solid-tumors-in-kidney-transplant-recipients-with-maintained-immunosuppression/</loc><lastmod>2022-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/do-bone-marrow-biopsies-aid-in-response-assessment-for-patients-with-follicular-lymphoma/</loc><lastmod>2022-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/president-biden-appoints-cancer-panel-members-and-cancer-cabinet-unveils-priority-actions/</loc><lastmod>2022-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-reveals-cancer-screening-decreased-worldwide-during-height-of-covid-19-pandemic/</loc><lastmod>2022-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/fda-authorizes-emergency-use-of-novavax-covid-19-vaccine-adjuvanted/</loc><lastmod>2022-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-atezolizumab-to-neoadjuvant-pertuzumabtrastuzumab-and-docetaxel-in-her2-positive-early-breast-cancer/</loc><lastmod>2022-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/immune-related-toxic-effects-and-treatment-outcomes-in-patients-with-cancer-and-autoimmune-diseases-receiving-ici-therapy/</loc><lastmod>2022-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-report-underscores-importance-of-health-insurance-status-and-cancer-stage-at-diagnosis-in-relation-to-patient-survival/</loc><lastmod>2022-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-antibody-therapy-shows-activity-in-patients-with-medulloblastoma/</loc><lastmod>2022-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-explores-community-health-worker-led-intervention-s-impact-on-acute-care-use-advance-care-planning-and-patient-reported-outcomes/</loc><lastmod>2022-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/tumor-grade-and-response-to-immune-checkpoint-inhibition-in-recurrent-or-metastatic-mucosal-hnscc/</loc><lastmod>2022-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/clinical-practice-guidelines-for-treatment-and-prophylaxis-of-vte-in-patients-with-cancer-including-those-infected-with-covid-19/</loc><lastmod>2022-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-brentuximab-vedotin-to-chemotherapy-in-patients-with-stage-iii-or-iv-hodgkin-lymphoma-overall-survival-analysis-from-echelon-1/</loc><lastmod>2022-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/lisocabtagene-maraleucel-as-second-line-treatment-for-relapsed-or-refractory-large-b-cell-lymphoma-transform-trial/</loc><lastmod>2022-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/trastuzumab-and-nivolumab-plus-either-ipilimumab-or-folfox-as-first-line-treatment-for-her2-positive-advanced-esophagogastric-adenocarcinoma/</loc><lastmod>2022-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-consensus-based-guidance-on-managing-cancer-pain-in-patients-with-opioid-use-disorder-or-opioid-misuse/</loc><lastmod>2022-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/eau22-study-finds-gut-microbes-differ-in-patients-with-prostate-cancer-vs-those-with-benign-biopsy-results/</loc><lastmod>2022-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/eau22-new-research-supports-risk-based-prostate-cancer-screening/</loc><lastmod>2022-07-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/analysis-of-high-risk-hpv-mrna-vs-dna-testing-in-screening-for-cervical-cancer/</loc><lastmod>2022-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/outcomes-of-the-sars-cov-2-omicron-variant-outbreak-among-european-patients-with-cancer/</loc><lastmod>2022-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/physician-adenoma-detection-rates-and-risk-of-postcolonoscopy-colorectal-cancer-is-there-a-correlation/</loc><lastmod>2022-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-atezolizumab-to-neoadjuvant-anti-her2-therapy-and-chemotherapy-in-her2-positive-breast-cancer-impassion050/</loc><lastmod>2022-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-report-patients-report-increased-likelihood-to-enroll-in-decentralized-clinical-trials/</loc><lastmod>2022-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/oncolytic-virus-dnx-2401-for-newly-diagnosed-pediatric-patients-with-dipg/</loc><lastmod>2022-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/does-tmb-influence-response-to-pd-1pd-l1-inhibitors-among-patients-with-advanced-nsclc/</loc><lastmod>2022-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-finds-black-and-hispanic-men-with-throat-cancer-are-experiencing-higher-mortality-white-men-are-increasingly-being-diagnosed-at-a-late-stage/</loc><lastmod>2022-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/epov-susan-slovin/</loc><lastmod>2022-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/research-examines-which-demographic-is-most-likely-to-use-medical-aid-in-dying/</loc><lastmod>2022-07-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/second-line-lisocabtagene-maraleucel-in-patients-with-relapsed-or-refractory-large-b-cell-lymphoma-not-intended-for-hsct/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/zanubrutinib-vs-bendamustinerituximab-in-previously-untreated-patients-with-cll-or-sll/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-examines-quality-of-life-outcomes-among-patients-participating-in-phase-iii-randomized-trials-of-cancer-drugs/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/for-medicaid-insured-patients-with-cancer-health-insurance-does-not-always-mean-health-care-access/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/adagrasib-in-previously-treated-patients-with-kras-g12c-mutated-advanced-nsclc/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/caregivers-for-patients-with-multiple-myeloma-face-mental-health-challenges/</loc><lastmod>2022-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/cancercare-s-caregiver-decision-making-survey-results-reveal-gaps-in-support-for-caregivers-give-rise-to-recommendations-for-improving-caregiver-support/</loc><lastmod>2022-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/addition-of-trabectedin-to-doxorubicin-in-the-first-line-treatment-of-advanced-leiomyosarcoma/</loc><lastmod>2022-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/eprenetapoptazacitidine-maintenance-after-allogeneic-hsct-for-tp53-mutant-aml-and-mds/</loc><lastmod>2022-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/use-of-menopausal-hormone-therapy-and-breast-cancer-mortality/</loc><lastmod>2022-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/children-with-in-utero-exposure-to-maternal-cancer-short-and-long-term-outcomes/</loc><lastmod>2022-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/cog-trial-of-intensive-multimodality-therapy-for-extraocular-retinoblastoma/</loc><lastmod>2022-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/noncytotoxic-maintenance-with-niraparib-plus-either-nivolumab-or-ipilimumab-in-platinum-sensitive-advanced-pancreatic-cancer/</loc><lastmod>2022-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/judging-melanoma-thickness-comparison-of-dermatologists-and-machine-learning-algorithm/</loc><lastmod>2022-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/does-disclosing-maternal-brca-status-affect-children-s-health-behaviors/</loc><lastmod>2022-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/survey-finds-more-than-80-of-patients-with-cancer-and-survivors-say-copay-assistance-programs-help-them-afford-their-prescription-drugs/</loc><lastmod>2022-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/researchers-discover-protein-that-may-be-associated-with-better-prognosis-for-patients-with-ovarian-cancer/</loc><lastmod>2022-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/do-patients-tend-to-adhere-to-vte-prophylaxis-guidelines-after-pancreatic-cancer-surgery/</loc><lastmod>2022-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/venetoclax-plus-gilteritinib-in-flt3-mutated-relapsed-or-refractory-acute-myeloid-leukemia/</loc><lastmod>2022-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/effectiveness-and-risk-of-preterm-birth-with-local-treatments-for-cervical-malignancies/</loc><lastmod>2022-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-poster-track-at-jadpro-live-announced-apsho-patientadvocacy-perspective/</loc><lastmod>2022-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/downstaging-hepatocellular-carcinoma-prior-to-liver-transplant-10-year-outcomes/</loc><lastmod>2022-07-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/diagnosing-basal-cell-carcinoma-optical-coherence-tomography-vs-punch-biopsy/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/overall-survival-with-the-addition-of-pembrolizumab-to-chemotherapy-in-advanced-triple-negative-breast-cancer/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/neoadjuvant-mfolfirinox-with-or-without-radiotherapy-for-borderline-resectable-pancreatic-cancer/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/investigational-blood-test-may-help-improve-diagnosis-and-monitoring-of-glioma/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-examines-role-of-per-and-polyfluoroalkyl-substances-in-development-of-cancer-health-care-costs/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/study-sheds-light-on-mechanisms-driving-cancer-induced-by-organic-solvent-used-in-printing-industry/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/maintenance-olaparib-vs-placebo-in-germline-brca-mutated-metastatic-pancreatic-cancer/</loc><lastmod>2022-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/intensive-vs-minimalist-follow-up-strategies-for-patients-in-remission-after-surgery-for-endometrial-cancer/</loc><lastmod>2022-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/zandelisib-in-continuous-or-intermittent-dosing-schedules-with-or-without-rituximab-for-relapsed-or-refractory-b-cell-malignancies/</loc><lastmod>2022-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/researchers-find-potential-link-between-genetic-mutations-and-treatment-resistance-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/meta-analysis-examines-link-between-aspirin-use-and-ovarian-cancer-risk/</loc><lastmod>2022-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/risk-stratification-and-treatment-implications-for-patients-with-early-stage-melanoma-and-sentinel-node-metastasis/</loc><lastmod>2022-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/consolidation-radiotherapy-vs-autologous-stem-cell-transplantation-for-primary-cns-lymphoma/</loc><lastmod>2022-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/proton-craniospinal-irradiation-vs-photon-involved-field-radiotherapy-for-solid-tumor-leptomeningeal-metastasis/</loc><lastmod>2022-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/new-report-documents-lack-of-senior-leadership-diversity-in-the-nation-s-cancer-centers/</loc><lastmod>2022-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/07-july/early-research-finds-link-may-connect-cell-signaling-pathway-to-development-of-esophageal-cancers-barrett-s-esophagus/</loc><lastmod>2022-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/addition-of-denosumab-to-neoadjuvant-chemotherapy-containing-two-different-nab-paclitaxel-regimens-for-patients-with-breast-cancer/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/new-interactive-map-of-oncology-puts-covid-19-equity-data-into-perspective/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/addition-of-tiragolumab-to-atezolizumab-in-pd-l1-positive-nsclc/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/elevating-cancer-care-in-the-united-states-for-all-current-challenges-and-potential-solutions/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/looking-back-at-telemedicine-during-the-covid-19-era-lessons-learned-and-disparities-identified/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/rates-of-active-surveillance-rising-among-men-with-low-risk-prostate-cancer-but-still-suboptimal/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/cancer-and-war-in-ukraine-how-the-world-can-help-win-this-battle/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/rucaparib-improves-progression-free-survival-vs-chemotherapy-in-relapsed-ovarian-cancer-with-brca12-mutations/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ariel4-confirms-rucaparib-s-efficacy-in-recurrent-brca-mutated-ovarian-cancer-does-it-tell-us-anything-new/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/history-of-radiation-oncology-in-the-united-states/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nivolumab-in-combination-with-chemotherapy-and-in-combination-with-ipilimumab-in-advanced-esophageal-squamous-cell-carcinoma/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/immunotherapy-has-given-me-back-my-life/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/an-oncology-surgeon-leads-mexico-s-melanoma-program/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/cancer-death-rates-among-black-people-declined-over-time-but-remain-higher-than-other-racial-and-ethnic-groups/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-s-cancerlinq-and-count-me-in-collaborate-to-empower-patient-participation-in-clinical-cancer-research/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-relaunches-survivorship-compendium-with-new-features-and-resources/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/interventions-needed-to-improve-data-collection-on-sexual-orientation-and-gender-identity-in-oncology-practice-survey-finds/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/invest-in-the-unexpected-basic-research-enterprise-needs-adequate-funding-to-foster-treatment-innovation/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ariela-l-marshall-md-advocates-for-equity-and-reproductive-health-in-the-hematology-oncology-community/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-kimmie-ng/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/tropics-02-sacituzumab-govitecan-effective-in-hormone-receptor-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-debu-tripathy/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/notable-trial-survival-in-pancreatic-kras-wild-type-cancer-improved-with-addition-of-nimotuzumab-to-gemcitabine/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-thomas-seufferlein/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/american-cancer-society-investigators-present-studies-on-covid-19-pandemic-racialethnic-disparities-and-coverage-for-genomic-testing/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-william-catalona/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/checkmate-274-adjuvant-immunotherapy-improves-disease-free-survival-in-metastatic-urothelial-cancer/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-guru-sonpavde/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/destiny-breast04-trial-t-dxd-significantly-improves-survival-in-patients-with-her2-low-metastatic-breast-cancer/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-patricia-lorusso/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/100-percent-complete-response-rate-in-14-patients-with-rectal-cancer-treated-with-neoadjuvant-dostarlimab-gxly/</loc><lastmod>2022-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ibrutinib-added-to-standard-therapy-prolongs-progression-free-survival-in-older-patients-with-mantle-cell-lymphoma/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-jeremy-abramson/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fda-approves-two-nivolumab-based-regimens-as-first-line-treatments-for-unresectable-advanced-or-metastatic-esophageal-squamous-cell-carcinoma/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/t-dxd-improves-progression-free-survival-vs-t-dm1-in-metastatic-her2-positive-breast-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/monaleesa-3-ribociclib-plus-fulvestrant-improves-overall-survival-over-fulvestrant-alone-in-the-first-line-setting/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/destiny-breast03-should-trastuzumab-deruxtecan-be-the-preferred-second-line-regimen-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fda-approves-azacitidine-for-newly-diagnosed-juvenile-myelomonocytic-leukemia/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fda-approves-ivosidenibazacitidine-for-certain-patients-with-newly-diagnosed-aml/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/topical-imiquimod-vs-surgery-for-vulvar-high-grade-squamous-intraepithelial-neoplasia/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ipilimumabnivolumab-in-patients-with-metastatic-pancreatic-or-biliary-cancer-and-hrd-pathogenic-germline-variants/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/trends-in-hysterectomy-corrected-uterine-cancer-mortality-and-racialethnic-differences/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-refines-guidance-on-using-biomarkers-for-adjuvant-endocrine-and-chemotherapy-in-early-stage-breast-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-and-accc-release-joint-recommendations-to-increase-equity-diversity-and-inclusion-in-clinical-trials/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/multiple-myeloma-treatment-conundrums/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/no-good-treatment-options-so-i-ll-eat-ice-cream/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-finds-state-public-welfare-spending-was-associated-with-improved-5-year-overall-survival-in-black-patients-with-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/raceethnicity-and-poverty-are-associated-with-worse-outcomes-among-children-with-high-risk-neuroblastoma/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fred-hutch-scca-seattle-children-s-and-uw-medicine-complete-restructure-of-partnership/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/cleveland-clinic-announces-new-appointments-to-oncology-staff/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/the-mark-foundation-for-cancer-research-appoints-ryan-schoenfeld-phd-as-chief-executive-officer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/uicc-and-multiple-partners-to-increase-access-to-essential-cancer-medicines-in-low-and-lower-middle-income-countries/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ralph-lauren-corporate-foundation-announces-25-million-commitment-to-five-us-cancer-centers-to-help-reduce-disparities-in-cancer-care-in-underserved-communities/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-s-cancerlinq-and-atropos-health-collaborate-to-harness-real-world-data-to-provide-point-of-care-informatics-consult-to-oncologists/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/emily-whitehead-first-pediatric-patient-to-receive-car-t-cell-therapy-celebrates-remission-10-years-later/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/tj-gan-md-frca-uk-to-join-md-anderson-as-division-head-of-anesthesiology-critical-care-and-pain-medicine/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/researcher-xiao-jing-wang-md-phd-joins-uc-davis-cancer-center-s-leadership-team/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/jennifer-willcox-jd-named-senior-vice-president-general-counsel-and-chief-governance-officer-at-dana-farber/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/robotic-surgery-improves-perioperative-outcomes-vs-open-radical-cystectomy-in-bladder-cancer-trial/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-khurshid-guru/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/how-social-media-is-fueling-an-epidemic-of-misinformation-and-disinformation-and-distrust-in-science/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/traditional-chinese-medicine-herbal-formula-ma-zi-ren-wan-for-constipation/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/use-of-t-dxd-in-previously-treated-patients-with-advanced-her2-positive-breast-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/t-dxd-shows-efficacy-against-active-brain-metastases-in-her2-positive-breast-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/annual-meeting-of-the-moroccan-cancer-society-an-opportunity-for-young-cancer-researchers-to-evolve/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-mafalda-oliveira-2/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-mafalda-oliveira/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/begonia-trial-reports-activity-with-datopotamab-deruxtecan-plus-durvalumab-in-triple-negative-breast-cancer/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/epov-mafalda-oliveira-1/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/cemiplimab-rwlc-improves-overall-survival-vs-chemotherapy-in-recurrent-cervical-cancer-after-first-line-platinum-based-chemotherapy/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/cemiplimab-rwlc-following-platinum-based-chemotherapy-in-recurrent-or-metastatic-cervical-cancer-clinical-implications/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nccn-honors-oncology-leaders-promoting-progress-in-cancer-care/</loc><lastmod>2022-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-recognizes-2022-fellows-of-the-american-society-of-clinical-oncology/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/new-fda-approved-oncology-drugs-2021-2022/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-global-humanist-of-heroic-proportions-who-never-lost-sight-of-the-wounded-living-in-the-shadows-of-poverty/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/city-of-hope-receives-49-million-grant/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-establishes-center-for-equity-diversity-and-inclusion-sybil-green-jd-rph-mha-to-serve-as-center-s-vice-president/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/narratives-in-oncology-through-the-years/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/albert-einstein-cancer-center-announces-new-appointments-to-key-leadership-positions/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/city-of-hope-s-department-of-surgery-chair-awarded-2022-flance-karl-award-given-by-the-american-surgical-association/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/alex-choi-md-joins-palliative-care-program-at-smilow-cancer-hospital/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/mourned-and-missed/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/lynn-m-schuchter-md-fasco-to-become-asco-president-elect-2022-2023-following-annual-meeting/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/city-of-hope-researcher-receives-margaret-l-kripke-legend-award-for-promotion-of-women-in-cancer/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/turning-point/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/an-international-leader-bridges-the-political-divide-in-the-name-of-humanity-and-cancer-care/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nci-launches-program-to-offer-molecular-characterization-of-childhood-cancers/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/growing-up-in-a-house-filled-with-science-leads-to-a-career-in-breast-cancer-and-health-outcomes-research/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-leadership-for-2022-2023-term-announced/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-community-practitioner-and-policy-advocate-who-stresses-holistic-patient-centered-care/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-nationally-regarded-pediatric-oncologist-found-his-passion-early/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/mount-sinai-and-samuel-waxman-cancer-research-foundation-to-collaborate-on-aging-related-cancer/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-expands-oncology-summer-internship-program-with-aims-to-increase-workforce-diversity/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/sunil-verma-md-navigates-an-international-path-from-clinical-educator-in-oncology-to-leadership-in-industry/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/navigating-difficult-waters-a-cancer-journey/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-fascination-with-bats-leads-to-a-career-in-oncology-and-a-role-in-championing-equity-in-the-workforce/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-descendant-of-midwest-pioneers-follows-a-path-to-academic-genitourinary-oncology/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/missed-opportunities-in-geriatric-oncology-research/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/from-the-segregated-tennis-courts-of-washington-dc-to-a-leadership-role-in-surgical-oncology/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/aua-astro-release-new-clinically-localized-prostate-cancer-guideline/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-leader-in-oncology-balances-philosophy-medicine-and-humility/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-son-forges-a-noted-career-in-oncology-rather-than-follow-in-his-father-s-illustrious-footsteps-in-dermatology/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-honors-2022-special-awards-recipients/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/a-personal-cancer-journey-shifts-a-career-in-the-arts-to-a-career-in-radiation-oncology/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/after-rounds-on-the-leukemia-ward-a-young-doctor-finds-his-calling-in-stem-cell-transplantation/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-s-president-elect-makes-partnering-with-patients-the-cornerstone-of-his-presidential-term/</loc><lastmod>2022-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/three-arm-first-line-chemoimmunotherapy-study-in-patients-with-metastatic-pancreatic-cancer/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/immunotherapy-combination-in-newly-diagnosed-glioblastoma/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/patient-facing-screening-tool-could-increase-detection-of-individuals-with-lynch-syndrome/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/athena-mono-trial-rucaparib-maintenance-in-newly-diagnosed-patients-with-advanced-ovarian-cancer/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ramucirumabpembrolizumab-vs-standard-of-care-in-patients-with-advanced-nsclc-previously-treated-with-immune-checkpoint-inhibitors/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/mfolfoxiripanitumumab-vs-mfolfoxpanitumumab-for-the-initial-treatment-of-ras-and-braf-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/weekly-electronic-reporting-of-symptoms-improved-outcomes-in-patients-with-advanced-cancer/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/flt3-inhibitor-crenolanib-in-combination-with-chemotherapy-for-newly-diagnosed-flt3-mutant-aml/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/differences-in-germline-variant-spectrum-between-black-and-white-men-with-prostate-cancer/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/personalized-ctdna-testing-and-late-recurrence-in-high-risk-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/majestec-1-bispecific-antibody-teclistamab-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ponatinib-plus-blinatumomab-for-patients-with-philadelphia-chromosome-positive-all/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/allogeneic-car-t-cell-therapy-for-relapsed-or-refractory-t-cell-lymphoma/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/targeted-therapy-emavusertib-shows-activity-in-patients-with-mds-or-aml-with-specific-mutations/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/metformin-vs-placebo-in-patients-with-high-risk-operable-breast-cancer-receiving-standard-treatment/</loc><lastmod>2022-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/real-world-uptake-of-fgfr-alteration-testing-and-gene-targeted-therapy-for-patients-with-urothelial-cancer/</loc><lastmod>2022-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/intracranial-efficacy-of-lorlatinib-vs-crizotinib-in-alk-positive-advanced-nsclc/</loc><lastmod>2022-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/triplet-combination-therapy-yields-high-response-rates-in-patients-with-flt3-mutated-aml/</loc><lastmod>2022-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/magrolimab-plus-azacitidine-in-tp53-mutant-aml/</loc><lastmod>2022-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/adding-targeted-therapy-to-chemoimmunotherapy-may-offer-long-term-benefits-for-patients-with-ighv-mutated-cll/</loc><lastmod>2022-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/longitudinal-liquid-biopsy-for-circulating-tumor-cells-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2022-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/risk-of-skin-desquamation-with-breast-radiotherapy-does-position-change-outcomes-in-large-breasted-women/</loc><lastmod>2022-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/proposed-second-revision-of-the-international-staging-system-for-survival-in-multiple-myeloma/</loc><lastmod>2022-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/potential-association-of-the-2012-uspstf-grade-d-recommendation-against-psa-screening-with-changes-in-prostate-cancer-specific-mortality/</loc><lastmod>2022-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/demethylation-and-upregulation-of-the-oncogene-sall4-after-hypomethylating-therapy/</loc><lastmod>2022-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-finds-adult-survivors-of-childhood-cancer-may-often-be-undertreated-for-modifiable-cardiovascular-risk-factors/</loc><lastmod>2022-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/survival-with-stereotactic-radiosurgery-vs-whole-brain-radiotherapy-in-patients-with-sclc-and-intracranial-metastatic-disease/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/addition-of-atezolizumab-to-folfoxiribevacizumab-for-metastatic-colorectal-cancer/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/real-world-association-between-smoking-history-and-overall-survival-with-first-line-pembrolizumab-in-patients-with-advanced-nsclc/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/can-abemaciclib-provide-good-clinical-outcomes-in-patients-with-high-risk-hr-positive-her2-negative-breast-cancer-who-received-neoadjuvant-chemotherapy/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/androgen-receptor-signaling-may-contribute-to-targeted-therapy-resistance-in-patients-with-melanoma/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/brexucabtagene-autoleucel-in-relapsed-or-refractory-mantle-cell-lymphoma-3-year-follow-up-of-zuma-2-trial/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/incidence-of-major-adverse-cardiac-events-in-patients-receiving-immune-checkpoint-inhibitors/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma-2-year-follow-up-of-cartitude-1-trial/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fda-approves-foundationone-cdx-as-a-companion-diagnostic-for-entrectinib/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/momelotinib-for-symptomatic-and-anemic-patients-with-myelofibrosis/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/aacr-report-finds-racial-and-ethnic-minorities-continue-to-shoulder-a-disproportionate-burden-of-cancer/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/new-research-finds-computer-assisted-colonoscopy-may-identify-more-precancerous-polyps-than-traditional-colonoscopy/</loc><lastmod>2022-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/mrd-guided-cessation-of-treatment-in-patients-receiving-venetoclaxibrutinib-for-relapsed-or-refractory-cll/</loc><lastmod>2022-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fda-authorizes-moderna-and-pfizer-biontech-covid-19-vaccines-for-children-as-young-as-6-months-of-age/</loc><lastmod>2022-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/mmp-7-expression-and-pathologic-response-to-neoadjuvant-treatment-in-patients-with-pancreatic-cancer-undergoing-resection/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/four-new-teams-receive-100m-to-take-on-cancers-toughest-challenges/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/cabozantinib-and-atezolizumab-for-patients-with-progressive-metastatic-castration-resistant-prostate-cancer-post-hormonal-therapy/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/treatment-of-anal-high-grade-squamous-intraepithelial-lesions-to-prevent-anal-cancer-in-persons-with-hiv/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/does-receipt-of-adjuvant-chemotherapy-after-primary-retroperitoneal-lymph-node-dissection-affect-outcomes-for-patients-with-nonseminomatous-germ-cell-tumors/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-identifies-three-gene-signature-that-may-predict-response-to-selinexor-in-patients-with-multiple-myeloma/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/new-perspective-shows-higher-breast-cancer-mortality-for-black-women-emerged-40-years-ago/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ovarian-cancer-first-line-every-3-week-carboplatinpaclitaxel-vs-weekly-dose-dense-regimens/</loc><lastmod>2022-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/factors-that-may-predict-response-to-the-addition-of-bevacizumab-to-front-line-chemotherapy-in-patients-with-endometrial-cancer/</loc><lastmod>2022-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-examines-how-diet-quality-may-affect-breast-cancer-risk/</loc><lastmod>2022-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-links-sugar-sweetened-beverage-consumption-and-liver-cancer-risk/</loc><lastmod>2022-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/mismatch-in-breast-cancer-trial-results-and-real-world-outcomes-based-on-treatment-discontinuation/</loc><lastmod>2022-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/outcomes-of-pancreas-surveillance-in-the-caps5-study-and-total-caps-cohort/</loc><lastmod>2022-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/venetoclax-plus-cladribine-and-low-dose-cytarabine-alternating-with-azacitidine-and-venetoclax-in-newly-diagnosed-older-or-unfit-patients-with-aml/</loc><lastmod>2022-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nivolumabcabozantinib-vs-sunitinib-in-first-line-treatment-for-advanced-rcc-overall-survival-analysis-of-checkmate-9er-trial/</loc><lastmod>2022-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-predicts-cancer-cases-and-deaths-in-africa-could-double-by-2040/</loc><lastmod>2022-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-finds-diagnostic-mammography-performance-varies-across-racial-and-ethnic-groups/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fda-denies-authorization-to-market-juul-products/</loc><lastmod>2022-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ctcs-in-the-staging-of-newly-diagnosed-patients-with-transplant-eligible-multiple-myeloma/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ai-may-be-used-to-identify-benign-thyroid-nodules-and-reduce-unnecessary-biopsies/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-links-diabetes-and-worse-outcomes-in-long-term-survivors-of-metastatic-breast-cancer/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/chemicals-in-personal-care-products-may-cause-harmful-effects-in-breast-cancer-cells-in-black-women/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/role-of-combined-positive-score-with-treatment-outcomes-in-recurrent-or-metastatic-head-and-neck-cancer/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/structural-racism-and-health-care-system-barriers-may-contribute-to-breast-biopsy-delays/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/18-million-cancer-survivors-in-the-united-states-new-report-shows/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/children-s-cancer-cause-accepting-applications-through-july-31-for-2022-survivorship-champion-s-prize/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/risk-of-interval-invasive-and-advanced-breast-cancer-screening-with-digital-breast-tomosynthesis-vs-digital-mammography/</loc><lastmod>2022-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/is-focal-therapy-with-mri-guided-focused-ultrasound-safe-and-effective-for-grade-group-2-or-3-prostate-cancer/</loc><lastmod>2022-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/addition-of-trastuzumabpertuzumab-to-perioperative-flot-chemotherapy-in-her2-positive-esophagogastric-adenocarcinoma/</loc><lastmod>2022-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-finds-covid-19-vaccines-are-safe-for-patients-treated-with-immune-checkpoint-inhibitors-for-lung-cancer/</loc><lastmod>2022-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fulvestrantcapivasertib-for-aromatase-inhibitor-resistant-advanced-breast-cancer-overall-survival-and-expanded-genetic-panel-analysis-from-the-faktion-trial/</loc><lastmod>2022-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/direct-acting-antivirals-in-hcv-associated-indolent-non-hodgkin-lymphomas/</loc><lastmod>2022-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/outcomes-in-pancreatic-cancer-surveillance-program-for-carriers-of-germline-cdkn2a-pathogenic-variants/</loc><lastmod>2022-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-seeks-to-determine-if-her2-low-breast-cancer-is-a-distinct-biological-and-prognostic-subtype-of-disease/</loc><lastmod>2022-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/analysis-finds-prevalence-of-colorectal-cancer-screenings-remains-low-in-younger-adults/</loc><lastmod>2022-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-statement-on-supreme-court-decision-in-dobbs-v-jackson-women-s-health/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/biden-administration-announces-new-model-to-improve-cancer-care-for-medicare-patients/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/long-term-morbidity-in-aml-survivors-treated-with-blood-or-marrow-transplantation/</loc><lastmod>2022-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nejm-editors-publish-opinion-following-dobbs-v-jackson-decision/</loc><lastmod>2022-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/addition-of-adebrelimab-to-carboplatinetoposide-in-first-line-treatment-of-extensive-stage-sclc/</loc><lastmod>2022-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/vaccine-effectiveness-against-covid-19-breakthrough-infection-in-patients-with-cancer/</loc><lastmod>2022-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/postoperative-outcomes-with-robot-assisted-vs-open-radical-cystectomy-for-bladder-cancer/</loc><lastmod>2022-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/aumolertinib-vs-gefitinib-in-patients-with-advanced-nsclc-and-egfr-exon-19-deletion-or-l858r-mutation/</loc><lastmod>2022-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nimotuzumab-may-improve-overall-survival-in-patients-with-kras-wild-type-advanced-pancreatic-cancer/</loc><lastmod>2022-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/new-study-assesses-oncologists-ratings-of-the-importance-of-health-insurance-and-costs-for-genomic-testing/</loc><lastmod>2022-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/survival-and-surgery-to-radiotherapy-intervals-among-asian-american-and-pacific-islander-women-with-early-breast-cancer/</loc><lastmod>2022-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/analysis-of-circulating-tumor-dna-as-a-biomarker-in-stage-iii-or-iv-wilms-tumor/</loc><lastmod>2022-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/nemvaleukin-alfa-alone-and-in-combination-with-pembrolizumab-for-advanced-stage-solid-tumors/</loc><lastmod>2022-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/sacituzumab-govitecan-hziy-improves-progression-free-survival-in-endocrine-resistant-hormone-receptor-positiveher2-negative-metastatic-breast-cancer/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/ctdna-may-help-identify-the-need-for-adjuvant-therapy-in-stage-ii-colon-cancer/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/asco-and-who-to-collaborate-on-quality-indicators-for-cancer-facilities/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/adagrasib-improves-outcomes-in-kras-mutated-nsclc-phase-ii-study-shows/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/new-report-shows-covid-19-pandemic-increased-cancer-related-deaths-in-the-united-states/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-reveals-racial-disparities-in-guideline-concordant-care-for-patients-with-early-onset-colorectal-cancer/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/endocrine-sensitivity-test-predicts-survival-benefit-of-dose-dense-chemotherapy-for-patients-with-hormone-receptor-positive-breast-cancer/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/panitumumab-plus-mfolfox6-improves-overall-survival-in-a-type-of-newly-diagnosed-metastatic-colorectal-cancer/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/fam-trastuzumab-deruxtecan-nxki-doubles-progression-free-survival-in-her2-low-metastatic-breast-cancer/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-finds-high-dose-ifosfamide-superior-to-other-standard-of-care-treatments-in-recurrent-and-primary-refractory-ewing-sarcomas/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/including-asct-as-part-of-initial-therapy-improves-progression-free-survival-in-newly-diagnosed-patients-with-multiple-myeloma/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-offers-guidance-for-future-trials-of-adjuvant-therapy-for-early-stage-hormone-receptor-positiveher2-negative-breast-cancer/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/racialethnic-disparities-and-cardiovascular-mortality-among-cancer-survivors/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/brentuximab-vedotin-plus-chemotherapy-vs-chemotherapy-alone-for-pediatric-patients-with-hodgkin-lymphoma/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/dabrafenib-plus-trametinib-improve-overall-response-rates-vs-standard-of-care-chemotherapy-in-pediatric-patients-with-low-grade-gliomas/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/unprecedented-100-of-first-14-untreated-patients-with-rectal-cancer-respond-to-pd-1-blocker-dostarlimab-gxly/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-shows-children-whose-parents-have-a-cancer-history-have-increased-unmet-economic-needs-in-food-housing-and-transportation/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-examines-ancestry-specific-genetic-risk-for-triple-negative-breast-cancer/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/researchers-examine-racial-differences-in-treatment-and-outcomes-of-first-line-therapies-for-kidney-cancer/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/neoadjuvant-immunotherapy-may-improve-survival-for-patients-with-soft-tissue-sarcoma/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/biomarker-guidance-may-allow-patients-aged-55-or-older-with-low-grade-luminal-a-type-breast-cancer-to-avoid-radiation-therapy/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/did-the-aca-s-medicaid-expansion-affect-cancer-clinical-trial-enrollment/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/06-june/study-finds-genetic-mutations-differ-across-younger-and-older-patients-with-breast-cancer/</loc><lastmod>2022-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/fda-grants-regular-approval-to-fam-trastuzumab-deruxtecan-nxki-for-unresectable-or-metastatic-her2-positive-breast-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/preoperative-radiotherapy-and-diep-flap-reconstruction-in-women-requiring-mastectomy-for-breast-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/beyond-immunotherapy-new-targeted-agents-for-advanced-nsclc/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/long-term-quality-of-life-measures-in-women-undergoing-breast-conservation-vs-mastectomy-and-reconstruction-for-early-breast-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/rates-of-neurologic-adverse-events-in-randomized-trials-of-immune-checkpoint-inhibitors-in-patients-with-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/approaches-to-potentiate-immune-response-in-patients-who-do-not-respond-to-anti-pd-1-therapy-for-melanoma/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/polygenic-score-may-enable-more-precise-psa-screening-for-prostate-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/sentinel-node-may-not-be-informative-in-making-treatment-decisions-for-some-breast-cancer-subsets/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/president-biden-s-proposed-investment-for-cutting-edge-medical-research-should-not-jeopardize-funding-for-existing-cancer-research-enterprise/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/drug-developers-share-thoughts-on-the-oncology-pipeline-and-the-changes-in-clinical-trials/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/nccn-clinical-practice-guidelines-in-oncology-2022-updates/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/parp1-selective-inhibitor-offers-significant-benefits-over-older-predecessors-in-treatment-of-solid-tumors/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/the-future-of-community-oncology-practice/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/covac-1-vaccination-studied-for-prevention-of-severe-covid-19-in-immune-deficient-patients-with-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/finding-a-new-normal-after-classical-hodgkin-lymphoma/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/asco-guideline-rapid-update-addresses-the-use-of-neoadjuvant-pembrolizumab-in-high-risk-early-stage-triple-negative-breast-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/new-england-cancer-specialists-to-become-affiliate-member-of-dana-farber-cancer-institute/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/asco-expands-oncology-summer-internship-program-with-aims-to-increase-workforce-diversity/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/representatives-diana-degette-and-fred-upton-named-asco-congressional-champions-for-cancer-care/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/incidental-respiratory-disease-found-in-low-dose-ct-screens-challenges-and-opportunities/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/long-term-overall-survival-in-unresectable-stage-iii-nsclc-with-consolidation-durvalumab-in-the-pacific-trial-translation-to-real-world-outcomes/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/checkmate-816-neoadjuvant-nivolumab-plus-chemotherapy-improves-event-free-survival-over-chemotherapy-alone-in-resectable-nsclc/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-david-paul-carbone/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/a-second-edition-adds-new-value-to-personalized-medicine/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/an-emergency-room-physician-offers-hands-on-perspective-for-treating-patients-with-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/innovation-can-advance-equitable-cancer-care/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/asco-sets-goals-to-advance-the-clinician-educator-career-pathway-in-oncology/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/understanding-oncologists-perceptions-about-palliative-care-and-the-barriers-preventing-its-use/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/overall-survival-benefit-with-nivolumab-plus-chemotherapy-or-ipilimumab-vs-chemotherapy-alone-in-esophageal-squamous-cell-carcinoma/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/5-year-survival-outcomes-with-consolidation-durvalumab-after-chemoradiotherapy-in-unresectable-stage-iii-nsclc/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/pd-1-inhibition-in-first-line-treatment-of-advanced-esophageal-squamous-cell-carcinoma-more-to-come-on-new-paradigm/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/chop-establishes-the-susan-s-and-stephen-p-kelly-center-for-cancer-immunotherapy/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/elaine-jaffe-honored-with-inaugural-aacr-james-s-ewing-thelma-b-dunn-award-for-outstanding-achievement-in-pathology/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/pembrolizumab-for-msi-hdmmr-advanced-endometrial-carcinoma/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/tackling-the-global-burden-of-cancer-on-adolescents-and-young-adults-with-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/perlmutter-cancer-center-appoints-inaugural-director-of-center-for-blood-cancers/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/john-e-dick-phd-faacr-to-receive-inaugural-aacr-award-for-outstanding-achievement-in-blood-cancer-research/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/the-impact-of-war-on-patients-with-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/surgical-approach-and-overall-survival-in-younger-women-with-breast-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/how-st-jude-and-the-who-are-sparking-an-international-movement-to-increase-treatment-access-for-children-with-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/covid-19-restrictions-linked-to-delayed-breast-cancer-care-at-safety-net-hospital/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/uc-davis-launches-center-for-advancing-cancer-health-equity/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/axicabtagene-ciloleucel-for-second-line-treatment-of-large-b-cell-lymphoma/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/steven-rosenberg-recognized-with-2022-pezcoller-foundation-aacr-international-award/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-mario-sznol-and-stefania-scala/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/combination-therapy-of-olaparib-cyclophosphamide-and-metformin-under-study-in-advanced-endometrial-cancer/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/an-early-love-of-science-led-to-a-career-in-breast-cancer-research-for-sara-m-tolaney-md-mph/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/novel-neoadjuvant-therapy-may-boost-response-in-resectable-nsclc/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-edward-garon/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/diversity-in-clinical-trials-training-program-renamed-to-honor-robert-winn/</loc><lastmod>2022-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/intraperitoneal-carboplatin-plus-paclitaxel-vs-intravenous-chemotherapy-in-ovarian-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/deborah-k-armstrong-md-on-the-rationale-for-intraperitoneal-treatment-of-ovarian-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/accelerating-delivery-of-multiple-myeloma-therapies-to-all-patients/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/niraparib-maintenance-therapy-improves-progression-free-survival-in-advanced-ovarian-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-barbara-norquist/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/asco-honors-2022-special-awards-recipients/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/msk-introduces-the-starr-foundation-program-for-discovery-science/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/destiny-lung01-t-dxd-shows-durable-activity-in-previously-treated-metastatic-her2-mutant-nsclc/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/destiny-lung01-is-trastuzumab-deruxtecan-the-answer-for-her2-mutant-lung-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/from-a-small-village-in-china-to-cutting-edge-clinical-cancer-research-for-cynthia-ma/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/music-interventions-for-improving-psychological-and-physical-symptoms-in-people-with-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/assessing-food-insecurity-among-patients-with-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/short-and-shorter-screening-tools-for-food-insecurity/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/why-are-black-women-still-dying-at-higher-rates-than-white-women-from-breast-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/j-paul-taylor-md-phd-named-scientific-director-and-executive-vice-president-of-st-jude/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/sam-mbulaiteye-mbchb-mphil-mmed-named-2022-scientist-of-the-year-by-lymphoma-foundation-of-america/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/david-braun-md-phd-joins-prostate-and-urologic-cancers-program-at-yale-cancer-center/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/penn-medicine-appoints-robert-vonderheide-md-dphil-to-second-5-year-term-as-director-of-abramson-cancer-center/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/nccn-announces-indiana-university-melvin-and-bren-simon-comprehensive-cancer-center-joins-member-institutions/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/natural-killer-cells-precomplexed-with-innate-cell-engager-show-activity-in-cd30-positive-lymphoma/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-julio-chavez-and-hayder-saeed/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/aacr-honors-lee-ellis-md-for-contributions-to-education-and-training-in-cancer-research/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-for-early-nsclc/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-mark-awad/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/2-year-follow-up-shows-durable-responses-with-sotorasib-in-kras-g12c-mutated-non-small-cell-lung-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/demystifying-immunotherapy-for-early-stage-triple-negative-breast-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/soraya-trial-mirvetuximab-soravtansine-improves-response-rate-in-drug-resistant-ovarian-cancer/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-deborah-armstrong/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/how-to-get-the-dose-right/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/some-recurrences-of-ductal-carcinoma-in-situ-may-be-genetically-distinct-from-the-primary-tumor-study-reports/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-aditya-bardia/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/atezolizumab-plus-bevacizumab-shows-activity-in-advanced-neuroendocrine-tumors/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/fda-takes-steps-to-increase-racial-and-ethnic-diversity-in-clinical-trials/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/break-through-cancer-announces-50-million-in-grants-to-researchers-from-five-top-cancer-research-centers/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-carotuximab-to-pazopanib-in-advanced-angiosarcoma/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/anetumab-ravtansine-vs-vinorelbine-in-relapsed-mesothelin-positive-advanced-malignant-pleural-mesothelioma/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/fda-approves-nivolumabrelatlimab-rmbw-for-unresectable-or-metastatic-melanoma/</loc><lastmod>2022-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/hematologic-oncology-2021-2022-almanac/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/bispecific-antibodies-with-multiple-targets-moving-forward-in-multiple-myeloma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-joseph-mikhael/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/isatuximab-containing-induction-therapy-for-multiple-myeloma-increases-measurable-residual-disease-negativity/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/maia-trial-daratumumab-added-to-lenalidomide-plus-dexamethasone-improves-overall-survival-in-transplant-ineligible-multiple-myeloma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/maintenance-daratumumab-prolongs-progression-free-survival-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/subcutaneous-daratumumab-added-to-pomalidomide-plus-dexamethasone-improves-progression-free-survival-in-multiple-myeloma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/fda-approvals-in-hematologic-oncology-2021-2022/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-jane-n-winter/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/car-t-cell-therapy-fails-to-improve-outcomes-in-aggressive-non-hodgkin-lymphoma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-laurie-sehn/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/transform-lisocabtagene-maraleucel-improves-outcomes-in-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-laurie-h-sehn-1/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/mosunetuzumab-meets-primary-endpoint-of-phase-ii-trial-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-jane-n-winter-and-christopher-r-flowers/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-polatuzumab-vedotin-piiq-to-standard-of-care-significantly-reduces-progression-of-diffuse-large-b-cell-lymphoma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-laurie-h-sehn-and-alex-herrera/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/axicabtagene-ciloleucel-quadruples-event-free-survival-in-large-b-cell-lymphoma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/dual-pi3k%CE%B4ck1%CE%B5-inhibitor-umbralisib-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-susan-m-o-brien/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/improved-outcomes-with-time-limited-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-joshua-brody/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/fixed-duration-venetoclax-plus-ibrutinib-achieves-deep-and-durable-mrd-remissions-in-cll/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/zanubrutinib-superior-to-ibrutinib-for-cllsll-in-phase-iii-alpine-trial/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/epov-jacqueline-barrientos/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/elevate-rr-trial-acalabrutinib-as-effective-as-ibrutinib-with-fewer-cardiac-effects-in-resistant-cll/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-ivosidenib-to-azacitidine-in-newly-diagnosed-idh1-mutated-acute-myeloid-leukemia/</loc><lastmod>2022-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/cemiplimab-rwlc-improves-overall-survival-vs-chemotherapy-in-recurrent-cervical-cancer-after-first-line-platinum-based-chemotherapy/</loc><lastmod>2022-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/do-aya-cancer-survivors-face-a-higher-risk-of-developing-and-dying-from-a-new-primary-cancer/</loc><lastmod>2022-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/study-reports-new-potential-target-for-car-t-cell-therapy/</loc><lastmod>2022-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/swog-1216-orteronel-vs-bicalutamide-with-adt-for-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/sbrt-plus-nivolumab-with-or-without-ipilimumab-in-refractory-metastatic-pancreatic-cancer/</loc><lastmod>2022-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/cancer-rates-declining-in-canada-but-cases-and-deaths-increasing-because-of-demographic-factors/</loc><lastmod>2022-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/cancer-screening-accessibility-among-native-americans/</loc><lastmod>2022-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/patient-reported-outcomes-and-toxicity-with-adjuvant-stereotactic-pelvic-radiation-therapy-in-uterine-cancers/</loc><lastmod>2022-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/study-finds-long-term-increase-in-cancer-risk-after-high-childhood-bmi/</loc><lastmod>2022-05-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/concordance-with-pretreatment-staging-imaging-guidelines-in-rectal-cancer-asco-qopi-findings/</loc><lastmod>2022-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/case-study-examines-differences-between-ai-and-radiologist-perception-in-breast-cancer-screening/</loc><lastmod>2022-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/asco-s-cancerlinq-and-atropos-health-collaborate-to-harness-real-world-data-to-provide-point-of-care-informatics-consult-to-oncologists/</loc><lastmod>2022-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/research-suggests-over-half-of-eligible-women-would-prefer-self-sampling-for-cervical-screening/</loc><lastmod>2022-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/study-examines-link-between-emphysema-and-lung-cancer-risk/</loc><lastmod>2022-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/association-of-pathogenic-variants-in-hereditary-cancer-genes-with-additional-cancers-and-non-neoplastic-diseases/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/treatment-de-escalation-in-hpv-associated-oropharyngeal-cancer-using-primary-radiotherapy-vs-transoral-surgery/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/absence-of-fam19a4mir124-2-dna-methylation-and-clinical-regression-of-high-grade-cervical-intraepithelial-neoplasia/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/tuxedo-1-efficacy-of-t-dxd-for-patients-with-her2-positive-breast-cancer-and-active-brain-metastases/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/updated-overall-survival-results-from-monaleesa-3-show-improved-overall-survival-in-patients-with-hr-positiveher2-negative-breast-cancer/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/nivolumab-and-salvage-nivolumabipilimumab-for-previously-untreated-advanced-clear-cell-renal-cell-carcinoma/</loc><lastmod>2022-05-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/second-line-tislelizumab-vs-chemotherapy-for-advanced-esophageal-squamous-cell-carcinoma/</loc><lastmod>2022-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-ibandronate-to-adjuvant-endocrine-therapy-in-postmenopausal-women-with-er-positive-breast-cancer/</loc><lastmod>2022-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/comparison-of-2020-nice-criteria-for-preoperative-radiotherapy-in-rectal-cancer-treated-by-surgery-alone-with-established-mri-prognostic-factors/</loc><lastmod>2022-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/astro-issues-clinical-guideline-on-radiation-therapy-for-brain-metastases/</loc><lastmod>2022-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/segmentectomy-vs-lobectomy-in-small-sized-peripheral-nsclc/</loc><lastmod>2022-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/lenvatinibpembrolizumab-vs-sunitinib-in-patients-with-advanced-renal-cell-carcinoma-hrqol-outcomes/</loc><lastmod>2022-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/consolidation-durvalumab-alone-or-combined-with-oleclumab-or-monalizumab-for-unresectable-stage-iii-nsclc/</loc><lastmod>2022-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/can-ai-assist-in-predicting-spinal-fractures-in-patients-with-cancer/</loc><lastmod>2022-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/rehospitalization-and-emergency-department-visits-after-car-t-cell-therapy-in-commercially-insured-patients-with-cancer/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/report-finds-targeting-il-6-may-help-to-relieve-immunotherapy-side-effects/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/anti-ctla-4-antibody-based-treatment-in-patients-with-metastatic-melanoma-experiencing-disease-progression-on-relatlimabnivolumab/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/new-research-encourages-harnessing-health-technology-to-help-patients-with-cancer-quit-smoking/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/patients-with-nsclc-brain-metastases-undergoing-neurosurgical-resection-comparison-of-treatment-regimens/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/association-of-chromosome-3p253-gain-with-cisplatin-resistance-and-outcomes-in-male-malignant-germ-cell-tumors/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/mortality-and-perioperative-outcomes-with-open-vs-robot-assisted-radical-cystectomy-for-bladder-cancer/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/3-vs-6-months-of-adjuvant-oxaliplatin-and-fluoropyrimidine-based-therapy-for-stage-iii-colon-cancer/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/prevalence-of-plasma-cell-and-lymphoproliferative-disorders-in-relatives-of-probands-with-light-chain-amyloidosis/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/aya-leukemia-survivors-have-higher-mortality-rates-than-the-general-population/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/watch-and-wait-strategy-for-organ-preservation-in-patients-receiving-total-neoadjuvant-therapy-for-rectal-adenocarcinoma/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/report-investigates-potential-causes-of-decreasing-responses-to-car-t-cell-therapy-in-patients-with-non-hodgkin-lymphoma/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/neurologic-and-survival-outcomes-after-awake-craniotomy-for-glioblastoma/</loc><lastmod>2022-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-vistusertib-to-anastrozole-for-hr-positive-recurrent-or-metastatic-endometrial-cancer/</loc><lastmod>2022-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-adt-and-pelvic-lymph-node-radiotherapy-to-salvage-prostate-bed-radiotherapy-after-prostatectomy/</loc><lastmod>2022-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/report-finds-uptake-of-erdafitinib-for-urothelial-cancer-may-be-limited-despite-positive-real-world-survival-data/</loc><lastmod>2022-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/colonoscopy-after-positive-fit-test-may-reduce-risk-of-death-from-colorectal-cancer/</loc><lastmod>2022-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/guideline-concordant-treatment-of-women-with-nonmetastatic-breast-cancer-in-sub-saharan-africa/</loc><lastmod>2022-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/do-electronic-health-interventions-improve-quality-of-life-and-other-health-outcomes-in-patients-with-breast-cancer/</loc><lastmod>2022-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/early-postoperative-algorithm-based-vs-usual-care-after-pancreatic-resection/</loc><lastmod>2022-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/study-investigates-possible-link-between-risk-of-breast-cancer-in-males-and-male-infertility/</loc><lastmod>2022-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/longer-follow-up-shows-adjuvant-immunotherapy-after-bladder-cancer-surgery-may-be-associated-with-reduced-disease-recurrence/</loc><lastmod>2022-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/using-a-transcriptomic-profile-to-identify-plasma-cell-leukemia-like-disease-in-patients-with-newly-diagnosed-multiple-myeloma/</loc><lastmod>2022-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/medicaid-expansion-is-associated-with-increased-survival-in-newly-diagnosed-patients-with-cancer/</loc><lastmod>2022-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/hepatic-arterial-infusion-pump-chemotherapy-vs-resection-for-multifocal-intrahepatic-cholangiocarcinoma/</loc><lastmod>2022-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/delays-in-surgery-for-advanced-esophageal-cancer-result-in-significantly-worse-survival/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/etirinotecan-pegol-vs-physician-s-choice-of-chemotherapy-for-patients-with-metastatic-breast-cancer-and-brain-metastases/</loc><lastmod>2022-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/surgery-preference-and-surgery-received-in-women-with-dcis/</loc><lastmod>2022-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/intraoperative-margin-assessment-in-breast-conserving-surgery-using-a-pegulicianine-fluorescence-guided-system/</loc><lastmod>2022-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/mortality-and-associated-factors-among-patients-with-cancer-vs-no-cancer-infected-with-sars-cov-2/</loc><lastmod>2022-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/asco-and-accc-release-wide-ranging-recommendations-to-expand-diverse-participation-in-cancer-clinical-trials/</loc><lastmod>2022-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/researchers-develop-and-monitor-approaches-to-fix-blood-vessel-abnormalities-that-make-tumors-difficult-to-treat/</loc><lastmod>2022-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/f-18-fes-pet-assessment-of-er-status-in-metastases-from-newly-diagnosed-patients-with-metastatic-breast-cancer/</loc><lastmod>2022-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/report-examines-imaging-approach-with-potential-to-detect-lung-cancer-at-the-cellular-level/</loc><lastmod>2022-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/adverse-events-seen-with-abiraterone-or-enzalutamide-among-patients-with-advanced-prostate-cancer/</loc><lastmod>2022-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/tazemetostat-for-patients-with-relapsed-or-refractory-bap1-inactivated-malignant-pleural-mesothelioma/</loc><lastmod>2022-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/emerald-trial-elacestrant-vs-standard-endocrine-therapy-in-previously-treated-patients-with-er-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2022-05-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/does-treatment-with-5-aris-impact-the-risk-of-dying-of-prostate-cancer-among-men-without-a-prior-diagnosis-of-the-disease/</loc><lastmod>2022-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/gabapentin-may-be-an-effective-alternative-to-opioids-for-patients-with-head-and-neck-cancer-receiving-radiation/</loc><lastmod>2022-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/study-finds-screen-detected-colorectal-cancers-may-have-more-favorable-stage-distribution-than-colorectal-cancers-detected-otherwise/</loc><lastmod>2022-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/use-of-telemedicine-for-cancer-care-increased-during-the-covid-19-pandemic-but-varied-by-race-socioeconomic-status-and-other-factors/</loc><lastmod>2022-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/nearly-half-of-black-patients-with-metastatic-breast-cancer-report-not-being-informed-about-clinical-trials/</loc><lastmod>2022-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/persistent-racial-ethnic-disparities-found-in-survival-rates-for-early-onset-colon-cancer/</loc><lastmod>2022-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/rise-of-esophageal-cancer-and-barrett-s-esophagus-rates-in-middle-aged-adults/</loc><lastmod>2022-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/incidence-of-cholelithiasis-or-cholecystitis-in-the-year-prior-to-a-diagnosis-of-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2022-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/cancer-mortality-among-black-patients-in-the-united-states-1999-to-2019/</loc><lastmod>2022-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/association-of-chronic-hepatitis-b-virus-infection-and-antiviral-treatment-with-risk-of-extrahepatic-malignancies/</loc><lastmod>2022-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/neoadjuvant-nivolumab-plus-chemotherapy-in-resectable-stage-iiia-nsclc-overall-survival-and-biomarker-analyses/</loc><lastmod>2022-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/addition-of-everolimus-to-adjuvant-endocrine-therapy-for-high-risk-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2022-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/05-may/fda-approves-tisagenlecleucel-for-adult-patients-with-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/cardiovascular-mortality-and-cancer-mortality-over-time-among-cancer-survivors/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/how-asco-eco-and-who-are-marshalling-resources-to-provide-care-for-ukrainian-civilians-and-refugees-with-cancer/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/meta-analysis-of-aromatase-inhibitors-vs-tamoxifen-in-premenopausal-women-with-er-positive-early-stage-breast-cancer-receiving-ovarian-suppression/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fda-approves-radioligand-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/antibody-response-to-sars-cov-2-mrna-1273-vaccination-in-patients-with-cancer-single-institution-study/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fda-approves-axicabtagene-ciloleucel-for-the-second-line-treatment-of-large-b-cell-lymphoma/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/trials-of-parp-inhibitors-in-urothelial-cancer-more-questions-than-answers/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-sandy-srinivas/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/is-neoadjuvant-pembrolizumab-underused-in-the-treatment-of-early-stage-triple-negative-breast-cancer/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-julie-margenthaler/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/choice-01-toripalimab-plus-chemotherapy-improves-survival-in-advanced-nsclc-without-actionable-mutations/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-shows-pemigatinib-activity-in-treatment-of-myeloid-or-lymphoid-neoplasms-with-fgfr1-rearrangement/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-john-mascarenhas/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/novel-immunotherapy-duo-delays-disease-progression-in-advanced-melanoma/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-adil-daud-and-georgina-long/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/mantle-cell-lymphoma-previously-treated-with-btk-inhibitor-may-respond-to-a-newer-btk-inhibitor/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-charu-aggarwal/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/phase-iii-trials-and-tribulations/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fox-chase-cancer-center-appoints-elizabeth-plimack-md-ms-as-deputy-director/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/andrew-chapman-do-facp-appointed-director-of-the-sidney-kimmel-cancer-center-jefferson-health-philadelphia/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/selinexor-improves-progression-free-survival-in-endometrial-cancer/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-amit-oza/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/why-are-many-women-overdue-for-cervical-cancer-screening/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-reports-adjuvant-pembrolizumab-improves-disease-free-survival-in-early-stage-nsclc/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-martin-reck/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/phase-iii-trial-evaluates-the-role-of-aspirin-in-preventing-breast-cancer-recurrence/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-angela-demichele/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/norman-sharpless-md-to-step-down-as-director-of-the-nci/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/clinical-trials-updates-in-the-treatment-of-older-adults-with-gastrointestinal-malignancies/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/philip-d-greenberg-md-faacr-voted-aacr-president-elect-for-2022-2023/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/war-in-ukraine-statistics-do-not-keep-pace-with-reality/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/new-report-offers-guidance-for-standardizing-data-on-sex-gender-sexual-orientationnew-report-offers-guidance-for-standardizing-data-on-sex-gender-sexual-orientation/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fixed-dose-nivolumab-and-relatlimab-rmbw-for-unresectable-or-metastatic-melanoma/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/trametinib-improves-progression-free-survival-vs-standard-of-care-treatment-in-recurrent-low-grade-serous-ovarian-carcinoma/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/mek-inhibition-is-now-a-standard-of-care-in-recurrent-low-grade-serous-ovarian-cancer-what-next/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/addition-of-pembrolizumab-to-chemotherapy-improves-event-free-survival-in-triple-negative-breast-cancer/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/immune-checkpoint-inhibitors-in-neoadjuvant-or-adjuvant-therapy-for-triple-negative-breast-cancer-the-paradigm-shifts/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/association-of-lifestyle-and-cardiovascular-risk-factors-with-hospitalization-for-heart-failure-subtypes-in-breast-cancer-survivors/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/idh12-inhibitors-show-activity-in-patients-with-myelodysplastic-syndrome/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-mikkael-sekeres/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/aml-study-shows-benefit-of-cpx-351-vs-hypomethylating-agent-plus-venetoclax-in-subgroup-of-older-adults/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-amandeep-salhotra/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/incidental-findings-on-low-dose-ct-lung-cancer-screening-in-the-nlst-and-risk-of-respiratory-disease-mortality/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/new-breeze-of-immunotherapy-in-b-cell-non-hodgkin-lymphomas-off-the-shelf-bispecific-antibodies/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/from-iran-to-silicon-valley-a-cancer-survivor-shares-her-story/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/tony-hunter-phd-faacr-honored-with-2022-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/erratum/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/st-jude-receives-first-group-of-ukrainian-children-with-cancer-for-care-in-the-united-states/</loc><lastmod>2022-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/tislelizumab-plus-chemotherapy-improves-progression-free-survival-in-nasopharyngeal-cancer/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/second-line-combination-study-in-urothelial-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-guru-sonpavde/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/improving-oral-anticancer-therapy-adherence-a-call-to-action-and-an-upcoming-fda-asco-workshop/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/american-cancer-society-awards-16-million-in-grants-to-establish-cancer-health-equity-research-centers/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/the-hamoui-foundation-and-lungevity-foundation-present-awards-for-ret-positive-lung-cancer-research/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/city-of-hope-completes-strategic-acquisition-of-cancer-treatment-centers-of-america/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/parp-inhibitors-in-the-treatment-of-breast-cancer-what-s-next/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/emerging-endocrine-therapies-for-the-management-of-breast-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fda-approves-pembrolizumab-for-advanced-endometrial-carcinoma/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fda-approves-olaparib-for-adjuvant-treatment-of-high-risk-early-breast-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-gary-walker/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/protecting-the-immunocompromised-from-covid-19-practical-information-for-physicians/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/advances-in-managing-cardiac-side-effects-associated-with-breast-cancer-treatment/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-finds-ai-ultrasound-platform-can-predict-thyroid-malignancy-pathologic-stage-and-braf-mutation-status/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-alexander-pearson/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/several-studies-evaluate-agents-in-the-first-line-second-line-and-later-treatment-of-advanced-kidney-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-mark-robson/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/reflections-on-the-evolution-of-clinical-care-since-the-passage-of-the-national-cancer-act-of-1971/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/deciphering-clinical-outcomes-through-molecular-profiling-the-immotion151-trial/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/brazilian-oncologist-antonio-drauzio-varella-md-rises-from-the-streets-of-sao-paulo-to-international-fame/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/are-disadvantaged-patients-less-likely-to-receive-advanced-radiotherapy-techniques-for-head-and-neck-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/no-overall-survival-benefit-with-atezolizumab-plus-bevacizumab-vs-sunitinib-in-previously-untreated-metastatic-renal-cell-carcinoma/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/leader-in-the-field-of-integrative-oncology-barrie-cassileth-phd-dies-at-83/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/asco-provisional-clinical-opinion-offers-guidance-for-using-and-interpreting-genomic-testing-in-patients-with-advanced-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/supporting-and-mobilizing-resources-asco-joins-worldwide-efforts-to-support-ukrainian-cancer-care/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/rapid-guideline-revises-recommendations-for-adjuvant-therapy-in-patients-with-early-stage-lung-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/congress-increases-federal-funding-for-cancer-research/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/olympia-trial-adjuvant-olaparib-significantly-improves-overall-survival-in-germline-brca-mutated-breast-cancer/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/a-lifetime-of-pioneering-biologic-research-leads-to-a-new-history-of-evolution/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/use-of-traditional-chinese-medicine-herbal-formula-xiao-yao-san-to-relieve-depression-and-anxiety/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/having-metastatic-breast-cancer-has-led-me-to-focus-on-what-matters/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/national-brain-tumor-society-launches-dna-damage-response-consortium-with-yale-cancer-center/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/childhood-leukemia-pioneer-donald-p-pinkel-md-dies-at-95/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/aacr-and-mpm-oncology-charitable-foundation-announce-three-grants-to-support-transformative-cancer-research/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/addition-of-anti-lag-3-antibody-relatlimab-to-nivolumab-improves-progression-free-survival-in-previously-untreated-advanced-melanoma/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/relativity-047-relatlimab-plus-nivolumab-worthy-of-further-study-in-advanced-melanoma-and-beyond/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/seven-new-research-grants-awarded-by-the-prevent-cancer-foundation/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/jeffrey-peppercorn-named-editor-in-chief-of-jco-oncology-practice/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/conundrums-of-sars-cov-2-infection-in-cancer-care/</loc><lastmod>2022-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-gary-walker-1/</loc><lastmod>2022-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/are-disadvantaged-patients-less-likely-to-receive-advanced-radiotherapy-techniques-for-head-and-neck-cancer-1/</loc><lastmod>2022-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/epov-alexander-pearson-1/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-finds-ai-ultrasound-platform-can-predict-thyroid-malignancy-pathologic-stage-and-braf-mutation-status-1/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/induction-chemotherapy-with-paclitaxel-cisplatin-and-capecitabine-vs-cisplatin-and-fluorouracil-for-nasopharyngeal-carcinoma/</loc><lastmod>2022-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/updated-guidance-for-covid-19-vaccination-from-nccn-recommends-fifth-mrna-shot-second-booster-dose-for-immunocompromised-people/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/overall-survival-in-the-arches-trial-addition-of-enzalutamide-to-adt-for-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/less-prostate-cancer-screening-reduces-overdiagnosis-but-may-miss-aggressive-cases/</loc><lastmod>2022-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/selinexor-in-previously-treated-advanced-dedifferentiated-liposarcoma/</loc><lastmod>2022-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/maternal-malignancies-may-be-identified-through-noninvasive-prenatal-test-results/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fuzuloparib-maintenance-therapy-in-patients-with-platinum-sensitive-recurrent-ovarian-carcinoma/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/high-dose-radiotherapy-with-short-vs-long-term-androgen-deprivation-in-localized-prostate-cancer/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/ai-may-assist-physicians-in-better-assessing-the-effectiveness-of-bladder-cancer-treatment/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/addition-of-high-dose-treosulfan-and-melphalan-to-consolidation-in-high-risk-ewing-sarcoma/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-examines-rates-of-psychiatric-disorders-and-self-harm-among-patients-diagnosed-across-26-cancer-types/</loc><lastmod>2022-04-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/narsoplimab-for-hematopoietic-stem-cell-transplantation-associated-thrombotic-microangiopathy/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/assessment-of-cancer-risk-profile-for-germline-brca1-and-brca2-pathogenic-variants-in-patients-with-common-cancers/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/navicixizumab-plus-paclitaxel-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/new-study-examining-women-s-breast-density-knowledge-suggests-opportunities-for-improvement/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/two-studies-examine-use-of-proton-beam-therapy-in-the-united-states/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/internal-mammary-node-irradiation-in-node-positive-early-breast-cancer-15-year-outcomes/</loc><lastmod>2022-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/checkmate-816-neoadjuvant-nivolumab-plus-chemotherapy-in-resectable-nsclc/</loc><lastmod>2022-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/new-factors-that-can-predict-breast-cancer-recurrence-identified/</loc><lastmod>2022-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-finds-car-t-cell-therapy-outcomes-side-effects-are-similar-in-black-and-hispanic-patients-compared-to-white-and-asian-patients/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/switch-to-maintenance-endocrine-therapy-plus-bevacizumab-after-first-line-paclitaxelbevacizumab-induction-in-advanced-er-positive-her2-negative-breast-cancer/</loc><lastmod>2022-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/gut-microbiome-may-alter-response-to-cancer-therapy/</loc><lastmod>2022-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/increased-risk-of-cancer-in-early-life-among-individuals-with-autism-spectrum-disorders/</loc><lastmod>2022-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-identifies-genetic-changes-in-patients-with-barrett-s-esophagus-that-progresses-to-esophageal-cancer/</loc><lastmod>2022-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/patients-with-cancer-face-greater-risks-from-abdominal-aneurysm-repair/</loc><lastmod>2022-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-compares-surveillance-methods-and-schedules-in-stage-i-testicular-seminoma/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/association-of-serous-tubal-intraepithelial-carcinoma-at-risk-reducing-salpingo-oophorectomy-with-risk-of-subsequent-peritoneal-carcinomatosis/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/collaboration-finds-international-disparities-in-screening-treatment-and-outcomes-for-patients-with-lung-cancer/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/destiny-breast03-trial-t-dxd-vs-t-dm1-in-previously-treated-patients-with-metastatic-her2-positive-breast-cancer/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/effect-of-traditional-eligibility-criteria-on-enrollment-of-black-patients-in-pancreatic-cancer-clinical-trials/</loc><lastmod>2022-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/outcomes-with-pembrolizumab-pembrolizumabchemotherapy-and-cetuximabchemotherapy-by-pd-l1-cps-in-recurrentmetastatic-head-and-neck-cancer/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/addition-of-sorafenib-to-standard-chemotherapy-in-pediatric-patients-with-high-allelic-ratio-flt3-itd-positive-aml/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/immune-related-adverse-events-with-immune-checkpoint-inhibitor-treatment-for-melanoma-in-older-white-patients/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-explores-racial-disparities-among-patients-undergoing-gastrointestinal-cancer-surgery/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/tumor-budding-may-provide-independent-prognostic-value-for-disease-free-and-overall-survival-in-patients-with-stage-iii-colon-cancer/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/norman-sharpless-md-to-step-down-as-director-of-the-nci-1/</loc><lastmod>2022-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/induction-chemotherapy-with-paclitaxel-cisplatin-and-capecitabine-vs-cisplatin-and-fluorouracil-for-nasopharyngeal-carcinoma-1/</loc><lastmod>2022-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/hyperthermic-intraperitoneal-chemotherapy-with-primary-or-interval-cytoreductive-surgery-for-advanced-ovarian-cancer/</loc><lastmod>2022-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/telemedicine-vs-in-person-postoperative-follow-up-after-inpatient-oncologic-surgery/</loc><lastmod>2022-04-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/combined-bcma-and-cd19-car-t-cells-in-relapsed-or-refractory-multiple-myeloma-long-term-follow-up/</loc><lastmod>2022-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/egfr-inhibition-in-egfr-amplified-advanced-gastroesophageal-cancer/</loc><lastmod>2022-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/fda-approves-alpelisib-for-pik3ca-related-overgrowth-spectrum/</loc><lastmod>2022-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/prognostic-value-of-stils-in-young-women-with-node-negative-triple-negative-breast-cancer-who-did-not-receive-neoadjuvant-systemic-therapy/</loc><lastmod>2022-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-finds-covid-19-restrictions-delayed-breast-cancer-care-at-a-safety-net-hospital/</loc><lastmod>2022-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/positive-lymph-nodes-may-not-be-an-indicator-for-chemotherapy-in-older-patients-with-breast-cancer/</loc><lastmod>2022-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-finds-lumpectomy-may-be-as-effective-as-mastectomy-for-patients-with-nonmetastatic-breast-cancer-younger-than-40/</loc><lastmod>2022-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-identifies-decline-in-annual-screening-for-breast-cancer-survivors/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/multilevel-factors-related-to-changes-in-body-adiposity-in-black-survivors-of-breast-cancer/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/research-finds-covid-19-vaccine-protects-most-patients-with-cancer-but-risk-remains-higher-for-patients-with-blood-cancers/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/screening-platform-may-contribute-to-detection-of-early-stage-pancreatic-cancers-other-malignancies/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/ipilimumab-plus-nivolumab-improves-progression-free-survival-in-advanced-melanoma/</loc><lastmod>2022-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/association-of-pretreatment-lymphocyte-count-with-overall-survival-and-benefit-of-addition-of-cisplatin-to-radiotherapy-in-oropharyngeal-squamous-cell-carcinoma/</loc><lastmod>2022-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/patients-with-all-and-certain-gene-regulation-patterns-may-be-less-likely-to-respond-to-car-t-cell-therapy/</loc><lastmod>2022-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/new-bioinformatics-platform-optimizes-selection-of-combination-cancer-therapies/</loc><lastmod>2022-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/biomarker-driven-assessment-of-nivolumab-nivolumabipilimumab-and-vegfr-tyrosine-kinase-inhibitors-in-first-line-treatment-of-metastatic-clear-cell-rcc/</loc><lastmod>2022-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/ai-model-may-help-predict-adverse-events-from-new-drug-combinations/</loc><lastmod>2022-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/risk-of-cardiovascular-disease-and-mortality-in-women-with-breast-cancer-the-pathways-heart-study/</loc><lastmod>2022-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/turnaround-times-in-melanoma-braf-testing-and-effect-on-time-to-treatment-initiation/</loc><lastmod>2022-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/third-dose-of-covid-19-vaccine-significantly-increases-immune-responses-in-most-patients-with-multiple-myeloma/</loc><lastmod>2022-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-findings-broaden-repertoire-of-cancer-relevant-genes/</loc><lastmod>2022-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/selumetinib-in-children-and-young-adults-with-tumors-with-activating-mapk-pathway-alterations/</loc><lastmod>2022-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/longitudinal-patterns-of-fatigue-after-breast-cancer-diagnosis-and-treatment/</loc><lastmod>2022-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/association-between-venous-thromboembolism-risk-and-blood-type/</loc><lastmod>2022-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/researchers-seek-to-expand-immunotherapy-options-for-patients-with-advanced-breast-and-colorectal-cancers/</loc><lastmod>2022-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/therapies-targeting-dna-damage-response-show-antitumor-activity/</loc><lastmod>2022-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/changes-in-the-nccn-guidelines-on-colorectal-cancer-screening/</loc><lastmod>2022-04-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/association-of-mrd-status-with-outcomes-after-autologous-stem-cell-transplantation-for-multiple-myeloma/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/an-ai-model-may-predict-elevated-pancreatic-cancer-risk-using-electronic-health-records/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/recurrent-noninvasive-breast-tumors-may-not-always-be-related-to-the-primary-lesion/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/patients-with-lung-cancer-and-a-genetic-variant-linked-to-autoimmune-disease-may-be-especially-responsive-to-immunotherapy/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/pediatric-patients-with-cancer-in-lower-and-middle-income-countries-faced-a-significantly-higher-mortality-risk-during-the-covid-19-pandemic/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/sotorasib-achieves-durable-responses-in-kras-g12c-mutated-lung-cancer/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/novel-approach-using-off-the-shelf-preactivated-nk-cells-achieves-promising-responses-in-cd30-positive-lymphoma/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-examines-disparities-in-relapse-among-pediatric-patients-with-all/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/accounting-for-genetic-factors-that-cause-normal-variations-in-psa-levels-may-improve-the-accuracy-of-prostate-cancer-detection/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/new-car-t-cell-therapy-for-solid-tumors-was-safe-and-showed-early-efficacy/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/in-the-neoadjuvant-setting-combination-immunotherapy-with-durvalumab-is-more-effective-than-durvalumab-alone-for-early-stage-nsclc/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/novel-covid-19-vaccine-may-provide-protection-for-patients-with-b-cell-deficiencies/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/adjuvant-pembrolizumab-in-resected-stage-iib-or-iic-melanoma/</loc><lastmod>2022-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/factors-contributing-to-mortality-and-second-cancer-incidence-after-treatment-for-testicular-cancer/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/effect-of-changes-to-california-medicaid-dental-benefits-on-earlier-diagnosis-of-oral-cavity-cancer/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/diagnosis-of-cancer-within-30-days-after-emergency-hospital-admission/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/peace-1-trial-addition-of-abiraterone-plus-prednisone-to-adt-and-docetaxel-in-de-novo-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2022-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/addition-of-nintedanib-to-neoadjuvant-gemcitabinecisplatin-in-locally-advanced-muscle-invasive-bladder-cancer/</loc><lastmod>2022-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/role-of-21-gene-recurrence-score-and-preoperative-endocrine-therapy-response-in-guiding-treatment-in-early-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/nominations-open-for-king-hussein-award-for-cancer-research/</loc><lastmod>2022-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/virtual-panel-explores-impact-of-racism-on-the-cancer-burden-facing-asian-americans/</loc><lastmod>2022-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/study-shows-medical-financial-hardship-increases-mortality-risk-for-cancer-survivors/</loc><lastmod>2022-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/raceethnicity-mortality-disparity-in-patients-with-de-novo-stage-iv-breast-cancer-effect-of-medicaid-expansion/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/association-of-preexisting-thyroid-autoimmunity-with-risk-of-papillary-thyroid-cancer/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/breast-cancer-screening-with-digital-breast-tomosynthesis-plus-synthesized-mammography-vs-digital-mammography/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/ai-may-reduce-miss-rate-of-precancerous-polyps-during-colorectal-cancer-screening/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/tislelizumab-plus-chemotherapy-improves-progression-free-survival-in-nasopharyngeal-cancer-1/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/04-april/overall-survival-in-keynote-177-pembrolizumab-vs-chemotherapy-in-microsatellite-instability-high-or-mismatch-repair-deficient-metastatic-colorectal-cancer/</loc><lastmod>2022-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-e-gabriela-chiorean/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/codebreak-100-sotorasib-shows-activity-in-kras-g12c-mutated-pancreatic-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-mandana-kamgar/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/krystal-1-adagrasib-controls-disease-in-gastrointestinal-malignancies-beyond-colorectal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-anthony-el-khoueiry/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/himalaya-trial-first-line-tremelimumab-plus-durvalumab-improves-overall-survival-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-ian-chau/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cosmic-312-cabozantinib-plus-atezolizumab-improves-progression-free-survival-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-chris-verslype/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/rationale-208-durable-clinical-activity-reported-with-tislelizumab-in-advanced-liver-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-nilofer-azad/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/topaz-1-overall-survival-prolonged-with-first-line-immunotherapy-plus-chemotherapy-in-biliary-tract-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/ivosidenib-vs-placebo-for-previously-treated-advanced-idh1-mutated-cholangiocarcinoma-final-overall-survival-analysis-of-the-claridhy-trial/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adjuvant-nivolumab-improves-disease-free-survival-vs-placebo-in-resected-esophageal-or-gastroesophageal-junction-cancer-after-neoadjuvant-chemoradiotherapy/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-gabriel-brooks/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adjuvant-therapy-for-colon-cancer-impact-of-stopping-treatment-early/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-rona-yaeger/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/high-response-rate-seen-with-nivolumab-added-to-encorafenib-and-cetuximab-in-braf-v600e-mutated-metastatic-colorectal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/keynote-811-pembrolizumab-plus-trastuzumab-and-chemotherapy-in-previously-untreated-advanced-her2-positive-gastric-adenocarcinoma/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/recent-fda-approvals-in-gastrointestinal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-benoit-rousseau-md-phd/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-samuel-klempner/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/promising-outcomes-with-shorter-duration-of-checkpoint-inhibition-in-metastatic-colorectal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/sotorasib-in-previously-treated-patients-with-kras-g12c-mutant-colorectal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/neoadjuvant-checkpoint-inhibitor-doublet-yields-complete-responses-in-gastroesophageal-cancers/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adding-pembrolizumab-to-chemotherapy-improves-overall-and-progression-free-survival-in-first-line-treatment-of-advanced-esophageal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-elena-elez/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adding-first-line-nivolumab-to-chemotherapy-improves-survival-in-gastric-gastroesophageal-junction-and-esophageal-adenocarcinomas/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/braf-mutant-colorectal-cancer-latest-findings-for-targeted-treatment/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/addition-of-neoadjuvant-folfirinox-to-preoperative-chemoradiotherapy-in-locally-advanced-rectal-cancer/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/gastrointestinal-oncology-2021-2022-almanac/</loc><lastmod>2022-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/most-favored-nation-model-s-withdrawal-complete-asco-applauds-decision-preserving-access-to-care/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/new-asco-sno-guideline-addresses-treatment-recommendations-tailored-to-glioma-subtypes/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/societies-team-up-to-provide-support-for-ukrainian-patients-with-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/abemaciclib-for-previously-treated-patients-with-p16ink4a-deficient-mesothelioma/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/tofacitinib-for-rheumatoid-arthritis-cancer-and-cardiovascular-event-risks/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/american-cancer-society-names-arif-kamal-first-chief-patient-officer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/blood-test-predicts-recurrence-of-hpv-driven-oropharyngeal-cancer-after-treatment/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-quynh-thu-le-1/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/outcomes-and-toxicity-with-single-agent-immune-checkpoint-inhibitor-treatment-in-geriatric-patients-with-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/should-patients-aged-80-and-older-receive-single-agent-immune-checkpoint-inhibitor-treatment/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/asco-provisional-clinical-opinion-offers-guidance-for-using-and-interpreting-genomic-testing-in-patients-with-advanced-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/accc-appoints-david-penberthy-as-new-president/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/midtreatment-imaging-de-escalates-therapy-for-half-of-study-patients-with-oropharyngeal-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-quynh-thu-le/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/robert-otto-valdez-named-director-of-the-ahrq/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/new-role-for-raymond-dubois-at-the-mark-foundation-for-cancer-research/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/i-enrolled-in-the-wisdom-study-and-learned-i-am-at-high-risk-for-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/lu-177-dotatate-plus-long-acting-octreotide-vs-high-dose-long-acting-octreotide-in-midgut-neuroendocrine-tumors/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/peptide-receptor-radionuclide-therapy-for-gastroenteropancreatic-neuroendocrine-tumors-implications-for-current-practice/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-e-gabriela-chiorean-1/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/arul-chinnaiyan-awarded-sjoberg-prize-for-cancer-research/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/allogeneic-transplantation-for-hematologic-neoplasms-in-adults/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/new-appointments-for-ecog-acrin-and-nci-committees/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/avelumab-failed-to-improve-1-year-survival-in-pd-l1-positive-advanced-urothelial-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-xin-gao/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/atezolizumab-induces-responses-in-advanced-penile-cancer-but-biomarkers-needed-to-improve-patient-selection/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-hao-nguyen/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/sotorasib-shows-activity-in-kras-g12c-mutated-pancreatic-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/accc-welcomes-matt-devino-as-director-cancer-care-delivery-and-health-policy/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/neoadjuvant-enfortumab-vedotin-ejfv-shows-activity-in-muscle-invasive-bladder-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-guru-p-sonpavde-md/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-elisabeth-heath-oliver-sartor/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/keynote-564-update-supports-benefit-of-adjuvant-pembrolizumab-in-high-risk-renal-cell-carcinoma/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-daniel-geynisman/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/bj-rimel-named-medical-director-cancer-clinical-trials-office/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-evaluates-whether-ctdna-has-demonstrable-advantage-over-standard-surveillance-methods-for-colorectal-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/triplet-combination-of-darolutamide-docetaxel-and-androgen-deprivation-therapy-extends-survival-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/asco-stands-with-ukraine-s-cancer-community/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/first-line-olaparib-plus-abiraterone-extends-radiographic-progression-free-survival-in-men-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-celestia-higano/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-reports-modest-gain-in-progression-free-survival-with-continued-enzalutamide-in-advanced-prostate-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/oncolytic-virus-plus-nivolumab-demonstrates-durable-response-in-nonmelanoma-skin-cancer-of-the-head-and-neck/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adjuvant-therapy-for-colon-cancer-impact-of-stopping-treatment-early-1/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-gabriel-brooks-1/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/war-is-hell-it-s-also-a-public-health-disaster-especially-for-people-with-cancer/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/fda-approves-ciltacabtagene-autoleucel-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/fda-approves-pacritinib-for-adult-patients-with-myelofibrosis-and-thrombocytopenia/</loc><lastmod>2022-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/genitourinary-oncology-2021-2022-almanac/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-reports-modest-gain-in-progression-free-survival-with-continued-enzalutamide-in-advanced-prostate-cancer-1/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-elisabeth-heath-oliver-sartor-1/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/triplet-combination-of-darolutamide-docetaxel-and-androgen-deprivation-therapy-extends-survival-in-metastatic-hormone-sensitive-prostate-cancer-1/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-celestia-higano-1/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/addition-of-ipatasertib-to-abiraterone-plus-prednisolone-improves-radiographic-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-sophia-c-kamran-2/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/shorter-course-radiation-therapy-a-new-practice-standard-after-prostatectomy/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-eleni-efstathiou-md/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/stampede-in-nonmetastatic-castration-sensitive-prostate-cancer-abiraterone-added-to-androgen-deprivation-therapy-improves-survival/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/maintained-benefit-of-apalutamide-plus-androgen-deprivation-therapy-shown-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2022-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-daniel-geynisman-1/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/keynote-564-update-supports-benefit-of-adjuvant-pembrolizumab-in-high-risk-renal-cell-carcinoma-1/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/keynote-564-adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/first-line-nivolumab-plus-cabozantinib-improves-progression-free-and-overall-survival-vs-sunitinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-guru-p-sonpavde-md-1/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/neoadjuvant-enfortumab-vedotin-ejfv-shows-activity-in-muscle-invasive-bladder-cancer-1/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/neoadjuvant-dd-mvac-improves-local-control-and-progression-free-survival-in-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/enfortumab-vedotin-ejfv-improves-overall-survival-vs-chemotherapy-in-previously-treated-advanced-urothelial-carcinoma/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/sacituzumab-govitecan-hziy-in-urothelial-carcinoma-progressing-after-platinum-based-chemotherapy-and-checkpoint-inhibitor-therapy/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-celestia-higano-2/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/first-line-olaparib-plus-abiraterone-extends-radiographic-progression-free-survival-in-men-with-metastatic-castration-resistant-prostate-cancer-1/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/thyroidectomy-with-or-without-radioiodine-for-low-risk-thyroid-cancer/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/humanitarian-paul-farmer-md-phd-dies-at-62/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/atul-gawande-md-mph-appointed-to-senior-post-at-us-agency-for-international-development/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/oneoncology-names-davey-daniel-md-chief-medical-officer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/monica-bertagnolli-md-facs-fasco-joins-prevent-cancer-foundation-board-of-directors/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/linda-fleisher-phd-mph-appointed-co-chair-of-american-cancer-society-s-national-navigation-roundtable/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cancer-physician-and-researcher-philip-philip-md-phd-to-join-henry-ford-cancer-institute/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cms-expands-coverage-of-lung-cancer-screening-with-low-dose-ct/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/pyrotinib-and-capecitabine-in-her2-positive-breast-cancer-with-brain-metastases/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/new-asco-report-clarifies-potential-value-and-utility-of-biosimilars-in-oncology/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/prevent-pandemics-act-would-improve-public-health-in-the-united-states/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/2023-aca-proposal-aims-to-advance-health-equity-and-improve-access-to-health-care-coverage/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/association-of-breast-cancer-subtypes-with-pathogenic-germline-variants-in-nine-breast-cancer-susceptibility-genes/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/reduction-in-elective-radiotherapy-dose-and-field-in-definitive-chemoradiotherapy-for-hpv-associated-oropharyngeal-carcinoma/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/robert-califf-confirmed-as-fda-commissioner/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/the-road-to-a-career-in-breast-oncology-took-several-twists-and-turns-for-sara-hurvitz/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/project-confirm-an-initiative-to-promote-transparency-of-the-accelerated-approval-program-for-oncology-indications/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/managing-long-term-toxicity-from-pelvic-radiation-therapy/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/importing-oncology-trials-from-china-or-other-single-foreign-countries-for-consideration-of-us-regulatory-approvals/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/the-virtues-of-ruth-gratitude-advocacy-and-service/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/asco-and-ontario-health-provide-updated-recommendations-on-using-adjuvant-bone-modifying-treatments-in-nonmetastatic-breast-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/abc-sixth-international-consensus-conference-updates-guidelines-for-advanced-breast-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/clinical-trials-underway-for-t-dxd-in-breast-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/t-dxd-shows-activity-in-her2-low-her2-undetectable-breast-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-priyanka-sharma-md/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/lenvatinibpembrolizumab-improves-progression-free-and-overall-survival-vs-chemotherapy-in-previously-treated-advanced-endometrial-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/time-for-a-radical-change-in-the-treatment-of-endometrial-cancer-keynote-775-and-beyond/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-matthew-genyeh-mei/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/memorial-sloan-kettering-president-and-chief-executive-officer-craig-b-thompson-to-step-down/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/chip-mutations-surprisingly-associated-with-lower-risk-of-alzheimer-s-disease/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-mikkael-a-sekeres/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/iberia-romina-sosa-appointed-new-chief-of-division-of-hematology-at-fox-chase/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/margaret-von-mehren-appointed-new-vice-chair-of-department-of-hematologyoncology-at-fox-chase/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-identifies-factors-impacting-adherence-to-oral-medications-for-metastatic-breast-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-stefano-cascinu/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/grieving-the-loss-of-sexual-intimacy-as-a-result-of-cancer-and-its-treatment/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/american-cancer-society-reports-breast-cancer-is-now-the-leading-cause-of-cancer-mortality-in-black-women/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/laura-bukavina-wins-asco-genitourinary-conquer-cancer-merit-award-for-microbiome-research-in-bladder-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/combinations-advance-the-power-of-pembrolizumab-in-hodgkin-lymphoma/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cancercare-offers-patients-financial-assistance-for-transportation-pet-care/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/leukemia-committee-of-national-cooperative-clinical-trials-group-names-new-co-chairs/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/report-on-covid-19-outlines-the-pandemics-negative-impact-on-patient-care-and-clinical-research-and-the-lessons-learned/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/from-a-low-income-family-in-puerto-rico-to-a-leadership-role-in-oncology-for-gerardo-colon-otero-md/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/checkpoint-inhibitors-in-esophagogastric-cancer-updates-of-landmark-trials/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cancer-in-the-arab-world-addressing-challenges-to-improve-outcomes/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/neoadjuvant-checkpoint-inhibitor-doublet-yields-complete-responses-in-gastroesophageal-cancers-1/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-samuel-klempner-1/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/massage-for-pain-management-in-the-cancer-population/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/small-study-reports-neoadjuvant-pd-1-blockade-yields-100-clinical-complete-response-rate-in-locally-advanced-mismatch-repair-deficient-rectal-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/emerging-issues-regarding-artificial-intelligence-in-cancer-research-and-clinical-practice/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-christopher-willett/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/gupta-shankar-ctdna-cns-lymphoma/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/robust-and-durable-responses-to-pembrolizumab-in-patients-with-previously-treated-msi-hdmmr-endometrial-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/nipicol-trial-promising-outcomes-with-shorter-duration-of-checkpoint-inhibition-in-metastatic-colorectal-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-benoit-rousseau/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/potential-for-curative-intent/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-celestia-higano-3/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/nci-office-of-cancer-survivorship-welcomes-michelle-mollica-phd-mph-rn-ocn-as-senior-advisor/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/president-s-cancer-panel-report-closing-gaps-in-cancer-screening-for-all-americans/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/car-t-cell-therapy-as-second-line-treatment-in-large-b-cell-lymphomas/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/updated-findings-on-t-dxd-in-gastrointestinal-malignancies/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/parp-inhibitor-plus-abiraterone-benefits-subgroups-of-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/noninvasive-diagnosis-of-cns-lymphoma-possible-through-ctdna/</loc><lastmod>2022-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/addition-of-selumetinib-to-adjuvant-radioactive-iodine-in-high-risk-differentiated-thyroid-cancer/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/trends-in-grade-5-toxicity-and-response-rates-in-phase-i-trials-for-hematologic-malignancies/</loc><lastmod>2022-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/genetic-testing-of-samples-from-deceased-patients-with-tubo-ovarian-cancer-to-inform-families-of-identification-of-pathogenic-variants/</loc><lastmod>2022-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/half-of-patients-with-cancer-and-survivors-report-incurring-cancer-related-medical-debt/</loc><lastmod>2022-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/asco-and-eco-present-update-on-how-the-war-in-ukraine-is-impacting-care-for-patients-with-cancer/</loc><lastmod>2022-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adjuvant-olaparib-significantly-improves-overall-survival-in-germline-brca-mutated-breast-cancer/</loc><lastmod>2022-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/early-intrathecal-therapy-for-high-grade-icans-in-patients-receiving-car-t-cell-therapy/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/characteristics-of-nonalcoholic-fatty-liver-disease-related-hcc-vs-hcc-from-other-causes/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/abemaciclibletrozole-in-patients-with-recurrent-er-positive-endometrial-cancer/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/soraya-trial-conjugate-therapy-produces-remissions-in-one-third-of-patients-with-drug-resistant-ovarian-cancer/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/atezolizumab-plus-chemoradiation-is-safe-demonstrates-signs-of-immune-activation-in-patients-with-cervical-cancer/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/all-cause-mortality-after-adjuvant-vs-early-salvage-radiation-therapy-following-radical-prostatectomy-for-pn1-prostate-cancer/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/sequencing-of-drug-combinations-could-amplify-antitumor-immune-response-in-liver-cancer/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/temozolomide-followed-by-low-dose-ipilimumabnivolumab-in-mss-and-mgmt-silenced-metastatic-colorectal-cancer/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/perioperative-dose-dense-mvac-vs-gemcitabinecisplatin-in-nonmetastatic-muscle-invasive-bladder-cancer/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/lung-cancer-diagnosis-with-low-dose-ct-screening-and-a-program-for-management-of-incidentally-detected-lung-nodules/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/researchers-identify-trends-in-treatment-for-retroperitoneal-soft-tissue-sarcoma/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/adjuvant-pembrolizumab-may-improve-disease-free-survival-in-patients-with-early-stage-nsclc/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/how-do-lifestyle-and-cardiovascular-risk-factors-relate-to-heart-failure-subtypes-in-postmenopausal-breast-cancer-survivors/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/younger-patients-with-appendicitis-may-be-at-increased-risk-for-appendiceal-cancer/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/hrr-mutational-status-may-be-prognostic-of-survival-outcomes-for-women-with-recurrent-platinum-sensitive-ovarian-cancer/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/guideline-concordant-surgery-and-adjuvant-chemotherapy-for-early-stage-nsclc/</loc><lastmod>2022-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/oncologists-use-of-geriatric-assessment-instruments-in-older-patients-with-cancer/</loc><lastmod>2022-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-evaluates-response-based-immunotherapy-strategy-in-patients-with-advanced-urothelial-carcinoma/</loc><lastmod>2022-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/concordance-in-symptomatic-adverse-event-reporting-by-children-clinicians-and-caregivers/</loc><lastmod>2022-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/results-from-mappyacts-trial-show-the-feasibility-and-benefit-of-molecular-profiling-at-cancer-recurrence-in-pediatric-patients/</loc><lastmod>2022-03-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/short-term-radiotherapy-plus-preoperative-chemotherapy-vs-long-term-chemoradiotherapy-for-locally-advanced-rectal-cancer/</loc><lastmod>2022-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/pd-1-inhibition-in-patients-with-classic-or-endemic-kaposi-sarcoma/</loc><lastmod>2022-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/risk-of-colorectal-cancer-linked-to-cumulative-time-with-excess-body-weight/</loc><lastmod>2022-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/third-covid-19-vaccine-dose-may-improve-immune-response-in-patients-with-lymphoma/</loc><lastmod>2022-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/thickness-specific-incidence-of-cutaneous-melanoma-in-the-united-states/</loc><lastmod>2022-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-finds-black-patients-with-cancer-diagnosed-with-covid-19-have-worse-outcomes-than-white-patients/</loc><lastmod>2022-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/long-term-survival-outcomes-with-adjuvant-capecitabine-in-biliary-tract-cancer/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/transportation-barriers-to-health-care-among-cancer-survivors-in-the-united-states/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cabozantinib-plus-nivolumab-in-advanced-non-clear-cell-renal-cell-carcinoma/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/ariel4-trial-rucaparib-vs-chemotherapy-in-patients-with-relapsed-ovarian-cancer-and-deleterious-brca1-or-brca2-mutations/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/registry-study-shows-a-real-world-increase-in-biomarker-testing-among-patients-with-advanced-nsclc/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/fda-clinical-trial-guidances-share-biden-administration-s-goals-for-advancing-development-of-cancer-treatments/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/racial-disparities-in-outcomes-for-patients-with-early-hr-positive-breast-cancer-after-adjustment-for-insurance-status-and-neighborhood-deprivation-index/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/do-diagnostic-delays-impact-overall-survival-in-patients-with-nsclc/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/prediction-model-for-brca-mutation-carrying-status-in-asian-patients-with-breast-cancer/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/pain-and-quality-of-life-in-the-profound-trial-olaparib-vs-next-generation-hormonal-agent-in-metastatic-castration-resistant-prostate-cancer-with-hrr-gene-alterations/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/midtreatment-imaging-de-escalates-therapy-for-half-of-patients-with-oropharyngeal-cancer/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/effect-of-screening-initiative-on-disparity-in-colorectal-cancer-mortality-between-black-and-white-patients/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/esophagus-sparing-vs-standard-palliative-radiation-for-patients-with-advanced-central-nsclc/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/mri-and-mammography-breast-cancer-screening-strategies-for-women-with-atm-chek2-and-palb2-pathogenic-variants/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/minority-enrollment-in-us-phase-ii-and-iii-trials-in-genitourinary-cancers/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/upfront-peptide-receptor-radionuclide-therapy-for-enteropancreatic-neuroendocrine-tumors/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/ai-model-may-aid-in-screening-staging-and-treatment-planning-for-thyroid-cancer/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/potential-contribution-of-nonmalignant-etiologies-to-back-pain-in-patients-with-metastatic-prostate-cancer/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/effect-of-secondary-cytoreductive-surgery-on-survival-in-patients-with-platinum-sensitive-recurrent-ovarian-cancer/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/addition-of-bcl-xlbcl-2-inhibitor-navitoclax-to-ongoing-ruxolitinib-in-patients-with-myelofibrosis-with-progression-or-suboptimal-response/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/addition-of-selumetinib-to-adjuvant-radioactive-iodine-in-high-risk-differentiated-thyroid-cancer-1/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/patients-with-merkel-cell-carcinoma-face-40-5-year-recurrence-rate-according-to-recent-study/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-finds-taller-adults-may-be-at-increased-risk-for-colorectal-cancer/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/fda-approves-neoadjuvant-nivolumab-and-platinum-doublet-chemotherapy-for-early-stage-nsclc/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/mutations-associated-with-resistance-to-noncovalent-btk-inhibitors-in-patients-with-cll/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/how-does-intake-of-unprocessed-red-meat-and-processed-meat-impact-risk-of-recurrence-and-mortality-in-patients-with-colon-cancer/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/pathologic-response-of-index-lymph-node-and-concordance-with-total-nodal-basin-pathologic-response-in-stage-iii-melanoma/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-defines-stem-cell-groups-that-may-drive-development-of-myelodysplastic-syndromes/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/disadvantaged-patients-less-likely-to-receive-advanced-radiotherapy-techniques-for-head-and-neck-cancer/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/sbrt-in-combination-with-pembrolizumabtrametinib-vs-gemcitabine-in-locally-recurrent-pancreatic-cancer/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-finds-world-trade-center-first-responders-have-high-burden-of-clonal-hematopoiesis/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/research-outlines-obstetric-and-perinatal-outcomes-for-female-survivors-of-childhood-cancer/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/interim-analysis-of-overall-survival-in-icaria-mm-addition-of-isatuximab-to-pomalidomidedexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/axicabtagene-ciloleucel-vs-standard-of-care-as-second-line-treatment-for-large-b-cell-lymphoma/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/biomarker-test-may-predict-recurrence-of-hpv-driven-oropharyngeal-cancer/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/symptom-monitoring-intervention-for-hospitalized-patients-with-advanced-cancer/</loc><lastmod>2022-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epigenetic-predisposing-factors-in-wilms-tumor/</loc><lastmod>2022-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/elective-upper-neck-vs-whole-neck-irradiation-in-nasopharyngeal-carcinoma/</loc><lastmod>2022-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/risk-of-major-adverse-cardiovascular-events-with-combined-immune-checkpoint-inhibition-and-vegfr-inhibition-in-patients-with-advanced-rcc/</loc><lastmod>2022-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/comparison-of-multiparametric-ultrasound-and-multiparametric-mri-for-the-diagnosis-of-prostate-cancer/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/risk-of-covid-19-infection-and-complications-among-survivors-of-childhood-adolescent-and-young-adult-cancers/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/postoperative-weekly-vs-every-3-week-cisplatin-in-chemoradiation-for-locally-advanced-head-and-neck-cancer/</loc><lastmod>2022-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/intervention-for-racial-disparities-in-time-to-lung-cancer-surgery/</loc><lastmod>2022-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/cancer-risk-among-patients-with-pediatric-onset-inflammatory-bowel-disease/</loc><lastmod>2022-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-shows-structural-racism-may-contribute-to-poorer-outcomes-in-patients-with-leukemia/</loc><lastmod>2022-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-patients-with-dual-medicare-and-medicaid-eligibility-have-poorer-outcomes-higher-spending-after-oncologic-surgery/</loc><lastmod>2022-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/final-overall-survival-analysis-of-monaleesa-2/</loc><lastmod>2022-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/keynote-564-update-supports-benefit-of-adjuvant-pembrolizumab-in-high-risk-renal-cell-carcinoma-2/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/epov-daniel-geynisman-2/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/factors-contributing-to-racial-disparities-in-the-use-of-prostate-mri-in-older-patients-with-prostate-cancer/</loc><lastmod>2022-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/racial-genomic-profiles-of-primary-and-metastatic-breast-cancer/</loc><lastmod>2022-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/novel-radioligand-therapy-improves-progression-free-and-overall-survival-in-patients-with-metastatic-prostate-cancer/</loc><lastmod>2022-03-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/new-research-measures-decrease-in-cancer-detection-due-to-the-covid-19-pandemic/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/thyroidectomy-with-or-without-radioiodine-for-low-risk-thyroid-cancer-1/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/addition-of-bortezomib-to-chemotherapy-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia-and-lymphoma/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/pfizer-announces-plan-to-maintain-humanitarian-supply-of-medicines-to-russians-donate-all-proceeds-to-humanitarian-support-for-the-people-of-ukraine/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/late-mortality-and-life-expectancy-after-autologous-blood-or-marrow-transplant-analysis-from-1981-to-2014/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-finds-cancer-treatment-creates-employment-difficulties-for-some-rural-women/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/asco-and-the-european-cancer-organisation-to-hold-briefing-on-providing-cancer-care-during-the-war-in-ukraine/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/front-line-toripalimab-plus-chemotherapy-improves-survival-in-patients-with-advanced-nsclc-without-actionable-mutations/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/study-identifies-genetic-variants-that-may-contribute-to-accelerated-aging-in-childhood-cancer-survivors/</loc><lastmod>2022-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/olaparib-with-or-without-cediranib-vs-platinum-based-chemotherapy-in-recurrent-platinum-sensitive-ovarian-cancer/</loc><lastmod>2022-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/checkmate-9er-final-results-support-first-line-regimen-of-nivolumab-plus-cabozantinib-in-advanced-kidney-cancer/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/the-university-of-texas-md-anderson-cancer-center-launches-james-p-allison-institute/</loc><lastmod>2022-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/observation-vs-screening-spinal-mri-in-patients-with-castration-resistant-prostate-cancer-and-asymptomatic-spinal-metastases/</loc><lastmod>2022-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/03-march/immunotherapy-duo-delays-disease-progression-in-previously-untreated-patients-with-melanoma-relativity-047/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-amy-tiersten-and-carlos-l-arteaga/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/pada-1-trial-with-early-identification-of-esr1-mutation-switch-to-fulvestrant-in-metastatic-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/emerald-trial-oral-selective-estrogen-receptor-degrader-as-second-or-third-line-therapy-for-advanced-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-charles-shapiro-md/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/metformin-added-to-standard-adjuvant-chemotherapy-fails-to-improve-outcomes-in-early-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-matthew-j-ellis/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/final-analysis-of-pallas-trial-no-benefit-of-adjuvant-palbociclib-plus-endocrine-therapy-in-early-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-anne-blaes/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/evidence-supports-ovarian-function-suppression-plus-aromatase-inhibitor-in-premenopausal-women-with-early-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-david-cescon/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/monaleesa-analyses-show-widespread-benefit-for-ribociclib-in-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-anne-blaes-md-ms-and-virginia-kaklamani-md/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/rxponder-update-explores-benefit-of-chemotherapy-in-subgroups/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-angela-demichele/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/dual-checkpoint-inhibitor-therapy-elicits-responses-in-highly-mutated-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-hope-rugo/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/identifying-women-with-triple-negative-breast-cancer-who-may-benefit-from-pembrolizumab-plus-chemotherapy/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-hope-s-rugo/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/keynote-522-sensitivity-analyses-confirm-value-of-neoadjuvant-pembrolizumab-in-triple-negative-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-debu-tripathy-and-hope-rugo/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/datopotamab-deruxtecan-shows-activity-in-advanced-triple-negative-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/clinical-trials-underway-for-t-dxd-in-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-priyanka-sharma-md/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/t-dxd-shows-activity-in-her2-low-her2-undetectable-breast-cancer/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-ciara-o-sullivan/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/second-line-t-dxd-improves-progression-free-survival-across-her2-positive-metastatic-breast-cancer-subgroups/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/highlights-from-the-2021-san-antonio-breast-cancer-symposium/</loc><lastmod>2022-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/european-genome-wide-association-study-of-genetic-variants-in-alcohol-related-hepatocellular-carcinoma/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fda-approves-tebentafusp-tebn-for-the-treatment-of-unresectable-or-metastatic-uveal-melanoma/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/no-significant-benefit-for-pevonedistat-plus-azacitidine-in-higher-risk-myelodysplastic-syndrome/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/neoadjuvant-cemiplimab-rwlc-for-patients-with-resectable-hepatocellular-carcinoma/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/adagrasib-controls-disease-in-gastrointestinal-malignancies-beyond-colorectal-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-mandana-kamgar/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/the-greek-alphabet-in-waves/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/circulating-tumor-dna-appears-prognostic-in-resected-colorectal-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-rona-yaeger/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/my-german-hodgkin-story/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/bispecific-antibodies-with-multiple-targets-moving-forward-in-multiple-myeloma/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-ajay-nooka/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/as-a-black-woman-i-knew-i-had-to-advocate-for-the-best-breast-cancer-care/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/why-some-patients-with-cancer-are-reluctant-to-receive-covid-19-vaccination-survey-shows-need-to-improve-patient-physician-communication/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/communication-is-key-to-overcoming-resistance-to-covid-19-vaccination/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/patricia-turner-takes-helm-of-american-college-of-surgeons/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/amid-health-care-workforce-shortages-staffing-guidance-should-ensure-protection-of-individuals-with-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/moonshot-expansion-offers-opportunity-to-increase-equity-in-cancer-recover-progress-on-screening/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/new-guideline-offers-most-comprehensive-summary-to-date-of-therapies-for-brain-metastases/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/astro-issues-clinical-guideline-on-external-beam-radiation-therapy-for-primary-liver-cancers/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/m-eileen-dolan-named-deputy-director-of-the-university-of-chicago-medicine-comprehensive-cancer-center/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/reflecting-on-the-past-50-years-of-cancer-progress-and-looking-ahead-to-the-next-50-years-of-advances/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-susan-m-o-brien/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/tebentafusp-tebn-for-unresectable-or-metastatic-uveal-melanoma/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/single-cell-spatial-connectivity-analysis-offers-unprecedented-information-in-breast-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-jenny-c-chang/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/asco-and-american-cancer-society-announce-collaboration-to-empower-people-with-cancer-information-they-can-trust/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/asco-updates-guidance-on-use-of-abemaciclib-and-endocrine-therapy-in-patients-with-high-risk-early-breast-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-rona-yaeger-1/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/understanding-how-lgbtqiplus-cancer-survivors-experience-cancer-care/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/similar-efficacy-but-better-tolerability-for-ripretinib-vs-sunitinib-in-second-line-gist-therapy/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-george-d-demetri-md-fasco/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/brief-highlights-from-the-2021-ash-annual-meeting-exposition/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/improved-outcomes-with-time-limited-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/effect-of-adt-use-and-duration-in-combination-with-definitive-radiotherapy-for-localized-prostate-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/studies-show-that-laws-to-limit-opioid-prescribing-have-hampered-pain-control-for-patients-with-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/centralizing-care-for-adolescents-and-young-adults-with-cancer-to-improve-long-term-survivorship/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/trifluridinetipiracil-plus-bevacizumab-in-metastatic-colorectal-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-demetris-papamichael/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/high-response-rate-seen-with-nivolumab-added-to-encorafenib-and-cetuximab-in-braf-v600e-mutated-metastatic-colorectal-cancer/</loc><lastmod>2022-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-joseph-mikhael/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/isatuximab-containing-induction-therapy-for-multiple-myeloma-increases-measurable-residual-disease-negativity/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-philip-mccarthy/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/studies-evaluate-screening-for-early-multiple-myeloma/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/panther-no-significant-benefit-for-pevonedistat-plus-azacitidine-in-higher-risk-myelodysplastic-syndrome/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/mosunetuzumab-meets-primary-endpoint-of-phase-ii-trial-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-laurie-sehn-and-alex-herrera/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/zuma-7-axicabtagene-ciloleucel-quadruples-event-free-survival-in-large-b-cell-lymphoma/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-laurie-sehn/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/transform-lisocabtagene-maraleucel-improves-outcomes-in-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-jane-winter-christopher-flowers/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/polarix-addition-of-polatuzumab-vedotin-piiq-to-standard-of-care-significantly-reduces-progression-of-diffuse-large-b-cell-lymphoma/</loc><lastmod>2022-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/parp-inhibitor-plus-abiraterone-benefits-subgroups-of-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-jane-n-winter/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/belinda-car-t-cell-therapy-fails-to-improve-outcomes-in-aggressive-non-hodgkin-lymphoma/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-mikkael-a-sekeres-1/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/agile-addition-of-ivosidenib-to-azacitidine-triples-median-overall-survival-in-difficult-to-treat-aml-population/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-joshua-brody/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fixed-duration-venetoclax-plus-ibrutinib-achieves-deep-and-durable-mrd-remissions-in-cll/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-susan-m-o-brien-md/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/improved-outcomes-with-time-limited-venetoclax-combinations-vs-chemoimmunotherapy-in-fit-patients-with-cll-1/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-laura-c-michaelis/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/aggressive-supportive-treatment-for-covid-19-may-be-needed-in-patients-with-hematologic-cancers/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-mikkael-a-sekeres/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/chip-mutations-associated-with-lower-risk-of-alzheimer-s-disease/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/highlights-from-the-2021-ash-annual-meeting-exposition/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/continued-progression-free-survival-benefit-with-carfilzomibdexamethasonedaratumumab-vs-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/in-all-candor-what-does-candor-bring-to-the-table-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/no-invasive-disease-free-survival-benefit-with-addition-of-adjuvant-palbociclib-to-endocrine-therapy-in-early-breast-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/pallas-trial-in-hormone-receptor-positive-her2-negative-breast-cancer-defining-the-role-of-adjuvant-cdk46-inhibition/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/ama-cdc-quarantine-and-isolation-guidance-is-confusing-counterproductive/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/pretreatment-cardiovascular-disease-and-events-in-patients-receiving-curative-intent-chemoradiation-for-esophageal-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/healthy-lifestyle-and-development-of-cardiovascular-disease-or-type-2-diabetes-in-patients-with-or-without-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/oncology-drugs-with-accelerated-approval-is-it-time-for-a-reset/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/city-of-hope-completes-strategic-acquisition-of-cancer-treatment-centers-of-america/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/topaz-1-overall-survival-prolonged-with-first-line-immunotherapy-plus-chemotherapy-in-biliary-tract-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-nilofer-azad/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/amit-maity-md-phd-to-lead-department-of-radiation-oncology-at-the-university-of-utah/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/himalaya-trial-first-line-tremelimumab-plus-durvalumab-improves-overall-survival-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-anthony-el-khoueiry/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fixed-duration-venetoclax-plus-ibrutinib-achieves-deep-and-durable-mrd-remissions-in-cll-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-joshua-brody-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/abatacept-for-prophylaxis-of-acute-graft-vs-host-disease/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/keynote-522-sensitivity-analyses-confirm-value-of-neoadjuvant-pembrolizumab-in-triple-negative-breast-cancer-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-hope-rugo-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/evidence-supports-ovarian-function-suppression-plus-aromatase-inhibitor-in-premenopausal-women-with-early-breast-cancer-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/mindfulness-in-pediatric-and-adolescent-patients-with-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-anne-blaes-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/datopotamab-deruxtecan-shows-activity-in-advanced-triple-negative-breast-cancer-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/after-two-cancer-diagnoses-i-m-grateful-for-another-day/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-debu-tripathy-and-hope-rugo-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/dual-checkpoint-inhibitor-therapy-elicits-responses-in-highly-mutated-breast-cancer-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/hematologist-and-bone-marrow-transplant-pioneer-tahir-shamsi-mbbs-mrcpath-frcpath-dies-at-59/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-angela-demichele-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/lymphoma-expert-barbara-pro-joins-herbert-irving-comprehensive-cancer-center/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/jaye-gardiner-receives-inaugural-black-in-cancer-postdoctoral-fellowship-for-pancreatic-cancer-research/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/jeffrey-farma-elected-to-leadership-position-in-the-society-of-university-surgeons/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/jane-winter-begins-term-as-2022-ash-president/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/metformin-added-to-standard-adjuvant-chemotherapy-fails-to-improve-outcomes-in-early-breast-cancer-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-charles-shapiro/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/improved-outcomes-with-adjuvant-chemoendocrine-vs-endocrine-therapy-in-premenopausal-women-with-node-positive-breast-cancer-and-recurrence-score-25/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/rxponder-trial-another-step-in-defining-which-patients-with-breast-cancer-may-be-spared-adjuvant-cytotoxic-chemotherapy/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-the-russian-federation/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/how-to-rein-in-oncology-costs-and-save-physician-owned-practices/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/use-of-consolidation-durvalumab-and-adjuvant-osimertinib-among-key-recommendations-in-new-asco-guideline-on-stage-iii-nsclc-treatment/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/guideline-update-highlights-the-importance-of-shared-decision-making-regarding-the-use-of-adjuvant-therapy-in-stage-ii-colon-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/kerryn-reding-daughter-of-health-care-workers-chooses-a-career-in-breast-cancer-survivorship/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-finds-pediatric-based-treatment-regimen-feasible-and-effective-in-older-adults-with-all/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-hanno-hock/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/challenges-for-oncologists-as-they-reach-retirement-age/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/assessing-value-in-gastrointestinal-cancer-treatments/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/siog-annual-conference-explores-the-past-present-and-future-of-geriatric-oncology/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/monaleesa-analyses-show-widespread-benefit-for-ribociclib-in-hormone-receptor-positive-her2-negative-breast-cancer-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-david-cescon-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/studies-evaluate-screening-for-early-multiple-myeloma-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/epov-philip-mccarthy-1/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-identifies-black-race-as-risk-factor-for-lymphedema-after-axillary-dissection-in-women-with-breast-cancer/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/association-of-hla-a03-with-outcomes-of-immune-checkpoint-inhibition-for-advanced-cancers/</loc><lastmod>2022-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-examines-risk-of-cancers-other-than-female-breast-and-ovarian-cancers-associated-with-brca1-and-brca2-pathogenic-variants/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fda-investigating-possible-increased-risk-of-death-with-lymphoma-treatment-umbralisib/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/use-of-autologous-metastasis-mutation-reactive-tils-in-metastatic-breast-cancer/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/nivolumab-plus-chemotherapy-or-ipilimumab-vs-chemotherapy-in-previously-untreated-advanced-esophageal-squamous-cell-carcinoma/</loc><lastmod>2021-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/reduced-intensity-chemoradiotherapy-in-ebv-dna-selected-locoregionally-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2021-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/pacific-trial-5-year-survival-outcomes-with-durvalumab-after-chemoradiotherapy-in-stage-iii-nsclc/</loc><lastmod>2021-02-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/ibrutinibrituximab-for-indolent-clinical-types-of-mantle-cell-lymphoma/</loc><lastmod>2022-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/outcomes-in-a-large-cohort-of-patients-with-ultra-low-risk-breast-cancer-analysis-from-the-mindact-trial/</loc><lastmod>2022-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/can-postsurgical-monoclonal-antibody-treatment-reduce-her2-positive-early-stage-breast-cancer-recurrence/</loc><lastmod>2022-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/can-weight-loss-in-adulthood-reduce-the-risk-of-developing-colorectal-adenomas/</loc><lastmod>2022-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-examines-role-of-hyaluronic-acid-in-pancreatic-cancer-growth/</loc><lastmod>2022-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/asco-statement-on-world-cancer-day/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/risk-standardized-mortality-rates-as-quality-proxy-for-surgical-oncology/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/cancercare-offers-patients-financial-assistance-for-transportation-pet-care/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/trastuzumab-pertuzumab-and-docetaxel-for-advanced-her2-mutant-nsclc/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fda-approves-second-covid-19-vaccine/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-examines-head-and-neck-cancer-incidence-in-black-populations-around-the-world/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fda-approves-new-label-update-for-car-t-cell-therapy-axicabtagene-ciloleucel/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/asco-and-american-cancer-society-announce-collaboration-to-empower-people-with-cancer-information-they-can-trust-1/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/teravolt-study-identifies-seven-factors-that-increase-mortality-risk-for-patients-with-lung-cancer-infected-with-covid-19/</loc><lastmod>2022-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/use-of-polygenic-cytarabine-response-score-to-identify-candidates-with-pediatric-aml-for-chemotherapy-augmentation/</loc><lastmod>2022-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/long-term-morbidity-in-patients-with-stage-i-to-iia-hodgkin-lymphoma-treated-with-abvd-and-limited-field-radiotherapy/</loc><lastmod>2022-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/addition-of-sugemalimab-to-platinum-based-chemotherapy-for-metastatic-squamous-or-nonsquamous-nsclc/</loc><lastmod>2022-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/president-biden-reignites-cancer-moonshot/</loc><lastmod>2022-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/can-an-intelligent-vacuum-assisted-biopsy-algorithm-reliably-identify-patients-with-breast-cancer-who-have-a-pathologic-complete-response-to-neoadjuvant-therapy/</loc><lastmod>2022-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/adverse-event-rates-after-two-doses-of-mrna-covid-19-vaccine-in-patients-with-vs-without-cancer/</loc><lastmod>2022-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/compression-sleeves-to-reduce-risk-of-arm-swelling-in-women-undergoing-surgery-for-breast-cancer/</loc><lastmod>2022-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/aacr-releases-report-on-the-impact-of-covid-19-on-cancer-research-and-patient-care/</loc><lastmod>2022-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/concordance-for-low-her2-protein-expression-in-breast-cancer-tissue-using-standard-immunohistochemistry-assays/</loc><lastmod>2022-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-finds-patients-with-lung-cancer-demonstrated-psychological-resilience-in-the-face-of-the-covid-19-pandemic/</loc><lastmod>2022-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-identifies-factors-impacting-adherence-to-oral-medications-for-metastatic-breast-cancer/</loc><lastmod>2022-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/importing-oncology-trials-from-china-or-other-single-countries-for-consideration-of-us-regulatory-approvals/</loc><lastmod>2022-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/neoadjuvant-atezolizumab-plus-gemcitabine-and-cisplatin-in-muscle-invasive-bladder-cancer/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/ibrutinibrituximab-induction-followed-by-r-hcvad-in-front-line-treatment-of-patients-aged-65-and-younger-with-mantle-cell-lymphoma/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/american-cancer-society-publishes-cancer-statistics-for-african-americanblack-people-2022/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/report-finds-cancer-immunotherapy-clinical-trials-continue-to-grow-globally/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/updated-efficacy-and-safety-data-from-checkmate-743-first-line-nivolumabipilimumab-vs-chemotherapy-for-unresectable-malignant-pleural-mesothelioma/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/comprehensive-genetic-risk-score-may-predict-risk-of-developing-metastatic-prostate-cancer-or-death-from-prostate-cancer-across-diverse-populations/</loc><lastmod>2022-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/cemiplimab-rwlc-vs-single-agent-chemotherapy-in-recurrent-cervical-cancer-after-first-line-platinum-based-chemotherapy/</loc><lastmod>2022-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/h1-antihistamine-use-and-risk-of-hepatocellular-carcinoma-in-patients-with-hepatitis-b-virus-hepatitis-c-virus-or-dual-infection/</loc><lastmod>2022-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/are-patients-undergoing-active-cancer-treatment-more-likely-to-believe-covid-19-misinformation/</loc><lastmod>2022-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/potential-use-of-fdg-pet-findings-in-reducing-duration-of-immunotherapy-in-patients-with-advanced-melanoma/</loc><lastmod>2022-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/differences-in-risk-of-severe-adverse-events-in-women-vs-men-receiving-immunotherapy-targeted-therapy-or-chemotherapy-in-cancer-clinical-trials/</loc><lastmod>2022-02-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/efficacy-of-trametinib-in-recurrent-low-grade-serous-ovarian-carcinoma/</loc><lastmod>2022-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-provides-insights-into-the-genomic-basis-of-cancer-metastasis/</loc><lastmod>2022-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/role-of-cecr2-gene-in-advanced-triple-negative-breast-cancer/</loc><lastmod>2022-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/predictive-model-for-severe-fatigue-after-breast-cancer-diagnosis/</loc><lastmod>2022-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/niraparib-in-previously-treated-patients-with-metastatic-castration-resistant-prostate-cancer-and-dna-repair-gene-defects/</loc><lastmod>2022-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/report-documents-third-known-case-of-hiv-remission-involving-stem-cell-transplant/</loc><lastmod>2022-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/kras-g12c-inhibitor-sotorasib-shows-activity-in-certain-patients-with-pancreatic-cancer/</loc><lastmod>2022-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/does-daily-aspirin-help-prevent-breast-cancer-recurrence/</loc><lastmod>2022-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/sugemalimab-after-concurrent-or-sequential-chemoradiation-for-unresectable-stage-iii-nsclc/</loc><lastmod>2022-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/neoadjuvant-chemoradiotherapy-vs-upfront-surgery-in-resectable-and-borderline-resectable-pancreatic-cancer/</loc><lastmod>2022-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/web-based-intervention-to-manage-symptoms-and-quality-of-life-in-women-with-recurrent-ovarian-cancer/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/researchers-identify-biomarkers-that-may-help-to-predict-response-to-immunotherapy-for-melanoma/</loc><lastmod>2022-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/new-data-validate-clinical-utility-of-genomic-classifier-test-to-help-guide-therapy-for-men-with-intermediate-risk-prostate-cancer/</loc><lastmod>2022-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-examines-relationship-between-angiotensin-blockade-and-pancreatic-cancer-survival/</loc><lastmod>2022-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/paul-farmer-md-phd-dies-at-62/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/fda-approves-foundationone-cdx-as-a-companion-diagnostic-for-pembrolizumab-to-identify-patients-with-msi-h-solid-tumors/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/gog-281logs-trametinib-vs-standard-of-care-in-recurrent-low-grade-serous-ovarian-carcinoma/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/adagrasib-in-advanced-kras-g12c-mutant-solid-tumors/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/keynote-522-event-free-survival-with-neoadjuvant-and-adjuvant-pembrolizumab-in-triple-negative-breast-cancer/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-investigates-the-risk-of-breast-cancer-mortality-after-late-breast-cancer-recurrence/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/jeffrey-peppercorn-md-mph-named-editor-in-chief-of-jco-oncology-practice/</loc><lastmod>2022-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/first-line-blinatumomab-and-pomp-maintenance-in-older-patients-with-philadelphia-chromosome-negative-b-cell-all/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/arasens-trial-addition-of-darolutamide-to-androgen-deprivation-therapy-and-docetaxel-in-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/incidental-findings-on-low-dose-ct-lung-cancer-screening-in-the-nlst-and-risk-of-respiratory-disease-mortality/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/t-cell-responses-may-help-predict-protection-against-sars-cov-2-infection-in-individuals-with-and-without-cancer/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/predictive-models-for-outcomes-with-immune-checkpoint-inhibitor-treatment-in-metastatic-melanoma/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/addition-of-autologous-dendritic-cell-based-immunotherapy-to-chemotherapy-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/long-term-rates-of-hospital-readmission-for-venous-thromboembolism-after-complex-cancer-surgery/</loc><lastmod>2022-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/pembrolizumab-plus-trastuzumab-and-chemotherapy-in-previously-untreated-advanced-her2-positive-gastric-adenocarcinoma/</loc><lastmod>2022-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/older-patients-with-cancer-and-high-risk-geriatric-profiles-at-greater-risk-for-death-and-other-adverse-sequelae-of-covid-19/</loc><lastmod>2022-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-identifies-new-mutation-that-may-define-novel-pediatric-aml-subtype/</loc><lastmod>2022-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/prediction-model-for-brca-mutation-carrying-status-in-asian-patients-with-breast-cancer/</loc><lastmod>2022-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/neoadjuvant-enfortumab-vedotin-ejfv-in-cisplatin-ineligible-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-examines-predictive-biomarker-for-bladder-cancer-survival/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/study-evaluates-effectiveness-of-existing-risk-stratification-system-for-hepatoblastoma/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/copanlisib-in-patients-with-pik3ca-mutated-tumors/</loc><lastmod>2022-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/02-february/does-mri-guided-radiotherapy-reduce-treatment-related-side-effects-in-patients-with-prostate-cancer/</loc><lastmod>2022-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-david-cescon/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/monaleesa-analyses-show-widespread-benefit-for-ribociclib-in-hormone-receptor-positive-her2-negative-breast-cancer/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/recent-study-aims-to-improve-the-quality-of-cancer-care-in-rural-areas/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/anthracycline-plus-taxane-reduces-risk-of-breast-cancer-recurrence-at-10-years/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-anne-blaes/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/emerald-trial-oral-selective-estrogen-receptor-degrader-as-second-or-third-line-therapy-for-advanced-breast-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/developing-a-comprehensive-system-for-personalized-survivorship-centered-care-plans/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/does-geography-play-a-role-in-early-onset-colorectal-cancer-in-young-black-men/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/disconnect-between-expectations-and-outcomes-major-factor-in-treatment-related-regret-among-patients-with-localized-prostate-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/be-realistic-about-what-patients-can-expect-after-prostate-cancer-treatment/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/lynn-m-schuchter-elected-asco-president-for-2023-2024-term/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/fda-approves-abatacept-based-combination-for-prophylaxis-of-acute-graft-vs-host-disease/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/sotorasib-in-previously-treated-patients-with-kras-g12c-mutant-colorectal-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/effect-of-statin-use-on-outcomes-of-psa-screening-for-prostate-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-ivosidenib-to-azacitidine-triples-median-overall-survival-in-difficult-to-treat-aml-population/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/second-line-t-dxd-improves-progression-free-survival-across-her2-positive-metastatic-breast-cancer-subgroups/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pi3k-pathway-activation-may-underlie-tamoxifen-associated-uterine-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-steven-isakoff/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-mikkael-a-sekeres/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/rxponder-update-explores-benefit-of-chemotherapy-in-subgroups/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-anne-blaes-and-virginia-kaklamani/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-ciara-o-sullivan/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/axicabtagene-ciloleucel-quadruples-event-free-survival-in-large-b-cell-lymphoma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-laurie-h-sehn-and-alex-herrera/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/better-federal-agency-coordination-is-needed-to-accelerate-progress-against-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pada-1-trial-with-early-identification-of-esr1-mutation-switch-to-fulvestrant-in-metastatic-breast-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-amy-tiersten-and-carlos-l-arteaga/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/karen-l-kelly-md-named-chief-executive-officer-of-the-international-association-for-the-study-of-lung-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/lisocabtagene-maraleucel-improves-outcomes-in-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-laurie-h-sehn/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-polatuzumab-vedotin-piiq-to-standard-of-care-significantly-reduces-progression-of-diffuse-large-b-cell-lymphoma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-jane-n-winter-and-christopher-r-flowers/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/mosunetuzumab-meets-primary-endpoint-of-phase-ii-trial-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-laurie-h-sehn-1/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/isatuximab-containing-induction-therapy-for-multiple-myeloma-increases-measurable-residual-disease-negativity/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-joseph-mikhael/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/metastatic-melanoma-improved-overall-survival-reported-with-immunotherapy-infusions-given-earlier-in-the-day/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/aggressive-supportive-treatment-for-covid-19-may-be-needed-in-patients-with-hematologic-cancers/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/circadian-timing-of-immune-checkpoint-inhibitors-beyond-good-times-and-bad-times/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-laura-c-michaelis/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/car-t-cell-therapy-fails-to-improve-outcomes-in-aggressive-non-hodgkin-lymphoma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/epov-jane-n-winter/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pembrolizumab-plus-chemotherapy-in-advanced-esophageal-cancer-good-news-for-some-but-more-work-to-be-done/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/new-zealand-to-ban-cigarette-sales-for-future-generations/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/health-groups-make-recommendations-to-strengthen-the-us-drug-supply-chain-during-the-pandemic-and-beyond/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/jonathan-wesley-riess-to-lead-uc-davis-comprehensive-cancer-center-s-thoracic-oncology-program/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/ian-krop-named-chief-clinical-research-officer-associate-cancer-center-director-for-clinical-research-at-yale-cancer-center/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/asco-unveils-new-equity-diversity-and-inclusion-action-plan/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/asco-statement-on-50th-anniversary-of-signing-of-national-cancer-act/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/promise-and-need-for-more-progress-in-treatment-of-squamous-cell-nsclc/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/adjuvant-atezolizumab-improves-disease-free-survival-following-adjuvant-chemotherapy-in-pd-l1-positive-resected-stage-ii-iiia-nsclc/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/adjuvant-atezolizumab-in-impower010-moving-the-needle-in-early-stage-nsclc/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/roswell-park-receives-nearly-1-million-to-address-race-related-disparities-in-prostate-cancer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/tennessee-oncology-appoints-stephen-schleicher-as-chief-medical-officer-and-natalie-dickson-as-chief-strategy-officer/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/rituximab-plus-chemotherapy-for-pediatric-mature-b-cell-non-hodgkin-lymphoma-and-mature-b-cell-acute-leukemia/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/daratumumabhyaluronidase-fihj-and-carfilzomib-in-multiple-myeloma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pembrolizumab-for-adjuvant-treatment-of-stage-iib-or-iic-melanoma/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/project-catalyst-educating-industry-to-help-develop-successful-cancer-therapies/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/from-the-vietnam-war-to-the-stanford-cancer-institute-the-professional-journey-of-quynh-thu-le/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/an-adventurous-spirit-led-to-a-prominent-role-in-radiation-oncology-for-geraldine-jacobson/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/incidence-and-cancer-related-mortality-in-burundi/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/a-guide-for-patients-with-breast-cancer-their-families-and-their-oncologists/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/cancer-has-made-me-a-risk-taker-and-that-s-good/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/cancer-biologist-beatrice-mintz-dies-at-100/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/emerald-trial-oral-selective-estrogen-receptor-degrader-as-second-or-third-line-therapy-for-advanced-breast-cancer-1/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/apatinib-for-advanced-radioactive-iodine-refractory-differentiated-thyroid-cancer/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/new-study-examines-role-of-genetic-ancestry-in-pediatric-leukemia/</loc><lastmod>2022-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-perioperative-trastuzumab-to-neoadjuvant-chemoradiation-for-patients-with-her2-overexpressing-esophageal-adenocarcinoma/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/early-research-shows-low-dose-light-therapy-may-aid-in-treating-skin-damage-from-radiation-therapy/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-that-compared-to-urban-residents-rural-residents-are-more-likely-to-have-fatalistic-beliefs-about-cancer/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/invasive-cervical-cancer-prognosis-according-to-high-risk-hpv-status/</loc><lastmod>2022-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/use-of-cancer-registry-and-credit-records-data-to-assess-risk-of-adverse-financial-events-in-patients-with-cancer/</loc><lastmod>2022-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/genetic-and-lifestyle-calculator-may-help-to-identify-younger-adults-at-risk-of-colorectal-cancer/</loc><lastmod>2022-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-radiotherapy-to-durvalumab-plus-tremelimumab-in-patients-with-metastatic-nsclc-refractory-to-pd-1pd-l1-inhibitor-therapy/</loc><lastmod>2022-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/risk-of-multiple-cancers-in-male-carriers-of-brca1-and-brca2-gene-mutations/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-spartalizumab-to-dabrafenibtrametinib-for-braf-v600-mutant-advanced-melanoma/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/young-adults-may-have-the-greatest-risk-of-distant-stage-colorectal-cancer-with-the-highest-risk-among-black-and-hispanic-patients/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pet-based-de-escalation-strategy-for-previously-untreated-advanced-hodgkin-lymphoma/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/binimetinib-plus-imatinib-in-previously-untreated-patients-with-advanced-gastrointestinal-stromal-tumor/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/palbociclib-exposure-and-discontinuation-and-potential-impact-on-outcome-in-the-pallas-trial/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/long-term-outcomes-after-neoadjuvant-chemotherapy-with-or-without-carboplatin-and-bevacizumab-for-triple-negative-breast-cancer/</loc><lastmod>2022-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/cardiometabolic-risk-factors-in-breast-cancer-survivors/</loc><lastmod>2022-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/risk-of-second-primary-malignancies-after-radioactive-iodine-treatment-for-pediatric-and-young-adult-patients-with-differentiated-thyroid-cancer/</loc><lastmod>2022-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/lenvatinibpembrolizumab-vs-chemotherapy-in-previously-treated-patients-with-advanced-endometrial-cancer/</loc><lastmod>2022-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/t-dxd-for-previously-treated-patients-with-metastatic-her2-mutant-nsclc/</loc><lastmod>2022-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/similar-efficacy-but-better-tolerability-for-ripretinib-vs-sunitinib-in-previously-treated-patients-with-advanced-gist/</loc><lastmod>2022-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/does-early-locoregional-therapy-for-the-primary-site-improve-survival-in-newly-diagnosed-metastatic-breast-cancer/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/long-term-swallowing-quality-of-life-results-with-radiotherapy-vs-transoral-robotic-surgery-for-oropharyngeal-cancer/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/erdafitinib-for-patients-with-advanced-urothelial-carcinoma-and-fgfr-alterations/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pretreatment-cardiovascular-disease-and-events-during-follow-up-in-patients-receiving-curative-intent-chemoradiation-for-esophageal-cancer/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pembrolizumab-in-previously-treated-patients-with-msi-hdmmr-endometrial-cancer/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/report-examines-online-learning-for-children-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2022-01-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/selecting-patients-with-barrett-s-esophagus-for-endoscopic-surveillance-role-of-nonendoscopic-device-biomarkers/</loc><lastmod>2022-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-diet-and-lifestyle-factors-to-recurrence-and-mortality-prediction-models-for-patients-with-stage-iii-colon-cancer/</loc><lastmod>2022-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/impact-of-a-healthy-lifestyle-on-risk-of-developing-cancer-cardiovascular-disease-or-type-2-diabetes/</loc><lastmod>2022-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/combination-therapies-may-improve-outcomes-due-to-independent-rather-than-synergistic-or-additive-drug-action/</loc><lastmod>2022-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/clinical-score-may-assist-in-guiding-peptide-receptor-radionuclide-therapy-decisions-for-patients-with-neuroendocrine-tumors/</loc><lastmod>2022-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/durvalumab-plus-gemcitabinecisplatin-improves-survival-in-patients-with-advanced-biliary-tract-cancer-topaz-1/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-examines-role-of-psychological-distress-in-aya-cancer-survivors/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-nivolumab-to-oxaliplatin-based-chemotherapy-for-her2-negative-unresectable-advanced-or-recurrent-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2022-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/inotuzumab-ozogamicin-for-pediatric-patients-with-relapsed-or-refractory-b-cell-all/</loc><lastmod>2022-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-direct-oral-anticoagulants-significantly-decrease-recurrent-venous-thrombosis-for-adult-patients-with-cancer/</loc><lastmod>2022-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/personalized-lung-cancer-risk-assessment-using-a-blood-based-biomarker-panel/</loc><lastmod>2022-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/durvalumabtremelimumab-improves-overall-survival-vs-sorafenib-in-patients-with-advanced-hepatocellular-carcinoma-himalaya/</loc><lastmod>2022-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-depression-screening-improves-behavioral-care-for-patients-with-breast-cancer/</loc><lastmod>2022-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-anti-lag-3-antibody-relatlimab-to-nivolumab-in-previously-untreated-patients-with-advanced-melanoma/</loc><lastmod>2022-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/single-cell-transcriptomic-and-imaging-atlas-of-colorectal-polyps-provides-insights-for-cancer-surveillance/</loc><lastmod>2022-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/response-adapted-omission-of-radiotherapy-and-comparison-of-consolidation-therapy-in-pediatric-classical-hodgkin-lymphoma/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/effect-of-recent-prior-radiotherapy-on-adverse-events-in-patients-receiving-immune-checkpoint-inhibitors/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/immunogenicity-of-covid-19-bnt162b2-mrna-vaccine-booster-in-patients-with-cancer-receiving-active-treatment/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/does-armodafinil-improve-cancer-related-fatigue-in-patients-with-high-grade-glioma/</loc><lastmod>2022-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/hrqol-with-enzalutamide-vs-standard-of-care-for-metastatic-hormone-sensitive-prostate-cancer-enzamet-trial/</loc><lastmod>2022-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/portable-prostate-cancer-screening-test-may-help-reach-underserved-patients/</loc><lastmod>2022-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/imaging-biomarker-may-help-to-risk-stratify-patients-with-head-and-neck-cancer/</loc><lastmod>2022-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/trends-in-population-level-stage-shift-and-mortality-among-us-patients-with-nsclc-2006-2016/</loc><lastmod>2022-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/fda-shortens-interval-for-booster-dose-of-moderna-covid-19-vaccine-to-5-months/</loc><lastmod>2022-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/comparison-of-efficiency-of-uspstf-vs-plco-criteria-in-determining-eligibility-for-lung-cancer-screening/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/apatinib-for-advanced-radioactive-iodine-refractory-differentiated-thyroid-cancer-1/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/interim-radiographic-assessment-for-adaptive-dosing-of-combination-immunotherapy-in-advanced-melanoma/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/smoking-cessation-after-lung-cancer-diagnosis-may-improve-overall-survival/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/stereotactic-radiation-may-prolong-duration-of-systemic-therapy-for-metastatic-kidney-cancer/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/bispecific-antibody-mosunetuzumab-in-relapsed-or-refractory-b-cell-lymphomas/</loc><lastmod>2022-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/association-of-response-rate-and-event-free-survival-with-overall-survival-in-newly-diagnosed-aml-fda-analysis/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/balstilimab-plus-zalifrelimab-for-the-second-line-treatment-of-advanced-cervical-cancer/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-fully-vaccinated-patients-with-cancer-and-breakthrough-covid-19-infection-remain-at-high-risk-for-severe-outcomes/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-examines-global-cancer-burden-from-2010-to-2019/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/nccn-updates-recommendations-on-covid-19-vaccination-and-preexposure-prophylaxis/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/pretreatment-disease-burden-and-outcomes-with-commercial-tisagenlecleucel-in-pediatricyoung-adult-b-cell-acute-lymphoblastic-leukemia/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/educational-intervention-increases-knowledge-about-prostate-cancer-and-intention-to-screen-among-high-risk-patients/</loc><lastmod>2022-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/mrd-response-adapted-therapy-in-patients-receiving-daratumumab-carfilzomib-lenalidomide-and-dexamethasone-plus-ahct-for-newly-diagnosed-multiple-myeloma/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/fda-takes-multiple-actions-to-expand-use-of-pfizer-biontech-covid-19-vaccine/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/is-a-high-fiber-diet-associated-with-improved-survival-and-treatment-response-in-patients-with-melanoma/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-third-covid-19-vaccine-dose-effectively-boosts-immunity-for-patients-with-solid-tumors/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/long-term-outcomes-according-to-residual-cancer-burden-after-neoadjuvant-chemotherapy-for-breast-cancer/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/global-burden-of-cancer-from-2010-to-2019/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/role-of-expression-of-erv-rna-in-prostate-cancer/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/paclitaxelcarboplatin-vs-paclitaxelifosfamide-in-chemotherapy-naive-patients-with-uterine-carcinosarcoma/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/antibiotics-after-endoprosthetic-reconstruction-for-lower-extremity-bone-tumors-comparison-of-two-intravenous-regimens/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/composition-of-academic-radiation-oncology-workforces-in-national-cancer-institute-designated-comprehensive-cancer-centers/</loc><lastmod>2022-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/new-research-aims-to-uncover-cellular-source-of-barrett-s-esophagus/</loc><lastmod>2022-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/atezolizumabbevacizumab-vs-sunitinib-in-previously-untreated-patients-with-metastatic-rcc-final-overall-survival-analysis-of-immotion151/</loc><lastmod>2021-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/new-study-examines-septic-shock-in-patients-with-hematologic-malignancies/</loc><lastmod>2022-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/astro-issues-clinical-guideline-on-external-beam-radiation-therapy-for-primary-liver-cancers/</loc><lastmod>2022-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/association-of-autoantibodies-to-gastric-mucosa-and-risk-of-gastric-cancer/</loc><lastmod>2022-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/is-the-development-of-cutaneous-immune-related-adverse-events-correlated-with-response-to-immunotherapy/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/report-describes-identification-of-a-novel-therapeutic-target-for-multiple-myeloma/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-abiraterone-acetate-and-prednisolone-with-or-without-enzalutamide-to-adt-in-high-risk-nonmetastatic-prostate-cancer/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/incidence-of-chronic-graft-vs-host-disease-effect-of-depleting-naive-t-cells-from-peripheral-blood-stem-cell-allografts-in-patients-with-leukemia/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-uses-data-from-a-nationally-representative-colonoscopy-registry-to-gather-information-on-early-onset-colorectal-precancerous-lesions/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/role-of-radiologist-experience-and-fatigue-level-in-recommending-additional-imaging-for-patients-undergoing-breast-cancer-screening/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/palliative-care-use-among-commercially-insured-us-patients-with-metastatic-cancer-2001-2016/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/is-there-an-association-between-maternal-hormonal-contraception-use-and-risk-of-cns-tumors-in-children/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/durvalumabtremelimumab-with-or-without-radiotherapy-in-resistant-nsclc/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/new-study-examines-genetic-effects-on-genitourinary-toxicity-in-patients-with-prostate-cancer/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/depression-screening-and-behavioral-health-referrals-for-patients-with-newly-diagnosed-breast-cancer-in-the-community-oncology-setting/</loc><lastmod>2022-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/interferon-alfa-vs-hydroxyurea-in-previously-untreated-patients-with-polycythemia-vera-and-essential-thrombocythemia/</loc><lastmod>2022-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/uicc-to-launch-3-year-campaign-to-create-more-equitable-access-to-cancer-services/</loc><lastmod>2022-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-guideline-concordant-cervical-cancer-screening-dropped-from-2005-to-2019-among-women-in-the-united-states/</loc><lastmod>2022-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/effect-of-daily-sitting-time-and-weekly-physical-activity-on-cancer-survivorship/</loc><lastmod>2022-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/study-finds-improved-2-year-survival-rate-for-adult-patients-with-relapsed-philadelphia-chromosome-positive-all-after-allogeneic-hematopoietic-cell-transplantation-over-20-years/</loc><lastmod>2022-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/association-of-genetic-alterations-with-disease-characteristics-and-response-to-treatment-in-pediatric-differentiated-thyroid-cancer/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/addition-of-capecitabine-to-taxaneanthracycline-adjuvant-chemotherapy-for-early-breast-cancer-15-year-overall-survival-results-of-the-finxx-trial/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/first-line-nivolumabcabozantinib-vs-sunitinib-for-advanced-renal-cell-carcinoma-patient-reported-outcomes/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2022/01-january/presurgical-chemosensitivity-may-play-a-role-in-informing-postsurgical-treatment-for-patients-with-gastric-cancer/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/changes-in-psa-screening-after-2017-uspstf-guidance-revision/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/eftilagimod-alpha-plus-paclitaxel-may-improve-survival-in-hr-positive-her2-negative-metastatic-breast-cancer-aipac-trial/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-pafolacianine-to-help-identify-ovarian-cancer-lesions/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/impact-of-time-of-day-of-immune-checkpoint-inhibitor-infusion-on-overall-survival-in-patients-with-metastatic-melanoma/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-treatment-related-regret-among-men-with-localized-prostate-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-triplet-therapy-for-previously-treated-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/novel-vaccine-platform-plus-pembrolizumab-may-boost-immune-response-in-advanced-hcc/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-rituximab-plus-chemotherapy-for-several-pediatric-hematologic-malignancies/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-maribavir-for-posttransplant-cmv/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-pembrolizumab-for-the-adjuvant-treatment-of-stage-iib-or-iic-melanoma/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/sotigalimab-plus-nivolumab-in-anti-pd-1pd-l1-refractory-melanoma/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/composite-biomarker-needed-to-predict-benefit-of-immunotherapy-in-triple-negative-breast-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/positive-practice-changes-after-the-covid-19-pandemic-from-the-advanced-practice-provider-perspective/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/diversity-in-clinical-trials-career-development-program/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/ash-recognizes-choosing-wisely-champions-at-63rd-annual-meeting/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/uc-davis-brain-surgeon-appointed-to-co-lead-cancer-center-biomedical-technology-program/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/addition-of-first-line-veliparib-to-chemotherapy-in-advanced-squamous-cell-nsclc-no-survival-benefit-in-current-smokers-but-potential-benefit-among-biomarker-selected-patients/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/san-antonio-breast-cancer-symposium/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/identifying-women-with-triple-negative-breast-cancer-who-may-benefit-from-pembrolizumab-plus-chemotherapy/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-hope-rugo/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/measurable-residual-disease-kinetics-a-potential-new-tool-in-cll/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-krish-patel/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/the-cancer-research-institute-in-morocco/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/final-analysis-of-pallas-trial-no-benefit-of-adjuvant-palbociclib-plus-endocrine-therapy-in-early-breast-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-matthew-ellis/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/sirolimus-protein-bound-particles-for-malignant-perivascular-epithelioid-cell-tumor/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/orient-31-novel-four-drug-regimen-evaluated-in-egfr-mutated-nsclc/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-myung-ju-ahn/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/cosmic-312-cabozantinib-plus-atezolizumab-improves-progression-free-survival-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-ian-chau/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/maia-trial-daratumumab-added-to-lenalidomide-plus-dexamethasone-improves-overall-survival-in-transplant-ineligible-multiple-myeloma/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/ash-recognizes-peter-marks-with-2021-outstanding-service-award/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/daratumumab-in-front-line-treatment-of-newly-diagnosed-transplant-ineligible-multiple-myeloma-questions-emerge-from-maia-trial/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/nyu-langone-opens-center-dedicated-to-blood-and-marrow-transplants/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/the-oncology-center-of-excellence-encourages-submissions-of-applied-regulatory-science-research-proposals/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/build-back-better-act-passes-in-the-house-moves-to-senate/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/asco-calls-on-congress-to-prevent-steep-medicare-cuts-before-end-of-year/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/cures-20-bill-may-increase-diversity-in-clinical-trials-expand-access-to-telehealth-invest-in-research/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/recruiting-practices-to-help-test-performance-measures-to-advance-oncology-quality-of-care/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/2021-fda-approvals-of-drugs-for-cancer-treatment/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/creating-a-more-equitable-health-care-system-for-patients-with-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/i-don-t-know-why-i-got-young-onset-colorectal-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/nccn-guidelines-for-prostate-cancer-panel-clarifies-role-of-active-surveillance-for-low-risk-prostate-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/more-than-two-dozen-sabcs-presenters-receive-research-scholarships/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/solving-the-conundrum-of-young-onset-colorectal-cancer/</loc><lastmod>2021-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/candor-updated-analysis-carfilzomib-dexamethasone-and-daratumumab-vs-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/friends-of-cancer-research-releases-white-paper-on-optimizing-dosing-in-oncology-drug-development/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-sirolimus-protein-bound-particles-for-rare-sarcoma/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/survey-shows-disparities-in-biomarker-testing-among-underserved-patients-with-lung-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-joshua-k-sabari-md/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/pharmacovigilance-study-of-pancytopenia-in-patients-receiving-parp-inhibitors/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-charles-shapiro/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/patients-with-multiple-myeloma-may-lack-t-cell-responses-to-covid-19-vaccination/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-finds-patients-infected-with-covid-19-who-underwent-recent-cancer-treatment-are-at-higher-risk-of-adverse-outcomes/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/effect-of-geriatric-assessment-and-management-recommendations-on-adverse-events-related-to-cancer-treatment/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-approves-pembrolizumab-for-adjuvant-treatment-of-renal-cell-carcinoma/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fda-expands-eligibility-for-covid-19-vaccine-boosters/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/adding-pembrolizumab-to-chemotherapy-improves-overall-and-progression-free-survival-in-first-line-treatment-of-advanced-esophageal-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/pembrolizumab-for-adjuvant-treatment-of-renal-cell-carcinoma/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/dreamseq-trial-in-advanced-melanoma-with-braf-mutations-start-with-immunotherapy/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/long-term-follow-up-of-monarche-benefit-of-abemaciclib-plus-endocrine-therapy-maintained-in-early-high-risk-breast-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-aditya-bardia/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/large-declines-in-ki67-index-seen-with-oral-selective-estrogen-receptor-degrader/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/cleveland-clinic-researcher-receives-nih-director-s-pioneer-award/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/radiation-therapy-for-hpv-related-oropharyngeal-squamous-cell-carcinoma-prospects-and-controversies/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-nabil-f-saba/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/big-data-and-vulnerable-populations-addressing-the-gap-in-lung-cancer-screening/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/low-dose-computed-tomography-a-window-into-early-lung-disease/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-lee-gazourian/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/to-elect-or-forgo-radiation-therapy-an-informed-decision-for-patients-with-breast-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/society-for-integrative-oncology-focuses-on-the-science-of-living-well-with-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/applying-research-data-to-clinical-practice-in-managing-head-and-neck-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/optimizing-the-use-of-checkpoint-inhibitors-in-recurrent-or-metastatic-head-and-neck-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-nabil-f-saba-1/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/lungevity-foundation-launches-new-online-gateways-for-patients-with-lung-cancer-and-actionable-mutations/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/update-on-the-incidence-of-nsclc-focus-on-need-to-implement-widescale-screening/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/atezolizumab-in-adjuvant-therapy-for-pd-l1-positive-nsclc/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/keynote-355-final-analysis-reveals-survival-benefit-with-pembrolizumab-in-triple-negative-breast-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-adam-m-brufsky/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/establishing-a-health-equity-report-card-to-eradicate-disparities-in-cancer-care/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/how-medical-oncology-came-to-be/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/nagi-el-saghir-md-facp-receives-the-susan-bulkeley-butler-leadership-excellence-award/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/i-m-living-and-thriving-with-stage-iv-non-small-cell-lung-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/the-national-cancer-act-of-1971/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/asco-releases-new-guidelines-on-the-management-of-adverse-events-in-patients-treated-with-immune-checkpoint-inhibitors-and-car-t-cell-therapy/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/covid-19-vaccine-requirements-for-medicare-medicaid-facilities-and-employers-of-100-or-more-staff-released/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/help-test-performance-measures-to-advance-oncology-quality-of-care/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/erudition-and-assessment-on-the-longest-war-in-the-modern-era/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/reclaiming-a-complicated-genius-who-pursued-cancer-with-single-minded-fury/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/the-high-price-of-pain/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/update-on-the-role-of-low-dose-aspirin-in-colorectal-cancer-prevention/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/expect-questions-on-use-of-low-dose-aspirin-to-help-prevent-colorectal-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/brexucabtagene-autoleucel-for-relapsed-or-refractory-b-cell-precursor-all/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/mount-sinai-health-system-and-bronxcare-health-system-open-comprehensive-cancer-facility/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/accc-presents-2021-annual-awards-for-significant-contributions-to-oncology-care/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/msk-inaugurates-new-center-for-myelodysplastic-syndromes-and-announces-new-appointments/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/the-history-of-medical-oncology-in-europe-1955-1985-1/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/last-hug/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/early-operation-with-general-anesthesia/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/mammen-chandy-md-fracp-fracpa-a-pioneer-in-india-s-bone-marrow-transplantation-services/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/newer-cancer-therapies-offer-hope-but-also-may-confer-cardiac-risk/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/asciminib-for-philadelphia-chromosome-positive-chronic-myeloid-leukemia/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/abemaciclib-with-endocrine-therapy-in-adjuvant-treatment-of-early-breast-cancer/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/three-investigators-named-winners-of-msk-cancer-center-s-2021-paul-marks-prize-for-cancer-research/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/margaret-foti-phd-md-hc-honored-with-2021-tara-withington-public-service-award/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/wendy-brewster-md-phd-named-associate-director-of-diversity-equity-and-inclusion/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/potential-impact-of-nurse-navigation-program-in-achieving-equitable-care-and-outcomes-in-patients-with-aggressive-large-b-cell-lymphoma/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/erratum/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/tara-o-henderson-md-mph-to-lead-programs-at-uchicago-medicine-chicagoland-children-s-health/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/mitchell-d-schnall-md-phd-re-elected-group-co-chair-of-the-ecog-acrin-cancer-research-group/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/cancer-researcher-and-biotech-founder-lewis-cantley-phd-joins-dana-farber/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/increased-risk-of-early-cardiac-toxicity-with-posttransplantation-cyclophosphamide-in-allogeneic-hsct/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/jordan-s-queen-rania-presents-king-hussein-awards-for-cancer-research/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/addressing-the-global-challenges-of-cancer-prevention-and-treatment/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/the-history-of-medical-oncology-in-europe-1955-1985/</loc><lastmod>2021-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-aditya-bardia-1/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/long-term-follow-up-of-monarche-benefit-of-abemaciclib-plus-endocrine-therapy-maintained-in-early-high-risk-breast-cancer-1/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/phase-i-trial-investigates-her-targeted-car-m-for-her2-overexpressing-solid-tumors/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/response-to-sars-cov-2-mrna-vaccination-in-patients-with-b-cell-depletion-associated-with-car-t-cell-therapy/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/belzutifan-shows-activity-in-patients-with-von-hippel-lindau-disease-associated-renal-cell-carcinoma/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/cancer-incidence-and-patterns-in-individuals-with-pathogeniclikely-pathogenic-germline-tp53-variants/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/high-response-rate-with-venetoclax-in-previously-treated-patients-with-waldenstroms-macroglobulinemia/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/can-antihistamines-influence-response-to-immunotherapy/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/neoadjuvant-chemoradiation-plus-pembrolizumab-shows-no-effect-on-tumor-infiltrating-lymphocytes-in-pancreatic-cancer/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/immunomodulatory-effects-of-neoadjuvant-nivolumab-chemotherapy-in-nsclc/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/cog-aaml1331-trial-arsenic-trioxide-and-all-trans-retinoic-acid-in-pediatric-patients-with-apl/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/first-line-ibrutinibrituximab-in-patients-with-mantle-cell-lymphoma-aged-65-and-older/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-the-effect-of-breast-mri-on-short-term-quality-of-life-in-women-with-dcis/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fosnetupitant-vs-fosaprepitant-for-prevention-of-chemotherapy-induced-nausea-and-vomiting/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/effect-of-the-covid-19-pandemic-on-cancer-imaging/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/epov-keith-flaherty/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/to-elect-or-forgo-radiation-therapy-an-informed-decision-for-patients-with-breast-cancer-1/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/trends-in-incidence-of-colorectal-cancer-among-black-and-white-individuals-aged-40-to-49-years-from-2000-to-2017/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/managing-illness-expectations-in-patients-with-advanced-cancer/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/dabrafenib-plus-trametinib-in-braf-v600e-mutant-high-and-low-grade-glioma/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/next-generation-sequencing-of-bone-marrow-dna-to-predict-relapse-following-car-t-cell-therapy-in-patients-with-all/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/fully-vaccinated-patients-with-multiple-myeloma-rates-of-sars-cov-2-breakthrough-infection-and-hospitalization/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/poziotinib-in-previously-treated-patients-with-nsclc-and-her2-exon-20-insertion-mutations/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-rates-of-lymphedema-in-black-and-white-patients-with-breast-cancer/</loc><lastmod>2021-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/i-spy2-study-finds-tumor-biology-is-a-more-significant-factor-than-race-in-predicting-response-to-breast-cancer-treatment/</loc><lastmod>2021-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/molecular-tumor-profiling-may-improve-treatment-matching-for-patients-with-metastatic-breast-cancer/</loc><lastmod>2021-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/researchers-identify-significant-differences-in-tumor-characteristics-between-younger-and-older-patients-with-cancer/</loc><lastmod>2021-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/covid-19-infection-after-sars-cov-2-messenger-rna-vaccination-in-patients-with-cancer/</loc><lastmod>2021-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/telemedicine-use-among-us-patients-with-newly-diagnosed-cancer-impact-of-socioeconomic-status/</loc><lastmod>2021-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/single-cell-spatial-analysis-may-help-to-predict-response-to-neoadjuvant-atezolizumab-in-patients-with-triple-negative-breast-cancer/</loc><lastmod>2021-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/pallas-trial-addition-of-adjuvant-palbociclib-to-endocrine-therapy-in-early-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2021-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/elacestrant-may-improve-outcomes-for-postmenopausal-patients-with-progressive-er-positive-her2-negative-metastatic-breast-cancer-1/</loc><lastmod>2021-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-safety-and-efficacy-of-retifanlimab-in-recurrent-msi-hdmmr-endometrial-cancer/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/vidutolimad-plus-pembrolizumab-in-pd-1-refractory-melanoma/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/evaluation-of-carfilzomib-based-induction-consolidation-and-maintenance-strategies-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/association-of-donor-clonal-hematopoiesis-with-outcomes-in-hematopoietic-stem-cell-transplant-recipients/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/response-to-third-dose-of-sars-cov-2-bnt162b2-mrna-vaccine-in-patients-with-solid-tumors-undergoing-active-treatment/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/addition-of-cytoreductive-surgery-to-platinum-based-chemotherapy-in-relapsed-ovarian-cancer/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/covid-19-vaccination-patients-with-multiple-myeloma-may-lack-t-cell-response/</loc><lastmod>2021-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/use-of-adjuvant-chemotherapy-in-older-patients-with-pancreatic-cancer-and-its-effect-on-overall-survival/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/long-term-outcomes-from-checkmate-067-nivolumabipilimumab-nivolumab-or-ipilimumab-in-advanced-melanoma/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/association-of-tp53-gain-of-function-and-non-gain-of-function-mutations-with-outcomes-in-left-sided-vs-right-sided-metastatic-colorectal-cancer/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/patients-with-hr-positive-breast-cancer-and-emergent-esr1-mutations-may-benefit-from-early-switch-to-fulvestrantpalbociclib/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/profiles-of-cancer-risk-associated-with-immune-mediated-diseases/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/outcomes-among-pediatric-and-young-adult-patients-with-all-differ-by-race-ethnicity-and-socioeconomic-status/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-reveals-underrepresentation-of-aya-hispanic-patients-in-a-large-all-clinical-trial/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/activity-of-mosunetuzumab-in-pretreated-patients-with-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/transform-trial-lisocabtagene-maraleucel-vs-standard-of-care-for-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/antibody-response-to-second-dose-of-mrna-covid-19-vaccine-in-patients-with-aml-and-mds/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/ivosidenibazacitidine-vs-azacitidine-alone-in-patients-with-newly-diagnosed-idh1-mutated-aml/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/ash-rc-covid-19-registry-for-hematology-risk-factors-for-hospitalization-and-death-among-patients-with-hematologic-malignancies-infected-with-covid-19/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/antibody-response-to-covid-19-vaccination-in-patients-with-myeloid-and-lymphoid-neoplasms/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-reveals-gaps-in-code-status-discussions-among-patients-with-high-risk-aml/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/isatuximabrvd-meets-primary-endpoint-for-newly-diagnosed-transplant-eligible-patients-with-multiple-myeloma/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/immune-checkpoint-inhibitor-treatment-in-patients-aged-65-and-older-with-advanced-melanoma-association-between-sex-and-survival/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/european-oncovid-registry-analysis-of-time-dependent-covid-19-mortality-in-patients-with-cancer/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/addition-of-romidepsin-to-chop-in-previously-untreated-patients-with-peripheral-t-cell-lymphoma/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-identifies-factors-for-severe-covid-19-illness-among-patients-with-acute-leukemia-or-mds/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/zuma-7-primary-analysis-axicabtagene-ciloleucel-quadruples-event-free-survival/</loc><lastmod>2021-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/hhs-secretary-becerra-names-dr-lawrence-tabak-acting-director-of-nih/</loc><lastmod>2021-12-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-socioeconomic-status-and-cervical-cancer-incidence-in-new-york-city/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-suggests-lack-of-benefit-with-the-addition-of-immune-checkpoint-inhibition-to-chemotherapy-in-low-pd-l1-expressing-gastric-or-esophageal-adenocarcinomas/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/outcomes-with-adjuvant-chemoendocrine-vs-endocrine-therapy-in-node-positive-breast-cancer-and-association-with-21-gene-assay-recurrence-score/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/belinda-study-second-line-tisagenlecleucel-equivalent-to-standard-of-care-for-relapsed-or-refractory-aggressive-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/polarix-pola-r-chp-vs-r-chop-for-previously-untreated-patients-with-dlbcl/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/american-cancer-society-releases-updated-report-on-status-of-cancer-disparities-in-the-united-states/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/global-burden-of-cancer-in-adolescent-and-young-adult-patients-in-2019/</loc><lastmod>2021-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/neoadjuvant-chemotherapy-and-mandibular-preservation-in-operable-oral-cavity-cancer/</loc><lastmod>2021-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/ibrutinib-plus-fludarabine-cyclophosphamide-and-rituximab-for-younger-patients-with-cll/</loc><lastmod>2021-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-a-potential-approach-to-mitigate-car-t-cell-therapy-toxicity/</loc><lastmod>2021-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/zuma-5-trial-axicabtagene-ciloleucel-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-possible-clinical-trial-bias-from-undisclosed-censoring/</loc><lastmod>2021-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/colorectal-cancer-screening-preferences-of-gastroenterologists-and-primary-care-clinicians/</loc><lastmod>2021-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/impact-of-small-cell-undifferentiated-histology-on-outcomes-in-pediatric-hepatoblastoma/</loc><lastmod>2021-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/effect-of-tp53-alterations-on-outcomes-of-cd19-targeted-car-t-cell-therapy-for-patients-with-large-b-cell-lymphoma/</loc><lastmod>2021-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/addition-of-monoclonal-antibody-hu1418k322a-to-chemotherapy-in-pediatric-patients-with-newly-diagnosed-high-risk-neuroblastoma/</loc><lastmod>2021-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/phoebe-trial-pyrotinibcapecitabine-vs-lapatinibcapecitabine-for-previously-treated-patients-with-her2-positive-metastatic-breast-cancer/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/who-launches-a-new-classification-system-for-pediatric-tumors/</loc><lastmod>2021-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/first-line-nivolumab-vs-sorafenib-in-advanced-hepatocellular-carcinoma-effect-on-overall-survival/</loc><lastmod>2021-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/calcineurin-inhibitor-free-chronic-graft-vs-host-disease-interventions-in-myeloablative-hct-for-hematologic-malignancies/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/postoperative-radiotherapy-for-patients-with-completely-resected-stage-iiia-nsclc-and-n2-involvement/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/effect-of-bupropion-vs-placebo-on-sexual-desire-in-postmenopausal-female-cancer-survivors/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/personalized-therapy-vs-physician-s-choice-of-treatment-for-patients-with-residual-triple-negative-breast-cancer-after-neoadjuvant-chemotherapy/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/molecular-analysis-advances-risk-profiling-and-assessment-of-immunotherapy-response-in-smoldering-myeloma/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/breast-cancer-index-may-predict-benefit-of-extended-endocrine-therapy-in-certain-patients-with-hormone-receptor-positive-disease/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/second-line-tisagenlecleucel-vs-standard-of-care-in-aggressive-b-cell-lymphoma/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/hepatic-arterial-infusion-chemotherapy-vs-sorafenib-for-advanced-hepatocellular-carcinoma/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/association-of-mrd-response-and-prognosis-in-patients-with-aml-treated-with-venetoclax-and-azacitidine/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/eight-substances-added-to-the-15th-report-on-carcinogens/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/new-national-study-finds-oropharyngeal-cancer-incidence-and-mortality-is-rising-in-the-united-states/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/polatuzumab-vedotin-piiq-plus-r-chp-vs-r-chop-for-previously-untreated-patients-with-dlbcl/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/study-examines-rates-of-breast-and-colorectal-cancer-screening-among-rural-women/</loc><lastmod>2021-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/association-of-cd123-expression-with-high-risk-disease-characteristics-and-outcomes-in-pediatric-aml/</loc><lastmod>2021-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/12-december/adjuvant-t-dm1pertuzumab-vs-taxanetrastuzumabpertuzumab-in-high-risk-her2-positive-breast-cancer/</loc><lastmod>2021-12-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/is-cabozantinib-active-in-treating-brain-metastases-from-renal-cell-carcinoma/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/addition-of-liposomal-irinotecan-to-fluorouracil-and-leucovorin-as-second-line-treatment-for-metastatic-biliary-tract-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-sophia-c-kamran-1/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-farzan-siddiqui/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/use-of-genomic-classifier-score-may-help-to-personalize-therapy-for-men-with-high-risk-prostate-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/optimizing-adjuvant-therapy-for-women-with-estrogen-receptor-positive-node-positive-breast-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/risk-reducing-medications-for-breast-cancer-are-becoming-safer-and-more-tolerable/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fear-of-side-effects-and-lack-of-awareness-barriers-to-greater-use-of-risk-reducing-medications-for-breast-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/no-survival-benefit-but-improved-secondary-endpoints-with-radiotherapy-plus-androgen-suppression-in-intermediate-risk-prostate-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-sophia-c-kamran/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/de-escalation-of-radiation-therapy-for-hpv-positive-intermediate-risk-oropharyngeal-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/newer-agents-on-the-horizon-for-refractory-or-relapsed-dlbcl/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/novel-therapies-under-study-in-acute-myeloid-leukemia/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/pembrolizumab-plus-chemotherapy-with-or-without-bevacizumab-in-first-line-treatment-of-advanced-cervical-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/can-sbrt-to-selected-sites-of-limited-progression-or-oligoprogression-extend-progression-free-survival-in-advanced-lung-cancer-but-not-breast-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-steven-j-chmura-md-phd/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/shorter-course-radiation-therapy-a-new-practice-standard-after-prostatectomy/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-sophia-c-kamran-2/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/from-cancer-survivor-to-citizen-astronaut/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/durable-responses-in-metastatic-nsclc-are-we-getting-closer-to-a-cure/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/accelerated-radiation-therapies-move-forward-in-early-breast-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-elizabeth-nichols/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/thomas-gruenberger-md-shares-thoughts-on-radiotherapy-for-colorectal-liver-metastases/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/numerous-regimens-proposed-for-relapsed-or-refractory-myeloma/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/for-liver-metastases-transarterial-radioembolization-with-yttrium-90-plus-chemotherapy-may-delay-disease-progression/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-authorizes-pfizer-biontech-covid-19-vaccine-for-emergency-use-in-children-aged-5-through-11-years/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-approves-asciminib-for-philadelphia-chromosome-positive-cml/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/choosing-wisely-researchers-look-at-access-to-essential-cancer-drugs-on-a-global-scale/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/in-case-you-missed-it-brief-highlights-from-esmo-congress-2021/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/t-dxd-makes-inroads-in-the-treatment-of-her2-mutant-nsclc/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-daniel-shao-weng-tan-bsc-md-phd/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/checkmate-743-supports-survival-benefit-of-nivolumab-plus-ipilimumab-in-malignant-pleural-mesothelioma/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-pilar-garrido/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/ukls-trial-meta-analysis-confirms-mortality-reduction-with-low-dose-ct-screening-for-lung-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-paul-wheatley-price/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/addition-of-ipatasertib-to-abiraterone-plus-prednisolone-improves-radiographic-progression-free-survival-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/taking-akt-ion-against-prostate-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/high-risk-multiple-myeloma-combination-regimens-and-car-t-cell-therapy/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/keynote-564-trial-adjuvant-pembrolizumab-improves-disease-free-survival-in-high-risk-renal-cell-carcinoma/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/adjuvant-immunotherapy-the-next-chapter-in-advancements-in-renal-cell-carcinoma/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/md-anderson-and-the-rare-cancer-research-foundation-announce-collaboration/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/no-disease-free-survival-difference-with-longer-anastrozole-treatment-after-endocrine-therapy-in-hr-positive-breast-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/achieving-equity-in-cancer-care-for-adolescents-and-young-adults-with-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/duration-of-endocrine-therapy-in-breast-cancer-how-much-of-a-good-thing-is-too-much/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/purdue-center-for-cancer-research-receives-15-million-for-endowed-professorship/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/msk-appoints-saad-usmani-chief-of-myeloma-service/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/craig-sauter-joins-cleveland-clinic/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/northwell-names-fidel-valea-to-leadership-roles-in-gynecologic-oncology/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/covid-19-resources-for-people-with-cancer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/mortality-risk-in-patients-with-cancer-and-sars-cov-2-higher-among-older-patients-with-b-cell-malignancies-and-those-who-previously-or-currently-smoke/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/five-percent-overall-medicare-reimbursement-cut-estimated-for-medical-oncology-in-2022/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/the-role-of-spirituality-in-palliative-care/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/the-promise-and-the-challenge-experts-and-innovators-explore-the-impact-of-new-technologies-in-cancer-care/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/tools-for-high-quality-accessible-care/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/maintenance-daratumumab-prolongs-progression-free-survival-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/maintenance-daratumumab-after-initial-therapy-for-transplant-eligible-multiple-myeloma-more-questions-than-answers-from-cassiopeia-part-2/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/passionate-about-surgical-oncology-masakazu-toi-is-a-leader-in-japanese-clinical-trials/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/shiitake-mushroom/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/american-cancer-society-and-flatiron-health-announce-recipients-of-real-world-data-impact-award/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/possible-impact-of-nurse-navigation-program-in-achieving-equitable-care-and-outcomes-in-minority-vs-white-patients/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/eric-winer-to-lead-yale-cancer-center-and-smilow-cancer-hospital/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/new-breast-cancer-survivorship-program-launched-by-usc-norris-comprehensive-cancer-center/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/sarc-appoints-jonathan-fletcher-to-new-role-of-chief-scientific-officer/</loc><lastmod>2021-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-farzan-siddiqui-1/</loc><lastmod>2022-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/de-escalation-of-radiation-therapy-for-hpv-positive-intermediate-risk-oropharyngeal-cancer-1/</loc><lastmod>2022-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/early-experiences-in-the-united-states-helped-shape-an-international-oncology-career-for-aleix-prat-md-phd/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/aml-pioneer-and-gentle-soul-elihu-h-estey-md-dies-at-75/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/astro-honors-2021-gold-medalists-and-others/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/sidney-kimmel-cancer-center-jefferson-health-welcomes-marcia-brose-md-phd-fasco/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/aaci-recognizes-robert-a-winn-md-with-inaugural-cancer-health-equity-award/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/cancer-researcher-and-drug-developer-joseph-r-bertino-md-dies-at-91/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/susan-g-komen-announces-15-million-in-grants-for-metastatic-breast-cancer-research/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/the-worst-part-of-having-cancer-was-the-guilt/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/who-director-general-grants-posthumous-award-to-henrietta-lacks/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/medication-nonadherence-among-cancer-survivors-are-indirect-health-care-costs-to-blame/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-michaela-dinan/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/mary-pasquinelli-receives-2021-national-leadership-award-from-the-prevent-cancer-foundation/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/many-patients-with-solid-tumors-mount-an-adequate-response-to-sars-cov-2-vaccine/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/pamela-kunz-named-2021-woman-oncologist-of-the-year/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/brightness-neoadjuvant-carboplatin-improves-event-free-survival-in-triple-negative-breast-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-monica-arnedos/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/lung-cancer-research-foundation-names-2021-recipients-of-grant-on-disparities-in-lung-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/david-morse-livingston-scientist-and-esteemed-mentor-dies-at-80/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/living-in-survival-mode/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/showcasing-50-years-of-advances-in-cancer-research-and-treatment/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/second-surprise-billing-rule-covers-dispute-resolution-processes-good-faith-estimates-for-the-uninsured/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/asco-quality-improvement-programs-helped-to-enhance-the-delivery-of-cancer-care-in-medically-underserved-communities-article-reports/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/asco-joins-effort-to-improve-covid-19-vaccination-rates-among-high-risk-adults-including-people-with-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/out-of-pocket-costs-on-the-rise-for-the-four-most-common-cancers-study-finds/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-michaela-dinan-1/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/evidence-for-efficacy-of-sunitinib-in-malignant-pheochromocytoma-and-paraganglioma/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-rocio-garcia-carbonero/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/patient-reported-outcomes-in-gastrointestinal-cancers-predicting-treatment-response-and-survival-outcomes/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-areej-el-jawahri/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/focus4-c-trial-hint-of-activity-reported-with-adavosertib-in-metastatic-colorectal-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-pierre-laurent-puig/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-arjun-gupta-mbbs/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/is-precision-oncology-an-unsustainable-promise/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/impower010-adjuvant-atezolizumab-improves-disease-free-survival-and-nsclc-relapse-in-patients-whose-tumors-express-pd-l1/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-benjamin-besse/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fox-chase-cancer-center-welcomes-teresa-y-lee-md-phd/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/hossein-borghaei-do-ms-honored-with-lung-cancer-heroes-award/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/kras-g12c-inhibitor-adagrasib-shows-activity-in-colorectal-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-federica-di-nicolantonio/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/effect-of-geriatric-assessment-driven-intervention-on-incidence-of-severe-chemotherapy-related-toxicity-in-older-patients-with-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/does-a-longer-interval-before-surgery-among-patients-with-locally-advanced-rectal-cancer-lead-to-worse-survival/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-approves-brexucabtagene-autoleucel-for-relapsed-or-refractory-b-cell-precursor-all/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/addition-of-ramucirumab-or-merestinib-to-first-line-chemotherapy-in-advanced-biliary-tract-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/patients-with-hematologic-malignancies-how-robust-is-their-immunity-to-sars-cov-2/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/secombit-trial-evaluates-optimal-treatment-sequencing-in-braf-mutated-melanoma/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/epov-omid-hamid/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-approves-atezolizumab-as-adjuvant-treatment-for-nsclc/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-approves-abemaciclib-in-combination-with-endocrine-therapy-for-early-breast-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-approves-pembrolizumab-combination-for-the-first-line-treatment-of-cervical-cancer/</loc><lastmod>2021-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/primary-transoral-surgery-and-reduced-dose-adjuvant-radiation-therapy-for-hpv-positive-locally-advanced-oropharyngeal-cancer/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/research-assesses-molecular-hallmarks-of-moles-and-melanomas/</loc><lastmod>2021-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/impact-of-prior-blinatumomab-exposure-on-cd19-targeted-car-t-cell-therapy-outcomes-in-pediatric-patients-with-b-cell-all/</loc><lastmod>2021-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/cdk46-inhibitors-combined-with-fulvestrant-for-hr-positive-her2-negative-advanced-breast-cancer-fda-analysis-of-overall-survival/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-pipeline-reviews-and-designations-in-hematology/</loc><lastmod>2021-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/does-yoga-improve-quality-of-life-in-men-with-prostate-cancer/</loc><lastmod>2021-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/alk-inhibition-for-pediatric-patients-with-advanced-alk-positive-malignancies/</loc><lastmod>2021-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/cancer-related-financial-toxicity-role-of-race/</loc><lastmod>2021-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/research-letter-examines-changes-in-cancer-mortality-50-years-after-passage-of-the-national-cancer-act/</loc><lastmod>2021-11-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/addition-of-fdg-petct-and-staging-laparoscopy-to-the-initial-staging-of-locally-advanced-gastric-cancer/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-finds-type-1-interferon-may-enhance-the-anti-leukemia-effect-of-allogeneic-transplantation/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/adjuvant-internal-mammary-node-irradiation-in-node-positive-breast-cancer/</loc><lastmod>2021-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/ibrutinib-plus-r-chop-for-younger-patients-with-dlbcl/</loc><lastmod>2021-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/early-warning-system-model-may-help-to-predict-deterioration-of-hospitalized-patients-with-cancer/</loc><lastmod>2021-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/nsclc-in-the-united-states-update-on-incidence-prevalence-and-survival/</loc><lastmod>2021-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/esmo-women-for-oncology-studies-examine-female-leadership-in-oncology-over-time/</loc><lastmod>2021-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/studies-find-b7-h3-protein-may-be-a-target-for-prostate-cancer-treatment/</loc><lastmod>2021-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/risks-and-benefits-associated-with-gastrostomy-tubes-for-patients-with-cancer/</loc><lastmod>2021-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-pipeline-novel-treatments-in-lymphoma-nasopharyngeal-cancer-solid-tumors-and-more/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/do-solid-organ-transplant-recipients-with-a-previous-cancer-diagnosis-have-high-cure-probabilities/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/role-of-age-at-smoking-start-and-cessation-in-risk-of-overall-cancer-mortality-among-current-smokers-vs-never-smokers/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/primary-transoral-surgery-and-reduced-dose-adjuvant-radiation-therapy-for-hpv-positive-locally-advanced-oropharyngeal-cancer-1/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/characteristics-effects-and-outcomes-of-sars-cov-2-infection-in-pediatric-patients-with-cancer/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/effect-of-social-determinants-of-health-on-receipt-of-survivorship-care-plans/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-finds-younger-b-cell-non-hodgkin-lymphoma-survivors-may-have-a-higher-risk-of-age-related-diseases-than-older-survivors/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/retrospective-study-examines-real-world-survival-in-us-women-treated-for-early-stage-breast-cancer/</loc><lastmod>2021-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/germline-pathogenic-variants-in-cancer-predisposition-genes-and-risk-for-invasive-lobular-carcinoma-of-the-breast/</loc><lastmod>2021-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/model-may-help-identify-subtypes-of-multiple-myeloma/</loc><lastmod>2021-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/2021-state-of-lung-cancer-report-finds-survival-has-increased-but-remains-significantly-lower-for-people-of-color/</loc><lastmod>2021-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/overall-survival-with-laparoscopic-vs-open-distal-gastrectomy-for-locally-advanced-gastric-cancer/</loc><lastmod>2021-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/modified-folfirinox-vs-cisplatingemcitabine-for-advanced-biliary-tract-cancer/</loc><lastmod>2021-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/definitive-radiotherapy-without-systemic-therapy-for-oligometastatic-renal-cell-carcinoma/</loc><lastmod>2021-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/five-year-follow-up-of-olaparib-maintenance-for-newly-diagnosed-patients-with-advanced-brca-mutant-ovarian-cancer/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/early-study-examines-potential-benefits-of-a-fasting-mimicking-diet-in-patients-with-cancer/</loc><lastmod>2021-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/ai-based-breast-cancer-risk-model-multi-institution-validation/</loc><lastmod>2021-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/novel-therapies-under-study-in-acute-myeloid-leukemia-1/</loc><lastmod>2021-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/long-term-outcomes-with-chemoradiotherapy-before-vs-after-chemotherapy-in-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/</loc><lastmod>2021-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-finds-unique-genomic-and-molecular-features-in-young-adult-patients-with-cancer/</loc><lastmod>2021-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/netter-1-trial-final-overall-survival-analysis-of-lu-177-dotatate-plus-long-acting-octreotide-vs-high-dose-long-acting-octreotide-for-midgut-neuroendocrine-tumors/</loc><lastmod>2021-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-examines-availability-of-all-trans-retinoic-acid-in-us-hospitals/</loc><lastmod>2021-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/immunotherapy-followed-by-targeted-therapy-yields-greater-overall-survival-in-patients-with-braf-v600-mutated-advanced-melanoma/</loc><lastmod>2021-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/digital-symptom-monitoring-system-may-improve-patients-symptom-control-and-physical-function-during-cancer-therapy/</loc><lastmod>2021-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/effect-of-embedding-a-palliative-care-nurse-practitioner-in-an-oncology-clinic/</loc><lastmod>2021-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/evorpacept-alone-and-combined-with-pembrolizumab-or-trastuzumab-for-advanced-solid-tumors/</loc><lastmod>2021-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/exercise-program-may-help-to-reduce-upper-limb-disability-after-breast-cancer-surgery/</loc><lastmod>2021-11-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/fda-approves-ropeginterferon-alfa-2b-njft-for-adults-with-polycythemia-vera/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/method-to-selectively-grow-tumor-targeting-t-cells-for-cancer-therapy/</loc><lastmod>2021-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/stampede-trial-quality-of-life-with-abiraterone-vs-docetaxel-in-advanced-hormone-sensitive-prostate-cancer/</loc><lastmod>2021-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/brain-substructure-informed-radiotherapy-planning-may-improve-neurocognitive-outcomes-in-pediatric-patients-with-medulloblastoma/</loc><lastmod>2021-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/development-of-phenotypic-spectrum-categorization-for-li-fraumeni-syndrome/</loc><lastmod>2021-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/immunogenicity-of-covid-19-vaccination-in-patients-receiving-systemic-therapy-for-solid-tumors/</loc><lastmod>2021-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/checkmate-214-longer-treatment-free-survival-with-immunotherapy-vs-targeted-therapy-in-patients-with-advanced-renal-cell-carcinoma/</loc><lastmod>2021-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/incidence-of-pancreatic-cancer-in-the-united-states-by-age-and-sex-2000-2018/</loc><lastmod>2021-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/treatment-adherence-toxicity-and-outcomes-with-adjuvant-fluoropyrimidine-plus-oxaliplatin-in-early-onset-colorectal-cancer/</loc><lastmod>2021-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/french-study-finds-covid-19-vaccine-effective-in-patients-with-lung-cancer/</loc><lastmod>2021-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-reveals-genomic-differences-between-14-tumor-types-in-younger-vs-older-adults/</loc><lastmod>2021-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/association-of-kras-variants-with-outcomes-after-curative-resection-of-intrahepatic-cholangiocarcinoma/</loc><lastmod>2021-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/international-medullary-thyroid-carcinoma-grading-system-detecting-adverse-outcomes/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/arginine-may-enhance-effectiveness-of-radiation-therapy-for-brain-metastases/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/international-conference-updates-guidelines-for-advanced-breast-cancer/</loc><lastmod>2021-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/outcomes-and-toxicity-with-single-agent-immune-checkpoint-inhibitor-treatment-in-patients-with-cancer-aged-80-years/</loc><lastmod>2021-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-examines-covid-19-outcomes-in-pediatric-patients-with-cancer/</loc><lastmod>2021-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/researchers-identify-key-link-between-stress-and-cancer/</loc><lastmod>2021-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/immunogenicity-of-sars-cov-2-vaccines-in-patients-with-cancer/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/covid-19-sequelae-prevalence-risk-factors-and-outcomes-in-patients-with-cancer/</loc><lastmod>2021-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-finds-lack-of-health-insurance-may-hinder-recommended-cancer-screening-in-unemployed-adults/</loc><lastmod>2021-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/adjuvant-gefitinib-vs-cisplatinvinorelbine-for-completely-resected-egfr-mutant-stage-ii-to-iiia-nsclc/</loc><lastmod>2021-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/racial-disparities-in-use-of-prostate-mri-after-detection-of-elevated-psa-levels/</loc><lastmod>2021-11-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/health-related-quality-of-life-with-pembrolizumab-vs-chemotherapy-for-advanced-esophageal-cancer/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/rituximab-maintenance-vs-response-adapted-postinduction-strategy-in-advanced-follicular-lymphoma/</loc><lastmod>2021-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/president-biden-nominates-robert-m-califf-md-macc-as-fda-commissioner/</loc><lastmod>2021-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-examines-immunotherapy-outcomes-in-patients-with-solid-tumors-who-are-ineligible-for-clinical-trials/</loc><lastmod>2021-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/extended-follow-up-in-cll14-trial-of-venetoclaxobinutuzumab-in-previously-untreated-chronic-lymphocytic-leukemia/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/long-term-outcomes-with-nivolumab-plus-ipilimumab-in-active-melanoma-brain-metastases/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/novel-drug-combination-may-help-children-with-acute-promyelocytic-leukemia-avoid-conventional-chemotherapy/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/study-examines-breakthrough-covid-19-infection-in-vaccinated-patients-with-hematologic-cancers/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/nci-designated-cancer-center-compliance-with-cms-price-transparency-rules/</loc><lastmod>2021-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/effect-of-national-hpv-vaccination-program-on-the-incidence-of-cervical-cancer-and-intraepithelial-neoplasia-in-young-women-in-england/</loc><lastmod>2021-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/11-november/us-multisociety-task-force-on-colorectal-cancer-releases-updated-screening-recommendations/</loc><lastmod>2021-11-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-grants-accelerated-approval-to-mobocertinib-for-patients-with-metastatic-nsclc-and-egfr-exon-20-insertion-mutations/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/clayton-dunklin-pruett-business-professional-asco-member-dies-at-age-86/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/having-stage-iv-lung-cancer-has-refocused-my-life/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/novel-urine-based-test-evaluated-in-prostate-cancer-detection-and-risk-stratification/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/international-survey-on-access-to-cancer-medicines-considered-essential-by-oncologists/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/risk-of-pancreatic-cancer-associated-with-germline-atm-pathogenic-variants/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/ga-68-psma-11-pet-for-detection-of-pelvic-nodal-metastasis-in-intermediate-to-high-risk-prostate-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/cardio-oncology/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-expands-cetuximab-label-for-encorafenib-combination-in-braf-v600e-mutation-positive-metastatic-colorectal-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/acupuncture-vs-cognitive-behavioral-therapy-for-cognitive-function-in-cancer-survivors-with-insomnia/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/msk-launches-new-center-to-expand-commitment-to-meeting-the-unique-needs-of-adolescents-and-young-adults-with-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/zanubrutinib-for-relapsed-or-refractory-marginal-zone-lymphoma/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/md-anderson-and-siemens-healthineers-collaborate-to-enable-consistent-clinical-implementation-of-quantitative-mri/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/an-atypical-road-to-a-career-in-medicine-and-leading-a-cancer-center-for-robert-a-winn/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/mobocertinib-for-previously-treated-advanced-nsclc-with-egfr-exon-20-insertion-mutations/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/memorial-sloan-kettering-cancer-center-announces-new-early-career-physician-research-program-in-cancer-science/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/extended-open-enrollment-special-enrollment-periods-finalized-for-some-insurance-exchanges-increasing-access-to-cancer-care/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/urbanization-in-bangladesh-the-prevalence-of-breast-cancer-brings-unique-challenges/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/md-anderson-and-bostongene-announce-strategic-alliance-to-advance-personalized-cancer-diagnostics-and-treatments/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/caroline-chung-named-md-andersons-first-chief-data-officer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/noninferior-progression-free-survival-and-reduced-cardiovascular-toxicity-with-acalabrutinib-vs-ibrutinib-in-previously-treated-cll/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/jco-op-special-series-disparities-in-cancer-care-for-hispanic-latinx-people/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/advance-care-planning-is-crucial-component-of-cancer-care/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/ruxolitinib-for-chronic-graft-vs-host-disease-after-failure-of-systemic-therapy/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/cleveland-clinic-launches-center-for-young-onset-colorectal-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/financial-toxicity-associated-with-atherosclerotic-cardiovascular-disease-cancer-and-both-in-us-adult-patients/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/tisotumab-vedotin-tftv-in-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/financial-impact-of-cardiovascular-disease-and-cancer-care-overlapping-toxicities/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/urge-congress-to-avoid-shutdown-increase-funding-for-cancer-research-in-fiscal-year-2022/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/cabozantinib-for-previously-treated-advanced-differentiated-thyroid-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-bhutan/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/phase-ii-trial-finds-atezolizumab-of-benefit-in-patients-with-lung-cancer-and-brain-metastases/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-heather-a-wakelee-md-fasco-and-erika-hlavacek/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/dual-checkpoint-blockade-plus-chemotherapy-improves-survival-in-first-line-metastatic-nsclc/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-julie-brahmer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/pretreatment-levels-of-circulating-tumor-dna-may-predict-long-term-survival-in-nsclc/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-bruna-pellini/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-eleni-efstathiou-md/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/michael-diaz-md-named-president-and-managing-physician-at-florida-cancer-specialists-research-institute/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/iaslc-names-kristin-richeimer-cae-des-interim-chief-executive-officer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/iaslc-presents-wclc-2021-lectureship-awards-to-international-array-of-lung-cancer-researchers/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-j-kellogg-parsons/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/msk-announces-appointment-of-deb-schrag-md-fasco-mph-as-chair-of-the-department-of-medicine/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/another-antibody-drug-conjugate-enters-the-metastatic-breast-cancer-landscape/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-barbara-pistilli/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/francis-collins-to-step-down-as-director-of-the-national-institutes-of-health/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/checkmate-649-long-term-data-support-nivolumab-plus-chemotherapy-but-not-nivolumab-plus-ipilimumab-in-gastric-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-florian-lordick/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/stampede-in-nonmetastatic-castration-sensitive-prostate-cancer-abiraterone-added-to-androgen-deprivation-therapy-improves-survival/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/btk-inhibition-in-cll-an-embarrassment-of-riches/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/national-cancer-act-and-lung-cancer-screening-an-example-of-intended-impact/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/did-change-in-psa-based-screening-recommendation-hinder-prostate-cancer-specific-survival/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-johnie-rose-md-phd/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/neoadjuvant-dd-mvac-improves-local-control-and-progression-free-survival-in-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-enrique-grande-md/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-johnie-rose/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/peace-1-abiraterone-plus-androgen-deprivation-therapy-and-docetaxel-boosts-survival-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-eleni-efstathiou/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/st-jude-names-shannon-dean-md-as-chief-medical-information-officer/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/monaleesa-2-overall-survival-benefit-with-first-line-ribociclib-plus-letrozole/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-gonzalo-gomez-abuin-md-and-gabriel-n-hortobagyi-md-macp-fasco/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/parp-rechallenge-slows-ovarian-cancer-progression-in-platinum-sensitive-disease/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-clare-scott/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-finds-medicaid-expansion-may-be-associated-with-decrease-in-early-lung-cancer-mortality/</loc><lastmod>2021-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/recent-fda-approvals-in-breast-cancer/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-yuan-yuan-md-phd-and-elizabeth-mittendorf-md-phd/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/pembrolizumab-plus-chemotherapy-improves-progression-free-survival-in-pd-l1-enriched-advanced-triple-negative-breast-cancer/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-melinda-l-telli-md/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/platinum-not-equal-to-capecitabine-for-residual-disease-in-triple-negative-breast-cancer/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/sacituzumab-govitecan-hziy-improves-survival-vs-single-agent-chemotherapy-in-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-melinda-l-telli/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/neoadjuvant-durvalumab-improves-long-term-outcomes-in-the-geparnuevo-trial/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-giuseppe-curigliano/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/neoadjuvant-pembrolizumab-improves-event-free-survival-in-triple-negative-breast-cancer/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/early-triple-negative-breast-cancer-are-checkpoint-inhibitors-ready-for-neoadjuvant-or-adjuvant-use/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/margetuximab-cmkb-plus-chemotherapy-prolongs-progression-free-survival-in-heavily-pretreated-her2-positive-breast-cancer/</loc><lastmod>2021-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/excellent-outcomes-reported-with-neoadjuvant-dual-her2-therapy-in-breast-cancer/</loc><lastmod>2021-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-evandro-de-azambuja/</loc><lastmod>2021-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/long-term-analysis-of-short-her-trial-of-adjuvant-trastuzumab/</loc><lastmod>2021-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/novel-her2-targeted-therapies-pose-sequencing-challenges/</loc><lastmod>2021-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-c-kent-osborne/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/rxponder-many-postmenopausal-patients-with-node-positive-breast-cancer-can-avoid-chemotherapy/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-osborne-and-oregan/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/a-tale-of-two-cdk46-inhibitors-in-early-breast-cancer/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/addition-of-adjuvant-palbociclib-to-ongoing-endocrine-therapy-in-hr-positive-her2-negative-early-breast-cancer-pallas-trial/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-nadine-tung/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/olympia-trial-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-breast-cancer/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/beyond-cdk46-inhibitors-in-metastatic-breast-cancer-what-s-next/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/breast-cancer-2020-2021-almanac/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-eleni-efstathiou-1/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/peace-1-abiraterone-plus-androgen-deprivation-therapy-and-docetaxel-boosts-survival-in-metastatic-castration-sensitive-prostate-cancer-1/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/donations-to-st-jude-children-s-research-center-soar-inspiration4-spacex-journey-exceeds-200-million-goal/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/how-asco-is-expanding-its-commitment-to-diversity-and-equity-in-cancer-care/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/glancing-back-and-looking-forward-in-the-fight-against-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/a-guide-to-end-of-life-care-by-a-veteran-in-hospice/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/overcoming-the-stigma-of-small-cell-lung-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/enhanced-surveillance-and-risk-reducing-intervention-options-for-individuals-with-palb2-variants/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/palb2-added-to-secondary-findings-list/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/franco-m-muggia-md-internationally-regarded-chemotherapy-pioneer-dies-at-85/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/destiny-breast03-trial-supports-second-line-use-of-t-dxd-in-metastatic-her2-positive-breast-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-shanu-modi/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/impower010-benefits-observed-with-atezolizumab-regardless-of-stage-type-of-prior-treatment/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-ichiro-yoshino/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/oncology-care-remains-under-strain-in-the-ongoing-covid-19-pandemic/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/phase-iii-trial-supports-adjuvant-endocrine-therapy-for-7-years-in-early-stage-breast-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-monica-arnedos/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-shows-pembrolizumab-plus-chemotherapy-improves-survival-in-advanced-cervical-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-mansoor-raza-mirza/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/adjuvant-pembrolizumab-shows-efficacy-in-high-risk-stage-ii-melanoma-in-adults-and-children-older-than-12/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-omid-hamid/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/aacr-announces-2021-distinguished-lectureship-on-the-science-of-cancer-health-disparities/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/roswell-park-and-university-of-chicago-medicine-comprehensive-cancer-centers-awarded-nearly-9m-for-ovarian-cancer-research/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/msk-announces-new-senior-vice-president-chief-nurse-executive-and-chair-of-nursing/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/michael-boyer-honored-with-adi-gazdar-iaslc-merit-award/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/the-wistar-institute-appoints-italo-tempera-as-associate-director-for-cancer-research-career-enhancement/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/benefits-seen-with-lurbinectedin-plus-doxorubicin-in-small-cell-lung-cancer-but-primary-endpoint-missed/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-charles-rudin/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/neoadjuvant-atezolizumab-under-study-in-mesothelioma/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/cabozantinib-prolongs-progression-free-survival-in-previously-treated-radioiodine-refractory-differentiated-thyroid-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/totally-implanted-ports-associated-with-reduced-complication-rates-vs-other-central-venous-access-devices-used-in-anticancer-therapy/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/reduction-in-ipsilateral-recurrence-risk-with-radiotherapy-vs-observation-after-lumpectomy-for-good-risk-dcis/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/breast-cancer-research-foundation-conquer-cancer-and-asco-celebrate-20th-year-of-collaboration/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/administration-outlines-plan-to-address-high-prescription-drug-costs/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/340b-needs-reforms-not-cuts-to-improve-low-income-americans-access-to-care/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/new-certification-pilot-focuses-on-patient-centered-cancer-care/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/resurgence-of-covid-19-infection-in-a-large-highly-vaccinated-us-health-system-workforce/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/adding-value-to-clinical-decision-making-in-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/emily-bergsland-specializing-in-neuroendocrine-tumors-with-a-broad-focus-on-collaborative-research/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/tackling-a-growing-need-options-after-car-t-cell-therapy-for-lymphoma/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/maintenance-durvalumab-increased-utilization-may-improve-outcomes-in-nsclc/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/epov-jyoti-patel-md/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/the-evolution-of-liquid-biopsy-in-cancer-care/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/president-biden-appoints-members-to-national-cancer-advisory-board/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/zanubrutinib-for-waldenstroem-s-macroglobulinemia/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/a-look-at-tomorrow-s-car-t-cell-therapy-today/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/ruxolitinib-granted-fda-approval-for-chronic-graft-vs-host-disease/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-authorizes-booster-dose-of-pfizer-biontech-covid-19-vaccine-for-certain-populations/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-grants-accelerated-approval-to-tisotumab-vedotin-tftv-for-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-grants-zanubrutinib-accelerated-approval-in-relapsed-or-refractory-marginal-zone-lymphoma/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/ensartinib-shows-superior-efficacy-to-crizotinib-in-advanced-alk-positive-nsclc-exalt3-trial/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-approves-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-differentiated-thyroid-cancer/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/rates-of-newly-diagnosed-cancer-among-us-patients-during-the-first-full-year-of-the-covid-19-pandemic/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/hpv-vaccination-and-projected-oropharyngeal-cancer-incidence-through-the-year-2045/</loc><lastmod>2021-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/addition-of-panitumumab-to-fluorouracilleucovorin-as-maintenance-therapy-for-ras-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2021-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/ivosidenib-vs-placebo-for-previously-treated-advanced-idh1-mutated-cholangiocarcinoma-final-overall-survival-analysis-of-the-claridhy-trial/</loc><lastmod>2021-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/radioembolization-plus-second-line-chemotherapy-for-colorectal-liver-metastases/</loc><lastmod>2021-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/improved-health-insurance-coverage-access-to-care-may-lessen-racialethnic-disparities-in-childhood-cancer-survival/</loc><lastmod>2021-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/characteristics-of-and-outcomes-in-luminal-and-basal-subtypes-of-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/two-studies-show-health-care-costs-may-impact-follow-up-care-after-cancer-screening/</loc><lastmod>2021-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/axicabtagene-ciloleucel-for-adult-patients-with-primary-mediastinal-b-cell-lymphoma-real-world-outcomes/</loc><lastmod>2021-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/trends-in-use-of-neoadjuvant-chemotherapy-and-association-with-overall-survival-in-patients-with-advanced-ovarian-cancer/</loc><lastmod>2021-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/factors-associated-with-early-discontinuation-of-endocrine-therapy-for-ductal-carcinoma-in-situ/</loc><lastmod>2021-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/adjuvant-atezolizumab-following-adjuvant-chemotherapy-for-resected-stage-ib-to-iiia-nsclc/</loc><lastmod>2021-10-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/rates-of-post-protocol-immunotherapy-use-in-patients-enrolled-in-kidney-cancer-clinical-trials/</loc><lastmod>2021-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/black-patients-with-advanced-nsclc-receiving-immunotherapy-may-have-a-lower-risk-of-death-than-white-patients/</loc><lastmod>2021-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-examines-benefits-of-cervical-cancer-screening-program-tailored-to-transgender-men-and-nonbinary-people/</loc><lastmod>2021-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/da-epoch-r-for-children-and-adolescents-with-newly-diagnosed-primary-mediastinal-b-cell-lymphoma/</loc><lastmod>2021-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/factors-associated-with-risk-of-hearing-loss-in-pediatric-patients-receiving-radiation-and-chemotherapy/</loc><lastmod>2021-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/disparities-in-terminal-hospitalization-among-adults-with-metastatic-cancer/</loc><lastmod>2021-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/antibody-response-to-covid-19-vaccination-in-patients-with-hematologic-or-solid-cancers/</loc><lastmod>2021-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/rates-and-causes-of-second-primary-cancers-in-patients-with-neuroendocrine-tumors/</loc><lastmod>2021-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-finds-significant-variation-in-the-incidence-of-nasopharyngeal-cancer-among-ethnic-subgroups-of-asian-americans/</loc><lastmod>2021-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/aramis-analysis-darolutamide-shows-similar-benefits-for-black-patients-as-observed-in-the-overall-population/</loc><lastmod>2021-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/effect-of-chronic-stress-on-treatment-completion-and-survival-outcomes-in-patients-with-breast-cancer/</loc><lastmod>2021-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-pipeline-recent-reviews-designations-applications-and-authorizations-in-the-oncology-space/</loc><lastmod>2021-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-finds-some-pancreatic-cancer-trial-eligibility-criteria-disproportionately-exclude-black-patients/</loc><lastmod>2021-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-recognizes-memorial-sloan-kettering-database-of-molecular-tumor-marker-information/</loc><lastmod>2021-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-tracks-parental-hesitancy-trends-over-the-hpv-vaccine-from-2010-to-2019/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/goal-focused-emotion-regulation-therapy-for-young-adult-testicular-cancer-survivors/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/camrelizumabapatinib-for-high-risk-chemorefractory-or-relapsed-gestational-trophoblastic-neoplasia/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-examines-cost-of-cancer-care-in-the-united-states-in-2018/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/acis-trial-addition-of-apalutamide-to-abiraterone-acetateprednisone-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/is-baseline-brain-white-matter-microstructure-associated-with-cognitive-decline-after-chemotherapy-for-breast-cancer/</loc><lastmod>2021-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/risk-of-cancer-in-children-with-fanconi-anemia-and-ataxia-telangiectasia/</loc><lastmod>2021-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/international-study-of-the-effects-of-covid-19-lockdowns-on-planned-cancer-surgeries/</loc><lastmod>2021-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/aacr-cancer-progress-report-2021-showcases-50-years-of-advances-in-cancer-research-and-treatment/</loc><lastmod>2021-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/who-director-general-grants-posthumous-award-to-henrietta-lacks/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/characteristics-of-genomically-targeted-single-patient-use-requests-for-pediatric-cancers/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/genomic-profiling-of-lung-adenocarcinoma-in-never-smokers-vs-smokers/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-examines-potential-link-between-cancer-and-physical-inactivity/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/nodal-recurrence-with-sentinel-node-biopsy-alone-following-neoadjuvant-chemotherapy-for-node-positive-breast-cancer/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/final-analysis-of-innovate-addition-of-ibrutinib-to-rituximab-for-waldenstroem-s-macroglobulinemia/</loc><lastmod>2021-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/abiraterone-for-castration-resistant-androgen-receptor-expressing-salivary-gland-cancer/</loc><lastmod>2021-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/fda-perspective-on-drug-dosing-in-oncology-from-more-is-better-to-less-can-be-more/</loc><lastmod>2021-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/can-inhibition-of-the-aurora-kinase-a-protein-help-to-overcome-resistance-to-kras-inhibition-in-patients-with-lung-cancer/</loc><lastmod>2021-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/dm-choc-pen-may-improve-outcomes-for-adolescents-and-young-adults-with-central-nervous-system-tumors/</loc><lastmod>2021-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/second-line-sotorasib-plus-afatinib-for-kras-mutant-nsclc/</loc><lastmod>2021-10-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/ibrutinib-vs-placebo-following-achievement-of-undetectable-mrd-with-first-line-ibrutinibvenetoclax-in-cll/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/global-analysis-of-national-health-system-characteristics-and-breast-cancer-mortality-and-stage-at-diagnosis/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/first-line-fulvestrantpalbociclib-vs-letrozolepalbociclib-for-endocrine-sensitive-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/primary-tumor-resection-followed-by-systemic-treatment-vs-systemic-treatment-in-metastatic-colorectal-cancer-60-day-mortality/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/preclinical-study-examines-relationship-between-aging-breast-tissue-and-invasive-breast-cancer/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/efficacy-of-quadrivalent-hpv-vaccine-in-girls-in-india-against-persistent-hpv-1618-infection-10-year-protection-analysis/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/nivolumablow-dose-ipilimumab-produces-responses-in-patients-with-msi-hdmmr-metastatic-colorectal-cancer/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/mobocertinib-for-platinum-pretreated-patients-with-egfr-exon-20-insertion-positive-metastatic-nsclc/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-examines-opinions-on-telemedicine-among-patients-undergoing-radiotherapy/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/do-patients-diagnosed-with-cancer-living-in-low-income-and-rural-areas-face-an-increased-risk-of-suicide/</loc><lastmod>2021-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/relationship-between-preexisting-tp53-chip-variants-and-risk-of-secondary-myeloid-neoplasms-in-high-grade-ovarian-cancer/</loc><lastmod>2021-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/development-of-a-breast-cancer-risk-prediction-model-for-black-women-in-the-united-states/</loc><lastmod>2021-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/activity-of-nab-sirolimus-in-malignant-perivascular-epithelioid-cell-tumors/</loc><lastmod>2021-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/rates-of-diagnosis-of-gastrointestinal-cancers-and-stage-at-diagnosis-before-and-during-the-covid-19-pandemic-in-japan/</loc><lastmod>2021-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/risk-based-treatment-of-pediatric-and-young-adult-synovial-sarcoma/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/two-studies-examine-the-efficacy-of-immunotherapy-for-leptomeningeal-carcinomatosis/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-assesses-benefit-of-digital-health-tools-for-cancer-survivors/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/overall-survival-in-the-maia-trial-daratumumab-lenalidomide-and-dexamethasone-for-newly-diagnosed-transplant-ineligible-patients-with-multiple-myeloma/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/melphalan-flufenamide-withdrawn-from-the-us-market/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-examines-relationship-between-risk-of-cancer-and-age-of-smoking-initiationcessation/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/22-gene-classifier-score-may-allow-for-personalization-of-therapy-in-patients-with-high-risk-prostate-cancer/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/accure-trial-aims-to-eliminate-disparities-in-survival-in-black-and-white-patients-with-early-stage-lung-and-breast-cancers/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/annual-report-to-the-nation-part-2-focus-on-patient-economic-burden-associated-with-cancer-care/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/baseline-health-related-quality-of-life-and-outcomes-in-patients-with-advanced-cancer/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/addition-of-vincristine-topotecan-and-cyclophosphamide-to-five-drug-interval-compressed-chemotherapy-for-ewing-sarcoma/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-examines-use-of-external-beam-radiotherapy-as-a-bridging-therapy-for-patients-with-hcc-awaiting-transplant/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/phase-iii-trial-evaluates-efficacy-of-total-androgen-suppression-plus-dose-escalated-radiotherapy-for-patients-with-intermediate-risk-prostate-cancer/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/nivolumab-for-relapsed-malignant-mesothelioma-improvements-in-progression-free-and-overall-survival/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/addition-of-enasidenib-to-azacitidine-in-newly-diagnosed-idh2-mutant-acute-myeloid-leukemia/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-finds-similar-survival-rates-among-patients-with-metastatic-colorectal-cancer-younger-and-older-than-age-50/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/survey-of-us-oncologists-on-genetic-counseling-and-testing-for-black-women-with-breast-cancer/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/hypofractionated-postoperative-prostate-bed-radiotherapy-does-not-increase-patient-reported-toxicity-for-men-with-prostate-cancer/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/first-round-results-of-prostate-cancer-screening-for-men-with-pathogenic-variants-in-mismatch-repair-genes/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/rates-of-occult-gastric-carcinoma-in-patients-with-hereditary-lobular-breast-cancer-due-to-cdh1-genetic-variants/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/integrated-molecular-morphologic-risk-predictor-for-recurrence-of-meningioma/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/hepatic-arterial-infusion-of-folfox-vs-transarterial-chemoembolization-for-unresectable-large-hepatocellular-carcinoma/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-finds-incidence-of-pancreatic-cancer-may-be-rising-in-younger-women/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/do-diet-related-molecules-play-a-role-in-the-development-of-aggressive-prostate-cancer/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/10-october/study-finds-prior-authorization-costs-academic-radiation-oncology-clinics-more-than-40-million-every-year/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/overcoming-the-disparities-in-cancer-survival-among-aya-minority-patients/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/patients-first/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/bispecific-antibodies-find-a-place-in-b-cell-lymphoma-treatment/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/putting-radiotherapy-to-best-use-with-car-t-cell-therapy-in-lymphoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/lymphoid-malignancies-what-s-next-for-antibody-drug-conjugates/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/braf-mutant-colorectal-cancer-latest-findings-for-targeted-treatment/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-elena-elez/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/asco-2021-roundup-of-studies-you-may-have-missed/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adding-first-line-nivolumab-to-chemotherapy-improves-survival-in-gastric-gastroesophageal-junction-and-esophageal-adenocarcinomas/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/nivolumab-plus-chemotherapy-improves-survival-in-advanced-gastric-and-esophageal-adenocarcinomas-now-to-figure-out-the-details-in-these-heterogeneous-diseases/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/dostarlimab-gxly-for-mismatch-repair-deficient-recurrent-or-advanced-solid-tumors/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/belzutifan-for-cancers-associated-with-von-hippel-lindau-disease/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adoptive-cell-therapy-may-soon-be-available-for-patients-with-melanoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/myeloma-trial-updates-focus-on-high-risk-patients-and-measurable-residual-disease-negativity/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-gordon-cook-mbchb-phd-and-sagar-lonial-md/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/building-a-better-normal-of-oncology-care-to-strengthen-global-health-security-after-the-covid-19-pandemic/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/minnesota-senator-amy-klobuchar-announces-breast-cancer-diagnosis/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/new-evidence-drives-need-for-revised-guideline-on-hormone-sensitive-advanced-breast-cancer/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/asco-applauds-administration-decision-to-withdraw-most-favored-nation-model/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/conquer-cancer-updates-mission-vision-adopts-values-inspired-by-its-donors/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/guideline-rapid-update-provides-new-direction-on-the-care-of-patients-with-residual-disease-in-locally-advanced-esophageal-cancer/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/disaster-assistance-resources-available-for-cancer-care-physicians-patients-impacted-by-hurricane-ida/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/iaslc-announces-lifetime-achievement-awards/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/lenvatinib-plus-pembrolizumab-for-first-line-treatment-of-advanced-renal-cell-carcinoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/nivolumab-for-adjuvant-treatment-of-urothelial-carcinoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/gastrointestinal-oncologist-katherine-van-loon-a-pioneer-in-global-oncology/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/paradox-between-cost-and-hematopoietic-cell-transplant-rate-in-latin-america/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/kombucha/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/pembrolizumab-and-lenvatinib-in-advanced-endometrial-carcinoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/older-adults-with-primary-cns-lymphoma-treatment-opportunities-and-challenges/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-brunei-darussalam/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/a-deadly-superbug-launches-a-medical-life-and-death-drama/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/new-chief-of-thoracic-and-head-and-neck-medical-oncology-named-to-new-jersey-cancer-center/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/breathing-properly-may-help-you-live-longer/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/ivosidenib-for-previously-treated-idh1-mutant-advanced-or-metastatic-cholangiocarcinoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/the-wistar-institute-recruits-vaccine-researcher-amelia-escolanonand-immunologist-nan-zhang-as-assistant-professors/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/acs-names-elvan-daniels-senior-vice-president-of-extramural-discovery-science/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fox-chase-renewed-as-clinical-center-of-excellence-and-named-academic-center-of-excellence-for-pancreatic-cancer/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/2021-pan-pacific-lymphoma-conference-honors-outstanding-clinical-investigators/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/unmc-professor-emeritus-james-edney-dies-tragically-at-73/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/update-on-us-indication-for-atezolizumab-in-pd-l1-positive-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/update-to-nccn-cancer-and-covid-19-vaccination-guidance-announced/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/combination-of-lenvatinib-and-etoposideifosfamide-for-relapsed-or-refractory-osteosarcoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/outcomes-notably-improving-for-adult-all/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-revises-label-for-pembrolizumab-in-patients-with-advanced-urothelial-carcinoma/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-approves-zanubrutinib-for-waldenstroem-s-macroglobulinemia/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-grants-accelerated-approval-to-dostarlimab-gxly-for-dmmr-advanced-solid-tumors/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/pulsed-vincristinedexamethasone-maintenance-in-pediatric-acute-lymphoblastic-leukemia/</loc><lastmod>2021-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-approves-cabozantinib-for-patients-with-previously-treated-radioactive-iodine-refractory-differentiated-thyroid-cancer/</loc><lastmod>2021-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-carol-aghajanian/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/strict-adherence-to-algorithm-required/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/bevacizumab-in-advanced-ovarian-cancer-phase-iii-trial-finds-more-is-not-better/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-shows-sentinel-lymph-node-biopsy-to-be-viable-option-for-surgical-staging-of-endometrial-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-ursula-a-matulonis/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/lenvatinibpembrolizumab-improves-survival-in-advanced-endometrial-cancer-in-a-phase-iii-trial/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-angeles-alvarez-secord/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-ana-oaknin/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/hormonal-intrauterine-device-under-study-for-managing-early-endometrial-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/novel-treatments-show-activity-in-advanced-cervical-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/recent-fda-approvals-in-endometrial-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/benefit-of-niraparib-maintenance-therapy-extends-beyond-first-disease-progression-in-recurrent-ovarian-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/with-the-exception-of-cervical-cancer-hpv-associated-cancers-are-on-the-rise-especially-in-older-adults/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/niraparib-plus-bevacizumab-shows-clinical-benefit-in-advanced-ovarian-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-deborah-armstrong/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-mansoor-raza-mirza/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/sustained-benefit-for-maintenance-olaparib-in-ovarian-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/imagyn050-trial-addition-of-atezolizumab-to-bevacizumab-and-chemotherapy-for-newly-diagnosed-stage-iii-or-iv-ovarian-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/overall-survival-with-olaparib-vs-placebo-maintenance-in-patients-with-platinum-sensitive-relapsed-ovarian-cancer-and-brca12-mutation/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-ursula-a-matulonis-and-konstantin-zakashansky/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/phase-iii-ariel4-trial-confirms-rucaparib-s-benefit-in-brca-mutated-relapsed-ovarian-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-thomas-herzog/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fuzuloparib-maintenance-therapy-improves-progression-free-survival-in-patients-with-recurrent-ovarian-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/immunotherapy-with-cemiplimab-rwlc-yields-survival-benefit-in-advanced-cervical-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-kunle-odunsi-and-lilian-gien/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/outback-no-benefit-for-adjuvant-chemotherapy-in-cervical-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/gynecologic-cancers-2020-2021-almanac/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-mark-kris/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/sotorasib-subgroup-analysis-of-phase-ii-trial-shows-activity-with-breakthrough-kras-inhibitor-in-lung-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/atezolizumab-reduces-risk-of-disease-progression-in-patients-with-pd-l1-expressing-early-stage-nsclc/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/extended-follow-up-of-paloma-3-supports-survival-benefit-of-palbociclib-plus-fulvestrant-in-advanced-breast-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adapt-trial-excellent-outcomes-reported-with-neoadjuvant-dual-her2-therapy-in-breast-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/roundup-of-notable-abstracts-in-hematologic-malignancies/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-melinda-telli/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-jacqueline-c-barrientos-md-ms/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/ea1131-trial-platinum-not-equal-to-capecitabine-for-residual-disease-in-triple-negative-breast-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fixed-dose-first-line-ibrutinibvenetoclax-combination-achieves-durable-remissions-in-cll/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-jacqueline-c-barrientos/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-nadine-tung/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/acalabrutinib-as-effective-as-ibrutinib-with-fewer-cardiac-effects-in-resistant-cll/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/olympia-trial-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-breast-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-surbhi-sidana/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/highlights-from-the-2021-asco-annual-meeting/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/bispecific-antibodies-advance-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-jason-j-luke/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/lifileucel-after-disease-progression-in-metastatic-melanoma-durable-responses-achieved-in-phase-ii-trial/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/targeting-lag-3-and-pd-1-with-relatlimab-and-nivolumab-a-new-option-under-study-in-advanced-melanoma/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adavosertib-effective-in-parp-resistant-ovarian-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-kunle-odunsi-and-lilian-t-gien/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/no-benefit-for-adjuvant-chemotherapy-in-cervical-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-rana-r-mckay/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-mary-ellen-taplin/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/novel-psma-targeted-radiotherapy-improves-outcomes-in-metastatic-prostate-cancer/</loc><lastmod>2021-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-david-cunningham/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/first-line-nivolumab-regimens-improve-survival-in-esophageal-squamous-cell-carcinoma/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-anthony-tc-chan/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/novel-monoclonal-antibody-emerges-as-potential-first-line-standard-in-nasopharyngeal-cancer/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cemiplimab-rwlc-improves-outcomes-in-first-line-treatment-of-nsclc-with-brain-metastases/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-nicolas-girard/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/amivantamablazertinib-combination-may-overcome-osimertinib-resistance-in-patients-with-egfr-positive-nsclc/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/assumptions-data-and-more-questions/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-south-africa/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/yale-cancer-center-names-barbara-burtness-md-interim-associate-director-for-diversity-equity-and-inclusion/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/lakshmanan-krishnamurti-md-joins-yale-school-of-medicine-in-department-of-pediatrics/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/judy-e-garber-md-phd-faacr-to-receive-aaci-distinguished-scientist-award/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/pembrolizumab-for-high-risk-early-stage-triple-negative-breast-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/enfortumab-vedotin-ejfv-in-urothelial-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/highlights-from-transplantation-and-cellular-therapy-meetings-of-astct-and-cibmtr/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/dana-farber-cancer-institute-establishes-the-david-liposarcoma-research-initiative/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fifty-for-fifty-campaign-to-commemorate-the-national-cancer-act-s-50th-anniversary/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/pembrolizumab-combined-with-trastuzumab-and-chemotherapy-for-her2-positive-gastric-or-gastroesophageal-junction-adenocarcinoma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/amivantamab-vmjw-for-previously-treated-advanced-nsclc-with-egfr-mutation/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/an-oncologist-s-prescription-humanity-and-love/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/a-scientific-detective-tale-with-consequences-for-the-future-of-our-species/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/reduced-intensity-chemotherapy-for-older-frail-patients-with-advanced-gastroesophageal-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/listen-to-patients-concerns-about-quality-of-life/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cellular-therapy-pioneer-renier-brentjens-md-phd-joins-roswell-park-as-deputy-director-and-chair-of-medicine/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/accc-releases-annual-report-on-current-state-of-immuno-oncology/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/2021-basser-global-prize-presented-to-andre-nussenzweig-phd/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/maintained-benefit-of-apalutamide-plus-androgen-deprivation-therapy-shown-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-finds-lower-income-eligibility-limits-for-medicaid-associated-with-worse-long-term-survival-for-newly-diagnosed-patients-with-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/improving-end-of-life-discussions-with-patients-who-have-advanced-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/recommendations-from-asco-for-discussing-patients-goals-of-care-through-survivorship-to-end-of-life/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cancer-is-trying-to-steal-my-body-but-i-will-not-allow-it-to-steal-my-joy/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/daratumumab-and-hyaluronidase-fihj-with-pomalidomide-plus-dexamethasone-in-multiple-myeloma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/launch-of-mskcc-india-expands-access-to-oncologists-cancer-care-research-and-education/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adding-lupsma-to-standard-care-improves-outcomes-in-castration-resistant-prostate-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/lutetium-177-psma-617-a-first-in-class-radioligand-therapeutic-in-metastatic-prostate-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/high-prevalence-of-germline-brca-mutations-in-indian-women-with-ovarian-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/prevalence-of-germline-brca-mutations-in-indian-women-with-ovarian-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/subcutaneous-daratumumab-added-to-pomalidomide-plus-dexamethasone-improves-progression-free-survival-in-multiple-myeloma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/treatment-of-relapsed-myeloma-options-include-new-drugs-novel-combinations/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/elevate-rr-trial-acalabrutinib-as-effective-as-ibrutinib-with-fewer-cardiac-effects-in-resistant-cll/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/epov-jacqueline-barrientos/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/former-medical-director-at-princess-margaret-cancer-centre-to-lead-new-commission-on-global-cancer-care/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/titan-confirms-survival-benefit-of-apalutamide-plus-adt-in-metastatic-prostate-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/covid-19-pandemic-spurs-quick-uptick-in-telehealth-adoption-asco-provides-guidance-for-oncologists/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/guideline-update-addresses-treatments-for-her2-negative-advanced-breast-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/conquer-cancer-names-inaugural-recipients-of-asco-registry-research-grants/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/introducing-the-asco-plenary-series/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/music-therapy-for-cancer-related-fatigue/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/how-covid-19-is-spotlighting-the-role-of-palliative-medicine/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/gastrointestinal-oncologist-focuses-on-both-the-art-and-science-of-treating-patients-with-cancer/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/safety-efficacy-of-neoadjuvant-pertuzumab-plus-trastuzumab-maintained-in-final-analysis-of-berenice-trial/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/evandro-de-azambuja-comments-on-the-berenice-trial/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/are-triplets-necessary-for-braf-mutated-melanoma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-grants-approval-to-the-pfizer-biontech-covid-19-vaccine/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-approves-nivolumab-for-adjuvant-treatment-of-urothelial-carcinoma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/prostate-cancer-diagnostics-novel-approaches-are-leaving-conventional-imaging-behind/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-finds-evidence-based-interventions-added-to-screening-did-not-improve-cancer-pain/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-approves-ivosidenib-for-advanced-or-metastatic-idh1-mutated-cholangiocarcinoma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/early-phase-study-rediscovers-potential-alternative-to-methadone-for-cancer-pain/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/liquid-biopsy-is-changing-colon-cancer-management/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-approves-lenvatinibpembrolizumab-for-advanced-renal-cell-carcinoma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/impact-of-nurse-navigation-program-on-outcomes-in-minority-patients-with-aggressive-lymphoma/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/breakthrough-covid-19-infection-in-fully-vaccinated-health-care-workers/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/annual-report-to-the-nation/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/hpv-vaccination-and-projected-oropharyngeal-cancer-incidence-through-the-year-2045/</loc><lastmod>2021-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/global-breast-cancer-survival-estimated-impact-of-scaling-up-access-to-treatmentimaging-modalities-and-quality-of-care/</loc><lastmod>2021-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/inguinofemoral-radiotherapy-vs-inguinofemoral-lymphadenectomy-for-patients-with-vulvar-cancer-and-sentinel-node-metastasis/</loc><lastmod>2021-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/addition-of-atr-inhibitor-berzosertib-to-cisplatingemcitabine-in-metastatic-urothelial-carcinoma/</loc><lastmod>2021-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-examines-link-between-in-utero-events-and-risk-of-colorectal-cancer-in-adult-offspring/</loc><lastmod>2021-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/addition-of-venetoclax-to-daratumumabdexamethasone-with-or-without-bortezomib-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/effects-of-covid-19-infection-in-children-and-adolescents-with-cancer-global-analysis/</loc><lastmod>2021-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/triplet-therapy-and-maintenance-to-prevent-disease-progression-in-high-risk-smoldering-myeloma/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/liver-biopsy-for-evaluation-of-hepatitis-associated-with-immunotherapy/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adavosertib-for-patients-with-tp53-and-ras-mutant-metastatic-colorectal-cancer/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/effectiveness-of-mrna-covid-19-vaccination-in-preventing-symptomatic-infection-in-health-care-personnel/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-finds-genetic-predisposition-to-higher-lymphocyte-production-may-lead-to-higher-all-risk/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/biomarker-may-help-to-predict-response-to-gemcitabine-for-patients-with-high-grade-serous-ovarian-cancer/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/poziotinib-a-tyrosine-kinase-inhibitor-for-her2-exon-20-mutant-nsclc/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-examines-efficacy-of-sunitinib-in-malignant-pheochromocytoma-and-paraganglioma/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/capecitabine-maintenance-after-first-line-therapy-for-metastatic-colorectal-cancer/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/overall-survival-with-stereotactic-ablative-radiotherapy-for-operable-stage-ia-nsclc/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/is-mri-cost-effective-for-detecting-cancer-in-women-with-very-dense-breasts/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/fda-expands-cetuximab-label-with-combination-of-encorafenib-for-pretreated-braf-v600e-mutation-positive-metastatic-colorectal-cancer/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/hepatectomy-with-or-without-adjuvant-mfolfox6-for-liver-only-metastatic-colorectal-cancer-disease-free-and-overall-survival/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/classifying-egfr-mutations-by-structure-and-function-may-help-to-match-patients-with-nsclc-to-more-effective-treatments/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-shows-benefits-of-a-next-day-access-program-for-patients-with-cancer/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/efficacy-of-risk-calculator-in-treating-elderly-patients-with-cancer/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cassiopeia-part-2-maintenance-daratumumab-after-initial-therapy-for-newly-diagnosed-multiple-myeloma/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/extended-adjuvant-letrozole-after-tamoxifen-in-postmenopausal-women-with-early-stage-breast-cancer-gim4/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/consolidation-treatment-with-vrd-followed-by-lenalidomide-maintenance-in-newly-diagnosed-patients-with-multiple-myeloma/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/peace-1-and-stampede-trials-abiraterone-acetate-plus-prednisolone-in-prostate-cancer/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/new-study-aims-to-measure-success-of-phase-iii-oncology-trials/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/active-living-after-cancer-program-may-improve-physical-functioning-for-breast-cancer-survivors/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/are-rates-of-hepatocellular-carcinoma-rising-in-rural-areas-of-the-united-states/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/overall-survival-with-the-bispecific-fusion-protein-tebentafusp-for-metastatic-uveal-melanoma/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/single-fraction-vs-multifraction-sabr-for-pulmonary-oligometastases/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/long-term-outcomes-in-juliet-trial-of-tisagenlecleucel-for-relapsed-or-refractory-aggressive-b-cell-lymphomas/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/dd-mvac-vs-gemcitabinecisplatin-for-muscle-invasive-bladder-cancer/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/relacorilant-plus-nab-paclitaxel-may-improve-progression-free-survival-in-recurrent-platinum-resistant-ovarian-cancer/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/first-line-acalabrutinib-venetoclax-and-obinutuzumab-for-chronic-lymphocytic-leukemia/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/does-adjuvant-image-guided-intensity-modulated-radiotherapy-for-cervical-cancer-lead-to-increased-rates-of-late-toxicity/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/covid-19-lockdown-may-be-associated-with-higher-tumor-burden-in-newly-diagnosed-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/addition-of-ramucirumab-to-gemcitabine-in-second-line-treatment-of-malignant-pleural-mesothelioma/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cosmic-021-cabozantinib-plus-atezolizumab-for-advanced-renal-cell-carcinoma/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/destiny-lung01-fam-trastuzumab-deruxtecan-nxki-in-previously-treated-her2-mutant-nsclc/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/role-of-geriatric-assessment-in-personalizing-therapy-for-elderly-patients-with-head-and-neck-cancer/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/association-of-pathologic-residual-cancer-burden-and-event-free-survival-after-neoadjuvant-treatment-for-high-risk-breast-cancer/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/estimated-impact-of-the-covid-19-pandemic-on-cancer-diagnosis-and-survival-in-chile-over-the-next-decade/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/monaleesa-2-ribociclib-plus-endocrine-therapy-extends-overall-survival-in-postmenopausal-patients-with-metastatic-breast-cancer/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/adjuvant-pembrolizumab-for-high-risk-stage-ii-melanoma-efficacy-and-safety-examined/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/integrating-community-based-interventions-into-cancer-care-for-low-income-and-minority-patients-may-improve-quality-of-life-reduce-care-disparities/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-finds-prior-authorization-may-be-associated-with-delayed-receipt-of-oral-anticancer-drugs/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/mortality-trends-after-allogeneic-blood-or-marrow-transplantation/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/long-term-therapy-with-bintrafusp-alfa-in-hpv-associated-cancers/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/destiny-gastric02-trastuzumab-deruxtecan-produces-responses-in-patients-with-her2-positive-gastric-cancers/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/keynote-826-pembrolizumab-plus-chemotherapy-in-advanced-cervical-cancer/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/destiny-breast03-second-line-trastuzumab-deruxtecan-for-metastatic-her2-positive-breast-cancer/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/association-of-skeletal-muscle-area-and-adiposity-measures-with-inflammation-and-outcomes-in-nonmetastatic-colon-cancer/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/bispecific-antibody-epcoritamab-in-relapsed-or-refractory-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/several-studies-show-rovalpituzumab-tesirine-is-ineffective-against-sclc/</loc><lastmod>2021-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/can-diabetes-affect-the-efficacy-of-immune-checkpoint-inhibitors-in-patients-with-advanced-cancer/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-examines-how-children-cope-with-a-parent-s-cancer-diagnosis/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-finds-up-to-15-of-patients-with-cancer-experience-long-haul-covid-19/</loc><lastmod>2021-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/phase-iii-trial-investigates-extended-adjuvant-endocrine-therapy-for-postmenopausal-patients-with-breast-cancer/</loc><lastmod>2021-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/atr-inhibitor-ceralasertib-in-arid1a-deficient-and-arid1a-intact-solid-tumors/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/genomic-analysis-of-lung-cancer-in-never-smokers/</loc><lastmod>2021-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/technology-enabled-monitoring-of-adverse-reactions-to-immune-checkpoint-inhibitors/</loc><lastmod>2021-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/racial-disparities-among-men-with-prostate-cancer/</loc><lastmod>2021-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/no-overall-survival-benefit-with-lurbinectedindoxorubicin-in-small-cell-lung-cancer/</loc><lastmod>2021-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/impower010-study-of-atezolizumab-in-resectable-nsclc-benefits-observed-regardless-of-stage-type-of-prior-treatment/</loc><lastmod>2021-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/poseidon-trial-dual-checkpoint-blockade-plus-chemotherapy-improves-survival-in-first-line-metastatic-nsclc/</loc><lastmod>2021-09-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/atezolizumab-plus-chemotherapy-in-patients-with-advanced-nsclc-and-brain-metastases/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/ibrutinib-and-cardiovascular-risk-in-patients-with-chronic-lymphocytic-leukemia/</loc><lastmod>2021-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/phase-ii-trial-evaluates-oncolytic-coxsackievirus-a21-for-unresectable-advanced-melanoma/</loc><lastmod>2021-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/teleoncology-for-veterans-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2021-09-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/pharmacy-strategy-to-decrease-patient-copayments-for-high-cost-cancer-drugs-through-financial-assistance-applications/</loc><lastmod>2021-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/biomarker-analysis-evaluates-potential-for-immune-checkpoint-blockade-response-in-older-patients-with-cancer/</loc><lastmod>2021-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/neoadjuvant-atezolizumab-under-study-for-resectable-pleural-mesothelioma/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/rates-of-adverse-reactions-to-the-moderna-mrna-1273-covid-19-vaccine-in-patients-with-cancer-and-recent-radiotherapy/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/inclusion-of-women-in-oncology-clinical-trials-from-2000-to-2020/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/nivolumab-vs-gemcitabine-or-pegylated-liposomal-doxorubicin-what-regimen-improves-survival-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/survey-examines-oncology-clinician-perceptions-of-biomarker-testing-for-underserved-patients-with-lung-cancer/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/almost-two-thirds-of-thoracic-oncologists-reported-using-telehealth-for-the-first-time-during-the-covid-19-pandemic/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/iaslc-2021-single-center-study-examines-psychological-impact-of-the-covid-19-pandemic-on-patients-with-lung-cancer/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/effect-of-mindfulness-meditation-and-survivorship-education-on-depressive-symptoms-in-younger-breast-cancer-survivors/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cancer-specific-urgent-care-center-effect-on-emergency-department-use-and-hospitalization-rate/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/auto1-car-t-cell-product-for-adult-patients-with-relapsed-or-refractory-b-cell-all/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/maintenance-durvalumab-increased-utilization-could-improve-nsclc-outcomes/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/radical-cystectomy-early-stage-micropapillary-bladder-cancer-outcomes-similar-to-late-stage-conventional-urothelial-carcinoma/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-suggests-demographic-enrollment-reporting-requirements-for-acute-leukemia-clinical-trials-are-lacking/</loc><lastmod>2021-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/effect-of-high-intensity-interval-training-on-biochemical-progression-in-patients-with-localized-prostate-cancer-under-active-surveillance/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/resurgence-of-covid-19-infection-in-a-large-vaccinated-health-system-workforce/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/study-finds-low-poverty-us-counties-may-eliminate-cervical-cancer-14-years-earlier-than-high-poverty-counties/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/iaslc-2021-study-examines-global-risk-of-lung-cancer-due-to-air-pollution/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/iaslc-2021-enrollment-in-clinical-trials-for-lung-cancer-declined-significantly-during-the-covid-19-pandemic/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/early-stage-research-on-dual-action-estrogen-receptor-inhibitors-for-breast-cancer/</loc><lastmod>2021-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/pembrolizumabentinostat-for-metastatic-uveal-melanoma/</loc><lastmod>2021-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/addition-of-everolimus-to-letrozole-in-premenopausal-women-with-advanced-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2021-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/effect-of-concurrent-focal-22q1122-deletions-and-ikzf1-alterations-on-outcomes-in-pediatric-patients-with-b-cell-all/</loc><lastmod>2021-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/neoadjuvant-gemcitabine-and-split-dose-cisplatin-plus-pembrolizumab-for-muscle-invasive-bladder-cancer/</loc><lastmod>2021-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/09-september/cell-free-dna-analysis-to-distinguish-development-of-malignant-peripheral-nerve-sheath-tumors-from-plexiform-neurofibromas/</loc><lastmod>2021-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/more-widespread-biomarker-testing-for-nsclc-in-oncology-practices-and-more-testing-in-black-patients/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-christine-lovly/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-approves-pembrolizumab-in-combination-for-high-risk-early-stage-triple-negative-breast-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/global-estimates-of-new-cancers-attributable-to-alcohol-use-in-2020/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/cancer-vs-non-cancer-related-deaths-among-older-patients-selected-for-surgical-treatment/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/durable-clinical-activity-reported-with-tislelizumab-in-advanced-liver-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-chris-verslype/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/gut-microbiome-and-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/tackling-the-challenge-of-pancreatic-cancer-new-approaches/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/avelumab-under-study-as-adjunct-to-neoadjuvant-therapy-for-rectal-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-eric-deutsch/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/axicabtagene-ciloleucel-improves-multiple-clinical-endpoints-in-relapsed-follicular-lymphoma/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/low-dose-ct-screening-for-lung-cancer-and-the-incidental-findings-that-may-improve-future-health/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/historic-present-and-future-perspectives-on-breast-cancer-in-egypt/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/winette-van-der-graaf-md-phd-named-eortc-president-elect-2021-2024/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/northwell-health-new-york-appoints-regional-director-of-urology/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/vanderbilt-university-appoints-karen-winkfield-md-phd-professor-of-radiation-oncology/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/heather-wakelee-md-fasco-honored-with-the-2021-bonnie-j-addario-lectureship-award/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/isatuximab-irfc-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/new-guideline-provides-clarity-on-timing-treatment-of-axilla-in-early-stage-breast-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/high-prevalence-of-previously-undiagnosed-emphysema-among-individuals-undergoing-low-dose-ct-screening-for-lung-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/beth-karlan-receives-lifetime-achievement-award-for-contributions-to-gynecologic-oncology/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/belumosudil-for-chronic-graft-vs-host-disease/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/sacituzumab-govitecan-hziy-for-locally-advanced-or-metastatic-urothelial-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/marcus-bosenberg-named-inaugural-director-of-yale-center-for-immuno-oncology/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/sacituzumab-govitecan-hziy-for-locally-advanced-or-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/neuroendocrine-tumor-specialist-pamela-kunz-looks-to-promote-equity-in-the-workforce/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/i-m-a-two-time-breast-cancer-survivor-and-the-experience-has-been-life-altering/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/leland-chung-dies-at-80/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/asco-joins-statement-supporting-mandatory-health-employer-covid-19-vaccination/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/asco-and-masccisoo-publish-joint-guideline-on-prevention-treatment-of-salivary-gland-hypofunction-and-xerostomia/</loc><lastmod>2021-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/first-line-cisplatin-plus-gemcitabine-or-fluorouracil-for-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2021-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-jacqueline-barrientos-1/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/apact-5-year-overall-survival-data-suggest-improved-outcomes-in-pancreatic-cancer-with-nab-paclitaxelgemcitabine/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-thomas-seufferlein/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/tislelizumab-improves-overall-survival-as-second-line-treatment-of-esophageal-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-kei-muro/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/zanubrutinib-superior-to-ibrutinib-for-cllsll-in-phase-iii-alpine-trial/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/radiation-oncologists-urge-congress-to-create-more-equity-in-access-to-care/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-approves-belumosudil-for-chronic-graft-vs-host-disease/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/does-the-presence-of-neuronal-autoantibodies-contribute-to-cognitive-impairment-in-patients-with-lung-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/predicting-chemotherapy-resistance-in-patients-with-gestational-trophoblastic-neoplasia/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/trilaciclib-to-reduce-chemotherapy-induced-bone-marrow-suppression-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/sacituzumab-govitecan-hziy-vs-single-agent-chemotherapy-in-relapsed-or-refractory-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/how-climate-change-is-impacting-cancer-care/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-grants-regular-approval-to-pembrolizumablenvatinib-for-advanced-endometrial-carcinoma/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/international-esodata-study-group-model-for-predicting-90-day-mortality-after-esophagectomy/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-approves-daratumumab-and-hyaluronidase-fihj-with-pomalidomide-and-dexamethasone-for-pretreated-patients-with-multiple-myeloma/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-grants-regular-approval-to-enfortumab-vedotin-ejfv-for-locally-advanced-or-metastatic-urothelial-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-surbhi-sidana/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/neoadjuvant-pembrolizumab-improves-event-free-survival-in-triple-negative-breast-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/no-subgroup-benefits-more-from-t-dm1-plus-chemotherapy-for-her2-positive-early-breast-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-evandro-de-azambuja/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/single-agent-talazoparib-shows-activity-in-the-neoadjuvant-treatment-of-triple-negative-breast-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-lisa-carey/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/from-istanbul-to-orange-county-an-oncologist-s-journey-to-a-leadership-role-in-quality-care/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-finds-cytarabine-prodrug-active-and-safe-in-older-compromised-patients-with-aml/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-guru-subramanian-guru-murthy/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/an-egyptian-surgical-oncologist-urges-global-cooperation-to-achieve-equitable-cancer-care/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-giuseppe-curigliano/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/bispecific-antibodies-advance-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/olufunmilayo-olopade-to-receive-sabcs-2021-william-l-mcguire-memorial-lecture-award/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/incidence-and-cancer-related-mortality-in-bahrain/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/adjuvant-nivolumab-improves-disease-free-survival-in-high-risk-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma-is-disease-free-survival-the-best-endpoint/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/a-new-era-of-hope-for-patients-with-triple-negative-breast-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/car-t-cell-gene-therapy-in-non-hodgkin-lymphomas/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fred-hutchinson-cancer-research-center-seattle-childrens-and-uw-medicine-lay-groundwork-for-cancer-partnership/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/the-patient-we-see-and-the-person-we-may-not/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/asparaginase-erwinia-chrysanthemi-recombinant-rywn-for-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/oncology-practices-nationwide-show-high-interest-in-diversifying-cancer-clinical-trials/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/asco-and-community-oncology-alliance-publish-standards-for-oncology-medical-home-model/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/conquer-cancer-announces-2021-israel-cancer-research-fund-career-development-award/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-nicole-chau/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/nccn-foundation-announces-awards-for-rising-cancer-research-leaders/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/mortality-risk-with-adjuvant-vs-early-salvage-radiotherapy-in-men-with-adverse-pathology-at-radical-prostatectomy-for-prostate-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/salvage-and-adjuvant-radiotherapy-after-radical-prostatectomy-for-prostate-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/no-progression-free-survival-benefit-with-first-line-avelumab-plus-chemoradiotherapy-in-squamous-cell-carcinoma-of-the-head-and-neck/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/javelin-head-and-neck-100-trial-when-failure-seems-fatal-hope-is-not-lost/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/facing-the-trauma-of-colorectal-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/novel-antibody-drug-conjugate-under-study-in-refractory-dlbcl/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-leslie-popplewell/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/neoadjuvant-durvalumab-improves-long-term-outcomes-in-the-geparnuevo-trial/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/epov-melinda-telli/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/cabozantinib-potential-new-option-for-treatment-refractory-thyroid-cancer/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/roswell-park-approved-to-provide-care-for-world-trade-center-911-first-responders/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/mount-sinai-welcomes-robotic-prostate-surgery-pioneer-mani-menon-md/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/nationally-recognized-biostatistician-joins-rutgers-to-focus-on-cancer-research/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/2021-asco-annual-meeting-next-generation-oncology-highlights/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/aaci-members-choose-robert-winn-md-as-vice-presidentpresident-elect-and-other-new-leaders/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/ama-satcher-health-leadership-institute-announce-inaugural-recipients-of-health-equity-advocacy-fellowship/</loc><lastmod>2021-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/adjuvant-nivolumab-improves-disease-free-survival-in-high-risk-muscle-invasive-urothelial-carcinoma-1/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/seroconversion-after-covid-19-vaccination-in-adult-patients-with-hematologic-malignancies/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/avapritinib-vs-regorafenib-in-molecularly-unselected-previously-treated-advanced-gist/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/genomic-adjusted-radiation-dose-model-to-predict-radiotherapy-benefit-across-cancer-types/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/wearable-temperature-sensor-may-aid-in-detecting-febrile-adverse-events-in-patients-with-cancer/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/teclistamab-shows-efficacy-produces-durable-responses-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/analyses-examine-relationship-between-treatment-with-parp-inhibitors-and-risk-of-secondary-malignancies/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/addition-of-entinostat-to-exemestane-in-aromatase-inhibitor-resistant-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2021-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/hypofractionated-image-guided-vs-conventional-radiotherapy-in-patients-with-stage-iiiii-nsclc-ineligible-for-concurrent-chemoradiation/</loc><lastmod>2021-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/simulation-model-based-clinical-decision-tool-for-predicting-benefit-of-adjuvant-chemoendocrine-vs-endocrine-therapy-in-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2021-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/small-study-evaluates-combination-ipilimumabnivolumab-in-patients-with-angiosarcoma/</loc><lastmod>2021-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/does-sparing-the-hippocampus-during-prophylactic-cranial-irradiation-for-sclc-help-to-preserve-cognitive-function/</loc><lastmod>2021-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/removing-race-from-kidney-function-estimates-may-impact-care-of-black-patients-with-cancer/</loc><lastmod>2021-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-identifies-potential-mechanisms-of-resistance-to-sacituzumab-govitecan-in-patients-with-triple-negative-breast-cancer/</loc><lastmod>2021-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/do-muscle-strengthening-activities-plus-aerobic-activities-reduce-cancer-mortality/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-pipeline-reviews-for-agents-in-lung-cancer-thyroid-cancer-kidney-cancer-and-more/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/vincristineirinotecan-with-or-without-temozolomide-for-relapsed-or-refractory-rhabdomyosarcoma/</loc><lastmod>2021-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/causes-of-death-among-men-diagnosed-with-metastatic-prostate-cancer/</loc><lastmod>2021-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/financial-toxicity-associated-with-atherosclerotic-cardiovascular-disease-and-cancer/</loc><lastmod>2021-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-approves-belzutifan-for-cancers-associated-with-von-hippel-lindau-disease/</loc><lastmod>2021-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/retrospective-study-compares-characteristics-of-early-onset-vs-average-onset-colorectal-cancer/</loc><lastmod>2021-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/experimental-small-molecule-inhibitor-may-improve-responses-to-cellular-therapies-in-advanced-cll/</loc><lastmod>2021-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/talazoparib-in-patients-with-metastatic-castration-resistant-prostate-cancer-and-dna-repair-gene-alterations/</loc><lastmod>2021-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/extended-follow-up-of-paloma-3-supports-survival-benefit-of-palbociclib-plus-fulvestrant-in-advanced-breast-cancer/</loc><lastmod>2021-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/non-testicular-cancer-mortality-rates-in-men-with-testicular-cancer-in-the-cisplatin-era/</loc><lastmod>2021-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/adjuvant-pembrolizumab-may-improve-disease-free-survival-in-patients-with-high-risk-renal-cell-carcinoma/</loc><lastmod>2021-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/patients-with-melanoma-previously-treated-with-pd-1-or-mapk-inhibitors-may-be-less-likely-to-respond-to-act-til-therapy/</loc><lastmod>2021-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-examines-link-between-obesity-in-long-term-cancer-survivors-and-increased-health-care-utilization-and-spending/</loc><lastmod>2021-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/fda-pipeline-reviews-for-agents-in-acute-graft-vs-host-disease-nasopharyngeal-and-ovarian-cancers/</loc><lastmod>2021-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/donor-derived-cd7-car-t-cells-may-lead-to-remissions-in-patients-with-relapsed-or-refractory-t-all/</loc><lastmod>2021-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/first-line-cisplatin-plus-gemcitabine-or-fluorouracil-for-advanced-nasopharyngeal-carcinoma-1/</loc><lastmod>2021-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-finds-cannabis-use-is-lower-among-patients-with-cancer-than-those-with-no-cancer-history/</loc><lastmod>2021-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/can-consumption-of-vitamin-d-reduce-the-risk-of-early-onset-colorectal-cancer/</loc><lastmod>2021-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/prediction-models-may-reduce-false-positives-in-women-with-dense-breasts-undergoing-mri-screening/</loc><lastmod>2021-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/cetuximab-plus-avelumab-as-rechallenge-therapy-for-ras-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2021-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-identifies-possible-new-genetic-biomarkers-of-pediatric-leukemia/</loc><lastmod>2021-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/does-antibiotic-exposure-affect-response-to-first-line-chemoimmunotherapy-in-patients-with-nsclc/</loc><lastmod>2021-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/profile-of-adverse-events-related-to-pd-1-and-pd-l1-inhibitor-based-therapy/</loc><lastmod>2021-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/does-radiotherapy-reduce-the-long-term-risk-of-ipsilateral-breast-recurrence-in-women-with-dcis-who-underwent-lumpectomy/</loc><lastmod>2021-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/report-aims-to-assess-contemporary-burden-of-brain-tumors-in-the-united-states/</loc><lastmod>2021-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/antihypertensive-medications-may-improve-survival-among-patients-with-stage-i-to-iii-colorectal-cancer/</loc><lastmod>2021-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/japanese-study-examines-how-intervention-encourages-screening-for-colorectal-cancer-among-patients-with-schizophrenia/</loc><lastmod>2021-08-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/cancer-predisposition-screening-tool-for-predicting-subsequent-malignancies-in-childhood-cancer-survivors/</loc><lastmod>2021-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/ixazomibrituximabdexamethasone-for-relapsed-or-refractory-waldenstroem-s-macroglobulinemia/</loc><lastmod>2021-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/prostate-cancer-screening-using-the-stockholm3-screening-test-with-mri-guided-biopsy/</loc><lastmod>2021-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/two-studies-explore-the-role-of-primary-care-providers-in-effective-cancer-care/</loc><lastmod>2021-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-finds-drop-in-breast-cancer-screening-rates-in-low-income-communities-during-the-covid-19-pandemic/</loc><lastmod>2021-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-examines-association-between-benign-prostatic-hyperplasia-and-prostate-cancer/</loc><lastmod>2021-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/physical-activity-and-cognitive-function-before-during-and-after-chemotherapy-for-breast-cancer/</loc><lastmod>2021-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/personalized-risk-prediction-model-for-patients-with-myelodysplastic-syndromes/</loc><lastmod>2021-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/effects-of-removing-race-in-the-ckd-epi-equation-for-estimated-glomerular-filtration-rate/</loc><lastmod>2021-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/alk-fusion-positive-high-grade-glioma-response-to-lorlatinib-in-a-single-pediatric-case/</loc><lastmod>2021-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-examines-cancer-specific-mortality-among-patients-with-neuroendocrine-tumors/</loc><lastmod>2021-08-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/excess-cardiovascular-disease-risk-in-patients-with-early-stage-lymphoma-personalizing-radiotherapy-delivery/</loc><lastmod>2021-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/caution-with-robotically-assisted-surgical-devices-for-mastectomy-fda-safety-communication/</loc><lastmod>2021-08-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/pharmacologic-cardioprotection-in-women-with-nonmetastatic-breast-cancer-receiving-anthracycline-based-chemotherapy/</loc><lastmod>2021-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/first-line-veliparib-plus-platinum-based-chemotherapy-in-current-smokers-with-advanced-squamous-cell-nsclc/</loc><lastmod>2021-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-explores-relationship-between-anti-cd20-therapy-and-reduced-responses-to-mrna-covid-19-vaccines/</loc><lastmod>2021-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-highlights-gaps-between-lung-cancer-treatment-recommendations-and-real-world-use-of-durvalumab/</loc><lastmod>2021-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/cross-sectional-survey-reveals-disparities-in-care-of-patients-with-brain-metastases/</loc><lastmod>2021-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/addition-of-pembrolizumab-to-chemotherapy-for-the-first-line-treatment-of-advanced-esophageal-cancer-keynote-590/</loc><lastmod>2021-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/carboplatin-intensification-for-the-treatment-of-pediatric-high-risk-medulloblastoma/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/neoadjuvant-cabozantinibnivolumab-may-make-resection-possible-for-some-patients-with-liver-cancer/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/addition-of-metformin-to-chemoradiotherapy-for-locally-advanced-nsclc/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/tremelimumab-durvalumab-or-both-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/second-generation-androgen-receptor-inhibitors-for-older-men-with-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/revised-children-s-oncology-group-neuroblastoma-risk-classification-system/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/does-pain-affect-the-employment-and-financial-outcomes-of-cancer-survivors/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-highlights-gaps-in-mental-health-and-chemical-dependency-care-at-us-cancer-centers/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/use-of-statins-and-survival-outcomes-among-patients-with-triple-negative-breast-cancer/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/lung-cancer-screening-rates-improved-in-19-states-despite-the-covid-19-pandemic/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/cutaneous-hpv-may-be-a-predictor-of-cutaneous-squamous-cell-carcinoma-risk/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/2-vs-5-years-of-hormone-therapy-following-adjuvant-endocrine-therapy-in-postmenopausal-women-with-hr-positive-breast-cancer/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/elevate-rr-trial-acalabrutinib-vs-ibrutinib-in-previously-treated-patients-with-cll/</loc><lastmod>2021-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/adding-short-term-androgen-suppression-to-radiotherapy-for-patients-with-localized-intermediate-risk-prostate-cancer/</loc><lastmod>2021-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/i-131-metaiodobenzylguanidine-containing-regimens-in-relapsed-or-refractory-neuroblastoma/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/racialethnic-disparities-in-emergency-department-visits-after-breast-cancer-surgery/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/maintaining-a-healthy-lifestyle-may-decrease-cancer-incidence-in-high-risk-individuals/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/continuous-azacitidine-vs-reduced-intensity-conditioning-hsct-in-older-patients-with-advanced-myelodysplastic-syndrome/</loc><lastmod>2021-08-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/addition-of-metformin-to-chemoradiation-in-locally-advanced-nsclc/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/minimally-invasive-esophagectomy-followed-by-intrathoracic-vs-cervical-anastomosis-for-esophageal-cancer/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/covid-19-vaccine-is-safe-in-patients-with-hematologic-malignancies-but-some-do-not-produce-detectable-antibodies/</loc><lastmod>2021-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/pertuzumab-and-trastuzumab-in-previously-treated-patients-with-her2-positive-metastatic-biliary-tract-cancer/</loc><lastmod>2021-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/s-1-chemoradiation-vs-radiotherapy-alone-in-patients-aged-70-to-85-with-esophageal-cancer/</loc><lastmod>2021-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/topical-hdac-inhibitor-remetinostat-for-basal-cell-carcinoma/</loc><lastmod>2021-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/disparities-observed-in-follow-up-care-among-young-adult-childhood-cancer-survivors/</loc><lastmod>2021-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/study-investigates-relationship-between-peanut-agglutinin-and-cancer-metastasis/</loc><lastmod>2021-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/adjuvant-nivolumab-improves-disease-free-survival-in-high-risk-muscle-invasive-urothelial-carcinoma-2/</loc><lastmod>2021-08-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/ribociclib-plus-topotecantemozolomide-or-everolimus-in-pediatric-patients-with-advanced-cancer-enriched-for-target-pathway-alterations/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/addition-of-avelumab-to-chemotherapy-in-previously-untreated-patients-with-advanced-epithelial-ovarian-cancer/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/association-of-incomplete-polyp-removal-with-risk-of-post-colonoscopy-colorectal-cancer/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/enrollment-of-aya-patients-into-nci-sponsored-clinical-trials-25-year-analysis/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/outcomes-and-behaviors-among-women-receiving-or-declining-their-breast-cancer-polygenic-risk-score/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/risk-of-early-cardiac-toxicity-with-posttransplantation-cyclophosphamide-after-hsct/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/evaluation-of-baseline-cancer-mortality-risk-in-medicaid-expansion-and-nonexpansion-states/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/effect-of-regionalization-of-gastric-cancer-care-in-an-integrated-health-care-system/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/amivantamab-for-patients-with-egfr-exon-20-insertion-mutated-nsclc-after-disease-progression-on-platinum-therapy/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/08-august/meta-analysis-of-outcomes-with-the-addition-of-adjuvant-trastuzumab-to-chemotherapy-for-her2-positive-breast-cancer/</loc><lastmod>2021-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/lisocabtagene-maraleucel-for-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/novel-monoclonal-antibody-emerges-as-potential-first-line-standard-in-nasopharyngeal-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/inclusion-of-patients-with-brain-metastases-in-phase-iii-trials-in-advanced-breast-cancer-lung-cancer-and-melanoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/adjuvant-metronomic-capecitabine-for-locoregionally-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/loncastuximab-tesirine-lpyl-for-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-jason-luke/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/long-term-analysis-of-short-her-trial-of-adjuvant-trastuzumab/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/evandro-de-azambuja-discusses-the-short-her-trial/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/leap-004-trial-update-on-lenvatinib-plus-pembrolizumab-after-disease-progression-in-metastatic-melanoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/vision-trial-novel-psma-targeted-radiotherapy-improves-outcomes-in-metastatic-prostate-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-mary-ellen-taplin/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/impact-of-covid-19-on-cancer-treatment-and-early-detection-data-driven-insights/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-clifford-goodman/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/addition-of-adavosertib-to-gemcitabine-improves-outcomes-in-high-grade-serous-ovarian-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/factoring-fertility-preservation-into-breast-cancer-treatment/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/dual-pi3k%CE%B4ck1%CE%B5-inhibitor-umbralisib-in-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/overall-survival-benefit-reported-with-daratumumab-plus-lenalidomide-in-myeloma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/role-of-pi3k-inhibition-in-indolent-lymphomas/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-philip-mccarthy/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/avapritinib-for-advanced-systemic-mastocytosis/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/bridging-the-gender-gap-in-oncology/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/oncology-community-mourns-the-loss-of-investigator-angelo-di-leo/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/phase-iii-glow-trial-improved-outcomes-with-first-line-ibrutinib-plus-venetoclax-in-elderly-patients-with-cll/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/bringing-palliative-care-to-native-american-patients-with-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/sukhmani-padda-to-direct-thoracic-medical-oncology-at-cedars-sinai-cancer-center/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-kostas-stamatopoulos/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/ucsf-names-ajay-maker-chief-of-surgical-oncology/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/early-phase-trial-finds-mirvetuximab-soravtansine-plus-bevacizumab-active-in-recurrent-ovarian-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/b-cell-acute-lymphoblastic-leukemia-update-on-clinical-trials/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/axicabtagene-ciloleucel-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-amit-m-oza/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/canadian-oncologists-report-costly-delays-in-their-drug-regulatory-process/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/american-ginseng/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/memorial-sloan-kettering-announces-new-initiative-to-focus-on-lung-cancer-research/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/dostarlimab-gxly-for-mismatch-repair-deficient-recurrent-or-advanced-endometrial-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/small-study-suggests-alk-targeting-may-be-of-benefit-in-adult-neuroblastoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-jaishri-o-blakeley/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/tivozanib-for-relapsed-or-refractory-advanced-renal-cell-carcinoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/bone-protecting-agents-shown-to-reduce-fracture-rate-in-men-with-metastatic-prostate-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/the-compelling-story-of-cystic-fibrosis-and-the-dawn-of-precision-medicine/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-lisa-horvath/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/i-m-alive-by-sheer-force-of-will-and-a-lot-of-luck/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/public-comment-on-national-coverage-analysis-of-screening-for-lung-cancer-with-low-dose-computed-tomography/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/mindact-trial-shows-excellent-outcomes-in-ultra-low-risk-breast-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-fabrice-andre/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/sarah-tasian-md-appointed-chief-of-the-section-of-hematologic-malignancies-children-s-hospital-of-philadelphia/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fox-chase-cancer-center-welcomes-peter-abdelmessieh-do-msc/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/cleveland-clinic-cancer-center-recognizes-shilpa-gupta-md-and-nima-sharifi-md/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/erica-sirrine-phd-named-director-of-social-work-at-st-jude-children-s-research-hospital/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/breast-cancer-in-2030-predictions-from-a-breast-cancer-luminary/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/how-covid-19-can-lead-to-improvements-in-cancer-care/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/road-map-to-more-equitable-care-from-the-centers-for-medicare-and-medicaid-services/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-shonta-chambers/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/pembrolizumab-combined-with-chemotherapy-for-advanced-esophageal-or-gastroesophageal-junction-carcinoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/lorlatinib-for-metastatic-alk-positive-nsclc/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/adjuvant-pembrolizumab-improves-distant-metastasis-free-survival-in-resected-high-risk-stage-iii-melanoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/benefits-of-adjuvant-pembrolizumab-in-melanoma-reinforced-by-eortc-1325keynote-054-updates/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-publishes-resource-stratified-guideline-on-assessment-and-treatment-of-ovarian-cancer/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-calls-for-increased-funding-for-cancer-research-in-fiscal-year-2022/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/ascofriends-of-cancer-research-joint-position-statement-encourages-enrollment-of-patients-with-cancer-in-covid-19-vaccine-studies/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-honors-john-v-cox-do-mba-facp-fasco-with-2021-joseph-v-simone-award/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fda-approves-expanded-indication-for-pembrolizumab-in-locally-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/bevacizumab-in-advanced-ovarian-cancer-phase-iii-trial-finds-more-is-not-better/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-carol-aghajanian/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-mary-ellen-taplin-1/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/vision-trial-novel-psma-targeted-radiotherapy-improves-outcomes-in-metastatic-prostate-cancer-1/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/responses-to-pembrolizumab-and-ipilimumab-after-anti-pd-1l1-failure-in-advanced-melanoma/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/a-shift-in-the-treatment-of-advanced-melanoma/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/personalizing-treatment-of-early-her2-positive-breast-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/modified-folfirinox-established-as-preferred-neoadjuvant-treatment-of-borderline-resectable-pancreatic-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-rebecca-a-snyder/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/beyond-cdk46-inhibitors-in-metastatic-breast-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/caryn-lerman-phd-elected-president-of-the-aaci/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/the-wistar-institute-recruits-noam-auslander-phd-as-assistant-professor/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/new-medical-director-named-to-lead-clinical-cancer-research/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/disease-risk-associated-with-protein-truncating-and-rare-missense-variants-in-breast-cancer-risk-genes/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/postoperative-mortality-and-complications-after-cancer-surgery-in-high-vs-low-or-middle-income-countries/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/enfortumab-vedotin-ejfv-improves-overall-survival-vs-chemotherapy-in-previously-treated-advanced-urothelial-carcinoma/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/enfortumab-vedotin-represents-a-community-of-work-in-antibody-drug-conjugate-targeting-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/reducing-prostate-cancer-disparity-by-bringing-care-to-underserved-populations/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/sacituzumab-govitecan-hziy-in-urothelial-carcinoma-progressing-after-platinum-based-chemotherapy-and-checkpoint-inhibitor-therapy/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/sacituzumab-govitecan-hziy-welcome-addition-to-advanced-urothelial-cancer-treatments-but-time-to-figure-out-sequencing-and-combinations/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/adapt-trial-excellent-outcomes-reported-with-neoadjuvant-dual-her2-therapy-in-breast-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/predicting-global-cancer-trends-in-2021/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/lifileucel-after-disease-progression-in-metastatic-melanoma-durable-responses-achieved-in-phase-ii-trial/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/early-adopter-of-breast-conservation-surgical-oncologist-augusto-leon-md-reflects-on-cancer-care-in-chile/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-jason-luke-1/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fixed-dose-first-line-ibrutinibvenetoclax-combination-achieves-durable-remissions-in-cll/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-jacqueline-barrientos/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/novel-bcl2-inhibitor-shows-activity-in-cll-in-phase-i-trial/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/novel-targeted-agents-for-the-treatment-of-myelofibrosis/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-jacqueline-barrientos-1/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/amivantamablazertinib-combination-may-overcome-osimertinib-resistance-in-patients-with-egfr-positive-nsclc/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-nicolas-girard/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/ea1131-trial-platinum-not-equal-to-capecitabine-for-residual-disease-in-triple-negative-breast-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/julio-aguirre-ghiso-phd-to-lead-new-cancer-dormancy-and-tumor-microenvironment-institute-at-albert-einstein-cancer-center/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-melinda-telli/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/new-iaslc-leadership-to-assume-roles-at-2021-world-conference-on-lung-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/sarah-cannon-names-navneet-majhail-md-ms-fastct-deputy-physician-in-chief-of-blood-cancers/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-finds-bevacizumab-offers-no-boost-to-second-line-osimertinib-in-egfr-t790m-mutated-lung-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-edward-garon/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/being-both-a-cancer-provider-and-a-cancer-survivor-is-a-rare-privilege/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/risk-of-atrial-fibrillation-after-allogeneic-hct-and-association-with-poor-outcomes/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/conquer-cancer-the-asco-foundation-awards-more-than-10-million-to-support-cancer-research/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/reflections-on-evolution-of-breast-cancer-care-in-india-over-the-past-4-decades/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/defining-cure-in-multiple-myeloma/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-releases-new-recommendations-on-systemic-therapy-dosing-for-adults-with-obesity-and-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-congratulates-chiquita-brooks-lasure-on-confirmation-as-cms-administrator/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/suresh-ramalingam-named-new-executive-director-at-winship-cancer-institute/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/breast-cancer-expert-joseph-sparano-to-join-mount-sinai-health-system/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/improving-screening-of-dense-breasts-with-newer-mri-technologies/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fda-oncology-center-of-excellence-launches-national-black-family-cancer-awareness-week/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/patient-reported-outcomes-from-the-imbrave150-trial-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fda-approves-avapritinib-for-advanced-systemic-mastocytosis/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-releases-rapid-guideline-recommendation-update-for-patients-with-high-risk-her2-negative-germline-brca-mutated-breast-cancer/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/effect-of-time-to-surgery-on-recurrence-and-survival-in-clinical-stage-i-nsclc/</loc><lastmod>2021-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/bcma-directed-car-t-cell-therapy-ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/oral-anticancer-agent-use-in-patients-with-metastatic-renal-cell-carcinoma/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/humanized-cd19-targeted-car-t-cell-treatment-in-patients-with-relapsed-or-refractory-b-cell-all/</loc><lastmod>2021-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/recovery-of-gonadal-function-with-pet-adapted-regimen-for-advanced-hodgkin-lymphoma/</loc><lastmod>2021-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/sbrt-plus-pembrolizumabtrametinib-vs-gemcitabine-in-locally-recurrent-resected-pancreatic-cancer/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-explores-ketogenic-diet-and-intermittent-fasting-in-patients-with-brain-cancer/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/majority-of-patients-with-cancer-achieve-immune-response-after-covid-19-vaccination/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/prevalence-of-homologous-recombination-deficiency-in-patients-with-pancreatic-cancer/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/addition-of-docetaxel-to-radiotherapy-and-adt-in-nonmetastatic-unfavorable-risk-prostate-cancer/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/risk-of-bleeding-complications-during-central-venous-catheter-placement-in-pediatric-patients-with-cancer/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-identifies-gut-microbes-associated-with-combination-immunotherapy-response-and-adverse-events/</loc><lastmod>2021-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/bcma-directed-car-t-cell-therapy-ciltacabtagene-autoleucel-in-relapsed-or-refractory-multiple-myeloma-1/</loc><lastmod>2021-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/is-there-a-link-between-use-of-antibiotics-and-early-onset-colorectal-cancer/</loc><lastmod>2021-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-finds-response-to-covid-19-vaccination-varies-widely-in-patients-with-multiple-myeloma/</loc><lastmod>2021-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/genomic-characteristics-of-pediatric-rhabdomyosarcoma-tumors/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/evaluation-of-two-doses-of-imetelstat-in-patients-with-relapsed-or-refractory-myelofibrosis-after-jak-inhibitor-treatment/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-investigates-influence-of-race-on-receipt-of-care-for-prostate-cancer/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/registry-provides-information-on-pediatric-melanoma/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/cabozantinib-in-previously-treated-radioiodine-refractory-differentiated-thyroid-cancer-cosmic-311/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/quality-of-life-with-general-practitioner-vs-surgeon-led-colon-cancer-survivorship-care/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/calaspargase-pegol-vs-pegaspargase-in-pediatric-acute-lymphoblastic-leukemia/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/five-year-overall-survival-data-suggest-improved-outcomes-in-pancreatic-cancer-with-nab-paclitaxel-plus-gemcitabine/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/destiny-gastric01-exploratory-biomarker-analysis-examines-efficacy-of-trastuzumab-deruxtecan-nxki-among-patients-with-her2-positive-and-low-gastric-cancer/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/epov-thomas-seufferlein/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/asco-and-coa-jointly-release-oncology-medical-home-standards/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/effect-of-obesity-on-receipt-of-chemotherapy-in-patients-with-colorectal-cancer/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/identification-of-prognostic-transcriptional-profile-in-ctcs-with-multiplex-liquid-biopsy-in-metastatic-prostate-cancer/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/outcomes-in-patients-with-her2-low-positive-breast-cancer-participating-in-neoadjuvant-clinical-trials/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/implementation-of-a-program-providing-free-cancer-screenings-same-day-results/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/addition-of-ipilimumab-to-nivolumab-in-previously-treated-immunotherapy-naive-stage-iv-squamous-nsclc/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/nomograms-for-predicting-outcomes-with-lupsma-therapy-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fda-pipeline-designations-for-therapies-in-myelodysplastic-syndromes-and-triple-negative-breast-cancer/</loc><lastmod>2021-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-suggests-substantial-delays-in-diagnosis-and-treatment-for-cancer-during-the-covid-19-pandemic/</loc><lastmod>2021-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-explores-co-occurring-mutations-in-her2-and-her3/</loc><lastmod>2021-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/oncolytic-adenovirus-for-malignant-glioma-feasibility-and-safety/</loc><lastmod>2021-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/addition-of-pembrolizumab-to-chemoradiotherapy-in-total-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/</loc><lastmod>2021-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/individualized-nutritional-support-for-patients-with-cancer/</loc><lastmod>2021-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-finds-reduced-treatment-delays-for-patients-with-breast-cancer-may-improve-survival-rates/</loc><lastmod>2021-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/new-recommendations-from-who-and-hrp-for-the-screening-and-treatment-of-cervical-cancer/</loc><lastmod>2021-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/mechanisms-of-acquired-resistance-to-kras-g12c-inhibition-in-patients-with-cancer/</loc><lastmod>2021-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/arsenic-plus-all-trans-retinoic-acid-for-pediatric-patients-with-acute-promyelocytic-leukemia/</loc><lastmod>2021-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/donafenib-may-improve-survival-vs-sorafenib-in-first-line-treatment-of-unresectable-or-metastatic-hepatocellular-carcinoma/</loc><lastmod>2021-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-recommends-improvements-for-cancer-care-at-network-sites/</loc><lastmod>2021-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/molecular-imaging-may-improve-the-staging-and-treatment-of-pancreatic-ductal-adenocarcinoma/</loc><lastmod>2021-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/using-ctdna-to-measure-molecular-residual-disease-in-patients-with-colorectal-cancer/</loc><lastmod>2021-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/parenthood-status-and-use-of-assisted-reproductive-techniques-in-younger-hodgkin-lymphoma-survivors/</loc><lastmod>2021-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/is-chemotherapy-associated-with-complications-or-poorer-outcomes-among-women-undergoing-immediate-breast-reconstruction/</loc><lastmod>2021-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fda-approves-alternative-to-e-coli-derived-asparaginase-for-leukemia-and-lymphoma/</loc><lastmod>2021-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/mortgage-lending-bias-and-survival-among-older-women-with-breast-cancer-in-the-united-states/</loc><lastmod>2021-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/despite-gains-in-breast-cancer-survival-black-women-continue-to-experience-significant-mortality-disparities/</loc><lastmod>2021-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/effect-of-myeloid-progenitor-cell-product-on-the-risk-of-infection-during-induction-chemotherapy-for-acute-myeloid-leukemia/</loc><lastmod>2021-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/phase-iii-trial-compares-induction-regimens-in-high-risk-neuroblastoma/</loc><lastmod>2021-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/fda-pipeline-recent-designations-in-nsclc-leukemia-and-lymphoma/</loc><lastmod>2021-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/second-line-pembrolizumab-plus-chemotherapy-regimen-for-relapsed-or-refractory-classical-hodgkin-lymphoma/</loc><lastmod>2021-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/assessment-of-targeted-methylation-based-multicancer-early-detection-test-in-independent-validation-cohort/</loc><lastmod>2021-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/effect-of-alk-amplification-and-mutation-on-outcomes-in-high-risk-neuroblastoma/</loc><lastmod>2021-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/efficiency-of-virtual-care-for-oncology-patients-during-the-covid-19-pandemic/</loc><lastmod>2021-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/kit-inhibitor-combination-shows-efficacy-in-refractory-gist/</loc><lastmod>2021-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/real-world-survival-outcomes-with-pertuzumab-plus-t-dm1-for-her2-positive-metastatic-breast-cancer/</loc><lastmod>2021-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/initial-pandemic-related-disruptions-in-breast-cancer-care-may-result-in-increased-mortality-over-the-next-decade/</loc><lastmod>2021-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/her2-specific-car-t-cell-trial-addresses-pediatric-brain-and-spinal-cord-tumors/</loc><lastmod>2021-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/consensus-statement-from-iaslc-on-liquid-biopsy-for-advanced-nsclc/</loc><lastmod>2021-07-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/adding-perioperative-durvalumab-to-neoadjuvant-chemotherapy-in-stage-iiia-nsclc/</loc><lastmod>2021-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/pregnancy-outcomes-and-maternal-complications-among-survivors-of-breast-cancer/</loc><lastmod>2021-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/mri-targeted-vs-standard-biopsy-for-prostate-cancer-screening-in-men-with-elevated-psa-levels/</loc><lastmod>2021-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-estimates-costs-associated-with-metastatic-breast-cancer-treatment-may-increase-substantially-in-the-coming-decade/</loc><lastmod>2021-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/atezolizumab-plus-bevacizumab-in-malignant-peritoneal-mesothelioma/</loc><lastmod>2021-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/combination-ficlatuzumab-and-cytarabine-show-clinical-activity-in-relapsedrefractory-acute-myeloid-leukemia/</loc><lastmod>2021-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/addition-of-prime-boost-vaccination-regimen-to-atezolizumab-in-soft-tissue-sarcomas-expressing-ny-eso-1/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/breast-conserving-surgery-plus-radiotherapy-may-yield-better-survival-than-mastectomy-with-or-without-radiotherapy/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/addition-of-akt-inhibitor-ipatasertib-to-abirateroneprednisolone-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-identifies-met-amplification-as-a-driver-for-some-non-small-cell-lung-cancers/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/efficacy-of-dendritic-cell-vaccines-plus-standard-therapy-for-breast-cancer/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/transvaginal-ultrasound-screening-misses-more-cases-of-endometrial-cancer-in-black-women-vs-white-women/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/interleukin-2-pathway-agonist-bempegaldesleukin-plus-nivolumab-in-the-first-line-treatment-of-metastatic-melanoma/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/is-there-a-disease-free-survival-benefit-with-adjuvant-celecoxib-in-her2-negative-breast-cancer/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/ruxolitinib-for-glucocorticoid-refractory-or-dependent-chronic-graft-vs-host-disease-after-allogeneic-stem-cell-transplantation/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-finds-the-covid-19-pandemic-created-significant-disruptions-in-cancer-screenings-at-federally-qualified-health-centers/</loc><lastmod>2021-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/weekly-outpatient-palliative-care-interventions-among-patients-with-head-and-neck-cancer/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/pembrolizumab-shows-durable-antitumor-activity-in-both-locally-advanced-and-recurrentmetastatic-squamous-cell-carcinomas/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/survival-trends-for-adolescents-and-young-adults-with-cancer-40-year-analysis/</loc><lastmod>2021-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-explores-cost-effectiveness-of-chop-therapy-for-patients-with-dlbcl-in-sub-saharan-africa/</loc><lastmod>2021-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/can-treatment-with-thiopurines-induce-mutations-that-may-lead-to-pediatric-leukemia-relapse/</loc><lastmod>2021-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/trends-in-opioid-prescriptions-among-patients-with-cancer-near-the-end-of-life/</loc><lastmod>2021-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/comparison-of-first-line-chemotherapy-strategies-in-metastatic-pancreatic-cancer/</loc><lastmod>2021-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/complication-rates-among-central-venous-access-devices-compared/</loc><lastmod>2021-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/clinical-trial-results-show-an-increased-risk-of-death-associated-with-melphalan-flufenamide/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-explores-rates-of-reconstruction-for-women-with-inflammatory-breast-cancer-undergoing-mastectomy/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/astro-issues-new-clinical-guideline-on-radiation-therapy-for-adult-patients-with-soft-tissue-sarcoma/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/risk-of-breast-cancer-in-women-older-than-age-65-with-germline-pathogenic-variants-in-predisposition-genes/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-examines-prevalence-of-cancer-misinformation-and-harmful-information-on-social-media/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/perioperative-or-postoperative-oxaliplatins-1-vs-postoperative-oxaliplatincapecitabine-for-locally-advanced-gastric-cancer/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/association-of-baseline-fatigue-with-survival-and-adverse-events-in-patients-with-advanced-cancer/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/frailty-and-neurocognitive-decline-among-young-adult-childhood-cancer-survivors/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/incidence-of-axillary-adenopathy-in-screening-or-diagnostic-mammography-after-covid-19-vaccination/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/meta-analysis-identifies-genetic-markers-for-inherited-testicular-cancer/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/study-shows-cancer-trials-adapted-rapidly-during-the-covid-19-pandemic/</loc><lastmod>2021-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/07-july/prostate-cancer-surgery-rates-in-black-vs-white-men-with-nonmetastatic-disease-during-the-covid-19-pandemic/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-approves-sotorasib-for-kras-g12c-mutated-nsclc/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-grants-accelerated-approval-to-infigratinib-for-metastatic-cholangiocarcinoma-with-an-fgfr2-fusion-or-rearrangement/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/innovator-in-treatment-of-infectious-diseases-francisco-marty-md-dies-at-53/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/survivors-of-early-stage-breast-cancer-face-broad-range-of-symptoms-and-concerns/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/first-line-immune-checkpoint-inhibitor-monotherapy-vs-chemoimmunotherapy-in-advanced-nsclc-according-to-kras-variant-status/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/contralateral-esophagus-sparing-radiotherapy-technique-reduces-rates-of-esophagitis-in-patients-with-lung-cancer-receiving-high-dose-chemoradiation/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/daratumumab-in-combination-with-carfilzomib-lenalidomide-and-dexamethasone-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/with-the-exception-of-cervical-cancer-hpv-related-cancers-are-on-the-rise/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/whispers-over-my-shoulder/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/cancer-in-morocco-access-to-innovative-treatments-and-research-status/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/keynote-564-adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-rana-r-mckay/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/do-community-oncologists-have-access-to-geriatric-specialty-care-for-older-patients/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/outback-no-benefit-for-adjuvant-chemotherapy-in-cervical-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/mary-daly-receives-nccn-2021-rodger-winn-award/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/chanita-hughes-halbert-to-advance-cancer-equity-at-usc-norris-comprehensive-cancer-center/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/cynthia-yoshida-honored-nationally-for-increasing-colorectal-cancer-screening-rates/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/margaret-foti-to-receive-gallery-of-success-award-from-temple-university/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/young-urologist-of-the-year-award-winners/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-mark-g-kris/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/olympia-trial-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-breast-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/lessons-from-pneumococcal-vaccine-responses-in-patients-with-cll-in-an-evolving-vaccine-landscape/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-nadine-tung/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/how-ras-mutations-in-early-onset-colorectal-cancer-may-impact-patient-survival/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/subgroup-analysis-of-phase-ii-trial-shows-activity-with-breakthrough-kras-inhibitor-in-lung-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/harnessing-a-worldwide-effort-to-combat-covid-19-and-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/asco-releases-recommendations-for-management-of-salivary-gland-malignancies/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/watch-now-discussion-on-eligibility-criteria-and-the-impact-on-access-to-clinical-trials/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/asco-accc-piloting-project-to-test-tools-to-diversify-cancer-clinical-trials/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/biden-administration-reverses-rule-limiting-access-to-equitable-cancer-care-for-sexual-and-gender-minority-community/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-sarah-blair-md-facs/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/low-response-rates-to-conjugate-pneumococcal-vaccine-in-patients-with-chronic-lymphocytic-leukemia/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-kemi-doll/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pi3k-inhibition-with-copanlisib-plus-rituximab-in-relapsed-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/better-responses-to-hepatic-arterial-infusion-therapy-among-patients-with-kras-wild-type-metastatic-colorectal-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/how-to-talk-with-teens-and-young-adults-about-their-end-of-life-goals/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/emerging-reasons-for-optimism-in-lung-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/new-asco-journal-series-examines-disparities-in-cancer-care-for-black-people-in-the-united-states/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-kunle-odunsi-and-lilian-gien/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/checkmate-648-first-line-nivolumab-regimens-improve-survival-in-esophageal-squamous-cell-carcinoma/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-rui-hua-xu/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/nih-names-marie-a-bernard-md-chief-officer-for-scientific-workforce-diversity/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/sidney-kimmel-cancer-center-jefferson-health-names-andrew-aplin-phd-deputy-director-for-scientific-strategy/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/survey-finds-bullying-sexual-harassment-not-uncommon-for-women-in-gynecologic-oncology/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/md-anderson-and-broad-institute-launch-new-translational-research-platform-focused-on-rare-cancers/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pancreatic-cancer-center-of-excellence-to-leverage-research-and-clinical-care-innovations-for-patients/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addressing-sexuality-challenges-throughout-the-cancer-care-continuum/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/breast-cancer-has-taught-me-many-life-lessons/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/dana-farber-and-harvard-street-neighborhood-health-center-to-connect-patients-to-cancer-services/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/gauri-varadhachary-dies-at-52/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/cryoablation-in-low-risk-breast-cancers-minimally-invasive-procedure-with-minimal-risk/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-henry-kuerer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-copanlisib-to-rituximab-improves-progression-free-survival-in-relapsed-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/newly-diagnosed-multiple-myeloma/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/inaugural-vice-chair-for-diversity-health-equity-appointed-by-nyu-langonenyu-grossman-school-of-medicine/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/john-d-carpten-to-join-the-aacr-board-of-directors/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/de-escalating-surgery-for-women-with-breast-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/immunotherapy-with-cemiplimab-rwlc-yields-survival-benefit-in-advanced-cervical-cancer/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-mansoor-raza-mirza/</loc><lastmod>2021-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-copanlisib-to-rituximab-improves-progression-free-survival-in-relapsed-indolent-non-hodgkin-lymphoma-1/</loc><lastmod>2022-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/machine-learning-based-algorithm-accurately-predicts-short-term-mortality-in-patients-with-cancer-and-prompts-serious-illness-conversations/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/actionable-mutations-identified-in-majority-of-genome-sequenced-resected-cholangiocarcinomas/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/targeting-lag-3-and-pd-1-with-relatlimab-and-nivolumab-a-new-option-under-study-in-advanced-melanoma/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/omid-hamid-discusses-relativity-047/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-approves-piflufolastat-f-18-injection-for-the-detection-of-metastatic-or-recurrent-prostate-cancer/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/new-approaches-needed-for-patients-with-locoregional-breast-cancer-progression-during-neoadjuvant-systemic-therapy/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/seattle-s-fred-hutchinson-cancer-research-center-launches-redesigned-culinary-website-for-cancer-patients-and-survivors/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-approves-nivolumab-for-resected-esophageal-or-gastroesophageal-junction-cancer/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-grants-accelerated-approval-to-amivantamab-vmjw-for-metastatic-egfr-exon-20-insertion-mutated-nsclc/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/updated-information-on-sotorasib-dose-comparison-study/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-grants-accelerated-approval-to-pembrolizumab-combination-for-her2-positive-gastric-cancer/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/update-on-clinical-trials-in-acute-myeloid-leukemia/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/first-lady-dr-jill-biden-assures-the-nci-of-the-administration-s-commitment-to-advancing-cancer-research/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/how-the-biden-administration-is-changing-oncology-care/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/jadpro-live-announces-dates-for-2021-annual-conference-for-oncology-advanced-practitioners/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/eduardo-m-sotomayor-md-to-lead-new-tampa-general-hospital-cancer-institute/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/the-ohio-state-recruits-marcos-j-de-lima-md-to-lead-blood-and-marrow-transplant-and-cellular-therapy-programs/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/atezolizumab-reduces-risk-of-disease-progression-in-patients-with-pd-l1-expressing-early-stage-nsclc/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/gustavo-fonseca-assumes-new-role-at-florida-cancer-specialists-research-institute/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/cabozantinib-with-nivolumab-for-metastatic-renal-cell-carcinoma/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adjuvant-nivolumab-improves-disease-free-survival-vs-placebo-in-resected-esophageal-or-gastroesophageal-junction-cancer-after-neoadjuvant-chemoradiotherapy/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/disease-free-survival-benefit-with-adjuvant-immunotherapy-in-resectable-esophageal-cancer-practice-changing-for-all-patients/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adding-targeted-agent-to-treatment-shows-significant-benefits-in-pediatric-patients-with-high-risk-hodgkin-lymphoma/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/radiation-is-not-the-enemy/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/jennifer-barsky-reese-receives-new-investigator-award/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/gouri-shankar-bhattacharyya-dies-of-covid-19-related-complications/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adjuvant-imatinib-therapy-offers-survival-benefit-in-patients-with-resected-gist/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/i-was-given-a-death-sentence-at-just-17/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/global-responses-to-covid-19-pandemic-related-disruptions-in-cancer-care/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/lobaplatin-vs-cisplatin-based-induction-and-chemoradiotherapy-in-previously-untreated-locoregionally-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/tisotumab-vedotin-in-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/could-risk-based-triage-system-alter-surgical-practice-in-ovarian-cancer/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/data-analysis-on-early-onset-colorectal-cancer-sheds-light-on-the-rising-rates-in-young-adults/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/national-advocacy-organization-children-s-cancer-cause-invites-applications-for-2021-survivorship-champion-s-prize/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pershing-square-sohn-cancer-research-alliance-awards-36-million-to-six-emerging-pioneers-in-cancer-research/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-thomas-herzog/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/roswell-park-immunologist-promoted-to-endowed-chair-role/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/the-brooklyn-cancer-center-announces-new-chief-of-hematology-and-medical-oncology/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/selected-poster-presentations-from-the-nccn-2021-annual-conference/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/is-tumor-mutational-burden-predictive-of-survival-outcomes-in-solid-tumors-treated-with-immune-checkpoint-inhibitors/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/carol-prives-receives-aacr-gha-clowes-award-for-outstanding-basic-cancer-research/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/is-high-tumor-mutational-burden-predictive-of-immune-checkpoint-blockade-efficacy-across-all-cancer-types/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/nivolumabipilimumab-improves-overall-survival-vs-chemotherapy-in-first-line-treatment-for-unresectable-malignant-pleural-mesothelioma/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/dual-immune-checkpoint-blockade-with-nivolumab-and-ipilimumab-for-treatment-of-malignant-pleural-mesothelioma/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/two-memorial-sloan-kettering-experts-awarded-for-pioneering-work/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/new-study-shows-difficulty-in-identifying-transgender-individuals-using-ehr-data/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/senators-richard-burr-and-ben-cardin-recognized-as-asco-congressional-champions-for-cancer-care/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/telehealth-flexibilities-helping-people-have-uninterrupted-access-to-cancer-care-should-continue-after-the-covid-19-pandemic/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/navigating-the-post-vaccine-pandemic/</loc><lastmod>2021-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/mourned-and-missed/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/asco-board-of-directors-and-nominating-committee/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/the-daughter-of-a-fighter-pilot-becomes-a-leader-in-compassionate-cancer-care/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/working-on-the-night-shift-a-connection-to-a-patient-with-cancer-inspires-a-career/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/after-a-flirtation-with-infectious-disease-hematology-calls-leading-to-a-notable-career/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-pioneer-in-head-and-neck-cancer-surgery-whose-career-was-founded-on-passion-and-dedication/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-career-in-cardio-oncology-founded-on-simple-principles-taught-by-her-immigrant-parents/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/serendipity-plays-a-role-in-a-journey-to-a-noted-career-in-surgical-oncology/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-pioneer-in-geriatric-oncology-leaves-his-mark-and-marches-forward/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-brooklyn-girl-bucks-her-old-fashioned-upbringing-to-become-a-leader-in-bone-marrow-transplantation/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-junior-high-school-teacher-sparks-a-love-for-science/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-doctor-s-daughter-becomes-a-pioneer-in-cancer-survivorship/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/new-fda-approved-oncology-drugs-and-label-updates-between-may-8-2020-and-may-8-2021/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/narratives-in-oncology-through-the-years/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/eric-p-winer-elected-asco-president-for-2022-2023-term/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/a-love-for-surgery-underpins-a-career-devoted-to-patients-with-pancreatic-cancer/</loc><lastmod>2021-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/continuous-coverage-of-covid-19/</loc><lastmod>2020-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/neoadjuvant-chemotherapy-de-escalation-using-f-18-fdg-pet-response-based-strategy-in-her2-positive-breast-cancer/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pembrolizumab-in-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer-keynote-057/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/are-there-differences-in-the-prevalence-of-germline-pathogenic-variants-in-susceptibility-genes-in-black-vs-white-women-with-breast-cancer/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/real-world-survival-outcomes-with-various-treatment-regimens-for-metastatic-renal-cell-carcinoma/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/predictors-of-emergency-department-visits-after-a-new-diagnosis-of-cancer/</loc><lastmod>2021-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/noninvasive-imaging-biomarker-and-pathologic-complete-response-to-neoadjuvant-pertuzumabtrastuzumab-in-her2-positive-breast-cancer/</loc><lastmod>2021-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/third-party-bk-virus-specific-cytotoxic-t-lymphocyte-therapy-for-bk-virus-associated-hemorrhagic-cystitis-after-stem-cell-transplant/</loc><lastmod>2021-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/hipec-with-carboplatin-for-platinum-sensitive-recurrent-ovarian-cancer-safety-and-outcomes/</loc><lastmod>2021-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-examines-barriers-to-survivorship-care/</loc><lastmod>2021-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/organizations-issue-statement-encouraging-return-to-hpv-vaccination/</loc><lastmod>2021-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/checkmate-274-adjuvant-nivolumab-in-high-risk-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2021-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adapt-survival-outcomes-after-neoadjuvant-dual-her2-therapy-for-hr-negative-her2-positive-breast-cancer/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/does-vitamin-d-supplementation-improve-prognosis-for-patients-with-breast-cancer/</loc><lastmod>2021-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/choice-of-first-line-platinum-chemotherapy-does-not-significantly-impact-efficacy-of-second-line-immunotherapy-in-advanced-urothelial-carcinoma/</loc><lastmod>2021-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/lay-health-worker-led-intervention-may-improve-care-for-low-income-and-minority-patients-with-cancer/</loc><lastmod>2021-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pertuzumabtrastuzumab-demonstrates-activity-in-tissue-agnostic-trial-for-patients-with-her2-positive-tumors/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-examines-aromatase-inhibitor-associated-musculoskeletal-symptoms-in-a-diverse-population-with-early-breast-cancer/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/community-based-engagement-initiative-improves-accrual-of-black-participants-in-clinical-trials/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/ponatinibblinatumomab-demonstrates-high-rates-of-complete-molecular-response-in-philadelphia-chromosome-positive-all/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/toripalimab-plus-gemcitabinecisplatin-extends-progression-free-survival-in-recurrent-or-metastatic-nasopharyngeal-carcinoma-jupiter-02/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/olympia-adjuvant-olaparib-extends-disease-free-survival-in-brca-mutated-early-stage-her2-negative-breast-cancer/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/transoral-surgery-followed-by-lower-dose-radiation-in-patients-with-hpv-associated-oropharyngeal-cancer-at-intermediate-risk-of-recurrence/</loc><lastmod>2021-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-examines-relationship-between-risk-of-covid-19-infection-and-breast-cancer-treatment/</loc><lastmod>2021-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/sotorasib-for-kras-g12c-mutated-nsclc-overall-survival-and-exploratory-subgroup-analyses/</loc><lastmod>2021-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/electronic-olfaction-system-under-study-as-screening-tool-for-pancreatic-and-ovarian-cancers/</loc><lastmod>2021-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/outback-trial-no-survival-benefit-with-adjuvant-chemotherapy-after-standard-chemoradiation-for-locally-advanced-cervical-cancer/</loc><lastmod>2021-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/novel-psma-targeted-radiotherapy-improves-radiographic-progression-free-and-overall-survival-in-metastatic-prostate-cancer/</loc><lastmod>2021-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/extended-follow-up-of-nivolumabipilimumab-for-metastatic-melanoma/</loc><lastmod>2021-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/remote-monitoring-program-reduced-hospitalization-among-patients-with-cancer-infected-with-covid-19/</loc><lastmod>2021-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/efficacy-of-platinum-chemotherapy-vs-capecitabine-for-basal-like-triple-negative-breast-cancer/</loc><lastmod>2021-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/nivolumab-plus-chemotherapy-and-nivolumab-plus-ipilimumab-as-first-line-treatment-for-patients-with-advanced-esophageal-cancer/</loc><lastmod>2021-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adjuvant-pembrolizumab-extends-disease-free-survival-in-high-risk-renal-cell-carcinoma/</loc><lastmod>2021-06-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/high-dose-interferon-or-ipilimumab-vs-pembrolizumab-for-high-risk-resected-melanoma/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/results-of-a-restrictive-opioid-prescription-protocol-for-patients-with-cancer-undergoing-surgery/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/no-survival-difference-for-front-line-combination-regimens-in-intermediate-and-poor-risk-clear-cell-rcc/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/use-of-integrative-medicine-by-patients-with-breast-cancer/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-finds-need-to-improve-knowledge-about-palliative-care-among-us-adults/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/keynote-361-first-line-pembrolizumab-with-or-without-chemotherapy-vs-chemotherapy-in-advanced-urothelial-carcinoma/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/apollo-trial-addition-of-subcutaneous-daratumumab-to-pomalidomidedexamethasone-in-previously-treated-patients-with-multiple-myeloma/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/new-web-based-lesion-selection-tool-may-improve-coordination-performance-and-management-of-biopsy-specimens/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-approves-new-pediatric-indication-for-technetium-tc-99m-tilmanocept-injection/</loc><lastmod>2021-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/effect-of-the-covid-19-pandemic-on-delivery-of-oncology-services-in-india/</loc><lastmod>2021-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/global-registry-analysis-of-nrg1-fusion-positive-lung-cancer/</loc><lastmod>2021-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/breast-cancer-risk-prediction-model-for-childhood-cancer-survivors-who-received-chest-radiation/</loc><lastmod>2021-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/ibrutinibvenetoclax-provides-durable-remission-for-patients-with-newly-diagnosed-cll/</loc><lastmod>2021-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/real-world-survival-outcomes-with-targeted-therapy-for-intracranial-metastatic-disease/</loc><lastmod>2021-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pet-response-adapted-chemoradiotherapy-for-esophageal-and-esophagogastric-junction-adenocarcinoma/</loc><lastmod>2021-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adjuvant-trastuzumab-emtansine-vs-paclitaxeltrastuzumab-in-stage-i-her2-positive-breast-cancer/</loc><lastmod>2021-06-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/computational-tool-suggests-optimal-treatment-for-patients-with-high-grade-ovarian-cancer/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/pralsetinib-in-advanced-ret-fusion-positive-nsclc-arrow-trial/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/venetoclax-plus-flag-ida-induction-and-consolidation-for-aml/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/adjuvant-platinum-vs-capecitabine-in-patients-with-basal-subtype-triple-negative-breast-cancer/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/overall-survival-benefit-with-upfront-daratumumab-plus-lenalidomidedexamethasone-for-newly-diagnosed-transplant-ineligible-patients-with-multiple-myeloma/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/nearly-half-of-surveyed-patients-with-gynecologic-cancer-report-experiencing-financial-toxicity/</loc><lastmod>2021-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/all-cause-mortality-risk-with-adjuvant-vs-early-salvage-radiotherapy-after-radical-prostatectomy/</loc><lastmod>2021-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/axicabtagene-ciloleucel-demonstrates-improvement-across-multiple-endpoints-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2021-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/colorectal-cancer-incidence-and-mortality-in-european-countries/</loc><lastmod>2021-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/reduced-intensity-conditioning-allogeneic-hct-based-on-donor-availability-in-older-patients-with-advanced-myelodysplastic-syndrome/</loc><lastmod>2021-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-gemtuzumab-ozogamicin-to-conventional-background-chemotherapy-in-pediatric-patients-with-kmt2a-rearranged-aml/</loc><lastmod>2021-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/alkylating-signature-in-colorectal-cancer-linked-to-high-red-meat-intake/</loc><lastmod>2021-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/zanubrutinib-vs-ibrutinib-in-relapsedrefractory-cllsll-alpine-trial/</loc><lastmod>2021-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/ctdna-and-early-relapse-after-axicabtagene-ciloleucel-infusion-in-large-b-cell-lymphoma/</loc><lastmod>2021-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/reduced-dose-and-reduced-volume-radiotherapy-plus-chemotherapy-in-newly-diagnosed-patients-with-average-risk-medulloblastoma/</loc><lastmod>2021-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/overall-survival-with-the-addition-of-ixazomib-to-lenalidomidedexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-pipeline-priority-reviews-in-multiple-myeloma-cervical-cancer-neutropenia-and-myelofibrosis/</loc><lastmod>2021-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/stereotactic-body-radiotherapy-vs-conventional-external-beam-radiotherapy-for-pain-control-of-spinal-metastases/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/convalescent-plasma-therapy-for-patients-with-hematologic-cancers-hospitalized-for-covid-19/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/survival-of-patients-with-colon-cancer-enrolled-in-the-us-military-health-system/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-finds-patients-with-bladder-cancer-and-ureteric-obstruction-may-safely-receive-chemotherapy/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-explores-taste-and-smell-dysfunction-in-head-and-neck-cancer-survivors/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-neoadjuvant-chemotherapy-to-surgery-and-adjuvant-s-1-in-locally-advanced-gastric-cancer/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/prevalence-of-germline-brca-mutations-in-women-with-ovarian-cancer-in-india/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/effect-of-radiotherapy-dose-escalation-in-definitive-chemoradiation-for-locally-advanced-esophageal-cancer/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-isatuximab-irfc-to-carfilzomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma-ikema-trial/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/ibrutinibvenetoclax-vs-chlorambucilobinutuzumab-in-previously-untreated-older-patients-with-cllsll/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-explores-incidence-rates-for-various-pediatric-cancers-across-age-and-racial-groups/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/testing-of-lymph-nodes-for-breast-cancer-recurrence-after-neoadjuvant-chemotherapy/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/brexucabtagene-autoleucel-in-adults-with-relapsed-or-refractory-b-cell-all-zuma-3/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/is-lenvatinib-plus-pembrolizumab-an-effective-treatment-for-patients-with-metastatic-renal-cell-carcinoma/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/ascofriends-of-cancer-research-joint-position-statement-encourages-enrollment-of-patients-with-cancer-in-covid-19-vaccine-studies/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/avelumab-with-or-without-pegylated-liposomal-doxorubicin-in-platinum-resistantrefractory-ovarian-cancer/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/phase-ii-study-of-naratuximab-emtansine-plus-rituximab-in-diffuse-large-b-cell-lymphoma/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-evaluates-residential-racial-segregation-and-nsclc-treatment-and-outcomes/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/epov-anthony-tc-chan/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/all-cause-mortality-in-covid-19-positive-and-covid-19-negative-patients-with-cancer/</loc><lastmod>2021-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/effect-of-polygenic-risk-score-on-estimated-breast-cancer-risk-among-carriers-of-pathogenic-variants-in-predisposition-genes/</loc><lastmod>2021-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/retrospective-study-explores-variation-in-colorectal-cancer-risk-in-families-with-lynch-syndrome/</loc><lastmod>2021-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-first-line-nivolumab-to-chemotherapy-in-advanced-gastric-cancers-checkmate-649/</loc><lastmod>2021-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/fda-encourages-inclusion-of-patients-with-incurable-cancers-in-oncology-clinical-trials-regardless-of-prior-therapies/</loc><lastmod>2021-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/vision-trial-lu-177-psma-617-radioligand-therapy-prolongs-survival-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/effects-of-foxr2-expression-in-neuroblastoma/</loc><lastmod>2021-06-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/use-of-germline-mutation-profiling-in-patients-with-advanced-cancers/</loc><lastmod>2021-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/immunotherapy-may-be-effective-for-subset-of-patients-with-prostate-cancer/</loc><lastmod>2021-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-examines-mechanisms-of-resistance-in-early-stage-breast-cancer-after-endocrine-plus-cdk46-therapy/</loc><lastmod>2021-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/sintilimab-plus-bevacizumab-biosimilar-vs-sorafenib-in-unresectable-or-metastatic-hbv-associated-hepatocellular-carcinoma/</loc><lastmod>2021-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/survey-finds-covid-19-vaccine-hesitancy-among-many-adolescent-and-young-adult-cancer-survivors/</loc><lastmod>2021-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/outcomes-with-5-vs-2-years-of-zoledronate-treatment-following-adjuvant-chemotherapy-in-early-breast-cancer/</loc><lastmod>2021-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/study-examines-impact-of-covid-19-on-breast-and-cervical-cancer-screening-programs/</loc><lastmod>2021-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/association-between-increased-bmi-and-endometrial-cancer-risk-in-asian-women-with-postmenopausal-bleeding/</loc><lastmod>2021-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/neoadjuvant-trastuzumab-emtansine-vs-trastuzumab-pertuzumab-and-docetaxel-in-her2-positive-breast-cancer/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/are-patients-with-primary-lung-cancer-detected-by-low-dose-ct-at-reduced-risk-of-brain-metastases/</loc><lastmod>2021-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/addition-of-first-line-camrelizumab-to-gemcitabinecisplatin-in-recurrent-or-metastatic-nasopharyngeal-carcinoma/</loc><lastmod>2021-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/06-june/risk-factors-for-early-discontinuation-of-adjuvant-endocrine-therapy-for-breast-cancer/</loc><lastmod>2021-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/second-line-folfox-vs-active-symptom-control-in-advanced-biliary-tract-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-grants-regular-approval-to-sacituzumab-govitecan-hziy-for-pretreated-patients-with-triple-negative-breast-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-approves-new-dosing-regimen-for-cetuximab-in-colorectal-cancer-head-and-neck-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-approves-isatuximab-irfc-combination-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/chernobyl-at-35-years-an-oncologist-s-perspective/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-grants-accelerated-approval-to-loncastuximab-tesirine-lpyl-for-large-b-cell-lymphoma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-grants-accelerated-approval-to-sacituzumab-govitecan-hziy-for-advanced-urothelial-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/addition-of-neoadjuvant-folfirinox-to-preoperative-chemoradiotherapy-in-locally-advanced-rectal-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/ixabepilone-plus-bevacizumab-active-in-platinum-resistant-or-recurrent-ovarian-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-thomas-herzog/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/early-triple-negative-breast-cancer-are-checkpoint-inhibitors-ready-for-neoadjuvant-or-adjuvant-use/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/drive-curiosity-and-a-love-of-science-one-nurse-s-road-to-a-leadership-role-in-oncology/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/asco-honors-2021-special-awards-recipients/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/asco-issues-guideline-on-dyspnea-in-advanced-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/douglas-r-lowy-md-faacr-honored-with-2021-aacr-margaret-foti-award/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/nccn-clinical-practice-guidelines-in-oncology-2021-updates/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/melphalan-flufenamide-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/advancements-in-the-care-of-older-adults-with-prostate-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/pembrolizumab-improves-progression-free-survival-vs-brentuximab-vedotin-in-relapsed-or-refractory-classic-hodgkin-lymphoma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/pembrolizumab-as-long-term-treatment-option-in-relapsed-or-refractory-classic-hodgkin-lymphoma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/oral-azacitidine-improves-overall-survival-vs-placebo-as-maintenance-therapy-for-aml-in-first-remission/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-odac-meeting-focuses-on-dangling-accelerated-approvals-of-anti-pd-1pd-l1-antibodies/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/first-line-cemiplimab-rwlc-improves-outcomes-vs-platinum-doublet-chemotherapy-in-advanced-nsclc-pd-l1-expression/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/empower-lung-1-trial-new-options-no-new-answers/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fam-trastuzumab-deruxtecan-nxki-for-trastuzumab-pretreated-advanced-her2-positive-gastric-adenocarcinoma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/first-line-nivolumab-plus-cabozantinib-improves-progression-free-and-overall-survival-vs-sunitinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/stand-up-to-cancer-funds-6-million-for-disparities-in-cancer-clinical-trials-research/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/ton-schumacher-receives-2021-aacr-cri-lloyd-j-old-award-in-cancer-immunology/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/nima-sharifi-receives-2021-aacr-waun-ki-hong-award-in-translational-and-clinical-cancer-research/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/roswell-park-wilmot-cancer-institute-collaborate-in-study-of-immunotherapy-for-black-patients-with-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/how-the-national-cancer-act-of-1971-revolutionized-cancer-care-and-what-lies-ahead/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/st-jude-children-s-research-hospital-announces-its-largest-strategic-expansion/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/celebrating-50-years-of-cancer-progress-the-international-view/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/sloan-kettering-institute-researchers-awarded-2021-kravis-women-in-science-endeavor-fellowship-grants/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/improving-prediction-of-risk-for-10-year-left-ventricular-systolic-dysfunction-in-survivors-of-childhood-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/refining-cardiovascular-risk-assessment-in-childhood-cancer-survivors/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/aua-names-2021-award-recipients/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/american-academy-of-hiv-medicine-names-leslie-mcgorman-as-director-of-public-policy/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/an-epiphany-during-fellowship-led-to-a-career-in-geriatric-oncology-for-heidi-d-klepin/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/idecabtagene-vicleucel-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/balancing-a-reverence-for-life-with-a-belief-that-patients-have-a-right-to-a-dignified-death/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/agnes-witkiewicz-to-lead-roswell-park-s-cancer-genetics-and-genomics-department/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/coagulopathy-and-covid-19-infection/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cancer-has-taught-me-to-live-with-purpose/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/a-seasoned-journalist-seeking-answers-reports-from-the-front-lines-of-the-covid-19-pandemic/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/enduring-cancer-and-its-treatment-with-resilience-and-humor/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/lustgarten-foundation-aacr-career-development-awards-for-pancreatic-cancer-research/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/new-president-and-executive-council-officers-for-the-society-of-surgical-oncology/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/lisa-m-coussens-phd-faacr-elected-aacr-president-elect-for-2021-2022/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/selpercatinib-makes-inroads-in-other-ret-fusion-positive-tumor-types/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-ezra-ew-cohen/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/oncolytic-virotherapy-achieves-early-signs-of-success-in-high-grade-gliomas/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-patrick-y-wen/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/aacr-to-recognize-the-st-baldrick-s-foundation-su2c-pediatric-cancer-dream-team-with-2021-team-science-award/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/aacr-announces-recipients-of-2021-scientific-achievement-awards-and-lectureships/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-jamie-n-bakkum-gamez/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/frailty-can-be-a-serious-issue-in-ovarian-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/asco-s-president-elect-focuses-on-advancing-global-cancer-care-innovations-accelerated-by-the-covid-19-pandemic/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/equitable-cancer-care-steps-toward-meaningful-change/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fuzuloparib-maintenance-therapy-improves-progression-free-survival-in-patients-with-recurrent-ovarian-cancer/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-thomas-herzog-1/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/single-agent-pembrolizumab-yields-high-response-rates-in-patients-with-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-stefania-scala/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/stage-iv-pd-l1-high-non-small-cell-lung-cancer-immunotherapy-alone-or-with-chemotherapy/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-federico-cappuzzo/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/dual-brafmek-inhibition-under-study-in-braf-v600e-mutant-gliomas/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/zach-test/</loc><lastmod>2021-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/phase-ii-trial-reports-anticancer-activity-with-novel-fgfr-inhibitor-in-advanced-intrahepatic-cholangiocarcinoma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-ezra-cohen/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/first-line-pembrolizumab-plus-chemotherapy-in-pd-l1-positive-locally-recurrent-triple-negative-breast-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/chenevert-family-brain-tumor-center-launched-at-yale/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/virtual-meetings-are-here-to-stay/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/are-prevalent-cardiovascular-risk-factors-associated-with-increased-risk-of-subsequent-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/shared-risk-factors-for-preventing-cancer-and-cardiovascular-disease-the-evolving-focus-of-cardio-oncology/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/neoadjuvant-nivolumab-plus-chemotherapy-boosts-pathologic-complete-response-in-resectable-nsclc/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-jhanelle-gray/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/maryam-lustberg-md-mph-accepts-leadership-roles-at-smilow-cancer-hospital-yale-cancer-center/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/phase-iii-ariel4-confirms-rucaparib-s-benefit-in-brca-mutated-relapsed-ovarian-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-ursula-matulonis-and-konstantin-zakashansky/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/tebentafusp-shows-overall-survival-benefit-in-first-line-treatment-of-metastatic-uveal-melanoma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/frederick-w-alt-phd-honored-with-2021-aacr-award-for-lifetime-achievement-in-cancer-research/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/new-director-of-neuro-oncology-named-to-rutgers-cancer-institute-of-new-jersey/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/ucla-team-receives-6-million-from-nih-to-explore-new-pancreatic-cancer-therapies/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/bispecific-antibody-platform-early-data-in-relapsed-and-refractory-myeloma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/methylationtoactivity-a-deep-learning-framework-for-epigenetic-research/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/a-sense-of-duty-shapes-the-career-of-medical-oncologist-aparna-parikh-md/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/dana-farber-cancer-institute-opens-new-state-of-the-art-location/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-caroline-robert/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/city-of-hope-renames-research-center-as-the-arthur-riggs-diabetes-metabolism-research-institute/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/addition-of-copanlisib-to-rituximab-extends-progression-free-survival-in-relapsed-indolent-nhl/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-peter-martin/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cannabis/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/aacr-inaugurates-new-leadership-at-virtual-aacr-annual-business-meeting-2021/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/roswell-park-is-first-site-in-region-named-a-resource-for-patients-with-rare-genetic-disease/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-approves-nivolumab-in-combination-with-chemotherapy-for-metastatic-gastric-cancer-and-esophageal-adenocarcinoma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/comparing-nivolumab-plus-ipilimumab-vs-nivolumab-alone-in-resected-stage-iii-to-iv-melanoma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/lombardi-comprehensive-cancer-center-georgetown-university-names-kieron-dunleavy-md-to-leadership-positions-in-hematology/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-alexander-eggermont/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/surge-of-patients-with-advanced-cancer-expected-due-to-delayed-diagnosis-and-treatment-during-pandemic/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cemiplimab-rwlc-for-first-line-treatment-of-nsclc-with-high-pd-l1-expression/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/rare-genitourinary-tumors-global-society/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/covid-19-pandemic-underscores-shortage-of-oncologists/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/randall-holcombe-named-director-of-uvm-cancer-center-and-chief-of-hematology-and-oncology/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/upmc-hillman-names-new-hematology-oncology-chief/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/adjuvant-immunotherapy-of-benefit-to-patients-with-stage-iibc-melanoma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/margetuximab-cmkb-plus-chemotherapy-prolongs-progression-free-survival-in-heavily-pretreated-her2-positive-breast-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/margetuximab-cmkb-a-novel-agent-overshadowed-by-an-abundance-of-options-in-her2-positive-breast-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/what-you-need-to-know-about-cancer-and-the-coronavirus/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fostering-a-global-community-of-early-career-oncologists-virtually/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/asco-answers-guide-cancer-survivorship/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/new-savings-on-healthcaregov-follow-covid-relief-package/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/asco-and-ontario-health-publish-joint-update-on-guideline-for-targeted-therapy-in-nsclc-with-driver-alterations/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/how-mrd-assessment-may-help-guide-treatment-selection-for-patients-with-aml/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/expanding-role-of-liquid-biopsies-in-cancer-detection-and-therapeutics-now-and-in-the-near-future/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/heritability-genes-identified-in-childhood-neuroblastoma/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-antoni-ribas/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/hormonal-intrauterine-device-under-study-for-managing-early-endometrial-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/epov-angeles-alvarez-secord/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/american-cancer-society-names-karen-knudsen-its-next-chief-executive-officer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/patrizia-cavazzoni-named-director-of-the-fda-center-for-drug-evaluation-and-research/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/squamous-cell-carcinoma-of-the-head-and-neck-current-status-and-future-directions/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cleveland-clinic-appoints-brian-bolwell-to-new-leadership-role-jame-abraham-to-serve-as-acting-chair-taussig-cancer-institute/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/pembrolizumab-in-microsatellite-instability-high-advanced-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/overall-survival-with-olaparib-vs-placebo-maintenance-in-patients-with-platinum-sensitive-relapsed-ovarian-cancer-and-brca12-mutation/</loc><lastmod>2021-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/imagyn050-trial-addition-of-atezolizumab-to-bevacizumab-and-chemotherapy-for-newly-diagnosed-stage-iii-or-iv-ovarian-cancer/</loc><lastmod>2021-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/diagnosis-to-treatment-interval-and-circulating-tumor-dna-levels-in-diffuse-large-b-cell-lymphoma/</loc><lastmod>2021-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/oncologists-views-on-challenges-in-opioid-prescribing-for-patients-with-cancer-related-pain/</loc><lastmod>2021-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/the-covid-19-pandemic-and-cancer-screening-deficits-in-the-united-states/</loc><lastmod>2021-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/expert-panel-endorsed-quality-measures-for-end-of-life-care-for-children-with-cancer/</loc><lastmod>2021-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/accuracy-of-lung-cancer-risk-model-in-diverse-populations/</loc><lastmod>2021-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-authorizes-pfizer-biontech-covid-19-vaccine-for-emergency-use-in-adolescents/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/surveillance-protocol-and-early-cancer-detection-in-patients-with-constitutional-mismatch-repair-deficiency-syndrome/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/phase-ii-study-of-trilaciclib-in-pretreated-patients-with-metastatic-nsclc-initiated-preserve-4/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/evolution-to-her2-low-breast-cancer-investigating-potential-therapeutics/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-pipeline-priority-reviews-in-kidney-and-endometrial-cancers-cholangiocarcinoma/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/biomarker-analysis-of-the-kaitlin-trial-no-subgroup-benefits-more-from-t-dm1-plus-chemo/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/shorter-duration-of-adjuvant-trastuzumab-in-her2-positive-early-breast-cancer/</loc><lastmod>2021-05-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/first-line-single-agent-carboplatin-vs-carboplatinpaclitaxel-in-older-women-with-ovarian-cancer/</loc><lastmod>2021-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/antiviral-t-cells-for-bk-virus-associated-hemorrhagic-cystitis/</loc><lastmod>2021-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/brentuximab-vedotin-plus-chemotherapy-in-newly-diagnosed-early-stage-unfavorable-risk-hodgkin-lymphoma/</loc><lastmod>2021-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-pipeline-priority-reviews-of-treatments-for-bladder-and-lung-cancers/</loc><lastmod>2021-05-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/ten-year-outcomes-with-neoadjuvant-chemoradiotherapy-plus-surgery-vs-surgery-alone-for-esophageal-cancer/</loc><lastmod>2021-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/variations-in-testing-and-treatment-across-medical-specialties-for-men-initiating-active-surveillance-for-prostate-cancer/</loc><lastmod>2021-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/one-vs-two-doses-of-the-bnt162b2-covid-19-vaccine-in-patients-with-cancer-immunogenicity-and-efficacy/</loc><lastmod>2021-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/risk-of-colorectal-cancer-and-colorectal-polyps-in-first-degree-family-members/</loc><lastmod>2021-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/imaging-study-aims-to-detect-rates-of-cancer-in-medieval-britain/</loc><lastmod>2021-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/hla-mismatched-unrelated-donor-bone-marrow-transplant-with-posttransplant-cyclophosphamide/</loc><lastmod>2021-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/ai-system-may-aid-in-diagnosing-cancer-of-unknown-primary/</loc><lastmod>2021-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/prospective-study-explores-prostate-cancer-and-treatment-outcomes-by-race/</loc><lastmod>2021-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/effect-of-oral-chemotherapy-management-program-on-capecitabine-toxicity/</loc><lastmod>2021-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/relationship-between-germline-brca-pathogenic-variants-and-diminished-ovarian-reserve/</loc><lastmod>2021-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/increased-loneliness-among-patients-with-cancer-during-the-covid-19-pandemic-may-affect-symptom-burden/</loc><lastmod>2021-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/study-explores-racial-disparities-in-renal-cell-carcinoma-by-stage-and-mortality/</loc><lastmod>2021-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/maintenance-rucaparib-in-patients-with-platinum-sensitive-pancreatic-cancer-and-germline-or-somatic-brca1-brca2-or-palb2-variants/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/apalutamide-in-metastatic-castration-sensitive-prostate-cancer-final-overall-survival-analysis-of-the-titan-trial/</loc><lastmod>2021-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/pembrolizumabipilimumab-after-disease-progression-on-pd-1pd-l1-inhibitor-therapy-in-advanced-melanoma/</loc><lastmod>2021-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/addition-of-celecoxib-to-standard-adjuvant-therapy-in-stage-iii-colon-cancer/</loc><lastmod>2021-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/acmg-clinical-practice-resource-provides-new-guidance-for-management-of-individuals-with-palb2-gene-variants/</loc><lastmod>2021-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/long-term-follow-up-of-premenopausal-patients-with-er-positive-breast-cancer-goserelin-and-tamoxifen/</loc><lastmod>2021-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cardiac-safety-efficacy-of-neoadjuvant-pertuzumabtrastuzumab-for-early-stage-her2-positive-breast-cancer/</loc><lastmod>2021-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/effect-of-publication-of-the-lacc-trial-on-use-of-minimally-invasive-surgery-for-cervical-cancer/</loc><lastmod>2021-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/trastuzumab-deruxtecan-nxki-in-her2-positive-metastatic-colorectal-cancer-destiny-crc01/</loc><lastmod>2021-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/disparities-in-enrollment-into-electronic-health-record-patient-portals-for-oncology-patients/</loc><lastmod>2021-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/frail-patients-with-newly-diagnosed-multiple-myeloma-triplet-regimen/</loc><lastmod>2021-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/abemaciclib-associated-adverse-events-safety-analysis-of-monarche/</loc><lastmod>2021-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/mutational-profile-of-acral-nevi-may-differ-from-acral-melanoma/</loc><lastmod>2021-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/pertuzumabhigh-dose-trastuzumab-in-patients-with-her2-positive-metastatic-breast-cancer-and-progressive-brain-metastases/</loc><lastmod>2021-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/axillary-node-pathologic-complete-response-after-systemic-neoadjuvant-therapy-according-to-breast-cancer-subtype/</loc><lastmod>2021-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/uk-collaborative-trial-of-ovarian-cancer-screening/</loc><lastmod>2021-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/tlr4-as-a-possible-therapeutic-target-to-mitigate-cisplatin-induced-hearing-loss/</loc><lastmod>2021-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/report-shows-medicaid-expansion-alone-does-not-resolve-disparities-in-cancer-care/</loc><lastmod>2021-05-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/lenvatinib-for-previously-treated-advanced-pancreatic-and-gastrointestinal-neuroendocrine-tumors/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/atezolizumabcarboplatin-as-immune-induction-in-patients-with-metastatic-invasive-lobular-breast-cancer/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/incidence-of-interstitial-lung-disease-related-to-trastuzumab-deruxtecan-nxki-in-patients-with-her2-positive-metastatic-breast-cancer/</loc><lastmod>2021-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/longitudinal-evaluation-of-functioning-in-children-with-retinoblastoma/</loc><lastmod>2021-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/lifileucel-for-patients-with-previously-treated-metastatic-melanoma/</loc><lastmod>2021-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/loncastuximab-tesirine-lpyl-for-heavily-pretreated-patients-with-relapsed-or-refractory-dlbcl/</loc><lastmod>2021-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/risk-of-second-cancer-by-hormone-receptor-status-among-breast-cancer-survivors/</loc><lastmod>2021-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/income-eligibility-limits-for-medicaid-and-long-term-survival-among-newly-diagnosed-patients-with-cancer/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/does-adjuvant-atezolizumab-extend-disease-free-survival-in-patients-with-resected-early-stage-nsclc/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/increased-psa-screening-linked-to-lower-risk-of-advanced-prostate-cancer-at-diagnosis-and-death-from-the-disease-in-younger-black-patients/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/first-line-nivolumabrelatlimab-vs-nivolumab-alone-for-advanced-melanoma/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/receptor-tyrosine-kinase-inhibitor-lenvatinib-for-anaplastic-thyroid-cancer/</loc><lastmod>2021-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/black-and-white-women-with-nonmetastatic-triple-negative-breast-cancer-differences-in-treatment-and-mortality/</loc><lastmod>2021-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/pembrolizumab-plus-cetuximab-in-recurrent-or-metastatic-head-and-neck-cancer/</loc><lastmod>2021-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/standard-multigene-testing-could-detect-more-hereditary-cancer-syndromes-in-patients-with-colorectal-cancer/</loc><lastmod>2021-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/american-cancer-society-releases-report-on-cancer-prevention-and-screening/</loc><lastmod>2021-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/sacituzumab-govitecan-hziy-for-patients-with-pretreated-metastatic-urothelial-carcinoma/</loc><lastmod>2021-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/uspstf-issues-new-recommendation-statement-on-colorectal-cancer-screening/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/study-investigates-nongenetic-factors-linked-to-development-of-early-onset-colorectal-cancer/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/avapritinib-vs-other-tyrosine-kinase-inhibitors-for-pdgfra-d842v-mutated-gastrointestinal-stromal-tumors/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/ipilimumab-plus-anti-pd-1-therapy-vs-ipilimumab-alone-for-patients-with-advanced-melanoma-resistant-to-anti-pd-1l1-monotherapy/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/reduced-intensity-oxaliplatincapecitabine-for-older-and-frail-patients-with-advanced-gastroesophageal-cancer/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fda-pipeline-applications-accepted-for-marginal-zone-lymphoma-and-lung-cancer/</loc><lastmod>2021-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/inequities-in-breast-cancer-screening-during-the-covid-19-pandemic/</loc><lastmod>2021-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cognitive-performance-at-baseline-and-over-time-in-infants-treated-for-brain-tumors/</loc><lastmod>2021-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/does-long-term-suppression-of-hepatitis-b-in-patients-with-hiv-lower-risk-of-hcc/</loc><lastmod>2021-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/enfortumab-vedotin-ejfv-after-pd-1-or-pd-l1-inhibitor-therapy-for-cisplatin-ineligible-patients-with-advanced-urothelial-carcinoma/</loc><lastmod>2021-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/fluciclovine-f-18-petct-vs-conventional-imaging-alone-in-guiding-postsurgery-salvage-radiotherapy-for-prostate-cancer/</loc><lastmod>2021-05-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/association-of-community-cancer-centers-releases-report-trending-now-in-cancer-care-2020/</loc><lastmod>2021-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/oncology-hospital-at-home-program-reduced-unplanned-health-care-utilization-and-costs/</loc><lastmod>2021-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/perioperative-systemic-therapy-for-patients-with-resectable-colorectal-peritoneal-metastases/</loc><lastmod>2021-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/adjuvant-and-concurrent-temozolomide-in-1p19q-non-co-deleted-anaplastic-glioma-survival-benefit-analysis/</loc><lastmod>2021-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/orient-12-study-addition-of-sintilimab-to-gemcitabineplatinum-in-advanced-squamous-nsclc/</loc><lastmod>2021-05-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/effect-of-lower-endoscopy-on-colorectal-cancer-incidence-and-mortality-in-individuals-older-than-75/</loc><lastmod>2021-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/use-of-systemic-therapy-at-the-end-of-life-in-patients-with-cancer-effect-of-approval-of-immunotherapies/</loc><lastmod>2021-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/cemiplimab-rwlc-for-patients-with-locally-advanced-basal-cell-carcinoma-after-hedgehog-inhibitor-therapy/</loc><lastmod>2021-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/aua-announces-updates-to-clinical-guidance-for-renal-mass-and-localized-renal-cancer/</loc><lastmod>2021-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/neoadjuvant-durvalumab-with-vs-without-stereotactic-body-radiotherapy-in-early-stage-nsclc/</loc><lastmod>2021-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/stereotactic-radiosurgery-for-brainstem-metastases/</loc><lastmod>2021-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/does-the-addition-of-bevacizumab-to-gemcitabinecisplatin-for-metastatic-urothelial-carcinoma-improve-survival/</loc><lastmod>2021-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/three-year-outcomes-after-neoadjuvant-chemotherapy-with-or-without-anthracycline-plus-dual-her2-blockade-in-her2-positive-breast-cancer/</loc><lastmod>2021-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/05-may/school-based-hpv-vaccination-program-reduces-rates-of-hpv-in-gay-and-bisexual-men/</loc><lastmod>2021-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/clear-trial-is-lenvatinib-plus-pembrolizumab-the-best-first-line-immunotherapy-doublet-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cardiovascular-events-with-transdermal-estradiol-vs-lhrh-agonists-for-androgen-suppression-in-advanced-prostate-cancer/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/complete-mesocolic-excision-vs-d2-dissection-in-patients-undergoing-laparoscopic-colectomy-for-right-sided-colon-cancer/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/role-of-antibody-drug-conjugates-across-breast-cancer-subtypes/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/neeraj-agarwal-named-senior-director-of-clinical-research-innovation-by-huntsman-cancer-institute/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cancercare-appoints-mark-d-peters-ii-pharmd-as-vice-president-for-new-business-development-and-outreach/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/brendon-stiles-named-chief-of-thoracic-surgery-and-surgical-oncology-at-montefiore-and-albert-einstein/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/narjust-duma-md-appointed-to-dual-role-at-dana-farber-cancer-institute-harvard-medical-school/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cemiplimab-rwlc-for-locally-advanced-and-metastatic-basal-cell-carcinoma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/transmission-of-cancer-to-infants-from-mothers-with-cervical-cancer-during-vaginal-delivery/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/sitagliptin-added-to-tacrolimussirolimus-prophylaxis-regimen-for-acute-graft-vs-host-disease-after-hsct/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/a-physician-scientist-s-mother-fueled-his-passion-for-biomedical-research/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/ethical-considerations-before-launching-a-clinical-cancer-trial/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/imf-launches-initiative-to-improve-outcomes-in-multiple-myeloma-among-black-americans/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/anti-bcma-directed-car-t-cell-gene-therapy-in-relapsed-or-refractory-myeloma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/umbralisib-for-previously-treated-relapsed-or-refractory-marginal-zone-lymphoma-and-follicular-lymphoma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cancer-care-in-sudan-during-the-covid-19-pandemic/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/incidence-and-cancer-related-mortality-in-belize/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/grateful-to-be-alive/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/how-interested-are-patients-in-integrative-therapies-and-how-much-are-they-willing-to-pay-for-them/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/clinician-recommendations-may-pique-patients-interest-in-complementary-and-integrative-therapies/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/aacr-distinguished-public-service-awards/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/turning-confusion-into-clarity-lessons-learned-from-autism-spectrum-disorder/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/nci-statement-on-ending-structural-racism-in-biomedical-research/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/ama-salutes-end-to-ban-on-transgender-americans-in-the-military/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/aacr-and-the-mark-foundation-for-cancer-research-announce-new-grants/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/increasing-cervical-cancer-prevention-and-care-in-nepal/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/new-asco-guideline-offers-recommendations-for-neoadjuvant-breast-cancer-treatment/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/addressing-oncologist-burnout-emotional-well-being-and-moral-distress-in-the-pandemic/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/improvement-programs-to-optimize-patient-care-for-black-americans-with-breast-cancer/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/first-line-nivolumabipilimumab-plus-chemotherapy-improves-overall-survival-vs-chemotherapy-in-stage-iv-or-recurrent-nsclc/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/nivolumabipilimumab-plus-two-cycles-of-histology-based-chemotherapy-another-option-in-first-line-metastatic-nsclc/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/study-finds-tranexamic-acid-unable-to-prevent-bleeding-in-patients-with-hematologic-malignancies/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-lisa-baumann-kreuziger/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/nccn-2021-virtual-annual-conference/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-aaron-t-gerds/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/manifest-2-cpi-0610-shows-benefit-in-myelofibrosis/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/two-lenvatinib-combinations-improve-progression-free-survival-vs-sunitinib-alone-in-first-line-treatment-of-advanced-renal-cell-carcinoma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/to-advance-health-equity-put-real-world-cancer-data-to-work/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/rara-agonist-plus-azacitidine-shows-encouraging-activity-in-relapsedrefractory-aml/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-jacqueline-s-garcia/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cardiovascular-disease-in-hematologic-malignancies/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-approves-idecabtagene-vicleucel-for-heavily-pretreated-patients-with-multiple-myeloma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-approves-new-indication-for-daunorubicincytarabine-secondary-acute-myeloid-leukemia-in-pediatric-patients/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/sustained-benefit-for-maintenance-olaparib-in-ovarian-cancer/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-deborah-armstrong/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/belzutifan-shows-activity-in-advanced-renal-cell-carcinoma-both-as-a-single-agent-and-in-combination-therapy/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-david-braun/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/olaparib-for-previously-treated-patients-with-pancreatic-cancer-and-ddr-genetic-alterations-other-than-brca-variants/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/novel-her2-targeted-therapies-pose-sequencing-challenges/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-approves-tivozanib-for-relapsed-or-refractory-advanced-renal-cell-carcinoma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-approves-pembrolizumab-combination-for-advanced-esophageal-or-gastroesophageal-junction-carcinoma/</loc><lastmod>2021-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/genitourinary-oncology-highlights-2020-2021-almanac/</loc><lastmod>2021-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/effect-of-salpingo-oophorectomy-on-breast-cancer-risk-in-women-with-brca1-or-brca2-pathogenic-variants/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-approves-lorlatinib-for-metastatic-alk-positive-nsclc/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/meta-analysis-of-hypofractionated-vs-conventionally-fractionated-radiotherapy-for-locally-advanced-bladder-cancer/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cardiovascular-risks-associated-with-checkpoint-inhibitors-and-car-t-cell-therapy/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/younger-vs-older-women-with-breast-cancer-understanding-the-differences/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/how-exceptional-responders-are-providing-clues-to-personalizing-cancer-treatment/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/stand-up-to-cancer-announces-325-million-in-grants-for-headneck-cancer-research/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/first-line-pembrolizumab-shows-activity-in-advanced-clear-cell-and-non-clear-cell-kidney-cancers/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/pembrolizumab-in-first-line-treatment-of-metastatic-clear-cell-and-non-clear-cell-renal-cell-carcinoma/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/new-jersey-oncology-care-providers-form-astera-cancer-care-join-oneoncology/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/william-tseng-md-joins-sarcoma-alliance-board-of-directors/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/clinical-breast-examination-screening-results-in-lower-stage-at-breast-cancer-diagnosis-and-reduced-breast-cancer-mortality-in-india/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/breast-cancer-screening-with-clinical-breast-examination-in-low-and-middle-income-countries/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/an-oncologist-and-his-wife-share-a-personal-cancer-story/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/i-m-living-the-life-i-was-destined-to-have/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/yoga-in-oncologic-care-an-evidence-based-treatment-to-improve-outcomes/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/towering-figure-in-cancer-drug-development-jose-baselga-md-phd-fasco-dies-at-age-61/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/lenvatinibpembrolizumab-improves-survival-in-advanced-endometrial-cancer/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-ursula-matulonis/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/patient-reported-outcomes-with-nivolumab-plus-cabozantinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-xin-gao/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/dana-farber-oncologist-benjamin-ebert-awarded-sjoberg-prize-for-cancer-research/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/association-of-community-cancer-centers-names-new-president/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fox-chase-welcomes-cihangir-duy/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/city-of-hope-announces-new-radiation-oncology-chair/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/ze-ev-ronai-named-director-of-sanford-burnham-prebys-cancer-center/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/novel-decision-making-tool-for-androgen-deprivation-therapy-for-patients-with-prostate-cancer/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-richard-valicenti/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cardiovascular-concerns-with-the-use-of-vegfr-tyrosine-kinase-inhibitors/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/lung-cancers-with-rare-egfr-mutations-being-tackled-by-novel-agents/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/epov-gillianne-lai/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/johan-vansteenkiste-and-fiona-blackhall-honored-for-lung-cancer-research-by-esmo-and-iaslc/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/andrew-ewald-named-director-of-johns-hopkins-medicine-s-department-of-cell-biology/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/leslie-boyd-appointed-director-of-gynecologic-oncology-at-perlmutter-cancer-center/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/jeff-walker-returns-to-roswell-park-in-newly-created-executive-role/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/novel-insights-in-myelodysplastic-syndromes-highlights-from-2020-ash-meeting/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/legislation-aims-to-increase-hpv-vaccine-awareness-access-and-research/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/knuckles/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/executive-order-aims-to-secure-access-to-essential-pharmaceuticals-by-strengthening-supply-chains/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/oncology-clinician-well-being-roadmap-provides-5-year-plan-to-address-provider-burnout/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cancer-and-covid-19-reflections-at-1-year/</loc><lastmod>2021-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/small-study-explores-car-t-cell-therapy-for-relapsed-or-refractory-b-cell-lymphoma/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/unselected-autologous-tumor-infiltrating-lymphocyte-therapy-for-metastatic-cutaneous-melanoma/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/adverse-events-in-patients-with-melanoma-treated-with-ipilimumab-results-of-a-toxicity-monitoring-program/</loc><lastmod>2021-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/discrepancies-in-her2-assessment-for-metastatic-gastric-cancer/</loc><lastmod>2021-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/outcomes-with-ribociclib-across-intrinsic-subtypes-of-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2021-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/tebentafusp-first-treatment-to-improve-overall-survival-in-metastatic-uveal-melanoma/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/youtube-videos-on-bladder-cancer-study-focuses-on-quality-of-content/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/covid-19-pandemic-drove-strategic-new-breast-cancer-approaches-to-avoid-hospitalization/</loc><lastmod>2021-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cryoablation-emerging-as-effective-treatment-for-low-risk-breast-cancers/</loc><lastmod>2021-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/low-risk-breast-cancer-survivors-may-experience-long-term-physical-and-psychological-effects/</loc><lastmod>2021-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/breast-reconstruction-disparities-improved-with-medicaid-expansion/</loc><lastmod>2021-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-odac-votes-in-favor-of-retaining-accelerated-approval-for-bladder-cancer-treatments/</loc><lastmod>2021-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/lobaplatin-vs-cisplatin-based-induction-and-chemoradiotherapy-in-previously-untreated-locoregionally-advanced-nasopharyngeal-carcinoma/</loc><lastmod>2021-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/safety-of-stereotactic-body-radiotherapy-for-treatment-of-patients-with-multiple-metastases/</loc><lastmod>2021-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-odac-votes-in-favor-of-maintaining-accelerated-approval-of-atezolizumabnab-paclitaxel-for-pd-l1-positive-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/sentinel-lymph-node-biopsy-navigated-vs-elective-neck-dissection-for-early-oral-cancer/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/health-related-quality-of-life-with-adjuvant-pembrolizumab-vs-placebo-in-resected-stage-iii-melanoma/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/new-research-finds-few-young-adult-men-have-received-the-hpv-vaccine/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/meta-analysis-of-treatment-modalities-for-locally-advanced-head-and-neck-cancer/</loc><lastmod>2021-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/glofitamab-for-relapsed-or-refractory-b-cell-lymphoma/</loc><lastmod>2021-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-pipeline-bemarituzumab-granted-breakthrough-therapy-designation-for-fgfr2b-overexpressing-her2-negative-gastric-cancer/</loc><lastmod>2021-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/can-brachytherapy-for-cervical-cancer-continue-after-uterine-perforation/</loc><lastmod>2021-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/dangling-accelerated-approvals-of-anti-pd-1pd-l1-antibodies-to-be-discussed-at-fda-oncologic-drugs-advisory-committee-meeting/</loc><lastmod>2021-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/rock2-inhibitor-belumosudil-for-chronic-graft-vs-host-disease/</loc><lastmod>2021-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/pembrolizumab-monotherapy-for-heavily-pretreated-patients-with-metastatic-breast-cancer-and-high-tumor-mutational-burden/</loc><lastmod>2021-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/tisotumab-vedotin-in-recurrent-or-metastatic-cervical-cancer/</loc><lastmod>2021-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/improvement-in-survival-with-adjuvant-pembrolizumab-for-resected-stage-iii-melanoma/</loc><lastmod>2021-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/national-survey-finds-average-risk-individuals-prefer-stool-based-tests-over-colonoscopy-for-colorectal-cancer-screening/</loc><lastmod>2021-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/study-explores-rates-of-germline-mutations-in-patients-with-colorectal-cancer/</loc><lastmod>2021-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-grants-accelerated-approval-to-dostarlimab-gxly-for-dmmr-endometrial-cancer/</loc><lastmod>2021-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/acute-myeloid-leukemia-world-awareness-day-2021-april-21/</loc><lastmod>2021-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/immune-checkpoint-inhibitors-and-cutaneous-toxicity-population-level-analysis/</loc><lastmod>2021-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/effect-of-antihypertensive-medications-on-risk-of-cancer/</loc><lastmod>2021-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/effect-of-genomic-prostate-score-testing-on-choice-of-active-surveillance-in-a-predominantly-black-patient-population/</loc><lastmod>2021-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/long-term-outcomes-with-electron-intraoperative-irradiation-vs-whole-breast-irradiation-for-early-breast-cancer/</loc><lastmod>2021-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/alpelisib-plus-fulvestrant-in-pik3ca-mutant-hr-positive-her2-negative-advanced-breast-cancer-after-disease-progression/</loc><lastmod>2021-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/patients-with-ovarian-cancer-face-an-increased-risk-of-mental-illness/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/liquid-biopsy-plus-mri-for-predicting-response-to-neoadjuvant-chemotherapy-in-patients-with-breast-cancer/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/long-term-follow-up-of-children-and-young-adults-with-b-cell-all-treated-with-cd19-car-t-cell-therapy/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/anesthesiologist-volume-and-adverse-short-term-outcomes-after-complex-surgery-for-gastrointestinal-cancer/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/pediatric-patients-with-high-grade-gliomas-treatment-with-oncolytic-hsv-1-g207-immunovirotherapy/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-pipeline-recent-designations-in-urothelial-cancer-cervical-cancer-cholangiocarcinoma-and-more/</loc><lastmod>2021-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/factors-associated-with-unplanned-hospitalizations-among-older-patients-receiving-chemotherapy/</loc><lastmod>2021-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fertility-concerns-may-influence-decisions-about-endocrine-therapy-in-young-women-with-breast-cancer/</loc><lastmod>2021-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/five-year-efficacy-outcomes-with-pembrolizumab-vs-chemotherapy-in-metastatic-nsclc-with-pd-l1-tps-of-at-least-50/</loc><lastmod>2021-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/more-from-the-fda-odac-votes-on-agents-for-pretreated-hepatocellular-carcinoma-and-gastric-cancer/</loc><lastmod>2021-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/patient-centered-outcomes-in-the-solo-1-trial-of-maintenance-olaparib-for-advanced-ovarian-cancer/</loc><lastmod>2021-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/patients-of-different-races-with-early-onset-colorectal-cancer-exhibit-distinct-genetic-features/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/tipifarnib-for-patients-with-advanced-hras-mutant-head-and-neck-cancer-and-high-variant-allele-frequency/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/locally-advanced-esophageal-cancer-neoadjuvant-chemoradiotherapy-vs-chemotherapy-followed-by-minimally-invasive-esophagectomy/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/expert-panel-issues-recommendations-for-addressing-inequities-in-cancer-care/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/patients-with-nsclc-and-driver-mutations-may-be-more-likely-to-present-with-brain-metastasis-at-diagnosis/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/improving-survival-for-patients-with-stage-ii-pancreatic-cancer-chemotherapy-followed-by-resection/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/adjuvant-trastuzumab-with-or-without-chemotherapy-in-older-patients-with-her2-positive-breast-cancer-hrqol/</loc><lastmod>2021-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/addition-of-pegaspargase-intensification-to-standard-low-intensity-chemotherapy-backbone-in-pediatric-low-risk-b-all/</loc><lastmod>2021-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/detection-of-emphysema-among-patients-with-or-without-prior-copd-diagnosis-undergoing-low-dose-ct-screening-for-lung-cancer/</loc><lastmod>2021-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/astro-survey-explores-effect-of-the-covid-19-pandemic-on-radiation-oncology/</loc><lastmod>2021-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/role-of-whole-genome-sequencing-in-identifying-patients-with-mgus-at-risk-of-progression-to-multiple-myeloma/</loc><lastmod>2021-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/medicaid-expansion-is-associated-with-earlier-diagnosis-of-gastric-cancer-improved-survival/</loc><lastmod>2021-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/low-dose-tamoxifen-for-reduction-of-mammographic-density-in-women-undergoing-breast-cancer-screening/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/effect-of-gamification-with-social-incentives-on-increased-mobility-after-hospital-discharge/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/mutations-in-ctcs-may-predict-clinical-outcomes-in-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/president-biden-issues-proclamation-on-national-cancer-control-month-2021/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/meta-analysis-finds-liver-tumors-may-be-resistant-to-immunotherapy-in-patients-with-underlying-nonalcoholic-steatohepatitis/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/risk-of-venous-and-arterial-thromboembolism-in-patients-with-cancer-receiving-immune-checkpoint-inhibitors/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/impact-of-covid-19-pandemic-on-delivery-of-breast-cancer-care-in-new-york/</loc><lastmod>2021-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/diet-and-exercise-intervention-may-increase-efficacy-of-chemotherapy-in-pediatric-patients-with-leukemia/</loc><lastmod>2021-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/inpatient-radiation-oncology-consult-model-for-metastatic-cancer-to-reduce-hospital-length-of-stay/</loc><lastmod>2021-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/end-of-life-care-remains-aggressive-for-patients-with-ovarian-cancer/</loc><lastmod>2021-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/oral-azacitidine-in-lower-risk-myelodysplastic-syndromes/</loc><lastmod>2021-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/risk-of-leukemia-in-pediatric-patients-with-down-syndrome/</loc><lastmod>2021-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/chronic-immune-related-adverse-events-associated-with-adjuvant-immunotherapy-for-advanced-melanoma/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/palbociclib-for-residual-invasive-hr-positive-her2-negative-early-breast-cancer-after-neoadjuvant-chemotherapy/</loc><lastmod>2021-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/germline-brca12-and-other-predisposition-genes-in-patients-with-metastatic-breast-cancer-prevalence-and-association-with-prognosis/</loc><lastmod>2021-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/gene-sequencing-esophageal-brushings-may-identify-patients-with-barrett-s-esophagus-at-risk-for-cancer-progression/</loc><lastmod>2021-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/screening-and-education-in-melanoma-prone-families-may-improve-early-detection-of-disease/</loc><lastmod>2021-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/image-guided-percutaneous-thermal-ablation-for-advanced-gynecologic-cancers/</loc><lastmod>2021-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/is-tumor-mutational-burden-alone-sufficient-to-predict-response-to-immunotherapy/</loc><lastmod>2021-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/adult-survivors-of-aya-cancers-may-be-more-likely-to-experience-medical-financial-hardship/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/fda-approves-nivolumab-in-combination-with-chemotherapy-for-metastatic-gastric-cancer-and-esophageal-adenocarcinoma/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/recent-studies-explore-efficacy-of-covid-19-vaccination-in-patients-with-leukemia-and-myeloma/</loc><lastmod>2021-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/overweight-breast-cancer-survivors-may-be-at-increased-risk-of-developing-a-secondary-malignancy/</loc><lastmod>2021-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/addition-of-avelumab-to-chemoradiotherapy-in-previously-untreated-patients-with-locally-advanced-head-and-neck-cancer/</loc><lastmod>2021-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/pediatric-adrenocortical-carcinoma-different-treatment-strategies-by-disease-stage/</loc><lastmod>2021-04-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/new-study-finds-baseline-brain-imaging-should-be-considered-for-patients-with-metastatic-rcc/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/certain-genetic-mutations-may-increase-risk-of-death-from-infection-in-patients-with-cll/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/updated-outcomes-for-patients-with-metastatic-nonseminomatous-germ-cell-tumors-and-development-of-new-prognostic-model/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/patient-knowledge-and-expectations-regarding-genomic-testing-results/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/outcomes-with-mri-based-image-guided-adaptive-brachytherapy-for-locally-advanced-cervical-cancer/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/first-line-pembrolizumab-vs-chemotherapy-for-msi-h-or-dmmr-metastatic-colorectal-cancer-health-related-quality-of-life/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/study-evaluates-method-to-reduce-medication-errors-and-side-effects-of-newer-oral-anticancer-drugs/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/first-line-tislelizumab-plus-chemotherapy-vs-chemotherapy-alone-in-advanced-squamous-nsclc/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/short-term-safety-of-the-bnt162b2-mrna-covid-19-vaccine-in-patients-receiving-immunotherapy/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/genome-wide-association-study-of-variants-linked-to-cervical-preinvasive-and-invasive-disease/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/integration-of-brentuximab-vedotin-into-front-line-treatment-for-pediatric-patients-with-high-risk-hodgkin-lymphoma/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/addition-of-alpelisib-to-fulvestrant-for-pik3ca-mutant-hr-positive-her2-negative-advanced-breast-cancer-patient-reported-outcomes/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/copanlisib-rituximab-extends-progression-free-survival-vs-rituximab-placebo-in-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/neoadjuvant-nivolumab-plus-chemotherapy-boosts-pathologic-complete-response-rate-for-patients-with-resectable-nsclc/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/tumor-mutational-burden-as-predictor-of-immune-response-variance-between-female-and-male-patients-with-melanoma/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/cancer-aneuploidy-may-predict-response-to-immunotherapy-in-patients-with-nsclc/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/estimated-shifts-in-cancer-incidence-and-death-over-next-2-decades/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/04-april/adjuvant-nivolumab-for-resected-esophageal-or-gastroesophageal-junction-cancer-after-neoadjuvant-chemoradiotherapy/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-rutika-mehta/</loc><lastmod>2021-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/targeting-fgfr2b-with-bemarituzumab-plus-chemotherapy-in-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2021-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-elizabeth-smyth/</loc><lastmod>2021-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/nivolumab-plus-chemotherapy-new-standard-of-care-in-advanced-gastric-cancer/</loc><lastmod>2021-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/an-integrated-framework-for-improving-outcomes-in-pancreatic-cancer/</loc><lastmod>2021-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-maintenance-therapies-in-metastatic-pancreatic-cancer-aim-to-end-perpetual-chemotherapy/</loc><lastmod>2021-03-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-marcus-noel-and-susan-tsai/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/swog-s1505-trial-evaluates-neoadjuvant-regimens-in-pancreatic-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/cholangiocarcinoma-often-misdiagnosed-always-impactful/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/novel-ck2-inhibitor-silmitasertib-shows-promise-in-cholangiocarcinoma/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/in-cholangiocarcinoma-does-chemotherapy-response-vary-according-to-fgfr2-status/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-rachna-shroff-and-gentry-king/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fgfr2-inhibitor-infigratinib-active-in-chemotherapy-refractory-cholangiocarcinoma/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-rachna-shroff/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/claridhy-trial-idh1-inhibitor-ivosidenib-improves-survival-in-cholangiocarcinoma/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/imbrave150-a-new-standard-of-care-to-treat-hepatocellular-cancers/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/atezolizumab-plus-bevacizumab-improves-survival-in-unresectable-hepatocellular-carcinoma/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/solving-the-mystery-of-why-colorectal-cancer-is-on-the-rise-in-young-adults/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/novel-therapies-and-new-indications-for-use-in-the-treatment-of-gastrointestinal-cancers/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/molecular-testing-in-metastatic-colorectal-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-christopher-leigh-hallemeier/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/two-studies-validate-neoadjuvant-chemotherapy-with-short-course-radiotherapy-or-long-term-chemoradiotherapy-in-locally-advanced-rectal-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-autumn-mcree/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fam-trastuzumab-deruxtecan-nxki-shows-benefit-in-refractory-colorectal-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-michael-overman/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/keynote-177-new-analysis-confirms-benefit-of-pembrolizumab-vs-chemotherapy-in-microsatellite-instability-high-advanced-colorectal-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/treating-colorectal-cancer-in-the-time-of-covid-19/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/gastrointestinal-oncology-highlights-2020-2021-almanac/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-joshi-j-alumkal/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/adding-apalutamide-to-abirateroneprednisone-extends-radiographic-progression-free-but-not-overall-survival/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-stephanie-berg-1/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/swog-1500-cabozantinib-extends-progression-free-survival-vs-sunitinib-in-metastatic-papillary-renal-cell-carcinoma/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-richard-k-valicenti/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/association-of-braf-v600-mutant-ctdna-with-outcomes-in-patients-with-advanced-melanoma-receiving-dabrafenib-or-dabrafenibtrametinib/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/updated-recommendations-on-the-treatment-of-multiple-myeloma-related-bone-disease-from-the-bone-working-group-of-the-international-myeloma-working-group/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-approves-cemiplimab-rwlc-for-patients-with-nsclc-and-high-pd-l1-expression/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/mri-targeted-biopsy-vs-systematic-transrectal-ultrasonography-biopsy-for-detection-of-disease-in-men-at-risk-for-prostate-cancer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-grants-accelerated-approval-to-melphalan-flufenamide-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-reports-little-benefit-to-adding-pembrolizumab-to-neoadjuvant-therapy-for-locally-advanced-rectal-cancer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-john-c-krauss/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-grants-accelerated-approval-to-axicabtagene-ciloleucel-for-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/uspstf-issues-final-recommendation-statement-on-screening-for-lung-cancer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/overcoming-gender-disparity-in-evaluating-sexual-health-following-a-cancer-diagnosis/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/international-perspectives-on-integrative-medicine-for-cancer-prevention-and-management/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/older-breast-cancer-survivors-may-consider-discontinuing-screening-mammography-in-the-setting-of-limited-life-expectancy/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/expect-questions-from-older-breast-cancer-survivors-about-discontinuing-routine-surveillance-mammography/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/cancer-cell-therapy-pioneer-carl-june-md-named-2021-dan-david-prize-laureate/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/physician-patient-relationship-sacred-and-sacrosanct/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/lenvatinibpembrolizumab-combination-improves-outcomes-vs-sunitinib-in-renal-cell-carcinoma/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-stephanie-berg/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/no-benefit-found-for-everolimus-plus-adjuvant-hormone-therapy-in-high-risk-early-stage-breast-cancer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/repurposing-available-drugs-for-covid-19/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/roswell-park-bristol-myers-squibb-foundation-team-up-to-fight-cancer-in-native-and-rural-communities/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/hematologic-cancers-increase-risk-of-covid-19-related-death-vs-solid-tumors/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-joseph-alvarnas/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/evidence-based-strategy-for-improving-access-to-colorectal-cancer-screening-for-diverse-populations/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-ana-maria-lopez/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/itaca-trial-no-survival-benefit-for-tailoring-adjuvant-chemotherapy-in-nsclc/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-tetsuya-mitsudomi/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/brian-druker-shows-no-signs-of-slowing-down/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/nivolumab-plus-cabozantinib-as-first-line-treatment-of-advanced-renal-cell-carcinoma/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/winthrop-p-rockefeller-cancer-institute-appoints-new-deputy-director/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/patrick-delaney-named-new-executive-director-of-nccn-foundation/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/gynecologic-oncology-leader-named-at-new-jersey-s-only-nci-designated-comprehensive-cancer-center/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/next-up-in-nsclc-antibody-drug-conjugates/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-ignatius-ou/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/sachin-apte-joins-huntsman-cancer-institute-as-chief-clinical-officer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/sara-schottenstein-foundation-dedicated-to-gastric-cancer-announces-launch/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/sgo-and-fwc-issue-joint-statement-on-the-elimination-of-hpv/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/prevent-cancer-foundation-awards-nine-new-research-grants/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/lydia-pace-a-primary-care-physician-on-the-front-lines-of-oncology-both-nationally-and-globally/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/american-cancer-society-announces-new-diversity-in-cancer-research-program/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/female-breast-cancer-surpasses-lung-cancer-as-the-most-commonly-diagnosed-cancer-worldwide/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/challenges-in-managing-hodgkin-lymphoma-focus-on-use-of-brentuximab-vedotin/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/cancer-control-in-egypt/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/asco-publishes-guideline-endorsement-of-astro-guideline-for-radiation-therapy-in-sclc/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/leading-health-and-cancer-advocacy-groups-unite-to-reduce-racial-disparities-in-cancer-care/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/health-care-policy-expert-sybil-r-green-jd-rph-mha-brings-wealth-of-experience-as-asco-s-first-diversity-and-inclusion-officer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/us-population-based-study-of-prevalence-of-and-risk-associated-with-breast-cancer-predisposition-genes/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/oncology-clinician-well-being-roadmap-provides-5-year-plan-to-address-provider-burnout/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/breast-cancer-susceptibility-genes-putting-the-pieces-together/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/actions-early-in-biden-administration-mirror-asco-road-to-recovery-report/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/eleven-oncology-practices-receive-quality-certification-from-the-association-for-clinical-oncology/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/hans-clevers-recognized-with-2021-pezcoller-foundation-aacr-international-award/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/ravi-bellamkonda-named-provost-of-emory-university/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/memorial-sloan-kettering-establishes-tow-center-for-developmental-oncology/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/astro-recommendation-on-covid-19-vaccination-for-patients-receiving-radiation-therapy/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/i-want-to-live-long-and-i-want-to-live-well/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-peter-schmid/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/comparing-radiotherapy-regimens-for-biochemically-recurrent-prostate-cancer-after-radical-prostatectomy/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-oliver-sartor/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/lupsma-outperforms-cabazitaxel-for-metastatic-castration-resistant-prostate-cancer-in-phase-ii-trial/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-arlene-o-siefker-radtke/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/ev-301-and-ev-201-trials-enfortumab-vedotin-ejfv-improves-survival-in-metastatic-urothelial-cancer/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-sumanta-pal/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/nivolumab-first-adjuvant-immunotherapy-to-show-survival-benefit-in-high-risk-muscle-invasive-urothelial-cancer/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/asco-s-road-to-recovery-report-outlines-lessons-learned-from-the-covid-19-pandemic-to-improve-oncology-care/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/updates-from-selected-clinical-trials-in-breast-cancer/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-analysis-confirms-benefit-of-pembrolizumab-vs-chemotherapy-in-microsatellite-instability-high-advanced-colorectal-ca/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-michael-overman-1/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/the-impact-of-a-pandemic-on-mentorship-in-medicine/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/changes-in-radiotherapy-use-in-england-during-the-first-peak-of-the-covid-19-pandemic/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/development-and-performance-of-a-population-based-benchmark-model-for-use-of-cancer-surgery-in-high-income-countries/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-approves-cemiplimab-rwlc-for-locally-advanced-and-metastatic-basal-cell-carcinoma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/mfolfirinox-or-gemcitabinenab-paclitaxel-for-resectable-pancreatic-cancer/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/breast-cancer-specific-mortality-by-raceethnicity-and-21-gene-recurrence-scores/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/arthur-w-nienhuis-dies-at-79/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-grants-accelerated-approval-to-umbralisib-for-the-treatment-of-marginal-zone-lymphoma-and-follicular-lymphoma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-approves-lisocabtagene-maraleucel-for-patients-with-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-approves-trilaciclib-to-reduce-chemotherapy-induced-bone-marrow-suppression-in-adults-being-treated-for-sclc/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/prognostic-tool-rsclin-introduced-for-early-breast-cancer/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-meredith-regan-and-sara-hurvitz/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/novel-therapies-under-study-in-chronic-myeloid-leukemia/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/continued-survival-benefit-with-durvalumab-plus-chemotherapy-vs-chemotherapy-alone-in-extensive-stage-sclc/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/the-emerging-role-of-exercise-in-cancer-prevention-and-treatment/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/memorial-sloan-kettering-announces-newly-endowed-chair-and-fellowships-for-health-equity-and-diversity/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/outcomes-with-internal-mammary-and-medial-supraclavicular-nodal-irradiation-in-stage-i-to-iii-breast-cancer/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/tepotinib-for-metastatic-nsclc-with-met-exon-14-skipping-alterations/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/crizotinib-for-children-and-young-adults-with-relapsed-or-refractory-systemic-alk-positive-anaplastic-large-cell-lymphoma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/studies-provide-guidance-on-the-use-of-blinatumomab-in-pediatric-acute-lymphoblastic-leukemia/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-frank-keller-and-e-anders-kolb/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/moise-danielpour-md-named-editor-in-chief-of-pediatric-neurosurgery/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/kratom/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/once-weekly-selinexor-plus-bortezomibdexamethasone-vs-twice-weekly-bortezomibdexamethasone-in-multiple-myeloma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/confirm-trial-reports-improvement-in-survival-with-nivolumab-in-relapsed-malignant-mesothelioma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-rina-hui-and-melina-marmarelis/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fallout-from-covid-19-decline-in-cancer-screening-and-increase-in-cancer-related-deaths/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-ana-maria-lopez-1/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-finds-more-than-half-of-cancer-survivors-have-underlying-medical-conditions-associated-with-developing-severe-covid-19/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/oncologist-survey-identifies-knowledge-gaps-in-cholangiocarcinoma-mutations/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/in-cholangiocarcinoma-does-chemotherapy-response-vary-according-to-fgfr2-status-1/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/belantamab-mafodotin-blmf-plus-pomalidomide-and-dexamethasone-elicits-responses-in-myeloma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/caroline-dive-honored-with-mary-j-matthews-pathologytranslational-research-award/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/neoadjuvant-atezolizumab-in-lung-cancer-lcmc3-trial-meets-primary-endpoint/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/epov-roy-herbst-and-shinichi-toyooka/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/yale-school-of-medicine-announces-new-section-chief-of-breast-surgery/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/asco-and-friends-of-cancer-research-recommend-expanding-patient-access-to-cancer-clinical-trials-by-further-broadening-eligibility-criteria/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-research-statement-recommends-streamlining-and-standardizing-clinical-trial-site-feasibility-assessments/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/asco-guideline-update-offers-four-standards-of-care-for-noncastrate-advanced-recurrent-or-metastatic-prostate-cancer/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/anti-cd20-monoclonal-antibodies-and-risk-of-severe-covid-19-infection-and-death-in-patients-with-lymphoma/</loc><lastmod>2021-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/pyrotinibcapecitabine-vs-lapatinibcapecitabine-in-her2-positive-metastatic-breast-cancer-previously-treated-with-trastuzumab/</loc><lastmod>2021-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/first-line-cemiplimab-rwlc-vs-platinum-doublet-chemotherapy-in-advanced-nsclc-with-pd-l1-expression-50/</loc><lastmod>2021-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/enfortumab-vedotin-ejfv-in-previously-treated-advanced-urothelial-carcinoma/</loc><lastmod>2021-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-issues-emergency-use-authorization-for-third-covid-19-vaccine/</loc><lastmod>2021-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/swog-1500-cabozantinib-crizotinib-or-savolitinib-vs-sunitinib-in-metastatic-papillary-renal-cell-carcinoma/</loc><lastmod>2021-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/pembrolizumabs-indication-in-small-cell-lung-cancer-is-withdrawn/</loc><lastmod>2021-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/uc-davis-comprehensive-cancer-center-elected-as-nccn-member-institution/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-grants-two-new-breakthrough-device-designations-for-molecular-residual-disease-test/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/pembrolizumab-vs-brentuximab-vedotin-in-relapsed-or-refractory-classical-hodgkin-lymphoma/</loc><lastmod>2021-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/does-adding-adjuvant-concurrent-trastuzumab-to-radiotherapy-after-lumpectomy-for-her2-positive-dcis-reduce-ipsilateral-recurrence/</loc><lastmod>2021-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/studies-presented-at-sgo-examine-racial-health-care-disparities-in-patients-with-gynecologic-cancers/</loc><lastmod>2021-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/analysis-identifies-frequency-of-pi3k-pathway-alterations-in-patients-with-nsclc/</loc><lastmod>2021-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/lymph-node-collection-kit-may-help-improve-outcomes-after-lung-cancer-surgery/</loc><lastmod>2021-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/distant-metastasis-free-survival-with-adjuvant-vs-no-adjuvant-chemotherapy-according-to-genomic-and-clinical-risk-in-early-breast-cancer/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/risk-of-artery-dissection-or-aneurysm-with-use-of-antiangiogenic-drugs/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/despite-access-to-clinical-trials-patients-from-socioeconomically-disadvantaged-areas-have-worse-cancer-outcomes/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/adjuvant-nivolumab-in-resected-esophageal-or-gastroesophageal-junction-cancer-following-neoadjuvant-chemoradiation-therapy/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/incidence-of-brain-metastases-in-patients-diagnosed-with-stage-iv-nsclc-during-the-covid-19-pandemic/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/does-consumption-of-ultra-processed-food-and-drink-increase-colorectal-cancer-risk/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/electroacupuncture-and-auricular-acupuncture-vs-usual-care-for-chronic-musculoskeletal-pain-in-cancer-survivors/</loc><lastmod>2021-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/factors-associated-with-severity-of-covid-19-infection-in-patients-with-cancer-data-from-ccc19/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/some-patients-with-lung-cancer-report-feeling-uninformed-about-their-disease-uninvolved-with-their-treatment/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/definitive-ablative-radiation-therapy-in-inoperable-locally-advanced-pancreatic-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/inclusion-of-surveillance-ejection-fraction-in-predicting-risk-of-10-year-left-ventricular-systolic-dysfunction-in-survivors-of-childhood-cancer/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/adagrasib-for-patients-with-advanced-kras-g12c-mutated-nsclc/</loc><lastmod>2021-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/wee1-inhibition-in-patients-with-recurrent-uterine-serous-carcinoma/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/time-to-treatment-initiation-for-breast-cancer-during-the-covid-19-pandemic-single-institution-study/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-establishes-global-burden-of-gallbladder-and-biliary-tract-cancer/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/rates-of-seroconversion-among-patients-with-cancer-infected-with-covid-19/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/surgical-management-of-melanoma-with-the-advent-of-adjuvant-systemic-therapy/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/discontinuation-of-development-of-oral-taxane-tesetaxel-announced/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/outcomes-of-complex-gastrointestinal-cancer-surgeries-at-ranked-vs-nonranked-hospitals/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/lowering-kras-activity-may-lead-to-improved-therapy-response-in-pancreatic-cancer/</loc><lastmod>2021-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-study-finds-muscle-mass-and-density-are-correlated-with-survival-and-outcomes-in-patients-with-advanced-cancer/</loc><lastmod>2021-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/effect-of-risk-adapted-therapy-on-long-term-morbidity-in-pediatric-patients-with-hodgkin-lymphoma/</loc><lastmod>2021-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/analysis-from-the-international-germ-cell-cancer-collaborative-group-update-consortium/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/identification-of-genomic-subgroups-of-patients-with-myelodysplastic-syndromes-new-prognostic-modeling/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/adjuvant-atezolizumab-in-muscle-invasive-urothelial-carcinoma-imvigor010/</loc><lastmod>2021-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/image-guided-intensity-modulated-radiotherapy-in-patients-with-cervical-cancer/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-oncologic-drugs-advisory-committee-to-review-status-of-six-indications-granted-accelerated-approval/</loc><lastmod>2021-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-finds-regularly-drinking-sugar-sweetened-soda-may-increase-total-and-breast-cancer-mortality/</loc><lastmod>2021-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/high-vs-standard-dose-thoracic-radiotherapy-for-limited-stage-small-cell-lung-cancer/</loc><lastmod>2021-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/value-of-global-scale-up-of-cancer-care-investment-in-treatment-imaging-and-quality-of-care/</loc><lastmod>2021-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/checkmate-9er-first-line-nivolumab-plus-cabozantinib-vs-sunitinib-for-advanced-renal-cell-carcinoma/</loc><lastmod>2021-03-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/hormonal-iud-may-be-a-potential-nonsurgical-treatment-for-early-endometrial-cancer-or-precancer/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/patient-refusal-of-provider-recommended-locoregional-treatment-for-prostate-cancer-sociodemographic-factors/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/first-line-tpex-vs-extreme-regimen-for-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/older-patients-with-multiple-myeloma-may-be-able-to-avoid-long-term-steroid-use/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/niraparib-plus-bevacizumab-shows-clinical-benefit-in-patients-with-advanced-ovarian-cancer/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/kras-mutation-status-may-predict-outcomes-after-hepatic-arterial-infusion-pump-therapy-for-unresectable-colorectal-liver-metastases/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/olaparib-shows-efficacy-in-ovarian-cancer-regardless-of-number-of-prior-lines-of-chemotherapy-brca-mutation-status/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/recent-chemotherapy-or-immunotherapy-for-gynecologic-cancer-does-not-raise-risk-of-death-due-to-covid-19/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/frailty-may-impact-surgical-outcomes-in-patients-with-ovarian-cancer/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/phase-iii-ariel4-trial-confirms-benefit-of-rucaparib-in-brca-mutated-relapsed-ovarian-cancer/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/benefit-of-niraparib-maintenance-therapy-extends-beyond-first-disease-progression-in-recurrent-ovarian-cancer/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/maintenance-olaparib-yields-strong-and-sustained-benefit-in-ovarian-cancer/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/association-of-cardiovascular-risk-factors-with-risk-of-subsequent-cancer/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/utilization-and-survival-benefit-of-adjuvant-immunotherapy-for-resected-high-risk-stage-ii-melanoma/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/predicting-survival-in-patients-with-extremity-and-trunk-sarcomas-in-the-united-states/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/dcis-biologic-risk-signature-may-predict-risk-of-recurrence-and-radiation-benefit-after-breast-conserving-surgery/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/pembrolizumablenvatinib-may-improve-survival-in-advanced-endometrial-cancer/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/survey-reveals-workplace-bullying-gender-discrimination-and-microaggressions-not-uncommon-for-women-gynecologic-oncologists/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/circulating-hybrid-cells-may-help-to-monitor-treatment-response-in-patients-with-rectal-and-esophageal-cancers/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/improving-the-prognostic-accuracy-of-residual-cancer-burden-after-neoadjuvant-chemotherapy-for-breast-cancer/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-approves-therasphere-y-90-glass-microspheres-for-unresectable-hepatocellular-carcinoma/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/immunotherapy-doublet-as-maintenance-therapy-for-extensive-disease-small-cell-lung-cancer/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/hybrid-minimally-invasive-vs-open-esophagectomy-for-esophageal-cancer-5-year-outcomes/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/noncovalent-btk-inhibitor-pirtobrutinib-in-relapsed-or-refractory-b-cell-malignancies/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/updated-evidence-report-and-systematic-review-of-low-dose-ct-screening-for-lung-cancer/</loc><lastmod>2021-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/can-treatment-for-prostate-cancer-affect-smell-and-taste/</loc><lastmod>2021-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/using-ct-colonography-as-a-noninvasive-colorectal-cancer-screening-test-for-advanced-neoplasia/</loc><lastmod>2021-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-pipeline-priority-review-for-kidney-cancer-treatment-fast-track-designation-for-nsclc-treatment/</loc><lastmod>2021-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/use-of-chemotherapy-and-risk-of-alzheimer-s-disease-in-colorectal-cancer-survivors/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/umbralisib-for-relapsed-or-refractory-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/persistent-use-of-low-value-breast-cancer-surgeries-designated-for-deimplementation-by-choosing-wisely/</loc><lastmod>2021-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/is-hpv-vaccination-for-adults-aged-26-and-older-cost-effective/</loc><lastmod>2021-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-identifies-factors-that-may-lower-the-risk-of-cns-relapse-in-pediatric-patients-with-all/</loc><lastmod>2021-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/high-tumor-mutational-burden-predicts-immunotherapy-response-in-some-but-not-all-cancers/</loc><lastmod>2021-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/pembrolizumab-vs-chemotherapy-in-previously-treated-patients-with-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/whole-genome-sequencing-vs-cytogenetic-analysis-in-myeloid-cancers/</loc><lastmod>2021-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/immunotherapy-for-advanced-kidney-cancer-effect-of-body-mass-index/</loc><lastmod>2021-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/meta-analysis-of-intermediate-clinical-endpoints-as-surrogates-for-overall-survival-in-localized-prostate-cancer/</loc><lastmod>2021-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/why-might-night-shift-workers-have-a-higher-risk-of-developing-cancer/</loc><lastmod>2021-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-survey-reveals-hesitancy-around-covid-19-vaccination-among-patients-with-hematologic-malignancies-and-survivors/</loc><lastmod>2021-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/secondary-cytoreduction-plus-chemotherapy-vs-chemotherapy-alone-in-relapsed-platinum-sensitive-epithelial-ovarian-cancer/</loc><lastmod>2021-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/robust-trial-addition-of-lenalidomide-to-r-chop-in-previously-untreated-abc-type-dlbcl/</loc><lastmod>2021-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/updated-analysis-of-outcomes-with-entrectinib-for-advanced-ros1-fusion-positive-nsclc/</loc><lastmod>2021-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-global-breast-cancer-initiative-highlights-renewed-commitment-to-improve-survival/</loc><lastmod>2021-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/updated-destiny-breast01-results-show-trastuzumab-deruxtecan-nxki-delivers-durable-responses/</loc><lastmod>2021-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/responses-to-conjugate-pneumococcal-vaccine-in-patients-with-chronic-lymphocytic-leukemia/</loc><lastmod>2021-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/assays-show-utility-in-predicting-pathologic-complete-response-rate-in-pre-and-postmenopausal-patients-with-breast-cancer/</loc><lastmod>2021-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/weight-gain-in-childhood-brain-tumor-survivors-and-potential-association-with-hypothalamic-pituitary-dysfunction/</loc><lastmod>2021-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/childhood-cancer-survivors-and-health-care-providers-satisfied-with-video-visits-during-the-covid-19-pandemic/</loc><lastmod>2021-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/machine-learning-algorithm-is-successful-in-predicting-malignancy-in-patients-with-multiple-pulmonary-nodules/</loc><lastmod>2021-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/eprenetapopt-plus-azacitidine-in-tp53-mutated-mds-and-aml/</loc><lastmod>2021-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/new-whoiaea-publication-provides-guidance-on-radiotherapy-equipment-procurement/</loc><lastmod>2021-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/atezolizumab-s-indication-in-previously-treated-metastatic-bladder-cancer-is-withdrawn/</loc><lastmod>2021-03-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/nomograms-to-predict-local-regional-and-distant-recurrence-in-patients-with-thin-melanomas/</loc><lastmod>2021-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/adherence-to-adjuvant-hormonal-therapy-among-commercially-insured-women-with-breast-cancer/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-finds-cancer-survivors-with-poor-ambulatory-function-may-be-at-an-increased-risk-of-death/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/role-of-collagen-in-pancreatic-cancer-development/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/idecabtagene-vicleucel-for-heavily-pretreated-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/increase-in-diagnosis-of-node-positive-and-stage-iii-breast-cancer-after-screening-interruption-due-to-the-covid-19-pandemic/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/fda-pipeline-designations-in-ovarian-head-and-neck-and-thyroid-cancers/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/un-human-rights-experts-comment-on-environmental-racism-in-louisiana-s-cancer-alley/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/mental-health-service-use-among-testicular-cancer-survivors/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/long-term-follow-up-of-adjuvant-imatinib-for-localized-gastrointestinal-stromal-tumors/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/effect-of-clinical-breast-examination-screening-on-stage-at-diagnosis-and-breast-cancer-mortality/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-identifies-mechanisms-tied-to-immunotherapy-resistance-among-patients-with-melanoma/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-examines-response-to-neoadjuvant-chemotherapy-in-hispanic-and-black-patients/</loc><lastmod>2021-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-examines-extrapleural-pneumonectomy-after-imrt-for-malignant-pleural-mesothelioma/</loc><lastmod>2021-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/five-year-outcomes-with-tisagenlecleucel-in-patients-with-relapsed-or-refractory-b-cell-lymphomas/</loc><lastmod>2021-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/bipolar-androgen-therapy-vs-enzalutamide-in-asymptomatic-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/study-finds-missing-annual-mammogram-increases-risk-of-death-from-breast-cancer/</loc><lastmod>2021-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/recent-study-examines-potential-new-therapies-assessment-of-biomarkers-in-endometrial-cancer/</loc><lastmod>2021-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/03-march/preclinical-research-shows-activity-of-fidaxomicin-combination-therapy-in-mll-aml/</loc><lastmod>2021-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/hyperthermic-intraperitoneal-chemotherapy-plus-cytoreductive-surgery-for-colorectal-cancer-metastases-does-not-improve-overall-survival/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-grants-accelerated-approval-to-tepotinib-for-patients-with-metastatic-nsclc-and-met-exon-14-skipping-alterations/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-wee1-inhibitor-adavosertib-to-gemcitabine-in-platinum-resistantrefractory-recurrent-ovarian-cancer/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/phase-ii-codebreak-100-validates-benefit-of-kras-inhibitor-sotorasib-in-advanced-lung-cancer/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-pasi-a-jaenne-and-charu-aggarwal/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/updated-findings-bolster-the-use-of-checkpoint-inhibitors-in-treatment-of-liver-cancer/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/how-the-covid-19-pandemic-can-help-improve-cancer-research/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/b-cell-and-t-cell-non-hodgkin-lymphomas/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fgfr2-inhibitor-infigratinib-active-in-chemotherapy-refractory-cholangiocarcinoma/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-rachna-t-shroff-and-gentry-king/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/novel-approaches-in-chronic-lymphocytic-leukemia/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/genome-edited-donor-derived-anti-cd19-car-t-cell-therapy-is-active-in-b-cell-acute-lymphoblastic-leukemia/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/covid-19-and-cancer-a-toxic-combination/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/the-carg-bc-score-novel-tool-for-predicting-chemotherapy-toxicity-in-early-stage-breast-cancer/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/oncology-community-mourns-the-death-of-chemotherapy-pioneer-emil-j-freireich/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/conversations-with-the-pioneers-of-oncology-emil-j-freireich-md-fasco/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/joseph-simone-visionary-pediatric-oncologist-and-quintessential-mentor-dies-at-85/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/gert-brieger-historian-of-medicine-and-public-health-dies-at-89/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/john-bartlett-pioneer-in-infectious-diseases-research-and-treatment-dies-at-83/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/professor-gordon-mcvie-international-cancer-researcher-and-patient-advocate-dies-at-76/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/no-improvement-with-addition-of-ipilimumab-to-pembrolizumab-in-nsclc/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/ongoing-surveillance-and-efforts-to-reduce-smoking-and-obesity-needed-to-lower-cancer-survivors-risks-of-new-cancers/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/when-to-start-a-conversation-with-patients-about-subsequent-primary-cancers/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-yun-fan-and-deborah-doroshow/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/iaslc-honors-pan-chyr-yang-md-phd-for-contributions-to-lung-cancer-prevention/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/crystal-denlinger-named-chief-scientific-officer-for-nccn/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/paul-a-bunn-jr-scientific-award-presented-to-joan-h-schiller-md-fasco/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/i-let-science-not-emotion-dictate-my-treatment/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/simplify-trials-jak-inhibitor-yields-long-term-survival-benefit-and-transfusion-independence-in-myelofibrosis/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-lucia-masarova/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-kenya/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/brief-highlights-from-ash-2020/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/new-framework-to-address-cancer-care-disparities-in-medically-underserved-populations/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/standardized-streamlined-processes-key-to-implementing-electronic-prior-authorization/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/medicare-physician-fee-schedule-conversion-factor-updated-to-reflect-2021-federal-funding-package/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/biden-administration-new-congress-review-recent-rules-affecting-cancer-care-delivery/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-adjuvant-palbociclib-to-ongoing-endocrine-therapy-in-hr-positive-her2-negative-early-breast-cancer-pallas-trial/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/variation-in-active-surveillance-for-low-risk-prostate-cancer-in-the-united-states/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/ruxolitinib-improves-outcomes-in-steroid-refractory-or-steroid-dependent-graft-vs-host-disease/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/transplant-may-improve-survival-in-older-patients-with-high-risk-myelodysplastic-syndrome/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/dreamm-2-analysis-number-of-prior-treatments-no-hindrance-to-efficacy-of-belantamab-mafodotin-blmf/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/ash-recognizes-choosing-wisely-champions/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/belantamab-mafodotin-blmf-plus-pomalidomide-and-dexamethasone-elicits-responses-in-myeloma/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-ajay-nooka/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/new-targets-explored-for-bispecific-t-cell-engaging-antibodies-in-myeloma/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-sagar-lonial/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/subcutaneous-daratumumab-meets-primary-endpoint-in-apollo-trial-in-myeloma/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/treatment-with-loxo-305-results-in-durable-efficacy-in-heavily-pretreated-patients-with-cllsll/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/novel-therapies-and-new-indications-for-use-in-treatment-of-hematologic-malignancies/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-marco-ruella/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/overcoming-cd58-loss-may-be-promising-path-to-overcoming-resistance-to-car-t-cell-therapies/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-james-essell/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/zuma-5-axicabtagene-ciloleucel-elicits-response-in-indolent-non-hodgkin-lymphoma/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/chemotherapy-plus-blinatumomab-for-philadelphia-chromosome-negative-b-cell-all/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/study-finds-survival-disparities-and-mutational-differences-for-black-patients-younger-than-60-with-aml/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-david-snyder/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/study-finds-asciminib-safer-more-effective-than-bosutinib-in-chronic-phase-cml/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/ash-2020-meeting-highlights/</loc><lastmod>2021-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/improvement-in-patient-reported-outcomes-after-stopping-tyrosine-kinase-inhibitor-therapy-for-chronic-myeloid-leukemia/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/the-lustgarten-foundation-and-aacr-honor-two-american-icons-by-establishing-new-career-development-awards/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/miami-cancer-institute-appoints-new-deputy-director-chief-scientific-officer-and-chief-of-solid-tumor-medical-oncology/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/looking-back-on-the-40-year-career-of-richard-l-schilsky-md-facp-fsct-fasco/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/enrollment-up-at-us-medical-schools/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/capivasertib-for-akt1-e17k-mutated-metastatic-cancers-nci-match-subprotocol-eay131-y/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/stereotactic-ablative-body-radiotherapy-in-extracranial-oligometastatic-cancers/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-sitagliptin-to-prophylaxis-for-acute-graft-vs-host-disease/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/vanderbilt-university-medical-center-appoints-interim-director-of-the-division-of-hematology-and-oncology/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/tuya-pal-md-named-to-cancer-research-national-leadership-posts/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/i-credit-cancer-research-with-saving-my-life/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/claridhy-trial-idh1-inhibitor-ivosidenib-benefits-survival-in-cholangiocarcinoma/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-rachna-shroff/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/predicting-postoperative-recurrence-in-stage-i-to-iii-colorectal-cancer-with-circulating-tumor-dna/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-michael-overman/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/anti-pd-1-antibody-dostarlimab-active-in-mismatch-repair-deficient-gastrointestinal-tumors/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-john-krauss/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/zuma-5-axicabtagene-ciloleucel-elicits-response-in-indolent-non-hodgkin-lymphoma-1/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-james-essell-1/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/can-a-high-carbohydrate-diet-increase-the-risk-for-breast-cancer/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-neil-iyengar/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/study-examines-pregnancy-outcomes-in-breast-cancer-survivors/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/allogeneic-stem-cell-transplant-improves-survival-in-peripheral-t-cell-lymphoma/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-deepa-jagadeesh/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/phase-ii-primo-dose-optimization-trial-of-duvelisib-in-peripheral-t-cell-lymphoma/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-deepa-jagadeesh-1/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/covid-virus-specific-t-cells-potential-treatment-of-severe-covid-19-infection-under-study/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/novel-insights-into-multiple-myeloma/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/is-trop-2-expression-associated-with-benefit-from-sacituzumab-govitecan/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-william-gradishar/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/meditation-and-education-interventions-may-improve-depressive-symptoms-in-young-breast-cancer-survivors/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-shoshana-rosenberg/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/patients-with-chronic-graft-vs-host-disease-face-lifelong-complications/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/high-risk-cutaneous-squamous-cell-carcinomas-the-present-and-future/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/chinese-society-of-clinical-oncology-and-asco-approve-first-joint-guideline-for-treatment-of-stage-ii-to-iva-nasopharyngeal-carcinoma/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/asco-congratulates-joseph-r-biden-jr-on-presidential-inauguration/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/asco-advocates-for-priority-status-for-patients-with-cancer-in-covid-19-vaccine-distribution-plans/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/severity-of-patients-symptoms-may-be-underrecognized-during-and-after-breast-radiotherapy/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-virginia-kaklamani/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/early-research-explores-relationship-between-cd58-loss-and-resistance-to-car-t-cell-therapies/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-marco-ruella-1/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/janet-woodcock-md-named-acting-fda-commissioner/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/murano-trial-venetoclax-plus-rituximab-achieves-durable-progression-free-survival-in-resistant-cll/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-jacob-soumerai/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/nccn-shares-new-recommendations-for-vaccinating-patients-with-cancer-against-covid-19/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/understanding-patients-needs-and-preferences-cancer-care-stakeholders-explore-barriers-and-best-practices/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/first-line-lorlatinib-improves-progression-free-survival-vs-crizotinib-in-advanced-alk-positive-nsclc/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-previously-treated-patients-with-her2-positive-gastric-cancers/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-grants-accelerated-approval-to-daratumumab-plus-hyaluronidase-fihj-for-newly-diagnosed-light-chain-amyloidosis/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/sean-khozin-named-new-chief-executive-officer-of-cancerlinq/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-approves-nivolumab-plus-cabozantinib-for-advanced-renal-cell-carcinoma/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/asco-statement-on-2021-annual-meeting/</loc><lastmod>2021-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/have-breast-cancer-mortality-rates-stopped-declining-for-younger-women/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-primary-tumor-resection-to-chemotherapy-for-asymptomatic-primary-colorectal-cancer-tumors-and-synchronous-unresectable-metastases/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-ipilimumab-to-pembrolizumab-in-previously-untreated-patients-with-metastatic-nsclc-and-high-pd-l1-expression/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/keynote-427-first-line-pembrolizumab-in-advanced-clear-cell-renal-cell-carcinoma/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/lupsma-vs-cabazitaxel-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/effect-of-organ-function-based-eligibility-criteria-on-clinical-trial-enrollment-for-patients-with-dlbcl/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/prevalence-of-cisplatin-related-hearing-loss-in-pediatric-adolescent-and-young-adult-patients/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/joint-ascoacs-can-letter-states-must-include-patients-with-cancer-on-their-covid-19-vaccine-priority-lists/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-adjuvant-pertuzumab-to-chemotherapy-plus-trastuzumab-in-early-her2-positive-breast-cancer/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/comparison-of-imaging-regimens-for-stage-i-seminoma-after-orchiectomy/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-pipeline-priority-reviews-in-kras-g12c-mutated-nsclc-non-muscle-invasive-bladder-cancer/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/reduced-dose-intensity-modulated-radiation-therapy-for-hpv-associated-oropharyngeal-carcinoma/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/mapkerk-inhibitor-mirdametinib-in-adolescents-and-adult-patients-with-nf1-related-plexiform-neurofibromas/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/pet-guided-omission-of-consolidation-radiotherapy-in-early-stage-unfavorable-hodgkin-lymphoma/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/trends-in-germline-genetic-testing-in-women-diagnosed-with-breast-or-ovarian-cancer/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-andecaliximab-to-mfolfox6-in-first-line-treatment-of-her2-negative-advanced-gastric-cancer/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/chemotherapy-induced-dormancy-in-aml-allows-cancer-cell-survival-may-contribute-to-relapse/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/can-weight-loss-during-treatment-and-follow-up-affect-breast-cancer-outcomes/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/bevacizumab-beyond-disease-progression-plus-carboplatin-based-doublet-in-platinum-sensitive-ovarian-cancer/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/two-adaura-analyses-support-the-use-of-osimertinib-in-patients-with-surgically-resected-nsclc/</loc><lastmod>2021-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/taiwanese-talent-study-supports-effectiveness-of-low-dose-ct-for-lung-cancer-in-certain-populations/</loc><lastmod>2021-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/long-term-quality-of-life-with-ultrahypofractionated-vs-conventionally-fractionated-radiotherapy-for-prostate-cancer/</loc><lastmod>2021-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/emil-j-freireich-md-dies-at-93/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/adolescent-and-young-adult-cancer-survivors-are-at-increased-risk-for-adverse-mental-health-outcomes/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/lcmc3-trial-neoadjuvant-atezolizumab-for-patients-with-stage-ib-to-iiib-resectable-lung-cancer/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/nivolumab-monotherapy-improves-survival-in-patients-with-relapsed-malignant-mesothelioma/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/wclc-press-briefing-focuses-on-the-connection-between-lung-cancer-and-covid-19/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/asco-names-advance-of-the-year-molecular-profiling-drives-progress-in-gastrointestinal-cancers-1/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/new-burkitt-lymphoma-international-prognostic-index/</loc><lastmod>2021-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/protein-truncating-and-rare-missense-variants-in-breast-cancer-risk-genes/</loc><lastmod>2021-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/margetuximab-vs-trastuzumab-in-heavily-pretreated-patients-with-her2-positive-breast-cancer-sophia-trial/</loc><lastmod>2021-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/familiarity-with-complementary-and-integrative-therapies-among-patients-with-cancer-and-caregivers/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/first-in-class-eprenetapopt-plus-azacitidine-for-tp53-mutant-myelodysplastic-syndromes/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/outcomes-and-patterns-of-relapse-in-pediatric-medulloblastoma/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/phase-ii-codebreak-100-validates-early-benefit-for-kras-inhibitor-in-nsclc/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/ipilimumab-adds-no-benefit-to-pembrolizumab-as-first-line-therapy-for-nsclc-with-high-pd-l1-expression/</loc><lastmod>2021-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/featured-presentations-at-wclc-focus-on-disparities-in-patients-with-lung-cancer/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/lenalidomide-plus-subcutaneous-rituximab-minichop-in-patients-aged-80-or-older-with-dlbcl/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/increase-in-metastatic-prostate-cancer-diagnoses-in-the-united-states-after-reduction-in-psa-screening/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/checkmate-274-adjuvant-nivolumab-may-improve-disease-free-survival-in-patients-with-muscle-invasive-urothelial-carcinoma/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-lenalidomide-to-r-chop-in-newly-diagnosed-patients-with-dlbcl/</loc><lastmod>2021-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/one-third-of-cancer-survivors-reported-worry-about-health-care-disruptions-early-in-the-covid-19-pandemic/</loc><lastmod>2021-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/bone-metastatic-burden-and-survival-outcomes-with-prostate-radiotherapy-for-newly-diagnosed-metastatic-disease/</loc><lastmod>2021-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/responses-to-anti-pd-1pd-l1-immunotherapy-in-patients-with-mss-solid-tumors-and-high-tumor-mutational-burden/</loc><lastmod>2021-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/united-states-surpasses-500-000-deaths-due-to-covid-19/</loc><lastmod>2021-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/addition-of-second-line-pegilodecakin-to-folfox-in-metastatic-pancreatic-cancer-sequoia-trial/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/new-recommendations-aim-to-eliminate-racial-disparities-in-multiple-myeloma-therapies-and-trials/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/neostar-neoadjuvant-nivolumab-or-nivolumabipilimumab-in-operable-nsclc/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/telephone-supported-depression-self-care-intervention-for-cancer-survivors/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/new-report-reviews-methods-for-reducing-waste-improving-efficiency-with-expensive-injectable-medications/</loc><lastmod>2021-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/lupsma-leads-to-improved-psa-response-fewer-severe-adverse-events-than-cabazitaxel-in-patients-with-metastatic-prostate-cancer/</loc><lastmod>2021-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/endoscopic-nasopharyngectomy-vs-imrt-for-previously-treated-resectable-locally-recurrent-nasopharyngeal-carcinoma/</loc><lastmod>2021-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/keynote-427-first-line-pembrolizumab-in-advanced-non-clear-cell-renal-cell-carcinoma/</loc><lastmod>2021-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/delay-in-time-between-abnormal-at-home-screening-and-colonoscopy-may-increase-colorectal-cancer-risk/</loc><lastmod>2021-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/mental-health-related-symptoms-among-cancer-survivors-during-the-first-wave-of-the-covid-19-pandemic-in-the-us/</loc><lastmod>2021-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/role-of-twitter-in-identifying-barriers-to-care-among-patients-with-metastatic-breast-cancer/</loc><lastmod>2021-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/five-year-outcomes-from-the-checkmate-017-and-057-trials-of-nivolumab-vs-docetaxel-in-previously-treated-patients-with-nsclc/</loc><lastmod>2021-02-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/hero-together-opportunity-for-health-care-workers-to-share-their-experience-with-covid-19-vaccination/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/patient-reported-outcomes-from-the-crown-trial-first-line-lorlatinib-vs-crizotinib-for-alk-positive-nsclc/</loc><lastmod>2021-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/germline-whole-exome-sequencing-reveals-the-potential-role-of-hereditary-predisposition-and-therapeutic-implications-in-sclc/</loc><lastmod>2021-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/impact-of-covid-19-on-cancer-care-has-been-profound-according-to-who/</loc><lastmod>2021-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/study-finds-more-than-half-of-us-cancer-survivors-have-underlying-medical-conditions-associated-with-severe-covid-19-illness/</loc><lastmod>2021-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/socially-distant-drive-by-flufit-clinics-may-increase-colorectal-cancer-screening-rates-among-black-patients-during-the-covid-19-pandemic/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/patients-on-active-chemotherapy-may-not-be-at-increased-risk-for-covid-19-infection/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/patients-with-lymphoma-receiving-b-cell-depleting-therapies-may-be-at-greater-risk-for-persistent-covid-19-infection/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/hic-assays-may-aid-in-predicting-response-to-immunotherapy-among-patients-with-nsclc/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/study-shows-aspirin-use-before-diagnosis-may-lower-colorectal-cancer-mortality/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-update-advisory-committee-meeting-to-discuss-covid-19-vaccine-candidate-statement-on-product-development-to-address-virus-variants/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/nivolumabipilimumab-vs-chemotherapy-as-first-line-treatment-for-unresectable-malignant-pleural-mesothelioma-checkmate-743-trial/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/sitagliptin-added-to-tacrolimussirolimus-prophylaxis-regimen-for-acute-graft-vs-host-disease-after-hsct/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/jak-inhibitor-yields-long-term-survival-benefit-and-transfusion-independence-in-myelofibrosis/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/epov-lucia-masarova-1/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/study-links-exposure-to-nighttime-artificial-lights-with-possible-elevated-risk-of-thyroid-cancer/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/nivolumab-plus-cabozantinib-shows-sustained-benefits-as-first-line-treatment-for-advanced-rcc/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/achievement-and-maintenance-of-mrd-negativity-with-daratumumab-containing-regimens-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/implications-of-delaying-surgery-for-renal-cell-carcinoma-during-the-covid-19-pandemic/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/ash-2021-guidelines-for-prevention-and-treatment-of-venous-thromboembolism-in-patients-with-cancer/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fda-pipeline-breakthrough-designations-in-cml-and-for-cachexia-eua-for-covid-19/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/update-from-acis-trial-of-apalutamide-plus-abirateroneprednisone-in-metastatic-prostate-cancer/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/enfortumab-vedotin-ejfv-prolongs-survival-in-patients-with-metastatic-urothelial-carcinoma/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/genetic-mutations-linked-to-worse-b-cell-all-outcomes-in-pediatric-hispanic-and-latino-patients/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/fecal-microbiota-transplants-may-help-patients-with-advanced-melanoma-respond-to-immunotherapy/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/optimal-radiotherapy-dose-for-follicular-and-marginal-zone-lymphoma/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/dose-intensified-radiotherapy-not-superior-to-conventional-regimen-for-biochemically-recurrent-prostate-cancer-after-radical-prostatectomy/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/elacestrant-for-heavily-pretreated-patients-with-er-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/lenvatinib-combination-regimens-vs-sunitinib-in-renal-cell-carcinoma-phase-iii-clear-trial/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/02-february/new-report-says-cancer-and-its-therapies-may-impair-survivors-ability-to-work/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-approves-first-oral-hormone-therapy-for-treating-advanced-prostate-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-approves-selinexor-for-refractory-or-relapsed-multiple-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-approves-margetuximab-cmkb-plus-chemotherapy-for-previously-treated-patients-with-metastatic-her2-positive-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/radiation-facility-volume-and-overall-survival-in-patients-with-node-positive-prostate-cancer-treated-with-external-beam-radiation-therapy-and-adt/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/cost-effectiveness-of-neoadjuvantadjuvant-treatment-strategies-for-her2-positive-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/interference-of-clonal-hematopoiesis-in-dna-repair-genes-with-prostate-cancer-plasma-cell-free-dna-testing/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/community-oncology-alliance-elects-new-president-officers-and-board-members/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/allogeneic-hematopoietic-cell-transplantation-in-acute-leukemias-and-myelodysplastic-syndromes/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/asco-statement-on-cancer-statistics-2021/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/empowering-the-fda-to-require-dose-optimization-of-all-new-oncology-drugs/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/belantamab-mafodotin-blmf-in-multiple-myeloma-number-of-prior-treatments-no-hindrance-to-efficacy/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/genesiscare-announces-new-global-chief-medical-officer-and-winship-cancer-institute-names-interim-executive-director/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/margetuximab-cmkb-for-previously-treated-metastatic-her2-positive-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/chronic-graft-vs-host-disease-future-directions-in-treatment/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/selinexor-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/dr-eric-p-winer-elected-asco-president-for-2022-2023-term/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/conquer-cancer-announces-2020-career-development-award-in-breast-cancer-recipient/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/asco-applauds-congress-for-expanding-clinical-trial-access-for-medicaid-beneficiaries/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/continuing-education-credits-for-gastrointestinal-cancers-symposium/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/clinician-scientist-hopes-to-attract-new-investigators-in-gynecologic-cancer-by-establishing-conquer-cancer-award/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/gastrointestinal-oncologist-laura-goff-md-sees-potential-in-emerging-immunotherapies-and-novel-targeted-agents/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/cancer-on-the-global-stage-incidence-and-cancer-related-mortality-in-burkina-faso/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/relugolix-for-advanced-prostate-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/unexpected-survival-benefit-reported-with-trilaciclib-in-metastatic-triple-negative-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-cristina-saura-manich/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/asco-s-new-chief-medical-officer-plans-to-tackle-the-global-burden-of-cancer-and-disparities-in-access-to-care/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/oral-taxanes-moving-forward-in-metastatic-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-william-gradishar/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/anastrozole-vs-tamoxifen-to-prevent-dcis-recurrence-key-difference-may-be-side-effect-profile/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/keynote-355-pembrolizumab-plus-chemotherapy-improves-progression-free-survival-in-pd-l1-enriched-advanced-triple-negative-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-hatem-soliman/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-yuan-yuan-and-elizabeth-mittendorf/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/adding-entinostat-to-exemestane-fails-to-overcome-aromatase-inhibitor-resistance-in-advanced-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-yuan-yuan/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/ipatasertib-plus-paclitaxel-falters-in-advanced-triple-negative-breast-cancer-phase-iii-trial/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-yuan-yuan-1/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/long-term-follow-up-of-ifm-2009-confirms-benefit-of-front-line-transplant-in-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/city-of-hope-announces-its-first-chief-diversity-equity-and-inclusion-officer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-suzanne-lentzsch/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/ama-underscores-need-for-coordinated-comprehensive-pandemic-response/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/oral-azacitidine-is-noninferior-to-placebo-for-health-related-quality-of-life-in-aml/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/venetoclax-added-to-bortezomib-plus-dexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-marlise-luskin/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/ama-statement-on-the-nominations-of-xavier-becerra-jd-as-hhs-secretary-and-vivek-murthy-md-as-us-surgeon-general/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/innovation-discovery-grants-awarded-to-mass-general-brigham-for-scientific-advancements-in-2020/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/novel-anti-bcma-car-t-cell-therapies-show-activity-in-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/researchers-use-artificial-intelligence-in-oral-cancers-with-33-million-nih-grant/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-sagar-lonial-and-adam-cohen/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/association-of-community-cancer-centers-announces-new-senior-director/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/osimertinib-in-adjuvant-therapy-for-nsclc-with-egfr-mutations/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/indian-surgical-oncologist-offers-insights-into-delivering-equitable-cancer-care-in-a-resource-challenged-country/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/research-leader-named-to-rutgers-cancer-institute-to-build-world-class-cancer-immunology-and-immunotherapy-programs/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/erratum/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/a-tale-of-two-cdk46-inhibitors-in-early-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-c-kent-osborne-and-ruth-m-o-regan/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/winners-of-40-under-40-in-cancer-awards-announced/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/high-recurrence-free-survival-rates-in-rectal-cancer-after-clinical-complete-response-to-neoadjuvant-chemoradiotherapy/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/duration-of-adjuvant-chemotherapy-assessed-in-stage-iii-colon-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/chemotherapy-added-to-local-therapy-improves-overall-survival-in-older-women-with-triple-negative-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/aaas-announces-leading-scientists-elected-as-2020-fellows/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/significant-survival-benefit-from-chemotherapy-for-older-women-with-triple-negative-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/expect-questions-about-adjuvant-chemotherapy-for-older-women/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/huntsman-cancer-institute-appoints-cancer-center-research-program-leaders/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/cdc-awards-huntsman-cancer-institute-3-million-to-improve-colorectal-cancer-screening/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/kenneth-kim-to-lead-cedars-sinai-women-s-cancer-program/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/mayo-clinic-care-network-expands-to-include-minnesota-oncology/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/sarah-cannon-names-melissa-johnson-program-director-of-lung-cancer-research/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/finding-hope-with-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-nccn-resource-offers-practical-suggestions-for-cancer-survivors/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/it-all-began-with-a-lump-in-the-throat/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/subcutaneous-daratumumab-meets-primary-endpoint-in-apollo-trial-in-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-sagar-lonial/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/subcutaneous-fixed-dose-vs-intravenous-pertuzumabtrastuzumab-for-her2-positive-early-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/nivolumab-indication-in-small-cell-lung-cancer-withdrawn-in-us-market/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/record-drop-in-cancer-mortality-for-second-straight-year-due-to-improved-lung-cancer-treatment-reported-in-cancer-statistics-2021/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/nih-radx-rad-grants-support-investigation-of-novel-covid-19-testing-and-surveillance-approaches/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/neoadjuvant-chemotherapy-and-overall-survival-in-metastatic-endometrial-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/coa-submits-letter-to-governors-public-health-officials-to-request-independent-oncology-practices-be-given-priority-approval-to-administer-covid-19-vaccines/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-targets-explored-for-bispecific-t-cell-engaging-antibodies-in-myeloma/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-ajay-nooka/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-approves-crizotinib-for-children-and-young-adults-with-relapsed-or-refractory-systemic-alk-positive-alcl/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/can-postoperative-whole-breast-irradiation-be-safely-omitted-in-older-women-with-low-risk-breast-cancer/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/epov-alphonse-taghian/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/covid-19-and-integrative-oncology-meeting-the-global-challenges-of-health-equity/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-approves-rituximab-arrx-a-biosimilar-to-rituximab/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/evolving-landscape-of-first-line-therapy-for-metastatic-renal-cell-carcinoma/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/italian-study-of-electronic-medical-record-assisted-telephone-follow-up-of-breast-cancer-survivors-during-the-covid-19-pandemic/</loc><lastmod>2021-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/study-finds-artificial-intelligence-may-help-to-identify-new-risk-factors-for-early-onset-colorectal-cancer/</loc><lastmod>2021-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-pipeline-two-fast-track-designations-for-cavrotolimod-in-nonmelanoma-skin-cancers/</loc><lastmod>2021-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-study-examines-patterns-of-opioid-use-among-patients-with-metastatic-breast-cancer/</loc><lastmod>2021-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/rates-of-eligible-people-missing-timely-cancer-screenings-a-canadian-analysis/</loc><lastmod>2021-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/adding-oxaliplatin-to-fluoropyrimidine-for-patients-with-stage-iii-colon-cancer-and-microsatellite-instability/</loc><lastmod>2021-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/single-institution-study-examines-safety-of-routine-thoracic-surgery-examinations-during-the-covid-19-pandemic/</loc><lastmod>2021-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/addition-of-abatacept-to-acute-graft-vs-host-disease-prophylaxis/</loc><lastmod>2021-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-surveillance-mammography-screening-guidelines-issued-for-breast-cancer-survivors-aged-75-and-older/</loc><lastmod>2021-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/shorter-radiation-course-for-men-with-advanced-prostate-cancer/</loc><lastmod>2021-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/addition-of-intraprostatic-focal-boost-to-external-beam-radiotherapy-in-localized-prostate-cancer/</loc><lastmod>2021-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/state-of-tobacco-control-2021-report-says-ending-tobacco-use-is-critical-especially-during-the-covid-19-pandemic/</loc><lastmod>2021-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/variation-in-postoperative-mortality-and-complications-after-cancer-surgery-between-high-vs-low-and-middle-income-countries/</loc><lastmod>2021-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/estimated-global-demand-for-cancer-surgery-and-its-associated-workforce-over-the-next-2-decades/</loc><lastmod>2021-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/early-integration-of-nutritional-and-psychological-interventions-for-previously-untreated-patients-with-metastatic-esophagogastric-cancer/</loc><lastmod>2021-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-pipeline-priority-reviews-for-immunotherapies-in-gastric-cancers-anal-cancer/</loc><lastmod>2021-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-clinical-calculator-may-predict-recurrence-risk-after-curative-colectomy-for-colon-cancer/</loc><lastmod>2021-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/adjuvant-doublet-chemotherapy-for-high-risk-stage-ii-colorectal-cancer-3-or-6-month-duration/</loc><lastmod>2021-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/checkmate-9la-trial-first-line-nivolumabipilimumab-plus-chemotherapy-vs-chemotherapy-alone-in-stage-iv-or-recurrent-nsclc/</loc><lastmod>2021-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/world-cancer-day-2021-to-focus-on-adaptations-and-innovations-in-cancer-care-through-covid-19-and-beyond/</loc><lastmod>2021-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/prevalence-of-and-risk-associated-with-breast-cancer-predisposition-genes/</loc><lastmod>2021-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/emergency-department-use-and-unplanned-hospitalization-among-patients-with-head-and-neck-cancer/</loc><lastmod>2021-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/study-identifies-four-unique-subtypes-of-small-cell-lung-cancer/</loc><lastmod>2021-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/patients-in-cancer-remission-also-at-higher-risk-for-severe-covid-19-illness/</loc><lastmod>2021-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/small-study-finds-personalized-neoantigen-vaccines-may-result-in-durable-immune-response-for-patients-with-melanoma/</loc><lastmod>2021-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/addition-of-vemurafenib-to-irinotecancetuximab-in-previously-treated-patients-with-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2021-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/first-line-nivolumabipilimumab-in-metastatic-uveal-melanoma/</loc><lastmod>2021-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/impower133-update-atezolizumab-plus-carboplatinetoposide-for-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2021-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/risk-of-atrial-fibrillation-and-associated-outcomes-after-allogeneic-hematopoietic-stem-cell-transplantation/</loc><lastmod>2021-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-study-finds-suspicious-lesions-on-breast-mri-in-neoadjuvant-setting-are-unlikely-to-be-malignant/</loc><lastmod>2021-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/nccn-shares-new-recommendations-for-vaccinating-patients-with-cancer-against-covid-19/</loc><lastmod>2021-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/preemptive-tocilizumab-for-cytokine-release-syndrome-in-pediatric-patients-with-b-cell-all-receiving-car-t-cell-therapy/</loc><lastmod>2021-01-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/are-some-oral-pathogens-more-common-in-patients-with-esophageal-cancer/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/janet-woodcock-md-named-acting-fda-commissioner/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/prevalence-of-kras-g12c-somatic-mutations-by-cancer-type-race-and-sex/</loc><lastmod>2021-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/reduced-frequency-of-vincristinedexamethasone-pulses-in-maintenance-therapy-for-pediatric-patients-with-average-risk-b-cell-all/</loc><lastmod>2021-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/cancer-related-suicide-has-declined-in-the-united-states-over-the-past-2-decades/</loc><lastmod>2021-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/single-institution-study-finds-decrease-in-cancer-screenings-diagnoses-during-the-first-wave-of-the-covid-19-pandemic/</loc><lastmod>2021-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/anti-pd-1-therapy-dostarlimab-for-dmmr-gastrointestinal-cancers/</loc><lastmod>2021-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/novel-risk-tool-for-predicting-severe-toxicity-in-older-patients-receiving-chemotherapy-for-early-stage-breast-cancer/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/lenalidomide-plus-epoetin-alfa-vs-lenalidomide-alone-in-refractory-non-del-5q-mds/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/risk-categories-for-pediatric-patients-with-medulloblastoma/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-report-shows-alcohol-consumption-is-linked-to-cancer-incidence-and-mortality-in-all-50-states/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/dense-breast-notification-legislation-recorded-effects-and-future-recommendations/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/patients-with-recurrent-glioblastoma-and-a-very-low-mutation-burden-may-respond-best-to-immunotherapy/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/electronic-patient-self-reporting-of-adverse-events-during-cancer-chemotherapy-erapid-system/</loc><lastmod>2020-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/addition-of-sitagliptin-to-tacrolimussirolimus-prophylaxis-for-acute-graft-vs-host-disease/</loc><lastmod>2021-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/does-cabozantinib-reduce-tumor-volume-and-pain-in-patients-with-nf1/</loc><lastmod>2021-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/performing-mammograms-for-targeted-hospitalized-patients/</loc><lastmod>2021-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/bemarituzumab-plus-chemotherapy-improves-outcomes-in-advanced-gastricgastroesophageal-junction-cancer/</loc><lastmod>2021-01-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/maintenance-oral-azacitidine-for-patients-with-aml-in-first-remission/</loc><lastmod>2021-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/association-between-toxoplasma-gondii-infection-and-risk-of-glioma/</loc><lastmod>2021-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-study-investigates-role-of-ultraviolet-radiation-in-conjunctival-melanoma/</loc><lastmod>2021-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/idh-inhibitor-ivosidenib-improves-overall-survival-in-previously-treated-patients-with-cholangiocarcinoma/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/postsurgical-disease-recurrence-in-stage-i-iii-colorectal-cancer-may-be-predicted-by-ctdna/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/length-of-hospital-stay-with-laparoscopic-vs-open-gastrectomy-for-gastric-cancer/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/effect-of-covid-19-infection-on-cancer-management/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/transmission-of-maternal-cancer-in-two-infants-from-mothers-with-cervical-cancer-during-delivery/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-issues-alert-regarding-sars-cov-2-viral-mutation-to-health-care-providers-and-clinical-laboratory-staff/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/comprehensive-multiomic-resource-for-hpv-negative-head-and-neck-cancers/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/can-use-of-opioids-contribute-to-pancreatic-cancer-risk/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/intensified-reduced-intensity-conditioning-for-allogeneic-stem-cell-transplantation-in-aml-or-mds/</loc><lastmod>2021-01-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/total-neoadjuvant-therapy-vs-standard-therapy-for-locally-advanced-rectal-cancer/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/invasive-diagnostic-procedure-complication-rates-after-lung-cancer-screening/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/immune-response-to-covid-19-reduced-in-patients-with-hematologic-malignancies-vs-solid-tumors/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/does-following-a-mediterranean-diet-reduce-the-risk-of-disease-progression-in-men-on-active-surveillance-for-prostate-cancer/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-pipeline-two-reviews-in-nsclc-plus-prescribing-information-update-for-darolutamide/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/analysis-of-cardiac-data-among-patients-treated-with-osimertinib/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/new-study-explores-the-use-of-focused-ultradeep-dna-sequencing-to-quantify-skin-cancer-risk/</loc><lastmod>2021-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/total-body-irradiationetoposide-vs-chemotherapy-conditioning-before-stem-cell-transplant-for-pediatric-patients-with-all/</loc><lastmod>2021-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/does-anticancer-therapy-impact-unplanned-hospital-care-in-patients-with-nsclc/</loc><lastmod>2021-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/facebook-posts-and-the-spread-of-incorrect-information-about-perceived-risks-of-hpv-vaccination/</loc><lastmod>2021-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/distinct-t-cell-signature-in-black-patients-with-breast-cancer-may-contribute-to-more-aggressive-disease/</loc><lastmod>2020-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/three-vs-four-courses-of-chemotherapy-in-younger-patients-with-acute-myeloid-leukemia/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/multiancestry-meta-analysis-of-prostate-cancer-genetics/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/study-focuses-on-single-cell-analysis-of-peritoneal-carcinomatosis/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/outcomes-after-neoadjuvant-carboplatinpaclitaxel-in-women-with-ovarian-cancer-and-planned-delayed-surgery/</loc><lastmod>2021-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/adjuvant-gefitinib-vs-vinorelbinecisplatin-in-stage-ii-iiia-egfr-mutant-nsclc/</loc><lastmod>2021-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/addition-of-gemcitabine-to-pazopanib-for-refractory-soft-tissue-sarcoma/</loc><lastmod>2021-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/study-finds-inflammation-due-to-androgen-deprivation-therapy-may-contribute-to-fatigue-other-side-effects-in-men-with-prostate-cancer/</loc><lastmod>2021-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/do-adult-onset-cancer-survivors-have-a-higher-risk-of-developing-a-subsequent-malignancy/</loc><lastmod>2021-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/surgical-intervention-may-offer-survival-advantage-for-certain-patients-with-metastatic-breast-cancer/</loc><lastmod>2021-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/fda-statement-on-following-the-authorized-dosing-schedules-for-covid-19-vaccines/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/use-of-a-novel-car-t-cell-therapy-in-pediatric-and-adult-patients-with-advanced-b-cell-all/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/sars-cov-2-infection-among-patients-in-italy-undergoing-active-cancer-treatment/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/feasibility-study-of-radical-cystectomy-vs-intravesical-bcg-for-high-grade-non-muscle-invasive-bladder-cancer/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/palbociclib-plus-endocrine-therapy-vs-capecitabine-for-patients-with-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2021-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/stereotactic-ablative-body-radiotherapy-in-extracranial-oligometastatic-cancers/</loc><lastmod>2021-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/capivasertib-for-akt1-e17k-mutated-metastatic-cancers-nci-match-subprotocol-eay131-y/</loc><lastmod>2021-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/patient-reported-outcomes-with-triplet-therapy-for-newly-diagnosed-multiple-myeloma/</loc><lastmod>2021-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/integrated-palliative-and-oncology-care-for-patients-receiving-treatment-for-acute-myeloid-leukemia/</loc><lastmod>2021-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2021/01-january/final-overall-survival-results-of-the-idea-collaboration-3-vs-6-months-of-adjuvant-chemotherapy-for-stage-iii-colon-cancer/</loc><lastmod>2021-01-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/baseline-characteristics-of-asian-patients-enrolled-in-the-monarche-trial/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/early-detection-and-localization-of-cancer-using-a-blood-based-assay/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/case-series-study-explores-experiences-of-transgender-patients-with-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/effect-of-fertility-preservation-on-reproductive-outcomes-in-patients-after-breast-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/subgroup-analysis-of-japanese-patients-with-ovarian-cancer-treated-with-maintenance-olaparibbevacizumab/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/phase-ii-study-of-combination-immunotherapy-for-advanced-nasopharyngeal-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/phase-iii-gemstone-302-trial-finds-cs1001-plus-platinum-chemotherapy-prolongs-progression-free-survival-in-nsclc/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/phase-ii-study-investigates-efficacy-of-anlotinib-in-radioiodine-refractory-differentiated-thyroid-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/first-line-sintilimab-plus-bevacizumab-biosimilar-for-advanced-hepatocellular-carcinoma/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/reconstruction-implant-surface-texture-and-risk-of-breast-cancer-recurrence/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-explores-duration-of-shedding-of-viable-sars-cov-2-in-patients-with-cancer-after-immunosuppressive-therapy/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-authorizes-antigen-test-as-first-over-the-counter-fully-at-home-diagnostic-test-for-covid-19/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/eric-p-winer-md-fasco-elected-asco-president-for-2022-2023-term/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-issues-emergency-use-authorization-for-first-covid-19-vaccine/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/reducing-the-risk-of-lymphedema-in-patients-with-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/overcoming-the-challenges-of-addressing-race-culture-and-structural-inequality-in-medical-education/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/roswell-park-experts-named-to-highly-cited-researchers-list/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/pembrolizumab-plus-chemotherapy-for-locally-recurrent-unresectable-or-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-shows-sentinel-lymph-node-biopsy-to-be-viable-option-for-surgical-staging-of-endometrial-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/strict-adherence-to-algorithm-required/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-finds-survival-disparities-and-mutational-differences-for-black-patients-younger-than-60-with-aml/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/selected-ash-abstracts-on-novel-treatments-of-polycythemia-vera/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/two-leading-institutions-collaborate-to-advance-treatment-of-smoldering-multiple-myeloma/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/chronicling-a-family-s-history-of-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/pembrolizumab-improves-progression-free-survival-vs-chemotherapy-in-first-line-treatment-of-microsatellite-instability-high-advanced-colorectal-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/john-ryan-jd-named-senior-vice-president-and-general-counsel-at-dana-farber-cancer-institute/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-reports-highly-skilled-surgeons-significantly-reduce-death-from-colon-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-cathy-eng/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/northwell-invests-6m-in-comprehensive-cancer-center-in-riverhead-new-york/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/anthony-fauci-md-encourages-patients-with-cancer-to-receive-covid-19-vaccine/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/susan-e-hankinson-scd-mph-receives-aacr-distinguished-lectureship-in-breast-cancer-research-award/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/daughter-of-a-dance-band-leader-becomes-nationally-regarded-expert-in-disparities-of-cancer-care/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/roy-herbst-named-accc-2020-clinical-research-award-winner/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/disparities-in-socioeconomic-status-treatment-complications-and-obesity-impact-outcomes-in-minority-patients-with-aml/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/transplant-may-improve-survival-in-older-patients-with-high-risk-myelodysplastic-syndrome-study-reports/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/identifying-multiple-myeloma-prognostic-subgroups-with-distinct-genetic-and-clinical-features/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/2020-fda-approvals-of-drugs-for-cancer-treatment/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/rxponder-many-postmenopausal-patients-with-node-positive-breast-cancer-can-avoid-chemotherapy/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/initial-therapy-for-asymptomatic-follicular-lymphoma-start-with-watch-and-wait-or-rituximab/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-c-kent-osborne-md/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/stephanie-halene-appointed-chief-of-hematology-at-yale-cancer-center-and-smilow-cancer-hospital/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/naxitamab-for-high-risk-neuroblastoma-in-bone-or-bone-marrow/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/life-and-death-under-covid-19/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/germline-somatic-interactions-in-advanced-urothelial-cancer-and-their-role-in-disease-progression/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/challenges-related-to-informed-consent-and-information-sharing-for-minors-with-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/tabare-vazquez-dies-at-80/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/adamantinoma-of-the-mandible/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/cancer-survivor-offers-roadmap-for-managing-the-turmoil-of-diagnosis-and-treatment/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fan-therapy-may-relieve-breathlessness-associated-with-advanced-cancers/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ruxolitinib-improves-outcomes-in-patients-with-steroid-refractory-or-steroid-dependent-graft-vs-host-disease/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/my-life-of-service-to-other-cancer-survivors/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/first-sign-of-myeloproliferative-neoplasms-may-be-in-utero/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-robert-brodsky/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fixed-duration-first-line-ibrutinib-plus-venetoclax-yields-treatment-free-remission-in-some-patients-with-cll/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-jacob-soumerai/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ash-announces-donation-of-next-generation-sequencing-equipment-to-countries-in-the-international-consortium/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ash-registry-treasure-trove-of-data-on-covid-19-and-hematologic-malignancies/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-stephanie-lee-md-mph/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/welela-tereffe-md-mph-named-chief-medical-executive-at-md-anderson/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/edith-mitchell-md-elected-to-fellowship-in-the-royal-college-of-physicians-of-london/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ctc-enumeration-predicts-survival-early-in-treatment-of-metastatic-breast-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/pralsetinib-for-ret-altered-thyroid-cancers/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/novel-radiomodulation-approach-with-dismutase-mimetic-plus-sbrt-in-resectable-pancreatic-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-laura-dawson/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sexual-health-an-issue-for-many-survivors-of-cancer/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-karen-winkfield/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/novel-combination-under-study-in-first-line-treatment-of-metastatic-melanoma/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-omid-hamid/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/intratumoral-injections-may-boost-neoadjuvant-response-in-resectable-melanoma/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/iu-simon-researcher-receives-13-million-grant-to-improve-breast-cancer-treatment-for-black-women/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addressing-inequality-in-cancer-care-on-a-global-scale/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/panel-on-global-cancer-control-looks-for-ways-forward-in-a-war-that-s-proving-hard-to-win/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/european-experts-tackle-hpv-related-cancers/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ash-recognizes-choosing-wisely-champions-at-annual-meeting-exposition/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/rutgers-researcher-receives-400k-grant-to-examine-racial-health-disparities-in-cancer-care/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/2020-basser-global-prize-awarded-to-bella-kaufman-md-of-israel-s-sheba-medical-center/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/city-of-hope-physician-joins-carol-emmott-fellowship/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sue-s-yom-md-phd-fastro-named-editor-in-chief-of-astro-s-red-journal/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/increase-your-knowledge-and-practice-of-cultural-competence-with-asco-elearning-course-collection/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/the-heart-of-catherine-handy-marshalls-work/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/asco-s-oncologist-approved-patient-information-website-cancernet/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/cms-increases-access-to-telemedicine-in-home-health-care/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/new-recommendations-for-advancing-the-scholarly-discipline-of-global-oncology/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/reducing-disparities-in-cancer-care-for-sexual-and-gender-minority-patients/</loc><lastmod>2020-12-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/continued-progression-free-and-overall-survival-superiority-of-first-line-pembrolizumabaxitinib-vs-sunitinib/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/extranodal-marginal-zone-lymphoma-of-mucosa-associated-lymphoid-neoplasms/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/meta-analysis-of-outcomes-with-systemic-therapy-in-first-and-second-line-treatments-of-advanced-hcc/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/project-orbis-partnering-with-international-regulatory-agencies-to-bring-earlier-global-access-to-novel-cancer-treatments/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/staying-a-step-ahead-of-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/career-development-award-winner-dr-aparna-parikh/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/new-asco-series-for-early-career-cancer-providers-on-impacts-of-social-determinants-of-health/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/save-20-when-you-stock-your-practice-with-asco-answers-materials-for-2021/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/the-problem-of-heterogeneity-within-stage/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/huntsman-cancer-institute-leadership-announces-two-new-appointments/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/world-health-organization-launches-first-ever-global-commitment-to-eliminate-cervical-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/abraham-chachoua-md-announced-as-new-director-of-perlmutter-cancer-center-s-lung-cancer-center/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/city-of-hope-orange-county-names-edward-kim-its-physician-in-chief/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/albert-einstein-college-of-medicine-researchers-receive-grant-from-the-national-institutes-of-health/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/shilpi-gupta-md-joins-atlantic-health-system-cancer-care-s-comprehensive-breast-health-program/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/new-rules-on-health-care-price-transparency-and-coverage-for-covid-19-vaccines/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ash-awards-henry-m-stratton-medal-to-hematology-researchers/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/2020-william-dameshek-prize-awarded-to-adolfo-ferrando-md-phd/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/2020-e-donnall-thomas-lecture-and-prize-awarded-to-toshio-suda-md-phd/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sara-federico-md-receives-nci-award-for-leadership-in-developing-clinical-trials-for-pediatric-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sitc-announces-creation-of-steven-a-rosenberg-md-phd-endowed-scholars-fund/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/an-early-love-of-the-duck-billed-platypus-sparks-a-career-in-cancer-research/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/discerning-the-underlying-mechanisms-of-endometrial-cancer-disparities-in-black-women/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/incidence-and-cancer-related-mortality-in-colombia/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/erratum/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/living-well-before-we-die/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-and-aacr-launch-project-livin-label/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/geriatric-assessment-vital-element-in-individualizing-care-for-older-patients-with-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/surgical-resection-of-stage-i-lung-cancer-rating-the-evidence-of-benefit/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-matthijs-oudkerk/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/single-fraction-sbrt-may-be-equivalent-to-four-in-patients-with-oligometastatic-lung-disease/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-thomas-dilling/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/low-dose-radiotherapy-for-covid-19-related-pneumonia/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-ramesh-rengan/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/early-stage-lung-cancer-an-overview-of-the-clinical-trial-landscape/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/daniel-von-hoff-receives-inaugural-aacr-scientific-achievement-award-established-in-his-honor/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/lung-cancer-pfs-with-immunotherapy-varies-significantly-by-tumor-mutation-subtype-real-world-data-show/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-joel-neal/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/hannah-hazard-jenkins-named-permanent-director-of-the-wvu-cancer-institute/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/front-line-nonchemotherapy-regimens-may-improve-long-term-outcomes-in-cll/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ash-recognizes-admiral-brett-giroir-with-2020-outstanding-service-award/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/physician-scientist-judah-folkman-md-faced-years-of-skepticism-before-his-theory-of-angiogenesis-was-proven/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/researchers-join-10-million-project-to-better-understand-sex-differences-in-brain-cancer-outcomes/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/understanding-breast-cancer-diagnosis-and-treatment-disparities-in-resource-challenged-nations/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/emerging-data-on-parp-inhibition-in-prostate-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/immunotherapy-for-triple-negative-breast-cancer-an-evolving-story/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/dana-farberbrigham-and-women-s-cancer-center-and-stamford-hospital-expand-collaboration/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/progress-report-on-checkpoint-inhibitors-in-rare-tumors/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/the-lung-microbiome-may-affect-lung-cancer-pathogenesis-and-prognosis/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addressing-disparities-in-care-among-black-men-and-women-with-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/edward-benz-jr-receives-2020-ash-award-for-leadership-in-promoting-diversity/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/facing-life-s-adversities-even-cancer-from-the-back-of-a-horse-named-buddy/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/older-woman-with-eye-tumor/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/meta-analysis-shows-superior-disease-free-and-overall-survival-with-measurable-residual-disease-negativity-in-aml/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/what-is-the-measure-of-minimal-residual-disease-in-aml/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/bristol-myers-squibb-foundation-and-national-medical-fellowships-launch-program-to-increase-diversity-in-clinical-trials/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/asco-releases-guideline-on-systemic-therapy-for-advanced-hepatocellular-carcinoma/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/no-reduced-recurrence-risk-with-perioperative-aromatase-inhibitor-use-in-hr-positive-breast-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/improved-outcomes-with-neoadjuvant-paclitaxel-plus-trastuzumablapatinib-vs-paclitaxeltrastuzumab-in-her2-positive-breast-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/cu-cancer-center-leukemia-researcher-receives-nci-outstanding-investigator-award/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/breaking-the-cultural-norms-a-young-indian-girl-attains-her-dream-of-becoming-a-global-oncologist/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/asco-issues-comprehensive-recommendations-to-strengthen-cancer-care-and-research-during-and-beyond-the-covid-19-pandemic/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/assessing-the-progress-made-in-global-cancer-care-and-looking-toward-the-future/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-finds-asciminib-safer-more-effective-than-bosutinib-in-chronic-phase-cml/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-david-snyder/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/options-for-maintenance-therapy-for-metastatic-pancreatic-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/2020-ernest-beutler-lecture-and-prize-presented-to-ari-melnick-md-and-courtney-dinardo-md/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/mohandas-narla-receives-2020-wallace-h-coulter-award-for-lifetime-achievement-in-hematology/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/statins-reduced-risk-of-colorectal-cancer-in-meta-analysis/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/complexity-of-designing-clinical-trials-for-sarcoma/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/epov-brooks-cash/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-approves-gallium-68-psma-11-for-psma-targeted-pet-imaging-in-prostate-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-approves-pralsetinib-for-ret-altered-thyroid-cancers/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/managing-checkpoint-inhibitor-mediated-colitis/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-grants-accelerated-approval-to-naxitamab-for-high-risk-neuroblastoma-in-bone-or-bone-marrow/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sentinel-lymph-node-biopsy-vs-lymphadenectomy-for-staging-of-intermediate-and-high-grade-endometrial-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/can-circulating-tumor-cell-count-guide-first-line-chemotherapy-or-endocrine-therapy-for-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/researchers-develop-prognostic-model-to-guide-systemic-therapy-for-early-stage-her2-positive-breast-cancer/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-issues-emergency-use-authorization-for-first-covid-19-test-for-self-testing-at-home/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addition-of-ablative-therapy-to-transarterial-chemoembolization-in-nonmetastatic-unresectable-hepatocellular-carcinoma/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/global-burden-of-cervical-cancer-and-association-with-hiv/</loc><lastmod>2020-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/risk-for-osteonecrosis-of-the-jaw-after-treatment-with-zoledronic-acid-for-metastatic-bone-disease/</loc><lastmod>2020-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/effect-of-the-covid-19-pandemic-on-lung-cancer-screening/</loc><lastmod>2020-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/american-cancer-society-report-identifies-critical-gaps-and-research-opportunities-for-improved-cancer-care/</loc><lastmod>2020-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-issues-emergency-use-authorization-for-second-covid-19-vaccine/</loc><lastmod>2020-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/globocan-2020-database-provides-latest-global-data-on-cancer-burden-cancer-deaths/</loc><lastmod>2020-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/left-anterior-descending-coronary-artery-radiation-exposure-cardiac-events-and-mortality-in-nsclc/</loc><lastmod>2020-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ganglioside-vaccine-plus-oral-therapy-for-patients-with-high-risk-neuroblastoma-and-prior-disease-progression/</loc><lastmod>2020-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/time-dependent-effects-of-oral-contraceptives-on-risk-of-ovarian-and-endometrial-cancers/</loc><lastmod>2020-12-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sintilimab-vs-docetaxel-for-advanced-squamous-nsclc/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addition-of-capivasertib-to-docetaxelprednisolone-in-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/intensity-of-active-surveillance-in-patients-with-rectal-cancer-managed-with-a-watch-and-wait-approach/</loc><lastmod>2020-12-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/risk-of-covid-19-infection-in-patients-with-cancer-effect-of-time-of-diagnosis-and-race/</loc><lastmod>2020-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/gemogenovatucel-t-maintenance-in-stage-iiiiv-ovarian-cancer/</loc><lastmod>2020-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addition-of-first-line-pembrolizumab-to-chemotherapy-in-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-12-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/radiotherapy-and-chemotherapy-before-total-mesorectal-excision-for-locally-advanced-rectal-cancer/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/first-line-anti-pd-1-therapy-vs-brafmek-inhibition-for-advanced-braf-v600-mutated-melanoma/</loc><lastmod>2020-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-approves-adjuvant-osimertinib-for-egfr-mutated-nsclc/</loc><lastmod>2020-12-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addition-of-durvalumab-with-or-without-tremelimumab-to-chemotherapy-in-extensive-stage-sclc/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/pembrolizumab-in-combination-with-a-therapeutic-dna-vaccine-for-hpv-positive-advanced-cervical-cancer/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/does-melflufen-plus-dexamethasone-show-activity-in-heavily-pretreated-patients-with-relapsed-and-refractory-multiple-myeloma/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/spectrum-of-germline-somatic-interactions-in-advanced-urothelial-cancer/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/changes-in-care-and-well-being-among-patients-with-cancer-during-initial-stage-of-the-covid-19-pandemic/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/addition-of-chemotherapy-to-local-therapy-in-women-aged-70-or-older-with-triple-negative-breast-cancer/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/tebentafusp-shows-activity-in-metastatic-uveal-melanoma/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-finds-incidence-of-young-onset-esophageal-adenocarcinoma-is-rapidly-increasing/</loc><lastmod>2020-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/association-of-out-of-pocket-costs-for-tyrosine-kinase-inhibitors-with-outcomes-in-patients-with-egfr-and-alk-positive-advanced-nsclc/</loc><lastmod>2020-12-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/initiative-to-increase-referrals-of-patients-with-gastrointestinal-cancer-to-a-specialized-rehabilitation-program/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/trends-in-aya-cancer-incidence-in-the-united-states-over-4-decades/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/oral-panobinostat-and-dexamethasone-plus-subcutaneous-bortezomib-for-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/how-did-the-covid-19-pandemic-affect-initiation-of-cancer-treatment-in-england/</loc><lastmod>2020-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/radiotherapy-omission-after-breast-conserving-surgery-for-older-patients-with-hr-positive-breast-cancer/</loc><lastmod>2020-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/adjuvant-atezoliumab-for-patients-with-muscle-invasive-urothelial-cancer-and-presence-of-postsurgical-ctdna/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/meta-analysis-of-toxicity-and-treatment-outcomes-with-stereotactic-ablative-radiotherapy-for-oligometastatic-cancer/</loc><lastmod>2020-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/pembrolizumab-vs-chemotherapy-in-first-line-treatment-of-microsatellite-instability-high-advanced-colorectal-cancer/</loc><lastmod>2020-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/does-pleural-effusion-affect-survival-in-patients-treated-with-immunotherapy-for-nsclc/</loc><lastmod>2020-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ctdna-may-indicate-increased-risk-of-relapse-after-stem-cell-transplant-in-patients-with-dlbcl/</loc><lastmod>2020-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/postoperative-cancer-surgery-mortality-rates-have-improved-but-gap-still-exists-between-black-and-white-patients/</loc><lastmod>2020-12-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/meta-analysis-of-radiotherapy-with-adjuvant-vs-neoadjuvant-androgen-deprivation-therapy-for-localized-prostate-cancer/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/follow-up-data-from-monarche-show-continued-abemaciclib-benefit-in-high-risk-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2020-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/phase-ii-zuma-12-study-investigates-axicabtagene-ciloleucel-for-high-risk-large-b-cell-lymphoma/</loc><lastmod>2020-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/rxponder-study-shows-postmenopausal-patients-with-node-positive-breast-cancer-may-be-able-to-avoid-chemotherapy/</loc><lastmod>2020-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/new-prognostic-tool-to-determine-individual-risk-of-distant-recurrence-benefit-of-adjuvant-chemotherapy-in-early-breast-cancer/</loc><lastmod>2020-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/patient-reported-outcomes-from-the-phase-iii-impassion031-trial/</loc><lastmod>2020-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ctc-enumeration-may-be-predictive-of-survival-during-treatment-for-metastatic-breast-cancer/</loc><lastmod>2020-12-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/early-signs-of-risk-for-myeloproliferative-neoplasms-may-appear-in-childhood-or-in-utero/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/meta-analysis-of-pregnancy-outcomes-in-breast-cancer-survivors/</loc><lastmod>2020-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/opioid-and-sedative-hypnotic-use-after-mastectomy-with-reconstructive-surgery/</loc><lastmod>2020-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/patients-with-breast-cancer-undergoing-radiotherapy-may-have-underrecognized-side-effects/</loc><lastmod>2020-12-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/potential-impact-of-state-government-crisis-standards-of-care-guidelines-on-resource-allocation-for-patients-with-cancer/</loc><lastmod>2020-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/can-mindfulness-meditation-and-survivorship-education-help-to-reduce-depression-in-young-breast-cancer-survivors/</loc><lastmod>2020-12-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/role-of-venetoclax-in-high-risk-myeloid-malignancies/</loc><lastmod>2020-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/multiple-myeloma-patient-similarity-network-identifies-prognostic-subgroups-with-distinct-genetic-and-clinical-features/</loc><lastmod>2020-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/zuma-5-trial-finds-axicabtagene-ciloleucel-shows-activity-in-patients-with-indolent-non-hodgkin-lymphoma/</loc><lastmod>2020-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/circulating-tumor-dna-and-disease-free-survival-in-patients-with-breast-cancer/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/chemotherapy-plus-blinatumomab-for-philadelphia-chromosome-negative-b-cell-all/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/proportion-of-never-smokers-among-patients-with-lung-cancer-in-seven-us-states/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/the-covid-19-pandemic-and-cancer-care-for-older-patients-in-the-united-states/</loc><lastmod>2020-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-examines-impact-of-neighborhood-socioeconomic-status-on-outcomes-in-minority-patients-with-aml/</loc><lastmod>2020-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/does-race-contribute-to-poor-outcomes-in-younger-black-patients-diagnosed-with-aml/</loc><lastmod>2020-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-finds-prophylactic-tranexamic-acid-has-no-effect-on-bleeding-in-patients-with-hematologic-malignancies/</loc><lastmod>2020-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/environmental-surface-testing-for-presence-of-sars-cov-2-in-inpatient-and-outpatient-hematologyoncology-settings/</loc><lastmod>2020-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/subcutaneous-teclistamab-for-relapsed-or-refractory-multiple-myeloma-studied-in-phase-i-trial/</loc><lastmod>2020-12-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/information-on-patients-with-covid-19-and-hematologic-malignancies-provided-by-ash-research-collaborative-data-hub/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/reduced-intensity-allogeneic-hematopoietic-stem-cell-transplant-may-improve-survival-in-older-patients-with-high-risk-mds/</loc><lastmod>2020-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/early-research-shows-cd58-may-be-a-biomarker-for-response-to-axicabtagene-ciloleucel-in-patients-with-large-b-cell-lymphoma/</loc><lastmod>2020-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/clonal-hematopoiesis-in-donors-aged-40-and-older-may-be-linked-to-improved-survival-in-stem-cell-transplant-recipients/</loc><lastmod>2020-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/novel-antibody-drug-conjugate-shows-activity-in-rare-aggressive-form-of-leukemia/</loc><lastmod>2020-12-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/analysis-of-adjuvant-therapies-for-early-stage-triple-negative-breast-cancer/</loc><lastmod>2020-12-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/association-of-fall-and-fracture-risk-with-androgen-receptor-inhibitor-therapy-for-prostate-cancer/</loc><lastmod>2020-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/native-american-ancestry-may-impact-somatic-alterations-among-latin-american-patients-with-lung-cancer/</loc><lastmod>2020-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/study-shows-regional-variation-in-genomic-testing-for-men-with-prostate-cancer/</loc><lastmod>2020-12-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/ruxolitinib-for-steroid-refractorysteroid-dependent-chronic-graft-vs-host-disease/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/subcutaneous-daratumumab-plus-pomalidomidedexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/sars-cov-2-multivirus-specific-t-cells-for-the-treatment-of-hospitalized-patients-with-covid-19/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/discordance-among-risk-models-for-smoldering-multiple-myeloma/</loc><lastmod>2020-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/avelumab-maintenance-vs-continued-chemotherapy-after-first-line-induction-for-advanced-gastric-cancer/</loc><lastmod>2020-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-announces-advisory-committee-meeting-to-discuss-second-covid-19-vaccine-candidate/</loc><lastmod>2020-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/does-concurrent-treatment-with-dexamethasone-diminish-the-efficacy-of-immune-checkpoint-inhibitors-in-patients-with-glioblastoma/</loc><lastmod>2020-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/preoperative-radiotherapy-dose-reduction-in-patients-with-myxoid-liposarcoma/</loc><lastmod>2020-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/fda-pipeline-agents-in-dlbcl-sclc-aml-and-more/</loc><lastmod>2020-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/end-of-life-care-among-commercially-insured-women-younger-than-65-with-metastatic-breast-cancer/</loc><lastmod>2020-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/definitive-sbrt-and-outcomes-in-adult-patients-with-extracranial-oligometastasis/</loc><lastmod>2020-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/social-needs-may-be-linked-to-low-health-related-quality-of-life-among-black-cancer-survivors/</loc><lastmod>2020-12-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/12-december/positive-brca-test-result-trends-among-women-aged-65-and-older-in-the-united-states/</loc><lastmod>2020-12-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/virtual-mind-body-services-for-patients-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/closing-the-gap-in-integrative-oncology-education/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/ask-patients-with-advanced-cancer-about-fatigue-the-answer-may-reveal-survival-odds/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-therese-marie-mulvey/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/genetic-variants-linked-to-bevacizumab-induced-adverse-effects/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-william-r-sellers-md/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/biomarker-driven-master-protocol-to-test-therapies-for-previously-treated-patients-with-squamous-nsclc/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fluciclovine-pet-imaging-benefits-radiotherapy-treatment-planning-compared-with-conventional-imaging-in-prostate-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/nivolumab-plus-ipilimumab-in-first-line-nsclc-two-new-indications-many-more-questions/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-deborah-doroshow/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/impact-of-covid-19-on-cancer-care-in-india/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/image-guided-imrt-reduces-gi-toxicity-without-compromising-pelvic-recurrence-in-intermediate-to-high-risk-cervical-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/guideline-update-offers-new-directions-about-trastuzumab-emtansine-for-her2-positive-breast-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/management-of-painful-spinal-metastases-sbrt-vs-conventional-radiotherapy/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-kristin-redmond/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/stereotactic-radiosurgery-may-delay-cognitive-deterioration-vs-whole-brain-radiotherapy-for-multiple-brain-metastases/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/nagi-s-el-saghir-md-facp-fasco-receives-lebanon-s-national-cedar-medal-award/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/use-of-pembrolizumab-in-advanced-pleural-mesothelioma-results-from-keynote-158/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-melina-marmarelis/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/daniel-sullivan-md-honored-for-leadership-in-quantitative-imaging-biomarkers/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/kras-inhibitor-adagrasib-shows-activity-in-non-small-cell-lung-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-howard-west-md-and-william-sellers/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/can-antihypertensives-improve-outcomes-with-immunotherapy/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-emiliano-calvo-and-udai-banerji/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/hairy-cell-leukemia-foundation-and-leukemia-lymphoma-society-join-forces/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/mindact-at-87-years-primary-findings-confirmed/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-keerthi-gogineni/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/mode-of-detection-of-high-risk-breast-cancer-linked-to-prognosis/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-david-cameron/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/pembrolizumab-in-adult-and-pediatric-classical-hodgkin-lymphoma/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/growing-interest-in-antiandrogens-to-treat-male-breast-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/aacr-announces-move-to-virtual-meeting-for-2021/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/final-analysis-of-solar-1-8-month-survival-benefit-misses-statistical-significance-for-alpelisib/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-fatima-cardoso/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/new-pediatric-neuro-oncology-research-lab-established-at-hackensack-university-medical-center/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/adam-bass-md-named-director-center-for-precision-cancer-medicine-at-columbia-university/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/support-builds-for-anti-bcma-car-t-cell-therapy-in-multiple-myeloma/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-ajay-nooka/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/new-leadership-elected-to-american-society-of-hematology/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/this-year-s-fda-asco-workshop-focused-on-collection-of-patient-reported-tolerability-data-from-clinical-trials/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/a-urologic-surgeon-assesses-the-current-state-of-prostate-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/update-on-multiple-myeloma-highlights-from-nccn-virtual-congress-on-hematologic-malignancies/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/colorectal-cancer-alliance-launches-comprehensive-campaign-to-increase-screening-rates-during-covid-19-and-beyond/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/md-anderson-partners-with-investment-fund-to-generate-support-for-investigational-therapies/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/venetoclax-in-combination-therapy-for-untreated-acute-myeloid-leukemia/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/understanding-the-uniqueness-of-cancer-and-survival-in-adolescents-and-young-adults/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/rutgers-awarded-fema-grant-to-support-volunteer-firefighter-cancer-research-and-prevention/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/ut-austin-and-md-anderson-announce-first-collaborative-projects-in-improving-cancer-outcomes/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/racial-disparities-in-treatment-of-common-lung-cancer-persist-despite-gains/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/hci-researcher-receives-awards-for-community-contributions-and-neuroendocrine-tumor-research/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/acs-cancer-action-network-issues-new-recommendations-to-increase-access-to-cancer-biomarker-testing/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/ola-landgren-md-phd-joins-sylvester-comprehensive-cancer-center-at-university-of-miami/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/addition-of-abemaciclib-to-endocrine-therapy-improves-invasive-disease-free-survival-in-high-risk-early-breast-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/first-line-atezolizumab-improves-overall-survival-vs-chemotherapy-in-certain-patients-with-metastatic-nsclc/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/final-efficacy-results-from-extenet-trial-of-neratinib-in-subgroup-of-patients-with-hr-positive-her2-positive-early-breast-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/the-us-oncology-network-welcomes-two-more-practices/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/ixazomib-maintenance-in-patients-with-newly-diagnosed-multiple-myeloma-who-did-not-receive-asct/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/dasatinibblinatumomab-produces-high-rates-of-molecular-response-and-survival-in-philadelphia-chromosome-positive-all/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/darolutamide-improves-overall-survival-in-nonmetastatic-castration-resistant-prostate-cancer-aramis-trial/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/william-dameshek-helped-take-hematology-from-a-minor-medical-discipline-to-a-major-scientific-field/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/what-is-quality-oncology-care-during-the-covid-19-pandemic/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-shows-equivalence-of-sentinel-node-biopsy-vs-neck-node-dissection-in-operable-oral-or-oropharyngeal-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/a-daughter-of-immigrants-chooses-a-challenging-but-rewarding-career-in-surgical-oncology/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/medicaid-expansion-may-be-linked-to-lower-mortality-rates-for-three-major-types-of-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-offers-guidance-to-enhance-diversity-in-clinical-trials-encourage-inclusivity-in-medical-product-development/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/south-florida-cancer-experts-make-the-move-to-sylvester/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/no-benefit-of-adjuvant-sorafenib-in-intermediate-or-high-risk-renal-cell-carcinoma/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/mount-sinai-receives-4-million-gift-to-support-prostate-health-and-urology-department/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/sio-and-asco-collaborate-to-develop-evidence-based-guidelines-for-integrative-therapies-for-oncology/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/penn-medicine-researchers-receive-54-million-grant-to-find-genetic-drivers-of-testicular-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/yes-men-get-breast-cancer-too/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/mohs-surgery-vs-wide-local-excision-for-trunk-and-extremity-melanomas/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/expect-questions-about-mohs-micrographic-surgery/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/global-cancer-institute-extends-programs-to-bangladesh-for-underserved-patients-with-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/us-multisociety-task-force-on-colorectal-cancer-offers-management-strategies-for-malignant-colorectal-polyps/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/rogel-team-at-university-of-michigan-receives-112m-to-leverage-the-microbiome-against-graft-vs-host-disease/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/elnec-project-reaches-historic-milestone-in-end-of-life-care/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/job-loss-during-cancer-how-to-cope-and-continue-treatment/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/gateway-for-cancer-research-and-conquer-cancer-offer-grant-funding-to-research-health-disparities/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/time-is-running-out-prepare-for-2021-em-changes-today/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/new-global-survey-finds-more-education-needed-to-increase-provider-geriatric-assessments-for-older-adults-with-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/asco-launches-educational-series-on-social-determinants-of-health/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/asco-s-free-app-for-patients-cancernet-mobile/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/conquer-cancer/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/association-of-minimal-residual-disease-with-disease-free-and-overall-survival-in-patients-with-aml/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/addition-of-bevacizumab-to-paclitaxel-in-relapsed-ovarian-sex-cord-stromal-tumors/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/do-patients-with-early-stage-nsclc-have-a-higher-tumor-mutational-burden/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/immediate-breast-reconstruction-vs-conventional-mastectomy-after-neoadjuvant-chemotherapy/</loc><lastmod>2020-11-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-alejandro-berlin/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/adjuvant-vs-neoadjuvant-androgen-deprivation-therapy-with-radiotherapy-for-prostate-cancer/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/4-year-findings-from-murano-trial-venetoclax-plus-rituximab-for-relapsed-chronic-lymphocytic-leukemia/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/final-ascend-results-confirm-acalabrutinib-as-a-standard-for-relapsed-cll/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/acalabrutinib-improves-progression-free-survival-vs-idelalisib-plus-rituximab-or-bendamustine-plus-rituximab-in-relapsed-or-refractory-cll/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/carfilzomib-vs-bortezomib-each-combined-with-lenalidomidedexamethasone-in-newly-diagnosed-patients-with-multiple-myeloma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-ajay-nooka-1/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/support-builds-for-anti-bcma-car-t-cell-therapy-in-multiple-myeloma-1/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-philip-mccarthy/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/responses-achieved-with-belantamab-mafodotin-in-relapsed-or-refractory-myeloma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/novel-therapies-and-new-indications-for-use-in-treatment-of-hematologic-malignancies-1/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/novel-treatment-approaches-on-the-horizon-in-multiple-myeloma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/novel-therapies-and-new-indications-for-use-in-treatment-of-hematologic-malignancies/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/hematologic-oncology-highlights-2019-2020-almanac/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-results-with-pet-directed-therapy-for-limited-stage-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-basem-m-william-and-caron-jacobson/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/bispecific-antibodies-poised-to-impact-treatment-of-lymphoma-and-other-blood-cancers/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/chemotherapy-free-approaches-in-follicular-and-mantle-cell-lymphomas/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/newer-therapeutic-approaches-improving-outcomes-in-hodgkin-lymphoma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/role-of-rituximab-in-treatment-of-children-and-adolescents-with-mature-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/addition-of-rituximab-to-standard-chemotherapy-improves-event-free-and-overall-survival-in-children-with-high-risk-mature-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/venetoclax-combination-in-newly-diagnosed-aml/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/ash-releases-new-clinical-practice-guidelines-on-treatment-of-older-adults-with-newly-diagnosed-acute-myeloid-leukemia/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/optimizing-the-treatment-of-adults-with-acute-lymphoblastic-leukemia/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-kilian-gust/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/front-line-avelumab-maintenance-improved-survival-across-subgroups-with-advanced-urothelial-carcinoma/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/novel-treatments-show-activity-in-advanced-cervical-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-ana-oaknin/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-approves-remdesivir-for-patients-with-covid-19-requiring-hospitalization/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/solo-1-trial-after-5-years-maintenance-olaparib-still-keeps-ovarian-cancer-at-bay/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-jonathan-ledermann/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/new-maintenance-therapies-in-metastatic-pancreatic-cancer-aim-to-end-perpetual-chemotherapy/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/adjuvant-vs-early-salvage-radiotherapy-after-radical-prostatectomy-in-high-risk-prostate-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/astro-issues-clinical-guideline-on-radiation-therapy-for-rectal-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/hypofractionated-stereotactic-radiotherapy-to-the-resection-cavity-in-patients-with-brain-metastases/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/tazemetostat-in-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/swedish-study-of-hpv-vaccination-and-risk-of-invasive-cervical-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-extends-the-approval-of-pembrolizumab-for-patients-with-classical-hodgkin-lymphoma/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-approves-venetoclax-combination-regimen-for-certain-adult-patients-with-aml/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/jame-abraham-md-facp-named-deputy-editor-of-jco-oncology-practice/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/first-line-pembrolizumab-delays-disease-progression-in-pd-l1-expressing-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-amy-tiersten-and-erika-hamilton/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/richard-pazdur-md-awarded-the-simon-m-shubitz-cancer-prize-and-lectureship/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/after-surgery-for-colorectal-cancer-intensive-monitoring-of-little-benefit-prodige-13/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-tim-price/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/nccn-announces-beth-gaffney-mba-as-new-vice-president-of-us-and-global-business-development/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/surgery-improves-survival-in-older-women-with-early-estrogen-receptor-positive-breast-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/lung-cancer-precision-therapies-at-the-forefront/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/results-from-asco-s-2020-national-cancer-opinions-survey/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/no-biochemical-pfs-benefit-with-adjuvant-vs-salvage-radiotherapy-after-radical-prostatectomy-for-prostate-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/do-all-patients-with-refractory-diffuse-large-b-cell-lymphoma-need-car-t-cell-therapy/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fragment-analysis-as-a-met-exon-14-screening-strategy-in-nsclc-tumors/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/cure-media-group-announces-recipients-of-2020-lung-cancer-heroes-award/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/chronic-lymphocytic-leukemia-new-treatments-achieve-deeper-remissions/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/after-leaving-his-home-in-syria-to-train-abroad-an-oncologist-makes-a-tough-decision-to-return/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/medical-financial-hardship-pervasive-and-possibly-linked-to-mortality-among-patients-with-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-reginald-tucker-seeley/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/reducing-emergency-department-visits-better-patient-outreach-may-improve-care-treatment-costs/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-sonali-smith/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/liquid-biopsy-mounting-evidence-shows-clinical-utility-in-tumor-monitoring/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/oncology-drug-development-marches-on-amid-a-pandemic/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/pancreatic-adenocarcinoma-leveraging-molecular-data-to-drive-clinical-advances/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/oneoncology-launches-community-oncology-research-network/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/companion-diagnostic-to-identify-ntrk-fusions-in-patients-with-solid-tumors-eligible-for-larotrectinib-treatment-approved-by-fda/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/enrique-soto-perez-de-celis-met-a-career-changing-mentor-at-the-asco-annual-meeting/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/accc-statement-on-rise-of-cancer-mortality-and-advanced-cancer-rates-in-2020/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/paloma-3-exploratory-analysis-who-benefits-most-from-palbociclib/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/using-meaning-centered-interventions-to-address-suffering-on-the-cancer-journey/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-charles-shapiro/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/astro-honors-2020-gold-medalists/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/predicting-cardiovascular-disease-risk-via-routine-ct-scans-in-women-with-breast-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/dr-christina-cone-honored-with-mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/three-new-transatlantic-research-teams-to-study-difficult-to-treat-childhood-cancers/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/an-emergency-room-physician-explores-her-own-healing-through-a-life-of-medical-service/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/reducing-symptomatic-toxicity-burden-in-older-patients-with-advanced-cancer-via-geriatric-assessment/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-monika-krzyzanowska/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/platinum-based-regimens-remain-standard-of-care-in-recurrent-platinum-sensitive-ovarian-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-andreas-du-bois/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/avelumab-maintenance-therapy-improves-overall-survival-in-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/incidence-and-cancer-related-mortality-in-chile/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-approves-companion-diagnostic-for-three-targeted-therapies-for-advanced-ovarian-breast-and-non-small-cell-lung-cancers/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/huntsman-cancer-institute-names-new-chief-academic-officer-and-senior-director-of-basic-science/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/aaci-president-knudsen-to-focus-2-year-term-on-mitigating-health-disparities/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/selpercatinib-shows-activity-in-ret-fusion-positive-nsclc-and-ret-altered-thyroid-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/second-line-pembrolizumab-improves-overall-survival-vs-chemotherapy-in-patients-with-advanced-esophageal-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/national-academy-of-medicine-elects-new-members/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/cancer-in-older-adults-the-history-of-geriatric-oncology-part-3/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/lungevity-launches-new-lung-cancer-advocacy-program/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/recently-approved-and-emerging-therapies-for-triple-negative-breast-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/cancercare-welcomes-j-leonard-lichtenfeld-md-macp-to-board-of-trustees/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/erratum/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/an-integrated-framework-for-improving-outcomes-in-pancreatic-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/a-doctor-shares-his-rich-life-in-medicine-and-cancer-research/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/danube-trial-reports-no-survival-benefit-with-first-line-durvalumab-in-metastatic-urothelial-carcinoma/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/just-the-beginning-for-veliparib-based-therapy-in-advanced-brca-mutated-breast-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/combination-of-nivolumab-and-ipilimumab-for-unresectable-malignant-pleural-mesothelioma/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/michaela-a-dinan-phd-named-co-leader-of-cancer-prevention-and-control-research-program-at-yale/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/my-age-may-have-been-a-barrier-to-timely-diagnosis-of-glioblastoma-multiforme/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/stereo-x-ray-of-stomach-cancer/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/inaugural-class-of-fda-aacr-oncology-educational-fellows-announced/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/covid-19-s-impact-on-cancer-care-around-the-world/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/support-caregivers-during-national-family-caregivers-month-with-asco-answers/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/your-stories-being-your-own-advocate/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/hospital-outpatient-payment-proposal-has-potential-to-undermine-patient-access-to-cancer-care/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/project-n95-partnership-provided-asco-members-with-access-to-personal-protective-equipment/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/rising-tide-foundation-for-clinical-cancer-research-career-pathway-grants-in-symptom-management/</loc><lastmod>2020-11-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/epov-richard-cathomas/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/checkpoint-inhibitor-and-chemotherapy-combinations-as-first-line-therapy-for-advanced-urothelial-cancer/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/prediagnosis-and-postdiagnosis-physical-activity-and-survival-in-endometrial-cancer/</loc><lastmod>2020-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/development-of-a-clinical-prognostic-stage-group-system-for-nonmetastatic-prostate-cancer/</loc><lastmod>2020-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/imetelstat-in-lower-risk-mds-with-high-transfusion-dependence/</loc><lastmod>2020-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/should-patients-with-a-complete-response-to-neoadjuvant-chemoradiation-for-rectal-cancer-also-undergo-surgery/</loc><lastmod>2020-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/breast-cancer-risk-and-disease-causing-genetic-mutations-in-women-older-than-65/</loc><lastmod>2020-11-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/futibatinib-for-patients-with-refractory-intrahepatic-cholangiocarcinoma-and-fgfr2-fusionsrearrangements/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/once-weekly-selinexor-plus-bortezomibdexamethasone-vs-twice-weekly-bortezomibdexamethasone-in-previously-treated-patients-with-multiple-myeloma/</loc><lastmod>2020-11-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/adoption-of-hypofractionated-radiation-therapy-after-change-in-prostate-cancer-clinical-pathway/</loc><lastmod>2020-11-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/no-reduction-in-recurrence-risk-with-perioperative-aromatase-inhibitor-therapy-in-postmenopausal-patients-with-hr-positive-breast-cancer/</loc><lastmod>2020-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/performance-of-immunoscore-in-asian-patients-with-early-stage-colon-cancer/</loc><lastmod>2020-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/machine-learning-algorithms-may-help-predict-response-to-immunotherapy-in-patients-with-advanced-melanoma/</loc><lastmod>2020-11-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/analysis-seeks-to-identify-characteristics-of-exceptional-responders-to-cancer-therapy/</loc><lastmod>2020-11-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/self-reported-financial-distress-among-older-adults-with-cancer-prior-to-initiating-therapy/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/association-of-fdg-uptake-according-to-deauville-criteria-with-survival-outcomes-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/does-supplementation-with-vitamin-d-reduce-the-risk-of-developing-advanced-cancer/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-finds-medicaid-expansion-in-louisiana-increased-early-stage-breast-cancer-diagnosis-and-access-to-treatment/</loc><lastmod>2020-11-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/novel-pd-l1-antibody-shows-activity-in-advanced-msi-hdmmr-tumors/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/effect-of-ash-choosing-wisely-recommendations-on-frequency-of-surveillance-imaging-in-patients-with-dlbcl/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/nivolumab-plus-ipilimumab-for-metastatic-uveal-melanoma/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/bispecific-anti-cd20anti-cd19-car-t-cells-for-patients-with-relapsed-b-cell-malignancies/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/uk-based-study-finds-evidence-of-covid-19-infection-antibody-presence-in-oncology-health-care-staff/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/impact-of-covid-19-on-well-being-in-the-oncology-workforce/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-expands-approval-of-companion-diagnostic-for-olaparib-in-prostate-cancer/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/outcomes-with-second-line-therapy-after-relapse-in-patients-with-early-stage-favorable-classical-hodgkin-lymphoma/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/intermittent-dosing-schedules-of-rafmek-inhibitor-in-rasraf-mutant-solid-tumors-and-multiple-myeloma/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/response-based-management-of-nivolumab-and-ipilimumab-therapy-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/multisystem-immune-related-adverse-events-and-disease-outcomes-among-patients-with-nsclc-treated-with-immunotherapy/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-finds-universal-genetic-testing-uncovers-more-inherited-mutations-vs-guideline-based-genetic-testing/</loc><lastmod>2020-11-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/olaparib-for-patients-with-metastatic-breast-cancer-and-mutations-in-homologous-recombination-related-genes/</loc><lastmod>2020-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/effect-of-a-pay-for-performance-program-on-prescriptions-and-spending-for-oncology-drugs/</loc><lastmod>2020-11-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/first-in-human-study-of-lsd1-inhibitor-iadademstat-for-patients-with-relapsed-or-refractory-aml/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/systemic-therapy-in-the-first-and-second-line-treatment-of-advanced-hcc/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/are-neighborhood-poverty-public-insurance-linked-to-poorer-outcomes-in-children-with-cancer-undergoing-stem-cell-transplant/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-finds-distinct-genomic-alterations-may-contribute-to-more-aggressive-prostate-cancer-in-black-men/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/is-a-high-dose-intermittent-sunitinib-regimen-for-advanced-solid-tumors-linked-to-improved-survival/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/first-line-lorlatinib-vs-crizotinib-in-advanced-alk-positive-nsclc/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/potential-factors-in-prognostic-discrepancies-among-tests-for-recurrence-risk-in-patients-with-breast-cancer-receiving-endocrine-therapy/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/predicting-mortality-outcomes-after-intensive-chemotherapy-for-aml/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/first-line-pembrolizumabaxitinib-vs-sunitinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-identifies-genetic-variants-linked-to-bevacizumab-induced-adverse-events/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-pipeline-priority-reviews-in-nsclc-gastric-cancer/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/screening-younger-women-for-variants-linked-to-breast-and-ovarian-cancers-may-be-cost-effective/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/emergency-use-authorization-request-to-be-submitted-to-fda-today-for-covid-19-vaccine/</loc><lastmod>2020-11-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-announces-advisory-committee-meeting-to-discuss-covid-19-vaccine-candidate/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/pembrolizumab-plus-bevacizumab-and-oral-metronomic-cyclophosphamide-for-recurrent-ovarian-cancer/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/effect-of-anterior-approach-vs-conventional-hepatectomy-in-resection-of-colorectal-liver-metastases-on-intraoperative-tumor-cell-dissemination/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/asco-announces-julie-r-gralow-md-facp-fasco-as-new-chief-medical-officer/</loc><lastmod>2020-11-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-pipeline-fast-track-designations-in-liver-and-pancreatic-cancers/</loc><lastmod>2020-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/ivosidenib-plus-azacitidine-in-newly-diagnosed-idh1-mutant-acute-myeloid-leukemia/</loc><lastmod>2020-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/survey-finds-patients-with-cancer-may-be-less-likely-to-enroll-in-clinical-trials-during-the-covid-19-pandemic/</loc><lastmod>2020-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/study-finds-the-lung-microbiome-may-affect-tumor-progression-and-prognosis-in-patients-with-lung-cancer/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/effects-of-stopping-tyrosine-kinase-inhibitor-treatment-for-chronic-myeloid-leukemia-on-molecular-response-and-patient-reported-outcomes/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/state-of-lung-cancer-report-finds-people-of-color-face-greater-burden-worse-lung-cancer-outcomes-in-the-united-states/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/is-maintenance-treatment-with-olaparib-for-brca-mutated-pancreatic-cancer-cost-effective/</loc><lastmod>2020-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/addition-of-venetoclax-to-bortezomibdexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-11-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/fda-grants-accelerated-approval-to-pembrolizumab-for-locally-recurrent-unresectable-or-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-11-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/cancer-deaths-linked-to-4-million-potential-years-of-life-lost-in-2017/</loc><lastmod>2020-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/addition-of-irinotecan-to-neoadjuvant-capecitabine-chemoradiation-guided-by-ugt1a1-genotype-in-locally-advanced-rectal-cancer/</loc><lastmod>2020-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/paclitaxel-plus-trastuzumab-with-or-without-lapatinib-in-her2-positive-breast-cancer-long-term-follow-up-and-genomic-analysis/</loc><lastmod>2020-11-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/comanagement-of-induction-therapy-for-acute-promyelocytic-leukemia-by-experts-and-community-practices/</loc><lastmod>2020-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/addition-of-indoximod-to-taxane-chemotherapy-in-first-line-treatment-of-her2-negative-metastatic-breast-cancer/</loc><lastmod>2020-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/state-level-lung-cancer-screening-rates-not-aligned-with-lung-cancer-burden-in-the-united-states/</loc><lastmod>2020-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/surgical-technical-skill-and-long-term-survival-after-surgery-for-colon-cancer/</loc><lastmod>2020-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/adjuvant-irinotecancisplatin-vs-etoposidecisplatin-for-resected-high-grade-neuroendocrine-carcinoma-of-the-lung/</loc><lastmod>2020-11-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/meta-analysis-of-outcomes-with-gamma-knife-radiosurgery-for-uveal-melanoma-or-ocular-metastases/</loc><lastmod>2020-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/risk-of-metachronous-contralateral-testicular-cancer-according-to-platinum-based-chemotherapy-exposure/</loc><lastmod>2020-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/rhg-csf-and-decitabine-to-reduce-risk-of-relapse-in-patients-with-aml-after-stem-cell-transplant/</loc><lastmod>2020-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/reduced-breast-cancer-mortality-and-risk-of-recurrence-with-internal-mammary-and-medial-supraclavicular-nodal-irradiation-in-stage-i-to-iii-breast-cancer/</loc><lastmod>2020-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/medicaid-expansion-associated-with-decreased-mortality-in-patients-with-newly-diagnosed-breast-colorectal-and-lung-cancers/</loc><lastmod>2020-11-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/11-november/serial-covid-19-screening-in-asymptomatic-patients-receiving-treatment-for-cancer/</loc><lastmod>2020-11-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-henrik-groenberg-1/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/ipatasertibabiraterone-combination-shows-potential-in-metastatic-castration-resistant-prostate-cancer-with-pten-loss/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-henrik-groenberg/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/olaparib-improves-outcomes-in-metastatic-castration-resistant-prostate-cancer-with-brca12-alterations/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/fda-approves-nivolumab-plus-ipilimumab-for-the-first-line-treatment-of-unresectable-malignant-pleural-mesothelioma/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/liquid-biopsy-may-be-a-timely-and-effective-testing-method-for-patients-with-nsclc/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/pilot-study-finds-liquid-biopsy-delivers-results-faster-than-tissue-biopsy/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/long-term-impact-of-adt-in-favorable-vs-unfavorable-intermediate-risk-prostate-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/meta-analysis-of-adjuvant-vs-early-salvage-radiotherapy-in-localized-and-locally-advanced-prostate-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-finds-black-and-hispanic-patients-with-cancer-used-telehealth-less-often-than-white-patients-during-the-covid-19-pandemic/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/small-case-study-explores-novel-approach-to-neoadjuvant-therapy-for-skin-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/steven-d-wexner-md-facs-elected-vice-chair-of-board-of-regents-of-american-college-of-surgeons/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/advanced-practitioner-leadership-in-times-of-crisis/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/joan-h-marks-pioneer-in-genetic-counseling-dies-at-91/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/tomas-lyons-dies-at-38/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/remembering-patrick-h-beauregard/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/becoming-acquainted-with-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/shp2-inhibition-may-counter-resistance-mechanisms-in-lung-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/survey-shows-many-patients-with-cancer-willing-to-take-part-in-clinical-trials-despite-coronavirus/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/focus-on-preventing-invasive-recurrence-in-women-with-dcis-does-not-sufficiently-address-breast-cancer-mortality/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/breaking-social-barriers-to-conquer-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/expect-questions-about-increased-cancer-mortality-risk-among-patients-diagnosed-with-dcis/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/your-stories-the-family-business/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/did-you-know-asco-has-resources-on-covid-19-for-people-with-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/continued-benefit-of-first-line-nivolumab-vs-dacarbazine-in-advanced-braf-wild-type-melanoma/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/new-asco-sep-edition-available-expands-reach-to-global-oncology-community/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/preliminary-progress-with-genetically-engineered-t-cells-in-treating-childhood-all/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/2020-snapshot-state-of-the-oncology-workforce-in-america/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/personal-testimonial-car-modified-t-cells-in-adults/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/emily-whitehead-celebrates-8-years-cancer-free/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/impactful-2020-virtual-advocacy-summit-new-environment-same-goals/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/a-gritty-journey-into-a-rare-cancer-and-back/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/the-secret-history-of-cancer-chemotherapy/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/breast-cancer-and-radiation-researcher-david-gius-md-phd-joins-mays-cancer-center/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/recurrence-free-survival-benefit-maintained-with-adjuvant-nivolumab-vs-ipilimumab-in-stage-iiib-iiic-and-iv-melanoma/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/uicc-welcomes-new-president-president-elect-and-board-of-directors-for-2020-2022/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/bloodletting-by-a-phleam/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/pay-for-performance-program-to-reimburse-oncology-practices-for-prescribing-evidence-based-cancer-drugs/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/advanced-melanoma-lenvatinib-plus-pembrolizumab-after-disease-progression-on-anti-pd-1-based-therapy/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-bartosz-chmielowski-1/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/the-gut-our-choices-and-gynecologic-cancers/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/ucla-researchers-efforts-in-melanoma-receive-13m-boost-from-nih/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/cleveland-clinic-announces-oncology-staff-appointments/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/susan-g-komen-to-present-2020-brinker-awards-for-scientific-distinction/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/isabelle-tabah-fisch-md-drug-researcher-industry-executive-dies-at-64/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/panel-with-diverse-perspectives-explores-strategies-to-reduce-costs-for-cancer-care/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-pembrolizumab-plus-chemotherapy-improves-survival-in-esophageal-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/dana-farberharvard-cancer-center-wins-federal-grant-to-accelerate-ovarian-cancer-research/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-salah-eddin-al-batran/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/how-telemedicine-is-impacting-oncology-care-during-the-covid-19-pandemic/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/dana-farber-announces-center-for-salivary-and-rare-head-and-neck-cancers/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/astro-calls-for-changes-to-benefits-manager-policy/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/city-of-hope-launches-innovative-support-model-for-employers/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/abigail-berman-finds-radiation-oncology-intriguing/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/lesley-solomon-receives-extraordinary-women-advancing-healthcare-award/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/fda-awards-six-grants-to-fund-new-clinical-trials-of-medical-products-for-treatment-of-rare-diseases/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/james-k-mccloskey-ii-named-division-chief-of-the-division-of-leukemia-at-john-theurer-cancer-center/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/cancer-in-older-adults-the-history-of-geriatric-oncology-part-2-1990-2020/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/mountainside-medical-center-appoints-co-medical-director/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/surgical-and-radiation-oncology-in-elderly-patients-with-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/2020-nih-director-s-early-independence-awards-announced/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/capmatinib-active-in-advanced-nsclc-with-met-exon-14-skipping-mutations/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/uicc-launches-new-program-at-the-start-of-breast-cancer-awareness-month/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/activity-of-the-kras-g12c-inhibitor-sotorasib-in-kras-g12c-mutant-advanced-solid-tumors/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-pembrolizumab-in-metastatic-colorectal-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-chiara-cremolini/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-rodabe-amaria/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/rutgers-cancer-institute-of-new-jersey-awarded-16m-for-youth-science-program/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/thinking-out-of-the-box-to-advance-the-management-of-chronic-graft-vs-host-disease/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/yale-cancer-center-awarded-nih-spore-grant-for-head-and-neck-cancer-research/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/anthony-fauci-md-to-receive-lifetime-achievement-award-from-national-minority-quality-forum/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/lourdes-a-baezconde-garbanati-receives-aacr-distinguished-lectureship-on-cancer-health-disparities/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/early-phase-study-reports-progress-in-targeting-kras-mutated-tumors-with-sotorasib/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/2020-nobel-prize-in-physiology-or-medicine-awarded-to-team-who-discovered-hepatitis-c-virus/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/emmanuelle-charpentier-phd-and-jennifer-a-doudna-phd-honored-with-nobel-prize-in-chemistry-2020/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/are-delays-in-breast-cancer-treatment-as-harmful-as-commonly-thought/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/asco-approves-first-joint-mstsastroasco-guideline-on-treatment-of-metastatic-carcinoma-and-myeloma-of-the-femur/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/long-term-benefit-of-adjuvant-immunotherapy-sustained-in-stage-iii-or-iv-melanoma/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-fatima-cardoso/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/novel-iap-blocker-plus-chemoradiotherapy-improved-outcomes-in-head-and-neck-cancer-trial/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-sjoukje-oosting/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/co-leader-of-immunotherapy-trial-reflects-on-practice-changing-results-in-advanced-bladder-and-other-urinary-tract-cancers/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/empower-lung-1-trial-cemiplimab-improves-survival-over-chemotherapy-in-advanced-nsclc/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-roy-herbst/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/clinical-challenges-of-managing-breast-cancer-brain-metastases/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/lorlatinib-improves-outcomes-over-crizotinib-in-first-line-setting-of-alk-positive-nsclc-crown-trial/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-christine-m-lovly/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/should-body-mass-index-guide-the-choice-of-chemotherapy-in-patients-with-breast-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/covid-19-cancer-and-the-older-adult/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/sacituzumab-govitecan-yields-survival-benefit-as-third-line-treatment-in-triple-negative-breast-cancer-ascent-trial/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/association-of-tmb-with-response-to-pembrolizumab-in-previously-treated-patients-with-advanced-solid-tumors/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/research-into-cold-tumors-heating-up-in-pancreatic-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/making-strides-in-the-management-of-pancreatic-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/combi-i-trial-no-statistical-benefit-to-adding-spartalizumab-to-dabrafenibtrametinib-in-melanoma/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-bartosz-chmielowski/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/asco-s-policy-statement-on-skin-cancer-prevention-focuses-on-four-key-areas-to-reduce-incidence-and-save-lives/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/black-patients-with-cancer-may-be-at-increased-risk-for-hospitalization-related-to-covid-19-infection/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/cancerlinq-data-reveal-black-and-hispanic-patients-with-cancer-face-greater-risk-of-covid-19-infection/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-examines-combined-impact-of-aspirin-metformin-and-statins-on-lung-cancer-risk/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-immunotherapy-to-other-treatments-in-patients-with-brain-metastases-after-definitive-surgery/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/use-of-ctdna-to-direct-therapy-in-advanced-breast-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/is-drinking-coffee-daily-linked-to-improved-survival-in-patients-with-advanced-colorectal-cancer/</loc><lastmod>2020-10-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-pd-1-inhibitor-with-or-without-chemotherapy-vs-chemotherapy-alone-in-advanced-gastric-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/surgery-with-or-without-preoperative-radiotherapy-for-primary-retroperitoneal-sarcoma/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/neoadjuvant-therapy-for-borderline-resectable-pancreatic-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/aacr-releases-10th-edition-of-annual-cancer-progress-report/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/ending-systemic-racism-in-oncology-is-everyone-s-responsibility/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/an-msk-hospitalist-looks-at-oncologists-attitudes-about-inpatient-cancer-care/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/newer-therapeutic-approaches-improving-outcomes-in-hodgkin-lymphoma/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/adjuvant-chemotherapy-after-pancreatic-cancer-resection-and-neoadjuvant-folfirinox/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/conquer-cancer-announces-2020-quality-care-symposium-merit-awards/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/unique-patient-identifiers-could-help-streamline-nation-s-health-information-technology-infrastructure/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/tell-your-patients-about-asco-s-oncologist-approved-patient-information-website/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/impassion131-no-benefit-for-atezolizumab-plus-paclitaxel-in-triple-negative-breast-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-lisa-carey/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/long-term-outcomes-with-neoadjuvant-therapy-followed-by-surgery-in-rectal-adenocarcinoma/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-veliparib-to-carboplatinpaclitaxel-in-brca-mutated-advanced-breast-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/surgical-oncologist-diane-simeone-strives-to-improve-outcomes-for-patients-with-pancreatic-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/dana-farber-opens-clinical-trial-to-evaluate-simple-blood-test-for-many-types-of-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/art-of-oncology-on-the-page-and-in-a-podcast/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/conquer-cancer-offers-new-research-grants-targeting-diversity-in-research-underserved-patients/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/bolder-more-aggressive-steps-needed-to-achieve-cancer-care-equity/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/impact-of-cytotoxic-chemotherapy-within-5-weeks-of-covid-19-diagnosis-in-patients-with-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/how-anxiety-depression-and-low-social-support-impact-the-intensity-of-cancer-pain/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/dana-farber-cancer-institute-to-establish-benderson-family-program-for-triple-negative-breast-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/patricia-keegan-reflects-on-making-a-difference-in-cancer-care/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/pralsetinib-for-nsclc-with-ret-gene-fusions/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/trends-to-watch-in-early-onset-cancer-among-young-adults/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/nivolumab-plus-chemotherapy-new-standard-of-care-in-advanced-gastric-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-elizabeth-smyth/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/debbie-s-dream-foundation-launches-new-covid-19-resources-and-support-program/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-nelarabine-to-standard-therapy-improves-disease-free-survival-in-newly-diagnosed-t-cell-all/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/eliminating-routine-opioids-while-maintaining-pain-control-for-women-undergoing-lumpectomy-or-excisional-biopsy/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/rucaparib-produces-durable-responses-in-previously-treated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-rafal-dziadziuszko/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/impact-of-adjuvant-osimertinib-on-cns-recurrence-of-nsclc-adaura-trial/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-johan-vansteenkiste/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/total-neoadjuvant-therapy-for-pancreatic-adenocarcinoma/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/carfilzomib-and-daratumumab-with-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/immunologist-thirumala-devi-kanneganti-receives-nci-outstanding-investigator-award/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/deirdre-j-cohen-md-ms-appointed-director-of-mount-sinai-health-system-s-gi-oncology-program/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/wesley-family-donates-10-million-to-seidman-cancer-center/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/a-leading-light-in-cancer-advances-mary-lasker-used-wealth-and-connections-to-increase-funding-for-medical-research/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/city-of-hope-scientists-explore-combination-immunotherapy-for-solid-tumors/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-camillo-porta/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-questions-role-of-routine-postoperative-radiotherapy-in-nsclc-with-mediastinal-nodes/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/astragalus/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/dana-farber-researcher-receives-victoria-mock-new-investigator-award/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/the-history-of-geriatric-oncology-1980-2015/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/the-history-of-geriatric-oncology-1980-2015-part-1/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/managing-breast-cancer-in-a-pregnant-patient/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/timeless-lessons-from-oncology-fellowship/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-george-sledge/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/mobilizing-for-greater-equity-in-health-care-despite-the-challenges-of-covid-19/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/a-primary-care-physician-explores-barriers-to-cancer-prevention-and-clinical-trial-accrual/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/red-flag-presentations-of-immunoglobulin-light-chain-amyloidosis-in-patients-with-multiple-myeloma/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/cancer-centers-nationwide-join-to-address-the-impact-of-covid-19-on-cancer-prevention-and-treatment/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/retrospective-analysis-from-the-big-2-98-trial-of-adjuvant-docetaxel-based-chemotherapy-for-early-breast-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/2020-class-of-giants-of-cancer-care-announced/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/city-of-hope-hires-stephen-gruber-md-phd-mph-to-head-its-center-for-precision-medicine/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/my-inherited-condition-has-led-to-a-life-and-career-i-love/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/lungevity-foundation-recognizes-recipients-of-2020-career-development-awards/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/111-million-nih-grant-awarded-to-prevent-and-treat-hiv-associated-cancers/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-abemaciclib-to-endocrine-therapy-reduces-recurrence-in-early-breast-cancer/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/a-young-oncologist-cares-for-patients-with-cancer-amid-covid-19-pandemic/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/cedars-sinai-announces-addition-of-new-researchers-physicians-to-faculty/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/university-of-rochester-school-of-medicine-and-dentistry-names-ruth-o-regan-md-chair-department-of-medicine/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/neck-tumor/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-finds-racial-disparities-in-management-of-colorectal-cancer-spreading-to-the-liver/</loc><lastmod>2020-10-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-nivolumab-plus-cabozantinib-improves-outcomes-vs-sunitinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2020-10-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/phase-iii-nala-trial-meets-primary-endpoint-in-previously-treated-her2-positive-breast-cancer/</loc><lastmod>2020-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/tucatinib-combination-extends-survival-in-her2-positive-metastatic-breast-cancer-including-patients-with-brain-metastases/</loc><lastmod>2020-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/high-risk-her2-positive-breast-cancer-neoadjuvant-and-adjuvant-treatment-options/</loc><lastmod>2020-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/her2-positive-metastatic-breast-cancer-highlights-2019-2020-almanac/</loc><lastmod>2020-10-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/novel-indications-and-new-drugs-for-the-treatment-of-patients-with-breast-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/emerging-alternatives-in-the-third-line-setting-for-metastatic-her2-positive-breast-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/tucatinib-combination-in-previously-treated-her2-positive-metastatic-breast-cancer-with-brain-metastases/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/local-recurrence-with-radiation-boost-in-her2-positive-breast-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/advanced-her2-positive-breast-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/updates-from-additional-clinical-trials-in-her2-positive-breast-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/epov-ian-krop-angela-demichele-and-carlos-arteaga/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/phase-iii-sophia-trial-evaluates-margetuximabchemotherapy-vs-trastuzumabchemotherapy-for-her2-positive-breast-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/abemaciclibfulvestranttrastuzumab-for-patients-with-previously-treated-hr-positive-her2-positive-advanced-breast-cancer/</loc><lastmod>2020-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/neratinib-in-previously-treated-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-atezolizumab-to-neoadjuvant-chemotherapy-in-early-stage-triple-negative-breast-cancer/</loc><lastmod>2020-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-durvalumab-with-or-without-tremelimumab-vs-chemotherapy-for-metastatic-urothelial-carcinoma/</loc><lastmod>2020-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/novel-small-molecule-inhibitor-surufatinib-for-advanced-extrapancreatic-neuroendocrine-tumors/</loc><lastmod>2020-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-atezolizumab-vs-chemotherapy-in-pd-l1-positive-metastatic-nsclc/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-finds-disparities-in-microsatellite-instabilitymismatch-repair-biomarker-testing-for-patients-with-stage-iv-colorectal-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/survey-of-health-care-providers-finds-knowledge-about-unique-needs-of-lgbtq-patients-with-cancer-is-limited/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/effect-of-early-trastuzumab-interruption-on-recurrence-free-survival-in-her2-positive-breast-cancer/</loc><lastmod>2020-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/time-at-home-vs-in-health-care-institutions-for-older-patients-after-cancer-surgery/</loc><lastmod>2020-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/first-line-dasatinib-plus-blinatumomab-for-adult-patients-with-philadelphia-chromosome-positive-acute-lymphoblastic-leukemia/</loc><lastmod>2020-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/gemcitabine-and-daily-radiation-for-patients-with-muscle-invasive-bladder-cancer/</loc><lastmod>2020-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/effect-of-angiotensin-ii-inhibition-on-response-to-immunotherapy/</loc><lastmod>2020-10-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/surufatinib-in-advanced-pancreatic-neuroendocrine-tumors/</loc><lastmod>2020-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/sexual-health-often-overlooked-in-cancer-survivorship-care/</loc><lastmod>2020-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/pretreatment-ctdna-may-help-predict-outcomes-with-first-line-but-not-second-line-immunotherapy-for-patients-with-melanoma/</loc><lastmod>2020-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/camrelizumab-plus-apatinib-in-previously-treated-patients-with-advanced-cervical-cancer/</loc><lastmod>2020-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/effect-of-virtual-tumor-board-implementation-on-use-of-whole-breast-hypofractionated-radiation-therapy/</loc><lastmod>2020-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/radiation-induced-genetic-deletions-may-be-associated-with-poorer-patient-outcomes/</loc><lastmod>2020-10-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/adjuvant-vs-salvage-radiotherapy-plus-short-term-adt-after-radical-prostatectomy-for-localized-prostate-cancer/</loc><lastmod>2020-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/radiotherapy-with-cisplatin-vs-cetuximab-in-previously-untreated-patients-with-locoregionally-advanced-head-and-neck-cancer/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/next-generation-braf-inhibitor-shows-activity-in-phase-iii-trial/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/sbrt-for-multiple-lung-metastases-how-many-treatment-sessions-are-optimal/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/sbrt-may-provide-superior-pain-relief-from-spinal-metastases-vs-conventional-radiotherapy/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-finds-further-efforts-needed-for-inclusion-of-underrepresented-populations-in-radiotherapy-clinical-trials/</loc><lastmod>2020-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/geographic-access-to-radiotherapy-facilities-in-the-united-states/</loc><lastmod>2020-10-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/targeted-inhibitor-of-mutant-kras-gene-shows-activity-in-early-trial/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/fluciclovine-pet-imaging-vs-conventional-imaging-in-prostate-cancer/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/stereotactic-radiosurgery-may-delay-cognitive-deterioration-vs-wbrt-in-patients-with-numerous-brain-metastases/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/trends-and-outcomes-among-hispanic-women-of-different-races-with-breast-cancer/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/fda-approves-companion-diagnostic-for-three-targeted-therapies-for-advanced-ovarian-breast-and-non-small-cell-lung-cancers/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/uspstf-issues-draft-recommendation-on-screening-for-colorectal-cancer/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/final-efficacy-results-from-the-extenet-trial-neratinib-in-pretreated-patients-with-hr-positive-her2-positive-early-breast-cancer/</loc><lastmod>2020-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/neoadjuvant-dual-checkpoint-blockade-in-certain-patients-with-localized-bladder-cancer/</loc><lastmod>2020-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/behavioral-nudges-combined-with-machine-learning-mortality-estimates-may-improve-rate-of-advanced-cancer-care-conversations/</loc><lastmod>2020-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/dr-christina-cone-honored-with-the-mary-pazdur-award-for-excellence-in-advanced-practice-in-oncology-by-apsho/</loc><lastmod>2020-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/fda-pipeline-priority-reviews-in-egfr-mutant-lung-cancer-advanced-renal-cell-carcinoma-fast-track-designations-in-cll-and-solid-tumors/</loc><lastmod>2020-10-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/companion-diagnostic-to-identify-ntrk-fusions-in-patients-with-solid-tumors-eligible-for-treatment-with-larotrectinib-approved-by-the-fda/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/limited-english-language-proficiency-may-affect-frequency-of-screening-mammograms/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/sentinel-node-biopsy-vs-neck-node-dissection-in-operable-oral-or-oropharyngeal-cancer-equivalence-trial/</loc><lastmod>2020-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/fragment-analysis-as-a-met-exon-14-screening-strategy-in-nsclc-tumors/</loc><lastmod>2020-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/study-finds-combined-hdac-and-mtor-inhibition-may-improve-outcomes-in-patients-with-relapsed-or-refractory-hodgkin-lymphoma/</loc><lastmod>2020-10-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-oxaliplatin-to-preoperative-capecitabine-based-chemoradiation-and-adjuvant-capecitabine-in-locally-advanced-rectal-cancer/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/adjuvant-sorafenib-vs-placebo-in-patients-with-kidney-cancer-at-intermediate-or-high-risk-of-relapse/</loc><lastmod>2020-10-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/molecular-profiles-and-actionable-alterations-identified-in-the-nci-match-trial/</loc><lastmod>2020-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/long-term-follow-up-of-anti-cd19-car-t-cell-therapy-in-relapsed-b-cell-malignancies/</loc><lastmod>2020-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/urine-based-liquid-biopsy-may-perform-similarly-to-urine-cytology-in-detecting-urothelial-carcinoma/</loc><lastmod>2020-10-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-cetuximab-to-afatinib-in-first-line-treatment-of-egfr-mutant-nsclc/</loc><lastmod>2020-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/tazemetostat-in-patients-with-advanced-epithelioid-sarcoma-and-loss-of-ini1smarcb1/</loc><lastmod>2020-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/ixazomib-maintenance-in-newly-diagnosed-patients-with-multiple-myeloma-not-undergoing-stem-cell-transplant/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/can-routine-scans-help-predict-which-patients-with-breast-cancer-may-be-at-risk-for-heart-disease/</loc><lastmod>2020-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/keynote-181-trial-second-line-pembrolizumab-vs-chemotherapy-in-advanced-esophageal-cancer/</loc><lastmod>2020-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/new-study-offers-a-global-review-of-the-impact-of-covid-19-on-cancer-treatment-and-research/</loc><lastmod>2020-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/do-hospitals-that-primarily-serve-minority-patients-offer-standard-surgical-care-for-patients-with-breast-cancer/</loc><lastmod>2020-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/prognostic-model-for-outcomes-with-ibrutinib-treatment-for-chronic-lymphocytic-leukemia/</loc><lastmod>2020-10-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-atezolizumab-to-trastuzumab-emtansine-in-previously-treated-patients-with-her2-positive-advanced-breast-cancer/</loc><lastmod>2020-10-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/designations-for-treatments-of-rare-blood-cancer-b-cell-malignancies-and-gastric-cancers/</loc><lastmod>2020-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/pulmonary-complication-rates-after-elective-cancer-surgery-in-hospitals-with-vs-without-covid-19-free-surgical-pathways/</loc><lastmod>2020-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/association-of-adjuvant-chemotherapy-with-survival-in-early-stage-nsclc/</loc><lastmod>2020-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/biochemical-progression-free-survival-with-adjuvant-vs-salvage-radiotherapy-after-radical-prostatectomy/</loc><lastmod>2020-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/oral-cancer-pain-may-predict-likelihood-of-metastasis/</loc><lastmod>2020-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/identifying-characteristics-of-infused-car-t-cells-associated-with-efficacy-and-toxicity-in-patients-with-large-b-cell-lymphoma/</loc><lastmod>2020-10-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/long-term-evaluation-of-treatment-efficacy-after-primary-dcis-diagnosis/</loc><lastmod>2020-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/emmanuelle-charpentier-and-jennifer-a-doudna-honored-with-the-nobel-prize-in-chemistry-2020/</loc><lastmod>2020-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/addition-of-nivolumab-to-neoadjuvant-chemotherapy-in-resectable-stage-iiia-nsclc/</loc><lastmod>2020-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/nab-paclitaxel-vs-paclitaxel-in-platinum-refractory-metastatic-urothelial-cancer/</loc><lastmod>2020-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/neoadjuvant-lapatinibtrastuzumab-in-her2-positive-breast-cancer/</loc><lastmod>2020-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/new-study-finds-low-rates-of-bone-mineral-density-testing-in-men-treated-with-adt-for-prostate-cancer/</loc><lastmod>2020-10-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/priority-review-for-agents-in-multiple-myeloma-anaplastic-large-cell-lymphoma/</loc><lastmod>2020-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/patient-experiences-of-acute-toxicity-from-breast-radiotherapy-according-to-fractionation-scheme/</loc><lastmod>2020-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/four-year-findings-from-the-murano-trial-venetoclax-plus-rituximab-for-relapsed-chronic-lymphocytic-leukemia/</loc><lastmod>2020-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/2020-nobel-prize-in-physiology-or-medicine-awarded-to-team-who-discovered-hepatitis-c-virus-1/</loc><lastmod>2020-10-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/breast-cancer-risk-after-benign-breast-disease/</loc><lastmod>2020-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/cancer-therapy-based-on-molecular-tumor-board-recommendations/</loc><lastmod>2020-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/is-cancer-mortality-higher-in-counties-that-experience-persistent-poverty/</loc><lastmod>2020-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/asco-s-national-cancer-opinion-survey/</loc><lastmod>2020-10-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/avelumab-maintenance-therapy-in-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2020-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/five-year-outcomes-first-line-nivolumab-vs-dacarbazine-in-advanced-braf-wild-type-melanoma/</loc><lastmod>2020-10-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/adjuvant-nivolumab-vs-ipilimumab-in-stage-iiib-iiic-and-iv-melanoma/</loc><lastmod>2020-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/10-october/adjuvant-trastuzumab-with-or-without-chemotherapy-for-older-patients-with-her2-positive-early-breast-cancer/</loc><lastmod>2020-10-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/covid-19-prevalence-and-mortality-in-patients-with-cancer-in-the-uk/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fda-approves-oral-azacitidine-as-maintenance-therapy-for-adults-with-aml-in-first-remission/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/combination-immunotherapy-benefits-subset-of-patients-with-advanced-prostate-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/dr-kantarjian-shares-his-thoughts-on-optimizing-the-treatment-of-adults-with-all/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cigarette-smoking-associated-with-worse-outcomes-for-patients-with-bladder-cancer-after-surgery/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/selective-met-inhibitor-tepotinib-in-patients-with-advanced-nsclc-and-met-exon-14-skipping-mutation/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/greater-coverage-patient-education-and-research-for-telemedicine-needed-during-the-covid-19-pandemic-and-beyond/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/recognizing-the-coexistence-of-symptoms-of-pancreatic-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/in-marriage-and-medicine-judith-and-alan-kaur-vow-to-advance-cancer-research/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/sylvester-comprehensive-cancer-center-receives-gift/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/leukemia-lymphoma-society-launches-first-clinical-trial-in-patients-with-hematologic-malignancy-and-covid-19/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cancer-in-my-community-caring-for-children-with-cancer-in-armenia/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/conquer-cancer-collaborates-with-israel-cancer-research-fund-for-career-development-award-in-israel/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/october-cancer-awareness-month-patient-resources-from-asco/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nccn-adds-tafasitamab-cxix-to-its-clinical-practice-guidelines-in-oncology-for-b-cell-lymphomas/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/regional-council-for-a-stronger-society/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/study-finds-recent-onset-diabetes-with-unintentional-weight-loss-linked-to-increased-risk-of-pancreatic-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/pembrolizumab-produces-durable-responses-in-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cancer-center-at-brown-university-established/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cleveland-clinic-appoints-new-chair-of-head-and-neck-institute/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/effect-of-mammography-screening-from-age-40-on-breast-cancer-mortality-in-the-uk-age-trial/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/leading-cancer-treatment-recommendations-from-nccn-available-in-several-languages/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-venetoclax-to-azacitidine-in-acute-myeloid-leukemia/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/neratinib-in-previously-treated-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/new-breast-cancer-agents-and-concurrent-radiation/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/many-reasons-to-geriatricize-your-oncology-practice-research-updates-from-asco20/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/national-survey-shows-decline-in-overall-youth-e-cigarette-use-uptick-in-use-of-disposable-products/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/good-outcomes-with-pet-directed-therapy-for-limited-stage-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/covid-19-pandemic-delays-cancer-care-and-strains-resources/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/botswana/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/karmanos-receives-catch-up-grant-to-recruit-minority-rural-patients-to-clinical-trials/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/eric-winer-recipient-of-lifetime-achievement-in-mentoring-award/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/ezra-greenspan-helped-usher-in-the-modern-era-of-chemotherapy/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/never-say-never/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/i-ve-turned-my-pain-into-a-new-life-purpose/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nygc-launches-collaborative-cancer-genomics-research-projects-focused-on-underserved-populations/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/updates-on-bcma-directed-car-modified-t-cell-gene-therapies/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/brexucabtagene-autoleucel-for-relapsed-or-refractory-mantle-cell-lymphoma/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/irish-boy-with-his-scapula/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/iu-cancer-center-researcher-awarded-grant-to-study-chemotherapy-induced-hearing-loss-toxicities/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/early-cancer-experience-plants-the-seed-for-a-career-in-oncology-to-grow-for-joyce-liu/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-christopher-anker/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/age-at-diagnosis-may-improve-risk-stratification-for-patients-with-breast-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/avapritinib-produces-high-response-rate-in-advanced-pdgfra-d842v-mutant-gist/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/city-of-hope-leads-novel-clinical-trial-to-treat-patients-with-cancer-and-covid-19/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/sentinel-lymph-node-biopsy-and-age-related-mutations-therapeutic-and-predictive-implications-in-melanoma/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/phase-iii-nala-trial-meets-primary-endpoint-in-previously-treated-her2-positive-breast-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-david-scott/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/azacitidine-tablets-for-continued-treatment-in-acute-myeloid-leukemia/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/corticosteroids-improve-survival-in-critically-ill-patients-with-covid-19-according-to-international-trial/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/is-infiltrating-tumor-border-configuration-linked-to-poor-survival-in-colon-adenocarcinoma/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-george-j-chang/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/neoadjuvant-chemotherapy-alone-vs-chemoradiation-in-esophageal-cancer-no-difference-found-in-long-term-survival/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/impact-of-neoadjuvant-endocrine-therapy-and-neoadjuvant-chemotherapy-on-rates-of-breast-conserving-surgery/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/the-new-face-of-medical-visits/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/disparities-and-incidence-of-late-effects-of-treatment-for-aya-lymphoma-survivors/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-christopher-flowers/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/world-gynecologic-oncology-awareness-day/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/applications-of-circulating-tumor-dna-liquid-biopsy-continue-to-expand-in-lymphomas/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fda-issues-alert-about-efficacy-and-potential-safety-concerns-regarding-atezolizumab-plus-paclitaxel-in-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/enthusiastic-response-to-novel-therapies-on-the-horizon-in-multiple-myeloma/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/second-line-carboplatinetoposide-vs-topotecan-in-relapsed-small-cell-lung-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/caring-for-undocumented-patients-with-cancer/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/inaugural-aacr-cancer-disparities-progress-report-released/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/efforts-to-broaden-eligibility-criteria-for-clinical-trials-seek-to-include-more-racial-and-ethnic-minority-patients/</loc><lastmod>2020-09-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/chemotherapy-free-approaches-in-follicular-and-mantle-cell-lymphomas/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/reevaluating-the-delivery-of-palliative-care-in-the-era-of-covid-19/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/from-behind-the-iron-curtain-to-a-career-in-gynecologic-cancer-research-for-daniela-matei-md/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/developing-policies-to-address-patient-racial-bias-and-race-based-provider-requests/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/acupuncture-vs-sham-procedure-and-usual-care-for-chemotherapy-induced-peripheral-neuropathy/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/web-based-tool-may-help-patients-with-cancer-choose-the-best-insurance-for-their-needs/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-misako-nagasaka/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/meta-analysis-of-overall-survival-with-immunotherapy-in-patients-with-advanced-cancer-according-to-sex-age-and-performance-status/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fda-approves-daratumumab-plus-carfilzomib-and-dexamethasone-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/activity-of-olaparib-and-durvalumab-in-germline-brca-mutated-metastatic-breast-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/changes-in-overall-survival-in-patients-with-anaplastic-thyroid-carcinoma-from-2000-2019/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/implementation-of-race-for-children-act-helps-address-unmet-needs-of-children-with-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/strategies-for-early-detection-and-management-of-lymphedema/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/adjuvant-nivolumab-plus-ipilimumab-vs-nivolumab-alone-in-resected-stage-iv-melanoma-with-no-evidence-of-disease/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/is-it-time-to-add-checkpoint-inhibitors-to-the-treatment-of-locally-advanced-lung-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/metastatic-prostate-cancer-sorting-through-the-treatment-maze/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/orient-11-trial-shows-sintilimab-plus-chemotherapy-improves-progression-free-survival-in-advanced-nsclc/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/i-say-yes-to-life/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/asco-position-statement-recommends-specific-actions-for-applying-telemedicine-in-cancer-care-during-pandemic-and-beyond/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fine-tuning-car-t-cell-therapy-for-lymphomas/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/karmanos-receives-630-000-catch-up-grant-to-recruit-minority-rural-patients-to-clinical-trials/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/lymphomas-in-adolescents-and-young-adults-deserve-further-study/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/american-college-of-surgeons-launches-new-cancer-surgery-standards-program-to-improve-quality-of-care/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-electra-paskett/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cervical-cancer-screening-and-prevention-in-low-and-middle-income-countries-2020/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-atr-inhibitor-berzosertib-to-gemcitabine-improves-progression-free-survival-in-recurrent-platinum-resistant-high-grade-serous-ovarian-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/theodore-laetsch-md-joins-children-s-hospital-of-philadelphia-to-launch-very-rare-malignant-tumors-program/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/roger-h-herzig-md-pioneer-in-the-treatment-of-leukemia-dies-at-age-74/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/new-chief-of-oncologic-quality-at-rutgersrobert-wood-johnson/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/getting-up-to-speed-on-2021-updates-to-evaluation-and-management-codes/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/educate-patients-at-home-with-asco-answers/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/oral-combination-of-decitabine-and-cedazuridine-for-myelodysplastic-syndromes/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/belantamab-mafodotin-blmf-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/seattle-cancer-care-alliance-expands-south-lake-union-campus/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/simple-rapid-vinegar-screening-test-cuts-cervical-cancer-death-rates-by-one-third-in-rural-india/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fitness-based-treatment-of-older-adults-with-multiple-myeloma-who-are-transplant-ineligible/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/global-oncology-young-investigator-award/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/doctor-and-a-patient-advocate-team-up-to-conquer-desmoid-tumors/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/dana-farber-launches-new-center-for-prevention-and-treatment-of-brca-related-cancers/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/quality-payment-program-provisions-in-fee-schedule-proposal-set-stage-for-2021-and-postpandemic-landscape/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/marc-citron-establishes-grants-through-conquer-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/profound-trial-evaluates-olaparib-in-homologous-recombination-repair-gene-mutant-prostate-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/avelumab-in-maintenance-treatment-of-urothelial-carcinoma/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/setting-an-ambitious-path-to-ensure-health-equity-for-all-patients-with-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/lungevity-fda-launch-lung-cancer-patient-research-project/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/three-scientists-at-johns-hopkins-tapped-to-join-exclusive-research-network/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/atezolizumab-plus-cobimetinibvemurafenib-in-braf-v600-positive-unresectable-or-metastatic-melanoma/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/high-risk-her2-positive-breast-cancer-neoadjuvant-and-adjuvant-treatment-options/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/leaders-in-radiation-oncology-awarded-astro-fellow-designation/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cdc-data-show-disproportionate-covid-19-impact-in-american-indian-and-alaska-native-populations/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/large-study-finds-no-link-between-antihypertensives-and-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/a-moment-to-pause-reflect-and-act-amid-a-pandemic/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/how-patients-add-life-to-their-days/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/growing-body-of-evidence-supports-adjuvant-immunotherapy-for-stage-iv-melanoma-with-no-evidence-of-disease/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/mobilizing-to-meet-challenges-and-improve-survival-for-covid-19-positive-patients-and-health-care-professionals/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/personalized-medicine-meets-geriatric-oncology-tailoring-oncologic-care-for-older-adults/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fox-chase-cancer-center-welcomes-robert-brenchak/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/update-on-novel-immunotherapies-for-plasma-cell-disorders/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/primary-prevention-strategies-for-avoiding-cardiotoxicity-in-patients-with-cancer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/ensartinib-doubles-progression-free-survival-in-alk-positive-nsclc/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-christine-lovly/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/messino-cancer-centers-founder-receives-north-carolina-governor-s-award/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/tracy-onega-named-senior-director-of-population-sciences-at-huntsman-cancer-institute/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/moffitt-cancer-center-names-patrick-hwu-president-and-chief-executive-officer/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/challenges-to-providing-appropriate-care-in-the-age-of-covid-19/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/how-delays-in-screening-and-early-cancer-diagnosis-amid-the-covid-19-pandemic-may-result-in-increased-cancer-mortality/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nci-cancer-research-uk-launch-cancer-grand-challenges-partnership/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nivolumab-plus-ipilimumab-in-first-line-treatment-of-unresectable-malignant-pleural-mesothelioma/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-dean-fennell/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/targeting-kras-mutated-tumors/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/study-indicates-delaying-antiviral-treatment-may-boost-immunity-in-stem-cell-transplant-recipients/</loc><lastmod>2020-09-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-trophimmun/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/trophimmun-trial-finds-avelumab-effective-in-rare-gynecologic-tumor-resistant-to-chemotherapy/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/american-cancer-society-updates-guideline-for-cervical-cancer-screening/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/higher-risk-of-disease-recurrence-and-death-with-minimally-invasive-vs-open-surgery-for-early-stage-cervical-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/lenvatinibpembrolizumab-in-previously-treated-patients-with-advanced-endometrial-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-trastuzumab-to-carboplatinpaclitaxel-for-advanced-or-recurrent-her2-positive-uterine-serous-carcinoma/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/quality-of-life-with-open-vs-minimally-invasive-radical-hysterectomy-for-patients-with-cervical-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/effect-of-molecular-classification-of-endometrial-cancer-on-outcomes-with-adjuvant-therapy/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/gynecologic-oncologist-describes-practice-in-the-era-of-covid-19/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-shannon-westin/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/wee1-inhibitor-shows-activity-in-recurrent-uterine-serous-carcinoma/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-nicoletta-colombo/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-kathleen-moore/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/immunotherapy-in-cervical-and-endometrial-cancers/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/updated-analysis-of-velia-trial-shows-antitumor-activity-in-ovarian-cancer-but-is-it-enough/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cediranib-plus-olaparib-vs-standard-of-care-chemotherapy-for-platinum-sensitive-ovarian-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/effect-of-statins-on-survival-in-ovarian-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/in-women-with-advanced-ovarian-cancer-pembrolizumab-yields-modest-antitumor-efficacy/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/final-overall-survival-analysis-from-solo2-in-ovarian-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-robert-coleman/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/secondary-surgery-may-extend-survival-in-recurrent-ovarian-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/veliparib-plus-first-line-chemotherapy-and-as-maintenance-therapy-in-high-grade-ovarian-cancer/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-ana-oaknin/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/prima-trial-reports-benefit-with-niraparib-across-ovarian-cancer-subsets/</loc><lastmod>2020-09-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/novel-drug-approvals-and-new-indications-for-gynecologic-cancers/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/epov-thomas-j-herzog/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/updated-data-from-prima-trial-niraparib-as-first-line-maintenance-therapy-for-advanced-ovarian-cancer/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/clinical-perspective-on-paola-1-maintenance-therapy-for-advanced-ovarian-cancer/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-olaparib-to-bevacizumab-maintenance-in-advanced-ovarian-cancer-paola-1-trial/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/gynecologic-oncology-highlights-2019-2020-almanac/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/carfilzomib-vs-bortezomib-combined-with-lenalidomidedexamethasone-in-newly-diagnosed-patients-with-multiple-myeloma/</loc><lastmod>2020-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/assessment-of-potential-abscopal-effect-of-sbrt-added-to-nivolumab-in-metastatic-head-and-neck-cancer/</loc><lastmod>2020-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/geriatric-comanagement-after-cancer-surgery-in-patients-aged-75-and-older/</loc><lastmod>2020-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/are-patients-with-hematologic-cancers-more-vulnerable-to-the-effects-of-covid-19/</loc><lastmod>2020-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/impact-of-prior-insurance-coverage-disruptions-on-health-care-access-and-affordability-for-currently-insured-cancer-survivors/</loc><lastmod>2020-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/comparing-pazopanib-to-doxorubicin-in-patients-aged-60-and-older-with-soft-tissue-sarcoma/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/risk-reducing-early-salpingectomy-and-delayed-oophorectomy-among-premenopausal-women/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/association-of-adjuvant-endocrine-therapy-with-overall-survival-in-small-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-veliparib-to-carboplatinpaclitaxel-in-previously-treated-patients-with-brca-mutated-advanced-breast-cancer/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/does-binimetinib-improve-progression-free-survival-in-recurrent-or-persistent-low-grade-serous-ovarian-carcinomas/</loc><lastmod>2020-09-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/changes-in-reoperation-rates-after-publication-of-ssoastro-guideline-on-margins-for-breast-conserving-surgery/</loc><lastmod>2020-09-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/updated-results-of-the-alternative-trial-of-lapatinibtrastuzumab-plus-ai-in-her2-positive-hr-positive-metastatic-breast-cancer/</loc><lastmod>2020-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/long-term-outcomes-with-apbi-vs-wbi-in-patients-with-early-breast-cancer/</loc><lastmod>2020-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/first-line-durvalumab-plus-cisplatinpemetrexed-in-malignant-pleural-mesothelioma/</loc><lastmod>2020-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cryopreservation-may-be-associated-with-loss-of-quality-in-donor-stem-cell-products/</loc><lastmod>2020-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nyts-shows-decline-in-overall-youth-e-cigarette-use-uptick-in-use-of-disposable-products/</loc><lastmod>2020-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/adjuvant-dabrafenibtrametinib-in-patients-with-stage-iii-melanoma-and-braf-v600-mutations/</loc><lastmod>2020-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/phase-ii-trial-of-capmatinib-for-met-exon-14-mutated-or-met-amplified-advanced-nsclc/</loc><lastmod>2020-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/first-line-pazopanib-vs-doxorubicin-in-patients-aged-60-or-older-with-metastatic-soft-tissue-sarcoma/</loc><lastmod>2020-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/immune-checkpoint-inhibitor-therapy-may-contribute-to-arterial-inflammation/</loc><lastmod>2020-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/retrospective-study-explores-association-between-raceethnicity-and-overall-survival-in-colorectal-liver-metastases/</loc><lastmod>2020-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/efficacy-of-high-intensity-ultrasound-ablation-for-prostate-cancer/</loc><lastmod>2020-09-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-debio-1143-to-cisplatin-chemoradiotherapy-in-locoregionally-advanced-head-and-neck-cancer/</loc><lastmod>2020-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/racial-differences-in-genomic-profiles-of-primary-and-metastatic-prostate-cancer/</loc><lastmod>2020-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/association-of-immunoscore-with-time-to-recurrence-in-stage-iii-colon-cancer/</loc><lastmod>2020-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/role-of-inherited-gata3-variant-in-response-to-treatment-disease-relapse-in-pediatric-all/</loc><lastmod>2020-09-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/venetoclax-plus-obinutuzumab-in-previously-untreated-patients-with-cll/</loc><lastmod>2020-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/social-smoking-raises-risk-of-death-from-lung-disease-and-lung-cancer/</loc><lastmod>2020-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fda-pipeline-priority-reviews-in-multiple-myeloma-metastatic-breast-cancer-and-nsclc/</loc><lastmod>2020-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/fda-approves-pralsetinib-for-metastatic-ret-fusion-positive-nsclc/</loc><lastmod>2020-09-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/osimertinib-vs-platinumpemetrexed-in-patients-with-egfr-t790m-advanced-nsclc/</loc><lastmod>2020-09-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/new-study-focuses-on-multiorgan-immunotherapy-related-adverse-events-in-clinical-trials/</loc><lastmod>2020-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/research-seeks-to-provide-information-on-the-immune-microenvironment-of-pancreatic-neuroendocrine-tumors/</loc><lastmod>2020-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/qa-pfs-and-q-twist-in-the-ariel3-trial-of-rucaparib-maintenance-therapy-for-recurrent-ovarian-cancer/</loc><lastmod>2020-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/local-recurrence-with-radiation-boost-in-her2-positive-breast-cancer/</loc><lastmod>2020-09-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/lisocabtagene-maraleucel-for-relapsed-or-refractory-large-b-cell-lymphomas/</loc><lastmod>2020-09-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/eflornithine-plus-sulindac-vs-either-agent-alone-in-preventing-progression-of-familial-adenomatous-polyposis/</loc><lastmod>2020-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/meta-analysis-of-duration-of-adjuvant-trastuzumab-in-early-breast-cancer/</loc><lastmod>2020-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/overall-survival-with-darolutamide-in-patients-with-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/researchers-report-on-comprehensive-analysis-of-adenosquamous-carcinoma-of-the-pancreas/</loc><lastmod>2020-09-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/effect-of-machine-learning-directed-clinical-evaluations-on-acute-care-visits-during-outpatient-therapy/</loc><lastmod>2020-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/proton-pump-inhibitor-use-may-be-associated-with-worse-outcomes-in-patients-treated-with-atezolizumab-for-urothelial-cancer/</loc><lastmod>2020-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/viral-load-may-help-predict-mortality-rate-in-hospitalized-patients-with-cancer-and-covid-19/</loc><lastmod>2020-09-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/addition-of-pembrolizumab-to-eribulin-in-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2020-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/role-of-f-18-naf-petct-in-patients-with-metastatic-castration-resistant-prostate-cancer-treated-with-enzalutamide/</loc><lastmod>2020-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/designations-in-prostate-cancer-glioblastoma-and-pediatric-leukemia/</loc><lastmod>2020-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/access-to-treatments-and-trials-varies-widely-for-patients-with-cancer-across-europe/</loc><lastmod>2020-09-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/effects-of-the-covid-19-pandemic-on-cancer-care-provider-well-being/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/maintenance-avelumab-plus-best-supportive-care-in-advanced-bladder-cancer/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/checkmate-9er-trial-shows-benefit-of-nivolumabcabozantinib-for-advanced-kidney-cancer/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cancer-treatment-related-outcomes-in-patients-with-cancer-and-covid-19/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/kras-g12c-inhibitor-shows-activity-in-solid-tumors-lung-cancer/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/world-gynecologic-oncology-awareness-day-world-go-day/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/study-questions-role-of-routine-postoperative-radiotherapy-in-nsclc-with-mediastinal-nodes/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/abemaciclib-plus-endocrine-therapy-may-reduce-recurrence-in-early-breast-cancer/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/overall-survival-analysis-in-the-profound-trial-of-olaparib-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/first-line-checkpoint-inhibitors-may-improve-survival-in-gastroesophageal-cancers/</loc><lastmod>2020-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/new-report-focuses-on-cancer-statistics-in-adolescents-and-young-adults/</loc><lastmod>2020-09-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/olanzapine-for-children-and-adolescents-receiving-highly-emetogenic-chemotherapy/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/disease-free-survival-with-adjuvant-osimertinib-in-resected-egfr-mutant-nsclc/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/overall-survival-with-apalutamide-in-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/solo1-5-year-follow-up-maintenance-olaparib-for-brca-mutated-advanced-ovarian-cancer/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/joint-statement-from-the-ama-aha-and-ana-on-us-coronavirus-death-toll/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/cabozantinib-and-nivolumab-with-or-without-ipilimumab-in-advanced-genitourinary-malignancies/</loc><lastmod>2020-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/does-radical-hysterectomy-improve-survival-in-patients-with-cervical-cancer-and-intraoperative-detection-of-positive-lymph-nodes/</loc><lastmod>2020-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/adjuvant-nivolumab-vs-ipilimumab-in-resected-advanced-melanoma/</loc><lastmod>2020-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/continuous-vs-fixed-duration-immunotherapy-in-previously-treated-patients-with-advanced-nsclc/</loc><lastmod>2020-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nivolumab-shows-activity-in-edpole-mutated-mmr-proficient-advanced-cancers/</loc><lastmod>2020-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/elderly-patients-with-advanced-colorectal-cancer-treated-with-adjuvant-oxaliplatin-plus-fluoropyrimidines/</loc><lastmod>2020-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/abbreviated-breast-mri-as-supplementary-screening-method-in-women-with-dense-breasts/</loc><lastmod>2020-09-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/meta-analyses-of-quality-of-life-in-patients-treated-with-checkpoint-inhibitors/</loc><lastmod>2020-09-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/breast-induration-with-hypofractionated-vs-standard-fractionated-radiotherapy-in-patients-with-early-breast-cancer-or-dcis/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/quality-of-life-with-cabazitaxel-vs-abiraterone-or-enzalutamide-in-metastatic-prostate-cancer/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/pralsetinib-in-ret-mutated-medullary-thyroid-cancer/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/does-pembrolizumab-monotherapy-demonstrate-benefit-in-rare-sarcomas/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/malnutrition-among-patients-with-cancer-admitted-to-the-hospital-may-increase-the-risk-for-infection/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/benefit-of-pembrolizumab-in-high-risk-stage-iii-melanoma-3-year-follow-up/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/nonlymphoma-mortality-following-initial-chemotherapy-in-patients-with-classical-hodgkin-lymphoma/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/is-ctdna-effective-in-detecting-genomic-alterations-in-patients-with-metastatic-kidney-cancer/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/first-in-class-human-igg4-monoclonal-antibody-shows-activity-alone-and-combined-with-pembrolizumab-in-advanced-solid-tumors/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/consolidation-radiotherapy-for-patients-with-advanced-hodgkin-lymphoma-and-a-large-nodal-mass/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/activity-of-the-kras-g12c-inhibitor-sotorasib-in-kras-pg12c-mutant-advanced-solid-tumors/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/genetic-testing-may-be-cost-effective-for-newly-diagnosed-patients-with-gist/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/09-september/adjuvant-abemaciclib-plus-endocrine-therapy-in-patients-with-early-breast-cancer-at-high-risk-of-recurrence/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-grants-accelerated-approval-to-belantamab-mafodotin-blmf-for-pretreated-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nivolumab-and-ipilimumab-in-advanced-biliary-tract-cancers/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/uicc-applauds-who-global-strategy-on-eliminating-cervical-cancer-as-a-public-health-problem/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-locoregional-radiotherapy-to-chemotherapy-for-metastatic-nasopharyngeal-carcinoma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/update-on-detecting-and-treating-biologically-diverse-neuroendocrine-tumors/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/impact-of-immune-checkpoint-inhibitors-on-covid-19-in-patients-with-cancer/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/third-or-later-line-treatment-with-infigratinib-in-patients-with-cholangiocarcinoma-and-fgfr2-fusions/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-provisional-clinical-update-offers-new-recommendations-for-hbv-management-in-patients-with-cancer/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/ripretinib-improves-progression-free-survival-vs-placebo-in-previously-treated-advanced-gist/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/switch-control-inhibitor-for-gists-harboring-drug-resistance-mutations/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/repurposing-drugs-for-the-treatment-of-covid-19/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/tafasitamab-cxix-in-the-treatment-of-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/bert-o-malley-jr-named-president-and-chief-executive-officer-of-the-university-of-maryland-medical-center/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/association-of-american-cancer-institutes-to-honor-nobel-laureate-william-g-kaelin-jr-md/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/heather-brandt-to-lead-cancer-prevention-community-outreach-projects-for-st-jude/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/raymond-n-dubois-md-phd-named-director-musc-hollings-cancer-center/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/steven-grossman-named-cancer-physician-in-chief-of-usc-norris-comprehensive-cancer-center/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/researchers-outline-need-for-evaluation-of-gene-expression-profiling-in-melanoma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/the-parker-institute-for-cancer-immunotherapy-appoints-john-connolly-phd-as-chief-scientific-officer/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-atezolizumab-to-vemurafenibcobimetinib-in-unresectable-advanced-braf-v600-mutant-melanoma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/adding-immunotherapy-to-brafmek-inhibition-in-braf-v600-mutant-melanoma-first-step-on-the-journey/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/jae-jung-phd-appointed-chair-of-cleveland-clinic-lerner-research-institute-s-cancer-biology-department/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/acalabrutinib-improves-progression-free-survival-vs-idelalisib-plus-rituximab-or-bendamustine-plus-rituximab-in-relapsed-or-refractory-cll/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/final-ascend-results-confirm-acalabrutinib-as-a-standard-for-relapsed-cll/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/an-expert-qa-on-cancer-disparities-and-health-equity/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/brca-study-clinic-is-saving-men-s-lives-in-israel/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/health-groups-oppose-suspending-immigration-for-health-care-providers-and-family-members/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/into-the-ring-with-tap-cancer-out/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/rural-cancer-care-models-of-success-and-barriers-highlighted-in-new-state-of-cancer-care-in-america-package/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-answers-guide-to-cancer-survivorship/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/how-the-first-international-summit-on-interventional-pharmacoeconomics-is-sparking-discussion-on-reducing-cancer-costs/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/how-to-treat-patients-with-multiple-myeloma-cost-effectively-without-compromising-outcome/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/david-a-karnofsky-s-early-contributions-to-cancer-research-helped-establish-oncology-as-a-medical-discipline/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/association-of-community-cancer-centers-announces-2020-innovator-award-recipients/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/mary-claire-king-phd-honored-with-2020-william-l-mcguire-memorial-lecture-award/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/go2-foundation-for-lung-cancer-to-honor-charles-swanton-md-with-the-2020-bonnie-j-addario-lectureship-award/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/managing-cancer-in-older-adults-during-the-covid-19-pandemic/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/penn-medicine-receives-49-million-grant-to-improve-uptake-of-cancer-care-best-practices/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/incidence-and-cancer-related-mortality-in-cambodia/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/ashwagandha/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/after-immigrating-from-india-neha-vapiwala-md-facr-followed-her-dream-of-a-career-in-medicine/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/dana-farber-launches-new-center-for-prevention-and-treatment-of-brca-related-cancers/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/tumeur-fibro-plastique/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/one-in-six-premenopausal-women-with-invasive-breast-cancer-is-nonadherent-to-tamoxifen-therapy/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/anticipate-difficulties-by-patients-in-adhering-to-tamoxifen-therapy/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/cornelius-o-skip-granai-md-champion-of-cancer-care-for-women-dies-at-71/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/gynecologic-cancer-advocate-wendy-noelle-ericsson-dies-at-age-60/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/sanjiv-sam-gambhir-md-phd-pioneer-in-molecular-imaging-dies-at-57/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/two-organizations-collaborate-to-evaluate-the-utility-of-liquid-biopsy-in-treating-lung-cancer/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/roswell-park-care-network-and-oneida-health-name-new-radiation-oncology-medical-director/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/balancing-efficacy-and-safety-of-targeted-therapy-in-breast-cancer-care/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-taimur-sher/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/subcutaneous-daratumumab-improves-outcomes-for-patients-with-light-chain-amyloidosis-study-finds/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/novel-tremelimumabdurvalumab-regimen-active-in-advanced-hepatocelluar-carcinoma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-amit-mahipal/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/tumor-mutational-burden-and-the-future-of-complex-biomarkers/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/molecular-testing-in-metastatic-colorectal-cancer-understanding-how-when-and-what-to-profile/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-updates-metastatic-pancreatic-cancer-guideline/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/updated-registry-data-confirm-higher-covid-19-related-mortality-in-patients-with-cancer/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/past-cms-and-fda-head-discusses-challenges-in-us-health-care-policy-and-possible-solutions/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pet-therapy-how-the-cat-i-never-wanted-saved-my-life/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-approves-atezolizumab-plus-cobimetinibvemurafenib-for-advanced-braf-v600-mutated-melanoma/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-approves-tafasitamab-cxix-plus-lenalidomide-to-treat-adults-with-relapsedrefractory-dlbcl/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/second-look-surgery-plus-hipec-vs-surveillance-for-patients-at-high-risk-for-colorectal-peritoneal-metastases/</loc><lastmod>2020-08-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/titan-trial-apalutamide-adds-to-options-for-men-with-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/first-line-atezolizumab-plus-platinum-based-chemotherapy-vs-chemotherapy-alone-in-advanced-urothelial-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/long-term-outcomes-with-pembrolizumab-for-cisplatin-ineligible-advanced-urothelial-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/switch-maintenance-pembrolizumab-for-metastatic-urothelial-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-toni-choueiri/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/novel-indications-and-new-drugs-for-the-treatment-of-bladder-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/study-supports-pembrolizumab-plus-axitinib-in-previously-untreated-advanced-renal-cell-carcinoma/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-philip-saylor/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/early-data-show-activity-for-enfortumab-vedotin-plus-pembrolizumab-in-advanced-bladder-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/erdafitinib-in-fgfr-altered-advanced-urothelial-carcinoma/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/many-choices-now-for-men-with-metastatic-hormone-sensitive-prostate-cancer-how-to-decide/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/maintenance-avelumab-improves-survival-in-advanced-bladder-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/salvage-nivolumab-plus-ipilimumab-after-prior-immune-checkpoint-inhibitor-therapy-in-patients-with-metastatic-rcc/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/first-line-combination-treatments-improve-outcomes-vs-sunitinib-in-advanced-renal-cell-carcinoma/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/enzalutamide-improves-survival-vs-standard-first-linetreatment-in-hormone-sensitive-metastatic-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/novel-indications-and-new-drugs-for-the-treament-of-patients-with-renal-cell-carcinoma/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/immune-checkpoint-inhibitor-rechallenge-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-apalutamide-to-androgen-deprivation-therapy-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/phase-iii-study-of-ar-antagonist-in-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/novel-indications-and-new-drugs-for-castration-resistant-or-castrate-sensitive-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/phase-ii-triton2-study-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/final-analysis-of-the-aramis-trial-in-men-with-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/final-overall-survival-analysis-of-the-prosper-trial-in-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/androgen-deprivation-with-oral-relugolix-vs-leuprolide-in-advanced-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/in-biochemically-recurrent-prostate-cancer-psma-targeted-petct-imaging-may-be-useful/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-scott-tagawa/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/lutetium-177-labeled-psma-617-improves-psa-response-in-first-analysis-from-therap-trial-in-metastatic-prostate-cancer/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/genitourinary-oncology-highlights-2019-2020-almanac/</loc><lastmod>2020-08-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pevonedistat-plus-azacitidine-may-be-of-benefit-in-higher-risk-myelodysplastic-syndromes/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-david-sallman/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-approves-brexucabtagene-autoleucel-for-relapsed-or-refractory-mantle-cell-lymphoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/jonathan-w-friedberg-md-mmsc-named-next-editor-in-chief-of-the-journal-of-clinical-oncology/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/first-line-liposomal-irinotecan-containing-regimen-studied-in-advanced-pancreatic-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-approves-pembrolizumab-for-adults-and-children-with-tmb-h-solid-tumors/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/managing-anxiety-in-older-adults-with-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-guideline-supports-continued-use-of-dexamethasone-for-patients-receiving-checkpoint-inhibitors-and-emetogenic-chemotherapy/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/yoram-unguru-explains-the-economic-origins-of-drug-shortages-and-other-ethical-issues/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/snmmi-names-alan-packard-as-president-and-richard-wahl-as-president-elect/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fred-hutch-announces-new-additions-and-leadership-to-board-of-trustees/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/gita-suneja-holds-community-service-in-high-esteem/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/memorial-sloan-kettering-launches-women-in-science-endeavor/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/multiple-lesions-not-a-contraindication-for-cosmetically-acceptable-lumpectomy/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/measuring-the-impact-of-the-plunge-in-cancer-screenings-during-the-covid-19-pandemic/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/juanita-merchant-appointed-to-ludwig-institute-s-scientific-advisory-committee/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/incorporating-immunotherapy-into-treatment-of-early-stage-nsclc/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/can-radiotherapy-be-omitted-for-some-patients-with-pet-negative-early-stage-unfavorable-hodgkin-lymphoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/geraldine-jacobson-elected-as-future-chair-of-astro/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-stephen-ansell/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/huntsman-cancer-institute-brings-home-cancer-care-to-rural-utah/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/novel-treatments-emerge-for-patients-with-lower-risk-myelodysplastic-syndromes/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/edward-chu-to-lead-cancer-medicine-at-albert-einstein-college-of-medicine-and-montefiore-health-system/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-david-sallman-1/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/roswell-park-gynecologic-oncologists-awarded-leadership-roles/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/ntrk-fusions-in-gastrointestinal-cancers-rare-but-responsive-to-treatment/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-juan-valle/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/sabcs-teams-with-tigerlily-foundation/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/mustafa-raoof-recognized-for-pancreatic-cancer-research/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/higher-prevalence-of-germline-mutations-identified-in-young-adults-with-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/improving-communication-skills-for-oncology-clinicians-during-the-covid-pandemic/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/national-comprehensive-cancer-network-celebrates-its-25th-year/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nccn-member-institutions/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/lost-in-translation-a-fisherman-s-tale/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nccn-clinical-practice-guidelines-in-oncology-2020-updates/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/tazemetostat-for-adults-with-relapsed-or-refractory-follicular-lymphoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/highlights-of-research-in-lymphomas-presented-during-the-eha25-virtual-congress/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/jimmie-holland-s-research-has-long-underscored-the-importance-of-caring-for-the-whole-patient/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fixed-dose-subcutaneous-combination-of-pertuzumab-trastuzumab-and-hyaluronidase-zzxf-in-her2-positive-breast-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/neoadjuvant-atezolizumab-plus-chemotherapy-produces-high-major-and-complete-pathologic-response-rates-in-resectable-nsclc/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/translated-tool-from-nccn-measures-mental-health-temperature-of-people-with-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/selinexor-in-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/cicero-software-may-enable-detection-of-cancer-causing-gene-fusions/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/american-cancer-society-and-flatiron-health-announce-recipients-of-the-real-world-data-impact-award/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fox-chase-cancer-center-welcomes-new-staff-members/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/gemtuzumab-ozogamicin-in-pediatric-patients-with-newly-diagnosed-cd33-positive-aml/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/a-pioneering-neurosurgeon-shares-hard-earned-wisdom-gained-along-the-road-from-the-segregated-south/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/flossie-wong-staal-molecular-biologist-who-uncovered-the-secrets-of-human-immunodeficiency-virus-dies-at-73/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nrg-oncology-biospecimen-bank-awarded-nci-funding-for-next-6-years/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pembrolizumab-for-first-line-treatment-of-unresectable-or-metastatic-msi-h-or-dmmr-colorectal-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nci-funds-studies-of-impact-of-telehealth-and-telemedicine-capacity-for-rural-patients-amid-covid-19-pandemic/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/cleveland-clinic-cancer-center-oncologists-earn-national-recognition-as-institution-expands-staff/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/florida-cancer-specialists-appoints-new-chief-executive-officer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pembrolizumab-for-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/physicians-new-drugs-and-pharma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/a-health-care-journalist-explores-breast-cancer-in-america-through-the-lens-of-her-own-diagnosis/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/new-effort-to-address-health-disparities-for-black-men/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/stand-up-to-cancer-announces-new-research-and-education-effort-to-improve-care-for-underserved-patients-with-lung-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/having-cancer-has-not-affected-me-in-any-negative-way/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-special-report-resuming-cancer-care-delivery-during-the-covid-19-pandemic/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/conquer-cancer-donors-provide-key-resources-for-patients-and-providers-during-the-covid-19-pandemic/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-conducting-open-search-for-chief-medical-officer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/cms-cmmi-announce-flexibilities-for-oncology-practices-impacted-by-covid-19/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/managing-the-cost-of-cancer-care-can-be-overwhelming/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/10-year-study-indicates-pembrolizumab-provides-long-term-benefits-for-patients-with-metastatic-melanoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/overcoming-the-challenges-of-improving-psychosocial-care-for-patients-with-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/top-scientists-share-early-research-on-intersection-of-covid-19-and-cancer-care-at-aacr-virtual-meeting/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/updated-asco-guideline-revisits-evidence-on-prevention-and-treatment-of-chemotherapy-induced-neuropathy/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/anti-tigit-antibody-plus-atezolizumab-move-forward-in-advanced-nsclc/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-michele-teng/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/statin-use-linked-to-improvement-in-survival-in-ovarian-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-antoni-ribas-and-richard-penson/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/epov-philip-a-philip/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-capecitabine-to-t-dm1-in-previously-treated-patients-with-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/potential-association-of-impaired-spermatogenesis-and-immune-checkpoint-inhibitor-therapy-in-patients-with-metastatic-melanoma/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pembrolizumab-for-advanced-melanoma-impact-of-braf-mutation-status-and-prior-therapy-regimens/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/anthony-fauci-explores-what-we-know-about-covid-19-and-what-s-being-done-to-combat-it/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-and-accc-join-forces-to-increase-participation-of-racial-and-ethnic-minority-populations-in-cancer-treatment-trials/</loc><lastmod>2020-08-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-bevacizumab-to-mfolfox6-for-the-first-line-treatment-of-ras-mutant-unresectable-colorectal-liver-metastases/</loc><lastmod>2020-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/study-finds-residents-of-low-income-neighborhoods-have-less-access-to-icu-beds-amidst-coronavirus-pandemic/</loc><lastmod>2020-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/classification-of-prostate-cancer-using-tests-for-small-noncoding-rnas-in-urinary-exosomes/</loc><lastmod>2020-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/approval-for-first-liquid-biopsy-next-generation-sequencing-companion-diagnostic/</loc><lastmod>2020-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/new-masccisoo-guidelines-for-managing-mucositis/</loc><lastmod>2020-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/study-suggests-drop-in-non-small-cell-lung-cancer-mortality-rates-due-to-treatment-advances-reduction-in-incidence/</loc><lastmod>2020-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/study-finds-radiotherapy-may-be-associated-with-long-term-impact-on-the-cardiovascular-and-metabolic-health-of-childhood-cancer-survivors/</loc><lastmod>2020-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/effect-of-axillary-surgery-approach-and-nodal-irradiation-on-risk-of-lymphedema-in-patients-with-breast-cancer/</loc><lastmod>2020-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/early-rituximab-intensification-in-r-chop-for-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/aspirin-may-accelerate-the-progression-of-advanced-cancers-in-older-adults/</loc><lastmod>2020-08-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/essential-components-of-palliative-medicine/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/increased-time-to-breast-cancer-surgery-may-not-impact-overall-survival-for-patients-with-early-stage-disease/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/ash-releases-new-clinical-practice-guidelines-on-the-treatment-of-older-adults-with-newly-diagnosed-aml/</loc><lastmod>2020-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/risk-of-breast-cancer-after-total-body-irradiation-and-blood-or-marrow-transplantation-for-hematologic-malignancies/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/severe-hearing-impairment-associated-with-neurocognitive-deficits-in-childhood-cancer-survivors/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-pipeline-designations-in-kidney-and-lung-cancers-myelodysplastic-syndromes-and-more/</loc><lastmod>2020-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/first-line-lenvatinib-plus-pembrolizumab-in-patients-with-unresectable-hepatocellular-carcinoma/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/association-of-pathologic-complete-response-with-3-year-outcomes-in-the-i-spy2-trial-of-neoadjuvant-therapy-for-stage-ii-or-iii-breast-cancer/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/avelumab-for-patients-with-gestational-trophoblastic-tumors-resistant-to-single-agent-chemotherapy/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/refinement-of-european-leukemianet-classification-recommendations-for-younger-patients-with-aml/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/effect-of-molecular-classification-of-endometrial-cancer-on-adjuvant-therapy-outcomes/</loc><lastmod>2020-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pembrolizumab-monotherapy-as-first-line-treatment-for-patients-with-unresectable-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-08-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-pegvorhyaluronidase-alfa-to-nab-paclitaxel-and-gemcitabine-in-hyaluronan-high-metastatic-pancreatic-cancer/</loc><lastmod>2020-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/anti-cd30-car-t-cell-therapy-for-patients-with-relapsed-or-refractory-hodgkin-lymphoma/</loc><lastmod>2020-08-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pfs-subgroup-analysis-of-olaparib-maintenance-therapy-in-advanced-brca-mutated-ovarian-cancer/</loc><lastmod>2020-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/effect-of-mammography-screening-from-age-40-on-breast-cancer-mortality/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/rucaparib-in-metastatic-castration-resistant-prostate-cancer-with-deleterious-brca-alterations/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/has-racial-disparity-in-lung-cancer-incidence-lessened-among-young-adults/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/chemotherapy-and-covid-19-outcomes-in-patients-with-cancer-at-memorial-sloan-kettering-cancer-center/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/sortilin-may-be-a-potential-therapeutic-target-in-pancreatic-cancer/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/transoral-robotic-surgery-may-improve-outcomes-in-early-stage-oropharyngeal-cancer/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/obinutuzumab-ibrutinib-and-venetoclax-in-treatment-naive-and-relapsed-or-refractory-chronic-lymphocytic-leukemia/</loc><lastmod>2020-08-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/breast-cancer-survival-is-significantly-decreased-among-premenopausal-women-previously-treated-with-radiation-for-childhood-or-aya-cancer/</loc><lastmod>2020-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-nelarabine-to-standard-therapy-in-newly-diagnosed-t-cell-acute-lymphoblastic-leukemia/</loc><lastmod>2020-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/medicare-part-d-spending-on-oncology-drugs/</loc><lastmod>2020-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/austrian-study-of-sars-cov-2-testing-in-patients-with-cancer-treated-at-a-tertiary-care-hospital-during-the-covid-19-pandemic/</loc><lastmod>2020-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/ret-inhibitor-selpercatinib-achieves-durable-responses-in-majority-of-patients-with-ret-gene-fusions/</loc><lastmod>2020-08-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/effect-of-timing-of-radiotherapy-relative-to-adt-on-overall-survival-in-prostate-cancer/</loc><lastmod>2020-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/cost-effectiveness-of-screening-guidelines-to-prevent-heart-failure-in-survivors-of-childhood-cancer/</loc><lastmod>2020-08-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/use-of-risk-prediction-model-for-bloodstream-infection-in-febrile-pediatric-patients-with-cancer-without-severe-neutropenia/</loc><lastmod>2020-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/race-disparities-in-receipt-of-proton-radiotherapy-in-children-s-oncology-group-trials/</loc><lastmod>2020-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/meta-analysis-of-folfoxiribevacizumab-vs-doubletsbevacizumab-as-initial-treatment-for-unresectable-metastatic-colorectal-cancer/</loc><lastmod>2020-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/fda-approves-foundationone-liquid-cdx-a-pan-tumor-liquid-biopsy-test/</loc><lastmod>2020-08-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/sorafenib-maintenance-after-allogeneic-hct-in-patients-with-flt3-itd-positive-aml/</loc><lastmod>2020-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/neratinibcapecitabine-vs-lapatinibcapecitabine-for-pretreated-patients-with-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/esmo-issues-consensus-on-the-management-of-patients-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2020-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pan-bet-bromodomain-inhibitor-plus-enzalutamide-in-advanced-prostate-cancer/</loc><lastmod>2020-08-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/pyrotinib-for-pretreated-patients-with-her2-mutated-advanced-nsclc/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/late-morbidity-and-mortality-in-survivors-of-childhood-all-receiving-contemporary-risk-stratified-therapy/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/does-adding-neoadjuvant-chemohormonal-therapy-to-surgery-in-patients-with-localized-high-risk-prostate-cancer-improve-biochemical-pfs/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/nationwide-trends-show-fewer-patients-with-cancer-in-the-united-states-seeking-care-since-start-of-the-covid-19-pandemic/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/ash-annual-meeting-announced-as-an-all-virtual-event/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/role-of-tp53-mutations-on-disease-severity-in-myelodysplastic-syndromes/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/outcomes-with-adjuvant-postradiation-chemotherapy-vs-radiotherapy-in-high-risk-low-grade-glioma/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/hypofractionated-vs-conventionally-fractionated-radiotherapy-after-breast-conserving-surgery-in-women-with-breast-cancer/</loc><lastmod>2020-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/characteristics-of-neuroendocrine-carcinomas-of-the-gallbladder/</loc><lastmod>2020-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/study-finds-treatment-delays-for-patients-with-breast-cancer-early-in-the-covid-19-pandemic/</loc><lastmod>2020-08-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/link-between-gut-microbiome-and-treatment-outcomes-in-patients-with-metastatic-kidney-cancer/</loc><lastmod>2020-08-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/effect-of-muscle-mass-and-radiodensity-on-postoperative-complications-and-outcomes-of-colon-cancer-surgery/</loc><lastmod>2020-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/sorafenib-maintenance-after-stem-cell-transplant-in-flt3-itd-acute-myeloid-leukemia/</loc><lastmod>2020-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/priority-reviews-for-immunotherapy-dose-regimen-small-cell-lung-cancer-fast-track-designations-in-brain-cancer-and-leukemia/</loc><lastmod>2020-08-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/risk-stratified-stem-cell-transplant-and-vinblastine-monotherapy-for-relapsed-pediatric-anaplastic-large-cell-lymphoma/</loc><lastmod>2020-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/brigatinib-vs-crizotinib-in-alk-inhibitor-naive-patients-with-alk-positive-advanced-nsclc/</loc><lastmod>2020-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/asco-members-can-access-special-offer-for-ppe-through-project-n95-register-by-august-24/</loc><lastmod>2020-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/dabrafenibtrametinib-for-patients-with-braf-v600e-mutated-cholangiocarcinoma/</loc><lastmod>2020-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/genomic-analysis-of-cervical-cancer-in-ugandan-patients/</loc><lastmod>2020-08-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/addition-of-venetoclax-to-azacitidine-in-previously-untreated-patients-with-aml-ineligible-for-induction-therapy/</loc><lastmod>2020-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/association-of-surgical-volume-pledge-with-short-term-outcomes-after-lung-cancer-resection/</loc><lastmod>2020-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/dabrafenib-plus-trametinib-in-braf-v600e-mutated-tumors/</loc><lastmod>2020-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/current-lung-cancer-screening-guidelines-may-underselect-eligible-black-ever-smokers/</loc><lastmod>2020-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/three-novel-genetic-variants-linked-to-male-breast-cancer-discovered/</loc><lastmod>2020-08-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/providing-aid-for-patients-with-cancer-affected-by-the-beirut-explosion/</loc><lastmod>2020-08-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/08-august/impact-of-chromogranin-a-expression-on-disease-characteristics-and-prognosis-in-rectal-neuroendocrine-tumors/</loc><lastmod>2020-08-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/asco-s-cancerlinq-launches-the-smartlinq-qopi-certification-pathway/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/new-updated-asco-elearning-courses-put-oncology-education-at-your-fingertips/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/lasalle-leffall-jr-promotes-hard-work-and-education-to-overcome-boundaries/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/carolyn-anderson-receives-snmmi-2020-paul-c-aebersold-award/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/yale-names-markus-mueschen-inaugural-director-of-center-of-molecular-and-cellular-oncology/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/a-diagnosis-of-advanced-lung-cancer-is-no-longer-a-death-sentence/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/the-wake/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/personal-steps-toward-racial-equity-in-oncology/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/marcella-nunez-smith-named-director-of-center-for-community-engagement-and-health-equity-for-yale-cancer-center-and-smilow-cancer-hospital/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/first-line-osimertinibbevacizumab-for-metastatic-egfr-mutant-lung-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/addition-of-an-atr-inhibitor-to-gemcitabine-in-platinum-resistant-high-grade-serous-ovarian-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/uspstf-issues-draft-recommendation-statement-on-screening-for-lung-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-approves-oral-combination-of-decitabine-and-cedazuridine-for-adult-patients-with-mds/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-approves-maintenance-avelumab-for-the-treatment-of-advanced-urothelial-carcinoma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/viale-a-trial-supports-survival-benefit-of-venetoclax-plus-azacitidine-in-elderly-patients-with-aml/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-alice-mims/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/the-importance-of-measuring-health-related-quality-of-life-in-older-adults/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/combination-of-isatuximab-carfilzomib-and-dexamethasone-reduces-risk-of-disease-progression-in-myeloma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-craig-hofmeister/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/nivolumabipilimumab-shows-benefit-in-patients-with-non-small-cell-lung-cancer-and-brain-metastases/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/the-need-for-solid-data-during-a-global-pandemic/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/monumental-progress-in-the-treatment-of-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/can-radiomics-predict-survival-in-patients-with-nsclc-receiving-immunotherapy/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-john-minna/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/astro-to-host-virtual-annual-meeting-october-25-28-2020/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/ctdna-clearance-predicts-progression-free-survival-with-osimertinibsavolitinib-in-egfr-mutant-met-amplified-nsclc/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-alexander-drilon/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/aacr-holds-covid-19-and-cancer-virtual-meeting/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/small-study-evaluates-neoadjuvant-vs-adjuvant-nivolumab-plus-ipilimumab-in-stage-iii-melanoma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-ahmad-tarhini-and-larisa-geskin/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/double-pik3ca-mutations-and-response-benefit-in-breast-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/quick-takes-on-novel-therapies-for-solid-and-hematologic-malignancies/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/pembrolizumab-for-adult-and-pediatric-patients-with-tumor-mutational-burden-high-solid-tumors/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/when-paired-with-palbociclib-fulvestrant-and-letrozole-yield-comparable-results-in-parsifal-trial/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-komal-jhaveri/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/robert-winn-md-joins-lungevity-foundation-s-board-of-directors/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/expanded-access-to-cancer-drugs-in-africa-and-asia/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/two-cohort-studies-identify-risk-factors-for-mortality-in-patients-with-cancer-and-covid-19/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/pada-1-trial-examines-the-impact-of-esr1-mutations-in-metastatic-breast-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/bishal-gyawali-receives-young-health-researcher-award-from-nepali-government/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/nivolumab-in-previously-treated-esophageal-squamous-cell-carcinoma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/esmo-names-george-pentheroudakis-new-chief-medical-officer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/perlmutter-cancer-center-welcomes-janice-mehnert-as-associate-director-for-clinical-research/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/yang-shi-appointed-member-of-ludwig-institute-for-cancer-research/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-erika-hamilton-and-nikhil-wagle/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/blood-cancer-discoveries-program-names-grant-recipients/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/swog-s1505-trial-evaluates-neoadjuvant-regimens-in-pancreatic-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-marcus-noel-and-susan-tsai/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/yale-cancer-center-awarded-nih-spore-renewal-for-lung-cancer-research/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/marilyn-j-heine-md-facep-facp-fcpp-elected-ama-council-on-legislation-chair/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/joann-sweasy-named-director-of-university-of-arizona-cancer-center/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fox-chase-cancer-center-welcomes-two-new-staff-members/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/usc-norris-comprehensive-cancer-center-receives-5-million-for-cancer-drug-discoveries/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/addition-of-rituximab-to-standard-chemotherapy-improves-efs-and-os-in-children-with-high-risk-mature-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/new-guideline-for-locally-advanced-esophageal-cancer-supports-multimodality-therapy-and-multidisciplinary-treatment/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/if-you-have-self-doubt-when-caring-for-a-loved-one-with-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/role-of-rituximab-in-the-treatment-of-children-and-adolescents-with-mature-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/leading-organizations-release-new-clinical-guideline-on-advanced-prostate-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/small-goals-big-victories/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/lurbinectedin-in-previously-treated-metastatic-small-cell-lung-cancer/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/mark-lewis-md-and-jonathan-bleeker-md-reflect-in-from-every-angle/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/palliative-care-resource-for-your-patients-from-asco/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/responding-to-racism-and-health-inequality-as-a-cancer-care-community/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/cultivating-emotional-equanimity/</loc><lastmod>2020-07-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-daniel-heng-and-toni-choueiri/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/adjuvant-atezolizumab-fails-to-meet-primary-study-endpoint-in-high-risk-bladder-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/personalized-rna-based-vaccineatezolizumab-combination-produces-immune-response/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-lynn-schuchter-and-ravi-salgia/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/real-world-data-show-survival-benefit-for-adjuvant-immunotherapy-in-stage-iii-melanoma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/two-studies-report-secondary-surgery-extends-survival-in-recurrent-ovarian-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-robert-coleman/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/pembrolizumab-plus-axitinib-in-previously-untreated-advanced-renal-cell-carcinoma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-toni-choueiri/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/international-consortium-aims-to-enhance-decision-making-in-hodgkin-lymphoma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/novel-androgen-deprivation-therapy-with-relugolix-causes-fewer-cardiac-events-than-leuprolide-in-advanced-prostate-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-david-wise-and-celestia-higano/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-approves-combination-of-pertuzumab-trastuzumab-and-hyaluronidase-zzxf-for-her2-positive-breast-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-approves-pembrolizumab-for-the-first-line-treatment-of-msi-hdmmr-colorectal-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-announces-project-patient-voice-to-communicate-patient-reported-outcomes-from-cancer-clinical-trials/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/black-patient-representation-in-different-types-of-clinical-trials/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/addressing-discrimination-and-bias-in-medical-education/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/society-for-immunotherapy-of-cancer-names-recipients-of-memorial-award-and-lectureship/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/insomnia-in-adolescent-and-young-adult-cancer-survivors/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/asco-opens-search-for-chief-medical-officer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/new-nccn-guidelines-offer-patients-help-in-recognizing-side-effects-from-immunotherapy/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/glenn-d-steele-jr-md-phd-named-chair-of-city-of-hope-board-of-directors/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/2020-asco-presidential-address/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/guidance-available-on-telemedicine-coverage-during-covid-19-pandemic/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/asco-covid-19-registry/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/conquer-cancer-grants-more-than-8-million-to-cancer-research/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/go2-foundation-for-lung-cancer-unifies-to-drive-change/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/improving-the-quality-of-care-and-research-for-patients-with-cancer-and-the-ethics-behind-its-delivery/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/understanding-the-underlying-mechanisms-of-pain-in-patients-with-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/a-visiting-resident-oncologist-s-training-during-the-covid-19-pandemic/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/a-new-website-offers-support-for-adolescent-and-young-adults-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/daratumumab-and-hyaluronidase-fihj-for-multiple-myeloma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/her-grandfather-s-medical-practice-inspired-nathalie-levasseur-md-bsc-frcpc-to-improve-the-lives-of-women-with-breast-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/nivolumab-plus-ipilimumab-in-two-new-lung-cancer-indications/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/phase-ii-study-evaluates-chemotherapy-and-immunotherapy-in-patients-with-malignant-pleural-mesothelioma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/lung-cancer-research-foundation-names-trudy-oliver-phd-to-its-scientific-advisory-board/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/aacr-recognizes-new-2019-2020-research-grantees/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/responses-achieved-with-belantamab-mafodotin-in-relapsed-or-refractory-myeloma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-philip-mccarthy/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/geriatric-assessment-what-are-you-waiting-for/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/imbrave150-trial-atezolizumab-plus-bevacizumab-improves-survival-in-unresectable-hcc/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/roundup-of-high-impact-studies-in-early-breast-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/elotuzumab-fails-to-add-benefit-in-newly-diagnosed-high-risk-myeloma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-suzanne-lentzsch-and-joshua-richter/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/jessica-karen-wong-joins-radiation-oncology-department-at-fox-chase/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/two-studies-validate-neoadjuvant-chemotherapy-with-short-course-radiotherapy-or-long-term-chemoradiotherapy-in-locally-advanced-rectal-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-christopher-hallemeier/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/brian-j-bolwel-ultimately-takes-the-reins-at-the-taussig-cancer-institute/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/rucaparib-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/aacr-recognizes-achievements-of-three-cancer-researchers/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/adoptive-cell-therapy-with-tumor-infiltrating-lymphocytes-proves-active-in-refractory-metastatic-melanoma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-ryan-sullivan/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/a-palliative-care-specialist-explores-what-it-means-to-live-and-die-with-dignity-and-purpose/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-collaborating-on-use-of-real-world-data-to-inform-covid-19-response-effort/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/imbrave150-a-new-standard-of-care-to-treat-hepatocellular-cancers/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/atezolizumab-plus-bevacizumab-for-unresectable-or-metastatic-hepatocellular-carcinoma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/the-21st-century-cures-act-a-look-back-a-look-ahead/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/new-recommendations-offer-guidance-for-clinicians-and-patients-on-genetic-testing-for-prostate-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/young-adults-with-cancer-may-harbor-germline-mutations-and-benefit-from-germline-genetic-testing/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/nccn-working-group-policy-recommendations/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/elderberry/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/prolonged-overall-survival-with-autologous-allogeneic-vs-tandem-autologous-transplant-in-newly-diagnosed-myeloma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/do-not-rush-to-high-dose-twice-daily-radiation-for-limited-small-cell-lung-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/kunle-odunsi-elected-at-large-director-of-sitc-board-of-directors/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/cancer-genome-atlas-founding-members-and-current-project-team-awarded-2020-aacr-team-science-awards/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/a-doctor-battles-a-deadly-disease-and-turns-hope-into-action/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/the-piano/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/atezolizumab-as-first-line-treatment-of-metastatic-nsclc-with-high-pd-l1-expression-and-no-egfr-or-alk-aberrations/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/new-james-cancer-diagnostic-center-to-expedite-access-to-diagnostic-testing/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/oscar-colegio-dies-at-47/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/beth-levine-renowned-doctor-and-researcher-dies/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/neil-spector-physician-scientist-dies-at-63/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/charles-l-sawyers-md-faacr-voted-aacr-academy-president-elect-for-2020-2021/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/benjamin-f-cravatt-receives-award-for-outstanding-achievement-in-chemistry-in-cancer-research/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/christopher-i-amos-receives-award-for-research-excellence-in-cancer-epidemiology-and-prevention/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/patricia-s-steeg-phd-receives-women-in-cancer-research-charlotte-friend-lectureship/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/higher-risk-of-disease-recurrence-and-death-with-minimally-invasive-vs-open-surgery-for-early-stage-cervical-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/expect-questions-about-minimally-invasive-surgery-for-early-stage-cervical-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/facing-death-and-appreciating-life/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/pembrolizumab-trastuzumab-and-chemotherapy-in-her2-positive-metastatic-esophagogastric-cancer/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/survival-disparities-seen-in-hispanic-patients-with-blood-cancers-living-near-the-united-statesmexico-border/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-approves-selinexor-for-relapsed-or-refractory-dlbcl/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/first-line-stereotactic-radiosurgery-vs-whole-brain-radiotherapy-for-sclc-brain-metastases/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-grants-accelerated-approval-to-lurbinectedin-for-metastatic-sclc/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-extends-indication-of-gemtuzumab-ozogamicin-for-pediatric-patients-with-cd33-positive-aml/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-approves-nine-valent-hpv-vaccine-for-the-prevention-of-certain-hpv-related-head-and-neck-cancers/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/eha25-virtual-roundup-of-findings-in-leukemia-lymphoma-and-more/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-grants-accelerated-approval-to-tazemetostat-for-some-patients-with-follicular-lymphoma/</loc><lastmod>2020-07-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-scott-tagawa/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-don-dizon/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/longer-term-results-of-pivotal-study-in-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/psma-targeted-petct-imaging-may-be-useful-in-biochemically-recurrent-prostate-cancer/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/savolitinib-vs-sunitinib-in-met-driven-papillary-renal-cell-carcinoma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/final-analysis-of-phase-ii-trial-in-recurrent-platinum-sensitive-ovarian-cancer/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/maintenance-olaparib-shows-overall-survival-benefit-in-ovarian-cancer/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-trophimmun/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/avelumab-shown-effective-in-rare-chemotherapy-resistant-gynecologic-tumor-in-trophimmun-trial/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/for-patients-with-early-stage-cervical-cancer-sentinel-lymph-node-biopsy-declared-oncologically-safe/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/alpelisib-deemed-effective-in-advanced-breast-cancer-after-treatment-with-cdk46-inhibitor/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/tucatinib-combination-in-previously-treated-her2-positive-metastatic-breast-cancer-with-brain-metastases/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-scott-gettinger/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/first-line-nivolumab-plus-ipilimumab-shows-activity-in-nsclc-with-or-without-chemotherapy/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/phase-iii-boston-study-finds-selinexor-improves-outcomes-in-myeloma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/pembrolizumab-improves-pfs-vs-brentuximab-vedotin-in-patients-with-relapsedrefractory-classical-hodgkin-lymphoma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-philip-mccarthy-1/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/belantamab-mafodotin-shows-activity-in-relapsed-or-refractory-myeloma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/no-survival-benefit-from-local-therapy-in-de-novo-metastatic-breast-cancer-study/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-jesus-berdeja/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/outcomes-in-newly-diagnosed-multiple-myeloma-unimproved-by-carfilzomib-triplet-vs-standard-bortezomib-based-regimen/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-axel-grothey/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/rates-of-progression-free-survival-in-msi-hdmmr-metastatic-colorectal-cancer-doubled-by-pembrolizumab/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-jonathan-rosenberg/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/advanced-bladder-cancer-survival-improved-with-maintenance-avelumab/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/epov-lecia-sequist/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/disease-free-survival-in-early-stage-egfr-positive-nsclc-improved-by-adjuvant-osimertinib/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/conference-highlights-from-the-asco20-virtual-scientific-program/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/ursodeoxycholic-acid-for-preventing-gallstones-after-gastrectomy-for-gastric-cancer/</loc><lastmod>2020-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/a-visiting-resident-oncologist-s-training-during-the-covid-19-pandemic-1/</loc><lastmod>2020-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/risk-of-breast-cancer-recurrence-serum-detection-of-nonadherence-to-adjuvant-tamoxifen/</loc><lastmod>2020-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/effectiveness-of-maintenance-olaparib-for-germline-brca-mutated-pancreatic-cancer-across-age-groups-additional-analysis-of-the-polo-trial/</loc><lastmod>2020-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/esmo-world-gi-third-or-later-line-treatment-with-infigratinib-in-patients-with-cholangiocarcinoma-and-fgr2-fusions/</loc><lastmod>2020-07-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/post-hoc-analysis-of-outcomes-with-vandetanib-for-progressive-and-symptomatic-medullary-thyroid-cancer/</loc><lastmod>2020-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/survival-with-different-reduced-intensity-conditioning-regimens-for-allogeneic-stem-cell-transplant-in-patients-with-non-hodgkin-lymphoma/</loc><lastmod>2020-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/geographic-patterns-of-early-onset-colorectal-cancer-diagnoses-in-the-united-states/</loc><lastmod>2020-07-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-pipeline-agents-for-the-treatment-of-prostate-and-pancreatic-cancers-marginal-zone-lymphoma/</loc><lastmod>2020-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/patient-factors-associated-with-lack-of-provider-recommendation-for-hpv-vaccination-in-young-cancer-survivors/</loc><lastmod>2020-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/adding-cyclophosphamide-to-bortezomibdexamethasone-in-patients-with-multiple-myeloma-and-acute-kidney-injury-from-cast-nephropathy/</loc><lastmod>2020-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/lenvatinib-plus-pembrolizumab-for-advanced-gastric-cancer/</loc><lastmod>2020-07-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/study-finds-significant-variation-in-hispanic-patients-trust-of-cancer-information-sources/</loc><lastmod>2020-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/novel-radiopharmaceutical-aids-in-imaging-for-patients-with-neuroendocrine-tumors-and-liver-metastases/</loc><lastmod>2020-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/can-use-of-an-algorithm-improve-the-accuracy-and-efficiency-of-cervical-cancer-screening/</loc><lastmod>2020-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/phase-i-trial-of-berzosertib-alone-or-combined-with-carboplatin-in-advanced-solid-tumors/</loc><lastmod>2020-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/selinexor-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-07-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/gi-related-patient-reported-outcomes-in-those-receiving-chemoradiation-for-anal-cancer/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/early-screening-with-mri-may-reduce-breast-cancer-mortality-in-survivors-of-childhood-cancer-treated-with-chest-radiation/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/efs-as-a-surrogate-for-os-in-patients-with-localized-prostate-cancer-treated-with-radiotherapy/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/number-of-hospitalizations-may-be-an-important-indicator-of-survival-for-patients-with-head-and-neck-cancer/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/addition-of-trastuzumab-to-carboplatinpaclitaxel-for-advanced-or-recurrent-her2-positive-uterine-serous-carcinoma/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/avapritinib-in-advanced-pdgfra-d842v-mutant-gastrointestinal-stromal-tumors/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/commnetsnanets-guideline-for-the-diagnosis-and-management-of-lung-neuroendocrine-tumors/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/addition-of-antithymocyte-globulin-to-gvhd-prophylaxis-in-matched-sibling-donor-stem-cell-transplant/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/study-finds-higher-risk-for-covid-19-infection-among-minorities-and-patients-with-cancer/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/euproms-study-investigates-effect-of-prostate-cancer-treatment-on-quality-of-life/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/effect-of-breast-cancer-pathway-implementation-on-rate-of-referrals-for-genetic-counseling-and-testing/</loc><lastmod>2020-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/outcomes-with-axicabtagene-ciloleucel-in-the-nontrial-setting-in-patients-with-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2020-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/first-line-folfirinox-vs-gemcitabinenab-paclitaxel-for-localized-pancreatic-cancer/</loc><lastmod>2020-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/updated-ccc19-data-offer-insights-on-treatment-for-patients-with-cancer-infected-with-covid-19/</loc><lastmod>2020-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/t-dm1-in-patients-with-her2-positive-breast-cancer-and-brain-metastases/</loc><lastmod>2020-07-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/american-cancer-society-updates-guideline-for-hpv-vaccination/</loc><lastmod>2020-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/trends-in-policy-coverage-for-ctdna-testing/</loc><lastmod>2020-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/effect-of-medicaid-expansion-on-breast-cancer-stage-at-diagnosis/</loc><lastmod>2020-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/dental-infection-screening-before-induction-chemotherapy-for-aml/</loc><lastmod>2020-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/liver-transplantation-after-tumor-downstaging-in-patients-with-hepatocellular-carcinoma/</loc><lastmod>2020-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/common-hypertension-medications-may-also-reduce-risk-of-colorectal-cancer/</loc><lastmod>2020-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/presence-of-ctdna-and-ctcs-and-prediction-of-disease-recurrence-in-patients-with-triple-negative-breast-cancer/</loc><lastmod>2020-07-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/effects-of-exercise-intolerance-on-adult-survivors-of-childhood-cancer/</loc><lastmod>2020-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/teriparatide-for-medication-related-osteonecrosis-of-the-jaw/</loc><lastmod>2020-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/experimental-covid-19-vaccine-generates-immune-response-deemed-safe/</loc><lastmod>2020-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/lung-cancer-in-nonsmoking-individuals-shows-genetic-differences-is-likely-to-respond-differently-to-treatment/</loc><lastmod>2020-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/two-studies-focus-on-emerging-treatment-options-for-patients-with-neuroendocrine-tumors/</loc><lastmod>2020-07-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/outcomes-according-to-bmi-in-women-receiving-adjuvant-docetaxel-based-chemotherapy-for-early-breast-cancer/</loc><lastmod>2020-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/effectiveness-of-routine-blood-testing-in-detection-of-disease-during-active-surveillance-for-indolent-non-hodgkin-lymphoma/</loc><lastmod>2020-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/qol-with-timing-of-platinum-based-regimens-in-newly-diagnosed-patients-with-ovarian-cancer/</loc><lastmod>2020-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/study-identifies-factors-that-may-predict-toxicities-in-patients-treated-with-car-t-cell-therapy/</loc><lastmod>2020-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/study-links-mental-health-treatment-to-possible-improved-cancer-survival/</loc><lastmod>2020-07-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/longitudinal-analysis-of-health-related-quality-of-life-in-patients-with-hodgkin-lymphoma/</loc><lastmod>2020-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/fda-pipeline-novel-treatments-for-hematologic-malignancies/</loc><lastmod>2020-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/long-term-normal-tissue-effects-with-five-fraction-whole-breast-radiotherapy-for-early-breast-cancer/</loc><lastmod>2020-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/margetuximabpembrolizumab-for-previously-treated-patients-with-her2-positive-advanced-gastroesophageal-adenocarcinoma/</loc><lastmod>2020-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/survival-after-resection-of-isolated-synchronous-colorectal-peritoneal-metastases/</loc><lastmod>2020-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/cancer-survivors-are-adhering-to-covid-19-related-preventive-behaviors-but-continuity-of-care-may-be-impacted/</loc><lastmod>2020-07-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/effect-of-complete-vs-incomplete-macroscopic-excision-on-survival-in-stage-iv-high-risk-neuroblastoma/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/qol-with-open-vs-minimally-invasive-radical-hysterectomy-for-patients-with-cervical-cancer/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/novel-pet-radiotracer-for-glioblastoma/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/role-of-psma-petct-in-the-management-of-recurrent-prostate-cancer/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/first-results-of-total-body-dynamic-pet-scan/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/phase-ib-trial-of-atezolizumab-with-or-without-bevacizumab-in-patients-with-unresectable-hepatocellular-carcinoma/</loc><lastmod>2020-07-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/cabozantinib-in-platinum-refractory-metastatic-urothelial-carcinoma/</loc><lastmod>2020-07-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/neuroleptic-strategies-for-improving-terminal-agitation-in-patients-with-cancer-and-delirium/</loc><lastmod>2020-07-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/does-adjuvant-chemotherapy-improve-survival-among-older-patients-with-er-positive-node-positive-breast-cancer-and-multiple-comorbidities/</loc><lastmod>2020-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/risk-of-chronic-comorbidities-among-survivors-of-adolescent-and-young-adult-cancer/</loc><lastmod>2020-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/carfilzomib-dexamethasone-and-daratumumab-vs-carfilzomib-and-dexamethasone-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/are-patients-with-a-longer-established-diagnosis-of-cancer-at-higher-risk-for-more-severe-infection-or-death-from-covid-19/</loc><lastmod>2020-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/san-antonio-breast-cancer-symposium-to-be-held-virtually/</loc><lastmod>2020-07-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/pembrolizumab-in-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/first-line-s-1-plus-leucovorin-and-oxaliplatin-vs-s-1-plus-cisplatin-in-advanced-gastric-cancer/</loc><lastmod>2020-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/american-cancer-society-updates-guideline-for-cervical-cancer-screening/</loc><lastmod>2020-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/does-periodontal-disease-increase-the-risk-of-colorectal-cancer/</loc><lastmod>2020-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/analysis-of-deep-whole-genome-sequencing-in-patients-with-multiple-myeloma-identifies-superior-outcome-subgroup/</loc><lastmod>2020-07-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/addition-of-pazopanib-to-preoperative-chemoradiotherapy-in-children-and-adults-with-soft-tissue-sarcoma/</loc><lastmod>2020-07-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/impact-of-pregnancy-after-breast-cancer-in-women-with-deleterious-germline-brca-mutations/</loc><lastmod>2020-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/modeling-study-aims-to-estimate-the-effect-of-the-covid-19-pandemic-on-cancer-deaths-in-england/</loc><lastmod>2020-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/outcomes-with-pet-directed-therapy-for-limited-stage-dlbcl/</loc><lastmod>2020-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/07-july/study-finds-lack-of-parental-intent-to-initiate-and-complete-hpv-vaccination-in-the-united-states/</loc><lastmod>2020-07-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/first-line-atezolizumab-plus-platinum-based-chemotherapy-vs-chemotherapy-alone-in-advanced-urothelial-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/early-data-suggest-activity-for-oral-selective-estrogen-receptor-degrader-in-combination-regimen/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-scott-gettinger/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/positive-findings-in-nsclc-for-first-line-nivolumab-plus-ipilimumab-with-or-without-chemo/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ramucirumab-plus-erlotinib-in-treatment-of-egfr-mutant-metastatic-nsclc/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/acalabrutinib-with-or-without-obinutuzumab-vs-chlorambucilobinutuzumab-in-previously-untreated-cll/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ruxolitinib-improves-response-rates-in-glucocorticoid-refractory-acute-graft-vs-host-disease-after-allogeneic-sct/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/asco-survey-on-early-impact-of-covid-19-on-performance-of-oncology-clinical-trials/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/global-study-indicates-oncology-pharmacists-face-restricted-access-to-essential-ppe/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/blood-test-improves-screening-for-hepatocellular-carcinoma/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ganesh-rao-named-chair-of-neurosurgery-at-baylor-college-of-medicine/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/determining-the-best-place-to-die-for-patients-with-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/aacr-inaugurates-new-leadership/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/brigatinib-for-alk-positive-metastatic-non-small-cell-lung-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/grzegorz-ira-honored-with-baylor-s-debakey-award/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fox-chase-temple-university-hospital-announces-bone-marrow-transplant-program/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/jackson-laboratory-cancer-center-receives-continued-recognition-funding-by-nci/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/msk-hackensack-meridian-health-partnership-collaborate-on-immunology-research-projects/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/aacr-announces-distinguished-public-service-award-recipients/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/asco20-virtual-scientific-program-next-generation-oncology-highlights/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/survey-shows-young-onset-colorectal-cancer-may-be-overlooked-in-exam-rooms/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-finds-alpelisib-effective-after-cdk46-inhibition-in-advanced-breast-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-identifies-potential-approach-to-treat-severe-respiratory-distress-in-patients-with-covid-19/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/woman-with-an-ovarian-tumor/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-komal-jhaveri/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/you-can-do-anything-philosophy-early-in-life-inspired-breast-surgeon-laura-dominici/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-confirms-effective-less-toxic-alternative-to-standard-treatment-of-adults-with-burkitt-lymphoma/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/seattle-cancer-care-alliance-opens-new-clinic-dedicated-to-gastrointestinal-cancer-care/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/pomalidomide-for-treatment-of-kaposi-sarcoma/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/the-who-classification-of-tumors-of-hematopoietic-and-lymphoid-tissues-1/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/mickie-mcgraw-channels-the-power-of-creative-arts-to-heal-broken-bodies-and-minds/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/american-urological-association-recognizes-roswell-park-surgeon-eric-kauffman-md/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/penn-medicine-announces-appointment-of-daniel-yoshor/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/small-study-finds-olanzapine-reduces-nausea-and-vomiting-caused-by-advanced-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/asco-welcomes-2020-2021-board-of-directors/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/infographic-commentaries-in-jco-oncology-practice-examine-updates-to-asco-s-alternative-payment-model/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/pigeon-english/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/aacr-stands-against-racial-discrimination-and-inequality/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/do-you-know-about-asco-s-patient-education-materials/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/covid-19-and-patients-with-cancer-a-call-to-action-for-trainees/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/special-report-provides-guidance-to-oncology-practices-on-resuming-care-during-the-covid-19-pandemic/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/nci-renews-comprehensive-cancer-center-designation-for-norris-cotton-cancer-center/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/aids-research-led-to-appreciation-of-the-power-of-plants-and-integrative-medicine-in-cancer-care-for-donald-abrams/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/capmatinib-for-metastatic-nsclc-with-met-exon-14-skipping-mutation/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/integrating-physical-activity-into-cancer-care/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/advanced-practitioner-society-issues-statement-against-systemic-racism-discrimination/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/an-honored-poet-explores-a-lust-for-life-on-the-boundaries-of-near-death/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/extended-fraction-radiation-therapy-for-bone-metastases-represents-low-value-care-but-continues-to-be-widely-practiced/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/initiate-conversations-about-radiation-therapy-for-bone-metastases/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/melanoma-awareness-outlook-from-a-young-adult/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/new-information-from-nccn-on-overcoming-challenges-for-people-with-head-and-neck-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ama-board-of-trustees-pledges-action-against-racism-and-police-brutality/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ama-announces-new-president-and-president-elect/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/i-m-not-too-young-for-colorectal-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/association-of-american-cancer-institutes-issues-statement-about-racial-discrimination/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/conquer-cancer-honors-early-career-medical-professionals-from-around-the-world/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/leaders-of-the-promise-study-address-racial-inequities-in-the-united-states/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-nivolumab-for-pretreated-patients-with-esophageal-squamous-cell-carcinoma/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-scott-tagawa-1/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/in-biochemically-recurrent-prostate-cancer-psma-targeted-petct-imaging-may-be-useful/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-finds-no-survival-benefit-from-local-therapy-for-de-novo-metastatic-breast-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-julia-white/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/carfilzomib-triplet-fails-to-improve-outcomes-vs-standard-bortezomib-based-regimen-in-newly-diagnosed-myeloma/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-jesus-berdeja/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-pegfilgrastim-biosimilar-pegfilgrastim-apgf/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/role-of-race-ethnicity-and-region-in-mortality-among-pediatric-patients-with-cancer-admitted-to-the-icu/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/men-of-color-remain-underrepresented-in-prostate-cancer-clinical-trials/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/neoadjuvant-atezolizumab-plus-chemotherapy-for-resectable-nsclc/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/opioid-related-deaths-in-the-cancer-population-vs-the-general-population/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/lutetium-177-labeled-psma-617-improves-psa-response-in-first-analysis-from-therap-trial-in-metastatic-prostate-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-scott-tagawa/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/geriatric-assessment-driven-intervention-benefits-older-adults-with-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/highlights-from-complementary-and-integrative-medicine-research-and-implications-for-clinical-practice/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/first-line-pembrolizumab-added-to-standard-chemotherapy-improved-progression-free-survival-in-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-taofeek-kunie-owonikoko/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/responding-to-racism-and-health-inequality-as-a-cancer-care-community/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/repeat-breast-preservation-first-consideration-in-a-second-ipsilateral-breast-tumor-event/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/asco20-virtual-scientific-program-convened-record-number-of-oncology-professionals-from-across-the-globe/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/northwell-health-cancer-institute-of-new-york-appoints-oncology-experts-to-lead-new-programs/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/newer-late-line-treatments-may-change-front-line-standard-of-care-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-antonio-llombart-cussac/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/benefit-shown-for-akt-inhibitor-in-lotus-survival-analysis/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-suzette-delaloge/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ripretinib-in-previously-treated-advanced-gastrointestinal-stromal-tumor/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/olaparib-for-homologous-recombination-repair-gene-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/improving-care-for-women-with-late-stage-breast-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/trastuzumab-deruxtecan-shows-benefit-in-refractory-colorectal-cancer/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-michael-lee-autumn-mcree/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/nivolumab-vs-bevacizumab-in-recurrent-glioblastoma/</loc><lastmod>2020-06-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/precision-medicine-on-a-large-scale-for-pediatric-patients-with-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/patients-with-cancer-especially-progressive-disease-infected-with-covid-19-may-have-an-increased-risk-of-death/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/trophimmun-trial-finds-avelumab-effective-in-rare-gynecologic-tumor-resistant-to-chemotherapy/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/tucatinib-combination-in-previously-treated-her2-positive-metastatic-breast-cancer-with-brain-metastases/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/adjuvant-osimertinib-exceeds-expectations-in-egfr-positive-nsclc/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-lecia-sequist/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/abemaciclibfulvestranttrastuzumab-for-patients-with-previously-treated-hr-positive-her2-positive-advanced-breast-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/nivolumab-for-advanced-refractory-biliary-tract-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/new-recommendations-outline-approaches-to-reduce-burnout-in-oncology/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/news-highlights-for-patients-with-cancer-from-the-asco20-virtual-scientific-program/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/future-covid-19-legislation-must-protect-patient-access-to-cancer-care/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/imbassador250-trial/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-padmanee-sharma/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/sacituzumab-govitecan-hziy-for-previously-treated-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/veliparib-plus-chemotherapy-shows-antitumor-activity-in-front-line-treatment-of-ovarian-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-kathleen-moore/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/roswell-park-names-eunice-wang-medical-director-of-infusion-services/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/breastfeeding-associated-with-reduced-risk-of-invasive-ovarian-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/breastfeeding-a-public-health-strategy-for-reducing-risk-of-ovarian-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/the-power-of-mcode/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/acs-survey-finds-covid-19-health-impact-increasing-on-patients-with-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/keynote-555-supports-6-week-pembrolizumab-dosing-schedule-in-melanoma/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-siwen-hu-lieskovan/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/front-line-maintenance-with-olaparibbevacizumab-improves-outcomes-in-advanced-ovarian-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-thomas-herzog-and-kathleen-moore/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/niraparib-for-first-line-maintenance-treatment-of-advanced-ovarian-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-david-huntsman/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-shows-blood-test-can-identify-multiple-cancers-in-asymptomatic-women/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-david-huntsman-1/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/app-calculates-risk-of-delaying-cancer-care-during-the-covid-19-pandemic/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/talazoparib-yields-no-overall-survival-benefit-in-embraca-trial-update/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-susan-domchek-and-aditya-bardia/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-yvonne-chen-and-joseph-alvarnas/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/tyler-jacks-honored-with-2020-aacr-princess-takamatsu-memorial-lectureship/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/aacr-names-barbara-wold-recipient-of-distinguished-lectureship/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/sarcoma-foundation-of-america-announces-2020-research-grants/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/aacr-honors-nobel-laureate-phillip-sharp-phd-for-lifetime-achievement/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-finds-blood-test-detects-cancer-and-tissue-of-origin-in-those-with-or-suspected-to-have-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/staying-alert-to-lingering-cognitive-impairment-with-adjuvant-therapy-for-early-breast-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/my-future-is-doled-out-in-increments-of-6-months/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/when-is-it-time-to-pass/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-trophimmun/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/new-cancer-cachexia-guideline-addresses-common-quality-of-life-issue/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/off-the-shelf-car-t-cell-therapy-makes-inroads-in-acute-lymphoblastic-leukemia/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/andrew-e-aplin-receives-humanitarian-award-from-the-melanoma-research-foundation/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/selpercatinib-for-lung-and-thyroid-cancers-with-ret-gene-mutations-or-fusions/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/comprehensive-overview-of-how-to-start-or-improve-a-breast-cancer-unit-on-the-global-stage/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-combination-regimens-in-nsclc-hcc/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/the-gambler/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/cognitive-impairment-in-women-treated-for-early-breast-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/francis-collins-awarded-2020-templeton-prize/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/olaparib-plus-bevacizumab-in-maintenance-treatment-for-ovarian-fallopian-tube-or-primary-peritoneal-cancers/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/an-early-path-to-a-career-in-medicine-for-carlos-l-arteaga-md/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/cancer-and-covid-19/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/five-new-recipients-of-nccn-foundation-young-investigator-awards/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ibrutinib-in-combination-with-rituximab-in-chronic-lymphocytic-leukemia/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-nivolumabipilimumab-plus-chemotherapy-for-first-line-treatment-of-metastatic-or-recurrent-nsclc/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/pamela-hull-phd-appointed-associate-director-of-population-science-and-community-impact-at-kentucky-cancer-center/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/phyllis-f-cantor-center-for-research-in-nursing-and-patient-care-services-awarded-13-million-for-cancer-projects/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/spotlight-on-women-who-conquer-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/conquer-cancer-names-2020-women-who-conquer-cancer-mentorship-award-recipients/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/addition-of-cd38-directed-antibody-isatuximab-to-multiple-myeloma-armamentarium/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/maintenance-avelumab-improves-survival-in-advanced-bladder-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-jonathan-rosenberg/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/pembrolizumab-doubles-progression-free-survival-in-msi-hdmmr-metastatic-colorectal-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/epov-axel-grothey/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-atezolizumab-for-the-first-line-treatment-of-patients-with-metastatic-nsclc-and-high-pd-l1-expression/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-brigatinib-for-alk-positive-metastatic-nsclc/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/psa-level-prior-to-salvage-radiotherapy/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/presalvage-radiotherapy-psa-levels-and-outcomes-with-long-term-antiandrogen-therapy-in-prostate-ca/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/a-nobel-laureate-s-road-to-research-is-not-without-challenges/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/international-medical-and-radiation-oncologist-balances-cancer-research-and-clinical-practice/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/a-lung-cancer-specialist-s-winding-journey-from-venezuela-to-wisconsin/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/an-early-interest-in-cancer-immunology-inspires-a-life-s-work-in-melanoma/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/asco-s-president-aims-to-ensure-equitable-cancer-care-for-every-patient/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/from-the-united-states-to-germany-and-back-again-to-become-asco-president-in-2021-2022/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/the-asco-post-and-narratives-in-oncology-through-the-years/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/mourned-and-missed/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/reflections-of-an-asco-president/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/tribute-to-bernard-fisher-md/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/renowned-researcher-and-surgeon-helps-to-transform-treatment-of-breast-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/internationally-regarded-cancer-immunologist-did-not-stray-far-from-home/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/expert-in-clinical-trial-methodology-makes-his-mark-in-genitourinary-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/love-of-science-passion-for-research-and-belief-in-the-power-of-the-immune-system/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/love-of-science-and-a-family-tragedy-set-the-course-for-this-breast-cancer-researcher/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/meta-analysis-of-survival-after-minimally-invasive-vs-open-radical-hysterectomy-for-early-stage-cervical-cancer/</loc><lastmod>2020-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-finds-racial-disparities-in-esophageal-cancer-surgical-rates/</loc><lastmod>2020-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/picos-score-may-help-to-identify-patients-with-brain-metastases-at-risk-of-vte/</loc><lastmod>2020-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/addition-of-rituximab-to-standard-chemotherapy-in-pediatric-patients-with-high-risk-mature-b-cell-non-hodgkin-lymphoma/</loc><lastmod>2020-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/long-term-outcomes-with-pembrolizumab-for-cisplatin-ineligible-advanced-urothelial-cancer/</loc><lastmod>2020-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/novel-risk-calculator-for-sentinel-node-positivity-in-patients-with-melanoma/</loc><lastmod>2020-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/initial-report-from-the-teravolt-registry-study/</loc><lastmod>2020-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/biomarker-combination-may-help-predict-response-to-immunotherapy-in-patients-with-metastatic-urothelial-carcinoma/</loc><lastmod>2020-06-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/addition-of-first-line-atezolizumab-to-vemurafenib-and-cobimetinib-in-patients-with-unresectable-advanced-braf-v600-mutant-melanoma/</loc><lastmod>2020-06-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/results-of-a-covid-19-and-cancer-consortium-ccc19-cohort-study/</loc><lastmod>2020-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fda-approves-pembrolizumab-for-recurrent-or-metastatic-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/effect-of-radiation-boost-to-residual-disease-in-high-risk-neuroblastoma/</loc><lastmod>2020-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/long-term-survival-outcomes-with-3-years-vs-1-year-of-adjuvant-imatinib-for-high-risk-gist/</loc><lastmod>2020-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/sedentary-behavior-and-risk-of-cancer-mortality/</loc><lastmod>2020-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/variant-in-gene-may-increase-cancer-risk-in-those-with-common-tp53-r337h-mutations/</loc><lastmod>2020-06-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/astro-issues-clinical-guideline-on-radiation-therapy-for-cervical-cancer/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ivosidenib-for-idh1-mutant-advanced-glioma/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/lipophilic-statins-may-reduce-mortality-in-patients-with-ovarian-cancer/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/prognosis-of-patients-with-stage-iii-melanoma-according-to-ajccv8-vs-independent-cohorts/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-links-financial-hardship-to-more-emergency-room-visits-less-preventive-care-among-cancer-survivors/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/efficacy-outcomes-with-c-mtx-in-newly-diagnosed-patients-with-pediatric-t-cell-lymphoblastic-lymphoma/</loc><lastmod>2020-06-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/factors-associated-with-covid-19-infection-severity-in-patients-with-cancer/</loc><lastmod>2020-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/young-adults-with-cancer-may-benefit-from-germline-genetic-testing/</loc><lastmod>2020-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/effect-of-functional-impairment-on-hospitalized-patients-with-cancer/</loc><lastmod>2020-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/stereotactic-ablative-radiotherapy-for-oligometastatic-cancer-long-term-findings-from-sabr-comet/</loc><lastmod>2020-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/retrospective-study-of-characteristics-and-outcomes-in-patients-with-cancer-hospitalized-with-covid-19-in-hubei/</loc><lastmod>2020-06-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/impact-of-medicare-ocm-reporting-requirements-on-biomarker-testing-and-treatment-in-advanced-nsclc/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/percutaneous-cryoablation-vs-partial-or-radical-nephrectomy-for-early-stage-kidney-cancer/</loc><lastmod>2020-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/cisplatinfluorouracil-vs-carboplatinpaclitaxel-in-chemotherapy-naive-patients-with-advanced-anal-cancer/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/holographic-visualization-for-ablation-of-liver-tumors/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/transarterial-chemoperfusion-for-patients-with-mesothelioma/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fast-track-designations-in-colorectal-and-pancreatic-cancers-lymphoplasmacytic-lymphomawaldenstrom-s-macroglobulinemia/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/salvage-nivolumabipilimumab-after-prior-immune-checkpoint-inhibitor-therapy-in-patients-with-metastatic-rcc/</loc><lastmod>2020-06-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/hla-dp-expression-and-risk-of-acute-gvhd-after-unrelated-donor-hematopoietic-cell-transplantation/</loc><lastmod>2020-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ripretinib-in-previously-treated-patients-with-advanced-gist/</loc><lastmod>2020-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/immunogenomic-characteristics-of-advanced-clear-cell-kidney-cancer-treated-with-checkpoint-inhibitors/</loc><lastmod>2020-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/tafasitamab-plus-lenalidomide-for-relapsed-or-refractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/role-of-genetic-mutations-and-treatment-exposures-in-increased-subsequent-malignancy-risk-for-childhood-cancer-survivors/</loc><lastmod>2020-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ukccmp-prospective-cohort-study-of-covid-19-mortality-in-patients-with-cancer/</loc><lastmod>2020-06-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/addition-of-pemetrexed-vs-vinorelbine-to-adjuvant-cisplatin-for-nonsquamous-nsclc/</loc><lastmod>2020-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/factors-associated-with-all-cause-30-day-mortality-in-patients-with-cancer-infected-with-covid-19/</loc><lastmod>2020-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/acalabrutinib-vs-idelalisibrituximab-or-bendamustinerituximab-for-relapsed-or-refractory-cll/</loc><lastmod>2020-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/fgfr1-3-inhibitor-azd4547-in-refractory-tumors-harboring-fgfr-activating-mutations-and-fusions/</loc><lastmod>2020-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/immune-checkpoint-inhibitor-rechallenge-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2020-06-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/american-cancer-society-updates-guideline-for-diet-and-physical-activity/</loc><lastmod>2020-06-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/relationship-between-type-3c-diabetes-and-pancreatic-cancer/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/real-world-outcomes-with-axicabtagene-ciloleucel-therapy-in-relapsed-or-refractory-large-b-cell-lymphoma/</loc><lastmod>2020-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/meta-analysis-of-outcomes-with-checkpoint-inhibitor-treatment-in-advanced-msi-h-cancers/</loc><lastmod>2020-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/national-cost-of-cancer-care-in-the-united-states-expected-to-rise-to-over-246-billion-by-2030/</loc><lastmod>2020-06-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/first-line-platinum-based-chemotherapy-for-patients-with-metastatic-pancreatic-cancer-and-defects-in-homologous-recombination-genes/</loc><lastmod>2020-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/pembrolizumab-plus-chemoradiotherapy-for-locally-advanced-hnscc/</loc><lastmod>2020-06-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/standard-vs-histology-tailored-neoadjuvant-chemotherapy-for-high-risk-soft-tissue-sarcoma/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-explores-adding-trastuzumab-to-radiotherapy-for-women-with-her2-positive-dcis/</loc><lastmod>2020-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/impact-of-the-covid-19-pandemic-on-pediatric-cancer-care-in-latin-america/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/outcomes-with-minimally-invasive-vs-open-esophagectomy-in-routine-practice/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/safety-and-patient-reported-outcomes-from-the-impower150-trial-in-metastatic-nonsquamous-nsclc/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/rates-of-testicular-cancer-rising-among-racialethnic-minorities-in-the-united-states/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/adjuvant-nivolumabipilimumab-or-nivolumab-alone-vs-placebo-in-patients-with-resected-stage-iv-melanoma/</loc><lastmod>2020-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/risk-adapted-dose-adjusted-epoch-r-for-previously-untreated-adult-patients-with-burkitt-lymphoma/</loc><lastmod>2020-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/results-from-an-oncology-hospital-at-home-evaluation/</loc><lastmod>2020-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ret-kinase-inhibitor-for-patients-with-solid-tumors-and-ret-genetic-fusions/</loc><lastmod>2020-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/genomic-characteristics-of-smoldering-multiple-myeloma-and-risk-of-progression/</loc><lastmod>2020-06-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/first-line-atezolizumab-plus-chemotherapy-vs-chemotherapy-alone-in-advanced-urothelial-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/final-overall-survival-analysis-of-the-prosper-trial-in-nonmetastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/durvalumab-added-to-standard-chemotherapy-improved-os-in-patients-with-malignant-pleural-mesothelioma/</loc><lastmod>2020-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/ivosidenib-plus-venetoclax-with-or-without-azacitidine-for-idh1-mutated-aml/</loc><lastmod>2020-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/early-local-therapy-did-not-extend-survival-in-patients-with-newly-diagnosed-metastatic-breast-cancer/</loc><lastmod>2020-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/carfilzomib-vs-bortezomib-in-addition-to-lenalidomidedexamethasone-in-newly-diagnosed-multiple-myeloma/</loc><lastmod>2020-06-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/trastuzumab-deruxtecan-vs-chemotherapy-for-previously-treated-patients-with-her2-positive-advanced-gastric-cancer/</loc><lastmod>2020-06-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/liposomal-daunorubicin-and-cytarabine-followed-by-flag-for-pediatric-relapsed-aml/</loc><lastmod>2020-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/does-treatment-with-immune-checkpoint-inhibitors-cause-flare-ups-in-patients-with-preexisting-ibd-or-microscopic-colitis/</loc><lastmod>2020-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/androgen-deprivation-with-oral-relugolix-vs-leuprolide-in-advanced-prostate-cancer-hero-trial/</loc><lastmod>2020-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/study-finds-substantial-racialethnic-disparities-in-lost-earnings-from-cancer-mortality/</loc><lastmod>2020-06-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/cediranibolaparib-vs-standard-of-care-chemotherapy-for-platinum-sensitive-ovarian-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/06-june/remote-pre-and-post-test-genetic-counseling-for-breast-and-ovarian-cancer-risk/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/lymphoma-many-questions-too-few-answers/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/asco-as-a-public-organization/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/introducing-the-asco-post/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/why-the-asco-post/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/recurrence-of-iraes-after-checkpoint-inhibitor-rechallenge-in-patients-with-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/celebrating-the-role-of-nurses-in-meeting-the-current-challenges-of-cancer-care-delivery/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/addition-of-pembrolizumab-to-docetaxel-for-previously-treated-immunotherapy-naive-patients-with-advanced-nsclc/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/durvalumab-for-solid-tumors-in-patients-with-virologically-controlled-hiv-1-infection/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-selpercatinib-for-lung-and-thyroid-cancers-with-ret-mutations-or-fusions/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-pomalidomide-for-kaposi-sarcoma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/continuous-dosing-of-dabrafenib-plus-trametinib-improves-pfs-vs-intermittent-dosing-in-advanced-melanoma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-charles-sawyers-1/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/how-the-lung-cancer-community-came-together-during-the-covid-19-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/cancer-vs-covid-19-clinical-trial-research-during-the-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/study-finds-cancer-related-deaths-declined-in-states-with-expanded-access-to-medicaid/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/overall-survival-benefit-shown-for-maintenance-olaparib-in-ovarian-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-don-dizon/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/geriatrician-assessment-and-integrated-care-may-help-older-patients-as-well-as-the-health-care-system/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-william-dale/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/videoconference-intervention-can-reduce-levels-of-anxiety-and-distress-among-distance-caregivers/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-olaparib-plus-bevacizumab-as-maintenance-treatment-for-ovarian-fallopian-tube-or-primary-peritoneal-cancers/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/prioritizing-patients-with-metastatic-disease-for-palliative-radiotherapy/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/use-of-neoadjuvant-chemotherapy-increasing-along-with-survival-in-advanced-ovarian-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-alexandra-leary/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/mortality-rate-of-patients-with-cancer-and-covid-19-in-a-new-york-hospital/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-capmatinib-for-patients-with-metastatic-nsclc-with-confirmed-met-exon-14-skipping/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/treating-colorectal-cancer-in-the-time-of-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/triplet-regimen-improves-progression-free-survival-in-advanced-melanoma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-charles-sawyers/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-issues-emergency-use-authorization-for-remdesivir-for-treatment-of-severe-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-daratumumab-and-hyaluronidase-fihj-in-multiple-myeloma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/on-the-shoulders-of-giants/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/radiation-and-chemoradiation-interruption-and-noncompletion-in-squamous-cell-anal-carcinoma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/allocating-ventilators-in-times-of-crisis/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/durvalumabolaparibpaclitaxel-graduates-in-her2-negative-breast-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/hypercoagulability-in-critically-ill-patients-with-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-niraparib-as-maintenance-therapy-for-advanced-ovarian-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-new-pembrolizumab-dosing-regimen/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/10-changes-i-will-make-in-my-oncology-practice-as-a-result-of-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/selected-poster-presentations-on-cancer-therapeutics-and-more/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/new-asco-guideline-addresses-headneck-squamous-cell-carcinoma-of-unknown-primary/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/online-guide-offers-tips-for-communicating-with-patients-during-the-covid-19-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/lessons-learned-on-rotation-at-covid-19-inpatient-service-at-new-york-city-hospital/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/united-against-cancer-to-accelerate-progress-for-patients/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/overcoming-the-challenges-of-presenting-the-asco-annual-meeting-during-the-covid-19-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/wee1-inhibitor-shows-activity-in-recurrent-uterine-serous-carcinoma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-pamela-munster/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-shannon-westin-and-alexander-melamed/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/niraparib-as-first-line-maintenance-therapy-for-advanced-ovarian-cancers/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-thomas-herzog/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/perspectives-on-how-the-covid-19-pandemic-is-impacting-oncology-care/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/evolving-insights-into-covid-19-and-cancer-care/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/aacr-virtual-annual-meeting-i-draws-over-61-000-registrants/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/pemigatinib-for-previously-treated-cholangiocarcinoma-with-fgfr2-rearrangement-or-fusion/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/asco-s-president-elect-aims-to-ensure-equitable-cancer-care-for-every-patient/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/eric-brown-joins-staff-at-karmanos-cancer-institute/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/city-of-hope-welcomes-stanley-hamilton-and-alexey-danilov/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/selumetinib-for-pediatric-neurofibromatosis-type-1-with-symptomatic-inoperable-plexiform-neurofibromas/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/luspatercept-aamt-for-anemia-in-adults-with-myelodysplastic-syndromes/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/genetics-may-soon-guide-targeted-treatment-of-brain-metastases/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/mitomycin-gel-for-low-grade-upper-tract-urothelial-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/tucatinib-in-previously-treated-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/yale-cancer-center-announces-hematology-leadership-appointments/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/how-the-covid-19-pandemic-is-propelling-the-delivery-of-home-care-for-patients-with-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/john-craig-venter-sequencing-the-human-genome/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/moffitt-appoints-john-cleveland-as-new-director/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/martin-dietrich-joins-florida-cancer-institute/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/being-interviewed-on-zoom/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/treatment-related-sequelae-in-pediatric-neuro-oncology/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/robert-bona-named-director-of-benign-hematology-program/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/melanoma-research-alliance-announces-funding-for-grant-awards/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/oneoncology-names-jeff-patton-chief-executive-officer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/nih-aims-to-quantify-undetected-cases-of-coronavirus-infection/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ecog-acrin-conducts-smoking-cessation-study-in-patients-with-cancer/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/treating-patients-with-leukemia-during-the-covid-19-era-at-md-anderson-cancer-center/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/roswell-park-investigators-study-immunotherapy-combination-in-patients-with-cancer-infected-with-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/is-estrogen-protective-against-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/novel-imaging-application-illuminates-processes-in-cancer-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/patient-centered-research-for-treatment-of-insomnia/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/american-academy-of-arts-sciences-inducts-members-of-class-of-2020/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/indiana-university-researcher-receives-nci-grant-for-multiple-myeloma/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/nih-begins-clinical-trial-of-combination-regimen-to-treat-covid-19/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/gynecologic-oncologist-describes-his-new-normal-in-a-new-york-hospital/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/artificial-blood-substitute/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ancestry-and-molecular-makeup-of-cancer-evaluated-in-new-study/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/the-story-of-three-patients-with-leukemia/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/what-have-i-learned-in-more-than-half-a-century-in-cancer-medicine/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/rosemary-yancik-dies-at-86/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/john-yarbro-dies-at-88/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/paul-marks-dies-at-93/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/covid-19-evidence-accelerator-leverages-real-world-data/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/nina-kadan-lottick-chose-a-career-in-pediatric-oncology/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/the-arc-of-therapy-from-cure-to-humbling-legacy/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/brain-cancer-prepared-me-for-the-isolation-and-uncertainty-of-the-covid-19-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/jennifer-king-named-cso-of-go2-foundation/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/a-long-crusade-against-some-of-the-world-s-most-virulent-diseases-for-anthony-fauci/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/tips-for-first-time-abstract-presenters/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/conquer-cancer-researcher-searches-for-colorectal-cancer-cures/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fundraising-to-help-patients-and-oncologists-during-the-covid-19-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/help-your-patients-manage-their-weight-with-this-asco-resource/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/new-guidance-released-for-oncology-community-on-allocation-of-limited-resources-during-the-covid-19-pandemic/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/new-article-analyzes-impact-of-pbms-on-quality-cancer-care/</loc><lastmod>2020-05-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/highlights-from-ash-2019/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/the-role-of-adipose-tissue-in-cancer-aggressiveness/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/understanding-patient-reported-outcomes-in-cancer-trials/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/encorafenib-combined-with-cetuximab-in-previously-treated-braf-v600e-mutant-metastatic-colorectal-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/grace-and-forgiveness/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/durvalumab-plus-chemotherapy-for-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/parker-institute-for-cancer-immunotherapy-appoints-frederic-pla-as-coo/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fox-chase-cancer-center-welcomes-andres-correa/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/aria-vaishnavi-receives-nci-s-pathway-to-independence-award/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/larry-kwak-named-aimbe-fellow/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/kristin-brill-joins-sidney-kimmel-cancer-center/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/global-covid-19-observatory-and-resource-center-for-childhood-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/yoga-for-pediatric-and-adolescent-patients-with-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/i-have-multiple-myeloma-and-am-concerned-about-the-coronavirus/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ongoing-efforts-toward-vaccine-development-for-covid-19/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/my-asco-journey-opportunities-for-gratitude-and-breaking-glass-ceilings/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/breakthroughs-in-combination-therapy-for-colorectal-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/covid-19-what-people-with-cancer-need-to-know/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/asco-s-covid-19-cancer-registry/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/financial-support-available-to-providers-during-covid-19-pandemic/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/in-remembering-mum-siblings-honor-their-mother-with-action-and-innovation/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/camrelizumab-for-previously-treated-advanced-hepatocellular-carcinoma/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/surgical-margins-and-survival-in-trial-of-adjuvant-imatinib-for-localized-gist/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/delayed-targeted-intraoperative-radiotherapy-vs-whole-breast-radiotherapy-in-early-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/practical-approach-to-management-of-patients-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-mitomycin-for-low-grade-upper-tract-urothelial-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-sacituzumab-govitecan-hziy-for-patients-with-previously-treated-metastatic-triple-negative-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/david-a-tuveson-md-phd-faacr-elected-aacr-president-elect-for-2020-2021/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/april-is-the-cruelest-month/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-ibrutinibrituximab-for-cllsll/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-pemigatinib-for-patients-with-cholangiocarcinoma-and-an-fgfr2-rearrangement-or-fusion/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-tucatinib-in-combination-with-trastuzumabcapecitabine-for-advanced-unresectable-or-metastatic-her2-positive-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/quality-of-life-after-adjuvant-radiotherapy-with-vs-without-tumor-bed-boost-for-patients-with-non-low-risk-dcis/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-selumetinib-for-pediatric-patients-with-nf1-and-symptomatic-inoperable-plexiform-neurofibromas/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/outcomes-of-covid-19-infection-in-patients-with-cancer-in-wuhan/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/noninferiority-of-four-vs-six-cycles-of-chop-for-patients-with-favorable-prognosis-b-cell-lymphoma/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/managing-multiple-myeloma-during-the-covid-19-pandemic/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/negotiating-the-obstacles-to-conducting-clinical-trials-of-immunotherapy-during-the-coronavirus-pandemic/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/parp-inhibitors-in-maintenance-treatment-for-advanced-ovarian-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/new-guideline-on-systemic-therapy-for-melanoma-tackles-rapid-developments-in-treatment-options/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/novel-treatment-strategies-under-study-in-advanced-melanoma/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-omid-hamid/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/early-signs-of-activity-with-immunotherapies-in-low-incidence-cancers/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/can-breast-cancer-surgery-be-eliminated-in-exceptional-responders-to-neoadjuvant-therapy/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/timothy-chan-named-director-of-cleveland-clinic-s-center-for-immunotherapy-and-precision-immuno-oncology/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/vascular-imaging-for-detection-of-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/joint-guideline-sheds-light-on-management-of-hereditary-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/addition-of-olaparib-to-bevacizumab-maintenance-in-advanced-ovarian-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/addition-of-pembrolizumab-to-docetaxel-for-previously-treated-immunotherapy-naive-patients-with-advanced-lung-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/actively-recruiting-clinical-trials-studying-cancer-prevention-measures/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/bispecific-antibodies-poised-to-impact-treatment-of-lymphoma-and-other-blood-cancers/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-basem-william-and-caron-jacobson/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/studies-show-circulating-tumor-material-may-predict-outcomes-after-neoadjuvant-therapy-for-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/epov-virginia-kaklamani-and-minetta-liu/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/neoadjuvant-and-adjuvant-pembrolizumab-improves-outcomes-in-early-triple-negative-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/a-biomarker-resource-for-pd-1-inhibition-in-early-triple-negative-breast-cancer/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/pooled-analysis-supports-benefit-of-dual-her2-targeted-therapy/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/american-cancer-society-awards-new-research-training-grants/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/avoiding-use-of-prophylactic-peg-filgrastim-during-paclitaxel-treatment-in-dose-dense-chemotherapy-for-breast-cancer/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/treatment-and-outcomes-in-patients-with-metastatic-colorectal-cancer-in-washington-state-and-canada/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/are-there-racial-differences-in-time-to-treatment-for-melanoma/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/priority-review-in-aml-fast-track-designations-for-pancreatic-cancer-and-neuroendocrine-tumors/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/asco-survey-on-early-impact-of-covid-19-on-the-performance-of-oncology-clinical-trials/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/neoadjuvant-nivolumab-for-resectable-merkel-cell-carcinoma/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/outcomes-with-autologous-allogeneic-vs-tandem-autologous-hematopoietic-cell-transplantation-in-patients-with-newly-diagnosed-multiple-myeloma/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ai-model-accurately-classifies-colorectal-polyps-from-histopathologic-slides/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/olaparib-for-patients-with-mcrpc-and-homologous-recombination-repair-gene-alterations/</loc><lastmod>2020-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/regorafenib-plus-nivolumab-in-advanced-gastric-and-colorectal-cancers/</loc><lastmod>2020-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/issues-with-travel-faced-by-patients-undergoing-lu-177-dotatate-radiation-therapy/</loc><lastmod>2020-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/atezolizumab-alone-or-in-combination-with-cobimetinib-for-biliary-tract-cancer/</loc><lastmod>2020-05-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/long-term-outcomes-with-adjuvant-hypofractionated-radiotherapy-for-1-vs-3-weeks-in-early-breast-cancer/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/dexrazoxane-cardiac-function-and-treatment-outcomes-in-pediatric-aml/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/chemoablation-of-low-grade-upper-tract-urothelial-cancer-with-mitomycin-containing-reverse-thermal-gel/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/reduction-in-cancer-diagnoses-in-the-netherlands-during-the-covid-19-pandemic/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/wee1-inhibition-in-recurrent-uterine-serous-carcinoma/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/benefit-of-increased-dietary-antioxidants-during-induction-therapy-for-pediatric-all/</loc><lastmod>2020-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/chemoimmunotherapy-for-pediatric-refractory-or-relapsed-neuroblastoma/</loc><lastmod>2020-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/distinct-new-mds-subtype-proposed-based-on-presence-of-genetic-mutation/</loc><lastmod>2020-05-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/spartalizumab-for-locally-advanced-or-metastatic-anaplastic-thyroid-carcinoma/</loc><lastmod>2020-05-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/half-of-surveyed-cancer-researchers-report-their-work-is-on-hold-due-to-the-covid-19-pandemic/</loc><lastmod>2020-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/can-a-culturally-tailored-education-program-improve-colorectal-cancer-awareness-and-screening/</loc><lastmod>2020-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ruxolitinib-in-glucocorticoid-refractory-acute-graft-vs-host-disease-after-stem-cell-transplant/</loc><lastmod>2020-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/communication-skills-training-for-oncologists-and-discussion-of-goals-of-care/</loc><lastmod>2020-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/don-t-touch-me-with-a-6-foot-pole/</loc><lastmod>2020-05-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/quitting-smoking-at-any-point-improves-lung-cancer-survival/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/effectiveness-of-different-severity-thresholds-for-chemotherapy-related-symptom-alerts/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/first-line-concomitant-and-sequential-nivolumabavd-for-early-stage-unfavorable-classical-hodgkin-lymphoma/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/combining-pembrolizumab-with-il-12-electroporation-may-improve-clinical-response-in-patients-with-immunologically-cold-melanoma/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/new-study-shows-patients-with-cancer-had-lower-rates-of-detected-covid-19-antibodies-vs-health-care-workers/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/does-text-messaging-support-adherence-to-adjuvant-aromatase-inhibitor-therapy-in-women-with-early-stage-breast-cancer/</loc><lastmod>2020-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/exposure-to-fine-particulate-matter-may-increase-mortality-among-pediatric-and-aya-patients-with-certain-cancers/</loc><lastmod>2020-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/prevalence-of-endosalpingiosis-and-association-with-ovarian-cancer/</loc><lastmod>2020-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/astro-survey-finds-fewer-patients-visiting-radiation-oncology-clinics-despite-enhanced-covid-19-safety-measures/</loc><lastmod>2020-05-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/study-finds-a-high-rate-of-intra-and-postoperative-conversions-to-total-thyroidectomy/</loc><lastmod>2020-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-nivolumabipilimumab-for-the-first-line-treatment-of-patients-with-metastatic-nsclc-and-pd-l1-tumor-expression-1/</loc><lastmod>2020-05-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-ripretinib-for-previously-treated-patients-with-advanced-gastrointestinal-stromal-tumor/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-rucaparib-in-brca-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/cancer-care-at-tata-memorial-centre-during-the-covid-19-pandemic/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/two-breakthrough-therapy-designations-for-fam-trastuzumab-deruxtecan-nxki-and-more/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/physical-activity-and-neurocognitive-function-in-adult-survivors-of-childhood-cancers/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/detecting-relapse-in-patients-with-lymphoma-in-first-remission-value-of-surveillance-laboratory-testing/</loc><lastmod>2020-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/nih-led-activ-program-for-the-development-of-covid-19-vaccines/</loc><lastmod>2020-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/os-with-the-addition-of-adt-or-brachytherapy-boost-to-external-beam-radiotherapy-in-patients-with-localized-prostate-cancer/</loc><lastmod>2020-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/can-pain-after-prostatectomy-or-nephrectomy-be-managed-without-opioids/</loc><lastmod>2020-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/low-intensity-surveillance-as-an-option-for-some-patients-with-non-muscle-invasive-bladder-cancer/</loc><lastmod>2020-05-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-olaparib-for-hrr-gene-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/do-men-treated-with-adt-for-prostate-cancer-have-a-lesser-chance-of-acquiring-covid-19/</loc><lastmod>2020-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/asco-special-report-provides-guidance-to-oncology-practices-on-resuming-cancer-care-during-the-covid-19-pandemic/</loc><lastmod>2020-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/atezolizumab-plus-bevacizumab-vs-sorafenib-in-treatment-naive-patients-with-unresectable-hepatocellular-carcinoma/</loc><lastmod>2020-05-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/cosmetic-outcomes-with-lumpectomy-for-multiple-ipsilateral-breast-cancer/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/phone-outreach-and-scheduling-assistance-boost-mammography-uptake-at-an-urban-safety-net-hospital/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/analysis-of-women-younger-than-40-with-breast-cancer/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/patient-preference-for-subcutaneous-vs-intravenous-pertuzumabtrastuzumab-for-her2-positive-early-breast-cancer/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ipatasertibpaclitaxel-vs-paclitaxel-alone-in-advanced-triple-negative-breast-cancer/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/physical-activity-supportive-care-to-relieve-cancer-related-fatigue-may-be-underutilized-by-breast-cancer-survivors/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/novel-biomarkers-may-predict-immunotherapy-benefit-in-metastatic-breast-cancer/</loc><lastmod>2020-05-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/ivosidenib-for-idh1-mutant-chemotherapy-refractory-cholangiocarcinoma/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/use-of-symptom-assessment-scale-vs-routine-management-in-patients-with-cancer-receiving-radiotherapy/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/sources-for-better-gvhd-free-relapse-free-survival-after-adult-alternative-donor-hct/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/covid-19-infection-in-pediatric-patients-with-cancer/</loc><lastmod>2020-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/do-marital-status-and-race-affect-the-treatment-of-esophageal-cancer/</loc><lastmod>2020-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/antihistamines-may-improve-survival-among-patients-with-malignant-melanoma/</loc><lastmod>2020-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/germline-genetic-variants-in-atm-and-lung-cancer-susceptibility/</loc><lastmod>2020-05-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/first-line-pembrolizumab-plus-etoposideplatinum-for-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/intensive-remote-monitoring-of-high-risk-patients-initiating-antineoplastic-treatment/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/transoral-resection-followed-by-low-dose-radiation-for-some-oropharyngeal-cancers/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-atezolizumab-plus-bevacizumab-for-patients-with-unresectable-or-metastatic-hcc/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/fda-approves-first-line-ramucirumab-plus-erlotinib-for-metastatic-egfr-mutated-nsclc/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/is-sentinel-lymph-node-biopsy-alone-oncologically-safe-for-patients-with-early-stage-cervical-cancer/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/data-from-tapur-study-cohorts-on-olaparib-for-brca-mutated-advanced-prostate-and-pancreatic-cancers/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/tepotinib-shows-activity-in-patients-with-nsclc-and-met-exon-14-skipping-mutation/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/hif2a-inhibitor-for-von-hippel-lindau-disease-associated-renal-cell-carcinoma/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/05-may/study-finds-patients-with-lung-cancer-infected-with-covid-19-recently-treated-with-chemotherapy-at-higher-risk-of-death/</loc><lastmod>2020-05-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/covid-19-may-remain-stable-for-hours-to-days-in-aerosols-and-on-surfaces/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/covid-19-infection-in-patients-with-cancer-in-china/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pemigatinib-for-previously-treated-advanced-cholangiocarcinoma/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/covid-19-cancer-and-the-need-for-more-data/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-approves-durvalumab-as-part-of-a-first-line-combination-regimen-for-extensive-stage-sclc/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/french-guidelines-on-patients-with-cancer-and-sars-cov-2-infection/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/patient-with-multiple-myeloma-treated-for-covid-19-with-tocilizumab/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/does-pembrolizumab-show-activity-in-some-rare-cancers/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/mind-body-therapies-for-relieving-anxiety-and-stress-in-patients-with-cancer-during-covid-19-pandemic/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/20-million-in-grants-awarded-to-identify-therapies-for-covid-19/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/indigenous-american-ancestry-may-be-associated-with-her2-positive-breast-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/harvard-medical-student-s-innovation-disinfection-you-can-see/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-approves-luspatercept-aamt-for-second-line-treatment-of-anemia-in-mds/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/ash-research-collaboratives-data-hub-creates-international-data-registry-for-patients-with-blood-cancers-and-covid-19/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/oncologists-on-the-front-lines-of-the-covid-19-pandemic-miriam-knoll/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/maintaining-blood-donations-during-the-covid-19-pandemic/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/vitamin-d-and-lymphoma-an-apparent-benefit-but-further-study-required/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/budwig-diet/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/after-training-across-three-continents-a-hematologist-leads-the-wisconsin-hematologyoncology-division/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/gut-microbiota-emerging-as-key-player-in-response-to-immunotherapy/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/survey-of-patients-experience-with-radiation-therapy-for-cancer-finds-some-gaps-in-expectation-vs-reality/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/helping-patients-to-feel-informed-about-goals-and-adverse-effects-of-cancer-treatments/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fox-chase-cancer-center-announces-new-name-and-recertification-for-palliative-care-program/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/nih-launches-1-million-competition-to-target-disease-diagnostics/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/unnecessary-barrier-to-blood-donation-for-british-nationals/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/chemotherapy-and-the-sweat-lodge/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/inoperable-carcinoma-of-the-breast/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/nivolumabipilimumab-in-patients-with-sorafenib-pretreated-hepatocellular-carcinoma/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/a-clinical-trial-saved-my-life/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/statins-with-or-without-metformin-are-associated-with-increased-survival-in-patients-with-high-risk-prostate-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/expect-interest-and-questions-about-statins-and-metformin/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/aacr-provides-scientific-expertise-to-assist-fda-s-public-health-initiative/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/aacr-annual-meeting-to-be-held-in-two-part-virtual-platform/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/intestinal-microbiota-and-mortality-in-recipients-of-allogeneic-hematopoietic-cell-transplantation/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/it-s-t-time-for-peripheral-t-cell-lymphoma/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pembrolizumab-plus-cetuximab-shows-antitumor-activity-in-squamous-cell-head-and-neck-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-charu-aggarwal/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-s-draft-guidance-will-improve-evidence-base-for-older-adults-with-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/chemoradiation-plus-bevacizumab-in-locally-or-regionally-advanced-nasopharyngeal-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/conquer-cancer-researchers-remember-jane-c-wright-md-fasco/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-resources-on-covid-19-for-the-oncology-community/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/better-mental-health-screening-needed-for-survivors-of-head-and-neck-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/free-practice-resource-cancernet-patient-referral-cards-from-asco/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/merry-jennifer-markham-md-facp-fasco-rose-from-humble-beginnings-to-a-leadership-role-in-oncology/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/upfront-apalutamide-delays-time-to-second-progression-in-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-dana-rathkopf/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/what-s-the-current-status-of-neoadjuvant-immunotherapy/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/do-hiv-positivity-and-autoimmune-disease-preclude-treatment-with-checkpoint-inhibitors/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/more-antibody-drug-conjugates-on-the-horizon-for-breast-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/beyond-cdk46-inhibitors-what-subsequent-treatment-is-best/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/ascent-study-halted/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/checkmate-142-updated-analysis/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/how-crispr-cas9-gene-editing-may-improve-the-effectiveness-of-cellular-therapeutics-in-patients-with-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-john-carethers-and-joseph-sung/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/selected-ash-abstracts-on-novel-treatments-for-non-hodgkin-lymphomas/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/gut-bacterial-diversity-a-marker-or-driver-of-outcomes-after-hematopoietic-cell-transplantation/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/addition-of-isatuximab-to-pomalidomide-and-dexamethasone-in-relapsed-and-refractory-multiple-myeloma/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/actively-recruiting-clinical-trials-studying-multiple-myeloma/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/nci-match-subprotocol-finds-nivolumab-active-in-mismatch-repair-deficient-cancers-other-than-colorectal-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pd-1-inhibition-in-mismatch-repair-deficientmicrosatellite-instability-high-cancers-other-than-colorectal-cancer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/radon-exposure-a-leading-environmental-cause-of-cancer-mortality-in-the-united-states/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/21-gene-assay-recurrence-score-and-risk-of-locoregional-recurrence/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/adapting-adjuvant-endocrine-therapy-by-patient-age-and-risk/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-accelerates-development-of-novel-therapies-for-covid-19/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/virtual-appointments-help-patients-with-cancer-continue-care-during-covid-19-health-crisis/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/ama-highlights-mental-health-resources-for-physicians-during-covid-19-pandemic/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/smilow-cancer-hospital-and-yale-cancer-center-appoint-deputy-chief-medical-officer/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/nci-awards-grant-for-immunotherapy-research/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/robert-l-coleman-named-chief-scientific-officer-for-the-us-oncology-network/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/isatuximab-irfc-for-previously-treated-multiple-myeloma/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-conquer-cancer-honor-leaders-in-cancer-care-with-2020-special-awards/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/ringing-a-bell-on-the-last-day-of-radiation-therapy/</loc><lastmod>2020-04-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/brief-highlights-on-novel-therapies-for-prostate-bladder-and-kidney-cancers/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/bispecific-antibodies-successes-and-challenges/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/immunotherapy-comes-of-age-in-breast-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-releases-resource-stratified-guideline-on-the-treatment-of-late-stage-colorectal-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/study-suggests-adjuvant-everolimus-may-benefit-patients-with-advanced-head-and-neck-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-tanguy-seiwert/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/abstracts-from-the-nccn-2020-annual-conference-now-available/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pembrolizumab-plus-radiotherapy-in-locally-advanced-squamous-cell-head-and-neck-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-sue-sun-yom/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-board-concludes-annual-meeting-cannot-occur-in-person/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/should-restrictions-on-genetic-testing-be-loosened/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/prior-antibiotic-use-and-survival-in-patients-with-advanced-melanoma-receiving-immune-checkpoint-inhibitors/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-jarushka-naidoo/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/sema4d-inhibition-a-novel-means-of-improving-immune-response/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/epov-timothy-yap/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/reshma-jagsi-tirelessly-advocates-for-women-s-health-and-careers-in-medicine/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/msk-and-city-college-of-new-york-researchers-awarded-grant-from-nci/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/updates-from-selected-clinical-trials-in-breast-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/philadelphia-t-cell-lymphomaleukemia-initiative-to-be-launched/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/donald-sullivan-receives-ats-foundation-research-programamerican-lung-association-partner-grant/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/highlights-from-transplantation-and-cellular-therapy-meetings-of-astct-and-cibmtr/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/using-respectful-language-to-reduce-unconscious-bias-in-oncology-care/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/what-s-in-a-name/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/a-hallmark-moment/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/city-of-hope-deploys-platform-makes-study-data-accessible/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/living-a-full-life-after-pancreatic-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/breast-cancer-specialist-lawrence-solin-dies/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/international-palliative-care-workshop-in-russia/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/r-kate-kelley-breakthroughs-for-hepatocellular-carcinoma/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/significant-changes-to-evaluation-and-management-codes-in-2021/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/house-bill-supports-innovative-payment-models/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/lawrence-einhorn-reflects-on-the-path-to-a-cure/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/join-the-conquerors-community/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-answers-fact-sheet-on-fertility-and-cancer-treatment/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/a-message-from-the-fda-oce-on-covid-19/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/practicing-oncology-in-the-era-of-covid-19/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/testing-ppe-and-practice-support-needed-during-covid-19-crisis/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/oncologists-on-the-front-lines-of-covid-19/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-approves-nivolumabipilimumab-for-pretreated-patients-with-hepatocellular-carcinoma/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/adjuvant-gemcitabineplatinum-based-chemotherapy-vs-surveillance-for-upper-tract-urothelial-carcinoma/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/mitigating-the-spread-of-covid-19-and-its-impact-on-cancer/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/how-covid-19-is-affecting-the-oncology-community/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/strategies-for-protecting-patients-and-health-care-providers-against-covid-19/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/spring-2020-abim-maintenance-of-certification-exams-canceled/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/concurrent-pembrolizumab-and-chemoradiotherapy-in-locally-advanced-nsclc/</loc><lastmod>2020-04-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/outcomes-of-covid-19-infection-in-patients-with-vs-without-cancer/</loc><lastmod>2020-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/mortality-rate-from-covid-19-in-patients-with-thoracic-cancers/</loc><lastmod>2020-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/risk-prediction-model-for-pancreatic-cancer/</loc><lastmod>2020-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/risk-of-thromboembolic-complications-in-patients-with-covid-19/</loc><lastmod>2020-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/disruptions-in-health-insurance-coverage-and-cancer-care-survival/</loc><lastmod>2020-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/high-vs-low-dose-anti-cd19-car-t-cell-therapy-in-patients-with-relapsed-or-refractory-cll/</loc><lastmod>2020-04-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-shares-new-clinical-trial-data-initiatives-and-path-forward-for-post-covid-19-cancer-care-delivery-system/</loc><lastmod>2020-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/prognosis-of-patients-with-cancer-and-covid-19-outcomes-from-a-center-in-new-york-city/</loc><lastmod>2020-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/continuous-vs-intermittent-dabrafenibtrametinib-dosing-in-patients-with-braf-mutated-melanoma/</loc><lastmod>2020-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/study-finds-vape-shops-are-mostly-concentrated-in-low-resource-minority-communities/</loc><lastmod>2020-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/cfdna-liquid-biopsy-may-provide-an-early-detection-test-for-patients-with-suspected-cancer/</loc><lastmod>2020-04-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/nivolumabipilimumab-vs-nivolumab-alone-in-recurrent-or-persistent-ovarian-cancer/</loc><lastmod>2020-04-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/effect-of-payer-s-utilization-management-policy-on-uptake-of-hypofractionated-radiotherapy-among-eligible-patients-with-early-stage-breast-cancer/</loc><lastmod>2020-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asparaginase-discontinuation-and-outcomes-in-pediatric-all/</loc><lastmod>2020-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/progression-of-advanced-small-bowel-neuroendocrine-tumors-after-multimodal-surgical-therapy/</loc><lastmod>2020-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/final-overall-survival-results-from-the-phase-iii-embraca-trial/</loc><lastmod>2020-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/ctdna-may-be-a-prognostic-biomarker-of-disease-recurrence-in-patients-with-lung-cancer/</loc><lastmod>2020-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/long-term-outcomes-with-triplet-induction-and-risk-adapted-maintenance-therapy-for-newly-diagnosed-multiple-myeloma/</loc><lastmod>2020-04-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/postdiagnosis-weight-and-mortality-by-cause-in-survivors-of-nonmetastatic-prostate-cancer/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-releases-new-guidance-on-allocation-of-limited-resources-in-the-oncology-community-during-covid-19-pandemic/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/neoadjuvant-immunotherapy-in-early-stage-colon-cancer/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/differences-in-melanoma-incidence-in-men-vs-women-by-age-and-anatomic-site/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/intermittent-dawn-to-sunset-fasting-and-anticancer-serum-proteome/</loc><lastmod>2020-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/acalabrutinib-with-or-without-obinutuzumab-vs-chlorambucilobinutuzumab-in-patients-with-previously-untreated-cll/</loc><lastmod>2020-04-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/treatment-with-checkpoint-inhibitors-may-cause-thyroid-dysfunction/</loc><lastmod>2020-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/textbook-outcome-in-patients-undergoing-resection-of-pancreatic-neuroendocrine-tumors/</loc><lastmod>2020-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/nccn-issues-guidance-on-improving-covid-19-safety-for-patients-and-health-care-providers/</loc><lastmod>2020-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/asco-s-new-covid-19-cancer-registry/</loc><lastmod>2020-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-pipeline-priority-reviews-for-immunotherapy-based-on-biomarker-status-combination-first-line-therapy-in-lung-cancer/</loc><lastmod>2020-04-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/activity-of-pembrolizumab-in-patients-with-nsclc-brain-metastases/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/second-line-lurbinectedin-in-small-cell-lung-cancer/</loc><lastmod>2020-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/clinical-trials-to-evaluate-activity-of-biologics-other-agents-against-covid-19/</loc><lastmod>2020-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/kte-x19-for-relapsed-or-refractory-mantle-cell-lymphoma-zuma-2-trial/</loc><lastmod>2020-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/does-breastfeeding-affect-invasive-ovarian-cancer-risk/</loc><lastmod>2020-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/methylation-signatures-from-sequencing-cfdna-detected-different-types-of-cancer-across-multiple-stages/</loc><lastmod>2020-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/daratumumab-for-relapsed-or-refractory-multiple-myeloma-subcutaneous-vs-intravenous-dosing/</loc><lastmod>2020-04-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/cancer-care-in-the-time-of-covid-19-statement-from-fox-chase-cancer-center/</loc><lastmod>2020-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/trastuzumab-beyond-progression-in-her2-positive-advanced-gastricgastroesophageal-junction-cancer/</loc><lastmod>2020-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/apixaban-for-cancer-associated-vte/</loc><lastmod>2020-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-pipeline-approval-of-new-dosing-for-biosimilar-plus-two-fast-track-designations/</loc><lastmod>2020-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/aacr-annual-meeting-2020-to-be-held-in-a-virtual-only-format/</loc><lastmod>2020-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/first-in-human-study-of-anteumab-ravtansine-for-advanced-solid-tumors/</loc><lastmod>2020-04-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/ivosidenib-in-patients-with-advanced-idh1-mutated-chondrosarcoma/</loc><lastmod>2020-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/disparities-in-receipt-of-chemotherapy-among-patients-with-pn1-lung-cancer/</loc><lastmod>2020-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/gynecologic-cancer-screening-after-a-natural-disaster/</loc><lastmod>2020-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pembrolizumab-in-previously-treated-metastatic-high-grade-neuroendocrine-neoplasms/</loc><lastmod>2020-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/factors-associated-with-small-adult-height-in-childhood-cancer-survivors/</loc><lastmod>2020-04-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/gallium-68-psma-petct-prior-to-surgery-or-radiotherapy-in-high-risk-prostate-cancer/</loc><lastmod>2020-04-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/cognitive-impairment-with-adjuvant-chemoendocrine-vs-endocrine-therapy-for-early-breast-cancer-in-the-tailorx-trial/</loc><lastmod>2020-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/potential-protective-effect-of-ibrutinib-against-pulmonary-injury-in-patients-with-covid-19/</loc><lastmod>2020-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/acs-releases-new-guidance-on-resuming-elective-surgery-past-covid-19-peak/</loc><lastmod>2020-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/anti-cd22-car-t-cell-therapy-for-cd22-positive-b-cell-malignancies/</loc><lastmod>2020-04-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/covid-19-and-pediatric-patients-with-cancer/</loc><lastmod>2020-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/effect-of-familial-and-hereditary-cancer-syndromes-on-risk-of-prostate-cancer/</loc><lastmod>2020-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/quantitative-micro-elastography-for-tumor-detection-in-breast-conserving-surgical-margins/</loc><lastmod>2020-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/switch-maintenance-pembrolizumab-for-metastatic-urothelial-cancer/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/addition-of-capecitabine-to-taxaneanthracycline-adjuvant-chemotherapy-for-triple-negative-breast-cancer/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/survey-shows-covid-19-pandemic-is-affecting-patients-access-to-cancer-care/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/patients-may-experience-increased-infections-preceding-a-cancer-diagnosis/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-authorizes-first-covid-19-test-for-patient-at-home-sample-collection/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pooled-meta-analysis-of-cancer-prevalence-in-patients-with-covid-19-infection/</loc><lastmod>2020-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/hospitals-report-challenges-in-responding-to-the-covid-19-pandemic/</loc><lastmod>2020-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/program-for-improving-vte-risk-assessment-patient-education-and-prophylaxis-use-in-an-ambulatory-cancer-clinic/</loc><lastmod>2020-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-encourages-plasma-donation-from-recovered-covid-19-patients-collaborates-to-produce-supplies-for-testing/</loc><lastmod>2020-04-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/a-segregated-team-workflow-model-during-the-covid-19-pandemic-in-a-cancer-center/</loc><lastmod>2020-04-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/psa-dynamics-and-response-to-androgen-deprivation-therapy/</loc><lastmod>2020-04-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/online-mind-body-resources-for-oncologists-and-health-care-workers-during-the-covid-19-pandemic/</loc><lastmod>2020-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/stereotactic-ablative-radiation-vs-observation-in-oligometastatic-prostate-cancer-oriole-trial/</loc><lastmod>2020-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pediatric-cancer-investment-needs-and-benefitsfindings-from-a-commission-created-by-the-lancet-oncology/</loc><lastmod>2020-04-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/patterns-in-physician-use-of-extended-fraction-radiation-therapy-for-bone-metastases/</loc><lastmod>2020-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/aspirin-use-and-risk-of-cancers-of-the-digestive-tract/</loc><lastmod>2020-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/multidisciplinary-recommendations-for-breast-cancer-care-during-the-covid-19-pandemic/</loc><lastmod>2020-04-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/new-prognostic-score-for-asymptomatic-patients-with-early-stage-cll/</loc><lastmod>2020-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/t-cell-responses-and-benefit-from-treatment-with-ipilimumab-in-patients-with-mcrpc/</loc><lastmod>2020-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/immune-checkpoint-inhibitor-treatment-for-patients-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2020-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/joint-publication-focuses-on-clinical-practice-guidelines-on-opioid-use-for-pain-management/</loc><lastmod>2020-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/outcomes-in-patients-with-retroperitoneal-soft-tissue-sarcoma-by-hospital-type/</loc><lastmod>2020-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/first-line-durvalumab-with-or-without-tremelimumab-vs-chemotherapy-for-metastatic-nsclc/</loc><lastmod>2020-04-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/fda-approves-encorafenibcetuximab-for-braf-v600e-mutated-metastatic-colorectal-cancer/</loc><lastmod>2020-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/pre-salvage-radiotherapy-psa-levels-and-outcomes-with-long-term-antiandrogen-therapy-in-prostate-cancer/</loc><lastmod>2020-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/04-april/factors-associated-with-early-readmissions-to-hospital-oncology-services/</loc><lastmod>2020-04-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/psma-petct-may-have-major-impact-on-treatment-of-patients-with-prostate-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-charles-drake/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/addition-of-pembrolizumab-to-neoadjuvant-chemotherapy-in-early-stage-her2-negative-breast-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/anti-cd19-car-nk-therapy-in-relapsed-or-refractory-cd19-positive-lymphoid-tumors/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/fda-approves-isatuximab-irfc-based-triplet-regimen-for-patients-with-relapsed-and-refractory-multiple-myeloma/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/former-fda-commissioner-relays-opinions-on-coronavirus/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/selected-abstracts-on-novel-treatments-in-colon-hepatocellular-and-biliary-tract-cancers/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/study-focuses-on-role-of-microbes-in-pancreatic-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/new-asco-guideline-highlights-the-management-of-male-breast-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/survival-benefits-achieved-with-pembrolizumab-in-some-gastric-and-gastroesophageal-junction-cancers/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-daniel-catenacci/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/haplo2019-advances-in-haploidentical-transplantation-and-other-novel-cellular-therapies/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/enfortumab-vedotin-plus-pembrolizumab-in-advanced-bladder-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-philip-saylor/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/how-exercise-oncology-can-improve-cancer-outcome-and-survivorship/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/cancer-during-pregnancy/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/immune-restorative-agent-may-boost-immunotherapy-response-in-advanced-head-and-neck-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/phase-ii-trial-finds-neoadjuvant-immunotherapy-feasible-in-oral-cavity-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-tanguy-seiwert/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/neratinib-combined-with-capecitabine-in-previously-treated-advanced-her2-positive-breast-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/mixed-results-with-adding-radiotherapy-to-immunotherapy-in-renal-cell-carcinoma/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/actively-recruiting-clinical-trials-on-colorectal-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/memorial-sloan-kettering-announces-two-new-appointments/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/charles-sawyers-receives-knudson-award-in-cancer-genetics/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/iaslc-names-research-award-after-fred-hirsch/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/randall-oyer-named-president-of-accc/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/veterans-health-bill-promotes-comprehensive-prostate-cancer-care-program/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/studies-aim-to-understand-young-onset-colorectal-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-john-carethers/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/selected-ash-abstracts-on-cll-and-sll-newly-diagnosed-disease/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/selected-ash-abstracts-on-cll-and-sll-relapsed-or-refractory-disease/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/a-cello-for-michayla/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/the-opioid-crisis-as-told-from-the-streets-to-the-clinics-and-its-unintended-consequences/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/i-wasn-t-prepared-for-the-emotional-turmoil-of-breast-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/aml-pioneer-and-giant-clara-d-bloomfield-md-fasco-dies-at-77/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/addressing-the-needs-of-transgender-patients-for-breast-cancer-screening/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/don-t-expect-transgender-patients-to-out-themselves/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/the-parker-institute-for-cancer-immunotherapy-awards-275-million/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/asco-and-project-echo-in-nepal/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/a-low-tech-approach-leads-to-high-quality-care-in-south-africa/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/surgeon-general-s-report-on-smoking-cessation/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/study-highlights-smoking-cessation-initiative-success-for-patients-with-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/conquer-cancer-rtfccr-career-pathway-grants/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/leaving-no-stone-unturned-in-research-to-cure-a-rare-kidney-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/prepare-your-patients-for-potential-side-effects-with-asco-answers-fact-sheets/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/early-fdg-pet-allows-de-escalation-of-chemotherapy-in-metastatic-seminoma/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-peter-albers/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/pulmonary-pathology-of-early-covid-19-pneumonia-identified-retrospectively-in-two-patients-with-lung-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/off-the-shelf-dendritic-vaccine-shows-benefit-in-kidney-cancer/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-navid-hafez/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/expert-on-public-health-and-policy-looks-at-precision-oncology/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/vitamin-d-supplementation-may-protect-against-checkpoint-inhibitor-induced-colitis/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-jarushka-naidoo/</loc><lastmod>2020-03-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/subanalysis-of-keynote-059-061-and-062/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-richard-schilsky/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/cisplatingemcitabine-alone-and-with-veliparib-in-brca-mutated-advanced-pancreatic-cancer/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/genetic-counseling-and-testing-of-patients-with-pancreatic-cancer/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/maintenance-olaparib-in-brca12-positive-pancreatic-cancer-yields-improved-pfs-preserves-qol/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-christopher-booth/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/mature-follow-up-of-beacon-crc-study-reports-quality-of-life-measures-and-survival-outcomes/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/tapur-basket-study-biomarker-driven-treatment-strategies-yield-benefits-in-colorectal-cancer/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-a-craig-lockhart/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/imbrave150-prespecified-analysis-quality-of-life-with-atezolizumab-plus-bevacizumab/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/conference-highlights-from-the-2020-gastrointestinal-cancers-symposium/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/phase-iii-javelin-gastric-100-trial-finds-no-survival-benefit-for-maintenance-avelumab/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-daniel-catenacci-1/</loc><lastmod>2020-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/participating-in-tremendous-progress-in-hematologic-oncology/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/mk-6482-shows-activity-across-all-risk-categories-in-metastatic-clear-cell-kidney-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-daniel-geynisman/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/an-education-in-human-suffering/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/asco-and-cap-release-updated-guideline-on-estrogen-and-progesterone-testing-in-breast-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/richard-schilsky-designated-a-national-associate-of-the-national-academies-of-sciences-engineering-and-medicine/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/drug-repository-programs/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/trifluridinetipiracil-plus-bevacizumab-for-chemorefractory-metastatic-colorectal-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/no-survival-benefit-for-maintenance-avelumab-in-advanced-gastric-or-gastroesophageal-junction-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-daniel-catenacci-2/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/new-polo-data-further-support-maintenance-olaparib-in-brca-positive-pancreatic-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/automated-referral-process-for-genetic-counseling-and-testing-of-patients-with-pancreatic-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/fda-approves-neratinibcapecitabine-for-pretreated-patients-with-metastatic-her2-positive-breast-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/immune-checkpoint-inhibitors-in-solid-organ-transplant-recipients/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/roles-are-reversed-in-personalized-medicine-as-physicians-care-for-parents-with-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/qopi-round-1-now-open-for-data-abstraction/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/help-patients-do-more-to-cope-with-cancer-related-pain/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/perioperative-chemotherapy-with-or-without-cetuximab-in-patients-with-resectable-colorectal-cancer-liver-metastases/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/new-guideline-tackles-rapidly-evolving-imaging-strategies-for-advanced-prostate-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/active-hexose-correlated-compound/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/therapy-is-keeping-my-metastatic-breast-cancer-manageable/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/zelia-correa-joins-sylvester-comprehensive-cancer-center-and-bascom-palmer-eye-institute/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/conquer-cancer-funded-research-highlighted-in-clinical-cancer-advances-2020/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/33-oncology-practices-receive-qopi-certification-from-the-association-for-clinical-oncology/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/conquer-cancer-honors-early-career-cancer-researchers-with-merit-awards/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/medicaid-block-grants-threaten-beneficiary-access-to-cancer-care/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/tazemetostat-for-advanced-epithelioid-sarcoma/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/attempt-to-transform-venipuncture/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/former-asco-president-sandra-swain-shares-highlights-of-a-noted-career/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/building-onco-primary-care-to-close-the-black-hole-in-cancer-survivorship-care/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/reflections-on-a-career-in-hematologyoncology/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/susan-band-horwitz-named-recipient-of-2020-szent-gyoergyi-prize/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/smilow-cancer-hospital-and-yale-cancer-center-to-welcome-pamela-kunz/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/brief-highlights-from-the-2019-san-antonio-breast-cancer-symposium/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/21-gene-assay-recurrence-score-and-risk-of-locoregional-recurrence/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/avapritinib-for-gastrointestinal-stromal-tumor-with-pdgfra-exon-18-mutation/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/selected-ash-abstracts-on-novel-treatments-in-acute-lymphoblastic-leukemia/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/nci-awards-grant-to-cedars-sinai-for-research-on-dietary-fat-and-liver-metastasis/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/acalabrutinib-plus-obinutuzumab-as-front-line-treatment-of-cll/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-javier-pinilla-ibarz/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/treating-patients-with-chronic-lymphocytic-leukemia-in-2020/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/oral-regimen-of-ibrutinibvenetoclax-achieves-high-rates-of-undetectable-minimal-residual-disease-in-cll/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-james-gerson/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/h-timothy-hsiao-joins-astro-as-director-of-scientific-affairs/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/tapur-study-biomarker-driven-treatment-paying-off-in-colorectal-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-richard-schilsky-1/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/cabozantinib-plus-atezolizumab-shows-benefit-in-patients-with-advanced-prostate-cancer/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-charles-drake-1/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/rush-university-medical-center-earns-national-center-of-excellence-for-pancreatic-cancer-designation/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/translational-research-in-oncology-board-of-directors/</loc><lastmod>2020-03-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/nsabp-b-42-trial-10-year-update/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/availability-cost-and-use-of-biosimilar-trastuzumab-in-patients-with-her2-positive-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-sara-tolaney/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/small-study-explores-impact-of-novel-regimen-on-pembrolizumab-for-triple-negative-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/margetuximab-plus-chemotherapy-vs-trastuzumab-plus-chemotherapy-for-her2-positive-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/pembrolizumab-benefits-outcome-in-neoadjuvant-adjuvant-settings-in-triple-negative-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/adding-capecitabine-to-systemic-therapies-improves-outcomes-in-triple-negative-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-a-jo-chien/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/adjuvant-ado-trastuzumab-emtansine-vs-paclitaxel-plus-trastuzumab-in-early-her2-positive-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-steven-isakoff-1/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/t-dxd-effective-in-pretreated-metastatic-her2-positive-breast-cancer/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-steven-isakoff/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/six-year-follow-up-of-aphinity-trial/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/phase-iii-her2climb-trial-yields-positive-data-in-patients-with-her2-positive-metastatic-breast-cancer-and-brain-metastasis/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/conference-highlights-from-the-2019-san-antonio-breast-cancer-symposium/</loc><lastmod>2020-03-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/gi-pros-with-postoperative-intensity-modulated-radiotherapy-vs-standard-radiotherapy/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/initiative-to-reduce-petct-radiotracer-infiltrations/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/malnutrition-evaluation-before-oncologic-surgery/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/long-term-outcomes-and-retreatment-outcomes-with-pembrolizumab-in-pd-l1-positive-advanced-nsclc/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/cabozantinib-for-advanced-ewing-sarcoma-or-osteosarcoma/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/two-recent-studies-show-low-nicotine-cigarettes-are-unlikely-to-increase-compensatory-smoking/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/weight-gain-after-breast-cancer-diagnosis-in-australia/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/plasma-based-tumor-mutational-burden-may-predict-response-to-immunotherapy-in-patients-with-metastatic-nsclc/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/ai-algorithms-plus-radiologist-assessment-may-help-to-improve-accuracy-in-reading-mammography-results/</loc><lastmod>2020-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/are-those-who-have-lost-a-partner-at-a-higher-risk-of-dying-of-melanoma/</loc><lastmod>2020-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/pembrolizumab-plus-bevacizumab-for-metastatic-renal-cell-carcinoma/</loc><lastmod>2020-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/adjuvant-anthracycline-based-chemotherapy-vs-docetaxelcapecitabine-for-early-breast-cancer/</loc><lastmod>2020-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/pooled-analysis-of-phase-iii-trials-of-larotrectinib-in-trk-fusion-positive-solid-tumors/</loc><lastmod>2020-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/phenelzine-for-biochemical-recurrent-castration-sensitive-prostate-cancer/</loc><lastmod>2020-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/nccn-postpones-2020-annual-conference-citing-precautions-against-potential-exposure-to-covid-19/</loc><lastmod>2020-03-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/priority-review-in-dlbcl-fast-track-designations-in-t-cell-lymphoma-and-adenoid-cystic-carcinoma/</loc><lastmod>2020-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/first-line-cladribine-with-concurrent-or-delayed-rituximab-for-hairy-cell-leukemia/</loc><lastmod>2020-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/prognostic-value-of-teratoma-in-metastatic-nonseminomatous-germ-cell-tumor/</loc><lastmod>2020-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/evaluation-of-different-methods-of-biopsy-for-the-diagnosis-of-prostate-cancer/</loc><lastmod>2020-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/study-examines-survival-rates-in-pediatric-and-young-adult-patients-with-colon-cancer/</loc><lastmod>2020-03-11</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/preoperative-chemoradiotherapy-vs-immediate-surgery-for-pancreatic-cancer/</loc><lastmod>2020-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/association-of-genomic-prostate-score-with-adverse-pathology-at-radical-prostatectomy-after-initial-active-surveillance/</loc><lastmod>2020-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/4-decade-analysis-of-5-year-survival-for-cancers-in-adolescents-and-young-adults/</loc><lastmod>2020-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/receipt-of-adjuvant-vs-neoadjuvant-chemotherapy-and-start-of-treatment-in-patients-with-breast-cancer/</loc><lastmod>2020-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/ho-166-radioembolization-after-peptide-receptor-radionuclide-therapy-for-neuroendocrine-tumor-liver-metastases/</loc><lastmod>2020-03-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/preoperative-letrozole-for-postmenopausal-patients-with-estrogen-receptor-positive-dcis/</loc><lastmod>2020-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/bendamustinedexamethasone-in-relapsedrefractory-systemic-light-chain-amyloidosis/</loc><lastmod>2020-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/survival-in-patients-with-pancreatic-cancer-receiving-molecularly-matched-therapies/</loc><lastmod>2020-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/annual-report-to-the-nation-on-the-status-of-cancer-released/</loc><lastmod>2020-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/pembrolizumab-plus-radiotherapy-in-locally-advanced-squamous-cell-head-and-neck-cancer/</loc><lastmod>2020-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/epov-sue-sun-yom/</loc><lastmod>2020-03-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/conventionally-fractionated-vs-moderate-hypofractionated-radiation-therapy-for-localized-prostate-cancer/</loc><lastmod>2020-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/evaluation-of-genetic-testing-in-nccn-criteria-for-women-with-breast-cancer/</loc><lastmod>2020-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/addition-of-venetoclax-to-cytarabine-in-pediatric-patients-with-relapsed-or-refractory-acute-myeloid-leukemia/</loc><lastmod>2020-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/colorectal-cancer-statistics-2020-published/</loc><lastmod>2020-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/breakthrough-therapy-for-nsclc-with-specific-mutation-approval-of-test-for-cervical-cancer-and-more/</loc><lastmod>2020-03-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/neoadjuvant-cisplatin-vs-doxorubicincyclophosphamide-for-patients-with-her2-negative-breast-cancer-and-a-brca-mutation/</loc><lastmod>2020-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/adjuvant-etoposidecisplatin-for-pathologic-stage-ii-nonseminomatous-germ-cell-tumors/</loc><lastmod>2020-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/risk-of-cervical-cancer-with-different-types-of-intrauterine-devices/</loc><lastmod>2020-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/younger-cancer-survivors-and-financialfood-insecurity/</loc><lastmod>2020-03-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/diversity-of-intestinal-microbiota-and-mortality-in-patients-undergoing-allogeneic-hematopoietic-cell-transplantation/</loc><lastmod>2020-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/young-women-diagnosed-with-breast-cancer-may-face-employment-disruption-and-financial-hardship/</loc><lastmod>2020-03-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/addition-of-vincristineirinotecan-to-established-chemotherapy-regimen-in-patients-with-diffuse-anaplastic-wilms-tumor/</loc><lastmod>2020-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/proton-beam-therapy-vs-intensity-modulated-radiation-therapy-for-locally-advanced-esophageal-cancer/</loc><lastmod>2020-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/cancer-incidence-and-survivorship-in-transgender-patients/</loc><lastmod>2020-03-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/reintroduction-of-folfoxiri-plus-bevacizumab-after-first-line-progression-in-patients-with-metastatic-colorectal-cancer/</loc><lastmod>2020-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/does-aspirin-use-lower-the-risk-of-hcc-and-liver-related-mortality-in-patients-with-chronic-viral-hepatitis/</loc><lastmod>2020-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/surveillance-for-second-malignant-neoplasms-and-cardiac-dysfunction-in-childhood-cancer-survivors/</loc><lastmod>2020-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/digital-breast-tomosynthesis-vs-digital-mammography-outcomes-comparison-over-5-years/</loc><lastmod>2020-03-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/adding-pembrolizumab-to-pemetrexedplatinum-for-nonsquamous-nsclc/</loc><lastmod>2020-03-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/association-of-germline-variant-status-and-response-to-neoadjuvant-chemotherapy-in-high-risk-early-breast-cancer/</loc><lastmod>2020-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/trends-in-deaths-from-cutaneous-melanoma-in-the-united-states/</loc><lastmod>2020-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/managing-cancer-care-during-the-covid-19-pandemic/</loc><lastmod>2020-03-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/nivolumab-for-children-and-young-adults-with-relapsed-or-refractory-solid-tumors-or-lymphoma/</loc><lastmod>2020-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/lenvatinibpembrolizumab-in-previously-treated-patients-with-advanced-endometrial-cancer/</loc><lastmod>2020-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/patients-with-certain-cancers-may-be-at-a-higher-risk-for-atrial-fibrillation/</loc><lastmod>2020-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/clinical-and-dermoscopic-features-of-uncommon-melanoma-variants/</loc><lastmod>2020-03-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/international-uptake-of-molecular-testing-across-tumor-types/</loc><lastmod>2020-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/prognostic-impact-of-tumor-deposits-in-patients-receiving-adjuvant-therapy-for-stage-iii-colon-cancer/</loc><lastmod>2020-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/predicting-which-patients-with-ovarian-cancer-may-respond-to-combination-parp-and-pd-1-inhibition/</loc><lastmod>2020-03-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/end-of-study-results-from-cleopatra/</loc><lastmod>2020-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/first-in-human-study-of-raf-family-kinase-inhibitor-lifirafenib-in-solid-tumors/</loc><lastmod>2020-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/american-college-of-surgeons-issues-covid-19-guidelines-for-triage-of-patients-undergoing-cancer-surgery/</loc><lastmod>2020-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/trends-in-global-rates-of-liver-cancer-from-1990-to-2017/</loc><lastmod>2020-03-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/polypharmacy-and-inpatient-hospitalization-rates-in-older-patients-with-cancer/</loc><lastmod>2020-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/imaging-based-radiotherapy-target-volume-reduction-in-locally-advanced-nsclc/</loc><lastmod>2020-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/selumetinib-for-inoperable-plexiform-neurofibromas-in-children-with-nf1/</loc><lastmod>2020-03-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/evidence-based-anticancer-drug-use-in-physician-offices-vs-hospital-outpatient-facilities/</loc><lastmod>2020-03-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/olaparib-vs-nonplatinum-chemotherapy-in-platinum-sensitive-relapsed-brca12-mutated-ovarian-cancer/</loc><lastmod>2020-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/geographic-and-racial-variability-in-germline-brca-mutation-prevalence-among-patients-with-metastatic-pancreatic-cancer/</loc><lastmod>2020-03-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/03-march/neoadjuvant-and-adjuvant-pembrolizumab-in-early-triple-negative-breast-cancer/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/beacon-crc-quality-of-life-may-be-well-maintained-with-targeted-treatment/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-christopher-booth/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/nci-s-james-n-kochenderfer-md-receives-clinical-research-achievement-award/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/data-from-colorectal-cancer-cohorts-of-tapur-study-presented/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/pembrolizumab-for-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/stand-up-to-cancer-announces-gastric-cancer-interception-research-team/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/poster-to-bedside-geriatric-oncology-research-updates-from-2019-asco-annual-meeting/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/edna-cukierman-phd-receives-grant-to-study-biology-of-pancreatic-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/strong-activity-shown-for-lisocabtagene-maraleucel-car-t-cell-therapy-in-aggressive-large-b-cell-lymphoma/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-basem-william/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/flag-go-achieves-deeper-remission-than-flag-ida-in-favorable-risk-aml/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-chetasi-talati/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/using-machine-learning-to-prompt-serious-illness-conversations/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/rami-k-daya-md-leads-perlmutter-cancer-center-s-new-location-in-sunset-park-brooklyn/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/postmenopausal-estrogen-and-risk-of-breast-cancer-what-is-the-real-story/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/neoadjuvant-cisplatin-for-brca-mutation-carriers-pruning-the-dead-branches/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/no-improved-pcr-with-atezolizumab-in-early-triple-negative-breast-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/study-finds-bridge-to-car-t-cell-therapy-may-be-detrimental-to-survival/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-edmund-waller/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-marcia-cruz-correa/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/venetoclax-plus-dexamethasone-shows-activity-in-multiple-myeloma/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-suzanne-lentzsch/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/asco-endorses-cco-guideline-on-bone-health-and-bone-targeted-therapies-for-prostate-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/patient-reported-outcomes-from-imbrave150/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-a-craig-lockhart/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/redefining-what-it-means-to-have-precursor-myeloma/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/value-is-the-benefit-worth-the-cost/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/use-of-cell-free-dna-methylation-based-blood-test-in-detecting-gi-cancers/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-george-fisher/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/cancer-in-the-aging-population/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/mixed-results-with-durvalumab-maintenance-in-her2-negative-advanced-breast-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-kevin-kalinsky/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/prevent-cancer-foundation-awards-cancer-research-and-global-grants/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/update-on-project-facilitate-at-the-oncology-center-of-excellence/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/updates-in-hematopoietic-cell-transplantation/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/eileen-smith-named-chair-of-department-of-hematology-and-hematopoietic-cell-transplantation/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/dana-farber-cancer-institute-to-establish-riney-family-multiple-myeloma-initiative/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/ehe-foundation-receives-award-from-the-chan-zuckerberg-initiative/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/new-maintenance-of-certification-pathway/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/nebraska-oncology-society/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/qopi-round-1-now-open/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/asco-submits-pcop-model/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/preliminary-study-finds-asco-decision-aid-may-improve-quality-of-serious-adverse-events-reporting/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/stock-your-practice-for-cancer-awareness-month-in-march-with-asco-answers-materials/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/join-the-conquerors-community/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/your-stories-podcast/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/cancer-has-made-me-the-person-i-am-and-i-m-grateful/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/hematologist-usama-gergis-md-mba-joins-sidney-kimmel-cancer-center/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/new-cancer-center-established-at-johns-hopkins-university/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/collaborative-team-receives-funding-to-enhance-participation-of-black-women-in-cancer-clinical-trials/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/using-antioxidants-and-other-supplements-with-chemotherapy-may-increase-risk-of-breast-cancer-recurrence-and-mortality/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/ask-patients-about-their-use-of-dietary-supplements/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/jason-luke-md-facp-receives-sy-holzer-endowed-immunotherapy-research-award/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/new-asco-guideline-highlights-need-to-improve-germline-somatic-tumor-testing-in-epithelial-ovarian-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/nci-appoints-satish-gopal-md-mph-as-director-of-center-for-global-health/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/nobel-laureate-stanley-cohen-phd-dies-at-97/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/the-ohio-state-james-cancer-repository-program-now-accepting-oral-cancer-therapy-donations-for-patients-in-need/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/searching-for-evidence-based-reassurance-where-none-could-be-found/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/new-center-for-indigenous-cancer-research-at-roswell-park-has-regional-focus-global-reach/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/two-novel-pegylated-agents-fail-in-metastatic-pancreatic-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-andrea-wang-gillam/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/asco-cco-update-guideline-for-selecting-systemic-treatment-in-stage-iv-nsclc-without-driver-mutations/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/pooled-analysis-of-bmi-and-overall-survival-with-immune-checkpoint-inhibitor-therapy-in-nsclc/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/effect-of-volume-based-ct-screening-on-lung-cancer-mortality-in-high-risk-patients/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/cemiplimab-in-locally-advanced-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/h-pylori-infection-treatment-and-gastric-cancer-risk/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/cms-expands-coverage-of-ngs-for-patients-with-breast-or-ovarian-cancer/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/safety-analysis-results-for-first-line-durvalumab-plus-platinumetoposide-in-extensive-stage-sclc/</loc><lastmod>2020-02-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/new-data-in-leukemia-lymphoma-and-multiple-myeloma/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-javier-pinilla-ibarz/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/second-generation-btk-inhibitor-alone-and-in-combination-with-obinutuzumab-for-cll/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/btk-inhibitor-yields-high-overall-response-rates-in-del17p-cll-and-sll/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-thierry-facon-and-michael-jain/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/bcma-targeted-car-t-cell-therapies-for-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/combination-brentuximab-vedotin-and-nivolumab-explored-in-hodgkin-lymphoma/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/early-data-suggest-efficacy-of-innovative-car-nk-cell-therapy-for-b-cell-malignancies/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/bispecific-antibody-shows-activity-in-post-car-t-cell-therapy-for-non-hodgkin-lymphoma/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-howard-weinstein-and-robert-brodsky/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/blinatumomab-in-young-patients-with-b-cell-all/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-basem-william-and-caron-jacobson/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/will-bispecific-antibodies-compete-with-car-t-cell-therapy-in-lymphoma/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/conference-highlights-from-2019-ash/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/is-there-an-association-between-powder-use-and-risk-of-ovarian-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/luspatercept-in-transfusion-dependent-lower-risk-myelodysplastic-syndromes/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/activity-of-belantamab-mafodotin-in-patients-with-heavily-pretreated-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/fda-approves-tazemetostat-for-epithelioid-sarcoma/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/surgeon-general-releases-report-focused-on-smoking-cessation/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/unprecedented-responses-to-cisplatingemcitabine-in-brca-mutated-advanced-pancreatic-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/join-the-conquerors-community-1/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/over-30-oncology-practices-achieve-asco-s-qopi-certification-in-fourth-quarter-of-2019/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/asco-analysis-demonstrates-need-to-harmonize-disclosure-policies-across-medicine/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/congress-increases-federal-investment-in-cancer-research-raises-tobacco-purchasing-age/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/a-breast-cancer-clinical-trial-includes-a-meal-delivery-service-in-prescribing-a-diet-to-conquer-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-jeremy-abramson/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-michael-jain/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/university-of-maryland-greenebaum-comprehensive-cancer-center-joins-big-ten-cancer-research-consortium/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/a-hopeful-look-ahead-in-oncology/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/overcoming-barriers-to-alleviating-cancer-related-pain-in-ethiopia/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/clinical-cancer-advances-2020-asco-names-advance-of-the-year-issues-research-priorities-for-the-cancer-community/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/free-practice-resource-cancernet-patient-referral-cards/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/susan-sturgeon-receives-nih-grant/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/urology-of-virginia-welcomes-new-chief-medical-officer-joshua-langston/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/ash-presents-2019-joanne-levy-memorial-award-for-outstanding-achievement/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/stand-up-to-cancer-announces-initiative-to-increase-diversity-in-clinical-trials/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/fox-chase-cancer-center-certified-under-asco-s-quality-oncology-practice-initiative/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/real-world-data-for-car-t-cell-therapy-show-benefit-in-older-patients-with-lymphoma/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/damon-runyon-cancer-research-foundation-awards-early-career-scientists/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/neoadjuvant-and-adjuvant-pembrolizumab-improves-pcr-rate-in-tnbc/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/triple-negative-breast-cancer-responds-to-novel-therapy/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-sarah-tolaney/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/is-there-a-future-role-for-secondary-cytoreductive-surgery-in-the-treatment-of-recurrent-ovarian-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/fox-chase-cancer-center-welcomes-claudia-kasales/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/laura-van-t-veer-phd-honored-with-precision-medicine-world-conference-luminary-award/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/asco-s-inaugural-breakthrough-global-summit-showcased-evolving-technologies-poised-to-revolutionize-cancer-care/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/asco-guideline-addresses-surveillance-of-lung-cancer-after-curative-intent-therapy/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/clinical-cancer-advances-2020/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/genomics-guided-molecular-targeted-therapy-gave-me-back-my-life/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/douglas-hanahan-phd-appointed-distinguished-scholar-of-the-ludwig-institute-for-cancer-research/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/addressing-symptom-control-and-palliative-care-needs/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/denial-s-many-faces/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/karen-l-reckamp-md-ms-to-head-medical-oncology-at-cedars-sinai-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/seattle-cancer-care-alliance-appoints-aaron-crane-as-executive-vice-president/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/dolores-hambardzumyan-phd-mba-joins-neurosurgery-faculty-at-mount-sinai/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/prevent-cancer-foundation-benefits-global-cancer-research/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/selected-ash-abstracts-on-myelodysplastic-syndromes/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/car-t-cell-gene-therapy-in-non-hodgkin-lymphomas-present-and-future/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/comparing-prescribing-habits-in-academic-and-nonacademic-oncology-settings/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/a-retired-oncologist-remains-involved-in-the-science-and-policy-of-oncology/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/early-steroid-use-may-reduce-toxicity-with-car-t-cell-therapy/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/doctoring-in-the-digital-age-modern-stressors-ancient-strategies-to-cope/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/when-added-to-other-systemic-therapies-capecitabine-improves-outcomes-in-triple-negative-breast-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/real-world-use-of-palbociclib-and-abemaciclib-explored-in-two-studies-based-on-ehr-database/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-harold-burstein/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/addition-of-secondary-surgical-cytoreduction-to-chemotherapy-in-recurrent-platinum-sensitive-ovarian-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/ama-foundation-launches-new-initiative-to-address-lgbtq-health-disparities/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/actively-recruiting-clinical-trials-for-cervical-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-joshua-brody/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/keynote-158-trial-pembrolizumab-produces-durable-responses-in-select-noncolorectal-tumors/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/car-t-cell-therapy-comes-to-mantle-cell-lymphoma/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-basem-william-1/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/gabrielle-rocque-followed-three-generations-of-doctors-into-a-career-in-medicine/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/addition-of-olaparib-to-bevacizumab-maintenance-in-patients-with-advanced-ovarian-cancer-responding-to-first-line-therapy/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-richard-schilsky/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/how-real-world-data-can-help-contextualize-new-treatments-in-older-patients/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/study-reports-similar-efficacy-but-no-less-toxicity-with-adjuvant-t-dm1-vs-taxanetrastuzumab-in-early-breast-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/epov-a-jo-chien/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/novel-guideline-addresses-the-clinical-utility-of-molecular-biomarkers-in-localized-prostate-cancer/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/two-clinical-trials-show-zanubrutinib-achieves-high-response-rates-in-del-17p-cll-and-sll/</loc><lastmod>2020-02-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/do-socioeconomic-factors-play-a-role-in-outcomes-for-hpv-positive-head-and-neck-cancer/</loc><lastmod>2020-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/women-with-variants-in-breast-cancer-associated-genes-may-not-always-be-receiving-guideline-concordant-care/</loc><lastmod>2020-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/circulating-tumor-cell-assessment-to-predict-melanoma-relapse/</loc><lastmod>2020-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/is-distance-to-treatment-a-burden-for-rural-patients-with-breast-cancer/</loc><lastmod>2020-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/incidence-increases-in-new-colorectal-cancer-diagnoses-in-patients-between-49-and-50-years-old/</loc><lastmod>2020-02-05</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/dengue-virus-infection-may-increase-risk-of-developing-leukemia/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/diffusion-weighted-mri-may-help-to-predict-treatment-response-in-patients-with-advanced-ovarian-cancer/</loc><lastmod>2020-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/peripheral-blood-lymphocytes-and-t-cells-targeting-tp53-mutations-in-patients-with-metastatic-solid-tumors/</loc><lastmod>2020-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/patient-aid-improved-lung-cancer-screening-informed-decision-making/</loc><lastmod>2020-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/iraes-in-patients-with-cancer-receiving-influenza-vaccination-during-treatment-with-pembrolizumab/</loc><lastmod>2020-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/preliminary-results-show-antitumor-activity-with-pepinemabavelumab-in-patients-with-advanced-nsclc/</loc><lastmod>2020-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/dasatinib-vs-imatinib-in-pediatric-philadelphia-chromosome-positive-all/</loc><lastmod>2020-02-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/vitamin-d-may-reduce-risk-for-immune-checkpoint-inhibitor-associated-colitis/</loc><lastmod>2020-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/world-cancer-day-2020/</loc><lastmod>2020-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/who-and-iarc-release-reports-in-response-to-government-s-role-in-cancer-control/</loc><lastmod>2020-02-04</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/three-vs-six-months-of-adjuvant-chemotherapy-for-high-risk-stage-ii-colorectal-cancer/</loc><lastmod>2020-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/abbreviated-breast-mri-vs-digital-breast-tomosynthesis-screening-in-women-with-dense-breasts/</loc><lastmod>2020-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/adjuvant-everolimus-for-advanced-head-and-neck-cancer/</loc><lastmod>2020-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/immune-restorative-agent-may-boost-immunotherapy-response-in-advanced-head-and-neck-cancer/</loc><lastmod>2020-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/priority-review-in-lung-cancer-breakthrough-therapy-designation-in-head-and-neck-cancer-and-more/</loc><lastmod>2020-02-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/fear-of-recurrence-patients-prognostic-understanding-examined-in-genitourinary-cancers/</loc><lastmod>2020-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/physical-activity-and-quality-of-life-in-african-american-cancer-survivors/</loc><lastmod>2020-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/depression-and-suicidal-ideation-in-patients-with-cancer/</loc><lastmod>2020-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/treatment-and-outcomes-for-african-american-and-white-women-with-triple-negative-breast-cancer/</loc><lastmod>2020-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/trends-in-lung-cancer-incidence-in-young-women-vs-young-men-across-40-countries/</loc><lastmod>2020-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/pembrolizumab-plus-radiotherapy-for-platinum-ineligible-patients-with-locally-advanced-hnscc/</loc><lastmod>2020-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/nivolumab-with-or-without-ipilimumab-for-the-neoadjuvant-treatment-of-patients-with-oral-cavity-cancer/</loc><lastmod>2020-02-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/hippocampal-avoidance-during-whole-brain-radiotherapy/</loc><lastmod>2020-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/psa-stratified-screening-for-prostate-cancer/</loc><lastmod>2020-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/immunogenomic-profiling-of-osteosarcoma/</loc><lastmod>2020-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/treating-typical-solitary-fibrous-tumor-with-a-tyrosine-kinase-inhibitor/</loc><lastmod>2020-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/models-for-predicting-acute-ovarian-failure-in-survivors-of-childhood-cancer/</loc><lastmod>2020-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/trastuzumab-deruxtecan-in-her2-low-expressing-previously-treated-advanced-breast-cancer/</loc><lastmod>2020-02-26</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/long-term-outcomes-with-pd-1-inhibitor-treatment-and-response-to-retreatment-in-advanced-melanoma/</loc><lastmod>2020-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/pros-with-addition-of-pembrolizumab-vs-placebo-to-pemetrexed-and-platinum-for-nonsquamous-nsclc/</loc><lastmod>2020-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/quality-of-life-with-tisagenlecleucel-therapy-for-relapsed-or-refractory-dlbcl/</loc><lastmod>2020-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/priority-reviews-in-lung-cancers-lymphoma/</loc><lastmod>2020-02-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/late-mortality-and-chronic-health-conditions-in-long-term-survivors-of-aya-cancers/</loc><lastmod>2020-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/capivasertib-and-fulvestrant-in-advanced-er-positive-breast-cancer-after-relapse-or-progression-with-ai-treatment/</loc><lastmod>2020-02-24</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/osimertinib-plus-savolitinib-for-egfr-mutated-met-amplified-nsclc-after-progression-on-egfr-tyrosine-kinase-inhibitors/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/haploidentical-related-donor-vs-unrelated-cord-blood-hematopoietic-cell-transplantation-for-hodgkin-and-non-hodgkin-lymphoma/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/hsd3b1-genotype-and-its-effect-on-castration-resistance-and-overall-survival-in-prostate-cancer/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/proteomic-analysis-of-endometrial-cancer/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/diagnostic-and-treatment-technology-disparities-among-patients-with-colorectal-cancer/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/cervical-cancer-recurrence-open-vs-minimally-invasive-radical-hysterectomy/</loc><lastmod>2020-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/oral-hif2a-inhibitor-for-advanced-clear-cell-renal-cell-carcinoma/</loc><lastmod>2020-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/enfortumab-vedotin-plus-pembrolizumab-in-bladder-cancer/</loc><lastmod>2020-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/talazoparib-for-pretreated-patients-with-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/priority-reviews-in-lymphoma-lung-cancer-gist-and-breast-cancer/</loc><lastmod>2020-02-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/states-with-highest-rates-of-cutaneous-melanoma-due-to-ultraviolet-exposure/</loc><lastmod>2020-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/prh-hhex-transcription-factor-as-a-treatment-target-in-patients-with-cholangiocarcinoma/</loc><lastmod>2020-02-18</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/five-year-patient-reported-outcomes-for-various-prostate-cancer-treatments/</loc><lastmod>2020-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/ilixadencelsunitinib-vs-sunitinib-alone-in-synchronous-metastatic-kidney-cancer/</loc><lastmod>2020-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/biomarker-analysis-in-the-combi-ad-trial/</loc><lastmod>2020-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/plasma-circulating-tumor-hpv-dna-for-the-detection-of-recurrent-hpv-associated-oropharyngeal-cancer/</loc><lastmod>2020-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/low-fat-diets-with-increased-vegetable-fruit-and-grain-intake-linked-to-reduced-risk-of-breast-cancer-mortality-in-postmenopausal-women/</loc><lastmod>2020-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/therapy-associated-polyposis-in-survivors-of-childhood-cancer/</loc><lastmod>2020-02-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/do-gay-and-bisexual-men-have-an-increased-risk-of-developing-skin-cancer/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/iaslc-early-lung-imaging-confederation-initiative-for-analysis-of-low-dose-ct-images/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/enfortumab-vedotin-in-metastatic-urothelial-carcinoma/</loc><lastmod>2020-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/impact-of-hpv-vaccination-and-cervical-screening-on-cervical-cancer-elimination/</loc><lastmod>2020-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/low-incidence-of-nivolumab-induced-radiation-recall-pneumonitis-among-patients-with-nsclc/</loc><lastmod>2020-02-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/02-february/genetic-mutations-in-donor-stem-cells-may-affect-hematopoietic-transplant-recipients/</loc><lastmod>2020-02-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cancer-no-longer-scares-me/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/new-nccn-pediatric-cancer-guidelines-for-b-cell-lymphomas/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/mixed-results-with-weekly-nab-paclitaxel-denosumab-in-primary-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/impact-of-the-nci-cell-line-database/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/supportive-care-in-oncology-symposium-emphasized-caring-for-the-whole-patient-from-diagnosis-to-end-of-life/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/african-americans-with-cancer-at-higher-risk-for-blood-clots/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cxcr4-inhibitor-in-combination-with-pembrolizumabchemotherapy-for-metastatic-pancreatic-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/first-line-immunotherapy-combination-for-patients-with-advanced-nsclc-and-comorbidities-or-poor-performance-status/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-approves-fam-trastuzumab-deruxtecan-nxki-for-patients-with-unresectable-or-metastatic-her2-positive-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/javelin-bladder-100-study-of-avelumab-for-urothelial-cancer-meets-primary-endpoint/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/pembrolizumab-in-kras-mutant-and-wild-type-pd-l1-positive-nonsquamous-nsclc/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-approves-olaparib-for-patients-with-germline-brca-mutated-metastatic-pancreatic-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-approves-enzalutamide-for-patients-with-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/sitravatinibtislelizumab-shows-antitumor-activity-in-ovarian-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/patient-access-to-high-quality-oncologic-pathology-improves-care/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/transplantation-specialist-karen-ballen-treasures-long-term-connections-with-her-patients/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-approves-pd-1-inhibitor-for-bcg-unresponsive-high-risk-non-muscle-invasive-bladder-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/preliminary-data-on-multiantigen-targeted-car-nk-cell-therapy-for-b-cell-malignancies/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-gary-schiller/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-approves-avapritinib-for-pdgfra-mutated-gastrointestinal-stromal-tumor/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/ovarian-tissue-cryopreservation-to-preserve-fertility-in-pediatric-patients-with-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/blinatumomab-outperforms-chemotherapy-as-post-reinduction-consolidation-therapy-in-younger-patients-with-b-cell-all/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/selected-abstracts-on-novel-therapies-for-chronic-myeloid-leukemia/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-howard-weinstein/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/selected-abstracts-on-new-therapies-for-newly-diagnosed-multiple-myeloma/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/gilteritinib-improves-overall-survival-in-relapsed-or-refractory-flt3-mutated-aml/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-michael-jain/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/extended-letrozole-boosts-disease-free-survival-in-10-year-update-of-nsabp-b-42-trial/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-debra-patt/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/residual-cancer-burden-is-prognostic-of-outcomes-across-breast-cancer-subtypes/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-hope-rugo-and-laura-esserman/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/society-for-integrative-oncology-s-16th-international-conference/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/optimizing-metabolic-discoveries/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/ten-oncology-practices-in-underserved-communities-receive-funding-to-participate-in-quality-improvement-programs/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/steven-kalkanis-selected-to-lead-henry-ford-medical-group/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cancercare-to-provide-support-for-patients-with-cancer-impacted-by-the-california-wildfires/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/felix-feng-strives-for-balance-between-work-and-family-life/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/brentuximab-vedotin-plus-nivolumab-in-hodgkin-lymphoma/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/value-based-and-patient-centered-cancer-care/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-s-pilot-project-patient-voice-website-and-workshop-with-asco/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/asco-announces-newly-elected-leadership/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/asco-releases-major-update-to-payment-reform-model/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/motivating-yourself-for-exercise-goals-in-the-new-year/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/stock-your-practice-with-trusted-patient-information-resources-from-asco/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/yale-cancer-center-launches-center-for-community-engagement-and-health-equity/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/six-year-aphinity-trial-update/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-steven-isakoff/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/acs-welcomes-three-new-members-to-the-board-of-directors/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/stephanie-lee-begins-term-as-ash-president/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/two-new-grants-to-support-transformative-cancer-research/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/dolores-hambardzumyan-joins-faculty-at-mount-sinai/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/elizabeth-fox-named-svp-of-clinical-trials-research-at-st-jude/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/studies-find-estrogen-alone-protective-estrogen-plus-progestin-detrimental-in-postmenopausal-women/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/oral-paclitaxel-outperforms-intravenous-formulation-in-phase-iii-trial/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-charles-shapiro/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-virginia-kaklamani-steven-vogl-gary-lyman-ginny-mason/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/largest-single-year-drop-in-cancer-mortality-ever-reported-2016-2017/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/partial-breast-irradiation-favored-over-whole-breast-in-early-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/celebrating-20-years-of-world-cancer-day/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-shelley-hwang/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/dana-farber-to-establish-chen-huang-center-for-egfr-mutant-lung-cancers/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/kunle-odunsi-elected-to-lead-aacr-immunology-working-group/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/olaparib-as-maintenance-therapy-for-germline-brca-mutated-metastatic-pancreatic-adenocarcinoma/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/accc-project-focuses-on-improving-care-of-older-adults-with-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cleveland-clinic-taussig-cancer-institute-recognizes-new-staff-new-appointments/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/innovator-and-leader-in-radiation-oncology-eli-j-glatstein-dies/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/oral-cc-486-maintenance-therapy-extends-survival-in-older-patients-with-aml/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/study-suggests-new-approaches-needed-to-manage-ibrutinib-related-toxicities-in-patients-with-cll/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/first-line-atezolizumab-plus-nab-paclitaxel-in-advanced-triple-negative-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/tivo-3-third-or-fourth-line-tivozanib-vs-sorafenib-in-metastatic-renal-cell-carcinoma/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/more-than-standard-chemotherapy-needed-for-flt3-mutant-advanced-aml/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/olaparib-for-previously-treated-metastatic-castration-resistant-prostate-cancer-with-dna-repair-gene-aberrations/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/community-oncology-alliance-elects-officers-and-new-board-members-for-2020/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/aaci-marks-milestone-with-new-member/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fam-trastuzumab-deruxtecan-nxki-for-previously-treated-unresectable-or-metastatic-her2-positive-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/epov-debra-patt-and-c-kent-osborne/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/enfortumab-vedotin-ejfv-for-previously-treated-advanced-urothelial-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fred-hutch-names-thomas-j-lynch-new-president-and-director/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/emerging-fertoprotective-therapeutic-options-for-female-fertility-preservation/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/recurrence-risk-in-black-and-white-women-with-borderline-estrogen-receptor-positive-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/a-caregiver-s-tale-of-struggle-and-lingering-questions/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/a-deeper-understanding-of-the-miracle-of-the-human-body/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/ash-honors-member-of-congress-and-leaders-of-niddk-and-nci/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/practicing-wellness-to-reduce-burnout/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/atezolizumab-with-chemotherapy-for-metastatic-nonsquamous-nsclc-without-egfralk-aberrations/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/breast-cancer-chemoprevention-effect-maintained-long-after-stopping-anastrozole-therapy/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/enzalutamide-for-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/tucatinib-combination-extends-survival-in-her2-positive-metastatic-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-grants-breakthrough-therapy-designation-to-tucatinib-in-combination-therapy-for-her2-positive-breast-cancer/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/seven-haircuts/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/forbes-magazine-names-2020-class-of-30-under-30/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/the-anesthesia-era-1845-1875/</loc><lastmod>2020-01-25</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/screening-rates-rose-among-people-age-45-49-after-release-of-updated-colorectal-cancer-guidelines/</loc><lastmod>2020-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/asciminib-for-patients-with-cml-after-failure-of-abl-kinase-inhibitor-treatment/</loc><lastmod>2020-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/adjuvant-denosumab-for-patients-with-early-breast-cancer/</loc><lastmod>2020-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/osimertinib-in-patients-with-nsclc-harboring-uncommon-egfr-mutations/</loc><lastmod>2020-01-02</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-finalizes-enforcement-policy-on-unauthorized-flavored-cartridge-based-e-cigarettes/</loc><lastmod>2020-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/saliva-test-may-play-a-role-in-the-early-detection-of-hpv-related-oropharyngeal-cancer/</loc><lastmod>2020-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cardiovascular-risks-after-bleomycinetoposidecisplatin-treatment-for-germ-cell-cancer/</loc><lastmod>2020-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/long-term-results-of-ibis-ii/</loc><lastmod>2020-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/overall-survival-with-the-addition-of-daratumumab-to-vmp-in-newly-diagnosed-transplant-ineligible-multiple-myeloma/</loc><lastmod>2020-01-03</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/os-with-the-addition-of-ribociclib-to-fulvestrant-in-hr-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2020-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/rates-of-guideline-aligned-genomic-profiling-in-patients-diagnosed-with-metastatic-colon-cancer/</loc><lastmod>2020-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/neoadjuvant-vs-concurrent-adt-with-dose-escalated-radiotherapy-for-localized-prostate-cancer/</loc><lastmod>2020-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/dietary-supplement-use-during-adjuvant-chemotherapy-and-treatment-outcomes-in-patients-with-early-breast-cancer/</loc><lastmod>2020-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/prevalence-of-alcohol-use-among-patients-with-cancer-and-survivors/</loc><lastmod>2020-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/step-counts-may-help-predict-treatment-outcomes-for-patients-with-nsclc/</loc><lastmod>2020-01-09</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/one-cycle-of-bleomycinetoposidecisplatin-may-be-as-effective-as-two-for-patients-with-testicular-cancer/</loc><lastmod>2020-01-06</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/long-term-results-of-standard-vs-high-dose-chemoradiotherapy-with-or-without-cetuximab-in-patients-with-stage-iii-nsclc/</loc><lastmod>2020-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-pooled-analysis-of-cdk46-inhibitor-treatment-for-advanced-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2020-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/is-pembrolizumab-active-in-pediatric-patients-with-pd-l1-positive-advanced-solid-tumors-or-lymphoma/</loc><lastmod>2020-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/physical-activity-at-recommended-levels-may-lower-risk-of-multiple-cancers/</loc><lastmod>2020-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/t-dm1-shows-activity-in-her2-amplified-salivary-gland-cancer-in-small-patient-sample-of-nci-match/</loc><lastmod>2020-01-07</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/olaparib-for-previously-treated-metastatic-castration-resistant-prostate-cancer-with-dna-repair-gene-aberrations-1/</loc><lastmod>2020-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/recurrence-risk-with-accelerated-partial-vs-whole-breast-irradiation-after-breast-conserving-surgery-for-early-breast-cancer/</loc><lastmod>2020-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/largest-single-year-drop-in-cancer-mortality-reported-in-cancer-statistics-2020/</loc><lastmod>2020-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/does-weight-loss-surgery-lower-the-risk-of-malignant-melanoma/</loc><lastmod>2020-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/many-pelvic-examinations-and-papanicolaou-tests-performed-on-young-women-may-be-unnecessary/</loc><lastmod>2020-01-08</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/does-adding-trastuzumab-to-adjuvant-chemotherapy-improve-idfs-for-patients-with-her2-negative-breast-cancer/</loc><lastmod>2020-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/does-statin-use-increase-overall-survival-in-patients-with-colorectal-cancer/</loc><lastmod>2020-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fast-trackorphan-drug-designation-for-cholangiocarcinoma-treatment-breakthrough-device-designation-for-bladder-cancer-test/</loc><lastmod>2020-01-10</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/activity-of-ruxolitinib-in-chronic-neutrophilic-leukemia-and-atypical-chronic-myeloid-leukemia/</loc><lastmod>2020-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/entrectinib-in-advanced-or-metastatic-ntrk-fusion-positive-solid-tumors/</loc><lastmod>2020-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/association-between-colorectal-cancer-and-ulcerative-colitis/</loc><lastmod>2020-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/molecular-characteristics-of-leptomeningeal-melanoma-metastases/</loc><lastmod>2020-01-13</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/patient-reported-functional-outcomes-with-hypofractionated-vs-conventionally-fractionated-radiotherapy-for-nonmetastatic-prostate-cancer/</loc><lastmod>2020-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/are-racialethnic-disparities-in-breast-cancer-diagnosis-caused-by-health-insurance-coverage/</loc><lastmod>2020-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/patients-with-hpv-positive-and-hpv-negative-oropharyngeal-cancer-may-have-different-rates-of-mortality/</loc><lastmod>2020-01-14</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/higher-21-gene-recurrence-score-may-be-associated-with-increased-risk-of-locoregional-recurrence-in-patients-with-breast-cancer/</loc><lastmod>2020-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/use-of-ai-for-diagnosing-and-grading-prostate-cancer/</loc><lastmod>2020-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/different-doses-of-adjuvant-ipilimumab-vs-high-dose-interferon-alfa-2b-in-patients-with-resected-high-risk-melanoma/</loc><lastmod>2020-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cancer-survivors-face-substantial-medical-financial-hardship/</loc><lastmod>2020-01-15</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/are-women-in-europe-or-asia-more-likely-to-have-breast-conserving-therapy-than-those-in-the-united-states/</loc><lastmod>2020-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/genomic-aberrations-and-pancreatic-cancer-subtypes/</loc><lastmod>2020-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/maintenance-bevacizumab-with-or-without-pemetrexed-in-advanced-nonsquamous-nsclc/</loc><lastmod>2020-01-16</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/conditioning-intensity-for-allogeneic-transplantation-in-patients-with-aml/</loc><lastmod>2020-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/external-beam-apbi-vs-wbi-after-breast-conserving-surgery-in-dcis-or-node-negative-breast-cancer/</loc><lastmod>2020-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/treatment-resistance-and-novel-therapies-in-fgfr-mutated-cholangiocarcinoma/</loc><lastmod>2020-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-pipeline-priority-reviews-in-ovarian-cancer-prostate-cancer-and-nsclc/</loc><lastmod>2020-01-17</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/iraes-and-recurrence-free-survival-with-adjuvant-immunotherapy-vs-placebo-in-stage-iii-melanoma/</loc><lastmod>2020-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/using-t-cell-fraction-to-predict-melanoma-recurrence/</loc><lastmod>2020-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/does-proton-pump-inhibitor-use-affect-cognition-in-breast-cancer-survivors/</loc><lastmod>2020-01-21</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/detecting-gi-tumors-using-a-cell-free-dna-test/</loc><lastmod>2020-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/patient-reported-outcomes-from-imbrave150-beacon-crc/</loc><lastmod>2020-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/young-adults-with-colorectal-cancer-living-in-areas-of-low-income-education-likely-to-have-worse-survival-outcomes/</loc><lastmod>2020-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/price-transparency-and-variation-for-prostate-cancer-radiation-therapy/</loc><lastmod>2020-01-22</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/addition-of-ramucirumab-or-merestinib-to-gemcitabinecisplatin-for-biliary-tract-cancer/</loc><lastmod>2020-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/does-receipt-of-palliative-care-increase-survival-in-patients-with-metastatic-esophageal-cancer-declining-chemotherapy/</loc><lastmod>2020-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/entrectinib-in-advanced-ros1-fusion-positive-nsclc/</loc><lastmod>2020-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/relapse-and-outcomes-in-men-receiving-adjuvant-bleomycinetoposidecisplatin-for-clinical-stage-i-nonseminoma/</loc><lastmod>2020-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/three-studies-examine-relationship-between-b-cell-enrichment-and-response-to-immunotherapy/</loc><lastmod>2020-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cancer-incidence-in-general-wtc-responders-to-the-september-11-attacks/</loc><lastmod>2020-01-20</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/higher-concentration-of-fusobacterium-nucleatum-found-in-colorectal-tumors-in-patients-younger-than-45/</loc><lastmod>2020-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/pathologic-fracture-and-prognosis-in-adult-and-pediatric-patients-with-high-grade-osteosarcoma/</loc><lastmod>2020-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/everolimusoctreotide-shows-antitumor-activity-in-recurrent-meningioma/</loc><lastmod>2020-01-23</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-pipeline-priority-reviews-in-multiple-myeloma-prostate-cancer/</loc><lastmod>2020-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/obstacles-to-early-detection-of-skin-cancer-in-patients-living-in-rural-western-states/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/few-patients-enroll-in-clinical-trials-of-first-line-therapies/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/aya-cancer-survivors-at-greater-risk-of-inpatient-hospitalization/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/data-from-colorectal-cancer-cohorts-of-tapur-study-presented/</loc><lastmod>2020-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/cost-of-pancreatic-cancer-care-over-time/</loc><lastmod>2020-01-27</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/dual-vegf-and-pd-1-inhibition-in-advanced-solid-tumors/</loc><lastmod>2020-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/late-stage-cancer-diagnoses-after-massachusetts-health-insurance-reform-law/</loc><lastmod>2020-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/intraoperative-molecular-imaging-technology-helps-surgeons-to-detect-nsclc/</loc><lastmod>2020-01-29</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/risk-of-cns-metastasis-in-patients-with-ajcc-8th-edition-stage-iii-melanoma/</loc><lastmod>2020-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/talimogene-laherparepvecpembrolizumab-in-previously-treated-advanced-sarcoma/</loc><lastmod>2020-01-01</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/fda-pipeline-priority-review-for-product-for-lung-and-thyroid-cancers/</loc><lastmod>2020-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/psilocybin-assisted-psychotherapy-and-cancer-related-psychiatric-distress/</loc><lastmod>2020-01-31</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/activity-of-anti-bcma-bite-molecule-amg-420-in-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/are-patient-reported-outcomes-predictive-of-survival-and-likelihood-of-hospitalization/</loc><lastmod>2020-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/gabapentin-and-methadone-for-patients-undergoing-treatment-of-head-and-neck-cancer/</loc><lastmod>2020-01-30</lastmod></url>
<url><loc>https://ascopost.com/articles/2020/01-january/equal-access-health-care-system-for-african-american-and-white-men-with-prostate-cancer/</loc><lastmod>2020-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/all-newsreels/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/giannis-s-mountzios-on-sclc-intracranial-effect-of-tarlatamab-vs-chemotherapy/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/ramaswamy-govindan-on-egfr-mutant-nsclc-final-overall-survival-results-from-alliance-a081105/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/lauren-averett-byers-on-abbv-706-in-relapsed-or-refractory-sclc/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/asaf-maoz-on-pancreatic-cancer-screening-potential-blood-based-biomarkers/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/robert-c-stein-on-er-positive-her2-negative-early-breast-cancer-test-directed-chemotherapy/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/marlana-m-orloff-on-metastatic-uveal-melanoma-first-line-therapy-for-hla-a2-negative-disease/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/linda-r-mileshkin-on-puxitatug-samrotecan-for-endometrial-or-ovarian-cancer/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/kevin-kalinsky-on-metastatic-triple-negative-breast-cancer-more-results-from-ascent-04/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/yelena-y-janjigian-on-safety-results-from-destiny-gastric03/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/brendan-heiden-on-lung-cancer-screening-eligibility-smoking-duration-vs-pack-years/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/nicholas-c-turner-on-er-positive-her2-negative-advanced-breast-cancer-persevera-bc-trial/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/misty-dawn-shields-on-sclc-expert-point-of-view/</loc><lastmod>2026-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/ghassan-k-abou-alfa-on-unresectable-embolization-eligible-hcc-efficacy-and-safety-data-from-emerald3/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/angimar-uriepero-palma-md-on-cll-impact-of-sglt2-inhibitors-on-patients-with-diabetes/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/bjorn-henning-gronberg-on-extensive-stage-sclc-concurrent-trt-and-chemoimmunotherapy/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/colton-jones-on-glp1-ras-for-the-prevention-of-hcc-in-high-risk-individuals/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/shilpa-gupta-on-locally-advanced-metastatic-urothelial-cancer-phase-iii-main-cav-trial/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/jason-r-westin-on-updated-safety-and-efficacy-from-the-sunmo-trial-in-lbcl/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/xin-gao-on-advanced-or-metastatic-urothelial-carcinoma-ly4101174/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/noelle-cloven-on-rainfol-03-actively-recruiting-trial-in-pretreated-endometrial-cancer/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/krishnan-r-patel-on-high-risk-prostate-cancer-clinico-transcriptomic-risk-stratification/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/mark-a-dickson-on-advanced-dedifferentiated-liposarcoma-sarc041-trial/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/julie-r-brahmer-on-previously-untreated-advanced-squamous-nsclc-harmoni-6-trial/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/jana-de-boniface-on-breast-cancer-with-sentinel-lymph-node-macrometastases-can-axillary-dissection-be-omitted/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/christopher-a-barker-md-on-locally-advanced-unresectable-cscc-rampart-trial/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/danny-rischin-on-adjuvant-cemiplimab-for-high-risk-cscc/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/shailender-bhatia-on-adjuvant-avelumab-in-patients-with-metastatic-merkel-cell-carcinoma/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/jennifer-j-knox-on-rasolute-302-findings-expert-point-of-view/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/ronald-c-chen-on-high-risk-muscle-invasive-urothelial-carcinoma-hrqol-with-pembrolizumab-vs-observation/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/richard-cathomas-on-mibc-perioperative-intravesical-recombinant-bcg-combined-with-chemoimmunotherapy/</loc><lastmod>2026-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/adela-elacestrant-plus-everolimus-in-esr1-mutated-er-positive-her2-negative-advanced-breast-cancer/</loc><lastmod>2026-06-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/first-line-therapy-for-cll-real-world-outcomes-among-medicare-beneficiaries/</loc><lastmod>2026-06-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/two-agents-in-treatment-naive-patients-with-cll-real-world-treatment-and-survival-outcomes/</loc><lastmod>2026-06-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/atrial-fibrillation-and-outcomes-and-health-care-utilization-among-patients-with-cll/</loc><lastmod>2026-06-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/pretreated-relapsed-or-refractory-cll-sll-ongoing-rocket-cll-trial/</loc><lastmod>2026-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/her2-positive-metastatic-breast-cancer-overall-survival-by-genomic-profile/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/francois-clement-bidard-on-advanced-breast-cancer-with-emergent-esr1-mutations-first-line-option/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/time-on-systemic-therapy-for-patients-with-hr-positive-breast-cancer-and-a-pathogenic-variant/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/siddhartha-yadav-on-germline-pathogenic-variants-among-patients-with-breast-or-ovarian-cancer/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/martine-j-piccart-gebhart-on-personalizing-treatments-in-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2026-06-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/new-data-in-gastricgastroesophageal-cancers/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/katharina-c-kaehler-on-daromun-in-resectable-locally-advanced-melanoma-trial-updates/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/multiple-myeloma-cfdna-wgs-vs-plasma-proteomics-for-minimally-invasive-mrd-assessment/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/jame-abraham-on-update-on-the-destiny-breast05-trial/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/jame-abraham-on-first-results-of-the-optima-trial-in-breast-cancer-expert-perspective/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/krishnansu-s-tewari-on-gynecologic-cancers-expert-perspective-on-major-data/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/sclc-no-longer-too-small-to-ignore/</loc><lastmod>2026-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/christine-lovly-on-adjuvant-selpercatinib-in-ret-fusion-positive-early-stage-nsclc-expert-perspective/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/elizabeth-mcdonald-on-glp-1-agonists-and-breast-cancer-incidence/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/mali-barbi-on-endometrial-cancer-data-in-dmmr-disease-and-b7-h4-adcs-for-advanced-disease/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/correlation-between-blood-and-tissue-tumor-mutation-burden/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/tegavivint-in-advanced-hcc/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/chrysalis-2-study-in-atypical-egfr-mutated-advanced-nsclc/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/bcc-of-the-head-and-neck-neoadjuvant-cemiplimab/</loc><lastmod>2026-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/ly4052031-for-advanced-or-metastatic-urothelial-carcinoma/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/regimen-for-older-unfit-or-frail-patients-with-newly-diagnosed-dlbcl/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/implant-based-breast-reconstruction-techniques-after-mastectomy/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/new-data-on-combination-therapy-immunotherapy-and-adcs-in-sclc/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/overall-survival-by-prior-taxane-use-in-the-phase-iii-rosella-trial/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/nivolumab-after-surgery-and-adjuvant-chemotherapy-in-nsclc/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/digital-prehabilitation-model-in-older-adults-undergoing-hepatobiliary-cancer-surgery/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/pirtobrutinib-in-treatment-naive-patients-with-cllsll/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/expanding-the-hcc-treatment-landscape/</loc><lastmod>2026-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/john-v-heymach-on-first-line-therapy-for-advanced-nsclc-with-egfr-exon-20-insertions/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/shubham-pant-md-mbbs-on-novel-ras-targeting-therapy-daraxonrasib-doubles-overall-survival-in-metastatic-pancreatic-cancer/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/mazyar-shadman-on-cll-sll-sonorotoclax-and-zanubrutinib/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/erika-p-hamilton-on-her2-positive-metastatic-breast-cancer-maintenance-therapy-comparison/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/elena-elimova-on-pd-l1-subgroup-analysis-from-herizon-gea-01/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/06-june/yashasvini-sampathkumar-on-job-retention-intervention-for-patients-undergoing-breast-cancer-therapy-digital-vs-print-format/</loc><lastmod>2026-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/thomas-a-jandl-on-dlbcl-first-line-odronextamab-plus-chemotherapy/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/samuel-j-klempner-on-advanced-her2-negative-gastroesophageal-cancer-ivonescimab-plus-folfox/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/peter-schmid-on-er-positive-her2-negative-early-breast-cancer-giredestrant-by-menopausal-status/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/john-m-burke-on-newly-diagnosed-dlbcl-frontmind-trial/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/adam-kibel-on-proteus-trial-in-high-risk-prostate-cancer-a-surgical-oncologists-perspective/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/alicia-k-morgans-on-cognitive-effects-of-darolutamide-vs-enzalutamide/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/julie-r-gralow-on-highlights-of-the-2026-asco-annual-meeting/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/brian-m-wolpin-and-eileen-m-oreilly-on-daraxonrasib-in-previously-treated-metastatic-pancreatic-cancer/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/jonathan-w-goldman-on-ret-fusion-positive-nsclc-adjuvant-selpercatinib/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/mary-ellen-taplin-on-high-risk-localized-or-locally-advanced-prostate-cancer-proteus-trial/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/lillian-l-siu-on-liquid-kras-mutation-screening-in-patients-with-advanced-pancreatic-cancer/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/veronica-diermayr-on-ai-driven-prediction-of-n256-glycosylated-ceacam56-expression-in-gastric-and-esophageal-cancer/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/evan-t-hall-on-merkel-cell-carcinoma-tuvusertib-with-or-without-avelumab/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/jessica-j-lin-on-neladalkib-in-advanced-alk-positive-nsclc/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/sanjay-popat-on-ret-fusion-positive-nsclc-first-line-pralsetinib/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/manali-kamdar-on-rapid-oral-abstract-highlights-three-emerging-trends-in-lymphoma-care/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/sara-a-hurvitz-on-metastatic-triple-negative-breast-cancer-more-results-from-ascent-03/</loc><lastmod>2026-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/tony-sk-mok-on-advanced-alk-positive-nsclc-7-year-update-from-the-crown-trial/</loc><lastmod>2026-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/atish-choudhury-on-can-patients-with-an-exceptional-response-to-arpis-interrupt-adt/</loc><lastmod>2026-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/supriya-gupta-on-investigational-car-t-cell-therapy-in-relapsed-or-refractory-nhl-and-cll/</loc><lastmod>2026-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/05-may/ramez-n-eskander-on-endometrial-cancer-pembrolizumab-plus-carboplatinpaclitaxel/</loc><lastmod>2026-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/advanced-nonsquamous-nsclc-second-line-risvutatug-rezetecan-and-adebrelimab/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/her2-mutant-nsclc-mechanisms-of-zongertinib-resistance/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/ros1-positive-nsclc-taletrectinib-in-tki-naive-patients/</loc><lastmod>2026-04-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/resectable-nsclc-iph5201-plus-durvalumab-and-platinum-based-chemotherapy/</loc><lastmod>2026-04-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/novel-strategy-to-eliminate-mrd-in-her2-mutant-nsclc/</loc><lastmod>2026-04-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/zoldonrasib-in-previously-treated-patients-with-kras-g12d-mutant-nsclc/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/04-april/histopathology-of-lung-cancer-in-neversmokers/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/03-march/highlights-in-prostate-cancer-from-asco-gu-2026/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/03-march/mcrpc-brcaaway-trial-in-patients-with-dna-repair-defects/</loc><lastmod>2026-03-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/03-march/muscle-invasive-bladder-cancer-enfortumab-vedotin-and-pembrolizumab/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/03-march/novel-antibody-drug-conjugate-in-previously-treated-advanced-urothelial-cancer/</loc><lastmod>2026-03-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/recurrent-prostate-cancer-hormone-therapy-and-postoperative-radiotherapy/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/mcrpc-enzalutamide-with-or-without-radium-223/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/localized-prostate-cancer-mmai-derived-biomarker/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/localized-prostate-cancer-external-beam-vs-brachytherapy-boost-rt/</loc><lastmod>2026-02-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/multimodal-ai-models-for-predicting-breast-cancer-recurrence/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/her2-positive-metastatic-breast-cancer-choosing-a-regimen-in-clinical-practice/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/t-dxd-in-her2-positive-early-breast-cancer-follow-up-data/</loc><lastmod>2026-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/02-february/novel-oral-serd-for-er-positive-her2-negative-early-breast-cancer/</loc><lastmod>2026-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/resectable-gastric-cancer-comparing-three-preoperative-regimens/</loc><lastmod>2026-01-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/hcc-pembrolizumab-after-resection-or-local-ablation/</loc><lastmod>2026-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/locally-advanced-gastric-gej-cancer-tislelizumab-plus-chemoradiotherapy/</loc><lastmod>2026-01-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/disparities-in-hcc-do-they-affect-systemic-care/</loc><lastmod>2026-01-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/surgical-journey-in-the-matterhorn-trial/</loc><lastmod>2026-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/her2-positive-gastroesophageal-cancer-zanidatamab-plus-chemotherapy/</loc><lastmod>2026-01-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/flot-administration-in-the-matterhorn-trial/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/advanced-gastric-gej-cancer-zolbetuximab-plus-mfolfox6-and-nivolumab/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/tremelimumab-rechallenge-in-unresectable-hcc-safety-outcomes/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/01-january/novel-first-line-regimen-for-unresectable-hcc-under-study/</loc><lastmod>2026-01-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/07-july/elacestrant-plus-capivasertib-in-er-positiveher2-negative-advanced-breast-cancer/</loc><lastmod>2026-07-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/sonesitatug-vedotin-in-cldn182-positive-gastroesophageal-cancer-expert-point-of-view/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/platinum-resistant-ovarian-cancer-torvutatug-samrotecan/</loc><lastmod>2026-11-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/brca-wild-type-recurrent-ovarian-cancer-novel-triplet-maintenance-regimen/</loc><lastmod>2026-11-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/sacituzumab-tirumotecan-in-previously-treated-advanced-or-recurrent-endometrial-cancer/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/g-hope-001-arcotatug-tavatecan-in-gigej-cancer/</loc><lastmod>2026-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/clarity-gastric-01-sonesitatug-vedotin-in-cldn182-positive-gastroesophageal-cancer/</loc><lastmod>2026-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/esophagealgej-cancer-pembrolizumab-or-placebo-plus-concurrent-definitive-chemoradiotherapy/</loc><lastmod>2026-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/11-november/gastricgej-cancer-novel-cldn182-targeting-adc/</loc><lastmod>2026-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/esophageal-cancer-active-surveillance-vs-standard-surgery-after-neoadjuvant-crt/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/advanced-biliary-tract-cancer-ivonescimabchemotherapy-vs-durvalumabchemotherapy/</loc><lastmod>2026-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/advanced-or-recurrent-endometrial-cancer-duo-egog-3041engot-en10/</loc><lastmod>2026-10-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/dmmr-advanced-or-recurrent-endometrial-cancer-keynote-c93gog-3064engot-en15/</loc><lastmod>2026-10-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/extensive-stage-sclc-subcutaneous-tarlatamab/</loc><lastmod>2026-10-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/relapsed-or-refractory-sclc-phase-i-study-of-novel-car-t-cell-therapy/</loc><lastmod>2026-10-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/metastatic-pd-l1-high-nsclc-sacituzumab-govitecanpembrolizumab/</loc><lastmod>2026-10-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/10-october/advanced-lung-cancer-pumitamig-plus-elfetabart-drozuntecan/</loc><lastmod>2026-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/targeting-b7-h3-in-second-line-sclc-treatment-novel-adcs/</loc><lastmod>2026-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/mobile-lung-ct-screening-in-resource-limited-settings-brelt3/</loc><lastmod>2026-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/sclc-tarlatamab-extended-interval-dosing-regimens/</loc><lastmod>2026-09-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/metastatic-her2-mutant-nsclc-first-line-t-dxd/</loc><lastmod>2026-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/resectableborderline-resectable-nsclc-neoadjuvant-durvalumab-plus-chemotherapy/</loc><lastmod>2026-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/metastatic-egfr-mutated-nsclc-global-study-of-izalontamab-brenitecan/</loc><lastmod>2026-09-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/nsclc-with-egfr-exon-20-insertions-first-line-amivantamabchemotherapy-vs-chemotherapy/</loc><lastmod>2026-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/sclc-brain-mri-surveillance-with-or-without-prophylactic-cranial-irradiation/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/resected-egfr-mutated-nsclc-long-term-overall-survival-with-osimertinib/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2026/09-september/advanced-metastatic-ros1-positive-nsclc-zidesamtinib-in-tki-naive-patients/</loc><lastmod>2026-09-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/mds-and-exposure-to-agent-orange/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/triplet-regimen-for-richter-transformation/</loc><lastmod>2025-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/multiple-myeloma-real-world-outcomes-with-elranatamab/</loc><lastmod>2025-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/tp53-mutated-higher-risk-mds-bexmarilimab-plus-azacitidine/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/lower-risk-mds-treatment-emergent-cytopenias-and-clinical-response/</loc><lastmod>2025-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/relapsedrefractory-cll-next-generation-btk-inhibitor/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/cllsll-pirtobrutinib-vs-ibrutinib-in-treatment-naive-and-relapsedrefractory-disease/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/higher-risk-mds-bexmarilimab-and-azacitidine/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/pausing-or-discontinuing-elranatamab/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/ultra-high-risk-multiple-myeloma-radar-trial-in-newly-diagnosed-transplant-eligible-patients/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/relapsedrefractory-multiple-myeloma-novel-doublet-in-patients-with-extramedullary-disease/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/using-an-ai-system-to-identify-patients-eligible-for-a-polycythemia-vera-trial/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/newly-diagnosed-multiple-myeloma-ultradeep-whole-genome-sequencing-of-cfdna/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/mds-research-highlights-from-ash-2025/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/novel-quadruplet-for-relapsedrefractory-multiple-myeloma/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/anitocabtagene-autoleucel-for-relapsedrefractory-multiple-myeloma/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/newly-diagnosed-aml-azacitidine-and-venetoclax-vs-conventional-induction-chemotherapy/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/previously-untreated-cll-fixed-duration-vs-continuous-targeted-treatment/</loc><lastmod>2025-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/ph-positive-all-tki-plus-inotuzumab-ozogamicin-based-therapy/</loc><lastmod>2025-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/older-adults-with-b-cell-all-cd19-car-t-cell-therapy/</loc><lastmod>2025-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/imetelstat-for-lower-risk-mds-long-term-outcomes-from-the-imerge-trial/</loc><lastmod>2025-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/b-cell-all-brexucabtagene-autoleucel-as-consolidation-therapy/</loc><lastmod>2025-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/r-r-b-cell-all-real-world-data-on-brexucabtagene-autoleucel-and-transplant/</loc><lastmod>2025-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/multiple-myeloma-burixafor-and-propranolol-with-g-csf-before-transplant/</loc><lastmod>2025-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/12-december/platinum-resistant-ovarian-cancer-relacorilant-and-nab-paclitaxel-in-pretreated-patients/</loc><lastmod>2025-12-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/11-november/high-risk-ovarian-cancer-weekly-dose-dense-and-every-3-week-chemotherapy-plus-bevacizumab/</loc><lastmod>2025-11-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/11-november/jadpro-live-2025-united-in-care/</loc><lastmod>2025-11-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/11-november/platinum-resistant-recurrent-ovarian-cancer-pembrolizumab-plus-weekly-paclitaxel/</loc><lastmod>2025-11-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/10-october/car-t-cell-therapy-in-all/</loc><lastmod>2025-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/what-is-the-optimal-upper-age-limit-for-lung-cancer-screening/</loc><lastmod>2025-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/zongertinib-in-patients-with-previously-treated-her2-mutant-nsclc-and-baseline-brain-metastases/</loc><lastmod>2025-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/alk-positive-nsclc-crizotinib-vs-observation-for-surgically-resected-early-stage-disease/</loc><lastmod>2025-09-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/focus-on-tp53-mutated-all/</loc><lastmod>2025-09-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/debate-lower-intensity-regimens-in-aml/</loc><lastmod>2025-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/extensive-stage-sclc-tarlatamab-plus-anti-pd-l1-as-maintenance-therapy/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/enable-study-in-heavily-pretreated-patients-with-cml/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/ros1-fusion-positive-nsclc-efficacy-of-zidesamtinib/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/egfr-mutated-nsclc-subcutaneous-amivantamab-plus-lazertinib/</loc><lastmod>2025-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/perioperative-immunotherapy-for-resectable-nsclc-hrqol-outcomes/</loc><lastmod>2025-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/concurrent-and-consolidation-durvalumab-for-unresectable-stage-iii-nsclc/</loc><lastmod>2025-09-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/btk-degrader-in-relapsed-or-refractory-cll/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/aumolertinib-plus-chemotherapy-in-egfr-mutated-nsclc/</loc><lastmod>2025-09-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/aml-highlights-of-ongoing-research/</loc><lastmod>2025-09-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/09-september/car-t-cell-therapy-for-adult-patients-with-rr-b-cell-all/</loc><lastmod>2025-09-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/erika-hamilton-on-the-veritac-2-trial/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/gerhardt-attard-on-the-amplitude-trial/</loc><lastmod>2025-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/ruben-a-mesa-on-essential-thrombocythemia-surpass-et-trial/</loc><lastmod>2025-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/violaine-randrian-on-lynch-syndrome-genetics-and-immunotherapy/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/breast-cancer-data-highlights-sequencing-of-endocrine-therapy/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/neil-iyengar-on-cancer-risk-reduction-effects-of-menopausal-hrt-and-glp-1-ras/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/eric-bent-on-oligometastatic-prostate-cancer-intensified-hormonal-blockade/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/praful-ravi-on-high-risk-localized-prostate-cancer-docetaxel-with-adt-and-radiotherapy/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/suneel-kamath-on-disparities-in-nih-and-federal-funding-across-different-cancer-types/</loc><lastmod>2025-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/luis-g-paz-ares-on-extensive-stage-sclc-comparison-of-first-line-regimens/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/luis-g-paz-ares-on-imforte-trial-in-extensive-stage-sclc/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/nitin-jain-on-front-line-therapies-for-cll-research-highlights-from-asco-2025/</loc><lastmod>2025-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/shahzad-raza-on-relapsed-or-refractory-al-amyloidosis-first-us-trial-of-car-t-cell-therapy/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/jamie-e-chaft-on-resectable-egfr-mutated-nsclc-neoadaura-results/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/bjorn-henning-gronberg-md-phd-on-sclc-adjuvant-immunotherapy-after-crt/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/d-james-on-using-ai-to-identify-benefit-from-prostate-cancer-therapy/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/alicia-k-morgans-on-how-does-androgen-receptor-inhibition-affect-quality-of-life/</loc><lastmod>2025-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/rami-manochakian-on-tarlatamab-vs-chemotherapy-for-second-line-treatment-of-sclc-expert-point-of-view/</loc><lastmod>2025-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/asaf-maoz-on-li-fraumeni-syndrome-multimodality-screening-program/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/asaf-maoz-on-pancreatic-surveillance-eligibility-criteria/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/martin-reck-on-postsurgical-mrd-genomic-mutations-and-outcomes-in-resectable-nsclc-aegean-trial/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/frank-a-sinicrope-on-adjuvant-treatment-strategies-for-stage-iii-dmmr-colon-cancer/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/alicia-latham-on-using-ctdna-to-detect-endometrial-cancer/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/stephen-kl-chia-on-advanced-her2-negative-and-er-positive-breast-cancer-serd-and-akt-inhibitor/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/david-r-spigel-on-nsclc-treatment-planning-role-of-14-gene-molecular-assay/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/angela-r-bradbury-on-genetic-testing-approach-in-patients-with-metastatic-cancers/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/sameek-roychowdhury-on-telemedicine-in-clinical-trials/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/manmeet-singh-ahluwalia-on-liquid-biopsy-in-glioblastoma/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/karen-eubanks-jackson-on-receiving-the-2025-asco-patient-advocate-award/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/elena-elez-on-updated-survival-data-from-the-breakwater-trial/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/sara-m-tolaney-on-pd-l1-positive-advanced-tnbc-first-line-doublet-comparison/</loc><lastmod>2025-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/arelis-esther-martir-negron-on-prevalence-of-brca-variants-in-hispanic-residents-of-south-florida/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/mafalda-oliveira-on-how-does-hyperglycemia-affect-treatment-of-advanced-breast-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/david-allen-barbie-on-clinical-and-molecular-features-of-participants-in-the-adriatic-trial/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/andrew-j-armstrong-md-ms-on-arches-5-year-overall-survival-follow-up/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/clifford-a-hudis-on-asco-guidelines-assistant/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/heinz-josef-lenz-on-msihdmmr-metastatic-colorectal-cancer-expanded-analyses-from-checkmate-8hw/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/mazyar-shadman-on-doublet-for-treatment-naive-cll-sll/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/yelena-y-janjigian-on-gastric-gej-cancer-immunotherapy-plus-flot/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/raffaele-califano-on-egfr-mutant-advanced-nsclc-mariposa-2/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/nicholas-c-turner-on-treating-emergent-esr1-mutations-in-advanced-breast-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/stuart-j-wong-on-adjuvant-regimen-in-resected-hnscc/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/andrew-kuykendall-on-hepcidin-mimetic-for-polycythemia-vera/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/christopher-m-booth-on-a-structured-exercise-program-for-patients-with-colon-cancer/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/06-june/constantine-si-lun-tam-on-cll-sll-first-line-zanubrutinib-monotherapy-in-patients-with-del17p/</loc><lastmod>2025-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/05-may/nicholas-c-turner-on-inavo120-final-overall-survival-analysis/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/05-may/giuseppe-curigliano-on-patient-reported-outcomes-from-ember-3/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/05-may/william-wierda-on-lisocabtagene-maraleucel-in-relapsed-refractory-cll-transcend-cll-004/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/05-may/william-g-wierda-on-fixed-duration-ibrutinib-and-venetoclax-in-first-line-cll/</loc><lastmod>2025-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/ezh2-inhibitor-plus-enzalutamide-in-mcrpc/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/posttransplant-gvhd-prophylaxis-strategy/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/alpha-1-antitrypsin-for-high-risk-acute-gvhd/</loc><lastmod>2025-02-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/rock12-inhibition-and-gvhd/</loc><lastmod>2025-02-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/mcrpc-talazoparib-plus-enzalutamide-as-first-line-treatment/</loc><lastmod>2025-02-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/hrr-deficient-mcrpc-final-overall-survival-in-talapro-2/</loc><lastmod>2025-02-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/research-highlights-in-gvhd/</loc><lastmod>2025-02-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/specialized-diet-in-men-on-active-surveillance-for-prostate-cancer/</loc><lastmod>2025-02-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/mobile-prostate-cancer-clinical-unit/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/mrcpc-lupsma-with-or-without-arpis/</loc><lastmod>2025-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/adt-option-transdermal-estradiol-patches/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/02-february/exercise-therapy-for-patients-with-advanced-prostate-cancer/</loc><lastmod>2025-02-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/alascca-trial-in-colorectal-cancer/</loc><lastmod>2025-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/fresco-2-study-in-metastatic-colorectal-cancer/</loc><lastmod>2025-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/breakwater-study-in-braf-v600-mutant-metastatic-colorectal-cancer/</loc><lastmod>2025-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/phase-iii-starter-net-study-in-gep-net/</loc><lastmod>2025-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/first-results-from-checkmate-8hw/</loc><lastmod>2025-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/a-blood-based-test-for-colorectal-cancer-screening/</loc><lastmod>2025-01-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/sherko-kuemmel-md-on-final-survival-results-from-the-wsg-adapt-hrplusher2-negative-chemotherapy-trial/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2025/01-january/komal-jhaveri-md-facp-on-the-phase-iii-ember-trial/</loc><lastmod>2025-01-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/cara-norelli-on-managing-dermatologic-side-effects-in-patients-with-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/andrew-tutt-on-olympia-high-risk-brca-positive-breast-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/nan-chen-on-impact-of-anthracyclines-in-high-genomic-risk-node-negative-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/kathryn-newlin-on-updates-in-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/adrienne-waks-on-margot-tbcrc052-phase-ii-trial-in-her2-positive-breast-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/aditya-bardia-on-destiny-breast06-an-additional-analysis/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/mafalda-oliveira-on-primary-results-of-solti-valentine/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/sibylle-loibl-on-primary-results-of-the-randomized-phase-iii-padma-study-in-her2-negative-hr-positive-metastatic-breast-cancer/</loc><lastmod>2024-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/justin-arnall-on-complicating-factors-when-malignancy-and-non-malignant-hematology-collide/</loc><lastmod>2024-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/tiffany-traina-on-advances-in-the-treatment-of-hr-positive-breast-cancer/</loc><lastmod>2024-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/erik-thiele-orberg-on-recovery-of-the-intestinal-microbiome-in-patients-at-day-100-after-allogeneic-stem-cell-transplantation-is-defined-by-microbial-metabolite-profiles-and-linked-to-long-term-outcomes/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/hannah-choe-md-on-dynamics-of-overall-and-organ-specific-responses-to-axatilimab-in-chronic-graft-versus-host-disease-analysis-from-the-agave-201-study/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/natalie-wuliji-and-mohamed-sorror-on-the-impact-of-socioeconomic-factors-on-access-to-and-outcomes-of-allogeneic-hematopoietic-cell-transplantation-for-aml/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/jenny-paredes-on-how-increased-fiber-intake-results-in-better-overall-survival-and-lower-gi-agvhd-in-allo-hct-recipients-and-pre-clinical-gvhd-models/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/matthew-s-davids-on-triplet-therapy-of-acalabrutinib-venetoclax-and-obinutuzumab-focus-on-tp53-aberrant-cll/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/john-o-mascarenhas-md-on-myelofibrosis-novel-combination-of-imetelstat-plus-ruxolitinib/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/john-o-mascarenhas-on-relapsed-refractory-myelofibrosis-navtemadlin-vs-best-available-therapy-after-jak-inhibitor-treatment/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/timothy-s-fenske-on-lack-of-benefit-of-autologous-hematopoietic-cell-transplantation-in-mantle-cell-lymphoma-patients/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/rachel-e-rau-and-sumit-gupta-on-pediatric-b-cell-all-blinatumomab-added-to-chemotherapy-in-newly-diagnosed-disease/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/nitin-jain-on-first-line-treatment-with-pirtobrutinib-based-regimen-in-cll/</loc><lastmod>2024-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/danielle-wolfe-cohen-on-mechanisms-of-relapse-in-b-cell-acute-lymphoblastic-leukemia/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/anne-sophie-michallet-on-mrd-guided-vs-standard-combination-therapy-for-select-untreated-patients-with-cll/</loc><lastmod>2024-12-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/jennifer-r-brown-on-fixed-duration-acalabrutinibvenetoclax-in-fit-patients-with-cll-amplify-trial/</loc><lastmod>2024-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/maayan-levy-and-marco-ruella-on-how-a-ketogenic-diet-enhances-car-t-cell-antitumor-function-via-beta-hydroxybutyrate-bhb/</loc><lastmod>2024-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/nikolaos-katsivelos-and-john-levine-on-how-serial-clinical-and-biomarker-monitoring-during-treatment-can-stratify-patients-with-low-risk-gvhd/</loc><lastmod>2024-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/12-december/komal-jhaveri-on-antibody-drug-conjugates-in-breast-cancer/</loc><lastmod>2024-12-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/11-november/william-gradishar-md-about-the-lynn-sage-breast-cancer-symposium/</loc><lastmod>2024-11-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/11-november/vered-stearns-on-shifting-patient-outcomes-updates-in-triple-negative-breast-cancer/</loc><lastmod>2024-11-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/11-november/william-gradishar-md-on-advances-in-endocrine-therapeutic-options-for-patients-with-er-positive-her2-negative-breast-cancer/</loc><lastmod>2024-11-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/11-november/charles-e-geyer-jr-on-management-of-the-patient-with-her2-positive-breast-cancer-in-2024/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/11-november/sunil-s-badve-md-frcpath-on-tumor-infiltrating-lymphocytes-in-the-patient-with-breast-cancer/</loc><lastmod>2024-11-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/10-october/frederick-howard-md-on-targeted-therapy-and-endocrine-therapy-in-the-patient-with-breast-cancer/</loc><lastmod>2024-10-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/09-september/maeve-lowery-on-a-novel-bifunctional-antibody-in-advanced-hepatocellular-carcinoma/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/09-september/rachna-shroff-on-advanced-hepatocellular-carcinoma-anlotinib-plus-penpulimab-vs-sorafenib/</loc><lastmod>2024-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/09-september/josep-llovet-on-treatment-options-in-hepatocellular-carcinoma/</loc><lastmod>2024-09-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/09-september/josep-llovet-on-intermediate-stage-hepatocellular-carcinoma-addition-of-lenvatinib-plus-pembrolizumab-to-tace/</loc><lastmod>2024-09-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/09-september/ghassan-abou-alfa-and-lorenza-rimassa-on-unresectable-hepatocellular-carcinoma-5-year-overall-survival-results-from-the-himalaya-trial/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/09-september/ghassan-abou-alfa-and-lorenza-rimassa-on-doublet-immunotherapy-for-unresectable-hcc/</loc><lastmod>2024-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/sara-hurvitz-on-new-therapeutic-strategies-for-her2-positive-metastatic-disease-including-brain-metastases/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/kristin-rojas-on-improving-sexual-health-during-breast-cancer-treatment/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/joseph-sparano-on-premenopausal-hr-positive-early-breast-cancer/</loc><lastmod>2024-07-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/paolo-tarantino-on-current-and-future-landscape-of-antibody-drug-conjugates/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/aditya-bardia-on-novel-therapies-targeting-the-estrogen-receptor/</loc><lastmod>2024-07-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/heather-mcarthur-on-immunotherapy-for-high-risk-early-stage-breast-cancer/</loc><lastmod>2024-07-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/07-july/aditya-bardia-on-on-the-current-and-future-landscape-of-antibody-drug-conjugates/</loc><lastmod>2024-07-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/molecular-profiling-prognosis-and-treatment-options-in-her2-positive-early-stage-breast-cancer/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/her2-positive-breast-cancer-expert-commentary-on-treatments-under-study/</loc><lastmod>2024-06-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/claudio-cerchione-on-staging-multiple-myeloma-new-findings-on-fdg-petct-scans-and-whole-body-mri/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/ai-in-the-clinic-understanding-how-to-use-this-21st-century-tool/</loc><lastmod>2024-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/andrea-cercek-on-rectal-cancer-durable-complete-responses-to-pd-1-blockade-alone/</loc><lastmod>2024-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/georgina-long-on-braf-mutated-melanoma-long-term-follow-up-of-adjuvant-dabrafenib-plus-trametinib-vs-placebo/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/yasmin-h-karimi-on-large-b-cell-lymphoma-follow-up-on-subcutaneous-epcoritamab-monotherapy/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/yasmin-h-karimi-on-diffuse-large-b-cell-lymphoma-update-on-use-of-epcoritamab-plus-chemotherapy/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/alicia-morgans-and-samuel-denmeade-on-prostate-cancer-results-from-the-transformer-trial/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/multiple-myeloma-moving-bcma-directed-therapies-to-earlier-use/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/multiple-myeloma-findings-from-the-perseus-trial-on-a-regimen-for-transplant-eligible-patients/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/william-g-wierda-on-cllsll-updated-findings-on-ibrutinib-and-venetoclax/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/yukio-suzuki-on-endometrial-cancer-long-term-survival-outcomes-with-hormonal-therapy-in-reproductive-age-patients/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/prostate-cancer-study-findings-on-health-related-quality-of-life-and-pain/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/laurence-albiges-on-renal-cell-carcinoma-biomarker-analysis-of-the-immotion010-study/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/yeon-hee-park-on-metastatic-breast-cancer-updated-survival-results-of-the-young-pearl-study/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/efrat-dotan-on-pancreatic-cancer-in-older-adults-defining-the-optimal-treatment-approach/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/jeanne-tie-on-colon-cancer-new-data-on-ctdna-guiding-adjuvant-therapy/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/narjust-florez-and-suresh-s-ramalingam-on-egfr-mutated-nsclc-update-on-osimertinib-and-chemoradiotherapy/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/jonathan-rosenberg-and-thomas-powles-on-urothelial-carcinoma-expert-commentary-on-two-key-abstracts/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/minesh-p-mehta-on-nsclc-tumor-treating-fields-for-brain-metastases/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/urothelial-carcinoma-the-destiny-pan-tumor02-study-and-new-findings-on-sacituzumab-govitecan/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/omid-hamid-on-cutaneous-melanoma-update-on-a-bispecific-protein-under-study/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/christos-kyriakopoulos-on-prostate-cancer-chaarted2-trial-results-on-cabazitaxel-and-abiraterone/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/narjust-florez-and-david-spigel-on-limited-stage-small-cell-lung-cancer-results-from-the-adriatic-study/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/brian-rini-on-renal-cell-carcinoma-exploratory-biomarker-results/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/alex-andrea-francoeur-on-endometrial-cancer-and-obesity-trends/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/tony-mok-on-nsclc-adagrasib-vs-docetaxel-in-kras-g12c-mutated-disease/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/heather-wakelee-on-nsclc-impower010-survival-results-after-long-term-follow-up-of-atezolizumab-vs-best-supportive-care/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/reshma-jagsi-and-tarah-j-ballinger-on-early-stage-breast-cancer-in-black-women-docetaxel-and-peripheral-neuropathy/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/pierfranco-conte-on-early-stage-triple-negative-breast-cancer-trial-update-on-avelumab-as-adjuvant-treatment/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/sherene-loi-on-early-stage-breast-cancer-weighing-the-prognostic-value-of-ctdna-detection/</loc><lastmod>2024-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/joshua-d-brody-on-follicular-lymphoma-new-data-on-epcoritamab-rituximab-and-lenalidomide/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/allison-winter-on-richter-transformation-new-data-on-a-car-t-cell-treatment/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/peter-riedell-on-the-echelon-3-study-in-dlbcl/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/thierry-facon-on-multiple-myeloma-results-from-the-imroz-study-on-isatuximab-bortezomib-lenalidomide-and-dexamethasone/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/peter-riedell-on-the-deb-study-dlbcl/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/emily-podany-on-metastatic-breast-cancer-racial-differences-in-genomic-profiles-and-targeted-treatment-use/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/yucai-wang-md-phd-on-richter-transformation-of-cll-findings-on-combination-therapy-with-an-immune-checkpoint-inhibitor/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/axel-hauschild-on-melanoma-findings-from-the-pivotal-trial-of-daromun-vs-surgery/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/mostafa-eyada-on-oral-cyclophosphamide-plus-bevacizumab-in-recurrent-ovarian-cancer/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/eva-ciruelos-on-her2-positive-and-pam50-luminal-breast-cancer-patricia-trial/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/luciano-j-costa-md-phd-on-multiple-myeloma-subgroup-analysis-of-cartitude-4-on-ciltacabtagene-autoleucel/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/suzanne-trudel-on-multiple-myeloma-results-from-the-dreamm-8-study/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/jean-marc-classe-on-ovarian-cancer-new-data-on-lymphadenectomy-from-the-caraco-trial/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/david-andorsky-on-dlbcl-and-fl-new-data-on-use-of-subcutaneous-epcoritamab/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/prostate-cancer-new-findings-on-classifying-patients-into-risk-groups/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/pauline-funchain-and-paolo-ascierto-on-advanced-melanoma-results-from-the-relativity-048-trial/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/melanoma-new-data-on-encorafenib-binimetinib-ipilimumab-and-nivolumab/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/clifford-a-hudis-and-karen-e-knudsen-an-asco-american-cancer-society-partnership-to-benefit-patients/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/clifford-a-hudis-a-message-from-asco-s-ceo/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/belinda-lee-on-early-stage-pancreatic-cancer-new-data-on-guiding-adjuvant-chemotherapy/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/reshma-jagsi-and-christian-f-singer-on-early-stage-breast-cancer-adding-a-vaccine-to-neoadjuvant-systemic-therapy/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/joseph-a-greer-phd-on-lung-cancer-telehealth-vs-in-person-palliative-care/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/don-s-dizon-on-ovarian-and-other-extrarenal-clear-cell-carcinomas-update-on-nivolumab-and-ipilimumab/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/christian-u-blank-on-melanoma-potentially-practice-changing-results-from-the-nadina-trial/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/lisa-a-carey-and-dejan-juric-on-breast-cancer-updates-from-the-inavo120-trial/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/jens-marquardt-and-jens-hoeppner-on-esophageal-cancer-phase-iii-findings-on-chemotherapy-vs-chemoradiation/</loc><lastmod>2024-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/lisa-a-carey-and-kevin-kalinsky-on-advanced-breast-cancer-new-data-on-abemaciclib-and-fulvestrant-from-the-postmonarch-trial/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/anthony-m-joshua-on-low-risk-prostate-cancer-and-metformin-new-trial-data/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/denise-a-yardley-on-early-breast-cancer-findings-from-the-natalee-trial-on-patients-with-node-negative-disease/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/ana-c-garrido-castro-on-managing-metastatic-breast-cancer-in-2024/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/ana-c-garrido-castro-on-metastatic-breast-cancer-trial-update-on-sacituzumab-govitecan-with-or-without-pembrolizumab/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/mazyar-shadman-on-chronic-lymphocytic-leukemia-recruiting-for-the-celestial-tncll-study/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/mazyar-shadman-on-chronic-lymphocytic-leukemia-update-on-btk-inhibitors/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/06-june/katherine-c-fuh-on-ovarian-cancer-new-data-on-batiraxcept-and-paclitaxel/</loc><lastmod>2024-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/05-may/fabrice-andre-on-breast-cancer-interim-analysis-from-destiny-breast07/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/05-may/tomasz-jankowski-on-non-small-cell-lung-cancer-new-data-on-a-telomere-targeting-agent/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/05-may/xavier-leleu-on-multiple-myeloma-update-on-isatuximab-lenalidomide-dexamethasone-and-bortezomib/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/05-may/toni-choueiri-on-rcc-biomarker-analysis-from-the-clear-trial/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/05-may/muhit-ozcan-on-cllsll-study-of-nemtabrutinib-venetoclax-and-rituximab/</loc><lastmod>2024-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/05-may/pasi-janne-on-nsclc-osimertinib-chemotherapy-update-from-flaura2/</loc><lastmod>2024-05-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/kelly-hunt-on-breast-cancer-and-neoadjuvant-therapy-expert-commentary/</loc><lastmod>2024-04-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/douglas-johnson-on-cutaneous-melanoma-treatment-updates/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/wendy-vogel-on-the-evolving-role-of-advanced-practice-providers-in-oncology-care/</loc><lastmod>2024-04-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/natalie-callander-on-multiple-myeloma-management-updates/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/william-gradishar-on-hr-positive-her2-negative-breast-cancer-management-update/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/sophia-mckinley-on-cutaneous-melanoma-outcomes-with-adjuvant-immunotherapy/</loc><lastmod>2024-04-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/jenny-chang-on-new-findings-on-merkel-cell-carcinoma-and-neoadjuvant-immunotherapy/</loc><lastmod>2024-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/ana-oaknin-on-recurrent-cervical-cancer-new-findings-on-atezolizumab-bevacizumab-and-chemotherapy/</loc><lastmod>2024-04-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/judy-boughey-on-de-escalating-axillary-surgery-after-chemotherapy-for-breast-cancer/</loc><lastmod>2024-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/akhil-pachimatla-on-nsclc-a-link-between-image-based-measures-of-obesity-and-metabolic-pathways/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/kerollos-wanis-on-risks-for-brca-mutation-carriers-treated-with-breast-conserving-therapy/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/heather-mcarthur-on-early-stage-high-risk-er-positive-her2-negative-breast-cancer-new-pcr-results-for-pembrolizumab-and-chemotherapy/</loc><lastmod>2024-04-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/04-april/natalia-polidorio-on-triple-negative-breast-cancer-impact-of-race-on-treatment-efficacy/</loc><lastmod>2024-04-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/matthew-powell-on-endometrial-cancer-overall-survival-update-on-dostarlimab-gxly-plus-chemotherapy/</loc><lastmod>2024-03-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/anne-knisely-on-ovarian-cancer-and-the-implications-of-detecting-residual-disease-and-ctdna/</loc><lastmod>2024-03-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/mary-mccormack-on-locally-advanced-cervical-cancer-results-from-the-interlace-trial/</loc><lastmod>2024-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/mansoor-mirza-on-endometrial-cancer-update-on-combination-regimen-of-dostarlimab-chemotherapy-and-niraparib/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/brian-slomovitz-on-cervical-cancer-update-on-tisotumab-vedotin-vs-chemotherapy/</loc><lastmod>2024-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/marcin-dzienis-on-update-on-pembrolizumab-carboplatin-and-paclitaxel-in-hnscc/</loc><lastmod>2024-03-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/dan-zandberg-on-personalized-immunotherapy-for-hnscc-progress-report/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/samuel-regan-and-benjamin-rosen-on-de-escalating-radiotherapy-for-hpv-related-oropharyngeal-cancer/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/eleni-rettig-on-hpv-related-oropharyngeal-cancers-early-detection-and-disease-surveillance/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/evan-graboyes-on-decreasing-delays-in-adjuvant-therapy-for-head-and-neck-cancer/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/evan-graboyes-on-addressing-body-image-distress-critical-care-for-head-and-neck-cancer-survivors/</loc><lastmod>2024-03-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/pooja-karukonda-on-coping-with-financial-toxicity-in-head-and-neck-cancer/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/03-march/nabil-saba-on-preventing-radiation-induced-mucositis-in-patients-with-squamous-cell-carcinoma-of-the-head-and-neck/</loc><lastmod>2024-03-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/christopher-barker-on-new-data-on-vismodegib-and-radiotherapy-for-basal-cell-carcinoma-of-the-head-and-neck/</loc><lastmod>2024-02-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/nabil-saba-on-head-and-neck-cancer-long-term-survival-findings-with-pembrolizumab-and-cabozantinib/</loc><lastmod>2024-02-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/andrea-apolo-on-urothelial-carcinoma-phase-iii-findings-on-pembrolizumab-vs-observation/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/rohit-jain-on-urothelial-carcinoma-new-data-on-cabozantinib-plus-pembrolizumab/</loc><lastmod>2024-02-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/bishoy-faltas-on-upper-tract-urothelial-carcinoma-how-biology-shapes-therapy/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/thomas-powles-on-clear-cell-kidney-cancer-overall-survival-update-with-adjuvant-pembrolizumab/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/andrew-johns-on-clear-cell-renal-cell-carcinoma-data-on-tivozanib-in-pretreated-patients/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/david-aggen-on-advanced-bladder-cancer-her2-and-pd-l1-immunohistochemistry-and-her2-genomic-alterations/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/enrique-grande-on-adrenocortical-carcinoma-phase-ii-results-on-cabozantinib-plus-atezolizumab/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/michiel-van-der-heijden-on-metastatic-urothelial-carcinoma-enfortumab-vedotin-plus-pembrolizumab-vs-chemotherapy/</loc><lastmod>2024-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/sumanta-pal-on-prostate-cancer-impact-of-the-microbiome-on-immune-therapy/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/saby-george-on-clear-cell-kidney-cancer-subcutaneous-vs-intravenous-nivolumab/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/umang-swami-on-prostate-cancer-differences-in-genomic-transcriptomic-and-immune-landscape-based-on-site-of-metastasis/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/02-february/syed-muneeb-alam-on-urothelial-carcinoma-microsatellite-instability-and-response-to-immune-checkpoint-blockade/</loc><lastmod>2024-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/thomas-powles-on-rcc-patient-reported-outcomes-with-belzutifan-vs-everolimus/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/amanda-nizam-on-urothelial-carcinoma-study-results-on-enfortumab-vedotin-and-avelumab/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/maha-hussain-on-prostate-cancer-new-data-on-abiraterone-and-prednisone-plus-olaparib/</loc><lastmod>2024-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/neeraj-agarwal-on-prostate-cancer-phase-iii-trial-update-on-cabozantinib-atezolizumab-and-hormonal-therapy/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/ian-chau-on-gastrointestinal-cancers-real-world-effectiveness-of-nivolumab-plus-chemotherapy/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/dominik-modest-on-colorectal-cancer-health-related-quality-of-life-findings-from-codebreak-300/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/yasunobu-ishizuka-on-gastric-cancer-does-nivolumab-infusion-time-of-day-matter/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/milind-javle-on-cholangiocarcinoma-new-data-on-tinengotinib-as-monotherapy/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/lorraine-chantrill-on-gastrointestinal-neuroendocrine-carcinomas-first-line-treatment-with-nab-paclitaxel-plus-carboplatin/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/jennifer-yon-li-wo-on-colorectal-and-pancreatic-cancers-new-findings-on-sbrt-with-ipilimumab-and-nivolumab/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/riccardo-lencioni-on-hcc-tace-durvalumab-and-bevacizumab/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/van-morris-on-colon-cancer-ctdna-as-a-predictive-biomarker/</loc><lastmod>2024-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/anant-ramaswamy-on-advanced-gastric-cancers-new-findings-on-adding-docetaxel-to-doublet/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/frank-kullmann-on-metastatic-pancreatic-cancer-recent-data-on-gemcitabine-and-nab-paclitaxel/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/manish-shah-on-esophageal-cancer-long-term-outcomes-of-pembrolizumab-and-chemotherapy/</loc><lastmod>2024-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/ian-chau-on-esophageal-squamous-cell-carcinoma-new-data-on-nivolumab-ipilimumab-and-chemotherapy/</loc><lastmod>2024-01-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/ken-kato-on-advanced-esophageal-cancer-biomarker-analyses-from-checkmate-648/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/michael-gibson-on-esophageal-cancer-expert-commentary-on-two-key-studies/</loc><lastmod>2024-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/tnbc-trial-update-on-pembrolizumab-plus-olaparib-vs-pembrolizumab-plus-chemotherapy/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/ibrahim-aldoss-on-kmt2a-rearranged-acute-leukemia-new-data-on-revumenib-monotherapy/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/harinder-gill-on-acute-promyelocytic-leukemia-assessing-the-use-of-oral-arsenic-trioxide-retinoic-acid-and-ascorbic-acid/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/mazyar-shadman-on-large-b-cell-lymphoma-autologous-transplantation-vs-car-t-cell-therapy/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/jeffrey-rubnitz-on-pediatric-aml-outcomes-and-racial-disparities/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/reshma-jagsi-on-early-stage-breast-cancer-5-year-outcomes-with-endocrine-therapy-and-breast-conserving-surgery/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/seema-khan-on-ductal-carcinoma-in-situ-central-mri-and-a-12-gene-expression-assay-to-optimize-local-therapy/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/andrew-srisuwananukorn-on-myelofibrosis-vs-essential-thrombocythemia-a-potential-new-clinical-decision-tool/</loc><lastmod>2024-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/sanjal-desai-on-classical-hodgkin-lymphoma-improving-outcomes-with-pd-1-blockade/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/sara-khan-on-the-gender-gap-in-receiving-nih-grants-for-hematology-research/</loc><lastmod>2024-01-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/adam-kittai-on-richters-transformation-anti-cd19-car-t-cell-therapy/</loc><lastmod>2024-01-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/jame-abraham-md-facp-on-the-phase-iii-zest-trial/</loc><lastmod>2024-01-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/jame-abraham-md-facp-on-the-patina-trial/</loc><lastmod>2024-01-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/michael-wang-on-mantle-cell-lymphoma-new-results-on-ibrutinib-plus-venetoclax/</loc><lastmod>2024-01-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/jennifer-woyach-on-cllsll-30-month-follow-up-and-subgroup-analysis-of-pirtobrutinib/</loc><lastmod>2024-01-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/sarah-rutherford-on-hodgkin-lymphoma-nivolumab-plus-avd-in-older-patients-with-advanced-stage-disease/</loc><lastmod>2024-01-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/peter-schmid-on-early-stage-tnbc-updated-survival-results-from-keynote-522/</loc><lastmod>2024-01-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/potential-clinical-uses-of-identifying-new-hematologic-malignancy-predisposition-gene/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/cynthia-ma-on-metastatic-breast-cancer-early-results-on-copanlisib-fulvestrant-and-abemaciclib/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2024/01-january/rana-mckay-on-mutated-prostate-cancer-parp-inhibition-and-radical-prostatectomy/</loc><lastmod>2024-01-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/paul-richardson-on-multiple-myeloma-mezigdomide-plus-dexamethasone-in-relapsed-and-refractory-disease/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/sean-khozin-on-randomized-trials-vs-real-world-evidence-in-patients-with-advanced-cancer/</loc><lastmod>2022-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/jennifer-brown-on-cll-sll-new-findings-on-zanubrutinib-vs-ibrutinib-for-relapsed-or-refractory-disease/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/mark-litzow-on-all-consolidation-therapy-with-blinatumomab-improves-overall-survival/</loc><lastmod>2022-12-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/irene-roberts-on-leukemogenesis-in-infants-with-trisomy-21/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/jiye-liu-on-multiple-myeloma-genome-wide-crispr-cas9-screening-identifies-kdm6a-as-a-modulator-of-daratumumab-sensitivity/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/francesco-maura-on-genomic-determinants-of-resistance-in-newly-diagnosed-multiple-myeloma-treated-with-targeted-immunotherapy/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/abdul-rahman-al-armashi-on-aml-racial-disparities-in-mortality-trends/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/prudence-francis-on-premenopausal-er-positive-breast-cancer/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/anand-jillella-on-acute-promyelocytic-leukemia-a-simplified-patient-care-strategy-to-decrease-early-deaths/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/eileen-boyle-on-multiple-myeloma-sustained-mrd-negativity-in-newly-diagnosed-disease-treated-with-immunotherapy-regimens/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/smita-bhatia-some-clonal-mutations-may-predict-therapy-related-myeloid-neoplasms/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/julie-cote-on-multiple-myeloma-real-world-results-of-autologous-stem-cell-transplantation-in-newly-diagnosed-patients/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/kathryn-tringale-on-primary-cns-lymphoma-initial-treatment-response-in-more-than-500-patients/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/andrew-matthews-on-aml-real-world-effectiveness-of-7-3-intensive-chemotherapy-vs-venetoclax-and-a-hypomethylating-agent/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/eva-hoster-on-mantle-cell-lymphoma-predictive-value-of-minimal-residual-disease-on-efficacy-of-rituximab-maintenance/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/jia-ruan-on-mantle-cell-lymphoma-phase-ii-findings-on-acalabrutinib-lenalidomide-rituximab/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/jorge-cortes-on-cml-efficacy-and-safety-of-vodobatinib/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/elias-jabbour-on-cml-and-all-olverembatinib-overcomes-ponatinib-resistance/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/stephen-ansell-and-patrizia-mondello-new-findings-on-how-the-irf4-gene-shapes-tumor-immunity-in-follicular-lymphoma/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/joseph-schroers-martin-on-posttransplant-lymphoproliferative-disorders-tumor-microenvironment-determinants-of-immunotherapy-response/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/tomohiro-aoki-on-the-spatial-tumor-microenvironment-and-outcome-of-relapsedrefractory-classic-hodgkin-lymphoma/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/andrea-de-censi-on-noninvasive-breast-cancer-10-year-results-on-low-dose-tamoxifen/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/ann-partridge-on-interrupting-breast-cancer-treatment-to-attempt-pregnancy/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/mafalda-oliveira-on-camizestrant-vs-fulvestrant-in-advanced-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/marleen-kok-year-in-review-early-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/francois-clement-bidard-circulating-tumor-cells-may-help-improve-outcomes-in-metastatic-disease/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/erica-mayer-on-metastatic-breast-cancer-new-findings-on-palbociclib-after-prior-cdk46-inhibitor-and-endocrine-therapy/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/tycel-phillips-on-mantle-cell-lymphoma-new-findings-on-glofitamab-monotherapy/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/paolo-caimi-on-dlbcl-outcomes-after-r-ice-chemoimmunotherapy/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/aditya-bardia-on-elacestrant-vs-standard-of-care-endocrine-therapy-in-er-positive-her2-negative-breast-cancer/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/judy-boughey-on-new-findings-on-the-impact-of-breast-conservation-therapy-on-local-recurrence/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/per-karlsson-new-data-on-breast-conserving-surgery-with-or-without-radiotherapy/</loc><lastmod>2022-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/joannie-ivory-and-lisa-carey-on-pam50-subtype-and-21-gene-recurrence-scores-in-younger-and-black-women-with-breast-cancer/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/mariana-chavez-macgregor-on-adjuvant-endocrine-therapy-and-everolimus-in-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/nicholas-turner-on-new-data-on-capivasertib-and-fulvestrant-for-advanced-breast-cancer/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/joseph-sparano-on-long-term-breast-cancer-recurrence-and-survival-data-from-tailorx/</loc><lastmod>2022-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/sara-hurvitz-new-findings-on-neoadjuvant-trastuzumab-deruxtecan-and-anastrozole-in-early-stage-breast-cancer/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/sara-hurvitz-on-updated-survival-results-on-t-dxd-vs-t-dm1-in-metastatic-breast-cancer/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/ruth-oregan-on-evaluation-of-the-breast-cancer-index-in-early-stage-breast-cancer/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/yara-abdou-on-race-and-clinical-outcomes-in-the-rxponder-breast-cancer-trial/</loc><lastmod>2022-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/sumanta-pal-md-on-renal-cell-carcinoma-crispr-engineered-car-t-cells-in-advanced-disease/</loc><lastmod>2022-12-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/roger-li-on-bladder-cancer-boosting-immune-checkpoint-blockade-with-an-oncolytic-adenovirus/</loc><lastmod>2022-12-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/12-december/eunice-wang-on-aml-gemtuzumab-ozogamicin-plus-standard-induction-chemotherapy-improves-outcomes/</loc><lastmod>2022-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/michael-atkins-on-reconciling-differences-in-phase-ii-and-iii-immuno-oncology-trial-data/</loc><lastmod>2022-11-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/kishu-ranjan-on-non-small-cell-lung-cancer-new-findings-on-a-biomarker-and-immunotherapy-resistance/</loc><lastmod>2022-11-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/jonathan-chen-on-nsclc-predicting-response-to-immunotherapy/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/saman-maleki-on-melanoma-reducing-primary-resistance-to-immunotherapy/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/julia-tchou-on-triple-negative-breast-cancer-radiation-boost-plus-pembrolizumab/</loc><lastmod>2022-11-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/antoni-ribas-on-solid-tumors-safety-and-efficacy-of-tcr-t-cell-therapy/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/michael-postow-on-using-the-novel-radiotracer-crefmirlimab-berdoxam-for-imaging-to-assess-immunotherapy-responsiveness/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/david-reardon-on-glioblastoma-a-microbiome-based-vaccine-nivolumab-and-bevacizumab/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/wade-iams-on-nsclc-combining-an-antigen-presenting-cell-activator-with-pembrolizumab/</loc><lastmod>2022-11-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/for-patients-living-with-hiv-and-cancer-new-data-on-immune-checkpoint-inhibitors/</loc><lastmod>2022-11-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/jonathan-rosenberg-on-urothelial-cancer-results-from-ev-103-cohort-k-on-enfortumab-vedotin-and-pembrolizumab/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/11-november/robert-motzer-on-renal-cell-carcinoma-new-results-with-nivolumab-and-ipilimumab/</loc><lastmod>2022-11-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/xuesong-han-on-medicaid-expansion-and-receipt-of-palliative-care-among-individuals-newly-diagnosed-with-advanced-stage-cancers/</loc><lastmod>2022-10-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/samyukta-mullangi-on-predictors-of-compliance-with-payer-led-oncology-clinical-pathways/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/regina-barragan-carrillo-on-breast-cancer-screening-in-the-transgender-population/</loc><lastmod>2022-10-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/jensa-morris-on-oncology-hospitalist-co-management/</loc><lastmod>2022-10-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/sm-qasim-hussaini-on-colon-cancer-treatment-outcomes-and-historical-housing-discrimination/</loc><lastmod>2022-10-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/sandra-wong-on-severe-symptom-reporting-in-patients-with-cancer-who-have-undergone-surgery/</loc><lastmod>2022-10-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/qinjin-fan-on-equitable-lung-cancer-care-and-mortgage-discrimination/</loc><lastmod>2022-10-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/joannie-ivory-on-increasing-participation-of-black-patients-with-cancer-in-clinical-trials/</loc><lastmod>2022-10-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/changchuan-jiang-on-transportation-barriers-delays-in-cancer-care-and-increased-mortality-for-patients-with-cancer/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/christopher-jensen-on-older-adults-with-aml-a-price-paid-for-high-intensity-chemotherapy/</loc><lastmod>2022-10-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/dawn-hershman-on-prophylactic-colony-stimulating-factors-for-neutropenia-improving-clinicians-prescribing-practices/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/justin-barnes-on-medicaid-expansion-and-changes-in-cancer-mortality-rates/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/barbara-eichhorst-on-cll-venetoclax-and-obinutuzumab-with-or-without-ibrutinib-vs-chemoimmunotherapy/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/10-october/john-haanen-on-melanoma-phase-iii-data-on-treatment-with-tumor-infiltrating-lymphocytes-vs-ipilimumab/</loc><lastmod>2022-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/marleen-kok-on-triple-negative-breast-cancer-nivolumab-monotherapy-or-in-combination-therapy/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/laurence-buisseret-on-triple-negative-breast-cancer-chemoimmunotherapy-with-or-without-an-anti-cd73-antibody/</loc><lastmod>2022-09-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/julien-taieb-on-colorectal-cancer-recent-findings-on-avelumab-vs-standard-second-line-chemotherapy/</loc><lastmod>2022-09-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/nizar-tannir-on-rcc-data-on-bempegaldesleukin-plus-nivolumab-vs-tyrosine-kinase-inhibitors-in-untreated-disease/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/tony-mok-on-nsclc-review-of-recent-data-from-the-sunrise-and-orient-31-trials/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/matteo-lambertini-on-oncofertility-care-for-young-women-with-breast-cancer/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/georgina-long-on-melanoma-findings-on-circulating-tumor-dna-disease-recurrence-and-immunotherapy/</loc><lastmod>2022-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/neil-gross-on-cutaneous-squamous-cell-carcinoma-recent-findings-on-cemiplimab/</loc><lastmod>2022-09-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/gerard-zalcman-on-non-small-cell-lung-cancer-phase-iii-trial-findings-on-nivolumab-and-ipilimumab/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/jean-pascal-machiels-on-head-and-neck-cancer-recent-data-on-pembrolizumab-and-chemoradiation-therapy/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/neal-shore-on-prostate-cancer-biomarker-analysis-enzalutamide-and-active-surveillance/</loc><lastmod>2022-09-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/rcc-recent-phase-iii-data-on-cabozantinib-nivolumab-and-ipilimumab-from-the-cosmic-313-trial/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/axel-bex-on-renal-cell-carcinoma-phase-iii-results-with-atezolizumab-as-adjuvant-therapy/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/martin-reck-md-phd-on-nsclc-new-findings-on-cemiplimab-nivolumab-and-ipilimumab/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/richard-finn-on-hepatocellular-carcinoma-recent-data-on-lenvatinib-plus-pembrolizumab/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/rcc-review-of-two-key-abstracts-on-belzutifan-plus-cabozantinib-and-pembrolizumab-plus-lenvatinib/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/charles-swanton-on-non-small-cell-lung-cancer-induced-by-air-pollution/</loc><lastmod>2022-09-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/marinde-bond-on-colorectal-liver-metastases-folfoxfolfiri-bevacizumab-and-panitumumab/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/sapna-patel-on-melanoma-new-data-on-pembrolizumab-adjuvant-vs-neoadjuvant/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/antonio-marra-on-metastatic-breast-cancer-patterns-of-genomic-instability-and-their-effect-on-treatment/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/ana-oaknin-on-cervical-cancer-safety-and-efficacy-results-with-nivolumab-and-ipilimumab/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/ana-oaknin-on-cervical-cancer-new-findings-on-cemiplimab-in-recurrent-or-metastatic-disease/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/christelle-de-la-fouchardiere-on-pancreatic-ductal-adenocarcinoma-phase-iii-trial-results-with-gemcitabine-plus-paclitaxel/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/bernd-kasper-on-desmoid-tumors-results-on-nirogacestat-vs-placebo/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/09-september/paul-disilvestro-on-ovarian-cancer-new-data-on-olaparib-in-newly-diagnosed-disease/</loc><lastmod>2022-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/08-august/anna-sureda-on-large-b-cell-lymphoma-new-data-on-axicabtagene-ciloleucel-vs-standard-of-care/</loc><lastmod>2022-08-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/08-august/harry-erba-on-aml-new-data-on-quizartinib-plus-standard-chemotherapy/</loc><lastmod>2022-08-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/07-july/nicholas-short-on-all-updated-phase-ii-study-results-on-ponatinib-and-blinatumomab/</loc><lastmod>2022-07-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/07-july/rami-manochakian-on-nsclc-clinical-implications-of-findings-on-nivolumab-plus-chemotherapy/</loc><lastmod>2022-07-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/07-july/bradley-monk-on-ovarian-cancer-new-data-on-rucaparib-monotherapy-vs-placebo-as-maintenance-treatment/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/07-july/michael-dickinson-on-dlbcl-phase-ii-expansion-results-on-glofitamab/</loc><lastmod>2022-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/maxwell-oluwole-akanbi-on-lung-cancer-the-effect-of-screening-on-the-incidence-of-advanced-disease/</loc><lastmod>2022-06-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/gilberto-de-lima-lopes-and-oladimeji-akinboro-on-nsclc-outcomes-of-anti-pd-l-1-therapy-with-or-without-chemotherapy-in-the-first-line-setting/</loc><lastmod>2022-06-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/martin-mccabe-on-ewing-sarcoma-assessment-of-topotecan-cyclophosphamide-and-high-dose-ifosfamide/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/akihiro-ohba-on-biliary-tract-cancer-new-findings-on-fam-trastuzumab-deruxtecan-nxki/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/rainer-fietkau-on-pancreatic-cancer-initial-trial-results-on-sequential-chemotherapy-and-chemoradiotherapy/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/etienne-brain-on-breast-cancer-adjuvant-endocrine-therapy-with-or-without-chemotherapy-in-older-patients/</loc><lastmod>2022-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ann-partridge-and-veronique-dieras-on-the-future-of-cytotoxic-therapy-antibody-drug-conjugates/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/gilberto-de-lima-lopes-and-matthew-krebs-on-nsclc-updated-results-with-amivantamab-vmjw/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ann-partridge-and-ian-krop-on-metastatic-breast-cancer-new-early-data-on-patritumab-deruxtecan/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/erika-hamilton-on-metastatic-breast-cancer-safety-follow-up-data-on-t-dxd-vs-t-dm1/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/michael-overman-and-smitha-krishnamurthi-on-ras-wild-type-metastatic-colorectal-cancer-refining-treatment-strategy/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/apar-kishor-ganti-on-sclc-comparing-quality-of-life-with-once-and-twice-daily-thoracic-radiotherapy/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/eunice-wang-on-aml-long-term-results-with-crenolanib-plus-chemotherapy/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/lisa-carey-and-shanu-modi-on-breast-cancer-is-t-dxd-a-potential-new-standard-of-care-for-her2-low-disease/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/gilberto-de-lima-lopes-and-karen-reckamp-on-nsclc-overall-survival-results-with-ramucirumab-plus-pembrolizumab-vs-standard-of-care/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/andrew-zelenetz-and-michael-wang-on-mantle-cell-lymphoma-new-data-on-ibrutinib-in-combination-with-bendamustinerituximab-and-rituximab-maintenance/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ann-partridge-and-kevin-kalinsky-on-breast-cancer-latest-findings-on-fulvestrant-or-exemestane-with-or-without-ribociclib/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ursula-matulonis-and-domenica-lorusso-on-gynecologic-cancers-new-findings-on-trabectedin-vs-clinician-s-choice-chemotherapy/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/nancy-davidson-in-it-for-the-long-haul-outcomes-in-hormone-receptor-positive-breast-cancer/</loc><lastmod>2022-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/clifford-hudis-and-karen-knudsen-on-how-asco-and-the-american-cancer-society-are-collaborating-to-help-patients-with-cancer/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/nabil-saba-on-head-and-neck-squamous-cell-carcinoma-phase-ii-findings-on-pembrolizumab-and-cabozantinib/</loc><lastmod>2022-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/jonathan-rosenberg-and-thomas-powles-on-renal-cell-carcinoma-new-data-on-pembrolizumab-plus-axitinib-vs-sunitinib-as-first-line-therapy/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/thomas-powles-and-jonathan-rosenberg-on-urothelial-carcinoma-long-term-outcomes-with-enfortumab-vedotin-ejfv-vs-chemotherapy/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/manali-patel-on-equitable-value-based-care-the-effectiveness-of-community-health-worker-led-interventions/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/timothy-whelan-when-can-radiotherapy-be-avoided-after-breast-conserving-surgery/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/neal-shore-on-germline-genetic-testing-and-its-impact-on-prostate-cancer-clinical-decision-making/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/sue-yom-on-oropharyngeal-cancer-and-the-feasibility-of-a-cell-free-dna-plasma-assay/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/jenny-guadamuz-on-racial-and-socioeconomic-disparities-in-telemedicine-use-among-us-patients-with-cancer-during-the-covid-19-pandemic/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/michael-overman-and-jeanne-tie-on-colon-cancer-guiding-adjuvant-chemotherapy-with-ctdna/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/tara-sanft-on-how-diet-and-exercise-may-affect-completion-of-chemotherapy-for-breast-cancer/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/alicia-morgans-and-michael-hofman-on-prostate-cancer-new-data-on-lupsma-vs-cabazitaxel/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/alicia-morgans-and-ian-davis-on-prostate-cancer-updated-overall-survival-outcomes-with-enzalutamide/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/sumanta-pal-on-urothelial-carcinoma-new-results-on-cabozantinib-plus-atezolizumab/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/richard-finn-on-advanced-breast-cancer-new-data-on-palbociclib-plus-letrozole-from-paloma-2/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ursula-matulonis-and-ignace-vergote-on-cervical-cancer-interim-results-on-tisotumab-vedotin-tftv-plus-pembrolizumab/</loc><lastmod>2022-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/georgina-long-on-melanoma-distant-metastasis-free-survival-with-adjuvant-pembrolizumab/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/alfredo-carrato-on-pancreatic-cancer-nab-paclitaxel-gemcitabine-and-folfox-for-metastatic-disease/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/mairead-mcnamara-on-neuroendocrine-carcinoma-findings-on-liposomal-irinotecan-plus-fluorouracil-and-folinic-acid-or-docetaxel/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/robert-hugh-jones-on-breast-cancer-updated-overall-survival-data-on-fulvestrant-plus-capivasertib/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/georgina-long-on-melanoma-new-data-on-pembrolizumab-dabrafenib-and-trametinib/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/shilpa-gupta-on-urothelial-cancer-defining-who-is-platinum-ineligible/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/courtney-dinardo-and-stephane-de-botto-on-aml-new-data-on-idh2-mutant-alleles-enasidenib-and-conventional-care/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/carryn-anderson-on-head-and-neck-cancer-new-data-on-avasopasem-manganese-for-oral-mucositis/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/stephen-m-ansell-on-hodgkin-lymphoma-an-updated-analysis-on-first-line-brentuximab-vedotin-plus-chemotherapy/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ursula-a-matulonis-and-nicoletta-colombo-on-ovarian-cancer-overall-survival-data-on-relacorilant-plus-nab-paclitaxel/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/courtney-d-dinardo-and-jorge-e-cortes-on-cml-new-efficacy-and-safety-results-for-asciminib/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/lisa-a-carey-and-hope-s-rugo-on-advanced-breast-cancer-new-data-on-sacituzumab-govitecan-hziy-vs-treatment-of-physician-s-choice/</loc><lastmod>2022-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/michael-j-overman-and-takayuki-yoshino-on-colorectal-cancer-phase-iii-data-on-panitumumab-or-bevacizumab-plus-mfolfox6/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/benoit-you-on-ovarian-cancer-who-benefits-from-bevacizumab-in-the-first-line-setting/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/stephanie-walker-on-increasing-the-participation-of-black-women-with-metastatic-breast-cancer-in-clinical-trials/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/sriram-yennu-on-cancer-related-fatigue-is-open-labeled-placebo-an-effective-treatment/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/karim-chamie-on-bladder-cancer-final-results-on-n-803-and-bacillus-calmette-guerin/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/paul-g-richardson-on-multiple-myeloma-new-data-on-lenalidomide-bortezomib-and-dexamethasone-with-or-without-asct/</loc><lastmod>2022-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/ruben-a-mesa-on-myelofibrosis-phase-iii-results-on-momelotinib-vs-danazol/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/06-june/pamela-l-kunz-on-pancreatic-neuroendocrine-tumors-a-final-analysis-of-temozolomide-or-temozolomide-plus-capecitabine/</loc><lastmod>2022-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/smitha-krishnamurthi-on-colorectal-cancer-treatment-updates/</loc><lastmod>2022-05-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/matthew-meyerson-on-lung-adenocarcinoma-somatic-mutations-germline-risk-and-ancestry/</loc><lastmod>2022-05-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/pedro-ramirez-on-hysterectomy-for-early-cervical-cancer-new-findings-on-open-vs-minimally-invasive-surgery/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/ursula-matulonis-on-ovarian-cancer-new-data-on-mirvetuximab-soravtansine/</loc><lastmod>2022-05-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/nickolas-papadopoulos-on-multicancer-early-detection-opportunities-and-challenges/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/maria-alma-rodriguez-on-vaccinations-for-patients-with-cancer-and-cancer-survivors/</loc><lastmod>2022-05-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/ara-klijian-on-lung-cancer-operability-in-patients-with-poor-pulmonary-function/</loc><lastmod>2022-05-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/christine-iacobuzio-donahue-on-pancreatic-cancer-novel-insights-into-genetics-and-evolution/</loc><lastmod>2022-05-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/05-may/charles-sawyers-on-transforming-patient-outcomes-the-future-of-cancer-research/</loc><lastmod>2022-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/matthew-smith-on-prostate-cancer-phase-iii-data-on-darolutamide-androgen-deprivation-and-docetaxel/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/priscilla-brastianos-on-cns-metastases-understanding-their-evolution-and-the-clinical-implications/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/timothy-yap-on-ovarian-breast-pancreatic-and-prostate-cancers-with-genetic-mutations-a-first-in-human-trial-of-azd5305/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/timothy-yap-on-developing-novel-therapeutic-strategies-to-target-dna-damage-response-in-the-clinic/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/timothy-yap-on-advanced-solid-tumors-with-dna-damage-response-defects-early-data-on-elimusertib/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/gulam-manji-on-gastric-and-gastroesophageal-junction-adenocarcinomas-new-data-on-pembrolizumab-plus-capecitabine-and-oxaliplatin/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/lillian-siu-on-looking-toward-the-future-of-clinical-research-and-clinical-trials/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/marcia-cruz-correa-on-a-vision-for-the-future-of-cancer-research-and-treatment/</loc><lastmod>2022-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/cheryl-willman-on-cancer-genomic-sequencing-in-tribal-nations-of-the-american-southwest/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/zev-wainberg-on-gastroesophageal-junction-adenocarcinoma-early-results-with-anti-cd39-antibody-plus-chemoimmunotherapy/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/david-barbie-on-mesothelioma-activating-the-sting-pathway-may-promote-antitumor-immunity/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/jia-luo-on-nsclc-clinicopathologic-and-molecular-characterization-of-kras-g12d-mutated-disease/</loc><lastmod>2022-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/ann-lacasce-on-relapsedrefractory-indolent-follicular-lymphoma-management-updates/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/genevieve-boland-on-advanced-melanoma-best-management-practices/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/gautam-mehta-on-precision-oncology-an-overview-of-the-accelerated-approval-program/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/nicolas-girard-on-nsclc-new-data-on-event-free-survival-with-nivolumab-plus-platinum-doublet-chemotherapy/</loc><lastmod>2022-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/maria-elena-martinez-on-colorectal-cancer-screening-in-underserved-populations/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/electra-paskett-on-social-stresses-and-cancer-treatment-an-expert-perspective/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/meenakshi-anurag-on-breast-cancer-new-data-on-combining-anastrozole-and-fulvestrant/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/ivan-marquez-rodas-on-advanced-melanoma-efficacy-of-intratumoral-bo-112-with-systemic-pembrolizumab/</loc><lastmod>2022-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/silvia-formenti-on-adapting-radiation-therapy-to-immune-checkpoint-blockade/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/tina-cascone-on-nsclc-new-findings-from-the-neocoast-trial-on-durvalumab-based-therapy/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/patricia-lorusso-on-targeting-kras-clinical-successes-and-challenges/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/klaus-pantel-on-liquid-biopsy-research-opportunities-and-challenges/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/ari-vanderwalde-on-melanoma-new-data-on-ipilimumab-and-nivolumab/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/vivek-subbiah-on-designing-clinical-trials-for-precision-oncology/</loc><lastmod>2022-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/benoit-you-on-endometrial-cancer-new-data-on-combining-olaparib-cyclophosphamide-and-metformin/</loc><lastmod>2022-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/josh-neman-on-brain-metastasis-a-neuroscience-perspective/</loc><lastmod>2022-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/alana-welm-on-metastatic-outgrowth-in-the-lungs-identifying-a-new-immune-mediated-pathway/</loc><lastmod>2022-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/yaqi-zhao-on-all-molecular-profile-and-efficacy-of-inotuzumab-ozogamicin/</loc><lastmod>2022-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/john-haanen-on-solid-tumors-early-study-results-on-car-t-cells-and-the-carvac-vaccine-strategy/</loc><lastmod>2022-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/reid-ness-on-colorectal-cancer-updates-in-screening-recommendations/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/thomas-flaig-on-bladder-cancer-new-treatment-options/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/margaret-tempero-on-pancreatic-adenocarcinoma-emerging-systemic-therapy-options/</loc><lastmod>2022-04-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/04-april/julio-pow-sang-on-nonmetastatic-prostate-cancer-update-on-best-management-practices/</loc><lastmod>2022-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/xin-gao-on-prostate-cancer-early-phase-results-on-bavdegalutamide/</loc><lastmod>2022-03-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/tanya-dorff-on-prostate-cancer-early-data-on-psca-targeted-car-t-cell-therapy/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/neil-fleshner-on-high-risk-prostate-cancer-new-data-on-abiraterone-and-cabazitaxel/</loc><lastmod>2022-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/sue-yom-on-thyroid-cancer-expert-perspective-on-the-state-of-the-field/</loc><lastmod>2022-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/elizabeth-cash-on-addressing-the-psychological-aspects-of-head-and-neck-cancer/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/michelle-mierzwa-on-oropharyngeal-cancer-early-results-on-de-escalated-radiotherapy/</loc><lastmod>2022-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/david-hong-on-new-findings-on-tisotumab-vedotin-tftv-in-patients-with-head-and-neck-squamous-cell-carcinoma/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/peter-zeng-immune-cell-signature-predicts-survival-in-hpv-associated-head-and-neck-cancer/</loc><lastmod>2022-03-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/nancy-lee-toward-personalization-of-radiotherapy-for-hpv-related-oropharyngeal-carcinoma/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/glenn-hanna-on-oropharyngeal-squamous-cell-carcinoma-detecting-occult-recurrence/</loc><lastmod>2022-03-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/sumanta-k-pal-md-on-advances-in-genitourinary-cancer-treatment-expert-perspective/</loc><lastmod>2022-03-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/petros-grivas-on-urothelial-cancer-new-data-on-sacituzumab-govitecan-hziy-and-pembrolizumab/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/alicia-morgans-on-prostate-cancer-profiles-of-patients-and-their-journeys/</loc><lastmod>2022-03-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/massimo-di-maio-on-urothelial-cancer-data-on-niraparib-and-best-supportive-care-as-maintenance-therapy/</loc><lastmod>2022-03-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/toni-choueiri-on-renal-cell-carcinoma-follow-up-data-on-pembrolizumab/</loc><lastmod>2022-03-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/jonathan-rosenberg-on-urothelial-cancer-new-conclusions-about-durvalumab-plus-olaparib/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/kim-nguyen-chi-on-prostate-cancer-new-findings-on-niraparib-abiraterone-and-prednisone/</loc><lastmod>2022-03-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/karim-fizazi-on-prostate-cancer-early-results-from-the-cypides-trial-of-odm-208/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/karen-knudsen-on-addressing-disparities-in-genitourinary-cancers/</loc><lastmod>2022-03-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/wesley-yip-on-urothelial-carcinoma-new-data-on-neoadjuvant-gemcitabine-and-cisplatin/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/simon-crabb-on-urothelial-carcinoma-switch-maintenance-therapy-with-rucaparib-following-chemotherapy/</loc><lastmod>2022-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/axel-merseburger-on-prostate-cancer-new-data-from-the-preside-trial-on-enzalutamide-docetaxel-and-prednisolone/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/fred-saad-on-prostate-cancer-results-from-the-propel-trial-on-olaparib-and-abiraterone/</loc><lastmod>2022-03-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/03-march/phillip-pifer-on-head-and-neck-squamous-cell-carcinoma-new-data-on-focal-adhesion-kinase/</loc><lastmod>2022-03-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/axel-bex-on-renal-cell-carcinoma-new-findings-from-the-neoavax-trial-on-avelumab-and-axitinib/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/daniel-petrylak-on-bladder-cancer-study-ev-103-cohort-h-findings-on-enfortumab-vedotin-ejfv/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/alfredo-berruti-on-adrenocortical-carcinoma-preliminary-study-results-with-adjuvant-mitotane/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/hielke-martijn-de-vries-on-penile-cancer-new-data-on-atezolizumab-and-radiotherapy/</loc><lastmod>2022-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/matthew-zibelman-on-renal-cell-carcinoma-new-results-on-combination-of-nivolumab-and-axitinib/</loc><lastmod>2022-02-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/sara-hurvitz-on-her2-positive-metastatic-breast-cancer-t-dxd-vs-t-dm1/</loc><lastmod>2022-02-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/narjust-duma-on-advanced-nsclc-reducing-racial-disparities-in-outcomes/</loc><lastmod>2022-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/mirek-fatyga-on-nsclc-new-data-on-stereotactic-body-radiotherapy-vs-conventionally-fractionated-radiotherapy/</loc><lastmod>2022-02-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/pranshu-mohindra-on-nsclc-benefits-of-intensity-modulated-proton-therapy-based-reirradiation/</loc><lastmod>2022-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/thierry-andre-on-esophagogastric-adenocarcinoma-new-findings-on-nivolumab-and-ipilimumab/</loc><lastmod>2022-02-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/romain-cohen-on-metastatic-colorectal-cancer-long-term-follow-up-on-nivolumab-plus-ipilimumab/</loc><lastmod>2022-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/melissa-amy-lumish-on-rectal-cancer-pd-1-blockade-for-mismatch-repair-deficient-disease/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/02-february/van-morris-on-metastatic-colorectal-cancer-early-trial-results-on-encorafenib-cetuximab-and-nivolumab/</loc><lastmod>2022-02-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/gabriel-brooks-on-colorectal-cancer-expert-perspective-on-the-need-to-deintensify-oxaliplatin/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/anthony-el-khoueiry-on-hepatocellular-carcinoma-expert-perspective-on-novel-additive-strategies/</loc><lastmod>2022-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/francesca-battaglin-on-upper-gi-cancers-and-the-potential-value-of-recurrent-neoantigens/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/zev-wainberg-on-gastric-or-gastroesophageal-junction-adenocarcinoma-follow-up-data-on-pembrolizumab-and-chemotherapy/</loc><lastmod>2022-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/carolyn-presley-on-dementia-in-patients-treated-for-thoracic-cancer/</loc><lastmod>2022-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/julia-rotow-on-patient-selection-in-treating-thoracic-cancers-looking-to-driver-mutations-and-biomarkers/</loc><lastmod>2022-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/matthew-s-davids-md-on-younger-patients-with-cll-ibrutinib-plus-fludarabine-cyclophosphamide-and-rituximab-as-initial-therapy/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/afsaneh-barzi-on-colorectal-cancer-early-data-on-regorafenib-and-pembrolizumab/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/tanios-bekaii-saab-on-pancreatic-and-other-tumors-with-kras-g12c-mutation-updated-data-on-use-of-adagrasib/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/ghassan-abou-alfa-on-hepatocellular-carcinoma-open-label-trial-of-tremelimumab-and-durvalumab/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/nilofer-saba-azad-on-novel-treatment-combinations-under-study-in-biliary-tract-cancers/</loc><lastmod>2022-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/heinz-josef-lenz-on-colorectal-cancer-update-from-the-checkmate-9x8-trial-on-nivolumab-mfolfox6-and-bevacizumab/</loc><lastmod>2022-01-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/yu-sunakawa-on-gastric-cancer-predicting-treatment-related-toxicities-with-biomarkers/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/kohei-shitara-on-gastric-and-esophageal-cancers-long-term-follow-up-on-nivolumab-plus-chemotherapy/</loc><lastmod>2022-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/yevgeniy-semenov-on-cutaneous-immune-related-adverse-events-and-response-to-immune-checkpoint-inhibitors/</loc><lastmod>2022-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/tycel-phillips-on-marginal-zone-lymphoma-efficacy-and-safety-of-parsaclisib/</loc><lastmod>2022-01-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/mehmet-altan-on-solid-tumors-interim-safety-and-efficacy-results-on-nktr-255-plus-cetuximab/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/lynda-chin-on-the-landscape-and-future-of-digital-medicine/</loc><lastmod>2022-01-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/meredith-regan-on-early-breast-cancer-updated-results-from-the-text-and-soft-trials/</loc><lastmod>2022-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/elizabeth-mittendorf-on-making-strides-in-managing-triple-negative-breast-cancer/</loc><lastmod>2022-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/romanos-sklavenitis-pistofidis-on-smoldering-myeloma-identifying-biomarkers-of-response-to-immunotherapy/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/anil-aktas-samur-on-identifying-low-risk-smoldering-multiple-myeloma/</loc><lastmod>2022-01-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/musa-yilmaz-on-flt3-itd-mutated-aml-findings-on-quizartinib-with-decitabine-and-venetoclax/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/manali-kamdar-on-large-b-cell-lymphoma-lisocabtagene-maraleucel-vs-the-standard-of-care/</loc><lastmod>2022-01-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/banu-arun-on-fine-tuning-risk-assessment-and-risk-reduction-in-breast-cancer/</loc><lastmod>2022-01-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/patrick-hwu-and-mary-dean-on-what-s-ahead-for-cancer-immunology-and-sitc/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/joe-schroers-martin-on-follicular-lymphoma-precursor-mutations-may-be-detectable-years-before-diagnosis/</loc><lastmod>2022-01-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/nikhil-munshi-on-covid-19-vaccine-effectiveness-in-patients-with-multiple-myeloma/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2022/01-january/ann-partridge-on-sabcs-meeting-highlights-expert-perspective/</loc><lastmod>2022-01-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/sangeetha-venugopal-on-secondary-aml-impact-of-front-line-treatment-approach/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/andrew-matthews-on-aml-cpx-351-vs-venetoclaxazacitidine-for-initial-therapy/</loc><lastmod>2021-12-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/lisa-carey-on-hr-positive-and-her2-negative-advanced-breast-cancer-overall-survival-by-subtype-across-three-monaleesa-studies/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/charles-coombes-on-hormone-receptor-positive-her2-negative-breast-cancer-use-of-samuraciclib-plus-fulvestrant/</loc><lastmod>2021-12-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/alba-rodriguez-meira-on-tp53-mutated-leukemic-transformation-in-myeloproliferative-neoplasms/</loc><lastmod>2021-12-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/leslie-kean-on-bone-marrow-transplantation-using-abatacept-to-prevent-graft-vs-host-disease/</loc><lastmod>2021-12-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/eunice-wang-on-flt3-mutated-aml-gilteritinib-and-azacitidine-for-intensive-induction-chemotherapy-ineligible-patients/</loc><lastmod>2021-12-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/roni-shouval-on-tp53-mutant-large-b-cell-lymphoma-and-car-t-cell-therapy/</loc><lastmod>2021-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/michael-bishop-on-aggressive-b-cell-nhl-tisagenlecleucel-vs-standard-of-care-as-second-line-therapy/</loc><lastmod>2021-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/carsten-utoft-niemann-on-cll-time-limited-venetoclax-and-ibrutinib-for-patients-with-relapsed-or-refractory-disease/</loc><lastmod>2021-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/masayuki-umeda-on-pediatric-aml-identifying-a-key-subtype-defining-lesion/</loc><lastmod>2021-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/tarek-mouhieddine-on-relapsedrefractory-multiple-myeloma-and-bispecific-antibodies/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/talha-bada-on-tp53-mutated-aml-and-the-impact-of-allogeneic-stem-cell-transplantation-on-survival/</loc><lastmod>2021-12-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/daniel-ermann-on-dlbcl-outcomes-with-consolidative-radiation-therapy/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/l-elizabeth-budde-on-relapsedrefractory-follicular-lymphoma-early-results-on-mosunetuzumab-monotherapy/</loc><lastmod>2021-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/patricia-ganz-on-early-breast-cancer-olaparib-chemotherapy-and-quality-of-life/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/komal-jhaveri-on-triple-negative-and-metastatic-breast-cancers-new-data-on-neratinib-fulvestrant-and-trastuzumab/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/paolo-ghia-on-cll-new-data-on-treatment-with-ibrutinib-plus-venetoclax/</loc><lastmod>2021-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/michael-gnant-on-hr-positive-her2-negative-early-breast-cancer-trial-results-with-palbociclib-treatment/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/francois-clement-bidard-on-metastatic-breast-cancer-endocrine-therapy-and-palbociclib/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/javier-cortes-on-previously-untreated-triple-negative-breast-cancer-pembrolizumab-plus-chemotherapy/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/kevin-kalinsky-on-hr-positive-her2-negative-breast-cancer-endocrine-therapy-and-chemotherapy/</loc><lastmod>2021-12-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/peter-schmid-on-early-stage-triple-negative-breast-cancer-neoadjuvant-treatment-with-pembrolizumab-and-chemotherapy/</loc><lastmod>2021-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/sean-khozin-on-delivering-precision-cancer-care-in-the-era-of-digital-medicine/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/jeffrey-weber-on-coronavirus-cancer-and-immunotherapy-navigating-clinical-trials-and-treatment/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/john-kirkwood-on-melanoma-early-study-results-on-vidutolimod-and-pembrolizumab/</loc><lastmod>2021-12-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/hannah-dzimitrowicz-on-covid-19-vaccination-in-patients-with-cancer-receiving-immune-checkpoint-inhibitors/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/hans-wildiers-on-metastatic-breast-cancer-comparing-addition-of-eftilagimod-alpha-vs-placebo-to-paclitaxel/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/yuki-muroyama-on-a-novel-marker-of-clinical-response-to-pd-1-blockade-under-study/</loc><lastmod>2021-12-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/12-december/emily-keung-on-interactions-of-sarcoma-immune-infiltrates-and-checkpoint-blockade/</loc><lastmod>2021-12-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/kim-reiss-on-her2-overexpressing-solid-tumors-first-in-human-study-of-anti-her2-car-macrophages/</loc><lastmod>2021-11-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/stephanie-schmidt-on-nsclc-the-immunomodulatory-impact-of-neoadjuvant-chemotherapy-and-immune-based-treatments/</loc><lastmod>2021-11-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/yongbae-kim-on-node-irradiation-in-women-with-node-positive-breast-cancer/</loc><lastmod>2021-11-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/ronald-go-on-managing-histiocytic-neoplasms-new-nccn-guidelines/</loc><lastmod>2021-11-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/shaji-kumar-on-newly-diagnosed-multiple-myeloma-how-many-drugs-are-enough/</loc><lastmod>2021-11-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/jennifer-woyach-on-cll-sll-using-minimal-residual-disease-assessment-in-clinical-practice/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/alice-mims-on-aml-updates-on-managing-newly-diagnosed-disease/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/howard-sandler-on-prostate-cancer-highlights-an-expert-perspective/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/daniel-hayes-on-liquid-biopsies-to-detect-and-monitor-oligometastases/</loc><lastmod>2021-11-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/shauna-campbell-on-head-and-neck-cancer-toxicity-associated-with-hypofractionated-imrt/</loc><lastmod>2021-11-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/erin-murphy-on-low-grade-glioma-neurocognitive-function-following-treatment/</loc><lastmod>2021-11-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/amar-kishan-on-prostate-cancer-impact-of-androgen-deprivation-therapy-with-radiotherapy/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/matthew-manning-on-resolving-racial-disparities-in-the-treatment-of-breast-and-lung-cancers/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/karen-winkfield-on-digital-health-to-improve-patient-outcomes-and-experience/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/mark-buyyounouski-on-prostate-cancer-hypofractionated-vs-conventional-radiotherapy-after-surgery/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/11-november/benjamin-movsas-on-prostate-cancer-patient-reported-outcomes-on-radiotherapy-and-androgen-suppression/</loc><lastmod>2021-11-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/morgan-lichtenstein-on-insurance-plan-prior-authorization-and-time-to-receipt-of-oral-anticancer-drugs/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/daniel-ma-on-hpv-associated-oropharyngeal-squamous-cell-carcinoma-comparing-longer-and-shorter-courses-of-radiotherapy/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/c-jillian-tsai-on-using-radiotherapy-to-thwart-tumor-growth-in-advanced-cancers/</loc><lastmod>2021-10-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/aadel-chaudhuri-on-personalizing-treatment-for-oligometastatic-cancer/</loc><lastmod>2021-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/youssef-zeidan-on-her2-positive-breast-cancer-treatment-related-cardiotoxicity/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/david-palma-on-hpv-associated-oropharyngeal-squamous-cell-carcinoma-radiotherapy-vs-surgery/</loc><lastmod>2021-10-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/diana-shi-on-idh-mutant-gliomas-de-novo-pyrmidine-synthesis-inhibitor-under-study/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/robert-olson-on-oligometastases-new-data-on-stereotactic-ablative-radiotherapy/</loc><lastmod>2021-10-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/katherine-reeder-hayes-on-geography-breast-cancer-treatment-and-racial-disparities/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/aakash-desai-on-the-precision-oncology-promise/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/jenny-jing-xiang-on-improving-clinical-trial-recruitment-with-a-universal-prescreening-protocol/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/hope-rugo-on-triple-negative-breast-cancer-treatment-findings-from-keynote-355-on-pembrolizumab-and-chemotherapy/</loc><lastmod>2021-10-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/susana-banerjee-on-ovarian-cancer-novel-combination-therapy-under-study/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/susana-banerjee-on-ovarian-fallopian-tube-or-primary-peritoneal-adenocarcinoma-treatment-findings-from-the-eortc-1508-trial/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/dieter-horsch-for-patients-with-bronchopulmonary-neuroendocrine-tumors-lanreotide-autogel-may-be-beneficial/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/filippo-pietrantonio-and-federica-morano-on-colorectal-cancer-and-the-maya-trial-strategy-temozolomide-ipilimumab-and-nivolumab/</loc><lastmod>2021-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/neeraj-agarwal-on-advanced-prostate-cancer-data-on-cabozantinib-plus-atezolizumab/</loc><lastmod>2021-10-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/thomas-powles-on-urothelial-carcinoma-erdafitinib-cetrelimab-and-fgfr-alterations/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/joseph-unger-on-the-impact-of-nci-sponsored-treatment-trials/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/jonathan-lim-the-future-of-the-oncology-workforce-since-the-covid-19-pandemic/</loc><lastmod>2021-10-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/john-cox-on-reshaping-practice-models-to-better-care-for-patients-with-cancer/</loc><lastmod>2021-10-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/divya-gupta-on-improving-advance-care-planning-conversations-with-patients/</loc><lastmod>2021-10-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/divya-parikh-on-improving-care-documentation-with-a-patient-conversation-guide/</loc><lastmod>2021-10-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/courtney-williams-on-cancer-survivors-working-together-to-improve-patient-adherence/</loc><lastmod>2021-10-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/benjamin-corn-on-integrating-hope-into-clinical-oncology/</loc><lastmod>2021-10-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/10-october/jenny-seligmann-on-colorectal-cancer-adavosertib-compared-with-active-monitoring/</loc><lastmod>2021-10-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/luis-aguirre-on-chronic-myelomonocytic-leukemia-keys-to-assessment-and-treatment/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/kieron-dunleavy-update-on-primary-mediastinal-b-cell-lymphoma/</loc><lastmod>2021-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/sarah-mougalian-on-a-next-day-access-program-for-patients-with-cancer/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/leticia-nogueira-on-the-association-of-medicaid-expansion-and-early-mortality-following-lung-cancer-surgery/</loc><lastmod>2021-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/nasser-altorki-on-nsclc-adjuvant-atezolizumab-for-stage-ib-iiia-disease/</loc><lastmod>2021-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/manali-patel-on-community-based-intervention-and-cancer-care-disparity/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/tina-shih-on-trends-in-total-and-out-of-pocket-costs-of-cancer-care/</loc><lastmod>2021-09-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/saad-usmani-on-multiple-myeloma-updated-results-from-the-cartitude-1-study-of-ciltacabtagene-autoleucel/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/robin-cornelissen-on-her2-exon-20-mutated-nsclc-poziotinib-in-treatment-naive-disease/</loc><lastmod>2021-09-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/benjamin-besse-on-nsclc-a-vaccine-under-study-to-treat-advanced-disease/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/karim-fizazi-on-prostate-cancer-newly-reported-survival-rates-with-abiraterone-docetaxel-and-prednisone/</loc><lastmod>2021-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/gerhardt-attard-on-prostate-cancer-abiraterone-and-prednisolone-in-the-stampede-protocol/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/naveen-vasudev-on-rcc-changing-the-dosing-schedule-of-ipilimumab-plus-nivolumab/</loc><lastmod>2021-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/toni-choueiri-on-renal-cell-carcinoma-quality-of-life-data-from-keynote-564-on-pembrolizumab-vs-placebo/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/gabriel-hortobagyi-on-advanced-breast-cancer-treated-with-endocrine-therapy-and-ribociclib/</loc><lastmod>2021-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/jason-luke-on-melanoma-keynote-716-trial-of-pembrolizumab-vs-placebo/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/javier-cortes-on-her2-positive-breast-cancer-trastuzumab-deruxtecan-vs-trastuzumab-emtansine/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/nicoletta-colombo-md-on-cervical-cancer-keynote-826-trial-of-pembrolizumab-plus-chemotherapy/</loc><lastmod>2021-09-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/helena-earl-on-her2-positive-early-breast-cancer-a-meta-analysis-of-trastuzumab-trials/</loc><lastmod>2021-09-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/curtis-lachowiez-on-aml-venetoclax-combined-with-flag-ida/</loc><lastmod>2021-09-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/prasad-adusumilli-on-car-t-cell-therapy-for-mesothelioma/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/jamie-studts-on-the-stigma-of-lung-cancer/</loc><lastmod>2021-09-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/christine-berg-on-lung-cancer-deaths-attributable-to-air-pollution/</loc><lastmod>2021-09-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/alex-adjei-on-disparities-in-lung-cancer-care-the-global-burden/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/09-september/matthew-smeltzer-on-international-lung-cancer-clinical-trials-the-impact-of-covid-19/</loc><lastmod>2021-09-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/muhamed-baljevic-on-multiple-myeloma-review-of-novel-management-strategies/</loc><lastmod>2021-08-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/nina-shah-on-newly-diagnosed-multiple-myeloma-novel-combination-therapies/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/steven-horwitz-on-advanced-stage-mycosis-fungoides-and-sezary-syndrome/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/james-armitage-on-advanced-hodgkin-lymphoma-choosing-among-beacopp-a-avd-and-checkpoint-inhibitors/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/sonali-smith-can-cns-prophylaxis-prevent-secondary-high-grade-b-cell-lymphomas/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/bruce-cheson-and-stephen-ansell-on-non-hodgkin-and-follicular-lymphomas-integrating-non-car-t-based-treatments/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/alison-moskowitz-on-abvd-in-hodgkin-lymphoma-adding-brentuximab-vedotin-and-checkpoint-inhibitors-to-standard-treatment/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/alexey-danilov-on-lymphoid-malignancies-novel-agents-targeting-btk-inhibitor-resistant-disease/</loc><lastmod>2021-08-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/jonathan-friedberg-on-managing-indolent-nhl-with-oral-therapies/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/andrew-zelenetz-on-mrd-testing-in-the-management-of-non-hodgkin-lymphoma/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/jared-matya-on-supportive-therapies-for-side-effects-related-to-novel-oral-treatments/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/david-kroll-on-recognizing-and-treating-depression-and-anxiety-in-patients-with-lymphoma/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/08-august/peihua-peggy-lu-on-car-t-cell-therapy-research-in-china/</loc><lastmod>2021-08-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/07-july/terry-mamounas-on-extended-aromatase-inhibitor-therapy/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/07-july/melinda-telli-on-breast-cancer-neoadjuvant-talazoparib-for-early-her2-negative-disease/</loc><lastmod>2021-07-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/07-july/paul-richardson-on-multiple-myeloma-and-covid-19-an-update/</loc><lastmod>2021-07-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/07-july/martin-dreyling-on-follicular-lymphoma-safety-and-efficacy-of-tisagenlecleucel/</loc><lastmod>2021-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/cristina-gasparetto-on-multiple-myeloma-selinexor-carfilzomib-and-dexamethasone-in-carfilzomib-nonrefractory-patients/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/ruben-mesa-on-myelofibrosis-transfusion-independence-and-momelotinib/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/claire-harrison-on-myelofibrosis-fedratinib-as-first-line-therapy-after-prior-ruxolitinib/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/martin-hutchings-on-hodgkin-lymphoma-brentuximab-vedotin-with-chemotherapy/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/philippe-moreau-on-newly-diagnosed-multiple-myeloma-daratumumab-maintenance-vs-observation/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/martin-kaiser-on-myeloma-and-plasma-cell-leukemia-transplantation-plus-daratumumabcvrd-therapy/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/gaurav-goyal-on-dlbcl-comparing-r-chop-and-r-epoch-for-overall-survival-benefits/</loc><lastmod>2021-06-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/neeraj-agarwal-on-treatment-patterns-and-disparities-in-patients-with-prostate-cancer/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/bijal-shah-on-cll-car-t-cell-therapy-with-brexucabtagene-autoleucel/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/martin-reck-on-nsclc-nivolumab-ipilimumab-and-chemotherapy-for-advanced-disease/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/priya-rastogi-on-breast-cancer-predicting-the-benefit-of-extended-letrozole-therapy/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/peter-o-donnell-on-urothelial-cancer-first-line-pembrolizumab-in-cisplatin-ineligible-patients/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/brian-link-on-mantle-cell-lymphoma-expert-perspective-on-treatments-now-and-those-to-come/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/paolo-ghia-on-cllsll-and-ibrutinib-plus-venetoclax-a-primary-analysis-of-the-captivate-trial/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/matt-galsky-on-bladder-cancer-neoadjuvant-therapy-with-gemcitabine-cisplatin-and-nivolumab/</loc><lastmod>2021-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/neeraj-agarwal-on-prostate-cancer-androgen-deprivation-therapy-with-orteronel-or-bicalutamide/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/sibylle-loibl-on-triple-negative-breast-cancer-improving-long-term-outcomes-with-durvalumab/</loc><lastmod>2021-06-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/arnon-kater-on-cll-fixed-duration-ibrutinib-and-venetoclax-vs-chlorambucil-plus-obinutuzumab/</loc><lastmod>2021-06-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/peter-black-on-prostate-cancer-health-care-disparities/</loc><lastmod>2021-06-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/keith-pratz-on-aml-venetoclax-azacitidine-and-disease-response/</loc><lastmod>2021-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/efstathios-kastritis-on-amyloidosis-standard-of-care-plus-daratumumab/</loc><lastmod>2021-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/geoffrey-lindeman-on-breast-cancer-venetoclax-and-fulvestrant-in-er-positive-her2-negative-disease/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/nicholas-short-on-all-ponatinib-plus-blinatumomab-may-help-patients-avoid-transplants/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/ann-lacasce-on-hodgkin-lymphoma-pet-adapted-therapy-for-bulky-disease/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/nadia-harbeck-on-luminal-breast-cancer/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/sumanta-pal-on-urothelial-carcinoma-comparing-cisplatin-and-gemcitabine-with-or-without-berzosertib/</loc><lastmod>2021-06-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/cathy-eng-on-colorectal-cancer-folfoxiri-cetuximab-and-bevacizumab-as-first-line-treatment/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/thierry-andre-on-pembrolizumab-vs-chemotherapy-in-msi-high-colorectal-cancer/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/nadia-harbeck-on-early-breast-cancer-benefit-of-a-de-escalated-regimen/</loc><lastmod>2021-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/ingrid-mayer-on-triple-negative-breast-cancer-platinum-based-chemotherapy-vs-capecitabine/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/karim-fizazi-on-prostate-cancer-abiraterone-acetate-prednisone-and-radiotherapy-in-metastatic-disease/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/robert-motzer-on-rcc-quality-of-life-for-patients-treated-with-lenvatinib-based-therapy-vs-sunitinib/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/massimo-cristofanilli-on-breast-cancer-updated-analysis-on-palbociclib-plus-fulvestrant/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/brian-rini-on-rcc-pembrolizumab-plus-axitinib-vs-sunitinib-as-first-line-therapy/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/vamsidhar-velcheti-on-nsclc-sotorasib-in-kras-mutated-disease/</loc><lastmod>2021-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/byoung-chul-cho-on-nsclc-amivantamab-plus-lazertinib-for-treatment-of-relapsed-disease/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/pasi-janne-on-nsclc-patritumab-deruxtecan-to-target-her3/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/taiga-nishihori-on-multiple-myeloma-maintenance-ixazomib-after-transplant/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/debora-bruno-on-nsclc-racial-disparities-in-biomarker-testing-and-clinical-trial-enrollment/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/linda-mileshkin-on-cervical-cancer-adjuvant-chemotherapy-after-chemoradiation/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/michael-morris-on-prostate-cancer-lupsma-in-the-metastatic-setting/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/ian-chau-on-esophageal-squamous-cell-carcinoma-nivolumab-ipilimumab-and-chemotherapy/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/toni-choueiri-on-renal-cell-carcinoma-pembrolizumab-vs-placebo-in-adjuvant-treatment/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/06-june/andrew-tutt-on-olaparib-after-chemotherapy-in-germline-brca12-mutated-breast-cancer/</loc><lastmod>2021-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/05-may/evan-lipson-on-melanoma-relatlimab-and-nivolumab-in-first-line-treatment-of-advanced-disease/</loc><lastmod>2021-05-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/05-may/narjust-duma-and-gladys-i-rodriguez-formation-of-a-yia-for-latinas/</loc><lastmod>2021-05-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/05-may/heather-wakelee-on-nsclc-atezolizumab-vs-best-supportive-care-after-chemotherapy/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/05-may/jingxuan-zhao-on-how-medicaid-expansion-affects-long-term-cancer-survival/</loc><lastmod>2021-05-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/georgina-long-on-melanoma-nivolumab-plus-ipilimumab-vs-nivolumab-alone/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/lipika-goyal-on-treating-intrahepatic-cholangiocarcinoma-with-futibatinib/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/michel-sadelain-on-the-road-to-synthetic-immunity-novel-car-designs/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/matthew-vander-heiden-and-karen-vousden-a-conversation-about-the-role-of-diet-in-cancer/</loc><lastmod>2021-04-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/ralph-weichselbaum-on-oligometastasis-biologic-basis-and-therapeutic-opportunities/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/charlotte-ariyan-on-metastasectomy-after-immunotherapy/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/jeanne-tie-on-circulating-tumor-dna-minimal-residual-disease-and-adjuvant-treatment/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/joann-elmore-on-cancer-diagnosis-when-pathologists-disagree-artificial-intelligence-may-help/</loc><lastmod>2021-04-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/melinda-telli-on-her2-positive-breast-cancer-nccn-guidelines-update/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/linda-vahdat-on-triple-negative-breast-cancer-targeting-the-tumor-microenvironment/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/richard-finn-on-treating-hepatocellular-carcinoma-with-atezolizumab-bevacizumab-and-sorafenib/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/dennis-slamon-on-exploiting-cancer-biology-in-developing-new-treatment-paradigms/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/katelyn-byrne-on-the-clinical-impact-of-t-cell-inflammation-in-the-tumor-microenvironment/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/carey-anders-on-brain-metastases-integrating-immunotherapy-into-clinical-care/</loc><lastmod>2021-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/enrique-grande-on-urothelial-carcinoma-treatment-with-atezolizumab-platinum-and-gemcitabine/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/samra-turajlic-on-understanding-metastatic-disease-in-renal-cancer-and-melanoma/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/brian-rini-on-rcc-data-on-atezolizumab-bevacizumab-and-sunitinib/</loc><lastmod>2021-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/jessica-hassel-on-uveal-melanoma-comparing-tebentafusp-with-standard-therapies/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/matthew-matasar-on-indolent-nhl-new-data-on-copanlisib-plus-rituximab/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/patrick-forde-on-nsclc-nivolumab-and-chemotherapy-as-neoadjuvant-treatment/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/vivek-subbiah-on-ret-fusion-positive-cancers-efficacy-of-selpercatinib/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/rita-nanda-on-triple-negative-breast-cancer-emerging-therapeutic-strategies/</loc><lastmod>2021-04-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/jennifer-brown-on-managing-chronic-lymphocytic-leukemia-small-lymphocytic-lymphoma/</loc><lastmod>2021-04-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/april-salama-on-managing-melanoma-brain-metastases/</loc><lastmod>2021-04-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/david-pfister-on-supportive-care-in-head-and-neck-cancers-multidisciplinary-management/</loc><lastmod>2021-04-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/thomas-varghese-on-the-effects-of-the-covid-19-pandemic-on-cancer-care/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/mary-mulcahy-and-crystal-denlinger-on-nccn-guidelines-updates-gastric-and-esophageal-cancers/</loc><lastmod>2021-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/anthony-costales-on-advanced-ovarian-cancer-predicting-the-benefits-of-minimally-invasive-surgery/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/eric-jonasch-md-on-hereditary-renal-cell-carcinoma-screening-diagnosis-and-management/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/04-april/alexander-perl-on-acute-myeloid-leukemia-treatment-updates/</loc><lastmod>2021-04-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/lori-wirth-on-advanced-thyroid-carcinoma-evolving-systemic-therapy-options/</loc><lastmod>2021-03-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/andreas-obermair-on-treating-endometrial-adenocarcinoma-with-a-levonorgestrel-intrauterine-device/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/amir-jazaeri-on-metastatic-cervical-cancer-the-role-of-immunotherapy/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/eric-pujade-lauraine-on-first-line-maintenance-therapy-in-ovarian-cancer/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/brittany-davidson-on-a-model-to-predict-the-need-for-opioids-after-gynecologic-surgery/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/dana-roque-on-ovarian-fallopian-tube-and-peritoneal-cancers/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/laura-chambers-on-treating-epithelial-ovarian-cancer-with-cisplatin-and-paclitaxel-during-surgery/</loc><lastmod>2021-03-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/shaji-kumar-on-multiple-myeloma-nccn-guidelines-update/</loc><lastmod>2021-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/gabrielle-zecha-and-aaron-begue-on-the-role-of-advanced-practice-providers-in-oncology-care/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/susan-swetter-on-molecular-testing-for-cutaneous-melanoma/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/supriya-chopra-on-cervical-cancer-reducing-late-effects-of-bowel-toxicity/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/lauren-thomaier-on-predicting-chemotherapy-induced-peripheral-neuropathy/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/emily-hinchcliff-on-treating-non-clear-cell-ovarian-cancer-with-durvalumab-and-tremelimumab/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/sandro-pignata-on-brca-mutated-ovarian-cancer-maintenance-olaparib-outcomes/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/alice-barr-on-advanced-ovarian-cancer-minimally-invasive-vs-open-surgery-after-chemotherapy/</loc><lastmod>2021-03-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/charles-landen-on-newly-diagnosed-ovarian-cancer-brca-mutations-pd-l1-expression-and-combination-chemoimmunotherapy/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/hyun-chung-on-pembrolizumab-for-advanced-cervical-cancer-update-from-keynote-158/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/shannon-westin-on-treating-endometrial-cancer-with-enzalutamide-paclitaxel-and-carboplatin/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/ursula-matulonis-on-ovarian-cancer-niraparib-as-maintenance-therapy/</loc><lastmod>2021-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/morcos-nakhla-on-surgical-outcomes-for-frail-patients-with-ovarian-cancer/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/brian-slomovitz-on-the-impact-of-covid-19-on-gynecologic-cancer-research/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/edward-trimble-on-cervical-cancer-a-global-who-initiative/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/william-bradley-on-ovarian-cancer-5-year-follow-up-on-maintenance-olaparib/</loc><lastmod>2021-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/rebecca-kristeleit-on-relapsed-ovarian-cancer-rucaparib-vs-chemotherapy/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/arlene-siefker-radtke-on-urothelial-bladder-cancer-new-settings-for-immune-checkpoint-inhibitors/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/vicky-makker-on-endometrial-cancer-lenvatinib-plus-pembrolizumab/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/robert-winn-on-strategies-for-reducing-racial-disparities-in-oncology/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/william-gradishar-on-triple-negative-breast-cancer-nccn-guidelines-update/</loc><lastmod>2021-03-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/shivan-mehta-on-preventing-and-controlling-hpv-associated-cancers/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/sandy-srinivas-on-managing-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-03-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/fred-hirsch-on-therapeutic-strategies-for-patients-with-lung-cancer-and-covid-19-infection/</loc><lastmod>2021-03-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/hossein-borghaei-on-bispecific-t-cell-engager-immune-therapy-for-small-cell-lung-cancer/</loc><lastmod>2021-03-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/david-fajgenbaum-on-repurposing-cancer-drugs-to-treat-covid-19/</loc><lastmod>2021-03-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/giuseppe-curigliano-in-the-face-of-covid-continuity-in-cancer-care/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/03-march/antoni-ribas-on-highlights-of-aacr-s-covid-19-and-cancer-meeting/</loc><lastmod>2021-03-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/tracy-rose-on-bladder-cancer-gemcitabine-cisplatin-and-pembrolizumab-as-neoadjuvant-therapy/</loc><lastmod>2021-02-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/elizabeth-plimack-on-bladder-cancer-highlights-from-the-2021-genitourinary-cancers-symposium/</loc><lastmod>2021-02-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/elizabeth-plimack-on-renal-cell-cancer-highlights-from-the-2021-genitourinary-cancers-symposium/</loc><lastmod>2021-02-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/elizabeth-plimack-on-rcc-outcomes-with-pembrolizumab-plus-axitinib/</loc><lastmod>2021-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/felix-feng-on-prostate-cancer-choosing-patients-who-may-benefit-from-apalutamide/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/neeraj-agarwal-on-prostate-cancer-apalutamide-vs-placebo-in-treatment-of-metastatic-disease/</loc><lastmod>2021-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/roy-herbst-on-lung-map-circulating-tumor-dna-and-tissue-molecular-analysis/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/sumanta-pal-on-advanced-rcc-tivozanib-to-treat-disease-progression-after-axitinib/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/toni-choueiri-on-the-effects-of-cancer-treatments-on-patients-infected-with-covid-19/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/sumanta-pal-on-papillary-rcc-sunitinib-vs-cabozantinib-crizotinib-or-savolitinib-in-metastatic-disease/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/christopher-sweeney-and-thomas-powles-on-treating-gu-malignancies/</loc><lastmod>2021-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/toni-choueiri-on-clear-cell-rcc-treatment-with-belzutifan-plus-cabozantinib/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/monika-joshi-on-urothelial-cancer-of-the-bladder-durvalumab-and-radiotherapy-for-localized-disease/</loc><lastmod>2021-02-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/daniel-geynisman-on-bladder-cancer-risk-enabled-treatment-after-neoadjuvant-chemotherapy/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/toni-choueiri-on-rcc-treatment-with-lenvatinib-plus-pembrolizumab-or-everolimus-vs-sunitinib/</loc><lastmod>2021-02-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/thomas-powles-on-urothelial-carcinoma-enfortumab-vedotin-ejfv-vs-chemotherapy/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/christopher-sweeney-on-prostate-cancer-analyzing-biomarkers-ipatasertib-plus-abiraterone/</loc><lastmod>2021-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/martin-reck-on-sclc-maintenance-therapy-for-patients-with-extensive-stage-disease/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/martin-reck-on-nsclc-pembrolizumab-platinum-chemotherapy-and-radiotherapy-in-advanced-disease/</loc><lastmod>2021-02-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/linda-kerkmeijer-on-prostate-cancer-adding-a-focal-boost-to-external-beam-radiotherapy/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/jill-feldman-a-determined-cancer-survivor-shares-her-story-of-a-family-devastated-by-lung-cancer/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/luis-montuenga-on-noninvasive-biomarkers-in-lung-cancer-screening/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/bruce-johnson-on-evolving-challenges-in-lung-cancer-drug-development/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/roy-herbst-on-nsclc-osimertinib-and-patient-reported-outcomes/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/justin-gainor-on-nsclc-study-results-on-nivolumab-vs-ipilimumab-bemcentinib-plus-pembrolizumab/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/martin-reck-on-nsclc-pembrolizumab-plus-ipilimumab-in-first-line-treatment/</loc><lastmod>2021-02-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/jill-feldman-on-diversifying-the-criteria-for-inclusion-in-clinical-trials/</loc><lastmod>2021-02-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/fred-hirsch-on-lung-cancer-survival-and-tumor-mutation-burden/</loc><lastmod>2021-02-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/prasad-adusumilli-on-cell-therapy-for-solid-tumors/</loc><lastmod>2021-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/silvia-novello-on-nsclc-pharmacogenomics-driven-vs-standard-adjuvant-chemotherapy/</loc><lastmod>2021-02-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/dean-fennell-on-mesothelioma-nivolumab-vs-placebo-in-relapsed-disease/</loc><lastmod>2021-02-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/02-february/giorgio-scagliotti-on-doubling-the-lung-cancer-cure-rate-by-2025/</loc><lastmod>2021-02-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/rocio-garcia-carbonero-on-treating-neuroendocrine-tumors-of-nonpancreatic-origin-with-octreotide-acetate-and-axitinib/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/thierry-andre-on-mismatch-repair-deficient-solid-cancers-safety-and-efficacy-of-dostarlimab/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/andrew-zhu-on-idh1-mutant-cholangiocarcinoma-ivosidenib-vs-placebo/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/matthew-katz-on-pancreatic-cancer-preoperative-mfolfirinox-for-resectable-disease/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/talia-golan-on-pancreatic-cancer-olaparib-for-brca-mutated-disease/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/richard-finn-on-hcc-atezolizumab-plus-bevacizumab-vs-sorafenib/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/tenna-henriksen-on-colorectal-cancer-circulating-tumor-dna-analysis-to-improve-treatment/</loc><lastmod>2021-01-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/milind-javle-on-cholangiocarcinoma-treatment-with-infigratinib/</loc><lastmod>2021-01-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/kai-keen-shiu-on-colorectal-cancer-pembrolizumab-vs-chemotherapy-for-microsatellite-instability-high-disease/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/romain-cohen-md-phd-on-colon-cancer-prognostic-value-of-tumor-deposits/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/rutika-mehta-on-gastric-cancer-adjuvant-chemotherapy-with-s-1-and-docetaxel/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/afsaneh-barzi-on-disparities-in-access-to-screening-and-treatment-of-gi-cancers/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/wasat-mansoor-on-esophageal-cancer-quality-of-life-with-pembrolizumab-and-chemotherapy/</loc><lastmod>2021-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/zev-wainberg-on-gastricgastroesophageal-junction-adenocarcinoma-bemarituzumab-and-folfox/</loc><lastmod>2021-01-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/ann-partridge-on-erplus-her2-breast-cancer-more-effective-treatments-needed/</loc><lastmod>2021-01-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/elizabeth-mittendorf-on-local-regional-management-following-neoadjuvant-therapy/</loc><lastmod>2021-01-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/sara-zarnegar-lumley-on-aml-prognostic-effects-of-idh-mutations/</loc><lastmod>2021-01-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/lena-winestone-on-health-care-disparities-in-hematologic-cancers-real-world-data/</loc><lastmod>2021-01-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/christian-marinaccio-genetic-driver-may-play-a-role-in-progression-of-myeloproliferative-neoplasms-to-aml/</loc><lastmod>2021-01-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/steven-horwitz-on-ptcl-update-on-efficacy-of-duvelisib-dose-optimization/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/tycel-phillips-on-marginal-zone-lymphoma-efficacy-and-safety-of-parsaclisib/</loc><lastmod>2021-01-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2021/01-january/steven-horwitz-on-t-cell-lymphoma-update-on-allogeneic-hematopoietic-transplant/</loc><lastmod>2021-01-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/sibylle-loibl-on-hrplus-her2-primary-breast-cancer-palbociclib-and-endocrine-therapy/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/joyce-lee-on-triple-negative-breast-cancer-myc-as-a-predictor-of-treatment-response/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/roisin-connolly-on-hrplus-advanced-breast-cancer-endocrine-therapy-and-entinostat/</loc><lastmod>2020-12-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/nitin-jain-on-b-cell-all-expert-perspective-on-key-car-t-cell-treatment-advances/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/lee-schwartzberg-on-her2-hrplus-breast-cancer-tesetaxel-and-capecitabine/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/sara-hurvitz-on-triple-negative-breast-cancer-sacituzumab-govitecan-and-chemotherapy/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/patricia-ganz-on-younger-breast-cancer-survivors-managing-depression/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/joseph-sparano-on-hrplus-her2-breast-cancer-individualizing-prognosis-and-predicting-treatment-success/</loc><lastmod>2020-12-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/nadia-harbeck-on-early-breast-cancer-endocrine-therapy-after-preoperative-treatment/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/farhad-ravandi-on-aml-novel-combination-therapies-for-newly-diagnosed-disease/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/jorge-cortes-on-cml-expert-perspective-on-key-ash-abstracts/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/hassan-awada-on-aml-and-machine-learning-improving-prognostication/</loc><lastmod>2020-12-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/andrew-zelenetz-on-mantle-cell-lymphoma-expert-perspective-on-key-clinical-trials/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/andrew-zelenetz-on-mantle-cell-lymphoma-immunochemotherapy-plus-lenalidomide/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/debra-pratt-on-time-to-completion-of-breast-cancer-treatment-and-survival/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/chirag-shah-on-assessing-dcis-recurrence-risk/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/meletios-dimopoulos-on-multiple-myeloma-daratumumab-pomalidomide-and-dexamethasone/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/ari-melnick-on-activated-b-cell-like-dlbcl-gain-of-function-mutations-and-resistance-to-ibrutinib/</loc><lastmod>2020-12-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/caron-jacobson-on-treating-large-b-cell-lymphoma-with-axicabtagene-ciloleucel/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/matthew-davids-on-cllsll-new-data-on-ibrutinib-venetoclax-and-rituximab-therapies/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/paul-richardson-on-multiple-myeloma-roundup-of-three-key-studies/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/david-teachey-on-pediatric-leukemia-and-lymphoma-new-findings-on-cranial-radiation-and-bortezomib/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/jyoti-nangalia-on-mpn-a-new-paradigm-for-the-development-of-blood-cancer/</loc><lastmod>2020-12-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/sagar-lonial-on-car-t-cell-therapies-for-myeloma-novel-approaches-and-longer-term-follow-up-data/</loc><lastmod>2020-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/curtis-lachowiez-on-venetoclax-in-combination-with-standard-intensive-inductionconsolidation-therapy-in-aml/</loc><lastmod>2020-12-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/radhika-gangaraju-and-smita-bhatia-on-coronary-heart-disease-risk-in-blood-or-marrow-transplant-survivors/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/emmanuel-bachy-on-peripheral-t-cell-lymphoma-romidepsin-plus-chop/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/corey-cutler-on-evaluating-treatments-in-older-patients-with-advanced-mds/</loc><lastmod>2020-12-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/12-december/ann-kathrin-eisfeld-on-aml-in-black-patients-racial-disparities-in-survival-outcomes/</loc><lastmod>2020-12-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/dafna-bar-sagi-on-covid-19-and-how-cancer-researchers-can-help-address-the-challenges/</loc><lastmod>2020-11-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/mary-pasquinelli-on-addressing-lung-cancer-care-equity-in-vulnerable-communities/</loc><lastmod>2020-11-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/james-mulshine-on-advancing-quantitative-low-dose-ct-imaging-in-thoracic-disease/</loc><lastmod>2020-11-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/david-yankelevitz-on-early-stage-lung-cancer-renewed-interest-in-combined-modality-treatment/</loc><lastmod>2020-11-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/fred-hirsch-on-early-stage-lung-cancer-targeted-treatment-and-screening/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/daniel-petereit-on-disparities-in-lung-cancer-care-for-northern-plains-american-indians/</loc><lastmod>2020-11-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/jeff-michalski-on-medulloblastoma-and-radiation-treatment-in-pediatric-patients/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/11-november/justin-oh-on-prostate-cancer-brachytherapy-vs-external-beam-radiation-therapy/</loc><lastmod>2020-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/jing-li-on-brain-metastases-stereotactic-radiosurgery-vs-whole-brain-radiation-therapy/</loc><lastmod>2020-10-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/vinai-gondi-on-glioblastoma-dose-intensification-imrt-standard-radiotherapy-and-temozolomide/</loc><lastmod>2020-10-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/alphonse-taghian-on-irradiation-for-breast-cancer-defining-the-optimal-dose/</loc><lastmod>2020-10-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/daniel-spratt-on-prostate-cancer-relugolix-vs-leuprolide/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/daniel-spratt-on-prostate-cancer-short-term-adjuvant-vs-neoadjuvant-hormone-therapy/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/cynthia-menard-on-prostate-cancer-psma-pet-and-ct-guided-intensification-of-radiotherapy/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/youssef-zeidan-on-her2-positive-breast-cancer-deintensifying-radiation-therapy/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/paul-sargos-on-prostate-cancer-adjuvant-or-early-salvage-radiotherapy-plus-androgen-deprivation/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/juliane-horner-rieber-on-breast-cancer-boosting-intensity-modulated-and-conventional-radiotherapies/</loc><lastmod>2020-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/arjun-sahgal-on-reducing-the-pain-of-spinal-metastases-sbrt-vs-palliative-radiotherapy/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/neha-vapiwala-on-prostate-cancer-imaging-and-the-decision-to-treat-with-radiation/</loc><lastmod>2020-10-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/james-murphy-on-opioid-use-among-patients-with-cancer/</loc><lastmod>2020-10-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/cardinale-smith-on-redesigning-care-coordination-from-the-patient-perspective/</loc><lastmod>2020-10-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/cardinale-smith-on-telehealth-disparities-during-the-covid-19-pandemic/</loc><lastmod>2020-10-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/anne-barry-weers-on-decreasing-hospitalizations-for-patients-receiving-iv-chemotherapy/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/marie-flannery-and-eva-culakova-on-managing-symptoms-in-older-adults-with-advanced-cancer/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/katherine-enright-on-improving-the-quality-of-oral-cancer-drug-delivery/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/joseph-unger-on-patient-interest-in-clinical-trial-enrollment/</loc><lastmod>2020-10-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/veena-shankaran-on-colorectal-cancer-cumulative-financial-hardship-of-treatment/</loc><lastmod>2020-10-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/melissa-accordino-on-breast-cancer-care-delivery-impact-of-the-covid-19-pandemic/</loc><lastmod>2020-10-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/matti-aapro-on-curing-sarcomas-an-expert-review/</loc><lastmod>2020-10-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/andreas-du-bois-on-niraparib-trabectedin-plus-doxorubicin-platinum-and-carboplatin-in-ovarian-cancer/</loc><lastmod>2020-10-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/leonard-saltz-on-the-future-of-interventional-pharmacoeconomics/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/focus-on-optimized-dosing-of-ibrutinib-panel-discussion/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/mark-ratain-on-the-justification-for-a-randomized-trial-of-low-dose-ibrutinib/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/steven-coutre-on-ibrutinib-dosing/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/javid-moslehi-on-cardiovascular-and-thrombotic-considerations-of-kinase-inhibitors/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/the-interventional-pharmacoeconomic-toolbox-panel-discussion/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/deborah-collyar-whats-in-it-for-patients/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/r-donald-harvey-on-alternative-dispensing-strategies/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/david-hyman-on-inclusive-shared-savings/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/victoria-brown-on-payer-intervention-the-example-of-abiraterone/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/opportunities-to-optimize-cancer-policies-panel-discussion/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/boon-cher-goh-on-cancer-drugs-in-singapore/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/kelvin-chan-on-opportunities-to-optimize-cancer-drug-policies-the-canadian-perspective/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/blase-polite-on-transforming-the-drug-cost-curve-in-the-united-states/</loc><lastmod>2020-10-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/10-october/jeffrey-weber-on-adjuvant-nivolumab-vs-ipilimumab-in-melanoma/</loc><lastmod>2020-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/cs-pramesh-on-opportunities-in-india/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/matthew-seymour-a-clinical-trialist-s-perspective/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/amit-sanyal-a-clinician-s-perspective/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/peter-clark-a-payer-perspective/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/robin-feldman-are-dubious-patents-a-large-or-small-issue/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/david-rubin-on-biosimilars-for-inflammatory-bowel-disease/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/sarah-yim-on-clinical-development-of-biosimilars/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/clinical-trial-design-statistical-optionschallenges-panel-discussion/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/mark-sculpher-on-assessing-the-value-of-cancer-drug-optimization/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/gary-rosner-on-bayesian-non-inferiority/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/ian-tannock-on-near-equivalence/</loc><lastmod>2020-09-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/garth-strohbehn-on-interventional-pharmacoeconomics-and-covid-19/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/charles-schiffer-on-cost-effective-use-of-tyrosine-kinase-inhibitors-for-chronic-myelogenous-leukemia/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/s-vincent-rajkumar-on-cost-effective-treatment-of-multiple-myeloma/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/cody-peer-on-simulating-alternative-schedules-for-checkpoint-inhibitors/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/varsha-gandhi-on-ibrutinib/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/helena-margaret-earl-on-trastuzumab/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/russell-szmulewitz-on-alternative-dosing-of-abiraterone-in-prostate-cancer-pharmacoeconomic-proof-of-concept/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/opening-session-panel-discussion/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/daniel-goldstein-interventional-pharmacoeconomics-why-and-how/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/clifford-hudis-are-cancer-drug-prices-in-the-us-the-problem-or-the-symptom/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/welcome-and-introduction-to-vi3c/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/monika-krzyzanowska-on-ambulatory-toxicity-management-in-early-stage-breast-cancer/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/lisa-carey-on-triple-negative-breast-cancer-paclitaxel-nab-paclitaxel-and-atezolizumab-in-impassion-trials/</loc><lastmod>2020-09-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/alexander-eggermont-on-melanoma-pembrolizumab-vs-placebo-after-complete-resection/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/aditya-bardia-on-triple-negative-breast-cancer-sacituzumab-govitecan-vs-treatment-of-physician-s-choice/</loc><lastmod>2020-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/erica-mayer-on-early-breast-cancer-palbociclib-with-endocrine-therapy-vs-endocrine-therapy-alone/</loc><lastmod>2020-09-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/cecile-le-pechoux-on-comparing-postoperative-radiotherapy-with-no-radiotherapy-in-nsclc/</loc><lastmod>2020-09-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/benjamin-besse-on-neoadjuvant-atezolizumab-for-resectable-nsclc/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/paolo-ascierto-on-sequencing-targeted-treatments-and-immunotherapy-in-melanoma/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/thierry-andre-on-hrqol-with-pembrolizumab-vs-chemotherapy-in-colorectal-cancer/</loc><lastmod>2020-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/stephen-johnston-on-abemaciclib-in-high-risk-early-breast-cancer/</loc><lastmod>2020-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/nicholas-james-on-abiraterone-acetate-plus-prednisolone-for-hormone-naive-prostate-cancer/</loc><lastmod>2020-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/sumanta-pal-on-cabozantinib-plus-atezolizumab-as-first-line-therapy-for-rcc/</loc><lastmod>2020-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/david-hong-on-durability-of-clinical-benefit-and-biomarkers-in-patients-treated-with-sotorasib/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/ezra-cohen-on-avelumab-and-chemoradiotherapy-in-locally-advanced-head-and-neck-cancer/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/erika-hamilton-on-abemaciclib-with-or-without-tamoxifen-in-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/andreas-schneeweiss-on-comparing-neoadjuvant-chemotherapy-with-paclitaxel-doxorubicin-and-carboplatin/</loc><lastmod>2020-09-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/masahiro-tsuboi-on-adjuvant-osimertinib-in-egfr-mutated-nsclc/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/toni-choueiri-on-nivolumab-plus-cabozantinib-vs-sunitinib-in-first-line-treatment-of-rcc/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/09-september/mansoor-raza-mirza-on-palbociclib-plus-letrozole-in-er-positive-endometrial-cancer/</loc><lastmod>2020-09-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/marina-c-garassino-md-on-covid-19-and-thoracic-malignancies-teravolt-registry/</loc><lastmod>2020-08-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/leora-horn-md-on-nsclc-ensartinib-vs-crizotinib-in-alk-positive-disease/</loc><lastmod>2020-08-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/misako-nagasaka-md-on-nsclc-sintilimab-pemetrexed-and-platinum-as-first-line-therapy/</loc><lastmod>2020-08-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/paul-baas-on-first-line-nivolumab-plus-ipilimumab-vs-chemotherapy-for-mesothelioma/</loc><lastmod>2020-08-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/gabriella-pravettoni-on-psychological-effects-of-covid-19-on-patients-and-oncologists/</loc><lastmod>2020-08-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/elizabeth-stover-on-nivolumab-plus-bevacizumab-for-relapsed-ovarian-cancer/</loc><lastmod>2020-08-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/robert-winn-on-the-impact-of-covid-19-on-cancer-care-among-racial-and-ethnic-minorities/</loc><lastmod>2020-08-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/kala-visvanathan-on-lowering-ovarian-cancer-mortality-with-lipophilic-statins/</loc><lastmod>2020-08-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/jessica-islam-on-covid-19-preventive-behaviors-among-cancer-survivors/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/nancy-davidson-on-bringing-patients-with-cancer-back-to-the-clinic-during-the-covid-19-pandemic/</loc><lastmod>2020-08-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/antoni-ribas-on-turning-science-into-life-saving-care/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/antoni-ribas-on-meeting-highlights/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/catherine-marshall-on-promoting-recovery-from-covid-19-infection-with-endocrine-therapy/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/karen-knudsen-on-the-challenges-of-using-telehealth-in-cancer-care/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/arthur-caplan-on-ethics-cancer-and-covid-19/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/ralph-weichselbaum-on-radiotherapy-and-immunotherapy-in-oligometastatic-disease/</loc><lastmod>2020-08-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/ramaswamy-govindan-on-differences-among-male-and-female-patients-with-lung-cancer/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/08-august/silvia-formenti-on-testing-radiation-and-immune-checkpoint-blockade-in-different-tumor-settings/</loc><lastmod>2020-08-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/xavier-llor-on-why-are-more-younger-people-are-being-affected-by-colorectal-cancer/</loc><lastmod>2020-07-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/leonard-saltz-on-interventional-pharmacoeconomics/</loc><lastmod>2020-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/antoni-ribas-on-racism-and-racial-inequities-in-cancer-research/</loc><lastmod>2020-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/alfonso-bencomo-alvarez-on-survival-for-hispanic-patients-with-all-aml-and-cml-living-near-the-usmexico-border/</loc><lastmod>2020-07-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/stacey-fedewa-on-cancers-in-younger-populations/</loc><lastmod>2020-07-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/clifford-hudis-and-allen-lichter-on-oncology-drug-pricing-in-the-united-states/</loc><lastmod>2020-07-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/adam-palmer-on-immune-checkpoint-inhibitors-additive-to-or-synergistic-with-other-treatments/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/nasser-altorki-on-lung-cancer-radiotherapy-and-immune-checkpoint-blockade-in-the-neoadjuvant-setting/</loc><lastmod>2020-07-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/miguel-angel-perales-and-syed-abutalib-on-bone-marrow-transplants-during-the-covid-19-pandemic/</loc><lastmod>2020-07-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/andrew-wei-on-venetoclax-plus-cytarabine-in-older-patients-with-aml/</loc><lastmod>2020-07-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/eric-zhou-on-insomnia-in-young-cancer-survivors/</loc><lastmod>2020-07-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/mark-ratain-and-daniel-goldstein-on-value-in-cancer-care/</loc><lastmod>2020-07-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/deborah-schrag-on-clinical-trial-design/</loc><lastmod>2020-07-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/mark-ratain-on-making-a-case-for-low-dose-ibrutinib-for-cll/</loc><lastmod>2020-07-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/r-donald-harvey-on-cutting-cancer-care-costs-with-alternative-pharmacologic-options/</loc><lastmod>2020-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/blase-polite-on-optimizing-cancer-policies-in-the-united-states/</loc><lastmod>2020-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/arnon-kater-on-efficacy-of-venetoclax-in-relapsed-or-refractory-cll/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/jorge-cortes-on-comparing-three-starting-doses-of-ponatinib-for-chronic-phase-cml/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/efstathios-kastritis-on-daratumumab-plus-cyclophosphamide-bortezomib-and-dexamethasone-for-amyloidosis/</loc><lastmod>2020-07-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/elizabeth-phillips-on-inotuzumab-ozogamicin-plus-chemotherapy-in-front-line-setting-for-dlbcl/</loc><lastmod>2020-07-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/john-byrd-on-acalabrutinib-in-treatment-naive-patients-with-cllsll/</loc><lastmod>2020-07-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/sarah-holstein-on-multiple-myeloma-expert-perspective-on-five-key-asco20-abstracts/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/elias-jabbour-on-venetoclax-and-navitoclax-in-relapsed-or-refractory-acute-lymphoblastic-leukemia-and-lymphoblastic-lymphoma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/michael-dickinson-on-a-novel-t-cell-engaging-bispecific-antibody-for-non-hodgkin-lymphoma/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/anthony-moorman-improving-all-outcomes-with-a-tyrosine-kinase-inhibitor-plus-chemotherapy/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/07-july/courtney-dinardo-on-venetoclax-and-azacitidine-for-treatment-naive-patients-with-aml/</loc><lastmod>2020-07-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/abhishek-maiti-on-decitabine-and-venetoclax-vs-intensive-chemotherapy-in-aml/</loc><lastmod>2020-06-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/parameswaran-hari-on-multiple-myeloma-expert-commentary-on-four-key-abstracts/</loc><lastmod>2020-06-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/paul-richardson-on-first-in-human-study-of-the-novel-agent-cc-92480/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/patricia-pautier-on-doxorubicin-and-trabectedin-for-first-line-treatment-of-leiomyosarcoma/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/nikhil-munshi-on-idecabtagene-vicleucel-in-patients-with-relapsed-or-refractory-multiple-myeloma/</loc><lastmod>2020-06-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/parameswaran-hari-on-post-autologous-hematopoietic-cell-transplantation-strategies-in-upfront-treatment-for-multiple-myeloma/</loc><lastmod>2020-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/peter-reichardt-on-adjuvant-imatinib-for-high-risk-gist/</loc><lastmod>2020-06-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/egbert-smit-on-treatment-with-fam-trastuzumab-deruxtecan-for-nsclc/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/lakshmi-nayak-on-primary-cns-lymphoma-first-line-treatment/</loc><lastmod>2020-06-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/suresh-ramalingam-on-nivolumab-plus-ipilimumab-vs-chemotherapy-in-nsclc/</loc><lastmod>2020-06-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/nirav-niranjan-shah-on-autologous-transplant-vs-car-t-cell-therapy-for-dlbcl/</loc><lastmod>2020-06-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/rachel-sanborn-on-maximizing-the-benefits-of-targeted-therapies-for-egfr-mutated-nsclc/</loc><lastmod>2020-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/christopher-nutting-on-dysphagia-optimized-vs-standard-imrt-for-head-and-neck-cancer/</loc><lastmod>2020-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/douglas-johnson-on-melanoma-clinical-trials-update-on-pd-1-and-ctla-4-blockade/</loc><lastmod>2020-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/jeremy-warner-on-the-clinical-impact-of-covid-19-on-patients-with-cancer/</loc><lastmod>2020-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/reshma-jagsi-and-narjust-duma-on-diversity-in-oncology/</loc><lastmod>2020-06-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/farhad-ravandi-kashani-on-amg-330-in-patients-with-relapsed-or-refractory-aml/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/mikkael-sekeres-on-pevonedistat-and-azacitidine-for-mds-cmml-or-aml/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/lourdes-gil-deza-on-caring-for-transgender-patients-with-cancer/</loc><lastmod>2020-06-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/ursula-matulonis-on-olaparib-cediranib-mirvetuximab-soravtansine-bevacizumab-and-pembrolizumab-in-ovarian-cancer/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/leora-horn-on-thoracic-cancer-and-covid-19/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/daniel-petrylak-on-arv-110-in-prostate-cancer/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/andres-poveda-on-maintenance-olaparib-in-ovarian-cancer/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/howard-burris-on-the-asco20-virtual-scientific-program-after-action-report/</loc><lastmod>2020-06-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/tingyan-shi-on-secondary-cytoreductive-surgery-for-recurrent-ovarian-cancer/</loc><lastmod>2020-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/michael-morris-on-the-impact-of-psma-targeted-imaging-on-clinical-management-of-prostate-cancer/</loc><lastmod>2020-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/sara-hurvitz-on-four-major-studies-in-breast-cancer/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/meletios-dimopoulos-on-selinexor-bortezomib-and-dexamethasone-for-previously-treated-multiple-myeloma/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/eric-jonasch-on-a-novel-therapy-for-von-hippel-lindau-disease-associated-rcc/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/cynthia-ma-on-neoadjuvant-endocrine-treatment-for-er-positive-her2-negative-breast-cancer/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/neal-shore-on-relugolix-vs-leuprolide-for-advanced-prostate-cancer/</loc><lastmod>2020-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/alberto-sobrero-on-adjuvant-oxaliplatin-and-fluoropyrimidine-based-therapy-for-stage-iii-colon-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/rana-mckay-on-intense-adt-before-radical-prostatectomy/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/seema-khan-on-systemic-vs-locoregional-therapies-for-metastatic-breast-cancer/</loc><lastmod>2020-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/howard-burris-on-highlights-of-the-asco20-virtual-scientific-program/</loc><lastmod>2020-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/06-june/thierry-andre-on-pembrolizumab-vs-chemotherapy-for-metastatic-colorectal-cancer/</loc><lastmod>2020-06-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/david-wise-on-novel-biomarkers-in-prostate-cancer/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/michael-hofman-on-lupsma-vs-cabazitaxel-in-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/richard-schilsky-on-this-year-s-practice-changing-findings/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/merry-jennifer-markham-perspectives-on-three-abstracts/</loc><lastmod>2020-05-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/jeffrey-meyerhardt-on-celecoxib-and-folfox-for-stage-iii-colon-cancer/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/fatima-cardoso-on-mammaprint-as-guidance-for-adjuvant-chemotherapy/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/a-message-from-asco-president-howard-burris/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/david-fajgenbaum-on-chasing-his-cure-for-castleman-disease/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/scott-kopetz-on-encorafenib-plus-cetuximab-with-or-without-binimetinib-in-colorectal-cancer/</loc><lastmod>2020-05-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/nancy-lin-on-tucatinib-trastuzumab-and-capecitabine-for-metastatic-breast-cancer/</loc><lastmod>2020-05-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/shaji-kumar-on-carfilzomib-lenalidomide-bortezomib-and-dexamethasone-in-multiple-myeloma/</loc><lastmod>2020-05-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/christopher-sweeney-and-thomas-powles-on-avelumab-vs-best-supportive-care-in-urothelial-cancer/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/roy-herbst-on-osimertinib-in-stage-ib-iiia-egfr-mutation-positive-nsclc/</loc><lastmod>2020-05-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/metastatic-urothelial-cancer-a-conversation-before-the-asco20-virtual-scientific-program/</loc><lastmod>2020-05-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/andrew-zhu-on-atezolizumabbevacizumab-in-hcc/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/qi-liu-on-pneumonitis-immunotherapy-and-chemotherapy-in-nsclc/</loc><lastmod>2020-05-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mikkael-sekeres-on-cancer-treatment-in-the-age-of-covid-19/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/jennifer-litton-on-embraca-trial-on-talazoparib-vs-chemotherapy/</loc><lastmod>2020-05-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/edward-garon-on-geometry-mono-1-trial-of-capmatinib/</loc><lastmod>2020-05-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/edward-garon-on-long-term-use-of-pemetrexed-plus-platinum-with-pembrolizumab-in-nsclc/</loc><lastmod>2020-05-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/nickolas-papadopoulos-on-liquid-biopsy-to-screen-for-multiple-cancer-types/</loc><lastmod>2020-05-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/byoung-chul-cho-genetic-mutations-in-nsclc-and-immunotherapy-vs-chemotherapy/</loc><lastmod>2020-05-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mikkael-sekeres-on-cancer-treatment-in-the-age-of-covid-19-1/</loc><lastmod>2020-05-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/kimlin-ashing-on-tobacco-and-vape-shops-in-neighborhoods-with-lower-income-and-minority-populations/</loc><lastmod>2020-05-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/ryan-sullivan-on-com701-plus-nivolumab-in-advanced-solid-tumors/</loc><lastmod>2020-05-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/grant-mcarthur-on-atezolizumab-cobimetinib-and-vemurafenib-for-melanoma/</loc><lastmod>2020-05-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/steven-o-day-on-pembrolizumab-plus-imprime-pgg-in-tnbc/</loc><lastmod>2020-05-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/laura-michaelis-on-treating-cll-and-cml-in-the-community-oncology-setting/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/laura-michaelis-on-pausing-therapy-for-cll/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/laura-michaelis-on-best-practices-for-treating-cll-during-the-pandemic/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/laura-michaelis-on-treating-advanced-cml-during-the-pandemic/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/laura-michaelis-on-selecting-tkis-for-patients-with-cml-during-the-pandemic/</loc><lastmod>2020-05-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mehdi-hamadani-on-transplant-for-mantle-cell-lymphoma/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mehdi-hamadani-on-treating-nhl-in-the-community-oncology-setting-during-the-pandemic/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mehdi-hamadani-on-cibmtr-in-the-pandemic/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mehdi-hamadani-on-immediate-upfront-autologous-transplant-for-t-cell-nhl/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mehdi-hamadani-on-delaying-autologous-transplant-in-patients-with-dlbcl-during-the-pandemic/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/mehdi-hamadani-on-administering-outpatient-lymphoma-therapy-during-the-pandemic/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/william-dale-on-best-practices-for-special-populations-during-the-covid-19-pandemic/</loc><lastmod>2020-05-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/lajos-pusztai-on-i-spy2-trial-on-durvalumab-olaparib-and-paclitaxel/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/saad-usmani-on-community-oncologists-treating-myeloma-during-the-covid-19-pandemic/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/christopher-davella-on-a-specialized-urgent-care-center-for-patients-with-cancer/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/pam-baker-deguzman-on-assessing-distress-during-telemedicine-visits-with-rural-survivors-of-head-and-neck-cancer/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/saad-usmani-on-myeloma-clinical-trials-during-covid-19/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/saad-usmani-on-posttransplant-care-during-covid-19/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/saad-usmani-on-delaying-upfront-autologous-transplant-in-the-era-of-covid-19/</loc><lastmod>2020-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/rafal-dziadziuszko-on-using-telemedicine-during-the-pandemic/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/saad-usmani-on-decision-models-for-front-line-multiple-myeloma-therapy-in-the-era-of-covid-19/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/05-may/rafal-dziadziuszko-on-helping-ease-patients-fears-of-contracting-covid-19/</loc><lastmod>2020-05-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/barbara-devivo-on-tumor-boards-and-influence-of-social-hierarchy-on-cancer-treatment-decision-making/</loc><lastmod>2020-04-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/jacek-jassem-on-fighting-covid-19-and-cancer-in-poland/</loc><lastmod>2020-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/paolo-ascierto-on-cancer-treatment-during-the-covid-19-pandemic-in-southern-italy/</loc><lastmod>2020-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/joseph-alvarnas-on-increased-risk-of-side-effects-for-some-patients-with-cancer-and-covid-19/</loc><lastmod>2020-04-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/hope-rugo-on-talazoparib-for-advanced-solid-tumors/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/sara-hurvitz-on-talazoparib-vs-chemotherapy-for-breast-cancer/</loc><lastmod>2020-04-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/giorgio-scagliotti-on-the-oncoming-waves-of-covid-19/</loc><lastmod>2020-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/giorgio-scagliotti-on-the-ongoing-battle-against-covid-19-update-from-italy/</loc><lastmod>2020-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/eduardo-cazap-on-covid-19-the-view-from-south-america/</loc><lastmod>2020-04-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/derek-raghavan-on-covid-19-and-cancer-care-the-view-from-north-carolina/</loc><lastmod>2020-04-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/apar-kishor-ganti-on-real-world-adherence-and-persistence-of-alk-inhibitors-in-nsclc/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/karen-wonders-on-benefits-of-exercise-during-cancer-treatment/</loc><lastmod>2020-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/william-gradishar-on-innovating-pathways-for-patient-self-management-in-breast-cancer/</loc><lastmod>2020-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/elizabeth-reed-on-helping-providers-in-rural-areas-meet-the-needs-of-younger-patients-with-breast-cancer/</loc><lastmod>2020-04-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/nancy-davidson-on-covid-19-and-cancer-care/</loc><lastmod>2020-04-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/04-april/william-wood-on-the-new-ash-covid-19-registry/</loc><lastmod>2020-04-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/irene-ghobrial-on-how-covid-19-is-changing-the-conduct-of-clinical-trials/</loc><lastmod>2020-03-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/giuseppe-curigliano-on-how-covid-19-is-affecting-cancer-care-in-italy/</loc><lastmod>2020-03-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/karen-knudsen-on-delivering-cancer-care-during-the-covid-19-pandemic-report-from-philadelphia/</loc><lastmod>2020-03-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/sue-sun-yom-on-challenges-in-deintensifying-radiation-therapy-for-hpv-associated-oropharyngeal-cancer/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/jared-weiss-on-radioimmunotherapy-for-squamous-cell-carcinoma-of-the-head-and-neck/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/jonathan-schoenfeld-on-neoadjuvant-nivolumab-with-or-without-ipilimumab-for-oral-cavity-cancer/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/gopal-bajaj-on-reducing-opioid-use-in-patients-with-head-and-neck-cancer/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/david-adelstein-on-guidelines-for-treating-hpv-associated-oropharyngeal-squamous-cell-carcinoma/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/jill-gilbert-on-challenges-in-de-intensifying-systemic-therapies-for-hpv-associated-oropharyngeal-cancer/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/assuntina-sacco-on-pembrolizumab-and-cetuximab-in-hnscc/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/nadeem-riaz-on-established-and-emerging-biomarkers-for-immunotherapy-in-head-and-neck-cancer/</loc><lastmod>2020-03-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/carryn-anderson-on-reducing-severe-oral-mucositis-and-its-effect-on-patient-outcomes/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/03-march/francis-worden-on-the-role-of-induction-chemotherapy-in-laryngeal-preservation/</loc><lastmod>2020-03-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/nicholas-james-on-cost-effectiveness-in-the-stampede-trial/</loc><lastmod>2020-02-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/ziad-bakouny-on-sarcomatoid-and-rhabdoid-rcc/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/toni-choueiri-on-cosmic-313/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/hannah-rush-on-quality-of-life-in-patients-receiving-docetaxel-or-abiraterone/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/nizar-tannir-on-nivolumab-plus-ipilimumab-vs-sunitinib-in-advanced-kidney-cancer/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/thomas-powles-on-adding-radiation-to-immunotherapy-for-rcc/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/karim-fizazi-on-pain-and-quality-of-life-in-patients-receiving-cabazitaxel-vs-abiraterone-or-enzalutamide/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/nicholas-james-on-cetuximab-with-chemoradiotherapy-for-bladder-cancer/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/maha-hussain-on-next-generation-sequencing-of-prostate-tumor-tissue/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/neeraj-agarwal-on-results-from-the-cosmic-021-study-of-cabozantinib-and-atezolizumab/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/toni-choueiri-on-an-hif2a-inhibitor-for-advanced-clear-cell-rcc/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/david-dearnaley-on-conventional-vs-hypofractionated-high-dose-radiotherapy-for-prostate-cancer/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/ziad-bakouny-on-defining-the-role-of-cytoreductive-nephrectomy/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/julie-graff-results-from-keynote-199-on-pembrolizumab-plus-enzalutamide/</loc><lastmod>2020-02-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/syed-hussain-on-neo-blade-trial-of-nintedanib-plus-chemotherapy/</loc><lastmod>2020-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/jonathan-rosenberg-on-enfortumab-vedotin-plus-pembrolizumab-for-urothelial-carcinoma/</loc><lastmod>2020-02-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/jarrett-failing-on-human-leukocyte-antigen-expression-in-nsclc-with-brain-metastases/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/john-lukens-on-antibiotics-survival-and-colitis-in-patients-with-melanoma-receiving-immunotherapy/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/christopher-cole-on-interferon-activated-autologous-monocytes-in-ovarian-cancer/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/kevin-tyan-on-colitis-induced-by-immune-checkpoint-inhibitors/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/jacob-adashek-on-immunoregulatory-molecules-cancer-genes-and-therapeutic-insights/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/martin-mccarter-on-refinement-of-surgical-treatment-2020-advance-of-the-year/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/philippa-corrie-on-patient-outcomes-in-melanoma-after-immune-checkpoint-inhibition/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/luis-ruffolo-on-augmenting-immunotherapy-with-antibody-blockade-of-semaphorin-4d/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/dario-vignali-on-immune-resistance-mechanisms-in-cancer/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/02-february/elizabeth-mittendorf-on-mobilizing-the-immune-system-to-treat-select-solid-tumors/</loc><lastmod>2020-02-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/thomas-yau-on-nivolumab-ipilimumab-and-cabozantinib-for-advanced-hcc/</loc><lastmod>2020-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/brian-wolpin-on-performance-of-a-blood-based-test-for-the-detection-of-multiple-cancers/</loc><lastmod>2020-01-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/danielle-bitterman-on-plasma-ctdna-in-pancreatic-cancer/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/thibaud-koessler-on-neoadjuvant-pembrolizumab-and-radiotherapy-for-localized-rectal-cancer/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/eyal-meiri-on-pembrolizumab-in-colorectal-cancer/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/franck-pages-on-the-idea-study-on-a-risk-assessment-tool/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/van-morris-on-ctdna-as-a-predictive-biomarker-for-adjuvant-chemotherapy-in-colon-cancer/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/peter-galle-on-patient-reported-outcomes-for-atezolizumabbevacizumab-vs-sorafenib-in-hcc/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/zev-wainberg-on-pd-l1-positive-advanced-gastric-cancer/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/heinz-josef-lenz-on-nivolumab-plus-low-dose-ipilimumab-as-first-line-therapy-for-metastatic-crc/</loc><lastmod>2020-01-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/scott-kopetz-on-quality-of-life-results-on-encorafenib-cetuximab-and-binimetinib-in-crc/</loc><lastmod>2020-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/eileen-o-reilly-on-gemcitabine-cisplatin-and-veliparib-for-pancreatic-adenocarcinoma/</loc><lastmod>2020-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2020/01-january/hope-rugo-on-a-retrospective-analysis-of-pd-l1-immunohistochemistry-assays/</loc><lastmod>2020-01-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/william-wierda-on-use-of-pirtobrutinib-for-richter-transformation/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/mikkael-sekeres-on-therapies-for-hematologic-cancers/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/darren-denjay-pan-on-multiple-myeloma-inflammatory-biomarkers-and-outcomes-after-car-t-cell-therapy/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/hope-rugo-on-advanced-breast-cancer-patient-reported-outcomes-from-the-capitello-291-trial/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/eleftherios-mamounas-on-locoregional-irradiation-axillary-lymph-node-involvement-and-conversion-to-negative-nodes/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/daniel-kates-harbeck-and-nadia-harbeck-on-personalizing-breast-cancer-management-with-ai/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/luca-gianni-on-locally-advanced-her2-positive-breast-cancer-new-data-on-neoadjuvant-therapy-and-atezolizumab/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/oleg-gluz-on-response-to-endocrine-therapy-findings-from-the-adaptcycle-trial/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/pieter-sonneveld-on-newly-diagnosed-multiple-myeloma-daratumumab-plus-bortezomib-lenalidomide-and-dexamethasone/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/bijal-shah-on-previously-treated-mantle-cell-lymphoma-brexucabtagene-autoleucel-and-pirtobrutinib/</loc><lastmod>2023-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/danai-dima-on-multiple-myeloma-update-on-safety-and-efficacy-of-teclistamab/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/jonathon-cohen-on-mantle-cell-lymphoma-new-data-on-pirtobrutinib/</loc><lastmod>2023-12-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/barbara-pistilli-update-on-capivasertib-plus-a-cdk46-inhibitor-and-fulvestrant/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/sherene-loi-on-biomarker-results-in-er-positive-her2-negative-primary-breast-cancer/</loc><lastmod>2023-12-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/sherene-loi-on-triple-negative-breast-cancer-phase-ii-study-results-of-nivolumab-carboplatin-and-paclitaxel/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/aditya-bardia-early-stage-high-risk-breast-cancer-new-data-on-pembrolizumab-plus-chemotherapy/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/daniel-stover-on-early-stage-breast-cancer-a-biomarker-analysis-from-the-pallas-trial/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/senthil-damodaran-on-locally-advanced-or-metastatic-breast-cancer-phase-ii-results-on-futibatinib/</loc><lastmod>2023-12-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/nicholas-turner-on-high-risk-early-stage-breast-cancer-profiling-primary-tumors/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/gabriel-hortobagyi-on-final-invasive-disease-free-analysis-from-the-natalee-trial/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/aditya-bardia-on-hr-positive-her2-negative-advanced-breast-cancer-datopotamab-deruxtecan-vs-chemotherapy/</loc><lastmod>2023-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/amy-tiersten-on-metastatic-breast-cancer-a-possible-chemotherapy-free-front-line-regimen/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/sara-hurvitz-on-metastatic-breast-cancer-new-data-on-tucatinib-and-trastuzumab-emtansine/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/stephen-freedland-on-managing-prostate-cancer-in-transgender-women/</loc><lastmod>2023-12-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/mark-tyson-on-high-risk-non-muscle-invasive-bladder-cancer-a-potential-new-treatment/</loc><lastmod>2023-12-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/samson-fine-on-clinical-significance-of-atypical-small-acinar-and-intraductal-proliferations-in-the-prostate/</loc><lastmod>2023-12-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/12-december/william-catalona-on-genetic-testing-in-prostate-cancer/</loc><lastmod>2023-12-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/jarushka-naidoo-on-lung-cancer-practice-changing-advances-reported-at-esmo-2023/</loc><lastmod>2023-11-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/benjamin-besse-on-nsclc-safety-and-efficacy-data-on-novel-bispecific-antibody/</loc><lastmod>2023-11-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/benjamin-besse-on-egfr-mutated-nsclc-update-on-patritumab-deruxtecan-in-previously-treated-disease/</loc><lastmod>2023-11-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/nadia-harbeck-on-high-risk-early-breast-cancer-overall-survival-data-on-abemaciclib-plus-endocrine-therapy/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/peter-schmid-on-triple-negative-breast-cancer-updated-results-on-pembrolizumab-plus-chemotherapy/</loc><lastmod>2023-11-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/mark-awad-on-nsclc-neoadjuvant-nivolumab-plus-ipilimumab-vs-chemotherapy/</loc><lastmod>2023-11-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/11-november/hossein-borghaei-on-nonsquamous-nsclc-findings-on-sitravatinib-plus-nivolumab-vs-docetaxel/</loc><lastmod>2023-11-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/ze-rui-zhao-on-resectable-nsclc-sbrt-with-sequential-immunochemotherapy/</loc><lastmod>2023-10-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/jonathan-spicer-on-early-stage-nsclc-survival-results-with-pembrolizumab/</loc><lastmod>2023-10-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/tina-cascone-on-nsclc-phase-iii-results-on-nivolumab-chemotherapy-and-surgery/</loc><lastmod>2023-10-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/gilberto-de-lima-lopes-jr-md-mba-on-lung-cancer-management-expert-update/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/xiuning-le-md-phd-on-update-on-the-use-of-tepotinib-to-treat-an-nsclc-subset/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/ilias-houda-md-phd-candidate-on-results-of-an-eortc-survey-on-nsclc-resectability/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/seshiru-nakazawa-md-phd-on-nsclc-and-point-mutations-as-de-novo-oncogenic-drivers/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/shirish-m-gadgeel-md-on-pembrolizumab-plus-chemotherapy-for-metastatic-nsclc-5-year-follow-up/</loc><lastmod>2023-10-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/yasir-y-elamin-md-on-brigatinib-in-alk-rearranged-metastatic-non-small-cell-lung-cancer/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/chee-k-lee-phd-mbbs-on-durvalumab-tremelimumab-and-chemotherapy-in-nsclc/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/david-h-harpole-jr-md-on-perioperative-durvalumab-plus-chemotherapy-in-resectable-nsclc/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/ticiana-a-leal-md-on-tumor-treating-fields-and-immune-checkpoint-inhibition-in-metastatic-nsclc/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/tom-e-stinchcombe-md-on-nsclc-strategies-for-managing-secondary-primary-disease/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/10-october/desheng-liang-md-phd-on-genetic-engineering-of-mesenchymal-stem-cells-for-cancer-therapy/</loc><lastmod>2023-10-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/ajay-k-nooka-mbbs-relapsed-or-refractory-multiple-myeloma-efficacy-and-safety-data-for-elranatamab/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/ajay-k-nooka-mbbs-high-risk-myeloma-data-on-carfilzomib-pomalidomide-and-dexamethasone/</loc><lastmod>2023-09-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/aki-morikawa-md-phd-on-brain-metastases-new-findings-on-predictive-drug-testing/</loc><lastmod>2023-09-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/wei-wu-md-phd-on-lung-cancer-deep-learning-as-a-tool-for-identifying-drug-tolerant-persister-cells/</loc><lastmod>2023-09-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/nicholas-j-short-on-acute-lymphoblastic-leukemia-phase-ii-findings-on-mini-hcvd-inotuzumab-and-blinatumomab/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/aaron-c-tan-phd-mbbs-on-circulating-tumor-dna-early-biomarker-of-therapeutic-response-in-phase-i-trials/</loc><lastmod>2023-09-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/nicholas-j-short-on-acute-lymphoblastic-leukemia-new-analysis-of-ponatinib-and-blinatumomab/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/09-september/nikhil-munshi-on-multiple-myeloma-data-from-the-cartitude-1-study-of-ciltacabtagene-autoleucel/</loc><lastmod>2023-09-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/08-august/rami-s-komrokji-on-myelodysplastic-neoplasms-classifying-risks-among-subsets-of-disease/</loc><lastmod>2023-08-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/08-august/nigel-russell-on-acute-myeloid-leukemia-new-findings-on-flag-ida-and-gemtuzumab-ozogamicin/</loc><lastmod>2023-08-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/08-august/paolo-corradini-md-on-pmbcl-and-dlbcl-comparing-outcomes-with-axicabtagene-ciloleucel/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/08-august/arnon-kater-md-phd-on-cll-recent-data-on-venetoclax-ibrutinib-and-undetectable-mrd/</loc><lastmod>2023-08-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/07-july/matthew-j-frank-on-large-b-cell-lymphoma-new-data-on-cd22-car-t-cell-therapy/</loc><lastmod>2023-07-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/07-july/jennifer-brown-on-cll-resistance-to-pirtobrutinib-in-pretreated-disease/</loc><lastmod>2023-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/07-july/aaron-gerds-on-anemia-in-myelofibrosis-new-data-on-treatment-with-luspatercept/</loc><lastmod>2023-07-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/carmen-guerra-on-diversity-equity-and-inclusion-in-clinical-trials/</loc><lastmod>2023-06-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/shailender-bhatia-on-merkel-cell-carcinoma-results-from-checkmate-358-on-nivolumab-with-or-without-ipilimumab/</loc><lastmod>2023-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/reid-merryman-on-high-risk-follicular-lymphoma-new-data-on-epcoritamab-rituximab-and-lenalidomide/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/narjust-florez-and-ferdinandos-skoulidis-on-nsclc-findings-on-sotorasib-vs-docetaxel-in-the-codebreak-200-trial/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/rami-manochakian-on-nsclc-commentary-on-the-adaura-trial-of-osimertinib/</loc><lastmod>2023-06-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/cathy-eng-and-thejus-jayakrishnan-on-colorectal-cancer-metabolomic-differences-in-young-onset-vs-average-onset-disease/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/jennifer-woyach-on-new-findings-on-cll-covid-19-and-treatment-with-obinutuzumab-plus-venetoclax/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/narjust-florez-and-ticiana-leal-on-metastatic-nsclc-tumor-treating-fields-therapy-after-platinum-resistance/</loc><lastmod>2023-06-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/alicia-morgans-and-karim-fizazi-on-prostate-cancer-phase-iii-results-on-talazoparib-plus-enzalutamide-as-first-line-treatment/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/tycelphillips-and-emanuele-zucca-on-primary-mediastinal-b-cell-lymphoma-new-data-on-observation-vs-radiotherapy/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/james-chih-hsin-yang-on-metastatic-nonsquamous-nsclc-evaluating-pemetrexed-and-platinum-with-or-without-pembrolizumab/</loc><lastmod>2023-06-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/allison-betof-warner-and-zeynep-eroglu-on-metastatic-melanoma-new-data-on-dabrafenib-trametinib-and-navitoclax/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/smitha-krishnamurthi-and-deb-schrag-on-rectal-cancer-new-findings-on-chemoradiation-chemotherapy-and-excision/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/cathy-eng-and-lars-henrik-jensen-on-locally-advanced-colon-cancer-efficacy-of-neoadjuvant-chemotherapy-and-standard-treatment/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/arlene-siefker-radtke-on-metastatic-urothelial-carcinoma-new-data-on-erdafitinib-and-cetrelimab-from-the-norse-study/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/alicia-morgans-and-praful-ravi-on-localized-prostate-cancer-prognostic-impact-of-psa-nadir/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/penelope-bradbury-on-pleural-mesothelioma-new-results-from-the-ind227-trial-of-cisplatin-and-pemetrexed-with-or-without-pembrolizumab/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/arlene-siefker-radtke-on-metastatic-urothelial-carcinoma-new-data-on-erdafitinib-vs-chemotherapy-from-the-thor-study/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/sarah-tasian-on-hematologic-malignancies-in-children-expert-commentary/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/jason-luke-on-melanoma-adjuvant-therapy-final-analysis-of-keynote-716/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/jonathan-riess-on-egfr-mutated-non-small-cell-lung-cancer-whats-next/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/jennifer-crombie-on-dlbcl-real-world-outcomes-with-novel-therapies-in-relapsed-or-refractory-disease/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/narjust-florez-and-heather-wakelee-on-early-stage-nsclc-phase-iii-findings-from-keynote-671-on-pembrolizumab-and-platinum-based-chemotherapy/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/lisa-carey-and-javier-cortes-on-her2-positive-early-breast-cancer-chemotherapy-de-escalation-under-study-in-phergain-trial/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/lisa-deangelis-and-ingo-mellinghoff-on-glioma-phase-iii-results-on-vorasidenib/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/lisa-carey-and-dennis-slamon-on-early-breast-cancer-findings-from-the-natalee-trial-on-ribociclib-plus-endocrine-therapy/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/niravnshah-on-mantle-cell-lymphoma-follow-up-data-on-pirtobrutinib-in-pretreated-disease/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/nirav-n-shah-on-dlbcl-new-data-on-split-dose-r-chop-for-older-patients/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/funda-meric-bernstam-md-on-her2-expressing-solid-tumors-efficacy-and-safety-of-trastuzumab-deruxtecan/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/catherine-c-coombs-md-on-b-cell-malignancies-and-long-term-safety-of-pirtobrutinib/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/allison-betof-warner-and-adnan-khattak-on-high-risk-resected-melanoma-survival-results-with-mrna-4157-and-pembrolizumab-in-keynote-942/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/rana-r-mckay-and-brian-i-rini-on-clear-cell-rcc-new-data-from-keynote-426-on-pembrolizumab-plus-axitinib-vs-sunitinib/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/rana-r-mckay-and-toni-k-choueiri-on-rcc-new-findings-on-efficacy-and-safety-of-atezolizumab-plus-cabozantinib/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/bobbie-j-rimel-and-mansoor-r-mirza-on-endometrial-cancer-patient-reported-outcomes-with-dostarlimab-carboplatin-and-paclitaxel/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/bobbie-j-rimel-and-isabelle-l-ray-coquard-on-cervical-squamous-carcinoma-neoadjuvant-nivolumab-plus-ipilimumab/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/bobbie-j-rimel-and-kathleen-n-moore-on-ovarian-cancer-new-findings-on-mirvetuximab-soravtansine-vs-chemotherapy/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/christian-pfister-on-bladder-cancer-new-overall-survival-data-on-perioperative-chemotherapy/</loc><lastmod>2023-06-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/georgina-long-on-resected-melanoma-biomarkers-for-and-efficacy-of-adjuvant-nivolumab-vs-placebo/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/omid-hamid-on-advanced-melanoma-durable-response-with-fianlimab-plus-cemiplimab/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/tycel-phillips-and-swetha-kambhampati-on-mantle-cell-lymphoma-real-world-outcomes-with-brexucabtagene-autoleucel/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/nagla-abdel-karim-on-small-cell-lung-cancer-swog-s1929-results-on-atezolizumab-plus-talazoparib/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/jennifer-ligibel-on-early-breast-cancer-and-weight-loss-results-from-the-bwel-trial/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/paula-aristizabal-on-surviving-childhood-leukemia-near-the-border-of-the-united-states-and-mexico/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/narjust-florez-and-filippo-gustavo-dallolio-on-nsclc-new-findings-on-tumor-fraction-durvalumab-and-survival/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/amer-methqal-zeidan-on-myelodysplastic-syndromes-new-data-from-the-imerge-study-of-imetelstat/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/bradley-monk-on-cervical-cancer-findings-on-pembrolizumab-plus-chemotherapy/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/shilpa-gupta-on-urothelial-carcinoma-long-term-outcome-of-enfortumab-vedotin-plus-pembrolizumab/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/enrique-grande-on-metastatic-urothelial-carcinoma-updated-data-from-imvigor130/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/manali-kamdar-on-primary-refractory-and-early-relapsing-dlbcl-therapeutic-options/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/narjust-florez-and-roy-s-herbst-on-nsclc-overall-survival-analysis-from-the-adaura-trial-of-osimertinib/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/guillermo-garcia-manero-on-myelodysplastic-syndromes-luspatercept-and-epoetin-alfa-in-lower-risk-disease/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/tycel-j-phillips-and-alex-f-herrera-on-classical-hodgkin-lymphoma-new-data-on-nivolumab-avd-and-brentuximab-vedotin/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/tycel-j-phillips-and-alex-f-herrera-on-dlbcl-new-data-on-ctdna-status-and-clinical-outcomes/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/alberto-bossi-on-prostate-cancer-peace-1-trial-findings-on-radiotherapy-plus-systemic-treatment/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/thierry-conroy-on-rectal-cancer-long-term-results-on-mfolfirinox-vs-preoperative-chemoradiation-therapy/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/thomas-e-hutson-on-rcc-overall-survival-analysis-of-lenvatinib-pembrolizumab-and-sunitinib/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/claire-roddie-on-b-all-safety-and-efficacy-data-of-obecabtagene-autoleucel/</loc><lastmod>2023-06-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/eunice-s-wang-and-gregory-roloff-on-b-all-outcomes-with-brexucabtagene-autoleucel-in-adult-patients/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/muhit-ozcan-on-dlbcl-now-recruiting-previously-untreated-patients-for-a-study-of-zilovertamab-vedotin-plus-chemotherapy/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/muhit-ozcan-on-dlbcl-early-results-on-zilovertamab-vedotin/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/sebastian-stintzing-on-colorectal-cancer-influence-of-liquid-biopsy-in-first-line-combination-treatment/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/laquisa-c-hill-on-relapsed-or-refractory-t-all-new-data-on-cd5-car-t-cells/</loc><lastmod>2023-06-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/marie-plante-on-cervical-cancer-new-data-on-hysterectomy-and-pelvic-node-dissection/</loc><lastmod>2023-06-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/06-june/clifford-hudis-on-asco-2023-perspectives-the-power-of-connecting-and-collaborating/</loc><lastmod>2023-06-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/marcus-o-butler-on-uveal-melanoma-tebentafusp-and-evidence-of-tumor-response/</loc><lastmod>2023-05-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/natalie-moryl-md-on-managing-pain-in-patients-with-cancer/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/mansoor-r-mirza-on-endometrial-cancer-new-findings-on-dostarlimab-gxly-plus-chemotherapy/</loc><lastmod>2023-05-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/ursula-a-matulonis-on-ovarian-cancer-new-data-on-niraparib-from-the-engot-ov16-nova-trial/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/anita-mamtani-on-axillary-dissection-for-what-types-of-breast-cancer-can-it-be-avoided/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/kari-rosenkranz-on-breast-cancer-impact-of-breast-conservation-on-local-recurrence/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/judy-boughey-on-changes-in-axillary-surgical-management-an-ispy2-analysis/</loc><lastmod>2023-05-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/lindsay-l-peterson-on-exercise-and-cancer-outcomes/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/05-may/carmen-e-guerra-on-strategies-for-equitable-access-to-cancer-clinical-trials/</loc><lastmod>2023-05-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/dario-avignali-on-lag3-the-third-checkpoint-inhibitor/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/jeffrey-s-weber-on-melanoma-new-data-on-a-cancer-vaccine-combined-with-pembrolizumab/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/christina-m-dieli-conwright-on-resistance-exercise-as-medicine-improving-health-and-cancer-outcomes/</loc><lastmod>2023-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/r-katie-kelley-on-biliary-tract-cancer-data-from-keynote-966-on-pembrolizumab-gemcitabine-and-cisplatin/</loc><lastmod>2023-04-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/harry-klein-on-matchminer-an-open-source-ai-precision-medicine-trial-matching-platform/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/karriem-s-watson-on-early-engagement-in-clinical-trials-for-underrepresented-communities/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/sherry-x-yang-on-breast-cancer-new-recurrence-score-data-from-the-tailorx-trial/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/timothy-a-yap-on-new-findings-on-treating-solid-tumors-with-parp-and-atr-inhibitors/</loc><lastmod>2023-04-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/pierce-k-h-chow-on-hepatocellular-carcinoma-new-data-from-the-imbrave050-trial-of-atezolizumab-bevacizumab-and-active-surveillance/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/diana-azzam-on-pediatric-cancers-efficacy-of-a-precision-medicine-approach/</loc><lastmod>2023-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/john-v-heymach-on-nsclc-new-data-on-durvalumab-plus-chemotherapy-from-the-aegean-trial/</loc><lastmod>2023-04-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/mitesh-borad-on-hepatobiliary-cancers-management-updates/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/shannon-n-westin-on-ovarian-cancer-results-from-the-now-trial-of-neoadjuvant-olaparib-in-brca-palb-or-rad51c-mutant-disease/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/shannon-n-westin-on-endometrial-and-ovarian-cancers-new-data-on-selumetinib-and-olaparib-from-the-solar-trial/</loc><lastmod>2023-04-14</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/arlene-siefker-radtke-on-urothelial-cancer-emerging-therapies/</loc><lastmod>2023-04-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/elena-ratner-md-mba-on-sexual-identity-and-function-in-cancer-survivors/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/ella-kazerooni-on-lung-cancer-screening-benefits-and-challenges/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/jordan-mcpherson-pharmd-ms-bcop-on-managing-immunotherapy-related-toxicities/</loc><lastmod>2023-04-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/deborah-stephens-on-cllsll-nccn-clinical-practice-guidelines-in-oncology-update/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/mandi-pratt-chapman-on-oncology-care-in-the-lgbtqiplus-community-best-practices-for-addressing-health-needs/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/midhun-malla-on-metastatic-colorectal-cancer-treatment-updates/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/louis-nabors-on-nccn-clinical-practice-guidelines-in-oncology-updates-for-cns-cancers-in-adults/</loc><lastmod>2023-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/04-april/michael-gibson-on-metastatic-esophageal-squamous-cell-carcinoma-new-first-line-systemic-treatment-options/</loc><lastmod>2023-04-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/alex-f-herrera-on-previously-untreated-dlbcl-circulation-tumor-dna-and-risk-profiling/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/jamie-takayesu-on-genitourinary-cancer-disparity-in-physicians-assessment-of-sexual-dysfunction-in-women-vs-men/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/alex-k-bryant-on-psa-screening-and-metastatic-prostate-cancer-in-the-va-health-care-system/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/thomas-powles-and-christopher-sweeney-on-rcc-expert-review-of-two-key-studies-on-atezolizumab-nivolumab-and-ipilimumab/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/myriam-chalabi-on-colon-cancer-new-findings-on-neoadjuvant-immune-checkpoint-inhibition/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/rahul-aggarwal-on-prostate-cancer-phase-iii-data-on-apalutamide-and-androgen-deprivation-in-relapsed-disease/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/matthew-goetz-on-breast-cancer-interim-survival-results-with-abemaciclib-plus-a-nonsteroidal-aromatase-inhibitor/</loc><lastmod>2023-03-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/vadim-koshkin-and-tanya-jindal-on-urothelial-carcinoma-biomarkers-of-response-to-enfortumab-vedotinejfv/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/03-march/updates-from-city-of-hope-on-renal-cell-prostate-and-urothelial-cancers/</loc><lastmod>2023-03-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/laurence-albiges-on-renal-cell-carcinoma-new-phase-ii-data-on-cabozantinib-and-checkpoint-inhibitor-therapy/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/daniel-petrylak-on-urothelial-cancer-phase-ii-trial-analysis-of-sacituzumab-govitecan-hziy-in-metastatic-disease/</loc><lastmod>2023-02-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/michael-atkins-on-renal-cell-carcinoma-phase-ii-findings-on-nivolumab-and-ipilimumab/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/matt-galsky-on-bladder-or-upper-urinary-tract-cancer-extended-follow-up-results-from-checkmate-274/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/scott-tagawa-on-prostate-cancer-phase-ii-results-on-ketoconazole-hydrocortisone-and-an-anti-psma-antibody/</loc><lastmod>2023-02-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/matt-galsky-on-urothelial-carcinoma-new-study-results-on-atezolizumab-platinum-and-gemcitabine/</loc><lastmod>2023-02-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/andrea-necchi-on-bladder-cancer-phase-ii-results-with-pembrolizumab-monotherapy/</loc><lastmod>2023-02-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/alan-bryce-on-prostate-cancer-phase-iii-results-on-rucaparib-docetaxel-and-androgen-pathway-inhibitor-therapy/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/daniel-petrylak-on-prostate-cancer-latest-data-on-pembrolizumab-plus-docetaxel/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/paul-nguyen-on-prostate-cancer-new-findings-on-treatment-with-salvage-radiotherapy-gnrh-agonist-abiraterone-prednisone-and-apalutamide/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/aristotelis-bamias-on-urothelial-carcinoma-final-overall-survival-analysis-of-atezolizumab-monotherapy-vs-chemotherapy/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/neeraj-agarwal-on-prostate-cancer-new-data-on-talazoparib-and-enzalutamide/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/thomas-powles-on-renal-cell-carcinoma-phase-iii-results-on-cabozantinib-nivolumab-and-ipilimumab/</loc><lastmod>2023-02-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/02-february/toni-choueiri-on-renal-cell-carcinoma-potential-predictive-biomarkers-of-treatment-efficacy/</loc><lastmod>2023-02-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/zev-wainberg-on-pancreatic-ductal-adenocarcinoma-recent-findings-on-nalirifox-vs-nab-paclitaxel-plus-gemcitabine/</loc><lastmod>2023-01-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/laura-dawson-on-hepatocellular-carcinoma-phase-iii-data-on-sorafenib-vs-stereotactic-body-radiation-therapy/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/kohei-shitara-on-gastric-or-gastroesophageal-junction-adenocarcinoma-recent-data-on-zolbetuximab-plus-mfolfox6/</loc><lastmod>2023-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/souya-nunobe-on-gastric-cancer-5-year-follow-up-on-s-1-chemotherapy-for-stage-ii-disease/</loc><lastmod>2023-01-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/laura-dawson-on-hepatocellular-carcinoma-and-liver-metastases-recent-treatment-data-on-palliative-radiotherapy/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/filippo-pietrantonio-on-gastric-or-gastroesophageal-junction-adenocarcinoma-recent-data-on-treatment-with-tremelimumab-and-durvalumab/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/julien-taieb-on-treating-colorectal-cancer-with-trifluridine-and-tipiracil-plus-bevacizumab/</loc><lastmod>2023-01-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/emily-daugherty-on-flash-radiotherapy-efficacy-and-safety-results-from-the-first-in-human-study/</loc><lastmod>2023-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/manik-amin-on-novel-immune-therapies-in-gi-cancers/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/nick-pavlakis-on-gastroesophageal-cancer-new-findings-on-the-use-of-regorafenib/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/richard-finn-on-hcc-tislelizumab-vs-sorafenib-and-their-impact-on-quality-of-life/</loc><lastmod>2023-01-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/josep-tabernero-on-colorectal-cancer-recent-data-on-treatment-with-trifluridine-and-tipiracil-plus-bevacizumab/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/newsreels/2023/01-january/rachna-shroff-on-biliary-tract-cancers-recent-findings-on-use-of-gemcitabine-cisplatin-and-nab-paclitaxel/</loc><lastmod>2023-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/andrew-zelenetz-and-stephen-schuster-on-car-t-cells-for-hematologic-malignancies/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/heinz-josef-lenz-and-axel-grothey-on-colorectal-cancer-molecular-testing-and-interpreting-an-ngs-report/</loc><lastmod>2021-04-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/heinz-josef-lenz-and-axel-grothey-on-liquid-biopsies-for-colorectal-and-other-gi-cancers/</loc><lastmod>2021-04-08</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/paul-richardson-and-peter-voorhees-on-multiple-myeloma-surveying-the-evolving-landscape-of-up-front-drugs/</loc><lastmod>2021-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/john-marshall-and-liza-marshall-when-cancer-strikes-an-oncologist-s-family/</loc><lastmod>2021-05-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/julie-gralow-on-goals-as-asco-cmo/</loc><lastmod>2021-01-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/karen-knudsen-the-american-cancer-society-s-first-female-ceo-speaks-out/</loc><lastmod>2021-05-05</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/s-vincent-rajkumar-on-multiple-myeloma-defining-cure/</loc><lastmod>2021-08-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/adjuvant-therapy-in-melanoma-how-does-gep-testing-factor-in/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/combination-treatment-and-patient-selection-for-relugolix-vs-leuprolide/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/ctdna-monitoring-in-standard-of-care-crc-surveillance/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/emerging-options-for-kras-g12c-mutated-nsclc-first-line-and-combination-therapies/</loc><lastmod>2026-07-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/first-line-treatment-of-dlbcl-polarix-long-term-update-and-implications/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/high-risk-dlbcl-frontmind-and-polarix-regimens/</loc><lastmod>2026-07-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/immunotherapy-in-advanced-unresectable-cscc/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/jak-inhibitors-and-beyond/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/kras-g12c-mutated-nsclc-current-treatment-landscape/</loc><lastmod>2026-07-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/managing-anemia-and-thrombocytopenia-in-patients-with-myelofibrosis/</loc><lastmod>2025-10-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/mrd-testing-recent-data-and-ongoing-efforts/</loc><lastmod>2025-08-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/neoadjuvant-and-adjuvant-treatment-in-cscc/</loc><lastmod>2025-12-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/oral-serds-in-breast-cancer-state-of-the-science/</loc><lastmod>2025-07-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/oral-vs-injectable-agents-for-androgen-deprivation-therapy-in-prostate-cancer/</loc><lastmod>2025-09-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/ovarian-cancer-2024-year-at-a-glance-part-2/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/ovarian-cancer-2024-year-at-a-glance-part-1/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/til-therapy-for-advanced-melanoma-innovative-clinical-advances-in-treatment/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/use-of-gep-for-slnb-and-follow-up-planning-in-melanoma/</loc><lastmod>2026-03-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/julie-gralow-on-managing-iv-fluid-shortages-and-conserving-supply/</loc><lastmod>2024-10-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/all-thematic-newsreels/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/co-occurring-mutations-in-advanced-breast-cancer-management-strategies/</loc><lastmod>2026-10-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/testing-for-esr1-mutations-in-er-positive-breast-cancer/</loc><lastmod>2026-10-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/how-does-car-t-cell-therapy-factor-in-with-tafasitamab-in-dlbcl/</loc><lastmod>2026-10-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/thematic-newsreels/dlbcl-are-frontmind-data-top-of-mind/</loc><lastmod>2026-10-09</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-myeloproliferative-neoplasms/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-myeloproliferative-neoplasms/managing-the-risk-of-thrombosis-in-polycythemia-vera/</loc><lastmod>2022-10-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-myeloproliferative-neoplasms/myelofibrosis-related-anemia/</loc><lastmod>2023-03-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-myeloproliferative-neoplasms/goals-of-care-in-primary-myelofibrosis/</loc><lastmod>2023-07-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-myeloma-and-lymphoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-myeloma-and-lymphoma/a-case-of-smoldering-myeloma/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-myeloma-and-lymphoma/a-case-of-relapsedrefractory-hodgkin-lymphoma/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-myeloma-and-lymphoma/a-case-of-relapsedrefractory-multiple-myeloma/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-myeloma-and-lymphoma/a-case-of-diffuse-large-b-cell-lymphoma/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-myeloma-and-lymphoma/a-discussion-about-car-t-cell-therapy-for-multiple-myeloma-and-lymphoma/</loc><lastmod>2020-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-lung-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-lung-cancer/combination-immunotherapy-approaches/</loc><lastmod>2020-07-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-lung-cancer/adjuvant-egfr-inhibition/</loc><lastmod>2020-07-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-lung-cancer/treatment-of-kras-g12c-mutation/</loc><lastmod>2020-07-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-lung-cancer/treatment-of-small-cell-lung-cancer/</loc><lastmod>2020-07-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/appropriate-management-of-challenging-cases-in-lung-cancer/treatment-of-mesothelioma/</loc><lastmod>2020-07-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-gynecologic-oncology/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-gynecologic-oncology/newly-diagnosed-advanced-brca-mutated-ovarian-cancer/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-gynecologic-oncology/platinum-sensitive-recurrent-ovarian-cancer/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-gynecologic-oncology/mismatch-repair-proficient-recurrent-endometrial-cancer/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-gynecologic-oncology/mismatch-repair-deficientmicrosatellite-instability-high-recurrent-endometrial-cancer/</loc><lastmod>2021-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer/low-volume-recurrent-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer/high-volume-de-novo-metastatic-castration-sensitive-prostate-cancer/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer/metastatic-castration-resistant-prostate-cancer-and-dna-repair-gene-alterations/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer/psma-pet-positive-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2021-07-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-breast-cancer/newly-diagnosed-her2-negative-metastatic-breast-cancer/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-breast-cancer/hr-positiveher2-negative-early-breast-cancer/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-breast-cancer/er-positiveher2-positive-breast-cancer-and-residual-disease/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-breast-cancer/hr-positiveher2-positive-metastatic-breast-cancer/</loc><lastmod>2021-07-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lung-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lung-cancer/ret-fusion-positive-non-small-cell-lung-cancer/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lung-cancer/ntrk-fusion-positive-non-small-cell-lung-cancer/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lung-cancer/alk-positive-non-small-cell-lung-cancer/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lung-cancer/pd-l1-positive-non-small-cell-lung-cancer/</loc><lastmod>2021-11-03</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-acute-myeloid-leukemia/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-acute-myeloid-leukemia/induction-therapy-for-a-young-patient-with-aml/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-acute-myeloid-leukemia/induction-therapy-for-an-older-patient-with-idh1-mutant-aml/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-acute-myeloid-leukemia/therapy-options-for-primary-refractory-flt3-itd-positive-aml/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-acute-myeloid-leukemia/therapy-options-for-mrd-positive-aml/</loc><lastmod>2022-03-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer-1/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer-1/elderly-patient-with-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer-1/doublet-or-triplet-androgen-deprivation-therapy-options-for-metastatic-prostate-cancer/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer-1/first-line-therapy-for-brca2-mutated-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-prostate-cancer-1/psma-targeted-radioligand-therapy-for-metastatic-castration-resistant-prostate-cancer/</loc><lastmod>2022-04-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lymphoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lymphoma/advanced-stage-hodgkin-lymphoma/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lymphoma/bulky-early-stage-hodgkin-lymphoma/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lymphoma/hodgkin-lymphoma-in-patients-age-60-years-and-older/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-lymphoma/relapsedrefractory-hodgkin-lymphoma/</loc><lastmod>2022-06-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-her2-positive-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-her2-positive-breast-cancer/metastatic-her2-positive-breast-cancer/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-her2-positive-breast-cancer/metastatic-her2-positive-breast-cancer-with-brain-metastases/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-her2-positive-breast-cancer/her2-positive-early-stage-breast-cancer/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-her2-positive-breast-cancer/her2-positive-residual-disease/</loc><lastmod>2022-07-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-colorectal-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-colorectal-cancer/role-of-circulating-tumor-dna-in-early-stage-colon-cancer/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-colorectal-cancer/role-of-neoadjuvant-therapy-in-t4-colon-cancer/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-colorectal-cancer/her2-positive-colorectal-cancer/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-colorectal-cancer/msi-high-rectal-adenocarcinoma/</loc><lastmod>2022-09-22</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-renal-cell-carcinoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-renal-cell-carcinoma/first-line-therapy-in-metastatic-clear-cell-rcc/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-renal-cell-carcinoma/second-line-therapy-and-beyond-in-clear-cell-rcc/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-renal-cell-carcinoma/adjuvant-therapy-in-rcc/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-renal-cell-carcinoma/treatment-of-non-clear-cell-rcc/</loc><lastmod>2022-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-hepatobiliary-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-hepatobiliary-cancer/front-line-therapy-in-metastatic-hepatocellular-carcinoma/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-hepatobiliary-cancer/second-line-therapy-and-beyond-in-hepatocellular-carcinoma/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-hepatobiliary-cancer/adjuvant-therapy-in-biliary-tract-cancer/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-hepatobiliary-cancer/treatment-of-ajcc-stage-iv-intrahepatic-cholangiocarcinoma/</loc><lastmod>2022-10-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-melanoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-melanoma/adjuvant-therapy-in-malignant-melanoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-melanoma/neoadjuvant-therapy-in-malignant-melanoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-melanoma/first-line-therapy-for-metastatic-malignant-melanoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-melanoma/emerging-second-and-third-line-therapies-for-unresectable-and-metastatic-melanoma/</loc><lastmod>2023-02-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-chronic-graft-vs-host-disease/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-chronic-graft-vs-host-disease/early-detection-of-chronic-graft-vs-host-disease/</loc><lastmod>2023-04-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-chronic-graft-vs-host-disease/early-intervention-for-steroid-refractory-chronic-graft-vs-host-disease/</loc><lastmod>2023-04-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-evolving-treatment-landscape-for-colorectal-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-evolving-treatment-landscape-for-colorectal-cancer/her2-positive-metastatic-colorectal-cancer/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-evolving-treatment-landscape-for-colorectal-cancer/braf-v600e-mutated-colon-cancer/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-evolving-treatment-landscape-for-colorectal-cancer/first-line-therapy-of-metastatic-colon-cancer/</loc><lastmod>2023-03-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-hormonal-therapies-for-prostate-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-hormonal-therapies-for-prostate-cancer/biochemical-recurrence-of-prostate-cancer/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-hormonal-therapies-for-prostate-cancer/de-novo-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-hormonal-therapies-for-prostate-cancer/locally-advanced-high-risk-prostate-cancer/</loc><lastmod>2023-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/advances-in-follicular-lymphoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/advances-in-follicular-lymphoma/newly-diagnosed-follicular-lymphoma/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/advances-in-follicular-lymphoma/recurrent-follicular-lymphoma/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/advances-in-follicular-lymphoma/third-line-treatment-of-follicular-lymphoma/</loc><lastmod>2023-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-mantle-cell-lymphoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-mantle-cell-lymphoma/newly-diagnosed-mantle-cell-lymphoma-in-a-younger-patient/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-mantle-cell-lymphoma/newly-diagnosed-mantle-cell-lymphoma-in-an-older-patient/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-mantle-cell-lymphoma/second-line-treatment-of-relapsed-refractory-mantle-cell-lymphoma/</loc><lastmod>2023-06-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-considerations-in-renal-cell-carcinoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-considerations-in-renal-cell-carcinoma/adjuvant-therapy-for-renal-cell-carcinoma/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-considerations-in-renal-cell-carcinoma/front-line-treatment-of-advanced-renal-cell-carcinoma/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-considerations-in-renal-cell-carcinoma/io-refractory-advanced-renal-cell-carcinoma/</loc><lastmod>2023-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-diffuse-large-b-cell-lymphoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-diffuse-large-b-cell-lymphoma/newly-diagnosed-high-risk-diffuse-large-b-cell-lymphoma/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-diffuse-large-b-cell-lymphoma/second-line-treatment-of-relapsed-refractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-advances-in-diffuse-large-b-cell-lymphoma/third-line-treatment-for-relapsedrefractory-diffuse-large-b-cell-lymphoma/</loc><lastmod>2023-07-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-advanced-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-advanced-breast-cancer/hormone-receptor-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-advanced-breast-cancer/role-of-her2-expression-in-hormone-receptor-positive-metastatic-breast-cancer/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-advanced-breast-cancer/treatment-of-relapsedrefractory-triple-negative-metastatic-breast-cancer/</loc><lastmod>2023-08-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-metastatic-colorectal-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-metastatic-colorectal-cancer/front-line-therapy-for-metastatic-colorectal-cancer/</loc><lastmod>2023-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-metastatic-colorectal-cancer/second-line-therapy-for-metastatic-colorectal-cancer/</loc><lastmod>2023-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-metastatic-colorectal-cancer/second-and-third-line-therapy-for-metastatic-colorectal-cancer/</loc><lastmod>2023-09-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/ovarian-function-suppression-in-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/ovarian-function-suppression-in-breast-cancer/management-of-stage-i-breast-cancer/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/ovarian-function-suppression-in-breast-cancer/management-of-recurrent-estrogen-receptor-positive-breast-cancer/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/ovarian-function-suppression-in-breast-cancer/management-of-de-novo-metastatic-estrogen-receptor-positive-breast-cancer/</loc><lastmod>2023-09-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-early-stage-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-early-stage-breast-cancer/early-hormone-receptor-positiveher2-negative-breast-cancer/</loc><lastmod>2023-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-early-stage-breast-cancer/early-node-negative-her2-positive-breast-cancer/</loc><lastmod>2023-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/updates-in-early-stage-breast-cancer/early-triple-negative-breast-cancer/</loc><lastmod>2023-10-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-skin-cancer-management/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-skin-cancer-management/nonsurgical-approaches-to-basal-cell-carcinoma/</loc><lastmod>2023-12-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-skin-cancer-management/multidisciplinary-management-in-cutaneous-squamous-cell-carcinoma/</loc><lastmod>2023-12-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-skin-cancer-management/early-detection-and-management-in-merkel-cell-carcinoma/</loc><lastmod>2023-12-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-skin-cancer-management/melanoma-in-younger-individuals/</loc><lastmod>2023-12-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-nonmetastatic-non-small-cell-lung-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-nonmetastatic-non-small-cell-lung-cancer/io-strategies-for-resectable-nsclc/</loc><lastmod>2024-01-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-nonmetastatic-non-small-cell-lung-cancer/pd-l1-negative-early-stage-nsclc/</loc><lastmod>2024-01-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-directions-in-nonmetastatic-non-small-cell-lung-cancer/egfr-mutated-early-stage-nsclc/</loc><lastmod>2024-01-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-the-treatment-of-metastatic-ros1-fusion-positive-nsclc/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-the-treatment-of-metastatic-ros1-fusion-positive-nsclc/newly-diagnosed-metastatic-ros1-positive-nsclc/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-the-treatment-of-metastatic-ros1-fusion-positive-nsclc/management-of-cns-metastases-in-ros1-positive-nsclc/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-considerations-in-the-treatment-of-metastatic-ros1-fusion-positive-nsclc/first-line-therapy-and-disease-progression-in-metastatic-ros1-positive-nsclc/</loc><lastmod>2024-01-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeting-endocrine-resistance-in-hr-positiveher2-negative-metastatic-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeting-endocrine-resistance-in-hr-positiveher2-negative-metastatic-breast-cancer/second-line-treatment-of-hr-positiveher2-negative-esr1-mutated-metastatic-breast-cancer/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeting-endocrine-resistance-in-hr-positiveher2-negative-metastatic-breast-cancer/hr-positiveher2-negative-metastatic-breast-cancer-with-pik3ca-mutation/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeting-endocrine-resistance-in-hr-positiveher2-negative-metastatic-breast-cancer/endocrine-resistant-hr-positiveher2-negative-metastatic-breast-cancer/</loc><lastmod>2024-03-07</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-outcomes-for-patients-with-locally-advanced-and-metastatic-nsclc/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-outcomes-for-patients-with-locally-advanced-and-metastatic-nsclc/locally-advanced-nsclc/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-outcomes-for-patients-with-locally-advanced-and-metastatic-nsclc/management-of-stage-iiia-nsclc-in-a-former-smoker/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-outcomes-for-patients-with-locally-advanced-and-metastatic-nsclc/neoadjuvant-therapy-for-egfr-positive-lung-adenocarcinoma/</loc><lastmod>2024-03-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-options-for-relapsed-refractory-follicular-lymphoma-what-comes-next/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-options-for-relapsed-refractory-follicular-lymphoma-what-comes-next/second-line-treatment-of-relapsed-follicular-lymphoma-in-a-patient-with-comorbidities/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-options-for-relapsed-refractory-follicular-lymphoma-what-comes-next/relapsed-follicular-lymphoma-with-pod-24/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-options-for-relapsed-refractory-follicular-lymphoma-what-comes-next/third-line-treatment-of-relapsed-refractory-follicular-lymphoma-in-a-patient-with-high-risk-features/</loc><lastmod>2024-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/addressing-unmet-needs-in-myelofibrosis/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/addressing-unmet-needs-in-myelofibrosis/managing-treatment-emergent-anemia-in-a-patient-with-myelofibrosis/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/addressing-unmet-needs-in-myelofibrosis/recognizing-the-role-of-hematopoietic-stem-cell-transplant-in-myelofibrosis/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/addressing-unmet-needs-in-myelofibrosis/managing-accelerated-and-blast-phase-myeloproliferative-neoplasms/</loc><lastmod>2024-04-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/later-line-considerations-in-relapsed-refractory-renal-cell-carcinoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/later-line-considerations-in-relapsed-refractory-renal-cell-carcinoma/metastatic-favorable-risk-rcc-after-progression-on-vegf-io-therapy/</loc><lastmod>2024-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/later-line-considerations-in-relapsed-refractory-renal-cell-carcinoma/refractory-rcc-after-disease-progression-on-adjuvant-io-therapy/</loc><lastmod>2024-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/later-line-considerations-in-relapsed-refractory-renal-cell-carcinoma/metastatic-rcc-after-disease-progression-on-vegf-io-therapy/</loc><lastmod>2024-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-strategies-for-transplant-ineligible-relapsedrefractory-dlbcl/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-strategies-for-transplant-ineligible-relapsedrefractory-dlbcl/early-relapsedrefractory-dlbcl/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-strategies-for-transplant-ineligible-relapsedrefractory-dlbcl/late-relapsing-dlbcl/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-strategies-for-transplant-ineligible-relapsedrefractory-dlbcl/third-line-therapy-for-transplant-ineligible-dlbcl/</loc><lastmod>2024-05-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/overcoming-platinum-resistance-in-ovarian-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/overcoming-platinum-resistance-in-ovarian-cancer/stage-iv-high-grade-endometrioid-ovarian-cancer-after-progression-on-platinum-based-therapy/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/overcoming-platinum-resistance-in-ovarian-cancer/stage-iiic-high-grade-serous-ovarian-cancer-with-disease-progression-after-platinum-based-therapy/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/overcoming-platinum-resistance-in-ovarian-cancer/stage-iiic-high-grade-serous-ovarian-cancer-after-progression-on-platinum-based-therapy-and-parp-inhibitor/</loc><lastmod>2024-06-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/alk-positive-metastatic-nsclc-where-are-we-now/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/alk-positive-metastatic-nsclc-where-are-we-now/first-line-alk-positive-nsclc-with-cns-metastases-at-baseline/</loc><lastmod>2024-07-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/alk-positive-metastatic-nsclc-where-are-we-now/first-line-alk-positive-nsclc-with-cns-metastases-at-baseline-and-cns-toxicity/</loc><lastmod>2024-07-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/alk-positive-metastatic-nsclc-where-are-we-now/second-line-alk-positive-nsclc-with-cns-progression-on-first-line-crizotinib/</loc><lastmod>2024-07-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-strategies-for-hepatobiliary-cancers/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-strategies-for-hepatobiliary-cancers/advanced-unresectable-hepatocellular-carcinoma/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-strategies-for-hepatobiliary-cancers/advanced-cholangiocarcinoma/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-strategies-for-hepatobiliary-cancers/localized-hepatocellular-carcinoma/</loc><lastmod>2024-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/next-generation-therapies-for-metastatic-hr-positive-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/next-generation-therapies-for-metastatic-hr-positive-breast-cancer/esr1-mutated-metastatic-breast-cancer/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/next-generation-therapies-for-metastatic-hr-positive-breast-cancer/pik3ca-mutated-metastatic-breast-cancer/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/next-generation-therapies-for-metastatic-hr-positive-breast-cancer/endocrine-resistant-metastatic-breast-cancer/</loc><lastmod>2024-07-31</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-immunotherapy-for-metastatic-nsclc-special-populations-and-unmet-needs/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-immunotherapy-for-metastatic-nsclc-special-populations-and-unmet-needs/patient-with-metastatic-squamous-nsclc/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-immunotherapy-for-metastatic-nsclc-special-populations-and-unmet-needs/patient-with-pd-l1-negative-metastatic-nsclc/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-immunotherapy-for-metastatic-nsclc-special-populations-and-unmet-needs/patient-with-metastatic-nsclc-and-brain-metastasis/</loc><lastmod>2024-11-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-perspectives-on-kras-mutant-nsclc/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-perspectives-on-kras-mutant-nsclc/first-line-treatment-of-kras-mutant-nsclc/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-perspectives-on-kras-mutant-nsclc/second-line-treatment-of-kras-mutant-metastatic-nsclc/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/clinical-perspectives-on-kras-mutant-nsclc/unresectable-locally-advanced-kras-mutant-nsclc/</loc><lastmod>2024-12-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-myelofibrosis/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-myelofibrosis/patient-with-newly-diagnosed-myelofibrosis-and-moderate-anemia/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-myelofibrosis/patient-with-ruxolitinib-treated-myelofibrosis-who-develops-anemia/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-myelofibrosis/patient-with-transfusion-dependent-myelofibrosis-and-severe-thrombocytopenia/</loc><lastmod>2024-12-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-sequencing-considerations-for-chronic-graft-vs-host-disease/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-sequencing-considerations-for-chronic-graft-vs-host-disease/acute-gvhd-in-a-patient-with-lymphoma/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-sequencing-considerations-for-chronic-graft-vs-host-disease/moderate-chronic-gvhd/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-sequencing-considerations-for-chronic-graft-vs-host-disease/steroid-refractory-chronic-gvhd-with-sclerosis/</loc><lastmod>2025-01-30</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-landscape-of-indolent-lymphoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-landscape-of-indolent-lymphoma/second-line-treatment-of-early-relapsing-follicular-lymphoma/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-landscape-of-indolent-lymphoma/third-line-treatment-of-relapsed-refractory-follicular-lymphoma/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-landscape-of-indolent-lymphoma/relapsed-refractory-nodal-marginal-zone-lymphoma/</loc><lastmod>2025-02-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-paradigms-in-the-treatment-of-hr-positive-her2-positive-metastatic-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-paradigms-in-the-treatment-of-hr-positive-her2-positive-metastatic-breast-cancer/de-novo-metastatic-hr-positive-her2-positive-breast-cancer/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-paradigms-in-the-treatment-of-hr-positive-her2-positive-metastatic-breast-cancer/next-steps-after-first-line-induction-therapy-for-hr-positive-her2-positive-metastatic-breast-cancer/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-paradigms-in-the-treatment-of-hr-positive-her2-positive-metastatic-breast-cancer/second-line-therapy-for-hr-positive-her2-positive-metastatic-breast-cancer/</loc><lastmod>2025-03-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/egfr-mutant-nsclc-treatment-considerations-for-early-stage-disease/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/egfr-mutant-nsclc-treatment-considerations-for-early-stage-disease/resected-egfr-mutant-nsclc/</loc><lastmod>2025-03-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/egfr-mutant-nsclc-treatment-considerations-for-early-stage-disease/resectable-egfr-mutant-nsclc/</loc><lastmod>2025-03-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/egfr-mutant-nsclc-treatment-considerations-for-early-stage-disease/unresectable-egfr-mutant-nsclc/</loc><lastmod>2025-03-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/pi3k-inhibition-strategies-for-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/pi3k-inhibition-strategies-for-hr-positive-her2-negative-metastatic-breast-cancer/first-line-therapy-in-hr-positive-metastatic-breast-cancer/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/pi3k-inhibition-strategies-for-hr-positive-her2-negative-metastatic-breast-cancer/progression-after-first-line-cdk46-inhibitors-in-er-positive-metastatic-breast-cancer/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/pi3k-inhibition-strategies-for-hr-positive-her2-negative-metastatic-breast-cancer/progression-of-hr-positive-her2-negative-metastatic-breast-cancer-after-adjuvant-cdk46-inhibition/</loc><lastmod>2025-03-26</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-approaches-in-muscle-invasive-bladder-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-approaches-in-muscle-invasive-bladder-cancer/neoadjuvant-therapy-in-a-patient-in-muscle-invasive-bladder-cancer-with-squamous-differentiation/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-approaches-in-muscle-invasive-bladder-cancer/adjuvant-therapy-in-a-patient-with-cisplatin-ineligible-pathologic-node-positive-muscle-invasive-bladder-cancer/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/immunotherapy-approaches-in-muscle-invasive-bladder-cancer/perioperative-strategies-for-a-patient-with-muscle-invasive-bladder-cancer-and-borderline-renal-function/</loc><lastmod>2025-04-18</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-approaches-to-treatment-sequencing-in-advanced-renal-cell-carcinoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-approaches-to-treatment-sequencing-in-advanced-renal-cell-carcinoma/patient-with-poor-risk-metastatic-rcc/</loc><lastmod>2025-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-approaches-to-treatment-sequencing-in-advanced-renal-cell-carcinoma/patient-with-recurrent-clear-cell-rcc/</loc><lastmod>2025-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/new-approaches-to-treatment-sequencing-in-advanced-renal-cell-carcinoma/patient-with-recurrent-chromophobe-rcc/</loc><lastmod>2025-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-approaches-to-relapsed-refractory-cll-what-comes-next/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-approaches-to-relapsed-refractory-cll-what-comes-next/front-line-treatment-of-cll/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-approaches-to-relapsed-refractory-cll-what-comes-next/second-line-treatment-of-cll/</loc><lastmod>2025-04-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/treatment-approaches-to-relapsed-refractory-cll-what-comes-next/third-line-treatment-of-cll/</loc><lastmod>2025-04-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-complexities-of-relapsed-refractory-aml/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-complexities-of-relapsed-refractory-aml/relapsed-kmt2a-rearranged-aml/</loc><lastmod>2025-05-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-complexities-of-relapsed-refractory-aml/relapsed-refractory-flt3-mutant-aml/</loc><lastmod>2025-05-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-complexities-of-relapsed-refractory-aml/refractory-aml-with-complex-karyotype-and-tp53-mutation/</loc><lastmod>2025-05-15</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/expert-perspectives-on-the-treatment-of-high-risk-myelofibrosis/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/expert-perspectives-on-the-treatment-of-high-risk-myelofibrosis/initial-management-of-a-patient-with-high-risk-myelofibrosis/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/expert-perspectives-on-the-treatment-of-high-risk-myelofibrosis/recognizing-cytopenias-and-comorbidities-in-the-first-line-management-of-myelofibrosis/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/expert-perspectives-on-the-treatment-of-high-risk-myelofibrosis/managing-myelofibrosis-beyond-the-first-line-setting/</loc><lastmod>2025-06-19</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-her2-positive-breast-cancer-brain-metastases/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-her2-positive-breast-cancer-brain-metastases/isolated-brain-relapse-in-her2-positive-breast-cancer/</loc><lastmod>2025-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-her2-positive-breast-cancer-brain-metastases/intracranial-progression-on-adc-therapy/</loc><lastmod>2025-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/novel-therapies-for-her2-positive-breast-cancer-brain-metastases/leptomeningeal-disease-in-her2-positive-breast-cancer/</loc><lastmod>2025-06-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-role-of-oral-serds-in-metastatic-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-role-of-oral-serds-in-metastatic-breast-cancer/first-line-treatment-of-metastatic-breast-cancer-with-esr1-y537s-mutation/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-role-of-oral-serds-in-metastatic-breast-cancer/second-line-treatment-of-metastatic-breast-cancer-and-esr1-d538g-mutation-after-progression-on-cdk46i/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/the-role-of-oral-serds-in-metastatic-breast-cancer/second-line-treatment-of-metastatic-breast-cancer-with-esr1-and-pik3ca-mutations/</loc><lastmod>2025-06-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-paradigms-for-neuroendocrine-tumors/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-paradigms-for-neuroendocrine-tumors/pancreatic-neuroendocrine-tumor/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-paradigms-for-neuroendocrine-tumors/well-differentiated-grade-3-small-bowel-neuroendocrine-tumor/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/evolving-treatment-paradigms-for-neuroendocrine-tumors/radioligands-in-advanced-neuroendocrine-tumor/</loc><lastmod>2025-06-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-approaches-to-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-approaches-to-metastatic-hormone-sensitive-prostate-cancer/de-novo-high-volume-metastatic-hormone-sensitive-prostate-cancer-with-pten-deficiency/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-approaches-to-metastatic-hormone-sensitive-prostate-cancer/high-risk-de-novo-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-approaches-to-metastatic-hormone-sensitive-prostate-cancer/recurrent-low-volume-metastatic-hormone-sensitive-prostate-cancer/</loc><lastmod>2025-07-02</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/emerging-treatment-options-for-small-cell-lung-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/emerging-treatment-options-for-small-cell-lung-cancer/relapsed-small-cell-lung-cancer/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/emerging-treatment-options-for-small-cell-lung-cancer/newly-diagnosed-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/emerging-treatment-options-for-small-cell-lung-cancer/newly-diagnosed-limited-stage-small-cell-lung-cancer/</loc><lastmod>2025-07-11</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-treatment-options-in-platinum-resistant-ovarian-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-treatment-options-in-platinum-resistant-ovarian-cancer/fr-alpha-positive-high-grade-platinum-resistant-ovarian-cancer/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-treatment-options-in-platinum-resistant-ovarian-cancer/her2-positive-platinum-resistant-ovarian-cancer/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/targeted-treatment-options-in-platinum-resistant-ovarian-cancer/low-grade-platinum-resistant-ovarian-cancer/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-systemic-treatment-of-advanced-hepatobiliary-cancers/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-systemic-treatment-of-advanced-hepatobiliary-cancers/metastatic-cholangiocarcinoma/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-systemic-treatment-of-advanced-hepatobiliary-cancers/advanced-hepatocellular-carcinoma/</loc><lastmod>2025-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-systemic-treatment-of-advanced-hepatobiliary-cancers/fibrolamellar-hepatocellular-carcinoma/</loc><lastmod>2025-07-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-patients-with-glioma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-patients-with-glioma/low-grade-oligodendroglioma/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-patients-with-glioma/low-grade-glioma/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-therapy-for-patients-with-glioma/high-grade-astrocytoma/</loc><lastmod>2025-07-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-t-cell-therapy-landscape-in-multiple-myeloma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-t-cell-therapy-landscape-in-multiple-myeloma/role-of-asct-in-the-era-of-quadruplet-induction-and-t-cell-redirected-therapies/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-t-cell-therapy-landscape-in-multiple-myeloma/role-of-t-cell-redirected-therapies-in-elderly-patients-with-relapsed-refractory-multiple-myeloma/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-t-cell-therapy-landscape-in-multiple-myeloma/optimal-sequencing-of-t-cell-redirected-therapies/</loc><lastmod>2025-08-12</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-management-of-myelofibrosis-balancing-watchful-waiting-and-early-action-1/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-management-of-myelofibrosis-balancing-watchful-waiting-and-early-action-1/patient-with-newly-diagnosed-post-pv-myelofibrosis/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-management-of-myelofibrosis-balancing-watchful-waiting-and-early-action-1/patient-with-myelofibrosis-and-anemia/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-management-of-myelofibrosis-balancing-watchful-waiting-and-early-action-1/patient-with-myelofibrosis-on-active-treatment/</loc><lastmod>2025-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/managing-cardiovascular-risk-in-metastatic-breast-cancer-clinical-insights-on-cdk46-inhibitors/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/managing-cardiovascular-risk-in-metastatic-breast-cancer-clinical-insights-on-cdk46-inhibitors/management-of-cardiovascular-risk-factors/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/managing-cardiovascular-risk-in-metastatic-breast-cancer-clinical-insights-on-cdk46-inhibitors/cdk46-inhibitor-choice-in-medically-fragile-patients-with-heart-failure/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/managing-cardiovascular-risk-in-metastatic-breast-cancer-clinical-insights-on-cdk46-inhibitors/cardiac-risk-stratification/</loc><lastmod>2025-08-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/balancing-benefit-and-burden-managing-toxicities-in-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/balancing-benefit-and-burden-managing-toxicities-in-hr-positive-her2-negative-metastatic-breast-cancer/pik3ca-altered-hr-positive-her2-negative-metastatic-breast-cancer/</loc><lastmod>2026-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/balancing-benefit-and-burden-managing-toxicities-in-hr-positive-her2-negative-metastatic-breast-cancer/de-novo-metastatic-pik3ca-altered-hr-positive-her2-negative-breast-cancer-and-non-insulin-dependent-diabetes/</loc><lastmod>2026-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/balancing-benefit-and-burden-managing-toxicities-in-hr-positive-her2-negative-metastatic-breast-cancer/metastatic-hr-positive-her2-negative-breast-cancer-with-pten-loss-and-emergent-esr1-mutation/</loc><lastmod>2026-01-23</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-treatment-pathways-in-relapsedrefractory-dlbcl/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-treatment-pathways-in-relapsedrefractory-dlbcl/management-of-early-relapsed-dlbcl/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-treatment-pathways-in-relapsedrefractory-dlbcl/second-line-management-of-relapsed-dlbcl/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/personalizing-treatment-pathways-in-relapsedrefractory-dlbcl/management-of-multiply-relapsed-dlbcl/</loc><lastmod>2026-02-04</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-the-care-continuum-for-egfr-mutant-nsclc/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-the-care-continuum-for-egfr-mutant-nsclc/first-line-therapy-for-egfr-mutant-metastatic-nsclc/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-the-care-continuum-for-egfr-mutant-nsclc/acquired-resistance-after-first-line-osimertinib-based-therapy-in-egfr-l858r-mutant-nsclc/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-the-care-continuum-for-egfr-mutant-nsclc/perioperative-management-of-resectable-egfr-mutant-nsclc/</loc><lastmod>2026-03-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-patient-selection-and-outcomes-in-post-io-advanced-rcc/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-patient-selection-and-outcomes-in-post-io-advanced-rcc/rcc-with-disease-progression-after-adjuvant-pembrolizumab/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-patient-selection-and-outcomes-in-post-io-advanced-rcc/advanced-rcc-with-mild-disease-progression-after-ioio/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/optimizing-patient-selection-and-outcomes-in-post-io-advanced-rcc/metastatic-rcc-with-symptomatic-progression-after-ioio/</loc><lastmod>2026-04-10</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/from-diagnosis-to-durability-elevating-outcomes-in-gastroesophageal-adenocarcinoma/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/from-diagnosis-to-durability-elevating-outcomes-in-gastroesophageal-adenocarcinoma/locally-advanced-gej-adenocarcinoma/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/from-diagnosis-to-durability-elevating-outcomes-in-gastroesophageal-adenocarcinoma/oligometastatic-gastric-adenocarcinoma/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/from-diagnosis-to-durability-elevating-outcomes-in-gastroesophageal-adenocarcinoma/distal-esophageal-her2-positive-adenocarcinoma/</loc><lastmod>2026-04-20</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-immunotherapy-landscape-in-advanced-recurrent-endometrial-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-immunotherapy-landscape-in-advanced-recurrent-endometrial-cancer/advanced-and-recurrent-mmrd-endometrioid-adenocarcinoma-of-the-uterus/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-immunotherapy-landscape-in-advanced-recurrent-endometrial-cancer/newly-diagnosed-advanced-mmrp-endometrioid-adenocarcinoma/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/navigating-the-immunotherapy-landscape-in-advanced-recurrent-endometrial-cancer/newly-diagnosed-advanced-uterine-papillary-serous-carcinoma/</loc><lastmod>2026-04-27</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/relapsedrefractory-follicular-lymphoma-choosing-the-right-regimen-for-the-right-patient/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/relapsedrefractory-follicular-lymphoma-choosing-the-right-regimen-for-the-right-patient/early-relapsed-follicular-lymphoma/</loc><lastmod>2026-05-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/relapsedrefractory-follicular-lymphoma-choosing-the-right-regimen-for-the-right-patient/follicular-lymphoma-with-relapse-after-rituximab-monotherapy/</loc><lastmod>2026-05-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/relapsedrefractory-follicular-lymphoma-choosing-the-right-regimen-for-the-right-patient/relapsedrefractory-follicular-lymphoma-in-the-third-line-and-beyond/</loc><lastmod>2026-05-21</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/collaboration-in-managing-targeted-therapy-for-hr-positive-her2-negative-breast-cancer/</loc><lastmod>2026-07-24</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/collaboration-in-managing-targeted-therapy-for-hr-positive-her2-negative-breast-cancer/treatment-considerations-at-disease-progression-on-cdki/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/collaboration-in-managing-targeted-therapy-for-hr-positive-her2-negative-breast-cancer/promoting-adherence-through-early-management-strategies/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/collaboration-in-managing-targeted-therapy-for-hr-positive-her2-negative-breast-cancer/managing-toxicity-to-maintain-long-term-benefit/</loc><lastmod>2026-05-28</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/all-series/</loc><lastmod>2026-08-25</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-targeted-therapies-in-mhspc-a-changing-treatment-landscape/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-targeted-therapies-in-mhspc-a-changing-treatment-landscape/psma-pet-positive-metastatic-prostate-cancer/</loc><lastmod>2026-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-targeted-therapies-in-mhspc-a-changing-treatment-landscape/pten-deficient-metastatic-prostate-cancer/</loc><lastmod>2026-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-targeted-therapies-in-mhspc-a-changing-treatment-landscape/brca-mutated-metastatic-prostate-cancer/</loc><lastmod>2026-07-29</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-hcc-in-focus-survival-safety-and-real-world-evidence/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-hcc-in-focus-survival-safety-and-real-world-evidence/liver-limited-hepatocellular-carcinoma/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-hcc-in-focus-survival-safety-and-real-world-evidence/metastatic-hepatocellular-carcinoma/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/first-line-hcc-in-focus-survival-safety-and-real-world-evidence/metastatic-hepatocellular-carcinoma-after-failure-of-first-line-immunotherapy/</loc><lastmod>2026-07-16</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-immunotherapy-across-the-sclc-spectrum/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-immunotherapy-across-the-sclc-spectrum/limited-stage-small-cell-lung-cancer/</loc><lastmod>2026-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-immunotherapy-across-the-sclc-spectrum/de-novo-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2026-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/integrating-immunotherapy-across-the-sclc-spectrum/second-line-treatment-of-extensive-stage-small-cell-lung-cancer/</loc><lastmod>2026-07-13</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/high-risk-hr-positive-her2-negative-early-stage-breast-cancer/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/high-risk-hr-positive-her2-negative-early-stage-breast-cancer/understanding-risk-of-recurrence-in-er-positive-early-breast-cancer/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/high-risk-hr-positive-her2-negative-early-stage-breast-cancer/high-risk-er-positive-early-breast-cancer-with-gbrcam/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/high-risk-hr-positive-her2-negative-early-stage-breast-cancer/toxicity-management-in-er-positive-breast-cancer/</loc><lastmod>2026-07-06</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/cll-treatment-sequencing-where-do-next-generation-btk-inhibitors-fit/</loc><lastmod>2026-08-17</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/cll-treatment-sequencing-where-do-next-generation-btk-inhibitors-fit/patient-with-btk-c481s-resistance-mutation-following-acalabrutinibobinutuzumab/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/cll-treatment-sequencing-where-do-next-generation-btk-inhibitors-fit/patient-with-double-refractory-high-risk-cll/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/multimedia/video-roundtables/cll-treatment-sequencing-where-do-next-generation-btk-inhibitors-fit/patient-with-richter-transformation-refractory-to-pola-r-chp/</loc><lastmod>2026-07-01</lastmod></url>
<url><loc>https://ascopost.com/editorial-board/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/advertising/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/disclosures/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/disclosures/the-asco-post-evening-news-terms-and-conditions/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/disclosures/the-asco-post-etoc-terms-and-conditions/</loc><lastmod>2026-11-17</lastmod></url>
<url><loc>https://ascopost.com/contact/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/disclaimer/</loc><lastmod>2026-08-27</lastmod></url>
<url><loc>https://ascopost.com/about-the-asco-post/</loc><lastmod>2026-08-31</lastmod></url>
<url><loc>https://ascopost.com/subscribe/</loc><lastmod>2026-11-17</lastmod></url>
<!-- 16120 urls, built 2026-11-18 19:32Z in 381 ms; skipped: no template 180, hidden 0, utility 2583, opted out 1, no url 0 -->
</urlset>

